# Date and time run: 2023-08-07 20:41:41.057748
# Target Ontology: http://www.ebi.ac.uk/efo/efo.owl
# Text2term version: 3.0.0
# Minimum Score: 0.60
# Mapper: tfidf
# Base IRIs: ('http://www.ebi.ac.uk/efo/', 'http://purl.obolibrary.org/obo/MONDO', 'http://purl.obolibrary.org/obo/HP', 'http://www.orpha.net/ORDO', 'http://purl.obolibrary.org/obo/DOID')
# Max Mappings: 1
# Term Type: classes
# Deprecated Terms Excluded
# Unmapped Terms Excluded
# Of 22406 entries, 11543 were successfully mapped to 5315 unique terms
Source Term ID,Source Term,Mapped Term Label,Mapped Term CURIE,Mapped Term IRI,Mapping Score,Tags
ieu-b-5103,Schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
ieu-b-5088,Sepsis (under 75),Sepsis,HP:0100806,http://purl.obolibrary.org/obo/HP_0100806,0.658,None
ieu-b-5086,Sepsis (28 day death),Sepsis,HP:0100806,http://purl.obolibrary.org/obo/HP_0100806,0.605,None
ukb-a-583,Diagnoses - main ICD10: R11 Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.681,None
finn-b-REAC_ARTHRO_NOS,Other/unspecified reactive arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.648,None
ukb-b-5326,Operative procedures - main OPCS: X33.9 Unspecified other blood transfusion,blood transfusion,EFO:0020988,http://www.ebi.ac.uk/efo/EFO_0020988,0.614,None
ebi-a-GCST009541,Heart failure,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
finn-b-O15_POSTPART_DEPR,Postpartum depression,postpartum depression,EFO:0007453,http://www.ebi.ac.uk/efo/EFO_0007453,0.993,None
ukb-e-2100_AFR,"Seen a psychiatrist for nerves, anxiety, tension or depression","seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported",EFO:0009821,http://www.ebi.ac.uk/efo/EFO_0009821,0.735,None
finn-b-H7_GLOBEDEGENERATED,Degenerated conditions of globe,eye degenerative disorder,MONDO:0004884,http://purl.obolibrary.org/obo/MONDO_0004884,0.681,None
ebi-a-GCST006654,Vaginal discharge (smell),abnormal vaginal discharge smell,EFO:0009408,http://www.ebi.ac.uk/efo/EFO_0009408,0.884,None
finn-b-CD2_BENIGN_TRANSVERSE_COLON_EXALLC,Benign neoplasm: Transverse colon (all cancers excluded),benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.701,None
finn-b-KRA_PSY_AUTISM_EXMORE,Autism spe (more controls excluded),autism,EFO:0003758,http://www.ebi.ac.uk/efo/EFO_0003758,0.846,None
finn-b-N14_VAGINITIS,Vaginitis/vulvovaginitis/vulvitis/abscess of vulva,vulvovaginitis,EFO:1001240,http://www.ebi.ac.uk/efo/EFO_1001240,0.849,None
finn-b-L12_PYOGENGRANUL,Pyogenic granuloma,pyogenic granuloma,MONDO:0022096,http://purl.obolibrary.org/obo/MONDO_0022096,0.993,None
ukb-d-22601_31113033,"Job coding: laboratory technician, scientific assistant, cytology screener; hospital, medical or health technician",technician,EFO:0009739,http://www.ebi.ac.uk/efo/EFO_0009739,0.668,None
finn-b-CD2_BENIGN_EAR_RESP_EXALLC,Benign neoplasm of middle ear and respiratory system (all cancers excluded),respiratory system benign neoplasm,MONDO:0000382,http://purl.obolibrary.org/obo/MONDO_0000382,0.789,None
ukb-b-4921,Diagnoses - main ICD10: M75.0 Adhesive capsulitis of shoulder,frozen shoulder,EFO:1000941,http://www.ebi.ac.uk/efo/EFO_1000941,0.781,None
ukb-b-15175,Vitamin and mineral supplements: Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.687,None
finn-b-E4_PANCSECNAS,"Disorder of pancreatic internal secretion, other and/or unspecified",pancreas disease,EFO:0009605,http://www.ebi.ac.uk/efo/EFO_0009605,0.741,None
finn-b-I9_AORTDIS,Dissection of aorta,Aortic dissection,HP:0002647,http://purl.obolibrary.org/obo/HP_0002647,0.82,None
ukb-b-11748,Diagnoses - main ICD10: I47.1 Supraventricular tachycardia,Supraventricular tachycardia,HP:0004755,http://purl.obolibrary.org/obo/HP_0004755,0.81,None
ebi-a-GCST90016625,Ulcerative colitis vs rheumatoid arthritis (ordinary least squares (OLS)),rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.723,None
finn-b-CHARCOT,Charcot foot,amyotrophic lateral sclerosis,MONDO:0004976,http://purl.obolibrary.org/obo/MONDO_0004976,0.716,None
ukb-a-214,Illnesses of mother: Chronic bronchitis/emphysema,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.655,None
finn-b-N14_OTHNONINFVAG,Other noninflammatory disorders of vagina,inflammatory disease,EFO:0009903,http://www.ebi.ac.uk/efo/EFO_0009903,0.723,None
ukb-b-8072,Diagnoses - secondary ICD10: N40 Hyperplasia of prostate,benign prostatic hyperplasia,EFO:0000284,http://www.ebi.ac.uk/efo/EFO_0000284,0.663,None
ukb-d-L12_ACTINKERA,Actinic keratosis,actinic keratosis,EFO:0002496,http://www.ebi.ac.uk/efo/EFO_0002496,0.988,None
ukb-e-30660_MID,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
finn-b-J10_NECROTIC,Suppurative and necrotic conditions of lower respiratory tract,lower respiratory tract disease,EFO:0009433,http://www.ebi.ac.uk/efo/EFO_0009433,0.624,None
ukb-d-LUNG_CANCER_MESOT,Lung cancer and mesothelioma,mesothelioma,EFO:0000588,http://www.ebi.ac.uk/efo/EFO_0000588,0.814,None
ukb-d-H7_EYELIDDIS,Other disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.935,None
ukb-e-24008_EAS,Particulate matter air pollution 2.5-10um; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.723,None
ieu-a-1112,Primary sclerosing cholangitis,sclerosing cholangitis,EFO:0004268,http://www.ebi.ac.uk/efo/EFO_0004268,0.994,None
ieu-a-834,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-e-20004_p40_AFR,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-I9_CHD,Major coronary heart disease event,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.77,None
finn-b-CD2_BENIGN_THYROID,Benign neoplasm of thyroid gland,Benign Thyroid Gland Neoplasm,EFO:1000122,http://www.ebi.ac.uk/efo/EFO_1000122,0.993,None
finn-b-L12_CHRONICULCEROFSKIN,"Chronic ulcer of skin, not elsewhere classified",chronic ulcer of skin,EFO:0007066,http://www.ebi.ac.uk/efo/EFO_0007066,0.993,None
ukb-e-R63_CSA,R63 Symptoms and signs concerning food and fluid intake,sign or symptom concerning food and fluid intake,EFO:0009825,http://www.ebi.ac.uk/efo/EFO_0009825,0.781,None
ukb-e-6164_p4_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-E4_DELPUB,Delayed puberty,Delayed puberty,HP:0000823,http://purl.obolibrary.org/obo/HP_0000823,0.995,None
finn-b-HYPOTHY_REIMB,"Hypothyroidism, drug reimbursement",hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.646,None
ukb-d-C79,Diagnoses - main ICD10: C79 Secondary malignant neoplasm of other sites,secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.663,None
ukb-e-20004_p97_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ukb-d-K11_OTHGASTR,Other gastritis (incl. Duodenitis),duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.73,None
ukb-e-52_p2_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-H8_EXT_ABSC,Abscess of external ear,external ear disease,EFO:0009668,http://www.ebi.ac.uk/efo/EFO_0009668,0.678,None
ukb-e-2020_EAS,"Loneliness, isolation",loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
ieu-a-1137,ER- Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.679,None
finn-b-AB1_ZOSTER,Zoster [herpes zoster],Herpes Zoster,EFO:0006510,http://www.ebi.ac.uk/efo/EFO_0006510,0.943,None
finn-b-MUCOPROCT,Mucosal proctocolitis,ulcerative proctosigmoiditis,EFO:1001223,http://www.ebi.ac.uk/efo/EFO_1001223,0.733,None
ukb-b-13998,Diagnoses - secondary ICD10: N84.0 Polyp of corpus uteri,uterine polyp,EFO:0009484,http://www.ebi.ac.uk/efo/EFO_0009484,0.655,None
ukb-d-M13_GANGLION,Ganglion,ganglioglioma,EFO:0003094,http://www.ebi.ac.uk/efo/EFO_0003094,0.821,None
ukb-e-30140_AFR,Neutrophill count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.886,None
finn-b-ASTHMA_NAS,"Asthma, unspecified (mode)",asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.809,None
ukb-e-30200_AFR,Neutrophill percentage,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.917,None
ukb-e-2020_MID,"Loneliness, isolation",loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
ukb-e-100490_AFR,Intake of sugar added to tea,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.615,None
finn-b-Z21_DEPENDENCE_ENABL_MACHINES_DEVICES_NOT_ELSEW_CLASSIFIED,"Dependence on enabling machines and devices, not elsewhere classified",dependence on enabling machines and devices,EFO:0020981,http://www.ebi.ac.uk/efo/EFO_0020981,0.944,None
finn-b-G6_NEUINFL,Inflammatory diseases of the central nervous system,encephalomyelitis,EFO:0001423,http://www.ebi.ac.uk/efo/EFO_0001423,0.858,None
finn-b-I9_PAROXTAC_EXNONE,Paroxysmal tachycardia (no controls excluded),paroxysmal tachycardia,EFO:0009493,http://www.ebi.ac.uk/efo/EFO_0009493,0.961,None
ukb-e-21000_p17_AFR,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
ebi-a-GCST90000514,Gastroesophageal reflux disease,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.993,None
finn-b-CD2_BENIGN_SKIN_LIP_EXALLC,Benign neoplasm: Skin of lip (all cancers excluded),benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.825,None
ukb-a-303,Hair/balding pattern: Pattern 4,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.687,None
ukb-e-709_p1_EAS,Number in household,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.709,None
finn-b-C3_UNCERTAIN_SECONDARY,Secondary uncertain malignant neoplasm,secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.81,None
ukb-e-recode167_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-4106_CSA,"Heel bone mineral density (BMD) T-score, automated (left)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.665,None
finn-b-AB1_VIRAL_ENCEPHALITIS_NOS,"Viral encephalitis, not elsewhere classified/unspecified",viral encephalitis,EFO:0007538,http://www.ebi.ac.uk/efo/EFO_0007538,0.99,None
ukb-e-5108_AFR,3mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
ukb-e-20502_AFR,Ever had period extreme irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.634,None
ukb-e-recode124_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-COLITNONINFNAS,Noninfectious colitis NAS,infectious colitis,EFO:1000035,http://www.ebi.ac.uk/efo/EFO_1000035,0.813,None
finn-b-CD2_BENIGN_MENINGES_SPINAL,Benign neoplasm: Spinal meninges,meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.789,None
finn-b-F5_DEMENTIA,Dementia,Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
ieu-a-966,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
finn-b-M13_DERMATOPOLY,Dermatopolymyositis,dermatomyositis,EFO:0000398,http://www.ebi.ac.uk/efo/EFO_0000398,0.993,None
ukb-b-4725,"Non-cancer illness code, self-reported: duodenal ulcer",duodenal ulcer,EFO:0004607,http://www.ebi.ac.uk/efo/EFO_0004607,0.684,None
ebi-a-GCST90016622,Schizophrenia vs major depressive disorder (ordinary least squares (OLS)),major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.649,None
ukb-e-5057_CSA,Number of older siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.851,None
finn-b-D3_COAGDEF,Chronic Coagulation defects,blood coagulation disease,EFO:0009314,http://www.ebi.ac.uk/efo/EFO_0009314,0.756,None
finn-b-CD2_BENIGN_TRANSVERSE_COLON,Benign neoplasm: Transverse colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.768,None
ukb-e-1920_AFR,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ukb-e-4548_EAS,Health satisfaction,health satisfaction measurement,EFO:0009724,http://www.ebi.ac.uk/efo/EFO_0009724,0.907,None
ukb-e-recode453_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AB1_HEPATITIS_OTHER_VIRAL,Other  viral hepatitis,animal viral hepatitis,EFO:0007540,http://www.ebi.ac.uk/efo/EFO_0007540,0.998,None
ukb-b-11064,Diagnoses - secondary ICD10: Z95.1 Presence of aortocoronary bypass graft,coronary artery bypass,EFO:0003776,http://www.ebi.ac.uk/efo/EFO_0003776,0.677,None
ukb-e-100013_CSA,Vitamin B12,vitamin B12 deficiency,EFO:0000734,http://www.ebi.ac.uk/efo/EFO_0000734,0.914,None
ukb-e-SBP_p2_AFR,"Systolic blood pressure, combined automated + manual reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.696,None
finn-b-CD2_BENIGN_SALIVARY_EXALLC,Benign neoplasm of major salivary glands (all cancers excluded),major salivary gland cancer,MONDO:0044743,http://purl.obolibrary.org/obo/MONDO_0044743,0.809,None
ukb-b-5617,Operation code: pilonidal sinus surgery (anal),Pilonidal sinus,HP:0010769,http://purl.obolibrary.org/obo/HP_0010769,0.739,None
finn-b-G6_ALCOPOLY,Alcohol induced polyneuropathy (G6_ALCOPOLY),alcoholic neuropathy,EFO:1000803,http://www.ebi.ac.uk/efo/EFO_1000803,0.769,None
finn-b-E4_HYPEROSMHNAT,Hyperosmolality and hypernatraemia,Hypernatremia,HP:0003228,http://purl.obolibrary.org/obo/HP_0003228,0.619,None
finn-b-ST19_FOCAL_BRAIN_INJURY,Focal brain injury,brain injury,MONDO:0043510,http://purl.obolibrary.org/obo/MONDO_0043510,0.794,None
ukb-a-520,Diagnoses - main ICD10: C61 Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.727,None
finn-b-L12_OTHERCONTACT,Other contact dermatitis,contact dermatitis,EFO:0005319,http://www.ebi.ac.uk/efo/EFO_0005319,0.989,None
ieu-a-90,Obesity class 1,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.791,None
ukb-e-20117_p2_CSA,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
ukb-e-recode213_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_AORTANEUR,Aortic aneurysm,aortic aneurysm,EFO:0001666,http://www.ebi.ac.uk/efo/EFO_0001666,0.993,None
finn-b-I9_INTRACRA_EXNONE,Nontraumatic intracranial haemmorrhage (no controls excluded),intracranial hemorrhage,EFO:0000551,http://www.ebi.ac.uk/efo/EFO_0000551,0.733,None
ukb-e-1339_MID,Non-oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.643,None
ukb-e-20004_p96_AFR,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-CD2_BENIGN_BREAST_EXALLC,Benign neoplasm of breast (all cancers excluded),breast benign neoplasm,MONDO:0000620,http://purl.obolibrary.org/obo/MONDO_0000620,0.888,None
ukb-d-N80,Diagnoses - main ICD10: N80 Endometriosis,endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.668,None
finn-b-F5_SEXDYS,Sexual dysfunction,sexual dysfunction,EFO:0004714,http://www.ebi.ac.uk/efo/EFO_0004714,0.984,None
finn-b-H7_LAGOPHTALMOS,Lagophthalmos,lagophthalmos,MONDO:0001604,http://purl.obolibrary.org/obo/MONDO_0001604,0.989,None
ukb-e-6149_p7_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
finn-b-C3_SMALL_INTESTINE_EXALLC,Malignant neoplasm of small intestine (all cancers excluded),small intestine cancer,MONDO:0000956,http://purl.obolibrary.org/obo/MONDO_0000956,0.922,None
finn-b-E4_DIABINSIPIDUS,Diabetes insipidus,diabetes insipidus,MONDO:0004782,http://purl.obolibrary.org/obo/MONDO_0004782,0.995,None
ukb-e-6155_p8_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-G6_HCNP,Normal-pressure hydrocephalus,normal pressure hydrocephalus,EFO:1001065,http://www.ebi.ac.uk/efo/EFO_1001065,0.982,None
ukb-e-1060_MID,Time spent outdoors in winter,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.849,None
finn-b-M13_BURSELBOWOTH,Other bursitis of elbow,olecranon bursitis,MONDO:0001557,http://purl.obolibrary.org/obo/MONDO_0001557,0.997,None
finn-b-CD2_BENIGN_SKIN_LOWERLIMB,"Benign neoplasm: Skin of lower limb, including hip",benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.633,None
finn-b-KRA_PSY_SPEELING,Speech and linguistic disorders,speech disorder,MONDO:0004730,http://purl.obolibrary.org/obo/MONDO_0004730,0.715,None
ukb-b-6740,Current employment status: In paid employment or self-employed,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.847,None
finn-b-AD_U,Alzheimer<c3><95>s disease (undefined),Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.805,None
finn-b-C3_CONNECTIVE_SOFT_NAS_EXALLC,Malignant neoplasm of other connective and soft tissue (all cancers excluded),malignant soft tissue neoplasm,MONDO:0024637,http://purl.obolibrary.org/obo/MONDO_0024637,0.814,None
finn-b-F5_EMOPER,Emotionally unstable personality disorder,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.683,None
ukb-e-30640_CSA,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ukb-e-670_p3_CSA,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
ebi-a-GCST005531,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
ukb-a-204,Illnesses of father: Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.657,None
finn-b-E4_GILBERT,Gilbert syndrome,Gilbert syndrome,EFO:0005556,http://www.ebi.ac.uk/efo/EFO_0005556,0.972,None
finn-b-R18_MALAI_FATIG,Malaise and fatigue,Fatigue,HP:0012378,http://purl.obolibrary.org/obo/HP_0012378,0.734,None
finn-b-M13_OSTEOMYELITIS,Osteomyelitis,osteomyelitis,EFO:0003102,http://www.ebi.ac.uk/efo/EFO_0003102,0.997,None
ebi-a-GCST006651,Menstruation quality of life impact (sleepiness),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.652,None
finn-b-G6_CARPTU,Carpal tunnel syndrome,carpal tunnel syndrome,EFO:0004143,http://www.ebi.ac.uk/efo/EFO_0004143,0.967,None
finn-b-RHEUMA_SEROPOS_OTH,Other/unspecified seropositiverheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.745,None
ukb-b-8517,"Non-cancer illness code, self-reported: urinary frequency / incontinence",Urinary incontinence,HP:0000020,http://purl.obolibrary.org/obo/HP_0000020,0.607,None
finn-b-GOUT_KIDNEY,Gout due to impairment of renal function,functional impairment measurement,EFO:0005412,http://www.ebi.ac.uk/efo/EFO_0005412,0.68,None
ukb-e-recode127_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_BURSITISHIPOTH,Other bursitis of hip,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.826,None
ukb-e-244_CSA,Hypothyroidism,hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.991,None
finn-b-CD2_BENIGN_INTRATHORACIC,Benign neoplasm of other and unspecified intrathoracic organs,thoracic benign neoplasm,MONDO:0000634,http://purl.obolibrary.org/obo/MONDO_0000634,0.78,None
finn-b-I9_ARTEMBTHR_EXNONE,Arterial embolism and thrombosis (no controls excluded),Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.834,None
ukb-e-21000_p16_EAS,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
ukb-b-1234,Doctor diagnosed chronic bronchitis,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.783,None
finn-b-F5_PERSMOOD,Persistent mood disorders,dysthymic disorder,EFO:0008623,http://www.ebi.ac.uk/efo/EFO_0008623,0.844,None
ukb-e-30280_EAS,Immature reticulocyte fraction,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.994,None
ukb-e-3077_EAS,Seating box height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.645,None
finn-b-CHOLELITH_BROAD,"Cholelithiasis, broad definition with cholecystitis",cholelithiasis,EFO:0004799,http://www.ebi.ac.uk/efo/EFO_0004799,0.74,None
ukb-d-1707_1,Handedness (chirality/laterality): Right-handed,handedness,EFO:0009902,http://www.ebi.ac.uk/efo/EFO_0009902,0.648,None
ukb-e-135_EAS,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
ukb-e-20003_p33_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-4537_AFR,Work/job satisfaction,job satisfaction measurement,EFO:0009723,http://www.ebi.ac.uk/efo/EFO_0009723,0.901,None
ukb-b-8210,"Non-cancer illness code, self-reported: crohns disease",Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.625,None
finn-b-P16_RESPI_DISTR_NEWBO,Respiratory distress of newborn,newborn respiratory distress syndrome,EFO:1000644,http://www.ebi.ac.uk/efo/EFO_1000644,0.952,None
finn-b-D3_KELA_IMMUDEF,Kela reimbursement Agammaglobulinemia (D80-84),agammaglobulinemia,MONDO:0015977,http://purl.obolibrary.org/obo/MONDO_0015977,0.643,None
finn-b-I9_HYPTENSRD,Hypertensive Renal Disease,hypertensive nephropathy,MONDO:0024633,http://purl.obolibrary.org/obo/MONDO_0024633,0.987,None
finn-b-D3_IMMUDEFANTIBODY,Immunodeficiency with predominantly antibody defects,Other immunodeficiency syndrome with predominantly antibody defects,ORPHANET.ORDO:331244,http://www.orpha.net/ORDO/Orphanet_331244,0.914,None
finn-b-Z21_PREGNAC_EXAM_TEST,Pregnancy examination and test,pregnancy test,EFO:0009643,http://www.ebi.ac.uk/efo/EFO_0009643,0.737,None
finn-b-OSTPOPATFRCTURE_POSTEMENO,Postmenopausal osteoporosis with pathological fracture,postmenopausal osteoporosis,EFO:0003854,http://www.ebi.ac.uk/efo/EFO_0003854,0.758,None
ukb-e-521_AFR,Diseases of hard tissues of teeth,tooth hard tissue disease,MONDO:0002220,http://purl.obolibrary.org/obo/MONDO_0002220,0.885,None
finn-b-E4_GOITREMULTINOD,Nontoxic multinodular goitre,multinodular goiter,MONDO:0000334,http://purl.obolibrary.org/obo/MONDO_0000334,0.738,None
finn-b-J10_PULMEOS,"Pulmonary eosinophilia, not elsewhere classified",eosinophilic pneumonia,EFO:0007257,http://www.ebi.ac.uk/efo/EFO_0007257,0.992,None
ukb-b-15686,"Diagnoses - secondary ICD10: I20.9 Angina pectoris, unspecified",angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.602,None
ukb-e-4803_AFR,Tinnitus,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.996,None
ukb-b-18157,Type of cancer: ICD10: C56 Malignant neoplasm of ovary,ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.731,None
finn-b-D3_EOSINOPHILIA,Eosinophilia,Eosinophilia,HP:0001880,http://purl.obolibrary.org/obo/HP_0001880,0.989,None
ukb-e-5257_AFR,Corneal resistance factor (right),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.886,None
ukb-b-13447,"Non-cancer illness code, self-reported: chronic obstructive airways disease/copd",chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.75,None
ukb-e-135_CSA,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
ukb-e-F17_CSA,F17 Mental and behavioural disorders due to use of tobacco,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.642,None
ukb-e-480_AFR,Pneumonia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.994,None
finn-b-R18_COUGH,Cough,Cough,HP:0012735,http://purl.obolibrary.org/obo/HP_0012735,0.997,None
finn-b-L12_PRURITUS,Pruritus,Pruritus,HP:0000989,http://purl.obolibrary.org/obo/HP_0000989,0.995,None
finn-b-HYPOTHY_LEVOTHY,"Hypothyroidism, levothyroxin purchases",hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.735,None
finn-b-M13_POLYMYO,Polymyositis,polymyositis,EFO:0003063,http://www.ebi.ac.uk/efo/EFO_0003063,0.992,None
finn-b-KRA_PSY_MOOD,Mood disorders,mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.986,None
finn-b-CD2_BENIGN_SALIVARY_NOS_EXALLC,Benign neoplasm: other/unspecified salivary gland (all cancers excluded),benign neoplasm of salivary gland,MONDO:0021460,http://purl.obolibrary.org/obo/MONDO_0021460,0.924,None
finn-b-H7_GLAUCOMA_XFG,"Glaucoma, exfoliation",exfoliation syndrome,EFO:0004235,http://www.ebi.ac.uk/efo/EFO_0004235,0.992,None
ebi-a-GCST006698,Parental longevity (both parents in top 10%),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.763,None
ukb-e-30640_EAS,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ukb-e-recode391_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-23111_AFR,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
ukb-a-176,Treatment/medication code: atorvastatin,atorvastatin measurement,EFO:0801115,http://www.ebi.ac.uk/efo/EFO_0801115,0.689,None
finn-b-I9_CARDMSEC_EXNONE,"""Cardiomyopathies, Secondary/extrinsic"" (no controls excluded)",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.802,None
finn-b-K11_OTHILEUS,"Other or unspecified ileus, impaction or obstruction",Nasal congestion,HP:0001742,http://purl.obolibrary.org/obo/HP_0001742,0.627,None
ukb-b-16713,Diagnoses - secondary ICD10: C78.7 Secondary malignant neoplasm of liver,secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.772,None
ukb-e-recode108_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-578_AFR,Gastrointestinal hemorrhage,Gastrointestinal hemorrhage,HP:0002239,http://purl.obolibrary.org/obo/HP_0002239,0.995,None
ieu-a-297,Alzheimer's disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
ukb-e-30010_CSA,Red blood cell (erythrocyte) count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.783,None
ukb-b-8906,Knee pain for 3+ months,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.712,None
finn-b-H7_KERATOCONUS,Hereditary corneal dystrophies,corneal dystrophy,MONDO:0018102,http://purl.obolibrary.org/obo/MONDO_0018102,0.689,None
finn-b-CD2_BENIGN_BONE_SCAPULA_LONG_UPPER,Benign neoplasm: Scapula and long bones of upper limb,bone benign neoplasm,MONDO:0000631,http://purl.obolibrary.org/obo/MONDO_0000631,0.601,None
ukb-b-11311,"Diagnoses - secondary ICD10: F41.9 Anxiety disorder, unspecified",anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.602,None
finn-b-C3_BREAST_HERNEG_EXALLC,"""Malignant neoplasm of breast, HER-negative"" (all cancers excluded)",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.747,None
finn-b-H8_EXTOTITIS,Otitis externa,otitis externa,EFO:0009560,http://www.ebi.ac.uk/efo/EFO_0009560,0.994,None
finn-b-CD2_BENIGN_BLADDER_EXALLC,Benign neoplasm: Bladder (all cancers excluded),bladder tumor,EFO:0000294,http://www.ebi.ac.uk/efo/EFO_0000294,0.768,None
finn-b-E4_NUTRIDEF,Other nutritional deficiencies,nutritional deficiency disease,EFO:1001067,http://www.ebi.ac.uk/efo/EFO_1001067,0.765,None
ukb-e-3148_EAS,Heel bone mineral density (BMD),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.878,None
finn-b-AB1_CMV,Cytomegaloviral disease,cytomegalovirus infection,EFO:0001062,http://www.ebi.ac.uk/efo/EFO_0001062,0.993,None
ukb-e-30750_CSA,Glycated haemoglobin (HbA1c),HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.632,None
finn-b-J10_ACUTEUPPERINFEC,Acute upper respiratory infections of multiple and unspecified sites,Recurrent respiratory infections,HP:0002205,http://purl.obolibrary.org/obo/HP_0002205,0.793,None
finn-b-I9_CARDARR,Cardiac arrest,cardiac arrest,EFO:0009492,http://www.ebi.ac.uk/efo/EFO_0009492,0.988,None
ukb-e-30050_EAS,Mean corpuscular haemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.986,None
finn-b-HERING_BILATERAL,"Inguinal hernia, bilateral",Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.816,None
finn-b-Z21_OTHER_ORTHOPA_FOLLOW__CARE,Other orthopaedic follow-up care,orthopedic nursing,EFO:0009577,http://www.ebi.ac.uk/efo/EFO_0009577,0.787,None
ukb-e-23098_EAS,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
ukb-e-30840_MID,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
finn-b-E4_DM2,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-recode307_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-59,Cancer code  self-reported: basal cell carcinoma,basal cell carcinoma,EFO:0004193,http://www.ebi.ac.uk/efo/EFO_0004193,0.741,None
finn-b-H7_RETINOPATHYDIAB_NAS,Other diabetic retinopathy,diabetic retinopathy,EFO:0003770,http://www.ebi.ac.uk/efo/EFO_0003770,0.987,None
finn-b-E4_AMYLNAS,"Amyloidosis, other/unspecified",amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.998,None
bbj-a-105,Cirrhosis,cirrhosis of liver,EFO:0001422,http://www.ebi.ac.uk/efo/EFO_0001422,0.99,None
finn-b-F5_SCHZPHR,Schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
ukb-d-M13_SPINSTENOSIS,Spinal stenosis,spinal stenosis,EFO:0007490,http://www.ebi.ac.uk/efo/EFO_0007490,0.993,None
ukb-e-recode169_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6148_p2_AFR,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ukb-e-recode170_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-455_CSA,Hemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.99,None
finn-b-C3_DIGESTIVE_ORGANS,Malignant neoplasm of digestive organs,digestive system cancer,MONDO:0002516,http://purl.obolibrary.org/obo/MONDO_0002516,0.78,None
ukb-e-3147_EAS,"Heel quantitative ultrasound index (QUI), direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.661,None
ukb-a-207,Illnesses of father: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.762,None
ieu-a-1189,Obsessive Compulsive Disorder,obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.985,None
finn-b-F5_OTHRET,Other and unspecified mental retardation,Intellectual disability,HP:0001249,http://purl.obolibrary.org/obo/HP_0001249,0.988,None
finn-b-KRA_PSY_DEVWIDE_EXMORE,Wide developmental disorders (more controls excluded),developmental disorder of mental health,EFO:0005548,http://www.ebi.ac.uk/efo/EFO_0005548,0.886,None
ukb-b-11531,Diagnoses - main ICD10: R32 Unspecified urinary incontinence,Urinary incontinence,HP:0000020,http://purl.obolibrary.org/obo/HP_0000020,0.708,None
finn-b-H8_SUP_ACUTE,Acute suppurative otitis media,suppurative otitis media,EFO:0007503,http://www.ebi.ac.uk/efo/EFO_0007503,0.884,None
ebi-a-GCST006652,Menstruation quality of life impact (stiff neck),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.657,None
finn-b-E4_GOITREDIFF,Nontoxic diffuse goitre,toxic diffuse goiter,MONDO:0001104,http://purl.obolibrary.org/obo/MONDO_0001104,0.807,None
ukb-e-5610_p3_AFR,Which eye(s) affected by presbyopia,presbyopia,MONDO:0001330,http://purl.obolibrary.org/obo/MONDO_0001330,0.662,None
ukb-e-20116_p3_CSA,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ukb-e-30730_AFR,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
ukb-e-30800_CSA,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
ukb-e-K40_CSA,K40 Inguinal hernia,Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.811,None
ukb-e-30020_AFR,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
ukb-e-SBP_p2_EAS,"Systolic blood pressure, combined automated + manual reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.696,None
ebi-a-GCST005038,"Allergic disease (asthma, hay fever or eczema)",allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.638,None
ukb-e-30270_AFR,Mean sphered cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.801,None
finn-b-ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN,Allergic contact dermatitis due to drugs in contact with skin,allergic contact dermatitis,EFO:1000668,http://www.ebi.ac.uk/efo/EFO_1000668,0.779,None
ukb-d-ILD_DIFF_DG,ILD differential diagnosis,differentiated,EFO:0002954,http://www.ebi.ac.uk/efo/EFO_0002954,0.719,None
finn-b-J10_VOCALLARYNX,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",upper respiratory tract disorder,MONDO:0004867,http://purl.obolibrary.org/obo/MONDO_0004867,0.684,None
ukb-e-30850_EAS,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
finn-b-ST19_FAILU_REJEC_TRANSPLANTED_ORGANS_TISSU,Failure and rejection of transplanted organs and tissues,heart transplant rejection,EFO:0003046,http://www.ebi.ac.uk/efo/EFO_0003046,0.618,None
ukb-e-4101_CSA,Heel broadband ultrasound attenuation (left),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.891,None
finn-b-K11_PARALIL,Paralytic ileus,Paralytic ileus,HP:0002590,http://purl.obolibrary.org/obo/HP_0002590,0.986,None
ukb-e-960_CSA,Poisoning by antibiotics,poisoning,EFO:0008546,http://www.ebi.ac.uk/efo/EFO_0008546,0.614,None
finn-b-F5_SCHIZPER,Schizoid personality disorder,schizoid personality disorder,MONDO:0001161,http://purl.obolibrary.org/obo/MONDO_0001161,0.995,None
ukb-e-MAP_p3_MID,"Mean arterial pressure, combined automated + manual reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.652,None
finn-b-AB1_BACT_BIR_OTHER_INF_AGENTS,"Bacterial, viral and other infectious agents",bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.71,None
ebi-a-GCST90020091,Estradiol levels,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.984,None
ukb-e-K22_CSA,K22 Other diseases of oesophagus,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.697,None
ukb-e-recode18_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-L12_DERM_NUMMULAR,Nummular dermatitis,Inflammatory abnormality of the skin,HP:0011123,http://purl.obolibrary.org/obo/HP_0011123,0.666,None
finn-b-N14_OTHINFVAGVULV,Other inflammation of vagina/vulva,vaginitis,MONDO:0002234,http://purl.obolibrary.org/obo/MONDO_0002234,0.783,None
ieu-b-88,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
ukb-e-recode298_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-I9_CORATHER,Coronary atherosclerosis,coronary atherosclerosis,MONDO:0021661,http://purl.obolibrary.org/obo/MONDO_0021661,0.996,None
finn-b-F5_MILDRET,Mild mental retardation,"Intellectual disability, mild",HP:0001256,http://purl.obolibrary.org/obo/HP_0001256,0.99,None
ebi-a-GCST90014122,Lacunar stroke,multi-infarct dementia,MONDO:0043224,http://purl.obolibrary.org/obo/MONDO_0043224,0.638,None
ukb-e-E11_AFR,E11 Non-insulin-dependent diabetes mellitus,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.829,None
finn-b-G6_ROOTPLEXOTHUNS,"Other and unspecified nerve root and plexus disorders, also in other diseases",nerve plexus disease,EFO:0009559,http://www.ebi.ac.uk/efo/EFO_0009559,0.806,None
ukb-e-23102_EAS,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
ukb-e-48_CSA,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
ukb-a-332,Fracture resulting from simple fall,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.628,None
finn-b-E4_DMNASNOCOMP,Unspecified diabetes without complications,"microvascular complications of diabetes, susceptibility",MONDO:0000065,http://purl.obolibrary.org/obo/MONDO_0000065,0.629,None
ukb-b-14796,"Non-cancer illness code, self-reported: diverticular disease/diverticulitis",diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.772,None
ukb-d-I9_STR_EXH,"Ischaemic Stroke, excluding all haemorrhages",Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.798,None
finn-b-ULCERRECT,Ulcerative rectosigmoiditis,ulcerative proctosigmoiditis,EFO:1001223,http://www.ebi.ac.uk/efo/EFO_1001223,0.878,None
ukb-b-3132,Operation code: eye surgery,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.783,None
finn-b-N14_RENFAILNAS,Unspesified kidney failure,kidney failure,EFO:1002048,http://www.ebi.ac.uk/efo/EFO_1002048,0.996,None
finn-b-N14_ENDOMETRIOSIS,Endometriosis,endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.992,None
finn-b-CD2_INSITU_CERVIX_UTERI_NOS_EXALLC,"""Carcinoma in situ of uteri, other/unspecified"" (all cancers excluded)",uterus carcinoma in situ,MONDO:0004710,http://purl.obolibrary.org/obo/MONDO_0004710,0.767,None
finn-b-C3_LIP_ORAL_PHARYNX,"Malignant neoplasm of lip, oral cavity and pharynx",pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.803,None
finn-b-L12_HIDRADENITISSUP,Hidradenitis suppurativa,hidradenitis suppurativa,EFO:1000710,http://www.ebi.ac.uk/efo/EFO_1000710,0.989,None
ukb-d-C_URINARY_TRACT,Cancer of urinary tract,urinary system neoplasm,MONDO:0021066,http://purl.obolibrary.org/obo/MONDO_0021066,0.762,None
finn-b-TONGUEABNORMALITY,Tongue abnormality,Abnormality of the tongue,HP:0000157,http://purl.obolibrary.org/obo/HP_0000157,0.991,None
ebi-a-GCST006096,Age spots,orthostatic intolerance,EFO:1000645,http://www.ebi.ac.uk/efo/EFO_1000645,0.708,None
ukb-d-O70,Diagnoses - main ICD10: O70 Perineal laceration during delivery,perineal laceration during delivery,EFO:0009816,http://www.ebi.ac.uk/efo/EFO_0009816,0.77,None
ukb-e-4124_CSA,Heel bone mineral density (BMD) (right),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.808,None
finn-b-M13_DISCINFECTION,Infection of intervertebral disc (pyogenic),lumbar disc degeneration,EFO:0004994,http://www.ebi.ac.uk/efo/EFO_0004994,0.663,None
ukb-a-595,Diagnoses - main ICD10: Z47 Other orthopaedic follow-up care,orthopedic nursing,EFO:0009577,http://www.ebi.ac.uk/efo/EFO_0009577,0.629,None
ukb-e-recode156_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_PROBL_RELATED_LIFESTYLE,Problems related to lifestyle,lifestyle measurement,EFO:0010724,http://www.ebi.ac.uk/efo/EFO_0010724,0.627,None
ukb-e-5109_AFR,6mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
finn-b-CD2_BENIGN_LIPOMATOUS,Benign lipomatous neoplasm,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.995,None
ukb-e-3647_CSA,Duration of other exercises,exercise,EFO:0000483,http://www.ebi.ac.uk/efo/EFO_0000483,0.756,None
finn-b-E4_OVARDYS,Ovarian dysfunction,ovarian dysfunction,EFO:0009003,http://www.ebi.ac.uk/efo/EFO_0009003,0.988,None
finn-b-H7_EYELIDNAS,Other specified and unspecified  disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.935,None
ukb-e-20003_p33_MID,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-recode140_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_OESULC,Ulcer of oesophagus,esophageal ulcer,MONDO:0044782,http://purl.obolibrary.org/obo/MONDO_0044782,0.85,None
finn-b-T2D_WIDE,"Type 2 diabetes, wide definition",type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-b-3703,"Non-cancer illness code, self-reported: heart arrhythmia",cardiac rhythm disease,MONDO:0007263,http://purl.obolibrary.org/obo/MONDO_0007263,0.633,None
finn-b-N14_RENFAIL,Renal failure,Renal insufficiency,HP:0000083,http://purl.obolibrary.org/obo/HP_0000083,0.995,None
ukb-e-23104_AFR,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
finn-b-H7_GLAUCCLOSEPRIM,Primary angle-closure glaucoma,primary angle closure glaucoma,EFO:1001506,http://www.ebi.ac.uk/efo/EFO_1001506,0.992,None
ukb-e-30700_EAS,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ukb-d-N13,Diagnoses - main ICD10: N13 Obstructive and reflux uropathy,urinary tract obstruction,EFO:0009571,http://www.ebi.ac.uk/efo/EFO_0009571,0.656,None
ukb-b-12930,Mouth/teeth dental problems: Dentures,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.619,None
finn-b-CD2_BENIGN_MOUTH_PHARYNX,Benign neoplasm of mouth and pharynx,benign neoplasm of oral cavity,MONDO:0021445,http://purl.obolibrary.org/obo/MONDO_0021445,0.795,None
ukb-e-30260_MID,Mean reticulocyte volume,mean reticulocyte volume,EFO:0010701,http://www.ebi.ac.uk/efo/EFO_0010701,0.982,None
ukb-b-12623,"Non-cancer illness code, self-reported: headaches (not migraine)",migraine disorder,MONDO:0005277,http://purl.obolibrary.org/obo/MONDO_0005277,0.645,None
bbj-a-101,Chronic hepatitis C,chronic hepatitis C virus infection,EFO:0004220,http://www.ebi.ac.uk/efo/EFO_0004220,0.993,None
finn-b-N14_ACUTENEPHRITIC,Acute nephritic syndrome,nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.684,None
ukb-e-1687_EAS,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
finn-b-J10_SINUSITIS,Acute sinusitis,sinusitis,EFO:0007486,http://www.ebi.ac.uk/efo/EFO_0007486,0.799,None
ukb-a-384,Tinnitus: Yes  now some of the time,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.642,None
ieu-a-31,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
ebi-a-GCST90016599,Anorexia nervosa vs autism spectrum disorder (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.653,None
ukb-e-1279_CSA,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
ukb-e-R00_AFR,R00 Abnormalities of heart beat,congenital heart disease,EFO:0005207,http://www.ebi.ac.uk/efo/EFO_0005207,0.768,None
finn-b-R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO,Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity,Elevated erythrocyte sedimentation rate,HP:0003565,http://purl.obolibrary.org/obo/HP_0003565,0.72,None
ieu-a-276,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
finn-b-Q17_OTHER_CONGEN_MALFO_NOT_ELSEW_CLASSIFIED,"Other congenital malformations, not elsewhere classified",developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.861,None
finn-b-CD2_BENIGN_BONE_SHORT_UPPER,Benign neoplasm: Short bones of upper limb,bone benign neoplasm,MONDO:0000631,http://purl.obolibrary.org/obo/MONDO_0000631,0.675,None
ukb-e-recode6_MID,"Estimated glomerular filtration rate, serum creatinine + cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.704,None
finn-b-CD2_NONFOLLICULAR_LYMPHOMA_EXALLC,Non-follicular lymphoma (all cancers excluded),follicular lymphoma,MONDO:0018906,http://purl.obolibrary.org/obo/MONDO_0018906,0.868,None
finn-b-K11_CROHN,Crohn disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
ukb-e-788_CSA,Syncope and collapse,Syncope,HP:0001279,http://purl.obolibrary.org/obo/HP_0001279,0.685,None
finn-b-AB1_SEQULAE_INF_NOS,Sequelae of other and unspecified infectious and parasitic diseases,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.756,None
finn-b-F5_OTHPER,Other specified and unspecified personality disorders,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.951,None
ukb-e-30750_EAS,Glycated haemoglobin (HbA1c),HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.632,None
finn-b-H7_DISORDERLENSNAS,Other specified and unspecified disorders of lens,lens disease,EFO:0009674,http://www.ebi.ac.uk/efo/EFO_0009674,0.861,None
ukb-e-5257_EAS,Corneal resistance factor (right),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.886,None
finn-b-DM_MACULOPATHY,Diabetic maculopathy (DM_MACULOPATHY),diabetic maculopathy,EFO:0010133,http://www.ebi.ac.uk/efo/EFO_0010133,0.893,None
finn-b-L12_PEMPHIGOID_BULL,Bullous pemphigoid,bullous pemphigoid,EFO:0007187,http://www.ebi.ac.uk/efo/EFO_0007187,0.995,None
ukb-e-4101_AFR,Heel broadband ultrasound attenuation (left),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.891,None
finn-b-CD2_BENIGN,Benign neoplasms,benign neoplasm of rectum,MONDO:0021462,http://purl.obolibrary.org/obo/MONDO_0021462,0.874,None
ukb-e-30620_EAS,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
ieu-a-990,Bulimia nervosa,bulimia nervosa,EFO:0005204,http://www.ebi.ac.uk/efo/EFO_0005204,0.993,None
finn-b-CD2_BENIGN_CONNSOFT_TRUNK_EXALLC,"""Benign neoplasm: Connective and other soft tissue of trunk, unspecified"" (all cancers excluded)",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.837,None
finn-b-TBC_RESP,Respiratory tuberculosis,tuberculosis,MONDO:0018076,http://purl.obolibrary.org/obo/MONDO_0018076,0.773,None
ieu-b-5067,Alzheimer's disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
finn-b-G6_PARALOTHUNS,Other and unspecified paralytic syndromes,syndromic disease,MONDO:0002254,http://purl.obolibrary.org/obo/MONDO_0002254,0.677,None
ebi-a-GCST000612,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
finn-b-H7_PTERYGIUM,Pterygium,pterygium,EFO:0000678,http://www.ebi.ac.uk/efo/EFO_0000678,0.99,None
finn-b-J10_OTHERINSTPULM,Other insterstitial pulmonary diseases,Abnormal pulmonary interstitial morphology,HP:0006530,http://purl.obolibrary.org/obo/HP_0006530,0.872,None
ukb-e-103140_CSA,Fish consumer,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.638,None
ieu-b-4953,Liver cell carcinoma,hepatocellular carcinoma,EFO:0000182,http://www.ebi.ac.uk/efo/EFO_0000182,0.981,None
ukb-d-AB1_INTESTINAL_INFECTIONS,Intestinal infectious diseases,intestinal infectious disease,MONDO:0000916,http://purl.obolibrary.org/obo/MONDO_0000916,0.956,None
ukb-e-recode91_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-129,Ischemic stroke,Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.988,None
finn-b-PSOR_ARTHR_OTH,Other psoriatic arthropathies,psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.868,None
ukb-b-20437,Current employment status: Full or part-time student,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.624,None
finn-b-E4_HYPODRUG,Drug-induced hypoglycaemia without coma,Hypoglycemia,HP:0001943,http://purl.obolibrary.org/obo/HP_0001943,0.666,None
finn-b-N14_URETHRALSTRICT,Urethral stricture,Urethral stricture,HP:0012227,http://purl.obolibrary.org/obo/HP_0012227,0.994,None
finn-b-I9_CVD_HARD,Hard cardiovascular diseases,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.89,None
ukb-b-12267,Diagnoses - main ICD10: I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities,Thrombophlebitis,HP:0004418,http://purl.obolibrary.org/obo/HP_0004418,0.725,None
ukb-d-K42,Diagnoses - main ICD10: K42 Umbilical hernia,Umbilical hernia,HP:0001537,http://purl.obolibrary.org/obo/HP_0001537,0.707,None
ukb-e-3647_AFR,Duration of other exercises,exercise,EFO:0000483,http://www.ebi.ac.uk/efo/EFO_0000483,0.756,None
finn-b-CD2_INSITU_CERVIX_UTERI_ENDOCERVIX,"Carcinoma in situ of cervix uteri, endocervix",uterine cervix carcinoma in situ,MONDO:0042487,http://purl.obolibrary.org/obo/MONDO_0042487,0.863,None
ukb-d-M13_ARTHROSIS_OTH,Other arthrosis,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.99,None
ukb-e-52_p10_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-K11_IBS,Irritable bowel syndrome,irritable bowel syndrome,EFO:0000555,http://www.ebi.ac.uk/efo/EFO_0000555,0.961,None
finn-b-CD2_BENIGN_ASCENDING_COLON_EXALLC,Benign neoplasm: Ascending colon (all cancers excluded),benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.741,None
ukb-e-2814_EAS,Ever used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.811,None
ukb-e-30660_CSA,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
finn-b-O15_OBSTET_TRAUMA_OTHER,Other obstetric trauma,obstetric disorder,MONDO:0700003,http://purl.obolibrary.org/obo/MONDO_0700003,0.664,None
ukb-e-MAP_p3_EAS,"Mean arterial pressure, combined automated + manual reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.652,None
ukb-e-680_p1_CSA,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-K11_CONSTIPATION,Constipation,Constipation,HP:0002019,http://purl.obolibrary.org/obo/HP_0002019,0.995,None
finn-b-Q17_CONGEN_MALFO_TRACHEA_BRONCHUS,Congenital malformations of trachea and bronchus,congenital heart malformation,EFO:0005269,http://www.ebi.ac.uk/efo/EFO_0005269,0.629,None
ukb-e-6164_p1_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-E4_THYROIDITSUBAC,Subacute thyroiditis,subacute thyroiditis,EFO:1001194,http://www.ebi.ac.uk/efo/EFO_1001194,0.991,None
finn-b-H7_VITRBODYGLOBE,Disorders of vitreous body,vitreous body disease,EFO:0008624,http://www.ebi.ac.uk/efo/EFO_0008624,0.952,None
finn-b-L12_SEBORRKERAT,Seborrhoeic keratosis,seborrheic keratosis,EFO:0005584,http://www.ebi.ac.uk/efo/EFO_0005584,0.789,None
ukb-e-6155_p4_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-20502_CSA,Ever had period extreme irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.634,None
ukb-e-recode239_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_THYTOXGOITMULT,Thyrotoxicosis with toxic multinodular goitre,Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.692,None
bbj-a-96,Cerebral aneurysm,brain aneurysm,EFO:0003870,http://www.ebi.ac.uk/efo/EFO_0003870,0.994,None
finn-b-K11_HERING,Inguinal hernia,Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.993,None
ukb-e-30860_AFR,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
finn-b-R18_ABNORMAL_SERUM_ENZYME_LEVELS,Abnormal serum enzyme levels,abnormality of serum enzyme levels,EFO:0009826,http://www.ebi.ac.uk/efo/EFO_0009826,0.921,None
finn-b-ST19_SUPERF_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS,Superficial injuries involving multiple body regions,multiple bone fractures,EFO:0009513,http://www.ebi.ac.uk/efo/EFO_0009513,0.713,None
finn-b-ST19_FRACT_SHOUL_UPPER_ARM,Fracture of shoulder and upper arm,shoulder fracture,EFO:0009621,http://www.ebi.ac.uk/efo/EFO_0009621,0.811,None
ukb-e-6149_p2_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-d-PULM_MEDICATIO_COMORB,Medication related adverse effects (Asthma/COPD),adverse effect,EFO:0009658,http://www.ebi.ac.uk/efo/EFO_0009658,0.603,None
ukb-e-recode303_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-SEPTICHE_PNEUMONIA,Pneumonia derived septichemia (SEPTICHE_PNEUMONIA),pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.727,None
ukb-d-ASTHMA_HOSPITAL1,"Asthma, hospital admissions 1",asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.949,None
finn-b-CD2_BENIGN_LIVE_BILE_EXALLC,Benign neoplasm: Liver/bile ducts (all cancers excluded),bile duct neoplasm,MONDO:0021662,http://purl.obolibrary.org/obo/MONDO_0021662,0.64,None
ukb-e-30060_EAS,Mean corpuscular haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.988,None
ukb-a-298,Ever had prostate specific antigen (PSA) test,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.669,None
finn-b-THROMBOCYTAEMIA,Essential (haemorrhagic) thrombocythaemia,essential thrombocythemia,EFO:0000479,http://www.ebi.ac.uk/efo/EFO_0000479,0.848,None
finn-b-O15_POLYHYDR,Polyhydramnios,Polyhydramnios,HP:0001561,http://purl.obolibrary.org/obo/HP_0001561,0.995,None
ukb-e-2395_p1_CSA,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
ukb-e-30010_MID,Red blood cell (erythrocyte) count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.783,None
finn-b-L12_DERMATITISNAS,Other and unspecified dermatitis (L12_DERMATITISNAS),Inflammatory abnormality of the skin,HP:0011123,http://purl.obolibrary.org/obo/HP_0011123,0.82,None
finn-b-ASTHMA_SEPTICHE_PNEUMONIA,Pneumonia derived septichemia (ASTHMA_SEPTICHE_PNEUMONIA),pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.702,None
finn-b-CD2_BENIGN_PANCREAS,Benign neoplasm: Pancreas,benign neoplasm of pancreas,MONDO:0021470,http://purl.obolibrary.org/obo/MONDO_0021470,0.99,None
ukb-e-E78_MID,E78 Disorders of lipoprotein metabolism and other lipidaemias,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.664,None
ukb-e-4124_EAS,Heel bone mineral density (BMD) (right),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.808,None
finn-b-AB1_EARLY_SYPHILIS,Early syphilis,syphilis,EFO:0007504,http://www.ebi.ac.uk/efo/EFO_0007504,0.796,None
ebi-a-GCST006090,Excessive sweating,Hyperhidrosis,HP:0000975,http://purl.obolibrary.org/obo/HP_0000975,0.99,None
ukb-e-52_p12_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-d-I9_DISVEINLYMPH,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified",Abnormality of the lymphatic system,HP:0100763,http://purl.obolibrary.org/obo/HP_0100763,0.683,None
ukb-d-K26,Diagnoses - main ICD10: K26 Duodenal ulcer,duodenal ulcer,EFO:0004607,http://www.ebi.ac.uk/efo/EFO_0004607,0.694,None
ieu-a-1131,Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.701,None
ukb-d-COX_ARTHROSIS,Coxarthrosis [arthrosis of hip](FG),"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.804,None
finn-b-D3_IMMUNEMECHANISMNAS,"Other and unspecified disorders involving the immune mechanism, not elsewhere classified",immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.966,None
ukb-e-AG_MID,Albumin/Globulin ratio,albumin:globulin ratio measurement,EFO:0005128,http://www.ebi.ac.uk/efo/EFO_0005128,0.894,None
ukb-e-6164_p1_MID,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-F5_SUBSTANCE,Mental and behavioural disorders due to psychoctive substance use,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.62,None
finn-b-CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA_EXALLC,"""Haemangioma and lymphangioma, any site"" (all cancers excluded)",lymphangioma,MONDO:0002013,http://purl.obolibrary.org/obo/MONDO_0002013,0.793,None
finn-b-N14_LUMPNASBREAST,Unspecified lump in breast,Breast mass,HP:0032408,http://purl.obolibrary.org/obo/HP_0032408,0.985,None
finn-b-H7_RETINAVASC,Retinal vascular disorders,retinal vascular disorder,MONDO:0002311,http://purl.obolibrary.org/obo/MONDO_0002311,0.949,None
ukb-a-136,Treatment/medication code: ibuprofen,ibuprofen measurement,EFO:0021158,http://www.ebi.ac.uk/efo/EFO_0021158,0.727,None
ukb-b-16451,Illnesses of mother: Diabetes,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.621,None
ukb-e-1210_AFR,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-1160_AFR,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
finn-b-Z21_PERSONAL_HISTORY_MALIG_NEOPLASM,Personal history of malignant neoplasm,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.745,None
finn-b-N14_SALPHOOPH,Salphingitis and oophoritis,oophoritis,EFO:1001071,http://www.ebi.ac.uk/efo/EFO_1001071,0.754,None
finn-b-L12_INFECT_SKIN_NAS,Other and unspecified local infections of skin and subcutaneous tissue,subcutaneous tissue infection,EFO:0010692,http://www.ebi.ac.uk/efo/EFO_0010692,0.849,None
finn-b-M13_MULTIFIBRO,Multifocal fibrosclerosis,IgG4-related disease,MONDO:0017287,http://purl.obolibrary.org/obo/MONDO_0017287,0.993,None
ukb-e-1508_p3_EAS,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-F5_BIPO,Bipolar affective disorders,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.953,None
finn-b-RX_CROHN_2NDLINE,Second line medication for Crohns disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.726,None
ebi-a-GCST006906,Stroke,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.986,None
finn-b-DM_POLYNEURO,Diabetic polyneuropathy,diabetic polyneuropathy,MONDO:0001583,http://purl.obolibrary.org/obo/MONDO_0001583,0.989,None
finn-b-CD2_BENIGN_TONSIL,Benign neoplasm: Tonsil,tonsil neoplasm,MONDO:0021250,http://purl.obolibrary.org/obo/MONDO_0021250,0.829,None
finn-b-L12_LOCALSCLERODERMA,Localized scleroderma [morphea],scleroderma,EFO:1001993,http://www.ebi.ac.uk/efo/EFO_1001993,0.845,None
ukb-d-M13_DUPUTRYEN,Palmar fascial fibromatosis [Dupuytren],Palmar Fibromatosis,EFO:1000438,http://www.ebi.ac.uk/efo/EFO_1000438,0.669,None
finn-b-M13_TOEDEFORMOTH,Other deformities of toe(s),Neuropathic spinal arthropathy,HP:0008443,http://purl.obolibrary.org/obo/HP_0008443,0.667,None
ukb-e-6138_p6_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ebi-a-GCST006867,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-24019_MID,Particulate matter air pollution (pm10); 2007,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.737,None
finn-b-ST19_ICTRAUOTHUNS,Other and unspecified intracranial injuries,brain neoplasm,EFO:0003833,http://www.ebi.ac.uk/efo/EFO_0003833,0.632,None
finn-b-L12_CELLULITIS,Cellulitis,cellulitis,EFO:0003035,http://www.ebi.ac.uk/efo/EFO_0003035,0.996,None
finn-b-N14_HYDROCELE,Hydrocele,testicular hydrocele,EFO:1001859,http://www.ebi.ac.uk/efo/EFO_1001859,0.768,None
ukb-e-30840_AFR,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
ukb-d-3859_3,Reason former drinker stopped drinking alcohol: Health precaution,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.603,None
finn-b-C3_CONNECTIVE_SOFT_NAS,Malignant neoplasm of other connective and soft tissue,malignant soft tissue neoplasm,MONDO:0024637,http://purl.obolibrary.org/obo/MONDO_0024637,0.86,None
finn-b-AB1_CANDIDIASIS,Candidiasis,candidiasis,MONDO:0002026,http://purl.obolibrary.org/obo/MONDO_0002026,0.985,None
ukb-b-5655,Diagnoses - main ICD10: R42 Dizziness and giddiness,Vertigo,HP:0002321,http://purl.obolibrary.org/obo/HP_0002321,0.628,None
ukb-e-NAP_CSA,Non-albumin protein,serum non-albumin protein measurement,EFO:0004568,http://www.ebi.ac.uk/efo/EFO_0004568,0.712,None
ukb-e-I48_CSA,I48 Atrial fibrillation and flutter,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.716,None
finn-b-ST19_FRACT_LUMBAR_SPINE_PELVIS,Fracture of lumbar spine and pelvis,fracture of pelvis,EFO:0009622,http://www.ebi.ac.uk/efo/EFO_0009622,0.752,None
finn-b-G6_ULLNLE,Lesion of ulnar nerve,ulnar nerve lesion,MONDO:0001458,http://purl.obolibrary.org/obo/MONDO_0001458,0.987,None
ukb-b-16573,Operative procedures - main OPCS: U21.2 Computed tomography NEC,computed tomography,EFO:0003960,http://www.ebi.ac.uk/efo/EFO_0003960,0.638,None
ukb-b-1251,Type of cancer: ICD10: C20 Malignant neoplasm of rectum,rectum cancer,EFO:1000657,http://www.ebi.ac.uk/efo/EFO_1000657,0.732,None
ukb-e-3063_CSA,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
finn-b-Q17_CYSTIC_KIDNEY_DISEA,Cystic kidney disease,Cystic Kidney Disease,EFO:0008615,http://www.ebi.ac.uk/efo/EFO_0008615,0.995,None
ukb-e-recode5_MID,"Estimated glomerular filtration rate, cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.778,None
finn-b-C3_BRAIN,Malignant neoplasm of brain,brain cancer,MONDO:0001657,http://purl.obolibrary.org/obo/MONDO_0001657,0.994,None
ukb-e-4120_EAS,Heel broadband ultrasound attenuation (right),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.883,None
ukb-e-52_p6_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-E4_GOITRENAS,Other and/or unspecified nontoxic goitre,nontoxic goiter,MONDO:0001658,http://purl.obolibrary.org/obo/MONDO_0001658,0.853,None
ieu-a-987,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
ukb-e-SBP_p1_CSA,"Systolic blood pressure, automated reading, adjusted by medication",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.622,None
ukb-e-318_CSA,Tobacco use disorder,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.987,None
finn-b-T1D,"Type1 diabetes, definitions combined",type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.711,None
ukb-e-401_AFR,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
finn-b-M13_MYOSITIS,Myositis,myositis,EFO:0000783,http://www.ebi.ac.uk/efo/EFO_0000783,0.993,None
finn-b-L12_HYPETROPHICSCAR,Hypertrophic scar,hypertrophy,EFO:0002460,http://www.ebi.ac.uk/efo/EFO_0002460,0.69,None
finn-b-F5_AUTISM,Autism,autism,EFO:0003758,http://www.ebi.ac.uk/efo/EFO_0003758,0.987,None
ukb-e-52_p9_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-6138_p4_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-CD2_BENIGN_PROSTATE,Benign neoplasm: Prostate,benign neoplasm of prostate,MONDO:0021510,http://purl.obolibrary.org/obo/MONDO_0021510,0.993,None
finn-b-H8_VERTIGOCENT,Vertigo of central origin,central nervous system origin vertigo,MONDO:0002317,http://purl.obolibrary.org/obo/MONDO_0002317,0.994,None
ukb-a-497,Mineral and other dietary supplements: Selenium,response to dietary selenium supplementation,EFO:0600021,http://www.ebi.ac.uk/efo/EFO_0600021,0.727,None
finn-b-N14_OLIGOMEN,Oligomenorrhoea,Oligomenorrhea,HP:0000876,http://purl.obolibrary.org/obo/HP_0000876,0.763,None
ukb-e-D25_CSA,D25 Leiomyoma of uterus,uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.773,None
ebi-a-GCST005522,Narcolepsy,narcolepsy,MONDO:0021107,http://purl.obolibrary.org/obo/MONDO_0021107,0.984,None
bbj-a-160,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
ukb-e-100240_CSA,Coffee consumed,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.787,None
finn-b-N14_ENDOMETRIOSIS_FALLOPIAN_TUBE,Endometriosis of fallopian tube,fallopian tube endometriosis,MONDO:0001282,http://purl.obolibrary.org/obo/MONDO_0001282,0.993,None
ukb-e-30160_MID,Basophill count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.886,None
ukb-e-E78_AFR,E78 Disorders of lipoprotein metabolism and other lipidaemias,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.664,None
ebi-a-GCST007518,Type 2 diabetes (adjusted for BMI),type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.646,None
ukb-e-3144_AFR,"Heel Broadband ultrasound attenuation, direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.835,None
ukb-e-4125_AFR,"Heel bone mineral density (BMD) T-score, automated (right)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.658,None
ukb-e-52_p7_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-ST19_SUPERF_FROST,Superficial frostbite,frostbite,EFO:0009527,http://www.ebi.ac.uk/efo/EFO_0009527,0.749,None
ukb-e-recode101_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_SPONDYLOPATHYNAS,Other specified/unspecified spondylopathies,spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.747,None
ukb-e-recode44_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-13584,Illnesses of mother: Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.656,None
finn-b-T1D_STRICT2,"Type 1 diabetes, strict definition, subgroup 2",type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.655,None
finn-b-M13_NECROVASC,Other necrotizing vasculopathies,necrotizing vasculitis,MONDO:0800113,http://purl.obolibrary.org/obo/MONDO_0800113,0.747,None
finn-b-E4_HYTHY_AI_STRICT_PURCH,"Hypothyroidism, strict autoimmune, 3 medication purchases required",Hashimoto's thyroiditis,EFO:0003779,http://www.ebi.ac.uk/efo/EFO_0003779,0.675,None
ukb-e-1970_EAS,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
ukb-e-24019_AFR,Particulate matter air pollution (pm10); 2007,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.737,None
ukb-e-recode51_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-4690,Vitamin and/or mineral supplement use: Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.695,None
finn-b-CD2_INSITU_MELANOMA,Melanoma in situ,melanoma,EFO:0000756,http://www.ebi.ac.uk/efo/EFO_0000756,0.784,None
finn-b-M13_SPONTRUPTSYNOTEND,Spontaneous rupture of synovium and tendon,Tendon rupture,HP:0100550,http://purl.obolibrary.org/obo/HP_0100550,0.647,None
finn-b-CD2_INSITU_SKIN_FACE_EXALLC,Carcinoma in situ of skin of other and unspecified parts of face (all cancers excluded),skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.752,None
finn-b-H7_LACRIMALSYSTEM,Disorders of lacrimal system,lacrimal apparatus disease,EFO:0009455,http://www.ebi.ac.uk/efo/EFO_0009455,0.95,None
finn-b-CD2_BENIGN_BONE_CARTILAGE_NOS,"Benign neoplasm: Bone and articular cartilage, unspecified",benign chondrogenic neoplasm,MONDO:0024470,http://purl.obolibrary.org/obo/MONDO_0024470,0.818,None
ieu-a-820,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
finn-b-G6_MYOPOTHUNS,Other and unspecified myopathies,myopathy,EFO:0004145,http://www.ebi.ac.uk/efo/EFO_0004145,0.723,None
ukb-e-20116_p1_AFR,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
finn-b-I9_ANEURYSM_EXNONE,"""Cerebral aneurysm, nonruptured"" (no controls excluded)",brain aneurysm,EFO:0003870,http://www.ebi.ac.uk/efo/EFO_0003870,0.668,None
finn-b-G6_SPINAMUSCOTH,Other and unspecified spinal muscular atrophies,spinal muscular atrophy,EFO:0008525,http://www.ebi.ac.uk/efo/EFO_0008525,0.858,None
ukb-e-3077_MID,Seating box height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.645,None
finn-b-R18_OTHER_ABNORMALITI_PLASMA_PROTEINS,Other abnormalities of plasma proteins,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.646,None
finn-b-D3_HAEMOLYTICANAEMIA,Haemolytic anaemias,Congenital hemolytic anemia,HP:0004804,http://purl.obolibrary.org/obo/HP_0004804,0.834,None
finn-b-CD2_BENIGN_RECTUM_EXALLC,Benign neoplasm: Rectum (all cancers excluded),benign neoplasm of rectum,MONDO:0021462,http://purl.obolibrary.org/obo/MONDO_0021462,0.891,None
ukb-e-30520_CSA,Potassium in urine,urinary potassium measurement,EFO:0010952,http://www.ebi.ac.uk/efo/EFO_0010952,0.875,None
ukb-b-9508,Coffee consumed,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.787,None
ukb-e-23127_EAS,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
ukb-e-5264_CSA,Corneal hysteresis (left),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.897,None
ukb-e-3063_AFR,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
finn-b-H8_MASTACU,Acute mastoiditis,Mastoiditis,HP:0000265,http://purl.obolibrary.org/obo/HP_0000265,0.821,None
ieu-b-42,schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
bbj-a-149,Pulmonary tuberculosis,pulmonary tuberculosis,EFO:1000049,http://www.ebi.ac.uk/efo/EFO_1000049,0.993,None
bbj-a-144,Peripheral artery disease,peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.991,None
ukb-e-30530_EAS,Sodium in urine,urinary sodium measurement,EFO:0021522,http://www.ebi.ac.uk/efo/EFO_0021522,0.963,None
finn-b-AB1_STREPTO_SEPSIS,Streptococcal septicaemia,streptococcal infection,EFO:1001476,http://www.ebi.ac.uk/efo/EFO_1001476,0.631,None
ebi-a-GCST90016613,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.661,None
finn-b-J10_BRONCH,"Bronchitis, not specified as acute or chronic",chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.849,None
ukb-b-17738,Fractured bone site(s): Other bones,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.802,None
bbj-a-159,Coronary artery disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.992,None
ukb-e-recode6_CSA,"Estimated glomerular filtration rate, serum creatinine + cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.704,None
finn-b-CD2_INSITU_SKIN_TRUNK_EXALLC,Carcinoma in situ of skin of trunk (all cancers excluded),skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.771,None
finn-b-M13_DEFORMACQ,Other acquired deformities of musculoskeletal system and connective tissue,musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.656,None
finn-b-I9_CABG,Coronary artery bypass grafting,coronary artery bypass,EFO:0003776,http://www.ebi.ac.uk/efo/EFO_0003776,0.989,None
ukb-e-21002_CSA,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
ukb-e-24007_AFR,Particulate matter air pollution (pm2.5) absorbance; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.651,None
ukb-e-recode406_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_INSITU_CERVIX_UTERI_NOS,"Carcinoma in situ of uteri, other/unspecified",uterus carcinoma in situ,MONDO:0004710,http://purl.obolibrary.org/obo/MONDO_0004710,0.834,None
finn-b-I9_OTHPER,Other peripheral vascular diseases,peripheral vascular disease,EFO:0003875,http://www.ebi.ac.uk/efo/EFO_0003875,0.988,None
ukb-e-1508_p1_AFR,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-DENTAL_TMD,TMD related pain,tibial muscular dystrophy,MONDO:0010870,http://purl.obolibrary.org/obo/MONDO_0010870,0.721,None
ieu-a-816,Neuroblastoma,neuroblastoma,EFO:0000621,http://www.ebi.ac.uk/efo/EFO_0000621,0.983,None
finn-b-MND,Motor neuron disease (with DMD),motor neuron disease,EFO:0003782,http://www.ebi.ac.uk/efo/EFO_0003782,0.756,None
finn-b-D3_ANAEMIA_IRONDEF_NAS,Other and unspecified iron deficiency,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.82,None
ukb-e-8_AFR,Intestinal infection,intestinal infectious disease,MONDO:0000916,http://purl.obolibrary.org/obo/MONDO_0000916,0.798,None
ukb-e-recode340_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-R18_ABNORMALITI_GAIT_MOBIL,Abnormalities of gait and mobility,Gait disturbance,HP:0001288,http://purl.obolibrary.org/obo/HP_0001288,0.834,None
ebi-a-GCST005528,Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular),"polyarticular juvenile idiopathic arthritis, rheumatoid factor negative",EFO:1002020,http://www.ebi.ac.uk/efo/EFO_1002020,0.893,None
ukb-e-30700_MID,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ukb-b-6721,Diagnoses - main ICD10: K60.3 Anal fistula,Anal fistula,HP:0010447,http://purl.obolibrary.org/obo/HP_0010447,0.65,None
ieu-a-1016,Oligoclonal band status,oligoclonal band measurement,EFO:0005206,http://www.ebi.ac.uk/efo/EFO_0005206,0.791,None
finn-b-D3_BLOODOTHER,Other diseases of blood and blood-forming organs,hematologic disease,EFO:0005803,http://www.ebi.ac.uk/efo/EFO_0005803,0.84,None
finn-b-L12_OTHERBULL,Other and unspecified bullous disorders,autoimmune bullous skin disease,EFO:0008598,http://www.ebi.ac.uk/efo/EFO_0008598,0.632,None
finn-b-I9_SEQULAE_EXNONE,Sequelae of cerebrovascular disease (no controls excluded),cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.76,None
finn-b-I9_PULMOTHHD,Other pulmonary heart/vessel disease,cor pulmonale,MONDO:0004596,http://purl.obolibrary.org/obo/MONDO_0004596,0.863,None
ukb-e-recode1_EAS,Indirect bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.66,None
finn-b-H8_EXT_NAS,"Otitis externa, unspecified",otitis externa,EFO:0009560,http://www.ebi.ac.uk/efo/EFO_0009560,0.994,None
finn-b-FG_CEREBVASC,Cerebrovascular diseases (FINNGEN),cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.798,None
ukb-d-M13_ARTHROSIS,#Arthrosis,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.99,None
finn-b-CD2_BENIGN_LIPOMATOUS_EXALLC,Benign lipomatous neoplasm (all cancers excluded),benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.917,None
ieu-b-14,"focal epilepsy, documented hippocampal sclerosis",mesial temporal lobe epilepsy with hippocampal sclerosis,MONDO:0020476,http://purl.obolibrary.org/obo/MONDO_0020476,0.668,None
ukb-e-recode437_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6138_p4_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-b-18023,Diagnoses - secondary ICD10: Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue,musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.601,None
ebi-a-GCST006465,Endometrial cancer (endometrioid histology),endometrial endometrioid carcinoma,EFO:1001514,http://www.ebi.ac.uk/efo/EFO_1001514,0.807,None
finn-b-E4_HYTHYPOSTINF,Postinfectious hypothyroidism,hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.752,None
ukb-e-30200_MID,Neutrophill percentage,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.917,None
ukb-e-recode6_EAS,"Estimated glomerular filtration rate, serum creatinine + cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.704,None
ukb-b-18009,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication",blood pressure,EFO:0004325,http://www.ebi.ac.uk/efo/EFO_0004325,0.639,None
bbj-a-140,Pancreatic cancer,Malignant Pancreatic Neoplasm,EFO:1000359,http://www.ebi.ac.uk/efo/EFO_1000359,0.987,None
ukb-e-20015_CSA,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
finn-b-CD2_IMMUNOPROLIFERATIVE,Malignant immunoproliferative diseases,immunoproliferative disorder,MONDO:0021334,http://purl.obolibrary.org/obo/MONDO_0021334,0.843,None
ukb-e-K59_CSA,K59 Other functional intestinal disorders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.752,None
ukb-e-recode90_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-462,Vitamin and mineral supplements: Vitamin D,vitamin D measurement,EFO:0004631,http://www.ebi.ac.uk/efo/EFO_0004631,0.692,None
ukb-e-K02_AFR,K02 Dental caries,dental caries,EFO:0003819,http://www.ebi.ac.uk/efo/EFO_0003819,0.712,None
ukb-d-M25,"Diagnoses - main ICD10: M25 Other joint disorders, not elsewhere classified",joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.604,None
finn-b-R18_ABNORMAL_WEIGHT_LOSS,Abnormal weight loss,Weight loss,HP:0001824,http://purl.obolibrary.org/obo/HP_0001824,0.745,None
ukb-e-recode228_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-C3_BILIARY_TRACT,Malignant neoplasm of other and unspecified parts of biliary tract,biliary tract cancer,MONDO:0003060,http://purl.obolibrary.org/obo/MONDO_0003060,0.753,None
ieu-a-996,Eczema,Eczema,HP:0000964,http://purl.obolibrary.org/obo/HP_0000964,0.989,None
finn-b-AB1_PARASITIC_NOS,Unspecified parasitic disease,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.987,None
ukb-e-recode178_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-b-4982,Sepsis (critical care),Sepsis,HP:0100806,http://purl.obolibrary.org/obo/HP_0100806,0.648,None
ukb-e-6164_p3_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-M13_SPINENTHES,Spinal enthesopathy,enthesopathy,EFO:0009666,http://www.ebi.ac.uk/efo/EFO_0009666,0.844,None
ukb-b-8463,Back pain for 3+ months,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.671,None
ukb-a-88,Non-cancer illness code  self-reported: ankylosing spondylitis,ankylosing spondylitis,EFO:0003898,http://www.ebi.ac.uk/efo/EFO_0003898,0.73,None
ukb-e-30890_CSA,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
ukb-e-614_AFR,Inflammatory diseases of female pelvic organs,Pelvic Inflammatory Disease,EFO:1001388,http://www.ebi.ac.uk/efo/EFO_1001388,0.776,None
ukb-e-recode155_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_BONE_SHORT_UPPER_EXALLC,Benign neoplasm: Short bones of upper limb (all cancers excluded),bone benign neoplasm,MONDO:0000631,http://purl.obolibrary.org/obo/MONDO_0000631,0.636,None
finn-b-CD2_BENIGN_COLON_NOS_EXALLC,"""Benign neoplasm: Colon, unspecified"" (all cancers excluded)",benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.887,None
ukb-e-41_CSA,Bacterial infection NOS,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.878,None
ieu-a-1188,Major Depressive Disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.987,None
ukb-b-8425,"Non-cancer illness code, self-reported: nasal polyps",Nasal polyposis,HP:0100582,http://purl.obolibrary.org/obo/HP_0100582,0.632,None
ieu-b-4915,Liver & bile duct cancer,bile duct cancer,MONDO:0003059,http://purl.obolibrary.org/obo/MONDO_0003059,0.873,None
ukb-d-M13_SOFTTISSUEOTH,"Other soft tissue disorders, not elsewhere classified",soft tissue disease,EFO:0009470,http://www.ebi.ac.uk/efo/EFO_0009470,0.792,None
finn-b-M13_POLYARTHROPATHIES,Polyarthropathies,polyarticular arthritis,MONDO:0024280,http://purl.obolibrary.org/obo/MONDO_0024280,0.626,None
finn-b-AB1_GHLAMY_OTHER,Other diseases caused by chlamydiae (AB1_GHLAMY_OTHER),Chlamydophila infectious disease,EFO:1000863,http://www.ebi.ac.uk/efo/EFO_1000863,0.687,None
finn-b-FG_CVD,Cardiovascular diseases (excluding rheumatic etc),cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.736,None
finn-b-CD2_BENIGN_MENINGES_EXALLC,Benign neoplasm of meninges (all cancers excluded),meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.782,None
ieu-b-10,"focal epilepsy, all documented cases",partial epilepsy,EFO:0004263,http://www.ebi.ac.uk/efo/EFO_0004263,0.761,None
finn-b-H7_MYOPIA,Myopia,Myopia,HP:0000545,http://purl.obolibrary.org/obo/HP_0000545,0.993,None
ukb-a-216,Illnesses of mother: Diabetes,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.621,None
ukb-e-102_CSA,"Pulse rate, automated reading",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
ukb-b-7178,Doctor diagnosed hayfever or allergic rhinitis,allergic rhinitis,EFO:0005854,http://www.ebi.ac.uk/efo/EFO_0005854,0.643,None
ukb-e-I25_AFR,I25 Chronic ischaemic heart disease,Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.647,None
finn-b-I9_RHEUVALV,Rheumatic valve diseases,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.771,None
ukb-e-30720_MID,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
finn-b-I9_CARDMYO,Cardiomyopathy,cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.996,None
ukb-e-recode6_AFR,"Estimated glomerular filtration rate, serum creatinine + cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.704,None
ukb-e-100200_AFR,Grapefruit juice intake,grapefruit juice consumption measurement,EFO:0010094,http://www.ebi.ac.uk/efo/EFO_0010094,0.766,None
finn-b-CD2_BENIGN_ANUS_ANAL_CANAL_EXALLC,Benign neoplasm: Anus and anal canal (all cancers excluded),benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.784,None
finn-b-R18_CONVU_NOT_ELSEW_CLASSIFIED,"Convulsions, not elsewhere classified",convulsion,EFO:0009853,http://www.ebi.ac.uk/efo/EFO_0009853,0.936,None
finn-b-CD2_INSITU_MELANOMA_EXALLC,Melanoma in situ (all cancers excluded),melanoma,EFO:0000756,http://www.ebi.ac.uk/efo/EFO_0000756,0.69,None
ieu-a-30,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
finn-b-ASTHMA_NOS_EXMORE,Undetermined asthma (more controls excluded),stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.642,None
finn-b-C3_CORPUS_UTERI_EXALLC,Malignant neoplasm of corpus uteri (all cancers excluded),uterine body mixed cancer,MONDO:0002879,http://purl.obolibrary.org/obo/MONDO_0002879,0.813,None
ukb-e-recode404_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-1025,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
finn-b-K11_HEPFAIL,"Hepatic failure, not elsewhere classified",Hepatic failure,HP:0001399,http://purl.obolibrary.org/obo/HP_0001399,0.996,None
finn-b-I9_CARDMPRI_EXNONE,"""Cardiomyopathies, Primary/intrinsic"" (no controls excluded)",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.847,None
finn-b-N14_INFLUTH,Inflammatory disease of uterus,uterine inflammatory disease,EFO:0009572,http://www.ebi.ac.uk/efo/EFO_0009572,0.952,None
finn-b-E4_AMYLOIDOSIS,Amyloidosis,amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.998,None
ieu-a-1232,Low malignant potential mucinous ovarian cancer,Borderline Ovarian Surface Epithelial-Stromal Tumor,EFO:1000140,http://www.ebi.ac.uk/efo/EFO_1000140,0.763,None
ukb-e-680_p1_MID,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-d-M65,Diagnoses - main ICD10: M65 Synovitis and tenosynovitis,tenosynovitis,EFO:1001435,http://www.ebi.ac.uk/efo/EFO_1001435,0.814,None
finn-b-G6_ATYFAC,Atypical facial pain,facial pain,EFO:0009625,http://www.ebi.ac.uk/efo/EFO_0009625,0.647,None
finn-b-AB1_SEXUAL_TRANSMISSION_NOS,"Other predominantly sexually transmitted diseases, not elsewhere classified",sexually transmitted disease,MONDO:0021681,http://purl.obolibrary.org/obo/MONDO_0021681,0.78,None
ukb-d-F5_DEPRESSIO,Depression,depressive disorder,MONDO:0002050,http://purl.obolibrary.org/obo/MONDO_0002050,0.992,None
ukb-e-30250_CSA,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
finn-b-K11_PERIODON_CHRON,Chronic periodontitis,chronic periodontitis,EFO:0006343,http://www.ebi.ac.uk/efo/EFO_0006343,0.995,None
ebi-a-GCST90014033,Haemorrhoidal disease,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.861,None
finn-b-G6_CPETAL,Cerebral palsy and other paralytic syndromes,cerebral palsy,EFO:1000632,http://www.ebi.ac.uk/efo/EFO_1000632,0.689,None
finn-b-J10_PYOTHORAX,Pyothorax,pleural empyema,EFO:0009680,http://www.ebi.ac.uk/efo/EFO_0009680,0.997,None
finn-b-J10_PNEUMOBACT,Bacterial pneumoniae,bacterial pneumonia,EFO:1001272,http://www.ebi.ac.uk/efo/EFO_1001272,0.878,None
ukb-e-2355_AFR,Most recent bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.609,None
ukb-e-30100_MID,Mean platelet (thrombocyte) volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.741,None
ukb-b-19386,"Diagnoses - main ICD10: K51.9 Ulcerative colitis, unspecified",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.667,None
finn-b-C3_LIVER_INTRAHEPATIC_BILE_DUCTS,Malignant neoplasm of liver and intrahepatic bile ducts,intrahepatic bile duct cancer,MONDO:0001487,http://purl.obolibrary.org/obo/MONDO_0001487,0.948,None
ukb-e-100490_CSA,Intake of sugar added to tea,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.615,None
finn-b-NEURODEGOTH,Other degenerative diseases of the nervous system (NEURODEGOTH),neurodegenerative disease,EFO:0005772,http://www.ebi.ac.uk/efo/EFO_0005772,0.742,None
ukb-b-15025,"Non-cancer illness code, self-reported: ovarian cyst or cysts",Ovarian cyst,HP:0000138,http://purl.obolibrary.org/obo/HP_0000138,0.654,None
ukb-a-213,Illnesses of mother: Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.656,None
finn-b-K11_MALABSORB,Intestinal malabsorbtion,Malabsorption,HP:0002024,http://purl.obolibrary.org/obo/HP_0002024,0.698,None
ukb-b-12885,Current employment status: Unemployed,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.776,None
finn-b-I9_CABG_EXNONE,Coronary artery bypass grafting (no controls excluded),coronary artery bypass,EFO:0003776,http://www.ebi.ac.uk/efo/EFO_0003776,0.961,None
ieu-b-97,Oropharyngeal cancer,oropharynx cancer,EFO:1001931,http://www.ebi.ac.uk/efo/EFO_1001931,0.992,None
ebi-a-GCST90016600,Anorexia nervosa vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.716,None
ukb-a-302,Hair/balding pattern: Pattern 3,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.688,None
finn-b-ASTHMA_NONALLERG,Non-allergic asthma,allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.936,None
ukb-e-20082_AFR,Duration of questionnaire,health study participation,EFO:0010130,http://www.ebi.ac.uk/efo/EFO_0010130,0.678,None
ukb-e-30760_CSA,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
ukb-b-531,"Non-cancer illness code, self-reported: helicobacter pylori",Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.654,None
finn-b-M13_MUSCLEATROPH,"Muscle wasting and atrophy, not elsewhere classified",Skeletal muscle atrophy,HP:0003202,http://purl.obolibrary.org/obo/HP_0003202,0.863,None
ukb-a-565,Diagnoses - main ICD10: M21 Other acquired deformities of limbs,congenital deformities of limbs,MONDO:0017427,http://purl.obolibrary.org/obo/MONDO_0017427,0.662,None
finn-b-L12_DYSHIDROSIS,Dyshidrosis [pompholyx],dyshidrosis,EFO:1000688,http://www.ebi.ac.uk/efo/EFO_1000688,0.721,None
finn-b-AB1_STREPTSTAPHYCOCC_INOTHER,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,streptococcal infection,EFO:1001476,http://www.ebi.ac.uk/efo/EFO_1001476,0.733,None
finn-b-Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_CIRCUMSTANC_RELATED_REPRODUCTION,Persons encountering health services in circumstances related to reproduction,encounter with health service related to reproduction,EFO:0009787,http://www.ebi.ac.uk/efo/EFO_0009787,0.717,None
ukb-e-3710_AFR,Length of menstrual cycle,menstrual cycle measurement,EFO:0007786,http://www.ebi.ac.uk/efo/EFO_0007786,0.728,None
ukb-d-IX_CIRCULATORY,Diseases of the circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.941,None
ieu-a-298,Alzheimer's disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
finn-b-H7_VISUDISTURB,Visual disturbances,Gait disturbance,HP:0001288,http://purl.obolibrary.org/obo/HP_0001288,0.652,None
ukb-e-52_p11_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-K11_CHRONPANC,Chronic pancreatitis,chronic pancreatitis,EFO:0000342,http://www.ebi.ac.uk/efo/EFO_0000342,0.99,None
finn-b-G6_ATROPHCIRCUM,Circumscribed brain atrophy,alopecia areata,EFO:0004192,http://www.ebi.ac.uk/efo/EFO_0004192,0.702,None
finn-b-H8_EXTDISNAS,Other specified disorders of external ear,external ear disease,EFO:0009668,http://www.ebi.ac.uk/efo/EFO_0009668,0.944,None
ukb-e-1160_EAS,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
finn-b-CD2_BENIGN_BRAIN_CNS,Benign neoplasm of brain and other parts of central nervous system,central nervous system organ benign neoplasm,MONDO:0000628,http://purl.obolibrary.org/obo/MONDO_0000628,0.841,None
ukb-e-100005_AFR,Carbohydrate,carbohydrate measurement,EFO:0004998,http://www.ebi.ac.uk/efo/EFO_0004998,0.867,None
ukb-b-266,Current eye infection,eye infectious disorder,MONDO:0043885,http://purl.obolibrary.org/obo/MONDO_0043885,0.767,None
finn-b-R18_LOCALIZED_SWELL_MASS_LUMP_SKIN_SUBCU_TISSUE,"Localized swelling, mass and lump of skin and subcutaneous tissue",panniculitis,EFO:1000746,http://www.ebi.ac.uk/efo/EFO_1000746,0.618,None
ukb-e-23104_MID,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
finn-b-C3_CORPUS_UTERI,Malignant neoplasm of corpus uteri,uterine body mixed cancer,MONDO:0002879,http://purl.obolibrary.org/obo/MONDO_0002879,0.878,None
ukb-e-30810_CSA,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
ukb-e-6155_p2_EAS,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-recode307_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-G6_NEUATR,Systemic atrophies primarly affecting the central nervous system,central nervous system infection,EFO:1001456,http://www.ebi.ac.uk/efo/EFO_1001456,0.631,None
finn-b-O15_PUERP_COMPL_NAS,"Complications of the puerperium, not elsewhere classified",puerperal disorder,EFO:0009683,http://www.ebi.ac.uk/efo/EFO_0009683,0.697,None
ukb-b-14180,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ebi-a-GCST90014054,Shoulder impingement,shoulder impingement syndrome,EFO:1001178,http://www.ebi.ac.uk/efo/EFO_1001178,0.937,None
finn-b-O15_CONCEPT_ABNORM,Other abnormal products of conception,Lacrimation abnormality,HP:0000632,http://purl.obolibrary.org/obo/HP_0000632,0.642,None
ieu-a-1125,Endometrioid ovarian cancer,Ovarian Endometrioid Adenocarcinoma,EFO:1000416,http://www.ebi.ac.uk/efo/EFO_1000416,0.993,None
finn-b-M13_ARTHROSIS_KNEE,Gonarthrosis,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.68,None
finn-b-M13_FIBROMYALGIA,Fibromyalgia,fibromyalgia,EFO:0005687,http://www.ebi.ac.uk/efo/EFO_0005687,0.988,None
finn-b-CD2_BENIGN_SKIN_EYELID,"Benign neoplasm: Skin of eyelid, including canthus",benign tumor of palpebral epidermis,MONDO:0020173,http://purl.obolibrary.org/obo/MONDO_0020173,0.756,None
finn-b-R18_ABNORMALITI_BREAT,Abnormalities of breathing,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.842,None
finn-b-P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO,Haemorrhagic and haematological disorders of fetus and newborn,Abnormality of coagulation,HP:0001928,http://purl.obolibrary.org/obo/HP_0001928,0.692,None
finn-b-L12_ABSCESS_CUT,"Cutaneous abscess, furuncle and carbuncle",Furuncle,HP:0020083,http://purl.obolibrary.org/obo/HP_0020083,0.661,None
ukb-e-5264_EAS,Corneal hysteresis (left),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.897,None
finn-b-I9_AVBLOCK,AV-block,atrioventricular block,MONDO:0000465,http://purl.obolibrary.org/obo/MONDO_0000465,0.995,None
ukb-e-20111_p8_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-SLE_NOS,"Systemic lupus erythematosus, unspecified",systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
finn-b-F5_EATOTH,Other eating disorders,eating disorder,EFO:0005203,http://www.ebi.ac.uk/efo/EFO_0005203,0.899,None
ukb-e-30020_MID,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
finn-b-DRY_AMD,Dry age-related macular degeneration (includes geographic atrophy),dry age related macular degeneration,MONDO:0100114,http://purl.obolibrary.org/obo/MONDO_0100114,0.661,None
ukb-e-DBP_p2_MID,"Diastolic blood pressure, combined automated + manual reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.698,None
ukb-e-30520_MID,Potassium in urine,urinary potassium measurement,EFO:0010952,http://www.ebi.ac.uk/efo/EFO_0010952,0.875,None
ukb-e-E66_CSA,E66 Obesity,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.715,None
finn-b-M13_CONNECTNAS,Other specified/unspecified systemic involvement of connective tissue,Connective tissue disease with eye involvement,ORPHANET.ORDO:98702,http://www.orpha.net/ORDO/Orphanet_98702,0.756,None
finn-b-KRA_PSY_TIC,Tic disorders (KRA_PSY_TIC),Tics,HP:0100033,http://purl.obolibrary.org/obo/HP_0100033,0.657,None
ukb-e-6142_p8_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-e-52_p4_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-CD2_BENIGN_COLON,Benign neoplasm: Colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.995,None
finn-b-Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM,Other congenital malformations of circulatory system,congenital anomaly of cardiovascular system,MONDO:0024239,http://purl.obolibrary.org/obo/MONDO_0024239,0.745,None
finn-b-L12_VITILIGO,Vitiligo,vitiligo-associated multiple autoimmune disease susceptibility 1,MONDO:0011684,http://purl.obolibrary.org/obo/MONDO_0011684,0.993,None
ebi-a-GCST005811,Osteoarthritis (self-reported),osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.797,None
finn-b-CD2_INSITU_SKIN_UPPERLIMB,"Carcinoma in situ of skin of upper limb, including shoulder",skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.609,None
ieu-b-4961,Oral cavity cancer,oral cavity cancer,EFO:0005570,http://www.ebi.ac.uk/efo/EFO_0005570,0.995,None
ukb-e-recode108_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-34_CSA,Year of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.622,None
ebi-a-GCST009761,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-d-M13_SYNOTEND,Disorders of synovium and tendon,synovium disorder,MONDO:0056799,http://purl.obolibrary.org/obo/MONDO_0056799,0.819,None
ukb-e-4123_AFR,"Heel quantitative ultrasound index (QUI), direct entry (right)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.634,None
ukb-e-2966_AFR,Age high blood pressure diagnosed,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.803,None
finn-b-J10_ASTHMA_MAIN_EXMORE,Asthma (only as main-diagnosis) (more controls excluded),asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.912,None
ukb-a-517,Diagnoses - main ICD10: B37 Candidiasis,candidiasis,MONDO:0002026,http://purl.obolibrary.org/obo/MONDO_0002026,0.659,None
ukb-e-1687_MID,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
ukb-e-recode127_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-46_AFR,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
finn-b-AB1_MYCOSES,Mycoses,fungal infectious disease,MONDO:0002041,http://purl.obolibrary.org/obo/MONDO_0002041,0.973,None
ukb-d-22611_1,Workplace had a lot of cigarette smoke from other people smoking: Sometimes,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.617,None
ukb-d-22611_0,Workplace had a lot of cigarette smoke from other people smoking: Rarely/never,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.623,None
finn-b-D3_NUTRIANAEMIAOTHER,Other nutritional anaemias,nutritional disorder,EFO:0001069,http://www.ebi.ac.uk/efo/EFO_0001069,0.678,None
ukb-e-30640_MID,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ukb-b-16507,Vitamin supplement user,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.674,None
ukb-e-52_p5_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-CD2_INSITU_CERVIX_UTERI_ENDOCERVIX_EXALLC,"""Carcinoma in situ of cervix uteri, endocervix"" (all cancers excluded)",endocervical carcinoma,MONDO:0004259,http://purl.obolibrary.org/obo/MONDO_0004259,0.841,None
finn-b-C3_TESTIS,Malignant neoplasm of testis,testicular carcinoma,EFO:0005088,http://www.ebi.ac.uk/efo/EFO_0005088,0.992,None
finn-b-C_DIFFICILE_ENTEROCOLITIS,Enterocolitis due to Clostridium difficile,clostridium difficile infection,EFO:0009130,http://www.ebi.ac.uk/efo/EFO_0009130,0.725,None
finn-b-I9_ARTEMBTHRNAS,Other arterial embolism and thrombosis,Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.862,None
ukb-e-20004_p79_EAS,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-C3_VULVA_EXALLC,Malignant neoplasm of vulva (all cancers excluded),vulva cancer,MONDO:0001528,http://purl.obolibrary.org/obo/MONDO_0001528,0.928,None
finn-b-COPD_INSUFFICIENCY,COPD-related respiratory insufficiency,Respiratory insufficiency,HP:0002093,http://purl.obolibrary.org/obo/HP_0002093,0.837,None
ukb-e-30730_CSA,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
ebi-a-GCST003374,Chronic kidney disease,chronic kidney disease,EFO:0003884,http://www.ebi.ac.uk/efo/EFO_0003884,0.995,None
ukb-b-1508,Operation code: knee surgery (not replacement),total joint arthroplasty,EFO:0010726,http://www.ebi.ac.uk/efo/EFO_0010726,0.656,None
finn-b-G6_SLEEPDISOTH,Other sleepdisorders,sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.71,None
finn-b-H7_REFRAACCOMMODIS,Disorders of refraction and accommodation,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.81,None
ukb-e-recode425_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20004_p128_AFR,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ukb-b-17507,"Cancer code, self-reported: cin/pre-cancer cells cervix",cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.726,None
ukb-d-H7_LENS,Disorders of lens,lens disease,EFO:0009674,http://www.ebi.ac.uk/efo/EFO_0009674,0.861,None
finn-b-ST19_INJURI_HEAD,Injuries to the head,head injury,EFO:0009505,http://www.ebi.ac.uk/efo/EFO_0009505,0.712,None
ukb-e-2100_CSA,"Seen a psychiatrist for nerves, anxiety, tension or depression","seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported",EFO:0009821,http://www.ebi.ac.uk/efo/EFO_0009821,0.735,None
finn-b-CHONDRO_OTH,Other chondrocalcinosis,Chondrocalcinosis,HP:0000934,http://purl.obolibrary.org/obo/HP_0000934,0.983,None
finn-b-H8_HL_DEAFMUT,"Deaf mutism, not elsewhere classified",Mutism,HP:0002300,http://purl.obolibrary.org/obo/HP_0002300,0.669,None
ukb-e-30280_CSA,Immature reticulocyte fraction,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.994,None
finn-b-ALCODELIRIUM,Alcohol withdrawal state with delirium<c3><8a>,alcohol withdrawal delirium,EFO:1000800,http://www.ebi.ac.uk/efo/EFO_1000800,0.829,None
ukb-e-6164_p1_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-189_p1_CSA,Townsend deprivation index at recruitment,Townsend deprivation index,EFO:0009711,http://www.ebi.ac.uk/efo/EFO_0009711,0.806,None
finn-b-H7_OPTATROPHY,Optic atrophy,optic atrophy,MONDO:0003608,http://purl.obolibrary.org/obo/MONDO_0003608,0.986,None
finn-b-CD2_BENIGN_ADRENAL,Benign neoplasm: Adrenal gland,benign neoplasm of adrenal gland,MONDO:0021511,http://purl.obolibrary.org/obo/MONDO_0021511,0.994,None
ukb-e-recode363_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-5257_CSA,Corneal resistance factor (right),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.886,None
finn-b-H7_ANISOMETROPIA,Anisometropia and aniseikonia,Aniseikonia,EFO:1001266,http://www.ebi.ac.uk/efo/EFO_1001266,0.818,None
ukb-d-41231_1,Hospital episode type: General episode,manic episode measurement,EFO:0007705,http://www.ebi.ac.uk/efo/EFO_0007705,0.619,None
ieu-a-1228,High grade and low grade serous ovarian cancer,high grade ovarian serous adenocarcinoma,EFO:1001958,http://www.ebi.ac.uk/efo/EFO_1001958,0.772,None
finn-b-M13_OVERLAP,Other overlap syndromes,syndromic disease,MONDO:0002254,http://purl.obolibrary.org/obo/MONDO_0002254,0.65,None
ukb-b-12095,Treatment/medication code: lisinopril,lisinopril measurement,EFO:0801175,http://www.ebi.ac.uk/efo/EFO_0801175,0.671,None
finn-b-M13_RECUDISLOCATIO,Recurrent dislocation and subluxation of joint,Joint subluxation,HP:0032153,http://purl.obolibrary.org/obo/HP_0032153,0.746,None
finn-b-DM_OTHER_WIDE,"Other diabetes, wide definition",diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.997,None
finn-b-ST19_FRACT_FEMUR,Fracture of femur,femur fracture,EFO:0008553,http://www.ebi.ac.uk/efo/EFO_0008553,0.994,None
ebi-a-GCST009980,Major depressive disorder in trauma exposed individuals,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.619,None
finn-b-H8_MIDDLEADDH,Adhesive middle ear disease,middle ear disorder,MONDO:0003276,http://purl.obolibrary.org/obo/MONDO_0003276,0.783,None
ukb-e-5181_CSA,Ever had eye surgery,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.785,None
finn-b-CD2_BENIGN_UTERUS_NOS,Other benign neoplasm of uterus: Other parts/unspecified,uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.887,None
finn-b-H7_GLAUCSECDISEASE,Glaucoma secondary to other eye disorders,secondary dysgenetic glaucoma,MONDO:0020216,http://purl.obolibrary.org/obo/MONDO_0020216,0.655,None
finn-b-CD2_INSITU_SKIN_LOWERLIMB_EXALLC,"""Carcinoma in situ of skin of lower limb, including hip"" (all cancers excluded)",skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.64,None
finn-b-N14_OTHNONINFVULV,Other noninflammatory disorders of vulva and perineum,vulvar disease,MONDO:0002187,http://purl.obolibrary.org/obo/MONDO_0002187,0.644,None
ukb-e-30130_EAS,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
ukb-d-C34,Diagnoses - main ICD10: C34 Malignant neoplasm of bronchus and lung,bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.786,None
finn-b-ALCOGASTRITIS,Alcoholic gastritis (ALCOGASTRITIS),alcoholic gastritis,MONDO:0004640,http://purl.obolibrary.org/obo/MONDO_0004640,0.897,None
ukb-e-PP_p1_AFR,"Pulse pressure, automated reading",pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.626,None
finn-b-E4_ENDODIS,Other endocrine disorders,endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.989,None
ebi-a-GCST90013534,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-H7_OTHRETARTOCC,Other retinal artery occlusion,retinal artery occlusion,EFO:1001154,http://www.ebi.ac.uk/efo/EFO_1001154,0.997,None
ukb-e-2754_AFR,Age at first live birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.827,None
ukb-e-21001_MID,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
bbj-a-83,Smoking behaviors : Smoking cessation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.841,None
ukb-e-5159_AFR,3mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
ebi-a-GCST005194,Coronary artery disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.992,None
finn-b-L12_OTHERMELANIN,Other melanin hyperpigmentation,hyperpigmentation of the skin,MONDO:0019289,http://purl.obolibrary.org/obo/MONDO_0019289,0.725,None
ukb-e-1508_p2_CSA,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-F5_PERSOBEH,Disorders of adult personality and behaviour,Atypical behavior,HP:0000708,http://purl.obolibrary.org/obo/HP_0000708,0.677,None
finn-b-AB1_TOXOPLASMOSIS,Toxoplasmosis,toxoplasmosis,EFO:0007517,http://www.ebi.ac.uk/efo/EFO_0007517,0.992,None
finn-b-CD2_BENIGN_SKIN_NOS_EXALLC,"""Benign neoplasm: Skin, unspecified"" (all cancers excluded)",benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.882,None
ukb-a-210,Illnesses of mother: Alzheimer's disease/dementia,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.742,None
ukb-e-30090_AFR,Platelet crit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.994,None
ukb-e-5089_AFR,Astigmatism angle (left),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.746,None
ukb-e-recode322_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-563,Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee],joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.694,None
ieu-a-1229,Serous ovarian cancer: low grade and low malignant potential,Borderline Ovarian Serous Tumor,EFO:1000139,http://www.ebi.ac.uk/efo/EFO_1000139,0.827,None
finn-b-CREST,CR(E)ST syndrome,syndromic disease,MONDO:0002254,http://purl.obolibrary.org/obo/MONDO_0002254,0.734,None
finn-b-F5_NEUROTIC,"Neurotic, stress-related and somatoform disorders",somatoform disorder,EFO:0009687,http://www.ebi.ac.uk/efo/EFO_0009687,0.697,None
finn-b-M13_HTROMBMICROANG,Thrombotic microangiopathy,thrombotic microangiopathy,MONDO:0019737,http://purl.obolibrary.org/obo/MONDO_0019737,0.99,None
finn-b-ST19_INJURY_NERVES_FOREA_LEVEL,Injury of nerves at forearm level,nervous system injury,EFO:0009490,http://www.ebi.ac.uk/efo/EFO_0009490,0.616,None
ukb-e-100240_AFR,Coffee consumed,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.787,None
finn-b-R18_OTHER_LACK_COORD,Other lack of coordination,Dysmetria,HP:0001310,http://purl.obolibrary.org/obo/HP_0001310,0.828,None
ukb-b-6077,"Diagnoses - secondary ICD10: N39.0 Urinary tract infection, site not specified",urinary tract infection,EFO:0003103,http://www.ebi.ac.uk/efo/EFO_0003103,0.634,None
ukb-e-30600_CSA,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
finn-b-N14_FEMALEINFERT,Female infertility,female infertility,EFO:0008560,http://www.ebi.ac.uk/efo/EFO_0008560,0.992,None
finn-b-I9_RHEUFEVHRT,Rheumatic fever with heart involvement,rheumatic fever,EFO:1001160,http://www.ebi.ac.uk/efo/EFO_1001160,0.645,None
ukb-e-20003_p13_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-GE_MODE,"Generalized epilepsy, mode (most common among epilepsy diagnosis)",generalised epilepsy,EFO:0005917,http://www.ebi.ac.uk/efo/EFO_0005917,0.794,None
finn-b-F5_SCHIZOAFF,Schizoaffective disorder,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.994,None
finn-b-M13_POLYMYALGIA,Polymyalgia rheumatica,temporal arteritis,EFO:1001209,http://www.ebi.ac.uk/efo/EFO_1001209,0.994,None
ukb-e-5181_AFR,Ever had eye surgery,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.785,None
finn-b-E4_DM2KETO,Type 2 diabetes with ketoacidosis,diabetic ketoacidosis,EFO:1000897,http://www.ebi.ac.uk/efo/EFO_1000897,0.805,None
ukb-b-3700,Operation code: hysterectomy,hysterectomy,EFO:0003881,http://www.ebi.ac.uk/efo/EFO_0003881,0.785,None
ukb-e-5983_CSA,"ECG, heart rate",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.723,None
ukb-e-recode371_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-3062_MID,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
finn-b-NIV,Non-invasive ventilation,invasive mechanical ventilation,EFO:0010720,http://www.ebi.ac.uk/efo/EFO_0010720,0.953,None
finn-b-CD2_BENIGN_OTHER_NOS_EXALLC,Benign neoplasm of other and unspecified sites (all cancers excluded),benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.746,None
ukb-e-6017_CSA,Able to walk or cycle unaided for 10 minutes,"ability to walk or cycle unaided for 10 minutes, self-reported",EFO:0009822,http://www.ebi.ac.uk/efo/EFO_0009822,0.71,None
ukb-d-680_6,Own or rent accommodation lived in: Live in accommodation rent free,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.701,None
ukb-e-recode245_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1845_EAS,Mother's age,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.615,None
finn-b-CD2_BENIGN_CRANIAL_NERVE_EXALLC,Benign neoplasm: Cranial nerves (all cancers excluded),cranial nerve neoplasm,MONDO:0002633,http://purl.obolibrary.org/obo/MONDO_0002633,0.761,None
finn-b-G6_MIGRAINE_WITH_AURA,Migraine with aura,migraine with aura,MONDO:0005475,http://purl.obolibrary.org/obo/MONDO_0005475,0.993,None
finn-b-I9_MI_COMPLICATIONS,Complications following myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.737,None
finn-b-H7_STRABNAS,Other specified and unspecified strabismus,Strabismus,HP:0000486,http://purl.obolibrary.org/obo/HP_0000486,0.99,None
ukb-e-recode160_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-KRA_PSY_MENTALRET_EXMORE,Mental retardation (more controls excluded),Intellectual disability,HP:0001249,http://purl.obolibrary.org/obo/HP_0001249,0.988,None
ukb-b-2205,Diagnoses - secondary ICD10: Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.622,None
finn-b-C3_OTHER_SKIN,Other malignant neoplasms of skin (=non-melanoma skin cancer),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.807,None
finn-b-N14_BREASTDISOTH,Other disorders of breast,breast disease,EFO:0009483,http://www.ebi.ac.uk/efo/EFO_0009483,0.906,None
ukb-b-2592,"Non-cancer illness code, self-reported: irritable bowel syndrome",irritable bowel syndrome,EFO:0000555,http://www.ebi.ac.uk/efo/EFO_0000555,0.714,None
ukb-e-30090_CSA,Platelet crit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.994,None
finn-b-C3_RECTOSIGMOID_JUNCTION_EXALLC,Malignant neoplasm of rectosigmoid junction (all cancers excluded),rectosigmoid junction neoplasm,MONDO:0002423,http://purl.obolibrary.org/obo/MONDO_0002423,0.84,None
ukb-d-ASTHMA_MEDICATIO_COMORB,Medication related adverse effects,adverse effect,EFO:0009658,http://www.ebi.ac.uk/efo/EFO_0009658,0.725,None
finn-b-ARTHRO_SPEC,Other specific arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.61,None
finn-b-H7_DACRYOADENITIS,Dacryoadenitis,dacryoadenitis,MONDO:0004804,http://purl.obolibrary.org/obo/MONDO_0004804,0.988,None
ukb-e-Z85_CSA,Z85 Personal history of malignant neoplasm,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.667,None
finn-b-I9_CARDMPRI,"Cardiomyopathies, Primary/intrinsic",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.872,None
ebi-a-GCST005195,Coronary artery disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.992,None
ukb-d-H7_RETINALDETACH,Retinal detachments and breaks,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.768,None
ukb-e-20002_p180_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-H7_NYSTAGMUS,Nystagmus and other irregular eye movements,Nystagmus,HP:0000639,http://purl.obolibrary.org/obo/HP_0000639,0.659,None
finn-b-CD2_BENIGN_CAECUM,Benign neoplasm: Caecum,cecal neoplasm,EFO:0009255,http://www.ebi.ac.uk/efo/EFO_0009255,0.845,None
ieu-b-102,Major depression,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.994,None
ukb-e-100015_CSA,Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.797,None
ukb-e-1807_MID,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
ukb-a-295,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
ukb-e-20116_p1_EAS,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ukb-a-109,Non-cancer illness code  self-reported: hiatus hernia,Hiatus hernia,HP:0002036,http://purl.obolibrary.org/obo/HP_0002036,0.608,None
finn-b-L12_SKINSUBCUTISNAS,Other and unspecified disorders of skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.954,None
ukb-b-11413,Pain type(s) experienced in last month: Stomach or abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.633,None
finn-b-COPD_HOSPITAL,"COPD, hospital admissions",chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.999,None
finn-b-N14_FEMGENPROL,Female genital prolapse,prolapse of female genital organ,MONDO:0001592,http://purl.obolibrary.org/obo/MONDO_0001592,0.84,None
ukb-e-23127_AFR,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
ukb-e-recode1_MID,Indirect bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.66,None
ebi-a-GCST90026455,HTLV-1 associated myelopathy,tropical spastic paraparesis,EFO:0007527,http://www.ebi.ac.uk/efo/EFO_0007527,0.799,None
ukb-e-30110_CSA,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
finn-b-D3_ITP,Idiopathic thrombocytopenic purpura,autoimmune thrombocytopenic purpura,EFO:0007160,http://www.ebi.ac.uk/efo/EFO_0007160,0.989,None
ukb-e-recode431_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_ANEURYSM,"Cerebral aneurysm, nonruptured",brain aneurysm,EFO:0003870,http://www.ebi.ac.uk/efo/EFO_0003870,0.698,None
finn-b-G6_ENCEPHOTH,Other encephalitis,encephalitis,MONDO:0019956,http://purl.obolibrary.org/obo/MONDO_0019956,0.989,None
ebi-a-GCST001198,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
finn-b-H8_INNER,Diseases of inner ear,inner ear disease,EFO:0009672,http://www.ebi.ac.uk/efo/EFO_0009672,0.913,None
ukb-e-recode178_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_DORSALGIA,Dorsalgia,dorsal,EFO:0001656,http://www.ebi.ac.uk/efo/EFO_0001656,0.722,None
ukb-a-463,Vitamin and mineral supplements: Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.693,None
ukb-e-recode383_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_HYPERPRO,Hyperprolactinaemia,hyperprolactinemia,EFO:0007319,http://www.ebi.ac.uk/efo/EFO_0007319,0.981,None
ukb-e-1279_EAS,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
ukb-e-30000_AFR,White blood cell (leukocyte) count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.797,None
finn-b-CD2_BENIGN_PARATHYROID_EXALLC,Benign neoplasm: Parathyroid gland (all cancers excluded),benign neoplasm of parathyroid gland,MONDO:0021463,http://purl.obolibrary.org/obo/MONDO_0021463,0.929,None
finn-b-ST19_TRAUMAT_SUBAR_HAEMORRHAGE,Traumatic subarachnoid haemorrhage,subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.865,None
ukb-e-4559_EAS,Family relationship satisfaction,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.785,None
ukb-e-6142_p6_CSA,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-e-recode219_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-680_p4_CSA,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-H8_EAR,Diseases of the ear and mastoid process,auditory system disease,EFO:1001455,http://www.ebi.ac.uk/efo/EFO_1001455,0.756,None
finn-b-I9_THROMBOTH_EXNONE,Other embolism and thrombosis (no controls excluded),Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.916,None
finn-b-I9_INTRACRA,Nontraumatic intracranial haemmorrhage,intracranial hemorrhage,EFO:0000551,http://www.ebi.ac.uk/efo/EFO_0000551,0.759,None
finn-b-CD2_BENIGN_UTERUS_OTH_EXALLC,Other benign neoplasms of uterus (all cancers excluded),uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.896,None
ukb-e-6138_p3_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-30530_CSA,Sodium in urine,urinary sodium measurement,EFO:0021522,http://www.ebi.ac.uk/efo/EFO_0021522,0.963,None
finn-b-L12_URTICARIA,Urticaria,urticaria,EFO:0005531,http://www.ebi.ac.uk/efo/EFO_0005531,0.991,None
ukb-d-N39,Diagnoses - main ICD10: N39 Other disorders of urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.71,None
ukb-a-380,Shortness of breath walking on level ground,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.695,None
finn-b-D3_IMMUDEFANTIBODYNAS,Other and unspecified immunodeficiencies with predominantly antibody defects,Other immunodeficiency syndrome with predominantly antibody defects,ORPHANET.ORDO:331244,http://www.orpha.net/ORDO/Orphanet_331244,0.861,None
ukb-a-521,Diagnoses - main ICD10: D12 Benign neoplasm of colon  rectum  anus and anal canal,benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.634,None
ukb-e-740_CSA,Osteoarthrosis,osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.995,None
finn-b-CD2_BENIGN_MALE_GEN,Benign neoplasm of male genital organs,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.823,None
ukb-a-556,Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions,anus disease,EFO:0009660,http://www.ebi.ac.uk/efo/EFO_0009660,0.672,None
ukb-e-30630_CSA,Apolipoprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.853,None
finn-b-J10_COLD,Acute nasopharyngitis(common cold),common cold,EFO:0007214,http://www.ebi.ac.uk/efo/EFO_0007214,0.82,None
finn-b-N14_URETHRAOTH,Other disorders of urethra and urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.808,None
ukb-b-14699,Illnesses of mother: Alzheimer's disease/dementia,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.742,None
ukb-d-22506_114,Tobacco smoking: Never smoked,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.83,None
finn-b-H8_EXTDISINOTH,"Disorder of external ear, unspecified",external ear disease,EFO:0009668,http://www.ebi.ac.uk/efo/EFO_0009668,0.994,None
ukb-e-4120_AFR,Heel broadband ultrasound attenuation (right),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.883,None
ukb-e-20003_p5_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-d-K11_BARRET,Barret oesophagus,Barrett's esophagus,EFO:0000280,http://www.ebi.ac.uk/efo/EFO_0000280,0.814,None
finn-b-C3_SKIN,Malignant neoplasm of skin,skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.993,None
ukb-e-30710_EAS,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
ukb-e-197_AFR,Chemotherapy,response to combination chemotherapy,EFO:0007965,http://www.ebi.ac.uk/efo/EFO_0007965,0.674,None
ukb-d-I47,Diagnoses - main ICD10: I47 Paroxysmal tachycardia,paroxysmal tachycardia,EFO:0009493,http://www.ebi.ac.uk/efo/EFO_0009493,0.801,None
ieu-a-7,Coronary heart disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.993,None
finn-b-CD2_BENIGN_NOS,Benign neoplasm: Other/unspecified site,benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.866,None
ukb-b-5126,Diagnoses - main ICD10: I21.1 Acute transmural myocardial infarction of inferior wall,inferior myocardial infarction,EFO:1000983,http://www.ebi.ac.uk/efo/EFO_1000983,0.718,None
ukb-e-599_AFR,Other symptoms/disorders or the urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.762,None
ebi-a-GCST006650,Menstruation quality of life impact (pressure in breast),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.705,None
finn-b-Q17_ANKYLOGLOSSIA,Ankyloglossia,"cleft palate with or without ankyloglossia, X-linked",MONDO:0010560,http://purl.obolibrary.org/obo/MONDO_0010560,0.735,None
finn-b-CHRONMYELOPRO,Chronic myeloproliferative disease,myeloproliferative disorder,EFO:0004251,http://www.ebi.ac.uk/efo/EFO_0004251,0.99,None
ukb-a-306,Diabetes diagnosed by doctor,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.661,None
ukb-d-G6_CARPTU,Carpal tunnel syndrome,carpal tunnel syndrome,EFO:0004143,http://www.ebi.ac.uk/efo/EFO_0004143,0.967,None
ukb-e-1279_AFR,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
finn-b-H7_LENS,Disorders of lens,lens disease,EFO:0009674,http://www.ebi.ac.uk/efo/EFO_0009674,0.861,None
finn-b-G6_FACOTH,Other facial nerve disorders,facial nerve disease,EFO:1002051,http://www.ebi.ac.uk/efo/EFO_1002051,0.936,None
ieu-a-832,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-CD2_BENIGN_LIP,Benign neoplasm: Lip,benign neoplasm of lip,MONDO:0021496,http://purl.obolibrary.org/obo/MONDO_0021496,0.994,None
finn-b-N14_GLOMEINOTH,Glomerular disorders in diseases classified elsewhere,glomerular disease,EFO:1002049,http://www.ebi.ac.uk/efo/EFO_1002049,0.847,None
finn-b-DIABETES_FG,"Diabetes, varying definitions",diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.656,None
finn-b-DM_RETINA_PROLIF,Proliferative diabetic retinopathy (DM_RETINA_PROLIF),proliferative diabetic retinopathy,EFO:0009322,http://www.ebi.ac.uk/efo/EFO_0009322,0.897,None
finn-b-I9_ENDOCARD,Endocarditis,endocarditis,EFO:0000465,http://www.ebi.ac.uk/efo/EFO_0000465,0.997,None
ukb-e-21000_p17_CSA,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-H7_AMD,Age-related macular degeneration (whether dry or wet),wet macular degeneration,EFO:0004683,http://www.ebi.ac.uk/efo/EFO_0004683,0.84,None
ukb-e-recode177_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-C3_LARYNX_EXALLC,Malignant neoplasm of larynx (all cancers excluded),Malignant Laryngeal Neoplasm,EFO:1000354,http://www.ebi.ac.uk/efo/EFO_1000354,0.917,None
finn-b-I9_SECONDRIGHT_EXNONE,Secondary right heart disease (no controls excluded),heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.626,None
ukb-b-18018,Operative procedures - main OPCS: K49.1 Percutaneous transluminal balloon angioplasty of one coronary artery,percutaneous transluminal coronary angioplasty,EFO:0003951,http://www.ebi.ac.uk/efo/EFO_0003951,0.716,None
ebi-a-GCST90016620,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.661,None
finn-b-I9_STR_EXNONE,"""Stroke, excluding SAH"" (no controls excluded)",subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.654,None
ukb-e-120_p1_AFR,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
finn-b-J10_LARYNGITIS,Acute laryngitis and tracheitis,acute laryngitis,MONDO:0004777,http://purl.obolibrary.org/obo/MONDO_0004777,0.812,None
ukb-b-3083,Operation code: mastectomy,mastectomy,EFO:0020987,http://www.ebi.ac.uk/efo/EFO_0020987,0.779,None
finn-b-K11_RETROG_MAXILLAE,Maxillary retrognathism,Hypoplasia of the maxilla,HP:0000327,http://purl.obolibrary.org/obo/HP_0000327,0.882,None
ukb-e-recode196_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-R18_SYMPTOMS_SIGNS_INVOLVI_APPEA_BEHVI,Symptoms and signs involving appearance and behaviour,Atypical behavior,HP:0000708,http://purl.obolibrary.org/obo/HP_0000708,0.633,None
finn-b-G6_MUSDYST,Muscular dystrophy,muscular dystrophy,MONDO:0020121,http://purl.obolibrary.org/obo/MONDO_0020121,0.99,None
ukb-e-recode146_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_MINERAL_MET,Disorders of mineral metabolism,mineral metabolism disease,EFO:0009556,http://www.ebi.ac.uk/efo/EFO_0009556,0.956,None
ukb-e-3144_EAS,"Heel Broadband ultrasound attenuation, direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.835,None
ukb-d-L12_OTHERDISSKINANDSUBCUTIS,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.954,None
finn-b-E4_HYPERCHOL,Pure hypercholesterolaemia,familial hypercholesterolemia,EFO:0004911,http://www.ebi.ac.uk/efo/EFO_0004911,0.798,None
ukb-e-5540_p1_AFR,Surgery/amputation of toe or leg,amputation,EFO:0009632,http://www.ebi.ac.uk/efo/EFO_0009632,0.605,None
finn-b-AB1_SPIROCHE_OTHER,"Spirochaetal infections, other/unspecified",Spirochaetales Infections,EFO:0009567,http://www.ebi.ac.uk/efo/EFO_0009567,0.917,None
ukb-e-411_AFR,Ischemic Heart Disease,Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.991,None
ukb-e-2395_p4_AFR,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
ukb-d-N60,Diagnoses - main ICD10: N60 Benign mammary dysplasia,breast fibrocystic disease,EFO:0003014,http://www.ebi.ac.uk/efo/EFO_0003014,0.678,None
finn-b-E4_DMNASKETO,Unspecified diabetes with ketoacidosis,diabetic ketoacidosis,EFO:1000897,http://www.ebi.ac.uk/efo/EFO_1000897,0.854,None
ebi-a-GCST90014325,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
finn-b-CD2_FOLLICULAR_LYMPHOMA_EXALLC,Follicular lymphoma (all cancers excluded),follicular lymphoma,MONDO:0018906,http://purl.obolibrary.org/obo/MONDO_0018906,0.903,None
finn-b-L12_ERYTHEMANODOSUM,Erythema nodosum,Erythema nodosum,HP:0012219,http://purl.obolibrary.org/obo/HP_0012219,0.994,None
finn-b-N14_ENDOMETRIOSIS_UTERUS,Endometriosis of uterus,adenomyosis,MONDO:0010888,http://purl.obolibrary.org/obo/MONDO_0010888,0.992,None
finn-b-KRA_PSY_PUERPER,"Mental and behabioural disorders of puerperum, not classified elsewhere",puerperal disorder,EFO:0009683,http://www.ebi.ac.uk/efo/EFO_0009683,0.621,None
ukb-e-30830_MID,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
ukb-e-recode437_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-VWXY20_SUICI_OTHER_INTENTI_SELF_H,Suicide or other Intentional self-harm,suicide,EFO:0007624,http://www.ebi.ac.uk/efo/EFO_0007624,0.619,None
ebi-a-GCST90016606,Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.772,None
ebi-a-GCST005904,Major depressive disorder (probable),major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.839,None
finn-b-ASTHMA_HOSPITAL_MAIN,"Asthma, hospital admissions , main diagnosis only",asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-e-52_p6_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-M13_SPONDYLINFLAMNAS,Other specified/unspecified inflammatory spondylopathies,inflammatory spondylopathy,MONDO:0001434,http://purl.obolibrary.org/obo/MONDO_0001434,0.902,None
ukb-e-30260_CSA,Mean reticulocyte volume,mean reticulocyte volume,EFO:0010701,http://www.ebi.ac.uk/efo/EFO_0010701,0.982,None
ukb-b-11274,"Diagnoses - main ICD10: K60.2 Anal fissure, unspecified",Anal fissure,HP:0012390,http://purl.obolibrary.org/obo/HP_0012390,0.608,None
ukb-e-recode98_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1807_EAS,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
finn-b-I9_VARICVE,Varicose veins,Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.991,None
ieu-a-831,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-I9_HYPTENSHR_EXNONE,Hypertensive heart and/or renal disease (no controls excluded),hypertensive heart disease,MONDO:0001302,http://purl.obolibrary.org/obo/MONDO_0001302,0.87,None
finn-b-L12_PIGMENTNAS,Other and unspecified disorders of pigmentation,skin pigmentation disorder,MONDO:0019288,http://purl.obolibrary.org/obo/MONDO_0019288,0.815,None
finn-b-Z21_CARRIER_INFECTIOUS_DISEA,Carrier of infectious disease,infectious disease,EFO:0005741,http://www.ebi.ac.uk/efo/EFO_0005741,0.766,None
finn-b-H7_PAPILLOEDEMA,"Papilloedema, unspecified",papilledema,MONDO:0002003,http://purl.obolibrary.org/obo/MONDO_0002003,0.992,None
ukb-d-I9_UAP,Unstable angina pectoris,intermediate coronary syndrome,EFO:1000985,http://www.ebi.ac.uk/efo/EFO_1000985,0.821,None
finn-b-ASTHMA_INFECTIONS,Asthma-related infections,Prosthesis-Related Infections,EFO:1001406,http://www.ebi.ac.uk/efo/EFO_1001406,0.603,None
finn-b-K11_FEMHER,Femoral hernia,femoral hernia,EFO:1001791,http://www.ebi.ac.uk/efo/EFO_1001791,0.993,None
ukb-e-30890_EAS,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
finn-b-F5_OPIOIDS,Mental and behavioural disorders due to opioids,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.719,None
ukb-e-459_AFR,Other disorders of circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.951,None
finn-b-I9_HYPTENSPUL_EXNONE,"""Hypertension, Pulmonary Arterial"" (no controls excluded)",pulmonary arterial hypertension,EFO:0001361,http://www.ebi.ac.uk/efo/EFO_0001361,0.957,None
finn-b-CD2_BENIGN_RECTUM_ANAL_EXALLC,"""Benign neoplasm: Rectum, anus and anal canal"" (all cancers excluded)",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.73,None
ukb-e-20002_p19_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-P16_DISORD_RELATED_GESTATION_LOW_BIRTHWGHTT_NECIFIED,"Disorders related to short gestation and low birth weight, not elsewhere classified",Small for gestational age,HP:0001518,http://purl.obolibrary.org/obo/HP_0001518,0.625,None
finn-b-N14_TORSIOTEST,Torsion of testis,Testicular torsion,HP:0100813,http://purl.obolibrary.org/obo/HP_0100813,0.767,None
ukb-b-19191,Mouth/teeth dental problems: Toothache,toothache,EFO:0010072,http://www.ebi.ac.uk/efo/EFO_0010072,0.604,None
ukb-e-recode335_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-4507,Diagnoses - main ICD10: R04.2 Haemoptysis,Hemoptysis,HP:0002105,http://purl.obolibrary.org/obo/HP_0002105,0.718,None
ukb-b-13731,Diagnoses - main ICD10: K22.1 Ulcer of oesophagus,esophageal ulcer,MONDO:0044782,http://purl.obolibrary.org/obo/MONDO_0044782,0.637,None
ukb-e-30140_MID,Neutrophill count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.886,None
finn-b-I9_ANGINA_EXNONE,Angina pectoris (no controls excluded),angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.923,None
finn-b-G6_MIGRAINE_NO_AURA,Migraine without aura,migraine without aura,MONDO:0100431,http://purl.obolibrary.org/obo/MONDO_0100431,0.993,None
ieu-a-800,Bipolar disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.992,None
finn-b-M13_SHORTACHILLES,Short Achilles tendon (acquired),distal arthrogryposis type 10,MONDO:0016675,http://purl.obolibrary.org/obo/MONDO_0016675,0.993,None
finn-b-J10_RESPCONDEXT,Respiratory conditions due to other external agents,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.832,None
finn-b-R18_DISTU_SMELL_TASTE,Disturbances of smell and taste,disturbances of sensation of smell and taste,EFO:0009543,http://www.ebi.ac.uk/efo/EFO_0009543,0.912,None
finn-b-H7_PTOSIS,Ptosis of eyelid,ptosis,MONDO:0000728,http://purl.obolibrary.org/obo/MONDO_0000728,0.969,None
ukb-e-6155_p7_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-recode182_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-4303,Diagnoses - secondary ICD10: K80.2 Calculus of gallbladder without cholecystitis,acalculous cholecystitis,EFO:1000790,http://www.ebi.ac.uk/efo/EFO_1000790,0.654,None
ukb-e-2754_EAS,Age at first live birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.827,None
ukb-e-recode4_MID,"Estimated glomerular filtration rate, serum creatinine",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.759,None
ukb-d-IV_ENDOCRIN_NUTRIT,"Endocrine, nutritional and metabolic diseases",endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.645,None
finn-b-I9_MI_STRICT_EXNONE,"""Myocardial infarction, strict"" (no controls excluded)",myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.948,None
ukb-e-recode354_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-822,Pancreatic cancer,Malignant Pancreatic Neoplasm,EFO:1000359,http://www.ebi.ac.uk/efo/EFO_1000359,0.987,None
ukb-e-recode178_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-G6_PARKINSON_EXMORE,Parkinson's disease (more controls excluded),Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
ukb-d-I9_NONRHEVALV,Non-rheumatic valve diseases,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.739,None
finn-b-KRA_PSY_PERSON,Personality disorders,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.951,None
ukb-e-52_p4_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ieu-a-1096,Childhood obesity,childhood acute lymphoblastic leukemia,MONDO:0000870,http://purl.obolibrary.org/obo/MONDO_0000870,0.684,None
ieu-a-1122,Low grade serous ovarian cancer,ovarian serous adenocarcinoma,EFO:0002917,http://www.ebi.ac.uk/efo/EFO_0002917,0.802,None
finn-b-O15_ABORT_SPONTAN,Spontaneous abortion,Miscarriage,HP:0005268,http://purl.obolibrary.org/obo/HP_0005268,0.994,None
finn-b-M13_LIMBPAIN,Pain in limb,Limb pain,HP:0009763,http://purl.obolibrary.org/obo/HP_0009763,0.996,None
finn-b-C3_NSCLC_ADENO_EXALLC,"""Non-small cell lung cancer, adenocarcinoma"" (all cancers excluded)",lung adenocarcinoma,EFO:0000571,http://www.ebi.ac.uk/efo/EFO_0000571,0.734,None
finn-b-Q17_CRANIOSYNOSTOSIS,Craniosynostosis,craniosynostosis,MONDO:0015469,http://purl.obolibrary.org/obo/MONDO_0015469,0.989,None
ebi-a-GCST005810,Osteoarthritis of the hip (hospital diagnosed),"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.882,None
ukb-e-30700_CSA,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ukb-e-562_CSA,Diverticulosis and diverticulitis,diverticulitis,EFO:1001460,http://www.ebi.ac.uk/efo/EFO_1001460,0.92,None
ieu-a-1136,ER- Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.668,None
finn-b-CD2_BENIGN_EYE,Benign neoplasm of eye and adnexa,benign neoplasm of eye,MONDO:0021454,http://purl.obolibrary.org/obo/MONDO_0021454,0.771,None
ieu-b-4874,Bladder cancer,gallbladder cancer,MONDO:0005411,http://purl.obolibrary.org/obo/MONDO_0005411,0.866,None
finn-b-PULM_PNEUMONIA_SEPSIS,COPD/asthma/ILD related pneumonia or pneumonia derived septichaemia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.733,None
ukb-a-58,Cancer code  self-reported: malignant melanoma,melanoma,EFO:0000756,http://www.ebi.ac.uk/efo/EFO_0000756,0.714,None
ebi-a-GCST006643,Menstruation quality of life impact (bowel movement),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.674,None
finn-b-H7_ORBITINFLAMACU,Acute inflammation of orbit,acute orbital inflammation,MONDO:0001230,http://purl.obolibrary.org/obo/MONDO_0001230,0.995,None
finn-b-CD2_BENIGN_BONE_SHORT_LOWER_EXALLC,Benign neoplasm: Short bones of lower limb (all cancers excluded),cancer of long bone of lower limb,MONDO:0000952,http://purl.obolibrary.org/obo/MONDO_0000952,0.645,None
ukb-e-N18_CSA,N18 Chronic renal failure,stage 5 chronic kidney disease,EFO:0009909,http://www.ebi.ac.uk/efo/EFO_0009909,0.84,None
finn-b-I9_MI_STRICT,"Myocardial infarction, strict",myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
finn-b-C3_URINARY_TRACT,Malignant neoplasm of urinary organs,Malignant Urinary System Neoplasm,EFO:1000363,http://www.ebi.ac.uk/efo/EFO_1000363,0.759,None
ukb-e-78_p1_AFR,"Heel bone mineral density (BMD) T-score, automated",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.695,None
finn-b-CD2_BENIGN_BONE_SHORT_LOWER,Benign neoplasm: Short bones of lower limb,bone benign neoplasm,MONDO:0000631,http://purl.obolibrary.org/obo/MONDO_0000631,0.675,None
finn-b-K11_GULC,Gastric ulcer,gastric ulcer,EFO:0009454,http://www.ebi.ac.uk/efo/EFO_0009454,0.996,None
finn-b-VWXY20_ACCIDENTS,Accidents,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.686,None
finn-b-L12_PRURIGONOD,Prurigo nodularis,prurigo nodularis,MONDO:0026045,http://purl.obolibrary.org/obo/MONDO_0026045,0.992,None
ukb-b-4226,"Diagnoses - secondary ICD10: E03.9 Hypothyroidism, unspecified",central congenital hypothyroidism,MONDO:0016410,http://purl.obolibrary.org/obo/MONDO_0016410,0.73,None
ukb-e-6138_p2_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-20082_CSA,Duration of questionnaire,health study participation,EFO:0010130,http://www.ebi.ac.uk/efo/EFO_0010130,0.678,None
ukb-e-2100_MID,"Seen a psychiatrist for nerves, anxiety, tension or depression","seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported",EFO:0009821,http://www.ebi.ac.uk/efo/EFO_0009821,0.735,None
finn-b-I9_HEARTFAIL_NS,"Heart failure, not strict",heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
finn-b-M13_JUVOSTEOCHONRHIP,Juvenile osteochondrosis,Juvenile Osteochondrosis,EFO:0008577,http://www.ebi.ac.uk/efo/EFO_0008577,0.991,None
ukb-e-721_CSA,Spondylosis and allied disorders,spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.706,None
ukb-e-41231_EAS,Hospital episode type,episodic ataxia type 1,MONDO:0008047,http://purl.obolibrary.org/obo/MONDO_0008047,0.634,None
ukb-e-6149_p6_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-100022_AFR,Alcohol,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.796,None
finn-b-L12_ACNE_NAS,Other  and unspecified acne,acne,EFO:0003894,http://www.ebi.ac.uk/efo/EFO_0003894,0.999,None
ukb-e-4195_EAS,Pulse wave reflection index,pulse wave reflection index measurement,EFO:0009804,http://www.ebi.ac.uk/efo/EFO_0009804,0.927,None
ukb-e-41_AFR,Bacterial infection NOS,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.878,None
finn-b-AB1_SALMONELLA_OTH,Other salmonella infections,Salmonella Infections,EFO:1001418,http://www.ebi.ac.uk/efo/EFO_1001418,0.991,None
ukb-e-30210_AFR,Eosinophill percentage,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.922,None
finn-b-H7_CONVERGINSUFF,Convergence insufficiency and excess,Renal insufficiency,HP:0000083,http://purl.obolibrary.org/obo/HP_0000083,0.619,None
ukb-b-8193,"Cancer code, self-reported: bladder cancer",gallbladder cancer,MONDO:0005411,http://purl.obolibrary.org/obo/MONDO_0005411,0.685,None
ukb-e-20002_p19_EAS,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-G6_SCIALE,Lesion of sciatic nerve,lesion of sciatic nerve,MONDO:0001543,http://purl.obolibrary.org/obo/MONDO_0001543,0.994,None
finn-b-H7_ENTROPION,Entropion and trichiasis of eyelid,Trichiasis,HP:0001128,http://purl.obolibrary.org/obo/HP_0001128,0.692,None
finn-b-C3_LUNG_NONSMALL,Non-small cell lung cancer,small cell lung carcinoma,EFO:0000702,http://www.ebi.ac.uk/efo/EFO_0000702,0.942,None
ukb-e-20117_p3_EAS,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
bbj-a-151,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-C3_SECONDARY_NAS_EXALLC,Secondary malignant neoplasm of other and unspecified sites (all cancers excluded),secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.806,None
finn-b-ST19_CONCUSSION,Concussion,concussion,EFO:0011023,http://www.ebi.ac.uk/efo/EFO_0011023,0.992,None
ukb-a-553,Diagnoses - main ICD10: K51 Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.681,None
ukb-e-785_AFR,Abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.989,None
finn-b-H7_SCLERITIS,Scleritis,scleritis,MONDO:0001718,http://purl.obolibrary.org/obo/MONDO_0001718,0.997,None
bbj-a-78,Smoking behaviors : Smoking initiation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.852,None
finn-b-C3_BREAST_HERNEG,"Malignant neoplasm of breast, HER-negative",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.797,None
finn-b-F5_DEMNAS,Unspecified dementia,Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
ukb-d-4067,Facial pains for 3+ months,facial pain,EFO:0009625,http://www.ebi.ac.uk/efo/EFO_0009625,0.609,None
finn-b-M13_OTHERBONE,Otherdisorders of bone,bone disease,EFO:0004260,http://www.ebi.ac.uk/efo/EFO_0004260,0.632,None
ukb-e-100018_CSA,Retinol,retinol measurement,EFO:0007900,http://www.ebi.ac.uk/efo/EFO_0007900,0.758,None
finn-b-CD2_BENIGN_BRAIN_SUPRATENT,"Benign neoplasm: Brain, supratentorial",supratentorial cancer,MONDO:0002071,http://purl.obolibrary.org/obo/MONDO_0002071,0.823,None
finn-b-CD2_BENIGN_LIPO_SKIN_HEADFACENECK_EXALLC,"""Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck"" (all cancers excluded)",benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.634,None
ieu-b-4965,Colorectal cancer,colorectal cancer,EFO:0005842,http://www.ebi.ac.uk/efo/EFO_0005842,0.993,None
finn-b-M13_PATHODISLOCATIO,"Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified",Joint subluxation,HP:0032153,http://purl.obolibrary.org/obo/HP_0032153,0.663,None
finn-b-H7_RETINALDETACHBREAK,Retinal detachment with retinal break,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.813,None
ukb-d-X_RESPIRATORY,Diseases of the respiratory system,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.954,None
finn-b-THYROIDITIS,Thyroiditis,thyroiditis,MONDO:0004126,http://purl.obolibrary.org/obo/MONDO_0004126,0.995,None
ukb-b-10066,Eye problems/disorders: Other serious eye condition,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.684,None
ukb-b-11632,Treatment/medication code: atenolol,atenolol measurement,EFO:0801114,http://www.ebi.ac.uk/efo/EFO_0801114,0.635,None
ukb-d-K11_CHRONGASTR,Chronic gastritis,chronic gastritis,EFO:0000337,http://www.ebi.ac.uk/efo/EFO_0000337,0.996,None
ukb-b-7748,Illnesses of mother: Bowel cancer,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.686,None
ukb-e-20022_EAS,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
finn-b-CD2_BENIGN_LYMPHANGIOMA_EXALLC,"""Lymphangioma, anys site"" (all cancers excluded)",lymphangioma,MONDO:0002013,http://purl.obolibrary.org/obo/MONDO_0002013,0.685,None
ukb-e-622_CSA,Polyp of female genital organs,female genital tract polyp,EFO:0008622,http://www.ebi.ac.uk/efo/EFO_0008622,0.777,None
ukb-b-7007,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
finn-b-I9_VARICVESOTH,Varicose veins of other sites,Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.852,None
finn-b-BACT_INTEST_INFECTION_NOS,Other specified/unspecified bacterial intestinal infections,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.78,None
ukb-e-745_AFR,Pain in joint,Arthralgia,HP:0002829,http://purl.obolibrary.org/obo/HP_0002829,0.994,None
finn-b-CD2_BENIGN_SMALL_INTESTINE_OTH_EXALLC,Benign neoplasm: Other and unspecified parts of small intestine (all cancers excluded),benign neoplasm of small intestine,MONDO:0021501,http://purl.obolibrary.org/obo/MONDO_0021501,0.842,None
ukb-e-21021_EAS,Pulse wave Arterial Stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.706,None
ebi-a-GCST90016617,Obsessive compulsive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.734,None
finn-b-D3_COAGDEFNAS,Other and unspecified coagulation defects,blood coagulation disease,EFO:0009314,http://www.ebi.ac.uk/efo/EFO_0009314,0.876,None
finn-b-FEMHER_UNILATERAL,"Femoral hernia, unilateral",femoral hernia,EFO:1001791,http://www.ebi.ac.uk/efo/EFO_1001791,0.786,None
ukb-e-recode324_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-KNEE_ARTHROSIS,Gonarthrosis [arthrosis of knee](FG),joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.769,None
finn-b-AB1_OTHER_PROTOZOAL,Other protozoal intestinal diseases,protozoa infectious disease,MONDO:0002428,http://purl.obolibrary.org/obo/MONDO_0002428,0.679,None
finn-b-K11_FISSANAL,Fissure and fistula of anal and rectal regions,anus disease,EFO:0009660,http://www.ebi.ac.uk/efo/EFO_0009660,0.804,None
ukb-b-14518,Vitamin and/or mineral supplement use: Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.7,None
finn-b-HERING_UNILATERAL,"Inguinal hernia, unilateralk",Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.728,None
ukb-e-3077_CSA,Seating box height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.645,None
finn-b-J10_LOWERINF,Other acute lower respiratory infections,respiratory tract infectious disorder,MONDO:0024355,http://purl.obolibrary.org/obo/MONDO_0024355,0.782,None
finn-b-L12_PITYROCHEA,Pityriasis rosea,pityriasis rosea,EFO:1000756,http://www.ebi.ac.uk/efo/EFO_1000756,0.981,None
finn-b-E4_THYTOXGOITDIF,Thyrotoxicosis with diffuse goitre,toxic diffuse goiter,MONDO:0001104,http://purl.obolibrary.org/obo/MONDO_0001104,0.673,None
finn-b-CD2_BENIGN_MENINGES_CEREBRAL,Benign neoplasm: Cerebral meninges,meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.76,None
ukb-e-100025_AFR,Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.805,None
finn-b-M13_ARTHROPATHIES,Arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.779,None
finn-b-H7_PARASTRA4,Fourth [trochlear] nerve palsy,fourth cranial nerve palsy,MONDO:0001146,http://purl.obolibrary.org/obo/MONDO_0001146,0.974,None
ukb-b-20213,"Non-cancer illness code, self-reported: measles / morbillivirus",measles,EFO:1002025,http://www.ebi.ac.uk/efo/EFO_1002025,0.632,None
ukb-b-19391,Diagnoses - secondary ICD10: R06.0 Dyspnoea,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.629,None
ukb-e-recode68_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-b-94,Oral cavity cancer,oral cavity cancer,EFO:0005570,http://www.ebi.ac.uk/efo/EFO_0005570,0.995,None
ukb-e-680_p4_MID,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-e-23127_CSA,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
finn-b-G6_DRUGPOLY,Drug-induced polyneuropathy,polyneuropathy,EFO:0009562,http://www.ebi.ac.uk/efo/EFO_0009562,0.765,None
finn-b-Q17_PHAKOMATOSES_NOT_ELSEW_CLASSIFIED,"Phakomatoses, not elsewhere classified",neurocutaneous syndrome,MONDO:0042983,http://purl.obolibrary.org/obo/MONDO_0042983,0.979,None
ukb-e-411_CSA,Ischemic Heart Disease,Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.991,None
finn-b-H7_CONJUNCTIVITIS,Conjunctivitis,conjunctivitis,EFO:0009450,http://www.ebi.ac.uk/efo/EFO_0009450,0.995,None
ukb-e-DBP_p1_EAS,"Diastolic blood pressure, automated reading, adjusted by medication",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.623,None
ukb-e-30160_EAS,Basophill count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.886,None
ukb-e-23105_AFR,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
ieu-a-1168,Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.701,None
ukb-e-738_p1_AFR,Average total household income before tax,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.635,None
finn-b-Z21_SPECIAL_SCREEN_EXAM_INFECTIOUS_PARASITIC_DISEA,Special screening examination for infectious and parasitic diseases,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.667,None
finn-b-CD2_BENIGN_COLON_NOS,"Benign neoplasm: Colon, unspecified",benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.995,None
ieu-a-1169,Hip osteoarthritis,"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.994,None
finn-b-O15_PREG_DM,Diabetes mellitus in pregnancy,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.786,None
finn-b-ALCOPANCCHRON,Alcohol-induced chronic pancreatitis,chronic pancreatitis,EFO:0000342,http://www.ebi.ac.uk/efo/EFO_0000342,0.732,None
ieu-b-4963,Ovarian cancer,ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.992,None
ukb-a-50,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
finn-b-CD2_TNK_LYMPHOMA_EXALLC,Mature T/NK-cell lymphomas (all cancers excluded),T-cell non-Hodgkin lymphoma,MONDO:0015760,http://purl.obolibrary.org/obo/MONDO_0015760,0.631,None
ieu-a-1162,Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.687,None
ukb-e-30690_CSA,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
ukb-b-11268,Treatment/medication code: simvastatin,simvastatin measurement,EFO:0801219,http://www.ebi.ac.uk/efo/EFO_0801219,0.716,None
ukb-e-49_AFR,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
finn-b-H8_SUP_OTINAS,"Suppurative otitis media, unspecified",suppurative otitis media,EFO:0007503,http://www.ebi.ac.uk/efo/EFO_0007503,0.99,None
finn-b-G6_CNSOTH,Other disorders of central nervous system,central nervous system disease,EFO:0009386,http://www.ebi.ac.uk/efo/EFO_0009386,0.957,None
finn-b-R18_ABNORMAL_INVOLU_MOVEM,Abnormal involuntary movements,Myoclonus,HP:0001336,http://purl.obolibrary.org/obo/HP_0001336,0.683,None
finn-b-M13_SOFTTISSUE,Soft tissue disorders,soft tissue disease,EFO:0009470,http://www.ebi.ac.uk/efo/EFO_0009470,0.792,None
ukb-d-H7_RETINALDISOTH,Other retinal disorders,retinopathy,EFO:0003839,http://www.ebi.ac.uk/efo/EFO_0003839,0.91,None
finn-b-AB1_MEASLES,Measles,measles,EFO:1002025,http://www.ebi.ac.uk/efo/EFO_1002025,0.976,None
finn-b-CD2_BENIGN_UTERUS_NOS_EXALLC,Other benign neoplasm of uterus: Other parts/unspecified (all cancers excluded),uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.819,None
finn-b-I9_UAP_EXNONE,Unstable angina pectoris (no controls excluded),intermediate coronary syndrome,EFO:1000985,http://www.ebi.ac.uk/efo/EFO_1000985,0.787,None
ukb-a-438,Fractured bone site(s): Ankle,ankle fracture,EFO:0009615,http://www.ebi.ac.uk/efo/EFO_0009615,0.757,None
finn-b-N14_ABNORMALBLEED,Other abnormal uterine and caginal bleeding,Metrorrhagia,HP:0100608,http://purl.obolibrary.org/obo/HP_0100608,0.733,None
finn-b-C3_LYMPHNODES_SECONDARY_NAS,Secondary and unspecified malignant neoplasm of lymph nodes,lymph node cancer,MONDO:0001082,http://purl.obolibrary.org/obo/MONDO_0001082,0.839,None
finn-b-H7_OPTICDISCOTH,Other disorders of optic disc,visual pathway disorder,MONDO:0001834,http://purl.obolibrary.org/obo/MONDO_0001834,0.672,None
finn-b-K11_CHOLECYST,Chlocystitis,cystitis,EFO:1000025,http://www.ebi.ac.uk/efo/EFO_1000025,0.615,None
finn-b-CD2_BENIGN_ADRENAL_EXALLC,Benign neoplasm: Adrenal gland (all cancers excluded),benign neoplasm of adrenal gland,MONDO:0021511,http://purl.obolibrary.org/obo/MONDO_0021511,0.925,None
ukb-e-D25_AFR,D25 Leiomyoma of uterus,uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.773,None
finn-b-CD2_BENIGN_PARATHYROID,Benign neoplasm: Parathyroid gland,benign neoplasm of parathyroid gland,MONDO:0021463,http://purl.obolibrary.org/obo/MONDO_0021463,0.993,None
finn-b-M13_ENTESOPATHYNAS,"Other/unspecified enthesopathies, not elsewhere classified",rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.99,None
ukb-e-2804_CSA,Age when last used oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.707,None
ukb-b-16118,Neck/shoulder pain for 3+ months,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.706,None
ukb-e-20002_p124_EAS,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-H7_GLAUCOMA_POAG,"Primary open-angle glaucoma, strict",open-angle glaucoma,EFO:0004190,http://www.ebi.ac.uk/efo/EFO_0004190,0.989,None
ukb-e-30130_AFR,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
ebi-a-GCST010681,Type 1 diabetes,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
ieu-a-45,Anorexia nervosa,anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.987,None
ukb-d-3859_5,Reason former drinker stopped drinking alcohol: Other reason,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.613,None
ukb-e-20513_CSA,Recent thoughts of suicide or self-harm,suicidal ideation,EFO:0004320,http://www.ebi.ac.uk/efo/EFO_0004320,0.616,None
finn-b-K11_LIVER,Diseases of liver,liver disease,EFO:0001421,http://www.ebi.ac.uk/efo/EFO_0001421,0.94,None
ukb-e-4080_AFR,"Systolic blood pressure, automated reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
ukb-e-20002_p124_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-KRA_PSY_TIC_EXMORE,Tic disorders (more controls excluded),Tics,HP:0100033,http://purl.obolibrary.org/obo/HP_0100033,0.881,None
finn-b-CD2_BENIGN_MELANOCYTIC_LIP,Melanocytic naevi of lip,large congenital melanocytic nevus,MONDO:0044792,http://purl.obolibrary.org/obo/MONDO_0044792,0.634,None
finn-b-M13_RADICULOPATHY,Radiculopathy,radiculopathy,MONDO:0002959,http://purl.obolibrary.org/obo/MONDO_0002959,0.981,None
ukb-e-24019_CSA,Particulate matter air pollution (pm10); 2007,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.737,None
ukb-e-recode103_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-O15_ICP_EXMORE,Intrahepatic Cholestasis of Pregnancy (ICP)<c3><8a> (more controls excluded),Intrahepatic cholestasis of pregnancy,EFO:0009048,http://www.ebi.ac.uk/efo/EFO_0009048,0.798,None
ukb-e-3799_CSA,Headaches for 3+ months,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.737,None
ieu-a-1121,High grade serous ovarian cancer,high grade ovarian serous adenocarcinoma,EFO:1001958,http://www.ebi.ac.uk/efo/EFO_1001958,0.805,None
ebi-a-GCST90016610,Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS)),rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.705,None
finn-b-DM_NEOVASCULAR_GLAUCOMA,Neovascular glaucoma,neovascular glaucoma,EFO:1001060,http://www.ebi.ac.uk/efo/EFO_1001060,0.996,None
ukb-b-6562,Diagnoses - main ICD10: R06.0 Dyspnoea,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.682,None
ukb-e-recode432_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30660_AFR,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
finn-b-Q17_OTHER_CONGEN_MALFO_INTESTINE,Other congenital malformations of intestine,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.745,None
finn-b-M13_ARTHROSIS,Arthrosis,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.99,None
ukb-e-30240_CSA,Reticulocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.694,None
finn-b-R18_PAIN_NOT_ELSEW_CLASSIFIED,"Pain, not elsewhere classified",pain,EFO:0003843,http://www.ebi.ac.uk/efo/EFO_0003843,0.997,None
finn-b-P16_OTH_DISORD_ORIGINA_PERINA_PERIOD,Other disorders originating in the perinatal period,perinatal disease,EFO:0010238,http://www.ebi.ac.uk/efo/EFO_0010238,0.745,None
ukb-e-21000_p14_AFR,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
ukb-e-30690_MID,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
finn-b-I9_MI_COMPLICATIONS_EXNONE,Complications following myocardial infarction (no controls excluded),myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.721,None
ukb-b-9596,Vitamin and mineral supplements: Vitamin A,vitamin A measurement,EFO:0004857,http://www.ebi.ac.uk/efo/EFO_0004857,0.689,None
finn-b-E4_DISPUB,Disorders of puberty,puberty,EFO:0001382,http://www.ebi.ac.uk/efo/EFO_0001382,0.802,None
ukb-e-6138_p3_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-20116_p3_MID,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
finn-b-H7_OTHERCONJ,Other disorders of conjunctiva,Conjunctival Disorder,EFO:1000203,http://www.ebi.ac.uk/efo/EFO_1000203,0.951,None
ukb-d-M13_SOFTTISSUENAS,Other specified/unspecified soft tissue disorders,soft tissue disease,EFO:0009470,http://www.ebi.ac.uk/efo/EFO_0009470,0.792,None
ukb-e-recode278_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30150_MID,Eosinophill count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.895,None
finn-b-CD2_INSITU_SKIN_TRUNK,Carcinoma in situ of skin of trunk,skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.817,None
finn-b-R18_UNSPE_HAEMATU,Unspecified haematuria,Hematuria,HP:0000790,http://purl.obolibrary.org/obo/HP_0000790,0.728,None
ukb-e-recode338_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_ANXIETY,Other anxiety disorders,anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.987,None
ukb-e-276_CSA,"Disorders of fluid, electrolyte, and acid-base balance",Abnormal blood ion concentration,HP:0003111,http://purl.obolibrary.org/obo/HP_0003111,0.644,None
bbj-a-155,Urolithiasis,urolithiasis,MONDO:0024647,http://purl.obolibrary.org/obo/MONDO_0024647,0.989,None
ebi-a-GCST009983,Trauma exposure in major depressive disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.725,None
finn-b-AB1_VIRAL_MENINGITIS,Viral meningitis,viral meningitis,EFO:1001236,http://www.ebi.ac.uk/efo/EFO_1001236,0.994,None
ukb-e-H25_CSA,H25 Senile cataract,senile cataract,MONDO:0004847,http://purl.obolibrary.org/obo/MONDO_0004847,0.825,None
finn-b-CD2_BENIGN_SKIN_SCALPNECK_EXALLC,Benign neoplasm: Skin of scalp and neck (all cancers excluded),benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.713,None
ukb-e-23115_EAS,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
finn-b-APPENDACUT_NOCOMPLIC,"Acute appendicitis, no complications",appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.776,None
finn-b-C3_DIGESTIVE_ORGANS_EXALLC,Malignant neoplasm of digestive organs (all cancers excluded),digestive system cancer,MONDO:0002516,http://purl.obolibrary.org/obo/MONDO_0002516,0.731,None
ukb-e-recode10_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-C3_COLON,Malignant neoplasm of colon,malignant colon neoplasm,MONDO:0021063,http://purl.obolibrary.org/obo/MONDO_0021063,0.995,None
finn-b-CD2_BENIGN_EYE_EXALLC,Benign neoplasm of eye and adnexa (all cancers excluded),benign neoplasm of eye,MONDO:0021454,http://purl.obolibrary.org/obo/MONDO_0021454,0.721,None
ukb-e-recode145_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-K11_APPENDIX,Diseases of appendix,disorder of appendix,EFO:0009542,http://www.ebi.ac.uk/efo/EFO_0009542,0.953,None
finn-b-PDSTRICT_EXMORE,"""Parkinson's disease, strict definition"" (more controls excluded)",Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
ukb-e-recode404_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-G6_ALS,Motor neuron disease,motor neuron disease,EFO:0003782,http://www.ebi.ac.uk/efo/EFO_0003782,0.987,None
ukb-e-30620_AFR,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
ukb-a-574,Diagnoses - main ICD10: N20 Calculus of kidney and ureter,nephrolithiasis,EFO:0004253,http://www.ebi.ac.uk/efo/EFO_0004253,0.748,None
ukb-d-R56,"Diagnoses - main ICD10: R56 Convulsions, not elsewhere classified",convulsion,EFO:0009853,http://www.ebi.ac.uk/efo/EFO_0009853,0.649,None
ieu-b-4957,Multiple myeloma,multiple myeloma,EFO:0001378,http://www.ebi.ac.uk/efo/EFO_0001378,0.995,None
finn-b-O15_OEDEM_PROTUR_HYPERT,"Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.658,None
ukb-e-5264_AFR,Corneal hysteresis (left),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.897,None
finn-b-J10_CHRONLARYNGITIS,Chronic laryngitis and laryngotracheitis,laryngotracheitis,MONDO:0000263,http://purl.obolibrary.org/obo/MONDO_0000263,0.849,None
ebi-a-GCST005813,Osteoarthritis of the knee (hospital diagnosed),"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.886,None
finn-b-KRA_PSY_BEHAV_EXMORE,Behavioural disorders (more controls excluded),Atypical behavior,HP:0000708,http://purl.obolibrary.org/obo/HP_0000708,0.991,None
finn-b-M13_SPONDYLOPATHINOTH,Spondylopathies in diseases classified elsewhere,inflammatory spondylopathy,MONDO:0001434,http://purl.obolibrary.org/obo/MONDO_0001434,0.695,None
ukb-e-MAP_p3_AFR,"Mean arterial pressure, combined automated + manual reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.652,None
ukb-e-104910_CSA,Time spent doing moderate physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.648,None
ukb-a-61,Non-cancer illness code  self-reported: hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.615,None
finn-b-Q17_CONGEN_MALFO_GENITAL_ORGANS,Congenital malformations of genital organs,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.716,None
ukb-e-512_CSA,Other symptoms of respiratory system,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.715,None
finn-b-E4_VIT_D_DEF,Vitamin D deficiency,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.969,None
ebi-a-GCST009979,Major depressive disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.987,None
ukb-a-247,Seen a psychiatrist for nerves  anxiety  tension or depression,"seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported",EFO:0009821,http://www.ebi.ac.uk/efo/EFO_0009821,0.735,None
finn-b-M13_SYNOTEND,Disorders of synovium and tendon,synovium disorder,MONDO:0056799,http://purl.obolibrary.org/obo/MONDO_0056799,0.819,None
ukb-e-100014_AFR,Folate,red blood cell folate measurement,EFO:0009703,http://www.ebi.ac.uk/efo/EFO_0009703,0.75,None
ukb-b-11578,Chest pain or discomfort walking normally,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.684,None
ieu-a-1160,ER- Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.668,None
ukb-e-52_p10_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-AB1_ANOGENITAL_HERPES_SIMPLEX,Anogenital herpesviral [herpes simplex] infection,Herpes simplex infection,EFO:1002022,http://www.ebi.ac.uk/efo/EFO_1002022,0.799,None
ukb-d-R50,Diagnoses - main ICD10: R50 Fever of unknown origin,fever of unknown origin,EFO:0003952,http://www.ebi.ac.uk/efo/EFO_0003952,0.761,None
finn-b-AB1_BACTINF_NOS,"Bacterial infection, other or unspecified",bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.988,None
ukb-e-30080_AFR,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
ieu-a-44,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-e-recode138_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_FOREIGNBODY,Residual foreign body in soft tissue,foreign body,EFO:0009525,http://www.ebi.ac.uk/efo/EFO_0009525,0.617,None
finn-b-CD2_BENIGN_COLON_EXALLC,Benign neoplasm: Colon (all cancers excluded),benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.887,None
finn-b-R18_ENLARGED_LYMPH_NODES,Enlarged lymph nodes,Hepatomegaly,HP:0002240,http://purl.obolibrary.org/obo/HP_0002240,0.626,None
ebi-a-GCST004692,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO:0004976,http://purl.obolibrary.org/obo/MONDO_0004976,0.993,None
ukb-a-550,Diagnoses - main ICD10: K43 Ventral hernia,ventral hernia,EFO:1001866,http://www.ebi.ac.uk/efo/EFO_1001866,0.636,None
finn-b-K11_PSC_COLITIS,"Colitis, primary sclerosing",sclerosing cholangitis,EFO:0004268,http://www.ebi.ac.uk/efo/EFO_0004268,0.758,None
ukb-e-recode49_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-R18_ABNORMAL_RESULTS_FUNCTION_STUDI,Abnormal results of function studies,abnormal result of function studies,EFO:0009628,http://www.ebi.ac.uk/efo/EFO_0009628,0.916,None
finn-b-O15_PREECLAMPS,Pre-eclampsia,preeclampsia,EFO:0000668,http://www.ebi.ac.uk/efo/EFO_0000668,0.986,None
finn-b-E4_LIPOPROT,Disorders of lipoprotein metabolism and other lipidaemias,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.722,None
finn-b-R18_ABNORMAL_BLOOD_P_READI_WO_DIAGNOSIS,"Abnormal blood-pressure reading, without diagnosis",Abnormal systemic blood pressure,HP:0030972,http://purl.obolibrary.org/obo/HP_0030972,0.678,None
finn-b-C3_NSCLC_SQUAM_EXALLC,"""Non-small cell lung cancer, squamous"" (all cancers excluded)",squamous cell lung carcinoma,EFO:0000708,http://www.ebi.ac.uk/efo/EFO_0000708,0.89,None
ukb-b-8549,Diagnoses - main ICD10: D24 Benign neoplasm of breast,breast benign neoplasm,MONDO:0000620,http://purl.obolibrary.org/obo/MONDO_0000620,0.721,None
ukb-b-9242,Operative procedures - main OPCS: K75.1 Percutaneous transluminal balloon angioplasty and insertion of 1-2 drug-eluting stents into coronary artery,percutaneous transluminal coronary angioplasty,EFO:0003951,http://www.ebi.ac.uk/efo/EFO_0003951,0.616,None
finn-b-CD2_BENIGN_DUODENUM_EXALLC,Benign neoplasm: Duodenum (all cancers excluded),duodenal benign neoplasm,EFO:1000907,http://www.ebi.ac.uk/efo/EFO_1000907,0.91,None
ieu-a-973,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-e-48_AFR,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
finn-b-K11_DISORD_TEETH,Other disorders of teeth and supporting structures,periodontal disorder,MONDO:0002635,http://purl.obolibrary.org/obo/MONDO_0002635,0.868,None
finn-b-C3_SECONDARY_WITHOUT_SITESPEC,"Malignant neoplasm, without specification of site",cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.609,None
ukb-e-3647_EAS,Duration of other exercises,exercise,EFO:0000483,http://www.ebi.ac.uk/efo/EFO_0000483,0.756,None
finn-b-D3_NUTRIANAEMIA,Nutritional anaemias,nutritional disorder,EFO:0001069,http://www.ebi.ac.uk/efo/EFO_0001069,0.678,None
finn-b-L12_PRURIGONAS,Other  prurigo,prurigo,MONDO:0021739,http://purl.obolibrary.org/obo/MONDO_0021739,0.993,None
finn-b-I9_MYOCARD,Myocarditis,myocarditis,EFO:0009609,http://www.ebi.ac.uk/efo/EFO_0009609,0.997,None
finn-b-RHEU_ARTHRITIS_OTH,Other arthritis (FG),arthritis,EFO:0005856,http://www.ebi.ac.uk/efo/EFO_0005856,0.798,None
ukb-e-4194_CSA,Pulse rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.996,None
ukb-b-8085,Diagnoses - main ICD10: M65.3 Trigger finger,Digital flexor tenosynovitis,HP:0012276,http://purl.obolibrary.org/obo/HP_0012276,0.693,None
finn-b-J10_EPIGLOTTITIS,Acute epiglottitis,epiglottitis,EFO:0007261,http://www.ebi.ac.uk/efo/EFO_0007261,0.991,None
ukb-d-20126_4,Bipolar and major depression status: Probable Recurrent major depression (moderate),unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.802,None
ukb-e-recode147_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_TIA,Transient ischemic attack (I9_TIA),transient ischemic attack,EFO:0003764,http://www.ebi.ac.uk/efo/EFO_0003764,0.844,None
finn-b-G6_TIA,Transient ischemic attack (G6_TIA),transient ischemic attack,EFO:0003764,http://www.ebi.ac.uk/efo/EFO_0003764,0.843,None
ukb-d-RHEUMA_NOS,Other/unspecified rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-NONALLERG_ASTHMA,Non-allergic asthma (mode),allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.86,None
ukb-e-DBP_p1_MID,"Diastolic blood pressure, automated reading, adjusted by medication",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.623,None
ukb-e-5158_CSA,6mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
finn-b-CD2_BENIGN_BONE_LONG_LOWER,Benign neoplasm: Long bones of lower limb,cancer of long bone of lower limb,MONDO:0000952,http://purl.obolibrary.org/obo/MONDO_0000952,0.734,None
ukb-e-recode96_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-N32_CSA,N32 Other disorders of bladder,bladder disease,EFO:1000018,http://www.ebi.ac.uk/efo/EFO_1000018,0.766,None
finn-b-G6_CAUSALGIA,Causalgia,causalgia,EFO:1000854,http://www.ebi.ac.uk/efo/EFO_1000854,0.992,None
ukb-e-6138_p1_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-K11_HAEMORR,Haemmorrhoids and perianal venous thrombosis,Venous thrombosis,HP:0004936,http://purl.obolibrary.org/obo/HP_0004936,0.642,None
ieu-a-1183,ADHD,attention deficit hyperactivity disorder,EFO:0003888,http://www.ebi.ac.uk/efo/EFO_0003888,0.997,None
ukb-b-7872,Mouth/teeth dental problems: Bleeding gums,Gingival bleeding,HP:0000225,http://purl.obolibrary.org/obo/HP_0000225,0.674,None
ukb-e-I25_CSA,I25 Chronic ischaemic heart disease,Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.647,None
finn-b-SLE_STRICT,"SLE, strict definition",systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,1.0,None
finn-b-RESPIRATORYINSUFF,Respiratory insufficiency,Respiratory insufficiency,HP:0002093,http://purl.obolibrary.org/obo/HP_0002093,0.982,None
finn-b-I9_HYPOTE,Hypotension,hypotension,EFO:0005251,http://www.ebi.ac.uk/efo/EFO_0005251,0.977,None
ukb-e-30100_EAS,Mean platelet (thrombocyte) volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.741,None
finn-b-CD2_LYMPHOID_LEUKAEMIA,Lymphoid leukaemia,lymphoid leukemia,EFO:0004289,http://www.ebi.ac.uk/efo/EFO_0004289,0.77,None
ukb-e-DBP_p2_EAS,"Diastolic blood pressure, combined automated + manual reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.698,None
finn-b-F5_PSYCH,Psychiatric diseases,psychiatric disorder,MONDO:0002025,http://purl.obolibrary.org/obo/MONDO_0002025,0.96,None
ukb-b-2875,Diagnoses - main ICD10: M16.1 Other primary coxarthrosis,"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.613,None
ukb-b-5257,"Non-cancer illness code, self-reported: rheumatic fever",rheumatic fever,EFO:1001160,http://www.ebi.ac.uk/efo/EFO_1001160,0.642,None
finn-b-H8_NONSUPPNAS,Nonsuppurative otitis media,non-suppurative otitis media,MONDO:0001212,http://purl.obolibrary.org/obo/MONDO_0001212,0.991,None
bbj-a-127,Interstitial lung disease,interstitial lung disease,EFO:0004244,http://www.ebi.ac.uk/efo/EFO_0004244,0.989,None
ukb-b-3965,Diagnoses - main ICD10: G56.0 Carpal tunnel syndrome,carpal tunnel syndrome,EFO:0004143,http://www.ebi.ac.uk/efo/EFO_0004143,0.754,None
ukb-e-3829_CSA,Number of stillbirths,number of stillbirths,EFO:0009722,http://www.ebi.ac.uk/efo/EFO_0009722,0.988,None
ukb-e-2395_p2_AFR,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
finn-b-M13_ENTESOPATHYOTH,Other enthesopathies,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.99,None
finn-b-K11_EROSION,Erosion of teeth,Fused teeth,HP:0011090,http://purl.obolibrary.org/obo/HP_0011090,0.672,None
ukb-b-8961,"Non-cancer illness code, self-reported: chronic fatigue syndrome",chronic fatigue syndrome,EFO:0004540,http://www.ebi.ac.uk/efo/EFO_0004540,0.71,None
ukb-e-6138_p4_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-564_AFR,Functional digestive disorders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.655,None
ukb-e-recode2_AFR,"Number of cigarettes smoked daily, combined previous and current smoking",nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.628,None
ukb-e-24008_MID,Particulate matter air pollution 2.5-10um; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.723,None
ukb-e-recode175_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-C3_URINARY_TRACT,Malignant neoplasm of urinary organs,Malignant Urinary System Neoplasm,EFO:1000363,http://www.ebi.ac.uk/efo/EFO_1000363,0.759,None
finn-b-NECROVASC_FG,Other necrotizing vasculopathies (FG),necrotizing vasculitis,MONDO:0800113,http://purl.obolibrary.org/obo/MONDO_0800113,0.694,None
finn-b-MIGRAINE_UNSPE,"Migraine, unspecified, drug-induced",migraine disorder,MONDO:0005277,http://purl.obolibrary.org/obo/MONDO_0005277,0.655,None
ukb-d-S02,Diagnoses - main ICD10: S02 Fracture of skull and facial bones,Skull Fractures,EFO:1001425,http://www.ebi.ac.uk/efo/EFO_1001425,0.619,None
finn-b-MACULA_NAS,Degenerative macular diseases,macular degeneration,EFO:0009606,http://www.ebi.ac.uk/efo/EFO_0009606,0.799,None
ukb-b-1418,Diagnoses - main ICD10: M75.4 Impingement syndrome of shoulder,shoulder impingement syndrome,EFO:1001178,http://www.ebi.ac.uk/efo/EFO_1001178,0.774,None
ukb-e-30050_MID,Mean corpuscular haemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.986,None
ukb-e-20003_p393_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-F5_CANNABIS,Mental and behavioural disorders due to cannabinoids,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.68,None
finn-b-C3_THYROID_GLAND_EXALLC,Malignant neoplasm of thyroid gland (all cancers excluded),thyroid cancer,MONDO:0002108,http://purl.obolibrary.org/obo/MONDO_0002108,0.928,None
finn-b-C3_KIDNEY_NOTRENALPELVIS,"Malignant neoplasm of kidney, except renal pelvis",kidney cancer,MONDO:0002367,http://purl.obolibrary.org/obo/MONDO_0002367,0.952,None
finn-b-M13_MONOARTHRITIS,"Monoarthritis, not elsewhere classified",arthritis,EFO:0005856,http://www.ebi.ac.uk/efo/EFO_0005856,0.667,None
ukb-b-2160,Diagnoses - main ICD10: C61 Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.727,None
ukb-a-458,Vitamin and mineral supplements: Vitamin A,vitamin A measurement,EFO:0004857,http://www.ebi.ac.uk/efo/EFO_0004857,0.689,None
ukb-e-2335_CSA,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
ukb-e-1970_MID,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
ukb-e-recode338_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-KRA_PSY_ANXIETY_EXMORE,Anxiety disorders (more controls excluded),anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.987,None
finn-b-C3_EYE_BRAIN_NEURO,"Malignant neoplasm of eye, brain and central nervous system",central nervous system cancer,EFO:0000326,http://www.ebi.ac.uk/efo/EFO_0000326,0.878,None
ukb-e-5108_CSA,3mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
ukb-b-12753,Recent medication for hayfever or allergic rhinitis,allergic rhinitis,EFO:0005854,http://www.ebi.ac.uk/efo/EFO_0005854,0.66,None
finn-b-Q17_OTHER_CONGEN_MALFO_PERIP_VASCULAR_SYSTEM,Other congenital malformations of peripheral vascular system,congenital vascular malformation,MONDO:0024287,http://purl.obolibrary.org/obo/MONDO_0024287,0.764,None
ebi-a-GCST003045,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
finn-b-E4_ADRENAL,Other disorders of adrenal gland,adrenal gland disease,EFO:0005539,http://www.ebi.ac.uk/efo/EFO_0005539,0.972,None
ukb-e-23100_EAS,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
ukb-b-6911,Treatment/medication code: diclofenac,response to diclofenac,EFO:0007919,http://www.ebi.ac.uk/efo/EFO_0007919,0.625,None
finn-b-CD2_BENIGN_SIGMOID_COLON,Benign neoplasm: Sigmoid colon,sigmoid neoplasm,EFO:1001181,http://www.ebi.ac.uk/efo/EFO_1001181,0.877,None
bbj-a-74,Rheumatoid Arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-b-17961,Diagnoses - main ICD10: K58.9 Irritable bowel syndrome without diarrhoea,irritable bowel syndrome,EFO:0000555,http://www.ebi.ac.uk/efo/EFO_0000555,0.606,None
finn-b-AB1_GASTROENTERITIS_NOS,Diarrhoea and gastroenteritis of presumed infectious origin,diarrheal disease,MONDO:0001673,http://purl.obolibrary.org/obo/MONDO_0001673,0.723,None
ukb-e-30600_AFR,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ukb-e-H26_AFR,H26 Other cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.689,None
finn-b-M13_PSORIARTH_ICD10,"Psoriatic arthropathies, ICD10",psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.806,None
finn-b-E4_OBESITY,Obesity,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.998,None
ukb-b-12872,Diagnoses - main ICD10: M51.2 Other specified intervertebral disk displacement,Intervertebral Disc Displacement,EFO:1001800,http://www.ebi.ac.uk/efo/EFO_1001800,0.704,None
finn-b-I9_CORATHER_EXNONE,Coronary atherosclerosis (no controls excluded),coronary atherosclerosis,MONDO:0021661,http://purl.obolibrary.org/obo/MONDO_0021661,0.957,None
finn-b-I9_LBBB,Left bundle-branch block,Left bundle branch block,HP:0011713,http://purl.obolibrary.org/obo/HP_0011713,0.989,None
ukb-e-52_p7_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-C3_BLADDER,Malignant neoplasm of bladder,urinary bladder cancer,MONDO:0001187,http://purl.obolibrary.org/obo/MONDO_0001187,0.996,None
ukb-e-135_AFR,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
finn-b-N14_BARTHOABSCESS,Abscess of Bartholin gland,Bartholin gland disease,EFO:0009469,http://www.ebi.ac.uk/efo/EFO_0009469,0.692,None
ukb-e-100900_CSA,Intake of sugar added to cereal,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.604,None
ukb-e-1170_CSA,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
ukb-e-20414_AFR,Frequency of drinking alcohol,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.761,None
finn-b-L12_ACNE_VULGARIS,Acne vulgaris,acne,EFO:0003894,http://www.ebi.ac.uk/efo/EFO_0003894,0.994,None
finn-b-KRA_PSY_PERSON_EXMORE,Personality disorders (more controls excluded),Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.951,None
ukb-e-recode190_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6164_p6_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-5088_EAS,Astigmatism angle (right),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.732,None
finn-b-J10_UPPERDIS,Other diseases of upper respiratory tract,upper respiratory tract disorder,MONDO:0004867,http://purl.obolibrary.org/obo/MONDO_0004867,0.963,None
ukb-e-20003_p84_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-6142_p4_EAS,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-e-recode253_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-8837,"Cancer code, self-reported: basal cell carcinoma",basal cell carcinoma,EFO:0004193,http://www.ebi.ac.uk/efo/EFO_0004193,0.741,None
ukb-e-30880_EAS,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
finn-b-C3_URINARY_TRACT_EXALLC,Malignant neoplasm of urinary organs (all cancers excluded),Malignant Urinary System Neoplasm,EFO:1000363,http://www.ebi.ac.uk/efo/EFO_1000363,0.708,None
ukb-b-20211,Illnesses of father: Diabetes,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.629,None
ukb-b-10362,Diagnoses - main ICD10: K80.0 Calculus of gallbladder with acute cholecystitis,acalculous cholecystitis,EFO:1000790,http://www.ebi.ac.uk/efo/EFO_1000790,0.627,None
ukb-e-102_MID,"Pulse rate, automated reading",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
ukb-e-6148_p1_CSA,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ukb-e-137_EAS,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
ukb-b-15907,Vitamin and/or mineral supplement use: Other vitamin,vitamin measurement,EFO:0004729,http://www.ebi.ac.uk/efo/EFO_0004729,0.693,None
ukb-e-recode2_CSA,"Number of cigarettes smoked daily, combined previous and current smoking",nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.628,None
ukb-e-24005_CSA,Particulate matter air pollution (pm10); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.729,None
ukb-e-5089_EAS,Astigmatism angle (left),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.746,None
finn-b-F5_HYPERSOMNIA,Hypersomnia,hypersomnia,EFO:0005246,http://www.ebi.ac.uk/efo/EFO_0005246,0.976,None
ieu-b-18,multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
finn-b-CD2_BENIGN_URINARY,Benign neoplasm of urinary organs,benign urinary system neoplasm,MONDO:0004180,http://purl.obolibrary.org/obo/MONDO_0004180,0.768,None
ukb-e-30680_EAS,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
finn-b-H7_DIPLOPIA,Diplopia,Diplopia,HP:0000651,http://purl.obolibrary.org/obo/HP_0000651,0.99,None
ukb-e-recode371_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST90016609,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),Tourette syndrome,EFO:0004895,http://www.ebi.ac.uk/efo/EFO_0004895,0.64,None
ukb-a-217,Illnesses of siblings: Heart disease,heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.602,None
ukb-e-20116_p2_CSA,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ebi-a-GCST90016607,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.757,None
finn-b-O15_PREG_BIRTH_PUERP,"Pregnancy, childbirth and the puerperium",pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.836,None
ukb-e-recode1_CSA,Indirect bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.66,None
ukb-e-709_p1_MID,Number in household,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.709,None
finn-b-H8_EXT_INFNAS,Other infective otitis externa,otitis externa,EFO:0009560,http://www.ebi.ac.uk/efo/EFO_0009560,0.877,None
ukb-e-6155_p3_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-E4_VIT_DEF,Vitamin deficiency (E4_VIT_DEF),vitamin deficiency disorder,MONDO:0024298,http://purl.obolibrary.org/obo/MONDO_0024298,0.813,None
finn-b-H7_CONJUHAEMOR,conjunctival haemorrhage,conjunctival tumor,MONDO:0020204,http://purl.obolibrary.org/obo/MONDO_0020204,0.67,None
ukb-e-recode101_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-9263,Operation code: inguinal/femoral hernia repair,Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.639,None
ebi-a-GCST90016598,ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),Tourette syndrome,EFO:0004895,http://www.ebi.ac.uk/efo/EFO_0004895,0.624,None
ukb-e-135_MID,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
ukb-a-92,Non-cancer illness code  self-reported: vaginal prolapse/uterine prolapse,uterine prolapse,EFO:1001864,http://www.ebi.ac.uk/efo/EFO_1001864,0.73,None
ukb-e-2345_EAS,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
finn-b-H7_GLAUCOMA_NTG,Normotensive glaucoma,low tension glaucoma,EFO:1001022,http://www.ebi.ac.uk/efo/EFO_1001022,0.737,None
ebi-a-GCST004884,Neuroblastoma (1p deletion),partial deletion of the short arm of chromosome 1,MONDO:0016883,http://purl.obolibrary.org/obo/MONDO_0016883,0.731,None
ukb-e-3581_CSA,Age at menopause (last menstrual period),age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.693,None
ebi-a-GCST008036,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
finn-b-H7_OPTNEURITIS,Optic neuritis,optic neuritis,EFO:0007405,http://www.ebi.ac.uk/efo/EFO_0007405,0.99,None
finn-b-CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS_EXALLC,"""Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue"" (all cancers excluded)",hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.688,None
ukb-a-519,Diagnoses - main ICD10: C50 Malignant neoplasm of breast,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.731,None
finn-b-I9_VALVES,Valvular operations,heart valve disease,EFO:0009551,http://www.ebi.ac.uk/efo/EFO_0009551,0.628,None
ukb-e-MCP_MID,Multi-site chronic pain,multisite chronic pain,EFO:0010100,http://www.ebi.ac.uk/efo/EFO_0010100,0.859,None
ieu-b-4980,Sepsis,Sepsis,HP:0100806,http://purl.obolibrary.org/obo/HP_0100806,0.992,None
finn-b-N14_ENDOMETRIOSIS_NOS,Unspecified/other endometriosis,endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.992,None
ukb-e-48_MID,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
finn-b-C3_BONE_CARTILAGE_EXALLC,Malignant neoplasm of bone and articular cartilage (all cancers excluded),chondrogenic neoplasm,MONDO:0024469,http://purl.obolibrary.org/obo/MONDO_0024469,0.702,None
ukb-e-1508_p2_EAS,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
ukb-e-recode398_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30090_EAS,Platelet crit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.994,None
ukb-b-8297,"Non-cancer illness code, self-reported: kidney stone/ureter stone/bladder stone",bladder calculus,EFO:1000839,http://www.ebi.ac.uk/efo/EFO_1000839,0.671,None
ukb-e-6164_p5_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-1050_AFR,Time spend outdoors in summer,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.746,None
finn-b-AB1_VIRAL_OTHER_INTEST_INFECTIONS,Viral and other specified intestinal infections,viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.767,None
ukb-e-1508_p2_MID,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-J10_LOWCHRON,Chronic lower respiratory diseases,lower respiratory tract disease,EFO:0009433,http://www.ebi.ac.uk/efo/EFO_0009433,0.749,None
ukb-e-30280_MID,Immature reticulocyte fraction,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.994,None
finn-b-K11_DENTOFACIAL_ANOMALIES,Dentofacial anomalies [including malocclusion],Dental malocclusion,HP:0000689,http://purl.obolibrary.org/obo/HP_0000689,0.617,None
finn-b-C3_BREAST_HERPLUS_EXALLC,"""Malignant neoplasm of breast, HER-positive"" (all cancers excluded)",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.766,None
ukb-a-156,Treatment/medication code: diclofenac,response to diclofenac,EFO:0007919,http://www.ebi.ac.uk/efo/EFO_0007919,0.625,None
finn-b-L12_LOCALDCONNECTISSUEOTH,Other localized connective tissue disorders,connective tissue disease,EFO:1001986,http://www.ebi.ac.uk/efo/EFO_1001986,0.805,None
finn-b-P16_NEONTAL_JAUND_OTH_UNSP_CAUSES,Neonatal jaundice from other and unspecified causes,neonatal jaundice,EFO:1000739,http://www.ebi.ac.uk/efo/EFO_1000739,0.876,None
ukb-e-1737_CSA,Childhood sunburn occasions,sunburn,EFO:0003958,http://www.ebi.ac.uk/efo/EFO_0003958,0.615,None
finn-b-R18_UNSPE_URINARY_INCONTINENCE,Unspecified urinary incontinence,Urinary incontinence,HP:0000020,http://purl.obolibrary.org/obo/HP_0000020,0.993,None
finn-b-ST19_OPEN_WOUND_THORAX,Open wound of thorax,neoplasm of thorax,MONDO:0021350,http://purl.obolibrary.org/obo/MONDO_0021350,0.601,None
ukb-e-2020_AFR,"Loneliness, isolation",loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
ukb-d-II_NEOPLASM,Neoplasms,ear neoplasm,MONDO:0021233,http://purl.obolibrary.org/obo/MONDO_0021233,0.841,None
finn-b-AB1_ATYPICAL_CNS_VIRUS,Atypical virus infections of central nervous system,central nervous system infection,EFO:1001456,http://www.ebi.ac.uk/efo/EFO_1001456,0.782,None
finn-b-H8_BPV,Benign paroxysmal vertigo,familial Mediterranean fever,MONDO:0018088,http://purl.obolibrary.org/obo/MONDO_0018088,0.657,None
ukb-e-100670_CSA,White wine intake,white wine liking measurement,EFO:0006948,http://www.ebi.ac.uk/efo/EFO_0006948,0.603,None
ukb-b-18336,"Seen a psychiatrist for nerves, anxiety, tension or depression","seeing a psychiatrist for nerves, anxiety, tension or depression, self-reported",EFO:0009821,http://www.ebi.ac.uk/efo/EFO_0009821,0.735,None
bbj-a-157,Uterine fibroids,Uterine leiomyoma,HP:0000131,http://purl.obolibrary.org/obo/HP_0000131,0.893,None
finn-b-AB1_TUBERCULOSIS,Tuberculosis,tuberculosis,MONDO:0018076,http://purl.obolibrary.org/obo/MONDO_0018076,0.989,None
ukb-e-30670_MID,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
ukb-e-433_CSA,Cerebrovascular disease,cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.996,None
ukb-e-recode100_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_HYPTENSEC_EXNONE,Secondary hypertension (no controls excluded),secondary hypertension,EFO:1002034,http://www.ebi.ac.uk/efo/EFO_1002034,0.922,None
finn-b-H7_CONJUNAS,Other specified and unspecified disorders of conjunctiva,Conjunctival Disorder,EFO:1000203,http://www.ebi.ac.uk/efo/EFO_1000203,0.951,None
finn-b-O15_MULTIP_GEST,Multiple gestation,multiple gestation,EFO:0009576,http://www.ebi.ac.uk/efo/EFO_0009576,0.992,None
ukb-e-D17_CSA,D17 Benign lipomatous neoplasm,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.869,None
ukb-e-R10_EAS,R10 Abdominal and pelvic pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.677,None
ukb-e-30860_MID,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
finn-b-PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE,"Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced",Thrombophlebitis,HP:0004418,http://purl.obolibrary.org/obo/HP_0004418,0.796,None
finn-b-N14_UROLITHIASIS,Urolithiasis,urolithiasis,MONDO:0024647,http://purl.obolibrary.org/obo/MONDO_0024647,0.989,None
finn-b-L12_ALOPECANDRO,Androgenic alopecia,androgenetic alopecia,EFO:0004191,http://www.ebi.ac.uk/efo/EFO_0004191,0.977,None
finn-b-H8_EXTERNAL,Diseases of external ear,external ear disease,EFO:0009668,http://www.ebi.ac.uk/efo/EFO_0009668,0.947,None
finn-b-CD2_BENIGN_OTHER_NOS,Benign neoplasm of other and unspecified sites,benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.831,None
ukb-b-15695,Ever had prostate specific antigen (PSA) test,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.669,None
finn-b-E4_DM1REN,Type 1 diabetes with renal complications,familial renal glucosuria,MONDO:0009297,http://purl.obolibrary.org/obo/MONDO_0009297,0.613,None
finn-b-H7_VISDISTNAS,Other and unspecified visual disturbances,Gait disturbance,HP:0001288,http://purl.obolibrary.org/obo/HP_0001288,0.652,None
ebi-a-GCST001790,Gout,gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.998,None
ieu-a-808,Bipolar disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.992,None
ukb-d-H7_MACULADEGEN,Degeneration of macula and posterior pole,degeneration of macula and posterior pole,MONDO:0002175,http://purl.obolibrary.org/obo/MONDO_0002175,0.973,None
finn-b-I9_HYPTENSESS,"Hypertension, essential",essential hypertension,MONDO:0001134,http://purl.obolibrary.org/obo/MONDO_0001134,0.989,None
ukb-d-C67,Diagnoses - main ICD10: C67 Malignant neoplasm of bladder,urinary bladder cancer,MONDO:0001187,http://purl.obolibrary.org/obo/MONDO_0001187,0.749,None
finn-b-C3_FEMALE_GENITAL_NAS_EXALLC,Malignant neoplasm of other and unspecified female genital organs (all cancers excluded),"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.9,None
ukb-e-30710_CSA,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
ukb-e-596_CSA,Other disorders of bladder,bladder disease,EFO:1000018,http://www.ebi.ac.uk/efo/EFO_1000018,0.918,None
finn-b-D3_CVID,Common variable immunodeficiency,common variable immunodeficiency,MONDO:0015517,http://purl.obolibrary.org/obo/MONDO_0015517,0.98,None
ukb-e-5157_AFR,6mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
ebi-a-GCST005047,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-CD2_INSITU_GENITAL,Carcinoma in situ of other and unspecified genital organs,in situ carcinoma,MONDO:0004647,http://purl.obolibrary.org/obo/MONDO_0004647,0.687,None
ukb-e-recode173_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-DBP_p2_AFR,"Diastolic blood pressure, combined automated + manual reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.698,None
ukb-e-4570_EAS,Friendships satisfaction,friendship satisfaction measurement,EFO:0009725,http://www.ebi.ac.uk/efo/EFO_0009725,0.827,None
finn-b-H8_EUSTSALP,Eustachian salpingitis and obstruction,otosalpingitis,MONDO:0002172,http://purl.obolibrary.org/obo/MONDO_0002172,0.835,None
ukb-e-recode144_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_AVBLOCK_EXNONE,AV-block (no controls excluded),atrioventricular block,MONDO:0000465,http://purl.obolibrary.org/obo/MONDO_0000465,0.919,None
ukb-e-513_AFR,Respiratory abnormalities,Abnormality of the respiratory system,HP:0002086,http://purl.obolibrary.org/obo/HP_0002086,0.884,None
ukb-e-1239_EAS,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
ukb-e-30120_EAS,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
finn-b-K11_CD_NOUC,"Crohn disease (strict definition, all UC cases excluded)",Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.779,None
ebi-a-GCST006685,Sleep duration (oversleepers),sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.777,None
ukb-e-recode238_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-4079_CSA,"Diastolic blood pressure, automated reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
ukb-b-14944,Operation code: appendicectomy,appendectomy,EFO:0600086,http://www.ebi.ac.uk/efo/EFO_0600086,0.613,None
finn-b-SLEEP,Sleep disorders (combined),sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.99,None
finn-b-KRA_PSY_ANXIETY,Anxiety disorders,anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.987,None
finn-b-I9_PULMEMB,Pulmonary embolism,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.995,None
ukb-a-325,Bilateral oophorectomy (both ovaries removed),bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.716,None
ukb-a-354,Headaches for 3+ months,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.737,None
ukb-e-D12_CSA,"D12 Benign neoplasm of colon, rectum, anus and anal canal",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.695,None
finn-b-R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_OTHER_BODY_STRUCTURES,Abnormal findings on diagnostic imaging of other body structures,abnormal result of diagnostic imaging,EFO:0009827,http://www.ebi.ac.uk/efo/EFO_0009827,0.621,None
ukb-e-recode396_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30710_AFR,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
ukb-e-680_p1_AFR,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ebi-a-GCST90016619,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.678,None
ukb-e-30690_EAS,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
ukb-b-20289,"Non-cancer illness code, self-reported: hyperthyroidism/thyrotoxicosis",Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.629,None
ukb-b-8637,"Non-cancer illness code, self-reported: retinal detachment",retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.669,None
finn-b-CD2_BENIGN_SMALL_INTESTINE_OTH,Benign neoplasm: Other and unspecified parts of small intestine,benign neoplasm of small intestine,MONDO:0021501,http://purl.obolibrary.org/obo/MONDO_0021501,0.902,None
ukb-b-17670,"Non-cancer illness code, self-reported: multiple sclerosis",multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.681,None
ukb-d-KRA_PSY_MOOD,Mood disorders,mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.986,None
ukb-b-17324,Eye problems/disorders: Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.602,None
finn-b-CD2_BENIGN_SKIN_TRUNK,Benign neoplasm: Skin of trunk,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.836,None
finn-b-N14_EROSECTROPUT,Erosion and ectropion of cervix uteri,cervix erosion,EFO:1000862,http://www.ebi.ac.uk/efo/EFO_1000862,0.706,None
finn-b-KRA_PSY_HYPERKIN,Hyperkinetic disorders,attention deficit hyperactivity disorder,EFO:0003888,http://www.ebi.ac.uk/efo/EFO_0003888,0.709,None
ukb-e-30100_CSA,Mean platelet (thrombocyte) volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.741,None
ukb-b-14814,Diagnoses - main ICD10: K30 Dyspepsia,dyspepsia,EFO:0008533,http://www.ebi.ac.uk/efo/EFO_0008533,0.646,None
finn-b-PD2ND_EXMORE,Secondary parkinsonism (more controls excluded),secondary Parkinson disease,EFO:1001175,http://www.ebi.ac.uk/efo/EFO_1001175,0.983,None
ukb-e-20003_p410_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ebi-a-GCST005812,Osteoarthritis of the hip or knee (hospital diagnosed),"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.835,None
ukb-b-16340,Operation code: hip replacement/revision,total hip arthroplasty,EFO:0009806,http://www.ebi.ac.uk/efo/EFO_0009806,0.692,None
finn-b-K11_STOMATITIS,Stomatitis and related lesions,oral mucositis,EFO:1001904,http://www.ebi.ac.uk/efo/EFO_1001904,0.677,None
ukb-e-recode209_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_LOWBACKPAINORANDSCIATICA,Lower back pain or/and sciatica,Low back pain,HP:0003419,http://purl.obolibrary.org/obo/HP_0003419,0.765,None
ukb-b-11020,Diagnoses - main ICD10: K80.2 Calculus of gallbladder without cholecystitis,acalculous cholecystitis,EFO:1000790,http://www.ebi.ac.uk/efo/EFO_1000790,0.685,None
ukb-d-I9_HEARTFAIL,"Heart failure,strict",heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
finn-b-K11_ULCER,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ieu-a-1233,Low malignant potential ovarian cancer,Borderline Ovarian Surface Epithelial-Stromal Tumor,EFO:1000140,http://www.ebi.ac.uk/efo/EFO_1000140,0.882,None
ukb-e-2227_AFR,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
finn-b-ULCER_ARTHR,Arthropathy in ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.742,None
finn-b-M13_ATLOAXSUBLUX,Atlantoaxial subluxation,Lens subluxation,HP:0001132,http://purl.obolibrary.org/obo/HP_0001132,0.607,None
finn-b-CD2_BENIGN_NOS_EXALLC,Benign neoplasm: Other/unspecified site (all cancers excluded),benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.77,None
finn-b-L12_HYPERTROPHICSKIN,Hypertrophic disorders of skin,gastric mucosal hypertrophy,EFO:1000946,http://www.ebi.ac.uk/efo/EFO_1000946,0.643,None
finn-b-RHEUMA_OTHER_WIDE,"Other (seronegative) rheumatoid arthritis, wide",rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.786,None
finn-b-F5_CONDUCT,Conduct disorder,conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.994,None
ukb-e-recode90_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-2395_p3_AFR,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
ieu-b-4955,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
bbj-a-98,Cervical cancer,cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.996,None
finn-b-STILL_ADULT,Adult-onset Still disease,adult-onset Still's disease,EFO:0007135,http://www.ebi.ac.uk/efo/EFO_0007135,0.822,None
ukb-d-C_RESPIRATORY_INTRATHORACIC,Cancer of respiratory intrathoracic,respiratory or thoracic malformation,MONDO:0020001,http://purl.obolibrary.org/obo/MONDO_0020001,0.663,None
ukb-e-30220_MID,Basophill percentage,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.917,None
ukb-e-20003_p84_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-30060_MID,Mean corpuscular haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.988,None
finn-b-CD2_BENIGN_SKIN_LOWERLIMB_EXALLC,"""Benign neoplasm: Skin of lower limb, including hip"" (all cancers excluded)",benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.602,None
finn-b-CD2_BENIGN_DESCENDING_COLON_EXALLC,Benign neoplasm: Descending colon (all cancers excluded),benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.72,None
ukb-e-2090_CSA,"Seen doctor (GP) for nerves, anxiety, tension or depression",mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
ukb-e-52_p1_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-d-C_SKIN,Cancer of skin,skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.994,None
ukb-e-20003_p539_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-b-15904,"Non-cancer illness code, self-reported: prolapsed disc/slipped disc","Epiphyses, Slipped",EFO:1001317,http://www.ebi.ac.uk/efo/EFO_1001317,0.638,None
finn-b-H7_XANTHELASMA,Xanthelasma of eyelid,xanthoma,EFO:0003075,http://www.ebi.ac.uk/efo/EFO_0003075,0.789,None
finn-b-K11_GINGIVITIS_ACUTE,Acute gingivitis,gingivitis,MONDO:0002508,http://purl.obolibrary.org/obo/MONDO_0002508,0.838,None
finn-b-R18_DYSPHAGIA,Dysphagia,Dysphagia,HP:0002015,http://purl.obolibrary.org/obo/HP_0002015,0.977,None
finn-b-I9_VARICVEOES_EXNONE,Oesophageal varices (no controls excluded),esophageal varices,EFO:0009545,http://www.ebi.ac.uk/efo/EFO_0009545,0.828,None
ukb-e-318_AFR,Tobacco use disorder,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.987,None
ukb-b-11497,Operation code: tonsillectomy +/- adenoids,tonsillectomy,EFO:0010174,http://www.ebi.ac.uk/efo/EFO_0010174,0.688,None
finn-b-ST19_INTRACR_INJURY,Intracranial injury,brain aneurysm,EFO:0003870,http://www.ebi.ac.uk/efo/EFO_0003870,0.672,None
finn-b-ST19_OTHER_INJURI_UPPER_LIMB_LEVEL_UNSPE,"Other injuries of upper limb, level unspecified",neuritis of upper limb,MONDO:0003607,http://purl.obolibrary.org/obo/MONDO_0003607,0.618,None
ebi-a-GCST005898,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-b-18541,Ever used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.811,None
ukb-e-4728_AFR,Leg pain on walking,Lower limb pain,HP:0012514,http://purl.obolibrary.org/obo/HP_0012514,0.665,None
ebi-a-GCST90016616,Major depressive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.672,None
ukb-b-3073,Operative procedures - secondary OPCS: U21.2 Computed tomography NEC,computed tomography,EFO:0003960,http://www.ebi.ac.uk/efo/EFO_0003960,0.602,None
ukb-e-6164_p1_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-30290_MID,High light scatter reticulocyte percentage,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.991,None
ukb-e-23101_MID,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
finn-b-AB1_RESP_TUBERCU,Respiratry tuberculosis,tuberculosis,MONDO:0018076,http://purl.obolibrary.org/obo/MONDO_0018076,0.765,None
ukb-e-680_p4_AFR,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-G6_HEADACHE,Other headache syndromes,headache disorder,EFO:0009550,http://www.ebi.ac.uk/efo/EFO_0009550,0.95,None
ieu-b-4960,Oesophageal cancer,esophageal cancer,MONDO:0007576,http://purl.obolibrary.org/obo/MONDO_0007576,0.835,None
ukb-e-6155_p7_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-K11_IBD_STRICT_PSC,IBD (strict) with PSC,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.68,None
finn-b-Z21_CARE_INVOLVI_USE_REHAB_PROCED,Care involving use of rehabilitation procedures,rehabilitation,EFO:0009581,http://www.ebi.ac.uk/efo/EFO_0009581,0.639,None
finn-b-AB1_OTHER_BACT_INOTHER,Other bacterial agents as the cause of diseases classified to other chapters,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.643,None
finn-b-G6_ICNEUROP,Intercostal neuropathy,neuropathy,EFO:0004149,http://www.ebi.ac.uk/efo/EFO_0004149,0.725,None
finn-b-I9_ARTEMBTHR,Arterial embolism and thrombosis,Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.862,None
finn-b-C3_ANUS_ANALCANAL,Malignant neoplasm of anus and anal canal,anus cancer,MONDO:0001879,http://purl.obolibrary.org/obo/MONDO_0001879,0.874,None
ukb-e-78_p1_CSA,"Heel bone mineral density (BMD) T-score, automated",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.695,None
ieu-b-15,"focal epilepsy, documented lesion other than hippocampal sclerosis",mesial temporal lobe epilepsy with hippocampal sclerosis,MONDO:0020476,http://purl.obolibrary.org/obo/MONDO_0020476,0.639,None
ukb-e-2814_AFR,Ever used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.811,None
ukb-e-2463_AFR,Fractured/broken bones in last 5 years,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.641,None
finn-b-E4_TESTIDYS,Testicular dysfunction,impaired renal function disease,MONDO:0001343,http://purl.obolibrary.org/obo/MONDO_0001343,0.699,None
finn-b-H8_CONSENHEARINGLOSS,Conductive and sensorineural hearing loss,"hearing loss, mixed conductive-sensorineural",MONDO:0044001,http://purl.obolibrary.org/obo/MONDO_0044001,0.887,None
ebi-a-GCST007516,Type 2 diabetes (adjusted for BMI),type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.646,None
finn-b-CD2_BENIGN_COLORECANI,"Benign neoplasm of colon, rectum, anus and anal canal",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.748,None
ukb-e-20002_p91_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-MAP_p1_AFR,"Mean arterial pressure, automated reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.718,None
finn-b-M13_MEDIALEPICOND,Medial epicondylitis,epicondylitis,EFO:1001887,http://www.ebi.ac.uk/efo/EFO_1001887,0.99,None
ukb-e-100025_CSA,Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.805,None
finn-b-Z21_POSTPA_CARE_EXAMI,Postpartum care and examination,postpartum,EFO:0008562,http://www.ebi.ac.uk/efo/EFO_0008562,0.73,None
finn-b-G6_ALCODEGEN,Degeneration of the brain due to alcohol,Brain atrophy,HP:0012444,http://purl.obolibrary.org/obo/HP_0012444,0.708,None
ukb-a-406,Current employment status: Looking after home and/or family,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.614,None
finn-b-H8_STENOEXTCAN,Acquired stenosis of external ear canal,Stenosis of the external auditory canal,HP:0000402,http://purl.obolibrary.org/obo/HP_0000402,0.754,None
finn-b-K11_JAWS,Other diseases of jaws,jaw disease,EFO:0009468,http://www.ebi.ac.uk/efo/EFO_0009468,0.605,None
ukb-d-R93,Diagnoses - main ICD10: R93 Abnormal findings on diagnostic imaging of other body structures,abnormal result of diagnostic imaging,EFO:0009827,http://www.ebi.ac.uk/efo/EFO_0009827,0.614,None
finn-b-O15_PRE_OR_ECLAMPSIA,Pre-eclampsia or eclampsia,Eclampsia,HP:0100601,http://purl.obolibrary.org/obo/HP_0100601,0.974,None
finn-b-K11_DISTAL_BITE,Distal bite,distal,EFO:0001655,http://www.ebi.ac.uk/efo/EFO_0001655,0.672,None
ukb-e-6138_p7_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-d-K11_GIBLEEDING,GI-bleeding,Gingival bleeding,HP:0000225,http://purl.obolibrary.org/obo/HP_0000225,0.67,None
finn-b-R18_SENILITY,Senility,Hutchinson-Gilford progeria syndrome,MONDO:0008310,http://purl.obolibrary.org/obo/MONDO_0008310,0.614,None
finn-b-D3_OTHNONTHROMBOCYTOPENPURPURA,Other nonthrombocytopenic purpura,thrombocytopenic purpura,MONDO:0043768,http://purl.obolibrary.org/obo/MONDO_0043768,0.937,None
ukb-e-30880_AFR,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
finn-b-AB1_SEPSIS,Septicaemia,Pasteurella hemorrhagic septicemia,EFO:1001091,http://www.ebi.ac.uk/efo/EFO_1001091,0.7,None
ukb-e-20004_p62_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ukb-e-K62_CSA,K62 Other diseases of anus and rectum,rectal disease,EFO:0009685,http://www.ebi.ac.uk/efo/EFO_0009685,0.644,None
ukb-e-2345_CSA,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
finn-b-C3_MENINGES,Malignant neoplasm of meninges,malignant tumor of meninges,MONDO:0021322,http://purl.obolibrary.org/obo/MONDO_0021322,0.99,None
finn-b-E4_LACTONAS,"Lactose intolerance, other/unspecified",lactose intolerance,EFO:1000062,http://www.ebi.ac.uk/efo/EFO_1000062,0.985,None
ukb-d-H40,Diagnoses - main ICD10: H40 Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.606,None
ukb-e-6142_p7_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-I9_OTHHEART,Other heart diseases (I9_OTHHEART),heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.706,None
finn-b-G6_STATUSEPI,Status epilepticus,status epilepticus,EFO:0008526,http://www.ebi.ac.uk/efo/EFO_0008526,0.992,None
finn-b-E4_CUSHING,Cushing syndrome,Cushing syndrome,EFO:0003099,http://www.ebi.ac.uk/efo/EFO_0003099,0.953,None
ukb-e-6138_p7_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-6155_p1_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-23099_CSA,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
ukb-e-102190_CSA,Cake intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.638,None
ukb-e-recode321_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_ULCERVAGVUL,Ulcer of vagina/vulva,ulceration of vulva,MONDO:0001551,http://purl.obolibrary.org/obo/MONDO_0001551,0.76,None
finn-b-J10_PNEUMOTHORAX,Pneumothorax,Pneumothorax,HP:0002107,http://purl.obolibrary.org/obo/HP_0002107,0.994,None
ukb-e-recode154_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6138_p7_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-VOCALCORDDYS,Vocal cord dysfunction,Vocal cord dysfunction,HP:0031801,http://purl.obolibrary.org/obo/HP_0031801,0.984,None
finn-b-K11_COELIAC,Coeliac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.992,None
ukb-a-451,Medication for cholesterol  blood pressure  diabetes  or take exogenous hormones: Hormone replacement therapy,hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.65,None
finn-b-I9_HYPTENSPREG,"Hypertension complicating pregnancy, childbirth, and the puerperium",pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.702,None
finn-b-N14_SPERMATOCELE,Spermatocele,spermatocele,EFO:1001189,http://www.ebi.ac.uk/efo/EFO_1001189,0.992,None
ukb-e-4728_EAS,Leg pain on walking,Lower limb pain,HP:0012514,http://purl.obolibrary.org/obo/HP_0012514,0.665,None
finn-b-DM_BCKGRND_RETINA,Background diabetic retinopathy,non-proliferative diabetic retinopathy,EFO:0009760,http://www.ebi.ac.uk/efo/EFO_0009760,0.849,None
ukb-e-5265_CSA,Corneal resistance factor (left),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.903,None
finn-b-H8_MIDDLEMASTOID,Diseases of middle ear and mastoid,middle ear disorder,MONDO:0003276,http://purl.obolibrary.org/obo/MONDO_0003276,0.793,None
ukb-e-21002_MID,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
finn-b-R18_PAIN_THROAT_CHEST,Pain in throat and chest,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.702,None
finn-b-CD2_BENIGN_CONJUNCTIVA_EXALLC,Benign neoplasm: Conjunctiva (all cancers excluded),Benign Conjunctival Neoplasm,EFO:1000110,http://www.ebi.ac.uk/efo/EFO_1000110,0.924,None
finn-b-I9_ARTOTH,Other diseases of arteries and capillaries,capillary disorder,MONDO:0001574,http://purl.obolibrary.org/obo/MONDO_0001574,0.875,None
finn-b-OSTEON_DRUGS,Osteonecrosis due to drugs,osteonecrosis,EFO:0004259,http://www.ebi.ac.uk/efo/EFO_0004259,0.712,None
ukb-e-recode337_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_DISSYNOTENDNAS,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,synovium disorder,MONDO:0056799,http://purl.obolibrary.org/obo/MONDO_0056799,0.656,None
ukb-e-51_MID,Seated height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.793,None
ebi-a-GCST006414,Atrial fibrillation,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.996,None
finn-b-I9_PERICAOTH,Other diseases of pericardium,pericardium disorder,MONDO:0000474,http://purl.obolibrary.org/obo/MONDO_0000474,0.943,None
finn-b-CD2_BENIGN_MALE_GEN_EXALLC,Benign neoplasm of male genital organs (all cancers excluded),male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.771,None
finn-b-H7_CORNEALOTH,Other disorders of cornea,corneal disease,EFO:0009464,http://www.ebi.ac.uk/efo/EFO_0009464,0.927,None
finn-b-N14_ORHCEPINDIDYMITIS,Orchitis and epididymitis,Epididymitis,HP:0000031,http://purl.obolibrary.org/obo/HP_0000031,0.844,None
finn-b-E4_DM1NOCOMP,Type 1 diabetes without complications,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.604,None
ukb-e-4581_EAS,Financial situation satisfaction,financial situation satisfaction measurement,EFO:0009726,http://www.ebi.ac.uk/efo/EFO_0009726,0.927,None
finn-b-Q17_CLEFT_PALATE,Cleft palate,Cleft palate,HP:0000175,http://purl.obolibrary.org/obo/HP_0000175,0.99,None
finn-b-J10_ASTHMA_EXMORE,Asthma (more controls excluded),asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-e-120_p3_EAS,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
finn-b-D3_COAGOTHER,Other coagulation defects,blood coagulation disease,EFO:0009314,http://www.ebi.ac.uk/efo/EFO_0009314,0.876,None
finn-b-AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST,"Pediculosis, acariasis and other infestations",lice infestation,MONDO:0003472,http://purl.obolibrary.org/obo/MONDO_0003472,0.672,None
ukb-e-24007_EAS,Particulate matter air pollution (pm2.5) absorbance; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.651,None
ieu-a-1170,Knee and hip osteoarthritis,"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.917,None
ukb-e-recode66_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6142_p4_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-D3_OTHERBLOOD,Oher diseases of blood and blood-forming organs,hematologic disease,EFO:0005803,http://www.ebi.ac.uk/efo/EFO_0005803,0.773,None
ukb-e-339_CSA,Other headache syndromes,headache disorder,EFO:0009550,http://www.ebi.ac.uk/efo/EFO_0009550,0.95,None
finn-b-Q17_OTHER_CONGEN_MALFO_SKIN,Other congenital malformations of skin,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.78,None
finn-b-K11_VENTHER,Ventral hernia,ventral hernia,EFO:1001866,http://www.ebi.ac.uk/efo/EFO_1001866,0.993,None
ukb-e-6138_p7_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-b-19829,"Diagnoses - main ICD10: M16.9 Coxarthrosis, unspecified","osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.676,None
finn-b-F5_MENTALUNSPE,"Mental disorders, not otherwise specified",mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.6,None
finn-b-K11_OTHDISDIG,Other diseases of the digestive system (K11_OTHDISDIG),digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.672,None
ukb-b-6748,Current employment status: None of the above,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.712,None
finn-b-M13_ROTATORCUFF,Rotator cuff syndrome,rotator cuff tear,EFO:1001250,http://www.ebi.ac.uk/efo/EFO_1001250,0.952,None
ukb-e-1200_MID,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
finn-b-DM_SEVERAL_COMPLICATIONS,"Diabetes, several complications","microvascular complications of diabetes, susceptibility",MONDO:0000065,http://purl.obolibrary.org/obo/MONDO_0000065,0.657,None
finn-b-CD2_BENIGN_BLADDER,Benign neoplasm: Bladder,bladder tumor,EFO:0000294,http://www.ebi.ac.uk/efo/EFO_0000294,0.842,None
bbj-a-121,Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.993,None
ukb-e-recode19_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-918,"Type of cancer: ICD10: D06.9 Cervix, unspecified",cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.638,None
finn-b-M13_GANGLION,Ganglion,ganglioglioma,EFO:0003094,http://www.ebi.ac.uk/efo/EFO_0003094,0.821,None
finn-b-H8_PERIPHVERTIGO,Other peripheral vertigo,peripheral vertigo,MONDO:0004900,http://purl.obolibrary.org/obo/MONDO_0004900,0.996,None
ukb-b-14486,"Non-cancer illness code, self-reported: osteoarthritis",osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.657,None
ukb-b-323,Illnesses of father: Alzheimer's disease/dementia,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.747,None
ieu-b-2,Alzheimer's disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
ukb-e-6164_p3_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-a-383,Tinnitus: Yes  now most or all of the time,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.658,None
finn-b-ANTIDEPRESSANTS,Depression medications,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.787,None
ukb-e-recode375_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_BRONCHUS_LUNG,Benign neoplasm: Bronchus and lung,bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.784,None
ebi-a-GCST007800,Asthma (childhood onset),childhood onset asthma,MONDO:0005405,http://purl.obolibrary.org/obo/MONDO_0005405,0.991,None
bbj-a-158,hepatocellular carcinoma,hepatocellular carcinoma,EFO:0000182,http://www.ebi.ac.uk/efo/EFO_0000182,0.987,None
ieu-a-1019,Migraine in bipolar disorder,migraine disorder,MONDO:0005277,http://purl.obolibrary.org/obo/MONDO_0005277,0.801,None
finn-b-K11_IBD_STRICT,"Inflammatory bowel disease, strict (require KELA)",Inflammation of the large intestine,HP:0002037,http://purl.obolibrary.org/obo/HP_0002037,0.777,None
ieu-a-833,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-a-208,Illnesses of father: Diabetes,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.629,None
finn-b-M13_FORESTIER,Ankylosing hyperostosis [Forestier],diffuse idiopathic skeletal hyperostosis,EFO:0007236,http://www.ebi.ac.uk/efo/EFO_0007236,0.711,None
finn-b-C3_DLBCL,Diffuse large B-cell lymphoma,diffuse large B-cell lymphoma,EFO:0000403,http://www.ebi.ac.uk/efo/EFO_0000403,0.861,None
ukb-d-C_FEMALE_GENITAL,Cancer of female genital,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.797,None
ukb-e-3064_CSA,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
ukb-e-20004_p79_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ukb-e-6034_AFR,Target heart rate achieved,"achievement of target heart rate, self-reported",EFO:0009823,http://www.ebi.ac.uk/efo/EFO_0009823,0.658,None
finn-b-D3_IMMUNEMECHANISM,Certain disorders involving the immune mechanism,immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.966,None
ukb-a-80,Non-cancer illness code  self-reported: retinal detachment,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.669,None
finn-b-H7_BLINDMONOCULAR,"Blindness, monocular",Blindness,HP:0000618,http://purl.obolibrary.org/obo/HP_0000618,0.737,None
finn-b-I9_ARTOTH_EXNONE,Other diseases of arteries and capillaries (no controls excluded),capillary disorder,MONDO:0001574,http://purl.obolibrary.org/obo/MONDO_0001574,0.847,None
finn-b-E4_HYPERLIPMIX,Mixed hyperlipidaemia,Combined hyperlipidemia,ORPHANET.ORDO:79211,http://www.orpha.net/ORDO/Orphanet_79211,0.834,None
ebi-a-GCST009763,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ieu-b-85,Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.994,None
finn-b-M13_MUSCLEDISNAS,Other specified disorders of muscle,muscular disease,EFO:0002970,http://www.ebi.ac.uk/efo/EFO_0002970,0.959,None
ukb-e-278_AFR,"Overweight, obesity and other hyperalimentation",obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.793,None
ebi-a-GCST011365,Myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
finn-b-Z21_ADJUS_MANAG_IMPLANTNTED_DEVICE,Adjustment and management of implanted device,encounter with health service for adjustment and management of implanted device,EFO:0020982,http://www.ebi.ac.uk/efo/EFO_0020982,0.776,None
ukb-e-6149_p2_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-594_CSA,Urinary calculus,lower urinary tract calculus,MONDO:0004828,http://purl.obolibrary.org/obo/MONDO_0004828,0.779,None
finn-b-KRA_PSY_MOTOR_EXMORE,Motor disorders (more controls excluded),motor neuron disease,EFO:0003782,http://www.ebi.ac.uk/efo/EFO_0003782,0.747,None
ukb-e-recode18_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-537,Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis,Thrombophlebitis,HP:0004418,http://purl.obolibrary.org/obo/HP_0004418,0.854,None
finn-b-CD2_BENIGN_SPINAL_CORD_EXALLC,Benign neoplasm: Spinal cord (all cancers excluded),benign neoplasm of spinal cord,MONDO:0021506,http://purl.obolibrary.org/obo/MONDO_0021506,0.91,None
finn-b-I9_CORATHER,Coronary atherosclerosis,coronary atherosclerosis,MONDO:0021661,http://purl.obolibrary.org/obo/MONDO_0021661,0.996,None
finn-b-M13_JOINTOTH,Other specific joint derangements/joint disorders,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.731,None
finn-b-F5_ALCOHOLAC,Acute alcohol intoxication (F5_ALCOHOLAC),alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.682,None
ukb-e-recode232_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_SPONDYLOPATHY,Spondylopathies,spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.747,None
finn-b-CD2_BENIGN_SALIVARY_NOS,Benign neoplasm: other/unspecified salivary gland,benign neoplasm of salivary gland,MONDO:0021460,http://purl.obolibrary.org/obo/MONDO_0021460,0.994,None
finn-b-M13_VERTEBCOLLAPSE,"Collapsed vertebra, not elsewhere classified",vertebral disorder,MONDO:0045002,http://purl.obolibrary.org/obo/MONDO_0045002,0.617,None
ukb-e-recode268_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-G6_PARKINSON,Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
finn-b-CD2_INSITU_SKIN_SCALPNECK,Carcinoma in situ of skin of scalp and neck,skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.748,None
ukb-e-100012_CSA,Vitamin B6,vitamin B6 measurement,EFO:0004621,http://www.ebi.ac.uk/efo/EFO_0004621,0.864,None
ukb-b-4554,Diagnoses - secondary ICD10: R11 Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.625,None
finn-b-CD2_INSITU_BREAST_EXALLC,Carcinoma in situ of breast (all cancers excluded),breast carcinoma in situ,MONDO:0004658,http://purl.obolibrary.org/obo/MONDO_0004658,0.87,None
finn-b-E4_ADDISON,Adrenocortical insufficiency,adrenocortical insufficiency,EFO:0009491,http://www.ebi.ac.uk/efo/EFO_0009491,0.985,None
ukb-a-432,Mouth/teeth dental problems: Toothache,toothache,EFO:0010072,http://www.ebi.ac.uk/efo/EFO_0010072,0.604,None
ieu-a-1058,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
finn-b-AD_EO_EXMORE,Alzheimer<c3><95>s disease (Early onset) (more controls excluded),early-onset autosomal dominant Alzheimer disease,MONDO:0015140,http://purl.obolibrary.org/obo/MONDO_0015140,0.681,None
ukb-a-547,Diagnoses - main ICD10: K29 Gastritis and duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.626,None
ukb-a-110,Non-cancer illness code  self-reported: varicose veins,Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.623,None
ukb-e-recode177_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-INFLUENZA,All influenza (not pneumonia),influenza,EFO:0007328,http://www.ebi.ac.uk/efo/EFO_0007328,0.757,None
ukb-b-15826,Illnesses of siblings: Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.608,None
finn-b-H7_LACRIMINFLAMCHRON,Inflammation of lacrimal passages (chronic),dacryoadenitis,MONDO:0004804,http://purl.obolibrary.org/obo/MONDO_0004804,0.678,None
ukb-d-D50,Diagnoses - main ICD10: D50 Iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.753,None
finn-b-K11_GIBLEEDING,GI-bleeding,Gingival bleeding,HP:0000225,http://purl.obolibrary.org/obo/HP_0000225,0.67,None
ukb-d-H7_CHALAZION,Chalazion,meibomian cyst,EFO:0007363,http://www.ebi.ac.uk/efo/EFO_0007363,0.993,None
ukb-e-30650_CSA,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
ukb-a-72,Non-cancer illness code  self-reported: kidney stone/ureter stone/bladder stone,bladder calculus,EFO:1000839,http://www.ebi.ac.uk/efo/EFO_1000839,0.671,None
ukb-e-2355_CSA,Most recent bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.609,None
finn-b-L12_URTICARIAERYTHEMA,Urticaria and erythema,Erythema,HP:0010783,http://purl.obolibrary.org/obo/HP_0010783,0.725,None
finn-b-CD2_BENIGN_LIPO_SKIN_TRUNK_EXALLC,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk (all cancers excluded),benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.648,None
ebi-a-GCST006909,Ischemic stroke (small-vessel),small vessel stroke,EFO:1001504,http://www.ebi.ac.uk/efo/EFO_1001504,0.805,None
finn-b-TEMPOROMANDIB,Temporomandibular joint disorders,temporomandibular joint disorder,EFO:0005279,http://www.ebi.ac.uk/efo/EFO_0005279,0.957,None
ukb-b-2349,"Non-cancer illness code, self-reported: cervical spondylosis",cervical spondylosis,EFO:0009610,http://www.ebi.ac.uk/efo/EFO_0009610,0.701,None
finn-b-D3_ACUTEPOSTBLEEDANAEMIA,Acute posthaemorrhagic anaemia,gastritis,EFO:0000217,http://www.ebi.ac.uk/efo/EFO_0000217,0.656,None
finn-b-M13_CHONDROMALACIA,Chondromalacia,chondromalacia,MONDO:0002342,http://purl.obolibrary.org/obo/MONDO_0002342,0.974,None
ukb-b-14452,"Non-cancer illness code, self-reported: inguinal hernia",Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.623,None
bbj-a-117,Esophageal cancer,esophageal cancer,MONDO:0007576,http://purl.obolibrary.org/obo/MONDO_0007576,0.993,None
ukb-e-366_AFR,Cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.989,None
ieu-a-1124,Clear cell ovarian cancer,ovarian clear cell tumor,MONDO:0021144,http://purl.obolibrary.org/obo/MONDO_0021144,0.994,None
ukb-e-recode158_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30680_MID,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
finn-b-Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS,Asymptomatic human immunodeficiency virus [HIV] infection status,HIV infection,EFO:0000764,http://www.ebi.ac.uk/efo/EFO_0000764,0.834,None
finn-b-ST19_FOREI_BODY_EXTER_EYE,Foreign body on external eye,eye foreign body,EFO:1001322,http://www.ebi.ac.uk/efo/EFO_1001322,0.833,None
finn-b-D3_NONHEREDHYPOGAMMA,Nonhereditary hypogammaglobulinemia,agammaglobulinemia,MONDO:0015977,http://purl.obolibrary.org/obo/MONDO_0015977,0.809,None
ieu-b-5070,Schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
ukb-e-I84_CSA,I84 Haemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.682,None
finn-b-I9_CEREBVASC,Cerebrovascular diseases,cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.961,None
ukb-e-2744_CSA,Birth weight of first child,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.695,None
ukb-b-10387,Leg pain on walking,Lower limb pain,HP:0012514,http://purl.obolibrary.org/obo/HP_0012514,0.665,None
finn-b-Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1,Persons encountering health services in other circumstances (Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1),encounter with health service related to socioeconomic and psychosocial circumstances,EFO:0009788,http://www.ebi.ac.uk/efo/EFO_0009788,0.609,None
finn-b-K11_POSTOPDIS,"Postprocedural disorders of digestive system, not elsewhere classified",digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.728,None
finn-b-I9_MYOCARD_EXNONE,Myocarditis (no controls excluded),myocarditis,EFO:0009609,http://www.ebi.ac.uk/efo/EFO_0009609,0.927,None
finn-b-CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC,Leiomyoma of uterus (all cancers excluded),uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.794,None
finn-b-M13_ADHCAPSULITIS,Adhesive capsulitis of shoulder,frozen shoulder,EFO:1000941,http://www.ebi.ac.uk/efo/EFO_1000941,0.988,None
ukb-a-167,Treatment/medication code: venlafaxine,response to venlafaxine,EFO:0006328,http://www.ebi.ac.uk/efo/EFO_0006328,0.668,None
ieu-a-967,Squamous cell lung cancer,squamous cell lung carcinoma,EFO:0000708,http://www.ebi.ac.uk/efo/EFO_0000708,0.989,None
ukb-e-20003_p143_EAS,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-C3_MELANOMA_SKIN,Malignant melanoma of skin,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.988,None
ukb-a-55,Cancer code  self-reported: breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.727,None
finn-b-R18_FAECAL_INCONTINENCE,Faecal incontinence,fecal incontinence,EFO:0009523,http://www.ebi.ac.uk/efo/EFO_0009523,0.993,None
ukb-d-D05,Diagnoses - main ICD10: D05 Carcinoma in situ of breast,breast carcinoma in situ,MONDO:0004658,http://purl.obolibrary.org/obo/MONDO_0004658,0.692,None
finn-b-M13_MUSCLE,Disorders of muscles,muscular disease,EFO:0002970,http://www.ebi.ac.uk/efo/EFO_0002970,0.889,None
finn-b-AUTOIMMUNE_HYPERTHYROIDISM,Autoimmune hyperthyroidism,Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.921,None
ukb-e-recode343_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-362_CSA,Other retinal disorders,retinopathy,EFO:0003839,http://www.ebi.ac.uk/efo/EFO_0003839,0.91,None
finn-b-K11_CARIES,Dental caries,dental caries,EFO:0003819,http://www.ebi.ac.uk/efo/EFO_0003819,0.99,None
finn-b-R18_SYMPTOMS_SIGNS_INVOLVI_EMOTIONAL_STATE,Symptoms and signs involving emotional state,sign or symptom,EFO:0003765,http://www.ebi.ac.uk/efo/EFO_0003765,0.649,None
ukb-b-7428,Diagnoses - main ICD10: N63 Unspecified lump in breast,Breast mass,HP:0032408,http://purl.obolibrary.org/obo/HP_0032408,0.605,None
ukb-e-6155_p4_EAS,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-20003_p118_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-CD2_BENIGN_MENINGES_NOS_EXALLC,"""Beningn neoplasm: Meninges, unspecified"" (all cancers excluded)",meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.759,None
finn-b-CD2_BENIGN_BRAIN_NOS,"Benign neoplasm: Brain, unspecified",Benign Brain Neoplasm,EFO:1000107,http://www.ebi.ac.uk/efo/EFO_1000107,0.994,None
ukb-e-recode222_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-125,Hematological malignancy,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.943,None
ukb-e-30030_EAS,Haematocrit percentage,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.61,None
ukb-e-100016_AFR,Potassium,potassium measurement,EFO:0009283,http://www.ebi.ac.uk/efo/EFO_0009283,0.841,None
ukb-e-recode29_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-C_MALE_GENITAL,Cancer of male genital,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.96,None
finn-b-T1D_WIDE,"Type 1 diabetes, wide definition",type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
ukb-e-6155_p6_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-Q17_OTHER_CONGEN_MALFO_MALE_GENITAL_ORGANS,Other congenital malformations of male genital organs,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.712,None
ukb-a-431,Mouth/teeth dental problems: Loose teeth,tooth disease,EFO:1001216,http://www.ebi.ac.uk/efo/EFO_1001216,0.604,None
finn-b-ENCEPHALITIS,Encephalitis,encephalitis,MONDO:0019956,http://purl.obolibrary.org/obo/MONDO_0019956,0.989,None
ukb-e-30020_EAS,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
finn-b-H7_RETINOPATHYDIAB_PROLIF,Proliferative diabetic retinopathy (H7_RETINOPATHYDIAB_PROLIF),proliferative diabetic retinopathy,EFO:0009322,http://www.ebi.ac.uk/efo/EFO_0009322,0.864,None
ukb-e-6142_p6_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-I9_HYPTENSEC,Secondary hypertension,secondary hypertension,EFO:1002034,http://www.ebi.ac.uk/efo/EFO_1002034,0.977,None
ukb-b-18596,Pain type(s) experienced in last month: Neck or shoulder pain,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.653,None
finn-b-OSTEOPOROSIS_FRACTURE_FG,Osteoporosis with pathological fracture (FG),Pathologic fracture,HP:0002756,http://purl.obolibrary.org/obo/HP_0002756,0.651,None
finn-b-K11_HYPODONTIA,Hypodontia,tooth agenesis,EFO:0005410,http://www.ebi.ac.uk/efo/EFO_0005410,0.987,None
finn-b-N14_ENDOMETRIOSIS_PELVICPERITONEUM,Endometriosis of pelvic peritoneum,endometriosis of pelvic peritoneum,MONDO:0001285,http://purl.obolibrary.org/obo/MONDO_0001285,0.993,None
finn-b-M13_IMPINGEMENT,Impingement syndrome of shoulder,shoulder impingement syndrome,EFO:1001178,http://www.ebi.ac.uk/efo/EFO_1001178,0.957,None
ieu-a-798,Myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
ukb-e-136_p1_MID,"Number of operations, self-reported","number of operations, self-reported",EFO:0009802,http://www.ebi.ac.uk/efo/EFO_0009802,0.819,None
finn-b-E4_THYTOXNAS,"Thyrotoxicosis, other and/or unspecified",Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.991,None
finn-b-O15_DELIV_FORCEP_VAC,Single delivery by forceps and vacuum extractor,Forceps delivery,HP:0011411,http://purl.obolibrary.org/obo/HP_0011411,0.625,None
finn-b-ST19_FOREI_BODY_GENITO_TRACT,Foreign body in genitourinary tract,foreign body,EFO:0009525,http://www.ebi.ac.uk/efo/EFO_0009525,0.672,None
ukb-d-C43,Diagnoses - main ICD10: C43 Malignant melanoma of skin,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.729,None
finn-b-MENINGITIS,Meningitis,meningitis,MONDO:0021108,http://purl.obolibrary.org/obo/MONDO_0021108,0.993,None
ukb-b-19354,Diagnoses - main ICD10: K20 Oesophagitis,Esophagitis,HP:0100633,http://purl.obolibrary.org/obo/HP_0100633,0.698,None
ukb-e-103230_AFR,Other fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.846,None
ukb-e-NAP_EAS,Non-albumin protein,serum non-albumin protein measurement,EFO:0004568,http://www.ebi.ac.uk/efo/EFO_0004568,0.712,None
ieu-a-22,Schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
ukb-e-4125_CSA,"Heel bone mineral density (BMD) T-score, automated (right)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.658,None
ieu-b-4971,Cholecystitits,Cholecystitis,HP:0001082,http://purl.obolibrary.org/obo/HP_0001082,0.842,None
finn-b-CD2_BENIGN_CRANIAL_NERVE,Benign neoplasm: Cranial nerves,cranial nerve neoplasm,MONDO:0002633,http://purl.obolibrary.org/obo/MONDO_0002633,0.82,None
ukb-b-9925,"Diagnoses - secondary ICD10: J90 Pleural effusion, not elsewhere classified",pleural effusion,EFO:0009637,http://www.ebi.ac.uk/efo/EFO_0009637,0.64,None
ukb-b-13782,Diagnoses - secondary ICD10: Z86.7 Personal history of diseases of the circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.657,None
ukb-e-23101_EAS,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
ukb-e-recode16_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_ENTESOPATHYLOWNAS,"Other/unspecified enthesopathies of lower limb, excluding foot",rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.676,None
ebi-a-GCST003129,Primary biliary cholangitis,primary biliary cirrhosis,EFO:1001486,http://www.ebi.ac.uk/efo/EFO_1001486,0.992,None
ukb-e-30520_AFR,Potassium in urine,urinary potassium measurement,EFO:0010952,http://www.ebi.ac.uk/efo/EFO_0010952,0.875,None
finn-b-M13_PATELLAOTH,Other disorders of patella,disorder of patella,EFO:0009665,http://www.ebi.ac.uk/efo/EFO_0009665,0.92,None
ukb-b-129,Vitamin and/or mineral supplement use: Vitamin B6,vitamin B6 measurement,EFO:0004621,http://www.ebi.ac.uk/efo/EFO_0004621,0.724,None
finn-b-G6_TARSTUN,Tarsal tunnel syndrome,tarsal tunnel syndrome,EFO:1001208,http://www.ebi.ac.uk/efo/EFO_1001208,0.964,None
finn-b-H8_CERUMEN,Impacted cerumen,Impacted tooth,HP:0011079,http://purl.obolibrary.org/obo/HP_0011079,0.608,None
ukb-d-S72,Diagnoses - main ICD10: S72 Fracture of femur,femur fracture,EFO:0008553,http://www.ebi.ac.uk/efo/EFO_0008553,0.715,None
ukb-e-J45_CSA,J45 Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.683,None
ukb-e-recode95_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-21002_AFR,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
finn-b-G6_DISSOTH,Other acute disseminated demyelination,Peripheral demyelination,HP:0011096,http://purl.obolibrary.org/obo/HP_0011096,0.743,None
finn-b-H7_PARASTRA3,Third [oculomotor] nerve palsy,Oculomotor palsy,ORPHANET.ORDO:98685,http://www.orpha.net/ORDO/Orphanet_98685,0.776,None
ukb-e-8_CSA,Intestinal infection,intestinal infectious disease,MONDO:0000916,http://purl.obolibrary.org/obo/MONDO_0000916,0.798,None
ukb-d-20126_5,Bipolar and major depression status: Single Probable major depression episode,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.769,None
ukb-e-30040_MID,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
finn-b-G6_HEMIPLE,Hemiplegia,hemiplegia,EFO:0009453,http://www.ebi.ac.uk/efo/EFO_0009453,0.993,None
ebi-a-GCST000964,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-b-12648,Vitamin and mineral supplements: Vitamin D,vitamin D measurement,EFO:0004631,http://www.ebi.ac.uk/efo/EFO_0004631,0.692,None
finn-b-C3_MENINGES_EXALLC,Malignant neoplasm of meninges (all cancers excluded),malignant tumor of meninges,MONDO:0021322,http://purl.obolibrary.org/obo/MONDO_0021322,0.902,None
ukb-d-4803_12,"Tinnitus: Yes, now a lot of the time",Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.643,None
ukb-e-30840_CSA,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
finn-b-R18_HAEMORRHAGE_RESPI_PASSA,Haemorrhage from respiratory passages,Retinal hemorrhage,HP:0000573,http://purl.obolibrary.org/obo/HP_0000573,0.616,None
ukb-e-3062_AFR,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
finn-b-G6_TRINEU,Trigeminal neuralgia,trigeminal neuralgia,EFO:1001219,http://www.ebi.ac.uk/efo/EFO_1001219,0.986,None
ukb-e-120_p3_AFR,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
finn-b-CD2_BENIGN_CONNSOFT_HEADFACETRUNK_EXALLC,"""Benign neoplasm: Connective and other soft tissue of head, face and neck"" (all cancers excluded)",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.813,None
finn-b-O15_LABOUR_LONG,Long labour,Braxton-Hicks contractions,EFO:0009639,http://www.ebi.ac.uk/efo/EFO_0009639,0.634,None
finn-b-F5_MOODOTH,Other and unspecidied mood [affective] disorders,mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.661,None
finn-b-Q17_OTHER_OSTEOCHONDROD,Other osteochondrodysplasias,osteochondrodysplasia,EFO:0005571,http://www.ebi.ac.uk/efo/EFO_0005571,0.933,None
finn-b-I9_ATHSCLE_EXNONE,"""Atherosclerosis, excluding cerebral, coronary and PAD"" (no controls excluded)",cerebral atherosclerosis,EFO:1000860,http://www.ebi.ac.uk/efo/EFO_1000860,0.8,None
ukb-e-30790_AFR,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
ukb-a-65,Non-cancer illness code  self-reported: deep venous thrombosis (dvt),deep vein thrombosis,EFO:0003907,http://www.ebi.ac.uk/efo/EFO_0003907,0.685,None
finn-b-O15_DELIV_PERIN_LACER,Perineal laceration during delivery,perineal laceration during delivery,EFO:0009816,http://www.ebi.ac.uk/efo/EFO_0009816,0.992,None
ukb-b-19158,Mineral and other dietary supplements: Selenium,response to dietary selenium supplementation,EFO:0600021,http://www.ebi.ac.uk/efo/EFO_0600021,0.727,None
finn-b-O15_PLAC_PRAEVIA,Placenta praevia,placenta praevia,EFO:0007442,http://www.ebi.ac.uk/efo/EFO_0007442,0.985,None
finn-b-FALLS,Falls/tendenct to fall,fall,EFO:0009631,http://www.ebi.ac.uk/efo/EFO_0009631,0.729,None
ukb-e-23098_CSA,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
ukb-e-20018_AFR,Prospective memory result,episodic memory,EFO:0004333,http://www.ebi.ac.uk/efo/EFO_0004333,0.805,None
ukb-e-recode246_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_HYPTENS,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
ukb-e-30810_MID,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
finn-b-K11_OTHAPPEND,Other diseases of appendix,disorder of appendix,EFO:0009542,http://www.ebi.ac.uk/efo/EFO_0009542,0.953,None
finn-b-O15_PREG_GU_INFECT,Infections of genitourinary tract in pregnancy,urinary tract infection,EFO:0003103,http://www.ebi.ac.uk/efo/EFO_0003103,0.617,None
finn-b-AB1_TULARAEMIA,Tularaemia,Tularemia,EFO:1001444,http://www.ebi.ac.uk/efo/EFO_1001444,0.692,None
ukb-e-30070_EAS,Red blood cell (erythrocyte) distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
ukb-a-255,Doctor diagnosed asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.604,None
ukb-e-recode292_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20117_p1_EAS,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
finn-b-CD2_BENIGN_SKIN_TRUNK_EXALLC,Benign neoplasm: Skin of trunk (all cancers excluded),benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.769,None
finn-b-I9_VHD_EXNONE,Valvular heart disease including rheumatic fever (no controls excluded),heart valve disease,EFO:0009551,http://www.ebi.ac.uk/efo/EFO_0009551,0.657,None
ukb-b-2625,Diagnoses - secondary ICD10: M47.82 Other spondylosis (Cervical region),cervical spondylosis,EFO:0009610,http://www.ebi.ac.uk/efo/EFO_0009610,0.636,None
finn-b-H7_GLAUCPRIMOPEN,Primary open-angle glaucoma,open-angle glaucoma,EFO:0004190,http://www.ebi.ac.uk/efo/EFO_0004190,0.989,None
ukb-a-544,Diagnoses - main ICD10: K20 Oesophagitis,Esophagitis,HP:0100633,http://purl.obolibrary.org/obo/HP_0100633,0.698,None
finn-b-Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_SOCIO_PSYCHOSO_CIRCUMSTANC,Persons with potential health hazards related to socioeconomic and psychosocial circumstances,encounter with health service related to socioeconomic and psychosocial circumstances,EFO:0009788,http://www.ebi.ac.uk/efo/EFO_0009788,0.738,None
finn-b-M13_TROCHANTERICBURSITIS,Trochanteric bursitis,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.692,None
ukb-e-1508_p3_MID,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-I9_CONDUCTIO_EXNONE,Conduction disorders (no controls excluded),conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.756,None
finn-b-DM_NEPHROPATHY,Diabetic nephropathy,diabetic nephropathy,EFO:0000401,http://www.ebi.ac.uk/efo/EFO_0000401,0.985,None
finn-b-R18_GANGRENE_NOT_ELSEW_CLASSIFIED,"Gangrene, not elsewhere classified",gangrene,EFO:0008574,http://www.ebi.ac.uk/efo/EFO_0008574,0.996,None
finn-b-ST19_INJURY_UNSPE_BODY_REGION,Injury of unspecified body region,injury,EFO:0000546,http://www.ebi.ac.uk/efo/EFO_0000546,0.616,None
finn-b-I9_ATHSCLE,"Atherosclerosis, excluding cerebral, coronary and PAD",cerebral atherosclerosis,EFO:1000860,http://www.ebi.ac.uk/efo/EFO_1000860,0.822,None
ukb-e-recode435_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_RETVASCNAS,Other and unspecified vascular occlusions,vascular occlusion disorder,MONDO:0020672,http://purl.obolibrary.org/obo/MONDO_0020672,0.95,None
finn-b-C3_MELANOMA_SKIN_EXALLC,Malignant melanoma of skin (all cancers excluded),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.901,None
ukb-e-30790_EAS,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
finn-b-N14_FIOTHNAS,"Female infertility, cervigal, vaginal, other or unspecified origin",female infertility,EFO:0008560,http://www.ebi.ac.uk/efo/EFO_0008560,0.622,None
ieu-a-1133,ER+ Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.668,None
ukb-b-7773,Illnesses of father: Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.657,None
finn-b-DM_PERIPHATHERO,Peripheral atherosclerosis,atherosclerosis,EFO:0003914,http://www.ebi.ac.uk/efo/EFO_0003914,0.825,None
finn-b-G6_NEURODEG,Other degenerative diseases of the nervous system (G6_NEURODEG),neurodegenerative disease,EFO:0005772,http://www.ebi.ac.uk/efo/EFO_0005772,0.745,None
finn-b-M13_TIETZE,Chondrocostal junction syndrome [Tietze],Tietze syndrome,MONDO:0001858,http://purl.obolibrary.org/obo/MONDO_0001858,0.703,None
finn-b-CD2_BENIGN_APPENDIX_EXALLC,Benign neoplasm: Appendix (all cancers excluded),appendiceal neoplasm,EFO:0003880,http://www.ebi.ac.uk/efo/EFO_0003880,0.803,None
finn-b-K11_GINGIVITIS_PERIODONTAL,Gingivitis and periodontal diseases,periodontal disorder,MONDO:0002635,http://purl.obolibrary.org/obo/MONDO_0002635,0.704,None
finn-b-N14_BREAST,Disorders of breast,breast disease,EFO:0009483,http://www.ebi.ac.uk/efo/EFO_0009483,0.906,None
finn-b-K11_IMPACTED_TEETH,Impacted teeth,Impacted tooth,HP:0011079,http://purl.obolibrary.org/obo/HP_0011079,0.666,None
finn-b-G6_CERVROOT,Cervical root disorders,cervix disorder,MONDO:0002256,http://purl.obolibrary.org/obo/MONDO_0002256,0.754,None
ebi-a-GCST006640,Menstruation quality of life impact (acne),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.684,None
finn-b-ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL,Injury of nerves at ankle and foot level,ankle injury,EFO:1002021,http://www.ebi.ac.uk/efo/EFO_1002021,0.647,None
ebi-a-GCST004901,Amyotrophic lateral sclerosis (sporadic),sporadic amyotrophic lateral sclerosis,EFO:0001357,http://www.ebi.ac.uk/efo/EFO_0001357,0.99,None
ukb-e-51_AFR,Seated height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.793,None
finn-b-E4_POCS,Polycystic ovarian syndrome,polycystic ovary syndrome,EFO:0000660,http://www.ebi.ac.uk/efo/EFO_0000660,0.979,None
ukb-e-550_MID,Abdominal hernia,Hernia of the abdominal wall,HP:0004299,http://purl.obolibrary.org/obo/HP_0004299,0.792,None
finn-b-M13_ANKYLOSPON_STRICT,"Ankylosing spondylitis, strict definition",ankylosing spondylitis,EFO:0003898,http://www.ebi.ac.uk/efo/EFO_0003898,0.994,None
finn-b-L12_NAILNAS,Other and unspecified nail disorders,nail disorder,MONDO:0002884,http://purl.obolibrary.org/obo/MONDO_0002884,0.911,None
finn-b-CD2_BENIGN_LIPO_SKIN_NOS,Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.681,None
ukb-e-30670_CSA,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
ukb-e-30290_CSA,High light scatter reticulocyte percentage,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.991,None
finn-b-CD2_BENIGN_VAGINA_EXALLC,Benign neoplasm: Vulva (all cancers excluded),vulvar benign neoplasm,MONDO:0000643,http://purl.obolibrary.org/obo/MONDO_0000643,0.921,None
ukb-e-2090_EAS,"Seen doctor (GP) for nerves, anxiety, tension or depression",mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
ukb-d-I9_MI,Myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
ukb-b-18194,"Non-cancer illness code, self-reported: ankylosing spondylitis",ankylosing spondylitis,EFO:0003898,http://www.ebi.ac.uk/efo/EFO_0003898,0.73,None
ukb-d-22506_112,Tobacco smoking: Occasionally,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.721,None
finn-b-K11_VASCINT,Vascular disorders of the intestines,vascular disease,EFO:0004264,http://www.ebi.ac.uk/efo/EFO_0004264,0.765,None
finn-b-C3_STOMACH_EXALLC,Malignant neoplasm of stomach (all cancers excluded),gastric cancer,MONDO:0001056,http://purl.obolibrary.org/obo/MONDO_0001056,0.912,None
finn-b-G6_MUSCOTHUNS,Other and unspecified primary disorders of muscles,muscular disease,EFO:0002970,http://www.ebi.ac.uk/efo/EFO_0002970,0.725,None
finn-b-C3_MESTOTHEL_SOFTTISSUE,Melignant neoplasm of mesothelium and soft tissue,Malignant Mesothelioma,EFO:1000355,http://www.ebi.ac.uk/efo/EFO_1000355,0.79,None
finn-b-R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_CENTRAL_NERVOUS_SYSTEM,Abnormal findings on diagnostic imaging of central nervous system,Morphological central nervous system abnormality,HP:0002011,http://purl.obolibrary.org/obo/HP_0002011,0.662,None
finn-b-ABDOM_HERNIA,Hernia of abodminal wall,Hernia of the abdominal wall,HP:0004299,http://purl.obolibrary.org/obo/HP_0004299,0.652,None
finn-b-M13_FINGERDEFORM,Deformity of finger(s),congenital deformities of fingers,MONDO:0017428,http://purl.obolibrary.org/obo/MONDO_0017428,0.7,None
ukb-e-6148_p3_AFR,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ukb-b-20464,Doctor diagnosed COPD (chronic obstructive pulmonary disease),chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.866,None
ukb-e-20003_p283_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-C3_THYROID_GLAND,Malignant neoplasm of thyroid gland,thyroid cancer,MONDO:0002108,http://purl.obolibrary.org/obo/MONDO_0002108,0.995,None
ukb-e-593_CSA,Hematuria,Hematuria,HP:0000790,http://purl.obolibrary.org/obo/HP_0000790,0.996,None
finn-b-N14_BARTHOOTHNAS,Other and unspecified disease of Bartholin gland,Bartholin gland disease,EFO:0009469,http://www.ebi.ac.uk/efo/EFO_0009469,0.971,None
finn-b-C3_MALE_GENITAL_EXALLC,malignant neoplasm of male genital organs (all cancers excluded),male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.931,None
finn-b-L12_GRANUANNU,Granuloma annulare,granuloma annulare,EFO:1000704,http://www.ebi.ac.uk/efo/EFO_1000704,0.994,None
finn-b-AB1_WHOOPCOUGH,Whooping cough,whooping cough,EFO:0000650,http://www.ebi.ac.uk/efo/EFO_0000650,0.991,None
finn-b-DM_NEUROPATHY,Diabetic neuropathy,diabetic neuropathy,EFO:1000783,http://www.ebi.ac.uk/efo/EFO_1000783,0.984,None
ukb-a-346,Back pain for 3+ months,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.671,None
ukb-e-recode51_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-82,Smoking behaviors : Smoking cessation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.841,None
ukb-e-recode376_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-133,Hip pain for 3+ months,Hip pain,HP:0030838,http://purl.obolibrary.org/obo/HP_0030838,0.66,None
ukb-e-2375_AFR,Relative age of first facial hair,age at first facial hair,EFO:0009716,http://www.ebi.ac.uk/efo/EFO_0009716,0.823,None
finn-b-I9_PULMHEART,"Pulmonary heart disease, diseases of pulmonary circulation",lung disease,EFO:0003818,http://www.ebi.ac.uk/efo/EFO_0003818,0.884,None
ukb-e-4101_EAS,Heel broadband ultrasound attenuation (left),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.891,None
ukb-b-12191,"Diagnoses - secondary ICD10: K29.5 Chronic gastritis, unspecified",chronic gastritis,EFO:0000337,http://www.ebi.ac.uk/efo/EFO_0000337,0.622,None
ukb-e-20084_p5_AFR,Vitamin and/or mineral supplement use,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.624,None
finn-b-N14_PROSTHYPERPLA,Hyperplasia of prostate,benign prostatic hyperplasia,EFO:0000284,http://www.ebi.ac.uk/efo/EFO_0000284,0.981,None
ukb-e-2794_CSA,Age started oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.692,None
finn-b-I9_CERATHER_EXNONE,Cerebral atherosclerosis (no controls excluded),cerebral atherosclerosis,EFO:1000860,http://www.ebi.ac.uk/efo/EFO_1000860,0.957,None
finn-b-H7_PARASTRAB,Paralytic strabismus,paralytic strabismus,EFO:0009678,http://www.ebi.ac.uk/efo/EFO_0009678,0.991,None
finn-b-K11_DIVERTIC,Diverticular disease of intestine,diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.841,None
ukb-b-12040,"Non-cancer illness code, self-reported: deep venous thrombosis (dvt)",deep vein thrombosis,EFO:0003907,http://www.ebi.ac.uk/efo/EFO_0003907,0.685,None
ukb-e-MAP_p3_CSA,"Mean arterial pressure, combined automated + manual reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.652,None
ukb-b-19419,Diagnoses - main ICD10: R11 Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.681,None
ebi-a-GCST006466,Endometrial cancer (Non-endometrioid histology),endometrial endometrioid carcinoma,EFO:1001514,http://www.ebi.ac.uk/efo/EFO_1001514,0.793,None
ukb-e-recode76_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-563_CSA,Constipation,Constipation,HP:0002019,http://purl.obolibrary.org/obo/HP_0002019,0.995,None
finn-b-H7_MACULOPATHYDIAB,Diabetic maculopathy (H7_MACULOPATHYDIAB),diabetic maculopathy,EFO:0010133,http://www.ebi.ac.uk/efo/EFO_0010133,0.86,None
ukb-e-20003_p564_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-ALCOHOLACUTE10,Acute alcohol intoxication (ALCOHOLACUTE10),"Hepatitis, Alcoholic",EFO:1001345,http://www.ebi.ac.uk/efo/EFO_1001345,0.629,None
ukb-e-recode420_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6164_p6_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ebi-a-GCST005543,Sarcoidosis (non-Lofgren's syndrome),sarcoidosis,MONDO:0019338,http://purl.obolibrary.org/obo/MONDO_0019338,0.612,None
ukb-e-562_AFR,Diverticulosis and diverticulitis,diverticulitis,EFO:1001460,http://www.ebi.ac.uk/efo/EFO_1001460,0.92,None
finn-b-CD2_BENIGN_ENDOCRINE_OTH,Benign neoplasm of other and unspecified endocrine glands,benign endocrine neoplasm,MONDO:0000627,http://purl.obolibrary.org/obo/MONDO_0000627,0.93,None
ukb-e-23119_CSA,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
ukb-e-23127_MID,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
ieu-a-1102,Chronic kidney disease,chronic kidney disease,EFO:0003884,http://www.ebi.ac.uk/efo/EFO_0003884,0.995,None
ukb-e-SBP_p2_CSA,"Systolic blood pressure, combined automated + manual reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.696,None
ukb-e-680_p5_EAS,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-J10_VIRALPNEUMO,Viral pneumonia,viral pneumonia,EFO:0007541,http://www.ebi.ac.uk/efo/EFO_0007541,0.994,None
finn-b-CD2_BENIGN_SKIN_EAR_EXALLC,Benign neoplasm: Skin of ear and external auricular canal (all cancers excluded),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.614,None
ukb-e-30240_EAS,Reticulocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.694,None
ukb-b-7299,Diagnoses - secondary ICD10: Z85.5 Personal history of malignant neoplasm of urinary tract,Malignant Urinary System Neoplasm,EFO:1000363,http://www.ebi.ac.uk/efo/EFO_1000363,0.632,None
finn-b-Z21_ANKLE_FOOT,Ankle and foot,osteomyelitis,EFO:0003102,http://www.ebi.ac.uk/efo/EFO_0003102,0.708,None
ukb-e-5256_CSA,Corneal hysteresis (right),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.879,None
finn-b-C3_SECONDARY_NAS,Secondary malignant neoplasm of other and unspecified sites,secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.87,None
ukb-d-VIII_EAR_MASTOID,Diseases of the ear and mastoid process,auditory system disease,EFO:1001455,http://www.ebi.ac.uk/efo/EFO_1001455,0.756,None
ukb-a-98,Non-cancer illness code  self-reported: hypopituitarism,hypopituitarism,EFO:0001380,http://www.ebi.ac.uk/efo/EFO_0001380,0.694,None
finn-b-I9_OTHPER_EXNONE,Other peripheral vascular diseases (no controls excluded),peripheral vascular disease,EFO:0003875,http://www.ebi.ac.uk/efo/EFO_0003875,0.945,None
ukb-e-100002_AFR,Energy,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.718,None
ukb-e-250_CSA,Diabetes mellitus,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.993,None
finn-b-M13_THORACISPINEPAIN,Pain in thoracic spine,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.839,None
ukb-e-23099_MID,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
finn-b-H8_VERTIGO,Disorders of vestibular function (Vertigo),vestibular disease,EFO:0009691,http://www.ebi.ac.uk/efo/EFO_0009691,0.721,None
ukb-e-20004_p38_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ukb-a-324,Ever used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.811,None
finn-b-M13_POSTOPMUSCULOSKE,"Postprocedural musculoskeletal disorders, not elsewhere classified",musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.763,None
ukb-e-R06_CSA,R06 Abnormalities of breathing,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.729,None
finn-b-N14_FEMALEGENNONINF,Noninflammatory disorders of female genital tract,female reproductive system disease,EFO:0009549,http://www.ebi.ac.uk/efo/EFO_0009549,0.73,None
ukb-e-24007_CSA,Particulate matter air pollution (pm2.5) absorbance; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.651,None
finn-b-H7_CONJUNCTIVITISATOPIC,Atopic conjunctivitis,allergic conjunctivitis,EFO:0007141,http://www.ebi.ac.uk/efo/EFO_0007141,0.995,None
ukb-e-136_p1_EAS,"Number of operations, self-reported","number of operations, self-reported",EFO:0009802,http://www.ebi.ac.uk/efo/EFO_0009802,0.819,None
finn-b-G6_DEMYEL,Demyelenating diseases of the central nervous system,central nervous system disease,EFO:0009386,http://www.ebi.ac.uk/efo/EFO_0009386,0.749,None
ukb-e-218_CSA,Benign neoplasm of uterus,uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.996,None
ukb-e-2227_CSA,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
ukb-b-13745,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
ukb-e-recode146_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-C3_MALE_GENITAL,malignant neoplasm of male genital organs,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.989,None
ukb-e-recode286_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_DESEN_ALLERGE,Desensitization to allergens,allergic sensitization measurement,EFO:0005298,http://www.ebi.ac.uk/efo/EFO_0005298,0.71,None
bbj-a-131,Keloid,Keloid,EFO:0004212,http://www.ebi.ac.uk/efo/EFO_0004212,0.999,None
ukb-e-20453_CSA,Ever taken cannabis,Cannabis use,EFO:0007585,http://www.ebi.ac.uk/efo/EFO_0007585,0.659,None
finn-b-O15_PUERP_SEPSIS,Puerperal sepsis,puerperal disorder,EFO:0009683,http://www.ebi.ac.uk/efo/EFO_0009683,0.681,None
ukb-e-4079_AFR,"Diastolic blood pressure, automated reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
ukb-e-30850_MID,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
ukb-b-3095,Diagnoses - main ICD10: H25.1 Senile nuclear cataract,nuclear senile cataract,MONDO:0001847,http://purl.obolibrary.org/obo/MONDO_0001847,0.756,None
finn-b-L12_HAIRLOSSSCAR,Cicatricial alopecia [scarring hair loss],Scarring alopecia of scalp,HP:0004552,http://purl.obolibrary.org/obo/HP_0004552,0.719,None
ukb-e-6138_p3_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-C3_HEART_MEDIASTINUM_PLEURA,"Malignant neoplasm of heart, mediastinum and pleura",mediastinal cancer,EFO:0007362,http://www.ebi.ac.uk/efo/EFO_0007362,0.819,None
ieu-a-1187,Major Depressive Disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.987,None
finn-b-CD2_INSITU_SKIN_NOS_EXALLC,"""Carcinoma in situ of skin, other sites/unspecified"" (all cancers excluded)",skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.829,None
ukb-b-9127,Illnesses of father: Chronic bronchitis/emphysema,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.659,None
ieu-b-4968,Oropharyngeal cancer,oropharynx cancer,EFO:1001931,http://www.ebi.ac.uk/efo/EFO_1001931,0.992,None
ebi-a-GCST006645,Menstruation quality of life impact (edema),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.677,None
ukb-a-439,Fractured bone site(s): Wrist,wrist fracture,EFO:0009515,http://www.ebi.ac.uk/efo/EFO_0009515,0.761,None
ukb-e-recode235_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-8416,"Type of cancer: ICD10: C44.9 Malignant neoplasm of skin, unspecified",skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.707,None
finn-b-H7_CHORIORETINFLAM,Chorioretinal inflammation,posterior uveitis,EFO:1001119,http://www.ebi.ac.uk/efo/EFO_1001119,0.896,None
ukb-e-M17_CSA,M17 Gonarthrosis [arthrosis of knee],joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.756,None
ukb-e-709_p1_CSA,Number in household,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.709,None
finn-b-AB1_VIRAL_WARTS,Viral warts,common wart,EFO:0009662,http://www.ebi.ac.uk/efo/EFO_0009662,0.988,None
bbj-a-88,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-e-20116_p3_AFR,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
finn-b-H7_OPTNERVNAS,"Disorders of optic nerve, not elsewhere classified",optic nerve disorder,MONDO:0002135,http://purl.obolibrary.org/obo/MONDO_0002135,0.917,None
finn-b-D3_AGRANULOCYTOSIS,Agranulocytosis,Agranulocytosis,HP:0012234,http://purl.obolibrary.org/obo/HP_0012234,0.992,None
finn-b-H7_RETIVASCOCCLUSION,Retinal vascular occlusion,retinal vascular occlusion,MONDO:0002089,http://purl.obolibrary.org/obo/MONDO_0002089,0.996,None
ukb-b-19109,Diagnoses - main ICD10: R00.2 Palpitations,Palpitations,HP:0001962,http://purl.obolibrary.org/obo/HP_0001962,0.663,None
ukb-e-34_AFR,Year of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.622,None
finn-b-G6_EPLEPSY,Epilepsy,epilepsy,EFO:0000474,http://www.ebi.ac.uk/efo/EFO_0000474,0.998,None
finn-b-C3_FEMALE_GENITAL_EXALLC,malignant neoplasm of female genital organs (all cancers excluded),"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.9,None
finn-b-K11_ACHAL,Achalasia of cardia,Achalasia,HP:0002571,http://purl.obolibrary.org/obo/HP_0002571,0.801,None
bbj-a-73,Rheumatoid Arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-AB1_OTHER_MYCOBAC,Infection due to other mycobacteria,mycobacterial infectious disease,MONDO:0020590,http://purl.obolibrary.org/obo/MONDO_0020590,0.844,None
finn-b-Q17_CONGEN_MALFO_CIRCULATO_SYSTEM,Congenital malformations of the circulatory system,congenital anomaly of cardiovascular system,MONDO:0024239,http://purl.obolibrary.org/obo/MONDO_0024239,0.745,None
ukb-e-30830_CSA,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
ukb-e-recode395_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AD_LO_EXMORE,Alzheimer<c3><95>s disease (Late onset) (more controls excluded),late-onset Alzheimer's disease,EFO:1001870,http://www.ebi.ac.uk/efo/EFO_1001870,0.717,None
ukb-e-5256_EAS,Corneal hysteresis (right),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.879,None
ieu-a-1184,Autism Spectrum Disorder,autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.99,None
ukb-e-recode17_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30720_AFR,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
ukb-e-20002_p1_MID,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-ASTHMA_ALLERG_EXMORE,Asthma and allergy (more controls excluded),allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.788,None
finn-b-KRA_PSY_BEHAV,Behavioural disorders,Atypical behavior,HP:0000708,http://purl.obolibrary.org/obo/HP_0000708,0.991,None
finn-b-CD2_BENIGN_MENINGES_NOS,"Beningn neoplasm: Meninges, unspecified",meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.819,None
ieu-a-92,Obesity class 3,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.783,None
ieu-a-9,Coronary heart disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.993,None
ukb-e-495_CSA,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
finn-b-P16_DIGES_SYSTEM_DISORD_FETUS_NEWBO,Digestive system disorders of fetus and newborn,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.675,None
ebi-a-GCST006980,Fractures,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.874,None
ukb-d-Z30,Diagnoses - main ICD10: Z30 Contraceptive management,contraception,EFO:0009520,http://www.ebi.ac.uk/efo/EFO_0009520,0.728,None
finn-b-K11_CHOLANGI,"Cholangitis (primary sclerosing, PSC)",sclerosing cholangitis,EFO:0004268,http://www.ebi.ac.uk/efo/EFO_0004268,0.891,None
ukb-e-recode263_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_FLUIDELECTRONAS,"Other disorders of electrolyte and fluid balance, not elsewhere classified",Abnormal blood ion concentration,HP:0003111,http://purl.obolibrary.org/obo/HP_0003111,0.737,None
finn-b-M13_HALLUXVALGUS,Hallux valgus (acquired),Hallux valgus,HP:0001822,http://purl.obolibrary.org/obo/HP_0001822,0.994,None
finn-b-R18_ABDOMI_PELVIC_PAIN,Abdominal and pelvic pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.76,None
ukb-b-10923,Alcohol consumed,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.769,None
finn-b-CD2_BENIGN_LIPO_SKIN_TRUNK,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.669,None
ukb-e-23115_AFR,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
ukb-d-G43,Diagnoses - main ICD10: G43 Migraine,migraine disorder,MONDO:0005277,http://purl.obolibrary.org/obo/MONDO_0005277,0.6,None
finn-b-K11_OTHDISOES,Other diseases of oesophagus,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.811,None
ukb-e-6149_p6_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-30190_CSA,Monocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.994,None
ukb-d-K11_HERNIA,Hernia,Hernia,HP:0100790,http://purl.obolibrary.org/obo/HP_0100790,0.991,None
ukb-e-1050_CSA,Time spend outdoors in summer,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.746,None
finn-b-N14_OTHETNASKIDUR,Other specified disorders of kidney and ureter,kidney disease,EFO:0003086,http://www.ebi.ac.uk/efo/EFO_0003086,0.859,None
ebi-a-GCST003769,Depression,depressive disorder,MONDO:0002050,http://purl.obolibrary.org/obo/MONDO_0002050,0.992,None
finn-b-T1D_STRICT,"Type 1 diabetes, strict definition",type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
ebi-a-GCST003724,Bipolar disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.992,None
ukb-a-394,Target heart rate achieved,"achievement of target heart rate, self-reported",EFO:0009823,http://www.ebi.ac.uk/efo/EFO_0009823,0.658,None
finn-b-M13_SPONDYLOSIS,Spondylosis,spondylosis,MONDO:0002253,http://purl.obolibrary.org/obo/MONDO_0002253,0.994,None
ebi-a-GCST000679,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-VD_MX,Vascular dementia (mixed),vascular dementia,EFO:0004718,http://www.ebi.ac.uk/efo/EFO_0004718,0.818,None
ukb-e-6149_p6_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ebi-a-GCST007090,Knee osteoarthritis,"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.989,None
ukb-e-52_p3_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-30200_EAS,Neutrophill percentage,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.917,None
ukb-a-57,Cancer code  self-reported: prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.737,None
finn-b-G6_HERATAXIA,Hereditary ataxia,hereditary ataxia,EFO:0009671,http://www.ebi.ac.uk/efo/EFO_0009671,0.991,None
finn-b-ST19_SUPERF_INJURY_HEAD,Superficial injury of head,head injury,EFO:0009505,http://www.ebi.ac.uk/efo/EFO_0009505,0.674,None
ukb-e-20002_p180_EAS,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-R18_CARDIAC_MURMU_OTHER_CARDIAC_SOUNDS,Cardiac murmurs and other cardiac sounds,Heart murmur,HP:0030148,http://purl.obolibrary.org/obo/HP_0030148,0.869,None
finn-b-F5_ANOREX,Anorexia (incl.atypical),Anorexia,HP:0002039,http://purl.obolibrary.org/obo/HP_0002039,0.647,None
ukb-e-recode115_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-21001_CSA,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
ukb-b-11590,Vascular/heart problems diagnosed by doctor: Heart attack,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.64,None
finn-b-J10_CHRONRHINITIS,"Chronic rhinitsi, nasopharyngitis and pharyngitis",nasopharyngitis,MONDO:0001040,http://purl.obolibrary.org/obo/MONDO_0001040,0.835,None
ukb-d-M13_LIMBPAIN,Pain in limb,Limb pain,HP:0009763,http://purl.obolibrary.org/obo/HP_0009763,0.996,None
finn-b-M13_CRYSTALARTH,Other crystal arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.989,None
ukb-e-20111_p14_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-ST19_INJURY_NERVES_LOWER_LEG_LEVEL,Injury of nerves at lower leg level,leg injury,EFO:0009508,http://www.ebi.ac.uk/efo/EFO_0009508,0.617,None
ukb-e-20016_CSA,Fluid intelligence score,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.634,None
finn-b-DENTAL_TMD_FIBRO,TMD muscular pain lnked with fibromyalgia,fibromyalgia,EFO:0005687,http://www.ebi.ac.uk/efo/EFO_0005687,0.602,None
ukb-e-5159_CSA,3mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
ukb-e-197_CSA,Chemotherapy,response to combination chemotherapy,EFO:0007965,http://www.ebi.ac.uk/efo/EFO_0007965,0.674,None
ukb-e-2834_AFR,Bilateral oophorectomy (both ovaries removed),bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.716,None
ieu-a-971,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-b-3229,Diagnoses - secondary ICD10: D70 Agranulocytosis,Agranulocytosis,HP:0012234,http://purl.obolibrary.org/obo/HP_0012234,0.66,None
bbj-a-137,Osteoporosis,osteoporosis,EFO:0003882,http://www.ebi.ac.uk/efo/EFO_0003882,0.992,None
ukb-e-619_AFR,Noninflammatory female genital disorders,inflammatory disease,EFO:0009903,http://www.ebi.ac.uk/efo/EFO_0009903,0.681,None
finn-b-ST19_FRACT_WRIST_HAND_LEVEL,Fracture at wrist and hand level,wrist fracture,EFO:0009515,http://www.ebi.ac.uk/efo/EFO_0009515,0.774,None
ukb-e-30210_EAS,Eosinophill percentage,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.922,None
ukb-e-102320_AFR,Diet sweets intake,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.603,None
ukb-e-PP_p1_EAS,"Pulse pressure, automated reading",pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.626,None
ukb-e-535_AFR,Gastritis and duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.81,None
ieu-a-1060,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
finn-b-C3_BILIARY_TRACT_EXALLC,Malignant neoplasm of other and unspecified parts of biliary tract (all cancers excluded),biliary tract cancer,MONDO:0003060,http://purl.obolibrary.org/obo/MONDO_0003060,0.71,None
ukb-e-727_AFR,"Other disorders of synovium, tendon, and bursa",synovial bursa disorder,MONDO:0056802,http://purl.obolibrary.org/obo/MONDO_0056802,0.729,None
finn-b-CD2_BENIGN_CONNECTIVE_SOFT,Other benign neoplasms of connective and other soft tissue,benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.91,None
ebi-a-GCST005923,Maternal history of Alzheimer's disease,family history of Alzheimers disease,EFO:0009268,http://www.ebi.ac.uk/efo/EFO_0009268,0.811,None
ukb-e-100022_CSA,Alcohol,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.796,None
ukb-e-6155_p6_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-I9_NONISCHCARDMYOP_STRICT,Nonischemic cardiomyopathy,nonischemic cardiomyopathy,EFO:0009881,http://www.ebi.ac.uk/efo/EFO_0009881,0.988,None
finn-b-C3_BREAST_EXALLC,Malignant neoplasm of breast (all cancers excluded),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.894,None
ukb-a-543,Diagnoses - main ICD10: J44 Other chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.816,None
finn-b-CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9,Benign neoplasm: Rectum/anal canal icd-9,benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.768,None
finn-b-CD2_BENIGN_BRONCHUS_LUNG_EXALLC,Benign neoplasm: Bronchus and lung (all cancers excluded),bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.733,None
ukb-e-561_AFR,Symptoms involving digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.622,None
finn-b-G6_MERALGIA,Meralgia paraesthetica,meralgia paresthetica,MONDO:0023757,http://purl.obolibrary.org/obo/MONDO_0023757,0.826,None
ukb-e-20016_EAS,Fluid intelligence score,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.634,None
ukb-b-3044,"Non-cancer illness code, self-reported: colitis/not crohns or ulcerative colitis",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.658,None
ukb-d-C3_BRONCHUS_LUNG,Malignant neoplasm of bronchus and lung,bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.971,None
ukb-e-5157_CSA,6mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
ukb-e-23102_CSA,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
finn-b-L12_OTHPIGMENTATION,Other disorders of pigmentation,skin pigmentation disorder,MONDO:0019288,http://purl.obolibrary.org/obo/MONDO_0019288,0.815,None
finn-b-ALCOLIVER,Alcoholic liver disease (ALCOLIVER),alcoholic liver disease,EFO:0008573,http://www.ebi.ac.uk/efo/EFO_0008573,0.937,None
ukb-e-428_CSA,Congestive heart failure; nonhypertensive,congestive heart failure,EFO:0000373,http://www.ebi.ac.uk/efo/EFO_0000373,0.754,None
finn-b-D3_ANAEMIA_IRONDEF_BLOODLOSS,Iron deficiency anaemia secondary to blood loss (chronic),Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.705,None
ukb-e-100021_CSA,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
finn-b-CD2_BENIGN_CONNSOFT_UPPERLIMB,"Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.693,None
ukb-e-6138_p6_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-M13_SPONDYLOLISTHESIS,Spondylolisthesis/Spondylolysis,spondylolysis,EFO:0005649,http://www.ebi.ac.uk/efo/EFO_0005649,0.913,None
finn-b-CD2_BENIGN_CONNSOFT_UPPERLIMB_EXALLC,"""Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder"" (all cancers excluded)",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.672,None
ukb-e-4195_CSA,Pulse wave reflection index,pulse wave reflection index measurement,EFO:0009804,http://www.ebi.ac.uk/efo/EFO_0009804,0.927,None
ukb-e-3606_CSA,Chest pain or discomfort walking normally,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.684,None
ukb-e-recode345_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_ANOMAPUPFUNC,Anomalies of pupillary function,Abnormal pupillary function,HP:0007686,http://purl.obolibrary.org/obo/HP_0007686,0.74,None
ukb-e-PP_p1_CSA,"Pulse pressure, automated reading",pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.626,None
ukb-e-1160_MID,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
finn-b-RX_CROHN_1STLINE,First line medication for Crohns disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.706,None
ukb-d-20530,Witnessed sudden violent death,Sudden death,HP:0001699,http://purl.obolibrary.org/obo/HP_0001699,0.671,None
ukb-e-recode55_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-F5_MOOD,Mood [affective] disorders,mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.856,None
ukb-e-30600_EAS,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ukb-e-30270_CSA,Mean sphered cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.801,None
finn-b-CD2_BENIGN_VULVA,Benign neoplasm: Vagina,benign vaginal neoplasm,MONDO:0000647,http://purl.obolibrary.org/obo/MONDO_0000647,0.995,None
finn-b-C3_MALE_GENITAL,malignant neoplasm of male genital organs,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.989,None
finn-b-M13_SJOGREN,Sicca syndrome [Sj<c2><9a>gren],Sjogren syndrome,EFO:0000699,http://www.ebi.ac.uk/efo/EFO_0000699,0.641,None
ukb-e-recode94_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20004_p79_AFR,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-K11_GALLBILPANC,"Disorders of gallbladder, biliary tract and pancreas",gallbladder disease,EFO:0003832,http://www.ebi.ac.uk/efo/EFO_0003832,0.7,None
ukb-d-4803_13,"Tinnitus: Yes, now some of the time",Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.642,None
finn-b-L12_VASCULITISSKIN,"Vasculitis limited to skin, not elsewhere classified",vasculitis,EFO:0006803,http://www.ebi.ac.uk/efo/EFO_0006803,0.665,None
finn-b-H7_RETINALBREAK,Retinal breaks without detachment,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.709,None
finn-b-CD2_BENIGN_SKIN,Other benign neoplasms of skin,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.886,None
ukb-e-D50_AFR,D50 Iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.849,None
finn-b-CHRONLARGE,Crohn's disease of large intestine,large intestine disorder,MONDO:0024634,http://purl.obolibrary.org/obo/MONDO_0024634,0.787,None
finn-b-N14_CALCUKIDUR,Calculus of kidney and ureter,nephrolithiasis,EFO:0004253,http://www.ebi.ac.uk/efo/EFO_0004253,0.963,None
finn-b-CD2_BENIGN_MENINGES_SPINAL_EXALLC,Benign neoplasm: Spinal meninges (all cancers excluded),meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.731,None
ukb-e-285_AFR,Other anemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.818,None
ukb-e-2946_CSA,Father's age,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.647,None
ukb-e-47_AFR,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
finn-b-AB1_OTHER_SUPERF_MYCOSIS,Other superficial mycoses,superficial mycosis,MONDO:0024268,http://purl.obolibrary.org/obo/MONDO_0024268,0.903,None
finn-b-L12_DISORDSKINAPPENDIX,Disorders of skin appendages,skin appendage disorder,MONDO:0024481,http://purl.obolibrary.org/obo/MONDO_0024481,0.891,None
ukb-e-480_CSA,Pneumonia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.994,None
finn-b-FE_STRICT,"Focal epilepsy, strict definition",partial epilepsy,EFO:0004263,http://www.ebi.ac.uk/efo/EFO_0004263,0.997,None
finn-b-L12_HIRSUTISM,Hirsutism,Hirsutism,HP:0001007,http://purl.obolibrary.org/obo/HP_0001007,0.989,None
finn-b-ST19_TOXIC_EFFECT_CARBON_MONOX,Toxic effect of carbon monoxide,carbon monoxide poisoning,MONDO:0800373,http://purl.obolibrary.org/obo/MONDO_0800373,0.602,None
ukb-e-1050_EAS,Time spend outdoors in summer,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.746,None
ukb-e-SBP_p2_MID,"Systolic blood pressure, combined automated + manual reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.696,None
finn-b-M13_POLYARTHRITIS,"Polyarthritis, unspecified",polyarticular arthritis,MONDO:0024280,http://purl.obolibrary.org/obo/MONDO_0024280,0.998,None
finn-b-M13_CONTRACTUREJOINT,Contracture of joint,Limb joint contracture,HP:0003121,http://purl.obolibrary.org/obo/HP_0003121,0.834,None
ukb-e-30630_EAS,Apolipoprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.853,None
ukb-b-9565,Diagnoses - main ICD10: H02.8 Other specified disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.63,None
ukb-e-recode90_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-160,Treatment/medication code: warfarin,warfarin measurement,EFO:0801226,http://www.ebi.ac.uk/efo/EFO_0801226,0.646,None
ukb-e-537_CSA,Other disorders of stomach and duodenum,duodenal disorder,MONDO:0002866,http://purl.obolibrary.org/obo/MONDO_0002866,0.777,None
finn-b-G6_BRACHPLE,Brachial plexus disorders,brachial plexus neuropathy,EFO:1000844,http://www.ebi.ac.uk/efo/EFO_1000844,0.958,None
finn-b-K11_CROSSBITE,Crossbite,Dental malocclusion,HP:0000689,http://purl.obolibrary.org/obo/HP_0000689,0.847,None
finn-b-ASTHMA_CHILD_EXMORE,Childhood asthma (age<16) (more controls excluded),childhood onset asthma,MONDO:0005405,http://purl.obolibrary.org/obo/MONDO_0005405,0.869,None
finn-b-E4_PORBILIR,Disorders of porphyrin and bilirubin metabolism,bilirubin metabolism disease,MONDO:0024431,http://purl.obolibrary.org/obo/MONDO_0024431,0.827,None
finn-b-C3_GBM_EXALLC,Brain glioblastoma (all cancers excluded),brain glioblastoma,EFO:0006545,http://www.ebi.ac.uk/efo/EFO_0006545,0.907,None
ukb-a-522,Diagnoses - main ICD10: D25 Leiomyoma of uterus,uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.668,None
finn-b-N14_ENDOMETRIOSIS_OVARY,Endometriosis of ovary,Ovarian Endometriosis,EFO:1000418,http://www.ebi.ac.uk/efo/EFO_1000418,0.993,None
finn-b-CD2_BENIGN_LARYNX,Benign neoplasm: Larynx,benign laryngeal neoplasm,MONDO:0002354,http://purl.obolibrary.org/obo/MONDO_0002354,0.996,None
ukb-e-1060_AFR,Time spent outdoors in winter,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.849,None
finn-b-ULCERNAS,"Ulcerative colitis, NAS",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.913,None
finn-b-FG_OTHHEART,Other heart diseases (FG_OTHHEART),heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.719,None
ukb-e-recode47_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-41221_8,Delivery methods: Emergency caesarean section,cesarean section,EFO:0009636,http://www.ebi.ac.uk/efo/EFO_0009636,0.625,None
finn-b-Q17_OTHER_CONGEN_MALFO_FEMALE_GENITALIA,Other congenital malformations of female genitalia,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.708,None
ukb-e-recode78_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-41231_CSA,Hospital episode type,episodic ataxia type 1,MONDO:0008047,http://purl.obolibrary.org/obo/MONDO_0008047,0.634,None
ukb-e-1210_CSA,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
finn-b-CD2_BENIGN_STOMACH_EXALLC,Benign neoplasm: Stomach (all cancers excluded),benign neoplasm of stomach,MONDO:0021449,http://purl.obolibrary.org/obo/MONDO_0021449,0.904,None
ukb-e-23119_EAS,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
ukb-e-N17_CSA,N17 Acute renal failure,Acute kidney injury,HP:0001919,http://purl.obolibrary.org/obo/HP_0001919,0.841,None
finn-b-ST19_OTHER_UNSPE_INJURI_LOWER_LEG,Other and unspecified injuries of lower leg,leg injury,EFO:0009508,http://www.ebi.ac.uk/efo/EFO_0009508,0.605,None
finn-b-Q17_CONGEN_MALFO_AORTIC_MITRAL_VALVES,Congenital malformations of aortic and mitral valves,inherited mitral valve disease,MONDO:0042966,http://purl.obolibrary.org/obo/MONDO_0042966,0.823,None
finn-b-M13_SOFTTISSUENAS,Other specified/unspecified soft tissue disorders,soft tissue disease,EFO:0009470,http://www.ebi.ac.uk/efo/EFO_0009470,0.792,None
finn-b-F5_HABIT,Habit and impulse disorders,impulse control disorder,MONDO:0001162,http://purl.obolibrary.org/obo/MONDO_0001162,0.644,None
finn-b-J10_RESPOTHER,Other diseases of the respiratory system,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.954,None
ieu-a-26,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-670_p3_MID,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
finn-b-M13_GLUTEALTEND,Gluteal tendinitis,tendinitis,MONDO:0004857,http://purl.obolibrary.org/obo/MONDO_0004857,0.73,None
finn-b-O15_ANTEPART_HAEM_NAS,"Antepartum haemorrhage, not elsewhere classified",Antepartum hemorrhage,HP:0025328,http://purl.obolibrary.org/obo/HP_0025328,0.992,None
finn-b-AB1_OTHER_BACTERIAL,Other bacterial diseases,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.92,None
finn-b-AB1_TUBERCU_OTH_ORG,Tuberculosis of other organs,tuberculosis,MONDO:0018076,http://purl.obolibrary.org/obo/MONDO_0018076,0.807,None
finn-b-C3_CERVIX_UTERI_EXALLC,Malignant neoplasm of cervix uteri (all cancers excluded),cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.925,None
ebi-a-GCST009762,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
finn-b-Q17_CONGEN_MALFO_CARDIAC_SEPTA,Congenital malformations of cardiac septa,heart-hand syndrome type 3,MONDO:0007702,http://purl.obolibrary.org/obo/MONDO_0007702,0.652,None
finn-b-G6_ALZHEIMER_INCLAVO,"Alzheimer disease, including avohilmo",Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.626,None
ukb-e-1970_AFR,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
ukb-e-30890_AFR,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
ukb-a-296,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
finn-b-C3_RESPIRATORY_INTRATHORACIC,Malignant neoplasm of respiratory system and intrathoracic organs,respiratory system cancer,MONDO:0000376,http://purl.obolibrary.org/obo/MONDO_0000376,0.785,None
finn-b-K11_ALCGASTR,Alcoholic gastritis (K11_ALCGASTR),alcoholic gastritis,MONDO:0004640,http://purl.obolibrary.org/obo/MONDO_0004640,0.76,None
finn-b-I9_ARTEMBTHRLOW_EXNONE,Arterial embolism and thrombosis of lower extremity artery (no controls excluded),Arterial thrombosis,HP:0004420,http://purl.obolibrary.org/obo/HP_0004420,0.688,None
finn-b-H7_CONJUNCTIVA,Disorders of conjunctiva,Conjunctival Disorder,EFO:1000203,http://www.ebi.ac.uk/efo/EFO_1000203,0.951,None
finn-b-H7_LENSDISLOCATIO,Dislocation of lens,dislocation,EFO:0009521,http://www.ebi.ac.uk/efo/EFO_0009521,0.848,None
ukb-e-1010_AFR,Other tests,neuropsychological test,EFO:0003926,http://www.ebi.ac.uk/efo/EFO_0003926,0.69,None
finn-b-OTHER_DRUGADVERS_SECONDA_PARKINSONI,Other drug-induced secondary parkinsonism,secondary Parkinson disease,EFO:1001175,http://www.ebi.ac.uk/efo/EFO_1001175,0.778,None
finn-b-CD2_BENIGN_KIDNEY_EXALLC,Benign neoplasm: Kidney (all cancers excluded),Benign Kidney Neoplasm,EFO:1000111,http://www.ebi.ac.uk/efo/EFO_1000111,0.917,None
finn-b-G6_POLYOTHUNS,"Other and unspecified polyneuropathies, also in other diseases",polyneuropathy,EFO:0009562,http://www.ebi.ac.uk/efo/EFO_0009562,0.751,None
ukb-e-20002_p1_EAS,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-recode236_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-256,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
ukb-d-is_female,Genetic sex,inherited,MONDO:0021152,http://purl.obolibrary.org/obo/MONDO_0021152,0.762,None
ukb-e-52_p8_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-30260_AFR,Mean reticulocyte volume,mean reticulocyte volume,EFO:0010701,http://www.ebi.ac.uk/efo/EFO_0010701,0.982,None
finn-b-GEST_DIABETES,Gestational diabetes (for exclusion),Maternal diabetes,HP:0009800,http://purl.obolibrary.org/obo/HP_0009800,0.759,None
ukb-e-30210_MID,Eosinophill percentage,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.922,None
finn-b-H7_IRIDONAS,Other and unspecified iridocyclitis,Iridocyclitis,HP:0001094,http://purl.obolibrary.org/obo/HP_0001094,0.995,None
finn-b-Q17_CONGEN_MALFO_PULMONARY_TRICU_VALVES,Congenital malformations of pulmonary and tricuspid valves,congenital tricuspid malformation,MONDO:0020289,http://purl.obolibrary.org/obo/MONDO_0020289,0.747,None
ukb-a-575,Diagnoses - main ICD10: N32 Other disorders of bladder,bladder disease,EFO:1000018,http://www.ebi.ac.uk/efo/EFO_1000018,0.662,None
ieu-b-12,juvenile absence epilepsy,juvenile absence epilepsy,MONDO:0011876,http://purl.obolibrary.org/obo/MONDO_0011876,0.989,None
ukb-b-19807,Diagnoses - main ICD10: M51.3 Other specified intervertebral disk degeneration,Intervertebral disc degeneration,HP:0008419,http://purl.obolibrary.org/obo/HP_0008419,0.751,None
ukb-b-17194,Eye problems/disorders: Macular degeneration,age-related macular degeneration,EFO:0001365,http://www.ebi.ac.uk/efo/EFO_0001365,0.698,None
finn-b-L12_BULLOTH,Other bullous disorders,autoimmune bullous skin disease,EFO:0008598,http://www.ebi.ac.uk/efo/EFO_0008598,0.632,None
finn-b-ALLERG_RHINITIS,Allergic rhinitis,allergic rhinitis,EFO:0005854,http://www.ebi.ac.uk/efo/EFO_0005854,0.994,None
ukb-b-1977,Diagnoses - main ICD10: R51 Headache,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.614,None
finn-b-G6_POLYNEU,Polyneuropathies and other disorders of the peripheral nervous system,peripheral nervous system disease,EFO:0009387,http://www.ebi.ac.uk/efo/EFO_0009387,0.757,None
finn-b-C3_NSCLC_ADENO,"Non-small cell lung cancer, adenocarcinoma",lung adenocarcinoma,EFO:0000571,http://www.ebi.ac.uk/efo/EFO_0000571,0.829,None
ukb-e-709_p1_AFR,Number in household,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.709,None
ukb-e-recode110_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_DISIMPAIRRENTUB,Disorders resulting from impaired renal tubular function,impaired renal function disease,MONDO:0001343,http://purl.obolibrary.org/obo/MONDO_0001343,0.747,None
ukb-b-10756,Diagnoses - secondary ICD10: I20.0 Unstable angina,intermediate coronary syndrome,EFO:1000985,http://www.ebi.ac.uk/efo/EFO_1000985,0.628,None
ukb-e-K29_AFR,K29 Gastritis and duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.714,None
finn-b-H7_LACRIMALORBITINOTH,Disorders of lacrimal system and orbit in diseases classified elsewhere,lacrimal apparatus disease,EFO:0009455,http://www.ebi.ac.uk/efo/EFO_0009455,0.781,None
ukb-e-30000_MID,White blood cell (leukocyte) count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.797,None
finn-b-ALLERG_ASTHMA,Allergic asthma (mode),allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.9,None
finn-b-N14_PHIMOSIS,"Redundant prepuce, phimosis and paraphimosis",paraphimosis,EFO:1001086,http://www.ebi.ac.uk/efo/EFO_1001086,0.813,None
finn-b-Q17_CONGEN_MALFO_NERVOUS_SYSTEM,Congenital malformations of the nervous system,central nervous system malformation,MONDO:0020022,http://purl.obolibrary.org/obo/MONDO_0020022,0.754,None
finn-b-G6_SPINOTH,Other diseases of spinal cord,spinal cord disease,EFO:0009488,http://www.ebi.ac.uk/efo/EFO_0009488,0.941,None
ukb-e-120_p1_EAS,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-b-13525,Diagnoses - secondary ICD10: I34.0 Mitral (valve) insufficiency,Mitral regurgitation,HP:0001653,http://purl.obolibrary.org/obo/HP_0001653,0.716,None
ukb-e-670_p1_CSA,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
ukb-e-6155_p8_MID,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-2744_AFR,Birth weight of first child,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.695,None
finn-b-ST19_FRACT_FOREA,Fracture of forearm,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.686,None
finn-b-I9_HEARTFAIL_AND_ANTIHYPERT,Heart failure and antihypertensive medication,Antihypertensive use measurement,EFO:0009927,http://www.ebi.ac.uk/efo/EFO_0009927,0.608,None
finn-b-Q17_CLEFT_LIP_CLEFT_PALATE,Cleft lip and cleft palate,isolated cleft palate,MONDO:0007336,http://purl.obolibrary.org/obo/MONDO_0007336,0.914,None
ebi-a-GCST011364,Myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
finn-b-N14_URETHRITISANDURSYNDR,Urehtritis and urethral syndrome,urethral syndrome,MONDO:0001730,http://purl.obolibrary.org/obo/MONDO_0001730,0.749,None
ukb-e-24005_AFR,Particulate matter air pollution (pm10); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.729,None
finn-b-JUVEN_ARTHR,Juvenile arthritis (FINNGEN),juvenile arthritis due to defect in LACC1,MONDO:0032920,http://purl.obolibrary.org/obo/MONDO_0032920,0.827,None
finn-b-F5_Dementia_U_EXMORE,Undefined dementia (more controls excluded),Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
finn-b-R18_HYPERHIDROSIS,Hyperhidrosis,Hyperhidrosis,HP:0000975,http://purl.obolibrary.org/obo/HP_0000975,0.989,None
ukb-e-30020_CSA,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
finn-b-J10_CHRONSINUSITIS,Chronic sinusitis,chronic rhinosinusitis,EFO:1000024,http://www.ebi.ac.uk/efo/EFO_1000024,0.994,None
ukb-e-4104_AFR,"Heel quantitative ultrasound index (QUI), direct entry (left)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.639,None
ukb-e-30060_CSA,Mean corpuscular haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.988,None
ukb-e-20111_p14_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-G6_MONOPLE,Monoplegia,spastic monoplegia,MONDO:0001169,http://purl.obolibrary.org/obo/MONDO_0001169,0.8,None
ukb-b-18843,Diagnoses - secondary ICD10: C61 Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.67,None
finn-b-L12_FACTITIALDERMAT,Factitial dermatitis,neurotic excoriation,EFO:1000741,http://www.ebi.ac.uk/efo/EFO_1000741,0.955,None
ukb-e-3731_AFR,Former alcohol drinker,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.625,None
ukb-e-recode371_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_FEMALE_GEN_OTH,Benign neoplasm of other and unspecified female genital organs,"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.797,None
ukb-b-19294,"Delivery methods: Ventouse, vacuum extraction",Ventouse delivery,HP:0011412,http://purl.obolibrary.org/obo/HP_0011412,0.669,None
finn-b-AB1_POLIOMYELITIS,Acute poliomyelitis,poliomyelitis,EFO:0007450,http://www.ebi.ac.uk/efo/EFO_0007450,0.993,None
finn-b-AB1_CHLAMYDIA_OTHER,Other sexually transmitted chlamydial diseases,sexually transmitted disease,MONDO:0021681,http://purl.obolibrary.org/obo/MONDO_0021681,0.784,None
finn-b-I9_CARDMYO_EXNONE,Cardiomyopathy (no controls excluded),cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.944,None
finn-b-CD2_BENIGN_MELANOCYTIC_EXALLC,Melanocytic naevi (all cancers excluded),large congenital melanocytic nevus,MONDO:0044792,http://purl.obolibrary.org/obo/MONDO_0044792,0.629,None
finn-b-O15_GESTAT_HYPERT,Gestational [pregnancy-induced] hypertension,"hypertension, pregnancy-induced",MONDO:0024664,http://purl.obolibrary.org/obo/MONDO_0024664,0.865,None
finn-b-G6_BELLPA,Bell's palsy,Bell's palsy,EFO:0007167,http://www.ebi.ac.uk/efo/EFO_0007167,0.996,None
finn-b-I9_OTHINTRACRA,Other intracranial haemorrhages,intracranial hemorrhage,EFO:0000551,http://www.ebi.ac.uk/efo/EFO_0000551,0.935,None
ukb-e-49_EAS,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ukb-a-573,Diagnoses - main ICD10: N19 Unspecified renal failure,Renal insufficiency,HP:0000083,http://purl.obolibrary.org/obo/HP_0000083,0.658,None
finn-b-N14_CYSTKID,Cyst of kidney,Kidney Cyst,EFO:1000313,http://www.ebi.ac.uk/efo/EFO_1000313,0.971,None
ukb-e-20004_p172_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-M13_RHEUMA_INCLAVO,Rheumatoid arthritis (M13_RHEUMA_INCLAVO),rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.784,None
ukb-e-6155_p5_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-e-6149_p4_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-30500_AFR,Microalbumin in urine,urinary microalbumin measurement,EFO:0010967,http://www.ebi.ac.uk/efo/EFO_0010967,0.834,None
ukb-e-34_EAS,Year of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.622,None
ukb-e-100580_CSA,Alcohol consumed,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.769,None
ukb-e-30300_EAS,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
finn-b-HYPOTHY_PURCHASE,Hypothyroidism and >3 levothyroxin purchases,hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.729,None
finn-b-O15_MEMBR_PREMAT_RUPT,Premature rupture of membranes,Premature rupture of membranes,HP:0001788,http://purl.obolibrary.org/obo/HP_0001788,0.987,None
finn-b-F5_PTSD,Post-traumatic stress disorder,post-traumatic stress disorder,EFO:0001358,http://www.ebi.ac.uk/efo/EFO_0001358,0.933,None
ukb-b-11138,Vitamin and/or mineral supplement use: Fish oil,fish oil supplement exposure measurement,EFO:0600007,http://www.ebi.ac.uk/efo/EFO_0600007,0.609,None
ukb-b-4579,Diagnoses - secondary ICD10: R94.5 Abnormal results of liver function studies,abnormal result of function studies,EFO:0009628,http://www.ebi.ac.uk/efo/EFO_0009628,0.678,None
finn-b-M13_SHOULDER,Shoulder lesions,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.708,None
ebi-a-GCST006908,Ischemic stroke,Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.988,None
ukb-b-1316,"Type of cancer: ICD10: C64 Malignant neoplasm of kidney, except renal pelvis",kidney cancer,MONDO:0002367,http://purl.obolibrary.org/obo/MONDO_0002367,0.806,None
ukb-e-3526_EAS,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
finn-b-AB1_VIRAL_INOTHER,Viral agents as the cause of diseases classified to other chapters,viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.618,None
finn-b-AB1_VIRAL_HEPATITIS,Viral hepatitis,animal viral hepatitis,EFO:0007540,http://www.ebi.ac.uk/efo/EFO_0007540,0.998,None
ukb-d-20493,Severity of problems due to mania or irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.661,None
ukb-e-recode427_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-9882,Operation code: hip surgery (not replacement),total hip arthroplasty,EFO:0009806,http://www.ebi.ac.uk/efo/EFO_0009806,0.711,None
finn-b-N14_AMENORRHEAPRIM,Amenorrhoea,amenorrhea,EFO:0010269,http://www.ebi.ac.uk/efo/EFO_0010269,0.673,None
finn-b-H7_EYEADNEXOTH,Other specified and unspecified disorders of eye and adnexa,eye adnexa disease,EFO:0009546,http://www.ebi.ac.uk/efo/EFO_0009546,0.941,None
ebi-a-GCST90018120,Idiopathic pulmonary fibrosis,idiopathic pulmonary fibrosis,EFO:0000768,http://www.ebi.ac.uk/efo/EFO_0000768,0.988,None
ukb-e-30740_CSA,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
finn-b-H7_OCUPAIN,Ocular pain,Ocular pain,HP:0200026,http://purl.obolibrary.org/obo/HP_0200026,0.991,None
ukb-b-3469,"Diagnoses - main ICD10: I21.9 Acute myocardial infarction, unspecified",acute myocardial infarction,EFO:0008583,http://www.ebi.ac.uk/efo/EFO_0008583,0.789,None
ukb-d-VI_NERVOUS,Diseases of the nervous system,nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.953,None
finn-b-CD2_BENIGN_SIGMOID_COLON_EXALLC,Benign neoplasm: Sigmoid colon (all cancers excluded),sigmoid neoplasm,EFO:1001181,http://www.ebi.ac.uk/efo/EFO_1001181,0.816,None
ukb-a-461,Vitamin and mineral supplements: Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.687,None
finn-b-E4_MALNUTRITION,Malnutrition,nutritional deficiency disease,EFO:1001067,http://www.ebi.ac.uk/efo/EFO_1001067,0.996,None
finn-b-M13_MYALGIA,Myalgia,Myalgia,HP:0003326,http://purl.obolibrary.org/obo/HP_0003326,0.993,None
ukb-e-627_CSA,Menopausal and postmenopausal disorders,menopausal or post-menopausal disease,EFO:0010685,http://www.ebi.ac.uk/efo/EFO_0010685,0.896,None
ukb-e-K44_CSA,K44 Diaphragmatic hernia,diaphragmatic hernia,EFO:0008561,http://www.ebi.ac.uk/efo/EFO_0008561,0.869,None
finn-b-C3_EYE_BRAIN_NEURO_EXALLC,"""Malignant neoplasm of eye, brain and central nervous system"" (all cancers excluded)",central nervous system cancer,EFO:0000326,http://www.ebi.ac.uk/efo/EFO_0000326,0.839,None
ebi-a-GCST90020092,Estradiol levels,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.984,None
ieu-a-32,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
finn-b-C3_AML_EXALLC,Acute myeloid leukaemia (all cancers excluded),childhood acute myeloid leukemia,EFO:0000330,http://www.ebi.ac.uk/efo/EFO_0000330,0.757,None
ukb-e-1548_MID,Variation in diet,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.604,None
finn-b-ALCONEURODEGEN,Degeneration of nervous system due to alcohol,neurodegenerative disease,EFO:0005772,http://www.ebi.ac.uk/efo/EFO_0005772,0.649,None
ukb-b-17309,"Diagnoses - secondary ICD10: R00.0 Tachycardia, unspecified",Tachycardia,HP:0001649,http://purl.obolibrary.org/obo/HP_0001649,0.659,None
finn-b-G6_AUTONOM,Autonomic disorders,autonomic nervous system disease,EFO:0009532,http://www.ebi.ac.uk/efo/EFO_0009532,0.74,None
ukb-e-282_AFR,Hereditary hemolytic anemias,familial hemolytic anemia,MONDO:0003689,http://purl.obolibrary.org/obo/MONDO_0003689,0.943,None
ukb-e-3526_AFR,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
ukb-e-4104_EAS,"Heel quantitative ultrasound index (QUI), direct entry (left)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.639,None
finn-b-C3_BREAST_HER2NEG_EXALLC,"""Malignant neoplasm of breast, HER2-negative"" (all cancers excluded)",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.694,None
finn-b-H7_HERPESKERATITIS,Herpesviral keratitis and keratoconjunctivitis,keratoconjunctivitis,MONDO:0004768,http://purl.obolibrary.org/obo/MONDO_0004768,0.772,None
ukb-b-6223,Diagnoses - main ICD10: R10.4 Other and unspecified abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.646,None
ukb-e-20015_AFR,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
finn-b-C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS_EXALLC,"""Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system"" (all cancers excluded)",central nervous system cancer,EFO:0000326,http://www.ebi.ac.uk/efo/EFO_0000326,0.755,None
ukb-e-E11_CSA,E11 Non-insulin-dependent diabetes mellitus,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.829,None
finn-b-I9_ICH_EXNONE,Intracerebral haemmorrhage (no controls excluded),intracerebral hemorrhage,EFO:0005669,http://www.ebi.ac.uk/efo/EFO_0005669,0.749,None
ukb-d-C_OTHER_SKIN,Other malignant neoplasms of skin,skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.893,None
ukb-e-20003_p143_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-N14_OTHNONINFCERVIX,Other noninflammatory disorders of cervix uteri,Cervicitis,HP:0030160,http://purl.obolibrary.org/obo/HP_0030160,0.704,None
ebi-a-GCST90000032,Myeloproliferative neoplasms,chronic myeloproliferative disorder,EFO:0002428,http://www.ebi.ac.uk/efo/EFO_0002428,0.991,None
ukb-e-3064_EAS,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
ukb-e-recode406_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_OTHDISSTOMDUOD,Other diseases of stomach and duodenum,duodenal disorder,MONDO:0002866,http://purl.obolibrary.org/obo/MONDO_0002866,0.769,None
finn-b-J10_PHARYNGITIS,Acute pharyngitis,acute pharyngitis,EFO:0009657,http://www.ebi.ac.uk/efo/EFO_0009657,0.997,None
finn-b-K11_DIAHER,Diaphragmatic hernia,diaphragmatic hernia,EFO:0008561,http://www.ebi.ac.uk/efo/EFO_0008561,0.994,None
ebi-a-GCST006098,Vigorous physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.739,None
ukb-e-20111_p6_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-DEATH,Any death,Stillbirth,HP:0003826,http://purl.obolibrary.org/obo/HP_0003826,0.677,None
ukb-e-20127_CSA,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
ukb-d-S42,Diagnoses - main ICD10: S42 Fracture of shoulder and upper arm,shoulder fracture,EFO:0009621,http://www.ebi.ac.uk/efo/EFO_0009621,0.633,None
finn-b-M13_ANKLEFOOT,Other acquired deformities of ankle and foot,Abnormal foot morphology,HP:0001760,http://purl.obolibrary.org/obo/HP_0001760,0.825,None
ukb-e-recode376_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST004133,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
finn-b-CD2_INSITU_GENITAL_EXALLC,Carcinoma in situ of other and unspecified genital organs (all cancers excluded),in situ carcinoma,MONDO:0004647,http://purl.obolibrary.org/obo/MONDO_0004647,0.657,None
finn-b-I9_PHLETHROM,Phlebitis and thrombophlebitis (not including DVT),Thrombophlebitis,HP:0004418,http://purl.obolibrary.org/obo/HP_0004418,0.86,None
finn-b-AB1_SCHISTOSOMIASIS,Schistosomiasis [bilharziasis],schistosomiasis,EFO:1001475,http://www.ebi.ac.uk/efo/EFO_1001475,0.789,None
ukb-e-6142_p3_EAS,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ieu-a-812,Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
ukb-e-351_CSA,Other peripheral nerve disorders,peripheral nervous system disease,EFO:0009387,http://www.ebi.ac.uk/efo/EFO_0009387,0.951,None
ukb-b-9058,"Non-cancer illness code, self-reported: eye/eyelid problem",eyelid cancer,MONDO:0021313,http://purl.obolibrary.org/obo/MONDO_0021313,0.616,None
ukb-d-ULCERNAS,"Ulcerative colitis, NAS",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.913,None
finn-b-ASTHMA_NAS_EXMORE,"""Asthma, unspecified (mode)"" (more controls excluded)",asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.809,None
ukb-b-9797,Diagnoses - main ICD10: K56.6 Other and unspecified intestinal obstruction,intestinal obstruction,MONDO:0004565,http://purl.obolibrary.org/obo/MONDO_0004565,0.71,None
ukb-e-100005_CSA,Carbohydrate,carbohydrate measurement,EFO:0004998,http://www.ebi.ac.uk/efo/EFO_0004998,0.867,None
finn-b-K11_ACUTPANC,Acute pancreatitis,acute pancreatitis,EFO:1000652,http://www.ebi.ac.uk/efo/EFO_1000652,0.991,None
ukb-b-6834,Treatment/medication code: gabapentin,gabapentin measurement,EFO:0801161,http://www.ebi.ac.uk/efo/EFO_0801161,0.716,None
finn-b-I9_VTE,Venous thromboembolism,venous thromboembolism,EFO:0004286,http://www.ebi.ac.uk/efo/EFO_0004286,0.993,None
ukb-e-3581_AFR,Age at menopause (last menstrual period),age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.693,None
ukb-e-5540_p1_CSA,Surgery/amputation of toe or leg,amputation,EFO:0009632,http://www.ebi.ac.uk/efo/EFO_0009632,0.605,None
ebi-a-GCST005902,Depression (broad),depressive disorder,MONDO:0002050,http://purl.obolibrary.org/obo/MONDO_0002050,0.735,None
ukb-e-recode20_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20117_p3_AFR,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
ukb-d-L12_ATROPHICSKIN,Atrophic disorders of skin,skin atrophy,EFO:1000766,http://www.ebi.ac.uk/efo/EFO_1000766,0.793,None
ukb-d-4979,FI5 : family relationship calculation,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.739,None
finn-b-H7_GLOBE,Disorders of globe,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.934,None
ukb-e-30070_CSA,Red blood cell (erythrocyte) distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
ukb-e-5610_p3_CSA,Which eye(s) affected by presbyopia,presbyopia,MONDO:0001330,http://purl.obolibrary.org/obo/MONDO_0001330,0.662,None
ukb-e-1269_EAS,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
ukb-a-523,Diagnoses - main ICD10: E03 Other hypothyroidism,hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.706,None
ukb-e-30220_AFR,Basophill percentage,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.917,None
finn-b-G6_MONONPOTHUS,Other and unspecified mononeuropathies of upper limb,mononeuropathy,EFO:0009558,http://www.ebi.ac.uk/efo/EFO_0009558,0.628,None
ukb-e-30180_EAS,Lymphocyte percentage,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
ukb-e-726_AFR,Peripheral enthesopathies and allied syndromes,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.61,None
ukb-e-30690_AFR,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
finn-b-K11_PULP_PERIAPICAL,Diseases of pulp and periapical tissues,periapical tissue disease,EFO:0010688,http://www.ebi.ac.uk/efo/EFO_0010688,0.768,None
ukb-e-I84_EAS,I84 Haemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.682,None
ebi-a-GCST90001390,Dementia with Lewy bodies,Lewy body dementia,EFO:0006792,http://www.ebi.ac.uk/efo/EFO_0006792,0.99,None
finn-b-H7_IRIDOCYCLITIS,Iridocyclitis,Iridocyclitis,HP:0001094,http://purl.obolibrary.org/obo/HP_0001094,0.995,None
ukb-e-20003_p101_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-a-549,Diagnoses - main ICD10: K40 Inguinal hernia,Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.682,None
finn-b-GOUT_IDIO,Idiopathic gout,idiopathic,MONDO:0700005,http://purl.obolibrary.org/obo/MONDO_0700005,0.776,None
ukb-b-18105,Had menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.856,None
finn-b-H7_RETINAHAEMORR,Retinal haemorrhage,Retinal hemorrhage,HP:0000573,http://purl.obolibrary.org/obo/HP_0000573,0.991,None
ukb-e-6164_p2_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-F5_DISSOCIATIVE,Dissociative [conversion] disorders,dissociative disorder,MONDO:0001160,http://purl.obolibrary.org/obo/MONDO_0001160,0.732,None
finn-b-G6_AD_WIDE,"Alzheimer<c3><95>s disease, wide definition",Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.805,None
ukb-e-30870_EAS,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
ukb-e-20117_p3_MID,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
ukb-e-20003_p235_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-b-4637,Diagnoses - main ICD10: H00.1 Chalazion,meibomian cyst,EFO:0007363,http://www.ebi.ac.uk/efo/EFO_0007363,0.672,None
ukb-e-1518_MID,Hot drink temperature,temperature,EFO:0001702,http://www.ebi.ac.uk/efo/EFO_0001702,0.691,None
finn-b-N14_FITUB,"Female infertility, tubal origin",female infertility,EFO:0008560,http://www.ebi.ac.uk/efo/EFO_0008560,0.735,None
finn-b-I9_MI,Myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
finn-b-L12_FOLLICULARCYST,Follicular cysts of skin and subcutaneous tissue,panniculitis,EFO:1000746,http://www.ebi.ac.uk/efo/EFO_1000746,0.7,None
finn-b-Q17_CONGEN_OBSTRUCTIVE_DEFECTS_RENAL_PELVIS_CONGEN_MALFO_URETER,Congenital obstructive defects of renal pelvis and congenital malformations of ureter,congenital,MONDO:0021140,http://purl.obolibrary.org/obo/MONDO_0021140,0.608,None
finn-b-H7_EYEOTH,Other disorders of eye and adnexa,eye adnexa disease,EFO:0009546,http://www.ebi.ac.uk/efo/EFO_0009546,0.941,None
finn-b-CD2_BENIGN_CORPUS_UTERI,Other benign neoplasm of uterus: Corpus uteri,benign neoplasm of corpus uteri,MONDO:0021525,http://purl.obolibrary.org/obo/MONDO_0021525,0.91,None
finn-b-O15_PLAC_DISORD,Placental disorders,placenta disease,EFO:0007441,http://www.ebi.ac.uk/efo/EFO_0007441,0.922,None
finn-b-ASTHMA_PNEUMONIA,Asthma-related pneumonia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.714,None
ukb-e-30830_EAS,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
ukb-a-45,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ukb-d-L12_SKINSUBCUTISNAS,Other and unspecified disorders of skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.954,None
ukb-e-K57_AFR,K57 Diverticular disease of intestine,diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.736,None
finn-b-C3_CLL_EXALLC,Chronic lymphocytic leukaemia (all cancers excluded),chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.794,None
finn-b-CD2_BENIGN_THYROID_EXALLC,Benign neoplasm of thyroid gland (all cancers excluded),Benign Thyroid Gland Neoplasm,EFO:1000122,http://www.ebi.ac.uk/efo/EFO_1000122,0.923,None
finn-b-L12_XEROSCUT,Xerosis cutis,Dry skin,HP:0000958,http://purl.obolibrary.org/obo/HP_0000958,0.815,None
ukb-e-recode389_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-12047,Diagnoses - main ICD10: I20.0 Unstable angina,intermediate coronary syndrome,EFO:1000985,http://www.ebi.ac.uk/efo/EFO_1000985,0.686,None
finn-b-O15_PLAC_PREMAT_SEPAR,Premature separation of placenta [abruptio placentae],Abruptio Placentae,EFO:1001754,http://www.ebi.ac.uk/efo/EFO_1001754,0.944,None
finn-b-C3_PANCREAS,Malignant neoplasm of pancreas,Malignant Pancreatic Neoplasm,EFO:1000359,http://www.ebi.ac.uk/efo/EFO_1000359,0.989,None
ukb-b-10144,Diagnoses - secondary ICD10: K21.0 Gastro-oesophageal reflux disease with oesophagitis,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.741,None
ukb-e-30840_EAS,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
finn-b-G6_BASDEGENOTH,Other degenarative diseases of the basal ganglia,basal ganglia disease,EFO:0009533,http://www.ebi.ac.uk/efo/EFO_0009533,0.767,None
ukb-e-4581_CSA,Financial situation satisfaction,financial situation satisfaction measurement,EFO:0009726,http://www.ebi.ac.uk/efo/EFO_0009726,0.927,None
finn-b-G6_OTHNEU,Other neurological diseases,nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.948,None
finn-b-ST19_INJURY_NERVES_SPINAL_CORD_NECK_LEVEL,Injury of nerves and spinal cord at neck level,Spinal cord injury,EFO:1001919,http://www.ebi.ac.uk/efo/EFO_1001919,0.678,None
ukb-b-12506,Vitamin and mineral supplements: Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.693,None
ebi-a-GCST005647,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO:0004976,http://purl.obolibrary.org/obo/MONDO_0004976,0.993,None
finn-b-CD2_INSITU_BREAST_NOS_EXALLC,"""Carcinoma in situ of breast, other/unspecified"" (all cancers excluded)",breast carcinoma in situ,MONDO:0004658,http://purl.obolibrary.org/obo/MONDO_0004658,0.87,None
finn-b-I9_NONISCHCARDMYOP,Non-ischemic cardiomyopathy,ischemic cardiomyopathy,EFO:0001425,http://www.ebi.ac.uk/efo/EFO_0001425,0.957,None
ukb-e-1920_EAS,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ieu-b-93,Oral cavity cancer,oral cavity cancer,EFO:0005570,http://www.ebi.ac.uk/efo/EFO_0005570,0.995,None
ukb-a-531,Diagnoses - main ICD10: I10 Essential (primary) hypertension,essential hypertension,MONDO:0001134,http://purl.obolibrary.org/obo/MONDO_0001134,0.647,None
finn-b-R18_NAUSEA_VOMITI,Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.946,None
ukb-a-472,Pain type(s) experienced in last month: Neck or shoulder pain,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.653,None
ukb-e-49_MID,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ukb-b-5948,Diagnoses - main ICD10: R35 Polyuria,Polyuria,HP:0000103,http://purl.obolibrary.org/obo/HP_0000103,0.632,None
ukb-e-20003_p539_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-ST19_INJURI_ANKLE_FOOT,Injuries to the ankle and foot,ankle injury,EFO:1002021,http://www.ebi.ac.uk/efo/EFO_1002021,0.654,None
finn-b-O15_AMNIOT_OTHER,Other disorders of amniotic fluid and membranes,Abnormality of the amniotic fluid,HP:0001560,http://purl.obolibrary.org/obo/HP_0001560,0.671,None
ukb-e-3526_CSA,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
ukb-e-30710_MID,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
finn-b-KRA_PSY_PUERPER_EXMORE,"""Mental and behabioural disorders of puerperum, not classified elsewhere"" (more controls excluded)",puerperal disorder,EFO:0009683,http://www.ebi.ac.uk/efo/EFO_0009683,0.621,None
ukb-b-18163,"Non-cancer illness code, self-reported: bronchiectasis",Bronchiectasis,HP:0002110,http://purl.obolibrary.org/obo/HP_0002110,0.663,None
ebi-a-GCST007515,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ieu-a-985,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
finn-b-ST19_FOREI_BODY_ALIME_TRACT,Foreign body in alimentary tract,foreign body in gastrointestinal tract,EFO:0009526,http://www.ebi.ac.uk/efo/EFO_0009526,0.977,None
finn-b-ST19_FROSTBITE,Frostbite,frostbite,EFO:0009527,http://www.ebi.ac.uk/efo/EFO_0009527,0.998,None
ukb-b-19950,Operative procedures - main OPCS: X99.8 No procedure performed,medical procedure,EFO:0002571,http://www.ebi.ac.uk/efo/EFO_0002571,0.619,None
finn-b-T1D_WIDE1,"Type 1 diabetes, wide definition, subgroup 1",type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.682,None
finn-b-O15_EXIST_HYPERT_COMPLIC,"Pre-existing hypertension complicating pregnancy, childbirth and the puerperium","hypertension, pregnancy-induced",MONDO:0024664,http://purl.obolibrary.org/obo/MONDO_0024664,0.69,None
finn-b-G6_DYSTON,Dystonia,dystonic disorder,MONDO:0003441,http://purl.obolibrary.org/obo/MONDO_0003441,0.985,None
ukb-e-recode148_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-ST19_OTHER_UNSPE_INJURI_NECK,Other and unspecified injuries of neck,neck injury,EFO:0009476,http://www.ebi.ac.uk/efo/EFO_0009476,0.749,None
ukb-e-52_p12_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-1329_AFR,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
finn-b-R18_SPEECH_DISTU_NOT_ELSEW_CLASSIFIED,"Speech disturbances, not elsewhere classified",Gait disturbance,HP:0001288,http://purl.obolibrary.org/obo/HP_0001288,0.625,None
finn-b-CD2_BENIGN_ANUS_ANAL_CANAL,Benign neoplasm: Anus and anal canal,benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.87,None
finn-b-N14_HYPERTROPHYBREAST,Hypertrophy of breast,Breast hypertrophy,HP:0010313,http://purl.obolibrary.org/obo/HP_0010313,0.962,None
ukb-e-30890_MID,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
ukb-e-21002_EAS,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
ukb-e-20117_p1_CSA,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
finn-b-M13_HAMMERTOE,Other hammer toe(s) (acquired),Hammer Toe Syndrome,EFO:1001336,http://www.ebi.ac.uk/efo/EFO_1001336,0.908,None
finn-b-C3_BRONCHUS_LUNG,Malignant neoplasm of bronchus and lung,bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.971,None
finn-b-ST19_INJURY_OTHER_UNSPE_INTRAT_ORGANS,Injury of other and unspecified intrathoracic organs,intrathoracic organ injury,EFO:0009887,http://www.ebi.ac.uk/efo/EFO_0009887,0.945,None
ukb-e-120_p3_CSA,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-e-30010_AFR,Red blood cell (erythrocyte) count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.783,None
ukb-e-3062_CSA,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
finn-b-CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS,"Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.713,None
finn-b-G6_NEURO,Neurological diseases,nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.948,None
ebi-a-GCST010723,Early age-related macular degeneration,age-related macular degeneration,EFO:0001365,http://www.ebi.ac.uk/efo/EFO_0001365,0.872,None
ukb-d-H04,Diagnoses - main ICD10: H04 Disorders of lachrymal system,lacrimal apparatus disease,EFO:0009455,http://www.ebi.ac.uk/efo/EFO_0009455,0.771,None
finn-b-ST19_INJURI_KNEE_LOWER_LEG,Injuries to the knee and lower leg,knee injury,EFO:0009507,http://www.ebi.ac.uk/efo/EFO_0009507,0.614,None
ebi-a-GCST005212,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-d-20126_3,Bipolar and major depression status: Probable Recurrent major depression (severe),unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.802,None
finn-b-CHRONHEP_NAS,Chronic hepatitis NAS,chronic hepatitis,EFO:0008496,http://www.ebi.ac.uk/efo/EFO_0008496,0.919,None
ukb-e-785_MID,Abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.989,None
finn-b-CROHN_ARTHR,Arthropathy in Crohn disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.723,None
ukb-e-280_AFR,Iron deficiency anemias,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.921,None
ukb-d-20536_1,Weight change during worst episode of depression: Gained weight,Increased body weight,HP:0004324,http://purl.obolibrary.org/obo/HP_0004324,0.661,None
ukb-e-5265_EAS,Corneal resistance factor (left),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.903,None
finn-b-R18_DYSPNOEA,Dyspnoea,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.958,None
ukb-e-100011_AFR,Iron,iron metabolism disease,MONDO:0002279,http://purl.obolibrary.org/obo/MONDO_0002279,0.748,None
finn-b-E4_ENDOGLAND,Disorders of other endocrine glands,endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.874,None
ukb-e-4620_CSA,Number of depression episodes,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.613,None
ukb-e-4194_EAS,Pulse rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.996,None
finn-b-L12_PILONIDALCYST,Pilonidal cyst,Pilonidal sinus,HP:0010769,http://purl.obolibrary.org/obo/HP_0010769,0.991,None
ukb-d-20544_15,"Mental health problems ever diagnosed by a professional: Anxiety, nerves or generalized anxiety disorder",generalized anxiety disorder,EFO:1001892,http://www.ebi.ac.uk/efo/EFO_1001892,0.742,None
finn-b-O15_ABORT_MEDICAL,Medical abortion,abortion,EFO:1001491,http://www.ebi.ac.uk/efo/EFO_1001491,0.773,None
finn-b-FG_HYPERTENSION,Hypertensive diseases (excluding secondary),hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.8,None
finn-b-I9_HYPTENSRD_EXNONE,Hypertensive Renal Disease (no controls excluded),hypertensive nephropathy,MONDO:0024633,http://purl.obolibrary.org/obo/MONDO_0024633,0.939,None
ukb-e-23111_EAS,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
ieu-b-5063,URTI,urticaria,EFO:0005531,http://www.ebi.ac.uk/efo/EFO_0005531,0.621,None
ukb-e-20022_CSA,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
finn-b-E4_DM2NOCOMP,Type 2 diabetes without complications,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.606,None
finn-b-N14_FIANOV,"Female infertility, associated with anovulation",female infertility,EFO:0008560,http://www.ebi.ac.uk/efo/EFO_0008560,0.637,None
ukb-d-K11_ILEUS,Paralytic ileus and intestinal obstruction,intestinal obstruction,MONDO:0004565,http://purl.obolibrary.org/obo/MONDO_0004565,0.725,None
ukb-e-30750_AFR,Glycated haemoglobin (HbA1c),HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.632,None
finn-b-RHEUMA_NOS,Other/unspecified rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-M13_RHEUMATISM,"Rheumatism, unspecified",rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.994,None
finn-b-ULCERPROCT,Ulcerative proctitis,interstitial cystitis,EFO:0008507,http://www.ebi.ac.uk/efo/EFO_0008507,0.773,None
finn-b-L12_INFECT_SKIN,Infections of the skin and subcutaneous tissue,subcutaneous tissue infection,EFO:0010692,http://www.ebi.ac.uk/efo/EFO_0010692,0.907,None
finn-b-CD2_INSITU_BREAST_INTRADUCTAL_EXALLC,"""Carcinoma in situ of breast, intraductal"" (all cancers excluded)",breast ductal carcinoma in situ,EFO:0000432,http://www.ebi.ac.uk/efo/EFO_0000432,0.846,None
ukb-e-recode191_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-201,Illnesses of father: Heart disease,heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.663,None
ukb-e-recode266_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-815,Systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
finn-b-DRUGADVERS_TREMOR,Drug-induced tremor,drug-induced lupus erythematosus,MONDO:0016474,http://purl.obolibrary.org/obo/MONDO_0016474,0.677,None
ieu-b-4970,Cellulitis,cellulitis,EFO:0003035,http://www.ebi.ac.uk/efo/EFO_0003035,0.996,None
ukb-e-24019_EAS,Particulate matter air pollution (pm10); 2007,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.737,None
ukb-e-1920_CSA,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ukb-d-K58,Diagnoses - main ICD10: K58 Irritable bowel syndrome,irritable bowel syndrome,EFO:0000555,http://www.ebi.ac.uk/efo/EFO_0000555,0.759,None
ukb-e-4620_AFR,Number of depression episodes,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.613,None
ukb-e-3064_AFR,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
ukb-e-6138_p3_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-HYPOTE_DRUGS,Hypotension due to drugs,hypotension,EFO:0005251,http://www.ebi.ac.uk/efo/EFO_0005251,0.658,None
ukb-e-104670_AFR,Vitamin supplement user,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.674,None
finn-b-G6_NARCOCATA,Narcolepsy and cataplexy,narcolepsy-cataplexy syndrome,MONDO:0016158,http://purl.obolibrary.org/obo/MONDO_0016158,0.941,None
ieu-a-972,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-e-6155_p2_MID,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-G6_NEUROOTH,Other disorders of nervous system,nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.949,None
ukb-e-Z30_AFR,Z30 Contraceptive management,contraception,EFO:0009520,http://www.ebi.ac.uk/efo/EFO_0009520,0.838,None
finn-b-H7_IRIDOCHRONIC,Chronic iridocyclitis,Iridocyclitis,HP:0001094,http://purl.obolibrary.org/obo/HP_0001094,0.844,None
finn-b-GE,Generalized epilepsy,generalised epilepsy,EFO:0005917,http://www.ebi.ac.uk/efo/EFO_0005917,0.995,None
ukb-d-C_STROKE,STROKE,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.986,None
finn-b-Z21_PROBL_RELATED_EMPLO_UNEMP,Problems related to employment and unemployment,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.725,None
finn-b-H7_CENTRRETARTOCC,Central retinal artery occlusion,retinal artery occlusion,EFO:1001154,http://www.ebi.ac.uk/efo/EFO_1001154,0.9,None
ukb-b-17001,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
ukb-e-4106_AFR,"Heel bone mineral density (BMD) T-score, automated (left)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.665,None
finn-b-ST19_FRACT_FOOT_ANKLE,"Fracture of foot, except ankle",ankle fracture,EFO:0009615,http://www.ebi.ac.uk/efo/EFO_0009615,0.693,None
finn-b-CD2_BENIGN_TONGUE_EXALLC,Benign neoplasm: Tongue (all cancers excluded),benign neoplasm of tongue,MONDO:0021476,http://purl.obolibrary.org/obo/MONDO_0021476,0.906,None
finn-b-F5_PSYCHOTH,Other and unspecified nonorganic psychotic disorders,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.792,None
finn-b-G6_BENINTRAHYP,Benign intracranial hypertension,pseudotumor cerebri,EFO:1001132,http://www.ebi.ac.uk/efo/EFO_1001132,0.991,None
ebi-a-GCST90016604,Bipolar disorder vs ADHD (ordinary least squares (OLS)),bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.673,None
ukb-e-K80_CSA,K80 Cholelithiasis,cholelithiasis,EFO:0004799,http://www.ebi.ac.uk/efo/EFO_0004799,0.82,None
finn-b-G6_MONOLOWOTHUNS,Other and unspecified mononeuropathies of lower limb,mononeuropathy,EFO:0009558,http://www.ebi.ac.uk/efo/EFO_0009558,0.628,None
finn-b-K11_DISLIVOTH,Other diseases of liver,liver disease,EFO:0001421,http://www.ebi.ac.uk/efo/EFO_0001421,0.94,None
finn-b-I9_OTHANEUR_EXNONE,Other aneurysm (no controls excluded),aneurysm,EFO:0009659,http://www.ebi.ac.uk/efo/EFO_0009659,0.911,None
ukb-b-12849,Mouth/teeth dental problems: Loose teeth,tooth disease,EFO:1001216,http://www.ebi.ac.uk/efo/EFO_1001216,0.604,None
finn-b-AB1_AMOEBIASIS,Amoebiasis,amebiasis,EFO:0007144,http://www.ebi.ac.uk/efo/EFO_0007144,0.997,None
finn-b-G6_GUILBAR,Guillain-Barre syndrome,Guillain-Barre syndrome,EFO:0007292,http://www.ebi.ac.uk/efo/EFO_0007292,0.96,None
ukb-e-1259_CSA,Smoking/smokers in household,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.68,None
ukb-e-100002_CSA,Energy,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.718,None
ebi-a-GCST000998,Coronary heart disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.993,None
ukb-e-recode328_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-R63,Diagnoses - main ICD10: R63 Symptoms and signs concerning food and fluid intake,sign or symptom concerning food and fluid intake,EFO:0009825,http://www.ebi.ac.uk/efo/EFO_0009825,0.718,None
ukb-b-10668,"Diagnoses - main ICD10: N47 Redundant prepuce, phimosis and paraphimosis",paraphimosis,EFO:1001086,http://www.ebi.ac.uk/efo/EFO_1001086,0.729,None
ukb-e-recode234_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_MENINGES,Benign neoplasm of meninges,meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.858,None
ukb-e-4674_CSA,Private healthcare,nosocomial infection,MONDO:0043544,http://purl.obolibrary.org/obo/MONDO_0043544,0.616,None
ukb-e-20117_p1_MID,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
ukb-e-DBP_p1_CSA,"Diastolic blood pressure, automated reading, adjusted by medication",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.623,None
finn-b-G6_CP,Cerebral palsy,cerebral palsy,EFO:1000632,http://www.ebi.ac.uk/efo/EFO_1000632,0.997,None
finn-b-KRA_PSY_MENTALRET,Mental retardation (KRA_PSY_MENTALRET),Intellectual disability,HP:0001249,http://purl.obolibrary.org/obo/HP_0001249,0.699,None
ukb-e-5111_CSA,3mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
ukb-a-555,Diagnoses - main ICD10: K57 Diverticular disease of intestine,diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.664,None
ukb-e-K63_AFR,K63 Other diseases of intestine,intestinal disease,EFO:0009431,http://www.ebi.ac.uk/efo/EFO_0009431,0.734,None
finn-b-L12_URTICA_NAS,Other and unspecified urticaria,urticaria,EFO:0005531,http://www.ebi.ac.uk/efo/EFO_0005531,0.991,None
ukb-e-20111_p4_MID,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-L12_NECROLIPOIDIC,"Necrobiosis lipoidica, not elsewhere classified",necrobiosis lipoidica,EFO:1000738,http://www.ebi.ac.uk/efo/EFO_1000738,0.985,None
finn-b-K11_CHOLANGI_STRICT,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",sclerosing cholangitis,EFO:0004268,http://www.ebi.ac.uk/efo/EFO_0004268,0.664,None
ukb-e-1170_AFR,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
ukb-b-15531,Other non-alcoholic drinks,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.623,None
finn-b-AB1_MUMPS,Mumps,Mumps virus infectious disease,EFO:0007383,http://www.ebi.ac.uk/efo/EFO_0007383,0.991,None
ieu-a-1108,Ischemic stroke,Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.988,None
ukb-e-100001_AFR,Food weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.756,None
ukb-e-1920_MID,Mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.995,None
ukb-a-308,Fractured/broken bones in last 5 years,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.641,None
ukb-e-H40_AFR,H40 Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.736,None
finn-b-L12_URTICA_IDIOPAT,Idiopathic urticaria,idiopathic urticaria,MONDO:0044211,http://purl.obolibrary.org/obo/MONDO_0044211,0.983,None
finn-b-ILD_INSUFFICIENCY,ILD-related respiratory insufficiency,Respiratory insufficiency,HP:0002093,http://purl.obolibrary.org/obo/HP_0002093,0.863,None
ukb-e-6142_p1_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-b-20515,Recent medication for asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.643,None
ukb-b-11736,"Non-cancer illness code, self-reported: meniere's disease",Meniere disease,EFO:0006862,http://www.ebi.ac.uk/efo/EFO_0006862,0.616,None
finn-b-O15_ECLAMPSIA,Eclampsia,Eclampsia,HP:0100601,http://purl.obolibrary.org/obo/HP_0100601,0.988,None
ieu-a-296,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
ukb-e-D64_CSA,D64 Other anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.616,None
finn-b-G6_MIGRAINE_NO_AURA_ADVERSE,"Migraine without aura, drug-induced",migraine without aura,MONDO:0100431,http://purl.obolibrary.org/obo/MONDO_0100431,0.797,None
finn-b-CD2_BENIGN_CHOROID_EXALLC,Benign neoplasm: Choroid (all cancers excluded),benign neoplasm of choroid,MONDO:0021487,http://purl.obolibrary.org/obo/MONDO_0021487,0.902,None
finn-b-PSOR_ENTE_ARTHR,Psoriatic and enteropathic arthropathies,psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.758,None
finn-b-Q17_EHLER_SYNDR,Ehlers-Danlos syndrome,Ehlers-Danlos syndrome,MONDO:0020066,http://purl.obolibrary.org/obo/MONDO_0020066,0.961,None
ukb-e-30250_EAS,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
ukb-b-4379,Treatment/medication code: tamoxifen,response to tamoxifen,EFO:0009391,http://www.ebi.ac.uk/efo/EFO_0009391,0.619,None
finn-b-CD2_INSITU_CERVIX_UTERI_EXOCERVIX_EXALLC,"""Carcinoma in situ of cervix uteri, exocervix"" (all cancers excluded)",uterine cervix carcinoma in situ,MONDO:0042487,http://purl.obolibrary.org/obo/MONDO_0042487,0.827,None
finn-b-D3_OTHERANAEMIA,Other anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.827,None
finn-b-ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED,"Adverse effects, not elsewhere classified",adverse effect,EFO:0009658,http://www.ebi.ac.uk/efo/EFO_0009658,0.892,None
ukb-e-K44_AFR,K44 Diaphragmatic hernia,diaphragmatic hernia,EFO:0008561,http://www.ebi.ac.uk/efo/EFO_0008561,0.869,None
ukb-e-6164_p5_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-Q17_CONGEN_DEFORMITI_FEET,Congenital deformities of feet,congenital deformities of fingers,MONDO:0017428,http://purl.obolibrary.org/obo/MONDO_0017428,0.744,None
finn-b-AUTOIMMUNE,Autoimmune diseases,immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.983,None
finn-b-K11_PANCOTH,Other diseases of pancreas,pancreas disease,EFO:0009605,http://www.ebi.ac.uk/efo/EFO_0009605,0.931,None
finn-b-M13_PERONEALTEND,Peroneal tendinitis,tendinitis,MONDO:0004857,http://purl.obolibrary.org/obo/MONDO_0004857,0.734,None
ebi-a-GCST005840,Ischemic stroke (large artery atherosclerosis),atherosclerosis,EFO:0003914,http://www.ebi.ac.uk/efo/EFO_0003914,0.725,None
ukb-e-530_AFR,Diseases of esophagus,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.953,None
ieu-a-25,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-E4_VIT_B_DEF,Deficiency of other B group vitamins,vitamin B deficiency,MONDO:0042976,http://purl.obolibrary.org/obo/MONDO_0042976,0.788,None
ukb-a-525,Diagnoses - main ICD10: F31 Bipolar affective disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.741,None
ukb-e-30110_AFR,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
finn-b-C3_NSCLC_SQUAM,"Non-small cell lung cancer, squamous",squamous cell lung carcinoma,EFO:0000708,http://www.ebi.ac.uk/efo/EFO_0000708,0.892,None
ukb-b-8080,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy",hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.65,None
ukb-e-30300_MID,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
finn-b-I9_LYMPHOTH,Other noninfective disordersof lymphatic vessels and lymph nodes,lymphatic system disease,EFO:0007352,http://www.ebi.ac.uk/efo/EFO_0007352,0.675,None
finn-b-CD2_BENIGN_OROPHA_OTHER,Benign neoplasm: Other parts of oropharynx,neoplasm of oropharynx,MONDO:0021364,http://purl.obolibrary.org/obo/MONDO_0021364,0.809,None
finn-b-CAMPYLOENTERITIS,Campylobacter enteritis,campylobacteriosis,EFO:0007190,http://www.ebi.ac.uk/efo/EFO_0007190,0.806,None
finn-b-N14_HABITABORT,Habitual aborter,habitual abortion,EFO:1000954,http://www.ebi.ac.uk/efo/EFO_1000954,0.985,None
finn-b-H7_GLAUCOMA,Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.993,None
ukb-e-2966_CSA,Age high blood pressure diagnosed,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.803,None
finn-b-J10_ASTHMA_MAIN,Asthma (only as main-diagnosis),asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.912,None
finn-b-D3_HEREDOTHCLOFACTORS,Hereditary deficiency of other clotting factors,congenital factor X deficiency,MONDO:0009212,http://purl.obolibrary.org/obo/MONDO_0009212,0.72,None
ebi-a-GCST90016608,Bipolar disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.81,None
finn-b-I9_LYMPHADE_EXNONE,Nonspesific lymphadenitis (no controls excluded),Lymphadenitis,HP:0002840,http://purl.obolibrary.org/obo/HP_0002840,0.681,None
bbj-a-90,Atopic dermatitis,atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.996,None
ukb-b-16292,Diagnoses - secondary ICD10: I51.7 Cardiomegaly,cardiac hypertrophy,EFO:0002503,http://www.ebi.ac.uk/efo/EFO_0002503,0.624,None
ukb-e-272_AFR,Disorders of lipoid metabolism,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.802,None
ukb-e-recode407_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-100003_AFR,Protein,Proteinuria,HP:0000093,http://purl.obolibrary.org/obo/HP_0000093,0.744,None
ieu-b-4979,Pneumonia (death),pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.851,None
ukb-e-30790_MID,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
finn-b-K11_PERIODON_ACUTE,Acute periodontitis,periodontitis,EFO:0000649,http://www.ebi.ac.uk/efo/EFO_0000649,0.852,None
ukb-e-20111_p13_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-b-9125,"Non-cancer illness code, self-reported: rheumatoid arthritis",rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.693,None
ukb-e-SBP_p1_AFR,"Systolic blood pressure, automated reading, adjusted by medication",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.622,None
finn-b-CD2_BENIGN_COLORECANI_EXALLC,"""Benign neoplasm of colon, rectum, anus and anal canal"" (all cancers excluded)",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.691,None
finn-b-G6_FEMLE,Lesion of femoral nerve,femoral neuropathy,EFO:1000936,http://www.ebi.ac.uk/efo/EFO_1000936,0.91,None
finn-b-AB1_OTHER_CHLAMYDIAE,Other diseases caused by chlamydiae (AB1_OTHER_CHLAMYDIAE),Chlamydia trachomatis infectious disease,EFO:0007205,http://www.ebi.ac.uk/efo/EFO_0007205,0.769,None
ukb-e-2335_EAS,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
finn-b-J10_PNEUMONONBACT,"Pneumonia due to other infectious organisms, not elsewhere classified",pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.687,None
ukb-d-XV_PREGNANCY_BIRTH,"Pregnancy, childbirth and the puerperium",pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.836,None
finn-b-I9_PROGVASC_EXNONE,Progressive vascular leukoencephalopathy (no controls excluded),progressive cavitating leukoencephalopathy,MONDO:0015349,http://purl.obolibrary.org/obo/MONDO_0015349,0.754,None
finn-b-I9_HEARTFAIL_AND_HYPERTCARDIOM,Heart failure and hypertrophic cardiomyopathy,hypertrophic cardiomyopathy,EFO:0000538,http://www.ebi.ac.uk/efo/EFO_0000538,0.831,None
ukb-e-recode354_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-71,Atrial Fibrillation,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.996,None
ukb-e-3064_MID,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
ukb-e-SBP_p1_MID,"Systolic blood pressure, automated reading, adjusted by medication",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.622,None
finn-b-CD2_BENIGN_UTERINE_TUBES_LIGAMENTS,Benign neoplasm: Uterine tubes and ligaments,uterine ligament neoplasm,MONDO:0021629,http://purl.obolibrary.org/obo/MONDO_0021629,0.73,None
ukb-e-6148_p5_AFR,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ukb-e-recode359_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20003_p33_EAS,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-L12_LICHENSCLERATROPH,Lichen sclerosus et atrophicus,lichen sclerosus et atrophicus,MONDO:0007899,http://purl.obolibrary.org/obo/MONDO_0007899,0.995,None
ebi-a-GCST005841,Ischemic stroke (small-vessel),small vessel stroke,EFO:1001504,http://www.ebi.ac.uk/efo/EFO_1001504,0.805,None
ukb-e-recode254_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_LBBB_EXNONE,Left bundle-branch block (no controls excluded),Left bundle branch block,HP:0011713,http://purl.obolibrary.org/obo/HP_0011713,0.95,None
finn-b-CD2_INSITU_BREAST_INTRADUCTAL,"Carcinoma in situ of breast, intraductal",breast ductal carcinoma in situ,EFO:0000432,http://www.ebi.ac.uk/efo/EFO_0000432,0.894,None
ukb-e-SBP_p1_EAS,"Systolic blood pressure, automated reading, adjusted by medication",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.622,None
ukb-e-6164_p3_MID,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-recode18_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-139,Ovarian cancer,ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.992,None
ukb-e-30270_EAS,Mean sphered cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.801,None
ukb-e-30680_CSA,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
finn-b-CD2_BENIGN_APPENDIX,Benign neoplasm: Appendix,appendiceal neoplasm,EFO:0003880,http://www.ebi.ac.uk/efo/EFO_0003880,0.868,None
finn-b-M13_FLATFOOT,Flat foot [pes planus] (acquired),flatfoot,EFO:0003874,http://www.ebi.ac.uk/efo/EFO_0003874,0.749,None
finn-b-AB1_GONOCOCCAL,Gonococcal infection,meningococcal infection,EFO:0004249,http://www.ebi.ac.uk/efo/EFO_0004249,0.661,None
ukb-e-recode158_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-103190_AFR,White fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.67,None
finn-b-E4_HYPERKALAEMIA,Hyperkalaemia,Hyperkalemia,HP:0002153,http://purl.obolibrary.org/obo/HP_0002153,0.764,None
finn-b-I9_CARDMSEC,"Cardiomyopathies, Secondary/extrinsic",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.825,None
ieu-b-4913,Laryngeal cancer,laryngeal neoplasm,EFO:0003817,http://www.ebi.ac.uk/efo/EFO_0003817,0.992,None
ukb-e-20004_p96_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
ebi-a-GCST006464,Endometrial cancer,endometrial cancer,MONDO:0011962,http://purl.obolibrary.org/obo/MONDO_0011962,0.99,None
ukb-e-2227_MID,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
finn-b-ST19_FRACT_RIBS_STERNUM_THORACIC_SPINE,"Fracture of rib(s), sternum and thoracic spine",rib fracture,EFO:0009620,http://www.ebi.ac.uk/efo/EFO_0009620,0.619,None
finn-b-K11_GASTRODUOULC,Gastroduodenal ulcer,duodenal ulcer,EFO:0004607,http://www.ebi.ac.uk/efo/EFO_0004607,0.771,None
finn-b-GOUT_STRICT,"Gout, strict definition",gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.998,None
ukb-e-6149_p3_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-585_AFR,Renal failure,Renal insufficiency,HP:0000083,http://purl.obolibrary.org/obo/HP_0000083,0.995,None
finn-b-ST19_OPEN_WOUND_NECK,Open wound of neck,injury,EFO:0000546,http://www.ebi.ac.uk/efo/EFO_0000546,0.628,None
finn-b-M13_TRIGGERFINGER,Trigger finger,Digital flexor tenosynovitis,HP:0012276,http://purl.obolibrary.org/obo/HP_0012276,0.995,None
ukb-d-M13_IMPINGEMENT,Impingement syndrome of shoulder,shoulder impingement syndrome,EFO:1001178,http://www.ebi.ac.uk/efo/EFO_1001178,0.957,None
ukb-e-4728_CSA,Leg pain on walking,Lower limb pain,HP:0012514,http://purl.obolibrary.org/obo/HP_0012514,0.665,None
finn-b-C3_ANUS_ANALCANAL_EXALLC,Malignant neoplasm of anus and anal canal (all cancers excluded),anus cancer,MONDO:0001879,http://purl.obolibrary.org/obo/MONDO_0001879,0.793,None
ukb-e-23102_AFR,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
finn-b-CD2_INSITU_SKIN_SCALPNECK_EXALLC,Carcinoma in situ of skin of scalp and neck (all cancers excluded),skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.715,None
ukb-e-670_p3_EAS,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
ukb-e-2794_AFR,Age started oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.692,None
ukb-e-K31_CSA,K31 Other diseases of stomach and duodenum,duodenal disorder,MONDO:0002866,http://purl.obolibrary.org/obo/MONDO_0002866,0.666,None
ukb-e-30760_EAS,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
ukb-b-2750,"Type of cancer: ICD10: C43.7 Malignant melanoma of lower limb, including hip",cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.652,None
ukb-a-104,Non-cancer illness code  self-reported: ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.65,None
ieu-a-988,Small cell lung carcinoma,small cell lung carcinoma,EFO:0000702,http://www.ebi.ac.uk/efo/EFO_0000702,0.984,None
ukb-e-495_AFR,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ebi-a-GCST90014238,Systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
ukb-e-recode24_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_VALGUS,"Valgus deformity, not elsewhere classified",Pes valgus,HP:0008081,http://purl.obolibrary.org/obo/HP_0008081,0.868,None
ukb-e-30160_CSA,Basophill count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.886,None
ukb-d-C3_CORPUS_UTERI,Malignant neoplasm of corpus uteri,uterine body mixed cancer,MONDO:0002879,http://purl.obolibrary.org/obo/MONDO_0002879,0.878,None
finn-b-Q17_OTHER_CONGEN_MALFO_DIGES_SYSTEM1,Other congenital malformations of the digestive system,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.666,None
finn-b-AB1_RUBELLA,Rubella [German measles],rubella,EFO:1002026,http://www.ebi.ac.uk/efo/EFO_1002026,0.761,None
finn-b-R18_ELEVATED_BLOOD_GLUCOSE_LEVEL,Elevated blood glucose level,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.738,None
ukb-e-103040_AFR,Lamb intake,Carney complex,MONDO:0015285,http://purl.obolibrary.org/obo/MONDO_0015285,0.783,None
ukb-e-1259_EAS,Smoking/smokers in household,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.68,None
finn-b-N14_POLYPFEMGEN,Polyp of the female genital tract,female genital tract polyp,EFO:0008622,http://www.ebi.ac.uk/efo/EFO_0008622,0.993,None
ukb-e-100007_AFR,Polyunsaturated fat,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.795,None
ukb-e-recode138_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AB1_VIRAAL_CONJUNCT,Viral conjunctivitis,acute hemorrhagic conjunctivitis,EFO:0007131,http://www.ebi.ac.uk/efo/EFO_0007131,0.996,None
ukb-e-30300_AFR,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
ukb-b-5712,Diagnoses - main ICD10: N95.0 Postmenopausal bleeding,postmenopausal,EFO:0002721,http://www.ebi.ac.uk/efo/EFO_0002721,0.638,None
finn-b-K11_GINGIVITIS_CHRONIC,Chronic gingivitis,chronic gingivitis,MONDO:0020782,http://purl.obolibrary.org/obo/MONDO_0020782,0.993,None
ukb-e-4079_MID,"Diastolic blood pressure, automated reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
ukb-a-225,Smoking status: Current,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.717,None
finn-b-Q17_OTHER_CONGEN_MALFO_NERVOUS_SYSTEM,Other congenital malformations of nervous system,central nervous system malformation,MONDO:0020022,http://purl.obolibrary.org/obo/MONDO_0020022,0.754,None
ukb-b-3683,"Diagnoses - main ICD10: B34.9 Viral infection, unspecified",viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.615,None
ukb-e-recode335_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_BONE_CARTILAGE_NOS_EXALLC,"""Benign neoplasm: Bone and articular cartilage, unspecified"" (all cancers excluded)",benign chondrogenic neoplasm,MONDO:0024470,http://purl.obolibrary.org/obo/MONDO_0024470,0.783,None
finn-b-N14_FEMGENFISTUL,Fistulae involving female genital tract,female genital tract fistula,EFO:0009524,http://www.ebi.ac.uk/efo/EFO_0009524,0.764,None
ukb-e-20002_p57_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-G6_MENINGBACT,Bacterial meningitis,bacterial meningitis,EFO:1000831,http://www.ebi.ac.uk/efo/EFO_1000831,0.99,None
finn-b-R18_FLATU_RELATED_CONDI,Flatulence and related conditions,flatulence,EFO:0009669,http://www.ebi.ac.uk/efo/EFO_0009669,0.725,None
finn-b-Q17_OTHER_CONGEN_MALFO,Other congenital malformations,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.861,None
finn-b-H7_EXOPTHALMUS,Exophthalmic conditions,Proptosis,HP:0000520,http://purl.obolibrary.org/obo/HP_0000520,0.682,None
ieu-a-805,Major depressive disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.987,None
ieu-b-4972,Endocarditis,endocarditis,EFO:0000465,http://www.ebi.ac.uk/efo/EFO_0000465,0.997,None
finn-b-H8_HL_PRESBY,Presbycusis,presbycusis,MONDO:0043765,http://purl.obolibrary.org/obo/MONDO_0043765,0.995,None
ukb-b-1386,Diagnoses - main ICD10: K21.9 Gastro-oesophageal reflux disease without oesophagitis,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.751,None
finn-b-O15_COMPLIC_ABORT_ECTOP_MOLAR,Complications following abortion and ectopic and molar pregnancy,pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.6,None
ukb-e-6138_p2_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-a-424,Eye problems/disorders: Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.602,None
ieu-b-106,FEV1/FVC < 0.7,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.646,None
ukb-e-102190_AFR,Cake intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.638,None
finn-b-H8_CHRON_SUPOTITIS,Chronic suppurative otitis media,chronic non-suppurative otitis media,MONDO:0021206,http://purl.obolibrary.org/obo/MONDO_0021206,0.871,None
finn-b-H8_PERCHRONDR,Perichondritis of external ear,perichondritis of auricle,MONDO:0002246,http://purl.obolibrary.org/obo/MONDO_0002246,0.621,None
finn-b-D3_COMBIMMUDEF,Combined immunodeficiencies,Immunodeficiency,HP:0002721,http://purl.obolibrary.org/obo/HP_0002721,0.825,None
ukb-b-8814,"Diagnoses - main ICD10: N39.0 Urinary tract infection, site not specified",urinary tract infection,EFO:0003103,http://www.ebi.ac.uk/efo/EFO_0003103,0.655,None
ukb-a-596,Diagnoses - main ICD10: Z80 Family history of malignant neoplasm,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.778,None
finn-b-D3_IMMUDEF,Immunodeficiencies,Immunodeficiency,HP:0002721,http://purl.obolibrary.org/obo/HP_0002721,0.825,None
finn-b-Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE,Persons encountering health services for specific procedures and health care,encounter with health service,EFO:0009786,http://www.ebi.ac.uk/efo/EFO_0009786,0.682,None
ukb-e-20002_p6_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-N14_IMPOTENCE,Impotence,Impotence,HP:0000802,http://purl.obolibrary.org/obo/HP_0000802,0.987,None
ukb-e-4674_AFR,Private healthcare,nosocomial infection,MONDO:0043544,http://purl.obolibrary.org/obo/MONDO_0043544,0.616,None
finn-b-M13_INFBURSA,Infective bursitis,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.748,None
bbj-a-142,Periodontal disease,periodontal disorder,MONDO:0002635,http://purl.obolibrary.org/obo/MONDO_0002635,0.991,None
ukb-d-4803_0,"Tinnitus: No, never",Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.784,None
finn-b-CD2_BENIGN_LIPO_SKIN_HEADFACENECK,"Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck",benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.653,None
ukb-e-Z85_AFR,Z85 Personal history of malignant neoplasm,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.667,None
ukb-e-recode339_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_GIANTCELL,Giant cell arteritis,temporal arteritis,EFO:1001209,http://www.ebi.ac.uk/efo/EFO_1001209,0.992,None
ukb-d-D3_OTHERANAEMIA,Other anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.827,None
finn-b-VD_MI,Vascular dementia (multiple infarctations),multi-infarct dementia,MONDO:0043224,http://purl.obolibrary.org/obo/MONDO_0043224,0.667,None
ukb-b-12433,Operative procedures - main OPCS: N30.3 Circumcision,circumcision,EFO:0003953,http://www.ebi.ac.uk/efo/EFO_0003953,0.647,None
finn-b-F5_ALLANXIOUS,All anxiety disorders,anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.987,None
finn-b-G6_AD_WIDE_EXMORE,"""Alzheimer<c3><95>s disease, wide definition"" (more controls excluded)",Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.805,None
finn-b-M13_RHEUMA,Rheumatoid arthritis (M13_RHEUMA),rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.88,None
ukb-e-2345_AFR,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
ukb-b-1968,Diagnoses - main ICD10: K63.5 Polyp of colon,polyp of colon,MONDO:0021400,http://purl.obolibrary.org/obo/MONDO_0021400,0.647,None
finn-b-E4_ACIDOSIS,Acidosis,acidosis,EFO:1000014,http://www.ebi.ac.uk/efo/EFO_1000014,0.998,None
finn-b-I9_RBBB_EXNONE,Right bundle-branch block (no controls excluded),Right bundle branch block,HP:0011712,http://purl.obolibrary.org/obo/HP_0011712,0.949,None
finn-b-N14_HYDRONEPHR,Hydronephrosis,hydronephrosis,EFO:0005562,http://www.ebi.ac.uk/efo/EFO_0005562,0.989,None
finn-b-M13_BURSITISOTH,"Other bursitis, not elsewhere classified",bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.997,None
finn-b-NONALLERG_ASTHMA_EXMORE,Non-allergic asthma (mode) (more controls excluded),allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.86,None
ukb-e-30530_MID,Sodium in urine,urinary sodium measurement,EFO:0021522,http://www.ebi.ac.uk/efo/EFO_0021522,0.963,None
finn-b-OTHER_SYSTCON_FG,Other systemic involvement of connective tissue (FG),Connective tissue disease with eye involvement,ORPHANET.ORDO:98702,http://www.orpha.net/ORDO/Orphanet_98702,0.713,None
ukb-e-3148_AFR,Heel bone mineral density (BMD),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.878,None
ukb-b-19041,"Type of cancer: ICD10: C50.9 Breast, unspecified",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.603,None
finn-b-KNEE_ARTHROSIS,Gonarthrosis [arthrosis of knee](FG),joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.769,None
ukb-d-ASTHMA_PNEUMONIA,Asthma-related pneumonia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.714,None
finn-b-G6_XTRAPYROTH,Other extrapyramidal and movement disorders+ in other diseases,extrapyramidal and movement disease,MONDO:0001815,http://purl.obolibrary.org/obo/MONDO_0001815,0.873,None
ukb-b-11297,Doctor diagnosed asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.604,None
ukb-b-7211,"Diagnoses - main ICD10: J33.9 Nasal polyp, unspecified",Nasal Cavity Polyp,EFO:1000391,http://www.ebi.ac.uk/efo/EFO_1000391,0.638,None
finn-b-K11_TONGUE,Diseases of tongue,tongue disorder,MONDO:0001165,http://purl.obolibrary.org/obo/MONDO_0001165,0.935,None
finn-b-AB1_SEQULAE_TUBERCU,Sequelae of tuberculosis,tuberculosis,MONDO:0018076,http://purl.obolibrary.org/obo/MONDO_0018076,0.72,None
ukb-b-4724,Operative procedures - main OPCS: U05.1 Computed tomography of head,computed tomography,EFO:0003960,http://www.ebi.ac.uk/efo/EFO_0003960,0.63,None
ukb-e-100018_AFR,Retinol,retinol measurement,EFO:0007900,http://www.ebi.ac.uk/efo/EFO_0007900,0.758,None
finn-b-Q17_OTHER_CONGEN_MALFO_FACE_NECK,Other congenital malformations of face and neck,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.722,None
ukb-b-20176,Illnesses of mother: Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.678,None
ukb-e-recode55_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-18372,Diagnoses - main ICD10: N20.0 Calculus of kidney,nephrolithiasis,EFO:0004253,http://www.ebi.ac.uk/efo/EFO_0004253,0.711,None
ukb-d-KRA_PSY_ANYMENTAL,Any mental disorder,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.994,None
ukb-a-405,Current employment status: Retired,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.733,None
finn-b-RHINITIS_VASOMOTOR,Vasomotor rhinitis (mode),vasomotor rhinitis,EFO:0007533,http://www.ebi.ac.uk/efo/EFO_0007533,0.91,None
finn-b-N14_INFCERVIX,Inflammatory disease of cervix uteri,uterine inflammatory disease,EFO:0009572,http://www.ebi.ac.uk/efo/EFO_0009572,0.784,None
ukb-e-recode47_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-12974,Operation code: bone surgery/joint surgery,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.629,None
ieu-b-4969,Melanoma skin cancer,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.875,None
ukb-e-recode4_EAS,"Estimated glomerular filtration rate, serum creatinine",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.759,None
ebi-a-GCST005413,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-ALCOPANCACU,Acohol-induced acute pancreatitis,acute pancreatitis,EFO:1000652,http://www.ebi.ac.uk/efo/EFO_1000652,0.731,None
ukb-b-13092,Headaches for 3+ months,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.737,None
ukb-e-100023_AFR,Starch,multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,MONDO:0009359,http://purl.obolibrary.org/obo/MONDO_0009359,0.662,None
finn-b-Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM,Congenital malformations and deformations of the musculoskeletal system,congenital heart defects and skeletal malformations syndrome,MONDO:0060532,http://purl.obolibrary.org/obo/MONDO_0060532,0.647,None
finn-b-I9_HEARTFAIL_EXNONE,"""Heart failure,strict"" (no controls excluded)",heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.928,None
ebi-a-GCST001475,Obesity,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.998,None
ukb-e-4537_CSA,Work/job satisfaction,job satisfaction measurement,EFO:0009723,http://www.ebi.ac.uk/efo/EFO_0009723,0.901,None
ebi-a-GCST003044,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
ukb-e-2020_CSA,"Loneliness, isolation",loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
finn-b-CD2_BENIGN_PROSTATE_EXALLC,Benign neoplasm: Prostate (all cancers excluded),benign neoplasm of prostate,MONDO:0021510,http://purl.obolibrary.org/obo/MONDO_0021510,0.891,None
finn-b-L12_FOLICULAROTH,Other follicular disorders,Follicular Cyst,EFO:1001329,http://www.ebi.ac.uk/efo/EFO_1001329,0.668,None
ukb-e-519_CSA,"Other diseases of respiratory system, not elsewhere classified",respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.954,None
ukb-e-30290_AFR,High light scatter reticulocyte percentage,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.991,None
ieu-a-1059,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
ukb-e-K63_CSA,K63 Other diseases of intestine,intestinal disease,EFO:0009431,http://www.ebi.ac.uk/efo/EFO_0009431,0.734,None
finn-b-E4_METABO,Other metabolic disorders,metabolic disease,EFO:0000589,http://www.ebi.ac.uk/efo/EFO_0000589,0.99,None
ukb-d-M13_RHEUMA,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-b-9571,Fractured bone site(s): Wrist,wrist fracture,EFO:0009515,http://www.ebi.ac.uk/efo/EFO_0009515,0.761,None
ukb-b-2317,Pace-maker,artificial cardiac pacemaker,EFO:0009719,http://www.ebi.ac.uk/efo/EFO_0009719,0.825,None
ukb-e-30090_MID,Platelet crit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.994,None
finn-b-I9_PAD,Peripheral artery disease,peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.991,None
finn-b-L12_DERM_NAS,Other and unspecified dermatitis (L12_DERM_NAS),Inflammatory abnormality of the skin,HP:0011123,http://purl.obolibrary.org/obo/HP_0011123,0.715,None
finn-b-O15_LABOUR_OTHER,"Other complications of labour and delivery, not elsewhere classified",Abnormal delivery,HP:0001787,http://purl.obolibrary.org/obo/HP_0001787,0.755,None
ukb-e-MAP_p1_EAS,"Mean arterial pressure, automated reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.718,None
ukb-b-15775,Type of cancer: ICD10: C18.7 Sigmoid colon,sigmoid neoplasm,EFO:1001181,http://www.ebi.ac.uk/efo/EFO_1001181,0.609,None
finn-b-M13_ARTHROSIS_OTH,Other arthrosis,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.99,None
finn-b-K11_SALIVARY,Diseases of salivary glands,salivary gland disease,EFO:0008581,http://www.ebi.ac.uk/efo/EFO_0008581,0.847,None
finn-b-SCND_OTH_COXARTHROSIS,Other secondary coxarthrosis,"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.828,None
finn-b-M13_DUPUTRYEN,Palmar fascial fibromatosis [Dupuytren],Palmar Fibromatosis,EFO:1000438,http://www.ebi.ac.uk/efo/EFO_1000438,0.669,None
finn-b-ST19_POISO_MEDICI,Poisoning by medicine,poisoning,EFO:0008546,http://www.ebi.ac.uk/efo/EFO_0008546,0.752,None
finn-b-E4_METABOLIA,Metabolic disorders,metabolic disease,EFO:0000589,http://www.ebi.ac.uk/efo/EFO_0000589,0.99,None
finn-b-M13_METATARSALGIA,Metatarsalgia,metatarsalgia,EFO:1001370,http://www.ebi.ac.uk/efo/EFO_1001370,0.992,None
ukb-e-4123_CSA,"Heel quantitative ultrasound index (QUI), direct entry (right)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.634,None
ukb-a-441,Fractured bone site(s): Other bones,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.802,None
ukb-e-recode32_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_DELUSIO,Persistent delusional disorders,delusional disorder,MONDO:0004359,http://purl.obolibrary.org/obo/MONDO_0004359,0.757,None
bbj-a-115,Epilepsy,epilepsy,EFO:0000474,http://www.ebi.ac.uk/efo/EFO_0000474,0.998,None
finn-b-ST19_DIFFU_BRAIN_INJURY,Diffuse brain injury,brain injury,MONDO:0043510,http://purl.obolibrary.org/obo/MONDO_0043510,0.723,None
finn-b-CHRONNAS,Chron's disease NAS,chronic disease,EFO:0009714,http://www.ebi.ac.uk/efo/EFO_0009714,0.732,None
ebi-a-GCST90016618,Schizophrenia vs ADHD (ordinary least squares (OLS)),schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.731,None
ukb-d-M13_LOWBACKPAIN,Low back pain,Low back pain,HP:0003419,http://purl.obolibrary.org/obo/HP_0003419,0.994,None
ukb-e-1249_AFR,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
ukb-b-13038,"Non-cancer illness code, self-reported: varicose veins",Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.623,None
finn-b-Q17_CONGEN_MALFO_GREAT_ARTERIES,Congenital malformations of great arteries,congenital anomaly of the great arteries,MONDO:0020292,http://purl.obolibrary.org/obo/MONDO_0020292,0.693,None
ukb-e-3063_MID,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
ukb-e-1508_p3_CSA,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
ieu-a-24,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-24007_MID,Particulate matter air pollution (pm2.5) absorbance; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.651,None
finn-b-CD2_BENIGN_LIP_EXALLC,Benign neoplasm: Lip (all cancers excluded),benign neoplasm of lip,MONDO:0021496,http://purl.obolibrary.org/obo/MONDO_0021496,0.88,None
ieu-a-984,Lung adenocarcinoma,lung adenocarcinoma,EFO:0000571,http://www.ebi.ac.uk/efo/EFO_0000571,0.989,None
ukb-b-19473,Operation code: nasal polyp surgery / nasal polypectomy,Nasal Cavity Polyp,EFO:1000391,http://www.ebi.ac.uk/efo/EFO_1000391,0.802,None
ukb-d-AB1_OTHER_BACTERIAL,Other bacterial diseases,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.92,None
finn-b-L12_RADIATIONRELATEDSKIN,Radiation-related disorders of the skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.823,None
finn-b-G6_MIGRAINE_WITH_AURA_TRIPTAN,Migraine with aura and triptan purchases,migraine with aura,MONDO:0005475,http://purl.obolibrary.org/obo/MONDO_0005475,0.69,None
finn-b-F5_INSOMNIA,Insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.984,None
finn-b-ASTHMA_PNEUMONIA_AND_SEPSIS,Asthma-related pneumonia or sepsis,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.622,None
finn-b-O15_GESTAT_OEDEM_PREINUR,Gestational [pregnancy-induced] oedema and proteinuria without hypertension,preeclampsia,EFO:0000668,http://www.ebi.ac.uk/efo/EFO_0000668,0.703,None
ebi-a-GCST009982,Trauma exposure,trauma exposure measurement,EFO:0010703,http://www.ebi.ac.uk/efo/EFO_0010703,0.91,None
finn-b-DM_BCKGRND_RETINA_NONPROLIF,Severe non-proliferative background diabetic retinopathy,proliferative diabetic retinopathy,EFO:0009322,http://www.ebi.ac.uk/efo/EFO_0009322,0.767,None
ukb-e-recode123_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-ST19_INTRACRATRAUMA,Intracranial trauma,injury,EFO:0000546,http://www.ebi.ac.uk/efo/EFO_0000546,0.67,None
ieu-a-1166,ER- Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.679,None
ukb-e-4080_EAS,"Systolic blood pressure, automated reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
ukb-e-recode242_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6149_p7_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-100510_CSA,Other non-alcoholic drinks,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.623,None
ukb-e-214_CSA,Lipoma,familial multiple lipomatosis,MONDO:0007909,http://purl.obolibrary.org/obo/MONDO_0007909,0.989,None
finn-b-K11_PULC,Peptic ulcer,Peptic ulcer,HP:0004398,http://purl.obolibrary.org/obo/HP_0004398,0.995,None
ukb-e-103170_AFR,Breaded fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.657,None
ukb-e-2443_CSA,Diabetes diagnosed by doctor,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.661,None
finn-b-J10_COPDNAS_INCLAVO,Other chronic obstructive pulmonary disease (J10_COPDNAS_INCLAVO),chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.724,None
finn-b-N14_CHRONEPHROPATH,Chronic nephritic syndrome,nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.728,None
finn-b-E4_HYPERPRO_ADVERSE,"Hyperprolactinaemia, drug-induced",hyperprolactinemia,EFO:0007319,http://www.ebi.ac.uk/efo/EFO_0007319,0.775,None
ukb-e-R06_AFR,R06 Abnormalities of breathing,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.729,None
finn-b-K11_UC_STRICT2,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.607,None
finn-b-N14_CHRONKIDNEYDIS,Chronic kidney disease,chronic kidney disease,EFO:0003884,http://www.ebi.ac.uk/efo/EFO_0003884,0.995,None
ukb-e-30100_AFR,Mean platelet (thrombocyte) volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.741,None
finn-b-PRIM_COXARTHROSIS,"Primary coxarthrosis, bilateral","osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.702,None
ukb-e-727_CSA,"Other disorders of synovium, tendon, and bursa",synovial bursa disorder,MONDO:0056802,http://purl.obolibrary.org/obo/MONDO_0056802,0.729,None
ukb-e-4803_EAS,Tinnitus,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.996,None
finn-b-CD2_BENIGN_SPINAL_CORD,Benign neoplasm: Spinal cord,benign neoplasm of spinal cord,MONDO:0021506,http://purl.obolibrary.org/obo/MONDO_0021506,0.996,None
ukb-e-N84_CSA,N84 Polyp of female genital tract,female genital tract polyp,EFO:0008622,http://www.ebi.ac.uk/efo/EFO_0008622,0.868,None
ukb-e-R00_CSA,R00 Abnormalities of heart beat,congenital heart disease,EFO:0005207,http://www.ebi.ac.uk/efo/EFO_0005207,0.768,None
finn-b-CD2_BENIGN_CONNECTIVE_SOFT_EXALLC,Other benign neoplasms of connective and other soft tissue (all cancers excluded),benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.862,None
ukb-e-30610_EAS,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
finn-b-H7_SEVVISIMPMONOC,"Severe visual impairment, monocular",Visual impairment,HP:0000505,http://purl.obolibrary.org/obo/HP_0000505,0.758,None
ukb-e-30070_MID,Red blood cell (erythrocyte) distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
ukb-d-C3_DIGESTIVE_ORGANS,Malignant neoplasm of digestive organs,digestive system cancer,MONDO:0002516,http://purl.obolibrary.org/obo/MONDO_0002516,0.78,None
finn-b-DM_NEPHROPATHY_EXMORE,Diabetic nephropathy (more controls excluded),diabetic nephropathy,EFO:0000401,http://www.ebi.ac.uk/efo/EFO_0000401,0.985,None
finn-b-CD2_BENIGN_SKIN_SCALPNECK,Benign neoplasm: Skin of scalp and neck,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.763,None
ukb-b-13346,Fractured/broken bones in last 5 years,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.641,None
ukb-b-6514,"Non-cancer illness code, self-reported: hiatus hernia",Hiatus hernia,HP:0002036,http://purl.obolibrary.org/obo/HP_0002036,0.608,None
ukb-e-6164_p2_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-d-N95,Diagnoses - main ICD10: N95 Menopausal and other perimenopausal disorders,menopausal or post-menopausal disease,EFO:0010685,http://www.ebi.ac.uk/efo/EFO_0010685,0.767,None
finn-b-CD2_BENIGN_LIPO_SKIN_LIMBS_EXALLC,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs (all cancers excluded),benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.65,None
ukb-d-N87,Diagnoses - main ICD10: N87 Dysplasia of cervix uteri,dysplasia of cervix,EFO:1000910,http://www.ebi.ac.uk/efo/EFO_1000910,0.752,None
ukb-e-recode125_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_SPINALOSTEOCHON,Spinal osteochondrosis,Scheuermann disease,MONDO:0008410,http://purl.obolibrary.org/obo/MONDO_0008410,0.99,None
ebi-a-GCST002318,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-e-20505_CSA,Recent easy annoyance or irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.604,None
ukb-e-6155_p3_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ieu-b-4962,Oral and oropharyngeal cancer,oropharynx cancer,EFO:1001931,http://www.ebi.ac.uk/efo/EFO_1001931,0.923,None
finn-b-MYELOPROF,Myeloproliferative diseases,chronic myeloproliferative disorder,EFO:0002428,http://www.ebi.ac.uk/efo/EFO_0002428,0.857,None
finn-b-SLE_OTH,Other forms of systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.894,None
finn-b-ST19_INJURY_INTRA_AB_ORGANS,Injury of intra-abdominal organs,abdominal injury,EFO:0009502,http://www.ebi.ac.uk/efo/EFO_0009502,0.767,None
finn-b-K11_PERITONITIS,Acute peritonitis,peritonitis,EFO:0008588,http://www.ebi.ac.uk/efo/EFO_0008588,0.802,None
ukb-d-K08,Diagnoses - main ICD10: K08 Other disorders of teeth and supporting structures,periodontal disorder,MONDO:0002635,http://purl.obolibrary.org/obo/MONDO_0002635,0.71,None
finn-b-M13_WEGENER,Wegener granulomatosis,Granulomatosis with Polyangiitis,EFO:0005297,http://www.ebi.ac.uk/efo/EFO_0005297,0.99,None
ukb-e-6164_p5_MID,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-recode101_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-b-4809,Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.994,None
ukb-e-20111_p3_EAS,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-24006_EAS,Particulate matter air pollution (pm2.5); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.739,None
finn-b-ST19_MALTR_SYNDR,Maltreatment syndromes,syndromic disease,MONDO:0002254,http://purl.obolibrary.org/obo/MONDO_0002254,0.687,None
ukb-b-782,Diagnoses - secondary ICD10: R13 Dysphagia,Dysphagia,HP:0002015,http://purl.obolibrary.org/obo/HP_0002015,0.604,None
finn-b-M13_SPININSTAB,Spinal instabilities,Spinal instability,HP:0005881,http://purl.obolibrary.org/obo/HP_0005881,0.86,None
ukb-e-351_AFR,Other peripheral nerve disorders,peripheral nervous system disease,EFO:0009387,http://www.ebi.ac.uk/efo/EFO_0009387,0.951,None
ukb-b-19097,Stomach/abdominal pain for 3+ months,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.652,None
ukb-d-KRA_PSY_ANXIETY,Anxiety disorders,anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.987,None
finn-b-G6_CAUDA,Cauda equina syndrome,Cauda equina syndrome,EFO:0007196,http://www.ebi.ac.uk/efo/EFO_0007196,0.965,None
ukb-e-1060_CSA,Time spent outdoors in winter,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.849,None
finn-b-M13_POLYARTERETAL,Polyarteritis nodosa and related conditions,Polyarteritis Nodosa,EFO:0009012,http://www.ebi.ac.uk/efo/EFO_0009012,0.826,None
ukb-b-11282,"Non-cancer illness code, self-reported: vaginal prolapse/uterine prolapse",uterine prolapse,EFO:1001864,http://www.ebi.ac.uk/efo/EFO_1001864,0.73,None
finn-b-M13_OLECRANONBURSITIS,Olecranon bursitis,olecranon bursitis,MONDO:0001557,http://purl.obolibrary.org/obo/MONDO_0001557,0.994,None
finn-b-E4_OBESITYNAS,"Obesity, other/unspecified",obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.998,None
ukb-e-4105_EAS,Heel bone mineral density (BMD) (left),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.82,None
ukb-e-100021_AFR,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
ukb-e-100740_AFR,Other alcohol intake,alcohol dependence,MONDO:0007079,http://purl.obolibrary.org/obo/MONDO_0007079,0.66,None
ukb-b-10591,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
finn-b-H7_OPTNERVE,Disorders of optic nerve and visual pathways,visual pathway disorder,MONDO:0001834,http://purl.obolibrary.org/obo/MONDO_0001834,0.734,None
finn-b-M13_ARTHTROSIS_COX,"Coxarthrosis,","osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.986,None
finn-b-M13_SYSTCONNECT,Systemic connective tissue disorders,connective tissue disease,EFO:1001986,http://www.ebi.ac.uk/efo/EFO_1001986,0.849,None
finn-b-H8_HL_MIX_NAS,Mixed conductive and sensorineural hearing loss,"hearing loss, mixed conductive-sensorineural",MONDO:0044001,http://purl.obolibrary.org/obo/MONDO_0044001,0.971,None
finn-b-H7_KERATITISINOTH,Keratitis and keratoconjunctivitis in other diseases classified elsewhere,keratoconjunctivitis,MONDO:0004768,http://purl.obolibrary.org/obo/MONDO_0004768,0.865,None
finn-b-K11_FIBROCHIRLIV,Fibrosis and chirrhosis of liver,Hepatic fibrosis,HP:0001395,http://purl.obolibrary.org/obo/HP_0001395,0.737,None
finn-b-DM_RET_VEIN_OCCLU,Retinal vein occlusion (central or branch),retinal vein occlusion,EFO:1001157,http://www.ebi.ac.uk/efo/EFO_1001157,0.805,None
finn-b-C3_CERVIX_UTERI,Malignant neoplasm of cervix uteri,cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.989,None
ukb-e-6142_p1_EAS,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-b-11412,Diagnoses - main ICD10: R04.0 Epistaxis,epistaxis,EFO:0003895,http://www.ebi.ac.uk/efo/EFO_0003895,0.649,None
finn-b-ULCERENTER,Ulcerative enterocolitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.827,None
ukb-e-30050_CSA,Mean corpuscular haemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.986,None
finn-b-CD2_BENIGN_SKIN_EXALLC,Other benign neoplasms of skin (all cancers excluded),benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.801,None
ukb-e-2946_AFR,Father's age,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.647,None
ukb-e-6164_p3_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-G6_TRIOTHUNS,Other and unspecified trigeminal disorders,trigeminal nerve disease,EFO:0009569,http://www.ebi.ac.uk/efo/EFO_0009569,0.811,None
ukb-d-I9_ARTOTH,Other diseases of arteries and capillaries,capillary disorder,MONDO:0001574,http://purl.obolibrary.org/obo/MONDO_0001574,0.875,None
ukb-b-10903,"Non-cancer illness code, self-reported: endometriosis",endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.614,None
ukb-e-30670_EAS,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
finn-b-I9_PVT,Portal vein thrombosis,Portal vein thrombosis,HP:0030242,http://purl.obolibrary.org/obo/HP_0030242,0.985,None
ukb-e-30080_EAS,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
finn-b-M13_SYSTSLCE,Systemic sclerosis,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.992,None
ukb-e-578_CSA,Gastrointestinal hemorrhage,Gastrointestinal hemorrhage,HP:0002239,http://purl.obolibrary.org/obo/HP_0002239,0.995,None
finn-b-F5_MOTOR,Specific developmental disorder of motor function,specific developmental disorder,MONDO:0000592,http://purl.obolibrary.org/obo/MONDO_0000592,0.811,None
finn-b-ST19_EPIDU_HAEMORRHAGE,Epidural haemorrhage,Subdural hemorrhage,HP:0100309,http://purl.obolibrary.org/obo/HP_0100309,0.697,None
ukb-b-12465,Operation code: coronary artery bypass grafts (cabg),coronary artery bypass,EFO:0003776,http://www.ebi.ac.uk/efo/EFO_0003776,0.72,None
finn-b-C3_PANCREAS_EXALLC,Malignant neoplasm of pancreas (all cancers excluded),Malignant Pancreatic Neoplasm,EFO:1000359,http://www.ebi.ac.uk/efo/EFO_1000359,0.92,None
ukb-d-I63,Diagnoses - main ICD10: I63 Cerebral infarction,cerebral infarction,MONDO:0002679,http://purl.obolibrary.org/obo/MONDO_0002679,0.701,None
ukb-b-9496,"Non-cancer illness code, self-reported: oesophagitis/barretts oesophagus",Esophagitis,HP:0100633,http://purl.obolibrary.org/obo/HP_0100633,0.706,None
ukb-e-recode137_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-423,Eye problems/disorders: Diabetes related eye disease,Abnormality of the eye,HP:0000478,http://purl.obolibrary.org/obo/HP_0000478,0.713,None
finn-b-G6_XTRAPYR,Extrapyramidal and movement disorders,extrapyramidal and movement disease,MONDO:0001815,http://purl.obolibrary.org/obo/MONDO_0001815,0.864,None
ukb-e-30740_EAS,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
ukb-e-NAP_AFR,Non-albumin protein,serum non-albumin protein measurement,EFO:0004568,http://www.ebi.ac.uk/efo/EFO_0004568,0.712,None
finn-b-ASTHMA_OBESITY,Obesity related asthma,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.671,None
ukb-a-529,Diagnoses - main ICD10: H25 Senile cataract,senile cataract,MONDO:0004847,http://purl.obolibrary.org/obo/MONDO_0004847,0.686,None
finn-b-SMOKING,Smoking,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.994,None
finn-b-R18_DISTU_SKIN_SENSA,Disturbances of skin sensation,disturbance of skin sensation,EFO:0009522,http://www.ebi.ac.uk/efo/EFO_0009522,0.943,None
finn-b-I9_PAROXTAC,Paroxysmal tachycardia,paroxysmal tachycardia,EFO:0009493,http://www.ebi.ac.uk/efo/EFO_0009493,0.994,None
finn-b-L12_NAILDIS,Nail disorders,nail disorder,MONDO:0002884,http://purl.obolibrary.org/obo/MONDO_0002884,0.911,None
ukb-d-V_MENTAL_BEHAV,Mental and behavioural disorders,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.93,None
finn-b-CD2_BENIGN_OESOPHAGUS,Benign neoplasm: Oesophagus,neoplasm of esophagus,MONDO:0021355,http://purl.obolibrary.org/obo/MONDO_0021355,0.758,None
ukb-e-24005_EAS,Particulate matter air pollution (pm10); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.729,None
ukb-a-224,Smoking status: Previous,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.677,None
ukb-a-260,Tobacco smoking: Ex-smoker,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.859,None
bbj-a-113,Endometrial cancer,endometrial cancer,MONDO:0011962,http://purl.obolibrary.org/obo/MONDO_0011962,0.99,None
finn-b-CONGEN_HEART_ARTER,Congenital malformations of heart and great arteries,congenital heart malformation,EFO:0005269,http://www.ebi.ac.uk/efo/EFO_0005269,0.793,None
bbj-a-77,Type 2 Diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ieu-a-819,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
ukb-e-250_AFR,Diabetes mellitus,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.993,None
finn-b-H7_CHOROIDRETINA,Disorders of choroid and retina,optic choroid disorder,MONDO:0001898,http://purl.obolibrary.org/obo/MONDO_0001898,0.781,None
finn-b-Q17_OTHER_CONGEN_MALFO_HEART,Other congenital malformations of heart,congenital heart malformation,EFO:0005269,http://www.ebi.ac.uk/efo/EFO_0005269,0.938,None
ukb-e-recode215_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AB1_VIRAL_NOS,"Other viral diseases, not elsewhere classified",viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.913,None
finn-b-M13_BURSITISKNEEOTH,Other bursitis of knee,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.767,None
ukb-e-670_p1_EAS,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
finn-b-COPD_OPPORTUNIST_INFECTIONS,COPD related to chronic (opportunist) infections,opportunistic infectious,MONDO:0045035,http://purl.obolibrary.org/obo/MONDO_0045035,0.66,None
finn-b-H7_CONJUVASC,Other conjunctival vascular disorders and cysts,conjunctival vascular disorder,MONDO:0001174,http://purl.obolibrary.org/obo/MONDO_0001174,0.86,None
finn-b-CD2_INSITU_SKIN_FACE,Carcinoma in situ of skin of other and unspecified parts of face,skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.788,None
finn-b-ST19_EARLY_COMPLICATIO_TRAUMA,Early complications of trauma,trauma complication,EFO:0009888,http://www.ebi.ac.uk/efo/EFO_0009888,0.802,None
ieu-a-93,Overweight,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.808,None
ukb-e-6138_p6_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-d-M13_HALLUXRIGIDUS,Hallux rigidus,Hallux rigidus,HP:0025004,http://purl.obolibrary.org/obo/HP_0025004,0.992,None
ukb-e-recode167_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6164_p4_CSA,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-30110_MID,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
finn-b-N14_RENALTUB,Renal tubulo-intestitial diseases,interstitial nephritis,MONDO:0001085,http://purl.obolibrary.org/obo/MONDO_0001085,0.698,None
finn-b-J10_ABSCLUNGPNEUMO,Abscess of lung,Lung Abscess,EFO:1001362,http://www.ebi.ac.uk/efo/EFO_1001362,0.968,None
finn-b-M13_TEMPARTERIT,Temporal arteritis,temporal arteritis,EFO:1001209,http://www.ebi.ac.uk/efo/EFO_1001209,0.994,None
finn-b-D3_ANAEMIANAS,Other and unspecified anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.827,None
ukb-b-19886,Diagnoses - secondary ICD10: K21.9 Gastro-oesophageal reflux disease without oesophagitis,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.728,None
finn-b-H8_HL_IDIOP,Sudden idiopathic hearing loss,sudden hearing loss disorder,MONDO:0020677,http://purl.obolibrary.org/obo/MONDO_0020677,0.734,None
finn-b-K11_UC_STRICT,"Ulcerative colitis (strict definition, require KELA)",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.693,None
ukb-e-recode5_AFR,"Estimated glomerular filtration rate, cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.778,None
ukb-a-533,Diagnoses - main ICD10: I21 Acute myocardial infarction,acute myocardial infarction,EFO:0008583,http://www.ebi.ac.uk/efo/EFO_0008583,0.8,None
finn-b-RX_INFERTILITY,Medical treatment for female infertility,female infertility,EFO:0008560,http://www.ebi.ac.uk/efo/EFO_0008560,0.786,None
ukb-e-52_p4_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-680_p3_CSA,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-a-475,Pain type(s) experienced in last month: Hip pain,Hip pain,HP:0030838,http://purl.obolibrary.org/obo/HP_0030838,0.617,None
finn-b-C3_PROSTATE_EXALLC,Malignant neoplasm of prostate (all cancers excluded),prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.9,None
ukb-e-recode168_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST004131,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
finn-b-D3_SPLEENDISEASE,Diseases of spleen,splenic disease,EFO:0009002,http://www.ebi.ac.uk/efo/EFO_0009002,0.975,None
ukb-d-I_INFECT_PARASIT,Certain infectious and parasitic diseases,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.956,None
ukb-e-52_p2_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ieu-a-968,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-e-K57_CSA,K57 Diverticular disease of intestine,diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.736,None
ukb-d-D23,Diagnoses - main ICD10: D23 Other benign neoplasms of skin,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.641,None
finn-b-PD_DEMENTIA_EXMORE,Dementia due to Parkinsons disease (more controls excluded),Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.691,None
ukb-d-I9_INTRACRA,Nontraumatic intracranial haemmorrhage,intracranial hemorrhage,EFO:0000551,http://www.ebi.ac.uk/efo/EFO_0000551,0.759,None
ukb-b-13247,Diagnoses - secondary ICD10: Z80.0 Family history of malignant neoplasm of digestive organs,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.637,None
ukb-e-2375_CSA,Relative age of first facial hair,age at first facial hair,EFO:0009716,http://www.ebi.ac.uk/efo/EFO_0009716,0.823,None
finn-b-L12_ERYT_INTERTRIG,Erythema intertrigo,intertrigo,MONDO:0021340,http://purl.obolibrary.org/obo/MONDO_0021340,0.991,None
finn-b-ERECTILE_DYSFUNCTION,Erectile dysfunction,erectile dysfunction,EFO:0004234,http://www.ebi.ac.uk/efo/EFO_0004234,0.987,None
ukb-e-30750_MID,Glycated haemoglobin (HbA1c),HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.632,None
ieu-a-1185,Autism Spectrum Disorder,autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.99,None
finn-b-C3_MESOTHELIOMA,Mesothelioma,mesothelioma,EFO:0000588,http://www.ebi.ac.uk/efo/EFO_0000588,0.995,None
ukb-b-7150,"Non-cancer illness code, self-reported: urinary tract infection/kidney infection",pyelonephritis,EFO:1001141,http://www.ebi.ac.uk/efo/EFO_1001141,0.694,None
ukb-e-recode260_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_DESCENDING_COLON,Benign neoplasm: Descending colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.774,None
ukb-b-7582,"Non-cancer illness code, self-reported: essential hypertension",essential hypertension,MONDO:0001134,http://purl.obolibrary.org/obo/MONDO_0001134,0.715,None
ukb-b-13535,"Non-cancer illness code, self-reported: gestational hypertension/pre-eclampsia","hypertension, pregnancy-induced",MONDO:0024664,http://purl.obolibrary.org/obo/MONDO_0024664,0.602,None
ukb-b-17788,Operation code: carpal tunnel surgery,carpal tunnel syndrome,EFO:0004143,http://www.ebi.ac.uk/efo/EFO_0004143,0.712,None
ukb-e-23102_MID,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
finn-b-CD2_BENIGN_HEMANGIOMA_EXALLC,"""Haemangioma, any site"" (all cancers excluded)",hemangioma,EFO:1000635,http://www.ebi.ac.uk/efo/EFO_1000635,0.62,None
finn-b-J10_BRONCHIOLITIS,Acute bronchiolitis,bronchitis,EFO:0009661,http://www.ebi.ac.uk/efo/EFO_0009661,0.903,None
ukb-e-5983_AFR,"ECG, heart rate",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.723,None
finn-b-CD2_BENIGN_LIVER,Benign neoplasm: Liver,benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.867,None
ukb-d-20415,Ongoing addiction to alcohol,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.762,None
finn-b-M13_BONEDISNAS,Other specified/unspecified disorders of  bone/cartilage,cartilage disease,EFO:0005802,http://www.ebi.ac.uk/efo/EFO_0005802,0.832,None
ukb-e-4105_AFR,Heel bone mineral density (BMD) (left),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.82,None
ukb-d-I9_HYPERTENSION,Hypertensive diseases,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.94,None
ukb-e-recode178_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-348,Chest pain or discomfort walking normally,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.684,None
ukb-b-9074,"Diagnoses - main ICD10: N35.9 Urethral stricture, unspecified",Urethral stricture,HP:0012227,http://purl.obolibrary.org/obo/HP_0012227,0.715,None
finn-b-I9_SAHANEUR,"Aneurysms, operations, SAH",brain aneurysm,EFO:0003870,http://www.ebi.ac.uk/efo/EFO_0003870,0.604,None
finn-b-H7_GLAUCSECTRAUMA,Glaucoma secondary to eye trauma,secondary dysgenetic glaucoma,MONDO:0020216,http://purl.obolibrary.org/obo/MONDO_0020216,0.64,None
finn-b-R18_RASH_OTHER_NONSPECIFIC_SKIN_ERUPT,Rash and other nonspecific skin eruption,exanthem,EFO:1000697,http://www.ebi.ac.uk/efo/EFO_1000697,0.662,None
ukb-b-15749,"Non-cancer illness code, self-reported: transient ischaemic attack (tia)",transient ischemic attack,EFO:0003764,http://www.ebi.ac.uk/efo/EFO_0003764,0.731,None
ukb-e-52_p5_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-a-433,Mouth/teeth dental problems: Dentures,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.619,None
finn-b-K11_PSC_COLITIS_STRICT,"Colitis, primary sclerosing, strict definition",sclerosing cholangitis,EFO:0004268,http://www.ebi.ac.uk/efo/EFO_0004268,0.758,None
finn-b-K11_UC_NOCD,"Ulcerative colitis (strict definition, all Crohn cases excluded)",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.727,None
finn-b-K11_CROWDI_TEETH,Crowding of teeth,Dental crowding,HP:0000678,http://purl.obolibrary.org/obo/HP_0000678,0.798,None
finn-b-H8_VESTIFUNCNAS,Other/unspecified disorders of vestibular function,vestibular disease,EFO:0009691,http://www.ebi.ac.uk/efo/EFO_0009691,0.775,None
finn-b-E4_CONGEIOD,Congenital iodine-deficiency syndrome/hypothyroidism,Iodine Deficiency Hypothyroidism,EFO:0008614,http://www.ebi.ac.uk/efo/EFO_0008614,0.816,None
ukb-e-574_CSA,Cholelithiasis and cholecystitis,cholelithiasis,EFO:0004799,http://www.ebi.ac.uk/efo/EFO_0004799,0.817,None
ukb-e-30850_AFR,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
finn-b-O15_PUERP_INFECT_OTHER,Other puerperal infections,Puerperal Infection,EFO:1001407,http://www.ebi.ac.uk/efo/EFO_1001407,0.992,None
ukb-e-100510_AFR,Other non-alcoholic drinks,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.623,None
ukb-b-17868,Bilateral oophorectomy (both ovaries removed),bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.716,None
ukb-e-recode284_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_CONJUNCTDEGDEPOT,conjunctival degenerations and deposits,conjunctival degeneration,MONDO:0000949,http://purl.obolibrary.org/obo/MONDO_0000949,0.82,None
ukb-b-18408,Illnesses of father: Heart disease,heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.663,None
finn-b-CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC,Primary_lymphoid and hematopoietic malignant neoplasms,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.803,None
finn-b-O15_DELIV_CAESAR,Single delivery by caesarean section,cesarean section,EFO:0009636,http://www.ebi.ac.uk/efo/EFO_0009636,0.739,None
ukb-e-6164_p5_AFR,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
finn-b-N14_PROSTAOTH,Other disorders of prostate,prostate disease,EFO:0009602,http://www.ebi.ac.uk/efo/EFO_0009602,0.885,None
ieu-a-975,Paget's disease,Paget disease,MONDO:0021165,http://purl.obolibrary.org/obo/MONDO_0021165,0.988,None
ukb-e-2345_MID,Ever had bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.637,None
ukb-e-100010_CSA,Portion size,size,EFO:0001695,http://www.ebi.ac.uk/efo/EFO_0001695,0.775,None
ukb-e-R50_CSA,R50 Fever of unknown origin,fever of unknown origin,EFO:0003952,http://www.ebi.ac.uk/efo/EFO_0003952,0.863,None
finn-b-M13_KYPHOSIS,Kyphosis,Kyphosis,HP:0002808,http://purl.obolibrary.org/obo/HP_0002808,0.997,None
finn-b-F5_SCHIZOTYP,Schizotypal disorder,schizotypal personality disorder,MONDO:0001087,http://purl.obolibrary.org/obo/MONDO_0001087,0.832,None
finn-b-CD2_BENIGN_SKIN_EYELID_EXALLC,"""Benign neoplasm: Skin of eyelid, including canthus"" (all cancers excluded)",benign tumor of palpebral epidermis,MONDO:0020173,http://purl.obolibrary.org/obo/MONDO_0020173,0.703,None
ukb-e-1010_CSA,Other tests,neuropsychological test,EFO:0003926,http://www.ebi.ac.uk/efo/EFO_0003926,0.69,None
ukb-e-K92_AFR,K92 Other diseases of digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.823,None
ukb-e-recode225_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-O15_DELIVERY,Delivery,delivery measurement,EFO:0006922,http://www.ebi.ac.uk/efo/EFO_0006922,0.771,None
finn-b-I9_NONRHEVALV_EXNONE,Non-rheumatic valve diseases (no controls excluded),rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.691,None
finn-b-T1D_WIDE2,"Type 1 diabetes, wide definition, subgroup 2",type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.655,None
finn-b-CD2_LYMPHOID_LEUKAEMIA_EXALLC,Lymphoid leukaemia (all cancers excluded),lymphoid leukemia,EFO:0004289,http://www.ebi.ac.uk/efo/EFO_0004289,0.707,None
finn-b-G6_DIABETNEUR,Diabethic neuropathy,diabetic neuropathy,EFO:1000783,http://www.ebi.ac.uk/efo/EFO_1000783,0.855,None
ukb-e-512_AFR,Other symptoms of respiratory system,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.715,None
ukb-d-K63,Diagnoses - main ICD10: K63 Other diseases of intestine,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.61,None
finn-b-C3_OESOPHAGUS,Malignant neoplasm of oesophagus,esophageal cancer,MONDO:0007576,http://purl.obolibrary.org/obo/MONDO_0007576,0.897,None
ieu-a-976,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-455_EAS,Hemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.99,None
finn-b-I9_ANGINA,Angina pectoris,angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.991,None
ukb-e-23098_MID,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
ukb-e-4570_AFR,Friendships satisfaction,friendship satisfaction measurement,EFO:0009725,http://www.ebi.ac.uk/efo/EFO_0009725,0.827,None
bbj-a-76,Colorectal Cancer,colorectal cancer,EFO:0005842,http://www.ebi.ac.uk/efo/EFO_0005842,0.993,None
ukb-e-591_CSA,Urinary tract infection,urinary tract infection,EFO:0003103,http://www.ebi.ac.uk/efo/EFO_0003103,0.993,None
finn-b-O15_EXCESS_VOMIT_PREG,Excessive vomiting in pregnancy,hyperemesis gravidarum,EFO:1000971,http://www.ebi.ac.uk/efo/EFO_1000971,0.626,None
ukb-b-6295,Diagnoses - secondary ICD10: Z03.4 Observation for suspected myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.602,None
finn-b-N14_ACUTERENFAIL,Acute renal failure,Acute kidney injury,HP:0001919,http://purl.obolibrary.org/obo/HP_0001919,0.995,None
ukb-e-recode78_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-133,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
ukb-e-1339_AFR,Non-oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.643,None
ukb-e-591_AFR,Urinary tract infection,urinary tract infection,EFO:0003103,http://www.ebi.ac.uk/efo/EFO_0003103,0.993,None
ukb-d-I9_MI_STRICT,"Myocardial infarction, strict",myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.991,None
ukb-e-recode50_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-3606_AFR,Chest pain or discomfort walking normally,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.684,None
finn-b-L12_EPIDERMALTHICKOTH,Other epidermal thickening,Epidermal thickening,HP:0011368,http://purl.obolibrary.org/obo/HP_0011368,0.987,None
ukb-e-5256_AFR,Corneal hysteresis (right),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.879,None
finn-b-CD2_BENIGN_OVARY_EXALLC,Benign neoplasm of ovary (all cancers excluded),Benign Ovarian Neoplasm,EFO:1000116,http://www.ebi.ac.uk/efo/EFO_1000116,0.9,None
ebi-a-GCST008031,End-stage renal disease,stage 5 chronic kidney disease,EFO:0009909,http://www.ebi.ac.uk/efo/EFO_0009909,0.99,None
finn-b-H7_GLAUCNAS,Other and unspecified glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.993,None
finn-b-VIRALPNEUMONAS,"Viral pneumonia (unknown virus, not influenza)",influenza,EFO:0007328,http://www.ebi.ac.uk/efo/EFO_0007328,0.636,None
ieu-a-294,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
finn-b-C_STROKE,STROKE,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.986,None
finn-b-O15_PREG_ECTOP,Ectopic pregnancy,Ectopic pregnancy,HP:0031456,http://purl.obolibrary.org/obo/HP_0031456,0.982,None
finn-b-I9_VASCINT,Vascular diseases of the intestine,vascular disease,EFO:0004264,http://www.ebi.ac.uk/efo/EFO_0004264,0.803,None
finn-b-AB1_INFECTIONS,Certain infectious and parasitic diseases,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.956,None
finn-b-L12_POLYMORPHLIGHTERUPT,Polymorphous light eruption,polymorphic light eruption,MONDO:0041182,http://purl.obolibrary.org/obo/MONDO_0041182,0.987,None
finn-b-N14_KIDUROTH,Other disorders of kidney and ureter,kidney disease,EFO:0003086,http://www.ebi.ac.uk/efo/EFO_0003086,0.859,None
finn-b-L12_ROSACEANAS,Other and unspcified rosacea,rosacea,EFO:1000760,http://www.ebi.ac.uk/efo/EFO_1000760,0.985,None
ukb-e-530_CSA,Diseases of esophagus,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.953,None
finn-b-E4_THYROIDITNAS,"Thyroiditis, unspecified",thyroiditis,MONDO:0004126,http://purl.obolibrary.org/obo/MONDO_0004126,0.995,None
finn-b-M13_SHOULDERBURSITIS,Bursitis of shoulder,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.68,None
ukb-e-4979_CSA,FI5 : family relationship calculation,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.739,None
finn-b-L12_GRANULOMATOUSSKIN,Granulomatous disorders of skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.793,None
finn-b-VD_SC,Vascular dementia (subcortical),vascular dementia,EFO:0004718,http://www.ebi.ac.uk/efo/EFO_0004718,0.759,None
finn-b-IPF,Idiopathic pulmonary fibrosis,idiopathic pulmonary fibrosis,EFO:0000768,http://www.ebi.ac.uk/efo/EFO_0000768,0.988,None
finn-b-CD2_BENIGN_LARYNX_EXALLC,Benign neoplasm: Larynx (all cancers excluded),benign laryngeal neoplasm,MONDO:0002354,http://purl.obolibrary.org/obo/MONDO_0002354,0.91,None
ukb-e-recode185_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_SMALL_INTESTINE,Benign neoplasm: Small intestine,benign neoplasm of small intestine,MONDO:0021501,http://purl.obolibrary.org/obo/MONDO_0021501,0.994,None
ukb-e-6138_p4_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ieu-a-1230,Serous ovarian cancer: low malignant potential,Borderline Ovarian Serous Tumor,EFO:1000139,http://www.ebi.ac.uk/efo/EFO_1000139,0.889,None
ukb-e-789_CSA,Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.946,None
ukb-d-O03,Diagnoses - main ICD10: O03 Spontaneous abortion,Miscarriage,HP:0005268,http://purl.obolibrary.org/obo/HP_0005268,0.7,None
finn-b-F5_CONDUCTEMO,Mixed disorders of conduct and emotions (F5_CONDUCTEMO),conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.661,None
ukb-d-M51,Diagnoses - main ICD10: M51 Other intervertebral disk disorders,lumbar disc degeneration,EFO:0004994,http://www.ebi.ac.uk/efo/EFO_0004994,0.652,None
finn-b-L12_PSORIASIS,Psoriasis,psoriasis,EFO:0000676,http://www.ebi.ac.uk/efo/EFO_0000676,0.993,None
finn-b-I9_OTHOTH_EXNONE,Other other unspecified disorders of the circulatory system (no controls excluded),cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.911,None
ukb-e-6151_p7_CSA,Fractured bone site(s),bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.786,None
finn-b-J10_RESPIRATORY,Diseases of the respiratory system,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.954,None
ukb-e-recode291_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-69,"Non-cancer illness code, self-reported: chronic sinusitis",chronic rhinosinusitis,EFO:1000024,http://www.ebi.ac.uk/efo/EFO_1000024,0.644,None
ukb-d-H7_RETINALDETACHBREAK,Retinal detachment with retinal break,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.813,None
ukb-e-I20_CSA,I20 Angina pectoris,angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.813,None
ukb-d-M13_SHOULDER,Shoulder lesions,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.708,None
finn-b-INCREASEDMUSCLETONE,Increased muscle tone,Hypertonia,HP:0001276,http://purl.obolibrary.org/obo/HP_0001276,0.989,None
finn-b-C3_BREAST_HERPLUS,"Malignant neoplasm of breast, HER-positive",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.823,None
finn-b-M13_SYNOHYPERTROPH,"Synovial hypertrophy, not elsewhere classified",synovitis,EFO:0008997,http://www.ebi.ac.uk/efo/EFO_0008997,0.988,None
finn-b-D3_AIHA_OTHER,Other autoimmune haemolytic anaemias,"Anemia, Hemolytic, Autoimmune",EFO:1001264,http://www.ebi.ac.uk/efo/EFO_1001264,0.947,None
finn-b-M13_LOWBACKPAIN,Low back pain,Low back pain,HP:0003419,http://purl.obolibrary.org/obo/HP_0003419,0.994,None
finn-b-F5_ALZHDEMENT,Dementia in Alzheimer disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.898,None
ukb-e-30620_MID,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
ieu-b-43,frontotemporal dementia (TDP subtype),frontotemporal dementia,MONDO:0017276,http://purl.obolibrary.org/obo/MONDO_0017276,0.729,None
finn-b-R18_OTHER_GENERAL_SYMPTOMS_SIGNS,Other general symptoms and signs,sign or symptom,EFO:0003765,http://www.ebi.ac.uk/efo/EFO_0003765,0.853,None
finn-b-I9_PAD_EXNONE,Peripheral artery disease (no controls excluded),peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.938,None
finn-b-ST19_INJURY_CRANIAL_NERVES,Injury of cranial nerves,nervous system injury,EFO:0009490,http://www.ebi.ac.uk/efo/EFO_0009490,0.7,None
finn-b-FG_DOAAC,"Diseases of arteries, arterioles and capillaries (FINNGEN)",capillary disorder,MONDO:0001574,http://purl.obolibrary.org/obo/MONDO_0001574,0.654,None
finn-b-H8_HL_SEN_NAS,Sensorineural hearing loss,Sensorineural hearing impairment,HP:0000407,http://purl.obolibrary.org/obo/HP_0000407,0.991,None
ukb-e-418_AFR,Nonspecific chest pain,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.623,None
ukb-d-K11_OESULC,Ulcer of oesophagus,esophageal ulcer,MONDO:0044782,http://purl.obolibrary.org/obo/MONDO_0044782,0.85,None
ukb-e-4106_EAS,"Heel bone mineral density (BMD) T-score, automated (left)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.665,None
finn-b-H7_BCKRNDRETINOPAT,Background retinopathy and retinal vascular changes,non-proliferative diabetic retinopathy,EFO:0009760,http://www.ebi.ac.uk/efo/EFO_0009760,0.739,None
ukb-a-460,Vitamin and mineral supplements: Vitamin B,vitamin B measurement,EFO:0004843,http://www.ebi.ac.uk/efo/EFO_0004843,0.685,None
finn-b-E4_SHORT,"Short stature, not elsewhere classified",Short stature,HP:0004322,http://purl.obolibrary.org/obo/HP_0004322,0.996,None
ukb-e-396_CSA,Abnormal heart sounds,abnormal chest sounds,EFO:0010670,http://www.ebi.ac.uk/efo/EFO_0010670,0.756,None
finn-b-R18_UNSPE_JAUND,Unspecified jaundice,Jaundice,HP:0000952,http://purl.obolibrary.org/obo/HP_0000952,0.985,None
ukb-e-30040_CSA,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
finn-b-F5_SLEEP_NOS,"Sleep disorders, other/unspeficied",sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.99,None
finn-b-F5_ALCOHOL,Mental and behavioural disorders due to alcohol,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.746,None
ukb-e-52_p11_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-recode435_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-593_AFR,Hematuria,Hematuria,HP:0000790,http://purl.obolibrary.org/obo/HP_0000790,0.996,None
finn-b-H8_TINNITUS,Tinnitus,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.996,None
finn-b-ASTHMA_CHILD,Childhood asthma (age<16),childhood onset asthma,MONDO:0005405,http://purl.obolibrary.org/obo/MONDO_0005405,0.869,None
finn-b-AB1_CHOLERA,Cholera,Vibrio infectious disease,EFO:1001235,http://www.ebi.ac.uk/efo/EFO_1001235,0.996,None
ukb-b-15582,Fractured bone site(s): Ankle,ankle fracture,EFO:0009615,http://www.ebi.ac.uk/efo/EFO_0009615,0.757,None
ukb-d-J32,Diagnoses - main ICD10: J32 Chronic sinusitis,chronic rhinosinusitis,EFO:1000024,http://www.ebi.ac.uk/efo/EFO_1000024,0.687,None
ukb-e-J45_AFR,J45 Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.683,None
ebi-a-GCST006644,Menstruation quality of life impact (depression),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.69,None
ukb-e-427_AFR,Cardiac dysrhythmias,cardiac arrhythmia,EFO:0004269,http://www.ebi.ac.uk/efo/EFO_0004269,0.757,None
finn-b-SPONDYLOPATHY_FG,Spondylopathies (FG),spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.666,None
ieu-a-1057,Gallbladder cancer,gallbladder cancer,MONDO:0005411,http://purl.obolibrary.org/obo/MONDO_0005411,0.996,None
finn-b-CD2_BENIGN_TONSIL_EXALLC,Benign neoplasm: Tonsil (all cancers excluded),tonsil neoplasm,MONDO:0021250,http://purl.obolibrary.org/obo/MONDO_0021250,0.753,None
finn-b-F5_PERSONALITY,Specific personality disorders,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.782,None
finn-b-R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM,Other symptoms and signs involving the urinary system,sign or symptom,EFO:0003765,http://www.ebi.ac.uk/efo/EFO_0003765,0.641,None
finn-b-DM_HYPOGLYC,Diabetic hypoglycemia,Hypoglycemia,HP:0001943,http://purl.obolibrary.org/obo/HP_0001943,0.844,None
finn-b-CD2_BENIGN_EXALLC,Benign neoplasms (all cancers excluded),benign neoplasm of rectum,MONDO:0021462,http://purl.obolibrary.org/obo/MONDO_0021462,0.769,None
ukb-e-20111_p3_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ebi-a-GCST005536,Type 1 diabetes,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
finn-b-F5_OCD,Obsessive-compulsive disorder,obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.985,None
ukb-e-AG_CSA,Albumin/Globulin ratio,albumin:globulin ratio measurement,EFO:0005128,http://www.ebi.ac.uk/efo/EFO_0005128,0.894,None
finn-b-L12_PIGPURPDERM,Pigmented purpuric dermatosis,pigmented purpuric eruption,MONDO:0008248,http://purl.obolibrary.org/obo/MONDO_0008248,0.993,None
ukb-e-1687_CSA,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
finn-b-Z21_SHOUL_REGION,Shoulder region,Hemarthrosis,EFO:1001344,http://www.ebi.ac.uk/efo/EFO_1001344,0.784,None
finn-b-ULCERILEO,Ulcerative ileocolitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.781,None
ukb-e-recode440_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-XIV_GENITOURINARY,Diseases of the genitourinary system,disease of genitourinary system,EFO:0009663,http://www.ebi.ac.uk/efo/EFO_0009663,0.961,None
ukb-a-577,Diagnoses - main ICD10: N81 Female genital prolapse,prolapse of female genital organ,MONDO:0001592,http://purl.obolibrary.org/obo/MONDO_0001592,0.636,None
ukb-e-recode48_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_DM1OPTH,Type 1 diabetes with ophthalmic complications,ophthalmic herpes zoster,EFO:0007403,http://www.ebi.ac.uk/efo/EFO_0007403,0.624,None
finn-b-N14_FEMALEGENINF,Inflammatory diseases of female pelvic organs,Pelvic Inflammatory Disease,EFO:1001388,http://www.ebi.ac.uk/efo/EFO_1001388,0.776,None
ukb-e-AG_EAS,Albumin/Globulin ratio,albumin:globulin ratio measurement,EFO:0005128,http://www.ebi.ac.uk/efo/EFO_0005128,0.894,None
ukb-e-6148_p5_CSA,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ukb-e-23100_MID,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
finn-b-SMOKING_DEPEND,Smoking dependancy,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.617,None
finn-b-FE_MODE,"Focal epilepsy, mode (most common among epilepsy diagnosis)",partial epilepsy,EFO:0004263,http://www.ebi.ac.uk/efo/EFO_0004263,0.802,None
bbj-a-114,Endometriosis,endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.992,None
ukb-e-50_CSA,Standing height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.708,None
finn-b-C3_VULVA,Malignant neoplasm of vulva,vulva cancer,MONDO:0001528,http://purl.obolibrary.org/obo/MONDO_0001528,0.998,None
finn-b-H7_CORNEALSCAR,Corneal scars and opacities,Corneal opacity,HP:0007957,http://purl.obolibrary.org/obo/HP_0007957,0.853,None
ukb-e-30280_AFR,Immature reticulocyte fraction,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.994,None
finn-b-L12_ROSACEA,Rosacea,rosacea,EFO:1000760,http://www.ebi.ac.uk/efo/EFO_1000760,0.985,None
finn-b-R18_VOICE_DISTU,Voice disturbances,Gait disturbance,HP:0001288,http://purl.obolibrary.org/obo/HP_0001288,0.647,None
ukb-e-5089_CSA,Astigmatism angle (left),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.746,None
finn-b-CD2_INSITU_BREAST_NOS,"Carcinoma in situ of breast, other/unspecified",breast carcinoma in situ,MONDO:0004658,http://purl.obolibrary.org/obo/MONDO_0004658,0.949,None
finn-b-R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE,Symptoms and signs concerning food and fluid intake,sign or symptom concerning food and fluid intake,EFO:0009825,http://www.ebi.ac.uk/efo/EFO_0009825,0.853,None
ukb-e-recode366_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-121,Treatment/medication code: simvastatin,simvastatin measurement,EFO:0801219,http://www.ebi.ac.uk/efo/EFO_0801219,0.716,None
ukb-e-30140_CSA,Neutrophill count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.886,None
finn-b-DM_AION,AION (anterior ischemic optic neuropathy),anterior ischemic optic neuropathy,EFO:1000809,http://www.ebi.ac.uk/efo/EFO_1000809,0.901,None
bbj-a-72,Rheumatoid Arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
finn-b-DRUGADVERS_CATAR,Drug-induced cataract,drug-induced lupus erythematosus,MONDO:0016474,http://purl.obolibrary.org/obo/MONDO_0016474,0.654,None
finn-b-N14_NEPHROTICSYND,Nephrotic syndrome,nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.967,None
finn-b-Z21_ANTEN_SCREE,Antenatal screening,high content screen,EFO:0007550,http://www.ebi.ac.uk/efo/EFO_0007550,0.616,None
finn-b-Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED,"Congenital malformations of the musculoskeletal system, not elsewhere classified",musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.722,None
finn-b-M13_OSTEOCHONDROPATHY,Other osteochondropathies,Osteochondroma,EFO:1000411,http://www.ebi.ac.uk/efo/EFO_1000411,0.751,None
ukb-e-23099_AFR,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
ukb-e-6148_p2_EAS,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
finn-b-N14_MALEGEN,Diseases of male genital organs,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.705,None
finn-b-K11_OTHINFLIV,Other inflammatory liver diseases,inflammatory disease,EFO:0009903,http://www.ebi.ac.uk/efo/EFO_0009903,0.861,None
finn-b-H7_STRABOTH,Other strabismus,Strabismus,HP:0000486,http://purl.obolibrary.org/obo/HP_0000486,0.99,None
finn-b-E4_GOITRENOD,Nontoxic single thyroid nodule,thyroid nodule,EFO:1001436,http://www.ebi.ac.uk/efo/EFO_1001436,0.733,None
finn-b-F5_PSYCHDEVOTH,Other and unspecified disorders of psychological development,disorder of sexual differentiation,MONDO:0002145,http://purl.obolibrary.org/obo/MONDO_0002145,0.646,None
ukb-a-450,Medication for cholesterol  blood pressure  diabetes  or take exogenous hormones: Blood pressure medication,blood pressure,EFO:0004325,http://www.ebi.ac.uk/efo/EFO_0004325,0.639,None
ukb-e-20003_p564_MID,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-K21_CSA,K21 Gastro-oesophageal reflux disease,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.859,None
ukb-e-30220_EAS,Basophill percentage,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.917,None
finn-b-G6_HCOBSTR,Obstructive hydrocephalus,obstructive hydrocephalus,MONDO:0001896,http://purl.obolibrary.org/obo/MONDO_0001896,0.99,None
ukb-e-51_CSA,Seated height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.793,None
ukb-d-M13_POLYARTHROPATHIES,#Polyarthropathies,polyarticular arthritis,MONDO:0024280,http://purl.obolibrary.org/obo/MONDO_0024280,0.626,None
finn-b-K11_OTHABDHER,Other and unspecified abdominal hernia,Hernia of the abdominal wall,HP:0004299,http://purl.obolibrary.org/obo/HP_0004299,0.792,None
ukb-d-C3_RESPIRATORY_INTRATHORACIC,Malignant neoplasm of respiratory system and intrathoracic organs,respiratory system cancer,MONDO:0000376,http://purl.obolibrary.org/obo/MONDO_0000376,0.785,None
finn-b-DM_MACULOPATHY_EXMORE,Diabetic maculopathy (more controls excluded),diabetic maculopathy,EFO:0010133,http://www.ebi.ac.uk/efo/EFO_0010133,0.988,None
ukb-d-20406,Ever addicted to alcohol,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.797,None
ukb-e-23101_CSA,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
ukb-e-745_CSA,Pain in joint,Arthralgia,HP:0002829,http://purl.obolibrary.org/obo/HP_0002829,0.994,None
ukb-a-114,Non-cancer illness code  self-reported: hypertrophic cardiomyopathy (hcm / hocm),hypertrophic cardiomyopathy,EFO:0000538,http://www.ebi.ac.uk/efo/EFO_0000538,0.771,None
finn-b-L12_PSORI_PUSTUPALM,Pustulosis palmaris et plantaris,pustulosis palmaris et plantaris,MONDO:0015597,http://purl.obolibrary.org/obo/MONDO_0015597,0.994,None
ukb-b-14436,"Diagnoses - main ICD10: L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified",skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.602,None
finn-b-J10_EXTERLUNG,Lung diseases due to external agents,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.741,None
ukb-e-30150_EAS,Eosinophill count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.895,None
ukb-e-30200_CSA,Neutrophill percentage,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.917,None
ukb-e-recode213_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_PALINDROMIC,Palindromic rheumatism,palindromic rheumatism,MONDO:0001332,http://purl.obolibrary.org/obo/MONDO_0001332,0.978,None
ukb-e-6155_p2_CSA,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-I9_HEARTFAIL,"Heart failure,strict",heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
ukb-e-21000_p12_EAS,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-M13_PYOGARTH,Pyogenic arthritis,infectious arthritis,EFO:1001351,http://www.ebi.ac.uk/efo/EFO_1001351,0.996,None
ukb-e-5156_AFR,3mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
ukb-e-208_CSA,Benign neoplasm of colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.995,None
finn-b-C3_RECTUM,Malignant neoplasm of rectum,rectum cancer,EFO:1000657,http://www.ebi.ac.uk/efo/EFO_1000657,0.992,None
ukb-b-9536,"Diagnoses - main ICD10: D25.9 Leiomyoma of uterus, unspecified",uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.657,None
finn-b-I9_ANGIO,Coronary angiopasty,percutaneous transluminal coronary angioplasty,EFO:0003951,http://www.ebi.ac.uk/efo/EFO_0003951,0.717,None
ukb-d-22601_23173422,"Job coding: registrar or senior administrator of educational establishment, bursar, registrar, university administrator",administrator,EFO:0009743,http://www.ebi.ac.uk/efo/EFO_0009743,0.613,None
ukb-e-120_p2_EAS,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-a-559,Diagnoses - main ICD10: K80 Cholelithiasis,cholelithiasis,EFO:0004799,http://www.ebi.ac.uk/efo/EFO_0004799,0.699,None
finn-b-D3_APLASTICANDOTHANAEMIA,Aplastic and other anaemias,Aplastic anemia,HP:0001915,http://purl.obolibrary.org/obo/HP_0001915,0.894,None
finn-b-FG_PULMHEART,Pulmonary heart disease,cor pulmonale,MONDO:0004596,http://purl.obolibrary.org/obo/MONDO_0004596,0.994,None
ukb-b-9668,Diagnoses - secondary ICD10: N80.0 Endometriosis of uterus,adenomyosis,MONDO:0010888,http://purl.obolibrary.org/obo/MONDO_0010888,0.672,None
finn-b-C3_ENDOCRINE_EXALLC,Malignant neoplasm of endocrine gland (all cancers excluded),malignant endocrine neoplasm,MONDO:0021069,http://purl.obolibrary.org/obo/MONDO_0021069,0.933,None
ebi-a-GCST90016601,Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.623,None
finn-b-H7_VISFIELDDEF,Visual field defects,Visual field defect,HP:0001123,http://purl.obolibrary.org/obo/HP_0001123,0.987,None
ebi-a-GCST007799,Asthma (adult onset),adult onset asthma,EFO:1002011,http://www.ebi.ac.uk/efo/EFO_1002011,0.991,None
ebi-a-GCST005838,Stroke,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.986,None
finn-b-CD2_BENIGN_LIPO_NOS_EXALLC,Benign lipomatous neoplasm of other sites/unspecified (all cancers excluded),benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.842,None
bbj-a-153,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-recode362_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CPAP,Continuous positive airway pressure,continuous positive airway pressure,EFO:0010719,http://www.ebi.ac.uk/efo/EFO_0010719,0.993,None
finn-b-I9_LYMPHOTH_EXNONE,Other noninfective disordersof lymphatic vessels and lymph nodes (no controls excluded),lymphatic system disease,EFO:0007352,http://www.ebi.ac.uk/efo/EFO_0007352,0.665,None
finn-b-J10_PLEUREFFUSION,Pleural effusion,pleural effusion,EFO:0009637,http://www.ebi.ac.uk/efo/EFO_0009637,0.987,None
ukb-e-30600_MID,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ukb-e-1249_MID,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
ukb-b-12841,Bring up phlegm/sputum/mucus on most days,"bringing up phlegm, sputum or mucus on most days, self-reported",EFO:0009824,http://www.ebi.ac.uk/efo/EFO_0009824,0.708,None
ukb-e-20003_p64_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-CD2_BENIGN_SKIN_FACE_EXALLC,Benign neoplasm: Skin of other and unspecified parts of face (all cancers excluded),benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.762,None
finn-b-J10_EMPHYSEMA,Emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.989,None
ukb-e-30500_CSA,Microalbumin in urine,urinary microalbumin measurement,EFO:0010967,http://www.ebi.ac.uk/efo/EFO_0010967,0.834,None
finn-b-I9_RHEUFEVHRT_EXNONE,Rheumatic fever with heart involvement (no controls excluded),rheumatic fever,EFO:1001160,http://www.ebi.ac.uk/efo/EFO_1001160,0.627,None
finn-b-I9_SAH_EXNONE,Subarachnoid haemmorrhage (no controls excluded),subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.877,None
ukb-b-6716,"Diagnoses - main ICD10: K29.5 Chronic gastritis, unspecified",chronic gastritis,EFO:0000337,http://www.ebi.ac.uk/efo/EFO_0000337,0.682,None
ebi-a-GCST003395,Parental extreme longevity (95 years and older),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.632,None
finn-b-CD2_BENIGN_DUODENUM,Benign neoplasm: Duodenum,duodenal benign neoplasm,EFO:1000907,http://www.ebi.ac.uk/efo/EFO_1000907,0.991,None
finn-b-R18_DIZZI_GIDDI,Dizziness and giddiness,Vertigo,HP:0002321,http://purl.obolibrary.org/obo/HP_0002321,0.781,None
ukb-b-7643,Diagnoses - secondary ICD10: Z80.3 Family history of malignant neoplasm of breast,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.702,None
ukb-e-30790_CSA,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
finn-b-AB1_HIV_NOS,Unspecified human immunodeficiency virus [HIV] disease,HIV infection,EFO:0000764,http://www.ebi.ac.uk/efo/EFO_0000764,0.912,None
ukb-e-recode238_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-20145,"Cancer code, self-reported: colon cancer/sigmoid cancer",cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.717,None
ukb-e-6138_p6_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-21001_AFR,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
ukb-d-K04,Diagnoses - main ICD10: K04 Diseases of pulp and periapical tissues,periapical tissue disease,EFO:0010688,http://www.ebi.ac.uk/efo/EFO_0010688,0.613,None
finn-b-CD2_BENIGN_BRAIN_NOS_EXALLC,"""Benign neoplasm: Brain, unspecified"" (all cancers excluded)",Benign Brain Neoplasm,EFO:1000107,http://www.ebi.ac.uk/efo/EFO_1000107,0.889,None
ukb-e-4120_CSA,Heel broadband ultrasound attenuation (right),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.883,None
finn-b-K11_ASYMMETRY_JAW,Asymmetry of jaw,hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.682,None
ieu-b-4959,Malignant non-melanoma skin cancer,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.858,None
finn-b-R18_SYNCO_COLLAP,Syncope and collapse,Syncope,HP:0001279,http://purl.obolibrary.org/obo/HP_0001279,0.685,None
ukb-a-524,Diagnoses - main ICD10: E04 Other non-toxic goitre,nontoxic goiter,MONDO:0001658,http://purl.obolibrary.org/obo/MONDO_0001658,0.621,None
finn-b-J10_INFLUENZA,All influenza,influenza,EFO:0007328,http://www.ebi.ac.uk/efo/EFO_0007328,0.998,None
finn-b-I9_HYPTENSESS_EXNONE,"""Hypertension, essential"" (no controls excluded)",essential hypertension,MONDO:0001134,http://purl.obolibrary.org/obo/MONDO_0001134,0.939,None
finn-b-Q17_CONGEN_MALFO_UTERUS_CERVIX,Congenital malformations of uterus and cervix,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.647,None
ukb-e-recode235_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AD_AM,Alzheimer<c3><95>s disease (Atypical or mixed),Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.621,None
finn-b-CD2_BENIGN_ASCENDING_COLON,Benign neoplasm: Ascending colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.801,None
ukb-b-6458,Mouth/teeth dental problems: Mouth ulcers,Oral ulcer,HP:0000155,http://purl.obolibrary.org/obo/HP_0000155,0.728,None
ukb-e-30180_MID,Lymphocyte percentage,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
finn-b-L12_LYMPHADENITIS,Acute lymphadenitis,Lymphadenitis,HP:0002840,http://purl.obolibrary.org/obo/HP_0002840,0.844,None
finn-b-Z21_OTHER_SURGI_FOLLOW__CARE,Other surgical follow-up care,follow-up,EFO:0009642,http://www.ebi.ac.uk/efo/EFO_0009642,0.698,None
ukb-e-recode292_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-970,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-e-401_CSA,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
ukb-e-136_p1_AFR,"Number of operations, self-reported","number of operations, self-reported",EFO:0009802,http://www.ebi.ac.uk/efo/EFO_0009802,0.819,None
ukb-e-102_AFR,"Pulse rate, automated reading",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
finn-b-G6_MYASTHENIA,Myasthenia gravis,Myasthenia gravis,EFO:0004991,http://www.ebi.ac.uk/efo/EFO_0004991,0.994,None
finn-b-I9_PHLETHROM_EXNONE,Phlebitis and thrombophlebitis (not including DVT) (no controls excluded),Thrombophlebitis,HP:0004418,http://purl.obolibrary.org/obo/HP_0004418,0.849,None
ukb-b-3355,"Diagnoses - main ICD10: D50.9 Iron deficiency anaemia, unspecified",Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.742,None
finn-b-CML,"Chronic myeloid leukaemia [CML], BCR/ABL-positive",chronic myelogenous leukemia,EFO:0000339,http://www.ebi.ac.uk/efo/EFO_0000339,0.627,None
finn-b-CD2_BENIGN_ENDOCRINE_OTH_EXALLC,Benign neoplasm of other and unspecified endocrine glands (all cancers excluded),benign endocrine neoplasm,MONDO:0000627,http://purl.obolibrary.org/obo/MONDO_0000627,0.873,None
ebi-a-GCST006091,Freckles,freckles,EFO:0003963,http://www.ebi.ac.uk/efo/EFO_0003963,0.985,None
ukb-e-569_AFR,Other disorders of intestine,intestinal disease,EFO:0009431,http://www.ebi.ac.uk/efo/EFO_0009431,0.922,None
ukb-e-recode25_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-21000_p12_CSA,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-CD2_BENIGN_EAR_NASAL_SINUS,"Benign neoplasm: Middle ear, nasal cavity and accessory sinuses",paranasal sinus neoplasm,EFO:0003866,http://www.ebi.ac.uk/efo/EFO_0003866,0.616,None
ukb-e-3062_EAS,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
ukb-b-11709,Diagnoses - secondary ICD10: Z85.4 Personal history of malignant neoplasm of genital organs,male reproductive organ cancer,EFO:0007355,http://www.ebi.ac.uk/efo/EFO_0007355,0.618,None
finn-b-H7_VITROPACIT,Other vitreous opacities,Vitreous floaters,HP:0100832,http://purl.obolibrary.org/obo/HP_0100832,0.988,None
ukb-e-1548_EAS,Variation in diet,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.604,None
ukb-e-E78_CSA,E78 Disorders of lipoprotein metabolism and other lipidaemias,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.664,None
ukb-d-C3_SKIN,Malignant neoplasm of skin,skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.993,None
ukb-b-11535,Mineral and other dietary supplements: Glucosamine,glucosamine measurement,EFO:0803418,http://www.ebi.ac.uk/efo/EFO_0803418,0.613,None
finn-b-H7_PARASTRANAS,Other or unspecified paralytic strabismus,paralytic strabismus,EFO:0009678,http://www.ebi.ac.uk/efo/EFO_0009678,0.991,None
finn-b-N14_GLOMERULAR,Glomerular diseases,glomerular disease,EFO:1002049,http://www.ebi.ac.uk/efo/EFO_1002049,0.945,None
ukb-e-K29_CSA,K29 Gastritis and duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.714,None
ukb-e-100580_AFR,Alcohol consumed,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.769,None
ukb-e-366_EAS,Cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.989,None
ukb-e-680_p3_EAS,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-e-532_CSA,Dysphagia,Dysphagia,HP:0002015,http://purl.obolibrary.org/obo/HP_0002015,0.977,None
ukb-e-30190_EAS,Monocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.994,None
finn-b-I9_HYPTENSPUL,"Hypertension, Pulmonary Arterial",pulmonary arterial hypertension,EFO:0001361,http://www.ebi.ac.uk/efo/EFO_0001361,0.991,None
ukb-e-recode50_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-626_AFR,Disorders of menstruation and other abnormal bleeding from female genital tract,female reproductive system disease,EFO:0009549,http://www.ebi.ac.uk/efo/EFO_0009549,0.649,None
finn-b-ST19_INJURI_NECK,Injuries to the neck,neck injury,EFO:0009476,http://www.ebi.ac.uk/efo/EFO_0009476,0.728,None
ukb-a-67,Non-cancer illness code  self-reported: chronic obstructive airways disease/copd,chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.75,None
finn-b-H7_RETINOCHISISCYST,Retinoschisis and retinal cysts,retinoschisis,MONDO:0004579,http://purl.obolibrary.org/obo/MONDO_0004579,0.799,None
finn-b-O15_COMPLIC_LAB_DELIV,Complications of labour and delivery,Abnormal delivery,HP:0001787,http://purl.obolibrary.org/obo/HP_0001787,0.755,None
finn-b-M13_PANNICULITISNAS,"Panniculitis, unspecified",panniculitis,EFO:1000746,http://www.ebi.ac.uk/efo/EFO_1000746,0.998,None
ukb-d-5674,Severity of manic/irritable episodes,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.607,None
finn-b-H7_ALLERGICCONJUNCTIVITIS,Allergic conjunctivitis,allergic conjunctivitis,EFO:0007141,http://www.ebi.ac.uk/efo/EFO_0007141,0.995,None
finn-b-L12_LICHENPLANUS,Lichen planus,lichen planus,EFO:1000726,http://www.ebi.ac.uk/efo/EFO_1000726,0.996,None
ukb-b-5954,Part of a multiple birth,multiple births measurement,EFO:0009439,http://www.ebi.ac.uk/efo/EFO_0009439,0.652,None
bbj-a-148,Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.994,None
bbj-a-103,Chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.995,None
bbj-a-94,Cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.989,None
bbj-a-99,Chronic hepatitis B,chronic hepatitis B virus infection,EFO:0004239,http://www.ebi.ac.uk/efo/EFO_0004239,0.992,None
ukb-a-89,Non-cancer illness code  self-reported: iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.714,None
finn-b-F5_DEPPER,Dependent personality disorder,dependent personality disorder,MONDO:0001157,http://purl.obolibrary.org/obo/MONDO_0001157,0.992,None
finn-b-C3_LYMPHNODES_SECONDARY_NAS_EXALLC,Secondary and unspecified malignant neoplasm of lymph nodes (all cancers excluded),lymph node cancer,MONDO:0001082,http://purl.obolibrary.org/obo/MONDO_0001082,0.789,None
ukb-e-3773_AFR,Knee pain for 3+ months,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.712,None
ukb-e-100024_CSA,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
ukb-e-recode403_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST005540,Sarcoidosis (Lofgren's syndrome),sarcoidosis,MONDO:0019338,http://purl.obolibrary.org/obo/MONDO_0019338,0.626,None
finn-b-ULCEROTH,Other ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ieu-b-87,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
finn-b-C3_SMALL_INTESTINE,Malignant neoplasm of small intestine,small intestine cancer,MONDO:0000956,http://purl.obolibrary.org/obo/MONDO_0000956,0.991,None
ukb-d-H7_EYELIDNAS,Other specified and unspecified  disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.935,None
finn-b-F5_ANXPER,Anxious personality disorder,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.763,None
ukb-e-1210_MID,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-1508_p3_AFR,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-CD2_INSITU_SKIN,Carcinoma in situ of skin,skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.943,None
ukb-b-7844,"Diagnoses - secondary ICD10: D50.9 Iron deficiency anaemia, unspecified",Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.693,None
finn-b-ST19_INJURY_EYE_ORBIT,Injury of eye and orbit,eye injury,EFO:0009485,http://www.ebi.ac.uk/efo/EFO_0009485,0.766,None
finn-b-I9_HYPOTE_EXNONE,Hypotension (no controls excluded),hypotension,EFO:0005251,http://www.ebi.ac.uk/efo/EFO_0005251,0.898,None
ieu-b-4967,Appendicitis,appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.991,None
ukb-e-recode268_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-10753,Diabetes diagnosed by doctor,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.661,None
finn-b-L12_STRIAEATROPHICAE,Striae atrophicae,Striae distensae,HP:0001065,http://purl.obolibrary.org/obo/HP_0001065,0.993,None
ukb-e-recode105_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-12036,Operative procedures - main OPCS: A61.1 Excision of lesion of peripheral nerve,peripheral nerve lesion,MONDO:0024334,http://purl.obolibrary.org/obo/MONDO_0024334,0.633,None
finn-b-I9_VASCDEM,Vascular dementia (I9_VASCDEM),vascular dementia,EFO:0004718,http://www.ebi.ac.uk/efo/EFO_0004718,0.801,None
ukb-e-30130_CSA,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
finn-b-H7_MACULADEGEN,Degeneration of macula and posterior pole,degeneration of macula and posterior pole,MONDO:0002175,http://purl.obolibrary.org/obo/MONDO_0002175,0.973,None
ukb-e-20003_p33_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-H7_SCLERACORNEA,"Disorders of sclera, cornea, iris and ciliary body",ciliary body disorder,MONDO:0002970,http://purl.obolibrary.org/obo/MONDO_0002970,0.681,None
finn-b-L12_LICHENSIMPLEX,Lichen simplex chronicus,neurodermatitis,EFO:1000740,http://www.ebi.ac.uk/efo/EFO_1000740,0.996,None
ukb-e-20116_p2_MID,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
finn-b-O15_ABORT_OTHER,Other abortion,abortion,EFO:1001491,http://www.ebi.ac.uk/efo/EFO_1001491,0.993,None
finn-b-E4_ENDOMETPOSTOP,"Postprocedural endocrine and metabolic disorders, not elsewhere classified",endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.619,None
ukb-e-365_AFR,Glaucoma,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.993,None
ukb-e-120_p1_MID,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-e-680_p3_AFR,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-e-738_p1_MID,Average total household income before tax,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.635,None
ukb-b-13952,Illnesses of siblings: Chronic bronchitis/emphysema,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.628,None
ukb-e-recode391_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-19852,Current employment status: Retired,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.733,None
ukb-b-4963,"Diagnoses - secondary ICD10: N17.9 Acute renal failure, unspecified",Acute kidney injury,HP:0001919,http://purl.obolibrary.org/obo/HP_0001919,0.656,None
finn-b-ST19_HYPOTHERMIA,Hypothermia,Hypothermia,HP:0002045,http://purl.obolibrary.org/obo/HP_0002045,0.989,None
ukb-e-30610_MID,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
finn-b-NAFLD,Nonalcoholic fatty liver disease,non-alcoholic fatty liver disease,EFO:0003095,http://www.ebi.ac.uk/efo/EFO_0003095,0.991,None
finn-b-G6_SLEEPAPNO,Sleep apnoea,Apnea,HP:0002104,http://purl.obolibrary.org/obo/HP_0002104,0.77,None
finn-b-ACUTE_DRUGADVERS_INTERSTITIAL_LUNG_DISORD,Acute drug-induced interstitial lung disorder,Abnormal pulmonary interstitial morphology,HP:0006530,http://purl.obolibrary.org/obo/HP_0006530,0.608,None
finn-b-I9_HYPTENS_EXNONE,Hypertension (no controls excluded),hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.902,None
finn-b-O15_HYPTENSPREG,Pregnancy hypertension,preeclampsia,EFO:0000668,http://www.ebi.ac.uk/efo/EFO_0000668,0.893,None
ukb-e-4559_AFR,Family relationship satisfaction,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.785,None
finn-b-ST19_CRUSHI_INJURY_WRIST_HAND,Crushing injury of wrist and hand,crush injury,EFO:0009504,http://www.ebi.ac.uk/efo/EFO_0009504,0.636,None
finn-b-E4_OBESITY_HYPER,Obesity and other hyperalimentation,total parenteral nutrition,EFO:0010694,http://www.ebi.ac.uk/efo/EFO_0010694,0.744,None
ukb-b-9856,"Non-cancer illness code, self-reported: trapped nerve/compressed nerve",nerve compression syndrome,EFO:0009487,http://www.ebi.ac.uk/efo/EFO_0009487,0.685,None
ukb-e-4194_AFR,Pulse rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.996,None
ukb-e-F17_AFR,F17 Mental and behavioural disorders due to use of tobacco,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.642,None
ukb-e-137_MID,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
finn-b-H7_EYELIDINOTH,Disorders of eyelid in diseases classified elsewhere,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.879,None
finn-b-KRA_PSY_CODUCTEMOT_EXMORE,Mixed disorders of conduct and emotions (more controls excluded),conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.62,None
finn-b-ILD_SYST_AUTO,ILD related to systemic autoimmune disease,type II hypersensitivity reaction disease,EFO:0005809,http://www.ebi.ac.uk/efo/EFO_0005809,0.725,None
ebi-a-GCST006653,Vaginal discharge (itching),abnormal vaginal discharge itching,EFO:0009409,http://www.ebi.ac.uk/efo/EFO_0009409,0.903,None
finn-b-DRUGADVERS_NEUTROPENIA,Drug-induced neutropenia,neutropenia,MONDO:0001475,http://purl.obolibrary.org/obo/MONDO_0001475,0.693,None
finn-b-R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM,Symptoms and signs involving the urinary system,sign or symptom,EFO:0003765,http://www.ebi.ac.uk/efo/EFO_0003765,0.641,None
finn-b-H8_EXT_CELLUL,Cellulitis of external ear,cellulitis,EFO:0003035,http://www.ebi.ac.uk/efo/EFO_0003035,0.67,None
finn-b-CD2_BENIGN_BRAIN_SUPRATENT_EXALLC,"""Benign neoplasm: Brain, supratentorial"" (all cancers excluded)",supratentorial cancer,MONDO:0002071,http://purl.obolibrary.org/obo/MONDO_0002071,0.772,None
finn-b-CD2_BENIGN_CONNSOFT_TRUNK,"Benign neoplasm: Connective and other soft tissue of trunk, unspecified",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.879,None
ukb-e-1807_CSA,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
ukb-e-20002_p180_MID,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-20003_p34_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-H7_RETINALDETACH,Retinal detachments and breaks,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.768,None
finn-b-I9_STENOSIS,"Occlusion and stenosis of arteries, not leading to stroke",occlusion precerebral artery,EFO:0009677,http://www.ebi.ac.uk/efo/EFO_0009677,0.605,None
finn-b-AB1_DERMATOPHYTOSIS,Dermatophytosis,dermatophytosis,MONDO:0004678,http://purl.obolibrary.org/obo/MONDO_0004678,0.995,None
finn-b-I9_VARICVESOTH_EXNONE,Varicose veins of other sites (no controls excluded),Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.81,None
ukb-b-501,Diagnoses - main ICD10: L82 Seborrhoeic keratosis,seborrheic keratosis,EFO:0005584,http://www.ebi.ac.uk/efo/EFO_0005584,0.628,None
finn-b-K11_FUNCDYSP,Functional dyspepsia,dyspepsia,EFO:0008533,http://www.ebi.ac.uk/efo/EFO_0008533,0.744,None
finn-b-CD2_BENIGN_CORPUS_UTERI_EXALLC,Other benign neoplasm of uterus: Corpus uteri (all cancers excluded),benign neoplasm of corpus uteri,MONDO:0021525,http://purl.obolibrary.org/obo/MONDO_0021525,0.863,None
ukb-e-278_CSA,"Overweight, obesity and other hyperalimentation",obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.793,None
ukb-b-12801,Operation code: ectopic pregnancy surgery,Ectopic pregnancy,HP:0031456,http://purl.obolibrary.org/obo/HP_0031456,0.734,None
finn-b-Q17_CLEFT_AND_CARIES,Clefts and caries,dental caries,EFO:0003819,http://www.ebi.ac.uk/efo/EFO_0003819,0.631,None
finn-b-H7_CONJUNCTIVITISACUNONATOPIC,"Conjunctivitis (acute, non atopic)",allergic conjunctivitis,EFO:0007141,http://www.ebi.ac.uk/efo/EFO_0007141,0.863,None
finn-b-J10_PERITONSABSC,Peritonsillar abscess,peritonsillar abscess,EFO:0007429,http://www.ebi.ac.uk/efo/EFO_0007429,0.991,None
finn-b-I9_HYPTENSHD,Hypertensive Heart Disease,hypertensive heart disease,MONDO:0001302,http://purl.obolibrary.org/obo/MONDO_0001302,0.987,None
ukb-e-recode264_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-DBP_p2_CSA,"Diastolic blood pressure, combined automated + manual reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.698,None
ukb-a-97,Non-cancer illness code  self-reported: nasal polyps,Nasal polyposis,HP:0100582,http://purl.obolibrary.org/obo/HP_0100582,0.632,None
ukb-e-recode447_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-D3_ACQHAEMOLYTICANAEMIA,Acquired haemolytic anaemia,Congenital hemolytic anemia,HP:0004804,http://purl.obolibrary.org/obo/HP_0004804,0.884,None
ukb-e-20002_p1_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-21000_p9_CSA,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-F5_ANAPER,Anankastic personality disorder,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.691,None
finn-b-N14_GENITOUROTH,Other disorders of the genitourinary system,disease of genitourinary system,EFO:0009663,http://www.ebi.ac.uk/efo/EFO_0009663,0.842,None
finn-b-DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT,Drug-induced systemic lupus erythematosus,drug-induced lupus erythematosus,MONDO:0016474,http://purl.obolibrary.org/obo/MONDO_0016474,0.906,None
finn-b-CD2_BENIGN_VULVA_EXALLC,Benign neoplasm: Vagina (all cancers excluded),benign vaginal neoplasm,MONDO:0000647,http://purl.obolibrary.org/obo/MONDO_0000647,0.905,None
ukb-e-785_EAS,Abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.989,None
finn-b-C3_SCLC_EXALLC,Small cell lung cancer (all cancers excluded),small cell lung carcinoma,EFO:0000702,http://www.ebi.ac.uk/efo/EFO_0000702,0.939,None
finn-b-DM_PERIPH_ANGIOPATHY,Peripheral angiopathy,peripheral vascular disease,EFO:0003875,http://www.ebi.ac.uk/efo/EFO_0003875,0.992,None
finn-b-K11_ILEUS,Paralytic ileus and intestinal obstruction,intestinal obstruction,MONDO:0004565,http://purl.obolibrary.org/obo/MONDO_0004565,0.725,None
finn-b-C3_LARYNX,Malignant neoplasm of larynx,Malignant Laryngeal Neoplasm,EFO:1000354,http://www.ebi.ac.uk/efo/EFO_1000354,0.996,None
ukb-e-recode94_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-PP_p1_MID,"Pulse pressure, automated reading",pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.626,None
finn-b-J10_COPDNAS,Other chronic obstructive pulmonary disease (J10_COPDNAS),chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.81,None
finn-b-VWXY20_BLOOD_ALCOHOL_ALCOHOL_INTOX_LEVEL,Blood alcohol or alcohol intoxication level,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.703,None
finn-b-I9_CEREBDOTH,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.93,None
finn-b-M13_MUSCLESTRAIN,Muscle strain,muscle strain,EFO:0010686,http://www.ebi.ac.uk/efo/EFO_0010686,0.987,None
finn-b-M13_PREPATELLARBURSITIS,Prepatellar bursitis,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.71,None
finn-b-H7_RETINALDETACHOTH,"Other, unspecified and serous retinal detachments",retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.825,None
ukb-e-recode11_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-536,Diagnoses - main ICD10: I48 Atrial fibrillation and flutter,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.635,None
ieu-a-11,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
finn-b-G6_CERCYST,Cerebral cysts,Cerebellar cyst,HP:0002350,http://purl.obolibrary.org/obo/HP_0002350,0.685,None
finn-b-L12_ERYTHEMAMULTIF,Erythema multiforme,erythema multiforme,EFO:1000694,http://www.ebi.ac.uk/efo/EFO_1000694,0.992,None
finn-b-M13_SOFTTISSUEOTH,"Other soft tissue disorders, not elsewhere classified",soft tissue disease,EFO:0009470,http://www.ebi.ac.uk/efo/EFO_0009470,0.792,None
ukb-b-19456,Illnesses of father: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.762,None
ukb-e-20111_p8_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-30030_MID,Haematocrit percentage,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.61,None
ukb-e-100014_CSA,Folate,red blood cell folate measurement,EFO:0009703,http://www.ebi.ac.uk/efo/EFO_0009703,0.75,None
finn-b-G6_CNSABSC,Intracranial and intraspinal abscess and granuloma,epidural abscess,EFO:0007260,http://www.ebi.ac.uk/efo/EFO_0007260,0.603,None
ukb-e-4559_CSA,Family relationship satisfaction,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.785,None
finn-b-C3_ENDOCRINE,Malignant neoplasm of endocrine gland,malignant endocrine neoplasm,MONDO:0021069,http://purl.obolibrary.org/obo/MONDO_0021069,0.995,None
ukb-d-C3_PRIMARY_LYMPHOID_HEMATOPOIETIC,Primary_lymphoid and hematopoietic malignant neoplasms,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.803,None
finn-b-Z21_TOBAC_USE,Tobacco use,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.963,None
ukb-e-recode137_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_KELARET,Kela-code for behavioural disturbances in mental retardation,Atypical behavior,HP:0000708,http://purl.obolibrary.org/obo/HP_0000708,0.753,None
ukb-e-recode169_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1200_AFR,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
finn-b-L12_URTICA_DERTMATOG,Dermatographic urticaria,dermatographia,EFO:1000685,http://www.ebi.ac.uk/efo/EFO_1000685,0.993,None
ukb-e-30180_CSA,Lymphocyte percentage,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
finn-b-I9_CERATHER,Cerebral atherosclerosis (I9_CERATHER),cerebral atherosclerosis,EFO:1000860,http://www.ebi.ac.uk/efo/EFO_1000860,0.867,None
ukb-d-20431,Ever addicted to a behaviour or miscellanous,addictive behaviour,EFO:0004347,http://www.ebi.ac.uk/efo/EFO_0004347,0.667,None
ukb-e-789_AFR,Nausea and vomiting,Nausea and vomiting,HP:0002017,http://purl.obolibrary.org/obo/HP_0002017,0.946,None
finn-b-I9_PERIPH,Peripheral artery operations in Hilmo,peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.665,None
finn-b-L12_PYODERMA,Pyoderma,Pyoderma,HP:0000999,http://purl.obolibrary.org/obo/HP_0000999,0.993,None
finn-b-CD2_BENIGN_PHARYNX_NOS_EXALLC,"""Benign neoplasm: Pharynx, unspecified"" (all cancers excluded)",benign laryngeal neoplasm,MONDO:0002354,http://purl.obolibrary.org/obo/MONDO_0002354,0.811,None
finn-b-K11_IMPACT,Impaction of intestines,intestinal impaction,MONDO:0004571,http://purl.obolibrary.org/obo/MONDO_0004571,0.872,None
finn-b-F5_EATING,Eating disorders,eating disorder,EFO:0005203,http://www.ebi.ac.uk/efo/EFO_0005203,0.899,None
ukb-e-760_AFR,Back pain,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.993,None
finn-b-N14_CYSTITIS,Cystitis,cystitis,EFO:1000025,http://www.ebi.ac.uk/efo/EFO_1000025,0.996,None
ukb-e-100160_CSA,Low calorie drink intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.6,None
finn-b-L12_SKIN,Diseases of the skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.929,None
ukb-d-I9_CHD,Major coronary heart disease event,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.77,None
finn-b-M13_ACHILLESTEND,Achilles tendinitis,tendinitis,MONDO:0004857,http://purl.obolibrary.org/obo/MONDO_0004857,0.717,None
finn-b-I9_OTHILLHEART,Other or ill-defined heart diseases,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.74,None
finn-b-F5_TIC,Tic disorders (F5_TIC),Tics,HP:0100033,http://purl.obolibrary.org/obo/HP_0100033,0.747,None
ukb-e-30720_EAS,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
ukb-e-785_CSA,Abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.989,None
ukb-e-recode339_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-9838,Pain type(s) experienced in last month: Back pain,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.616,None
finn-b-CD2_MYELOID_LEUKAEMIA_EXALLC,Myeloid leukaemia (all cancers excluded),myeloid leukemia,MONDO:0004643,http://purl.obolibrary.org/obo/MONDO_0004643,0.697,None
ukb-b-12339,"Cancer code, self-reported: skin cancer",skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.727,None
ukb-e-recode153_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-455_AFR,Hemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.99,None
ukb-e-100024_AFR,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
bbj-a-86,Arrhythmia,cardiac rhythm disease,MONDO:0007263,http://purl.obolibrary.org/obo/MONDO_0007263,0.993,None
finn-b-H7_SCLERITISEPISCLERITIS,Scleritis and episcleritis,Episcleritis,HP:0100534,http://purl.obolibrary.org/obo/HP_0100534,0.929,None
ukb-b-373,Diagnoses - main ICD10: N32.8 Other specified disorders of bladder,bladder disease,EFO:1000018,http://www.ebi.ac.uk/efo/EFO_1000018,0.649,None
finn-b-M13_HYPERANG,Hypersensitivity angiitis,microscopic polyangiitis,EFO:1000784,http://www.ebi.ac.uk/efo/EFO_1000784,0.992,None
finn-b-CD2_BENIGN_RECTUM_ANAL,"Benign neoplasm: Rectum, anus and anal canal",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.799,None
finn-b-GOUT_NOS,"Gout, unspecified",gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.998,None
ukb-e-4548_CSA,Health satisfaction,health satisfaction measurement,EFO:0009724,http://www.ebi.ac.uk/efo/EFO_0009724,0.907,None
ukb-e-recode227_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST004695,Insomnia complaints,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.728,None
finn-b-C3_PROSTATE,Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.992,None
ukb-b-4561,"Non-cancer illness code, self-reported: stomach disorder",stomach disease,EFO:0009608,http://www.ebi.ac.uk/efo/EFO_0009608,0.619,None
ieu-b-4877,smoking initiation,smoking initiation,EFO:0005670,http://www.ebi.ac.uk/efo/EFO_0005670,0.988,None
ukb-e-680_p4_EAS,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-H8_PERFORATION,Perforation of tympanic membrane,tympanic membrane perforation,EFO:0009472,http://www.ebi.ac.uk/efo/EFO_0009472,0.983,None
ukb-e-recode266_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-189_p1_EAS,Townsend deprivation index at recruitment,Townsend deprivation index,EFO:0009711,http://www.ebi.ac.uk/efo/EFO_0009711,0.806,None
ukb-e-recode312_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20004_p66_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-F5_HISPER,Histrionic personality disorder,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.777,None
finn-b-CD2_BENIGN_BONE_CARTILAGE,Benign neoplasm of bone and articular cartilage,benign chondrogenic neoplasm,MONDO:0024470,http://purl.obolibrary.org/obo/MONDO_0024470,0.837,None
finn-b-DM_KETOACIDOSIS,Diabetic ketoacidosis,diabetic ketoacidosis,EFO:1000897,http://www.ebi.ac.uk/efo/EFO_1000897,0.993,None
ukb-e-20016_AFR,Fluid intelligence score,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.634,None
finn-b-AB1_SCARLET_FEVER,Scarlet fever,scarlet fever,EFO:0007477,http://www.ebi.ac.uk/efo/EFO_0007477,0.994,None
ieu-b-4956,Lymphoid leukaemia,lymphoid leukemia,EFO:0004289,http://www.ebi.ac.uk/efo/EFO_0004289,0.77,None
ukb-b-12938,Illnesses of siblings: Bowel cancer,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.621,None
finn-b-L12_PARAPSORI,Parapsoriasis,parapsoriasis,EFO:1000747,http://www.ebi.ac.uk/efo/EFO_1000747,0.989,None
finn-b-I9_PERICARD_EXNONE,Pericarditis (no controls excluded),pericarditis,EFO:0007427,http://www.ebi.ac.uk/efo/EFO_0007427,0.909,None
finn-b-K11_OTHFUNC,Other functional intestinal disroders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.669,None
ukb-a-246,Seen doctor (GP) for nerves  anxiety  tension or depression,mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
ukb-e-recode4_CSA,"Estimated glomerular filtration rate, serum creatinine",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.759,None
finn-b-L12_ERYTHEMATOUSOTH,Other erythematous conditions,Erythema,HP:0010783,http://purl.obolibrary.org/obo/HP_0010783,0.647,None
finn-b-M13_FIBROBLASTIC,Fibroblastic disorders,fibroblastic disorder,EFO:0009432,http://www.ebi.ac.uk/efo/EFO_0009432,0.94,None
finn-b-F5_PSYCHDEV,Disorders of psychological developtment,psychological measurement,EFO:0009095,http://www.ebi.ac.uk/efo/EFO_0009095,0.624,None
finn-b-KRA_PSY_MOTOR,Motor disorders,motor neuron disease,EFO:0003782,http://www.ebi.ac.uk/efo/EFO_0003782,0.747,None
finn-b-K11_APPENDIX,Diseases of appendix,disorder of appendix,EFO:0009542,http://www.ebi.ac.uk/efo/EFO_0009542,0.953,None
finn-b-G6_POSTOPNEURO,Postprocedural disorders of nervous system,nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.717,None
ukb-e-23101_AFR,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
ukb-b-16662,Diagnoses - secondary ICD10: I25.2 Old myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.686,None
ukb-e-21021_AFR,Pulse wave Arterial Stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.706,None
ukb-e-3147_AFR,"Heel quantitative ultrasound index (QUI), direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.661,None
ukb-e-1200_EAS,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
ukb-e-23105_EAS,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
finn-b-CD2_BENIGN_TONGUE,Benign neoplasm: Tongue,benign neoplasm of tongue,MONDO:0021476,http://purl.obolibrary.org/obo/MONDO_0021476,0.994,None
ukb-b-10188,Vitamin and mineral supplements: Vitamin B,vitamin B measurement,EFO:0004843,http://www.ebi.ac.uk/efo/EFO_0004843,0.685,None
finn-b-K11_ALCOLIV,Alcoholic liver disease (K11_ALCOLIV),alcoholic liver disease,EFO:0008573,http://www.ebi.ac.uk/efo/EFO_0008573,0.823,None
finn-b-CD2_INSITU_BREAST,Carcinoma in situ of breast,breast carcinoma in situ,MONDO:0004658,http://purl.obolibrary.org/obo/MONDO_0004658,0.949,None
ukb-d-M13_SPONDYLOPATHY,#Spondylopathies,spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.747,None
finn-b-CD2_MULTIPLE_MYELOMA_PLASMA_CELL,Multiple myeloma and malignant plasma cell neoplasms,multiple myeloma,EFO:0001378,http://www.ebi.ac.uk/efo/EFO_0001378,0.685,None
finn-b-COX_ARTHROSIS,Coxarthrosis [arthrosis of hip](FG),"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.804,None
finn-b-CD2_INSITU_MELANOMA_TRUNK,Melanoma in situ of trunk,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.705,None
finn-b-KRA_PSY_DEVWIDE,Wide developmental disorders,developmental disorder of mental health,EFO:0005548,http://www.ebi.ac.uk/efo/EFO_0005548,0.886,None
finn-b-I9_PROGVASC,Progressive vascular leukoencephalopathy,progressive cavitating leukoencephalopathy,MONDO:0015349,http://purl.obolibrary.org/obo/MONDO_0015349,0.771,None
ukb-e-20002_p180_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-N39_CSA,N39 Other disorders of urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.813,None
ukb-b-2953,Operation code: radical prostatectomy,radical prostatectomy,EFO:0020684,http://www.ebi.ac.uk/efo/EFO_0020684,0.845,None
finn-b-G6_ENCEPATH,Encephalopathy,Encephalopathy,HP:0001298,http://purl.obolibrary.org/obo/HP_0001298,0.989,None
ukb-e-5109_CSA,6mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
finn-b-H7_RETINANAS,Other specified and unspecified retinal disorders,retinopathy,EFO:0003839,http://www.ebi.ac.uk/efo/EFO_0003839,0.91,None
ukb-b-4280,Diagnoses - main ICD10: M20.2 Hallux rigidus,Hallux rigidus,HP:0025004,http://purl.obolibrary.org/obo/HP_0025004,0.74,None
ukb-e-30190_MID,Monocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.994,None
finn-b-I9_AORTANEUR_EXNONE,Aortic aneurysm (no controls excluded),aortic aneurysm,EFO:0001666,http://www.ebi.ac.uk/efo/EFO_0001666,0.946,None
ieu-a-1167,ER+ Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.679,None
ukb-e-1508_p2_AFR,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-CD2_BENIGN_SMALL_INTESTINE_EXALLC,Benign neoplasm: Small intestine (all cancers excluded),benign neoplasm of small intestine,MONDO:0021501,http://purl.obolibrary.org/obo/MONDO_0021501,0.913,None
finn-b-RESP_ILL_DIS_CLASS_ELSEWHERE,Respiratory disorders in diseases classified elsewhere,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.827,None
finn-b-RX_GLUCOSAMINE,Glucosamine medication,glucosamine measurement,EFO:0803418,http://www.ebi.ac.uk/efo/EFO_0803418,0.726,None
finn-b-H7_EYE,Diseases of the eye and adnexa,eye adnexa disease,EFO:0009546,http://www.ebi.ac.uk/efo/EFO_0009546,0.944,None
ukb-e-23105_MID,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
ieu-b-4978,Pneumonia (critical care),pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.735,None
finn-b-G6_MS,MS-disease / Multiple Sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.827,None
finn-b-CMV_NOS,Other/unspecified cytomegaloviral diseases,cytomegalovirus infection,EFO:0001062,http://www.ebi.ac.uk/efo/EFO_0001062,0.964,None
ukb-a-548,Diagnoses - main ICD10: K35 Acute appendicitis,appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.717,None
finn-b-L12_EXFOLIATIVE,Exfoliative dermatitis,exfoliative dermatitis,EFO:0009456,http://www.ebi.ac.uk/efo/EFO_0009456,0.992,None
finn-b-AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES,Sequelae of infectious and parasitic diseases,parasitic infection,EFO:0001067,http://www.ebi.ac.uk/efo/EFO_0001067,0.756,None
ukb-e-563_AFR,Constipation,Constipation,HP:0002019,http://purl.obolibrary.org/obo/HP_0002019,0.995,None
finn-b-M13_CARTILAGE,Other articular cartilage disorders,articular cartilage disorder,MONDO:0003816,http://purl.obolibrary.org/obo/MONDO_0003816,0.963,None
ukb-e-30530_AFR,Sodium in urine,urinary sodium measurement,EFO:0021522,http://www.ebi.ac.uk/efo/EFO_0021522,0.963,None
ukb-e-2976_CSA,Age diabetes diagnosed,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.717,None
finn-b-CD2_BENIGN_MOUTH_NOS_EXALLC,Benign neoplasm: Other and unspecified parts of mouth (all cancers excluded),benign neoplasm of oral cavity,MONDO:0021445,http://purl.obolibrary.org/obo/MONDO_0021445,0.815,None
ukb-d-C18,Diagnoses - main ICD10: C18 Malignant neoplasm of colon,malignant colon neoplasm,MONDO:0021063,http://purl.obolibrary.org/obo/MONDO_0021063,0.726,None
ukb-e-4080_MID,"Systolic blood pressure, automated reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
finn-b-C3_OESOPHAGUS_EXALLC,Malignant neoplasm of oesophagus (all cancers excluded),esophageal cancer,MONDO:0007576,http://purl.obolibrary.org/obo/MONDO_0007576,0.839,None
finn-b-E4_PARATHYRO,Disorders of parathyroid gland,parathyroid disease,EFO:0005754,http://www.ebi.ac.uk/efo/EFO_0005754,0.973,None
ukb-e-30740_MID,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
finn-b-M13_ARTHTROSIS_COX_PRIM_ICD10,"Coxarthrosis, primary","osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.804,None
finn-b-CD2_BENIGN_NASOPHARYNX_EXALLC,Benign neoplasm: Nasopharynx (all cancers excluded),nasopharyngeal neoplasm,EFO:0004252,http://www.ebi.ac.uk/efo/EFO_0004252,0.819,None
finn-b-F5_SUBSNOALCO,"Substance use, excluding alcohol",alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.654,None
finn-b-CD2_INSITU_SKIN_EXALLC,Carcinoma in situ of skin (all cancers excluded),skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.861,None
finn-b-G6_DISBROTHUNS,"Disorders of brain, other and unspecified",brain disease,EFO:0005774,http://www.ebi.ac.uk/efo/EFO_0005774,0.912,None
finn-b-K11_APPENDACUT,Acute appendicitis,appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.992,None
ieu-a-1161,ER+ Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.668,None
ukb-e-2724_CSA,Had menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.856,None
finn-b-E4_HYTHY_AI_STRICT,"Hypothyroidism, strict autoimmune",Hashimoto's thyroiditis,EFO:0003779,http://www.ebi.ac.uk/efo/EFO_0003779,0.922,None
ukb-d-K11_LIVER,Diseases of liver,liver disease,EFO:0001421,http://www.ebi.ac.uk/efo/EFO_0001421,0.94,None
finn-b-CD2_BENIGN_SKIN_FACE,Benign neoplasm: Skin of other and unspecified parts of face,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.82,None
finn-b-L12_BULLOUS,Bullous disorders,autoimmune bullous skin disease,EFO:0008598,http://www.ebi.ac.uk/efo/EFO_0008598,0.632,None
finn-b-K11_ADHE,Intestinal adhesions without obstruction,intestinal obstruction,MONDO:0004565,http://purl.obolibrary.org/obo/MONDO_0004565,0.728,None
finn-b-DIS_THYROID_OTH,Other disorders of thyroid,thyroid disease,EFO:1000627,http://www.ebi.ac.uk/efo/EFO_1000627,0.839,None
finn-b-FG_DISVEINLYMPH,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)",Abnormality of the lymphatic system,HP:0100763,http://purl.obolibrary.org/obo/HP_0100763,0.626,None
ukb-e-recode48_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-MYCOBLUNGATYPICA,Atypical mycobacterium lung infection,mycobacterial infectious disease,MONDO:0020590,http://purl.obolibrary.org/obo/MONDO_0020590,0.76,None
finn-b-KRA_PSY_AUTISM,Autism spe,autism,EFO:0003758,http://www.ebi.ac.uk/efo/EFO_0003758,0.846,None
ukb-b-20332,Operation code: inguinal hernia repair,Inguinal hernia,HP:0000023,http://purl.obolibrary.org/obo/HP_0000023,0.713,None
ieu-b-4958,Myeloid leukaemia,myeloid leukemia,MONDO:0004643,http://purl.obolibrary.org/obo/MONDO_0004643,0.761,None
finn-b-DRUGADVERS_OSTEOPO,Drug-induced osteoporosis,osteoporosis,EFO:0003882,http://www.ebi.ac.uk/efo/EFO_0003882,0.701,None
finn-b-CD2_BENIGN_RECTOSIGMOID_JUNC,Benign neoplasm: Rectosigmoid junction,rectosigmoid junction neoplasm,MONDO:0002423,http://purl.obolibrary.org/obo/MONDO_0002423,0.903,None
finn-b-G6_ALZHEIMER_EXMORE,Alzheimer disease (more controls excluded),Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
finn-b-CD2_BENIGN_MOUTH_NOS,Benign neoplasm: Other and unspecified parts of mouth,benign neoplasm of oral cavity,MONDO:0021445,http://purl.obolibrary.org/obo/MONDO_0021445,0.884,None
finn-b-CD2_BENIGN_CONNSOFT_NOS,"Benign neoplasm: Connective and other soft tissue, unspecified",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.97,None
ukb-e-1339_EAS,Non-oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.643,None
ukb-e-619_CSA,Noninflammatory female genital disorders,inflammatory disease,EFO:0009903,http://www.ebi.ac.uk/efo/EFO_0009903,0.681,None
finn-b-R18_SOMNOLENCE,Somnolence,idiopathic hypersomnia,MONDO:0018044,http://purl.obolibrary.org/obo/MONDO_0018044,0.674,None
ukb-b-14999,"Diagnoses - main ICD10: K92.2 Gastro-intestinal haemorrhage, unspecified",Gastrointestinal hemorrhage,HP:0002239,http://purl.obolibrary.org/obo/HP_0002239,0.7,None
finn-b-R18_ANOREXIA,Anorexia,Anorexia,HP:0002039,http://purl.obolibrary.org/obo/HP_0002039,0.982,None
ukb-e-recode365_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-7289,Pain type(s) experienced in last month: Hip pain,Hip pain,HP:0030838,http://purl.obolibrary.org/obo/HP_0030838,0.617,None
ukb-e-recode246_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-C3_BRAIN_EXALLC,Malignant neoplasm of brain (all cancers excluded),brain cancer,MONDO:0001657,http://purl.obolibrary.org/obo/MONDO_0001657,0.9,None
finn-b-CD2_LEUKAEMIA_NAS_EXALLC,Leukaemia of unspecified cell type (all cancers excluded),Acute Leukemia,EFO:1000068,http://www.ebi.ac.uk/efo/EFO_1000068,0.717,None
ukb-d-C_PRIMARY_LYMPHOID_HEMATOPOIETIC,Cancer of primary lymphoid hematopoietic,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.707,None
ukb-e-21000_p17_EAS,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-F5_PANIC,Panic disorder,panic disorder,EFO:0004262,http://www.ebi.ac.uk/efo/EFO_0004262,0.997,None
finn-b-CD2_HODGKIN_LYMPHOMA_EXALLC,Hodgkin lymphoma (all cancers excluded),Hodgkins lymphoma,EFO:0000183,http://www.ebi.ac.uk/efo/EFO_0000183,0.91,None
ebi-a-GCST90016602,Autism spectrum disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.764,None
ukb-e-30170_AFR,Nucleated red blood cell count,nucleated cell count,EFO:0803347,http://www.ebi.ac.uk/efo/EFO_0803347,0.819,None
ukb-e-20002_p19_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-1339_CSA,Non-oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.643,None
ukb-e-30080_CSA,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
finn-b-E4_OBESITYXTRMALV,Extreme obesity with alveolar hypoventilation,Hypoventilation,HP:0002791,http://purl.obolibrary.org/obo/HP_0002791,0.77,None
ukb-e-20003_p528_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-N14_OTHDISMALEGEN,Other disorders of male genital organs,reproductive system disease,EFO:0000512,http://www.ebi.ac.uk/efo/EFO_0000512,0.713,None
finn-b-M13_OSTEONECROSIS,Osteonecrosis,osteonecrosis,EFO:0004259,http://www.ebi.ac.uk/efo/EFO_0004259,0.993,None
finn-b-H7_AMBLYANOPSIA,Amblyopia ex anopsia,amblyopia,MONDO:0001020,http://purl.obolibrary.org/obo/MONDO_0001020,0.769,None
finn-b-Q17_CONGEN_MALFO_BREAST,Congenital malformations of breast,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.763,None
ukb-d-XI_DIGESTIVE,Diseases of the digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.966,None
finn-b-I9_DOAAC,"Diseases of arteries, arterioles and capillaries",capillary disorder,MONDO:0001574,http://purl.obolibrary.org/obo/MONDO_0001574,0.717,None
ukb-e-30650_EAS,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
finn-b-H7_GLAUCSECINFLAM,Glaucoma secondary to eye inflammation,eye inflammation,EFO:0005752,http://www.ebi.ac.uk/efo/EFO_0005752,0.681,None
ukb-b-50,Diagnoses - main ICD10: M75.1 Rotator cuff syndrome,rotator cuff tear,EFO:1001250,http://www.ebi.ac.uk/efo/EFO_1001250,0.722,None
finn-b-KRA_PSY_ALCOH_EXMORE,"""Alcohol abuse, main dg"" (more controls excluded)",alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.807,None
finn-b-AB1_ARTHROPOD,Arthropod-borne viral fevers and viral haemorrhagic fevers,viral hemorrhagic fever,MONDO:0018087,http://purl.obolibrary.org/obo/MONDO_0018087,0.771,None
ukb-e-20117_p3_CSA,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
finn-b-I9_HEARTFAIL_AND_CHD,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_HYPOGLYC,"Hypoglycaemia, other or unspecified",Hypoglycemia,HP:0001943,http://purl.obolibrary.org/obo/HP_0001943,0.979,None
finn-b-T1D_STRICT1,"Type 1 diabetes, strict definition, subgroup 1",type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.682,None
finn-b-H7_PERIPHRETINADEGEN,Peripheral retinal degeneration,Retinal dystrophy,ORPHANET.ORDO:71862,http://www.orpha.net/ORDO/Orphanet_71862,0.801,None
finn-b-H8_HL_CON_NAS,"Conductive hearing loss, unspecified",Conductive hearing impairment,HP:0000405,http://purl.obolibrary.org/obo/HP_0000405,0.993,None
finn-b-K11_VOLVU,Volvulus,intestinal volvulus,EFO:1000989,http://www.ebi.ac.uk/efo/EFO_1000989,0.992,None
ukb-e-R10_CSA,R10 Abdominal and pelvic pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.677,None
finn-b-M13_LATERALEPICOND,Lateral epicondylitis,lateral epicondylitis,EFO:1001896,http://www.ebi.ac.uk/efo/EFO_1001896,0.992,None
ukb-a-56,Cancer code  self-reported: small intestine/small bowel cancer,small intestine cancer,MONDO:0000956,http://purl.obolibrary.org/obo/MONDO_0000956,0.774,None
finn-b-I9_AF_EXNONE,Atrial fibrillation and flutter (no controls excluded),atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.793,None
finn-b-G6_HORNER,Horner syndrome,Horner syndrome,MONDO:0001294,http://purl.obolibrary.org/obo/MONDO_0001294,0.962,None
ieu-b-4878,haemotological cancer,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.61,None
ukb-d-20552_2,Behavioural and miscellaneous addictions: A behaviour,addictive behaviour,EFO:0004347,http://www.ebi.ac.uk/efo/EFO_0004347,0.786,None
finn-b-O15_OBSTET_NAS,"Other obstetric conditions, not elsewhere classified",obstetric disorder,MONDO:0700003,http://purl.obolibrary.org/obo/MONDO_0700003,0.679,None
finn-b-R18_SHOCK_NOT_ELSEW_CLASSIFIED,"Shock, not elsewhere classified",Shock,HP:0031273,http://purl.obolibrary.org/obo/HP_0031273,0.997,None
finn-b-C3_MESTOTHEL_SOFTTISSUE_EXALLC,Melignant neoplasm of mesothelium and soft tissue (all cancers excluded),Malignant Mesothelioma,EFO:1000355,http://www.ebi.ac.uk/efo/EFO_1000355,0.758,None
finn-b-F5_MIXPER,Mixed and other personality disorders,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.787,None
finn-b-AD_U_EXMORE,Alzheimer<c3><95>s disease (undefined) (more controls excluded),Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.805,None
finn-b-AB1_HIV,Human immunodeficiency virus [HIV] disease,HIV infection,EFO:0000764,http://www.ebi.ac.uk/efo/EFO_0000764,0.912,None
bbj-a-92,Biliary tract cancer,biliary tract cancer,MONDO:0003060,http://purl.obolibrary.org/obo/MONDO_0003060,0.983,None
ukb-e-1518_AFR,Hot drink temperature,temperature,EFO:0001702,http://www.ebi.ac.uk/efo/EFO_0001702,0.691,None
finn-b-AB1_OTHER_INFECTIONS,Other infectious diseases,infectious disease,EFO:0005741,http://www.ebi.ac.uk/efo/EFO_0005741,0.937,None
ukb-d-C3_FEMALE_GENITAL,malignant neoplasm of female genital organs,"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.952,None
finn-b-N14_PROSTATITIS,Inflammatory diseases of prostate (prostatitis),prostatitis,EFO:0003830,http://www.ebi.ac.uk/efo/EFO_0003830,0.702,None
finn-b-E4_FLUIDELECTRO,"Other disorders of fluid, electrolyte and acid-base balance",Abnormal blood ion concentration,HP:0003111,http://purl.obolibrary.org/obo/HP_0003111,0.644,None
finn-b-O15_PREG_VENOUS_HAEMORRH,Venous complications and haemorrhoids in pregnancy,pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.63,None
finn-b-H7_APHAKIA,Aphakia,congenital primary aphakia,MONDO:0012456,http://purl.obolibrary.org/obo/MONDO_0012456,0.812,None
ukb-b-19255,Fractured bone site(s): Arm,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.71,None
ukb-e-2834_CSA,Bilateral oophorectomy (both ovaries removed),bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.716,None
finn-b-K11_CD_STRICT,"Crohn disease (strict definition, require KELA)",Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.674,None
finn-b-F5_SEDAHYP,Mental and behavioural disorders due to sedatives or hypnotics,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.624,None
finn-b-C3_COLORECTAL,Colorectal cancer,colorectal cancer,EFO:0005842,http://www.ebi.ac.uk/efo/EFO_0005842,0.993,None
ukb-d-I50,Diagnoses - main ICD10: I50 Heart failure,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.664,None
ukb-e-20111_p4_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ieu-b-4954,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
ukb-e-MCP_EAS,Multi-site chronic pain,multisite chronic pain,EFO:0010100,http://www.ebi.ac.uk/efo/EFO_0010100,0.859,None
finn-b-H7_OTHIRISCILIARY,Other disorders of iris and ciliary body,ciliary body disorder,MONDO:0002970,http://purl.obolibrary.org/obo/MONDO_0002970,0.84,None
ukb-e-20116_p1_MID,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ukb-e-20002_p5_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-a-106,Non-cancer illness code  self-reported: osteoarthritis,osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.657,None
finn-b-E4_HYPOPIT,Hypopituitarism,hypopituitarism,EFO:0001380,http://www.ebi.ac.uk/efo/EFO_0001380,0.993,None
finn-b-R18_SYMPTOMS_SIGNS_INVOLVI_SKIN_SUBCU_TISSUE,Symptoms and signs involving the skin and subcutaneous tissue,panniculitis,EFO:1000746,http://www.ebi.ac.uk/efo/EFO_1000746,0.636,None
ukb-b-18167,Illnesses of mother: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.756,None
finn-b-E4_HYTHYNAS,"Hypothyroidism,  other/unspecified",hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.991,None
ukb-e-272_CSA,Disorders of lipoid metabolism,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.802,None
finn-b-H7_KERATITISOTH,Other keratitis,keratitis,EFO:0009449,http://www.ebi.ac.uk/efo/EFO_0009449,0.996,None
ebi-a-GCST003043,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
finn-b-L12_SEBORRHOEIC,Seborrhoeic dermatitis,seborrheic dermatitis,EFO:1000764,http://www.ebi.ac.uk/efo/EFO_1000764,0.994,None
ebi-a-GCST006487,Insomnia complaints,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.728,None
ukb-b-16958,Delivery methods: Spontaneous vertex,delivery method,EFO:0000395,http://www.ebi.ac.uk/efo/EFO_0000395,0.615,None
ukb-e-6149_p3_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-20127_AFR,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
finn-b-KRA_PSY_ANYMENTAL,Any mental disorder,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.994,None
ukb-a-564,Diagnoses - main ICD10: M20 Acquired deformities of fingers and toes,congenital deformities of fingers,MONDO:0017428,http://purl.obolibrary.org/obo/MONDO_0017428,0.618,None
ebi-a-GCST90016597,ADHD vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.815,None
ukb-e-6164_p6_MID,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-1249_EAS,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
ukb-e-30120_CSA,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
ukb-d-Z45,Diagnoses - main ICD10: Z45 Adjustment and management of implanted device,encounter with health service for adjustment and management of implanted device,EFO:0020982,http://www.ebi.ac.uk/efo/EFO_0020982,0.654,None
ukb-e-740_AFR,Osteoarthrosis,osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.995,None
finn-b-F5_TOBAC,Mental and behavioural disorders due to tobacco,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.722,None
ukb-e-30760_MID,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
finn-b-I9_MI_EXNONE,Myocardial infarction (no controls excluded),myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.948,None
finn-b-O15_PREG_PROLONGED,Prolonged pregnancy,post term pregnancy,EFO:0009681,http://www.ebi.ac.uk/efo/EFO_0009681,0.979,None
finn-b-E4_HYPERGLYCER,Pure hyperglyceridaemia,Hyperglycemia,HP:0003074,http://purl.obolibrary.org/obo/HP_0003074,0.698,None
ukb-b-5705,Operation code: cervix surgery,uterine cervix neoplasm,MONDO:0021230,http://purl.obolibrary.org/obo/MONDO_0021230,0.603,None
finn-b-I9_CARDARR_EXNONE,Cardiac arrest (no controls excluded),cardiac arrest,EFO:0009492,http://www.ebi.ac.uk/efo/EFO_0009492,0.922,None
ukb-a-209,Illnesses of mother: Heart disease,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.69,None
ukb-e-120_p3_MID,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-e-recode20_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST006639,Heavy vaginal discharge,vaginal discharge,EFO:0009365,http://www.ebi.ac.uk/efo/EFO_0009365,0.821,None
ukb-b-14211,"Non-cancer illness code, self-reported: other neurological problem",nervous system disease,EFO:0000618,http://www.ebi.ac.uk/efo/EFO_0000618,0.664,None
ieu-a-802,Autism,autism,EFO:0003758,http://www.ebi.ac.uk/efo/EFO_0003758,0.987,None
ukb-e-recode167_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_SUPERV_HIGH_R_PREGNAC,Supervision of high-risk pregnancy,high-risk pregnancy,EFO:0009573,http://www.ebi.ac.uk/efo/EFO_0009573,0.79,None
ebi-a-GCST009760,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-104250_AFR,Mushroom intake,mushroom workers' lung,EFO:0007385,http://www.ebi.ac.uk/efo/EFO_0007385,0.623,None
ukb-e-1239_MID,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
ukb-e-23111_CSA,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
finn-b-I9_PERIPH_EXNONE,Peripheral artery operations in Hilmo (no controls excluded),peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.643,None
finn-b-I9_DISVEINLYMPH,"Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified",Abnormality of the lymphatic system,HP:0100763,http://purl.obolibrary.org/obo/HP_0100763,0.683,None
bbj-a-135,Nephrotic syndrome,nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.967,None
bbj-a-146,Pollinosis,seasonal allergic rhinitis,EFO:0003956,http://www.ebi.ac.uk/efo/EFO_0003956,0.989,None
ieu-a-989,Squamous cell lung cancer,squamous cell lung carcinoma,EFO:0000708,http://www.ebi.ac.uk/efo/EFO_0000708,0.989,None
finn-b-E4_OBESITYDRUG,Drug-induced obesity,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.645,None
ebi-a-GCST90012792,Acceptance of an invitation to participate in a mental health questionnaire,health study participation,EFO:0010130,http://www.ebi.ac.uk/efo/EFO_0010130,0.739,None
ukb-e-recode448_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-VII_EYE_ADNEXA,Diseases of the eye and adnexa,eye adnexa disease,EFO:0009546,http://www.ebi.ac.uk/efo/EFO_0009546,0.944,None
ukb-e-recode335_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20127_MID,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
ukb-e-20015_EAS,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
finn-b-M13_JUVERHEU,Juvenile rheuma,juvenile idiopathic arthritis,EFO:0002609,http://www.ebi.ac.uk/efo/EFO_0002609,0.739,None
finn-b-K11_TOOTH_DEV,Disorders of tooth development and eruption,disorder of sexual differentiation,MONDO:0002145,http://purl.obolibrary.org/obo/MONDO_0002145,0.652,None
ukb-e-100011_CSA,Iron,iron metabolism disease,MONDO:0002279,http://purl.obolibrary.org/obo/MONDO_0002279,0.748,None
finn-b-K11_HERNIA,Hernia,Hernia,HP:0100790,http://purl.obolibrary.org/obo/HP_0100790,0.991,None
finn-b-CD2_BENIGN_OTHERDIGESTIVE,Benign neoplasm of other and ill-defined parts of digestive system,benign digestive system neoplasm,MONDO:0000385,http://purl.obolibrary.org/obo/MONDO_0000385,0.797,None
ukb-e-21000_p17_MID,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-I9_ICH,Intracerebral haemmorrhage,intracerebral hemorrhage,EFO:0005669,http://www.ebi.ac.uk/efo/EFO_0005669,0.777,None
ukb-e-21021_CSA,Pulse wave Arterial Stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.706,None
finn-b-E4_THYROIDNASOTH,"Disorder of thyroid, unspecified",thyroid disease,EFO:1000627,http://www.ebi.ac.uk/efo/EFO_1000627,0.857,None
finn-b-M13_PLANTARFASC,Plantar fascial fibromatosis,Plantar Fibromatosis,EFO:1000481,http://www.ebi.ac.uk/efo/EFO_1000481,0.978,None
ukb-e-6138_p2_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-100900_AFR,Intake of sugar added to cereal,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.604,None
finn-b-C3_CLL,Chronic lymphocytic leukaemia,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.844,None
finn-b-R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_BREAST,Abnormal findings on diagnostic imaging of breast,abnormal result of diagnostic imaging,EFO:0009827,http://www.ebi.ac.uk/efo/EFO_0009827,0.684,None
ukb-a-427,Mouth/teeth dental problems: Mouth ulcers,Oral ulcer,HP:0000155,http://purl.obolibrary.org/obo/HP_0000155,0.728,None
ukb-e-AG_AFR,Albumin/Globulin ratio,albumin:globulin ratio measurement,EFO:0005128,http://www.ebi.ac.uk/efo/EFO_0005128,0.894,None
finn-b-J10_BRONCHITIS,Acute bronchitis,Acute bronchitis,HP:0012388,http://purl.obolibrary.org/obo/HP_0012388,0.995,None
ukb-b-5479,Operation code: cone biopsy,biopsy,EFO:0009120,http://www.ebi.ac.uk/efo/EFO_0009120,0.694,None
ukb-d-FIBRO_COMORB,Fibromyalgia related co-morbidities,fibromyalgia,EFO:0005687,http://www.ebi.ac.uk/efo/EFO_0005687,0.708,None
finn-b-E4_LACTOSEINT,Lactose intolerance,lactose intolerance,EFO:1000062,http://www.ebi.ac.uk/efo/EFO_1000062,0.985,None
ukb-e-1970_CSA,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
ukb-e-recode80_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1060_EAS,Time spent outdoors in winter,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.849,None
ukb-e-30120_AFR,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
ukb-e-20513_AFR,Recent thoughts of suicide or self-harm,suicidal ideation,EFO:0004320,http://www.ebi.ac.uk/efo/EFO_0004320,0.616,None
finn-b-E4_ENDONUTRMET,"Endocrine, nutritional and metabolic diseases",endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.645,None
finn-b-R18_HEPATOM_SPLENO_NOT_ELSEW_CLASSIFIED,"Hepatomegaly and splenomegaly, not elsewhere classified",Splenomegaly,HP:0001744,http://purl.obolibrary.org/obo/HP_0001744,0.879,None
ukb-e-4581_AFR,Financial situation satisfaction,financial situation satisfaction measurement,EFO:0009726,http://www.ebi.ac.uk/efo/EFO_0009726,0.927,None
finn-b-K11_INTUSS,Intussusception,Intussusception,HP:0002576,http://purl.obolibrary.org/obo/HP_0002576,0.99,None
finn-b-I9_OTHILLHEART_EXNONE,Other or ill-defined heart diseases (no controls excluded),cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.704,None
finn-b-M13_OSTEOPOROSIS,Osteoporosis,osteoporosis,EFO:0003882,http://www.ebi.ac.uk/efo/EFO_0003882,0.992,None
finn-b-N14_OTHNONINFOVA,"Other and unspesified noninflammatory disorders of ovary, fallopian tube and broad ligament",salpingitis,MONDO:0003619,http://purl.obolibrary.org/obo/MONDO_0003619,0.658,None
finn-b-CD2_BENIGN_URINARY_EXALLC,Benign neoplasm of urinary organs (all cancers excluded),benign urinary system neoplasm,MONDO:0004180,http://purl.obolibrary.org/obo/MONDO_0004180,0.713,None
ukb-e-recode372_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-C3_COLORECTAL_EXALLC,Colorectal cancer (all cancers excluded),colorectal carcinoma,EFO:1001951,http://www.ebi.ac.uk/efo/EFO_1001951,0.936,None
ukb-d-2395_1,Hair/balding pattern: Pattern 1,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.69,None
finn-b-CD2_BENIGN_KIDNEY,Benign neoplasm: Kidney,kidney benign neoplasm,MONDO:0002513,http://purl.obolibrary.org/obo/MONDO_0002513,0.996,None
ukb-e-5674_CSA,Severity of manic/irritable episodes,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.607,None
ukb-a-572,Diagnoses - main ICD10: M72 Fibroblastic disorders,fibroblastic disorder,EFO:0009432,http://www.ebi.ac.uk/efo/EFO_0009432,0.684,None
finn-b-M13_DEQUERVAIN,Radial styloid tenosynovitis [de Quervain],De Quervain disease,EFO:1000891,http://www.ebi.ac.uk/efo/EFO_1000891,0.818,None
ukb-b-16254,Pain type(s) experienced in last month: Knee pain,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.631,None
finn-b-D3_IMMUNEMECHANISMOTHER,"Other disorders involving the immune mechanism, not elsewhere classified",immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.966,None
finn-b-I9_STR_EXH,"Ischaemic Stroke, excluding all haemorrhages",Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.798,None
finn-b-F5_HALLUCIN,Mental and behavioural disorders due to hallucinogens,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.686,None
ukb-e-6142_p3_CSA,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-AB1_SYPHILIS,Syphilis,syphilis,EFO:0007504,http://www.ebi.ac.uk/efo/EFO_0007504,0.993,None
finn-b-L12_FOLLICULARNAS,Other and unspecified follicular disorders,Follicular Cyst,EFO:1001329,http://www.ebi.ac.uk/efo/EFO_1001329,0.668,None
ieu-a-983,Hirschsprung's disease,Aganglionic megacolon,HP:0002251,http://purl.obolibrary.org/obo/HP_0002251,0.988,None
ukb-e-30000_CSA,White blood cell (leukocyte) count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.797,None
ukb-e-recode305_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-6155_p8_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-b-15251,Fracture resulting from simple fall,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.628,None
finn-b-Z21_PROBL_RELATED_CERTA_PSYCHOSO_CIRCUMSTANC,Problems related to certain psychosocial circumstances,encounter with health service related to socioeconomic and psychosocial circumstances,EFO:0009788,http://www.ebi.ac.uk/efo/EFO_0009788,0.631,None
ukb-e-20111_p3_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-AB1_HELMINTIASES,Helminthiases,Helminthiasis,EFO:1001342,http://www.ebi.ac.uk/efo/EFO_1001342,0.898,None
bbj-a-79,Smoking behaviors : Smoking initiation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.852,None
finn-b-R18_OEDEMA_NOT_ELSEW_CLASSIFIED,"Oedema, not elsewhere classified",edema,EFO:0009373,http://www.ebi.ac.uk/efo/EFO_0009373,0.988,None
ukb-e-23115_MID,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
ukb-e-30070_AFR,Red blood cell (erythrocyte) distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
ebi-a-GCST90013410,Basal cell carcinoma,basal cell carcinoma,EFO:0004193,http://www.ebi.ac.uk/efo/EFO_0004193,0.985,None
ukb-e-H26_CSA,H26 Other cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.689,None
ebi-a-GCST006095,Excessive hairiness,Hirsutism,HP:0001007,http://purl.obolibrary.org/obo/HP_0001007,0.991,None
finn-b-G6_HCOTHUNS,Other and unspecified hydrocephalus,Hydrocephalus,HP:0000238,http://purl.obolibrary.org/obo/HP_0000238,0.986,None
ukb-d-AB1_OTHER_VIRAL,Other viral diseases,viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.913,None
finn-b-K11_BILIAOTH,Other diseases of biliary tract,biliary tract disease,EFO:0009534,http://www.ebi.ac.uk/efo/EFO_0009534,0.92,None
finn-b-F5_PERVASIVE,Pervasive developmental disorders excl. Autism + Asperger,autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.756,None
finn-b-CD2_BENIGN_HEMANGIOMA,"Haemangioma, any site",hemangioma,EFO:1000635,http://www.ebi.ac.uk/efo/EFO_1000635,0.688,None
ukb-e-20111_p13_EAS,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-5156_CSA,3mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
ukb-b-17673,Fish consumer,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.638,None
finn-b-Q17_CLEFT_HARD_PALATE_W_CLEFT_LIP_UNILA,"Cleft hard palate with cleft lip, unilateral",Cleft palate,HP:0000175,http://purl.obolibrary.org/obo/HP_0000175,0.749,None
finn-b-C3_BLADDER_EXALLC,Malignant neoplasm of bladder (all cancers excluded),urinary bladder cancer,MONDO:0001187,http://purl.obolibrary.org/obo/MONDO_0001187,0.916,None
finn-b-G6_DEGENOTH,Other and unspecified degenerative diseases of nervous system,neurodegenerative disease,EFO:0005772,http://www.ebi.ac.uk/efo/EFO_0005772,0.81,None
ukb-d-COPD_EXCL,COPD differential diagnosis,differentiated,EFO:0002954,http://www.ebi.ac.uk/efo/EFO_0002954,0.671,None
ukb-e-1279_MID,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
ieu-b-16,generalized epilepsy with tonic-clonic seizures,epilepsy with generalized tonic-clonic seizures,EFO:0007262,http://www.ebi.ac.uk/efo/EFO_0007262,0.901,None
finn-b-I9_STR,"Stroke, excluding SAH",subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.705,None
ukb-e-J18_CSA,"J18 Pneumonia, organism unspecified",bronchiolitis obliterans,EFO:0007183,http://www.ebi.ac.uk/efo/EFO_0007183,0.668,None
ukb-e-52_p9_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-2365_CSA,Ever had prostate specific antigen (PSA) test,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.669,None
ukb-e-30830_AFR,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
finn-b-F5_GAD,Generalized anxiety disorder,generalized anxiety disorder,EFO:1001892,http://www.ebi.ac.uk/efo/EFO_1001892,0.99,None
ebi-a-GCST006636,Menstruation quality of life impact (dysmenorrhea),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.629,None
finn-b-G6_DISOTHUNS,Disorders of other and unspecified cranial nerves,cranial nerve neuropathy,MONDO:0003569,http://purl.obolibrary.org/obo/MONDO_0003569,0.884,None
ukb-e-6164_p2_MID,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-272_MID,Disorders of lipoid metabolism,Disorder of lipid metabolism,ORPHANET.ORDO:309005,http://www.orpha.net/ORDO/Orphanet_309005,0.802,None
ukb-b-15096,Operation code: tonsillectomy / tonsil surgery,tonsillectomy,EFO:0010174,http://www.ebi.ac.uk/efo/EFO_0010174,0.787,None
ukb-e-134_p1_CSA,Number of self-reported cancers,"number of cancers, self-reported",EFO:0009800,http://www.ebi.ac.uk/efo/EFO_0009800,0.808,None
ukb-e-100004_CSA,Fat,Lipoatrophy,HP:0100578,http://purl.obolibrary.org/obo/HP_0100578,0.617,None
finn-b-CD2_IMMUNOPROLIFERATIVE_EXALLC,Malignant immunoproliferative diseases (all cancers excluded),immunoproliferative disorder,MONDO:0021334,http://purl.obolibrary.org/obo/MONDO_0021334,0.793,None
finn-b-E4_HYPOPARA,Hypoparathyroidism,hypoparathyroidism,EFO:0009451,http://www.ebi.ac.uk/efo/EFO_0009451,0.99,None
finn-b-THYROTOXICOSIS,Thyrotoxicosis,Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.991,None
ukb-e-30010_EAS,Red blood cell (erythrocyte) count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.783,None
ukb-e-recode20_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-86,Extreme height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.654,None
finn-b-MACULAR_PUCKER,Macular pucker,Epiretinal membrane,HP:0100014,http://purl.obolibrary.org/obo/HP_0100014,0.992,None
finn-b-KRA_PSY_SPEELING_EXMORE,Speech and linguistic disorders (more controls excluded),speech disorder,MONDO:0004730,http://purl.obolibrary.org/obo/MONDO_0004730,0.715,None
ukb-e-recode252_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20015_MID,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
finn-b-N14_POSTMENATRVAG,Postmenopausal atrophic vaginitsi,postmenopausal atrophic vaginitis,MONDO:0001410,http://purl.obolibrary.org/obo/MONDO_0001410,0.869,None
ukb-e-N39_AFR,N39 Other disorders of urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.813,None
ukb-b-1668,Diagnoses - main ICD10: I25.1 Atherosclerotic heart disease,carotid atherosclerosis,EFO:0009783,http://www.ebi.ac.uk/efo/EFO_0009783,0.632,None
finn-b-K11_OTHGASTR,Other gastritis (incl. Duodenitis),duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.73,None
finn-b-F5_MENTRET,Mental retardation (F5_MENTRET),Intellectual disability,HP:0001249,http://purl.obolibrary.org/obo/HP_0001249,0.786,None
ukb-a-14,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-30640_AFR,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ukb-b-20190,"Diagnoses - main ICD10: L98.9 Disorder of skin and subcutaneous tissue, unspecified",subcutaneous tissue disorder,MONDO:0019296,http://purl.obolibrary.org/obo/MONDO_0019296,0.728,None
ukb-e-5057_EAS,Number of older siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.851,None
ukb-e-recode67_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_LIP_ORAL_MUCOSA,Other diseases of lip and oral mucosa,mouth mucosa disorder,MONDO:0044992,http://purl.obolibrary.org/obo/MONDO_0044992,0.632,None
ukb-d-I9_HYPTENS,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
finn-b-CD2_INSITU_SKIN_EAR,Carcinoma in situ of skin of ear and external auricular canal,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.644,None
ukb-b-14609,Treatment/medication code: metformin,metformin measurement,EFO:0801177,http://www.ebi.ac.uk/efo/EFO_0801177,0.692,None
ukb-e-recode293_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-PD2ND,Secondary parkinsonism,secondary Parkinson disease,EFO:1001175,http://www.ebi.ac.uk/efo/EFO_1001175,0.983,None
ukb-b-10181,Eye problems/disorders: Diabetes related eye disease,Abnormality of the eye,HP:0000478,http://purl.obolibrary.org/obo/HP_0000478,0.713,None
finn-b-CD2_BENIGN_MELANOCYTIC_NOS,"Melanocytic naevi, other sites/unspecified",large congenital melanocytic nevus,MONDO:0044792,http://purl.obolibrary.org/obo/MONDO_0044792,0.624,None
ukb-e-recode135_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-J10_PNEUMOBACTEROTH,"Bacterial pneumonia, not elsewhere classified",bacterial pneumonia,EFO:1001272,http://www.ebi.ac.uk/efo/EFO_1001272,0.989,None
ebi-a-GCST90016615,Major depressive disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.822,None
ukb-a-215,Illnesses of mother: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.756,None
finn-b-N14_BENIGNMAMDYSP,Benign mammary dysplasia,breast fibrocystic disease,EFO:0003014,http://www.ebi.ac.uk/efo/EFO_0003014,0.871,None
finn-b-FEMINGHER_BILATERAL,"Inguinal or femoral hernia, bilateral",femoral hernia,EFO:1001791,http://www.ebi.ac.uk/efo/EFO_1001791,0.709,None
ukb-b-12654,Former alcohol drinker,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.625,None
ukb-b-14206,"Diagnoses - main ICD10: I20.9 Angina pectoris, unspecified",angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.661,None
finn-b-M13_OSTEOMALACIA,Osteomalacia,abnormal mineralization disorder,MONDO:0800096,http://purl.obolibrary.org/obo/MONDO_0800096,0.992,None
ukb-b-11601,Diagnoses - main ICD10: N40 Hyperplasia of prostate,benign prostatic hyperplasia,EFO:0000284,http://www.ebi.ac.uk/efo/EFO_0000284,0.717,None
finn-b-P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO,Transitory disorders of carbohydrate metabolism specific to fetus and newborn,inborn carbohydrate metabolic disorder,MONDO:0019214,http://purl.obolibrary.org/obo/MONDO_0019214,0.663,None
finn-b-I9_THROMBICV_EXNONE,Nonpyogenic thrombosis of intracranial venous system (no controls excluded),intracranial thrombosis,MONDO:0002907,http://purl.obolibrary.org/obo/MONDO_0002907,0.612,None
ukb-d-M13_TRIGGERFINGER,Trigger finger,Digital flexor tenosynovitis,HP:0012276,http://purl.obolibrary.org/obo/HP_0012276,0.995,None
finn-b-ARTRHO_POSTDYSENTERIC,Postydysenteric arthropathy,reactive arthritis,EFO:0007460,http://www.ebi.ac.uk/efo/EFO_0007460,0.663,None
ukb-e-recode414_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-5079,Vitamin and/or mineral supplement use: Vitamin D,vitamin D measurement,EFO:0004631,http://www.ebi.ac.uk/efo/EFO_0004631,0.699,None
finn-b-E4_NUTRI_DEF_NAS,Other specified/unspecified nutritional deficiencies,nutritional deficiency disease,EFO:1001067,http://www.ebi.ac.uk/efo/EFO_1001067,0.765,None
finn-b-I9_ARTEMBTHRNAS_EXNONE,Other arterial embolism and thrombosis (no controls excluded),Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.834,None
finn-b-I9_PERICARD,Pericarditis,pericarditis,EFO:0007427,http://www.ebi.ac.uk/efo/EFO_0007427,0.992,None
ukb-e-20003_p118_MID,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-K11_GALLBLAOTH,Other diseases of gallbladder,gallbladder disease,EFO:0003832,http://www.ebi.ac.uk/efo/EFO_0003832,0.974,None
ukb-e-1687_AFR,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
ukb-a-562,Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip],"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.722,None
ukb-e-6138_p1_MID,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
finn-b-I9_DVTANDPULM,DVT of lower extremities and pulmonary embolism,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.68,None
finn-b-Q17_UNDES_TESTICLE,Undescended testicle,cryptorchidism,EFO:0004562,http://www.ebi.ac.uk/efo/EFO_0004562,0.989,None
ukb-e-6164_p6_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-recode67_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_PROCREATIVE_MANAG,Procreative management,contraception,EFO:0009520,http://www.ebi.ac.uk/efo/EFO_0009520,0.613,None
finn-b-AD_LO,Alzheimer<c3><95>s disease (Late onset),late-onset Alzheimer's disease,EFO:1001870,http://www.ebi.ac.uk/efo/EFO_1001870,0.717,None
finn-b-H7_CORNEALDEFORM,Keratoconus,keratoconus,MONDO:0015486,http://purl.obolibrary.org/obo/MONDO_0015486,0.997,None
finn-b-C3_SPINAL_CORD_CRANIAL_AND_OTHER_CNS,"Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",central nervous system cancer,EFO:0000326,http://www.ebi.ac.uk/efo/EFO_0000326,0.777,None
ebi-a-GCST004132,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
ukb-e-103160_AFR,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
ukb-d-SLEEP,Sleep disorders (combined),sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.99,None
ukb-e-3710_CSA,Length of menstrual cycle,menstrual cycle measurement,EFO:0007786,http://www.ebi.ac.uk/efo/EFO_0007786,0.728,None
finn-b-G6_HCCOMM,Communicating hydrocephalus,communicating hydrocephalus,MONDO:0002045,http://purl.obolibrary.org/obo/MONDO_0002045,0.985,None
finn-b-J10_RESPDISOTH,Other respiratory disorders and diseases,respiratory system disease,EFO:0000684,http://www.ebi.ac.uk/efo/EFO_0000684,0.827,None
ukb-d-M13_FIBROBLASTIC,Fibroblastic disorders,fibroblastic disorder,EFO:0009432,http://www.ebi.ac.uk/efo/EFO_0009432,0.94,None
ukb-e-100017_AFR,Magnesium,magnesium measurement,EFO:0004845,http://www.ebi.ac.uk/efo/EFO_0004845,0.846,None
ukb-b-10712,Diagnoses - main ICD10: O70.1 Second degree perineal laceration during delivery,perineal laceration during delivery,EFO:0009816,http://www.ebi.ac.uk/efo/EFO_0009816,0.675,None
ukb-e-recode241_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-16866,Treatment/medication code: ibuprofen,ibuprofen measurement,EFO:0021158,http://www.ebi.ac.uk/efo/EFO_0021158,0.727,None
ukb-e-recode305_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-52_p12_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-recode4_AFR,"Estimated glomerular filtration rate, serum creatinine",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.759,None
finn-b-I9_IHD,"Ischaemic heart disease, wide definition",Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.825,None
ukb-e-20003_p101_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-1050_MID,Time spend outdoors in summer,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.746,None
ukb-e-recode396_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
bbj-a-81,Smoking behaviors : Smoking cessation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.841,None
finn-b-C3_OVARY_EXALLC,Malignant neoplasm of ovary (all cancers excluded),ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.908,None
finn-b-CHIRBIL_PRIM,"Biliary chirrosis, primary",primary biliary cirrhosis,EFO:1001486,http://www.ebi.ac.uk/efo/EFO_1001486,0.723,None
finn-b-E4_DM1KETO,Type 1 diabetes with ketoacidosis,diabetic ketoacidosis,EFO:1000897,http://www.ebi.ac.uk/efo/EFO_1000897,0.806,None
finn-b-M13_ANKYLOSISJOINT,Ankylosis of joint,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.893,None
ukb-e-4548_AFR,Health satisfaction,health satisfaction measurement,EFO:0009724,http://www.ebi.ac.uk/efo/EFO_0009724,0.907,None
ukb-e-1518_CSA,Hot drink temperature,temperature,EFO:0001702,http://www.ebi.ac.uk/efo/EFO_0001702,0.691,None
finn-b-CD2_BENIGN_PAROTID,Benign neoplasm: Parotid gland,parotid neoplasm,EFO:0003873,http://www.ebi.ac.uk/efo/EFO_0003873,0.868,None
ukb-e-531_CSA,Peptic ulcer (excl. esophageal),esophageal ulcer,MONDO:0044782,http://purl.obolibrary.org/obo/MONDO_0044782,0.767,None
finn-b-L12_DERMATITISECZEMA,Dermatitis and eczema,atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.872,None
finn-b-AUD_SWEDISH,"Alcohol use disorder, Swedish definition",alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.763,None
finn-b-H8_VESTIBNEUR,Vestibular neuronitis,vestibular neuronitis,EFO:0007537,http://www.ebi.ac.uk/efo/EFO_0007537,0.993,None
finn-b-ESOSINOPHIL_DISEASE,Eosinophilic disease (BM),eosinophil disorder,MONDO:0044972,http://purl.obolibrary.org/obo/MONDO_0044972,0.739,None
finn-b-K11_ATROPHY_SALIVARY_GLAND,Atrophy of salivary gland,Mixed Tumor of the Salivary Gland,EFO:1000384,http://www.ebi.ac.uk/efo/EFO_1000384,0.709,None
ukb-e-20084_p5_CSA,Vitamin and/or mineral supplement use,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.624,None
ukb-e-recode50_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_PROBL_RELATED_PHYSIC_ENVIRONMENT,Problems related to physical environment,environmental factor,EFO:0000469,http://www.ebi.ac.uk/efo/EFO_0000469,0.616,None
ukb-e-recode100_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_PARAPER,Paranoid personality disorder,paranoid personality disorder,MONDO:0001163,http://purl.obolibrary.org/obo/MONDO_0001163,0.993,None
ebi-a-GCST90000529,Type 1 diabetes,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
finn-b-I9_RHEUFEV,Rheumatic fever incl heart disease,rheumatic heart disease,EFO:1001161,http://www.ebi.ac.uk/efo/EFO_1001161,0.794,None
ukb-b-19350,"Diagnoses - main ICD10: I63.9 Cerebral infarction, unspecified",cerebral infarction,MONDO:0002679,http://purl.obolibrary.org/obo/MONDO_0002679,0.689,None
ukb-e-2335_MID,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
ukb-e-2139_EAS,Age first had sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.849,None
ukb-a-551,Diagnoses - main ICD10: K44 Diaphragmatic hernia,diaphragmatic hernia,EFO:0008561,http://www.ebi.ac.uk/efo/EFO_0008561,0.784,None
finn-b-F5_DEPRESSIO,Depression,depressive disorder,MONDO:0002050,http://purl.obolibrary.org/obo/MONDO_0002050,0.992,None
ukb-e-418_CSA,Nonspecific chest pain,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.623,None
ukb-e-20510_AFR,Recent feelings of depression,depressive disorder,MONDO:0002050,http://purl.obolibrary.org/obo/MONDO_0002050,0.601,None
ukb-e-2395_p2_CSA,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
ukb-e-396_AFR,Abnormal heart sounds,abnormal chest sounds,EFO:0010670,http://www.ebi.ac.uk/efo/EFO_0010670,0.756,None
ukb-e-24006_CSA,Particulate matter air pollution (pm2.5); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.739,None
ieu-a-8,Coronary heart disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.993,None
ukb-e-30120_MID,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
finn-b-I9_RBBB,Right bundle-branch block,Right bundle branch block,HP:0011712,http://purl.obolibrary.org/obo/HP_0011712,0.986,None
ukb-e-recode288_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_BENIGN_MELANOCYTIC,Melanocytic naevi,large congenital melanocytic nevus,MONDO:0044792,http://purl.obolibrary.org/obo/MONDO_0044792,0.691,None
finn-b-CD2_BENIGN_LYMPHANGIOMA,"Lymphangioma, anys site",lymphangioma,MONDO:0002013,http://purl.obolibrary.org/obo/MONDO_0002013,0.735,None
ukb-e-recode259_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-R18_ASCITES,Ascites,Ascites,HP:0001541,http://purl.obolibrary.org/obo/HP_0001541,0.996,None
ukb-e-6149_p4_MID,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-b-16454,Operative procedures - secondary OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract,upper digestive tract disorder,MONDO:0044991,http://purl.obolibrary.org/obo/MONDO_0044991,0.681,None
ukb-e-recode343_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_SCHIZO,"Schizophrenia, schizotypal and delusional disorders",schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.722,None
finn-b-RHEUMA_SEROPOS,Seropositive rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.819,None
bbj-a-107,Colorectal cancer,colorectal cancer,EFO:0005842,http://www.ebi.ac.uk/efo/EFO_0005842,0.993,None
ukb-e-recode82_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-2395_p3_CSA,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
finn-b-P16_INFECTIONS_SPECIFIC_PERINA_PERIOD,Infections specific to the perinatal period,period of infection,EFO:0000648,http://www.ebi.ac.uk/efo/EFO_0000648,0.665,None
finn-b-PSORI_STRICT,"Psoriasis (vulgaris), strict definition",psoriasis vulgaris,EFO:1001494,http://www.ebi.ac.uk/efo/EFO_1001494,0.991,None
ukb-b-12477,Illnesses of mother: Heart disease,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.69,None
finn-b-CD2_BENIGN_OTHERDIGESTIVE_EXALLC,Benign neoplasm of other and ill-defined parts of digestive system (all cancers excluded),benign digestive system neoplasm,MONDO:0000385,http://purl.obolibrary.org/obo/MONDO_0000385,0.763,None
ukb-e-30870_MID,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
ukb-e-3571_AFR,Back pain for 3+ months,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.671,None
ukb-e-recode335_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_ENTEROARTHR,Enteropathic arthropathies,neurogenic arthropathy,EFO:1001378,http://www.ebi.ac.uk/efo/EFO_1001378,0.794,None
ukb-e-6155_p2_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-L12_ULCERLOWLIMB,"Ulcer of lower limb, not elsewhere classified",ulcer of lower limb,EFO:0007068,http://www.ebi.ac.uk/efo/EFO_0007068,0.999,None
ukb-e-20018_EAS,Prospective memory result,episodic memory,EFO:0004333,http://www.ebi.ac.uk/efo/EFO_0004333,0.805,None
ieu-a-969,Ulcerative colitis,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.996,None
ukb-e-4124_AFR,Heel bone mineral density (BMD) (right),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.808,None
ukb-e-2139_AFR,Age first had sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.849,None
finn-b-I9_AF_REIMB,Atrial fibrillation and flutter with reimbursement,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.606,None
finn-b-AB1_TRICHOMONIASIS,Trichomoniasis,trichomoniasis,DOID:1947,http://purl.obolibrary.org/obo/DOID_1947,0.992,None
ukb-b-14027,"Non-cancer illness code, self-reported: chickenpox",chickenpox,EFO:0007204,http://www.ebi.ac.uk/efo/EFO_0007204,0.686,None
finn-b-I9_OTH,Other CVD,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.998,None
ukb-e-52_p3_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-a-131,Treatment/medication code: atenolol,atenolol measurement,EFO:0801114,http://www.ebi.ac.uk/efo/EFO_0801114,0.635,None
ukb-e-670_p3_AFR,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
finn-b-I9_HYPERTENSION,Hypertensive diseases,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.94,None
finn-b-J10_PNEUMONAS,"Pneumonia, organism unsepcified",pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.672,None
finn-b-J10_HYPERSPNEUMONI,Hypersensitivity pneumonitis due to organic dust,hypersensitivity pneumonitis,MONDO:0017853,http://purl.obolibrary.org/obo/MONDO_0017853,0.752,None
ukb-e-recode167_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20111_p6_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ebi-a-GCST90016623,Schizophrenia vs obsessive compulsive disorder (ordinary least squares (OLS)),obsessive-compulsive disorder,EFO:0004242,http://www.ebi.ac.uk/efo/EFO_0004242,0.739,None
ukb-d-I26,Diagnoses - main ICD10: I26 Pulmonary embolism,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.744,None
ukb-e-30130_MID,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
finn-b-E4_DM1,Type 1 diabetes,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.986,None
ukb-e-6149_p2_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-b-4738,"Diagnoses - main ICD10: K25.9 Unspecified as acute or chronic, without haemorrhage or perforation",peptic ulcer disease,MONDO:0004247,http://purl.obolibrary.org/obo/MONDO_0004247,0.613,None
ukb-e-recode18_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-G6_SLEEPAPNO,Sleep apnoea,Apnea,HP:0002104,http://purl.obolibrary.org/obo/HP_0002104,0.77,None
finn-b-N14_CHRONEPHROPATH_ADVERSE,"Chronic nephritic syndrome, drug-induced",nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.601,None
finn-b-ST19_FOREI_BODY_EAR,Foreign body in ear,foreign body,EFO:0009525,http://www.ebi.ac.uk/efo/EFO_0009525,0.905,None
ukb-e-30040_EAS,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
ukb-d-RHEU_ARTHRITIS_OTH,Other arthritis (FG),arthritis,EFO:0005856,http://www.ebi.ac.uk/efo/EFO_0005856,0.798,None
ukb-b-18785,Diagnoses - main ICD10: K13.7 Other and unspecified lesions of oral mucosa,oral mucositis,EFO:1001904,http://www.ebi.ac.uk/efo/EFO_1001904,0.627,None
ukb-e-20002_p124_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS,Other specified congenital malformation syndromes affecting multiple systems,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.672,None
ukb-e-1170_EAS,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
finn-b-K11_OTHDIG,Other diseases of the digestive system (K11_OTHDIG),digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.721,None
ukb-e-20002_p1_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-6149_p1_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-b-19955,Diagnoses - secondary ICD10: I12.0 Hypertensive renal disease with renal failure,hypertensive nephropathy,MONDO:0024633,http://purl.obolibrary.org/obo/MONDO_0024633,0.637,None
ukb-b-12316,Diagnoses - main ICD10: K29.8 Duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.623,None
ukb-e-52_p1_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-J10_INFLUPNEU,Influenza and pneumonia,influenza,EFO:0007328,http://www.ebi.ac.uk/efo/EFO_0007328,0.757,None
ukb-e-20127_EAS,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
finn-b-F5_BULIMIA,Bulimia nervosa (incl. atypical),bulimia nervosa,EFO:0005204,http://www.ebi.ac.uk/efo/EFO_0005204,0.746,None
ukb-e-5110_AFR,6mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
ukb-e-189_p1_AFR,Townsend deprivation index at recruitment,Townsend deprivation index,EFO:0009711,http://www.ebi.ac.uk/efo/EFO_0009711,0.806,None
ieu-a-810,Schizophrenia,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.989,None
ukb-e-recode375_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_ENDOMETRIOSIS_RECTPVAGSEPT_VAGINA,Endometriosis of rectovaginal septum and vagina,endometriosis of rectovaginal septum and vagina,MONDO:0001288,http://purl.obolibrary.org/obo/MONDO_0001288,0.979,None
ukb-b-14395,"Medication for cholesterol, blood pressure or diabetes: Blood pressure medication",blood pressure,EFO:0004325,http://www.ebi.ac.uk/efo/EFO_0004325,0.726,None
ukb-e-23098_AFR,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
finn-b-COPD_EARLY,Early onset COPD,early onset hypertension,EFO:0004772,http://www.ebi.ac.uk/efo/EFO_0004772,0.621,None
ukb-e-4195_AFR,Pulse wave reflection index,pulse wave reflection index measurement,EFO:0009804,http://www.ebi.ac.uk/efo/EFO_0009804,0.927,None
ukb-e-20111_p1_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-H7_LACRIMINFLAMACU,Inflammation of lacrimal passages (acute and unspecified),dacryoadenitis,MONDO:0004804,http://purl.obolibrary.org/obo/MONDO_0004804,0.692,None
finn-b-CD2_BENIGN_NASOPHARYNX,Benign neoplasm: Nasopharynx,nasopharyngeal neoplasm,EFO:0004252,http://www.ebi.ac.uk/efo/EFO_0004252,0.879,None
ukb-e-K59_AFR,K59 Other functional intestinal disorders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.752,None
ukb-e-103040_CSA,Lamb intake,Carney complex,MONDO:0015285,http://purl.obolibrary.org/obo/MONDO_0015285,0.783,None
finn-b-O15_LABOUR_FETAL_STRESS,Labour and delivery complicated by fetal stress [distress],Fetal distress,HP:0025116,http://purl.obolibrary.org/obo/HP_0025116,0.641,None
ukb-d-D12,"Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal",benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.634,None
finn-b-DM_RETINA_NOS,Unspecified diabetic retinopathy,diabetic retinopathy,EFO:0003770,http://www.ebi.ac.uk/efo/EFO_0003770,0.987,None
finn-b-AB1_INTESTINAL_INFECTIONS,Intestinal infectious diseases,intestinal infectious disease,MONDO:0000916,http://purl.obolibrary.org/obo/MONDO_0000916,0.956,None
ukb-b-6863,Operation code: caesarean section / caesarian section,cesarean section,EFO:0009636,http://www.ebi.ac.uk/efo/EFO_0009636,0.881,None
ukb-e-104920_CSA,Time spent doing light physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.662,None
ukb-d-C_DIGESTIVE_ORGANS,Cancer of digestive organs,digestive system cancer,MONDO:0002516,http://purl.obolibrary.org/obo/MONDO_0002516,0.686,None
finn-b-AB1_MALARIA,Malaria,malaria,EFO:0001068,http://www.ebi.ac.uk/efo/EFO_0001068,0.995,None
finn-b-D3_ACQHAEMOLYTICANAEMIANAS,Other and unspecified acquired haemolytic anaemias,Congenital hemolytic anemia,HP:0004804,http://purl.obolibrary.org/obo/HP_0004804,0.834,None
ieu-a-1171,Knee osteoarthritis,"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.989,None
ukb-e-recode246_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20004_p18_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-ILD_ENDPOINTS,Interstitial lung disease endpoints,Abnormal pulmonary interstitial morphology,HP:0006530,http://purl.obolibrary.org/obo/HP_0006530,0.765,None
finn-b-CD2_BENIGN_CONNSOFT_NOS_EXALLC,"""Benign neoplasm: Connective and other soft tissue, unspecified"" (all cancers excluded)",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.915,None
ukb-e-30080_MID,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
finn-b-CARDIAC_ARRHYTM,Cardiac arrhytmias,cardiac arrhythmia,EFO:0004269,http://www.ebi.ac.uk/efo/EFO_0004269,0.761,None
finn-b-H7_ORBIT,Disorders of orbit,disease of orbital region,EFO:0009664,http://www.ebi.ac.uk/efo/EFO_0009664,0.705,None
ukb-e-738_p1_CSA,Average total household income before tax,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.635,None
ukb-d-22601_31193034,"Job coding: other science technician, materials technician, technical assistant, technical officer",technician,EFO:0009739,http://www.ebi.ac.uk/efo/EFO_0009739,0.878,None
ukb-e-2395_p1_AFR,Hair/balding pattern,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.62,None
ukb-a-159,Treatment/medication code: metformin,metformin measurement,EFO:0801177,http://www.ebi.ac.uk/efo/EFO_0801177,0.692,None
ukb-e-1259_AFR,Smoking/smokers in household,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.68,None
ukb-b-3798,Fractured bone site(s): Leg,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.716,None
finn-b-CD2_BENIGN_INTRATHORACIC_EXALLC,Benign neoplasm of other and unspecified intrathoracic organs (all cancers excluded),thoracic benign neoplasm,MONDO:0000634,http://purl.obolibrary.org/obo/MONDO_0000634,0.733,None
ieu-a-1085,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO:0004976,http://purl.obolibrary.org/obo/MONDO_0004976,0.993,None
ukb-d-M06,Diagnoses - main ICD10: M06 Other rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.729,None
finn-b-CD2_BENIGN_BONE_LONG_LOWER_EXALLC,Benign neoplasm: Long bones of lower limb (all cancers excluded),cancer of long bone of lower limb,MONDO:0000952,http://purl.obolibrary.org/obo/MONDO_0000952,0.792,None
finn-b-H8_EUSTNAS,Other disorders of Eustachian tube,eustachian tube disease,EFO:0009667,http://www.ebi.ac.uk/efo/EFO_0009667,0.962,None
ieu-b-91,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
finn-b-I9_OTHOTH,Other other unspecified disorders of the circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.951,None
finn-b-KRA_PSY_SCHIZODEL_EXMORE,Schizophrenia or delusion (more controls excluded),schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.802,None
ukb-e-134_p1_EAS,Number of self-reported cancers,"number of cancers, self-reported",EFO:0009800,http://www.ebi.ac.uk/efo/EFO_0009800,0.808,None
ebi-a-GCST006649,Menstruation quality of life impact (nervousness),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.634,None
finn-b-CD2_BENIGN_PAROTID_EXALLC,Benign neoplasm: Parotid gland (all cancers excluded),parotid neoplasm,EFO:0003873,http://www.ebi.ac.uk/efo/EFO_0003873,0.804,None
finn-b-H7_RETINOPATHYDIAB_BKG,Diabetic background retinopathy,non-proliferative diabetic retinopathy,EFO:0009760,http://www.ebi.ac.uk/efo/EFO_0009760,0.849,None
ukb-e-20111_p4_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-670_p1_AFR,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
ukb-e-6149_p5_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
finn-b-CD2_TNK_LYMPHOMA,Mature T/NK-cell lymphomas,T-cell non-Hodgkin lymphoma,MONDO:0015760,http://purl.obolibrary.org/obo/MONDO_0015760,0.688,None
finn-b-O15_MATERN_HYPERT_UNS,Unspecified maternal hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.796,None
finn-b-M13_PSORIARTH,Psoriatic arthropathies,psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.868,None
ukb-e-47_MID,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
ukb-d-41218_1,History of psychiatric care on admission: One or more previous psychiatric episodes with this Health Care Provider,psychiatric disorder,MONDO:0002025,http://purl.obolibrary.org/obo/MONDO_0002025,0.621,None
finn-b-N14_INFLAMALEGEN,"Inflammatory disorders of male genital organs, not elsewhere classified",inflammatory disease,EFO:0009903,http://www.ebi.ac.uk/efo/EFO_0009903,0.693,None
finn-b-C3_OTHER_SKIN_EXALLC,Other malignant neoplasms of skin (=non-melanoma skin cancer) (all cancers excluded),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.731,None
finn-b-N14_RENALTUBULOOTH,Other renal tubulo-interstitial diseases,interstitial nephritis,MONDO:0001085,http://purl.obolibrary.org/obo/MONDO_0001085,0.79,None
finn-b-J10_PLEURA,Other diseases of pleura,pleural disorder,MONDO:0002037,http://purl.obolibrary.org/obo/MONDO_0002037,0.929,None
finn-b-Z21_LUNG_TRANSPLANT_STATUS,Lung transplant status,lung transplantation,EFO:0010721,http://www.ebi.ac.uk/efo/EFO_0010721,0.844,None
finn-b-CD2_INSITU_CERVIX_UTERI_EXOCERVIX,"Carcinoma in situ of cervix uteri, exocervix",uterine cervix carcinoma in situ,MONDO:0042487,http://purl.obolibrary.org/obo/MONDO_0042487,0.849,None
ukb-d-H7_LACRIMALSYSTEM,Disorders of lacrimal system,lacrimal apparatus disease,EFO:0009455,http://www.ebi.ac.uk/efo/EFO_0009455,0.95,None
finn-b-CD2_BENIGN_PERIPH_AUTO_NEURO,Benign neoplasm: Peripheral nerves and autonomic nervous system,benign neoplasm of peripheral nervous system,MONDO:0056804,http://purl.obolibrary.org/obo/MONDO_0056804,0.83,None
finn-b-K11_OTHPERITON,Other diseases of peritoneum,disease of peritoneum,EFO:0009541,http://www.ebi.ac.uk/efo/EFO_0009541,0.944,None
ukb-e-1508_p1_EAS,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
ukb-d-M13_ROTATORCUFF,Rotator cuff syndrome,rotator cuff tear,EFO:1001250,http://www.ebi.ac.uk/efo/EFO_1001250,0.952,None
finn-b-O15_PREG_OTHER_MAT_DISORD,Other maternal disorders predominantly related to pregnancy,pregnancy disorder,EFO:0009682,http://www.ebi.ac.uk/efo/EFO_0009682,0.606,None
ukb-e-1269_MID,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
finn-b-F5_SPEECH,Specific development disorders of speech and language,Absent speech,HP:0001344,http://purl.obolibrary.org/obo/HP_0001344,0.792,None
finn-b-K11_BARRET,Barret oesophagus,Barrett's esophagus,EFO:0000280,http://www.ebi.ac.uk/efo/EFO_0000280,0.814,None
ukb-e-30630_MID,Apolipoprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.853,None
finn-b-H7_LACRIGLAND,Other disorders of lacrimal gland,disorder of lacrimal gland,MONDO:0024625,http://purl.obolibrary.org/obo/MONDO_0024625,0.95,None
ukb-a-206,Illnesses of father: Chronic bronchitis/emphysema,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.659,None
ukb-e-20111_p4_EAS,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-CD2_BENIGN_OESOPHAGUS_EXALLC,Benign neoplasm: Oesophagus (all cancers excluded),neoplasm of esophagus,MONDO:0021355,http://purl.obolibrary.org/obo/MONDO_0021355,0.705,None
finn-b-PD_DEMENTIA,Dementia due to Parkinsons disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.691,None
finn-b-K11_DISOESINOTH,Disorders of oesophagus in diseases classified elsewhere,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.802,None
ukb-a-87,Non-cancer illness code  self-reported: osteoporosis,osteoporosis,EFO:0003882,http://www.ebi.ac.uk/efo/EFO_0003882,0.639,None
ukb-e-41231_AFR,Hospital episode type,episodic ataxia type 1,MONDO:0008047,http://purl.obolibrary.org/obo/MONDO_0008047,0.634,None
finn-b-G6_HEREMOSEN,Hereditary monor and sensory neuropathy,hereditary sensory and autonomic neuropathy,MONDO:0015364,http://purl.obolibrary.org/obo/MONDO_0015364,0.916,None
ukb-b-4693,Treatment/medication code: co-enzyme q10/ubiquinone/bio-quinone/coenzyme q10,coenzyme Q10 measurement,EFO:0007836,http://www.ebi.ac.uk/efo/EFO_0007836,0.688,None
ukb-e-1269_AFR,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
finn-b-P16_MECONIUMI_CAUSED_CYSTIC_FIBROSIS,Meconiumileus caused by cystic fibrosis,cystic fibrosis associated meconium ileus,EFO:0004608,http://www.ebi.ac.uk/efo/EFO_0004608,0.721,None
finn-b-FEMNINGHER_UNILATERAL,"Inguinal of femoral hernia, unilateral",femoral hernia,EFO:1001791,http://www.ebi.ac.uk/efo/EFO_1001791,0.677,None
finn-b-C3_BREAST,Malignant neoplasm of breast,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.988,None
finn-b-H8_EXT_OTH,Other otitis externa (chronic),otitis externa,EFO:0009560,http://www.ebi.ac.uk/efo/EFO_0009560,0.813,None
ukb-a-63,Non-cancer illness code  self-reported: heart attack/myocardial infarction,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.628,None
ukb-e-E66_AFR,E66 Obesity,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.715,None
ukb-e-recode174_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-D3_ANAEMIA,Anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.827,None
ukb-b-12931,Operation code: ovarian cyst removal/surgery,Ovarian cyst,HP:0000138,http://purl.obolibrary.org/obo/HP_0000138,0.656,None
finn-b-R18_ANURIA_OLIGU,Anuria and oliguria,anuria,EFO:0009530,http://www.ebi.ac.uk/efo/EFO_0009530,0.738,None
finn-b-AB1_VIRAN_CNS_INFECTIONS_NOS,"Viral infections of central nervous system, not elsewhere classified/unspecified",viral infection of central nervous system,MONDO:0024318,http://purl.obolibrary.org/obo/MONDO_0024318,0.965,None
ieu-a-293,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
ebi-a-GCST006638,Menstruation quality of life impact (fever),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.709,None
finn-b-C3_DLBCL_EXALLC,Diffuse large B-cell lymphoma (all cancers excluded),diffuse large B-cell lymphoma,EFO:0000403,http://www.ebi.ac.uk/efo/EFO_0000403,0.801,None
ukb-b-15592,Operation code: varicose vein surgery,Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.628,None
ukb-e-recode268_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-L12_PSORI_VULG,Psoriasis vulgaris,psoriasis vulgaris,EFO:1001494,http://www.ebi.ac.uk/efo/EFO_1001494,0.991,None
finn-b-M13_TIBIALCOLLATERAL,Tibial collateral bursitis [Pellegrini-Stieda],tibial collateral ligament bursitis,MONDO:0001747,http://purl.obolibrary.org/obo/MONDO_0001747,0.624,None
finn-b-VD_U,Vascular dementia (undefined),vascular dementia,EFO:0004718,http://www.ebi.ac.uk/efo/EFO_0004718,0.995,None
finn-b-M13_ENTESOPATHYFOOT,Oher enthesopathy of foot (+metatarsalgia),metatarsalgia,EFO:1001370,http://www.ebi.ac.uk/efo/EFO_1001370,0.611,None
ukb-e-recode371_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-C3_COLON_ADENO_EXALLC,Colon adenocarcinoma (all cancers excluded),colon adenocarcinoma,EFO:1001949,http://www.ebi.ac.uk/efo/EFO_1001949,0.901,None
ieu-a-1130,Breast cancer (iCOGS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.687,None
finn-b-C3_FEMALE_GENITAL,malignant neoplasm of female genital organs,"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.952,None
finn-b-CD2_INSITU_CERVIX_UTERI,Carcinoma in situ of cervix uteri,uterine cervix carcinoma in situ,MONDO:0042487,http://purl.obolibrary.org/obo/MONDO_0042487,0.949,None
finn-b-E4_THYROIDITAUTOIM,Autoimmune thyroiditis,Hashimoto's thyroiditis,EFO:0003779,http://www.ebi.ac.uk/efo/EFO_0003779,0.995,None
finn-b-L12_PSORI_NAS,Other and unspecified psoriasis,psoriasis,EFO:0000676,http://www.ebi.ac.uk/efo/EFO_0000676,0.993,None
ukb-e-K21_AFR,K21 Gastro-oesophageal reflux disease,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.859,None
finn-b-R18_POLYURIA,Polyuria,Polyuria,HP:0000103,http://purl.obolibrary.org/obo/HP_0000103,0.986,None
ieu-a-804,Major depressive disorder,major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.987,None
finn-b-E4_CA_MET,Disorders of calcium metabolism,calcium metabolic disease,EFO:0005769,http://www.ebi.ac.uk/efo/EFO_0005769,0.98,None
ukb-e-6149_p7_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-recode286_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_DEMINOTH,Dementia in other diseases classified elsewhere,Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.784,None
finn-b-N14_TUBULOINTNEPHRNAS,"Tubulo-interstitial nephritis, not spesified as acute or chronic",Chronic tubulointerstitial nephritis,HP:0004743,http://purl.obolibrary.org/obo/HP_0004743,0.748,None
finn-b-I9_RHEUVALV_EXNONE,Rheumatic valve diseases (no controls excluded),rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.737,None
finn-b-G6_POSTZOST,Postzoster neuralgia,postherpetic neuralgia,MONDO:0041052,http://purl.obolibrary.org/obo/MONDO_0041052,0.672,None
ukb-e-recode182_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30220_CSA,Basophill percentage,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.917,None
ieu-b-4875,brain cancer,brain cancer,MONDO:0001657,http://purl.obolibrary.org/obo/MONDO_0001657,0.992,None
finn-b-N14_CALCULOWER,Calculus of lower urinary tract,lower urinary tract calculus,MONDO:0004828,http://purl.obolibrary.org/obo/MONDO_0004828,0.983,None
finn-b-CD2_NONHODGKIN_NAS_EXALLC,Other and unspecified types of non-Hodgkin lymphoma (all cancers excluded),Hodgkins lymphoma,EFO:0000183,http://www.ebi.ac.uk/efo/EFO_0000183,0.814,None
finn-b-I9_HEARTFAIL_ALLCAUSE,All-cause Heart Failure,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.85,None
finn-b-I9_ENDOCARD_EXNONE,Endocarditis (no controls excluded),endocarditis,EFO:0000465,http://www.ebi.ac.uk/efo/EFO_0000465,0.926,None
finn-b-F5_ORGANIC,"Organic, including symptomatic, mental disorders",cognitive disorder,MONDO:0002039,http://purl.obolibrary.org/obo/MONDO_0002039,0.649,None
finn-b-KRA_PSY_SCHIZODEL,Schizophrenia or delusion,schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.802,None
ukb-a-473,Pain type(s) experienced in last month: Back pain,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.616,None
ukb-e-recode110_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-G6_MIGRAINE_NO_AURA_TRIPTAN,Migraine without aura and triptan purchases,migraine without aura,MONDO:0100431,http://purl.obolibrary.org/obo/MONDO_0100431,0.723,None
finn-b-CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC,"""Benign neoplasm: Pituitary gland, craniopharyngeal duct"" (all cancers excluded)",benign neoplasm of pituitary gland,MONDO:0021439,http://purl.obolibrary.org/obo/MONDO_0021439,0.708,None
finn-b-C3_BONE_CARTILAGE,Malignant neoplasm of bone and articular cartilage,chondrogenic neoplasm,MONDO:0024469,http://purl.obolibrary.org/obo/MONDO_0024469,0.726,None
ukb-e-23123_CSA,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
finn-b-CD2_BENIGN_CONNSOFT_LOWERLIMB,"Benign neoplasm: Connective and other soft tissue of lower limb, including hip",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.738,None
ukb-e-6148_p2_CSA,Eye problems/disorders,eye disease,EFO:0003966,http://www.ebi.ac.uk/efo/EFO_0003966,0.704,None
ebi-a-GCST90016612,Major depressive disorder vs ADHD (ordinary least squares (OLS)),major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.741,None
ukb-e-5111_AFR,3mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
finn-b-CD2_FOLLICULAR_LYMPHOMA,Follicular lymphoma,follicular lymphoma,MONDO:0018906,http://purl.obolibrary.org/obo/MONDO_0018906,0.995,None
finn-b-K11_OTHANRECT,Other diseases of anus and rectum,rectal disease,EFO:0009685,http://www.ebi.ac.uk/efo/EFO_0009685,0.782,None
finn-b-H8_OTHHEARINGLOSS,Other hearing loss,hearing loss,EFO:0004238,http://www.ebi.ac.uk/efo/EFO_0004238,0.99,None
finn-b-CD2_BENIGN_CHOROID,Benign neoplasm: Choroid,benign neoplasm of choroid,MONDO:0021487,http://purl.obolibrary.org/obo/MONDO_0021487,0.996,None
ukb-e-21000_p10_CSA,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-J10_PLEURPLAGUE,Pleural plaque,neuritic plaque measurement,EFO:0006798,http://www.ebi.ac.uk/efo/EFO_0006798,0.64,None
finn-b-AB1_HERPES_SIMPLEX,Herpesviral [herpes simplex] infections,Herpes simplex infection,EFO:1002022,http://www.ebi.ac.uk/efo/EFO_1002022,0.845,None
ukb-e-20111_p11_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-H7_CHALAZION,Chalazion,meibomian cyst,EFO:0007363,http://www.ebi.ac.uk/efo/EFO_0007363,0.993,None
finn-b-H7_EPISCLERITIS,Episcleritis,Episcleritis,HP:0100534,http://purl.obolibrary.org/obo/HP_0100534,0.994,None
ukb-e-4079_EAS,"Diastolic blood pressure, automated reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
finn-b-M13_ARTHINOTH,Arthropathies in other diseases classified elsewhere,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.678,None
finn-b-ALCOHOLMENTAL,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.627,None
finn-b-C3_EYE_ADNEXA_EXALLC,Malignant neoplasm of eye and adnexa (all cancers excluded),ocular cancer,MONDO:0002236,http://purl.obolibrary.org/obo/MONDO_0002236,0.735,None
finn-b-C3_COLON,Malignant neoplasm of colon,malignant colon neoplasm,MONDO:0021063,http://purl.obolibrary.org/obo/MONDO_0021063,0.995,None
bbj-a-80,Smoking behaviors : Smoking initiation,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.852,None
ukb-e-20111_p13_MID,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-L12_PERIORALDERM,Perioral dermatitis,"Dermatitis, Perioral",EFO:1001305,http://www.ebi.ac.uk/efo/EFO_1001305,0.911,None
finn-b-KRA_PSY_ALCOH,"Alcohol abuse, main dg",alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.807,None
ukb-e-30870_AFR,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
finn-b-CD2_BENIGN_OVARY,Benign neoplasm of ovary,Benign Ovarian Neoplasm,EFO:1000116,http://www.ebi.ac.uk/efo/EFO_1000116,0.995,None
finn-b-GIANT_CELL_TEMP_ARTERITIS,Giant cell arteritis with polymyalgia rheumatica,temporal arteritis,EFO:1001209,http://www.ebi.ac.uk/efo/EFO_1001209,0.792,None
ukb-e-103140_AFR,Fish consumer,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.638,None
finn-b-AMN2,Transient global amnesia,amnestic disorder,MONDO:0001152,http://purl.obolibrary.org/obo/MONDO_0001152,0.673,None
finn-b-CD2_BENIGN_BONE_SKULL_FACE,Benign neoplasm: Bones of skull and face,skull neoplasm,MONDO:0024653,http://purl.obolibrary.org/obo/MONDO_0024653,0.749,None
ukb-b-873,Fractured bone site(s): Spine,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.711,None
finn-b-M13_ANKYLOSPON,Ankylosing spondylitis,ankylosing spondylitis,EFO:0003898,http://www.ebi.ac.uk/efo/EFO_0003898,0.994,None
ukb-e-recode54_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST003156,Systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
ieu-a-1123,Invasive mucinous ovarian cancer,mucinous ovarian cancer,MONDO:0024282,http://purl.obolibrary.org/obo/MONDO_0024282,0.815,None
ukb-e-30520_EAS,Potassium in urine,urinary potassium measurement,EFO:0010952,http://www.ebi.ac.uk/efo/EFO_0010952,0.875,None
finn-b-CD2_BENIGN_LEIOMYOMA_UTERI,Leiomyoma of uterus,uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.867,None
ukb-b-13348,"Cancer code, self-reported: prostate cancer",prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.737,None
finn-b-N14_OVARYCYST,Ovarian cyst,Ovarian cyst,HP:0000138,http://purl.obolibrary.org/obo/HP_0000138,0.991,None
finn-b-HYPOTHYROIDISM,Hypothyroidism (congenital or acquired),congenital hypothyroidism,MONDO:0018612,http://purl.obolibrary.org/obo/MONDO_0018612,0.991,None
finn-b-P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD,Respiratory and cardiovascular disorders specific to the perinatal period,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.626,None
ukb-e-46_CSA,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
finn-b-C3_SCLC,Small cell lung cancer,small cell lung carcinoma,EFO:0000702,http://www.ebi.ac.uk/efo/EFO_0000702,0.993,None
finn-b-G6_NERPLEX,"Nerve, nerve root and plexus disorders",nerve plexus disease,EFO:0009559,http://www.ebi.ac.uk/efo/EFO_0009559,0.839,None
ukb-d-BRONCHITIS,Bronchitis,bronchitis,EFO:0009661,http://www.ebi.ac.uk/efo/EFO_0009661,0.995,None
ukb-e-306_AFR,Other mental disorder,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.994,None
ukb-b-16818,"Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux",gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.799,None
finn-b-AB1_OTHER_CONDITIONS,Human immunodeficiency virus [HIV] disease resulting in other conditions,HIV infection,EFO:0000764,http://www.ebi.ac.uk/efo/EFO_0000764,0.849,None
ukb-e-6034_CSA,Target heart rate achieved,"achievement of target heart rate, self-reported",EFO:0009823,http://www.ebi.ac.uk/efo/EFO_0009823,0.658,None
ukb-a-352,Former alcohol drinker,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.625,None
ukb-d-22611_2,Workplace had a lot of cigarette smoke from other people smoking: Often,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.63,None
ukb-e-recode105_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-353,Knee pain for 3+ months,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.712,None
finn-b-F5_ALCOHOL_DEPENDENCE,Alcohol dependence,alcohol dependence,MONDO:0007079,http://purl.obolibrary.org/obo/MONDO_0007079,0.992,None
ukb-e-46_MID,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
finn-b-K11_ANOMALI_DENTAL_ARCH_RELATIONS1,Anomalies of dental arch relationship,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.642,None
finn-b-H7_CHOROIDOTH,Other disorders of choroid,optic choroid disorder,MONDO:0001898,http://purl.obolibrary.org/obo/MONDO_0001898,0.903,None
finn-b-L12_LUPUS,Lupus erythematosus,lupus erythematosus,MONDO:0004670,http://purl.obolibrary.org/obo/MONDO_0004670,0.995,None
finn-b-G6_ALZHEIMER,Alzheimer disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
finn-b-I9_PULMOTHHD_EXNONE,Other pulmonary heart/vessel disease (no controls excluded),cor pulmonale,MONDO:0004596,http://purl.obolibrary.org/obo/MONDO_0004596,0.83,None
ukb-b-1962,Operation code: bilateral oophorectomy,bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.881,None
ukb-e-recode44_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_CARDMYOOTH,"Cardiomyopathy, other and unspecified",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.996,None
ukb-d-III_BLOOD_IMMUN,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.686,None
ukb-d-N84,Diagnoses - main ICD10: N84 Polyp of female genital tract,female genital tract polyp,EFO:0008622,http://www.ebi.ac.uk/efo/EFO_0008622,0.764,None
finn-b-G6_PLANTAR,Lesion of plantar nerve,radial nerve lesion,EFO:1001143,http://www.ebi.ac.uk/efo/EFO_1001143,0.63,None
ukb-b-5188,"Non-cancer illness code, self-reported: ear/vestibular disorder",vestibular disease,EFO:0009691,http://www.ebi.ac.uk/efo/EFO_0009691,0.656,None
ukb-e-30810_AFR,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
finn-b-D3_ANAEMIA_IRONDEF,Iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.968,None
bbj-a-123,Graves' disease,Graves disease,EFO:0004237,http://www.ebi.ac.uk/efo/EFO_0004237,0.985,None
ebi-a-GCST90013429,Amyotrophic lateral sclerosis,amyotrophic lateral sclerosis,MONDO:0004976,http://purl.obolibrary.org/obo/MONDO_0004976,0.993,None
ukb-e-recode14_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_PERSONAL_HISTORY_RISK__NOT_ELSEW_CLASSIFIED,"Personal history of risk-factors, not elsewhere classified",risk factor,EFO:0003919,http://www.ebi.ac.uk/efo/EFO_0003919,0.704,None
finn-b-CD2_BENIGN_BRAIN_CNS_EXALLC,Benign neoplasm of brain and other parts of central nervous system (all cancers excluded),central nervous system organ benign neoplasm,MONDO:0000628,http://purl.obolibrary.org/obo/MONDO_0000628,0.804,None
finn-b-WEIGHTLOSS,Weight loss,Weight loss,HP:0001824,http://purl.obolibrary.org/obo/HP_0001824,0.985,None
ukb-b-18366,Diagnoses - main ICD10: I26.9 Pulmonary embolism without mention of acute cor pulmonale,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.685,None
ebi-a-GCST006910,Ischemic stroke (cardioembolic),cardioembolic stroke,EFO:1001976,http://www.ebi.ac.uk/efo/EFO_1001976,0.848,None
ukb-e-recode102_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-C3_MELANOMA_SKIN,Malignant melanoma of skin,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.988,None
finn-b-F5_SLEEP,Sleep disorders,sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.99,None
finn-b-I9_PERICAOTH_EXNONE,Other diseases of pericardium (no controls excluded),pericardium disorder,MONDO:0000474,http://purl.obolibrary.org/obo/MONDO_0000474,0.888,None
finn-b-M13_PATELLADISLOCATIO,Recurrent dislocation of patella,Patellar dislocation,HP:0002999,http://purl.obolibrary.org/obo/HP_0002999,0.808,None
finn-b-F5_PSYTRANS,Acute and transient psychotic disorders,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.768,None
ukb-e-401_MID,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
ukb-b-11664,"Diagnoses - secondary ICD10: R00.1 Bradycardia, unspecified",Bradycardia,HP:0001662,http://purl.obolibrary.org/obo/HP_0001662,0.683,None
finn-b-E4_THYROID,Disorders of the thyroid gland,thyroid disease,EFO:1000627,http://www.ebi.ac.uk/efo/EFO_1000627,0.97,None
ukb-e-3799_AFR,Headaches for 3+ months,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.737,None
ukb-e-1269_CSA,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
finn-b-D3_THROMBOCYTOPENIANAS,"Thrombocytopenia, unspecified",Thrombocytopenia,HP:0001873,http://purl.obolibrary.org/obo/HP_0001873,0.989,None
finn-b-C3_RECTOSIGMOID_JUNCTION,Malignant neoplasm of rectosigmoid junction,rectosigmoid junction neoplasm,MONDO:0002423,http://purl.obolibrary.org/obo/MONDO_0002423,0.886,None
ukb-d-STILL_ADULT,Adult-onset Still disease,adult-onset Still's disease,EFO:0007135,http://www.ebi.ac.uk/efo/EFO_0007135,0.822,None
ukb-e-100023_CSA,Starch,multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,MONDO:0009359,http://purl.obolibrary.org/obo/MONDO_0009359,0.662,None
finn-b-CD2_BENIGN_PANCREAS_EXALLC,Benign neoplasm: Pancreas (all cancers excluded),benign neoplasm of pancreas,MONDO:0021470,http://purl.obolibrary.org/obo/MONDO_0021470,0.912,None
finn-b-ST19_FRACT_SKULL_FACIAL_BONES,Fracture of skull and facial bones,Skull Fractures,EFO:1001425,http://www.ebi.ac.uk/efo/EFO_1001425,0.774,None
ukb-e-49_CSA,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ukb-a-586,Diagnoses - main ICD10: R35 Polyuria,Polyuria,HP:0000103,http://purl.obolibrary.org/obo/HP_0000103,0.632,None
finn-b-PDSTRICT,"Parkinson's disease, strict definition",Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
finn-b-H8_OTIMEDNAS,"Otitis media, unspecified",Otitis media,EFO:0004992,http://www.ebi.ac.uk/efo/EFO_0004992,0.985,None
ukb-a-64,Non-cancer illness code  self-reported: pulmonary embolism +/- dvt,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.65,None
ukb-d-M13_DORSALGIA,Dorsalgia,dorsal,EFO:0001656,http://www.ebi.ac.uk/efo/EFO_0001656,0.722,None
ukb-e-30760_AFR,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
ukb-b-15835,Vitamin and/or mineral supplement use: Multivitamin,vitamin measurement,EFO:0004729,http://www.ebi.ac.uk/efo/EFO_0004729,0.613,None
finn-b-H7_DIVERGSTRAB,Divergent concomitant strabismus,Strabismus,HP:0000486,http://purl.obolibrary.org/obo/HP_0000486,0.629,None
ieu-a-23,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-b-7196,Delivery methods: Elective caesarean section,cesarean section,EFO:0009636,http://www.ebi.ac.uk/efo/EFO_0009636,0.657,None
finn-b-ASTHMA_MODE,Asthma (mode),asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.809,None
ukb-e-1940_MID,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
ukb-e-20003_p564_EAS,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-E4_DM2OPTH,Type 2 diabetes with ophthalmic complications,ophthalmic herpes zoster,EFO:0007403,http://www.ebi.ac.uk/efo/EFO_0007403,0.623,None
ukb-e-2090_MID,"Seen doctor (GP) for nerves, anxiety, tension or depression",mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
ukb-e-1845_CSA,Mother's age,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.615,None
finn-b-O15_LABOUR_UMBILICAL,Labour and delivery complicated by umbilical cord complications,Abnormal delivery,HP:0001787,http://purl.obolibrary.org/obo/HP_0001787,0.737,None
finn-b-Q17_OTHER_CONGEN_MALFO_EAR,Other congenital malformations of ear,congenital heart malformation,EFO:0005269,http://www.ebi.ac.uk/efo/EFO_0005269,0.798,None
finn-b-H7_EYELIDDIS,Other disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.935,None
ukb-b-16364,Diagnoses - secondary ICD10: Z87.1 Personal history of diseases of the digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.617,None
finn-b-CD2_BENIGN_CONNSOFT_HEADFACETRUNK,"Benign neoplasm: Connective and other soft tissue of head, face and neck",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.847,None
ukb-a-112,Non-cancer illness code  self-reported: polio / poliomyelitis,poliomyelitis,EFO:0007450,http://www.ebi.ac.uk/efo/EFO_0007450,0.71,None
ukb-d-I9_STR,"Stroke, excluding SAH",subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.705,None
ukb-b-8746,Illnesses of siblings: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.711,None
ieu-a-818,Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
ukb-e-4123_EAS,"Heel quantitative ultrasound index (QUI), direct entry (right)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.634,None
finn-b-H7_ECTROPION,Ectropion of eyelid,ectropion,MONDO:0002043,http://purl.obolibrary.org/obo/MONDO_0002043,0.996,None
finn-b-CD2_BENIGN_PERIPH_AUTO_NEURO_EXALLC,Benign neoplasm: Peripheral nerves and autonomic nervous system (all cancers excluded),benign neoplasm of peripheral nervous system,MONDO:0056804,http://purl.obolibrary.org/obo/MONDO_0056804,0.802,None
ukb-e-1518_EAS,Hot drink temperature,temperature,EFO:0001702,http://www.ebi.ac.uk/efo/EFO_0001702,0.691,None
finn-b-H7_VITREOUS,Disorders of vitreous body and globe,vitreous body disease,EFO:0008624,http://www.ebi.ac.uk/efo/EFO_0008624,0.81,None
finn-b-G6_VASCSYND,Vascular syndromes of brain in cerebrovascular disorders (G6_VASCSYND),cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.672,None
ukb-e-1239_CSA,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
ukb-e-102_EAS,"Pulse rate, automated reading",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
finn-b-CD2_BENIGN_LIPO_SKIN_LIMBS,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.67,None
finn-b-C3_CANCER,Malignant neoplasm,cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.997,None
ukb-e-104010_CSA,Pulses intake,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.623,None
finn-b-COPD_MODE,COPD (mode),chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.801,None
finn-b-L12_CUTLAXSEN,Cutis laxa senilis,cutis laxa,MONDO:0016175,http://purl.obolibrary.org/obo/MONDO_0016175,0.805,None
ukb-e-52_p5_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-a-116,Treatment/medication code: lisinopril,lisinopril measurement,EFO:0801175,http://www.ebi.ac.uk/efo/EFO_0801175,0.671,None
finn-b-M13_HALLUXRIGIDUS,Hallux rigidus,Hallux rigidus,HP:0025004,http://purl.obolibrary.org/obo/HP_0025004,0.992,None
finn-b-E4_THYTOXNOD,Thyrotoxicosis with toxic single thyroid nodule,Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.783,None
finn-b-ST19_OTHER_UNSPE_INJURI_THORAX,Other and unspecified injuries of thorax,neoplasm of thorax,MONDO:0021350,http://purl.obolibrary.org/obo/MONDO_0021350,0.628,None
finn-b-CHRONSMALL,Crohn's disease of small interstine,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.712,None
ukb-e-recode319_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-137_CSA,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
finn-b-M13_NECROVASCNAS,Other specified/unspecified necrotizing vasculopathies,necrotizing vasculitis,MONDO:0800113,http://purl.obolibrary.org/obo/MONDO_0800113,0.747,None
finn-b-COPD_ASTHMA_PNEUMONIA_SEPSIS,COPD/asthma related pneumonia or pneumonia derived septichaemia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.749,None
finn-b-GAST_OPER,Any gastric operation,stomach disease,EFO:0009608,http://www.ebi.ac.uk/efo/EFO_0009608,0.624,None
finn-b-K11_CHOLELITH,Cholelithiasis,cholelithiasis,EFO:0004799,http://www.ebi.ac.uk/efo/EFO_0004799,0.988,None
ukb-e-recode196_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-11874,"Diagnoses - secondary ICD10: M06.99 Rheumatoid arthritis, unspecified (Site unspecified)",rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.622,None
ukb-e-23099_EAS,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
finn-b-M13_NEURALGIA,"Neuralgia and neuritis, unspecified",neuralgia,EFO:0009430,http://www.ebi.ac.uk/efo/EFO_0009430,0.834,None
ukb-e-20003_p263_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-d-20536_2,Weight change during worst episode of depression: Lost weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.642,None
finn-b-N14_DIALYSIS,Dialysis,renal dialysis,EFO:0010690,http://www.ebi.ac.uk/efo/EFO_0010690,0.805,None
ukb-e-recode368_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-558_CSA,Noninfectious gastroenteritis,gastroenteritis,EFO:1001463,http://www.ebi.ac.uk/efo/EFO_1001463,0.743,None
finn-b-CD2_BENIGN_SKIN_EAR,Benign neoplasm: Skin of ear and external auricular canal,cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.63,None
ukb-e-20018_CSA,Prospective memory result,episodic memory,EFO:0004333,http://www.ebi.ac.uk/efo/EFO_0004333,0.805,None
finn-b-CD2_INSITU_SKIN_EAR_EXALLC,Carcinoma in situ of skin of ear and external auricular canal (all cancers excluded),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.625,None
finn-b-I9_STR_EXH_EXNONE,"""Ischaemic Stroke, excluding all haemorrhages"" (no controls excluded)",Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.776,None
ukb-e-5265_AFR,Corneal resistance factor (left),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.903,None
ieu-b-90,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
finn-b-N14_CHRONTUBULOINTNEPHRITIS,Chronic tubulo-interstitial nephritis,Chronic tubulointerstitial nephritis,HP:0004743,http://purl.obolibrary.org/obo/HP_0004743,0.912,None
ukb-e-137_AFR,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
ieu-a-85,Extreme body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.779,None
ukb-e-726_CSA,Peripheral enthesopathies and allied syndromes,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.61,None
finn-b-CD2_BENIGN_MENINGES_CEREBRAL_EXALLC,Benign neoplasm: Cerebral meninges (all cancers excluded),meningeal neoplasm,EFO:0003851,http://www.ebi.ac.uk/efo/EFO_0003851,0.694,None
ukb-e-20003_p118_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-3571_CSA,Back pain for 3+ months,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.671,None
ukb-e-1548_CSA,Variation in diet,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.604,None
finn-b-E4_PLASMAPROT,"Disorders of plasma-protein metabolism, not elsewhere classified",plasma protein metabolism disease,MONDO:0002273,http://purl.obolibrary.org/obo/MONDO_0002273,0.829,None
finn-b-D3_IMMUDEFOTHER,Other immunodeficiencies,Immunodeficiency,HP:0002721,http://purl.obolibrary.org/obo/HP_0002721,0.825,None
finn-b-CD2_BENIGN_UTERUS_OTH,Other benign neoplasms of uterus,uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.979,None
ebi-a-GCST007236,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
ukb-a-490,Medication for cholesterol  blood pressure or diabetes: Blood pressure medication,blood pressure,EFO:0004325,http://www.ebi.ac.uk/efo/EFO_0004325,0.726,None
ukb-e-recode422_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_THROMBOTH,Other embolism and thrombosis,Thromboembolism,HP:0001907,http://purl.obolibrary.org/obo/HP_0001907,0.953,None
finn-b-N14_PROHERNOV,Prolapse and hernia of ovary and fallopian tube,fallopian tube disease,EFO:0009548,http://www.ebi.ac.uk/efo/EFO_0009548,0.659,None
finn-b-CD2_INSITU_CERVIX_UTERI_EXALLC,Carcinoma in situ of cervix uteri (all cancers excluded),uterine cervix carcinoma in situ,MONDO:0042487,http://purl.obolibrary.org/obo/MONDO_0042487,0.895,None
ukb-b-6026,Diagnoses - main ICD10: M20.1 Hallux valgus (acquired),Hallux valgus,HP:0001822,http://purl.obolibrary.org/obo/HP_0001822,0.728,None
finn-b-ST19_FRACT_NECK,Fracture of neck,femoral neck fracture,EFO:1001792,http://www.ebi.ac.uk/efo/EFO_1001792,0.786,None
finn-b-C3_RESPIRATORY_INTRATHORACIC_EXALLC,Malignant neoplasm of respiratory system and intrathoracic organs (all cancers excluded),respiratory system cancer,MONDO:0000376,http://purl.obolibrary.org/obo/MONDO_0000376,0.754,None
finn-b-I9_HYPERTROCARDMYOP,Hypertrophic cardiomyopathy,hypertrophic cardiomyopathy,EFO:0000538,http://www.ebi.ac.uk/efo/EFO_0000538,0.994,None
finn-b-D3_DEF_IGG,Selective deficiency of immunoglobulin G [IgG] subclasses,selective IgA deficiency disease,EFO:1001929,http://www.ebi.ac.uk/efo/EFO_1001929,0.79,None
ukb-e-561_CSA,Symptoms involving digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.622,None
finn-b-E4_HYPOKALAEMIA,Hypokalaemia,Hypokalemia,HP:0002900,http://purl.obolibrary.org/obo/HP_0002900,0.788,None
finn-b-CD2_INSITU_SKIN_LOWERLIMB,"Carcinoma in situ of skin of lower limb, including hip",skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.658,None
finn-b-C3_HEART_MEDIASTINUM_PLEURA_EXALLC,"""Malignant neoplasm of heart, mediastinum and pleura"" (all cancers excluded)",mediastinal cancer,EFO:0007362,http://www.ebi.ac.uk/efo/EFO_0007362,0.775,None
ukb-e-recode425_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-MCP_AFR,Multi-site chronic pain,multisite chronic pain,EFO:0010100,http://www.ebi.ac.uk/efo/EFO_0010100,0.859,None
finn-b-H7_CATARACTOTHER,Other cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.989,None
ieu-a-1120,Ovarian cancer,ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.992,None
ukb-d-D17,Diagnoses - main ICD10: D17 Benign lipomatous neoplasm,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.763,None
ukb-b-12493,Diagnoses - secondary ICD10: I10 Essential (primary) hypertension,essential hypertension,MONDO:0001134,http://purl.obolibrary.org/obo/MONDO_0001134,0.618,None
ukb-a-76,Non-cancer illness code  self-reported: hyperthyroidism/thyrotoxicosis,Thyrotoxicosis,EFO:0009190,http://www.ebi.ac.uk/efo/EFO_0009190,0.629,None
finn-b-CD2_BENIGN_PHARYNX_NOS,"Benign neoplasm: Pharynx, unspecified",benign laryngeal neoplasm,MONDO:0002354,http://purl.obolibrary.org/obo/MONDO_0002354,0.883,None
ukb-e-recode5_CSA,"Estimated glomerular filtration rate, cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.778,None
ukb-e-52_p8_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-M13_PATELLARTEND,Patellar tendinitis,tendinitis,MONDO:0004857,http://purl.obolibrary.org/obo/MONDO_0004857,0.749,None
finn-b-R18_OTHER_ABNORMAL_FINDI_URINE,Other abnormal findings in urine,Abnormal cerebrospinal fluid morphology,HP:0002921,http://purl.obolibrary.org/obo/HP_0002921,0.706,None
finn-b-Q17_CONGEN_MALFO_URINARY_SYSTEM,Congenital malformations of the urinary system,developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.686,None
finn-b-CD2_BENIGN_BREAST,Benign neoplasm of breast,breast benign neoplasm,MONDO:0000620,http://purl.obolibrary.org/obo/MONDO_0000620,0.989,None
ebi-a-GCST006686,Sleep duration (undersleepers),sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.778,None
ieu-a-986,Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.992,None
ukb-e-960_AFR,Poisoning by antibiotics,poisoning,EFO:0008546,http://www.ebi.ac.uk/efo/EFO_0008546,0.614,None
ieu-b-4966,Pan cancer,cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.714,None
finn-b-DERMATOPOLY_FG,Dermatopolymyositis (FG),dermatomyositis,EFO:0000398,http://www.ebi.ac.uk/efo/EFO_0000398,0.907,None
ukb-d-D3_ANAEMIA_IRONDEF,Iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.968,None
ukb-b-123,Diagnoses - main ICD10: N32.0 Bladder-neck obstruction,bladder neck obstruction,EFO:1000840,http://www.ebi.ac.uk/efo/EFO_1000840,0.763,None
finn-b-AB1_MENINGOCOCCAL,Meningococcal infection,meningococcal infection,EFO:0004249,http://www.ebi.ac.uk/efo/EFO_0004249,0.991,None
finn-b-H7_BINOCUMOVOTH,Other disorders of binocular movement,movement disorder,EFO:0004280,http://www.ebi.ac.uk/efo/EFO_0004280,0.76,None
ukb-e-100003_CSA,Protein,Proteinuria,HP:0000093,http://purl.obolibrary.org/obo/HP_0000093,0.744,None
ukb-a-111,Non-cancer illness code  self-reported: pneumothorax,Pneumothorax,HP:0002107,http://purl.obolibrary.org/obo/HP_0002107,0.67,None
finn-b-O15_POSTPART_HEAMORRH,Postpartum haemorrhage,postpartum hemorrhage,EFO:0009579,http://www.ebi.ac.uk/efo/EFO_0009579,0.993,None
finn-b-E4_HYPERPARA,Hyperparathyroidism,hyperparathyroidism,EFO:0008506,http://www.ebi.ac.uk/efo/EFO_0008506,0.992,None
ukb-e-738_p1_EAS,Average total household income before tax,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.635,None
ukb-e-20126_p5_CSA,Bipolar and major depression status,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.705,None
ukb-e-52_p1_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-AB1_PNEUMOCYSTOSIS,Pneumocystosis,pneumocystosis,EFO:0007448,http://www.ebi.ac.uk/efo/EFO_0007448,0.993,None
ukb-e-6149_p1_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-d-K11_OTHILEUS,"Other or unspecified ileus, impaction or obstruction",Nasal congestion,HP:0001742,http://purl.obolibrary.org/obo/HP_0001742,0.627,None
ukb-e-1508_p4_CSA,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
ebi-a-GCST005523,Celiac disease,celiac disease,EFO:0001060,http://www.ebi.ac.uk/efo/EFO_0001060,0.991,None
ukb-e-K62_AFR,K62 Other diseases of anus and rectum,rectal disease,EFO:0009685,http://www.ebi.ac.uk/efo/EFO_0009685,0.644,None
finn-b-I9_ISCHHEART,Ischemic heart diseases,Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.985,None
finn-b-M13_SCOLIOSIS,Scoliosis,scoliosis,EFO:0004273,http://www.ebi.ac.uk/efo/EFO_0004273,0.986,None
ukb-e-52_p6_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-e-MCP_CSA,Multi-site chronic pain,multisite chronic pain,EFO:0010100,http://www.ebi.ac.uk/efo/EFO_0010100,0.859,None
ukb-e-20003_p8_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-I9_VEINSOTH,Other disorders of veins,vein disorder,MONDO:0004634,http://purl.obolibrary.org/obo/MONDO_0004634,0.808,None
ukb-e-100016_CSA,Potassium,potassium measurement,EFO:0009283,http://www.ebi.ac.uk/efo/EFO_0009283,0.841,None
ukb-e-30860_CSA,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
finn-b-K11_UC_STRICT_PSC,Ulcerative colitis (strict) with PSC,ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.755,None
ebi-a-GCST006647,Menstruation quality of life impact (joint pain),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.691,None
finn-b-E4_DM1COMA,Type 1 diabetes with coma,type 1 diabetes mellitus,MONDO:0005147,http://purl.obolibrary.org/obo/MONDO_0005147,0.771,None
ukb-e-2804_AFR,Age when last used oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.707,None
finn-b-L12_LICHSIMPANDPRURIGO,Lichen simplex chronicus and prurigo,neurodermatitis,EFO:1000740,http://www.ebi.ac.uk/efo/EFO_1000740,0.823,None
ukb-d-I9_IHD,"Ischaemic heart disease, wide definition",Myocardial Ischemia,EFO:1001375,http://www.ebi.ac.uk/efo/EFO_1001375,0.825,None
ukb-e-recode298_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-5088_CSA,Astigmatism angle (right),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.732,None
finn-b-FE,Focal epilepsy,partial epilepsy,EFO:0004263,http://www.ebi.ac.uk/efo/EFO_0004263,0.997,None
finn-b-KRA_PSY_SUBSTANCE,Substance abuse,substance abuse,MONDO:0002491,http://purl.obolibrary.org/obo/MONDO_0002491,0.985,None
ukb-e-30860_EAS,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
finn-b-M13_SACROILIITIS,"Sacroiliitis, not elsewhere classified",Sacroiliac arthritis,HP:0012317,http://purl.obolibrary.org/obo/HP_0012317,0.988,None
finn-b-KRA_PSY_DEMENTIA_EXMORE,Any dementia (more controls excluded),Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
finn-b-PNEUMOBACTKNOWN,Bacterial pneumonia (organism specified),bacterial pneumonia,EFO:1001272,http://www.ebi.ac.uk/efo/EFO_1001272,0.794,None
finn-b-DRUGADVERS_ADRENOCORTICAL_INSUFFICIENCY,Drug-induced adrenocortical insufficiency,adrenocortical insufficiency,EFO:0009491,http://www.ebi.ac.uk/efo/EFO_0009491,0.838,None
ukb-b-9473,Operative procedures - main OPCS: G45.1 Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract,upper digestive tract disorder,MONDO:0044991,http://purl.obolibrary.org/obo/MONDO_0044991,0.693,None
ukb-d-22617_2132,Job SOC coding: Software professionals,software,EFO:0002029,http://www.ebi.ac.uk/efo/EFO_0002029,0.648,None
finn-b-CD2_BENIGN_SKIN_LIP,Benign neoplasm: Skin of lip,benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.91,None
finn-b-CD2_BENIGN_EAR_RESP,Benign neoplasm of middle ear and respiratory system,respiratory system benign neoplasm,MONDO:0000382,http://purl.obolibrary.org/obo/MONDO_0000382,0.83,None
ukb-e-21001_EAS,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
ukb-b-10008,Treatment/medication code: atorvastatin,atorvastatin measurement,EFO:0801115,http://www.ebi.ac.uk/efo/EFO_0801115,0.689,None
ukb-e-recode5_EAS,"Estimated glomerular filtration rate, cystain C",glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.778,None
finn-b-L12_INFECT_SKIN_OTHER,Other local infections of skin and subcutaneous tissue,subcutaneous tissue infection,EFO:0010692,http://www.ebi.ac.uk/efo/EFO_0010692,0.849,None
finn-b-GOUT,"Gout, FINNGEN",gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.623,None
finn-b-M13_OTHCONN,Other systemic involvement of connective tissue,Connective tissue disease with eye involvement,ORPHANET.ORDO:98702,http://www.orpha.net/ORDO/Orphanet_98702,0.756,None
ukb-e-47_CSA,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
finn-b-I9_CARDMYOHYP,"Cardiomyopathy, Hypertrophic obstructive",hypertrophic cardiomyopathy,EFO:0000538,http://www.ebi.ac.uk/efo/EFO_0000538,0.99,None
ukb-e-6142_p1_MID,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-e-recode303_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30290_EAS,High light scatter reticulocyte percentage,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.991,None
ukb-b-10098,"Non-cancer illness code, self-reported: iron deficiency anaemia",Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.714,None
finn-b-VIT_DEF,Vitamin deficiency (VIT_DEF),vitamin deficiency disorder,MONDO:0024298,http://purl.obolibrary.org/obo/MONDO_0024298,0.893,None
ukb-e-recode224_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20002_p172_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-GE_STRICT,"Generalized epilepsy, strict definition",generalised epilepsy,EFO:0005917,http://www.ebi.ac.uk/efo/EFO_0005917,0.995,None
ukb-e-4105_CSA,Heel bone mineral density (BMD) (left),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.82,None
ebi-a-GCST005814,Osteoarthritis (hospital diagnosed),osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.861,None
ukb-b-14521,Illnesses of father: Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.686,None
ukb-e-2744_EAS,Birth weight of first child,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.695,None
ukb-a-103,Non-cancer illness code  self-reported: crohns disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.625,None
finn-b-H8_OTALGIA,Otalgia,Ear pain,HP:0030766,http://purl.obolibrary.org/obo/HP_0030766,0.978,None
ebi-a-GCST90012857,Falling risk,risk factor,EFO:0003919,http://www.ebi.ac.uk/efo/EFO_0003919,0.618,None
ukb-e-30110_EAS,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
ukb-e-recode325_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20126_p4_CSA,Bipolar and major depression status,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.705,None
ukb-e-30610_CSA,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
finn-b-ASTHMA_OPPORTUNIST_INFECTIONS,Asthma and opportunit respiratory infection,opportunistic infectious,MONDO:0045035,http://purl.obolibrary.org/obo/MONDO_0045035,0.61,None
ukb-b-13391,"Diagnoses - main ICD10: G45.9 Transient cerebral ischaemic attack, unspecified",transient ischemic attack,EFO:0003764,http://www.ebi.ac.uk/efo/EFO_0003764,0.665,None
finn-b-R18_FEVER_OTHER_UNKNO_ORIGIN,Fever of other and unknown origin,fever of unknown origin,EFO:0003952,http://www.ebi.ac.uk/efo/EFO_0003952,0.988,None
ukb-b-3380,Treatment/medication code: pravastatin,pravastatin measurement,EFO:0801215,http://www.ebi.ac.uk/efo/EFO_0801215,0.674,None
ukb-d-1508_4,Coffee type: Other type of coffee,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.608,None
finn-b-K11_DULC,Duodenal ulcer,duodenal ulcer,EFO:0004607,http://www.ebi.ac.uk/efo/EFO_0004607,0.995,None
finn-b-SYSTSCLE_STRICT,"Systemic sclerosis,strict definition",systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.992,None
finn-b-F5_UNSMENDIS,Unspecified mental disorder,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.994,None
finn-b-L12_DERMATHERP,Dermatitis herpetiformis,dermatitis herpetiformis,EFO:1000684,http://www.ebi.ac.uk/efo/EFO_1000684,0.994,None
ukb-e-47_EAS,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
ukb-e-20002_p57_AFR,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ukb-e-recode235_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-22506_111,Tobacco smoking: Smokes on most or all days,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.752,None
ukb-b-6528,"Diagnoses - secondary ICD10: D25.9 Leiomyoma of uterus, unspecified",uterine fibroid,EFO:0000731,http://www.ebi.ac.uk/efo/EFO_0000731,0.607,None
finn-b-CD2_BENIGN_UTERINE_TUBES_LIGAMENTS_EXALLC,Benign neoplasm: Uterine tubes and ligaments (all cancers excluded),uterine ligament neoplasm,MONDO:0021629,http://purl.obolibrary.org/obo/MONDO_0021629,0.69,None
ukb-e-20003_p314_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-d-M13_JOINTOTH,Other specific joint derangements/joint disorders,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.731,None
ieu-a-1090,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-GLOMER_NEPHRITIS,Glomerulonephritis,glomerulonephritis,MONDO:0002462,http://purl.obolibrary.org/obo/MONDO_0002462,0.993,None
ebi-a-GCST008026,Chronic kidney disease,chronic kidney disease,EFO:0003884,http://www.ebi.ac.uk/efo/EFO_0003884,0.995,None
finn-b-C3_BREAST_HER2NEG,"Malignant neoplasm of breast, HER2-negative",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.733,None
ukb-b-16609,Target heart rate achieved,"achievement of target heart rate, self-reported",EFO:0009823,http://www.ebi.ac.uk/efo/EFO_0009823,0.658,None
ukb-e-recode71_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-L12_HYPERTRICHOSIS,Hypertrichosis,hypertrichosis,MONDO:0019280,http://purl.obolibrary.org/obo/MONDO_0019280,0.994,None
finn-b-CD2_BENIGN_VAGINA,Benign neoplasm: Vulva,vulvar benign neoplasm,MONDO:0000643,http://purl.obolibrary.org/obo/MONDO_0000643,0.997,None
ebi-a-GCST90016614,Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.727,None
ukb-b-6548,Illnesses of mother: Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.734,None
finn-b-H8_HL_NAS,Other specified/unspecified hearing loss,hearing loss,EFO:0004238,http://www.ebi.ac.uk/efo/EFO_0004238,0.99,None
finn-b-M13_CERVICOCRANSDR,Cervicocranial syndrome,Barre-Lieou syndrome,EFO:0007165,http://www.ebi.ac.uk/efo/EFO_0007165,0.97,None
ebi-a-GCST005527,Psoriasis,psoriasis,EFO:0000676,http://www.ebi.ac.uk/efo/EFO_0000676,0.993,None
ukb-e-recode366_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1940_AFR,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
finn-b-K11_CHRONGASTR,Chronic gastritis,chronic gastritis,EFO:0000337,http://www.ebi.ac.uk/efo/EFO_0000337,0.996,None
ukb-e-1239_AFR,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
ukb-e-recode262_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_TOXLIV,Toxic liver disease,Abnormality of the liver,HP:0001392,http://purl.obolibrary.org/obo/HP_0001392,0.735,None
finn-b-M13_SPINSTENOSIS,Spinal stenosis,spinal stenosis,EFO:0007490,http://www.ebi.ac.uk/efo/EFO_0007490,0.993,None
ieu-a-965,Lung adenocarcinoma,lung adenocarcinoma,EFO:0000571,http://www.ebi.ac.uk/efo/EFO_0000571,0.989,None
ukb-e-recode255_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-T2D,"Type 2 diabetes, definitions combined",type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-30300_CSA,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
ukb-d-PULMONARYDG,Other pulmonary diagnosis,lung disease,EFO:0003818,http://www.ebi.ac.uk/efo/EFO_0003818,0.874,None
finn-b-ST19_FRACT_LOWER_LEG_INCLU_ANKLE,"Fracture of lower leg, including ankle",ankle fracture,EFO:0009615,http://www.ebi.ac.uk/efo/EFO_0009615,0.661,None
finn-b-POLLENALLERG,Pollen allergy,seasonal allergic rhinitis,EFO:0003956,http://www.ebi.ac.uk/efo/EFO_0003956,0.989,None
ukb-e-20003_p231_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-b-5227,Operation code: male circumcision,circumcision,EFO:0003953,http://www.ebi.ac.uk/efo/EFO_0003953,0.875,None
ieu-a-821,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
ukb-e-F32_CSA,F32 Depressive episode,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.717,None
finn-b-D3_HAEMORRHAGICNAS,Otherand unspecified haemorrhagic conditions,hemorrhagic fever,MONDO:0600002,http://purl.obolibrary.org/obo/MONDO_0600002,0.618,None
finn-b-I9_SECONDRIGHT,Secondary right heart disease,heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.658,None
finn-b-AD_EO,Alzheimer<c3><95>s disease (Early onset),early-onset autosomal dominant Alzheimer disease,MONDO:0015140,http://purl.obolibrary.org/obo/MONDO_0015140,0.681,None
ukb-e-6149_p1_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-6155_p4_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-b-11550,"Non-cancer illness code, self-reported: atrial fibrillation",atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.69,None
finn-b-Z21_PROBL_RELATED_OTH_PSYCHOSO_CIRCUMSTANC,Problems related to other psychosocial circumstances,encounter with health service related to socioeconomic and psychosocial circumstances,EFO:0009788,http://www.ebi.ac.uk/efo/EFO_0009788,0.631,None
finn-b-I9_ARTEMBTHRLOW,Arterial embolism and thrombosis of lower extremity artery,Arterial thrombosis,HP:0004420,http://purl.obolibrary.org/obo/HP_0004420,0.701,None
ukb-b-15606,"Diagnoses - main ICD10: J18.9 Pneumonia, unspecified",pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.632,None
ukb-e-20004_p40_CSA,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-G6_MIGRAINE_WITH_AURA_ADVERSE,"Migraine with aura, drug-induced",migraine with aura,MONDO:0005475,http://purl.obolibrary.org/obo/MONDO_0005475,0.77,None
finn-b-C3_OVARY,Malignant neoplasm of ovary,ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.996,None
finn-b-CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9_EXALLC,Benign neoplasm: Rectum/anal canal icd-9 (all cancers excluded),benign neoplasm of anus,MONDO:0021469,http://purl.obolibrary.org/obo/MONDO_0021469,0.703,None
ukb-e-recode83_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-E4_OVARFAIL,Primary ovarian failure,primary ovarian insufficiency,EFO:0004266,http://www.ebi.ac.uk/efo/EFO_0004266,0.995,None
finn-b-C3_GBM,Brain glioblastoma,brain glioblastoma,EFO:0006545,http://www.ebi.ac.uk/efo/EFO_0006545,0.991,None
ieu-b-17,juvenile myoclonic epilepsy ,juvenile myoclonic epilepsy,MONDO:0009696,http://purl.obolibrary.org/obo/MONDO_0009696,0.996,None
finn-b-K11_GIDISEASES,Gastrointestinal diseases,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.986,None
ukb-e-recode218_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_NONHODGKIN_NAS,Other and unspecified types of non-Hodgkin lymphoma,Hodgkins lymphoma,EFO:0000183,http://www.ebi.ac.uk/efo/EFO_0000183,0.871,None
finn-b-MEMLOSS,Memory loss,amnesia,EFO:1001454,http://www.ebi.ac.uk/efo/EFO_1001454,0.609,None
ebi-a-GCST003116,Coronary artery disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.992,None
ebi-a-GCST90012794,Participation in an health questionnaire (not invited vs invited),health study participation,EFO:0010130,http://www.ebi.ac.uk/efo/EFO_0010130,0.687,None
ukb-e-20003_p564_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-C3_LIP_ORAL_PHARYNX_EXALLC,"""Malignant neoplasm of lip, oral cavity and pharynx"" (all cancers excluded)",oral cavity cancer,EFO:0005570,http://www.ebi.ac.uk/efo/EFO_0005570,0.765,None
finn-b-AB1_OTHER_VIRAL,Other viral diseases,viral disease,EFO:0000763,http://www.ebi.ac.uk/efo/EFO_0000763,0.913,None
ukb-e-recode420_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-L12_OTHERDISSKINANDSUBCUTIS,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.954,None
finn-b-C3_AML,Acute myeloid leukaemia,childhood acute myeloid leukemia,EFO:0000330,http://www.ebi.ac.uk/efo/EFO_0000330,0.813,None
ukb-a-254,Doctor diagnosed hayfever or allergic rhinitis,allergic rhinitis,EFO:0005854,http://www.ebi.ac.uk/efo/EFO_0005854,0.643,None
finn-b-H7_CATARACTSENILE,Senile cataract,senile cataract,MONDO:0004847,http://purl.obolibrary.org/obo/MONDO_0004847,0.988,None
ukb-b-4674,Type of cancer: ICD10: D05.1 Intraductal carcinoma in situ,breast ductal carcinoma in situ,EFO:0000432,http://www.ebi.ac.uk/efo/EFO_0000432,0.672,None
ieu-b-11,"focal epilepsy, documented lesion negative",partial epilepsy,EFO:0004263,http://www.ebi.ac.uk/efo/EFO_0004263,0.672,None
ukb-d-HEARTFAIL,Heart failure,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
finn-b-CD2_BENIGN_BONE_CARTILAGE_EXALLC,Benign neoplasm of bone and articular cartilage (all cancers excluded),benign chondrogenic neoplasm,MONDO:0024470,http://purl.obolibrary.org/obo/MONDO_0024470,0.802,None
finn-b-AB1_PROTOZOAL,Protozoal diseases,protozoa infectious disease,MONDO:0002428,http://purl.obolibrary.org/obo/MONDO_0002428,0.753,None
ukb-d-M13_ADHCAPSULITIS,Adhesive capsulitis of shoulder,frozen shoulder,EFO:1000941,http://www.ebi.ac.uk/efo/EFO_1000941,0.988,None
ukb-e-100012_AFR,Vitamin B6,vitamin B6 measurement,EFO:0004621,http://www.ebi.ac.uk/efo/EFO_0004621,0.864,None
ebi-a-GCST006810,Self-reported risk-taking behaviour,risk-taking behaviour,EFO:0008579,http://www.ebi.ac.uk/efo/EFO_0008579,0.676,None
finn-b-J10_PNEUMOPNEUMO,Pneumonia due to Streptococcus pneumoniae,streptococcal pneumonia,EFO:0007499,http://www.ebi.ac.uk/efo/EFO_0007499,0.951,None
finn-b-M13_CERVICDISC,Cervical disc disorders,cervix disorder,MONDO:0002256,http://purl.obolibrary.org/obo/MONDO_0002256,0.823,None
ukb-e-51_EAS,Seated height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.793,None
finn-b-H7_CORNEALDYSTROPHY,Corneal degeneration,corneal degeneration,MONDO:0001515,http://purl.obolibrary.org/obo/MONDO_0001515,0.994,None
finn-b-M13_BAKERCYST,Synovial cyst of popliteal space [Baker],Popliteal synovial cyst,HP:0032072,http://purl.obolibrary.org/obo/HP_0032072,0.812,None
finn-b-M13_VILLONODULAR,Villonodular synovitis (pigmented),pigmented villonodular synovitis,EFO:1001106,http://www.ebi.ac.uk/efo/EFO_1001106,0.989,None
finn-b-H7_RETINOPATHYDIAB_BKG_SEVERE,Severe diabetic background retinopathy,non-proliferative diabetic retinopathy,EFO:0009760,http://www.ebi.ac.uk/efo/EFO_0009760,0.784,None
ukb-e-recode122_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-L12_PSORI_ARTHRO,Arthropathic psoriasis,psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.99,None
ebi-a-GCST90000515,Barrett's esophagus,Barrett's esophagus,EFO:0000280,http://www.ebi.ac.uk/efo/EFO_0000280,0.995,None
ukb-e-20003_p182_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-e-100001_CSA,Food weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.756,None
ukb-a-471,Pain type(s) experienced in last month: Facial pain,facial pain,EFO:0009625,http://www.ebi.ac.uk/efo/EFO_0009625,0.642,None
finn-b-MACULAR_HOLE,Macular hole,macular holes,EFO:1001028,http://www.ebi.ac.uk/efo/EFO_1001028,0.993,None
ukb-e-1200_CSA,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
ukb-d-ASTHMA_CHILD,Childhood asthma (age<16),childhood onset asthma,MONDO:0005405,http://purl.obolibrary.org/obo/MONDO_0005405,0.869,None
finn-b-J10_SIMPLBRONCH,Simple and mucoplurulent chronic bronchitis,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.637,None
ukb-e-6149_p4_AFR,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
finn-b-N14_NEPHRITICNAS,Unspesified nephritic syndrome,nephrotic syndrome,EFO:0004255,http://www.ebi.ac.uk/efo/EFO_0004255,0.77,None
ebi-a-GCST004296,Atrial fibrillation,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.996,None
ukb-b-453,Diagnoses - main ICD10: I21.0 Acute transmural myocardial infarction of anterior wall,anterolateral myocardial infarction,EFO:1000812,http://www.ebi.ac.uk/efo/EFO_1000812,0.744,None
finn-b-I9_CEREBATHER,Cerebral atherosclerosis (I9_CEREBATHER),cerebral atherosclerosis,EFO:1000860,http://www.ebi.ac.uk/efo/EFO_1000860,0.824,None
ukb-e-23115_CSA,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
ieu-a-1111,Small vessel disease,cerebral small vessel disease,EFO:0008493,http://www.ebi.ac.uk/efo/EFO_0008493,0.839,None
ukb-b-7910,Illnesses of father: Bowel cancer,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.693,None
ukb-e-550_AFR,Abdominal hernia,Hernia of the abdominal wall,HP:0004299,http://purl.obolibrary.org/obo/HP_0004299,0.792,None
finn-b-I9_OTHINTRACRA_EXNONE,Other intracranial haemorrhages (no controls excluded),intracranial hemorrhage,EFO:0000551,http://www.ebi.ac.uk/efo/EFO_0000551,0.899,None
finn-b-M13_TENDOSYNOVITISNAS,Other/unspecified synovitis and tenosynovitis,tenosynovitis,EFO:1001435,http://www.ebi.ac.uk/efo/EFO_1001435,0.928,None
finn-b-VIRALPNEUMOKNOWN,"Viral pneumonia (known virus, not influenza)",influenza,EFO:0007328,http://www.ebi.ac.uk/efo/EFO_0007328,0.654,None
finn-b-M13_BICIPITALTEND,Bicipital tendinitis,tendinitis,MONDO:0004857,http://purl.obolibrary.org/obo/MONDO_0004857,0.652,None
finn-b-K11_IBD,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
ukb-e-23111_MID,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
ukb-e-30740_AFR,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
ukb-e-30620_CSA,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
ieu-b-4810,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
ukb-e-30050_AFR,Mean corpuscular haemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.986,None
finn-b-I9_LYMPHADE,Nonspesific lymphadenitis,Lymphadenitis,HP:0002840,http://purl.obolibrary.org/obo/HP_0002840,0.725,None
ukb-e-513_CSA,Respiratory abnormalities,Abnormality of the respiratory system,HP:0002086,http://purl.obolibrary.org/obo/HP_0002086,0.884,None
finn-b-ALCOPOLYNEU,Alcohol induced polyneuropathy (ALCOPOLYNEU),alcoholic neuropathy,EFO:1000803,http://www.ebi.ac.uk/efo/EFO_1000803,0.814,None
finn-b-CD2_BENIGN_STOMACH,Benign neoplasm: Stomach,benign neoplasm of stomach,MONDO:0021449,http://purl.obolibrary.org/obo/MONDO_0021449,0.994,None
ebi-a-GCST005842,Ischemic stroke (cardioembolic),cardioembolic stroke,EFO:1001976,http://www.ebi.ac.uk/efo/EFO_1001976,0.848,None
ukb-e-3077_AFR,Seating box height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.645,None
finn-b-O15_PREG_HYDAT,Hydatidiform mole,gestational trophoblastic neoplasm,MONDO:0018944,http://purl.obolibrary.org/obo/MONDO_0018944,0.984,None
ukb-a-404,Current employment status: In paid employment or self-employed,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.847,None
ukb-e-2090_AFR,"Seen doctor (GP) for nerves, anxiety, tension or depression",mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
finn-b-CD2_BENIGN_RECTOSIGMOID_JUNC_EXALLC,Benign neoplasm: Rectosigmoid junction (all cancers excluded),rectosigmoid junction neoplasm,MONDO:0002423,http://purl.obolibrary.org/obo/MONDO_0002423,0.854,None
finn-b-F5_SCHOLA,Specific development disorders of scholastic skills,specific developmental disorder,MONDO:0000592,http://purl.obolibrary.org/obo/MONDO_0000592,0.718,None
finn-b-CD2_BENIGN_PITUITARY_CRANIPHAR,"Benign neoplasm: Pituitary gland, craniopharyngeal duct",benign neoplasm of pituitary gland,MONDO:0021439,http://purl.obolibrary.org/obo/MONDO_0021439,0.733,None
finn-b-K11_OESSTODUO,"Diseases of oesophagus, stomach and duodenum",duodenal disorder,MONDO:0002866,http://purl.obolibrary.org/obo/MONDO_0002866,0.604,None
ukb-a-576,Diagnoses - main ICD10: N40 Hyperplasia of prostate,benign prostatic hyperplasia,EFO:0000284,http://www.ebi.ac.uk/efo/EFO_0000284,0.717,None
finn-b-M13_TRANSSYNOVITIS,Transient synovitis,synovitis,EFO:0008997,http://www.ebi.ac.uk/efo/EFO_0008997,0.762,None
finn-b-N14_DYSPLACERVUT,Dysplasia of cervi uteri,dysplasia of cervix,EFO:1000910,http://www.ebi.ac.uk/efo/EFO_1000910,0.837,None
ukb-e-recode23_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-DM_RETINOPATHY_EXMORE,Diabetic retinopathy (more controls excluded),diabetic retinopathy,EFO:0003770,http://www.ebi.ac.uk/efo/EFO_0003770,0.987,None
ukb-d-20126_0,Bipolar and major depression status: No Bipolar or Depression,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.691,None
ebi-a-GCST90016596,ADHD vs autism spectrum disorder (ordinary least squares (OLS)),autism spectrum disorder,EFO:0003756,http://www.ebi.ac.uk/efo/EFO_0003756,0.752,None
ukb-b-18948,Operative procedures - main OPCS: K75.3 Percutaneous transluminal balloon angioplasty and insertion of 1-2 stents into coronary artery,percutaneous transluminal coronary angioplasty,EFO:0003951,http://www.ebi.ac.uk/efo/EFO_0003951,0.659,None
finn-b-APPENDACUT_COMPLIC,"Acute appendicitis, with complications",appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.755,None
ukb-e-24006_MID,Particulate matter air pollution (pm2.5); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.739,None
ukb-e-30030_CSA,Haematocrit percentage,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.61,None
finn-b-RHEUMA_SEROPOS_WIDE,"Seropositive rheumatoid arthritis, wide",rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.819,None
ebi-a-GCST006642,Menstruation quality of life impact (increased appetite),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.612,None
ukb-e-recode338_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-541,Diagnoses - main ICD10: J33 Nasal polyp,Nasal Cavity Polyp,EFO:1000391,http://www.ebi.ac.uk/efo/EFO_1000391,0.651,None
finn-b-O15_ICP,Intrahepatic Cholestasis of Pregnancy (ICP)<c3><8a>,Intrahepatic cholestasis of pregnancy,EFO:0009048,http://www.ebi.ac.uk/efo/EFO_0009048,0.798,None
ukb-d-K92,Diagnoses - main ICD10: K92 Other diseases of digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.764,None
finn-b-H8_CHOLEASTOMA,Cholesteatoma of middle ear,cholesteatoma of middle ear,EFO:1000678,http://www.ebi.ac.uk/efo/EFO_1000678,0.992,None
ukb-e-20002_p34_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-D3_SARCOIDOSIS,Sarcoidosis,sarcoidosis,MONDO:0019338,http://purl.obolibrary.org/obo/MONDO_0019338,0.99,None
ukb-e-30800_AFR,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
finn-b-R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED,"Haemorrhage, not elsewhere classified",Gastrointestinal hemorrhage,HP:0002239,http://purl.obolibrary.org/obo/HP_0002239,0.872,None
finn-b-J10_COPD,COPD,chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.999,None
ukb-e-recode176_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST006802,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
ukb-d-C_RECTUM,Malignant neoplasm of rectum,rectum cancer,EFO:1000657,http://www.ebi.ac.uk/efo/EFO_1000657,0.992,None
finn-b-R18_GENERAL_SYMPTOMS_SIGNS,General symptoms and signs,sign or symptom,EFO:0003765,http://www.ebi.ac.uk/efo/EFO_0003765,0.853,None
ukb-b-6991,"Seen doctor (GP) for nerves, anxiety, tension or depression",mixed anxiety and depressive disorder,MONDO:0041086,http://purl.obolibrary.org/obo/MONDO_0041086,0.669,None
finn-b-G6_MIGRAINE,Migraine,migraine disorder,MONDO:0005277,http://purl.obolibrary.org/obo/MONDO_0005277,0.998,None
finn-b-K11_TEETH_HARD,Other diseases of hard tissues of teeth,tooth hard tissue disease,MONDO:0002220,http://purl.obolibrary.org/obo/MONDO_0002220,0.885,None
ukb-e-30140_EAS,Neutrophill count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.886,None
ukb-e-23104_EAS,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
finn-b-O15_ICP_WIDE,"Intrahepatic Cholestasis of Pregnancy (ICP)<c3><8a>, incl. ICD-8",Intrahepatic cholestasis of pregnancy,EFO:0009048,http://www.ebi.ac.uk/efo/EFO_0009048,0.718,None
ukb-e-2724_EAS,Had menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.856,None
finn-b-KRA_PSY_SLEEP_NONORG_EXMORE,Nonorganic sleeping disorders (more controls excluded),sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.691,None
ieu-b-41,bipolar disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.992,None
finn-b-H7_OPTNEUROTH,Other disorders of optic [2nd] nerve and visual pathways,visual pathway disorder,MONDO:0001834,http://purl.obolibrary.org/obo/MONDO_0001834,0.666,None
finn-b-M13_GOUT,Gout,gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.998,None
ukb-a-430,Mouth/teeth dental problems: Bleeding gums,Gingival bleeding,HP:0000225,http://purl.obolibrary.org/obo/HP_0000225,0.674,None
ukb-e-1940_EAS,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
ukb-e-30250_AFR,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
finn-b-C3_SKIN_EXALLC,Malignant neoplasm of skin (all cancers excluded),skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.894,None
finn-b-M13_ENTESOPATHYLOW,"Enthesopathies of lower limb, excluding foot",rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.676,None
finn-b-N14_VULVOVAGINFINOTH,Vulvovaginal ulceration/inflammation in other diseases,vaginitis,MONDO:0002234,http://purl.obolibrary.org/obo/MONDO_0002234,0.636,None
ukb-b-16048,"Non-cancer illness code, self-reported: pulmonary embolism +/- dvt",pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.65,None
finn-b-CD2_BENIGN_SALIVARY,Benign neoplasm of major salivary glands,major salivary gland cancer,MONDO:0044743,http://purl.obolibrary.org/obo/MONDO_0044743,0.855,None
ukb-b-9056,Current employment status: Looking after home and/or family,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.614,None
finn-b-C3_COLON_EXALLC,Malignant neoplasm of colon (all cancers excluded),malignant colon neoplasm,MONDO:0021063,http://purl.obolibrary.org/obo/MONDO_0021063,0.898,None
ukb-e-30150_CSA,Eosinophill count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.895,None
finn-b-I9_SEQULAE,Sequelae of cerebrovascular disease,cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.783,None
ukb-e-recode107_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_ACUTGASTR,Acute gastritis,gastritis,EFO:0000217,http://www.ebi.ac.uk/efo/EFO_0000217,0.997,None
finn-b-Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC2,Persons encountering health services in other circumstances (Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC2),encounter with health service related to socioeconomic and psychosocial circumstances,EFO:0009788,http://www.ebi.ac.uk/efo/EFO_0009788,0.609,None
finn-b-K11_APPENDOTH,Other appendicitis,appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.991,None
ebi-a-GCST006956,Erectile dysfunction,erectile dysfunction,EFO:0004234,http://www.ebi.ac.uk/efo/EFO_0004234,0.987,None
finn-b-C3_TESTIS_EXALLC,Malignant neoplasm of testis (all cancers excluded),testicular carcinoma,EFO:0005088,http://www.ebi.ac.uk/efo/EFO_0005088,0.898,None
ukb-e-3063_EAS,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
ukb-e-6164_p2_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-6142_p4_CSA,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ukb-e-716_CSA,Other arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.779,None
ukb-e-2139_CSA,Age first had sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.849,None
ukb-e-20116_p2_EAS,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ukb-e-30730_MID,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
finn-b-D3_WHITEBLOODCELLNAS,Other and unspecified disorders of white blood cells,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.862,None
ukb-b-8777,"Cancer code, self-reported: cervical cancer",cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.783,None
ukb-e-recode337_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-AB1_ASPERGILLOSIS,Aspergillosis,aspergillosis,EFO:0007157,http://www.ebi.ac.uk/efo/EFO_0007157,0.99,None
ukb-e-recode338_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_BARTHOCYS,Cyst of Bartholin Gland,Bartholin duct cyst,MONDO:0004593,http://purl.obolibrary.org/obo/MONDO_0004593,0.852,None
ukb-e-recode436_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-19805,Diagnoses - main ICD10: K62.1 Rectal polyp,polyp of rectum,MONDO:0021398,http://purl.obolibrary.org/obo/MONDO_0021398,0.641,None
ukb-e-recode357_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_MENOPAUSOT,Other menopausal disorders,menopausal or post-menopausal disease,EFO:0010685,http://www.ebi.ac.uk/efo/EFO_0010685,0.842,None
finn-b-I9_CONDUCTIO,Conduction disorders,conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.812,None
ukb-e-DBP_p1_AFR,"Diastolic blood pressure, automated reading, adjusted by medication",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.623,None
ukb-e-1737_EAS,Childhood sunburn occasions,sunburn,EFO:0003958,http://www.ebi.ac.uk/efo/EFO_0003958,0.615,None
finn-b-AB1_VIRAL_CNS,Viral infections of the central nervous system,viral infection of central nervous system,MONDO:0024318,http://purl.obolibrary.org/obo/MONDO_0024318,0.965,None
finn-b-ASTHMA_ALLERG,Asthma and allergy,allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.788,None
ukb-e-recode301_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_HYPERMETRO,Hypermetropia,Hypermetropia,HP:0000540,http://purl.obolibrary.org/obo/HP_0000540,0.992,None
ukb-e-I50_CSA,I50 Heart failure,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.789,None
ukb-b-14956,Type of cancer: ICD10: C54.1 Endometrium,endometrial cancer,MONDO:0011962,http://purl.obolibrary.org/obo/MONDO_0011962,0.703,None
finn-b-EPISEIZALCO,Epileptic seizures related to alcohol,epilepsy,EFO:0000474,http://www.ebi.ac.uk/efo/EFO_0000474,0.794,None
finn-b-F5_Dementia_U,Undefined dementia,Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
finn-b-Z21_DONORS_ORGANS_TISSU,Donors of organs and tissues,tissue donor,EFO:0009633,http://www.ebi.ac.uk/efo/EFO_0009633,0.655,None
ukb-e-20004_p38_AFR,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-H8_OTOSCLE,Otosclerosis,otosclerosis,EFO:0004213,http://www.ebi.ac.uk/efo/EFO_0004213,0.986,None
ukb-e-285_CSA,Other anemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.818,None
ukb-e-recode133_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-1134,ER+ Breast cancer (GWAS),breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.679,None
ukb-e-6149_p4_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-recode322_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-3829_AFR,Number of stillbirths,number of stillbirths,EFO:0009722,http://www.ebi.ac.uk/efo/EFO_0009722,0.988,None
ukb-e-1508_p1_CSA,Coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
finn-b-H7_USEOFEYEANTIALLERGENS,Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis),allergic conjunctivitis,EFO:0007141,http://www.ebi.ac.uk/efo/EFO_0007141,0.661,None
finn-b-N14_INFLAMMBREAST,Inflammatory disorders of breast,mastitis,EFO:1001034,http://www.ebi.ac.uk/efo/EFO_1001034,0.872,None
ukb-d-G6_NERPLEX,"Nerve, nerve root and plexus disorders",nerve plexus disease,EFO:0009559,http://www.ebi.ac.uk/efo/EFO_0009559,0.839,None
finn-b-LUNG_TRANSPLANTATION,Lung transplantation,lung transplantation,EFO:0010721,http://www.ebi.ac.uk/efo/EFO_0010721,0.989,None
finn-b-G6_PARKSCND,Secondary parkinsonism+Parkinsonism in other disease,Parkinsonism,HP:0001300,http://purl.obolibrary.org/obo/HP_0001300,0.919,None
ukb-e-3731_CSA,Former alcohol drinker,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.625,None
ebi-a-GCST004988,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
finn-b-R18_ABNORMALITI_HEART_BEAT,Abnormalities of heart beat,congenital heart disease,EFO:0005207,http://www.ebi.ac.uk/efo/EFO_0005207,0.856,None
ukb-e-23123_MID,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
finn-b-C3_LUNG_NONSMALL_EXALLC,Non-small cell lung cancer (all cancers excluded),small cell lung carcinoma,EFO:0000702,http://www.ebi.ac.uk/efo/EFO_0000702,0.907,None
ieu-b-69,sepsis,Sepsis,HP:0100806,http://purl.obolibrary.org/obo/HP_0100806,0.992,None
finn-b-E4_PARANAS,"Disorders of parathyroid gland, other and/or unspecified",parathyroid disease,EFO:0005754,http://www.ebi.ac.uk/efo/EFO_0005754,0.973,None
ukb-e-recode422_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-1548_AFR,Variation in diet,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.604,None
ukb-e-626_CSA,Disorders of menstruation and other abnormal bleeding from female genital tract,female reproductive system disease,EFO:0009549,http://www.ebi.ac.uk/efo/EFO_0009549,0.649,None
ukb-d-K11_OTHDISOES,Other diseases of oesophagus,esophageal disease,EFO:0009544,http://www.ebi.ac.uk/efo/EFO_0009544,0.811,None
ukb-d-H02,Diagnoses - main ICD10: H02 Other disorders of eyelid,eyelid disease,EFO:0009547,http://www.ebi.ac.uk/efo/EFO_0009547,0.643,None
finn-b-M13_SHOULDERNAS,Other shoulder lesions,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.708,None
ukb-e-6155_p5_AFR,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
ukb-a-527,Diagnoses - main ICD10: G47 Sleep disorders,sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.683,None
ukb-e-recode251_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30000_EAS,White blood cell (leukocyte) count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.797,None
finn-b-K11_STRICTURE,Intestinal stricture,stricture,EFO:0006818,http://www.ebi.ac.uk/efo/EFO_0006818,0.764,None
ukb-e-4803_CSA,Tinnitus,Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.996,None
ukb-d-K11_GASTRODUOULC,Gastroduodenal ulcer,duodenal ulcer,EFO:0004607,http://www.ebi.ac.uk/efo/EFO_0004607,0.771,None
ukb-e-21000_p4_MID,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
ukb-b-16890,"Cancer code, self-reported: breast cancer",breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.727,None
ukb-d-K02,Diagnoses - main ICD10: K02 Dental caries,dental caries,EFO:0003819,http://www.ebi.ac.uk/efo/EFO_0003819,0.603,None
ukb-e-1737_AFR,Childhood sunburn occasions,sunburn,EFO:0003958,http://www.ebi.ac.uk/efo/EFO_0003958,0.615,None
ukb-a-205,Illnesses of father: Lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.686,None
ebi-a-GCST002245,Alzheimer's disease (late onset),late-onset Alzheimer's disease,EFO:1001870,http://www.ebi.ac.uk/efo/EFO_1001870,0.827,None
ukb-e-6149_p2_MID,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-773_CSA,Pain in limb,Limb pain,HP:0009763,http://purl.obolibrary.org/obo/HP_0009763,0.996,None
ukb-e-recode154_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-3404_CSA,Neck/shoulder pain for 3+ months,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.706,None
ieu-a-1186,Anorexia Nervosa,anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.987,None
ukb-e-23123_AFR,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
ukb-e-4104_CSA,"Heel quantitative ultrasound index (QUI), direct entry (left)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.639,None
finn-b-N14_OBSTRUREFLUROPATH,Other obstructive and reflux uropathy,urinary tract obstruction,EFO:0009571,http://www.ebi.ac.uk/efo/EFO_0009571,0.809,None
ukb-b-15829,"Non-cancer illness code, self-reported: heart attack/myocardial infarction",myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.628,None
ebi-a-GCST006061,Atrial fibrillation,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.996,None
finn-b-L12_HAIRLOSSNONSCAR,Other nonscarring hair loss,cicatricial alopecia,EFO:1002028,http://www.ebi.ac.uk/efo/EFO_1002028,0.866,None
ukb-e-4080_CSA,"Systolic blood pressure, automated reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
finn-b-L12_VASCULITISNAS,Other and unspecified vasculitis limited to skin,vasculitis,EFO:0006803,http://www.ebi.ac.uk/efo/EFO_0006803,0.665,None
finn-b-AD_AM_EXMORE,Alzheimer<c3><95>s disease (Atypical or mixed) (more controls excluded),Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.621,None
ukb-e-20117_p1_AFR,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
ukb-d-20116_0,Smoking status: Never,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.749,None
ieu-b-4912,Head and neck cancer,head and neck carcinoma,MONDO:0002038,http://purl.obolibrary.org/obo/MONDO_0002038,0.943,None
finn-b-I9_CARDMYOOTH_EXNONE,"""Cardiomyopathy, other and unspecified"" (no controls excluded)",cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.944,None
ukb-e-recode229_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ebi-a-GCST90014243,Kawasaki disease,mucocutaneous lymph node syndrome,EFO:0004246,http://www.ebi.ac.uk/efo/EFO_0004246,0.988,None
ukb-e-30180_AFR,Lymphocyte percentage,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
finn-b-J10_VASOALLERRHIN,Vasomotor and allergic rhinitis,vasomotor rhinitis,EFO:0007533,http://www.ebi.ac.uk/efo/EFO_0007533,0.806,None
ukb-d-IBD_ENDOMETRIOSIS,"Endometriosis, IBD co-morbidity",endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.61,None
finn-b-E4_HYPOOSMNAT,Hypo-osmolality and hyponatraemia,Hyponatremia,HP:0002902,http://purl.obolibrary.org/obo/HP_0002902,0.603,None
ukb-d-K11_OTHDIG,Other diseases of the digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.966,None
finn-b-ST19_TRAUMAT_SUBDU_HAEMORRHAGE,Traumatic subdural haemorrhage,Subdural hemorrhage,HP:0100309,http://purl.obolibrary.org/obo/HP_0100309,0.84,None
ukb-e-23104_CSA,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
ieu-b-4975,Osteomyelitis,osteomyelitis,EFO:0003102,http://www.ebi.ac.uk/efo/EFO_0003102,0.997,None
ukb-e-23119_MID,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
ukb-e-24008_AFR,Particulate matter air pollution 2.5-10um; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.723,None
ukb-d-K25,Diagnoses - main ICD10: K25 Gastric ulcer,gastric ulcer,EFO:0009454,http://www.ebi.ac.uk/efo/EFO_0009454,0.668,None
ukb-e-760_CSA,Back pain,Back pain,HP:0003418,http://purl.obolibrary.org/obo/HP_0003418,0.993,None
finn-b-CD2_BENIGN_LIVE_BILE,Benign neoplasm: Liver/bile ducts,bile duct neoplasm,MONDO:0021662,http://purl.obolibrary.org/obo/MONDO_0021662,0.689,None
ukb-b-4929,"Diagnoses - secondary ICD10: I73.9 Peripheral vascular disease, unspecified",peripheral vascular disease,EFO:0003875,http://www.ebi.ac.uk/efo/EFO_0003875,0.679,None
ukb-d-K81,Diagnoses - main ICD10: K81 Cholecystitis,Cholecystitis,HP:0001082,http://purl.obolibrary.org/obo/HP_0001082,0.661,None
ukb-a-258,Cough on most days,Cough,HP:0012735,http://purl.obolibrary.org/obo/HP_0012735,0.632,None
ukb-e-6138_p5_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-MAP_p1_MID,"Mean arterial pressure, automated reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.718,None
ukb-e-23123_EAS,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
ieu-a-91,Obesity class 2,obesity,EFO:0001073,http://www.ebi.ac.uk/efo/EFO_0001073,0.788,None
ieu-a-1164,ER+ Breast cancer (Survival),survival time,EFO:0000714,http://www.ebi.ac.uk/efo/EFO_0000714,0.711,None
finn-b-E4_ENDODISNAS,"Endocrine disorders, other/unspecified",endocrine system disease,EFO:0001379,http://www.ebi.ac.uk/efo/EFO_0001379,0.989,None
finn-b-F5_STRESSOTH,"Other reactioin to severe stress, and adjustment disorders",adjustment disorder,MONDO:0003265,http://purl.obolibrary.org/obo/MONDO_0003265,0.642,None
finn-b-I9_HYPTENSHR,Hypertensive heart and/or renal disease,hypertensive heart disease,MONDO:0001302,http://purl.obolibrary.org/obo/MONDO_0001302,0.906,None
ukb-a-222,Illnesses of siblings: High blood pressure,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.711,None
ieu-a-14,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
finn-b-CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_EXALLC,Primary_lymphoid and hematopoietic malignant neoplasms (all cancers excluded),hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.77,None
finn-b-CD2_INSITU_MELANOMA_TRUNK_EXALLC,Melanoma in situ of trunk (all cancers excluded),cutaneous melanoma,EFO:0000389,http://www.ebi.ac.uk/efo/EFO_0000389,0.646,None
finn-b-L12_ERYTH_NAS,Other and unspecified erythematous conditions,Erythema,HP:0010783,http://purl.obolibrary.org/obo/HP_0010783,0.647,None
ukb-e-280_CSA,Iron deficiency anemias,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.921,None
finn-b-J10_UPPERINFEC,Acute upper respiratory infections,respiratory tract infectious disorder,MONDO:0024355,http://purl.obolibrary.org/obo/MONDO_0024355,0.834,None
ukb-e-4570_CSA,Friendships satisfaction,friendship satisfaction measurement,EFO:0009725,http://www.ebi.ac.uk/efo/EFO_0009725,0.827,None
finn-b-C3_BRONCHUS_LUNG_EXALLC,Malignant neoplasm of bronchus and lung (all cancers excluded),bronchus cancer,MONDO:0001672,http://purl.obolibrary.org/obo/MONDO_0001672,0.912,None
finn-b-AB1_SEQULAE_POLIO,Sequelae of poliomyelitis,postpoliomyelitis syndrome,EFO:0007454,http://www.ebi.ac.uk/efo/EFO_0007454,0.842,None
ukb-b-1763,"Non-cancer illness code, self-reported: nasal/sinus disorder",paranasal sinus disease,EFO:0009481,http://www.ebi.ac.uk/efo/EFO_0009481,0.639,None
finn-b-M13_DISCITIS,"Discitis, unspecified",discitis,EFO:1000900,http://www.ebi.ac.uk/efo/EFO_1000900,0.995,None
ukb-e-recode89_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-20126_p1_AFR,Bipolar and major depression status,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.705,None
finn-b-F5_MIXEDDEV,Mixed specific developmental disorders,specific developmental disorder,MONDO:0000592,http://purl.obolibrary.org/obo/MONDO_0000592,0.845,None
ukb-e-recode191_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_BINODISTOTH,Other disorders of binocular vision,binocular vision disease,EFO:0009535,http://www.ebi.ac.uk/efo/EFO_0009535,0.937,None
ukb-b-20386,Diagnoses - main ICD10: R07.2 Precordial pain,Precordial pain,HP:0032141,http://purl.obolibrary.org/obo/HP_0032141,0.624,None
ukb-e-20111_p14_EAS,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-C3_FEMALE_GENITAL_NAS,Malignant neoplasm of other and unspecified female genital organs,"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.952,None
finn-b-Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK,"Congenital malformations of eye, ear, face and neck",congenital heart malformation,EFO:0005269,http://www.ebi.ac.uk/efo/EFO_0005269,0.645,None
finn-b-CD2_BENIGN_CONNSOFT_LOWERLIMB_EXALLC,"""Benign neoplasm: Connective and other soft tissue of lower limb, including hip"" (all cancers excluded)",benign connective and soft tissue neoplasm,MONDO:0000654,http://purl.obolibrary.org/obo/MONDO_0000654,0.712,None
ebi-a-GCST005903,Major depressive disorder (ICD-10 coded),major depressive disorder,MONDO:0002009,http://purl.obolibrary.org/obo/MONDO_0002009,0.822,None
ukb-e-recode312_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-100200_CSA,Grapefruit juice intake,grapefruit juice consumption measurement,EFO:0010094,http://www.ebi.ac.uk/efo/EFO_0010094,0.766,None
ukb-e-2405_AFR,Number of children fathered,number of children fathered measurement,EFO:0009814,http://www.ebi.ac.uk/efo/EFO_0009814,0.914,None
finn-b-I9_SAH,Subarachnoid haemmorrhage,subarachnoid hemorrhage,EFO:0000713,http://www.ebi.ac.uk/efo/EFO_0000713,0.904,None
ukb-e-K92_CSA,K92 Other diseases of digestive system,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.823,None
finn-b-H7_VERTISTRAB,Vertical strabismus,Strabismus,HP:0000486,http://purl.obolibrary.org/obo/HP_0000486,0.809,None
ukb-e-D57_AFR,D57 Sickle-cell disorders,sickle cell anemia,MONDO:0011382,http://purl.obolibrary.org/obo/MONDO_0011382,0.633,None
ukb-e-1210_EAS,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-103080_CSA,Ham intake,tropical spastic paraparesis,EFO:0007527,http://www.ebi.ac.uk/efo/EFO_0007527,0.746,None
finn-b-R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_LUNG,Abnormal findings on diagnostic imaging of lung,abnormal result of diagnostic imaging,EFO:0009827,http://www.ebi.ac.uk/efo/EFO_0009827,0.683,None
finn-b-L12_IMPETIGO,Impetigo,impetigo,EFO:1000714,http://www.ebi.ac.uk/efo/EFO_1000714,0.997,None
ukb-e-783_CSA,Fever of unknown origin,fever of unknown origin,EFO:0003952,http://www.ebi.ac.uk/efo/EFO_0003952,0.988,None
ukb-e-23100_AFR,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
ukb-d-M13_HALLUXVALGUS,Hallux valgus (acquired),Hallux valgus,HP:0001822,http://purl.obolibrary.org/obo/HP_0001822,0.994,None
ebi-a-GCST90016595,ADHD vs anorexia nervosa (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.76,None
ukb-b-17107,Pain type(s) experienced in last month: Facial pain,facial pain,EFO:0009625,http://www.ebi.ac.uk/efo/EFO_0009625,0.642,None
ukb-e-3147_CSA,"Heel quantitative ultrasound index (QUI), direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.661,None
ukb-e-30650_MID,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
finn-b-I9_HYPTENSHD_EXNONE,Hypertensive Heart Disease (no controls excluded),hypertensive heart disease,MONDO:0001302,http://purl.obolibrary.org/obo/MONDO_0001302,0.94,None
ukb-d-C_LYMPHOMA,Lymphomas,lymphoma,EFO:0000574,http://www.ebi.ac.uk/efo/EFO_0000574,0.852,None
finn-b-H7_VITROTH,Other and unspecified disorders of vitreous body,vitreous body disease,EFO:0008624,http://www.ebi.ac.uk/efo/EFO_0008624,0.952,None
ebi-a-GCST005843,Ischemic stroke,Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.988,None
finn-b-Q17_CONGEN_DEFORMITI_HIP,Congenital deformities of hip,congenital deformities of fingers,MONDO:0017428,http://purl.obolibrary.org/obo/MONDO_0017428,0.771,None
ukb-e-30610_AFR,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
ukb-d-I9_HEARTFAIL_NS,"Heart failure, not strict",heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.996,None
finn-b-ST19_SUPERF_INJURY_ANKLE_FOOT,Superficial injury of ankle and foot,ankle injury,EFO:1002021,http://www.ebi.ac.uk/efo/EFO_1002021,0.649,None
ukb-d-XII_SKIN_SUBCUTAN,Diseases of the skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.929,None
ukb-e-599_CSA,Other symptoms/disorders or the urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.762,None
ebi-a-GCST006641,Menstruation quality of life impact (aggressiveness),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.605,None
ukb-b-17400,Snoring,Snoring,HP:0025267,http://purl.obolibrary.org/obo/HP_0025267,0.995,None
ukb-e-recode312_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-18578,"Non-cancer illness code, self-reported: heart valve problem/heart murmur",Heart murmur,HP:0030148,http://purl.obolibrary.org/obo/HP_0030148,0.691,None
finn-b-E4_IRON_MET,Disorders of iron metabolism,iron metabolism disease,MONDO:0002279,http://purl.obolibrary.org/obo/MONDO_0002279,0.957,None
ebi-a-GCST90014123,Lacunar stroke,multi-infarct dementia,MONDO:0043224,http://purl.obolibrary.org/obo/MONDO_0043224,0.638,None
finn-b-F5_SOMATOFORM,Somatoform disorder,somatoform disorder,EFO:0009687,http://www.ebi.ac.uk/efo/EFO_0009687,0.989,None
finn-b-H7_KERATITIS,Keratitis,keratitis,EFO:0009449,http://www.ebi.ac.uk/efo/EFO_0009449,0.996,None
ieu-a-6,Coronary heart disease,coronary artery disease,EFO:0001645,http://www.ebi.ac.uk/efo/EFO_0001645,0.993,None
ukb-e-20002_p95_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-E4_HYPERALDO,Hyperaldosteronism,hyperaldosteronism,EFO:0009452,http://www.ebi.ac.uk/efo/EFO_0009452,0.993,None
ukb-a-341,Neck/shoulder pain for 3+ months,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.706,None
ukb-e-recode98_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-F5_PHOBANX,Phobic anxiety disorders,anxiety disorder,EFO:0006788,http://www.ebi.ac.uk/efo/EFO_0006788,0.784,None
finn-b-ST19_SUPERF_INJURY_NECK,Superficial injury of neck,neck injury,EFO:0009476,http://www.ebi.ac.uk/efo/EFO_0009476,0.691,None
finn-b-E4_HYPERLIPNAS,"Hyperlipidaemia, other/unspecified",hyperlipidemia,MONDO:0021187,http://purl.obolibrary.org/obo/MONDO_0021187,0.769,None
ukb-b-10623,Diagnoses - main ICD10: D12.5 Sigmoid colon,sigmoid neoplasm,EFO:1001181,http://www.ebi.ac.uk/efo/EFO_1001181,0.619,None
finn-b-L12_URTICA_ALLERG,Allergic urticaria,allergic urticaria,EFO:1000669,http://www.ebi.ac.uk/efo/EFO_1000669,0.993,None
finn-b-I9_UAP,Unstable angina pectoris,intermediate coronary syndrome,EFO:1000985,http://www.ebi.ac.uk/efo/EFO_1000985,0.821,None
finn-b-Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD,Family history of other specific disorders,family history,EFO:0000493,http://www.ebi.ac.uk/efo/EFO_0000493,0.659,None
ukb-e-4674_EAS,Private healthcare,nosocomial infection,MONDO:0043544,http://purl.obolibrary.org/obo/MONDO_0043544,0.616,None
ukb-e-366_CSA,Cataract,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.989,None
ukb-e-30700_AFR,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
finn-b-J10_PLEUROTH,Other pleural conditions,disease,EFO:0000408,http://www.ebi.ac.uk/efo/EFO_0000408,0.616,None
ukb-e-recode275_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-D3_OTHERWHITECELL,Other disorders of white blood cells,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.862,None
finn-b-D3_BLOODNAS,Other and unspecified diseases of blood and blood-forming organs,hematologic disease,EFO:0005803,http://www.ebi.ac.uk/efo/EFO_0005803,0.84,None
ukb-e-6142_p7_CSA,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-POLYCYTVERA,Polycythaemia vera,polycythemia vera,EFO:0002429,http://www.ebi.ac.uk/efo/EFO_0002429,0.848,None
finn-b-H7_IRIDOACUTE,Acute and subacute iridocyclitis,Acute,HP:0011009,http://purl.obolibrary.org/obo/HP_0011009,0.66,None
finn-b-ATOPIC_STRICT,"Atopic  dermatitis, strict definition",atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.996,None
ieu-a-1081,IgA nephropathy,IGA glomerulonephritis,EFO:0004194,http://www.ebi.ac.uk/efo/EFO_0004194,0.979,None
ukb-a-105,Non-cancer illness code  self-reported: rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.693,None
finn-b-CD2_INSITU_SKIN_NOS,"Carcinoma in situ of skin, other sites/unspecified",skin carcinoma in situ,MONDO:0004641,http://purl.obolibrary.org/obo/MONDO_0004641,0.881,None
finn-b-K11_REFLUX,Gastro-oesophageal reflux disease,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.935,None
ukb-e-30680_AFR,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
finn-b-AB1_OTHER_SEPSIS,Other septicaemia,Pasteurella hemorrhagic septicemia,EFO:1001091,http://www.ebi.ac.uk/efo/EFO_1001091,0.7,None
finn-b-ST19_OPEN_WOUND_HEAD,Open wound of head,injury,EFO:0000546,http://www.ebi.ac.uk/efo/EFO_0000546,0.649,None
ukb-e-103080_AFR,Ham intake,tropical spastic paraparesis,EFO:0007527,http://www.ebi.ac.uk/efo/EFO_0007527,0.746,None
ukb-e-716_AFR,Other arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.779,None
finn-b-K11_UMBHER,Umbilical hernia,Umbilical hernia,HP:0001537,http://purl.obolibrary.org/obo/HP_0001537,0.988,None
ukb-e-20003_p229_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ukb-d-D3_ANAEMIANAS,Other and unspecified anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.827,None
ieu-b-95,Oral cavity cancer,oral cavity cancer,EFO:0005570,http://www.ebi.ac.uk/efo/EFO_0005570,0.995,None
ieu-a-801,Bipolar disorder,bipolar disorder,MONDO:0004985,http://purl.obolibrary.org/obo/MONDO_0004985,0.992,None
ukb-e-recode74_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-M13_REACTARTH,Reactive arthropathies,crystal arthropathy,MONDO:0022208,http://purl.obolibrary.org/obo/MONDO_0022208,0.648,None
finn-b-G6_TETRAPLE,Tetraplegia,quadriplegia,EFO:0009684,http://www.ebi.ac.uk/efo/EFO_0009684,0.984,None
ieu-a-1054,Gout,gout,EFO:0004274,http://www.ebi.ac.uk/efo/EFO_0004274,0.998,None
ukb-d-4803_11,"Tinnitus: Yes, now most or all of the time",Tinnitus,HP:0000360,http://purl.obolibrary.org/obo/HP_0000360,0.658,None
ukb-e-24005_MID,Particulate matter air pollution (pm10); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.729,None
finn-b-R18_RETEN_URINE,Retention of urine,Urinary retention,HP:0000016,http://purl.obolibrary.org/obo/HP_0000016,0.794,None
finn-b-F5_VASCDEM,Vascular dementia (F5_VASCDEM),vascular dementia,EFO:0004718,http://www.ebi.ac.uk/efo/EFO_0004718,0.8,None
ebi-a-GCST008048,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
ukb-e-6138_p1_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-20003_p5_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
finn-b-L12_ALLERGICCONTACT,Alergic contact dermatitis,allergic contact dermatitis,EFO:1000668,http://www.ebi.ac.uk/efo/EFO_1000668,0.928,None
ukb-e-5057_AFR,Number of older siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.851,None
finn-b-CD2_BENIGN_LIPO_NOS,Benign lipomatous neoplasm of other sites/unspecified,benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.9,None
ukb-b-13513,"Non-cancer illness code, self-reported: appendicitis",appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.609,None
finn-b-O15_FALSE_LAB,False labour,Braxton-Hicks contractions,EFO:0009639,http://www.ebi.ac.uk/efo/EFO_0009639,0.997,None
ieu-b-96,Oropharyngeal cancer,oropharynx cancer,EFO:1001931,http://www.ebi.ac.uk/efo/EFO_1001931,0.992,None
finn-b-D3_ANAEMIAINCHRONICDISEASE,Anaemia in chronic diseases classified elsewhere,chronic disease,EFO:0009714,http://www.ebi.ac.uk/efo/EFO_0009714,0.704,None
ukb-e-5110_CSA,6mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
finn-b-Z21_CONVALESCENCE,Convalescence,convalescence,EFO:0009630,http://www.ebi.ac.uk/efo/EFO_0009630,0.988,None
ukb-a-568,Diagnoses - main ICD10: M25 Other joint disorders  not elsewhere classified,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.604,None
ebi-a-GCST006657,Vaginal discharge (metrorrhagia),vaginal discharge,EFO:0009365,http://www.ebi.ac.uk/efo/EFO_0009365,0.737,None
finn-b-AB1_OTHER_SPIROCHAETAL,Other spirochaetal diseases,Spirochaetales Infections,EFO:0009567,http://www.ebi.ac.uk/efo/EFO_0009567,0.725,None
ukb-e-2335_AFR,Chest pain or discomfort,Chest pain,HP:0100749,http://purl.obolibrary.org/obo/HP_0100749,0.918,None
finn-b-M13_MUSCULOSKELEOTH,Other disorders of the musculoskeletal system and connective tissue,musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.795,None
ukb-e-recode236_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_RETINOPATHYDIAB,Diabetic retinopathy (H7_RETINOPATHYDIAB),diabetic retinopathy,EFO:0003770,http://www.ebi.ac.uk/efo/EFO_0003770,0.86,None
ukb-e-D64_AFR,D64 Other anaemias,anemia,MONDO:0002280,http://purl.obolibrary.org/obo/MONDO_0002280,0.616,None
finn-b-J10_NASALPOLYP,Nasal polyp,Nasal Cavity Polyp,EFO:1000391,http://www.ebi.ac.uk/efo/EFO_1000391,0.994,None
ukb-e-20111_p13_CSA,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
finn-b-CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC,Multiple myeloma and malignant plasma cell neoplasms (all cancers excluded),multiple myeloma,EFO:0001378,http://www.ebi.ac.uk/efo/EFO_0001378,0.659,None
ukb-e-E03_CSA,E03 Other hypothyroidism,hypothyroidism,EFO:0004705,http://www.ebi.ac.uk/efo/EFO_0004705,0.821,None
finn-b-APPENDICITIS_BROAD,"Appendicitis, broad definition",appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.815,None
finn-b-H8_EXT_NONINF,"Acute otitis externa, noninfective",otitis externa,EFO:0009560,http://www.ebi.ac.uk/efo/EFO_0009560,0.726,None
ukb-d-K11_GALLBILPANC,"Disorders of gallbladder, biliary tract and pancreas",gallbladder disease,EFO:0003832,http://www.ebi.ac.uk/efo/EFO_0003832,0.7,None
ukb-e-20116_p1_CSA,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
finn-b-N14_OTHPENIS,Other disorders of penis,penile disorder,MONDO:0002036,http://purl.obolibrary.org/obo/MONDO_0002036,0.917,None
ukb-e-100004_AFR,Fat,Lipoatrophy,HP:0100578,http://purl.obolibrary.org/obo/HP_0100578,0.617,None
finn-b-CD2_BENIGN_RECTUM,Benign neoplasm: Rectum,benign neoplasm of rectum,MONDO:0021462,http://purl.obolibrary.org/obo/MONDO_0021462,0.992,None
finn-b-AB1_EBV,Infectious mononucleosis,infectious mononucleosis,EFO:0007326,http://www.ebi.ac.uk/efo/EFO_0007326,0.994,None
finn-b-E4_DIABETES,Diabetes mellitus,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.993,None
ieu-b-4976,Pneumonia,pneumonia,EFO:0003106,http://www.ebi.ac.uk/efo/EFO_0003106,0.994,None
ukb-e-339_AFR,Other headache syndromes,headache disorder,EFO:0009550,http://www.ebi.ac.uk/efo/EFO_0009550,0.95,None
ebi-a-GCST007092,Osteoarthritis of the hip or knee,"osteoarthritis, knee",EFO:0004616,http://www.ebi.ac.uk/efo/EFO_0004616,0.919,None
ukb-e-1807_AFR,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
finn-b-G6_HYDROCEPH,Hydrocephalus,Hydrocephalus,HP:0000238,http://purl.obolibrary.org/obo/HP_0000238,0.986,None
finn-b-H7_ASTIGMATISM,Astigmatism,Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.992,None
finn-b-L12_URTICA_COLDHEAT,Urticaria due to cold and heat,cold urticaria,EFO:1001881,http://www.ebi.ac.uk/efo/EFO_1001881,0.774,None
ieu-a-814,Ischaemic stroke,Ischemic stroke,HP:0002140,http://purl.obolibrary.org/obo/HP_0002140,0.987,None
finn-b-J10_ACUTELOWERNAS,Unspecified acute lower respiratory infection,respiratory tract infectious disorder,MONDO:0024355,http://purl.obolibrary.org/obo/MONDO_0024355,0.72,None
ukb-e-46_EAS,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
finn-b-ST19_FOREI_BODY_RESPI_TRACT,Foreign body in respiratory tract,foreign body,EFO:0009525,http://www.ebi.ac.uk/efo/EFO_0009525,0.719,None
finn-b-J10_ASTHMA,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
finn-b-N14_MALEINFERT,Male infertility,male infertility,EFO:0004248,http://www.ebi.ac.uk/efo/EFO_0004248,0.99,None
finn-b-H7_BLEPHAROCHALASIS,Blepharochalasis,Ascher syndrome,MONDO:0007198,http://purl.obolibrary.org/obo/MONDO_0007198,0.707,None
ukb-e-recode53_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-N14_ENDOMETRIOSIS_INTESTINE,Endometriosis of intestine,endometriosis,EFO:0001065,http://www.ebi.ac.uk/efo/EFO_0001065,0.818,None
ukb-e-23100_CSA,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
ukb-e-6138_p1_AFR,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-b-1557,Diagnoses - main ICD10: M54.5 Low back pain,Low back pain,HP:0003419,http://purl.obolibrary.org/obo/HP_0003419,0.609,None
finn-b-H7_HEREDRETINADYST,Hereditary retinal dystrophy,inherited retinal dystrophy,MONDO:0019118,http://purl.obolibrary.org/obo/MONDO_0019118,0.985,None
ukb-e-recode347_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_THROMBICV,Nonpyogenic thrombosis of intracranial venous system,intracranial thrombosis,MONDO:0002907,http://purl.obolibrary.org/obo/MONDO_0002907,0.631,None
finn-b-D3_ANAEMIA_B12_DEF,Vitamin B12 deficiency anaemia,vitamin B12 deficiency,EFO:0000734,http://www.ebi.ac.uk/efo/EFO_0000734,0.844,None
finn-b-Z21_CONTRACEPTIVE_MANAG,Contraceptive management,contraception,EFO:0009520,http://www.ebi.ac.uk/efo/EFO_0009520,0.992,None
finn-b-L12_PSORI_GUTTATE,Guttate psoriasis,guttate psoriasis,MONDO:0023297,http://purl.obolibrary.org/obo/MONDO_0023297,0.973,None
ukb-e-52_p2_CSA,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ukb-a-434,Vascular/heart problems diagnosed by doctor: Heart attack,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.64,None
ukb-e-recode39_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_VHD,Valvular heart disease including rheumatic fever,heart valve disease,EFO:0009551,http://www.ebi.ac.uk/efo/EFO_0009551,0.672,None
ukb-d-M13_DORSALGIANAS,Other/unspecified dorsalgia,dorsal,EFO:0001656,http://www.ebi.ac.uk/efo/EFO_0001656,0.722,None
finn-b-KRA_PSY_DEMENTIA,Any dementia,Dementia,HP:0000726,http://purl.obolibrary.org/obo/HP_0000726,0.995,None
ukb-d-22660_103,Gap coding: Full-time or part-time education,time,EFO:0000721,http://www.ebi.ac.uk/efo/EFO_0000721,0.611,None
ukb-e-recode363_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-CD2_LEUKAEMIA_NAS,Leukaemia of unspecified cell type,Acute Leukemia,EFO:1000068,http://www.ebi.ac.uk/efo/EFO_1000068,0.793,None
ukb-b-18629,Diagnoses - main ICD10: N20.1 Calculus of ureter,ureterolithiasis,EFO:1001228,http://www.ebi.ac.uk/efo/EFO_1001228,0.674,None
ebi-a-GCST005569,Rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.997,None
ukb-e-1940_CSA,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
ebi-a-GCST006648,Menstruation quality of life impact (loss of concentration),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.674,None
ukb-e-680_p3_MID,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-e-recode137_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-218_AFR,Benign neoplasm of uterus,uterine benign neoplasm,MONDO:0000632,http://purl.obolibrary.org/obo/MONDO_0000632,0.996,None
finn-b-R18_HEADACHE1,Headache,Headache,HP:0002315,http://purl.obolibrary.org/obo/HP_0002315,0.969,None
finn-b-D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Purpura and other haemorrhagic conditions,Purpura,HP:0000979,http://purl.obolibrary.org/obo/HP_0000979,0.647,None
finn-b-CD2_BENIGN_OROPHA_OTHER_EXALLC,Benign neoplasm: Other parts of oropharynx (all cancers excluded),neoplasm of oropharynx,MONDO:0021364,http://purl.obolibrary.org/obo/MONDO_0021364,0.761,None
finn-b-CD2_BENIGN_CONJUNCTIVA,Benign neoplasm: Conjunctiva,Benign Conjunctival Neoplasm,EFO:1000110,http://www.ebi.ac.uk/efo/EFO_1000110,0.995,None
finn-b-VWXY20_UNSPE_FALL,Unspecified fall,fall,EFO:0009631,http://www.ebi.ac.uk/efo/EFO_0009631,0.999,None
finn-b-C3_KIDNEY_NOTRENALPELVIS_EXALLC,"""Malignant neoplasm of kidney, except renal pelvis"" (all cancers excluded)",kidney cancer,MONDO:0002367,http://purl.obolibrary.org/obo/MONDO_0002367,0.912,None
ukb-d-I9_VTE,Venous thromboembolism,venous thromboembolism,EFO:0004286,http://www.ebi.ac.uk/efo/EFO_0004286,0.993,None
finn-b-K11_OESITIS,Oesophagitis,Esophagitis,HP:0100633,http://purl.obolibrary.org/obo/HP_0100633,0.994,None
finn-b-AB1_ERYSIPELAS,Erysipelas,erysipelas,EFO:1001462,http://www.ebi.ac.uk/efo/EFO_1001462,0.997,None
ukb-e-20002_p62_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
finn-b-M13_JUVEARTH,Other juvenile arthritis,juvenile idiopathic arthritis,EFO:0002609,http://www.ebi.ac.uk/efo/EFO_0002609,0.991,None
finn-b-C3_LIVER_INTRAHEPATIC_BILE_DUCTS_EXALLC,Malignant neoplasm of liver and intrahepatic bile ducts (all cancers excluded),intrahepatic bile duct cancer,MONDO:0001487,http://purl.obolibrary.org/obo/MONDO_0001487,0.905,None
finn-b-M13_MUSCULOSKELETAL,Diseases of the musculoskeletal system and connective tissue,musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.793,None
bbj-a-109,Congestive heart failure,congestive heart failure,EFO:0000373,http://www.ebi.ac.uk/efo/EFO_0000373,0.994,None
finn-b-I9_CVD,Cardiovascular diseases,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.987,None
ukb-e-20126_p1_CSA,Bipolar and major depression status,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.705,None
ukb-b-12839,Operation code: umbilical hernia repair,Umbilical hernia,HP:0001537,http://purl.obolibrary.org/obo/HP_0001537,0.744,None
finn-b-ST19_TRAUMAT_ISCHA_MUSCLE,Traumatic ischaemia of muscle,ischemia,EFO:0000556,http://www.ebi.ac.uk/efo/EFO_0000556,0.609,None
ukb-e-6155_p8_EAS,Vitamin and mineral supplements,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.612,None
finn-b-M13_BONEDENSOTH,Other disorders of bone density and structure,disease of bone structure,MONDO:0000836,http://purl.obolibrary.org/obo/MONDO_0000836,0.705,None
ieu-a-1163,ER- Breast cancer (Survival),survival time,EFO:0000714,http://www.ebi.ac.uk/efo/EFO_0000714,0.711,None
ukb-e-20111_p14_MID,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-30060_AFR,Mean corpuscular haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.988,None
ieu-a-1024,Multiple sclerosis,multiple sclerosis,MONDO:0005301,http://purl.obolibrary.org/obo/MONDO_0005301,0.995,None
finn-b-G6_RADLES,Lesion of radial nerve,radial nerve lesion,EFO:1001143,http://www.ebi.ac.uk/efo/EFO_1001143,0.994,None
finn-b-F5_MOOD,Mood [affective] disorders,mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.856,None
finn-b-M13_DORSALGIANAS,Other/unspecified dorsalgia,dorsal,EFO:0001656,http://www.ebi.ac.uk/efo/EFO_0001656,0.722,None
finn-b-I9_ANGIO_EXNONE,Coronary angiopasty (no controls excluded),percutaneous transluminal coronary angioplasty,EFO:0003951,http://www.ebi.ac.uk/efo/EFO_0003951,0.682,None
ukb-e-D50_CSA,D50 Iron deficiency anaemia,Iron deficiency anemia,HP:0001891,http://purl.obolibrary.org/obo/HP_0001891,0.849,None
ieu-b-89,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
finn-b-Z21_PROBL_RELATED_SOCIAL_ENVIRONMENT,Problems related to social environment,social environment measurement,EFO:0010552,http://www.ebi.ac.uk/efo/EFO_0010552,0.751,None
ukb-e-I21_CSA,I21 Acute myocardial infarction,acute myocardial infarction,EFO:0008583,http://www.ebi.ac.uk/efo/EFO_0008583,0.884,None
ukb-b-8476,"Loneliness, isolation",loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
ukb-b-19482,Operation code: unilateral oophorectomy,bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.774,None
finn-b-F5_NEUROTICOTH,Other neurotic disorders,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.981,None
ukb-e-41231_MID,Hospital episode type,episodic ataxia type 1,MONDO:0008047,http://purl.obolibrary.org/obo/MONDO_0008047,0.634,None
ebi-a-GCST007091,Osteoarthritis (hip),"osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.994,None
ukb-e-recode85_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-ALLERG_ASTHMA_EXMORE,Allergic asthma (mode) (more controls excluded),allergic asthma,MONDO:0004784,http://purl.obolibrary.org/obo/MONDO_0004784,0.9,None
ukb-e-24008_CSA,Particulate matter air pollution 2.5-10um; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.723,None
ukb-e-30150_AFR,Eosinophill count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.895,None
ukb-e-NAP_MID,Non-albumin protein,serum non-albumin protein measurement,EFO:0004568,http://www.ebi.ac.uk/efo/EFO_0004568,0.712,None
finn-b-H7_RETINALDETACHTRACTION,Traction detachment of retina,retinal detachment,EFO:0005773,http://www.ebi.ac.uk/efo/EFO_0005773,0.834,None
ukb-e-recode285_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_EYELIDINFLAMMATION,Other inflammation of eyelid,blepharitis,EFO:0009536,http://www.ebi.ac.uk/efo/EFO_0009536,0.998,None
ukb-b-13248,Treatment/medication code: warfarin,warfarin measurement,EFO:0801226,http://www.ebi.ac.uk/efo/EFO_0801226,0.646,None
ukb-d-L98,"Diagnoses - main ICD10: L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified",skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.766,None
finn-b-K11_PERITON,Diseases of peritoneum,disease of peritoneum,EFO:0009541,http://www.ebi.ac.uk/efo/EFO_0009541,0.944,None
ukb-e-20111_p3_MID,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-e-N18_AFR,N18 Chronic renal failure,stage 5 chronic kidney disease,EFO:0009909,http://www.ebi.ac.uk/efo/EFO_0009909,0.84,None
ieu-a-813,Alcohol dependence,alcohol dependence,MONDO:0007079,http://purl.obolibrary.org/obo/MONDO_0007079,0.992,None
ebi-a-GCST007517,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-D3_SCNDTHROMBOCYTOPENIA,Secondary thrombocytopenia,acquired thrombocytopenia,MONDO:0001198,http://purl.obolibrary.org/obo/MONDO_0001198,0.976,None
ukb-b-16993,Operation code: unclassifiable,myelodysplastic syndrome,EFO:0000198,http://www.ebi.ac.uk/efo/EFO_0000198,0.712,None
ebi-a-GCST008311,Lymphangioleiomyomatosis (sporadic),lymphangioleiomyomatosis,MONDO:0011705,http://purl.obolibrary.org/obo/MONDO_0011705,0.888,None
ukb-a-301,Hair/balding pattern: Pattern 2,Abnormal hair pattern,HP:0010720,http://purl.obolibrary.org/obo/HP_0010720,0.689,None
ebi-a-GCST010004,Membranous nephropathy,membranous glomerulonephritis,EFO:0004254,http://www.ebi.ac.uk/efo/EFO_0004254,0.983,None
ukb-e-20117_p2_AFR,Alcohol drinker status,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.653,None
finn-b-MACULAR_CYST,Macular cyst,Cystoid macular dystrophy,ORPHANET.ORDO:75381,http://www.orpha.net/ORDO/Orphanet_75381,0.696,None
ebi-a-GCST90013831,Cisplatin-induced hearing loss in childhood cancer,childhood cancer,EFO:1000654,http://www.ebi.ac.uk/efo/EFO_1000654,0.615,None
finn-b-C3_RECTUM_EXALLC,Malignant neoplasm of rectum (all cancers excluded),rectum cancer,EFO:1000657,http://www.ebi.ac.uk/efo/EFO_1000657,0.901,None
ukb-b-16858,Cough on most days,Cough,HP:0012735,http://purl.obolibrary.org/obo/HP_0012735,0.632,None
ukb-b-8268,Diagnoses - main ICD10: K80.5 Calculus of bile duct without cholangitis or cholecystitis,acalculous cholecystitis,EFO:1000790,http://www.ebi.ac.uk/efo/EFO_1000790,0.714,None
ukb-e-recode82_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H8_OTHEREAR,Other disorders of ear,disorder of ear,MONDO:0021205,http://purl.obolibrary.org/obo/MONDO_0021205,0.899,None
finn-b-F5_SLEEPWAKE,Disorder of the sleep-wake schedule,sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.821,None
ukb-e-30270_MID,Mean sphered cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.801,None
finn-b-E4_DMNAS,Unspecified diabetes,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.997,None
ukb-e-30260_EAS,Mean reticulocyte volume,mean reticulocyte volume,EFO:0010701,http://www.ebi.ac.uk/efo/EFO_0010701,0.982,None
ebi-a-GCST90016611,Crohn's disease vs ulcerative colitis (ordinary least squares (OLS)),ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.635,None
ukb-a-476,Pain type(s) experienced in last month: Knee pain,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.631,None
finn-b-E4_HYPERPIT,Hyperfunction of pituitary gland,functioning pituitary gland adenoma,MONDO:0003429,http://purl.obolibrary.org/obo/MONDO_0003429,0.687,None
finn-b-AB1_VIRAL_HEMOR_FEVER_NOS,"Viral haemorrhagic fevers, not elsewhere classified/unspecified",viral hemorrhagic fever,MONDO:0018087,http://purl.obolibrary.org/obo/MONDO_0018087,0.959,None
ukb-e-30160_AFR,Basophill count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.886,None
ukb-e-recode68_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-4001,Operation code: prostate operation,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.642,None
ukb-b-956,Illnesses of father: Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.741,None
ukb-b-7584,"Non-cancer illness code, self-reported: ulcerative colitis",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.65,None
ukb-d-C3_BREAST_3,Malignant neoplasm of breast,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.988,None
ebi-a-GCST006862,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
finn-b-H8_MED_SUPP,Suppurative and unspecified otitis media,suppurative otitis media,EFO:0007503,http://www.ebi.ac.uk/efo/EFO_0007503,0.99,None
ukb-b-4876,Treatment/medication code: valsartan,valsartan measurement,EFO:0801224,http://www.ebi.ac.uk/efo/EFO_0801224,0.691,None
ukb-e-30850_CSA,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
ukb-e-3786_CSA,Age asthma diagnosed,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.661,None
finn-b-FG_CARDMYO,Cardiomyopathy (excluding other),cardiomyopathy,EFO:0000318,http://www.ebi.ac.uk/efo/EFO_0000318,0.996,None
ukb-e-3148_CSA,Heel bone mineral density (BMD),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.878,None
finn-b-R18_ISOLATED_PROTEINU,Isolated proteinuria,Proteinuria,HP:0000093,http://purl.obolibrary.org/obo/HP_0000093,0.759,None
finn-b-AB1_BACT_INTEST_OTH,Other bacterial intestinal infections,bacterial disease,EFO:0000771,http://www.ebi.ac.uk/efo/EFO_0000771,0.78,None
finn-b-C3_STOMACH,Malignant neoplasm of stomach,gastric cancer,MONDO:0001056,http://purl.obolibrary.org/obo/MONDO_0001056,0.994,None
ukb-b-686,"Diagnoses - main ICD10: K35.9 Acute appendicitis, unspecified",appendicitis,EFO:0007149,http://www.ebi.ac.uk/efo/EFO_0007149,0.704,None
ukb-e-23119_AFR,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
ukb-e-30870_CSA,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
finn-b-I9_HEARTFAIL_AND_OVERWEIGHT,Heart failure and bmi 25plus,heart failure,EFO:0003144,http://www.ebi.ac.uk/efo/EFO_0003144,0.642,None
ukb-d-22601_31313060,"Job coding: it operations technician, computer operator or technician, database manager, network or web technician, web master, systems administrator or officer",technician,EFO:0009739,http://www.ebi.ac.uk/efo/EFO_0009739,0.687,None
finn-b-I9_CEREBDOTH_EXNONE,"""Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere"" (no controls excluded)",cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.92,None
bbj-a-119,Gastric cancer,gastric cancer,MONDO:0001056,http://purl.obolibrary.org/obo/MONDO_0001056,0.993,None
ukb-e-103190_CSA,White fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.67,None
ukb-a-36,Handedness (chirality/laterality): Left-handed,handedness,EFO:0009902,http://www.ebi.ac.uk/efo/EFO_0009902,0.653,None
finn-b-E4_TESTICHYPO,Testicular hypofunction,ovarian dysfunction,EFO:0009003,http://www.ebi.ac.uk/efo/EFO_0009003,0.65,None
finn-b-WET_AMD,Wet age-related macular degeneration,wet macular degeneration,EFO:0004683,http://www.ebi.ac.uk/efo/EFO_0004683,0.993,None
finn-b-H7_GLAUCOMAMEDICATION,Use of antiglaucoma preparations and miotics,Antiglaucoma preparations and miotics use measurement,EFO:0009944,http://www.ebi.ac.uk/efo/EFO_0009944,0.915,None
finn-b-AUD,"Alcohol use disorder, ICD-based",alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.789,None
ukb-e-I20_AFR,I20 Angina pectoris,angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.813,None
ukb-e-459_CSA,Other disorders of circulatory system,cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.951,None
ukb-e-104910_AFR,Time spent doing moderate physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.648,None
finn-b-Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_COUNSELLI_MEDICAL_ADVICE_NOT_ELSEW_CLASSIFIED,"Persons encountering health services for other counselling and medical advice, not elsewhere classified",encounter with health service,EFO:0009786,http://www.ebi.ac.uk/efo/EFO_0009786,0.677,None
ieu-a-806,Autism,autism,EFO:0003758,http://www.ebi.ac.uk/efo/EFO_0003758,0.987,None
ukb-e-30030_AFR,Haematocrit percentage,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.61,None
ukb-e-recode291_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-J10_PNEUMONIA,All pneumoniae,Mycoplasma pneumoniae pneumonia,EFO:0007387,http://www.ebi.ac.uk/efo/EFO_0007387,0.873,None
ukb-e-52_p8_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-M13_CALCIFICTEND,Calcific tendinitis of shoulder,calcific tendinitis,MONDO:0001903,http://purl.obolibrary.org/obo/MONDO_0001903,0.773,None
ukb-e-134_p1_AFR,Number of self-reported cancers,"number of cancers, self-reported",EFO:0009800,http://www.ebi.ac.uk/efo/EFO_0009800,0.808,None
ukb-e-3773_CSA,Knee pain for 3+ months,Knee pain,HP:0030839,http://purl.obolibrary.org/obo/HP_0030839,0.712,None
finn-b-F5_MODRET,Moderate mental retardation,"Intellectual disability, moderate",HP:0002342,http://purl.obolibrary.org/obo/HP_0002342,0.985,None
finn-b-CD2_BENIGN_SKIN_NOS,"Benign neoplasm: Skin, unspecified",benign neoplasm of skin,MONDO:0021440,http://purl.obolibrary.org/obo/MONDO_0021440,0.993,None
ebi-a-GCST005920,Paternal history of Alzheimer's disease,family history of Alzheimers disease,EFO:0009268,http://www.ebi.ac.uk/efo/EFO_0009268,0.811,None
finn-b-H7_CORNEALNAS,Other and unspecified corneal deformities and disorders,corneal disease,EFO:0009464,http://www.ebi.ac.uk/efo/EFO_0009464,0.679,None
ukb-b-20544,Nervous feelings,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.783,None
ukb-b-16209,Diagnoses - secondary ICD10: K20 Oesophagitis,Esophagitis,HP:0100633,http://purl.obolibrary.org/obo/HP_0100633,0.637,None
ebi-a-GCST006488,Insomnia complaints,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.728,None
ukb-e-78_p1_EAS,"Heel bone mineral density (BMD) T-score, automated",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.695,None
finn-b-N14_POSTMENBLEED,Postmenopausal bleeding,postmenopausal,EFO:0002721,http://www.ebi.ac.uk/efo/EFO_0002721,0.827,None
ukb-e-104670_CSA,Vitamin supplement user,vitamin supplement exposure measurement,EFO:0009116,http://www.ebi.ac.uk/efo/EFO_0009116,0.674,None
ukb-b-3693,"Non-cancer illness code, self-reported: spontaneous pneumothorax/recurrent pneumothorax",Spontaneous pneumothorax,HP:0002108,http://purl.obolibrary.org/obo/HP_0002108,0.807,None
ebi-a-GCST006907,Ischemic stroke (large artery atherosclerosis),atherosclerosis,EFO:0003914,http://www.ebi.ac.uk/efo/EFO_0003914,0.725,None
finn-b-L12_INFECT_DERM,Infective dermatitis,Inflammatory abnormality of the skin,HP:0011123,http://purl.obolibrary.org/obo/HP_0011123,0.726,None
finn-b-H7_HORDEOLUM,Hordeolum and other deep inflammation of eyelid,blepharitis,EFO:0009536,http://www.ebi.ac.uk/efo/EFO_0009536,0.708,None
finn-b-C3_COLON_ADENO,Colon adenocarcinoma,colon adenocarcinoma,EFO:1001949,http://www.ebi.ac.uk/efo/EFO_1001949,0.988,None
finn-b-Z21_FAMILY_HISTORY_MALIG_NEOPLASM,Family history of malignant neoplasm,family history of cancer,EFO:0009640,http://www.ebi.ac.uk/efo/EFO_0009640,0.991,None
ukb-e-100010_AFR,Portion size,size,EFO:0001695,http://www.ebi.ac.uk/efo/EFO_0001695,0.775,None
ukb-b-5012,Surgery on leg arteries (other than for varicose veins),Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.639,None
finn-b-C3_MESOTHELIOMA_EXALLC,Mesothelioma (all cancers excluded),mesothelioma,EFO:0000588,http://www.ebi.ac.uk/efo/EFO_0000588,0.897,None
ukb-e-4125_EAS,"Heel bone mineral density (BMD) T-score, automated (right)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.658,None
finn-b-D3_SCNDPOLYCYTHAEMIA,Secondary polycythaemia,secondary polycythemia,MONDO:0020115,http://purl.obolibrary.org/obo/MONDO_0020115,0.856,None
ukb-a-54,Cancer code  self-reported: lung cancer,lung cancer,MONDO:0008903,http://purl.obolibrary.org/obo/MONDO_0008903,0.753,None
ukb-e-R10_AFR,R10 Abdominal and pelvic pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.677,None
ukb-e-3404_AFR,Neck/shoulder pain for 3+ months,Shoulder pain,HP:0030834,http://purl.obolibrary.org/obo/HP_0030834,0.706,None
finn-b-CD2_BENIGN_CAECUM_EXALLC,Benign neoplasm: Caecum (all cancers excluded),cecal neoplasm,EFO:0009255,http://www.ebi.ac.uk/efo/EFO_0009255,0.782,None
ukb-b-14649,"Invitation to physical activity study, acceptance",physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.608,None
ukb-e-recode215_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-518,Diagnoses - main ICD10: C44 Other malignant neoplasms of skin,skin cancer,MONDO:0002898,http://purl.obolibrary.org/obo/MONDO_0002898,0.663,None
ukb-d-1508_2,Coffee type: Instant coffee,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.637,None
finn-b-ST19_OTHER_UNSPE_INJURI_HEAD,Other and unspecified injuries of head,head injury,EFO:0009505,http://www.ebi.ac.uk/efo/EFO_0009505,0.734,None
finn-b-H8_MASTCHRON,Chronic mastoiditis,Mastoiditis,HP:0000265,http://purl.obolibrary.org/obo/HP_0000265,0.786,None
ukb-e-20003_p235_AFR,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ebi-a-GCST90016621,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),schizophrenia,MONDO:0005090,http://purl.obolibrary.org/obo/MONDO_0005090,0.679,None
ukb-d-20502,Ever had period extreme irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.634,None
ukb-e-30190_AFR,Monocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.994,None
ukb-e-427_CSA,Cardiac dysrhythmias,cardiac arrhythmia,EFO:0004269,http://www.ebi.ac.uk/efo/EFO_0004269,0.757,None
finn-b-H7_RETINALDISOTH,Other retinal disorders,retinopathy,EFO:0003839,http://www.ebi.ac.uk/efo/EFO_0003839,0.91,None
finn-b-N14_GENITOURINARY,Genitourinary diseases,disease of genitourinary system,EFO:0009663,http://www.ebi.ac.uk/efo/EFO_0009663,0.81,None
finn-b-DM_RET_ART_OCCLU_BRANCH,Retinal artery occlusion (branch),retinal artery occlusion,EFO:1001154,http://www.ebi.ac.uk/efo/EFO_1001154,0.874,None
finn-b-I9_PVT_EXNONE,Portal vein thrombosis (no controls excluded),Portal vein thrombosis,HP:0030242,http://purl.obolibrary.org/obo/HP_0030242,0.939,None
ukb-e-30660_EAS,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
ebi-a-GCST90011866,Systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
finn-b-M13_ALGONEURO,Alogoneurodystrophy,algoneurodystrophy,MONDO:0001859,http://purl.obolibrary.org/obo/MONDO_0001859,0.706,None
ukb-e-recode246_EAS,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-H7_EPIPHORA,Epiphora,Epiphora,HP:0009926,http://purl.obolibrary.org/obo/HP_0009926,0.995,None
ukb-a-70,Non-cancer illness code  self-reported: gastro-oesophageal reflux (gord) / gastric reflux,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.799,None
ukb-e-401_EAS,Hypertension,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.987,None
finn-b-KRA_PSY_MOOD_EXMORE,Mood disorders (more controls excluded),mood disorder,EFO:0004247,http://www.ebi.ac.uk/efo/EFO_0004247,0.986,None
ebi-a-GCST90016605,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),anorexia nervosa,MONDO:0005351,http://purl.obolibrary.org/obo/MONDO_0005351,0.711,None
ukb-e-recode32_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-Z21_CONTACT_W_EXPOS_COMMUNICAB_DISEA,Contact with and exposure to communicable diseases,infectious disease,EFO:0005741,http://www.ebi.ac.uk/efo/EFO_0005741,0.678,None
ukb-e-20003_p519_CSA,Treatment/medication code,age at initiation of treatment,EFO:0021779,http://www.ebi.ac.uk/efo/EFO_0021779,0.663,None
ieu-b-98,Oropharyngeal cancer,oropharynx cancer,EFO:1001931,http://www.ebi.ac.uk/efo/EFO_1001931,0.992,None
finn-b-M13_SLE,Systemic lupus erythematosus,systemic lupus erythematosus,MONDO:0007915,http://purl.obolibrary.org/obo/MONDO_0007915,0.993,None
finn-b-E4_PITUDISNAS,"Disorders of pituitary gland, other and/or unspecified",pituitary gland disease,EFO:0009607,http://www.ebi.ac.uk/efo/EFO_0009607,0.955,None
finn-b-I9_OTHANEUR,Other aneurysm,aneurysm,EFO:0009659,http://www.ebi.ac.uk/efo/EFO_0009659,0.993,None
finn-b-E4_CARCISDR,Carcinoid syndrome,carcinoid syndrome,EFO:1000852,http://www.ebi.ac.uk/efo/EFO_1000852,0.973,None
ebi-a-GCST006646,Menstruation quality of life impact (headache),quality of life during menstruation measurement,EFO:0009366,http://www.ebi.ac.uk/efo/EFO_0009366,0.655,None
ukb-a-558,Diagnoses - main ICD10: K76 Other diseases of liver,liver disease,EFO:0001421,http://www.ebi.ac.uk/efo/EFO_0001421,0.626,None
ieu-b-8,"epilepsy, all documented cases",Seizure,HP:0001250,http://purl.obolibrary.org/obo/HP_0001250,0.693,None
ukb-e-3144_CSA,"Heel Broadband ultrasound attenuation, direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.835,None
ukb-e-30880_CSA,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ukb-e-5158_AFR,6mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
ukb-b-13545,"Cancer code, self-reported: uterine/endometrial cancer",endometrial cancer,MONDO:0011962,http://purl.obolibrary.org/obo/MONDO_0011962,0.733,None
finn-b-F5_DISPER,Dissocial personality disorder,Personality disorder,HP:0012075,http://purl.obolibrary.org/obo/HP_0012075,0.812,None
ukb-b-964,Diagnoses - main ICD10: I48 Atrial fibrillation and flutter,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.635,None
finn-b-J10_ARDS,Adult respiratory distress syndrome,adult acute respiratory distress syndrome,MONDO:0100130,http://purl.obolibrary.org/obo/MONDO_0100130,0.965,None
ukb-e-2443_AFR,Diabetes diagnosed by doctor,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.661,None
ukb-e-recode150_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-b-16751,"Diagnoses - secondary ICD10: J44.9 Chronic obstructive pulmonary disease, unspecified",chronic obstructive pulmonary disease,EFO:0000341,http://www.ebi.ac.uk/efo/EFO_0000341,0.775,None
finn-b-H7_CORNULCER,Corneal ulcer,ulcer disease,MONDO:0043839,http://purl.obolibrary.org/obo/MONDO_0043839,0.665,None
finn-b-K11_OTHINT,Other diseases of intestine,intestinal disease,EFO:0009431,http://www.ebi.ac.uk/efo/EFO_0009431,0.924,None
finn-b-FG_OTH,Other CVD (FINNGEN),cardiovascular disease,EFO:0000319,http://www.ebi.ac.uk/efo/EFO_0000319,0.713,None
ukb-e-4717_AFR,Shortness of breath walking on level ground,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.695,None
finn-b-KRA_PSY_SUBSTANCE_EXMORE,Substance abuse (more controls excluded),substance abuse,MONDO:0002491,http://purl.obolibrary.org/obo/MONDO_0002491,0.985,None
ukb-e-30210_CSA,Eosinophill percentage,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.922,None
ukb-e-670_p1_MID,Type of accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.732,None
ukb-e-30650_AFR,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
finn-b-L12_ACNE,Acne,acne,EFO:0003894,http://www.ebi.ac.uk/efo/EFO_0003894,0.999,None
finn-b-N14_URINOTH,Other diseases of urinary system,urinary system disease,EFO:0009690,http://www.ebi.ac.uk/efo/EFO_0009690,0.93,None
ukb-e-104010_AFR,Pulses intake,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.623,None
ukb-e-100160_AFR,Low calorie drink intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.6,None
finn-b-PNEUMO_SEPTHICHE,Pneumococcal septichemia,pneumococcal pneumonia,EFO:1001474,http://www.ebi.ac.uk/efo/EFO_1001474,0.717,None
ukb-e-Z30_CSA,Z30 Contraceptive management,contraception,EFO:0009520,http://www.ebi.ac.uk/efo/EFO_0009520,0.838,None
ukb-e-recode418_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-BRONCHITIS,Bronchitis,bronchitis,EFO:0009661,http://www.ebi.ac.uk/efo/EFO_0009661,0.995,None
finn-b-E4_DM2COMA,Type 2 diabetes with coma,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.773,None
finn-b-H7_MODVISIMPBINOC,"Moderate visual impairment, binocular",Visual impairment,HP:0000505,http://purl.obolibrary.org/obo/HP_0000505,0.757,None
ukb-e-4537_EAS,Work/job satisfaction,job satisfaction measurement,EFO:0009723,http://www.ebi.ac.uk/efo/EFO_0009723,0.901,None
ukb-e-21000_p13_AFR,Ethnic background,ethnic group,EFO:0001799,http://www.ebi.ac.uk/efo/EFO_0001799,0.64,None
finn-b-Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO,Congenital malformations of cardiac chambers and connections,heart-hand syndrome type 3,MONDO:0007702,http://purl.obolibrary.org/obo/MONDO_0007702,0.602,None
ukb-e-recode436_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-I9_NONRHEVALV,Non-rheumatic valve diseases,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.739,None
finn-b-CD2_NONFOLLICULAR_LYMPHOMA,Non-follicular lymphoma,follicular lymphoma,MONDO:0018906,http://purl.obolibrary.org/obo/MONDO_0018906,0.949,None
ukb-e-30040_AFR,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
finn-b-I9_CARDMYOHYP_EXNONE,"""Cardiomyopathy, Hypertrophic obstructive"" (no controls excluded)",hypertrophic cardiomyopathy,EFO:0000538,http://www.ebi.ac.uk/efo/EFO_0000538,0.968,None
finn-b-ATOPIC_STRICT_REIMB,"Atopic dermatitis, strict definition with reimbursement",atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.646,None
ukb-b-16943,Illnesses of siblings: Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.688,None
ukb-a-60,Cancer code  self-reported: squamous cell carcinoma,squamous cell carcinoma,EFO:0000707,http://www.ebi.ac.uk/efo/EFO_0000707,0.801,None
ukb-e-30240_MID,Reticulocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.694,None
ukb-a-545,Diagnoses - main ICD10: K21 Gastro-oesophageal reflux disease,gastroesophageal reflux disease,EFO:0003948,http://www.ebi.ac.uk/efo/EFO_0003948,0.776,None
ukb-e-20002_p172_CSA,"Non-cancer illness code, self-reported","number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.639,None
ieu-a-1231,Mucinous ovarian cancer: invasive and low malignant potential,Borderline Ovarian Surface Epithelial-Stromal Tumor,EFO:1000140,http://www.ebi.ac.uk/efo/EFO_1000140,0.679,None
ukb-e-20111_p1_AFR,Illnesses of siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.61,None
ukb-a-570,Diagnoses - main ICD10: M67 Other disorders of synovium and tendon,synovium disorder,MONDO:0056799,http://purl.obolibrary.org/obo/MONDO_0056799,0.641,None
finn-b-H7_CONJUNCTIVITISCHRON,Chronic conjunctivitis,chronic conjunctivitis,MONDO:0002314,http://purl.obolibrary.org/obo/MONDO_0002314,0.993,None
finn-b-D3_VONVILLEBRAND,Von Willebrand disease,von Willebrand disease (hereditary or acquired),MONDO:0024574,http://purl.obolibrary.org/obo/MONDO_0024574,0.99,None
ieu-a-824,Alzheimer's disease,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.988,None
finn-b-H7_GLAUCSUSP,Glaucoma suspect,glaucoma,MONDO:0005041,http://purl.obolibrary.org/obo/MONDO_0005041,0.736,None
ukb-e-recode353_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-50_AFR,Standing height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.708,None
ukb-b-7421,"Diagnoses - secondary ICD10: K51.9 Ulcerative colitis, unspecified",ulcerative colitis,EFO:0000729,http://www.ebi.ac.uk/efo/EFO_0000729,0.609,None
ukb-e-100015_AFR,Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.797,None
ieu-a-12,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
finn-b-KRA_PSY_HYPERKIN_EXMORE,Hyperkinetic disorders (more controls excluded),attention deficit hyperactivity disorder,EFO:0003888,http://www.ebi.ac.uk/efo/EFO_0003888,0.709,None
ukb-e-30670_AFR,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
ukb-e-6017_AFR,Able to walk or cycle unaided for 10 minutes,"ability to walk or cycle unaided for 10 minutes, self-reported",EFO:0009822,http://www.ebi.ac.uk/efo/EFO_0009822,0.71,None
ukb-e-535_CSA,Gastritis and duodenitis,duodenitis,MONDO:0004627,http://purl.obolibrary.org/obo/MONDO_0004627,0.81,None
finn-b-I9_AORTDIS_EXNONE,Dissection of aorta (no controls excluded),Aortic dissection,HP:0002647,http://purl.obolibrary.org/obo/HP_0002647,0.774,None
finn-b-E4_DM2REN,Type 2 diabetes with renal complications,familial renal glucosuria,MONDO:0009297,http://purl.obolibrary.org/obo/MONDO_0009297,0.612,None
finn-b-CD2_MYELOID_LEUKAEMIA,Myeloid leukaemia,myeloid leukemia,MONDO:0004643,http://purl.obolibrary.org/obo/MONDO_0004643,0.761,None
finn-b-D3_BLOOD,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,immune system disease,EFO:0000540,http://www.ebi.ac.uk/efo/EFO_0000540,0.686,None
ukb-e-6138_p2_EAS,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ieu-a-295,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
finn-b-AB1_VARICELLA,Varicella [chickenpox],chickenpox,EFO:0007204,http://www.ebi.ac.uk/efo/EFO_0007204,0.82,None
ukb-e-30730_EAS,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
ukb-d-XIII_MUSCULOSKELET,Diseases of the musculoskeletal system and connective tissue,musculoskeletal system disease,EFO:0009676,http://www.ebi.ac.uk/efo/EFO_0009676,0.793,None
finn-b-MYELOPROF_NONCML,Myeloproliferative diseases (CML excluded),myeloproliferative disorder,EFO:0004251,http://www.ebi.ac.uk/efo/EFO_0004251,0.735,None
finn-b-C3_EYE_ADNEXA,Malignant neoplasm of eye and adnexa,ocular cancer,MONDO:0002236,http://purl.obolibrary.org/obo/MONDO_0002236,0.784,None
finn-b-D3_OTHERAPLASTICANAEMIA,Other and unspecified aplastic anaemias,Aplastic anemia,HP:0001915,http://purl.obolibrary.org/obo/HP_0001915,0.894,None
ukb-e-100013_AFR,Vitamin B12,vitamin B12 deficiency,EFO:0000734,http://www.ebi.ac.uk/efo/EFO_0000734,0.914,None
ebi-a-GCST006085,Prostate cancer,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.994,None
finn-b-M13_HYPERMOBILITY,Hypermobility syndrome,hypermobility syndrome,MONDO:0001798,http://purl.obolibrary.org/obo/MONDO_0001798,0.959,None
finn-b-AB1_LATE_SYPHILIS,Late syphilis,tertiary syphilis,MONDO:0004497,http://purl.obolibrary.org/obo/MONDO_0004497,0.99,None
bbj-a-111,Drug eruption,exanthem,EFO:1000697,http://www.ebi.ac.uk/efo/EFO_1000697,0.669,None
ukb-d-N35,Diagnoses - main ICD10: N35 Urethral stricture,Urethral stricture,HP:0012227,http://purl.obolibrary.org/obo/HP_0012227,0.727,None
finn-b-H7_IRIDOCYCLITISINOTH,Iridocyclitis in diseases classified elsewhere,Iridocyclitis,HP:0001094,http://purl.obolibrary.org/obo/HP_0001094,0.88,None
ukb-e-48_EAS,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
finn-b-Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED,"Chromosomal abnormalities, not elsewhere classified",chromosome 17 disorder,MONDO:0020583,http://purl.obolibrary.org/obo/MONDO_0020583,0.737,None
ieu-b-4876,cervical cancer,cervical cancer,MONDO:0002974,http://purl.obolibrary.org/obo/MONDO_0002974,0.996,None
ukb-e-I84_AFR,I84 Haemorrhoids,hemorrhoid,EFO:0009552,http://www.ebi.ac.uk/efo/EFO_0009552,0.682,None
finn-b-F5_MANIA,Manic episode,manic or hypomanic episode,EFO:0007706,http://www.ebi.ac.uk/efo/EFO_0007706,0.854,None
ukb-e-6142_p3_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-K11_OTHENTERCOL,Other noninfective gastroenteritis and colitis,gastroenteritis,EFO:1001463,http://www.ebi.ac.uk/efo/EFO_1001463,0.745,None
ukb-b-9597,Diagnoses - main ICD10: O70.0 First degree perineal laceration during delivery,perineal laceration during delivery,EFO:0009816,http://www.ebi.ac.uk/efo/EFO_0009816,0.661,None
ukb-e-426_CSA,Cardiac conduction disorders,heart conduction disease,MONDO:0000992,http://purl.obolibrary.org/obo/MONDO_0000992,0.953,None
finn-b-N14_PYELONEPHR,Acute tubulo-interstitial nephritis,interstitial nephritis,MONDO:0001085,http://purl.obolibrary.org/obo/MONDO_0001085,0.829,None
finn-b-H7_VASCCILIARY,Hyphaema and other vascular disorders of iris and ciliary body,ciliary body disorder,MONDO:0002970,http://purl.obolibrary.org/obo/MONDO_0002970,0.644,None
finn-b-G6_MEDLEOTH,Other lesions of median nerve,radial nerve lesion,EFO:1001143,http://www.ebi.ac.uk/efo/EFO_1001143,0.698,None
ukb-b-12944,Diagnoses - main ICD10: N84.0 Polyp of corpus uteri,uterine polyp,EFO:0009484,http://www.ebi.ac.uk/efo/EFO_0009484,0.709,None
ukb-b-7831,"Non-cancer illness code, self-reported: fracture wrist / colles fracture",wrist fracture,EFO:0009515,http://www.ebi.ac.uk/efo/EFO_0009515,0.702,None
finn-b-L12_ATOPIC,Atopic dermatitis,atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.996,None
ukb-e-208_AFR,Benign neoplasm of colon,benign colon neoplasm,MONDO:0002278,http://purl.obolibrary.org/obo/MONDO_0002278,0.995,None
finn-b-R18_OTHER_ABNORMAL_IMMUNOL_FINDI_SERUM,Other abnormal immunological findings in serum,Abnormality of the immune system,HP:0002715,http://purl.obolibrary.org/obo/HP_0002715,0.753,None
finn-b-I9_VEINSOTH_EXNONE,Other disorders of veins (no controls excluded),vein disorder,MONDO:0004634,http://purl.obolibrary.org/obo/MONDO_0004634,0.748,None
ukb-e-6142_p3_MID,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-RHEUMA_SEROPOS_STRICT,"Seropositive rheumatoid arthritis, strict definition",rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.819,None
ukb-e-100007_CSA,Polyunsaturated fat,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.795,None
ukb-b-12018,Illnesses of mother: Chronic bronchitis/emphysema,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.655,None
finn-b-SFN,Small fibre neuropathy,primary erythermalgia,MONDO:0007571,http://purl.obolibrary.org/obo/MONDO_0007571,0.791,None
ukb-d-M47,Diagnoses - main ICD10: M47 Spondylosis,spondylosis,MONDO:0002253,http://purl.obolibrary.org/obo/MONDO_0002253,0.664,None
ukb-d-K59,Diagnoses - main ICD10: K59 Other functional intestinal disorders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.667,None
ukb-e-103100_AFR,Other meat intake,fat intake measurement,EFO:0010809,http://www.ebi.ac.uk/efo/EFO_0010809,0.713,None
ukb-e-52_p7_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ieu-b-4914,Leukaemia,Acute Leukemia,EFO:1000068,http://www.ebi.ac.uk/efo/EFO_1000068,0.806,None
ukb-d-20401,Ever addicted to any substance or behaviour,addictive behaviour,EFO:0004347,http://www.ebi.ac.uk/efo/EFO_0004347,0.724,None
ukb-e-recode210_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
finn-b-K11_ABSCANAL,Abscess of anal and rectal regions,Rectal abscess,HP:0005224,http://purl.obolibrary.org/obo/HP_0005224,0.766,None
ukb-b-14057,"Non-cancer illness code, self-reported: hypertension",hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.615,None
finn-b-N14_OTHFEMPELINF,Other female pelvic inflammatory diseases,Pelvic Inflammatory Disease,EFO:1001388,http://www.ebi.ac.uk/efo/EFO_1001388,0.86,None
ukb-a-316,Had menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.856,None
finn-b-CD2_BENIGN_LIVER_EXALLC,Benign neoplasm: Liver (all cancers excluded),benign neoplasm,EFO:0002422,http://www.ebi.ac.uk/efo/EFO_0002422,0.771,None
ukb-a-47,Irritability,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.989,None
ukb-e-recode85_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-2139_MID,Age first had sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.849,None
ukb-e-M51_CSA,M51 Other intervertebral disk disorders,lumbar disc degeneration,EFO:0004994,http://www.ebi.ac.uk/efo/EFO_0004994,0.721,None
ukb-e-20116_p3_EAS,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ukb-e-52_p11_AFR,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
ieu-b-9,"generalized epilepsy, all documented cases",generalised epilepsy,EFO:0005917,http://www.ebi.ac.uk/efo/EFO_0005917,0.808,None
ukb-e-1249_CSA,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
ukb-e-M17_AFR,M17 Gonarthrosis [arthrosis of knee],joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.756,None
ukb-e-104250_CSA,Mushroom intake,mushroom workers' lung,EFO:0007385,http://www.ebi.ac.uk/efo/EFO_0007385,0.623,None
ukb-e-20004_p96_EAS,Operation code,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.625,None
finn-b-M13_CALCTENDINITIS,Calcific tendinitis,calcific tendinitis,MONDO:0001903,http://purl.obolibrary.org/obo/MONDO_0001903,0.993,None
finn-b-L12_ATROPHICSKIN,Atrophic disorders of skin,skin atrophy,EFO:1000766,http://www.ebi.ac.uk/efo/EFO_1000766,0.793,None
ukb-d-I9_DVTANDPULM,DVT of lower extremities and pulmonary embolism,pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.68,None
ukb-e-1329_CSA,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
ieu-b-86,Oral cavity and pharyngeal cancer,pharynx cancer,EFO:0005577,http://www.ebi.ac.uk/efo/EFO_0005577,0.791,None
finn-b-M13_ARTHTROSIS_COX_PRIM_HIPSURG,"Coxarthrosis, primary, with hip surgery","osteoarthritis, hip",EFO:1000786,http://www.ebi.ac.uk/efo/EFO_1000786,0.622,None
finn-b-I9_PULMEMB_EXNONE,Pulmonary embolism (no controls excluded),pulmonary embolism,EFO:0003827,http://www.ebi.ac.uk/efo/EFO_0003827,0.949,None
finn-b-INV_VENT,Invasive ventilation,invasive mechanical ventilation,EFO:0010720,http://www.ebi.ac.uk/efo/EFO_0010720,0.992,None
finn-b-H7_STRABISMUS,Strabismus,Strabismus,HP:0000486,http://purl.obolibrary.org/obo/HP_0000486,0.99,None
ukb-e-6149_p5_CSA,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-564_CSA,Functional digestive disorders,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.655,None
finn-b-JOINTPAIN,Pain in joint,Arthralgia,HP:0002829,http://purl.obolibrary.org/obo/HP_0002829,0.994,None
finn-b-L12_ALOPECAREATA,Alopecia areata,alopecia areata,EFO:0004192,http://www.ebi.ac.uk/efo/EFO_0004192,0.982,None
ukb-e-6164_p4_EAS,Types of physical activity in last 4 weeks,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.7,None
ukb-e-5088_AFR,Astigmatism angle (right),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.732,None
ukb-e-24006_AFR,Particulate matter air pollution (pm2.5); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.739,None
ukb-a-259,Bring up phlegm/sputum/mucus on most days,"bringing up phlegm, sputum or mucus on most days, self-reported",EFO:0009824,http://www.ebi.ac.uk/efo/EFO_0009824,0.708,None
ukb-b-17314,Treatment/medication code: venlafaxine,response to venlafaxine,EFO:0006328,http://www.ebi.ac.uk/efo/EFO_0006328,0.668,None
finn-b-M13_VARUS,"Varus deformity, not elsewhere classified",Equinovarus deformity,HP:0008110,http://purl.obolibrary.org/obo/HP_0008110,0.706,None
finn-b-M13_SACROCOGG,"Sacrococcygeal disorders, not elsewhere classified",Pilonidal abscess,HP:0010771,http://purl.obolibrary.org/obo/HP_0010771,0.757,None
ukb-d-J10_ASTHMA,Asthma,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.989,None
ukb-e-6138_p5_CSA,Qualifications,disease characteristic,EFO:0009813,http://www.ebi.ac.uk/efo/EFO_0009813,0.634,None
ukb-e-569_CSA,Other disorders of intestine,intestinal disease,EFO:0009431,http://www.ebi.ac.uk/efo/EFO_0009431,0.922,None
ukb-b-5474,Vitamin and/or mineral supplement use: Vitamin B12,vitamin B12 measurement,EFO:0004620,http://www.ebi.ac.uk/efo/EFO_0004620,0.732,None
ukb-e-30630_AFR,Apolipoprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.853,None
finn-b-C3_UNCERTAIN_SECONDARY_EXALLC,Secondary uncertain malignant neoplasm (all cancers excluded),secondary malignant neoplasm,EFO:0009812,http://www.ebi.ac.uk/efo/EFO_0009812,0.734,None
ukb-e-recode74_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30240_AFR,Reticulocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.694,None
finn-b-CHRONOTH,Other Chron's disease,chronic disease,EFO:0009714,http://www.ebi.ac.uk/efo/EFO_0009714,0.84,None
ukb-b-14043,Illnesses of siblings: Alzheimer's disease/dementia,Alzheimer disease,MONDO:0004975,http://purl.obolibrary.org/obo/MONDO_0004975,0.7,None
finn-b-D3_ALLERGPURPURA,Allergic purpura,Henoch-Schoenlein purpura,EFO:1000965,http://www.ebi.ac.uk/efo/EFO_1000965,0.997,None
finn-b-J10_ASBESTPNEUMOC,Pneumoconiosis due to asbestos and other mineral fibres,asbestosis,EFO:0007153,http://www.ebi.ac.uk/efo/EFO_0007153,0.819,None
ukb-e-1329_EAS,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
finn-b-I9_VARICVE_EXNONE,Varicose veins (no controls excluded),Varicose veins,HP:0002619,http://purl.obolibrary.org/obo/HP_0002619,0.927,None
ukb-e-30880_MID,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
finn-b-CD2_BENIGN_FEMALE_GEN_OTH_EXALLC,Benign neoplasm of other and unspecified female genital organs (all cancers excluded),"Genital neoplasm, female",EFO:1001331,http://www.ebi.ac.uk/efo/EFO_1001331,0.752,None
finn-b-ASTHMA_ACUTE_RESPIRATORY_INFECTIONS,Asthma-related acute respiratory infections,respiratory tract infectious disorder,MONDO:0024355,http://purl.obolibrary.org/obo/MONDO_0024355,0.719,None
finn-b-G6_PARDIPLE,"Paraplegia, diplegia of upper limbs",diplegia of upper limb,MONDO:0004618,http://purl.obolibrary.org/obo/MONDO_0004618,0.853,None
finn-b-CD2_BENIGN_HEAMANGIOMA_LYMPHANGIOMA,"Haemangioma and lymphangioma, any site",lymphangioma,MONDO:0002013,http://purl.obolibrary.org/obo/MONDO_0002013,0.826,None
finn-b-DM_RETINOPATHY,Diabetic retinopathy (DM_RETINOPATHY),retinopathy,EFO:0003839,http://www.ebi.ac.uk/efo/EFO_0003839,0.901,None
ukb-b-13532,"Non-cancer illness code, self-reported: thyroid problem (not cancer)",thyroid cancer,MONDO:0002108,http://purl.obolibrary.org/obo/MONDO_0002108,0.655,None
ukb-d-20483,Ever attempted suicide,attempted suicide,EFO:0004321,http://www.ebi.ac.uk/efo/EFO_0004321,0.922,None
finn-b-K11_MN_RERTGN_AND_SURG,Mandibular retrognathia AND surgery (BSSO),Micrognathia,HP:0000347,http://purl.obolibrary.org/obo/HP_0000347,0.798,None
ieu-a-1165,Breast cancer (Survival),survival time,EFO:0000714,http://www.ebi.ac.uk/efo/EFO_0000714,0.761,None
ukb-a-239,Loneliness  isolation,loneliness measurement,EFO:0007865,http://www.ebi.ac.uk/efo/EFO_0007865,0.628,None
ukb-e-2754_CSA,Age at first live birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.827,None
ukb-b-12313,Operation code: incisional hernia repair,Incisional hernia,HP:0004872,http://purl.obolibrary.org/obo/HP_0004872,0.742,None
ukb-e-4717_CSA,Shortness of breath walking on level ground,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.695,None
ukb-e-2724_AFR,Had menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.856,None
finn-b-N14_OTHBLADD,Other disorders of  bladder,bladder disease,EFO:1000018,http://www.ebi.ac.uk/efo/EFO_1000018,0.918,None
finn-b-CD2_HODGKIN_LYMPHOMA,Hodgkin lymphoma,Hodgkins lymphoma,EFO:0000183,http://www.ebi.ac.uk/efo/EFO_0000183,0.991,None
ukb-b-19425,Diagnoses - main ICD10: C20 Malignant neoplasm of rectum,rectum cancer,EFO:1000657,http://www.ebi.ac.uk/efo/EFO_1000657,0.731,None
ukb-d-R00,Diagnoses - main ICD10: R00 Abnormalities of heart beat,congenital heart disease,EFO:0005207,http://www.ebi.ac.uk/efo/EFO_0005207,0.684,None
ukb-a-532,Diagnoses - main ICD10: I20 Angina pectoris,angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.675,None
finn-b-H7_PRESBYOPIA,Presbyopia,presbyopia,MONDO:0001330,http://purl.obolibrary.org/obo/MONDO_0001330,0.982,None
ukb-e-1170_MID,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
ukb-e-100017_CSA,Magnesium,magnesium measurement,EFO:0004845,http://www.ebi.ac.uk/efo/EFO_0004845,0.846,None
finn-b-M13_POLNODOSA,Polyarteritis nodosa,Polyarteritis Nodosa,EFO:0009012,http://www.ebi.ac.uk/efo/EFO_0009012,0.995,None
ukb-e-2814_CSA,Ever used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.811,None
ukb-b-7073,Diagnoses - main ICD10: R13 Dysphagia,Dysphagia,HP:0002015,http://purl.obolibrary.org/obo/HP_0002015,0.664,None
ukb-e-MAP_p1_CSA,"Mean arterial pressure, automated reading",mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.718,None
ukb-e-recode158_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-d-I9_PAD,Peripheral artery disease,peripheral arterial disease,EFO:0004265,http://www.ebi.ac.uk/efo/EFO_0004265,0.991,None
ukb-e-34_MID,Year of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.622,None
finn-b-M13_OTHERJOINT,Other joint disorders,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.911,None
ieu-b-7,Parkinson's disease,Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.992,None
ieu-b-13,childhood absence epilepsy,childhood absence epilepsy,MONDO:0010826,http://purl.obolibrary.org/obo/MONDO_0010826,0.99,None
bbj-a-75,Open-angle glaucoma,open-angle glaucoma,EFO:0004190,http://www.ebi.ac.uk/efo/EFO_0004190,0.99,None
ukb-e-1329_MID,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
finn-b-N14_RENALTUBULOINOTH,Renal tubulo-interstitial disorders in diseases classified elsewhere,interstitial nephritis,MONDO:0001085,http://purl.obolibrary.org/obo/MONDO_0001085,0.736,None
finn-b-E4_VOLUME,Volume depletion,Hypovolemia,HP:0011106,http://purl.obolibrary.org/obo/HP_0011106,0.71,None
finn-b-O15_ABORT_UNS,Unspecified abortion,abortion,EFO:1001491,http://www.ebi.ac.uk/efo/EFO_1001491,0.993,None
finn-b-RHEUMA_SERONEG,Seronegative rheumatoid arthritis,rheumatoid arthritis,EFO:0000685,http://www.ebi.ac.uk/efo/EFO_0000685,0.786,None
ukb-b-12915,"Cancer code, self-reported: malignant melanoma",melanoma,EFO:0000756,http://www.ebi.ac.uk/efo/EFO_0000756,0.714,None
finn-b-I9_VARICVEOES,Oesophageal varices,esophageal varices,EFO:0009545,http://www.ebi.ac.uk/efo/EFO_0009545,0.865,None
finn-b-COPD_LATER,Later onset COPD,Onset,HP:0003674,http://purl.obolibrary.org/obo/HP_0003674,0.657,None
ukb-e-6149_p5_EAS,Mouth/teeth dental problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.657,None
ukb-e-1845_AFR,Mother's age,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.615,None
ukb-e-recode161_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30810_EAS,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
finn-b-F5_GENDER,Gender identity disorders,gender identity disorder,EFO:0008587,http://www.ebi.ac.uk/efo/EFO_0008587,0.939,None
ukb-e-104920_AFR,Time spent doing light physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.662,None
finn-b-L12_DECUBITANSULCERANDPRESSURE,Decubitus ulcer and pressure area,decubitus ulcer,EFO:0007067,http://www.ebi.ac.uk/efo/EFO_0007067,0.827,None
ukb-e-A09_CSA,A09 Diarrhoea and gastro-enteritis of presumed infectious origin,diarrheal disease,MONDO:0001673,http://purl.obolibrary.org/obo/MONDO_0001673,0.676,None
finn-b-K11_ENERCOLNONINF,Noninfective enteritis and colitis,noninfective encephalitis,EFO:0020926,http://www.ebi.ac.uk/efo/EFO_0020926,0.714,None
ukb-e-30250_MID,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
ukb-e-20022_AFR,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
ukb-a-381,Leg pain on walking,Lower limb pain,HP:0012514,http://purl.obolibrary.org/obo/HP_0012514,0.665,None
ukb-d-M13_OTHERJOINT,#Other joint disorders,joint disease,EFO:1000999,http://www.ebi.ac.uk/efo/EFO_1000999,0.911,None
ukb-e-50_EAS,Standing height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.708,None
ukb-e-680_p1_EAS,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
ukb-e-2365_AFR,Ever had prostate specific antigen (PSA) test,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.669,None
finn-b-ILD,Interstitial lung disease,interstitial lung disease,EFO:0004244,http://www.ebi.ac.uk/efo/EFO_0004244,0.989,None
finn-b-ST19_INJURY_BLOOD_VESSE_WRIST_HAND_LEVEL,Injury of blood vessels at wrist and hand level,blood vessel injury,EFO:0009886,http://www.ebi.ac.uk/efo/EFO_0009886,0.718,None
finn-b-I9_AF,Atrial fibrillation and flutter,atrial fibrillation,EFO:0000275,http://www.ebi.ac.uk/efo/EFO_0000275,0.825,None
finn-b-I9_VASCSYND,Vascular syndromes of brain in cerebrovascular disorders (I9_VASCSYND),cerebrovascular disorder,EFO:0003763,http://www.ebi.ac.uk/efo/EFO_0003763,0.673,None
ebi-a-GCST010005,Membranous nephropathy,membranous glomerulonephritis,EFO:0004254,http://www.ebi.ac.uk/efo/EFO_0004254,0.983,None
ebi-a-GCST010118,Type 2 diabetes,type 2 diabetes mellitus,MONDO:0005148,http://purl.obolibrary.org/obo/MONDO_0005148,0.986,None
finn-b-M13_SYNOTENDINOTH,Disorders of synovium and tendon in diseases classified elsewhere,synovium disorder,MONDO:0056799,http://purl.obolibrary.org/obo/MONDO_0056799,0.766,None
ukb-b-1392,Type of cancer: ICD10: C61 Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.727,None
ukb-e-recode67_AFR,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ieu-a-10,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
ieu-b-4964,Pan cancer,cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.714,None
ieu-a-13,Crohn's disease,Crohn's disease,EFO:0000384,http://www.ebi.ac.uk/efo/EFO_0000384,0.991,None
ukb-a-440,Fractured bone site(s): Arm,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.71,None
finn-b-G6_MENINGOTH,Other meningitis,meningitis,MONDO:0021108,http://purl.obolibrary.org/obo/MONDO_0021108,0.993,None
finn-b-J10_PULMOEDEMA,Pulmonary oedema,pulmonary edema,EFO:1001134,http://www.ebi.ac.uk/efo/EFO_1001134,0.993,None
ukb-b-14371,Illnesses of siblings: Heart disease,heart disease,EFO:0003777,http://www.ebi.ac.uk/efo/EFO_0003777,0.602,None
finn-b-KRA_PSY_SLEEP_NONORG,Nonorganic sleeping disorders,sleep-wake disorder,MONDO:0003406,http://purl.obolibrary.org/obo/MONDO_0003406,0.691,None
finn-b-E4_LIPOPROTNAS,"Disorder of lipoprotein metabolism, unspecified",metabolic disease,EFO:0000589,http://www.ebi.ac.uk/efo/EFO_0000589,0.801,None
finn-b-L12_ACTINKERA,Actinic keratosis,actinic keratosis,EFO:0002496,http://www.ebi.ac.uk/efo/EFO_0002496,0.988,None
finn-b-CHILDHOOD_ALLERGY,Childhood allergy (age < 16),childhood acute lymphoblastic leukemia,MONDO:0000870,http://purl.obolibrary.org/obo/MONDO_0000870,0.701,None
finn-b-L12_NAIL_DYSTROPHY,Nail dystrophy,Nail dystrophy,HP:0008404,http://purl.obolibrary.org/obo/HP_0008404,0.968,None
ukb-d-R06,Diagnoses - main ICD10: R06 Abnormalities of breathing,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.629,None
ieu-a-1082,Thyroid cancer,thyroid carcinoma,EFO:0002892,http://www.ebi.ac.uk/efo/EFO_0002892,0.988,None
finn-b-H7_VITRHAEMORR,Vitreous haemorrhage,vitreous hemorrhage,EFO:0008626,http://www.ebi.ac.uk/efo/EFO_0008626,0.879,None
ukb-d-XVII_MALFORMAT_ABNORMAL,"Congenital malformations, deformations and chromosomal abnormalities",developmental defect during embryogenesis,MONDO:0019755,http://purl.obolibrary.org/obo/MONDO_0019755,0.64,None
ukb-e-recode10_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-30720_CSA,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
finn-b-ST19_OTHER_UNSPE_INJURI_ANKLE_FOOT,Other and unspecified injuries of ankle and foot,ankle injury,EFO:1002021,http://www.ebi.ac.uk/efo/EFO_1002021,0.665,None
ukb-e-recode50_MID,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-306_CSA,Other mental disorder,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.994,None
ukb-a-102,Non-cancer illness code  self-reported: diverticular disease/diverticulitis,diverticular disease,EFO:0009959,http://www.ebi.ac.uk/efo/EFO_0009959,0.772,None
ukb-b-19388,Diagnoses - main ICD10: K85 Acute pancreatitis,acute pancreatitis,EFO:1000652,http://www.ebi.ac.uk/efo/EFO_1000652,0.687,None
finn-b-H7_LIDLACRIMALORBIT,"Disorders of eyelid, lacrimal system and orbit",lacrimal apparatus disease,EFO:0009455,http://www.ebi.ac.uk/efo/EFO_0009455,0.734,None
finn-b-L12_EPIDERMTHICKNAS,Other and unspecified epidermal thickening,Epidermal thickening,HP:0011368,http://purl.obolibrary.org/obo/HP_0011368,0.987,None
finn-b-M13_TORTICOLLIS,Torticollis,Torticollis,HP:0000473,http://purl.obolibrary.org/obo/HP_0000473,0.996,None
finn-b-Q17_CONGEN_MALFO_RESPI_SYSTEM,Congenital malformations of the respiratory system,respiratory malformation,MONDO:0015930,http://purl.obolibrary.org/obo/MONDO_0015930,0.726,None
ukb-e-6142_p5_CSA,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
finn-b-ST19_COMPLICATIO_PROCED_NOT_ELSEW_CLASSIFIED,"Complications of procedures, not elsewhere classified",complication,EFO:0009518,http://www.ebi.ac.uk/efo/EFO_0009518,0.68,None
ukb-e-recode31_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-a-474,Pain type(s) experienced in last month: Stomach or abdominal pain,Abdominal pain,HP:0002027,http://purl.obolibrary.org/obo/HP_0002027,0.633,None
ukb-e-52_p3_EAS,Month of birth,date of birth,EFO:0004950,http://www.ebi.ac.uk/efo/EFO_0004950,0.632,None
finn-b-L12_PEMPHIGOID,Pemphigoid,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.848,None
ebi-a-GCST004883,Neuroblastoma (11q deletion),partial deletion of the long arm of chromosome 11,MONDO:0016910,http://purl.obolibrary.org/obo/MONDO_0016910,0.723,None
ukb-e-2463_CSA,Fractured/broken bones in last 5 years,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.641,None
ukb-b-13770,Diagnoses - secondary ICD10: O70.1 Second degree perineal laceration during delivery,perineal laceration during delivery,EFO:0009816,http://www.ebi.ac.uk/efo/EFO_0009816,0.617,None
finn-b-M13_INTERVERTEB,Other intervertebral disc disorders,lumbar disc degeneration,EFO:0004994,http://www.ebi.ac.uk/efo/EFO_0004994,0.848,None
ukb-d-M13_ENTESOPATHYOTH,Other enthesopathies,rheumatic disease,EFO:0005755,http://www.ebi.ac.uk/efo/EFO_0005755,0.99,None
ukb-e-23105_CSA,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
ukb-e-6142_p5_AFR,Current employment status,employment status,EFO:0005241,http://www.ebi.ac.uk/efo/EFO_0005241,0.825,None
ieu-a-1109,Cardioembolic stroke,cardioembolic stroke,EFO:1001976,http://www.ebi.ac.uk/efo/EFO_1001976,0.99,None
ukb-e-20116_p2_AFR,Smoking status,smoking status measurement,EFO:0006527,http://www.ebi.ac.uk/efo/EFO_0006527,0.871,None
ebi-a-GCST005581,Primary biliary cirrhosis,primary biliary cirrhosis,EFO:1001486,http://www.ebi.ac.uk/efo/EFO_1001486,0.987,None
finn-b-J10_BRONCHIECTASIS,Bronchiectasis,Bronchiectasis,HP:0002110,http://purl.obolibrary.org/obo/HP_0002110,0.989,None
ebi-a-GCST005529,Ankylosing spondylitis,ankylosing spondylitis,EFO:0003898,http://www.ebi.ac.uk/efo/EFO_0003898,0.994,None
ukb-d-C3_PROSTATE,Malignant neoplasm of prostate,prostate cancer,MONDO:0008315,http://purl.obolibrary.org/obo/MONDO_0008315,0.992,None
ukb-b-9543,Shortness of breath walking on level ground,Dyspnea,HP:0002094,http://purl.obolibrary.org/obo/HP_0002094,0.695,None
finn-b-Q17_OTHER_CONGEN_MALFO_LIMBS,Other congenital malformations of limb(s),congenital limb malformation,MONDO:0019054,http://purl.obolibrary.org/obo/MONDO_0019054,0.94,None
finn-b-SPONDYLOARTHRITIS,Spondyloarthritis,spondyloarthropathy,EFO:0000706,http://www.ebi.ac.uk/efo/EFO_0000706,0.996,None
finn-b-R18_CRAMP_SPASM,Cramp and spasm,muscle cramp,EFO:0009846,http://www.ebi.ac.uk/efo/EFO_0009846,0.74,None
ukb-b-12141,"Non-cancer illness code, self-reported: osteoporosis",osteoporosis,EFO:0003882,http://www.ebi.ac.uk/efo/EFO_0003882,0.639,None
finn-b-J10_BRONCHNAS,Unspecified chronic bronchitis,chronic bronchitis,EFO:0006505,http://www.ebi.ac.uk/efo/EFO_0006505,0.994,None
finn-b-K11_CHRONHEP,"Chronic hepatitis, not elsewhere classified",chronic hepatitis,EFO:0008496,http://www.ebi.ac.uk/efo/EFO_0008496,0.997,None
ukb-e-recode156_CSA,NA,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.605,None
ukb-e-2227_EAS,Other eye problems,Abnormality of the dentition,HP:0000164,http://purl.obolibrary.org/obo/HP_0000164,0.687,None
ukb-a-494,Mineral and other dietary supplements: Glucosamine,glucosamine measurement,EFO:0803418,http://www.ebi.ac.uk/efo/EFO_0803418,0.613,None
finn-b-CD2_INSITU,In situ neoplasms,ear neoplasm,MONDO:0021233,http://purl.obolibrary.org/obo/MONDO_0021233,0.656,None
finn-b-ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS,Injuries involving multiple body regions,multiple bone fractures,EFO:0009513,http://www.ebi.ac.uk/efo/EFO_0009513,0.805,None
ukb-e-recode1_AFR,Indirect bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.66,None
ukb-e-120_p1_CSA,Birth weight known,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.765,None
ukb-e-680_p5_AFR,Own or rent accommodation lived in,eye accommodation disease,MONDO:0000926,http://purl.obolibrary.org/obo/MONDO_0000926,0.646,None
finn-b-CD2_BENIGN_MOUTH_PHARYNX_EXALLC,Benign neoplasm of mouth and pharynx (all cancers excluded),benign neoplasm of oral cavity,MONDO:0021445,http://purl.obolibrary.org/obo/MONDO_0021445,0.744,None
finn-b-CD2_BENIGN_BONE_SKULL_FACE_EXALLC,Benign neoplasm: Bones of skull and face (all cancers excluded),skull neoplasm,MONDO:0024653,http://purl.obolibrary.org/obo/MONDO_0024653,0.702,None
finn-b-CD2_BENIGN_LIPO_SKIN_NOS_EXALLC,Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites (all cancers excluded),benign lipomatous neoplasm,MONDO:0044983,http://purl.obolibrary.org/obo/MONDO_0044983,0.659,None
ebi-a-GCST001592,Osteoarthritis,osteoarthritis,MONDO:0005178,http://purl.obolibrary.org/obo/MONDO_0005178,0.997,None
ukb-d-I9_CONDUCTIO,Conduction disorders,conduct disorder,EFO:0004216,http://www.ebi.ac.uk/efo/EFO_0004216,0.812,None
finn-b-G6_OTHDEMYEL,Other demyelinating diseases of the central nervous system,central nervous system disease,EFO:0009386,http://www.ebi.ac.uk/efo/EFO_0009386,0.758,None
finn-b-K11_INTESTOTH,Other diseases of intestines,digestive system disease,EFO:0000405,http://www.ebi.ac.uk/efo/EFO_0000405,0.832,None
ukb-e-2405_CSA,Number of children fathered,number of children fathered measurement,EFO:0009814,http://www.ebi.ac.uk/efo/EFO_0009814,0.914,None
finn-b-L12_OTHERSKINSUBCUTIS,Other disorders of skin and subcutaneous tissue,skin disease,EFO:0000701,http://www.ebi.ac.uk/efo/EFO_0000701,0.954,None
ieu-b-5075,Systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
ieu-b-5089,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-c-2889_37_2,Cardiotrophin-1,cardiotrophin-1 measurement,EFO:0020235,http://www.ebi.ac.uk/efo/EFO_0020235,0.71,None
prot-a-1482,Interleukin-17A,interleukin-17A measurement,EFO:0022026,http://www.ebi.ac.uk/efo/EFO_0022026,0.739,None
prot-a-2537,Regulator of G-protein signaling 3,regulator of G-protein signaling 3 measurement,EFO:0803006,http://www.ebi.ac.uk/efo/EFO_0803006,0.766,None
prot-a-2921,Tachykinin-3,tachykinin-3 measurement,EFO:0803136,http://www.ebi.ac.uk/efo/EFO_0803136,0.754,None
prot-a-1406,ICOS ligand,icos ligand measurement,EFO:0020460,http://www.ebi.ac.uk/efo/EFO_0020460,0.83,None
ebi-a-GCST003401,Glomerular filtration rate in non diabetics (creatinine),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.752,None
prot-a-1898,MHC class I polypeptide-related sequence B,MHC class I polypeptide-related sequence B measurement,EFO:0008234,http://www.ebi.ac.uk/efo/EFO_0008234,0.885,None
met-a-332,Oleate (18:1n9),oleate 18:1n9 measurement,EFO:0021070,http://www.ebi.ac.uk/efo/EFO_0021070,0.668,None
prot-a-1942,"39S ribosomal protein L33, mitochondrial","39S ribosomal protein L33, mitochondrial measurement",EFO:0801332,http://www.ebi.ac.uk/efo/EFO_0801332,0.849,None
prot-a-1583,Integrin alpha-L,integrin alpha-5 measurement,EFO:0802637,http://www.ebi.ac.uk/efo/EFO_0802637,0.67,None
prot-a-748,C-X-C motif chemokine 5,C-C motif chemokine 5 measurement,EFO:0008053,http://www.ebi.ac.uk/efo/EFO_0008053,0.663,None
ebi-a-GCST90012077,C-C motif chemokine 20 levels,C-C motif chemokine 20 measurement,EFO:0010910,http://www.ebi.ac.uk/efo/EFO_0010910,0.648,None
prot-a-1604,Protein JTB,protein JTB measurement,EFO:0802948,http://www.ebi.ac.uk/efo/EFO_0802948,0.891,None
prot-a-2153,Osteoclast-associated immunoglobulin-like receptor,osteoclast-associated immunoglobulin-like receptor measurement,EFO:0802837,http://www.ebi.ac.uk/efo/EFO_0802837,0.836,None
prot-c-2992_59_2,IL-17 sR,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.698,None
prot-a-535,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2,coiled-coil-helix-coiled-coil-helix domain-containing protein 2 measurement,EFO:0802414,http://www.ebi.ac.uk/efo/EFO_0802414,0.736,None
prot-a-2013,Natural cytotoxicity triggering receptor 1,natural cytotoxicity triggering receptor 1 measurement,EFO:0020588,http://www.ebi.ac.uk/efo/EFO_0020588,0.943,None
ebi-a-GCST90010171,SLAM family member 7 levels,SLAM family member 7 measurement,EFO:0008287,http://www.ebi.ac.uk/efo/EFO_0008287,0.822,None
ebi-a-GCST90000458,CXCL1 levels,CXCL1 measurement,EFO:0010777,http://www.ebi.ac.uk/efo/EFO_0010777,0.762,None
prot-a-2331,Periostin,periostin measurement,EFO:0020628,http://www.ebi.ac.uk/efo/EFO_0020628,0.777,None
prot-a-3200,Selenoprotein S,selenoprotein S measurement,EFO:0802046,http://www.ebi.ac.uk/efo/EFO_0802046,0.782,None
prot-a-805,Protein DEPP,protein DEPP measurement,EFO:0801939,http://www.ebi.ac.uk/efo/EFO_0801939,0.855,None
prot-a-3203,Vacuolar protein sorting-associated protein 29,vacuolar protein sorting-associated protein 29 measurement,EFO:0802207,http://www.ebi.ac.uk/efo/EFO_0802207,0.878,None
prot-a-1835,Epididymis-specific alpha-mannosidase,epididymis-specific alpha-mannosidase measurement,EFO:0801577,http://www.ebi.ac.uk/efo/EFO_0801577,0.808,None
prot-a-21,2-phosphoxylose phosphatase 1,2-phosphoxylose phosphatase 1 measurement,EFO:0803305,http://www.ebi.ac.uk/efo/EFO_0803305,0.857,None
met-a-444,X-10510,X-10510 measurement,EFO:0021217,http://www.ebi.ac.uk/efo/EFO_0021217,0.682,None
prot-a-964,Ephrin type-B receptor 4,ephrin type-b receptor 4 measurement,EFO:0020354,http://www.ebi.ac.uk/efo/EFO_0020354,0.685,None
ebi-a-GCST90006890,Chlamydia trachomatis PorB antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.734,None
prot-a-2938,Transcobalamin-1,transcobalamin I deficiency,MONDO:0008659,http://purl.obolibrary.org/obo/MONDO_0008659,0.863,None
ebi-a-GCST006307,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-a-3178,Vesicle transport protein USE1,vesicle transport protein USE1 measurement,EFO:0803249,http://www.ebi.ac.uk/efo/EFO_0803249,0.934,None
ieu-a-1002,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
ebi-a-GCST004607,Plateletcrit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.993,None
prot-b-36,renin,renin measurement,EFO:0010616,http://www.ebi.ac.uk/efo/EFO_0010616,0.654,None
ebi-a-GCST006943,Feeling miserable,feeling miserable measurement,EFO:0009598,http://www.ebi.ac.uk/efo/EFO_0009598,0.897,None
prot-a-4,Multidrug resistance-associated protein 6,multidrug resistance-associated protein 6 measurement,EFO:0802760,http://www.ebi.ac.uk/efo/EFO_0802760,0.846,None
met-a-719,X-14189--leucylalanine,X-14189--leucylalanine measurement,EFO:0021364,http://www.ebi.ac.uk/efo/EFO_0021364,0.66,None
prot-a-137,Apolipoprotein M,apolipoprotein M measurement,EFO:0021945,http://www.ebi.ac.uk/efo/EFO_0021945,0.883,None
prot-a-3078,Torsin-1A-interacting protein 2,torsin-1A-interacting protein 2 measurement,EFO:0803160,http://www.ebi.ac.uk/efo/EFO_0803160,0.613,None
prot-a-691,CUB and sushi domain-containing protein 2,CUB and Sushi domain-containing protein 2 measurement,EFO:0803314,http://www.ebi.ac.uk/efo/EFO_0803314,0.872,None
prot-a-1311,Hepatitis A virus cellular receptor 2,hepatitis A virus cellular receptor 2 measurement,EFO:0008151,http://www.ebi.ac.uk/efo/EFO_0008151,0.925,None
prot-a-18,Low molecular weight phosphotyrosine protein phosphatase,low molecular weight phosphotyrosine protein phosphatase measurement,EFO:0008213,http://www.ebi.ac.uk/efo/EFO_0008213,0.96,None
prot-a-2796,Sorting nexin-8,sorting nexin-1 measurement,EFO:0803092,http://www.ebi.ac.uk/efo/EFO_0803092,0.708,None
bbj-a-16,Chloride,chloride measurement,EFO:0009284,http://www.ebi.ac.uk/efo/EFO_0009284,0.844,None
prot-a-2021,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement,EFO:0802332,http://www.ebi.ac.uk/efo/EFO_0802332,0.799,None
prot-c-5260_80_3,TYK2,immunodeficiency 35,MONDO:0012682,http://purl.obolibrary.org/obo/MONDO_0012682,0.811,None
prot-a-1542,Interleukin-6 receptor subunit beta,interleukin 6 receptor subunit beta measurement,EFO:0008188,http://www.ebi.ac.uk/efo/EFO_0008188,0.931,None
met-c-958,Concentration of chylomicrons and largest VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.707,None
prot-a-68,Aldose reductase,aldose reductase measurement,EFO:0801364,http://www.ebi.ac.uk/efo/EFO_0801364,0.878,None
prot-a-2100,Neuropilin-2,neuropilin-1 measurement,EFO:0020603,http://www.ebi.ac.uk/efo/EFO_0020603,0.615,None
ebi-a-GCST004455,Interleukin-2 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.809,None
prot-a-920,Eukaryotic translation initiation factor 3 subunit J,eukaryotic translation initiation factor 3 subunit J measurement,EFO:0801591,http://www.ebi.ac.uk/efo/EFO_0801591,0.955,None
ebi-a-GCST90012041,Kidney injury molecule 1 levels,kidney injury molecule 1 measurement,EFO:0010917,http://www.ebi.ac.uk/efo/EFO_0010917,0.854,None
prot-a-1298,Granzyme B,granzyme b measurement,EFO:0020418,http://www.ebi.ac.uk/efo/EFO_0020418,0.865,None
ebi-a-GCST90002245,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-a-2502,Probable RNA-binding protein 23,probable RNA-binding protein 23 measurement,EFO:0801917,http://www.ebi.ac.uk/efo/EFO_0801917,0.831,None
prot-c-2768_56_2,Hemopexin,hemopexin measurement,EFO:0008149,http://www.ebi.ac.uk/efo/EFO_0008149,0.841,None
ebi-a-GCST90007307,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-1629,Uncharacterized family 31 glucosidase KIAA1161,uncharacterized family 31 glucosidase KIAA1161 measurement,EFO:0802188,http://www.ebi.ac.uk/efo/EFO_0802188,0.962,None
prot-a-1518,Interleukin-2 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.9,None
ebi-a-GCST90002352,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
prot-a-1214,Gap junction alpha-8 protein,gap junction alpha-1 protein measurement,EFO:0801618,http://www.ebi.ac.uk/efo/EFO_0801618,0.78,None
prot-a-1902,MICOS complex subunit MIC10,MICOS complex subunit MIC10 measurement,EFO:0801800,http://www.ebi.ac.uk/efo/EFO_0801800,0.932,None
ebi-a-GCST90016666,Liver volume,liver volume,EFO:0600048,http://www.ebi.ac.uk/efo/EFO_0600048,0.989,None
prot-a-1709,Neutrophil gelatinase-associated lipocalin,neutrophil gelatinase-associated lipocalin measurement,EFO:0021964,http://www.ebi.ac.uk/efo/EFO_0021964,0.865,None
ebi-a-GCST90010142,Interleukin-1-receptor antagonist levels,interleukin 1 receptor antagonist measurement,EFO:0004754,http://www.ebi.ac.uk/efo/EFO_0004754,0.861,None
prot-a-637,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial","cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement",EFO:0801514,http://www.ebi.ac.uk/efo/EFO_0801514,0.909,None
met-b-172,DPT:%Exhausted,exhaustion,EFO:0009852,http://www.ebi.ac.uk/efo/EFO_0009852,0.697,None
ebi-a-GCST006675,Peak insulin response (BMI and insulin secretion adjusted),peak insulin response measurement,EFO:0008000,http://www.ebi.ac.uk/efo/EFO_0008000,0.678,None
prot-a-1006,Coagulation Factor X,coagulation factor X measurement,EFO:0020265,http://www.ebi.ac.uk/efo/EFO_0020265,0.885,None
prot-a-132,Apolipoprotein E (isoform E2),apolipoprotein E isoform E2 measurement,EFO:0008028,http://www.ebi.ac.uk/efo/EFO_0008028,0.93,None
ukb-a-9,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
prot-a-894,Elongation factor 1-beta,elongation factor 1-beta measurement,EFO:0020345,http://www.ebi.ac.uk/efo/EFO_0020345,0.747,None
prot-a-430,T-cell surface antigen CD2,t-cell surface antigen CD2 measurement,EFO:0803132,http://www.ebi.ac.uk/efo/EFO_0803132,0.819,None
prot-a-795,Beta-defensin 119,beta-defensin 119 measurement,EFO:0801419,http://www.ebi.ac.uk/efo/EFO_0801419,0.764,None
prot-a-3168,Netrin receptor UNC5C,netrin receptor UNC5C measurement,EFO:0020590,http://www.ebi.ac.uk/efo/EFO_0020590,0.922,None
prot-a-1841,Dual specificity mitogen-activated protein kinase kinase 3,dual specificity mitogen-activated protein kinase kinase 3 measurement,EFO:0022005,http://www.ebi.ac.uk/efo/EFO_0022005,0.898,None
bbj-a-36,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
ebi-a-GCST90006899,Epstein-Barr virus EBNA-1 antibody levels,anti-Epstein Barr virus antibody measurement,EFO:0009273,http://www.ebi.ac.uk/efo/EFO_0009273,0.655,None
prot-a-3198,Vascular endothelial growth factor A,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.977,None
prot-a-809,Integral membrane protein DGCR2/IDD,integral membrane protein DGCR2/IDD measurement,EFO:0802636,http://www.ebi.ac.uk/efo/EFO_0802636,0.787,None
prot-c-5231_79_3,PCSK9,proprotein convertase subtilisin/kexin type 9 measurement,EFO:0009312,http://www.ebi.ac.uk/efo/EFO_0009312,0.877,None
prot-a-2463,Peptide YY,peptide yy measurement,EFO:0020623,http://www.ebi.ac.uk/efo/EFO_0020623,0.88,None
ieu-a-781,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-a-2540,Rho-related GTP-binding protein RhoD,rho-related GTP-binding protein RhoD measurement,EFO:0803023,http://www.ebi.ac.uk/efo/EFO_0803023,0.742,None
prot-a-1610,Potassium voltage-gated channel subfamily E member 2,potassium voltage-gated channel subfamily E member 2 measurement,EFO:0801901,http://www.ebi.ac.uk/efo/EFO_0801901,0.89,None
prot-a-1353,High mobility group protein B3,high mobility group protein B3 measurement,EFO:0801677,http://www.ebi.ac.uk/efo/EFO_0801677,0.93,None
ukb-d-30620_raw,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
prot-a-2497,Retinoblastoma-binding protein 5,retinoblastoma-binding protein 5 measurement,EFO:0803012,http://www.ebi.ac.uk/efo/EFO_0803012,0.791,None
met-a-453,Threonate,threonate measurement,EFO:0021032,http://www.ebi.ac.uk/efo/EFO_0021032,0.835,None
met-a-697,2-methylbutyroylcarnitine,2-methylbutyroylcarnitine measurement,EFO:0021019,http://www.ebi.ac.uk/efo/EFO_0021019,0.855,None
prot-a-2000,Beta-soluble NSF attachment protein,beta-soluble NSF attachment protein measurement,EFO:0801423,http://www.ebi.ac.uk/efo/EFO_0801423,0.868,None
prot-a-1742,Leukocyte immunoglobulin-like receptor subfamily B member 1,leukocyte immunoglobulin-like receptor subfamily B member 1 measurement,EFO:0008208,http://www.ebi.ac.uk/efo/EFO_0008208,0.92,None
ebi-a-GCST90002041,CD45 on lymphocyte,pseudolymphoma,EFO:1001831,http://www.ebi.ac.uk/efo/EFO_1001831,0.65,None
ukb-d-30600_raw,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
prot-a-2469,Sulfhydryl oxidase 1,sulfhydryl oxidase 1 measurement,EFO:0802099,http://www.ebi.ac.uk/efo/EFO_0802099,0.929,None
prot-a-2203,Protocadherin beta-1,protocadherin beta-1 measurement,EFO:0802972,http://www.ebi.ac.uk/efo/EFO_0802972,0.754,None
prot-a-798,Beta-defensin 123,beta-defensin 123 measurement,EFO:0802325,http://www.ebi.ac.uk/efo/EFO_0802325,0.768,None
prot-a-3253,Tyrosine-protein kinase ZAP-70,tyrosine-protein kinase ZAP-70 measurement,EFO:0020833,http://www.ebi.ac.uk/efo/EFO_0020833,0.654,None
prot-a-631,Procollagen galactosyltransferase 1,procollagen galactosyltransferase 1 measurement,EFO:0801922,http://www.ebi.ac.uk/efo/EFO_0801922,0.934,None
met-d-L_VLDL_FC,Free cholesterol in large VLDL,free cholesterol in large LDL measurement,EFO:0022176,http://www.ebi.ac.uk/efo/EFO_0022176,0.815,None
prot-a-2098,Neuritin,neuritis,MONDO:0002122,http://purl.obolibrary.org/obo/MONDO_0002122,0.825,None
prot-a-1333,"Homogentisate 1,2-dioxygenase","homogentisate 1,2-dioxygenase measurement",EFO:0802609,http://www.ebi.ac.uk/efo/EFO_0802609,0.757,None
prot-c-2953_31_2,Luteinizing hormone,luteinizing hormone measurement,EFO:0007002,http://www.ebi.ac.uk/efo/EFO_0007002,0.899,None
prot-a-1951,Macrophage scavenger receptor types I and II,macrophage scavenger receptor types I and II measurement,EFO:0008222,http://www.ebi.ac.uk/efo/EFO_0008222,0.914,None
prot-a-2693,Corticosteroid-binding globulin,corticosteroid-binding globulin measurement,EFO:0020288,http://www.ebi.ac.uk/efo/EFO_0020288,0.801,None
prot-a-3126,"Thioredoxin reductase 1, cytoplasmic","thioredoxin reductase 1, cytoplasmic measurement",EFO:0802129,http://www.ebi.ac.uk/efo/EFO_0802129,0.885,None
prot-a-2359,Peroxiredoxin-1,peroxiredoxin-1 measurement,EFO:0020629,http://www.ebi.ac.uk/efo/EFO_0020629,0.819,None
prot-a-1448,Insulin-like growth factor-binding protein 2,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.823,None
prot-a-2564,RING finger protein 148,RING finger protein 148 measurement,EFO:0803029,http://www.ebi.ac.uk/efo/EFO_0803029,0.912,None
met-d-S_VLDL_CE_pct,Cholesteryl esters to total lipids ratio in small VLDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.703,None
met-a-421,3-methyl-2-oxobutyrate,3-methyl-2-oxobutyrate measurement,EFO:0021020,http://www.ebi.ac.uk/efo/EFO_0021020,0.657,None
met-d-M_VLDL_CE,Cholesteryl esters in medium VLDL,cholesterol esters in medium VLDL measurement,EFO:0022182,http://www.ebi.ac.uk/efo/EFO_0022182,0.822,None
met-a-439,X-09706,X-09706 measurement,EFO:0021210,http://www.ebi.ac.uk/efo/EFO_0021210,0.682,None
ebi-a-GCST90000462,CXCL6 levels,CXCL6 measurement,EFO:0009423,http://www.ebi.ac.uk/efo/EFO_0009423,0.801,None
met-d-DHA,Docosahexaenoic acid,docosahexaenoic acid measurement,EFO:0007761,http://www.ebi.ac.uk/efo/EFO_0007761,0.925,None
met-a-686,X-13477,X-13477 measurement,EFO:0021351,http://www.ebi.ac.uk/efo/EFO_0021351,0.721,None
prot-a-3185,Vesicle-associated membrane protein 3,vesicle-associated membrane protein 3 measurement,EFO:0803251,http://www.ebi.ac.uk/efo/EFO_0803251,0.843,None
prot-a-2394,Probable inactive serine protease 37,probable inactive serine protease 37 measurement,EFO:0802907,http://www.ebi.ac.uk/efo/EFO_0802907,0.942,None
met-a-449,N-acetylglycine,N-acetylglycine measurement,EFO:0021002,http://www.ebi.ac.uk/efo/EFO_0021002,0.72,None
prot-a-2696,Plasminogen activator inhibitor 1,plasminogen activator inhibitor 1 measurement,EFO:0004792,http://www.ebi.ac.uk/efo/EFO_0004792,0.933,None
prot-a-1970,Mitochondrial ubiquitin ligase activator of NFKB 1,mitochondrial ubiquitin ligase activator of NFKB 1 measurement,EFO:0801804,http://www.ebi.ac.uk/efo/EFO_0801804,0.953,None
prot-a-2385,Phosphoribosyl pyrophosphate synthase-associated protein 1,phosphoribosyl pyrophosphate synthase-associated protein 1 measurement,EFO:0802868,http://www.ebi.ac.uk/efo/EFO_0802868,0.912,None
prot-a-1959,S-methyl-5'-thioadenosine phosphorylase,s-methyl-5'-thioadenosine phosphorylase measurement,EFO:0803041,http://www.ebi.ac.uk/efo/EFO_0803041,0.679,None
ebi-a-GCST90000480,Interleukin-8 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.79,None
prot-a-2539,Transforming protein RhoA,transforming protein RhoA measurement,EFO:0802144,http://www.ebi.ac.uk/efo/EFO_0802144,0.915,None
ubm-a-2661,volume Left-Caudate,caudate nucleus volume,EFO:0004830,http://www.ebi.ac.uk/efo/EFO_0004830,0.714,None
met-d-Ala,Alanine,alanine measurement,EFO:0009765,http://www.ebi.ac.uk/efo/EFO_0009765,0.752,None
ukb-b-6811,Time spent outdoors in winter,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.849,None
bbj-a-63,Menopause,menopause,EFO:0003922,http://www.ebi.ac.uk/efo/EFO_0003922,0.992,None
ebi-a-GCST005061,Serum alkaline phosphatase levels,Elevated circulating alkaline phosphatase concentration,HP:0003155,http://purl.obolibrary.org/obo/HP_0003155,0.834,None
prot-a-2702,Serpin I2,serpin I2 measurement,EFO:0803068,http://www.ebi.ac.uk/efo/EFO_0803068,0.875,None
prot-a-1234,Progonadoliberin-2,progonadoliberin-1 measurement,EFO:0801924,http://www.ebi.ac.uk/efo/EFO_0801924,0.804,None
ukb-b-18377,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
met-d-S_VLDL_P,Concentration of small VLDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.984,None
prot-a-156,Rho guanine nucleotide exchange factor 2,rho guanine nucleotide exchange factor 2 measurement,EFO:0803018,http://www.ebi.ac.uk/efo/EFO_0803018,0.95,None
ebi-a-GCST004436,Macrophage colony stimulating factor levels,macrophage colony stimulating factor measurement,EFO:0008217,http://www.ebi.ac.uk/efo/EFO_0008217,0.876,None
met-d-L_HDL_TG_pct,Triglycerides to total lipids ratio in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.705,None
met-c-929,Total lipids in small VLDL,total lipids in small VLDL,EFO:0022148,http://www.ebi.ac.uk/efo/EFO_0022148,0.967,None
met-a-391,X-04495,X-04495 measurement,EFO:0021191,http://www.ebi.ac.uk/efo/EFO_0021191,0.674,None
prot-a-3100,Trem-like transcript 2 protein,trem-like transcript 2 protein measurement,EFO:0802159,http://www.ebi.ac.uk/efo/EFO_0802159,0.811,None
prot-a-3006,Transmembrane protein 234,transmembrane protein 234 measurement,EFO:0803183,http://www.ebi.ac.uk/efo/EFO_0803183,0.931,None
prot-a-1355,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic","hydroxymethylglutaryl-CoA synthase, cytoplasmic measurement",EFO:0802614,http://www.ebi.ac.uk/efo/EFO_0802614,0.868,None
met-a-504,X-11381,X-11381 measurement,EFO:0021228,http://www.ebi.ac.uk/efo/EFO_0021228,0.718,None
prot-a-489,Cadherin-related family member 3,cadherin-related family member 3 measurement,EFO:0802352,http://www.ebi.ac.uk/efo/EFO_0802352,0.86,None
ebi-a-GCST90002330,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
prot-a-982,ERO1-like protein alpha,ERO1-like protein alpha measurement,EFO:0801582,http://www.ebi.ac.uk/efo/EFO_0801582,0.705,None
prot-a-709,Transcriptional repressor CTCF,transcriptional repressor CTCF measurement,EFO:0803169,http://www.ebi.ac.uk/efo/EFO_0803169,0.942,None
prot-a-1605,Transcription factor AP-1,transcription factor AP-1 measurement,EFO:0021909,http://www.ebi.ac.uk/efo/EFO_0021909,0.743,None
ebi-a-GCST005921,Family history of Alzheimer's disease,family history of Alzheimers disease,EFO:0009268,http://www.ebi.ac.uk/efo/EFO_0009268,0.99,None
prot-c-4271_75_2,PFD5,McCune-Albright syndrome,MONDO:0018919,http://purl.obolibrary.org/obo/MONDO_0018919,0.605,None
prot-a-2144,Olfactomedin-like protein 3,olfactomedin-like protein 3 measurement,EFO:0802829,http://www.ebi.ac.uk/efo/EFO_0802829,0.832,None
prot-a-2688,Protein Z-dependent protease inhibitor,protein Z-dependent protease inhibitor measurement,EFO:0021849,http://www.ebi.ac.uk/efo/EFO_0021849,0.805,None
prot-b-64,endothelial cell specific molecule 1,endothelial cell-specific molecule 1 measurement,EFO:0010912,http://www.ebi.ac.uk/efo/EFO_0010912,0.827,None
prot-a-332,"Carbonic anhydrase 5A, mitochondrial","carbonic anhydrase 5A, mitochondrial measurement",EFO:0801450,http://www.ebi.ac.uk/efo/EFO_0801450,0.849,None
prot-a-925,Eukaryotic translation initiation factor 4 gamma 3,eukaryotic translation initiation factor 4 gamma 3 measurement,EFO:0802535,http://www.ebi.ac.uk/efo/EFO_0802535,0.95,None
prot-c-3050_7_2,vWF,von Willebrand factor measurement,EFO:0004629,http://www.ebi.ac.uk/efo/EFO_0004629,0.997,None
prot-a-738,C-X-C motif chemokine 10,CCL13 measurement,EFO:0009411,http://www.ebi.ac.uk/efo/EFO_0009411,0.615,None
prot-a-2806,Sperm-associated antigen 11A,sperm-associated antigen 11A measurement,EFO:0802082,http://www.ebi.ac.uk/efo/EFO_0802082,0.775,None
prot-a-2219,"cGMP-dependent 3',5'-cyclic phosphodiesterase","cGMP-dependent 3',5'-cyclic phosphodiesterase measurement",EFO:0802391,http://www.ebi.ac.uk/efo/EFO_0802391,0.704,None
prot-a-1508,Interleukin-22 receptor subunit alpha-1,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.841,None
ebi-a-GCST90001651,Granulocyte Absolute Count,granulocyte count,EFO:0007987,http://www.ebi.ac.uk/efo/EFO_0007987,0.813,None
ebi-a-GCST90012031,Myeloperoxidase levels,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.79,None
ebi-a-GCST90017135,Neck circumference,neck circumference,EFO:0011043,http://www.ebi.ac.uk/efo/EFO_0011043,0.993,None
prot-a-434,CMRF35-like molecule 6,CMRF35-like molecule 6 measurement,EFO:0008086,http://www.ebi.ac.uk/efo/EFO_0008086,0.801,None
ebi-a-GCST90012111,Sex hormone-binding globulin levels,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.921,None
prot-a-1497,Interleukin-1 receptor type 2,interleukin-1 receptor type 2 measurement,EFO:0021842,http://www.ebi.ac.uk/efo/EFO_0021842,0.795,None
prot-c-4919_56_2,LIF sR,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.755,None
prot-a-1878,Multiple epidermal growth factor-like domains protein 10,multiple epidermal growth factor-like domains protein 10 measurement,EFO:0802762,http://www.ebi.ac.uk/efo/EFO_0802762,0.877,None
prot-a-2135,Out at first protein homolog,out at first protein homolog measurement,EFO:0801862,http://www.ebi.ac.uk/efo/EFO_0801862,0.925,None
prot-a-337,Cell adhesion molecule 1,adhesion factor,EFO:0004521,http://www.ebi.ac.uk/efo/EFO_0004521,0.912,None
prot-a-2996,Transmembrane protein 119,transmembrane protein 119 measurement,EFO:0803182,http://www.ebi.ac.uk/efo/EFO_0803182,0.925,None
prot-a-2740,S-phase kinase-associated protein 1,s-phase kinase-associated protein 1 measurement,EFO:0020715,http://www.ebi.ac.uk/efo/EFO_0020715,0.712,None
met-c-838,Acetoacetate,acetoacetate measurement,EFO:0010111,http://www.ebi.ac.uk/efo/EFO_0010111,0.903,None
ieu-b-4902,Anti-Feline herpes virus IgG levels,anti-feline herpes IgG measurement,EFO:0801088,http://www.ebi.ac.uk/efo/EFO_0801088,0.606,None
prot-a-1633,Uncharacterized protein KIAA1467,uncharacterized protein KIAA1467 measurement,EFO:0803232,http://www.ebi.ac.uk/efo/EFO_0803232,0.951,None
prot-a-27,Disintegrin and metalloproteinase domain-containing protein 19,disintegrin and metalloproteinase domain-containing protein 19 measurement,EFO:0802470,http://www.ebi.ac.uk/efo/EFO_0802470,0.912,None
prot-a-41,Pituitary adenylate cyclase-activating polypeptide 38,pituitary adenylate cyclase-activating polypeptide 38 measurement,EFO:0020641,http://www.ebi.ac.uk/efo/EFO_0020641,0.891,None
prot-a-3228,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2","WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement",EFO:0008319,http://www.ebi.ac.uk/efo/EFO_0008319,0.843,None
prot-a-668,Cytokine receptor-like factor 2,cytokine receptor-like factor 2 measurement,EFO:0020306,http://www.ebi.ac.uk/efo/EFO_0020306,0.829,None
ebi-a-GCST90010168,Renin levels,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.65,None
prot-c-4267_81_3,PESC,cervical squamous cell carcinoma,EFO:1000172,http://www.ebi.ac.uk/efo/EFO_1000172,0.702,None
prot-a-486,Cadherin-7,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.628,None
prot-a-1565,IQ domain-containing protein F1,IQ domain-containing protein F1 measurement,EFO:0802664,http://www.ebi.ac.uk/efo/EFO_0802664,0.879,None
prot-a-1192,Growth/differentiation factor 11,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.815,None
ebi-a-GCST90010329,Nectin-2 levels,adiponectin measurement,EFO:0004502,http://www.ebi.ac.uk/efo/EFO_0004502,0.723,None
prot-c-5122_92_2,Semaphorin-6A,semaphorin-6A measurement,EFO:0020721,http://www.ebi.ac.uk/efo/EFO_0020721,0.627,None
prot-a-2986,Tolloid-like protein 1,tolloid-like protein 1 measurement,EFO:0802135,http://www.ebi.ac.uk/efo/EFO_0802135,0.74,None
prot-a-1287,Glutathione S-transferase Mu 1,glutathione S-transferase Mu 1 measurement,EFO:0801638,http://www.ebi.ac.uk/efo/EFO_0801638,0.806,None
prot-a-923,Eukaryotic translation initiation factor 4E type 2,eukaryotic translation initiation factor 4E type 2 measurement,EFO:0801593,http://www.ebi.ac.uk/efo/EFO_0801593,0.952,None
met-a-523,X-11485,X-11485 measurement,EFO:0021244,http://www.ebi.ac.uk/efo/EFO_0021244,0.703,None
prot-a-3258,Zinc fingers and homeoboxes protein 3,zinc fingers and homeoboxes protein 3 measurement,EFO:0803299,http://www.ebi.ac.uk/efo/EFO_0803299,0.923,None
prot-a-661,Cysteine-rich secretory protein 2,cysteine-rich secretory protein 2 measurement,EFO:0801511,http://www.ebi.ac.uk/efo/EFO_0801511,0.824,None
prot-a-3235,WSC domain-containing protein 2,WSC domain-containing protein 2 measurement,EFO:0802222,http://www.ebi.ac.uk/efo/EFO_0802222,0.871,None
prot-c-2796_62_2,Fibrinogen,fibrinogen measurement,EFO:0004623,http://www.ebi.ac.uk/efo/EFO_0004623,0.83,None
prot-a-1721,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
prot-c-4588_1_2,PH,primary hyperoxaluria type 3,MONDO:0013327,http://purl.obolibrary.org/obo/MONDO_0013327,0.656,None
met-b-165,CD8:%TM-like,targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.683,None
prot-a-2235,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial","[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement",EFO:0008010,http://www.ebi.ac.uk/efo/EFO_0008010,0.795,None
met-c-853,Free cholesterol to esterified cholesterol ratio,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.823,None
prot-a-435,CMRF35-like molecule 2,CMRF35-like molecule 2 measurement,EFO:0802406,http://www.ebi.ac.uk/efo/EFO_0802406,0.797,None
prot-c-2700_56_2,Protein S,Proteinuria,HP:0000093,http://purl.obolibrary.org/obo/HP_0000093,0.744,None
prot-a-2150,Oligophrenin-1,X-linked intellectual disability - cerebellar hypoplasia,ORPHANET.ORDO:137831,http://www.orpha.net/ORDO/Orphanet_137831,0.79,None
prot-c-3684_78_3,Macrophage scavenger receptor,macrophage scavenger receptor types I and II measurement,EFO:0008222,http://www.ebi.ac.uk/efo/EFO_0008222,0.808,None
prot-a-716,Chymotrypsin-like protease CTRL-1,chymotrypsin-like protease CTRL-1 measurement,EFO:0801476,http://www.ebi.ac.uk/efo/EFO_0801476,0.778,None
ieu-a-1091,Top 1 % survival,survival time,EFO:0000714,http://www.ebi.ac.uk/efo/EFO_0000714,0.824,None
ebi-a-GCST90012079,NF-kappa-B essential modulator levels,immunodeficiency 33,MONDO:0010386,http://purl.obolibrary.org/obo/MONDO_0010386,0.714,None
ieu-a-81,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-89,Alpha-amylase 1,alpha-amylase 1 measurement,EFO:0801371,http://www.ebi.ac.uk/efo/EFO_0801371,0.638,None
prot-c-4719_58_2,Protein disulfide isomerase A3,protein disulfide-isomerase a3 measurement,EFO:0020668,http://www.ebi.ac.uk/efo/EFO_0020668,0.805,None
prot-a-1751,Gastric triacylglycerol lipase,gastric triacylglycerol lipase measurement,EFO:0802563,http://www.ebi.ac.uk/efo/EFO_0802563,0.929,None
ebi-a-GCST90002078,SSC-A on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.636,None
prot-c-2879_9_2,a1-Antichymotrypsin,alpha-1-antichymotrypsin measurement,EFO:0008019,http://www.ebi.ac.uk/efo/EFO_0008019,0.643,None
prot-a-2419,26S proteasome non-ATPase regulatory subunit 7,26s proteasome non-atpase regulatory subunit 7 measurement,EFO:0020112,http://www.ebi.ac.uk/efo/EFO_0020112,0.889,None
prot-a-2225,Platelet-derived growth factor subunit A,platelet-derived growth factor subunit A measurement,EFO:0801890,http://www.ebi.ac.uk/efo/EFO_0801890,0.835,None
ukb-d-30180_irnt,Lymphocyte percentage,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
ubm-a-2677,volume Right-Cerebellum-Cortex,cerebellar cortex volume measurement,EFO:0010291,http://www.ebi.ac.uk/efo/EFO_0010291,0.846,None
prot-a-927,Eukaryotic translation initiation factor 5A-1,eukaryotic translation initiation factor 5 measurement,EFO:0020369,http://www.ebi.ac.uk/efo/EFO_0020369,0.862,None
prot-c-3685_53_1,MFRP,isolated microphthalmia 5,MONDO:0012605,http://purl.obolibrary.org/obo/MONDO_0012605,0.655,None
met-a-322,Inosine,inosine measurement,EFO:0010503,http://www.ebi.ac.uk/efo/EFO_0010503,0.7,None
ebi-a-GCST90010199,Complement component C1q receptor levels,complement component C1q receptor measurement,EFO:0802427,http://www.ebi.ac.uk/efo/EFO_0802427,0.908,None
prot-a-1945,"Ribosome-recycling factor, mitochondrial","ribosome-recycling factor, mitochondrial measurement",EFO:0803027,http://www.ebi.ac.uk/efo/EFO_0803027,0.822,None
prot-a-2529,Riboflavin kinase,riboflavin kinase measurement,EFO:0802016,http://www.ebi.ac.uk/efo/EFO_0802016,0.915,None
ukb-a-268,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
prot-a-2783,Submaxillary gland androgen-regulated protein 3B,submaxillary gland androgen-regulated protein 3B measurement,EFO:0803106,http://www.ebi.ac.uk/efo/EFO_0803106,0.878,None
ebi-a-GCST004432,Platelet-derived growth factor BB levels,platelet-derived growth factor BB measurement,EFO:0008264,http://www.ebi.ac.uk/efo/EFO_0008264,0.772,None
prot-a-1574,Ubiquitin-like protein ISG15,ubiquitin-like protein ISG15 measurement,EFO:0021875,http://www.ebi.ac.uk/efo/EFO_0021875,0.888,None
prot-a-1611,Potassium voltage-gated channel subfamily E member 3,potassium voltage-gated channel subfamily E member 3 measurement,EFO:0802889,http://www.ebi.ac.uk/efo/EFO_0802889,0.891,None
prot-a-1053,E3 ubiquitin-protein ligase FANCL,E3 ubiquitin-protein ligase FANCL measurement,EFO:0802504,http://www.ebi.ac.uk/efo/EFO_0802504,0.87,None
prot-a-1893,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase","alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase measurement",EFO:0802263,http://www.ebi.ac.uk/efo/EFO_0802263,0.696,None
prot-a-3046,Tumor necrosis factor receptor superfamily member 1A,tumor necrosis factor receptor superfamily member 1A measurement,EFO:0803201,http://www.ebi.ac.uk/efo/EFO_0803201,0.947,None
prot-a-2030,Protein kinase C-binding protein NELL1,protein kinase C-binding protein NELL1 measurement,EFO:0801950,http://www.ebi.ac.uk/efo/EFO_0801950,0.841,None
prot-a-865,Dorsal root ganglia homeobox protein,dorsal root ganglia homeobox protein measurement,EFO:0801545,http://www.ebi.ac.uk/efo/EFO_0801545,0.937,None
ebi-a-GCST90002324,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
met-a-609,X-12441--12-hydroxyeicosatetraenoate (12-HETE),X-12441--12-hydroxyeicosatetraenoate 12-HETE measurement,EFO:0021307,http://www.ebi.ac.uk/efo/EFO_0021307,0.633,None
prot-a-1510,Interleukin-22 receptor subunit alpha-2,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.84,None
ukb-b-17848,"Heel quantitative ultrasound index (QUI), manual entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.657,None
bbj-a-47,Prothrombin time,prothrombin time measurement,EFO:0008390,http://www.ebi.ac.uk/efo/EFO_0008390,0.848,None
prot-a-418,CD109 antigen,CD109 antigen measurement,EFO:0008076,http://www.ebi.ac.uk/efo/EFO_0008076,0.883,None
prot-a-541,Chitinase-3-like protein 2,chitinase-3-like protein 2 measurement,EFO:0801471,http://www.ebi.ac.uk/efo/EFO_0801471,0.662,None
prot-a-2674,Semaphorin-4C,semaphorin-4C measurement,EFO:0803050,http://www.ebi.ac.uk/efo/EFO_0803050,0.641,None
ebi-a-GCST90012075,"Fatty acid-binding protein, adipocyte levels","fatty acid-binding protein, adipocyte measurement",EFO:0010914,http://www.ebi.ac.uk/efo/EFO_0010914,0.74,None
ebi-a-GCST90012015,Tumor necrosis factor receptor 1 levels,tumor necrosis factor receptor 1 measurement,EFO:0010931,http://www.ebi.ac.uk/efo/EFO_0010931,0.847,None
prot-c-3314_74_2,GFRa-1,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.64,None
ebi-a-GCST90013453,Lack of behavioral control,functional laterality,EFO:0003889,http://www.ebi.ac.uk/efo/EFO_0003889,0.661,None
prot-a-42,Pituitary adenylate cyclase-activating polypeptide,pituitary adenylate cyclase-activating polypeptide measurement,EFO:0802869,http://www.ebi.ac.uk/efo/EFO_0802869,0.883,None
prot-a-1805,Lymphotoxin alpha2:beta1,lymphotoxin alpha2:beta1 measurement,EFO:0020543,http://www.ebi.ac.uk/efo/EFO_0020543,0.738,None
ebi-a-GCST90010205,Carboxypeptidase A1 levels,carboxypeptidase B measurement,EFO:0801453,http://www.ebi.ac.uk/efo/EFO_0801453,0.723,None
ieu-a-796,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-604,Ciliary neurotrophic factor,ciliary neurotrophic factor measurement,EFO:0020260,http://www.ebi.ac.uk/efo/EFO_0020260,0.894,None
prot-a-1484,Interleukin-17D,interleukin-17D measurement,EFO:0021976,http://www.ebi.ac.uk/efo/EFO_0021976,0.762,None
ebi-a-GCST005845,Heart rate increase in response to exercise,heart rate response to exercise,EFO:0009184,http://www.ebi.ac.uk/efo/EFO_0009184,0.888,None
ukb-a-22,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
ieu-b-4906,Anti-Herpes simplex virus 1 IgG levels,Anti-herpes simplex virus 1 IgG measurement,EFO:0009349,http://www.ebi.ac.uk/efo/EFO_0009349,0.767,None
prot-a-562,CDGSH iron-sulfur domain-containing protein 1,CDGSH iron-sulfur domain-containing protein 1 measurement,EFO:0801460,http://www.ebi.ac.uk/efo/EFO_0801460,0.861,None
prot-a-1260,Probable G-protein coupled receptor 101,probable G-protein coupled receptor 101 measurement,EFO:0802905,http://www.ebi.ac.uk/efo/EFO_0802905,0.845,None
ebi-a-GCST90010351,Trefoil factor 2 levels,trefoil factor 2 measurement,EFO:0021846,http://www.ebi.ac.uk/efo/EFO_0021846,0.804,None
prot-a-1137,Forkhead box protein J2,forkhead box protein J2 measurement,EFO:0801604,http://www.ebi.ac.uk/efo/EFO_0801604,0.937,None
ieu-a-299,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-3032,Tumor necrosis factor receptor superfamily member 10A,tumor necrosis factor receptor superfamily member 10A measurement,EFO:0020799,http://www.ebi.ac.uk/efo/EFO_0020799,0.95,None
prot-c-2421_7_3,BDNF,brain-derived neurotrophic factor measurement,EFO:0011018,http://www.ebi.ac.uk/efo/EFO_0011018,0.987,None
prot-a-2587,60S acidic ribosomal protein P2,60S acidic ribosomal protein P2 measurement,EFO:0802243,http://www.ebi.ac.uk/efo/EFO_0802243,0.928,None
met-a-490,X-11261,X-11261 measurement,EFO:0021221,http://www.ebi.ac.uk/efo/EFO_0021221,0.704,None
ebi-a-GCST90012034,Resistin levels,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.976,None
prot-c-3061_61_2,Cathepsin B,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.826,None
prot-a-1627,UPF0258 protein KIAA1024,UPF0258 protein KIAA1024 measurement,EFO:0803234,http://www.ebi.ac.uk/efo/EFO_0803234,0.959,None
prot-a-2281,Polycystin-2,polycystic ovary syndrome,EFO:0000660,http://www.ebi.ac.uk/efo/EFO_0000660,0.717,None
ebi-a-GCST90000479,Interleukin-7 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.788,None
prot-a-918,Translation initiation factor eIF-2B subunit alpha,translation initiation factor eIF-2B subunit alpha measurement,EFO:0802145,http://www.ebi.ac.uk/efo/EFO_0802145,0.814,None
prot-a-427,B-cell receptor CD22,B-cell receptor CD22 measurement,EFO:0020171,http://www.ebi.ac.uk/efo/EFO_0020171,0.763,None
prot-a-2422,Proteasome assembly chaperone 3,proteasome assembly chaperone 3 measurement,EFO:0802921,http://www.ebi.ac.uk/efo/EFO_0802921,0.931,None
ebi-a-GCST90002347,Mean platelet volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.978,None
prot-a-1348,Porphobilinogen deaminase,porphobilinogen deaminase measurement,EFO:0802887,http://www.ebi.ac.uk/efo/EFO_0802887,0.901,None
prot-a-2088,Glucocorticoid receptor,glucocorticoid receptor measurement,EFO:0020405,http://www.ebi.ac.uk/efo/EFO_0020405,0.91,None
ebi-a-GCST90000486,Monocyte chemoattractant protein-4 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.805,None
ebi-a-GCST90000505,Urokinase-type plasminogen activator levels,urokinase-type plasminogen activator measurement,EFO:0010803,http://www.ebi.ac.uk/efo/EFO_0010803,0.79,None
met-a-408,X-05907,X-05907 measurement,EFO:0021196,http://www.ebi.ac.uk/efo/EFO_0021196,0.683,None
prot-a-2485,DNA repair protein RAD51 homolog 1,DNA repair protein rad51 homolog 1 measurement,EFO:0020330,http://www.ebi.ac.uk/efo/EFO_0020330,0.944,None
ukb-b-11650,Corneal hysteresis (left),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.897,None
prot-a-1648,Killer cell immunoglobulin-like receptor 3DS1,killer cell immunoglobulin-like receptor 3DS1 measurement,EFO:0020519,http://www.ebi.ac.uk/efo/EFO_0020519,0.911,None
prot-a-2983,Tight junction protein ZO-1,tight junction protein ZO-1 measurement,EFO:0803155,http://www.ebi.ac.uk/efo/EFO_0803155,0.701,None
prot-a-1378,Heparan-sulfate 6-O-sulfotransferase 1,heparan sulfate glucosamine 3-O-sulfotransferase 4 measurement,EFO:0802593,http://www.ebi.ac.uk/efo/EFO_0802593,0.71,None
prot-a-1717,Low-density lipoprotein receptor,low-density lipoprotein receptor measurement,EFO:0021937,http://www.ebi.ac.uk/efo/EFO_0021937,0.772,None
prot-a-2733,Signal-regulatory protein beta-1,signal-regulatory protein beta-1 measurement,EFO:0802069,http://www.ebi.ac.uk/efo/EFO_0802069,0.719,None
met-a-495,X-11315,X-11315 measurement,EFO:0021223,http://www.ebi.ac.uk/efo/EFO_0021223,0.685,None
ebi-a-GCST006678,Acute insulin response (insulin secretion and BMI adjusted),acute insulin response measurement,EFO:0006831,http://www.ebi.ac.uk/efo/EFO_0006831,0.674,None
prot-a-1008,Tissue Factor,tissue factor measurement,EFO:0010623,http://www.ebi.ac.uk/efo/EFO_0010623,0.845,None
prot-a-2961,Transforming growth factor alpha,transforming growth factor-alpha measurement,EFO:0010798,http://www.ebi.ac.uk/efo/EFO_0010798,0.826,None
prot-a-2838,Serine/arginine-rich splicing factor 6,serine/arginine-rich splicing factor 6 measurement,EFO:0803062,http://www.ebi.ac.uk/efo/EFO_0803062,0.702,None
ieu-a-1022,Percent emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.816,None
prot-a-1592,Integral membrane protein 2C,integral membrane protein 2C measurement,EFO:0802635,http://www.ebi.ac.uk/efo/EFO_0802635,0.923,None
met-c-936,Total fatty acids,fatty acid measurement,EFO:0005110,http://www.ebi.ac.uk/efo/EFO_0005110,0.614,None
ebi-a-GCST90012115,Age-related hearing impairment (MTAG),age-related hearing impairment,EFO:0005782,http://www.ebi.ac.uk/efo/EFO_0005782,0.73,None
met-a-415,X-06350,X-06350 measurement,EFO:0021202,http://www.ebi.ac.uk/efo/EFO_0021202,0.675,None
prot-a-1773,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3","leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 measurement",EFO:0802703,http://www.ebi.ac.uk/efo/EFO_0802703,0.851,None
prot-a-3106,t-SNARE domain-containing protein 1,t-SNARE domain-containing protein 1 measurement,EFO:0802116,http://www.ebi.ac.uk/efo/EFO_0802116,0.73,None
prot-a-869,Desmoglein-1,desmoglein-1 measurement,EFO:0020321,http://www.ebi.ac.uk/efo/EFO_0020321,0.736,None
prot-b-44,CD40 ligand,CD40 ligand measurement,EFO:0004790,http://www.ebi.ac.uk/efo/EFO_0004790,0.865,None
prot-a-236,Apoptosis regulator Bcl-2,apoptosis regulator BCL-2 measurement,EFO:0020159,http://www.ebi.ac.uk/efo/EFO_0020159,0.753,None
prot-a-2927,Tapasin-related protein,tapasin-related protein measurement,EFO:0802119,http://www.ebi.ac.uk/efo/EFO_0802119,0.795,None
prot-a-1905,Histone-lysine N-methyltransferase 2D,histone-lysine N-methyltransferase 2D measurement,EFO:0801683,http://www.ebi.ac.uk/efo/EFO_0801683,0.783,None
ukb-a-3,Pulse rate  automated reading,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
prot-a-2448,Receptor-type tyrosine-protein phosphatase S,tyrosine-protein phosphatase non-receptor type 1 measurement,EFO:0020834,http://www.ebi.ac.uk/efo/EFO_0020834,0.772,None
prot-c-3761_4_2,COX-2,cytochrome-c oxidase deficiency disease,MONDO:0009068,http://purl.obolibrary.org/obo/MONDO_0009068,0.645,None
met-a-530,X-11537,X-11537 measurement,EFO:0021250,http://www.ebi.ac.uk/efo/EFO_0021250,0.704,None
prot-a-164,Armadillo repeat-containing protein 5,armadillo repeat-containing protein 5 measurement,EFO:0802288,http://www.ebi.ac.uk/efo/EFO_0802288,0.858,None
ieu-b-4853,Forced expiratory volume in 1-second,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.898,None
ukb-a-361,Heel bone mineral density (BMD) T-score  automated (left),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.665,None
prot-a-3092,Protein-tyrosine sulfotransferase 1,protein-tyrosine sulfotransferase 1 measurement,EFO:0801970,http://www.ebi.ac.uk/efo/EFO_0801970,0.848,None
prot-a-1825,Mitotic spindle assembly checkpoint protein MAD1,mitotic spindle assembly checkpoint protein MAD1 measurement,EFO:0801807,http://www.ebi.ac.uk/efo/EFO_0801807,0.961,None
prot-a-2646,Secretoglobin family 1C member 1,secretoglobin family 1C member 1 measurement,EFO:0802041,http://www.ebi.ac.uk/efo/EFO_0802041,0.936,None
prot-a-2374,"cGMP-dependent protein kinase 1, beta isozyme","cGMP-dependent protein kinase 1, beta isozyme measurement",EFO:0801468,http://www.ebi.ac.uk/efo/EFO_0801468,0.83,None
ubm-a-1169,NET100 0013,C1 100080013,EFO:0009496,http://www.ebi.ac.uk/efo/EFO_0009496,0.666,None
ukb-b-311,White wine intake,white wine liking measurement,EFO:0006948,http://www.ebi.ac.uk/efo/EFO_0006948,0.603,None
prot-a-1659,Kallikrein-14,kallikrein-14 measurement,EFO:0020513,http://www.ebi.ac.uk/efo/EFO_0020513,0.759,None
ebi-a-GCST90000463,CXCL9 levels,CXCL9 measurement,EFO:0010780,http://www.ebi.ac.uk/efo/EFO_0010780,0.806,None
prot-a-118,Amyloid beta A4 precursor protein-binding family B member 3,amyloid beta A4 precursor protein-binding family B member 3 measurement,EFO:0802276,http://www.ebi.ac.uk/efo/EFO_0802276,0.906,None
prot-c-3600_2_3,Chitotriosidase-1,chitotriosidase-1 measurement,EFO:0008084,http://www.ebi.ac.uk/efo/EFO_0008084,0.753,None
prot-a-2317,Podocalyxin,podocalyxin measurement,EFO:0802874,http://www.ebi.ac.uk/efo/EFO_0802874,0.886,None
prot-a-2461,Pyrin domain-containing protein 1,pyrin domain-containing protein 1 measurement,EFO:0802985,http://www.ebi.ac.uk/efo/EFO_0802985,0.858,None
met-a-372,X-03088,X-03088 measurement,EFO:0021187,http://www.ebi.ac.uk/efo/EFO_0021187,0.671,None
prot-a-2120,Netrin-G1,"tumor grade 1, general grading system",MONDO:0024491,http://purl.obolibrary.org/obo/MONDO_0024491,0.775,None
met-a-447,Hyodeoxycholate,hyodeoxycholate measurement,EFO:0010499,http://www.ebi.ac.uk/efo/EFO_0010499,0.9,None
prot-c-5028_59_1,sCD163,soluble CD163 measurement,EFO:0020072,http://www.ebi.ac.uk/efo/EFO_0020072,0.877,None
prot-a-3052,Tumor necrosis factor receptor superfamily member 6B,tumor necrosis factor receptor superfamily member 6B measurement,EFO:0020815,http://www.ebi.ac.uk/efo/EFO_0020815,0.949,None
prot-a-1335,Hepatocyte growth factor-regulated tyrosine kinase substrate,hepatocyte growth factor-regulated tyrosine kinase substrate measurement,EFO:0802595,http://www.ebi.ac.uk/efo/EFO_0802595,0.903,None
prot-a-3068,Tenascin-R,tenascin measurement,EFO:0008296,http://www.ebi.ac.uk/efo/EFO_0008296,0.759,None
met-d-VLDL_L,Total lipids in VLDL,total lipids in small VLDL,EFO:0022148,http://www.ebi.ac.uk/efo/EFO_0022148,0.89,None
met-a-714,Threitol,threitol measurement,EFO:0021031,http://www.ebi.ac.uk/efo/EFO_0021031,0.85,None
prot-a-1415,Gamma-interferon-inducible protein 16,gamma-interferon-inducible protein 16 measurement,EFO:0801617,http://www.ebi.ac.uk/efo/EFO_0801617,0.78,None
met-a-671,X-12990--docosapentaenoic acid (n6-DPA),X-12990--docosapentaenoic acid n6-DPA measurement,EFO:0021344,http://www.ebi.ac.uk/efo/EFO_0021344,0.667,None
prot-a-1147,Follistatin-related protein 5,follistatin-related protein 5 measurement,EFO:0802552,http://www.ebi.ac.uk/efo/EFO_0802552,0.827,None
ebi-a-GCST90002371,Red cell distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
prot-a-1251,Glycoprotein hormone alpha-2,glycoprotein hormones alpha chain measurement,EFO:0802577,http://www.ebi.ac.uk/efo/EFO_0802577,0.795,None
prot-a-2068,Palmitoleoyl-protein carboxylesterase NOTUM,palmitoleoyl-protein carboxylesterase NOTUM measurement,EFO:0802842,http://www.ebi.ac.uk/efo/EFO_0802842,0.875,None
ebi-a-GCST005059,Serum albumin level,serum albumin measurement,EFO:0004535,http://www.ebi.ac.uk/efo/EFO_0004535,0.799,None
prot-a-750,C-X-C motif chemokine 9,CCL13 measurement,EFO:0009411,http://www.ebi.ac.uk/efo/EFO_0009411,0.622,None
ukb-b-2909,Variation in diet,diet,EFO:0002755,http://www.ebi.ac.uk/efo/EFO_0002755,0.604,None
prot-a-1923,Multimerin-2,multimerin-2 measurement,EFO:0801809,http://www.ebi.ac.uk/efo/EFO_0801809,0.669,None
ieu-b-4843,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
met-a-739,Dimethylarginine (SDMA + ADMA),dimethylarginine (SDMA + ADMA) measurement,EFO:0800037,http://www.ebi.ac.uk/efo/EFO_0800037,0.746,None
ukb-b-17881,Potassium,potassium measurement,EFO:0009283,http://www.ebi.ac.uk/efo/EFO_0009283,0.841,None
prot-a-2288,Group IIE secretory phospholipase A2,group IIe secretory phospholipase A2 measurement,EFO:0020424,http://www.ebi.ac.uk/efo/EFO_0020424,0.942,None
prot-a-1241,"Aspartate aminotransferase, cytoplasmic","aspartate aminotransferase, cytoplasmic measurement",EFO:0008031,http://www.ebi.ac.uk/efo/EFO_0008031,0.906,None
ebi-a-GCST004941,Dehydroepiandrosterone sulphate levels,dehydroepiandrosterone sulphate measurement,EFO:0007001,http://www.ebi.ac.uk/efo/EFO_0007001,0.871,None
ubm-a-2660,volume Left-Thalamus-Proper,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.828,None
prot-a-285,Transmembrane protein C16orf54,transmembrane protein C16orf54 measurement,EFO:0803191,http://www.ebi.ac.uk/efo/EFO_0803191,0.956,None
ukb-a-336,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
ebi-a-GCST008029,Diastolic blood pressure,diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.99,None
prot-a-233,B-cell receptor-associated protein 29,B-cell receptor-associated protein 29 measurement,EFO:0802301,http://www.ebi.ac.uk/efo/EFO_0802301,0.737,None
ebi-a-GCST003770,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
ukb-a-342,Number of cigarettes currently smoked daily (current cigarette smokers),nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.63,None
prot-a-3026,Transmembrane protease serine 5,transmembrane protease serine 5 measurement,EFO:0803181,http://www.ebi.ac.uk/efo/EFO_0803181,0.933,None
prot-a-2980,Metalloproteinase inhibitor 4,metalloproteinase inhibitor 4 measurement,EFO:0801797,http://www.ebi.ac.uk/efo/EFO_0801797,0.921,None
ebi-a-GCST006328,Extraversion,extraversion,EFO:0004317,http://www.ebi.ac.uk/efo/EFO_0004317,0.995,None
prot-a-2802,Sortilin,sortilin measurement,EFO:0600000,http://www.ebi.ac.uk/efo/EFO_0600000,0.764,None
prot-a-2312,Mismatch repair endonuclease PMS2,mismatch repair endonuclease PMS2 measurement,EFO:0802748,http://www.ebi.ac.uk/efo/EFO_0802748,0.952,None
ebi-a-GCST90017093,Gut microbiota abundance (order Bifidobacteriales id.432),commensal Bifidobacteriales infectious disease,EFO:1000873,http://www.ebi.ac.uk/efo/EFO_1000873,0.603,None
met-c-876,Free cholesterol in large HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.915,None
prot-a-1559,Insulin-induced gene 1 protein,insulin-induced gene 1 protein measurement,EFO:0802629,http://www.ebi.ac.uk/efo/EFO_0802629,0.825,None
prot-a-3084,Thiamin pyrophosphokinase 1,thiamin pyrophosphokinase 1 measurement,EFO:0803146,http://www.ebi.ac.uk/efo/EFO_0803146,0.923,None
met-d-M_HDL_P,Concentration of medium HDL particles,concentration of medium VLDL particles,EFO:0022152,http://www.ebi.ac.uk/efo/EFO_0022152,0.811,None
prot-a-149,Rho GTPase-activating protein 30,rho GTPase-activating protein 30 measurement,EFO:0802012,http://www.ebi.ac.uk/efo/EFO_0802012,0.857,None
ukb-a-264,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
ebi-a-GCST90000485,Monocyte chemoattractant protein-3 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.806,None
ebi-a-GCST90012047,Myoglobin levels,myoglobin measurement,EFO:0005057,http://www.ebi.ac.uk/efo/EFO_0005057,0.713,None
prot-a-545,Neural cell adhesion molecule L1-like protein,neural cell adhesion molecule L1 measurement,EFO:0020594,http://www.ebi.ac.uk/efo/EFO_0020594,0.829,None
prot-a-1620,BTB/POZ domain-containing protein KCTD5,BTB/POZ domain-containing protein KCTD5 measurement,EFO:0802340,http://www.ebi.ac.uk/efo/EFO_0802340,0.803,None
ieu-a-104,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
ubm-a-2679,volume Right-Caudate,caudate nucleus volume,EFO:0004830,http://www.ebi.ac.uk/efo/EFO_0004830,0.698,None
prot-a-1182,GTP cyclohydrolase 1,GTP cyclohydrolase 1 measurement,EFO:0802583,http://www.ebi.ac.uk/efo/EFO_0802583,0.917,None
ebi-a-GCST002221,"Cholesterol, total",total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
met-a-637,X-12645,X-12645 measurement,EFO:0021319,http://www.ebi.ac.uk/efo/EFO_0021319,0.719,None
prot-a-2601,Ribonucleoside-diphosphate reductase large subunit,ribonucleoside-diphosphate reductase large subunit measurement,EFO:0802021,http://www.ebi.ac.uk/efo/EFO_0802021,0.894,None
ukb-b-10629,6mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
prot-b-2,interleukin 6,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.934,None
prot-a-1743,Leukocyte immunoglobulin-like receptor subfamily B member 2,leukocyte immunoglobulin-like receptor subfamily B member 2 measurement,EFO:0008209,http://www.ebi.ac.uk/efo/EFO_0008209,0.921,None
prot-a-104,Acidic leucine-rich nuclear phosphoprotein 32 family member A,acidic leucine-rich nuclear phosphoprotein 32 family member A measurement,EFO:0802250,http://www.ebi.ac.uk/efo/EFO_0802250,0.906,None
met-a-568,X-12040,X-12040 measurement,EFO:0021281,http://www.ebi.ac.uk/efo/EFO_0021281,0.697,None
prot-a-421,Antigen-presenting glycoprotein CD1d,antigen-presenting glycoprotein CD1d measurement,EFO:0802285,http://www.ebi.ac.uk/efo/EFO_0802285,0.858,None
prot-a-1550,Inosine-5'-monophosphate dehydrogenase 2,inosine-5'-monophosphate dehydrogenase 2 measurement,EFO:0008159,http://www.ebi.ac.uk/efo/EFO_0008159,0.705,None
ebi-a-GCST90010172,"Superoxide dismutase [Mn],mitochondrial levels","superoxide dismutase [Mn], mitochondrial measurement",EFO:0008294,http://www.ebi.ac.uk/efo/EFO_0008294,0.63,None
ieu-b-4823,Age at menopause,age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.987,None
prot-a-1433,Interferon gamma receptor 2,interferon gamma receptor 2 measurement,EFO:0022030,http://www.ebi.ac.uk/efo/EFO_0022030,0.906,None
prot-a-2112,"5'(3')-deoxyribonucleotidase, cytosolic type","5'(3')-deoxyribonucleotidase, cytosolic type measurement",EFO:0801336,http://www.ebi.ac.uk/efo/EFO_0801336,0.688,None
prot-a-2097,Neuregulin-4,neuregulin-1 measurement,EFO:0022029,http://www.ebi.ac.uk/efo/EFO_0022029,0.673,None
ubm-a-3003,a2009s lh S central thickness,central corneal thickness,EFO:0005213,http://www.ebi.ac.uk/efo/EFO_0005213,0.651,None
ebi-a-GCST90001404,Plasma Blast-Plasma Cell %B cell,plasma cell neoplasm,EFO:0000200,http://www.ebi.ac.uk/efo/EFO_0000200,0.81,None
prot-a-2957,Tissue factor pathway inhibitor,tissue factor pathway inhibitor measurement,EFO:0007968,http://www.ebi.ac.uk/efo/EFO_0007968,0.94,None
prot-a-2452,Poly(U)-binding-splicing factor PUF60,poly(U)-binding-splicing factor PUF60 measurement,EFO:0801895,http://www.ebi.ac.uk/efo/EFO_0801895,0.655,None
prot-a-360,Protein CASC4,protein CASC4 measurement,EFO:0802927,http://www.ebi.ac.uk/efo/EFO_0802927,0.883,None
met-a-541,X-11787,X-11787 measurement,EFO:0021258,http://www.ebi.ac.uk/efo/EFO_0021258,0.709,None
prot-a-1306,"3-hydroxyanthranilate 3,4-dioxygenase","3-hydroxyanthranilate 3,4-dioxygenase measurement",EFO:0021862,http://www.ebi.ac.uk/efo/EFO_0021862,0.731,None
prot-c-2858_29_2,Hat1,ataxia telangiectasia,MONDO:0008840,http://purl.obolibrary.org/obo/MONDO_0008840,0.768,None
prot-a-159,AT-rich interactive domain-containing protein 3A,AT-rich interactive domain-containing protein 3A measurement,EFO:0020165,http://www.ebi.ac.uk/efo/EFO_0020165,0.802,None
prot-a-2146,Oxidized low-density lipoprotein receptor 1,oxidized low-density lipoprotein receptor 1 measurement,EFO:0020620,http://www.ebi.ac.uk/efo/EFO_0020620,0.838,None
met-a-710,2-hydroxypalmitate,2-hydroxypalmitate measurement,EFO:0021507,http://www.ebi.ac.uk/efo/EFO_0021507,0.753,None
ebi-a-GCST000755,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
met-d-L_HDL_C_pct,Cholesterol to total lipids ratio in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.747,None
met-c-855,Omega-3 fatty acids,omega-3 polyunsaturated fatty acid measurement,EFO:0010119,http://www.ebi.ac.uk/efo/EFO_0010119,0.617,None
prot-a-2659,Protein SEC13 homolog,protein SEC13 homolog measurement,EFO:0801961,http://www.ebi.ac.uk/efo/EFO_0801961,0.916,None
prot-a-2014,Natural cytotoxicity triggering receptor 1,natural cytotoxicity triggering receptor 1 measurement,EFO:0020588,http://www.ebi.ac.uk/efo/EFO_0020588,0.943,None
prot-a-1814,Lysozyme g-like protein 1,lysozyme g-like protein 1 measurement,EFO:0801778,http://www.ebi.ac.uk/efo/EFO_0801778,0.773,None
ebi-a-GCST90012003,Proto-oncogene tyrosine-protein kinase Src levels,proto-oncogene tyrosine-protein kinase Src measurement,EFO:0010927,http://www.ebi.ac.uk/efo/EFO_0010927,0.766,None
prot-a-2367,cAMP-dependent protein kinase catalytic subunit alpha,cAMP-dependent protein kinase catalytic subunit alpha measurement,EFO:0020222,http://www.ebi.ac.uk/efo/EFO_0020222,0.865,None
prot-a-832,Delta-like protein 4,delta-like protein 4 measurement,EFO:0020317,http://www.ebi.ac.uk/efo/EFO_0020317,0.744,None
ebi-a-GCST90012033,Matrix metalloproteinase-1 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.855,None
prot-b-57,C-X-C motif chemokine ligand 16,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.612,None
prot-a-1603,Junctophilin-3,junctophilin-1 measurement,EFO:0802667,http://www.ebi.ac.uk/efo/EFO_0802667,0.717,None
prot-a-1675,NKG2-D type II integral membrane protein,NKG2-D type II integral membrane protein measurement,EFO:0008250,http://www.ebi.ac.uk/efo/EFO_0008250,0.791,None
prot-a-1884,Microfibrillar-associated protein 1,microfibrillar-associated protein 1 measurement,EFO:0802745,http://www.ebi.ac.uk/efo/EFO_0802745,0.821,None
prot-a-91,Anaphase-promoting complex subunit 7,anaphase-promoting complex subunit 7 measurement,EFO:0801381,http://www.ebi.ac.uk/efo/EFO_0801381,0.853,None
met-c-919,Phenylalanine,phenylketonuria,MONDO:0009861,http://purl.obolibrary.org/obo/MONDO_0009861,0.899,None
prot-a-308,"ES1 protein homolog, mitochondrial","ES1 protein homolog, mitochondrial measurement",EFO:0802529,http://www.ebi.ac.uk/efo/EFO_0802529,0.831,None
prot-a-2813,Spermatogenesis-associated protein 20,spermatogenesis-associated protein 20 measurement,EFO:0802083,http://www.ebi.ac.uk/efo/EFO_0802083,0.832,None
ebi-a-GCST90010143,Interleukin-1 receptor-like 2 levels,interleukin 1 receptor-like 2 measurement,EFO:0008169,http://www.ebi.ac.uk/efo/EFO_0008169,0.732,None
prot-a-1747,Leukocyte immunoglobulin-like receptor subfamily B member 5,leukocyte immunoglobulin-like receptor subfamily B member 5 measurement,EFO:0801769,http://www.ebi.ac.uk/efo/EFO_0801769,0.921,None
ukb-d-12338_irnt,P duration,duration,EFO:0000433,http://www.ebi.ac.uk/efo/EFO_0000433,0.823,None
prot-c-4923_79_1,MIS,microcephaly-micromelia syndrome,MONDO:0009619,http://purl.obolibrary.org/obo/MONDO_0009619,0.628,None
met-a-397,2-hydroxystearate,2-hydroxystearate measurement,EFO:0021059,http://www.ebi.ac.uk/efo/EFO_0021059,0.705,None
met-b-132,B Mem:%IgG,anti-IgG,EFO:0005030,http://www.ebi.ac.uk/efo/EFO_0005030,0.752,None
met-d-Glucose,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
prot-a-358,"Cysteine--tRNA ligase, cytoplasmic","cysteine--tRNA ligase, cytoplasmic measurement",EFO:0802445,http://www.ebi.ac.uk/efo/EFO_0802445,0.761,None
prot-a-1963,Myotubularin-related protein 1,myotubularin-related protein 1 measurement,EFO:0802773,http://www.ebi.ac.uk/efo/EFO_0802773,0.828,None
prot-a-1956,Growth/differentiation factor 8,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.835,None
ebi-a-GCST90000438,Adenosine Deaminase levels,adenosine deaminase measurement,EFO:0010761,http://www.ebi.ac.uk/efo/EFO_0010761,0.773,None
prot-c-3888_8_1,ING1,"goiter, multinodular 1, with or without Sertoli-Leydig cell tumors",MONDO:0007681,http://purl.obolibrary.org/obo/MONDO_0007681,0.669,None
ieu-a-94,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-797,Beta-defensin 121,beta-defensin 121 measurement,EFO:0802324,http://www.ebi.ac.uk/efo/EFO_0802324,0.763,None
met-a-443,X-10506,X-10506 measurement,EFO:0021216,http://www.ebi.ac.uk/efo/EFO_0021216,0.718,None
prot-a-2115,Neurotrophin-4,neurotrophin-3 measurement,EFO:0010791,http://www.ebi.ac.uk/efo/EFO_0010791,0.639,None
prot-a-937,EMI domain-containing protein 1,EMI domain-containing protein 1 measurement,EFO:0802521,http://www.ebi.ac.uk/efo/EFO_0802521,0.848,None
ebi-a-GCST90010323,Leucine-rich repeats and immunoglobulin-like domains protein 1 levels,leucine-rich repeats and immunoglobulin-like domains protein 3 measurement,EFO:0020534,http://www.ebi.ac.uk/efo/EFO_0020534,0.811,None
met-a-735,Octadecanedioate,octadecanedioate measurement,EFO:0021056,http://www.ebi.ac.uk/efo/EFO_0021056,0.906,None
met-a-602,1-eicosatrienoylglycerophosphocholine*,1-eicosatrienoylglycerophosphocholine measurement,EFO:0021081,http://www.ebi.ac.uk/efo/EFO_0021081,0.831,None
prot-a-3182,Uronyl 2-sulfotransferase,uronyl 2-sulfotransferase measurement,EFO:0803240,http://www.ebi.ac.uk/efo/EFO_0803240,0.798,None
ukb-d-30040_irnt,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
prot-a-2074,Nuclear pore complex-interacting protein family member B3,nuclear pore complex-interacting protein family member B3 measurement,EFO:0801850,http://www.ebi.ac.uk/efo/EFO_0801850,0.87,None
prot-c-2431_17_3,Cathepsin G,cathepsin G measurement,EFO:0020242,http://www.ebi.ac.uk/efo/EFO_0020242,0.829,None
prot-c-3201_49_2,kallikrein 5,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.779,None
met-d-VLDL_PL,Phospholipids in VLDL,phospholipids in small VLDL measurement,EFO:0022146,http://www.ebi.ac.uk/efo/EFO_0022146,0.842,None
prot-a-301,Complement C1q subcomponent subunit C,complement C1q subcomponent subunit C measurement,EFO:0801492,http://www.ebi.ac.uk/efo/EFO_0801492,0.967,None
prot-a-813,Desert hedgehog protein N-product,desert hedgehog protein n-product measurement,EFO:0020319,http://www.ebi.ac.uk/efo/EFO_0020319,0.865,None
met-a-668,Laurylcarnitine,laurylcarnitine measurement,EFO:0021041,http://www.ebi.ac.uk/efo/EFO_0021041,0.895,None
ebi-a-GCST006952,Feeling tense,feeling tense measurement,EFO:0009596,http://www.ebi.ac.uk/efo/EFO_0009596,0.859,None
ebi-a-GCST90002307,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
met-d-HDL_FC,Free cholesterol in HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.833,None
prot-a-1871,Midkine,midkine measurement,EFO:0020571,http://www.ebi.ac.uk/efo/EFO_0020571,0.872,None
prot-a-2541,Rho-related GTP-binding protein RhoG,rho-related GTP-binding protein RhoG measurement,EFO:0803024,http://www.ebi.ac.uk/efo/EFO_0803024,0.749,None
prot-a-433,CMRF35-like molecule 6,CMRF35-like molecule 6 measurement,EFO:0008086,http://www.ebi.ac.uk/efo/EFO_0008086,0.801,None
met-d-XL_VLDL_PL,Phospholipids in very large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.855,None
prot-a-2913,Synaptotagmin-2,synaptotagmin-2 measurement,EFO:0803118,http://www.ebi.ac.uk/efo/EFO_0803118,0.781,None
prot-a-2031,Protein kinase C-binding protein NELL2,protein kinase C-binding protein NELL2 measurement,EFO:0802949,http://www.ebi.ac.uk/efo/EFO_0802949,0.84,None
ebi-a-GCST90010141,Interleukin-18 levels,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.814,None
ebi-a-GCST90001424,IgD+ B cell %Lymphocyte,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.621,None
prot-c-5035_7_1,TS,Timothy syndrome,MONDO:0010979,http://purl.obolibrary.org/obo/MONDO_0010979,0.991,None
prot-a-2196,Protocadherin-15,protocadherin-15 measurement,EFO:0802974,http://www.ebi.ac.uk/efo/EFO_0802974,0.712,None
prot-a-309,Uncharacterized protein C22orf15,uncharacterized protein C22orf15 measurement,EFO:0803230,http://www.ebi.ac.uk/efo/EFO_0803230,0.953,None
prot-a-837,DnaJ homolog subfamily B member 12,DnaJ homolog subfamily B member 12 measurement,EFO:0802487,http://www.ebi.ac.uk/efo/EFO_0802487,0.948,None
ukb-b-18103,"Pulse rate, automated reading",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.659,None
met-a-713,X-13859,X-13859 measurement,EFO:0021360,http://www.ebi.ac.uk/efo/EFO_0021360,0.719,None
prot-a-655,CREB-binding protein,protein binding measurement,EFO:0010742,http://www.ebi.ac.uk/efo/EFO_0010742,0.62,None
ebi-a-GCST003371,Glomerular filtration rate (creatinine),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.869,None
prot-c-3448_13_2,IR,insulin resistance,EFO:0002614,http://www.ebi.ac.uk/efo/EFO_0002614,1.0,None
prot-c-4187_49_2,6-Phosphogluconate dehydrogenase,6-phosphogluconate dehydrogenase deficiency,MONDO:0020457,http://purl.obolibrary.org/obo/MONDO_0020457,0.799,None
prot-a-127,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
met-a-725,X-14473,X-14473 measurement,EFO:0021370,http://www.ebi.ac.uk/efo/EFO_0021370,0.702,None
prot-a-1450,Insulin-like growth factor-binding protein 6,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.815,None
prot-a-1411,Alpha-L-iduronidase,mucopolysaccharidosis type 1,MONDO:0001586,http://purl.obolibrary.org/obo/MONDO_0001586,0.65,None
prot-a-2522,Replication initiator 1,replication initiator 1 measurement,EFO:0802001,http://www.ebi.ac.uk/efo/EFO_0802001,0.886,None
met-a-427,2-hydroxyisobutyrate,3-hydroxyisobutyrate measurement,EFO:0010983,http://www.ebi.ac.uk/efo/EFO_0010983,0.818,None
prot-a-2805,Protein SPACA7,protein SPACA7 measurement,EFO:0801965,http://www.ebi.ac.uk/efo/EFO_0801965,0.887,None
prot-a-1967,Mucin-1,cutaneous mucinosis,MONDO:0002523,http://purl.obolibrary.org/obo/MONDO_0002523,0.721,None
ebi-a-GCST90010219,Granulins levels,progranulin measurement,EFO:0004625,http://www.ebi.ac.uk/efo/EFO_0004625,0.781,None
prot-a-1872,Nuclear protein MDM1,nuclear protein MDM1 measurement,EFO:0802822,http://www.ebi.ac.uk/efo/EFO_0802822,0.918,None
prot-a-633,COMM domain-containing protein 1,COMM domain-containing protein 1 measurement,EFO:0802424,http://www.ebi.ac.uk/efo/EFO_0802424,0.853,None
prot-a-1842,Dual specificity mitogen-activated protein kinase kinase 4,dual specificity mitogen-activated protein kinase kinase 4 measurement,EFO:0008113,http://www.ebi.ac.uk/efo/EFO_0008113,0.898,None
prot-a-3102,Thyrotropin-releasing hormone,thyrotropin-releasing hormone measurement,EFO:0803154,http://www.ebi.ac.uk/efo/EFO_0803154,0.835,None
met-d-L_LDL_PL,Phospholipids in large LDL,phospholipids in large LDL measurement,EFO:0022174,http://www.ebi.ac.uk/efo/EFO_0022174,0.908,None
prot-a-311,Uncharacterized protein C2orf66,uncharacterized protein C2orf66 measurement,EFO:0802192,http://www.ebi.ac.uk/efo/EFO_0802192,0.951,None
prot-a-674,Beta-crystallin B2,beta-crystallin B2 measurement,EFO:0801414,http://www.ebi.ac.uk/efo/EFO_0801414,0.746,None
ukb-b-469,Number of cigarettes currently smoked daily (current cigarette smokers),nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.63,None
ieu-b-4841,HbA1c,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.997,None
prot-a-480,Cadherin-1,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.66,None
ieu-a-27,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
ebi-a-GCST008032,Fasting blood glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.898,None
prot-a-3262,Zinc finger protein 175,zinc finger protein 175 measurement,EFO:0802225,http://www.ebi.ac.uk/efo/EFO_0802225,0.923,None
met-a-342,Glycerate,glycerate measurement,EFO:0021029,http://www.ebi.ac.uk/efo/EFO_0021029,0.788,None
prot-a-281,Platelet receptor Gi24,platelet receptor Gi24 measurement,EFO:0021877,http://www.ebi.ac.uk/efo/EFO_0021877,0.918,None
prot-a-227,B melanoma antigen 2,B melanoma antigen 2 measurement,EFO:0801401,http://www.ebi.ac.uk/efo/EFO_0801401,0.867,None
prot-a-1403,Inducible T-cell costimulator,inducible T-cell costimulator measurement,EFO:0021967,http://www.ebi.ac.uk/efo/EFO_0021967,0.826,None
ebi-a-GCST90000506,Vascular endothelial growth factor A levels,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.921,None
ebi-a-GCST90011772,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-a-36,A disintegrin and metalloproteinase with thrombospondin motifs 5,a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement,EFO:0008326,http://www.ebi.ac.uk/efo/EFO_0008326,0.942,None
ebi-a-GCST90001477,HLA DR++ monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.666,None
prot-a-825,"Dihydrolipoyl dehydrogenase, mitochondrial","dihydrolipoyl dehydrogenase, mitochondrial measurement",EFO:0802466,http://www.ebi.ac.uk/efo/EFO_0802466,0.921,None
prot-a-893,Early endosome antigen 1,early endosome antigen 1 measurement,EFO:0802514,http://www.ebi.ac.uk/efo/EFO_0802514,0.889,None
ieu-a-980,Femoral neck bone mineral density,femoral neck bone mineral density,EFO:0007785,http://www.ebi.ac.uk/efo/EFO_0007785,0.996,None
prot-a-93,Angiopoietin-2,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.74,None
ebi-a-GCST004074,Intraocular pressure,intraocular pressure measurement,EFO:0004695,http://www.ebi.ac.uk/efo/EFO_0004695,0.909,None
prot-a-2586,60S ribosomal protein L30,60S ribosomal protein L30 measurement,EFO:0801337,http://www.ebi.ac.uk/efo/EFO_0801337,0.925,None
prot-a-409,C-C motif chemokine 5,C-C motif chemokine 5 measurement,EFO:0008053,http://www.ebi.ac.uk/efo/EFO_0008053,0.681,None
prot-a-254,Bone morphogenetic protein 10,bone morphogenetic protein 10 measurement,EFO:0020185,http://www.ebi.ac.uk/efo/EFO_0020185,0.894,None
ukb-a-231,Forced expiratory volume in 1-second (FEV1)  Best measure,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.7,None
ebi-a-GCST90012036,Pappalysin-1 levels,pappalysin-1 measurement,EFO:0802845,http://www.ebi.ac.uk/efo/EFO_0802845,0.648,None
ebi-a-GCST003373,Glomerular filtration rate in diabetics (creatinine),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.763,None
prot-a-2730,Sialic acid-binding Ig-like lectin 8,sialic acid-binding Ig-like lectin 8 measurement,EFO:0802067,http://www.ebi.ac.uk/efo/EFO_0802067,0.675,None
prot-a-1330,Probable E3 ubiquitin-protein ligase HERC4,probable E3 ubiquitin-protein ligase HERC4 measurement,EFO:0802903,http://www.ebi.ac.uk/efo/EFO_0802903,0.91,None
prot-a-3083,Triosephosphate isomerase,triosephosphate isomerase measurement,EFO:0020785,http://www.ebi.ac.uk/efo/EFO_0020785,0.896,None
prot-a-1522,Interleukin-31 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.845,None
met-a-329,Palmitate (16:0),palmitate 16:0 measurement,EFO:0021071,http://www.ebi.ac.uk/efo/EFO_0021071,0.61,None
prot-c-4232_19_2,IGF-I sR,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.644,None
ieu-a-1107,Urinary albumin-to-creatinine ratio,urinary albumin to creatinine ratio,EFO:0007778,http://www.ebi.ac.uk/efo/EFO_0007778,0.995,None
ukb-b-1732,3mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
ebi-a-GCST90012056,Matrix metalloproteinase-7 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.84,None
prot-a-2917,Synaptotagmin-8,synaptotagmin-2 measurement,EFO:0803118,http://www.ebi.ac.uk/efo/EFO_0803118,0.768,None
prot-a-1661,Prostate-specific antigen,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.9,None
prot-a-1246,Glypican-3,glypican-1 measurement,EFO:0801649,http://www.ebi.ac.uk/efo/EFO_0801649,0.612,None
ieu-a-73,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-35,A disintegrin and metalloproteinase with thrombospondin motifs 4,a disintegrin and metalloproteinase with thrombospondin motifs 4 measurement,EFO:0020124,http://www.ebi.ac.uk/efo/EFO_0020124,0.942,None
prot-a-2672,Semaphorin-3E,semaphorin-3E measurement,EFO:0008279,http://www.ebi.ac.uk/efo/EFO_0008279,0.65,None
ebi-a-GCST003837,Chronotype,chronotype measurement,EFO:0008328,http://www.ebi.ac.uk/efo/EFO_0008328,0.818,None
met-d-VLDL_TG,Triglycerides in VLDL,triglycerides in small VLDL measurement,EFO:0022145,http://www.ebi.ac.uk/efo/EFO_0022145,0.837,None
ebi-a-GCST001969,Heart rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.998,None
prot-a-2560,E3 ubiquitin-protein ligase RNF114,E3 ubiquitin-protein ligase RNF114 measurement,EFO:0802510,http://www.ebi.ac.uk/efo/EFO_0802510,0.904,None
prot-a-287,Uncharacterized protein C17orf78,uncharacterized protein C17orf78 measurement,EFO:0802191,http://www.ebi.ac.uk/efo/EFO_0802191,0.954,None
ukb-b-10011,Townsend deprivation index at recruitment,Townsend deprivation index,EFO:0009711,http://www.ebi.ac.uk/efo/EFO_0009711,0.806,None
prot-b-48,matrix metallopeptidase 10,matrix metalloproteinase 10 measurement,EFO:0010589,http://www.ebi.ac.uk/efo/EFO_0010589,0.632,None
prot-a-1915,Matrix metalloproteinase-16,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.882,None
ukb-b-15590,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
met-d-M_HDL_FC_pct,Free cholesterol to total lipids ratio in medium HDL,free cholesterol:total lipids ratio,EFO:0020945,http://www.ebi.ac.uk/efo/EFO_0020945,0.681,None
ukb-b-12205,Chest pain felt during physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.647,None
met-a-547,X-11818,X-11818 measurement,EFO:0021264,http://www.ebi.ac.uk/efo/EFO_0021264,0.708,None
ebi-a-GCST90002293,Basophil count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.984,None
prot-a-2426,Prostaglandin-H2 D-isomerase,prostaglandin-H2 D-isomerase measurement,EFO:0801933,http://www.ebi.ac.uk/efo/EFO_0801933,0.639,None
prot-a-1833,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB","mannosyl-oligosaccharide 1,2-alpha-mannosidase IB measurement",EFO:0801783,http://www.ebi.ac.uk/efo/EFO_0801783,0.769,None
prot-a-2254,Placenta growth factor,placenta growth factor measurement,EFO:0010626,http://www.ebi.ac.uk/efo/EFO_0010626,0.902,None
prot-a-2923,Tumor-associated calcium signal transducer 2,tumor-associated calcium signal transducer 2 measurement,EFO:0020817,http://www.ebi.ac.uk/efo/EFO_0020817,0.865,None
prot-a-275,Basigin,basigin measurement,EFO:0020176,http://www.ebi.ac.uk/efo/EFO_0020176,0.798,None
prot-a-482,Cadherin-15,cadherin-15 measurement,EFO:0020211,http://www.ebi.ac.uk/efo/EFO_0020211,0.64,None
ebi-a-GCST001837,Intelligence (childhood),childhood cancer,EFO:1000654,http://www.ebi.ac.uk/efo/EFO_1000654,0.675,None
ebi-a-GCST90012070,Matrix metalloproteinase-12 levels,matrix metalloproteinase 12 measurement,EFO:0010590,http://www.ebi.ac.uk/efo/EFO_0010590,0.841,None
prot-a-997,Protein EVI2B,protein EVI2B measurement,EFO:0801943,http://www.ebi.ac.uk/efo/EFO_0801943,0.904,None
prot-a-2447,Receptor-type tyrosine-protein phosphatase R,tyrosine-protein phosphatase non-receptor type 1 measurement,EFO:0020834,http://www.ebi.ac.uk/efo/EFO_0020834,0.76,None
prot-a-3133,PolyUbiquitin K48-linked,polyUbiquitin K48-linked measurement,EFO:0022007,http://www.ebi.ac.uk/efo/EFO_0022007,0.793,None
prot-c-2429_27_4,C8,type II complement component 8 deficiency,MONDO:0013421,http://purl.obolibrary.org/obo/MONDO_0013421,0.649,None
prot-c-2523_31_3,RANTES,CCL5 measurement,EFO:0005117,http://www.ebi.ac.uk/efo/EFO_0005117,0.993,None
prot-a-88,Protein amnionless,protein amnionless measurement,EFO:0020667,http://www.ebi.ac.uk/efo/EFO_0020667,0.902,None
ubm-a-2684,volume Right-Accumbens-area,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.682,None
prot-a-935,ER membrane protein complex subunit 1,ER membrane protein complex subunit 1 measurement,EFO:0801579,http://www.ebi.ac.uk/efo/EFO_0801579,0.929,None
prot-a-1667,Kallikrein-8,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.772,None
ukb-b-20447,Iron,iron metabolism disease,MONDO:0002279,http://purl.obolibrary.org/obo/MONDO_0002279,0.748,None
ebi-a-GCST90010253,Myeloblastin levels,myeloblastin measurement,EFO:0020585,http://www.ebi.ac.uk/efo/EFO_0020585,0.726,None
prot-a-1948,Mesothelin,mesothelin measurement,EFO:0020565,http://www.ebi.ac.uk/efo/EFO_0020565,0.838,None
prot-a-1891,MAX gene-associated protein,MAX gene-associated protein measurement,EFO:0801790,http://www.ebi.ac.uk/efo/EFO_0801790,0.79,None
prot-a-3049,Tumor necrosis factor receptor superfamily member 21,tumor necrosis factor receptor superfamily member 21 measurement,EFO:0020810,http://www.ebi.ac.uk/efo/EFO_0020810,0.947,None
met-a-357,Biliverdin,biliverdin measurement,EFO:0021033,http://www.ebi.ac.uk/efo/EFO_0021033,0.826,None
prot-b-63,heparin binding EGF like growth factor,heparin-binding egf-like growth factor measurement,EFO:0020438,http://www.ebi.ac.uk/efo/EFO_0020438,0.757,None
prot-a-660,Cysteine-rich motor neuron 1 protein,cysteine-rich motor neuron 1 protein measurement,EFO:0802446,http://www.ebi.ac.uk/efo/EFO_0802446,0.817,None
ebi-a-GCST005848,Heart rate response to recovery post exercise (50 sec),heart rate response to recovery post exercise,EFO:0009185,http://www.ebi.ac.uk/efo/EFO_0009185,0.912,None
prot-a-3098,Triggering receptor expressed on myeloid cells 1,triggering receptor expressed on myeloid cells 1 measurement,EFO:0802161,http://www.ebi.ac.uk/efo/EFO_0802161,0.922,None
ebi-a-GCST90002339,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
ebi-a-GCST008037,Low density lipoprotein cholesterol levels,low density lipoprotein cholesterol measurement,EFO:0004611,http://www.ebi.ac.uk/efo/EFO_0004611,0.862,None
prot-a-1155,"Alpha-(1,3)-fucosyltransferase 9",fucosyltransferase 6 deficiency,MONDO:0013462,http://purl.obolibrary.org/obo/MONDO_0013462,0.737,None
ukb-a-319,Age at first live birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.827,None
prot-c-3034_1_2,GFAP,Familial adenomatous polyposis,ORPHANET.ORDO:733,http://www.orpha.net/ORDO/Orphanet_733,0.605,None
prot-a-1850,Mitogen-activated protein kinase 9,mitogen-activated protein kinase 9 measurement,EFO:0020581,http://www.ebi.ac.uk/efo/EFO_0020581,0.807,None
prot-a-3214,Vitronectin,vitronectin measurement,EFO:0021843,http://www.ebi.ac.uk/efo/EFO_0021843,0.829,None
prot-a-1502,Interleukin-1 receptor-like 1,interleukin 1 receptor-like 1 measurement,EFO:0008168,http://www.ebi.ac.uk/efo/EFO_0008168,0.816,None
prot-b-51,cathepsin D,cathepsin D measurement,EFO:0010611,http://www.ebi.ac.uk/efo/EFO_0010611,0.835,None
ukb-a-350,Duration of other exercises,exercise,EFO:0000483,http://www.ebi.ac.uk/efo/EFO_0000483,0.756,None
prot-a-2558,Ribonuclease H1,ribonuclease H1 measurement,EFO:0022020,http://www.ebi.ac.uk/efo/EFO_0022020,0.914,None
ebi-a-GCST90012080,Follistatin levels,follistatin measurement,EFO:0010614,http://www.ebi.ac.uk/efo/EFO_0010614,0.711,None
ebi-a-GCST90010321,Kynurenine-oxoglutarate transaminase 1 levels,kynurenine--oxoglutarate transaminase 3 measurement,EFO:0801752,http://www.ebi.ac.uk/efo/EFO_0801752,0.764,None
prot-c-2668_70_2,Calpain I,calpain I measurement,EFO:0008064,http://www.ebi.ac.uk/efo/EFO_0008064,0.837,None
met-d-S_LDL_C,Cholesterol in small LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.881,None
ebi-a-GCST90002233,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-2049,Nidogen-1,nidogen-1 measurement,EFO:0008249,http://www.ebi.ac.uk/efo/EFO_0008249,0.645,None
prot-a-1733,Leucine-rich repeat LGI family member 3,leucine-rich repeat LGI family member 3 measurement,EFO:0802694,http://www.ebi.ac.uk/efo/EFO_0802694,0.873,None
prot-a-401,C-C motif chemokine 24,CCL24 measurement,EFO:0009418,http://www.ebi.ac.uk/efo/EFO_0009418,0.751,None
ebi-a-GCST90000026,Appendicular lean mass,appendicular lean mass,EFO:0004980,http://www.ebi.ac.uk/efo/EFO_0004980,0.99,None
prot-a-1790,Leucine-rich repeat-containing protein 74A,leucine-rich repeat-containing protein 74A measurement,EFO:0801763,http://www.ebi.ac.uk/efo/EFO_0801763,0.816,None
ieu-b-4842,HbA1c,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.997,None
prot-a-2010,Nucleolin,nucleolin measurement,EFO:0801856,http://www.ebi.ac.uk/efo/EFO_0801856,0.839,None
prot-a-848,DnaJ homolog subfamily C member 27,DnaJ homolog subfamily C member 27 measurement,EFO:0802491,http://www.ebi.ac.uk/efo/EFO_0802491,0.95,None
prot-a-2998,Transmembrane protein 132B,transmembrane protein 132B measurement,EFO:0802151,http://www.ebi.ac.uk/efo/EFO_0802151,0.933,None
ebi-a-GCST90000498,Transforming growth factor-alpha levels,transforming growth factor-alpha measurement,EFO:0010798,http://www.ebi.ac.uk/efo/EFO_0010798,0.769,None
prot-a-888,Tumor necrosis factor receptor superfamily member EDAR,tumor necrosis factor receptor superfamily member EDAR measurement,EFO:0008310,http://www.ebi.ac.uk/efo/EFO_0008310,0.947,None
prot-a-1125,Leucine-rich repeat transmembrane protein FLRT3,leucine-rich repeat transmembrane protein FLRT3 measurement,EFO:0021861,http://www.ebi.ac.uk/efo/EFO_0021861,0.903,None
prot-c-2833_20_1,Kallikrein 4,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.782,None
ebi-a-GCST007432,FEV1,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.988,None
prot-c-5489_18_3,Stress-induced-phosphoprotein 1,stress-induced-phosphoprotein 1 measurement,EFO:0020755,http://www.ebi.ac.uk/efo/EFO_0020755,0.73,None
prot-a-2061,Normal mucosa of esophagus-specific gene 1 protein,normal mucosa of esophagus-specific gene 1 protein measurement,EFO:0801846,http://www.ebi.ac.uk/efo/EFO_0801846,0.86,None
prot-c-5358_3_3,OMD,occult macular dystrophy,MONDO:0013316,http://purl.obolibrary.org/obo/MONDO_0013316,0.998,None
met-c-918,Phosphatidylcholine and other cholines,phosphatidylcholine measurement,EFO:0010226,http://www.ebi.ac.uk/efo/EFO_0010226,0.839,None
met-c-943,Cholesterol esters in very large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.862,None
met-d-S_HDL_TG,Triglycerides in small HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.901,None
met-a-625,10-heptadecenoate (17:1n7),10-heptadecenoate 17:1n7 measurement,EFO:0021060,http://www.ebi.ac.uk/efo/EFO_0021060,0.661,None
prot-a-811,Diacylglycerol kinase beta,diacylglycerol kinase beta measurement,EFO:0801525,http://www.ebi.ac.uk/efo/EFO_0801525,0.917,None
prot-a-1716,L-lactate dehydrogenase C chain,L lactate dehydrogenase measurement,EFO:0004808,http://www.ebi.ac.uk/efo/EFO_0004808,0.782,None
ebi-a-GCST008403,Arterial stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.87,None
prot-a-1631,UPF0577 protein KIAA1324,UPF0577 protein KIAA1324 measurement,EFO:0803235,http://www.ebi.ac.uk/efo/EFO_0803235,0.958,None
prot-a-1350,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related measurement,EFO:0803114,http://www.ebi.ac.uk/efo/EFO_0803114,0.776,None
prot-a-2608,Retbindin,retbindin measurement,EFO:0803009,http://www.ebi.ac.uk/efo/EFO_0803009,0.88,None
ebi-a-GCST90001474,Plasmacytoid Dendritic Cell %Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.872,None
ieu-a-1033,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
prot-a-1804,Leukotriene A-4 hydrolase,leukotriene a-4 hydrolase measurement,EFO:0020535,http://www.ebi.ac.uk/efo/EFO_0020535,0.73,None
met-d-non_HDL_C,Total cholesterol minus HDL-C,total cholesterol in IDL,EFO:0022184,http://www.ebi.ac.uk/efo/EFO_0022184,0.662,None
prot-a-1564,Insulin receptor,insulin receptor measurement,EFO:0008160,http://www.ebi.ac.uk/efo/EFO_0008160,0.859,None
met-a-658,X-12776,X-12776 measurement,EFO:0021333,http://www.ebi.ac.uk/efo/EFO_0021333,0.709,None
met-a-445,1-linoleoylglycerol (1-monolinolein),1-linoleoylglycerol 1-monolinolein measurement,EFO:0021108,http://www.ebi.ac.uk/efo/EFO_0021108,0.796,None
met-d-M_HDL_PL,Phospholipids in medium HDL,phospholipids in medium LDL measurement,EFO:0022183,http://www.ebi.ac.uk/efo/EFO_0022183,0.783,None
met-c-935,Sphingomyelins,sphingomyelin measurement,EFO:0010118,http://www.ebi.ac.uk/efo/EFO_0010118,0.803,None
prot-a-503,Carcinoembryonic antigen-related cell adhesion molecule 21,carcinoembryonic antigen-related cell adhesion molecule 21 measurement,EFO:0802369,http://www.ebi.ac.uk/efo/EFO_0802369,0.905,None
ieu-b-4860,Physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.995,None
prot-a-2407,Pregnancy-specific beta-1-glycoprotein 8,pregnancy-specific beta-1-glycoprotein 8 measurement,EFO:0802898,http://www.ebi.ac.uk/efo/EFO_0802898,0.695,None
prot-c-4330_4_2,PSA,psoriatic arthritis,EFO:0003778,http://www.ebi.ac.uk/efo/EFO_0003778,0.995,None
ebi-a-GCST90001602,Lymphocyte %leukocyte,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.81,None
met-a-324,Threonine,threonine measurement,EFO:0009775,http://www.ebi.ac.uk/efo/EFO_0009775,0.831,None
prot-a-420,CD177 antigen,cD177 antigen measurement,EFO:0021866,http://www.ebi.ac.uk/efo/EFO_0021866,0.894,None
ieu-b-4808,25 hydroxyvitamin D level,25-hydroxyvitamin D2 measurement,EFO:0803356,http://www.ebi.ac.uk/efo/EFO_0803356,0.612,None
prot-a-2397,Proactivator polypeptide-like 1,proactivator polypeptide-like 1 measurement,EFO:0801912,http://www.ebi.ac.uk/efo/EFO_0801912,0.83,None
prot-a-32,A disintegrin and metalloproteinase with thrombospondin motifs 13,a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement,EFO:0008011,http://www.ebi.ac.uk/efo/EFO_0008011,0.944,None
prot-a-1281,"GrpE protein homolog 1, mitochondrial","grpE protein homolog 1, mitochondrial measurement",EFO:0802581,http://www.ebi.ac.uk/efo/EFO_0802581,0.871,None
met-c-913,Concentration of medium VLDL particles,concentration of medium VLDL particles,EFO:0022152,http://www.ebi.ac.uk/efo/EFO_0022152,0.987,None
prot-a-2869,Signal transducer and activator of transcription 3,signal transducer and activator of transcription 3 measurement,EFO:0021907,http://www.ebi.ac.uk/efo/EFO_0021907,0.941,None
ukb-b-2053,Health satisfaction,health satisfaction measurement,EFO:0009724,http://www.ebi.ac.uk/efo/EFO_0009724,0.907,None
prot-a-201,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,sarcoplasmic/endoplasmic reticulum calcium ATPase 3 measurement,EFO:0802036,http://www.ebi.ac.uk/efo/EFO_0802036,0.869,None
prot-a-742,Growth-regulated alpha protein,growth-regulated alpha protein measurement,EFO:0008146,http://www.ebi.ac.uk/efo/EFO_0008146,0.81,None
ieu-b-35,C-Reactive protein level,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.792,None
prot-a-539,Secretogranin-1,secretogranin-1 measurement,EFO:0803047,http://www.ebi.ac.uk/efo/EFO_0803047,0.749,None
met-a-390,X-04494,X-04494 measurement,EFO:0021190,http://www.ebi.ac.uk/efo/EFO_0021190,0.674,None
met-d-XL_VLDL_FC,Free cholesterol in very large VLDL,free cholesterol in large LDL measurement,EFO:0022176,http://www.ebi.ac.uk/efo/EFO_0022176,0.76,None
prot-a-1230,Glucosamine-6-phosphate isomerase 1,glucosamine-6-phosphate isomerase 1 measurement,EFO:0801627,http://www.ebi.ac.uk/efo/EFO_0801627,0.737,None
prot-a-1194,Growth/differentiation factor 11/8,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.794,None
prot-a-979,Endoplasmic reticulum lectin 1,endoplasmic reticulum lectin 1 measurement,EFO:0801567,http://www.ebi.ac.uk/efo/EFO_0801567,0.91,None
ebi-a-GCST90001578,Transitional B cell %lymphocyte,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.604,None
met-c-883,Total lipids in large LDL,total lipids in large LDL,EFO:0022163,http://www.ebi.ac.uk/efo/EFO_0022163,0.971,None
prot-a-1038,Protein FAM189A2,protein FAM189A2 measurement,EFO:0801949,http://www.ebi.ac.uk/efo/EFO_0801949,0.928,None
prot-a-1746,Leukocyte immunoglobulin-like receptor subfamily B member 4,leukocyte immunoglobulin-like receptor subfamily B member 4 measurement,EFO:0801768,http://www.ebi.ac.uk/efo/EFO_0801768,0.921,None
prot-a-871,E3 ubiquitin-protein ligase DTX1,E3 ubiquitin-protein ligase DTX1 measurement,EFO:0802503,http://www.ebi.ac.uk/efo/EFO_0802503,0.899,None
prot-a-3036,Tumor necrosis factor receptor superfamily member 11A,tumor necrosis factor receptor superfamily member 11A measurement,EFO:0020800,http://www.ebi.ac.uk/efo/EFO_0020800,0.948,None
ebi-a-GCST008045,Total cholesterol levels,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.987,None
prot-c-2771_35_2,IGFBP-1,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.629,None
prot-b-32,resistin,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.727,None
prot-c-2580_83_2,Myeloperoxidase,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.875,None
prot-a-779,Probable ATP-dependent RNA helicase DDX58,probable ATP-dependent RNA helicase DDX58 measurement,EFO:0801913,http://www.ebi.ac.uk/efo/EFO_0801913,0.876,None
prot-a-1314,Heparin-binding EGF-like growth factor,heparin-binding egf-like growth factor measurement,EFO:0020438,http://www.ebi.ac.uk/efo/EFO_0020438,0.757,None
prot-a-1554,Inhibin beta A chain:Inhibin beta B chain heterodimer,inhibin beta A chain:inhibin beta B chain heterodimer measurement,EFO:0020470,http://www.ebi.ac.uk/efo/EFO_0020470,0.9,None
prot-a-2884,Syntaxin-18,syntaxin-18 measurement,EFO:0803124,http://www.ebi.ac.uk/efo/EFO_0803124,0.616,None
prot-a-2258,Phosphoglucomutase-1,Glycogen storage disease due to phosphoglucomutase deficiency,ORPHANET.ORDO:711,http://www.orpha.net/ORDO/Orphanet_711,0.889,None
met-a-378,Acetylphosphate,acetylphosphate measurement,EFO:0021035,http://www.ebi.ac.uk/efo/EFO_0021035,0.885,None
prot-a-2579,Roundabout homolog 3,roundabout homolog 3 measurement,EFO:0020714,http://www.ebi.ac.uk/efo/EFO_0020714,0.921,None
prot-a-1640,Killer cell immunoglobulin-like receptor 2DL2,killer cell immunoglobulin-like receptor 2DL2 measurement,EFO:0801744,http://www.ebi.ac.uk/efo/EFO_0801744,0.909,None
ebi-a-GCST90010228,Interleukin-2 receptor subunit alpha levels,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.839,None
prot-a-836,DnaJ homolog subfamily B member 11,DnaJ homolog subfamily B member 11 measurement,EFO:0801537,http://www.ebi.ac.uk/efo/EFO_0801537,0.948,None
ebi-a-GCST90012046,P-selectin glycoprotein ligand 1 levels,P-selectin glycoprotein ligand 1 measurement,EFO:0010922,http://www.ebi.ac.uk/efo/EFO_0010922,0.709,None
ukb-d-30650_raw,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
ebi-a-GCST90012050,Matrix metalloproteinase-10 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.836,None
ebi-a-GCST90010332,Neuronal pentraxin receptor levels,neuronal pentraxin-1 measurement,EFO:0801833,http://www.ebi.ac.uk/efo/EFO_0801833,0.617,None
prot-a-598,UMP-CMP kinase,UMP-CMP kinase measurement,EFO:0008313,http://www.ebi.ac.uk/efo/EFO_0008313,0.681,None
ebi-a-GCST90012035,Tumor necrosis factor receptor superfamily member 6 levels,tumor necrosis factor receptor superfamily member 6 measurement,EFO:0010610,http://www.ebi.ac.uk/efo/EFO_0010610,0.902,None
prot-a-2962,Transforming growth factor beta-1,transforming growth factor beta measurement,EFO:0004818,http://www.ebi.ac.uk/efo/EFO_0004818,0.915,None
prot-a-1377,Heparan sulfate glucosamine 3-O-sulfotransferase 4,heparan sulfate glucosamine 3-O-sulfotransferase 4 measurement,EFO:0802593,http://www.ebi.ac.uk/efo/EFO_0802593,0.836,None
prot-a-2052,Nischarin,nischarin measurement,EFO:0801841,http://www.ebi.ac.uk/efo/EFO_0801841,0.828,None
prot-a-3159,NKG2D ligand 1,NKG2D ligand 1 measurement,EFO:0802814,http://www.ebi.ac.uk/efo/EFO_0802814,0.909,None
met-a-683,X-13429,X-13429 measurement,EFO:0021348,http://www.ebi.ac.uk/efo/EFO_0021348,0.702,None
ebi-a-GCST004617,Eosinophil percentage of granulocytes,eosinophil percentage of granulocytes,EFO:0007996,http://www.ebi.ac.uk/efo/EFO_0007996,0.992,None
prot-a-2286,"Phospholipase A2, membrane associated","phospholipase A2, membrane associated measurement",EFO:0008259,http://www.ebi.ac.uk/efo/EFO_0008259,0.837,None
ukb-a-17,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
prot-a-345,Neuron-specific vesicular protein calcyon,neuron-specific vesicular protein calcyon measurement,EFO:0802805,http://www.ebi.ac.uk/efo/EFO_0802805,0.876,None
prot-a-2641,Scavenger receptor class F member 2,scavenger receptor class F member 2 measurement,EFO:0020716,http://www.ebi.ac.uk/efo/EFO_0020716,0.937,None
prot-c-3373_5_2,Granzyme H,granzyme h measurement,EFO:0020419,http://www.ebi.ac.uk/efo/EFO_0020419,0.874,None
ukb-b-7217,3mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
met-d-XL_VLDL_C,Cholesterol in very large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.822,None
met-a-586,Eicosenoate (20:1n9 or 11),eicosenoate 20:1n9 or 11 measurement,EFO:0021065,http://www.ebi.ac.uk/efo/EFO_0021065,0.755,None
ebi-a-GCST90012114,Total testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.868,None
prot-a-708,Di-N-acetylchitobiase,di-N-acetylchitobiase measurement,EFO:0801524,http://www.ebi.ac.uk/efo/EFO_0801524,0.659,None
met-c-866,Histidine,histidinemia,MONDO:0009345,http://purl.obolibrary.org/obo/MONDO_0009345,0.827,None
prot-a-445,T-cell surface glycoprotein CD3 epsilon chain,T-cell surface glycoprotein CD3 epsilon chain measurement,EFO:0802114,http://www.ebi.ac.uk/efo/EFO_0802114,0.881,None
prot-a-1120,Filamin-A,myofibrillar myopathy 5,MONDO:0012289,http://purl.obolibrary.org/obo/MONDO_0012289,0.697,None
prot-a-396,C-C motif chemokine 20,C-C motif chemokine 20 measurement,EFO:0010910,http://www.ebi.ac.uk/efo/EFO_0010910,0.705,None
met-b-155,CD27 on CD4 T,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.658,None
prot-a-1168,Polypeptide N-acetylgalactosaminyltransferase 11,polypeptide N-acetylgalactosaminyltransferase 11 measurement,EFO:0802883,http://www.ebi.ac.uk/efo/EFO_0802883,0.89,None
met-b-161,CD3 on 127+DN T,liver dysplastic nodule,EFO:0007834,http://www.ebi.ac.uk/efo/EFO_0007834,0.608,None
prot-b-65,vascular endothelial growth factor D,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.968,None
prot-a-2763,Sodium- and chloride-dependent glycine transporter 1,sodium- and chloride-dependent glycine transporter 1 measurement,EFO:0803086,http://www.ebi.ac.uk/efo/EFO_0803086,0.818,None
prot-a-522,Complement factor H-related protein 5,complement factor H-related protein 5 measurement,EFO:0008098,http://www.ebi.ac.uk/efo/EFO_0008098,0.785,None
ebi-a-GCST001791,Urate levels,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.988,None
ieu-a-59,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-c-3606_2_1,Discoidin domain receptor 2,discoidin domain-containing receptor 2 measurement,EFO:0020327,http://www.ebi.ac.uk/efo/EFO_0020327,0.749,None
ebi-a-GCST90010346,Sialic acid-binding Ig-like lectin 7 levels,sialic acid-binding ig-like lectin 7 measurement,EFO:0020739,http://www.ebi.ac.uk/efo/EFO_0020739,0.638,None
prot-c-5034_79_1,Trypsin 2,trypsin-1 measurement,EFO:0020790,http://www.ebi.ac.uk/efo/EFO_0020790,0.682,None
ukb-a-317,Number of live births,number of stillbirths,EFO:0009722,http://www.ebi.ac.uk/efo/EFO_0009722,0.744,None
prot-a-239,Bcl-2-like protein 2,bcl-2-like protein 2 measurement,EFO:0021928,http://www.ebi.ac.uk/efo/EFO_0021928,0.618,None
prot-a-2475,Ras-related protein Rab-27B,ras-related protein Rab-27B measurement,EFO:0802993,http://www.ebi.ac.uk/efo/EFO_0802993,0.646,None
ieu-b-113,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-801,Beta-defensin 134,beta-defensin 134 measurement,EFO:0802327,http://www.ebi.ac.uk/efo/EFO_0802327,0.77,None
ubm-a-1158,NET100 0002,C1 100080002,EFO:0009494,http://www.ebi.ac.uk/efo/EFO_0009494,0.681,None
ebi-a-GCST001212,Proinsulin levels,insulin measurement,EFO:0004467,http://www.ebi.ac.uk/efo/EFO_0004467,0.727,None
met-c-948,Triglycerides in very large HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.68,None
prot-a-934,Engulfment and cell motility protein 1,engulfment and cell motility protein 1 measurement,EFO:0802522,http://www.ebi.ac.uk/efo/EFO_0802522,0.925,None
prot-a-1115,Inactive peptidyl-prolyl cis-trans isomerase FKBP6,inactive peptidyl-prolyl cis-trans isomerase FKBP6 measurement,EFO:0801694,http://www.ebi.ac.uk/efo/EFO_0801694,0.852,None
met-a-392,X-04498,X-04498 measurement,EFO:0021192,http://www.ebi.ac.uk/efo/EFO_0021192,0.674,None
ebi-a-GCST90011999,Placenta growth factor levels,placenta growth factor measurement,EFO:0010626,http://www.ebi.ac.uk/efo/EFO_0010626,0.81,None
prot-a-2753,Zinc transporter 3,zinc transporter 3 measurement,EFO:0803287,http://www.ebi.ac.uk/efo/EFO_0803287,0.9,None
ebi-a-GCST90010102,Angiotensin-converting enzyme 2 levels,angiotensin-converting enzyme 2 measurement,EFO:0020150,http://www.ebi.ac.uk/efo/EFO_0020150,0.813,None
ieu-a-61,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
ukb-b-4874,6mm asymmetry angle (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.602,None
ukb-d-4012_irnt,"Age deep-vein thrombosis (DVT, blood clot in leg) diagnosed",deep vein thrombosis,EFO:0003907,http://www.ebi.ac.uk/efo/EFO_0003907,0.649,None
prot-a-2873,Stanniocalcin-1,stanniocalcin-1 measurement,EFO:0020753,http://www.ebi.ac.uk/efo/EFO_0020753,0.763,None
met-a-394,X-04500,X-04500 measurement,EFO:0021194,http://www.ebi.ac.uk/efo/EFO_0021194,0.623,None
ukb-d-30670_irnt,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
prot-a-1103,Fibroblast growth factor receptor 3,fibroblast growth factor receptor 3 measurement,EFO:0020390,http://www.ebi.ac.uk/efo/EFO_0020390,0.929,None
ebi-a-GCST006344,Anti-cytomegalovirus IgG levels,Anti-cytomegalovirus IgG measurement,EFO:0009347,http://www.ebi.ac.uk/efo/EFO_0009347,0.734,None
ukb-a-13,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
ieu-b-4904,Anti-Influenza virus subtype H3N2 IgG levels,anti-influenza A subtype H3N2 IgG measurement,EFO:0801090,http://www.ebi.ac.uk/efo/EFO_0801090,0.792,None
ebi-a-GCST90000447,CCL28 levels,CCL28 measurement,EFO:0010769,http://www.ebi.ac.uk/efo/EFO_0010769,0.758,None
prot-a-3091,Tryptase gamma,tryptase gamma measurement,EFO:0020792,http://www.ebi.ac.uk/efo/EFO_0020792,0.878,None
prot-a-1653,Kit ligand,kit ligand measurement,EFO:0010612,http://www.ebi.ac.uk/efo/EFO_0010612,0.833,None
prot-a-1356,"Hydroxymethylglutaryl-CoA synthase, mitochondrial","hydroxymethylglutaryl-CoA synthase, mitochondrial measurement",EFO:0802615,http://www.ebi.ac.uk/efo/EFO_0802615,0.87,None
prot-a-2898,SUN domain-containing protein 3,SUN domain-containing protein 3 measurement,EFO:0802102,http://www.ebi.ac.uk/efo/EFO_0802102,0.861,None
prot-a-2372,Glucosidase 2 subunit beta,glucosidase 2 subunit beta measurement,EFO:0801628,http://www.ebi.ac.uk/efo/EFO_0801628,0.916,None
prot-a-477,CUB domain-containing protein 1,CUB domain containing protein 1 measurement,EFO:0010776,http://www.ebi.ac.uk/efo/EFO_0010776,0.928,None
met-c-914,Phospholipids in medium VLDL,phospholipids in medium VLDL measurement,EFO:0022154,http://www.ebi.ac.uk/efo/EFO_0022154,0.92,None
prot-a-1830,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2","membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 measurement",EFO:0802739,http://www.ebi.ac.uk/efo/EFO_0802739,0.88,None
prot-c-4249_64_2,NDP kinase B,nucleoside diphosphate kinase A measurement,EFO:0009947,http://www.ebi.ac.uk/efo/EFO_0009947,0.788,None
ieu-a-2,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
ieu-a-1088,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
prot-a-2267,PILR alpha-associated neural protein,PILR alpha-associated neural protein measurement,EFO:0021941,http://www.ebi.ac.uk/efo/EFO_0021941,0.838,None
ebi-a-GCST90012021,TNF-related apoptosis-inducing ligand receptor 2 levels,TNF-related apoptosis-inducing ligand receptor 2 measurement,EFO:0010930,http://www.ebi.ac.uk/efo/EFO_0010930,0.768,None
prot-a-686,Granulocyte colony-stimulating factor receptor,granulocyte colony-stimulating factor receptor measurement,EFO:0020416,http://www.ebi.ac.uk/efo/EFO_0020416,0.84,None
ebi-a-GCST90000457,CX3CL1 levels,CX3CL1 measurement,EFO:0009419,http://www.ebi.ac.uk/efo/EFO_0009419,0.818,None
prot-a-504,Carcinoembryonic antigen-related cell adhesion molecule 4,carcinoembryonic antigen-related cell adhesion molecule 4 measurement,EFO:0802370,http://www.ebi.ac.uk/efo/EFO_0802370,0.901,None
met-d-XL_VLDL_CE_pct,Cholesteryl esters to total lipids ratio in very large VLDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.687,None
prot-a-874,Dual specificity protein phosphatase 15,dual specificity protein phosphatase 15 measurement,EFO:0802494,http://www.ebi.ac.uk/efo/EFO_0802494,0.932,None
met-b-255,CD8:%TM (2),targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.77,None
prot-a-1167,Polypeptide N-acetylgalactosaminyltransferase 10,polypeptide N-acetylgalactosaminyltransferase 10 measurement,EFO:0802882,http://www.ebi.ac.uk/efo/EFO_0802882,0.888,None
ebi-a-GCST90001919,CD45 on Natural Killer T,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.625,None
ebi-a-GCST90001585,CD14+ CD16+ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.629,None
bbj-a-13,Creatine kinase,creatine kinase measurement,EFO:0004534,http://www.ebi.ac.uk/efo/EFO_0004534,0.841,None
prot-a-200,Sodium/potassium-transporting ATPase subunit beta-2,potassium-transporting ATPase subunit beta measurement,EFO:0801903,http://www.ebi.ac.uk/efo/EFO_0801903,0.765,None
prot-a-268,BPI fold-containing family B member 1,BPI fold-containing family B member 1 measurement,EFO:0801429,http://www.ebi.ac.uk/efo/EFO_0801429,0.857,None
prot-a-1826,Mucosal addressin cell adhesion molecule 1,mucosal addressin cell adhesion molecule 1 measurement,EFO:0802759,http://www.ebi.ac.uk/efo/EFO_0802759,0.941,None
prot-a-1280,Gastrin-releasing peptide,gastrin-releasing peptide measurement,EFO:0022000,http://www.ebi.ac.uk/efo/EFO_0022000,0.824,None
ukb-d-30800_raw,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
prot-a-2399,PH and SEC7 domain-containing protein 2,PH and SEC7 domain-containing protein 2 measurement,EFO:0803295,http://www.ebi.ac.uk/efo/EFO_0803295,0.865,None
prot-a-1774,Lymphoid-restricted membrane protein,lymphoid-restricted membrane protein measurement,EFO:0802716,http://www.ebi.ac.uk/efo/EFO_0802716,0.839,None
ebi-a-GCST90001587,CD16+ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.692,None
met-a-585,X-12116,X-12116 measurement,EFO:0021289,http://www.ebi.ac.uk/efo/EFO_0021289,0.678,None
ebi-a-GCST90010289,Soluble calcium-activated nucleotidase 1 levels,soluble calcium-activated nucleotidase 1 measurement,EFO:0803089,http://www.ebi.ac.uk/efo/EFO_0803089,0.823,None
prot-a-1952,Macrophage scavenger receptor types I and II,macrophage scavenger receptor types I and II measurement,EFO:0008222,http://www.ebi.ac.uk/efo/EFO_0008222,0.914,None
ieu-b-4830,Waist-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.784,None
prot-a-1855,Mannan-binding lectin serine protease 1,mannan-binding lectin serine protease 1 measurement,EFO:0008223,http://www.ebi.ac.uk/efo/EFO_0008223,0.821,None
prot-a-3122,Thioredoxin domain-containing protein 11,thioredoxin domain-containing protein 11 measurement,EFO:0803147,http://www.ebi.ac.uk/efo/EFO_0803147,0.895,None
prot-a-759,Cytohesin-2,cytohesin-2 measurement,EFO:0801517,http://www.ebi.ac.uk/efo/EFO_0801517,0.72,None
met-a-401,Gamma-glutamylleucine,gamma-glutamylleucine measurement,EFO:0021140,http://www.ebi.ac.uk/efo/EFO_0021140,0.795,None
ebi-a-GCST90011774,Capecitabine drug response (AUC),response to fluoropyrimidines,EFO:0010825,http://www.ebi.ac.uk/efo/EFO_0010825,0.766,None
prot-a-5,Monoacylglycerol lipase ABHD12,monoacylglycerol lipase ABHD12 measurement,EFO:0802754,http://www.ebi.ac.uk/efo/EFO_0802754,0.949,None
prot-c-3709_4_2,ALT,Atypical Lipomatous Tumor,EFO:1000099,http://www.ebi.ac.uk/efo/EFO_1000099,0.999,None
ieu-a-80,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ebi-a-GCST006351,Anti-measles virus IgG levels,Anti-measles virus IgG measurement,EFO:0009355,http://www.ebi.ac.uk/efo/EFO_0009355,0.736,None
prot-a-1997,"N-acetylglutamate synthase, mitochondrial","n-acetylglutamate synthase, mitochondrial measurement",EFO:0802776,http://www.ebi.ac.uk/efo/EFO_0802776,0.828,None
ebi-a-GCST90010282,Angiopoietin-related protein 1 levels,angiopoietin-related protein 1 measurement,EFO:0801382,http://www.ebi.ac.uk/efo/EFO_0801382,0.775,None
ebi-a-GCST004460,Eotaxin levels,eotaxin measurement,EFO:0008122,http://www.ebi.ac.uk/efo/EFO_0008122,0.707,None
met-a-716,X-14057,X-14057 measurement,EFO:0021362,http://www.ebi.ac.uk/efo/EFO_0021362,0.696,None
ieu-b-4900,Anti-Cytomegalovirus IgG levels,Anti-cytomegalovirus IgG measurement,EFO:0009347,http://www.ebi.ac.uk/efo/EFO_0009347,0.734,None
met-d-M_LDL_FC,Free cholesterol in medium LDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.791,None
prot-c-4907_56_1,D-dimer,D dimer measurement,EFO:0004507,http://www.ebi.ac.uk/efo/EFO_0004507,0.8,None
ebi-a-GCST90000473,Interleukin-12 subunit B levels,interleukin-12 subunit B measurement,EFO:0010787,http://www.ebi.ac.uk/efo/EFO_0010787,0.729,None
prot-a-1926,Adenylyltransferase and sulfurtransferase MOCS3,adenylyltransferase and sulfurtransferase MOCS3 measurement,EFO:0802257,http://www.ebi.ac.uk/efo/EFO_0802257,0.953,None
prot-a-3148,Ubiquitin domain-containing protein 2,ubiquitin domain-containing protein 2 measurement,EFO:0802180,http://www.ebi.ac.uk/efo/EFO_0802180,0.885,None
prot-a-185,Set1/Ash2 histone methyltransferase complex subunit ASH2,set1/Ash2 histone methyltransferase complex subunit ASH2 measurement,EFO:0803069,http://www.ebi.ac.uk/efo/EFO_0803069,0.874,None
prot-c-4294_16_2,Sphingosine kinase 1,sphingosine kinase 1 measurement,EFO:0020750,http://www.ebi.ac.uk/efo/EFO_0020750,0.885,None
prot-a-1282,GSK3-beta interaction protein,GSK3-beta interaction protein measurement,EFO:0802582,http://www.ebi.ac.uk/efo/EFO_0802582,0.736,None
ebi-a-GCST90014241,Forced vital capacity x sex interaction,vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.808,None
prot-c-4840_73_1,G-CSF,Abnormal cerebrospinal fluid morphology,HP:0002921,http://purl.obolibrary.org/obo/HP_0002921,0.625,None
ieu-b-103,HbA1C,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.997,None
prot-a-1660,Kallikrein-15,kallikrein-15 measurement,EFO:0802669,http://www.ebi.ac.uk/efo/EFO_0802669,0.745,None
prot-a-878,Segment polarity protein dishevelled homolog DVL-2,segment polarity protein dishevelled homolog DVL-2 measurement,EFO:0802044,http://www.ebi.ac.uk/efo/EFO_0802044,0.848,None
prot-c-5032_64_1,SSRP1,fact complex subunit ssrp1 measurement,EFO:0020371,http://www.ebi.ac.uk/efo/EFO_0020371,0.641,None
prot-a-1505,Interleukin-20,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.868,None
prot-a-2698,Pigment epithelium-derived factor,pigment epithelium-derived factor measurement,EFO:0021847,http://www.ebi.ac.uk/efo/EFO_0021847,0.825,None
prot-a-282,UPF0696 protein C11orf68,UPF0696 protein C11orf68 measurement,EFO:0802202,http://www.ebi.ac.uk/efo/EFO_0802202,0.962,None
prot-a-2389,Transmembrane gamma-carboxyglutamic acid protein 4,transmembrane gamma-carboxyglutamic acid protein 4 measurement,EFO:0803178,http://www.ebi.ac.uk/efo/EFO_0803178,0.892,None
prot-a-582,C-type lectin-like domain family 1,C-type lectin-like domain family 1 measurement,EFO:0802350,http://www.ebi.ac.uk/efo/EFO_0802350,0.7,None
prot-c-3073_51_2,IL-18 BPa,bisphenol A measurement,EFO:0801079,http://www.ebi.ac.uk/efo/EFO_0801079,0.633,None
ebi-a-GCST90010348,Sclerostin levels,sclerostin measurement,EFO:0010606,http://www.ebi.ac.uk/efo/EFO_0010606,0.67,None
met-a-635,X-12627,X-12627 measurement,EFO:0021317,http://www.ebi.ac.uk/efo/EFO_0021317,0.712,None
prot-a-1163,Gamma-aminobutyric acid type B receptor subunit 2,gamma-aminobutyric acid type B receptor subunit 2 measurement,EFO:0801615,http://www.ebi.ac.uk/efo/EFO_0801615,0.863,None
prot-a-2445,Receptor-type tyrosine-protein phosphatase H,receptor-type tyrosine-protein phosphatase H measurement,EFO:0801991,http://www.ebi.ac.uk/efo/EFO_0801991,0.767,None
prot-a-854,Dedicator of cytokinesis protein 9,dedicator of cytokinesis protein 9 measurement,EFO:0801521,http://www.ebi.ac.uk/efo/EFO_0801521,0.917,None
prot-a-2706,Splicing factor 1,splicing factor 1 measurement,EFO:0802085,http://www.ebi.ac.uk/efo/EFO_0802085,0.834,None
prot-a-394,C-C motif chemokine 17,CCL17 measurement,EFO:0009414,http://www.ebi.ac.uk/efo/EFO_0009414,0.742,None
prot-c-2795_23_3,"Alkaline phosphatase, bone",Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.84,None
ieu-a-67,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-b-31,matrix metallopeptidase 1,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.617,None
prot-a-1964,"Poly(A) RNA polymerase, mitochondrial","poly(A) RNA polymerase, mitochondrial measurement",EFO:0801893,http://www.ebi.ac.uk/efo/EFO_0801893,0.75,None
prot-a-2774,Structural maintenance of chromosomes protein 3,structural maintenance of chromosomes protein 3 measurement,EFO:0802096,http://www.ebi.ac.uk/efo/EFO_0802096,0.916,None
ebi-a-GCST90012008,Kallikrein-6 levels,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.688,None
met-d-L_VLDL_PL_pct,Phospholipids to total lipids ratio in large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.776,None
met-c-945,Total lipids in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.892,None
prot-c-3197_70_2,IDE,iDES,EFO:0008776,http://www.ebi.ac.uk/efo/EFO_0008776,0.601,None
met-d-XXL_VLDL_CE,Cholesteryl esters in chylomicrons and extremely large VLDL,cholesterol esters in large VLDL measurement,EFO:0022170,http://www.ebi.ac.uk/efo/EFO_0022170,0.617,None
ebi-a-GCST006679,insulin secretion rate (BMI adjusted),insulin secretion measurement,EFO:0008001,http://www.ebi.ac.uk/efo/EFO_0008001,0.636,None
ukb-b-12687,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
prot-a-3236,Lymphotactin,lymphotactin measurement,EFO:0008214,http://www.ebi.ac.uk/efo/EFO_0008214,0.852,None
prot-a-1687,Keratin-associated protein 2-4,keratin-associated protein 2-4 measurement,EFO:0801742,http://www.ebi.ac.uk/efo/EFO_0801742,0.656,None
prot-a-408,C-C motif chemokine 3-like 1,C-C motif chemokine 3-like 1 measurement,EFO:0008052,http://www.ebi.ac.uk/efo/EFO_0008052,0.636,None
prot-a-291,Uncharacterized protein C19orf18,uncharacterized protein C19orf18 measurement,EFO:0803225,http://www.ebi.ac.uk/efo/EFO_0803225,0.95,None
prot-a-580,C-type lectin domain family 6 member A,C-type lectin domain family 6 member A measurement,EFO:0802348,http://www.ebi.ac.uk/efo/EFO_0802348,0.797,None
ubm-a-2463,NET100 1307,GR1307,EFO:0004087,http://www.ebi.ac.uk/efo/EFO_0004087,0.601,None
prot-a-2818,Serine protease inhibitor Kazal-type 2,serine protease inhibitor Kazal-type 2 measurement,EFO:0802054,http://www.ebi.ac.uk/efo/EFO_0802054,0.863,None
ebi-a-GCST90010347,Synaptosomal-associated protein 23 levels,synaptosomal-associated protein 25 measurement,EFO:0021858,http://www.ebi.ac.uk/efo/EFO_0021858,0.658,None
prot-c-3873_51_2,TMA,trimethylaminuria,MONDO:0011182,http://purl.obolibrary.org/obo/MONDO_0011182,0.654,None
prot-a-2599,Cell differentiation protein RCD1 homolog,cell differentiation protein RCD1 homolog measurement,EFO:0802383,http://www.ebi.ac.uk/efo/EFO_0802383,0.935,None
prot-a-1393,Hyaluronidase-1,Hyaluronidase deficiency,ORPHANET.ORDO:67041,http://www.orpha.net/ORDO/Orphanet_67041,0.858,None
prot-a-368,Caveolin-2,Qualitative or quantitative defects of caveolin-3,ORPHANET.ORDO:207078,http://www.orpha.net/ORDO/Orphanet_207078,0.773,None
prot-a-3021,"Lamina-associated polypeptide 2, isoforms beta/gamma","lamina-associated polypeptide 2, isoforms beta/gamma measurement",EFO:0801754,http://www.ebi.ac.uk/efo/EFO_0801754,0.751,None
prot-c-3892_21_2,MED-1,multiple epiphyseal dysplasia,MONDO:0016648,http://purl.obolibrary.org/obo/MONDO_0016648,0.841,None
prot-a-1026,Membrane protein FAM159B,membrane protein FAM159B measurement,EFO:0802737,http://www.ebi.ac.uk/efo/EFO_0802737,0.939,None
prot-a-1917,Matrix metalloproteinase-17,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.88,None
ebi-a-GCST90007316,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-1368,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial","4-hydroxy-2-oxoglutarate aldolase, mitochondrial measurement",EFO:0802240,http://www.ebi.ac.uk/efo/EFO_0802240,0.696,None
prot-a-554,Carbohydrate sulfotransferase 1,carbohydrate sulfotransferase 1 measurement,EFO:0801447,http://www.ebi.ac.uk/efo/EFO_0801447,0.934,None
prot-b-73,leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
prot-a-1135,Glutamate carboxypeptidase 2,glutamate carboxypeptidase 2 measurement,EFO:0020408,http://www.ebi.ac.uk/efo/EFO_0020408,0.927,None
ukb-b-14166,Battered fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.622,None
prot-a-2130,Nuclear pore membrane glycoprotein 210-like,nuclear pore membrane glycoprotein 210-like measurement,EFO:0802821,http://www.ebi.ac.uk/efo/EFO_0802821,0.859,None
prot-a-1637,Kinesin-like protein KIF23,kinesin-like protein KIF23 measurement,EFO:0020522,http://www.ebi.ac.uk/efo/EFO_0020522,0.875,None
ieu-b-4856,FEV1/FVC,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.709,None
ebi-a-GCST90010114,SLAM family member 5 levels,SLAM family member 5 measurement,EFO:0020741,http://www.ebi.ac.uk/efo/EFO_0020741,0.819,None
ebi-a-GCST90002243,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-a-2103,Neurexin-1,neurexin-1 measurement,EFO:0801829,http://www.ebi.ac.uk/efo/EFO_0801829,0.692,None
prot-a-3108,Testis-specific serine/threonine-protein kinase 2,testis-specific serine/threonine-protein kinase 2 measurement,EFO:0803143,http://www.ebi.ac.uk/efo/EFO_0803143,0.72,None
ebi-a-GCST004630,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
prot-a-1777,"Low-density lipoprotein receptor-related protein 1, soluble","low-density lipoprotein receptor-related protein 1, soluble measurement",EFO:0801772,http://www.ebi.ac.uk/efo/EFO_0801772,0.802,None
ebi-a-GCST90012106,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.754,None
prot-c-5114_65_3,Prolactin Receptor,prolactin receptor measurement,EFO:0020656,http://www.ebi.ac.uk/efo/EFO_0020656,0.86,None
ukb-b-2729,Age heart attack diagnosed,myocardial infarction,EFO:0000612,http://www.ebi.ac.uk/efo/EFO_0000612,0.763,None
prot-c-2846_24_2,Ubiquitin+1,ubiquitin measurement,EFO:0020839,http://www.ebi.ac.uk/efo/EFO_0020839,0.842,None
prot-a-1082,Fc receptor-like protein 4,Fc receptor-like protein 4 measurement,EFO:0801599,http://www.ebi.ac.uk/efo/EFO_0801599,0.801,None
met-d-XL_VLDL_C_pct,Cholesterol to total lipids ratio in very large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.756,None
prot-a-447,CD40 ligand,CD40 ligand measurement,EFO:0004790,http://www.ebi.ac.uk/efo/EFO_0004790,0.865,None
prot-a-3169,Netrin receptor UNC5D,netrin receptor UNC5D measurement,EFO:0020591,http://www.ebi.ac.uk/efo/EFO_0020591,0.919,None
met-d-Omega_3,Omega-3 fatty acids,omega-3 polyunsaturated fatty acid measurement,EFO:0010119,http://www.ebi.ac.uk/efo/EFO_0010119,0.617,None
prot-c-4904_7_1,Caspase-2,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.673,None
ebi-a-GCST90000494,Sirtuin-2 levels,sirtuin-2 measurement,EFO:0010795,http://www.ebi.ac.uk/efo/EFO_0010795,0.621,None
met-a-430,Phenyllactate (PLA),phenyllactate measurement,EFO:0021511,http://www.ebi.ac.uk/efo/EFO_0021511,0.813,None
met-a-318,Allantoin,allantoin measurement,EFO:0010456,http://www.ebi.ac.uk/efo/EFO_0010456,0.809,None
prot-c-4957_1_2,40S ribosomal protein SA,40s ribosomal protein SA measurement,EFO:0020119,http://www.ebi.ac.uk/efo/EFO_0020119,0.906,None
ebi-a-GCST90002335,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
prot-a-2707,Splicing factor 3B subunit 4,splicing factor 3B subunit 4 measurement,EFO:0803100,http://www.ebi.ac.uk/efo/EFO_0803100,0.912,None
met-a-528,X-11529,X-11529 measurement,EFO:0021248,http://www.ebi.ac.uk/efo/EFO_0021248,0.71,None
prot-a-881,Dynein light chain Tctex-type 3,dynein light chain Tctex-type 3 measurement,EFO:0802497,http://www.ebi.ac.uk/efo/EFO_0802497,0.808,None
prot-a-552,Carbohydrate sulfotransferase 15,carbohydrate sulfotransferase 15 measurement,EFO:0008066,http://www.ebi.ac.uk/efo/EFO_0008066,0.939,None
prot-a-2441,Tyrosine-protein phosphatase non-receptor type 7,tyrosine-protein phosphatase non-receptor type 7 measurement,EFO:0802173,http://www.ebi.ac.uk/efo/EFO_0802173,0.81,None
bbj-a-38,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
prot-a-1639,DNA/RNA-binding protein KIN17,DNA/RNA-binding protein KIN17 measurement,EFO:0801536,http://www.ebi.ac.uk/efo/EFO_0801536,0.64,None
prot-a-2201,Protocadherin alpha-C2,protocadherin alpha-C2 measurement,EFO:0802971,http://www.ebi.ac.uk/efo/EFO_0802971,0.727,None
prot-a-1100,Fibroblast growth factor 8 isoform A,fibroblast growth factor 8 isoform A measurement,EFO:0020385,http://www.ebi.ac.uk/efo/EFO_0020385,0.934,None
prot-a-1288,Glutathione S-transferase omega-1,glutathione S-transferase omega-1 measurement,EFO:0801639,http://www.ebi.ac.uk/efo/EFO_0801639,0.704,None
prot-a-1686,"Keratin, type II cytoskeletal 7","keratin, type II cytoskeletal 7 measurement",EFO:0802675,http://www.ebi.ac.uk/efo/EFO_0802675,0.856,None
prot-a-2194,Protocadherin-10,protocadherin-10 measurement,EFO:0801978,http://www.ebi.ac.uk/efo/EFO_0801978,0.723,None
prot-c-3024_18_2,a2-Antiplasmin,alpha-2-plasmin inhibitor deficiency,MONDO:0009883,http://purl.obolibrary.org/obo/MONDO_0009883,0.695,None
prot-c-2753_2_2,C1q,C1Q deficiency,MONDO:0013343,http://purl.obolibrary.org/obo/MONDO_0013343,0.77,None
ukb-a-235,Forced expiratory volume in 1-second (FEV1)  predicted percentage,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.694,None
prot-a-387,Eotaxin,eotaxin measurement,EFO:0008122,http://www.ebi.ac.uk/efo/EFO_0008122,0.829,None
prot-a-331,Carbonic anhydrase 4,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.946,None
ubm-a-2683,volume Right-Amygdala,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.895,None
met-d-S_VLDL_FC_pct,Free cholesterol to total lipids ratio in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.742,None
prot-a-914,Histone-lysine N-methyltransferase EHMT2,histone-lysine n-methyltransferase EHMT2 measurement,EFO:0020455,http://www.ebi.ac.uk/efo/EFO_0020455,0.817,None
met-a-696,X-13619,X-13619 measurement,EFO:0021356,http://www.ebi.ac.uk/efo/EFO_0021356,0.702,None
ebi-a-GCST90010340,Reticulon-4 receptor levels,leptin receptor measurement,EFO:0004635,http://www.ebi.ac.uk/efo/EFO_0004635,0.639,None
ieu-a-1048,Thalamus volume,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.981,None
prot-a-671,Cytotoxic and regulatory T-cell molecule,cytotoxic and regulatory t-cell molecule measurement,EFO:0020311,http://www.ebi.ac.uk/efo/EFO_0020311,0.836,None
prot-a-727,Cathepsin S,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.762,None
prot-c-2635_61_2,Layilin,layilin measurement,EFO:0020529,http://www.ebi.ac.uk/efo/EFO_0020529,0.851,None
prot-a-2190,"Pyruvate carboxylase, mitochondrial","pyruvate carboxylase, mitochondrial measurement",EFO:0802986,http://www.ebi.ac.uk/efo/EFO_0802986,0.906,None
prot-a-639,Cytochrome c oxidase subunit 6C,cytochrome c oxidase subunit 6C measurement,EFO:0801515,http://www.ebi.ac.uk/efo/EFO_0801515,0.928,None
prot-a-1394,"Isoleucine--tRNA ligase, cytoplasmic","isoleucine--tRNA ligase, cytoplasmic measurement",EFO:0802666,http://www.ebi.ac.uk/efo/EFO_0802666,0.773,None
prot-a-2216,Programmed cell death protein 5,programmed cell death protein 5 measurement,EFO:0801927,http://www.ebi.ac.uk/efo/EFO_0801927,0.911,None
ieu-a-977,Forearm bone mineral density,bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.806,None
prot-a-2939,Holo-Transcobalamin-2,transcobalamin II deficiency,MONDO:0010149,http://purl.obolibrary.org/obo/MONDO_0010149,0.755,None
prot-c-3218_8_2,PSMA,Scapuloperoneal spinal muscular atrophy,EFO:1001992,http://www.ebi.ac.uk/efo/EFO_1001992,0.66,None
prot-a-2834,SPRY domain-containing SOCS box protein 1,SPRY domain-containing SOCS box protein 1 measurement,EFO:0803103,http://www.ebi.ac.uk/efo/EFO_0803103,0.899,None
prot-a-318,Complement component C6,complement component C6 measurement,EFO:0020281,http://www.ebi.ac.uk/efo/EFO_0020281,0.952,None
prot-a-2694,Serpin A9,serpin A9 measurement,EFO:0802062,http://www.ebi.ac.uk/efo/EFO_0802062,0.879,None
prot-a-1885,Microfibrillar-associated protein 2,microfibrillar-associated protein 2 measurement,EFO:0801801,http://www.ebi.ac.uk/efo/EFO_0801801,0.822,None
prot-a-1055,"Phenylalanine--tRNA ligase, mitochondrial","phenylalanine--tRNA ligase, mitochondrial measurement",EFO:0801879,http://www.ebi.ac.uk/efo/EFO_0801879,0.8,None
prot-a-1004,Ezrin,ezrin measurement,EFO:0801597,http://www.ebi.ac.uk/efo/EFO_0801597,0.881,None
prot-a-1416,Interferon-induced protein with tetratricopeptide repeats 2,interferon-induced protein with tetratricopeptide repeats 2 measurement,EFO:0802651,http://www.ebi.ac.uk/efo/EFO_0802651,0.912,None
prot-b-78,follistatin,follistatin measurement,EFO:0010614,http://www.ebi.ac.uk/efo/EFO_0010614,0.838,None
ebi-a-GCST90000047,Age at first sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.931,None
ebi-a-GCST90010317,GRB2-related adapter protein 2 levels,grb2-related adapter protein 2 measurement,EFO:0020420,http://www.ebi.ac.uk/efo/EFO_0020420,0.753,None
ukb-d-30760_raw,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-2247,Proenkephalin-A,proenkephalin-A measurement,EFO:0801923,http://www.ebi.ac.uk/efo/EFO_0801923,0.741,None
prot-a-996,Protein eva-1 homolog C,protein eva-1 homolog C measurement,EFO:0801942,http://www.ebi.ac.uk/efo/EFO_0801942,0.731,None
prot-a-2932,Serine/threonine-protein kinase TBK1,serine/threonine-protein kinase TBK1 measurement,EFO:0020734,http://www.ebi.ac.uk/efo/EFO_0020734,0.778,None
prot-a-1097,Fibroblast growth factor 7,fibroblast growth factor 7 measurement,EFO:0020384,http://www.ebi.ac.uk/efo/EFO_0020384,0.91,None
ebi-a-GCST90001652,Granulocyte %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.714,None
ebi-a-GCST005314,Offspring birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.674,None
prot-a-2853,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement",EFO:0801373,http://www.ebi.ac.uk/efo/EFO_0801373,0.722,None
prot-a-2373,Protein kinase C zeta type,protein kinase c zeta type measurement,EFO:0020683,http://www.ebi.ac.uk/efo/EFO_0020683,0.897,None
ubm-a-233,IDP dMRI TBSS FA Cingulum hippocampus L,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.601,None
prot-a-458,CD70 antigen,CD70 antigen measurement,EFO:0020249,http://www.ebi.ac.uk/efo/EFO_0020249,0.899,None
ebi-a-GCST90000478,Interleukin-6 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.794,None
prot-a-1998,Nicotinamide phosphoribosyltransferase,visfatin measurement,EFO:0801230,http://www.ebi.ac.uk/efo/EFO_0801230,0.993,None
prot-a-1085,Flap endonuclease 1,flap endonuclease 1 measurement,EFO:0802551,http://www.ebi.ac.uk/efo/EFO_0802551,0.913,None
prot-a-2650,Adseverin,adseverin measurement,EFO:0801358,http://www.ebi.ac.uk/efo/EFO_0801358,0.858,None
prot-a-51,Adenylosuccinate synthetase isozyme 2,adenylosuccinate synthetase isozyme 2 measurement,EFO:0801345,http://www.ebi.ac.uk/efo/EFO_0801345,0.94,None
ukb-d-20433_irnt,Age at first episode of depression,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.602,None
met-c-957,Total lipids in chylomicrons and largest VLDL particles,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.628,None
ukb-b-8428,"Forced expiratory volume in 1-second (FEV1), predicted",forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.731,None
prot-a-2444,Receptor-type tyrosine-protein phosphatase H,receptor-type tyrosine-protein phosphatase H measurement,EFO:0801991,http://www.ebi.ac.uk/efo/EFO_0801991,0.767,None
ubm-a-198,IDP dMRI TBSS FA Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.614,None
ubm-a-15,IDP T1 FIRST left putamen volume,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.713,None
prot-a-1988,Mitotic-spindle organizing protein 1,mitotic-spindle organizing protein 1 measurement,EFO:0802752,http://www.ebi.ac.uk/efo/EFO_0802752,0.842,None
prot-a-1351,High mobility group protein B1,high mobility group protein B1 measurement,EFO:0020449,http://www.ebi.ac.uk/efo/EFO_0020449,0.926,None
ebi-a-GCST004422,Vascular endothelial growth factor levels,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.935,None
prot-a-1153,"Alpha-(1,3)-fucosyltransferase 5",fucosyltransferase 6 deficiency,MONDO:0013462,http://purl.obolibrary.org/obo/MONDO_0013462,0.738,None
prot-a-515,Ceramide synthase 5,ceramide synthase 5 measurement,EFO:0802388,http://www.ebi.ac.uk/efo/EFO_0802388,0.872,None
prot-a-1028,Protein FAM163B,protein FAM163B measurement,EFO:0802936,http://www.ebi.ac.uk/efo/EFO_0802936,0.919,None
ieu-a-96,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
ebi-a-GCST90010207,Cystatin-B levels,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.796,None
ebi-a-GCST90000459,CXCL10 levels,CXCL10 measurement,EFO:0010778,http://www.ebi.ac.uk/efo/EFO_0010778,0.791,None
prot-a-1247,Glypican-5,glypican-1 measurement,EFO:0801649,http://www.ebi.ac.uk/efo/EFO_0801649,0.605,None
ebi-a-GCST90012069,vascular endothelial growth factor D levels,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.913,None
prot-a-1420,Interferon alpha-14,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.91,None
ebi-a-GCST90012006,Cystatin-B levels,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.796,None
prot-a-2071,Epididymal secretory protein E1,epididymal secretory protein E1 measurement,EFO:0801575,http://www.ebi.ac.uk/efo/EFO_0801575,0.928,None
prot-a-2208,Proliferating cell nuclear antigen,proliferating cell nuclear antigen measurement,EFO:0020657,http://www.ebi.ac.uk/efo/EFO_0020657,0.928,None
prot-a-3023,Transmembrane protease serine 11B,transmembrane protease serine 11B measurement,EFO:0803180,http://www.ebi.ac.uk/efo/EFO_0803180,0.941,None
prot-a-1273,Gremlin-1,gremlin-1 measurement,EFO:0020421,http://www.ebi.ac.uk/efo/EFO_0020421,0.735,None
prot-c-2888_49_2,C7,C7 carnitine measurement,EFO:0801154,http://www.ebi.ac.uk/efo/EFO_0801154,0.63,None
prot-a-887,Tumor necrosis factor receptor superfamily member 27,tumor necrosis factor receptor superfamily member 27 measurement,EFO:0020812,http://www.ebi.ac.uk/efo/EFO_0020812,0.946,None
prot-a-1009,Coagulation Factor VIII,prothrombin fragments F1+2 measurement,EFO:0007776,http://www.ebi.ac.uk/efo/EFO_0007776,0.735,None
met-a-319,Arachidonate (20:4n6),arachidonate 20:4n6 measurement,EFO:0021063,http://www.ebi.ac.uk/efo/EFO_0021063,0.709,None
prot-a-2715,SH2 domain-containing protein 1A,sh2 domain-containing protein 1a measurement,EFO:0020737,http://www.ebi.ac.uk/efo/EFO_0020737,0.873,None
prot-a-2177,Pappalysin-1,pappalysin-1 measurement,EFO:0802845,http://www.ebi.ac.uk/efo/EFO_0802845,0.726,None
met-d-VLDL_FC,Free cholesterol in VLDL,very low density lipoprotein cholesterol measurement,EFO:0008317,http://www.ebi.ac.uk/efo/EFO_0008317,0.77,None
prot-a-3027,Transmembrane and ubiquitin-like domain-containing protein 2,transmembrane and ubiquitin-like domain-containing protein 2 measurement,EFO:0803175,http://www.ebi.ac.uk/efo/EFO_0803175,0.855,None
prot-a-765,DDB1- and CUL4-associated factor 5,DDB1- and CUL4-associated factor 5 measurement,EFO:0802457,http://www.ebi.ac.uk/efo/EFO_0802457,0.702,None
prot-a-2368,cAMP-dependent protein kinase type I-beta regulatory subunit,cAMP-dependent protein kinase type I-beta regulatory subunit measurement,EFO:0801446,http://www.ebi.ac.uk/efo/EFO_0801446,0.783,None
prot-a-1239,RAB6-interacting golgin,RAB6-interacting Golgin measurement,EFO:0801983,http://www.ebi.ac.uk/efo/EFO_0801983,0.747,None
prot-a-202,Potassium-transporting ATPase subunit beta,potassium-transporting ATPase subunit beta measurement,EFO:0801903,http://www.ebi.ac.uk/efo/EFO_0801903,0.85,None
prot-a-2772,Mothers against decapentaplegic homolog 4,mothers against decapentaplegic homolog 4 measurement,EFO:0801808,http://www.ebi.ac.uk/efo/EFO_0801808,0.943,None
prot-c-4891_50_1,Glucagon,glucagon measurement,EFO:0008463,http://www.ebi.ac.uk/efo/EFO_0008463,0.866,None
ebi-a-GCST003372,Glomerular filtration rate (creatinine),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.869,None
ebi-a-GCST90012877,Alzheimer's disease or family history of Alzheimer's disease,family history of Alzheimers disease,EFO:0009268,http://www.ebi.ac.uk/efo/EFO_0009268,0.95,None
prot-a-1366,Heterogeneous nuclear ribonucleoprotein K,heterogeneous nuclear ribonucleoprotein k measurement,EFO:0020442,http://www.ebi.ac.uk/efo/EFO_0020442,0.953,None
ebi-a-GCST90010281,Angiopoietin-2 levels,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.659,None
met-a-359,Gamma-glutamylglutamine,gamma-glutamylglutamine measurement,EFO:0021138,http://www.ebi.ac.uk/efo/EFO_0021138,0.849,None
ukb-b-11312,Particulate matter air pollution (pm2.5) absorbance; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.651,None
ieu-a-56,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
met-a-406,Taurochenodeoxycholate,taurochenodeoxycholate measurement,EFO:0010537,http://www.ebi.ac.uk/efo/EFO_0010537,0.928,None
ieu-a-95,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-2486,DNA repair protein RAD51 homolog 4,DNA repair protein RAD51 homolog 4 measurement,EFO:0801531,http://www.ebi.ac.uk/efo/EFO_0801531,0.944,None
ieu-a-52,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
met-a-565,X-12029,X-12029 measurement,EFO:0021278,http://www.ebi.ac.uk/efo/EFO_0021278,0.687,None
met-c-885,Phospholipids in large LDL,phospholipids in large LDL measurement,EFO:0022174,http://www.ebi.ac.uk/efo/EFO_0022174,0.908,None
ukb-b-188,Private healthcare,nosocomial infection,MONDO:0043544,http://purl.obolibrary.org/obo/MONDO_0043544,0.616,None
met-d-LDL_L,Total lipids in LDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.878,None
met-d-His,Histidine,histidinemia,MONDO:0009345,http://purl.obolibrary.org/obo/MONDO_0009345,0.827,None
prot-a-2881,Stathmin-4,stathmin-2 measurement,EFO:0802087,http://www.ebi.ac.uk/efo/EFO_0802087,0.62,None
met-a-594,X-12231,X-12231 measurement,EFO:0021297,http://www.ebi.ac.uk/efo/EFO_0021297,0.698,None
prot-a-1021,Protein FAM107B,protein fam107b measurement,EFO:0020674,http://www.ebi.ac.uk/efo/EFO_0020674,0.921,None
prot-a-1882,Hepatocyte growth factor receptor,hepatocyte growth factor receptor measurement,EFO:0008153,http://www.ebi.ac.uk/efo/EFO_0008153,0.928,None
bbj-a-45,Phosphorus,phosphorus metabolism disease,MONDO:0002319,http://purl.obolibrary.org/obo/MONDO_0002319,0.869,None
prot-c-5262_57_3,BCAR3,Autosomal recessive cerebellar ataxia - blindness - deafness,ORPHANET.ORDO:95433,http://www.orpha.net/ORDO/Orphanet_95433,0.668,None
ebi-a-GCST008035,High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,EFO:0004612,http://www.ebi.ac.uk/efo/EFO_0004612,0.868,None
ebi-a-GCST90001822,IgD on IgD+ CD38-  B cell,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.64,None
ebi-a-GCST90001449,CD11c+ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.66,None
prot-a-640,"Cytochrome c oxidase subunit 7A1, mitochondrial","cytochrome c oxidase subunit 7A1, mitochondrial measurement",EFO:0802450,http://www.ebi.ac.uk/efo/EFO_0802450,0.884,None
ukb-b-11361,"ECG, heart rate",heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.723,None
ieu-a-793,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-1036,BRISC complex subunit Abro1,BRISC complex subunit Abro1 measurement,EFO:0802338,http://www.ebi.ac.uk/efo/EFO_0802338,0.935,None
ieu-b-30,white blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
met-a-469,Alanine,alanine measurement,EFO:0009765,http://www.ebi.ac.uk/efo/EFO_0009765,0.752,None
ukb-b-2209,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
ebi-a-GCST004437,Monocyte chemoattractant protein-3 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.806,None
prot-a-423,Cell surface glycoprotein CD200 receptor 1,cell surface glycoprotein CD200 receptor 1 measurement,EFO:0020253,http://www.ebi.ac.uk/efo/EFO_0020253,0.934,None
prot-a-3158,UDP-glucuronosyltransferase 2A1,UDP-glucuronosyltransferase 2A1 measurement,EFO:0802186,http://www.ebi.ac.uk/efo/EFO_0802186,0.851,None
prot-a-2316,Purine nucleoside phosphorylase,purine nucleoside phosphorylase measurement,EFO:0801981,http://www.ebi.ac.uk/efo/EFO_0801981,0.933,None
prot-a-2865,Signal-transducing adaptor protein 1,signal-transducing adaptor protein 1 measurement,EFO:0803075,http://www.ebi.ac.uk/efo/EFO_0803075,0.856,None
ebi-a-GCST90010208,Cathepsin D levels,cathepsin D measurement,EFO:0010611,http://www.ebi.ac.uk/efo/EFO_0010611,0.713,None
met-a-308,Phenylalanine,phenylketonuria,MONDO:0009861,http://purl.obolibrary.org/obo/MONDO_0009861,0.899,None
ukb-b-6515,Time since last prostate specific antigen (PSA) test,prostate specific antigen measurement,EFO:0004624,http://www.ebi.ac.uk/efo/EFO_0004624,0.624,None
prot-a-320,Bombesin receptor-activated protein C6orf89,bombesin receptor-activated protein C6orf89 measurement,EFO:0801428,http://www.ebi.ac.uk/efo/EFO_0801428,0.896,None
met-a-570,X-12063,X-12063 measurement,EFO:0021283,http://www.ebi.ac.uk/efo/EFO_0021283,0.697,None
ieu-a-791,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-2051,Magnesium transporter NIPA4,magnesium transporter NIPA4 measurement,EFO:0802723,http://www.ebi.ac.uk/efo/EFO_0802723,0.936,None
ukb-b-19524,Vitamin B12,vitamin B12 deficiency,EFO:0000734,http://www.ebi.ac.uk/efo/EFO_0000734,0.914,None
prot-a-1818,Lysophospholipase-like protein 1,lysophospholipase-like protein 1 measurement,EFO:0802719,http://www.ebi.ac.uk/efo/EFO_0802719,0.839,None
prot-a-785,Beta-defensin 107,beta-defensin 107 measurement,EFO:0802317,http://www.ebi.ac.uk/efo/EFO_0802317,0.773,None
prot-a-2048,NHP2-like protein 1,NHP2-like protein 1 measurement,EFO:0801840,http://www.ebi.ac.uk/efo/EFO_0801840,0.727,None
prot-a-2238,p53 and DNA damage-regulated protein 1,p53 and DNA damage-regulated protein 1 measurement,EFO:0803313,http://www.ebi.ac.uk/efo/EFO_0803313,0.858,None
ieu-a-1092,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
prot-a-3103,Tumor susceptibility gene 101 protein,tumor susceptibility gene 101 protein measurement,EFO:0803203,http://www.ebi.ac.uk/efo/EFO_0803203,0.915,None
prot-a-2810,SPARC-like protein 1,SPARC-like protein 1 measurement,EFO:0008289,http://www.ebi.ac.uk/efo/EFO_0008289,0.615,None
prot-a-3256,E3 ubiquitin-protein ligase ZFP91,E3 ubiquitin-protein ligase ZFP91 measurement,EFO:0802513,http://www.ebi.ac.uk/efo/EFO_0802513,0.912,None
prot-a-1359,Hepatocyte nuclear factor 1-alpha,hepatocyte nuclear factor 1-alpha measurement,EFO:0802596,http://www.ebi.ac.uk/efo/EFO_0802596,0.824,None
prot-a-1819,LysM and putative peptidoglycan-binding domain-containing protein 3,lysM and putative peptidoglycan-binding domain-containing protein 3 measurement,EFO:0802717,http://www.ebi.ac.uk/efo/EFO_0802717,0.856,None
met-d-S_LDL_TG,Triglycerides in small LDL,triglycerides in small VLDL measurement,EFO:0022145,http://www.ebi.ac.uk/efo/EFO_0022145,0.782,None
met-d-S_LDL_FC_pct,Free cholesterol to total lipids ratio in small LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.734,None
prot-c-2714_78_2,EMAP-2,familial adenomatous polyposis 2,MONDO:0012041,http://purl.obolibrary.org/obo/MONDO_0012041,0.684,None
prot-a-605,Ciliary neurotrophic factor receptor subunit alpha,ciliary neurotrophic factor receptor subunit alpha measurement,EFO:0020261,http://www.ebi.ac.uk/efo/EFO_0020261,0.938,None
met-a-627,Epiandrosterone sulfate,epiandrosterone sulfate measurement,EFO:0021120,http://www.ebi.ac.uk/efo/EFO_0021120,0.888,None
met-a-519,X-11469,X-11469 measurement,EFO:0021240,http://www.ebi.ac.uk/efo/EFO_0021240,0.702,None
prot-a-3004,Transmembrane protein 190,transmembrane protein 190 measurement,EFO:0802154,http://www.ebi.ac.uk/efo/EFO_0802154,0.929,None
prot-a-2877,Serine/threonine-protein kinase 16,serine/threonine-protein kinase 16 measurement,EFO:0020724,http://www.ebi.ac.uk/efo/EFO_0020724,0.72,None
prot-a-783,Beta-defensin 105,beta-defensin 105 measurement,EFO:0801417,http://www.ebi.ac.uk/efo/EFO_0801417,0.773,None
met-d-L_HDL_L,Total lipids in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.971,None
prot-a-1205,ADP-ribosylation factor-binding protein GGA1,ADP-ribosylation factor-binding protein GGA1 measurement,EFO:0801352,http://www.ebi.ac.uk/efo/EFO_0801352,0.806,None
prot-a-2718,SHC-transforming protein 2,SHC-transforming protein 2 measurement,EFO:0803070,http://www.ebi.ac.uk/efo/EFO_0803070,0.717,None
prot-a-949,AP-4 complex accessory subunit tepsin,AP-4 complex accessory subunit tepsin measurement,EFO:0801384,http://www.ebi.ac.uk/efo/EFO_0801384,0.81,None
prot-a-2016,Natural cytotoxicity triggering receptor 3,natural cytotoxicity triggering receptor 3 measurement,EFO:0008243,http://www.ebi.ac.uk/efo/EFO_0008243,0.943,None
prot-c-4769_10_3,Olfactomedin-4,olfactomedin-4 measurement,EFO:0020617,http://www.ebi.ac.uk/efo/EFO_0020617,0.7,None
prot-a-770,mRNA-decapping enzyme 1A,MRNA-decapping enzyme 1A measurement,EFO:0802757,http://www.ebi.ac.uk/efo/EFO_0802757,0.849,None
prot-c-4276_10_2,prostatic binding protein,protein binding measurement,EFO:0010742,http://www.ebi.ac.uk/efo/EFO_0010742,0.68,None
ebi-a-GCST008046,Triglyceride levels,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.987,None
prot-a-2390,Trypsin-1,trypsin-1 measurement,EFO:0020790,http://www.ebi.ac.uk/efo/EFO_0020790,0.686,None
prot-a-1839,MANSC domain-containing protein 4,MANSC domain-containing protein 4 measurement,EFO:0801785,http://www.ebi.ac.uk/efo/EFO_0801785,0.86,None
prot-a-2894,Sulfotransferase 4A1,sulfotransferase 4A1 measurement,EFO:0803108,http://www.ebi.ac.uk/efo/EFO_0803108,0.923,None
prot-a-860,Dipeptidyl peptidase 2,dipeptidyl peptidase 2 measurement,EFO:0020326,http://www.ebi.ac.uk/efo/EFO_0020326,0.937,None
prot-c-2794_60_2,SOD,Septo-optic dysplasia,ORPHANET.ORDO:3157,http://www.orpha.net/ORDO/Orphanet_3157,0.998,None
prot-a-1938,C-type mannose receptor 2,C-type mannose receptor 2 measurement,EFO:0020204,http://www.ebi.ac.uk/efo/EFO_0020204,0.711,None
prot-a-1527,Interleukin-36 beta,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.73,None
prot-a-2669,Semaphorin-3A,semaphorin-3A measurement,EFO:0008278,http://www.ebi.ac.uk/efo/EFO_0008278,0.657,None
prot-a-2762,Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5,orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 measurement,EFO:0802836,http://www.ebi.ac.uk/efo/EFO_0802836,0.887,None
bbj-a-31,Low-density-lipoprotein cholesterol,low density lipoprotein cholesterol measurement,EFO:0004611,http://www.ebi.ac.uk/efo/EFO_0004611,0.925,None
prot-a-1558,Insulin,pancreatic insulinoma,MONDO:0024677,http://purl.obolibrary.org/obo/MONDO_0024677,0.845,None
ieu-b-4760,Number of children,number of children fathered measurement,EFO:0009814,http://www.ebi.ac.uk/efo/EFO_0009814,0.801,None
ebi-a-GCST90002236,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
met-d-XL_VLDL_TG,Triglycerides in very large VLDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.847,None
ebi-a-GCST90012082,N-terminal prohormone brain natriuretic peptide levels,N-terminal prohormone brain natriuretic peptide measurement,EFO:0010921,http://www.ebi.ac.uk/efo/EFO_0010921,0.816,None
ebi-a-GCST90001650,HLA DR+ Natural Killer  %CD3- lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.605,None
ebi-a-GCST90012049,Pro-interleukin-16 levels,interleukin 16 measurement,EFO:0008173,http://www.ebi.ac.uk/efo/EFO_0008173,0.702,None
prot-a-1255,Transmembrane glycoprotein NMB,transmembrane glycoprotein NMB measurement,EFO:0008303,http://www.ebi.ac.uk/efo/EFO_0008303,0.937,None
ukb-a-389,Standing height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.708,None
prot-a-2510,Reticulocalbin-2,reticulocalbin-2 measurement,EFO:0803010,http://www.ebi.ac.uk/efo/EFO_0803010,0.735,None
prot-a-1870,"Malate dehydrogenase, cytoplasmic","malate dehydrogenase, cytoplasmic measurement",EFO:0020551,http://www.ebi.ac.uk/efo/EFO_0020551,0.875,None
ukb-b-12019,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
ebi-a-GCST006948,Feeling nervous,feeling nervous measurement,EFO:0009597,http://www.ebi.ac.uk/efo/EFO_0009597,0.87,None
prot-a-1477,Interleukin-15 receptor subunit alpha,interleukin 15 receptor subunit alpha measurement,EFO:0008172,http://www.ebi.ac.uk/efo/EFO_0008172,0.937,None
prot-a-2484,UV excision repair protein RAD23 homolog B,UV excision repair protein RAD23 homolog B measurement,EFO:0802206,http://www.ebi.ac.uk/efo/EFO_0802206,0.954,None
ukb-b-13246,Childhood sunburn occasions,sunburn,EFO:0003958,http://www.ebi.ac.uk/efo/EFO_0003958,0.615,None
prot-c-3729_16_2,Somatostatin-28,somatostatinoma,EFO:1001187,http://www.ebi.ac.uk/efo/EFO_1001187,0.748,None
ieu-a-782,Total cholesterol,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-c-3054_3_2,"Haptoglobin, Mixed Type",haptoglobin measurement,EFO:0004640,http://www.ebi.ac.uk/efo/EFO_0004640,0.659,None
met-d-XL_HDL_CE,Cholesteryl esters in very large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.731,None
prot-a-411,C-C motif chemokine 8,C-C motif chemokine 8 measurement,EFO:0008055,http://www.ebi.ac.uk/efo/EFO_0008055,0.684,None
prot-a-1541,Interleukin-6 receptor subunit alpha,interleukin 6 receptor subunit alpha measurement,EFO:0008187,http://www.ebi.ac.uk/efo/EFO_0008187,0.934,None
prot-a-1983,Histone H2A deubiquitinase MYSM1,histone H2A deubiquitinase MYSM1 measurement,EFO:0802602,http://www.ebi.ac.uk/efo/EFO_0802602,0.95,None
prot-a-1096,Fibroblast growth factor 6,fibroblast growth factor 6 measurement,EFO:0020383,http://www.ebi.ac.uk/efo/EFO_0020383,0.909,None
prot-a-1556,Inhibin beta C chain,inhibin beta C chain measurement,EFO:0801696,http://www.ebi.ac.uk/efo/EFO_0801696,0.901,None
prot-a-1711,Ligand-dependent nuclear receptor corepressor-like protein,ligand-dependent nuclear receptor corepressor-like protein measurement,EFO:0020536,http://www.ebi.ac.uk/efo/EFO_0020536,0.835,None
prot-a-2152,Oxysterol-binding protein-related protein 11,oxysterol-binding protein-related protein 11 measurement,EFO:0801864,http://www.ebi.ac.uk/efo/EFO_0801864,0.809,None
prot-a-223,Transcription regulator protein BACH2,transcription regulator protein BACH2 measurement,EFO:0803164,http://www.ebi.ac.uk/efo/EFO_0803164,0.941,None
prot-a-1200,Glial fibrillary acidic protein,glial fibrillary acidic protein measurement,EFO:0020404,http://www.ebi.ac.uk/efo/EFO_0020404,0.903,None
ebi-a-GCST90006910,Anti-helicobacter pylori IgG seropositivity,Helicobacter pylori seropositivity,EFO:0009341,http://www.ebi.ac.uk/efo/EFO_0009341,0.888,None
ebi-a-GCST006326,Conscientiousness,conscientiousness measurement,EFO:0007912,http://www.ebi.ac.uk/efo/EFO_0007912,0.895,None
prot-a-3012,Transmembrane protein 52,transmembrane protein 52 measurement,EFO:0803187,http://www.ebi.ac.uk/efo/EFO_0803187,0.918,None
met-d-M_LDL_PL_pct,Phospholipids to total lipids ratio in medium LDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.781,None
prot-a-1023,Protein FAM134B,protein FAM134B measurement,EFO:0802935,http://www.ebi.ac.uk/efo/EFO_0802935,0.917,None
prot-c-2751_16_2,Azurocidin,azurocidin measurement,EFO:0020170,http://www.ebi.ac.uk/efo/EFO_0020170,0.873,None
ukb-b-20032,"Heel bone mineral density (BMD) T-score, automated (right)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.658,None
ebi-a-GCST006363,Anti-Helicobacter pylori IgG levels,Anti-Helicobacter pylori IgG measurement,EFO:0009352,http://www.ebi.ac.uk/efo/EFO_0009352,0.768,None
prot-a-818,"Diablo homolog, mitochondrial","diablo homolog, mitochondrial measurement",EFO:0020323,http://www.ebi.ac.uk/efo/EFO_0020323,0.814,None
prot-a-617,Endostatin,endostatin measurement,EFO:0020347,http://www.ebi.ac.uk/efo/EFO_0020347,0.798,None
prot-a-2963,Transforming growth factor beta-1-induced transcript 1 protein,transforming growth factor beta-1-induced transcript 1 protein measurement,EFO:0803170,http://www.ebi.ac.uk/efo/EFO_0803170,0.872,None
bbj-a-28,Interventricular septum thickness,interventricular septum thickness,EFO:0009287,http://www.ebi.ac.uk/efo/EFO_0009287,0.986,None
bbj-a-44,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
bbj-a-102,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
prot-a-1173,N-acetylgalactosaminyltransferase 7,n-acetylgalactosaminyltransferase 7 measurement,EFO:0802774,http://www.ebi.ac.uk/efo/EFO_0802774,0.861,None
ebi-a-GCST90000495,SLAMF1 levels,signaling lymphocytic activation molecule 1 measurement,EFO:0010794,http://www.ebi.ac.uk/efo/EFO_0010794,0.889,None
met-a-589,X-12206,X-12206 measurement,EFO:0021292,http://www.ebi.ac.uk/efo/EFO_0021292,0.711,None
met-a-718,P-cresol sulfate,O-cresol sulfate measurement,EFO:0800955,http://www.ebi.ac.uk/efo/EFO_0800955,0.646,None
prot-a-2658,Signal peptidase complex catalytic subunit SEC11C,signal peptidase complex catalytic subunit SEC11C measurement,EFO:0802068,http://www.ebi.ac.uk/efo/EFO_0802068,0.951,None
ebi-a-GCST003392,Parental longevity (father's age at death),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.709,None
ebi-a-GCST90001619,HLA DR+ T cell%T cell,T-Cell Prolymphocytic Leukemia,EFO:1000560,http://www.ebi.ac.uk/efo/EFO_1000560,0.606,None
prot-c-5343_74_3,CBPE,red color blindness,EFO:0005580,http://www.ebi.ac.uk/efo/EFO_0005580,0.64,None
prot-a-1290,Glutathione S-transferase P,glutathione s-transferase p measurement,EFO:0020410,http://www.ebi.ac.uk/efo/EFO_0020410,0.795,None
prot-a-3058,Tumor necrosis factor ligand superfamily member 15,tumor necrosis factor ligand superfamily member 15 measurement,EFO:0020794,http://www.ebi.ac.uk/efo/EFO_0020794,0.94,None
prot-c-2637_77_2,Macrophage mannose receptor,macrophage mannose receptor 1 measurement,EFO:0020548,http://www.ebi.ac.uk/efo/EFO_0020548,0.897,None
prot-a-2974,Thyroid hormone receptor alpha,thyroid hormone receptor alpha measurement,EFO:0803153,http://www.ebi.ac.uk/efo/EFO_0803153,0.91,None
ebi-a-GCST90012081,Platelet endothelial cell adhesion molecule levels,platelet endothelial cell adhesion molecule measurement,EFO:0010598,http://www.ebi.ac.uk/efo/EFO_0010598,0.892,None
prot-a-1261,Protein GPR107,protein GPR107 measurement,EFO:0802946,http://www.ebi.ac.uk/efo/EFO_0802946,0.928,None
bbj-a-41,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
prot-a-2038,Neuralized-like protein 4,neuralized-like protein 4 measurement,EFO:0802796,http://www.ebi.ac.uk/efo/EFO_0802796,0.772,None
prot-a-372,Cerebellin-4,cerebellin-1 measurement,EFO:0801466,http://www.ebi.ac.uk/efo/EFO_0801466,0.629,None
met-a-712,Dihomo-linolenate (20:3n3 or n6),dihomo-linolenate 20:3n3 or n6 measurement,EFO:0021046,http://www.ebi.ac.uk/efo/EFO_0021046,0.697,None
prot-a-793,Beta-defensin 119,beta-defensin 119 measurement,EFO:0801419,http://www.ebi.ac.uk/efo/EFO_0801419,0.764,None
prot-a-3048,Tumor necrosis factor receptor superfamily member 1B,tumor necrosis factor receptor superfamily member 1B measurement,EFO:0010624,http://www.ebi.ac.uk/efo/EFO_0010624,0.947,None
met-d-M_HDL_L,Total lipids in medium HDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.802,None
prot-a-2369,Protein kinase C alpha type,protein kinase c alpha type measurement,EFO:0020677,http://www.ebi.ac.uk/efo/EFO_0020677,0.887,None
prot-a-1669,NKG2-A/NKG2-B type II integral membrane protein,NKG2-D type II integral membrane protein measurement,EFO:0008250,http://www.ebi.ac.uk/efo/EFO_0008250,0.731,None
ebi-a-GCST90000441,Caspase 8 levels,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.657,None
prot-a-2096,"Pro-neuregulin-2, membrane-bound isoform","pro-neuregulin-2, membrane-bound isoform measurement",EFO:0802900,http://www.ebi.ac.uk/efo/EFO_0802900,0.693,None
ukb-d-30290_irnt,High light scatter reticulocyte percentage,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.991,None
met-d-M_VLDL_C,Cholesterol in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.9,None
ukb-a-323,Age started oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.692,None
prot-a-946,Ecto-NOX disulfide-thiol exchanger 2,ecto-NOX disulfide-thiol exchanger 2 measurement,EFO:0802516,http://www.ebi.ac.uk/efo/EFO_0802516,0.796,None
ukb-b-5238,Fluid intelligence score,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.634,None
prot-a-2234,Protein disulfide-isomerase-like protein of the testis,protein disulfide-isomerase-like protein of the testis measurement,EFO:0802932,http://www.ebi.ac.uk/efo/EFO_0802932,0.802,None
prot-a-1949,Beta-microseminoprotein,beta-microseminoprotein measurement,EFO:0020955,http://www.ebi.ac.uk/efo/EFO_0020955,0.753,None
ieu-a-1000,Depressive symptoms,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.984,None
ebi-a-GCST90010165,P-selectin glycoprotein ligand 1 levels,P-selectin glycoprotein ligand 1 measurement,EFO:0010922,http://www.ebi.ac.uk/efo/EFO_0010922,0.709,None
prot-a-1179,Vitamin D-binding protein,vitamin D-binding protein measurement,EFO:0005675,http://www.ebi.ac.uk/efo/EFO_0005675,0.717,None
prot-a-123,Amyloid-like protein 2,amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.767,None
prot-a-1196,Growth/differentiation factor 5,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.84,None
prot-a-2683,Sentrin-specific protease 7,sentrin-specific protease 7 measurement,EFO:0803053,http://www.ebi.ac.uk/efo/EFO_0803053,0.81,None
prot-a-2780,Acid sphingomyelinase-like phosphodiesterase 3a,acid sphingomyelinase-like phosphodiesterase 3a measurement,EFO:0008013,http://www.ebi.ac.uk/efo/EFO_0008013,0.902,None
met-d-M_HDL_C_pct,Cholesterol to total lipids ratio in medium HDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.669,None
ubm-a-2236,NET100 1080,T1080,EFO:0007608,http://www.ebi.ac.uk/efo/EFO_0007608,0.705,None
ebi-a-GCST90010124,Fibroblast growth factor 23 levels,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.851,None
prot-a-1454,Insulin growth factor-like family member 4,insulin growth factor-like family member 4 measurement,EFO:0801701,http://www.ebi.ac.uk/efo/EFO_0801701,0.871,None
ieu-a-82,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-c-3396_54_2,Renin,renin measurement,EFO:0010616,http://www.ebi.ac.uk/efo/EFO_0010616,0.654,None
prot-a-2237,PDZ and LIM domain protein 4,PDZ and LIM domain protein 4 measurement,EFO:0802849,http://www.ebi.ac.uk/efo/EFO_0802849,0.9,None
prot-a-1670,NKG2-E type II integral membrane protein,NKG2-D type II integral membrane protein measurement,EFO:0008250,http://www.ebi.ac.uk/efo/EFO_0008250,0.79,None
ebi-a-GCST90001817,CD38 on Plasma Blast-Plasma Cell,plasma cell neoplasm,EFO:0000200,http://www.ebi.ac.uk/efo/EFO_0000200,0.738,None
ukb-d-30860_irnt,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
prot-a-1019,Fas apoptotic inhibitory molecule 3,fas apoptotic inhibitory molecule 3 measurement,EFO:0802540,http://www.ebi.ac.uk/efo/EFO_0802540,0.938,None
prot-a-1924,Motor neuron and pancreas homeobox protein 1,motor neuron and pancreas homeobox protein 1 measurement,EFO:0802755,http://www.ebi.ac.uk/efo/EFO_0802755,0.917,None
prot-a-327,Carbonic anhydrase-related protein 10,carbonic anhydrase-related protein 10 measurement,EFO:0020233,http://www.ebi.ac.uk/efo/EFO_0020233,0.858,None
prot-a-612,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial","cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement",EFO:0801513,http://www.ebi.ac.uk/efo/EFO_0801513,0.901,None
prot-a-1989,HemK methyltransferase family member 2,hemK methyltransferase family member 2 measurement,EFO:0021891,http://www.ebi.ac.uk/efo/EFO_0021891,0.947,None
prot-a-3073,TOM1-like protein 1,TOM1-like protein 1 measurement,EFO:0802136,http://www.ebi.ac.uk/efo/EFO_0802136,0.667,None
prot-a-184,Histone-lysine N-methyltransferase ASH1L,histone-lysine N-methyltransferase ASH1L measurement,EFO:0802603,http://www.ebi.ac.uk/efo/EFO_0802603,0.822,None
met-d-VLDL_C,VLDL cholesterol,very low density lipoprotein cholesterol measurement,EFO:0008317,http://www.ebi.ac.uk/efo/EFO_0008317,0.896,None
prot-a-1584,Integrin alpha-V: beta-5 complex,integrin alpha-I: beta-1 complex measurement,EFO:0008162,http://www.ebi.ac.uk/efo/EFO_0008162,0.627,None
prot-a-172,Arylsulfatase B,arylsulfatase B measurement,EFO:0008030,http://www.ebi.ac.uk/efo/EFO_0008030,0.898,None
met-a-365,3-methoxytyrosine,3-methoxytyrosine measurement,EFO:0021009,http://www.ebi.ac.uk/efo/EFO_0021009,0.823,None
ebi-a-GCST005850,Heart rate response to recovery post exercise (30 sec),heart rate response to recovery post exercise,EFO:0009185,http://www.ebi.ac.uk/efo/EFO_0009185,0.91,None
prot-c-3519_3_2,TARC,CCL17 measurement,EFO:0009414,http://www.ebi.ac.uk/efo/EFO_0009414,0.734,None
prot-a-272,BRICHOS domain-containing protein 5,BRICHOS domain-containing protein 5 measurement,EFO:0801430,http://www.ebi.ac.uk/efo/EFO_0801430,0.859,None
ebi-a-GCST005344,Total body bone mineral density (age 15-30),bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.688,None
met-d-Clinical_LDL_C,Clinical LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.776,None
ieu-b-4865,Total Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.694,None
prot-a-50,beta-adrenergic receptor kinase 1,beta-adrenergic receptor kinase 1 measurement,EFO:0020181,http://www.ebi.ac.uk/efo/EFO_0020181,0.807,None
prot-a-3165,Protein unc-13 homolog A,protein unc-13 homolog A measurement,EFO:0802968,http://www.ebi.ac.uk/efo/EFO_0802968,0.698,None
ukb-b-770,Other meat intake,fat intake measurement,EFO:0010809,http://www.ebi.ac.uk/efo/EFO_0010809,0.713,None
prot-a-1438,Interferon omega-1,interferon omega-1 measurement,EFO:0802647,http://www.ebi.ac.uk/efo/EFO_0802647,0.681,None
prot-a-634,COMM domain-containing protein 7,COMM domain-containing protein 7 measurement,EFO:0020273,http://www.ebi.ac.uk/efo/EFO_0020273,0.857,None
prot-a-1318,Hydroxycarboxylic acid receptor 2,hydroxycarboxylic acid receptor 2 measurement,EFO:0802613,http://www.ebi.ac.uk/efo/EFO_0802613,0.934,None
ebi-a-GCST90010159,Programmed cell death 1 ligand 2 levels,programmed cell death 1 ligand 2 measurement,EFO:0008268,http://www.ebi.ac.uk/efo/EFO_0008268,0.845,None
met-a-460,Androsterone sulfate,androsterone sulfate measurement,EFO:0021117,http://www.ebi.ac.uk/efo/EFO_0021117,0.865,None
prot-a-2382,Prokineticin-1,prokineticin-1 measurement,EFO:0020655,http://www.ebi.ac.uk/efo/EFO_0020655,0.676,None
prot-a-2874,Stanniocalcin-2,stanniocalcin-1 measurement,EFO:0020753,http://www.ebi.ac.uk/efo/EFO_0020753,0.761,None
prot-a-49,ADP-dependent glucokinase,ADP-dependent glucokinase measurement,EFO:0802258,http://www.ebi.ac.uk/efo/EFO_0802258,0.817,None
ukb-b-12854,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
prot-a-2250,Peroxisomal targeting signal 1 receptor,peroxisomal targeting signal 1 receptor measurement,EFO:0022001,http://www.ebi.ac.uk/efo/EFO_0022001,0.923,None
prot-a-3192,Guanine nucleotide exchange factor VAV3,guanine nucleotide exchange factor VAV3 measurement,EFO:0802587,http://www.ebi.ac.uk/efo/EFO_0802587,0.955,None
prot-a-2831,Sepiapterin reductase,sepiapterin reductase measurement,EFO:0803054,http://www.ebi.ac.uk/efo/EFO_0803054,0.906,None
ebi-a-GCST90001579,CD14- CD16+ monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.608,None
met-a-527,X-11521,X-11521 measurement,EFO:0021247,http://www.ebi.ac.uk/efo/EFO_0021247,0.702,None
met-a-618,Decanoylcarnitine,decanoylcarnitine measurement,EFO:0021039,http://www.ebi.ac.uk/efo/EFO_0021039,0.899,None
met-c-930,Concentration of small VLDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.984,None
met-d-S_HDL_FC_pct,Free cholesterol to total lipids ratio in small HDL,free cholesterol:total lipids ratio,EFO:0020945,http://www.ebi.ac.uk/efo/EFO_0020945,0.687,None
prot-a-12,Aggrecan core protein,aggrecan core protein measurement,EFO:0020133,http://www.ebi.ac.uk/efo/EFO_0020133,0.896,None
prot-a-2220,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A","cGMP-inhibited 3',5'-cyclic phosphodiesterase A measurement",EFO:0020255,http://www.ebi.ac.uk/efo/EFO_0020255,0.713,None
prot-a-1312,Hepatitis A virus cellular receptor 2,hepatitis A virus cellular receptor 2 measurement,EFO:0008151,http://www.ebi.ac.uk/efo/EFO_0008151,0.925,None
met-d-LDL_FC,Free cholesterol in LDL,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.838,None
prot-a-2517,RELT-like protein 1,RELT-like protein 1 measurement,EFO:0802000,http://www.ebi.ac.uk/efo/EFO_0802000,0.681,None
bbj-a-10,Blood sugar,Hypoglycemia,HP:0001943,http://purl.obolibrary.org/obo/HP_0001943,0.894,None
prot-a-182,Asialoglycoprotein receptor 1,asialoglycoprotein receptor 1 measurement,EFO:0020164,http://www.ebi.ac.uk/efo/EFO_0020164,0.9,None
met-a-592,X-12217,X-12217 measurement,EFO:0021295,http://www.ebi.ac.uk/efo/EFO_0021295,0.687,None
prot-a-1216,D-glucuronyl C5-epimerase,D-glucuronyl C5-epimerase measurement,EFO:0801519,http://www.ebi.ac.uk/efo/EFO_0801519,0.637,None
prot-a-2934,T-box transcription factor TBX22,t-box transcription factor TBX22 measurement,EFO:0803127,http://www.ebi.ac.uk/efo/EFO_0803127,0.863,None
prot-c-4131_72_2,Fibronectin,fibronectin measurement,EFO:0008133,http://www.ebi.ac.uk/efo/EFO_0008133,0.825,None
met-c-960,Triglycerides in chylomicrons and largest VLDL particles,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.617,None
ieu-a-1103,Serum creatinine (eGFRcrea),creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.634,None
ebi-a-GCST004600,Eosinophil percentage of white cells,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.989,None
prot-a-736,Fractalkine,fractalkine measurement,EFO:0020395,http://www.ebi.ac.uk/efo/EFO_0020395,0.855,None
prot-c-5316_54_3,Prothrombin,thrombin,EFO:0003183,http://www.ebi.ac.uk/efo/EFO_0003183,0.83,None
prot-a-830,Delta-like protein 1,delta-like protein 1 measurement,EFO:0020316,http://www.ebi.ac.uk/efo/EFO_0020316,0.739,None
prot-a-2005,Next to BRCA1 gene 1 protein,next to BRCA1 gene 1 protein measurement,EFO:0801838,http://www.ebi.ac.uk/efo/EFO_0801838,0.921,None
prot-a-981,Erythroid membrane-associated protein,erythroid membrane-associated protein measurement,EFO:0801585,http://www.ebi.ac.uk/efo/EFO_0801585,0.845,None
ieu-b-4849,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-2339,Peptidyl-prolyl cis-trans isomerase A,peptidyl-prolyl cis-trans isomerase A measurement,EFO:0020625,http://www.ebi.ac.uk/efo/EFO_0020625,0.77,None
ukb-a-359,Diastolic blood pressure  automated reading,diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
prot-a-365,Cas scaffolding protein family member 4,cas scaffolding protein family member 4 measurement,EFO:0802371,http://www.ebi.ac.uk/efo/EFO_0802371,0.949,None
ebi-a-GCST008033,Fasting blood insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.992,None
prot-a-1407,DNA-binding protein inhibitor ID-1,DNA-binding protein inhibitor ID-1 measurement,EFO:0802481,http://www.ebi.ac.uk/efo/EFO_0802481,0.721,None
prot-a-2162,Prolyl 4-hydroxylase subunit alpha-2,prolyl 4-hydroxylase subunit alpha-1 measurement,EFO:0802917,http://www.ebi.ac.uk/efo/EFO_0802917,0.74,None
prot-a-246,Osteocalcin,osteocalcin measurement,EFO:0010232,http://www.ebi.ac.uk/efo/EFO_0010232,0.847,None
prot-a-2340,Peptidyl-prolyl cis-trans isomerase B,peptidyl-prolyl cis-trans isomerase B measurement,EFO:0020626,http://www.ebi.ac.uk/efo/EFO_0020626,0.769,None
ebi-a-GCST90010121,Dickkopf-related protein 1 levels,Dickkopf-related protein 3 measurement,EFO:0008109,http://www.ebi.ac.uk/efo/EFO_0008109,0.693,None
prot-a-148,Rho GTPase-activating protein 25,rho GTPase-activating protein 25 measurement,EFO:0802011,http://www.ebi.ac.uk/efo/EFO_0802011,0.852,None
prot-a-1585,Integrin beta-7,integrin beta-7 measurement,EFO:0802639,http://www.ebi.ac.uk/efo/EFO_0802639,0.641,None
ubm-a-1586,NET100 0430,MT10430,EFO:0005493,http://www.ebi.ac.uk/efo/EFO_0005493,0.62,None
prot-a-2848,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1","CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 measurement",EFO:0802403,http://www.ebi.ac.uk/efo/EFO_0802403,0.658,None
met-d-XL_VLDL_P,Concentration of very large VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.876,None
prot-a-2240,Pyridoxal phosphate phosphatase,pyridoxal phosphate phosphatase measurement,EFO:0020694,http://www.ebi.ac.uk/efo/EFO_0020694,0.952,None
prot-a-2621,Protein S100-A7,A7,EFO:0002107,http://www.ebi.ac.uk/efo/EFO_0002107,0.676,None
ebi-a-GCST90012001,Epidermal growth factor levels,epidermal growth factor,EFO:0003298,http://www.ebi.ac.uk/efo/EFO_0003298,0.9,None
ebi-a-GCST90007315,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
ebi-a-GCST004438,Monocyte chemoattractant protein-1 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.809,None
ukb-d-30760_irnt,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-2140,OCIA domain-containing protein 1,OCIA domain-containing protein 1 measurement,EFO:0008252,http://www.ebi.ac.uk/efo/EFO_0008252,0.843,None
met-a-524,X-11491,X-11491 measurement,EFO:0021245,http://www.ebi.ac.uk/efo/EFO_0021245,0.713,None
ebi-a-GCST004624,Sum eosinophil basophil counts,sum of eosinophil and basophil counts,EFO:0009389,http://www.ebi.ac.uk/efo/EFO_0009389,0.959,None
prot-a-2854,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 measurement",EFO:0802270,http://www.ebi.ac.uk/efo/EFO_0802270,0.723,None
prot-a-2516,Transcription factor RelB,transcription factor RelB measurement,EFO:0802140,http://www.ebi.ac.uk/efo/EFO_0802140,0.921,None
prot-a-356,Calcyphosin-like protein,calcyphosin-like protein measurement,EFO:0802360,http://www.ebi.ac.uk/efo/EFO_0802360,0.833,None
prot-a-1061,Fatty acid hydroxylase domain-containing protein 2,fatty acid hydroxylase domain-containing protein 2 measurement,EFO:0802542,http://www.ebi.ac.uk/efo/EFO_0802542,0.889,None
ebi-a-GCST90006917,Anti-herpes simplex virus 1 IgG seropositivity,Herpes simplex virus 2 seropositivity,EFO:0009339,http://www.ebi.ac.uk/efo/EFO_0009339,0.87,None
ebi-a-GCST90010270,Tumor necrosis factor ligand superfamily member 13B levels,tumor necrosis factor ligand superfamily member 13B measurement,EFO:0020793,http://www.ebi.ac.uk/efo/EFO_0020793,0.906,None
prot-c-2620_4_2,"gp130, soluble",soluble gp130 measurement,EFO:0010696,http://www.ebi.ac.uk/efo/EFO_0010696,0.912,None
met-b-266,MDC:%32+,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.771,None
met-c-846,3-hydroxybutyrate,3-hydroxybutyrate measurement,EFO:0010982,http://www.ebi.ac.uk/efo/EFO_0010982,0.781,None
ieu-a-1105,Serum creatinine (eGFRcrea),creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.634,None
prot-a-1623,Kell blood group glycoprotein,kell blood group glycoprotein measurement,EFO:0802671,http://www.ebi.ac.uk/efo/EFO_0802671,0.924,None
prot-a-3208,V-set and immunoglobulin domain-containing protein 2,v-set and immunoglobulin domain-containing protein 2 measurement,EFO:0803308,http://www.ebi.ac.uk/efo/EFO_0803308,0.787,None
ukb-b-20175,"Systolic blood pressure, automated reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
prot-a-2009,Neutrophil cytosol factor 2,neutrophil cytosol factor 2 measurement,EFO:0801837,http://www.ebi.ac.uk/efo/EFO_0801837,0.899,None
ukb-a-374,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
prot-c-3438_10_2,FSTL3,"otospondylomegaepiphyseal dysplasia, autosomal dominant",MONDO:0008490,http://purl.obolibrary.org/obo/MONDO_0008490,0.722,None
prot-a-1178,Guanylate-binding protein 6,guanylate-binding protein 6 measurement,EFO:0801662,http://www.ebi.ac.uk/efo/EFO_0801662,0.811,None
prot-a-2742,SLAM family member 6,SLAM family member 6 measurement,EFO:0020742,http://www.ebi.ac.uk/efo/EFO_0020742,0.911,None
prot-a-263,Brother of CDO,brother of CDO measurement,EFO:0020194,http://www.ebi.ac.uk/efo/EFO_0020194,0.863,None
ukb-a-371,Friendships satisfaction,friendship satisfaction measurement,EFO:0009725,http://www.ebi.ac.uk/efo/EFO_0009725,0.827,None
ebi-a-GCST90002038,CD80 on CD62L+ plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.701,None
met-a-354,Cortisone,cortisone measurement,EFO:0021118,http://www.ebi.ac.uk/efo/EFO_0021118,0.783,None
ebi-a-GCST90012061,SIR2-like protein 2 levels,SIR2-like protein 2 measurement,EFO:0010928,http://www.ebi.ac.uk/efo/EFO_0010928,0.637,None
ieu-a-1097,Microalbuminuria,Moderate albuminuria,HP:0012594,http://purl.obolibrary.org/obo/HP_0012594,0.989,None
ukb-d-30010_irnt,Red blood cell (erythrocyte) count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.783,None
prot-a-2291,Secretory phospholipase A2 receptor,secretory phospholipase A2 receptor measurement,EFO:0802043,http://www.ebi.ac.uk/efo/EFO_0802043,0.932,None
prot-c-3344_60_4,Antithrombin III,Reduced antithrombin III activity,HP:0001976,http://purl.obolibrary.org/obo/HP_0001976,0.836,None
met-a-317,Linoleate (18:2n6),linoleate 18:2n6 measurement,EFO:0021510,http://www.ebi.ac.uk/efo/EFO_0021510,0.666,None
prot-a-2232,Protein disulfide-isomerase A3,protein disulfide-isomerase a3 measurement,EFO:0020668,http://www.ebi.ac.uk/efo/EFO_0020668,0.805,None
prot-a-1663,Kallikrein-5,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.779,None
met-a-511,X-11437,X-11437 measurement,EFO:0021232,http://www.ebi.ac.uk/efo/EFO_0021232,0.691,None
prot-a-2042,beta-nerve growth factor,beta-nerve growth factor measurement,EFO:0008035,http://www.ebi.ac.uk/efo/EFO_0008035,0.766,None
prot-b-1,"SRC proto-oncogene, non-receptor tyrosine kinase",proto-oncogene tyrosine-protein kinase Src measurement,EFO:0010927,http://www.ebi.ac.uk/efo/EFO_0010927,0.683,None
ubm-a-2646,IDP T1 FIRST left hippocampus volume plus IDP T1 FIRST right hippocampus volume,hippocampus fimbria volume,EFO:0009402,http://www.ebi.ac.uk/efo/EFO_0009402,0.685,None
prot-b-39,hepatitis A virus cellular receptor 1,hepatitis A virus cellular receptor 1 measurement,EFO:0010601,http://www.ebi.ac.uk/efo/EFO_0010601,0.925,None
prot-a-2556,Ribonuclease 4,ribonuclease 4 measurement,EFO:0802017,http://www.ebi.ac.uk/efo/EFO_0802017,0.893,None
prot-a-1429,Interferon gamma,interferon gamma,EFO:0003024,http://www.ebi.ac.uk/efo/EFO_0003024,0.996,None
ieu-b-4879,telomere length,telomere length,EFO:0004505,http://www.ebi.ac.uk/efo/EFO_0004505,0.98,None
prot-a-1504,Interleukin-1 receptor antagonist protein,interleukin 1 receptor antagonist measurement,EFO:0004754,http://www.ebi.ac.uk/efo/EFO_0004754,0.881,None
met-b-150,CD32 on mDC,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.692,None
prot-a-559,Carbohydrate sulfotransferase 9,carbohydrate sulfotransferase 9 measurement,EFO:0801449,http://www.ebi.ac.uk/efo/EFO_0801449,0.935,None
prot-a-1050,Protein FAM3B,protein FAM3B measurement,EFO:0021857,http://www.ebi.ac.uk/efo/EFO_0021857,0.898,None
prot-c-3026_5_2,Calpastatin,calpastatin measurement,EFO:0008065,http://www.ebi.ac.uk/efo/EFO_0008065,0.84,None
prot-c-2201_17_6,Endostatin,endostatin measurement,EFO:0020347,http://www.ebi.ac.uk/efo/EFO_0020347,0.798,None
ukb-a-266,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
prot-a-2408,Pregnancy-specific beta-1-glycoprotein 9,pregnancy-specific beta-1-glycoprotein 9 measurement,EFO:0801909,http://www.ebi.ac.uk/efo/EFO_0801909,0.695,None
prot-a-1607,Histone acetyltransferase KAT6A,histone acetyltransferase kat6a measurement,EFO:0020451,http://www.ebi.ac.uk/efo/EFO_0020451,0.948,None
prot-a-839,DnaJ homolog subfamily B member 14,DnaJ homolog subfamily B member 14 measurement,EFO:0801538,http://www.ebi.ac.uk/efo/EFO_0801538,0.948,None
ubm-a-2676,volume Right-Cerebellum-White-Matter,cerebellum white matter volume change measurement,EFO:0021498,http://www.ebi.ac.uk/efo/EFO_0021498,0.813,None
met-d-S_VLDL_CE,Cholesteryl esters in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.689,None
met-a-578,Erythronate*,erythronate measurement,EFO:0021025,http://www.ebi.ac.uk/efo/EFO_0021025,0.842,None
ieu-a-103,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-2968,Transforming growth factor beta receptor type 3,transforming growth factor beta receptor type 3 measurement,EFO:0020779,http://www.ebi.ac.uk/efo/EFO_0020779,0.942,None
prot-a-2966,Transforming growth factor-beta-induced protein ig-h3,transforming growth factor-beta-induced protein ig-h3 measurement,EFO:0008302,http://www.ebi.ac.uk/efo/EFO_0008302,0.708,None
met-a-704,X-13741,X-13741 measurement,EFO:0021359,http://www.ebi.ac.uk/efo/EFO_0021359,0.704,None
prot-a-705,Cystatin-F,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.767,None
prot-a-1791,Leucine-rich repeat serine/threonine-protein kinase 2,leucine-rich repeat serine/threonine-protein kinase 2 measurement,EFO:0021876,http://www.ebi.ac.uk/efo/EFO_0021876,0.726,None
prot-b-23,interleukin 6 receptor,interleukin 18 receptor 1 measurement,EFO:0008178,http://www.ebi.ac.uk/efo/EFO_0008178,0.77,None
prot-a-722,Cathepsin F,cathepsin F measurement,EFO:0022038,http://www.ebi.ac.uk/efo/EFO_0022038,0.842,None
prot-a-2477,Ras-related protein Rab-39B,ras-related protein Rab-39B measurement,EFO:0802994,http://www.ebi.ac.uk/efo/EFO_0802994,0.64,None
ieu-b-4814,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
met-a-424,1-oleoylglycerol (1-monoolein),1-oleoylglycerol 1-monoolein measurement,EFO:0021109,http://www.ebi.ac.uk/efo/EFO_0021109,0.702,None
ieu-b-4764,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
ukb-b-10817,Particulate matter air pollution (pm2.5); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.739,None
ebi-a-GCST90010336,Dihydropteridine reductase levels,dihydropteridine reductase measurement,EFO:0801527,http://www.ebi.ac.uk/efo/EFO_0801527,0.853,None
ukb-d-30810_raw,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
prot-a-1321,Hepatoma-derived growth factor-related protein 2,hepatoma-derived growth factor-related protein 2 measurement,EFO:0020439,http://www.ebi.ac.uk/efo/EFO_0020439,0.796,None
prot-a-1145,Follistatin-related protein 3,follistatin-related protein 3 measurement,EFO:0020394,http://www.ebi.ac.uk/efo/EFO_0020394,0.825,None
prot-a-350,Calcium/calmodulin-dependent protein kinase kinase 1,calcium/calmodulin-dependent protein kinase kinase 1 measurement,EFO:0020217,http://www.ebi.ac.uk/efo/EFO_0020217,0.834,None
prot-a-3273,Zinc finger protein 415,zinc finger protein 415 measurement,EFO:0803281,http://www.ebi.ac.uk/efo/EFO_0803281,0.924,None
prot-a-876,Dual specificity protein phosphatase 4,dual specificity protein phosphatase 4 measurement,EFO:0801550,http://www.ebi.ac.uk/efo/EFO_0801550,0.927,None
prot-a-2361,Prolargin,prolargin measurement,EFO:0801928,http://www.ebi.ac.uk/efo/EFO_0801928,0.809,None
prot-a-3041,Tumor necrosis factor receptor superfamily member 13B,tumor necrosis factor receptor superfamily member 13B measurement,EFO:0020803,http://www.ebi.ac.uk/efo/EFO_0020803,0.95,None
prot-a-2178,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 measurement,EFO:0802331,http://www.ebi.ac.uk/efo/EFO_0802331,0.756,None
prot-a-2443,Receptor-type tyrosine-protein phosphatase delta,receptor-type tyrosine-protein phosphatase delta measurement,EFO:0802998,http://www.ebi.ac.uk/efo/EFO_0802998,0.786,None
prot-a-2904,Histone-lysine N-methyltransferase SUV420H2,histone-lysine N-methyltransferase SUV420H2 measurement,EFO:0802606,http://www.ebi.ac.uk/efo/EFO_0802606,0.859,None
prot-c-3289_19_2,Carbonic Anhydrase X,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.943,None
prot-a-76,Aldehyde dehydrogenase family 3 member B1,aldehyde dehydrogenase family 3 member B1 measurement,EFO:0801361,http://www.ebi.ac.uk/efo/EFO_0801361,0.949,None
prot-c-3583_54_1,Arylsulfatase A,arylsulfatase A measurement,EFO:0020163,http://www.ebi.ac.uk/efo/EFO_0020163,0.898,None
prot-a-2628,Diamine acetyltransferase 1,diamine acetyltransferase 1 measurement,EFO:0802464,http://www.ebi.ac.uk/efo/EFO_0802464,0.918,None
prot-a-314,Uncharacterized protein C3orf18,uncharacterized protein C3orf18 measurement,EFO:0802193,http://www.ebi.ac.uk/efo/EFO_0802193,0.95,None
prot-a-2602,Ribonucleoside-diphosphate reductase subunit M2 B,ribonucleoside-diphosphate reductase subunit M2 B measurement,EFO:0802022,http://www.ebi.ac.uk/efo/EFO_0802022,0.897,None
met-a-307,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
ebi-a-GCST90010148,Leptin levels,leptin receptor measurement,EFO:0004635,http://www.ebi.ac.uk/efo/EFO_0004635,0.84,None
ebi-a-GCST90001646,Natural Killer %CD3- lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.674,None
prot-c-3399_31_2,STAB2,AB2,EFO:0004043,http://www.ebi.ac.uk/efo/EFO_0004043,0.772,None
prot-a-1382,Estradiol 17-beta-dehydrogenase 1,estradiol 17-beta-dehydrogenase 1 measurement,EFO:0020365,http://www.ebi.ac.uk/efo/EFO_0020365,0.72,None
prot-a-2085,Nuclear receptor subfamily 1 group D member 1,nuclear receptor subfamily 1 group d member 1 measurement,EFO:0020614,http://www.ebi.ac.uk/efo/EFO_0020614,0.953,None
prot-c-3798_71_1,Carbonic anhydrase 9,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.94,None
prot-a-1974,Matrix-remodeling-associated protein 7,matrix-remodeling-associated protein 7 measurement,EFO:0801789,http://www.ebi.ac.uk/efo/EFO_0801789,0.728,None
ebi-a-GCST003435,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
prot-a-1906,Promotilin,promotilin measurement,EFO:0801930,http://www.ebi.ac.uk/efo/EFO_0801930,0.778,None
ieu-a-1283,Alcohol consumption,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.998,None
prot-a-880,"Dynein light chain 1, cytoplasmic","dynein light chain 1, cytoplasmic measurement",EFO:0020339,http://www.ebi.ac.uk/efo/EFO_0020339,0.865,None
prot-a-1695,Laminin,laminin measurement,EFO:0020528,http://www.ebi.ac.uk/efo/EFO_0020528,0.762,None
prot-a-1725,Leptin receptor,leptin receptor measurement,EFO:0004635,http://www.ebi.ac.uk/efo/EFO_0004635,0.858,None
prot-a-602,CCR4-NOT transcription complex subunit 1,CCR4-NOT transcription complex subunit 1 measurement,EFO:0802377,http://www.ebi.ac.uk/efo/EFO_0802377,0.786,None
met-c-937,Total phosphoglycerides,phosphoglyceric acid measurement,EFO:0010523,http://www.ebi.ac.uk/efo/EFO_0010523,0.658,None
prot-a-3072,Toll-interacting protein,toll-interacting protein measurement,EFO:0802133,http://www.ebi.ac.uk/efo/EFO_0802133,0.738,None
ieu-a-974,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1296,Glycophorin-A,glycophorin-A measurement,EFO:0802576,http://www.ebi.ac.uk/efo/EFO_0802576,0.648,None
prot-a-2876,Stress-induced-phosphoprotein 1,stress-induced-phosphoprotein 1 measurement,EFO:0020755,http://www.ebi.ac.uk/efo/EFO_0020755,0.73,None
ebi-a-GCST004939,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-a-3277,Zinc finger protein 843,zinc finger protein 843 measurement,EFO:0803285,http://www.ebi.ac.uk/efo/EFO_0803285,0.929,None
ieu-b-4839,Depressive symptoms,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.984,None
met-c-939,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
prot-a-2470,Sulfhydryl oxidase 2,sulfhydryl oxidase 2 measurement,EFO:0802100,http://www.ebi.ac.uk/efo/EFO_0802100,0.93,None
ukb-b-4643,Age at hysterectomy,hysterectomy,EFO:0003881,http://www.ebi.ac.uk/efo/EFO_0003881,0.839,None
prot-a-2686,Protein SERAC1,protein SERAC1 measurement,EFO:0801963,http://www.ebi.ac.uk/efo/EFO_0801963,0.875,None
ebi-a-GCST90002080,SSC-A on T cell,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.769,None
ieu-b-4847,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
ebi-a-GCST90001795,CD25 on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.711,None
ukb-a-334,Potassium in urine,urinary potassium measurement,EFO:0010952,http://www.ebi.ac.uk/efo/EFO_0010952,0.875,None
ubm-a-2672,volume Left-vessel,volume,EFO:0001715,http://www.ebi.ac.uk/efo/EFO_0001715,0.613,None
prot-a-2654,SCP2 sterol-binding domain-containing protein 1,SCP2 sterol-binding domain-containing protein 1 measurement,EFO:0802038,http://www.ebi.ac.uk/efo/EFO_0802038,0.828,None
prot-a-867,Desmocollin-3,desmocollin-2 measurement,EFO:0021936,http://www.ebi.ac.uk/efo/EFO_0021936,0.72,None
prot-a-2712,Pulmonary surfactant-associated protein D,pulmonary surfactant-associated protein d measurement,EFO:0020693,http://www.ebi.ac.uk/efo/EFO_0020693,0.86,None
prot-c-5443_62_2,ANP,X-linked dyserythropoetic anemia with abnormal platelets and neutropenia,MONDO:0010444,http://purl.obolibrary.org/obo/MONDO_0010444,0.666,None
prot-a-2801,Vinexin b,vinexin b measurement,EFO:0803258,http://www.ebi.ac.uk/efo/EFO_0803258,0.858,None
prot-a-758,Protein CYR61,protein CYR61 measurement,EFO:0802929,http://www.ebi.ac.uk/efo/EFO_0802929,0.918,None
prot-a-576,C-type lectin domain family 4 member D,C-type lectin domain family 4 member D measurement,EFO:0802347,http://www.ebi.ac.uk/efo/EFO_0802347,0.799,None
prot-a-1981,Myomesin-2,benign muscle neoplasm,MONDO:0003061,http://purl.obolibrary.org/obo/MONDO_0003061,0.623,None
prot-a-328,Carbonic anhydrase 1,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.955,None
prot-c-2875_15_2,TBP,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.977,None
prot-b-12,TNF superfamily member 11,tumor necrosis factor alpha gene expression measurement,EFO:0600069,http://www.ebi.ac.uk/efo/EFO_0600069,0.704,None
prot-c-2977_7_2,EDAR,hypohidrotic ectodermal dysplasia,MONDO:0016535,http://purl.obolibrary.org/obo/MONDO_0016535,0.708,None
met-b-258,NKT:%TM,targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.637,None
prot-a-3270,Zinc finger protein 358,zinc finger protein 358 measurement,EFO:0803278,http://www.ebi.ac.uk/efo/EFO_0803278,0.926,None
prot-a-2866,"Steroidogenic acute regulatory protein, mitochondrial","steroidogenic acute regulatory protein, mitochondrial measurement",EFO:0802091,http://www.ebi.ac.uk/efo/EFO_0802091,0.902,None
prot-c-2693_20_3,OSM,oncostatin-M measurement,EFO:0010792,http://www.ebi.ac.uk/efo/EFO_0010792,0.998,None
prot-c-4234_8_2,IL-1 R4,ring chromosome 4,MONDO:0015439,http://purl.obolibrary.org/obo/MONDO_0015439,0.838,None
prot-a-1143,Follistatin-related protein 1,follistatin-related protein 1 measurement,EFO:0021934,http://www.ebi.ac.uk/efo/EFO_0021934,0.823,None
prot-a-2775,Single-pass membrane and coiled-coil domain-containing protein 2,single-pass membrane and coiled-coil domain-containing protein 2 measurement,EFO:0803078,http://www.ebi.ac.uk/efo/EFO_0803078,0.825,None
prot-a-266,Bactericidal permeability-increasing protein,bactericidal permeability-increasing protein measurement,EFO:0020172,http://www.ebi.ac.uk/efo/EFO_0020172,0.871,None
ieu-a-1101,Urinary albumin-to-creatinine ratio,urinary albumin to creatinine ratio,EFO:0007778,http://www.ebi.ac.uk/efo/EFO_0007778,0.995,None
met-a-600,X-10346,X-10346 measurement,EFO:0021212,http://www.ebi.ac.uk/efo/EFO_0021212,0.705,None
ebi-a-GCST90002037,CD80 on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.811,None
met-a-557,X-11876,X-11876 measurement,EFO:0021274,http://www.ebi.ac.uk/efo/EFO_0021274,0.718,None
met-a-471,2-aminobutyrate,2-aminobutyrate measurement,EFO:0020017,http://www.ebi.ac.uk/efo/EFO_0020017,0.717,None
prot-a-572,C-type lectin domain family 2 member A,C-type lectin domain family 2 member A measurement,EFO:0802344,http://www.ebi.ac.uk/efo/EFO_0802344,0.793,None
prot-a-1224,Glucocorticoid modulatory element-binding protein 2,glucocorticoid modulatory element-binding protein 2 measurement,EFO:0802569,http://www.ebi.ac.uk/efo/EFO_0802569,0.889,None
prot-a-2391,Brain-specific serine protease 4,brain-specific serine protease 4 measurement,EFO:0020192,http://www.ebi.ac.uk/efo/EFO_0020192,0.827,None
ebi-a-GCST90010337,Regenerating islet-derived protein 4 levels,regenerating islet-derived protein 4 measurement,EFO:0021921,http://www.ebi.ac.uk/efo/EFO_0021921,0.754,None
ebi-a-GCST90010277,Lysophosphatidic acid phosphatase type 6 levels,lysosomal acid phosphatase measurement,EFO:0801776,http://www.ebi.ac.uk/efo/EFO_0801776,0.658,None
ebi-a-GCST90014263,X-linked dystonia-parkinsonism,X-linked dystonia-parkinsonism,MONDO:0010747,http://purl.obolibrary.org/obo/MONDO_0010747,0.914,None
ebi-a-GCST90010179,Thrombopoietin levels,thrombopoietin,EFO:0003236,http://www.ebi.ac.uk/efo/EFO_0003236,0.893,None
prot-a-702,Cystatin-D,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.788,None
prot-c-4900_8_1,C3a,C3A,EFO:0002121,http://www.ebi.ac.uk/efo/EFO_0002121,0.999,None
met-c-902,Concentration of medium HDL particles,concentration of medium VLDL particles,EFO:0022152,http://www.ebi.ac.uk/efo/EFO_0022152,0.811,None
prot-a-2573,E3 ubiquitin-protein ligase RNF8,E3 ubiquitin-protein ligase RNF8 measurement,EFO:0801557,http://www.ebi.ac.uk/efo/EFO_0801557,0.898,None
ebi-a-GCST90010259,P-selectin levels,e-selectin measurement,EFO:0004575,http://www.ebi.ac.uk/efo/EFO_0004575,0.697,None
ubm-a-390,IDP dMRI TBSS L2 Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.605,None
prot-a-2825,Kunitz-type protease inhibitor 3,kunitz-type protease inhibitor 3 measurement,EFO:0801750,http://www.ebi.ac.uk/efo/EFO_0801750,0.784,None
ebi-a-GCST90006914,Helicobacter pylori OMP antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.665,None
prot-a-1471,Interleukin-23,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.839,None
prot-c-4237_70_3,LCMT1,Charcot-Marie-Tooth disease type 1,MONDO:0019011,http://purl.obolibrary.org/obo/MONDO_0019011,0.652,None
prot-a-3180,Ubiquitin carboxyl-terminal hydrolase 25,ubiquitin carboxyl-terminal hydrolase 25 measurement,EFO:0021881,http://www.ebi.ac.uk/efo/EFO_0021881,0.848,None
prot-a-3101,Trem-like transcript 4 protein,trem-like transcript 4 protein measurement,EFO:0802160,http://www.ebi.ac.uk/efo/EFO_0802160,0.813,None
prot-a-2879,Stathmin-2,stathmin-2 measurement,EFO:0802087,http://www.ebi.ac.uk/efo/EFO_0802087,0.628,None
ieu-a-790,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ebi-a-GCST90002360,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-a-1802,Leukocyte-specific transcript 1 protein,leukocyte-specific transcript 1 protein measurement,EFO:0802707,http://www.ebi.ac.uk/efo/EFO_0802707,0.865,None
prot-c-3069_52_3,IgM,hyper-IgM syndrome type 1,MONDO:0010626,http://purl.obolibrary.org/obo/MONDO_0010626,0.701,None
prot-a-826,Disks large homolog 3,disks large homolog 3 measurement,EFO:0802472,http://www.ebi.ac.uk/efo/EFO_0802472,0.915,None
ieu-a-1056,Heart rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.998,None
prot-a-1868,Induced myeloid leukemia cell differentiation protein Mcl-1,induced myeloid leukemia cell differentiation protein Mcl-1 measurement,EFO:0021910,http://www.ebi.ac.uk/efo/EFO_0021910,0.854,None
ukb-d-30600_irnt,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ukb-d-30680_irnt,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
prot-a-1901,Allergin-1,atopic eczema,EFO:0000274,http://www.ebi.ac.uk/efo/EFO_0000274,0.786,None
ebi-a-GCST004441,Interleukin-18 levels,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.814,None
prot-a-2293,Urokinase plasminogen activator surface receptor,urokinase plasminogen activator surface receptor measurement,EFO:0010932,http://www.ebi.ac.uk/efo/EFO_0010932,0.951,None
prot-a-2965,Transforming growth factor beta-3,transforming growth factor beta measurement,EFO:0004818,http://www.ebi.ac.uk/efo/EFO_0004818,0.91,None
prot-a-1275,Glutamate receptor 4,glutamate receptor 4 measurement,EFO:0801630,http://www.ebi.ac.uk/efo/EFO_0801630,0.886,None
prot-a-952,Ectonucleoside triphosphate diphosphohydrolase 3,ectonucleoside triphosphate diphosphohydrolase 3 measurement,EFO:0020343,http://www.ebi.ac.uk/efo/EFO_0020343,0.961,None
prot-a-2711,Pulmonary surfactant-associated protein C,pulmonary surfactant-associated protein C measurement,EFO:0801980,http://www.ebi.ac.uk/efo/EFO_0801980,0.858,None
prot-a-2401,Pregnancy-specific beta-1-glycoprotein 2,pregnancy-specific beta-1-glycoprotein 2 measurement,EFO:0802896,http://www.ebi.ac.uk/efo/EFO_0802896,0.69,None
prot-a-1341,Histone H1.2,H1-hESC,EFO:0003042,http://www.ebi.ac.uk/efo/EFO_0003042,0.631,None
prot-a-2056,"NACHT, LRR and PYD domains-containing protein 1","NACHT, LRR and PYD domains-containing protein 1 measurement",EFO:0802780,http://www.ebi.ac.uk/efo/EFO_0802780,0.829,None
ebi-a-GCST90012013,Angiopoietin-1 receptor levels,angiopoietin-1 receptor measurement,EFO:0010600,http://www.ebi.ac.uk/efo/EFO_0010600,0.733,None
prot-a-1487,Interleukin-17 receptor B,interleukin 17 receptor B measurement,EFO:0008176,http://www.ebi.ac.uk/efo/EFO_0008176,0.909,None
prot-a-1011,"Fatty acid-binding protein, liver","fatty acid-binding protein, liver measurement",EFO:0021855,http://www.ebi.ac.uk/efo/EFO_0021855,0.744,None
ukb-d-30100_irnt,Mean platelet (thrombocyte) volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.741,None
ebi-a-GCST90001821,IgD on IgD+ CD24- B cell,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.637,None
prot-a-2631,DNA-binding protein SATB2,DNA-binding protein SATB2 measurement,EFO:0802484,http://www.ebi.ac.uk/efo/EFO_0802484,0.814,None
met-c-953,Total lipids in very small VLDL,total lipids in very small VLDL measurement,EFO:0022156,http://www.ebi.ac.uk/efo/EFO_0022156,0.91,None
ebi-a-GCST90000503,Tumor necrosis factor ligand superfamily member 11 levels,tumor necrosis factor ligand superfamily member 11 measurement,EFO:0010617,http://www.ebi.ac.uk/efo/EFO_0010617,0.896,None
prot-a-1427,Interferon beta,interferon beta,EFO:0003023,http://www.ebi.ac.uk/efo/EFO_0003023,0.997,None
prot-a-1285,Glutathione S-transferase A4,glutathione S-transferase A4 measurement,EFO:0801637,http://www.ebi.ac.uk/efo/EFO_0801637,0.811,None
prot-a-822,Dickkopf-related protein 3,Dickkopf-related protein 3 measurement,EFO:0008109,http://www.ebi.ac.uk/efo/EFO_0008109,0.777,None
ukb-a-318,Birth weight of first child,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.695,None
ukb-d-30870_irnt,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-992,"Persulfide dioxygenase ETHE1, mitochondrial","persulfide dioxygenase ETHE1, mitochondrial measurement",EFO:0008258,http://www.ebi.ac.uk/efo/EFO_0008258,0.869,None
prot-a-1495,Interleukin-1 beta,interleukin-1 beta measurement,EFO:0004812,http://www.ebi.ac.uk/efo/EFO_0004812,0.879,None
prot-a-1007,Prothrombin,thrombin,EFO:0003183,http://www.ebi.ac.uk/efo/EFO_0003183,0.83,None
prot-a-677,Putative chondrosarcoma-associated gene 1 protein,putative chondrosarcoma-associated gene 1 protein measurement,EFO:0802980,http://www.ebi.ac.uk/efo/EFO_0802980,0.845,None
met-a-330,Nonadecanoate (19:0),nonadecanoate 19:0 measurement,EFO:0021069,http://www.ebi.ac.uk/efo/EFO_0021069,0.681,None
prot-c-2954_56_2,MMP-8,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.902,None
prot-a-1418,Interferon alpha-10,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.937,None
prot-a-1630,UPF0577 protein KIAA1324,UPF0577 protein KIAA1324 measurement,EFO:0803235,http://www.ebi.ac.uk/efo/EFO_0803235,0.958,None
prot-c-3743_1_2,MMP-10,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.883,None
met-c-867,Total cholesterol in IDL,total cholesterol in IDL,EFO:0022184,http://www.ebi.ac.uk/efo/EFO_0022184,0.965,None
prot-a-2309,Plexin-C1,plexin-C1 measurement,EFO:0008266,http://www.ebi.ac.uk/efo/EFO_0008266,0.613,None
prot-c-3896_5_2,Phosphoglycerate mutase 1,phosphoglycerate mutase 1 measurement,EFO:0020639,http://www.ebi.ac.uk/efo/EFO_0020639,0.908,None
ebi-a-GCST90010237,Matrix extracellular phosphoglycoprotein levels,matrix extracellular phosphoglycoprotein measurement,EFO:0020557,http://www.ebi.ac.uk/efo/EFO_0020557,0.9,None
met-d-Val,Valine,valine measurement,EFO:0009792,http://www.ebi.ac.uk/efo/EFO_0009792,0.716,None
ebi-a-GCST90000440,beta-nerve growth factor levels,beta-nerve growth factor measurement,EFO:0008035,http://www.ebi.ac.uk/efo/EFO_0008035,0.693,None
prot-a-2243,Platelet endothelial aggregation receptor 1,platelet endothelial aggregation receptor 1 measurement,EFO:0801886,http://www.ebi.ac.uk/efo/EFO_0801886,0.937,None
met-a-646,X-12728,X-12728 measurement,EFO:0021327,http://www.ebi.ac.uk/efo/EFO_0021327,0.699,None
prot-a-556,Carbohydrate sulfotransferase 3,carbohydrate sulfotransferase 3 measurement,EFO:0802367,http://www.ebi.ac.uk/efo/EFO_0802367,0.934,None
prot-a-280,Uncharacterized protein C10orf35,uncharacterized protein C10orf35 measurement,EFO:0802189,http://www.ebi.ac.uk/efo/EFO_0802189,0.953,None
prot-a-3252,Tyrosine-protein kinase ZAP-70,tyrosine-protein kinase ZAP-70 measurement,EFO:0020833,http://www.ebi.ac.uk/efo/EFO_0020833,0.654,None
prot-a-1159,Protein G6b,protein G6b measurement,EFO:0802945,http://www.ebi.ac.uk/efo/EFO_0802945,0.882,None
prot-a-1745,Leukocyte immunoglobulin-like receptor subfamily B member 3,leukocyte immunoglobulin-like receptor subfamily B member 3 measurement,EFO:0802705,http://www.ebi.ac.uk/efo/EFO_0802705,0.921,None
ukb-b-2105,Work/job satisfaction,job satisfaction measurement,EFO:0009723,http://www.ebi.ac.uk/efo/EFO_0009723,0.901,None
ukb-d-30870_raw,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-1770,Leucine-rich repeats and immunoglobulin-like domains protein 3,leucine-rich repeats and immunoglobulin-like domains protein 3 measurement,EFO:0020534,http://www.ebi.ac.uk/efo/EFO_0020534,0.854,None
prot-a-1316,Hemoglobin subunit theta-1,hemoglobin subunit theta-1 measurement,EFO:0801669,http://www.ebi.ac.uk/efo/EFO_0801669,0.805,None
ebi-a-GCST90012020,Lectin-like oxidized LDL receptor 1 levels,lectin-like oxidized LDL receptor 1 measurement,EFO:0010918,http://www.ebi.ac.uk/efo/EFO_0010918,0.824,None
met-a-695,X-13553,X-13553 measurement,EFO:0021355,http://www.ebi.ac.uk/efo/EFO_0021355,0.71,None
ieu-b-4845,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-c-2630_12_2,IL-1 R AcP,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,EFO:0009028,http://www.ebi.ac.uk/efo/EFO_0009028,0.641,None
met-a-679,"N2,N2-dimethylguanosine",N2,EFO:0004028,http://www.ebi.ac.uk/efo/EFO_0004028,0.727,None
prot-a-2149,Opioid-binding protein/cell adhesion molecule,opioid-binding protein/cell adhesion molecule measurement,EFO:0020618,http://www.ebi.ac.uk/efo/EFO_0020618,0.749,None
prot-a-1165,Growth arrest and DNA damage-inducible proteins-interacting protein 1,growth arrest and DNA damage-inducible proteins-interacting protein 1 measurement,EFO:0803291,http://www.ebi.ac.uk/efo/EFO_0803291,0.847,None
met-a-362,Betaine,proline betaine measurement,EFO:0011000,http://www.ebi.ac.uk/efo/EFO_0011000,0.715,None
prot-a-1252,Glucose-6-phosphate isomerase,hemolytic anemia due to glucophosphate isomerase deficiency,MONDO:0013275,http://purl.obolibrary.org/obo/MONDO_0013275,0.794,None
prot-a-2551,RecQ-mediated genome instability protein 1,recQ-mediated genome instability protein 1 measurement,EFO:0801992,http://www.ebi.ac.uk/efo/EFO_0801992,0.757,None
prot-c-2692_74_2,NPS-PLA2,nail-patella syndrome,MONDO:0008061,http://purl.obolibrary.org/obo/MONDO_0008061,0.748,None
prot-a-2868,Signal transducer and activator of transcription 1-alpha/beta,signal transducer and activator of transcription 3 measurement,EFO:0021907,http://www.ebi.ac.uk/efo/EFO_0021907,0.846,None
prot-a-446,T-cell surface glycoprotein CD3 gamma chain,t-cell surface glycoprotein CD3 gamma chain measurement,EFO:0803133,http://www.ebi.ac.uk/efo/EFO_0803133,0.873,None
prot-c-2925_9_1,PAI-1,Pai syndrome,MONDO:0007956,http://purl.obolibrary.org/obo/MONDO_0007956,0.758,None
prot-a-1862,Methyl-CpG-binding domain protein 4,enrichment of methylated DNA,EFO:0004185,http://www.ebi.ac.uk/efo/EFO_0004185,0.688,None
ieu-b-4817,Systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
met-d-IDL_PL,Phospholipids in IDL,phospholipids in IDL measurement,EFO:0022164,http://www.ebi.ac.uk/efo/EFO_0022164,0.888,None
ebi-a-GCST90016667,Spleen volume,spleen volume,EFO:0600047,http://www.ebi.ac.uk/efo/EFO_0600047,0.98,None
ebi-a-GCST90011310,F_Bacteroidaceae abundance,commensal Bacteroidaceae infectious disease,EFO:1000872,http://www.ebi.ac.uk/efo/EFO_1000872,0.697,None
met-a-398,X-05426,X-05426 measurement,EFO:0021195,http://www.ebi.ac.uk/efo/EFO_0021195,0.672,None
ukb-b-17952,"Heel Broadband ultrasound attenuation (BUA), manual entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.787,None
prot-a-1386,Endoplasmin,endoplasmin measurement,EFO:0801570,http://www.ebi.ac.uk/efo/EFO_0801570,0.83,None
prot-a-1961,Mitochondrial fission regulator 1,mitochondrial fission regulator 1 measurement,EFO:0802749,http://www.ebi.ac.uk/efo/EFO_0802749,0.916,None
met-d-L_HDL_FC,Free cholesterol in large HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.915,None
met-a-666,X-12847,X-12847 measurement,EFO:0021340,http://www.ebi.ac.uk/efo/EFO_0021340,0.702,None
prot-c-4135_84_2,IgE,"IgE responsiveness, atopic",MONDO:0007817,http://purl.obolibrary.org/obo/MONDO_0007817,0.719,None
prot-a-1750,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 measurement,EFO:0802692,http://www.ebi.ac.uk/efo/EFO_0802692,0.84,None
prot-a-1656,Kallikrein-11,kallikrein-11 measurement,EFO:0010573,http://www.ebi.ac.uk/efo/EFO_0010573,0.771,None
ukb-b-8537,Starch,multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,MONDO:0009359,http://purl.obolibrary.org/obo/MONDO_0009359,0.662,None
prot-a-599,UMP-CMP kinase,UMP-CMP kinase measurement,EFO:0008313,http://www.ebi.ac.uk/efo/EFO_0008313,0.681,None
prot-a-1481,Interleukin-17A,interleukin-17A measurement,EFO:0022026,http://www.ebi.ac.uk/efo/EFO_0022026,0.739,None
ebi-a-GCST90010284,DNA-(apurinic or apyrimidinic site) lyase levels,DNA-(apurinic or apyrimidinic site) lyase measurement,EFO:0801533,http://www.ebi.ac.uk/efo/EFO_0801533,0.725,None
bbj-a-49,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-a-2955,Tuftelin-interacting protein 11,tuftelin-interacting protein 11 measurement,EFO:0803199,http://www.ebi.ac.uk/efo/EFO_0803199,0.852,None
ebi-a-GCST90001466,CD86+ plasmacytoid Dendritic Cell Absolute Count,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.69,None
ebi-a-GCST90010263,Tissue factor pathway inhibitor levels,tissue factor pathway inhibitor measurement,EFO:0007968,http://www.ebi.ac.uk/efo/EFO_0007968,0.89,None
prot-a-348,Calcium/calmodulin-dependent protein kinase type II subunit alpha,calcium/calmodulin-dependent protein kinase type II subunit alpha measurement,EFO:0020218,http://www.ebi.ac.uk/efo/EFO_0020218,0.841,None
prot-a-1887,Microfibrillar-associated protein 5,microfibrillar-associated protein 5 measurement,EFO:0802746,http://www.ebi.ac.uk/efo/EFO_0802746,0.824,None
prot-a-2111,Neuron-specific protein family member 2,neuron-specific protein family member 2 measurement,EFO:0801832,http://www.ebi.ac.uk/efo/EFO_0801832,0.847,None
ebi-a-GCST90002331,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
prot-a-1212,Appetite-regulating hormone,appetite-regulating hormone measurement,EFO:0022016,http://www.ebi.ac.uk/efo/EFO_0022016,0.83,None
met-d-M_VLDL_FC,Free cholesterol in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.804,None
ebi-a-GCST006951,Feeling hurt,feeling emotionally hurt measurement,EFO:0009599,http://www.ebi.ac.uk/efo/EFO_0009599,0.707,None
prot-a-1911,Stromelysin-2,stromelysin-2 measurement,EFO:0802095,http://www.ebi.ac.uk/efo/EFO_0802095,0.672,None
prot-a-3157,UDP-glucuronosyltransferase 1-8,UDP-glucuronosyltransferase 2A1 measurement,EFO:0802186,http://www.ebi.ac.uk/efo/EFO_0802186,0.743,None
bbj-a-56,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
prot-a-3074,DNA topoisomerase 1,DNA topoisomerase 1 measurement,EFO:0020331,http://www.ebi.ac.uk/efo/EFO_0020331,0.88,None
met-c-959,Phospholipids in chylomicrons and largest VLDL particles,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.629,None
ebi-a-GCST90010272,Transferrin receptor protein 1 levels,transferrin receptor protein 1 measurement,EFO:0802142,http://www.ebi.ac.uk/efo/EFO_0802142,0.835,None
prot-a-1754,Vesicular integral-membrane protein VIP36,vesicular integral-membrane protein VIP36 measurement,EFO:0022012,http://www.ebi.ac.uk/efo/EFO_0022012,0.893,None
prot-c-4969_2_1,Carbonic anhydrase I,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.93,None
prot-a-405,C-C motif chemokine 27,C-C motif chemokine 27 measurement,EFO:0020198,http://www.ebi.ac.uk/efo/EFO_0020198,0.714,None
prot-a-2697,Glia-derived nexin,glia-derived nexin measurement,EFO:0020403,http://www.ebi.ac.uk/efo/EFO_0020403,0.762,None
prot-a-1621,KDEL motif-containing protein 2,KDEL motif-containing protein 2 measurement,EFO:0801740,http://www.ebi.ac.uk/efo/EFO_0801740,0.787,None
prot-a-1154,"Alpha-(1,6)-fucosyltransferase",fucosyltransferase 6 deficiency,MONDO:0013462,http://purl.obolibrary.org/obo/MONDO_0013462,0.799,None
bbj-a-42,Non-albumin protein,serum non-albumin protein measurement,EFO:0004568,http://www.ebi.ac.uk/efo/EFO_0004568,0.712,None
prot-a-60,Activator of 90 kDa heat shock protein ATPase homolog 1,activator of 90 kDa heat shock protein ATPase homolog 1 measurement,EFO:0801341,http://www.ebi.ac.uk/efo/EFO_0801341,0.956,None
prot-a-7,Tyrosine-protein kinase ABL1,tyrosine-protein kinase ABL1 measurement,EFO:0020818,http://www.ebi.ac.uk/efo/EFO_0020818,0.822,None
prot-a-3008,Collectrin,collectrin measurement,EFO:0802423,http://www.ebi.ac.uk/efo/EFO_0802423,0.811,None
met-a-532,X-11540,X-11540 measurement,EFO:0021252,http://www.ebi.ac.uk/efo/EFO_0021252,0.713,None
met-a-327,Methionine,methionine measurement,EFO:0009771,http://www.ebi.ac.uk/efo/EFO_0009771,0.823,None
prot-a-2086,Nuclear receptor subfamily 1 group D member 2,nuclear receptor subfamily 1 group D member 2 measurement,EFO:0801853,http://www.ebi.ac.uk/efo/EFO_0801853,0.952,None
prot-a-1136,Forkhead box protein C2,forkhead box protein C2 measurement,EFO:0802553,http://www.ebi.ac.uk/efo/EFO_0802553,0.929,None
prot-a-3089,Tubulin polymerization-promoting protein family member 2,tubulin polymerization-promoting protein family member 2 measurement,EFO:0802164,http://www.ebi.ac.uk/efo/EFO_0802164,0.902,None
ukb-b-11598,Pulse wave reflection index,pulse wave reflection index measurement,EFO:0009804,http://www.ebi.ac.uk/efo/EFO_0009804,0.927,None
prot-a-506,Adenosine deaminase CECR1,adenosine deaminase measurement,EFO:0010761,http://www.ebi.ac.uk/efo/EFO_0010761,0.674,None
prot-a-1980,Unconventional myosin-VI,unconventional myosin-VI measurement,EFO:0803233,http://www.ebi.ac.uk/efo/EFO_0803233,0.767,None
ukb-a-363,Pulse rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.996,None
prot-a-3111,Tetratricopeptide repeat protein 17,tetratricopeptide repeat protein 17 measurement,EFO:0803144,http://www.ebi.ac.uk/efo/EFO_0803144,0.936,None
prot-c-4996_66_1,HRG,heregulin B1,EFO:0003308,http://www.ebi.ac.uk/efo/EFO_0003308,0.996,None
prot-a-641,"Cytochrome c oxidase subunit 8A, mitochondrial","cytochrome c oxidase subunit 8A, mitochondrial measurement",EFO:0801516,http://www.ebi.ac.uk/efo/EFO_0801516,0.868,None
prot-a-2257,Peptidoglycan recognition protein 1,peptidoglycan recognition protein 1 measurement,EFO:0020624,http://www.ebi.ac.uk/efo/EFO_0020624,0.929,None
met-c-909,Total cholesterol in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.973,None
prot-a-1174,Galanin-like peptide,galanin-like peptide measurement,EFO:0801612,http://www.ebi.ac.uk/efo/EFO_0801612,0.8,None
ebi-a-GCST004421,beta-nerve growth factor levels,beta-nerve growth factor measurement,EFO:0008035,http://www.ebi.ac.uk/efo/EFO_0008035,0.693,None
prot-a-2215,Programmed cell death 1 ligand 2,programmed cell death 1 ligand 2 measurement,EFO:0008268,http://www.ebi.ac.uk/efo/EFO_0008268,0.91,None
met-a-677,Phenylacetylglutamine,phenylacetylglutamine measurement,EFO:0021013,http://www.ebi.ac.uk/efo/EFO_0021013,0.92,None
prot-a-723,Cathepsin G,cathepsin G measurement,EFO:0020242,http://www.ebi.ac.uk/efo/EFO_0020242,0.829,None
prot-a-1389,Oxidoreductase HTATIP2,oxidoreductase HTATIP2 measurement,EFO:0801863,http://www.ebi.ac.uk/efo/EFO_0801863,0.933,None
prot-a-2073,Pro-FMRFamide-related neuropeptide FF,pro-FMRFamide-related neuropeptide FF measurement,EFO:0801911,http://www.ebi.ac.uk/efo/EFO_0801911,0.757,None
prot-c-3415_61_2,BSP,BSPP,EFO:0008667,http://www.ebi.ac.uk/efo/EFO_0008667,0.612,None
prot-a-2766,SLIT and NTRK-like protein 1,SLIT and NTRK-like protein 1 measurement,EFO:0021974,http://www.ebi.ac.uk/efo/EFO_0021974,0.753,None
prot-a-1042,Protein FAM19A4,protein FAM19A4 measurement,EFO:0802941,http://www.ebi.ac.uk/efo/EFO_0802941,0.918,None
prot-a-2901,Sushi domain-containing protein 1,Sushi domain-containing protein 1 measurement,EFO:0803111,http://www.ebi.ac.uk/efo/EFO_0803111,0.862,None
ebi-a-GCST90001644,B cell %lymphocyte,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.705,None
ebi-a-GCST90001911,CD45 on Natural Killer,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.641,None
prot-a-1908,Membrane metallo-endopeptidase-like 1,membrane metallo-endopeptidase-like 1 measurement,EFO:0020564,http://www.ebi.ac.uk/efo/EFO_0020564,0.76,None
ebi-a-GCST004452,Interleukin-5 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.798,None
met-a-672,Isovalerate,isovalerate measurement,EFO:0021051,http://www.ebi.ac.uk/efo/EFO_0021051,0.846,None
met-a-662,X-12816,X-12816 measurement,EFO:0021336,http://www.ebi.ac.uk/efo/EFO_0021336,0.7,None
prot-a-1203,GDNF family receptor alpha-3,gdnf family receptor alpha-1 measurement,EFO:0020400,http://www.ebi.ac.uk/efo/EFO_0020400,0.828,None
met-a-732,X-14662,X-14662 measurement,EFO:0021377,http://www.ebi.ac.uk/efo/EFO_0021377,0.713,None
prot-a-2782,Submaxillary gland androgen-regulated protein 3A,submaxillary gland androgen-regulated protein 3A measurement,EFO:0802097,http://www.ebi.ac.uk/efo/EFO_0802097,0.878,None
ebi-a-GCST90010175,Serine/threonine-protein kinase 4 levels,serine/threonine-protein kinase PAK 4 measurement,EFO:0802059,http://www.ebi.ac.uk/efo/EFO_0802059,0.606,None
prot-a-1099,Fibroblast growth factor 8 isoform B,fibroblast growth factor 8 isoform b measurement,EFO:0020386,http://www.ebi.ac.uk/efo/EFO_0020386,0.933,None
prot-c-4924_32_1,MMP-1,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.95,None
prot-a-2055,"NACHT, LRR and PYD domains-containing protein 10","NACHT, LRR and PYD domains-containing protein 10 measurement",EFO:0802781,http://www.ebi.ac.uk/efo/EFO_0802781,0.833,None
met-a-629,X-12510--2-aminooctanoic acid,X-12510--2-aminooctanoic acid measurement,EFO:0021313,http://www.ebi.ac.uk/efo/EFO_0021313,0.673,None
prot-a-1863,Mannose-binding protein C,mannose-binding protein C measurement,EFO:0008224,http://www.ebi.ac.uk/efo/EFO_0008224,0.775,None
prot-c-5014_49_1,NCK1,cytoplasmic protein NCK1 measurement,EFO:0020307,http://www.ebi.ac.uk/efo/EFO_0020307,0.633,None
prot-a-1126,Receptor-type tyrosine-protein kinase FLT3,receptor-type tyrosine-protein kinase flt3 measurement,EFO:0020703,http://www.ebi.ac.uk/efo/EFO_0020703,0.786,None
prot-a-1170,Polypeptide N-acetylgalactosaminyltransferase 1,polypeptide N-acetylgalactosaminyltransferase 1 measurement,EFO:0801899,http://www.ebi.ac.uk/efo/EFO_0801899,0.886,None
ukb-b-4733,"Number of operations, self-reported","number of operations, self-reported",EFO:0009802,http://www.ebi.ac.uk/efo/EFO_0009802,0.819,None
ieu-b-4872,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
met-b-254,CD8:%R5+,ring chromosome 5,MONDO:0016654,http://purl.obolibrary.org/obo/MONDO_0016654,0.804,None
ukb-b-15730,"Heel bone mineral density (BMD) T-score, automated (left)",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.665,None
prot-a-536,Chromodomain-helicase-DNA-binding protein 7,chromodomain-helicase-DNA-binding protein 7 measurement,EFO:0802397,http://www.ebi.ac.uk/efo/EFO_0802397,0.691,None
met-a-652,Isovalerylcarnitine,isovalerylcarnitine measurement,EFO:0020019,http://www.ebi.ac.uk/efo/EFO_0020019,0.906,None
ebi-a-GCST90002083,SSC-A on HLA DR+ T cell,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.609,None
prot-a-590,Ceroid-lipofuscinosis neuronal protein 5,neuronal ceroid lipofuscinosis 5,MONDO:0009745,http://purl.obolibrary.org/obo/MONDO_0009745,0.948,None
prot-a-1520,Cytokine receptor common subunit gamma,cytokine receptor common subunit gamma measurement,EFO:0020304,http://www.ebi.ac.uk/efo/EFO_0020304,0.938,None
prot-a-807,Desmin,desmin measurement,EFO:0802463,http://www.ebi.ac.uk/efo/EFO_0802463,0.784,None
ebi-a-GCST90010177,Protein-glutamine gamma-glutamyltransferase 2 levels,protein-glutamine gamma-glutamyltransferase e measurement,EFO:0020690,http://www.ebi.ac.uk/efo/EFO_0020690,0.744,None
met-a-384,3-methylhistidine,methylhistidine measurement,EFO:0801178,http://www.ebi.ac.uk/efo/EFO_0801178,0.878,None
prot-a-2584,Ribulose-phosphate 3-epimerase,ribulose-phosphate 3-epimerase measurement,EFO:0802025,http://www.ebi.ac.uk/efo/EFO_0802025,0.706,None
prot-a-2175,Poly(A) polymerase gamma,poly(A) polymerase gamma measurement,EFO:0802878,http://www.ebi.ac.uk/efo/EFO_0802878,0.709,None
ebi-a-GCST90002353,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
ebi-a-GCST90010196,C-C motif chemokine 16 levels,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.648,None
prot-c-3522_57_1,Vasoactive Intestinal Peptide,vasoactive intestinal peptide measurement,EFO:0020849,http://www.ebi.ac.uk/efo/EFO_0020849,0.922,None
met-a-607,1-eicosadienoylglycerophosphocholine*,1-eicosadienoylglycerophosphocholine measurement,EFO:0021080,http://www.ebi.ac.uk/efo/EFO_0021080,0.835,None
prot-a-632,Procollagen galactosyltransferase 2,procollagen galactosyltransferase 2 measurement,EFO:0802911,http://www.ebi.ac.uk/efo/EFO_0802911,0.934,None
prot-a-1617,Calsenilin,calsenilin measurement,EFO:0802362,http://www.ebi.ac.uk/efo/EFO_0802362,0.823,None
ebi-a-GCST90000496,Sulfotrasferase 1A1 levels,sulfotrasferase 1A1 measurement,EFO:0010797,http://www.ebi.ac.uk/efo/EFO_0010797,0.873,None
prot-a-1449,Insulin-like growth factor-binding protein 3,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.849,None
met-a-339,4-acetamidobutanoate,4-acetamidobutanoate measurement,EFO:0021003,http://www.ebi.ac.uk/efo/EFO_0021003,0.787,None
prot-a-3261,Zinc finger protein 174,zinc finger protein 174 measurement,EFO:0803272,http://www.ebi.ac.uk/efo/EFO_0803272,0.922,None
prot-a-1890,"Beta-1,3-N-acetylglucosaminyltransferase manic fringe","beta-1,3-N-acetylglucosaminyltransferase manic fringe measurement",EFO:0802311,http://www.ebi.ac.uk/efo/EFO_0802311,0.761,None
ukb-b-6092,Age at cancer diagnosis,cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.644,None
prot-a-1706,Leucine carboxyl methyltransferase 1,leucine carboxyl methyltransferase 1 measurement,EFO:0008207,http://www.ebi.ac.uk/efo/EFO_0008207,0.939,None
prot-a-2748,Solute carrier family 22 member 16,solute carrier family 22 member 16 measurement,EFO:0802079,http://www.ebi.ac.uk/efo/EFO_0802079,0.939,None
prot-a-1688,Keratinocyte differentiation-associated protein,keratinocyte differentiation-associated protein measurement,EFO:0801743,http://www.ebi.ac.uk/efo/EFO_0801743,0.883,None
met-a-492,X-02249,X-02249 measurement,EFO:0021182,http://www.ebi.ac.uk/efo/EFO_0021182,0.658,None
met-a-399,Indolelactate,indolelactate measurement,EFO:0020012,http://www.ebi.ac.uk/efo/EFO_0020012,0.871,None
ebi-a-GCST90012007,Monocyte chemoattractant protein-1 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.809,None
prot-a-343,Calcium-binding protein 8,calcium-binding protein 8 measurement,EFO:0802357,http://www.ebi.ac.uk/efo/EFO_0802357,0.746,None
met-a-726,X-14541,X-14541 measurement,EFO:0021371,http://www.ebi.ac.uk/efo/EFO_0021371,0.696,None
bbj-a-22,Fibrinogen,fibrinogen measurement,EFO:0004623,http://www.ebi.ac.uk/efo/EFO_0004623,0.83,None
ebi-a-GCST90001623,Natural Killer T %lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.711,None
prot-a-1027,Protein FAM163A,protein FAM163A measurement,EFO:0801946,http://www.ebi.ac.uk/efo/EFO_0801946,0.919,None
prot-a-1618,Small conductance calcium-activated potassium channel protein 1,small conductance calcium-activated potassium channel protein 1 measurement,EFO:0803081,http://www.ebi.ac.uk/efo/EFO_0803081,0.894,None
ebi-a-GCST90010245,Plasminogen activator inhibitor-1 (PAI-1) levels,plasminogen activator inhibitor 1 measurement,EFO:0004792,http://www.ebi.ac.uk/efo/EFO_0004792,0.825,None
prot-a-1180,Grancalcin,grancalcin measurement,EFO:0801653,http://www.ebi.ac.uk/efo/EFO_0801653,0.842,None
prot-a-1254,Phosphatidylinositol-glycan-specific phospholipase D,phosphatidylinositol-glycan-specific phospholipase D measurement,EFO:0801882,http://www.ebi.ac.uk/efo/EFO_0801882,0.858,None
ebi-a-GCST90011786,Capecitabine drug response (AUC),response to fluoropyrimidines,EFO:0010825,http://www.ebi.ac.uk/efo/EFO_0010825,0.766,None
prot-a-972,Endoplasmic reticulum aminopeptidase 2,endoplasmic reticulum aminopeptidase 2 measurement,EFO:0801566,http://www.ebi.ac.uk/efo/EFO_0801566,0.933,None
ebi-a-GCST011039,Parkinson's disease progression (composite),Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.682,None
prot-a-1928,DNA-3-methyladenine glycosylase,DNA-3-methyladenine glycosylase measurement,EFO:0801534,http://www.ebi.ac.uk/efo/EFO_0801534,0.771,None
prot-a-1304,Histone H2A.z,histone H2A type 3 measurement,EFO:0021953,http://www.ebi.ac.uk/efo/EFO_0021953,0.758,None
prot-a-1936,Melanocortin-2 receptor accessory protein,melanocortin-2 receptor accessory protein 2 measurement,EFO:0802733,http://www.ebi.ac.uk/efo/EFO_0802733,0.867,None
prot-a-1820,LysM and putative peptidoglycan-binding domain-containing protein 4,lysM and putative peptidoglycan-binding domain-containing protein 4 measurement,EFO:0802718,http://www.ebi.ac.uk/efo/EFO_0802718,0.856,None
prot-c-4152_58_2,Prekallikrein,prekallikrein deficiency,MONDO:0044744,http://purl.obolibrary.org/obo/MONDO_0044744,0.891,None
prot-a-2381,Activated Protein C,activated protein C measurement,EFO:0020126,http://www.ebi.ac.uk/efo/EFO_0020126,0.867,None
prot-a-3045,Tumor necrosis factor receptor superfamily member 19,tumor necrosis factor receptor superfamily member 19 measurement,EFO:0020808,http://www.ebi.ac.uk/efo/EFO_0020808,0.946,None
ukb-b-6027,Heel broadband ultrasound attenuation (right),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.883,None
prot-c-3184_25_2,Coagulation Factor VII,prothrombin fragments F1+2 measurement,EFO:0007776,http://www.ebi.ac.uk/efo/EFO_0007776,0.774,None
prot-a-2900,Surfeit locus protein 1,surfeit locus protein 1 measurement,EFO:0802105,http://www.ebi.ac.uk/efo/EFO_0802105,0.916,None
ebi-a-GCST90014242,Peak expiratory flow x sex interaction,peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.827,None
prot-a-628,Collectin-11,collectin-11 measurement,EFO:0008088,http://www.ebi.ac.uk/efo/EFO_0008088,0.624,None
prot-a-652,Protein crumbs homolog 1,protein crumbs homolog 1 measurement,EFO:0802928,http://www.ebi.ac.uk/efo/EFO_0802928,0.913,None
ieu-b-4821,Age at menarche,age at menarche,EFO:0004703,http://www.ebi.ac.uk/efo/EFO_0004703,0.975,None
prot-a-3175,Cytochrome b-c1 complex subunit 7,cytochrome b-c1 complex subunit 7 measurement,EFO:0802447,http://www.ebi.ac.uk/efo/EFO_0802447,0.785,None
prot-a-1533,Interleukin-4 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.896,None
ieu-a-817,Alcohol dependence,alcohol dependence,MONDO:0007079,http://purl.obolibrary.org/obo/MONDO_0007079,0.992,None
prot-a-373,Carbonyl reductase [NADPH] 1,carbonyl reductase [NADPH] 1 measurement,EFO:0803310,http://www.ebi.ac.uk/efo/EFO_0803310,0.709,None
prot-a-551,Carbohydrate sulfotransferase 14,carbohydrate sulfotransferase 14 measurement,EFO:0802366,http://www.ebi.ac.uk/efo/EFO_0802366,0.938,None
prot-a-2643,Scavenger receptor class F member 2,scavenger receptor class F member 2 measurement,EFO:0020716,http://www.ebi.ac.uk/efo/EFO_0020716,0.937,None
prot-a-2569,RING finger protein 215,RING finger protein 215 measurement,EFO:0803031,http://www.ebi.ac.uk/efo/EFO_0803031,0.91,None
prot-b-15,colony stimulating factor 1,colony stimulating factor 1 measurement,EFO:0010775,http://www.ebi.ac.uk/efo/EFO_0010775,0.911,None
ebi-a-GCST90012068,Endothelial cell-specific molecule 1 levels,endothelial cell-specific molecule 1 measurement,EFO:0010912,http://www.ebi.ac.uk/efo/EFO_0010912,0.779,None
prot-c-2681_23_2,HGF,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.979,None
ukb-d-30700_raw,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ukb-b-1209,Number of live births,number of stillbirths,EFO:0009722,http://www.ebi.ac.uk/efo/EFO_0009722,0.744,None
ieu-a-83,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-3080,Cellular tumor antigen p53,cellular tumor antigen p53 measurement,EFO:0022006,http://www.ebi.ac.uk/efo/EFO_0022006,0.918,None
prot-a-2684,"Selenide, water dikinase 1","selenide, water dikinase 1 measurement",EFO:0802045,http://www.ebi.ac.uk/efo/EFO_0802045,0.836,None
met-a-676,7-methylguanine,1-methylguanine measurement,EFO:0801093,http://www.ebi.ac.uk/efo/EFO_0801093,0.745,None
prot-a-487,Cadherin-related family member 1,cadherin-related family member 1 measurement,EFO:0801439,http://www.ebi.ac.uk/efo/EFO_0801439,0.858,None
ieu-b-4763,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
ukb-b-3656,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
ebi-a-GCST90013405,Liver enzyme levels (alanine transaminase),liver enzyme measurement,EFO:0004582,http://www.ebi.ac.uk/efo/EFO_0004582,0.695,None
ukb-a-364,Pulse wave reflection index,pulse wave reflection index measurement,EFO:0009804,http://www.ebi.ac.uk/efo/EFO_0009804,0.927,None
ieu-a-1074,Copper,serum copper measurement,EFO:0005267,http://www.ebi.ac.uk/efo/EFO_0005267,0.631,None
met-b-177,CD4:%CD244+ Naive,CD244 measurement,EFO:0010772,http://www.ebi.ac.uk/efo/EFO_0010772,0.637,None
prot-a-1682,"Keratin, type I cytoskeletal 17","keratin, type I cytoskeletal 17 measurement",EFO:0802672,http://www.ebi.ac.uk/efo/EFO_0802672,0.86,None
prot-a-1954,Methionine-R-sulfoxide reductase B3,methionine-R-sulfoxide reductase B3 measurement,EFO:0802741,http://www.ebi.ac.uk/efo/EFO_0802741,0.793,None
prot-c-3173_49_2,ASAHL,acute hemorrhagic leukoencephalitis,EFO:0007132,http://www.ebi.ac.uk/efo/EFO_0007132,0.618,None
ebi-a-GCST90010320,Kallikrein-10 levels,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.679,None
prot-c-2686_67_2,IGFBP-6,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.614,None
ieu-a-1234,Ovarian cancer (survival),ovarian cancer,MONDO:0008170,http://purl.obolibrary.org/obo/MONDO_0008170,0.718,None
met-a-754,15-methylpalmitate (isobar with 2-methylpalmitate),15-methylpalmitate isobar with 2-methylpalmitate measurement,EFO:0021052,http://www.ebi.ac.uk/efo/EFO_0021052,0.868,None
prot-a-3232,WNT1-inducible-signaling pathway protein 3,WNT1-inducible-signaling pathway protein 3 measurement,EFO:0022003,http://www.ebi.ac.uk/efo/EFO_0022003,0.805,None
prot-a-129,Apolipoprotein D,apolipoprotein D measurement,EFO:0020156,http://www.ebi.ac.uk/efo/EFO_0020156,0.877,None
ebi-a-GCST90010307,Dipeptidyl peptidase 2 levels,dipeptidyl peptidase 2 measurement,EFO:0020326,http://www.ebi.ac.uk/efo/EFO_0020326,0.884,None
ieu-a-271,Mean cell haemoglobin,hemoglobin measurement,EFO:0004509,http://www.ebi.ac.uk/efo/EFO_0004509,0.765,None
prot-a-739,C-X-C motif chemokine 11,C-X-C motif chemokine 11 measurement,EFO:0008057,http://www.ebi.ac.uk/efo/EFO_0008057,0.621,None
prot-a-237,Bcl-2-related protein A1,BCL-2-related protein A1 measurement,EFO:0020178,http://www.ebi.ac.uk/efo/EFO_0020178,0.678,None
met-c-922,Concentration of small HDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.8,None
prot-c-4913_78_1,HCC-4,hepatocellular carcinoma,EFO:0000182,http://www.ebi.ac.uk/efo/EFO_0000182,0.945,None
prot-a-2472,Ras-related protein Rab-22A,ras-related protein Rab-22A measurement,EFO:0802991,http://www.ebi.ac.uk/efo/EFO_0802991,0.64,None
prot-c-4987_17_1,FCAR,Familial cold urticaria,ORPHANET.ORDO:47045,http://www.orpha.net/ORDO/Orphanet_47045,0.723,None
ieu-a-89,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
ukb-b-15892,Pulse rate,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.996,None
prot-a-230,Basic leucine zipper transcriptional factor ATF-like 3,basic leucine zipper transcriptional factor ATF-like 3 measurement,EFO:0801404,http://www.ebi.ac.uk/efo/EFO_0801404,0.859,None
prot-a-1511,Interleukin-22 receptor subunit alpha-2,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.84,None
prot-a-2487,NKG2D ligand 4,NKG2D ligand 4 measurement,EFO:0801843,http://www.ebi.ac.uk/efo/EFO_0801843,0.911,None
met-a-470,Glycochenodeoxycholate,glycochenodeoxycholate measurement,EFO:0010490,http://www.ebi.ac.uk/efo/EFO_0010490,0.923,None
prot-a-676,Quinone oxidoreductase-like protein 1,quinone oxidoreductase-like protein 1 measurement,EFO:0021880,http://www.ebi.ac.uk/efo/EFO_0021880,0.865,None
prot-a-1128,Fms-related tyrosine kinase 3 ligand,Fms-related tyrosine kinase 3 ligand measurement,EFO:0010594,http://www.ebi.ac.uk/efo/EFO_0010594,0.834,None
ebi-a-GCST90012054,Receptor for advanced glycosylation end products levels,advanced glycosylation end product-specific receptor ligand measurement,EFO:0010762,http://www.ebi.ac.uk/efo/EFO_0010762,0.715,None
prot-a-424,Cell surface glycoprotein CD200 receptor 2,cell surface glycoprotein CD200 receptor 2 measurement,EFO:0801462,http://www.ebi.ac.uk/efo/EFO_0801462,0.934,None
prot-a-960,Ephrin type-B receptor 2,ephrin type-B receptor 2 measurement,EFO:0008124,http://www.ebi.ac.uk/efo/EFO_0008124,0.681,None
prot-a-1045,Pseudokinase FAM20A,pseudokinase FAM20A measurement,EFO:0801979,http://www.ebi.ac.uk/efo/EFO_0801979,0.922,None
prot-a-251,Baculoviral IAP repeat-containing protein 3,baculoviral IAP repeat-containing protein 3 measurement,EFO:0020173,http://www.ebi.ac.uk/efo/EFO_0020173,0.872,None
prot-a-1925,MOB kinase activator 1A,MOB kinase activator 1A measurement,EFO:0802753,http://www.ebi.ac.uk/efo/EFO_0802753,0.906,None
prot-a-2126,Peroxisomal NADH pyrophosphatase NUDT12,peroxisomal NADH pyrophosphatase NUDT12 measurement,EFO:0801878,http://www.ebi.ac.uk/efo/EFO_0801878,0.95,None
prot-a-2129,"ADP-ribose pyrophosphatase, mitochondrial","ADP-ribose pyrophosphatase, mitochondrial measurement",EFO:0801349,http://www.ebi.ac.uk/efo/EFO_0801349,0.819,None
prot-a-1571,Interferon regulatory factor 9,interferon regulatory factor 9 measurement,EFO:0802650,http://www.ebi.ac.uk/efo/EFO_0802650,0.921,None
prot-a-312,Uncharacterized protein C2orf82,uncharacterized protein C2orf82 measurement,EFO:0803231,http://www.ebi.ac.uk/efo/EFO_0803231,0.951,None
ebi-a-GCST90001763,CD20 on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.696,None
prot-c-3802_50_1,Cystatin-S,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.882,None
prot-c-5363_51_3,Semaphorin 3E,semaphorin-3E measurement,EFO:0008279,http://www.ebi.ac.uk/efo/EFO_0008279,0.65,None
prot-a-1253,Phosphatidylinositol-glycan-specific phospholipase D,phosphatidylinositol-glycan-specific phospholipase D measurement,EFO:0801882,http://www.ebi.ac.uk/efo/EFO_0801882,0.858,None
prot-a-1129,Vascular endothelial growth factor receptor 3,vascular endothelial growth factor receptor 3 measurement,EFO:0008315,http://www.ebi.ac.uk/efo/EFO_0008315,0.939,None
prot-a-1219,Glucagon-like peptide 1 receptor,glucagon-like peptide 1 receptor measurement,EFO:0802568,http://www.ebi.ac.uk/efo/EFO_0802568,0.878,None
prot-c-2822_56_2,CD97,CD97 antigen measurement,EFO:0020250,http://www.ebi.ac.uk/efo/EFO_0020250,0.745,None
prot-a-1677,Importin subunit alpha-1,importin subunit alpha-1 measurement,EFO:0020467,http://www.ebi.ac.uk/efo/EFO_0020467,0.783,None
prot-a-514,Centrosomal protein of 57 kDa,centrosomal protein of 57 kDa measurement,EFO:0801465,http://www.ebi.ac.uk/efo/EFO_0801465,0.91,None
prot-a-442,Platelet glycoprotein 4,platelet glycoprotein 4 measurement,EFO:0008262,http://www.ebi.ac.uk/efo/EFO_0008262,0.888,None
prot-a-2726,Sialic acid-binding Ig-like lectin 12,sialic acid-binding Ig-like lectin 12 measurement,EFO:0802066,http://www.ebi.ac.uk/efo/EFO_0802066,0.688,None
met-a-474,Gamma-glutamylvaline,gamma-glutamylvaline measurement,EFO:0021145,http://www.ebi.ac.uk/efo/EFO_0021145,0.791,None
prot-b-20,KIT ligand,kit ligand measurement,EFO:0010612,http://www.ebi.ac.uk/efo/EFO_0010612,0.833,None
prot-a-1679,GTPase KRas,GTPase kras measurement,EFO:0020432,http://www.ebi.ac.uk/efo/EFO_0020432,0.893,None
ebi-a-GCST90002248,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
ebi-a-GCST90010309,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels,ectonucleotide pyrophosphatase/phosphodiesterase family member 7 measurement,EFO:0020344,http://www.ebi.ac.uk/efo/EFO_0020344,0.871,None
ieu-b-4844,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
met-d-Acetone,Acetone,acetone measurement,EFO:0010989,http://www.ebi.ac.uk/efo/EFO_0010989,0.788,None
prot-a-1262,Probable G-protein coupled receptor 135,probable G-protein coupled receptor 135 measurement,EFO:0801916,http://www.ebi.ac.uk/efo/EFO_0801916,0.844,None
prot-a-2784,N-lysine methyltransferase SMYD2,n-lysine methyltransferase SMYD2 measurement,EFO:0802778,http://www.ebi.ac.uk/efo/EFO_0802778,0.846,None
ebi-a-GCST90002015,CCR2 on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.775,None
prot-a-1202,GDNF family receptor alpha-2,gdnf family receptor alpha-1 measurement,EFO:0020400,http://www.ebi.ac.uk/efo/EFO_0020400,0.831,None
prot-a-3128,TYMS opposite strand protein,TYMS opposite strand protein measurement,EFO:0803206,http://www.ebi.ac.uk/efo/EFO_0803206,0.922,None
ukb-b-20486,6mm asymmetry index (right),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.609,None
ieu-b-114,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-c-3795_6_2,ADAM 9,Amniotic bands,ORPHANET.ORDO:1034,http://www.orpha.net/ORDO/Orphanet_1034,0.778,None
prot-a-3120,Alpha-taxilin,alpha-taxilin measurement,EFO:0801375,http://www.ebi.ac.uk/efo/EFO_0801375,0.63,None
prot-a-829,Protein delta homolog 2,protein delta homolog 2 measurement,EFO:0802930,http://www.ebi.ac.uk/efo/EFO_0802930,0.899,None
ebi-a-GCST90010155,Pappalysin-1 levels,pappalysin-1 measurement,EFO:0802845,http://www.ebi.ac.uk/efo/EFO_0802845,0.648,None
bbj-a-4,Albumin/globulin ratio,albumin:globulin ratio measurement,EFO:0005128,http://www.ebi.ac.uk/efo/EFO_0005128,0.894,None
met-a-661,X-12798,X-12798 measurement,EFO:0021335,http://www.ebi.ac.uk/efo/EFO_0021335,0.707,None
ieu-b-4862,Chronotype,chronotype measurement,EFO:0008328,http://www.ebi.ac.uk/efo/EFO_0008328,0.818,None
prot-a-1567,Interferon regulatory factor 1,interferon regulatory factor 1 measurement,EFO:0021908,http://www.ebi.ac.uk/efo/EFO_0021908,0.918,None
prot-a-1385,Heat shock protein HSP 90-beta,heat shock protein HSP 90-beta measurement,EFO:0021991,http://www.ebi.ac.uk/efo/EFO_0021991,0.768,None
met-c-840,Alanine,alanine measurement,EFO:0009765,http://www.ebi.ac.uk/efo/EFO_0009765,0.752,None
prot-c-3199_54_2,kallikrein 12,kallikrein-12 measurement,EFO:0008194,http://www.ebi.ac.uk/efo/EFO_0008194,0.771,None
prot-a-1419,Interferon alpha-10,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.937,None
met-a-720,X-14205--alpha-glutamyltyrosine,X-14205--alpha-glutamyltyrosine measurement,EFO:0021365,http://www.ebi.ac.uk/efo/EFO_0021365,0.643,None
ieu-a-1015,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
prot-c-5346_24_3,CPNE1,medulloblastoma,EFO:0002939,http://www.ebi.ac.uk/efo/EFO_0002939,0.665,None
prot-c-2597_8_3,VEGF,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.995,None
prot-a-1581,Integrin alpha-I: beta-1 complex,integrin alpha-I: beta-1 complex measurement,EFO:0008162,http://www.ebi.ac.uk/efo/EFO_0008162,0.64,None
prot-b-17,oxidized low density lipoprotein receptor 1,oxidized low-density lipoprotein receptor 1 measurement,EFO:0020620,http://www.ebi.ac.uk/efo/EFO_0020620,0.838,None
ukb-d-30750_raw,Glycated haemoglobin,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.72,None
prot-a-1156,Fragile X mental retardation syndrome-related protein 1,fragile X syndrome,MONDO:0010383,http://purl.obolibrary.org/obo/MONDO_0010383,0.877,None
ieu-b-4818,Systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
ubm-a-22,IDP T1 FIRST right amygdala volume,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.754,None
prot-a-180,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2","arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 measurement",EFO:0803306,http://www.ebi.ac.uk/efo/EFO_0803306,0.829,None
ebi-a-GCST006349,Anti-Toxoplasma gondii IgG levels,Anti-Toxoplasma gondii IgG measurement,EFO:0009353,http://www.ebi.ac.uk/efo/EFO_0009353,0.761,None
prot-c-4272_46_2,PHI,Harlequin ichthyosis,ORPHANET.ORDO:457,http://www.orpha.net/ORDO/Orphanet_457,0.604,None
prot-a-2614,Protein S100-A11,protein S100-A11 measurement,EFO:0801958,http://www.ebi.ac.uk/efo/EFO_0801958,0.668,None
ubm-a-12,IDP T1 FIRST right thalamus volume,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.722,None
prot-c-3581_53_3,a2-HS-Glycoprotein,glycoproteinosis,MONDO:0017731,http://purl.obolibrary.org/obo/MONDO_0017731,0.646,None
ebi-a-GCST90010211,Protein delta homolog 1 levels,protein delta homolog 1 measurement,EFO:0801938,http://www.ebi.ac.uk/efo/EFO_0801938,0.813,None
prot-a-1789,Leucine-rich repeat-containing protein 4C,leucine-rich repeat-containing protein 4C measurement,EFO:0802701,http://www.ebi.ac.uk/efo/EFO_0802701,0.802,None
prot-a-393,C-C motif chemokine 16,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.705,None
prot-a-75,"Aldehyde dehydrogenase, dimeric NADP-preferring","aldehyde dehydrogenase, dimeric NADP-preferring measurement",EFO:0801362,http://www.ebi.ac.uk/efo/EFO_0801362,0.873,None
prot-a-2060,Nucleoside diphosphate kinase B,nucleoside diphosphate kinase B measurement,EFO:0020615,http://www.ebi.ac.uk/efo/EFO_0020615,0.928,None
ebi-a-GCST90000474,interleukin 15 receptor subunit alpha levels,interleukin 15 receptor subunit alpha measurement,EFO:0008172,http://www.ebi.ac.uk/efo/EFO_0008172,0.88,None
prot-a-3137,Ubiquitin-conjugating enzyme E2 G2,ubiquitin-conjugating enzyme E2 G2 measurement,EFO:0022035,http://www.ebi.ac.uk/efo/EFO_0022035,0.913,None
prot-a-3177,U6 snRNA phosphodiesterase,U6 snRNA phosphodiesterase measurement,EFO:0803211,http://www.ebi.ac.uk/efo/EFO_0803211,0.946,None
bbj-a-3,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1652,Mast/stem cell growth factor receptor Kit,mast/stem cell growth factor receptor kit measurement,EFO:0020554,http://www.ebi.ac.uk/efo/EFO_0020554,0.793,None
ieu-a-108,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ukb-b-7953,Forced vital capacity (FVC),vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.849,None
ebi-a-GCST90002323,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
prot-c-3591_51_3,Cadherin-6,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.637,None
prot-a-958,Ephrin type-A receptor 5,ephrin type-a receptor 5 measurement,EFO:0020353,http://www.ebi.ac.uk/efo/EFO_0020353,0.683,None
prot-a-2122,BDNF/NT-3 growth factors receptor,bdnf/nt-3 growth factors receptor measurement,EFO:0020179,http://www.ebi.ac.uk/efo/EFO_0020179,0.673,None
ebi-a-GCST90002376,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
ebi-a-GCST005066,Creatinine levels,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.987,None
ubm-a-2673,volume Left-choroid-plexus,choroid plexus volume measurement,EFO:0010293,http://www.ebi.ac.uk/efo/EFO_0010293,0.84,None
prot-a-1245,Glypican-1,glypican-1 measurement,EFO:0801649,http://www.ebi.ac.uk/efo/EFO_0801649,0.62,None
prot-a-1811,Lymphocyte antigen 6 complex locus protein G6d,lymphocyte antigen 6 complex locus protein G6d measurement,EFO:0802714,http://www.ebi.ac.uk/efo/EFO_0802714,0.951,None
prot-a-1690,Neural cell adhesion molecule L1,neural cell adhesion molecule L1 measurement,EFO:0020594,http://www.ebi.ac.uk/efo/EFO_0020594,0.922,None
met-d-M_VLDL_P,Concentration of medium VLDL particles,concentration of medium VLDL particles,EFO:0022152,http://www.ebi.ac.uk/efo/EFO_0022152,0.987,None
prot-a-1699,Ragulator complex protein LAMTOR3,ragulator complex protein LAMTOR3 measurement,EFO:0801986,http://www.ebi.ac.uk/efo/EFO_0801986,0.943,None
bbj-a-60,Estimated glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.867,None
met-d-IDL_FC,Free cholesterol in IDL,free cholesterol in IDL measurement,EFO:0022181,http://www.ebi.ac.uk/efo/EFO_0022181,0.895,None
ebi-a-GCST004428,Stem cell growth factor beta levels,stem Cell Growth Factor beta measurement,EFO:0008292,http://www.ebi.ac.uk/efo/EFO_0008292,0.826,None
prot-a-86,Junctional adhesion molecule-like,junctional adhesion molecule-like measurement,EFO:0020511,http://www.ebi.ac.uk/efo/EFO_0020511,0.85,None
prot-a-1642,Killer cell immunoglobulin-like receptor 2DL4,killer cell immunoglobulin-like receptor 2DL4 measurement,EFO:0008197,http://www.ebi.ac.uk/efo/EFO_0008197,0.911,None
prot-a-2093,Nuclear receptor-binding protein,nuclear receptor-binding protein measurement,EFO:0801854,http://www.ebi.ac.uk/efo/EFO_0801854,0.804,None
prot-a-1880,Matrix extracellular phosphoglycoprotein,matrix extracellular phosphoglycoprotein measurement,EFO:0020557,http://www.ebi.ac.uk/efo/EFO_0020557,0.944,None
prot-a-2575,"rRNA methyltransferase 3, mitochondrial","rRNA methyltransferase 3, mitochondrial measurement",EFO:0802033,http://www.ebi.ac.uk/efo/EFO_0802033,0.881,None
ebi-a-GCST004137,Optic cup area,optic cup area measurement,EFO:0006940,http://www.ebi.ac.uk/efo/EFO_0006940,0.875,None
prot-a-2231,Platelet-derived growth factor receptor-like protein,platelet-derived growth factor receptor-like protein measurement,EFO:0801889,http://www.ebi.ac.uk/efo/EFO_0801889,0.798,None
met-a-347,Arginine,Argininemia,ORPHANET.ORDO:90,http://www.orpha.net/ORDO/Orphanet_90,0.827,None
ieu-a-272,Mean cell haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.811,None
prot-a-84,Muellerian-inhibiting factor,muellerian-inhibiting factor measurement,EFO:0020584,http://www.ebi.ac.uk/efo/EFO_0020584,0.836,None
ebi-a-GCST90010294,B-cell antigen receptor complex-associated protein beta chain levels,B-cell antigen receptor complex-associated protein beta chain measurement,EFO:0802300,http://www.ebi.ac.uk/efo/EFO_0802300,0.764,None
prot-c-2501_51_3,Cadherin E,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.621,None
met-a-721,X-14208--phenylalanylserine,X-14208--phenylalanylserine measurement,EFO:0021366,http://www.ebi.ac.uk/efo/EFO_0021366,0.727,None
prot-a-1718,Protein LDOC1,protein LDOC1 measurement,EFO:0801951,http://www.ebi.ac.uk/efo/EFO_0801951,0.879,None
prot-a-2660,Vesicle-trafficking protein SEC22a,vesicle-trafficking protein SEC22a measurement,EFO:0803256,http://www.ebi.ac.uk/efo/EFO_0803256,0.888,None
prot-a-2205,Protocadherin beta-4,protocadherin beta-1 measurement,EFO:0802972,http://www.ebi.ac.uk/efo/EFO_0802972,0.745,None
ebi-a-GCST002216,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-c-3799_11_2,Carbonic anhydrase III,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.862,None
ieu-b-4907,Anti-Measles virus IgG levels,Anti-measles virus IgG measurement,EFO:0009355,http://www.ebi.ac.uk/efo/EFO_0009355,0.736,None
prot-a-1456,Immunoglobulin E,immunoglobulin E measurement,EFO:0020464,http://www.ebi.ac.uk/efo/EFO_0020464,0.89,None
met-c-895,Total cholesterol in LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.885,None
met-b-160,CD3 on DN T,liver dysplastic nodule,EFO:0007834,http://www.ebi.ac.uk/efo/EFO_0007834,0.731,None
prot-c-4929_55_1,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
prot-c-3056_11_1,NKG2D,NKG2D ligand 1 measurement,EFO:0802814,http://www.ebi.ac.uk/efo/EFO_0802814,0.772,None
prot-a-1187,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 measurement",EFO:0801407,http://www.ebi.ac.uk/efo/EFO_0801407,0.634,None
met-a-382,N1-methyladenosine,N1-methyladenosine measurement,EFO:0021122,http://www.ebi.ac.uk/efo/EFO_0021122,0.71,None
ebi-a-GCST90012063,Agouti-related protein levels,Agouti-related protein measurement,EFO:0008016,http://www.ebi.ac.uk/efo/EFO_0008016,0.663,None
prot-a-1465,Interleukin-10 receptor subunit beta,interleukin 6 receptor subunit beta measurement,EFO:0008188,http://www.ebi.ac.uk/efo/EFO_0008188,0.875,None
prot-a-2251,Platelet factor 4 variant,platelet factor 4 variant measurement,EFO:0801887,http://www.ebi.ac.uk/efo/EFO_0801887,0.893,None
ebi-a-GCST006346,Anti-herpes simplex virus 1 IgG levels,Anti-herpes simplex virus 1 IgG measurement,EFO:0009349,http://www.ebi.ac.uk/efo/EFO_0009349,0.767,None
prot-a-2304,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2","procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement",EFO:0802912,http://www.ebi.ac.uk/efo/EFO_0802912,0.698,None
prot-a-858,Inactive dipeptidyl peptidase 10,inactive dipeptidyl peptidase 10 measurement,EFO:0802624,http://www.ebi.ac.uk/efo/EFO_0802624,0.947,None
prot-a-1691,Ladinin-1,ladinin-1 measurement,EFO:0802685,http://www.ebi.ac.uk/efo/EFO_0802685,0.614,None
prot-a-1158,G0/G1 switch protein 2,G0/G1 switch protein 2 measurement,EFO:0802559,http://www.ebi.ac.uk/efo/EFO_0802559,0.632,None
ieu-a-102,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
met-a-455,Cysteine,cysteine measurement,EFO:0021000,http://www.ebi.ac.uk/efo/EFO_0021000,0.758,None
ebi-a-GCST90010108,Brother of CDO levels,brother of CDO measurement,EFO:0020194,http://www.ebi.ac.uk/efo/EFO_0020194,0.757,None
ebi-a-GCST90002231,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-707,Cancer/testis antigen 55,cancer/testis antigen 55 measurement,EFO:0802365,http://www.ebi.ac.uk/efo/EFO_0802365,0.729,None
prot-a-2852,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 measurement",EFO:0802270,http://www.ebi.ac.uk/efo/EFO_0802270,0.724,None
prot-a-386,C-C motif chemokine 1,C-C motif chemokine 1 measurement,EFO:0008041,http://www.ebi.ac.uk/efo/EFO_0008041,0.674,None
prot-a-15,Acyl-CoA-binding domain-containing protein 7,acyl-CoA binding domain containing protein 5 deficiency,MONDO:0100112,http://purl.obolibrary.org/obo/MONDO_0100112,0.831,None
ukb-d-30030_irnt,Haematocrit percentage,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.61,None
prot-a-1309,Histone acetyltransferase type B catalytic subunit,histone acetyltransferase type b catalytic subunit measurement,EFO:0020452,http://www.ebi.ac.uk/efo/EFO_0020452,0.943,None
prot-a-3209,V-set and transmembrane domain-containing protein 2-like protein,v-set and transmembrane domain-containing protein 2-like protein measurement,EFO:0803246,http://www.ebi.ac.uk/efo/EFO_0803246,0.792,None
ukb-d-30630_raw,Apoliprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.658,None
met-a-452,Erythrose,erythrose measurement,EFO:0021026,http://www.ebi.ac.uk/efo/EFO_0021026,0.819,None
prot-a-100,Angiopoietin-related protein 7,angiopoietin-related protein 7 measurement,EFO:0802280,http://www.ebi.ac.uk/efo/EFO_0802280,0.844,None
ebi-a-GCST006804,Red cell distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
prot-a-1109,Polyphosphoinositide phosphatase,polyphosphoinositide phosphatase measurement,EFO:0802886,http://www.ebi.ac.uk/efo/EFO_0802886,0.946,None
prot-a-2547,Protein ripply1,protein ripply1 measurement,EFO:0802960,http://www.ebi.ac.uk/efo/EFO_0802960,0.915,None
met-a-311,3-hydroxybutyrate (BHBA),3-hydroxybutyrate measurement,EFO:0010982,http://www.ebi.ac.uk/efo/EFO_0010982,0.622,None
ebi-a-GCST90010170,Serpin A12 levels,serpin A12 measurement,EFO:0802061,http://www.ebi.ac.uk/efo/EFO_0802061,0.779,None
ieu-b-34,neutrophil cell count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.909,None
ieu-b-4903,Anti-Influenza virus subtype H1N1 IgG levels,anti-influenza A subtype H1N1 IgG measurement,EFO:0801089,http://www.ebi.ac.uk/efo/EFO_0801089,0.785,None
met-c-863,Glycoprotein acetyls,glycoproteinosis,MONDO:0017731,http://purl.obolibrary.org/obo/MONDO_0017731,0.61,None
prot-a-1213,Gap junction alpha-1 protein,gap junction alpha-1 protein measurement,EFO:0801618,http://www.ebi.ac.uk/efo/EFO_0801618,0.794,None
ebi-a-GCST90000500,Tumor necrosis factor receptor superfamily member 9 levels,tumor necrosis factor receptor superfamily member 9 measurement,EFO:0010802,http://www.ebi.ac.uk/efo/EFO_0010802,0.902,None
prot-c-4188_1_2,Aflatoxin B1 aldehyde reductase,aflatoxin B1 aldehyde reductase member 2 measurement,EFO:0020132,http://www.ebi.ac.uk/efo/EFO_0020132,0.864,None
ukb-b-4063,Number of self-reported non-cancer illnesses,"number of non-cancer illnesses, self-reported",EFO:0009801,http://www.ebi.ac.uk/efo/EFO_0009801,0.815,None
prot-c-4165_2_1,Thyroglobulin,thyroglobulin measurement,EFO:0010050,http://www.ebi.ac.uk/efo/EFO_0010050,0.856,None
met-d-XS_VLDL_TG_pct,Triglycerides to total lipids ratio in very small VLDL,triglycerides in very small VLDL measurement,EFO:0022144,http://www.ebi.ac.uk/efo/EFO_0022144,0.715,None
prot-c-4890_10_1,ACTH,ACTH-Producing Pituitary Gland Adenoma,EFO:1000066,http://www.ebi.ac.uk/efo/EFO_1000066,0.694,None
ebi-a-GCST90016935,Gut microbiota abundance (family Desulfovibrionaceae id.3169),commensal Desulfovibrionaceae infectious disease,EFO:1000875,http://www.ebi.ac.uk/efo/EFO_1000875,0.606,None
prot-a-1909,Membrane magnesium transporter 1,membrane magnesium transporter 1 measurement,EFO:0802736,http://www.ebi.ac.uk/efo/EFO_0802736,0.933,None
prot-a-1978,Myc proto-oncogene protein,myc proto-oncogene protein measurement,EFO:0021912,http://www.ebi.ac.uk/efo/EFO_0021912,0.791,None
prot-a-1544,Interleukin-7 receptor subunit alpha,interleukin 7 receptor subunit alpha measurement,EFO:0008190,http://www.ebi.ac.uk/efo/EFO_0008190,0.934,None
prot-a-390,C-C motif chemokine 14,C-C motif chemokine 14 measurement,EFO:0008042,http://www.ebi.ac.uk/efo/EFO_0008042,0.703,None
met-a-346,Ursodeoxycholate,ursodeoxycholate measurement,EFO:0010547,http://www.ebi.ac.uk/efo/EFO_0010547,0.913,None
ukb-d-30840_raw,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
prot-c-4905_63_1,Coactosin-like protein,coactosin-like protein measurement,EFO:0020262,http://www.ebi.ac.uk/efo/EFO_0020262,0.783,None
prot-a-2420,Proteasome activator complex subunit 1,proteasome activator complex subunit 1 measurement,EFO:0020661,http://www.ebi.ac.uk/efo/EFO_0020661,0.927,None
prot-a-3115,TPA-induced transmembrane protein,TPA-induced transmembrane protein measurement,EFO:0803162,http://www.ebi.ac.uk/efo/EFO_0803162,0.823,None
ebi-a-GCST90012027,Matrix metalloproteinase-3 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.85,None
prot-a-2559,Rho-related GTP-binding protein Rho6,rho-related GTP-binding protein Rho6 measurement,EFO:0803022,http://www.ebi.ac.uk/efo/EFO_0803022,0.772,None
ebi-a-GCST004629,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
ebi-a-GCST90001635,CD8dim Natural Killer T %lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.604,None
ukb-d-30620_irnt,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
prot-c-2515_14_3,GFRa-2,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.636,None
prot-a-3107,Ribosome biogenesis protein TSR3 homolog,ribosome biogenesis protein TSR3 homolog measurement,EFO:0803025,http://www.ebi.ac.uk/efo/EFO_0803025,0.939,None
ebi-a-GCST90000469,Fibroblast growth factor 5 levels,fibroblast growth factor 5 measurement,EFO:0010784,http://www.ebi.ac.uk/efo/EFO_0010784,0.834,None
prot-a-796,Beta-defensin 119,beta-defensin 119 measurement,EFO:0801419,http://www.ebi.ac.uk/efo/EFO_0801419,0.764,None
prot-c-4150_75_2,Plasmin,plasmin measurement,EFO:0020643,http://www.ebi.ac.uk/efo/EFO_0020643,0.749,None
prot-a-2789,Alpha-synuclein,alpha synuclein measurement,EFO:0009323,http://www.ebi.ac.uk/efo/EFO_0009323,0.871,None
ebi-a-GCST90007310,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
met-d-IDL_TG_pct,Triglycerides to total lipids ratio in IDL,triglycerides:total lipids ratio,EFO:0020947,http://www.ebi.ac.uk/efo/EFO_0020947,0.722,None
met-d-LA,Linoleic acid,linoleic acid measurement,EFO:0006807,http://www.ebi.ac.uk/efo/EFO_0006807,0.851,None
prot-a-2333,Periostin,periostin measurement,EFO:0020628,http://www.ebi.ac.uk/efo/EFO_0020628,0.777,None
ebi-a-GCST005069,Gamma glutamyl transferase levels,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.852,None
met-c-850,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ukb-d-30240_irnt,Reticulocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.694,None
ukb-b-12379,Fat,Lipoatrophy,HP:0100578,http://purl.obolibrary.org/obo/HP_0100578,0.617,None
ukb-a-360,Systolic blood pressure  automated reading,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.763,None
prot-a-2168,Polyadenylate-binding protein-interacting protein 1,polyadenylate-binding protein-interacting protein 1 measurement,EFO:0802880,http://www.ebi.ac.uk/efo/EFO_0802880,0.85,None
ebi-a-GCST90010244,Osteopontin levels,osteopontin measurement,EFO:0021776,http://www.ebi.ac.uk/efo/EFO_0021776,0.709,None
prot-c-3389_7_2,PCI,obesity due to prohormone convertase I deficiency,MONDO:0010961,http://purl.obolibrary.org/obo/MONDO_0010961,0.777,None
prot-a-2964,Transforming growth factor beta-2,transforming growth factor beta measurement,EFO:0004818,http://www.ebi.ac.uk/efo/EFO_0004818,0.913,None
prot-c-3440_7_2,granzyme A,granzyme A measurement,EFO:0008145,http://www.ebi.ac.uk/efo/EFO_0008145,0.865,None
prot-a-133,Apolipoprotein F,apolipoprotein F measurement,EFO:0801388,http://www.ebi.ac.uk/efo/EFO_0801388,0.881,None
ukb-d-30730_irnt,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
ukb-a-370,Family relationship satisfaction,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.785,None
prot-c-3352_80_3,Carbonic anhydrase 6,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.94,None
prot-a-2867,Signal transducer and activator of transcription 1-alpha/beta,signal transducer and activator of transcription 3 measurement,EFO:0021907,http://www.ebi.ac.uk/efo/EFO_0021907,0.846,None
prot-a-944,Gamma-enolase,gamma-enolase measurement,EFO:0021845,http://www.ebi.ac.uk/efo/EFO_0021845,0.629,None
ebi-a-GCST90002348,Mean platelet volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.978,None
prot-c-3554_24_1,Adiponectin,adiponectin measurement,EFO:0004502,http://www.ebi.ac.uk/efo/EFO_0004502,0.84,None
prot-a-1935,Melanocortin-2 receptor accessory protein 2,melanocortin-2 receptor accessory protein 2 measurement,EFO:0802733,http://www.ebi.ac.uk/efo/EFO_0802733,0.861,None
ebi-a-GCST90010111,C-C motif chemokine 3 levels,C-C motif chemokine 3 measurement,EFO:0008051,http://www.ebi.ac.uk/efo/EFO_0008051,0.618,None
prot-a-538,Chromogranin-A,chromogranin-A measurement,EFO:0022021,http://www.ebi.ac.uk/efo/EFO_0022021,0.661,None
ebi-a-GCST005846,Heart rate response to recovery post exercise (10 sec),heart rate response to recovery post exercise,EFO:0009185,http://www.ebi.ac.uk/efo/EFO_0009185,0.935,None
prot-a-1172,Polypeptide N-acetylgalactosaminyltransferase 3,polypeptide N-acetylgalactosaminyltransferase 3 measurement,EFO:0802885,http://www.ebi.ac.uk/efo/EFO_0802885,0.886,None
ebi-a-GCST90010178,Thrombospondin-2 levels,thrombospondin-1 measurement,EFO:0020770,http://www.ebi.ac.uk/efo/EFO_0020770,0.655,None
prot-a-725,Cathepsin H,cathepsin H measurement,EFO:0020243,http://www.ebi.ac.uk/efo/EFO_0020243,0.842,None
prot-a-1769,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement,EFO:0802689,http://www.ebi.ac.uk/efo/EFO_0802689,0.847,None
met-a-414,X-06307,X-06307 measurement,EFO:0021201,http://www.ebi.ac.uk/efo/EFO_0021201,0.674,None
prot-a-2379,Major prion protein,major prion protein measurement,EFO:0802725,http://www.ebi.ac.uk/efo/EFO_0802725,0.883,None
prot-a-2273,Paired immunoglobulin-like type 2 receptor alpha,paired immunoglobulin-like type 2 receptor alpha measurement,EFO:0801866,http://www.ebi.ac.uk/efo/EFO_0801866,0.892,None
prot-c-3640_14_3,RAP,RAP,EFO:0008880,http://www.ebi.ac.uk/efo/EFO_0008880,0.993,None
prot-a-313,C3a anaphylatoxin des Arginine,C3a anaphylatoxin des arginine measurement,EFO:0020206,http://www.ebi.ac.uk/efo/EFO_0020206,0.938,None
ukb-d-30860_raw,Total protein,total blood protein measurement,EFO:0004536,http://www.ebi.ac.uk/efo/EFO_0004536,0.772,None
prot-a-2561,RING finger protein 122,RING finger protein 122 measurement,EFO:0803028,http://www.ebi.ac.uk/efo/EFO_0803028,0.907,None
prot-a-261,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 measurement,EFO:0802304,http://www.ebi.ac.uk/efo/EFO_0802304,0.839,None
prot-a-2735,Signal-regulatory protein gamma,signal-regulatory protein gamma measurement,EFO:0802071,http://www.ebi.ac.uk/efo/EFO_0802071,0.82,None
prot-a-586,Dual specificity protein kinase CLK2,dual specificity protein kinase CLK2 measurement,EFO:0801548,http://www.ebi.ac.uk/efo/EFO_0801548,0.94,None
prot-a-2376,Prolactin-releasing peptide,prolactin-releasing peptide measurement,EFO:0802915,http://www.ebi.ac.uk/efo/EFO_0802915,0.83,None
prot-c-3708_62_1,a2-Macroglobulin,macroglobulinemia,EFO:0002616,http://www.ebi.ac.uk/efo/EFO_0002616,0.799,None
met-a-333,Pentadecanoate (15:0),pentadecanoate 15:0 measurement,EFO:0021073,http://www.ebi.ac.uk/efo/EFO_0021073,0.704,None
prot-a-823,Dickkopf-related protein 4,Dickkopf-related protein 4 measurement,EFO:0008110,http://www.ebi.ac.uk/efo/EFO_0008110,0.778,None
ebi-a-GCST90010305,Cathepsin O levels,cathepsin O measurement,EFO:0802375,http://www.ebi.ac.uk/efo/EFO_0802375,0.725,None
ebi-a-GCST008055,C-reactive protein levels,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.713,None
bbj-a-61,Serum creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.874,None
prot-a-2568,RING finger protein 165,RING finger protein 165 measurement,EFO:0802027,http://www.ebi.ac.uk/efo/EFO_0802027,0.911,None
ebi-a-GCST90000504,Tumor necrosis factor ligand superfamily member 12 levels,tumor necrosis factor ligand superfamily member 12 measurement,EFO:0010801,http://www.ebi.ac.uk/efo/EFO_0010801,0.896,None
ebi-a-GCST90002075,SSC-A on B cell,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.768,None
met-d-PUFA_by_MUFA,Ratio of polyunsaturated fatty acids to monounsaturated fatty acids,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.797,None
ukb-b-12963,Particulate matter air pollution 2.5-10um; 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.723,None
prot-c-4876_32_1,Coagulation Factor IX,coagulation factor IX measurement,EFO:0020263,http://www.ebi.ac.uk/efo/EFO_0020263,0.897,None
met-a-620,1-heptadecanoylglycerophosphocholine,1-heptadecanoylglycerophosphocholine measurement,EFO:0021082,http://www.ebi.ac.uk/efo/EFO_0021082,0.859,None
prot-a-2108,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating","sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating measurement",EFO:0802092,http://www.ebi.ac.uk/efo/EFO_0802092,0.787,None
prot-c-4278_14_3,Protein disulfide-isomerase,protein disulfide-isomerase measurement,EFO:0020669,http://www.ebi.ac.uk/efo/EFO_0020669,0.763,None
ebi-a-GCST90012072,Caspase 8 levels,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.657,None
prot-a-786,Beta-defensin 108B,beta-defensin 108B measurement,EFO:0802318,http://www.ebi.ac.uk/efo/EFO_0802318,0.813,None
prot-a-2501,Probable RNA-binding protein 19,probable RNA-binding protein 19 measurement,EFO:0802909,http://www.ebi.ac.uk/efo/EFO_0802909,0.829,None
ebi-a-GCST008593,Low density lipoprotein cholesterol levels,low density lipoprotein cholesterol measurement,EFO:0004611,http://www.ebi.ac.uk/efo/EFO_0004611,0.862,None
ebi-a-GCST90010242,Neurogenic locus notch homolog protein 3 levels,neurogenic locus notch homolog protein 3 measurement,EFO:0020600,http://www.ebi.ac.uk/efo/EFO_0020600,0.886,None
prot-a-1736,Leukemia inhibitory factor,leukemia inhibitory factor measurement,EFO:0801764,http://www.ebi.ac.uk/efo/EFO_0801764,0.906,None
ieu-b-111,triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-1810,Lymphocyte antigen 6 complex locus protein G6c,lymphocyte antigen 6 complex locus protein G6c measurement,EFO:0801774,http://www.ebi.ac.uk/efo/EFO_0801774,0.95,None
ebi-a-GCST90002345,Mean platelet volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.978,None
met-a-645,X-12726,X-12726 measurement,EFO:0021326,http://www.ebi.ac.uk/efo/EFO_0021326,0.706,None
ebi-a-GCST90010338,Eosinophil cationic protein levels,eosinophil cationic protein measurement,EFO:0010913,http://www.ebi.ac.uk/efo/EFO_0010913,0.821,None
ebi-a-GCST006345,Anti-Epstein-Barr virus early antigen (EA) IgG levels,Anti-Epstein-Barr virus early antigen IgG measurement,EFO:0009348,http://www.ebi.ac.uk/efo/EFO_0009348,0.751,None
ebi-a-GCST90007309,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-c-4336_2_1,SAA,severe aplastic anemia,EFO:0006927,http://www.ebi.ac.uk/efo/EFO_0006927,0.998,None
ebi-a-GCST90010116,Chymotrypsin C levels,chymotrypsin-C measurement,EFO:0802398,http://www.ebi.ac.uk/efo/EFO_0802398,0.698,None
met-d-M_LDL_FC_pct,Free cholesterol to total lipids ratio in medium LDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.742,None
prot-a-2174,Papilin,papilin measurement,EFO:0802844,http://www.ebi.ac.uk/efo/EFO_0802844,0.761,None
prot-b-55,growth differentiation factor 15,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.927,None
ebi-a-GCST90002304,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
met-a-558,1-arachidonoylglycerophosphocholine*,1-arachidonoylglycerophosphocholine measurement,EFO:0021076,http://www.ebi.ac.uk/efo/EFO_0021076,0.855,None
met-b-167,CD8:%SCM,diastematomyelia,MONDO:0009106,http://purl.obolibrary.org/obo/MONDO_0009106,0.718,None
ebi-a-GCST90012055,C-C motif chemokine 3 levels,C-C motif chemokine 3 measurement,EFO:0008051,http://www.ebi.ac.uk/efo/EFO_0008051,0.618,None
ebi-a-GCST90010223,Insulin-like growth factor-binding protein 7 levels,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.902,None
prot-a-3134,PolyUbiquitin K63-linked,polyUbiquitin K63-linked measurement,EFO:0022008,http://www.ebi.ac.uk/efo/EFO_0022008,0.797,None
ukb-a-278,Leg fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.654,None
prot-a-1079,Fc receptor-like protein 1,Fc receptor-like protein 1 measurement,EFO:0801598,http://www.ebi.ac.uk/efo/EFO_0801598,0.797,None
ebi-a-GCST90001915,CD45 on T cell,T-B+ severe combined immunodeficiency due to CD45 deficiency,MONDO:0015702,http://purl.obolibrary.org/obo/MONDO_0015702,0.624,None
ukb-d-30810_irnt,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
ebi-a-GCST90010276,vWF levels,von Willebrand factor measurement,EFO:0004629,http://www.ebi.ac.uk/efo/EFO_0004629,0.85,None
met-c-955,Phospholipids in very small VLDL,phospholipids in very small VLDL measurement,EFO:0022150,http://www.ebi.ac.uk/efo/EFO_0022150,0.917,None
prot-c-5412_53_3,CD27,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.818,None
prot-a-3118,Twinfilin-1,twinfilin-1 measurement,EFO:0803204,http://www.ebi.ac.uk/efo/EFO_0803204,0.753,None
prot-c-5060_62_3,B7-H1,H1-hESC,EFO:0003042,http://www.ebi.ac.uk/efo/EFO_0003042,0.671,None
ubm-a-20,IDP T1 FIRST right hippocampus volume,hippocampus fimbria volume,EFO:0009402,http://www.ebi.ac.uk/efo/EFO_0009402,0.672,None
prot-a-2362,Proteoglycan 3,proteoglycan 3 measurement,EFO:0802970,http://www.ebi.ac.uk/efo/EFO_0802970,0.863,None
prot-a-2841,Lupus La protein,lupus La protein measurement,EFO:0802713,http://www.ebi.ac.uk/efo/EFO_0802713,0.873,None
prot-a-856,Dipeptidase 1,dipeptidase 1 measurement,EFO:0802469,http://www.ebi.ac.uk/efo/EFO_0802469,0.869,None
ebi-a-GCST90010301,Clusterin-like protein 1 levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.614,None
prot-c-3198_4_1,IDS,mucopolysaccharidosis type 2,MONDO:0010674,http://purl.obolibrary.org/obo/MONDO_0010674,0.689,None
prot-c-3294_55_2,CFC1,cardiofaciocutaneous syndrome,MONDO:0015280,http://purl.obolibrary.org/obo/MONDO_0015280,0.614,None
prot-a-493,Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex,cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement,EFO:0020296,http://www.ebi.ac.uk/efo/EFO_0020296,0.827,None
prot-a-2633,Suprabasin,suprabasin measurement,EFO:0803110,http://www.ebi.ac.uk/efo/EFO_0803110,0.867,None
met-c-927,Total cholesterol in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.968,None
ebi-a-GCST90000484,Monocyte chemoattractant protein-2 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.808,None
prot-a-3033,Tumor necrosis factor receptor superfamily member 10B,tumor necrosis factor receptor superfamily member 10B measurement,EFO:0021993,http://www.ebi.ac.uk/efo/EFO_0021993,0.951,None
ebi-a-GCST90011997,CD40 ligand levels,CD40 ligand measurement,EFO:0004790,http://www.ebi.ac.uk/efo/EFO_0004790,0.749,None
prot-a-167,cAMP-regulated phosphoprotein 19,cAMP-regulated phosphoprotein 19 measurement,EFO:0020223,http://www.ebi.ac.uk/efo/EFO_0020223,0.827,None
ebi-a-GCST90012023,Stem cell factor levels,stem Cell Factor measurement,EFO:0008291,http://www.ebi.ac.uk/efo/EFO_0008291,0.703,None
prot-a-2490,Rap1 GTPase-GDP dissociation stimulator 1,rap1 GTPase-GDP dissociation stimulator 1 measurement,EFO:0802990,http://www.ebi.ac.uk/efo/EFO_0802990,0.834,None
bbj-a-5,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
prot-c-2961_1_2,Protein C,protein C measurement,EFO:0004633,http://www.ebi.ac.uk/efo/EFO_0004633,0.777,None
prot-a-831,Delta-like protein 1,delta-like protein 1 measurement,EFO:0020316,http://www.ebi.ac.uk/efo/EFO_0020316,0.739,None
met-a-363,Xanthine,xanthine measurement,EFO:0010548,http://www.ebi.ac.uk/efo/EFO_0010548,0.825,None
prot-a-2596,Ribosomal protein S6 kinase alpha-6,ribosomal protein s6 kinase alpha-3 measurement,EFO:0020709,http://www.ebi.ac.uk/efo/EFO_0020709,0.802,None
prot-a-2127,Protein syndesmos,protein syndesmos measurement,EFO:0801966,http://www.ebi.ac.uk/efo/EFO_0801966,0.837,None
prot-a-913,ETS homologous factor,ETS homologous factor measurement,EFO:0802533,http://www.ebi.ac.uk/efo/EFO_0802533,0.907,None
prot-a-654,Cyclic AMP-responsive element-binding protein 3-like protein 4,cyclic AMP-responsive element-binding protein 3-like protein 4 measurement,EFO:0801506,http://www.ebi.ac.uk/efo/EFO_0801506,0.805,None
ebi-a-GCST006940,Neurociticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.725,None
prot-a-2500,Retinoblastoma-like protein 1,retinoblastoma,MONDO:0008380,http://purl.obolibrary.org/obo/MONDO_0008380,0.815,None
prot-a-1912,Macrophage metalloelastase,macrophage metalloelastase measurement,EFO:0008220,http://www.ebi.ac.uk/efo/EFO_0008220,0.913,None
prot-a-473,Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex,cyclin-dependent kinase 1:g2/mitotic-specific cyclin-B1 complex measurement,EFO:0020294,http://www.ebi.ac.uk/efo/EFO_0020294,0.678,None
prot-a-2929,Tax1-binding protein 3,tax1-binding protein 3 measurement,EFO:0802120,http://www.ebi.ac.uk/efo/EFO_0802120,0.669,None
prot-b-24,TNF superfamily member 14,tumor necrosis factor alpha gene expression measurement,EFO:0600069,http://www.ebi.ac.uk/efo/EFO_0600069,0.703,None
prot-a-3090,Tryptase beta-2,tryptase beta-2 measurement,EFO:0008306,http://www.ebi.ac.uk/efo/EFO_0008306,0.707,None
prot-a-2623,Serum amyloid A-1 protein,serum amyloid A protein measurement,EFO:0004728,http://www.ebi.ac.uk/efo/EFO_0004728,0.883,None
met-c-940,Valine,valine measurement,EFO:0009792,http://www.ebi.ac.uk/efo/EFO_0009792,0.716,None
ieu-a-28,Infant head circumference,infant head circumference,EFO:0004577,http://www.ebi.ac.uk/efo/EFO_0004577,0.972,None
prot-c-3290_50_2,CD109,CD109 antigen measurement,EFO:0008076,http://www.ebi.ac.uk/efo/EFO_0008076,0.746,None
ebi-a-GCST90001605,T cell %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.769,None
prot-a-1229,Glycine N-methyltransferase,glycine N-methyltransferase measurement,EFO:0801641,http://www.ebi.ac.uk/efo/EFO_0801641,0.806,None
ebi-a-GCST90010344,Serpin B6 levels,vitamin B6 measurement,EFO:0004621,http://www.ebi.ac.uk/efo/EFO_0004621,0.642,None
ebi-a-GCST90010182,Tumor necrosis factor receptor superfamily member 10A levels,tumor necrosis factor receptor superfamily member 10A measurement,EFO:0020799,http://www.ebi.ac.uk/efo/EFO_0020799,0.913,None
prot-a-3097,T-cell receptor-associated transmembrane adapter 1,t-cell receptor-associated transmembrane adapter 1 measurement,EFO:0803131,http://www.ebi.ac.uk/efo/EFO_0803131,0.827,None
prot-a-1501,X-linked interleukin-1 receptor accessory protein-like 2,interleukin 1 Receptor accessory protein measurement,EFO:0008167,http://www.ebi.ac.uk/efo/EFO_0008167,0.769,None
met-a-753,Cis-4-decenoyl carnitine,Cis-4-decenoyl carnitine measurement,EFO:0022091,http://www.ebi.ac.uk/efo/EFO_0022091,0.699,None
prot-a-2328,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1","protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 measurement",EFO:0802954,http://www.ebi.ac.uk/efo/EFO_0802954,0.705,None
prot-a-2277,Pirin,pirin measurement,EFO:0801884,http://www.ebi.ac.uk/efo/EFO_0801884,0.737,None
prot-a-124,Adipocyte plasma membrane-associated protein,adipocyte plasma membrane-associated protein measurement,EFO:0801348,http://www.ebi.ac.uk/efo/EFO_0801348,0.866,None
prot-a-970,Epiphycan,epiphycan measurement,EFO:0801578,http://www.ebi.ac.uk/efo/EFO_0801578,0.846,None
ebi-a-GCST006407,Philtrum width,Long philtrum,HP:0000343,http://purl.obolibrary.org/obo/HP_0000343,0.65,None
prot-a-740,Stromal cell-derived factor 1,stromal cell-derived factor 1 measurement,EFO:0020756,http://www.ebi.ac.uk/efo/EFO_0020756,0.753,None
prot-c-3534_14_2,"CD40 ligand, soluble",CD40 ligand measurement,EFO:0004790,http://www.ebi.ac.uk/efo/EFO_0004790,0.654,None
prot-a-2449,Receptor-type tyrosine-protein phosphatase U,receptor-type tyrosine-protein phosphatase U measurement,EFO:0803002,http://www.ebi.ac.uk/efo/EFO_0803002,0.772,None
prot-a-597,Chymase,chymase measurement,EFO:0020259,http://www.ebi.ac.uk/efo/EFO_0020259,0.798,None
ebi-a-GCST90002321,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
prot-a-1548,Inositol monophosphatase 3,inositol monophosphatase 3 measurement,EFO:0801698,http://www.ebi.ac.uk/efo/EFO_0801698,0.905,None
ebi-a-GCST90001613,CD4-CD8- T cell %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.619,None
prot-c-4301_58_2,Thymidine kinase,"thymidine kinase, cytosolic measurement",EFO:0020773,http://www.ebi.ac.uk/efo/EFO_0020773,0.685,None
prot-a-2481,Rac GTPase-activating protein 1,rac GTPase-activating protein 1 measurement,EFO:0801985,http://www.ebi.ac.uk/efo/EFO_0801985,0.826,None
prot-a-2580,Rho-associated protein kinase 2,rho-associated protein kinase 2 measurement,EFO:0803021,http://www.ebi.ac.uk/efo/EFO_0803021,0.747,None
prot-a-2424,Patched domain-containing protein 3,patched domain-containing protein 3 measurement,EFO:0802848,http://www.ebi.ac.uk/efo/EFO_0802848,0.868,None
met-c-904,Total cholesterol in medium LDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.973,None
prot-a-2545,Receptor-interacting serine/threonine-protein kinase 2,receptor-interacting serine/threonine-protein kinase 2 measurement,EFO:0802997,http://www.ebi.ac.uk/efo/EFO_0802997,0.727,None
met-a-484,X-11204,X-11204 measurement,EFO:0021219,http://www.ebi.ac.uk/efo/EFO_0021219,0.694,None
prot-a-198,Ubiquitin-like modifier-activating enzyme ATG7,ubiquitin-like modifier-activating enzyme ATG7 measurement,EFO:0803218,http://www.ebi.ac.uk/efo/EFO_0803218,0.878,None
prot-a-2266,PILR alpha-associated neural protein,PILR alpha-associated neural protein measurement,EFO:0021941,http://www.ebi.ac.uk/efo/EFO_0021941,0.838,None
prot-a-1539,Interleukin-6,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.934,None
met-d-ApoB_by_ApoA1,Ratio of apolipoprotein B to apolipoprotein A1,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.786,None
ebi-a-GCST90000443,CCL19 levels,CCL19 measurement,EFO:0009415,http://www.ebi.ac.uk/efo/EFO_0009415,0.76,None
prot-a-2375,Prolactin,Prolactin-Producing Pituitary Gland Adenoma,EFO:1000496,http://www.ebi.ac.uk/efo/EFO_1000496,0.85,None
prot-a-606,Ciliary neurotrophic factor receptor subunit alpha,ciliary neurotrophic factor receptor subunit alpha measurement,EFO:0020261,http://www.ebi.ac.uk/efo/EFO_0020261,0.938,None
prot-a-2812,Spastin,spastin measurement,EFO:0803096,http://www.ebi.ac.uk/efo/EFO_0803096,0.731,None
bbj-a-20,Eosinophil count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.981,None
prot-c-3431_54_2,EphA1,autosomal dominant pseudohypoaldosteronism type 1,MONDO:0008329,http://purl.obolibrary.org/obo/MONDO_0008329,0.646,None
prot-a-1489,Interleukin-17 receptor D,interleukin 17 receptor D measurement,EFO:0008177,http://www.ebi.ac.uk/efo/EFO_0008177,0.912,None
ieu-a-1008,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-a-1778,Low-density lipoprotein receptor-related protein 1B,low-density lipoprotein receptor-related protein 1B measurement,EFO:0021873,http://www.ebi.ac.uk/efo/EFO_0021873,0.813,None
met-a-510,X-09789,X-09789 measurement,EFO:0021211,http://www.ebi.ac.uk/efo/EFO_0021211,0.685,None
prot-a-2624,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1,deoxynucleoside triphosphate triphosphohydrolase SAMHD1 measurement,EFO:0802459,http://www.ebi.ac.uk/efo/EFO_0802459,0.972,None
prot-a-1792,Leucine-rich repeat neuronal protein 1,leucine-rich repeat neuronal protein 1 measurement,EFO:0801760,http://www.ebi.ac.uk/efo/EFO_0801760,0.831,None
prot-a-2754,Zinc transporter 5,zinc transporter 5 measurement,EFO:0803288,http://www.ebi.ac.uk/efo/EFO_0803288,0.901,None
prot-a-968,Erythropoietin receptor,erythropoietin receptor measurement,EFO:0020364,http://www.ebi.ac.uk/efo/EFO_0020364,0.907,None
prot-a-694,Casein kinase I isoform gamma-2,casein kinase I isoform gamma-2 measurement,EFO:0801458,http://www.ebi.ac.uk/efo/EFO_0801458,0.816,None
prot-a-1354,3-hydroxy-3-methylglutaryl-coenzyme A reductase,3-hydroxy-3-methylglutaryl-coenzymeAreductase measurement,EFO:0020113,http://www.ebi.ac.uk/efo/EFO_0020113,0.657,None
ebi-a-GCST004627,Lymphocyte counts,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
prot-a-1854,MAP kinase-activated protein kinase 5,MAP kinase-activated protein kinase 5 measurement,EFO:0020553,http://www.ebi.ac.uk/efo/EFO_0020553,0.862,None
ubm-a-2490,NET100 1334,NCI-H1334,EFO:0003117,http://www.ebi.ac.uk/efo/EFO_0003117,0.617,None
met-a-303,Glutamine,glutamine measurement,EFO:0009768,http://www.ebi.ac.uk/efo/EFO_0009768,0.805,None
prot-a-3087,Tropomyosin alpha-3 chain,tropomyosin alpha-1 chain measurement,EFO:0020786,http://www.ebi.ac.uk/efo/EFO_0020786,0.769,None
prot-a-2616,Protein S100-A13,protein S100-A13 measurement,EFO:0801959,http://www.ebi.ac.uk/efo/EFO_0801959,0.667,None
prot-a-11,Acetyl-CoA carboxylase 2,acetyl-CoA carboxylase 2 measurement,EFO:0802248,http://www.ebi.ac.uk/efo/EFO_0802248,0.811,None
ukb-d-4056_irnt,Age stroke diagnosed,stroke,EFO:0000712,http://www.ebi.ac.uk/efo/EFO_0000712,0.648,None
ebi-a-GCST004433,Macrophage inflammatory protein 1b levels,macrophage inflammatory protein 1b measurement,EFO:0008219,http://www.ebi.ac.uk/efo/EFO_0008219,0.866,None
ebi-a-GCST90012004,Interleukin-1-receptor antagonist levels,interleukin 1 receptor antagonist measurement,EFO:0004754,http://www.ebi.ac.uk/efo/EFO_0004754,0.861,None
prot-a-2636,Scavenger receptor class A member 3,scavenger receptor class A member 3 measurement,EFO:0803044,http://www.ebi.ac.uk/efo/EFO_0803044,0.935,None
prot-a-2325,Beta-endorphin,beta-endorphin measurement,EFO:0008034,http://www.ebi.ac.uk/efo/EFO_0008034,0.672,None
met-a-432,Aspartylphenylalanine,aspartylphenylalanine measurement,EFO:0021127,http://www.ebi.ac.uk/efo/EFO_0021127,0.924,None
prot-a-3227,"WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1","wap, kazal, immunoglobulin, kunitz and ntr domain-containing protein 1 measurement",EFO:0020852,http://www.ebi.ac.uk/efo/EFO_0020852,0.843,None
prot-a-211,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 measurement,EFO:0801611,http://www.ebi.ac.uk/efo/EFO_0801611,0.92,None
prot-a-1503,Interleukin-1 receptor-like 2,interleukin 1 receptor-like 2 measurement,EFO:0008169,http://www.ebi.ac.uk/efo/EFO_0008169,0.806,None
prot-a-140,DCC-interacting protein 13-alpha,DCC-interacting protein 13-alpha measurement,EFO:0802455,http://www.ebi.ac.uk/efo/EFO_0802455,0.656,None
prot-a-1084,Fc receptor-like protein 6,Fc receptor-like protein 6 measurement,EFO:0801600,http://www.ebi.ac.uk/efo/EFO_0801600,0.803,None
prot-a-1142,Follistatin,follistatin measurement,EFO:0010614,http://www.ebi.ac.uk/efo/EFO_0010614,0.838,None
ebi-a-GCST90001840,CD3 on Terminally Differentiated CD8+ T cell,differentiated,EFO:0002954,http://www.ebi.ac.uk/efo/EFO_0002954,0.607,None
ebi-a-GCST90001640,CD3- lymphocyte %lymphocyte,pseudolymphoma,EFO:1001831,http://www.ebi.ac.uk/efo/EFO_1001831,0.755,None
prot-a-2578,Roundabout homolog 2,roundabout homolog 2 measurement,EFO:0020713,http://www.ebi.ac.uk/efo/EFO_0020713,0.92,None
prot-c-2946_52_2,Factor D,recurrent Neisseria infections due to factor D deficiency,MONDO:0013487,http://purl.obolibrary.org/obo/MONDO_0013487,0.737,None
prot-c-4428_1_2,CHST2,ST2 protein measurement,EFO:0010599,http://www.ebi.ac.uk/efo/EFO_0010599,0.63,None
prot-c-4920_10_1,Lysozyme,lysozyme C measurement,EFO:0008216,http://www.ebi.ac.uk/efo/EFO_0008216,0.824,None
ebi-a-GCST005067,C-reactive protein levels,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.713,None
prot-a-2268,Polymeric immunoglobulin receptor,polymeric immunoglobulin receptor measurement,EFO:0008267,http://www.ebi.ac.uk/efo/EFO_0008267,0.928,None
prot-a-2839,Serine/arginine-rich splicing factor 7,serine/arginine-rich splicing factor 7 measurement,EFO:0802057,http://www.ebi.ac.uk/efo/EFO_0802057,0.703,None
prot-a-3255,Transcriptional regulator Kaiso,transcriptional regulator Kaiso measurement,EFO:0803168,http://www.ebi.ac.uk/efo/EFO_0803168,0.94,None
prot-a-1076,Low affinity immunoglobulin gamma Fc region receptor III-B,low affinity immunoglobulin gamma Fc region receptor III-B measurement,EFO:0008212,http://www.ebi.ac.uk/efo/EFO_0008212,0.871,None
prot-a-2758,Electroneutral sodium bicarbonate exchanger 1,electroneutral sodium bicarbonate exchanger 1 measurement,EFO:0802520,http://www.ebi.ac.uk/efo/EFO_0802520,0.951,None
met-a-306,Leucine,leucine measurement,EFO:0009770,http://www.ebi.ac.uk/efo/EFO_0009770,0.786,None
prot-a-1295,Glucoside xylosyltransferase 1,glucoside xylosyltransferase 1 measurement,EFO:0801629,http://www.ebi.ac.uk/efo/EFO_0801629,0.934,None
prot-a-781,Beta-defensin 103,beta-defensin 103 measurement,EFO:0802315,http://www.ebi.ac.uk/efo/EFO_0802315,0.774,None
ebi-a-GCST90010151,Tyrosine-protein kinase Mer levels,tyrosine-protein kinase FER measurement,EFO:0020821,http://www.ebi.ac.uk/efo/EFO_0020821,0.638,None
ukb-b-17406,Retinol,retinol measurement,EFO:0007900,http://www.ebi.ac.uk/efo/EFO_0007900,0.758,None
ukb-a-282,Arm fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.652,None
prot-a-1919,Matrilysin,matrilysin measurement,EFO:0008227,http://www.ebi.ac.uk/efo/EFO_0008227,0.83,None
prot-a-1127,Fms-related tyrosine kinase 3 ligand,Fms-related tyrosine kinase 3 ligand measurement,EFO:0010594,http://www.ebi.ac.uk/efo/EFO_0010594,0.834,None
ebi-a-GCST90010210,C-X-C motif chemokine 16 levels,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.635,None
ukb-b-2047,Age started smoking in former smokers,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.651,None
ebi-a-GCST90002358,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
ukb-b-11971,Pulse wave Arterial Stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.706,None
prot-a-1058,Tumor necrosis factor receptor superfamily member 6,tumor necrosis factor receptor superfamily member 6 measurement,EFO:0010610,http://www.ebi.ac.uk/efo/EFO_0010610,0.944,None
prot-a-195,ATPase family AAA domain-containing protein 1,ATPase family AAA domain-containing protein 1 measurement,EFO:0802297,http://www.ebi.ac.uk/efo/EFO_0802297,0.902,None
prot-a-1220,"Glutaredoxin-2, mitochondrial","glutaredoxin-2, mitochondrial measurement",EFO:0801633,http://www.ebi.ac.uk/efo/EFO_0801633,0.795,None
prot-a-2519,Tumor necrosis factor receptor superfamily member 19L,tumor necrosis factor receptor superfamily member 19L measurement,EFO:0008309,http://www.ebi.ac.uk/efo/EFO_0008309,0.953,None
ubm-a-131,IDP T1 FAST ROIs R hippocampus,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.675,None
met-d-L_HDL_TG,Triglycerides in large HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.733,None
prot-a-1397,Intercellular adhesion molecule 1,intercellular adhesion molecule 1 measurement,EFO:0801707,http://www.ebi.ac.uk/efo/EFO_0801707,0.93,None
ukb-b-19390,Vitamin C,vitamin C measurement,EFO:0600003,http://www.ebi.ac.uk/efo/EFO_0600003,0.797,None
prot-a-3143,Ubiquitin-conjugating enzyme E2 N,ubiquitin-conjugating enzyme E2 N measurement,EFO:0020841,http://www.ebi.ac.uk/efo/EFO_0020841,0.905,None
ebi-a-GCST90001844,CD3 on Terminally Differentiated CD4+ T cell,differentiated,EFO:0002954,http://www.ebi.ac.uk/efo/EFO_0002954,0.61,None
prot-c-4832_75_2,TRAIL R1,tumor necrosis factor ligand superfamily member 10 measurement,EFO:0010800,http://www.ebi.ac.uk/efo/EFO_0010800,0.734,None
ebi-a-GCST006947,Feeling fed-up,Fish-eye disease,ORPHANET.ORDO:79292,http://www.orpha.net/ORDO/Orphanet_79292,0.622,None
bbj-a-7,Activated partial thromboplastin time,partial thromboplastin time,EFO:0004310,http://www.ebi.ac.uk/efo/EFO_0004310,0.987,None
ebi-a-GCST90011782,Capecitabine drug response (AUC),response to fluoropyrimidines,EFO:0010825,http://www.ebi.ac.uk/efo/EFO_0010825,0.766,None
prot-a-1093,Fibroblast growth factor 23,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.918,None
prot-a-1852,MAP kinase-activated protein kinase 3,MAP kinase-activated protein kinase 3 measurement,EFO:0008226,http://www.ebi.ac.uk/efo/EFO_0008226,0.861,None
ebi-a-GCST004442,Interleukin-17 levels,interleukin 17 measurement,EFO:0008174,http://www.ebi.ac.uk/efo/EFO_0008174,0.758,None
prot-a-152,Rho GDP-dissociation inhibitor 1,rho GDP-dissociation inhibitor 1 measurement,EFO:0802009,http://www.ebi.ac.uk/efo/EFO_0802009,0.846,None
met-d-L_LDL_CE,Cholesteryl esters in large LDL,cholesterol esters in large LDL measurement,EFO:0022165,http://www.ebi.ac.uk/efo/EFO_0022165,0.801,None
prot-a-956,Ephrin type-A receptor 1,ephrin type-A receptor 1 measurement,EFO:0008123,http://www.ebi.ac.uk/efo/EFO_0008123,0.675,None
prot-a-2668,P-selectin glycoprotein ligand 1,P-selectin glycoprotein ligand 1 measurement,EFO:0010922,http://www.ebi.ac.uk/efo/EFO_0010922,0.763,None
met-a-464,Serine,serine measurement,EFO:0009774,http://www.ebi.ac.uk/efo/EFO_0009774,0.712,None
prot-a-2318,GDP-fucose protein O-fucosyltransferase 1,GDP-fucose protein O-fucosyltransferase 1 measurement,EFO:0801621,http://www.ebi.ac.uk/efo/EFO_0801621,0.743,None
met-b-268,1c+mDC:%32+,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.636,None
ebi-a-GCST90002299,Eosinophil counts,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.922,None
prot-a-1436,Interferon lambda-2,interferon lambda receptor 1 measurement,EFO:0802646,http://www.ebi.ac.uk/efo/EFO_0802646,0.793,None
met-d-Total_TG,Total triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.681,None
prot-a-950,Ectonucleoside triphosphate diphosphohydrolase 1,ectonucleoside triphosphate diphosphohydrolase 1 measurement,EFO:0020342,http://www.ebi.ac.uk/efo/EFO_0020342,0.96,None
prot-a-109,Annexin A2,annexin A2 measurement,EFO:0008027,http://www.ebi.ac.uk/efo/EFO_0008027,0.872,None
prot-b-40,nerve growth factor,beta-nerve growth factor measurement,EFO:0008035,http://www.ebi.ac.uk/efo/EFO_0008035,0.719,None
prot-a-1488,Interleukin-17 receptor C,interleukin 17 receptor A measurement,EFO:0008175,http://www.ebi.ac.uk/efo/EFO_0008175,0.851,None
met-d-XL_VLDL_L,Total lipids in very large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.897,None
ebi-a-GCST90006901,Epstein-Barr virus ZEBRA antibody levels,anti-Epstein Barr virus antibody measurement,EFO:0009273,http://www.ebi.ac.uk/efo/EFO_0009273,0.662,None
met-a-497,1-linoleoylglycerophosphoethanolamine*,1-linoleoylglycerophosphoethanolamine measurement,EFO:0021084,http://www.ebi.ac.uk/efo/EFO_0021084,0.888,None
met-a-426,X-08402,X-08402 measurement,EFO:0021205,http://www.ebi.ac.uk/efo/EFO_0021205,0.676,None
ebi-a-GCST90001643,B cell %CD3- lymphocyte,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.628,None
ubm-a-2647,IDP T1 FIRST left amygdala volume plus IDP T1 FIRST right amygdala volume,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.767,None
ukb-b-12405,Age at first live birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.827,None
prot-c-3213_65_2,Nidogen,nidogen-1 measurement,EFO:0008249,http://www.ebi.ac.uk/efo/EFO_0008249,0.662,None
met-d-Pyruvate,Pyruvate,pyruvate measurement,EFO:0010117,http://www.ebi.ac.uk/efo/EFO_0010117,0.852,None
prot-a-630,Collectin-12,collectin-12 measurement,EFO:0020272,http://www.ebi.ac.uk/efo/EFO_0020272,0.623,None
prot-a-2285,HRAS-like suppressor 3,HRAS-like suppressor 3 measurement,EFO:0802611,http://www.ebi.ac.uk/efo/EFO_0802611,0.794,None
met-a-624,Stearidonate (18:4n3),stearidonate 18:4n3 measurement,EFO:0021075,http://www.ebi.ac.uk/efo/EFO_0021075,0.701,None
met-a-499,X-11334,X-11334 measurement,EFO:0021226,http://www.ebi.ac.uk/efo/EFO_0021226,0.7,None
prot-c-5002_76_1,MMP-14,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.838,None
prot-c-4160_49_1,MMP-2,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.943,None
prot-a-1971,"Muscle, skeletal receptor tyrosine-protein kinase","muscle, skeletal receptor tyrosine-protein kinase measurement",EFO:0802764,http://www.ebi.ac.uk/efo/EFO_0802764,0.828,None
ebi-a-GCST90000472,Interleukin-10 receptor B levels,interleukin 17 receptor B measurement,EFO:0008176,http://www.ebi.ac.uk/efo/EFO_0008176,0.709,None
prot-a-3187,Vesicle-associated membrane protein 5,vesicle-associated membrane protein 5 measurement,EFO:0803253,http://www.ebi.ac.uk/efo/EFO_0803253,0.844,None
prot-a-2794,Sorting nexin-4,sorting nexin-1 measurement,EFO:0803092,http://www.ebi.ac.uk/efo/EFO_0803092,0.72,None
met-a-599,X-12329,X-12329 measurement,EFO:0021302,http://www.ebi.ac.uk/efo/EFO_0021302,0.719,None
prot-a-2850,"Type 2 lactosamine alpha-2,3-sialyltransferase","type 2 lactosamine alpha-2,3-sialyltransferase measurement",EFO:0802170,http://www.ebi.ac.uk/efo/EFO_0802170,0.725,None
prot-a-659,Corticotropin-releasing factor-binding protein,corticotropin-releasing factor-binding protein measurement,EFO:0801501,http://www.ebi.ac.uk/efo/EFO_0801501,0.808,None
prot-a-1074,Low affinity immunoglobulin gamma Fc region receptor II-a,low affinity immunoglobulin gamma Fc region receptor II-b measurement,EFO:0021970,http://www.ebi.ac.uk/efo/EFO_0021970,0.867,None
prot-c-3291_30_2,CD23,ML-DmD23,EFO:0007113,http://www.ebi.ac.uk/efo/EFO_0007113,0.672,None
prot-a-1797,Leucine-rich repeat transmembrane neuronal protein 4,leucine-rich repeat transmembrane neuronal protein 4 measurement,EFO:0802697,http://www.ebi.ac.uk/efo/EFO_0802697,0.883,None
prot-a-85,Junctional adhesion molecule-like,junctional adhesion molecule-like measurement,EFO:0020511,http://www.ebi.ac.uk/efo/EFO_0020511,0.85,None
prot-c-3091_70_2,Aurora kinase A,aurora kinase A measurement,EFO:0020168,http://www.ebi.ac.uk/efo/EFO_0020168,0.861,None
met-a-304,Tryptophan,tryptophan measurement,EFO:0008534,http://www.ebi.ac.uk/efo/EFO_0008534,0.85,None
prot-a-2878,Serine/threonine-protein kinase 17B,serine/threonine-protein kinase 17B measurement,EFO:0008281,http://www.ebi.ac.uk/efo/EFO_0008281,0.749,None
ukb-b-13405,"Forced expiratory volume in 1-second (FEV1), predicted percentage",forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.694,None
prot-c-5030_52_1,SIRT2,sirtuin-2 measurement,EFO:0010795,http://www.ebi.ac.uk/efo/EFO_0010795,0.994,None
ieu-b-29,basophil cell count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.908,None
prot-a-2292,Urokinase-type plasminogen activator,urokinase-type plasminogen activator measurement,EFO:0010803,http://www.ebi.ac.uk/efo/EFO_0010803,0.841,None
prot-a-1650,Kin of IRRE-like protein 2,kin of IRRE-like protein 2 measurement,EFO:0802678,http://www.ebi.ac.uk/efo/EFO_0802678,0.783,None
prot-a-3086,Tropomyosin beta chain,tropomyosin beta chain measurement,EFO:0020787,http://www.ebi.ac.uk/efo/EFO_0020787,0.887,None
prot-a-1832,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA","mannosyl-oligosaccharide 1,2-alpha-mannosidase IA measurement",EFO:0802729,http://www.ebi.ac.uk/efo/EFO_0802729,0.765,None
ebi-a-GCST90012017,Interleukin-27 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.741,None
prot-a-113,Apoptotic protease-activating factor 1,apoptotic protease-activating factor 1 measurement,EFO:0801390,http://www.ebi.ac.uk/efo/EFO_0801390,0.846,None
met-a-352,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
prot-a-2170,Serine/threonine-protein kinase PAK 4,serine/threonine-protein kinase PAK 4 measurement,EFO:0802059,http://www.ebi.ac.uk/efo/EFO_0802059,0.746,None
met-d-HDL_L,Total lipids in HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.867,None
prot-a-19,Lysosomal acid phosphatase,lysosomal acid phosphatase measurement,EFO:0801776,http://www.ebi.ac.uk/efo/EFO_0801776,0.897,None
prot-c-3200_49_2,kallikrein 13,kallikrein-13 measurement,EFO:0020512,http://www.ebi.ac.uk/efo/EFO_0020512,0.761,None
prot-a-1294,Guanylate cyclase activator 2B,guanylate cyclase activator 2B measurement,EFO:0802589,http://www.ebi.ac.uk/efo/EFO_0802589,0.935,None
prot-a-3076,Torsin-1A-interacting protein 1,torsin-1A-interacting protein 1 measurement,EFO:0802137,http://www.ebi.ac.uk/efo/EFO_0802137,0.612,None
prot-a-1094,Fibroblast growth factor 4,fibroblast growth factor 4 measurement,EFO:0020382,http://www.ebi.ac.uk/efo/EFO_0020382,0.908,None
ebi-a-GCST004457,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,EFO:0008146,http://www.ebi.ac.uk/efo/EFO_0008146,0.742,None
prot-c-4159_130_1,Factor H,complement factor H deficiency,MONDO:0012350,http://purl.obolibrary.org/obo/MONDO_0012350,0.749,None
prot-a-1785,Leucine-rich repeat-containing protein 19,leucine-rich repeat-containing protein 19 measurement,EFO:0801762,http://www.ebi.ac.uk/efo/EFO_0801762,0.789,None
prot-c-2602_2_2,Angiopoietin-2,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.74,None
prot-c-3495_15_2,GCP-2,Greig cephalopolysyndactyly syndrome,MONDO:0008287,http://purl.obolibrary.org/obo/MONDO_0008287,0.636,None
met-a-544,X-11795,X-11795 measurement,EFO:0021261,http://www.ebi.ac.uk/efo/EFO_0021261,0.711,None
prot-a-1994,NAD kinase,NAD kinase measurement,EFO:0801821,http://www.ebi.ac.uk/efo/EFO_0801821,0.812,None
ebi-a-GCST90002300,Eosinophil counts,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.922,None
met-b-175,CD4:%TM (2),targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.783,None
ebi-a-GCST90010325,Multiple coagulation factor deficiency protein 2 levels,"factor V and factor VIII, combined deficiency of, type 1",MONDO:0009206,http://purl.obolibrary.org/obo/MONDO_0009206,0.876,None
prot-a-1441,Immunoglobulin superfamily DCC subclass member 3,immunoglobulin superfamily DCC subclass member 3 measurement,EFO:0801689,http://www.ebi.ac.uk/efo/EFO_0801689,0.958,None
prot-c-4703_87_2,TNF-b,tumor necrosis factor measurement,EFO:0010834,http://www.ebi.ac.uk/efo/EFO_0010834,0.761,None
ieu-a-1041,Intracranial volume,intracranial volume measurement,EFO:0004886,http://www.ebi.ac.uk/efo/EFO_0004886,0.881,None
met-c-874,Total cholesterol in large HDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.808,None
ukb-b-2303,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
prot-a-525,Properdin,properdin measurement,EFO:0008269,http://www.ebi.ac.uk/efo/EFO_0008269,0.799,None
ukb-b-1061,Age high blood pressure diagnosed,hypertension,EFO:0000537,http://www.ebi.ac.uk/efo/EFO_0000537,0.803,None
prot-a-388,C-C motif chemokine 1,C-C motif chemokine 1 measurement,EFO:0008041,http://www.ebi.ac.uk/efo/EFO_0008041,0.674,None
prot-a-3022,Transmembrane protease serine 11A,transmembrane protease serine 11A measurement,EFO:0803179,http://www.ebi.ac.uk/efo/EFO_0803179,0.94,None
met-d-LDL_size,Average diameter for LDL particles,LDL peak particle diameter measurement,EFO:0007677,http://www.ebi.ac.uk/efo/EFO_0007677,0.653,None
prot-a-1352,High mobility group protein B2,high mobility group protein B2 measurement,EFO:0801676,http://www.ebi.ac.uk/efo/EFO_0801676,0.929,None
met-c-894,Lactate,lactate measurement,EFO:0007745,http://www.ebi.ac.uk/efo/EFO_0007745,0.753,None
prot-a-3170,Netrin receptor UNC5D,netrin receptor UNC5D measurement,EFO:0020591,http://www.ebi.ac.uk/efo/EFO_0020591,0.919,None
prot-a-1278,Gastrin-releasing peptide,gastrin-releasing peptide measurement,EFO:0022000,http://www.ebi.ac.uk/efo/EFO_0022000,0.824,None
prot-a-462,B-cell antigen receptor complex-associated protein beta chain,B-cell antigen receptor complex-associated protein beta chain measurement,EFO:0802300,http://www.ebi.ac.uk/efo/EFO_0802300,0.799,None
met-a-520,X-11470,X-11470 measurement,EFO:0021241,http://www.ebi.ac.uk/efo/EFO_0021241,0.702,None
prot-a-697,Casein kinase II 2-alpha:2-beta heterotetramer,casein kinase II 2-alpha:2-beta heterotetramer measurement,EFO:0020236,http://www.ebi.ac.uk/efo/EFO_0020236,0.676,None
ebi-a-GCST005180,Homeostasis model assessment of beta-cell function,HOMA-B,EFO:0004469,http://www.ebi.ac.uk/efo/EFO_0004469,0.921,None
ieu-a-1284,Estimated glomerular filtration rate (eGFR),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.76,None
met-a-476,Butyrylcarnitine,butyrylcarnitine measurement,EFO:0020010,http://www.ebi.ac.uk/efo/EFO_0020010,0.909,None
prot-a-2148,Opalin,opalin measurement,EFO:0801861,http://www.ebi.ac.uk/efo/EFO_0801861,0.703,None
ieu-a-1049,Iron,iron metabolism disease,MONDO:0002279,http://purl.obolibrary.org/obo/MONDO_0002279,0.748,None
prot-a-1231,Glucosamine 6-phosphate N-acetyltransferase,glucosamine 6-phosphate N-acetyltransferase measurement,EFO:0801626,http://www.ebi.ac.uk/efo/EFO_0801626,0.77,None
prot-a-884,Endothelin-converting enzyme 1,endothelin-converting enzyme 1 measurement,EFO:0008121,http://www.ebi.ac.uk/efo/EFO_0008121,0.868,None
ieu-b-71,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
prot-a-103,Ankyrin repeat domain-containing protein 46,ankyrin repeat domain-containing protein 46 measurement,EFO:0802282,http://www.ebi.ac.uk/efo/EFO_0802282,0.904,None
prot-c-4480_59_2,C3b,complement C3B measurement,EFO:0020275,http://www.ebi.ac.uk/efo/EFO_0020275,0.631,None
prot-a-1516,Interleukin-27,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.85,None
ebi-a-GCST90001584,CD14- CD16+ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.629,None
prot-c-2636_10_2,Lymphotoxin b R,lymphotoxin-alpha measurement,EFO:0020544,http://www.ebi.ac.uk/efo/EFO_0020544,0.645,None
ebi-a-GCST006353,Anti-rubella virus IgG levels,Anti-rubella virus IgG measurement,EFO:0009357,http://www.ebi.ac.uk/efo/EFO_0009357,0.679,None
met-a-571,Gamma-tocopherol,gamma-tocopherol measurement,EFO:0007899,http://www.ebi.ac.uk/efo/EFO_0007899,0.739,None
prot-c-2826_53_2,EDA,hypohidrotic ectodermal dysplasia,MONDO:0016535,http://purl.obolibrary.org/obo/MONDO_0016535,0.99,None
ebi-a-GCST006681,Insulin disposition index (BMI adjusted),disposition index measurement,EFO:0006832,http://www.ebi.ac.uk/efo/EFO_0006832,0.693,None
ebi-a-GCST90000475,interleukin-18 receptor 1 levels,interleukin 18 receptor 1 measurement,EFO:0008178,http://www.ebi.ac.uk/efo/EFO_0008178,0.823,None
met-a-429,4-methyl-2-oxopentanoate,4-methyl-2-oxopentanoate measurement,EFO:0021022,http://www.ebi.ac.uk/efo/EFO_0021022,0.616,None
prot-a-1080,Fc receptor-like protein 2,Fc receptor-like protein 2 measurement,EFO:0802544,http://www.ebi.ac.uk/efo/EFO_0802544,0.798,None
prot-a-2289,Group IIE secretory phospholipase A2,group IIe secretory phospholipase A2 measurement,EFO:0020424,http://www.ebi.ac.uk/efo/EFO_0020424,0.942,None
prot-a-1772,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3","leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 measurement",EFO:0802703,http://www.ebi.ac.uk/efo/EFO_0802703,0.851,None
prot-a-1071,Immunoglobulin alpha Fc receptor,immunoglobulin alpha fc receptor measurement,EFO:0020462,http://www.ebi.ac.uk/efo/EFO_0020462,0.934,None
prot-a-1958,Metallothionein-1F,metallothionein-1F measurement,EFO:0801798,http://www.ebi.ac.uk/efo/EFO_0801798,0.713,None
met-a-734,Gamma-glutamylglutamate,gamma-glutamylglutamate measurement,EFO:0021137,http://www.ebi.ac.uk/efo/EFO_0021137,0.853,None
ebi-a-GCST006696,Parental longevity (mother's attained age),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.696,None
ukb-a-290,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
prot-a-760,Cytohesin-4,cytohesin-2 measurement,EFO:0801517,http://www.ebi.ac.uk/efo/EFO_0801517,0.714,None
ukb-a-41,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
ebi-a-GCST90000482,Leukemia inhibitory factor receptor levels,leukemia inhibitory factor receptor measurement,EFO:0010788,http://www.ebi.ac.uk/efo/EFO_0010788,0.885,None
ebi-a-GCST90002318,Lymphocyte counts,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
prot-a-1016,FAS-associated factor 2,fAS-associated factor 2 measurement,EFO:0802541,http://www.ebi.ac.uk/efo/EFO_0802541,0.746,None
ebi-a-GCST005367,Vitamin D levels,vitamin measurement,EFO:0004729,http://www.ebi.ac.uk/efo/EFO_0004729,0.91,None
met-a-374,Glycerol,glycerol measurement,EFO:0010115,http://www.ebi.ac.uk/efo/EFO_0010115,0.798,None
prot-a-2456,Transmembrane protein PVRIG,transmembrane protein PVRIG measurement,EFO:0803192,http://www.ebi.ac.uk/efo/EFO_0803192,0.936,None
prot-a-2792,Sorting nexin-17,sorting nexin-17 measurement,EFO:0803093,http://www.ebi.ac.uk/efo/EFO_0803093,0.71,None
ebi-a-GCST004449,Hepatocyte growth factor levels,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.91,None
prot-a-1755,Vesicular integral-membrane protein VIP36,vesicular integral-membrane protein VIP36 measurement,EFO:0022012,http://www.ebi.ac.uk/efo/EFO_0022012,0.893,None
ieu-a-1036,Difference in height between childhood and adulthood,interstitial lung disease in childhood and adulthood,MONDO:0017030,http://purl.obolibrary.org/obo/MONDO_0017030,0.678,None
ieu-a-55,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-273,Peregrin,peregrin measurement,EFO:0802853,http://www.ebi.ac.uk/efo/EFO_0802853,0.817,None
met-c-932,Triglycerides in small VLDL,triglycerides in small VLDL measurement,EFO:0022145,http://www.ebi.ac.uk/efo/EFO_0022145,0.905,None
ubm-a-2642,IDP T1 FIRST left thalamus volume plus IDP T1 FIRST right thalamus volume,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.74,None
ubm-a-130,IDP T1 FAST ROIs L hippocampus,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.674,None
prot-c-3042_7_2,Myoglobin,myoglobin measurement,EFO:0005057,http://www.ebi.ac.uk/efo/EFO_0005057,0.833,None
prot-a-1367,Heterogeneous nuclear ribonucleoprotein M,heterogeneous nuclear ribonucleoprotein M measurement,EFO:0801674,http://www.ebi.ac.uk/efo/EFO_0801674,0.953,None
prot-a-2619,Protein S100-A5,protein S100-A5 measurement,EFO:0801960,http://www.ebi.ac.uk/efo/EFO_0801960,0.615,None
ebi-a-GCST006348,Anti-varicella zoster virus IgG levels,Anti-varicella zoster virus IgG measurement,EFO:0009351,http://www.ebi.ac.uk/efo/EFO_0009351,0.738,None
prot-a-3007,Transmembrane protein 237,transmembrane protein 237 measurement,EFO:0803184,http://www.ebi.ac.uk/efo/EFO_0803184,0.93,None
prot-a-2045,Neugrin,neugrin measurement,EFO:0802794,http://www.ebi.ac.uk/efo/EFO_0802794,0.856,None
ebi-a-GCST90002237,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
ukb-d-30840_irnt,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
prot-a-3014,Transmembrane protein 59-like,transmembrane protein 59-like measurement,EFO:0802157,http://www.ebi.ac.uk/efo/EFO_0802157,0.766,None
prot-a-2721,Sialate O-acetylesterase,sialate O-acetylesterase measurement,EFO:0803073,http://www.ebi.ac.uk/efo/EFO_0803073,0.735,None
met-a-670,X-12855,X-12855 measurement,EFO:0021343,http://www.ebi.ac.uk/efo/EFO_0021343,0.714,None
ukb-b-8221,Fractured heel (left),bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.603,None
prot-a-2615,Protein S100-A12,protein S100-A12 measurement,EFO:0010925,http://www.ebi.ac.uk/efo/EFO_0010925,0.66,None
prot-a-2465,Glutaminyl-peptide cyclotransferase,glutaminyl-peptide cyclotransferase measurement,EFO:0802570,http://www.ebi.ac.uk/efo/EFO_0802570,0.856,None
met-c-887,Cholesterol esters in large VLDL,cholesterol esters in large VLDL measurement,EFO:0022170,http://www.ebi.ac.uk/efo/EFO_0022170,0.923,None
ebi-a-GCST90013454,Type A behavior,behavior or behavioral disorder measurement,EFO:0004782,http://www.ebi.ac.uk/efo/EFO_0004782,0.771,None
prot-a-693,Casein kinase I isoform delta,casein kinase I isoform delta measurement,EFO:0802372,http://www.ebi.ac.uk/efo/EFO_0802372,0.921,None
ebi-a-GCST004424,TRAIL levels,tumor necrosis factor ligand superfamily member 10 measurement,EFO:0010800,http://www.ebi.ac.uk/efo/EFO_0010800,0.75,None
met-d-M_VLDL_FC_pct,Free cholesterol to total lipids ratio in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.75,None
met-a-663,X-12830,X-12830 measurement,EFO:0021337,http://www.ebi.ac.uk/efo/EFO_0021337,0.707,None
ebi-a-GCST90000477,Interleukin-18 levels,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.814,None
met-a-729,X-14626,X-14626 measurement,EFO:0021374,http://www.ebi.ac.uk/efo/EFO_0021374,0.698,None
met-d-L_VLDL_P,Concentration of large VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.932,None
prot-a-931,ETS domain-containing protein Elk-3,ETS domain-containing protein Elk-1 measurement,EFO:0801587,http://www.ebi.ac.uk/efo/EFO_0801587,0.748,None
met-b-253,CD8:%TM (1),targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.775,None
prot-a-3162,NKG2D ligand 3,NKG2D ligand 3 measurement,EFO:0802816,http://www.ebi.ac.uk/efo/EFO_0802816,0.91,None
prot-a-213,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2","n-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 measurement",EFO:0801817,http://www.ebi.ac.uk/efo/EFO_0801817,0.762,None
prot-b-47,interleukin 16,interleukin 16 measurement,EFO:0008173,http://www.ebi.ac.uk/efo/EFO_0008173,0.872,None
prot-a-2563,E3 ubiquitin-protein ligase RNF13,E3 ubiquitin-protein ligase RNF13 measurement,EFO:0801556,http://www.ebi.ac.uk/efo/EFO_0801556,0.899,None
prot-a-459,HLA class II histocompatibility antigen gamma chain,HLA class II histocompatibility antigen gamma chain measurement,EFO:0802607,http://www.ebi.ac.uk/efo/EFO_0802607,0.947,None
bbj-a-54,Total cholesterol,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-a-2992,Transmembrane and coiled-coil domain-containing protein 5A,transmembrane and coiled-coil domain-containing protein 5A measurement,EFO:0803174,http://www.ebi.ac.uk/efo/EFO_0803174,0.864,None
met-a-540,X-11786--methylcysteine,X-11786--methylcysteine measurement,EFO:0021257,http://www.ebi.ac.uk/efo/EFO_0021257,0.656,None
prot-a-155,Rho guanine nucleotide exchange factor 1,rho guanine nucleotide exchange factor 1 measurement,EFO:0802013,http://www.ebi.ac.uk/efo/EFO_0802013,0.95,None
prot-a-1206,ADP-ribosylation factor-binding protein GGA3,ADP-ribosylation factor-binding protein GGA3 measurement,EFO:0801353,http://www.ebi.ac.uk/efo/EFO_0801353,0.812,None
prot-a-2253,Profilin-2,Profiler,EFO:0008870,http://www.ebi.ac.uk/efo/EFO_0008870,0.712,None
met-a-752,Phenylalanylphenylalanine,phenylalanylphenylalanine measurement,EFO:0021131,http://www.ebi.ac.uk/efo/EFO_0021131,0.965,None
prot-a-2552,Inactive ribonuclease-like protein 10,inactive ribonuclease-like protein 10 measurement,EFO:0802626,http://www.ebi.ac.uk/efo/EFO_0802626,0.867,None
ieu-a-788,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
met-a-748,"4-androsten-3beta,17beta-diol disulfate 2*","androsterone sulfate-to-4-androsten-3beta,17beta-diol disulfate 2 ratio",EFO:0021413,http://www.ebi.ac.uk/efo/EFO_0021413,0.648,None
prot-a-162,ADP-ribosylation factor-like protein 3,ADP-ribosylation factor-like protein 3 measurement,EFO:0801356,http://www.ebi.ac.uk/efo/EFO_0801356,0.749,None
prot-a-1757,LIM and cysteine-rich domains protein 1,LIM and cysteine-rich domains protein 1 measurement,EFO:0802708,http://www.ebi.ac.uk/efo/EFO_0802708,0.817,None
prot-a-298,Type III endosome membrane protein TEMP,type III endosome membrane protein TEMP measurement,EFO:0803207,http://www.ebi.ac.uk/efo/EFO_0803207,0.913,None
ukb-a-338,Peak expiratory flow (PEF),peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.903,None
prot-a-2440,Tyrosine-protein phosphatase non-receptor type 4,tyrosine-protein phosphatase non-receptor type 4 measurement,EFO:0802172,http://www.ebi.ac.uk/efo/EFO_0802172,0.808,None
prot-c-5017_19_1,Peroxiredoxin-5,peroxiredoxin-1 measurement,EFO:0020629,http://www.ebi.ac.uk/efo/EFO_0020629,0.809,None
prot-a-3132,PolyUbiquitin K48-linked,polyUbiquitin K48-linked measurement,EFO:0022007,http://www.ebi.ac.uk/efo/EFO_0022007,0.793,None
prot-a-1995,N-acetyl-D-glucosamine kinase,N-acetyl-D-glucosamine kinase measurement,EFO:0008239,http://www.ebi.ac.uk/efo/EFO_0008239,0.615,None
bbj-a-55,Triglyceride,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.863,None
bbj-a-39,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
met-a-545,X-11799,X-11799 measurement,EFO:0021262,http://www.ebi.ac.uk/efo/EFO_0021262,0.715,None
met-a-345,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-2930,Tubulin-specific chaperone A,tubulin-specific chaperone A measurement,EFO:0802166,http://www.ebi.ac.uk/efo/EFO_0802166,0.83,None
prot-a-1413,Immediate early response 3-interacting protein 1,immediate early response 3-interacting protein 1 measurement,EFO:0802619,http://www.ebi.ac.uk/efo/EFO_0802619,0.861,None
prot-a-2432,Parathyroid hormone-related protein,parathyroid hormone-related protein measurement,EFO:0020622,http://www.ebi.ac.uk/efo/EFO_0020622,0.826,None
prot-a-1545,Interleukin-9,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.934,None
met-a-556,X-11859,X-11859 measurement,EFO:0021273,http://www.ebi.ac.uk/efo/EFO_0021273,0.7,None
prot-a-2557,Ribonuclease K6,ribonuclease K6 measurement,EFO:0802018,http://www.ebi.ac.uk/efo/EFO_0802018,0.918,None
prot-a-2139,Odorant-binding protein 2b,odorant-binding protein 2b measurement,EFO:0801859,http://www.ebi.ac.uk/efo/EFO_0801859,0.804,None
met-b-136,MDC:%X-Presenting,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.654,None
prot-a-3057,Tumor necrosis factor ligand superfamily member 14,tumor necrosis factor ligand superfamily member 14 measurement,EFO:0010613,http://www.ebi.ac.uk/efo/EFO_0010613,0.94,None
prot-a-1783,"Leucine-rich PPR motif-containing protein, mitochondrial","leucine-rich PPR motif-containing protein, mitochondrial measurement",EFO:0801758,http://www.ebi.ac.uk/efo/EFO_0801758,0.781,None
prot-a-508,Chymotrypsin-like elastase family member 2A,chymotrypsin-like elastase family member 2A measurement,EFO:0802399,http://www.ebi.ac.uk/efo/EFO_0802399,0.902,None
ebi-a-GCST90010220,Intercellular adhesion molecule 2 levels,intercellular adhesion molecule 2 measurement,EFO:0008163,http://www.ebi.ac.uk/efo/EFO_0008163,0.87,None
prot-a-316,Protein CEI,protein CEI measurement,EFO:0801936,http://www.ebi.ac.uk/efo/EFO_0801936,0.848,None
prot-a-812,Dihydrofolate reductase,dihydrofolate reductase measurement,EFO:0801526,http://www.ebi.ac.uk/efo/EFO_0801526,0.911,None
prot-c-2617_56_35,ERBB3,lethal congenital contracture syndrome 2,MONDO:0011868,http://purl.obolibrary.org/obo/MONDO_0011868,0.612,None
prot-a-2692,Kallistatin,kallistatin measurement,EFO:0008196,http://www.ebi.ac.uk/efo/EFO_0008196,0.846,None
prot-a-2612,Relaxin receptor 1,relaxin receptor 1 measurement,EFO:0021950,http://www.ebi.ac.uk/efo/EFO_0021950,0.878,None
met-c-839,Acetate,acetate measurement,EFO:0010112,http://www.ebi.ac.uk/efo/EFO_0010112,0.761,None
prot-a-1577,Isthmin-1,isthmin-1 measurement,EFO:0801737,http://www.ebi.ac.uk/efo/EFO_0801737,0.665,None
ukb-d-30250_irnt,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
ieu-a-961,Cigarettes smoked per day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.773,None
prot-a-2749,Mitochondrial glutamate carrier 2,mitochondrial glutamate carrier 2 measurement,EFO:0020572,http://www.ebi.ac.uk/efo/EFO_0020572,0.923,None
prot-a-3220,WD repeat-containing protein 1,WD repeat-containing protein 1 measurement,EFO:0802221,http://www.ebi.ac.uk/efo/EFO_0802221,0.832,None
prot-a-2290,Calcium-dependent phospholipase A2,calcium-dependent phospholipase A2 measurement,EFO:0020216,http://www.ebi.ac.uk/efo/EFO_0020216,0.849,None
prot-a-1139,Tyrosine-protein kinase FRK,tyrosine-protein kinase FRK measurement,EFO:0802171,http://www.ebi.ac.uk/efo/EFO_0802171,0.819,None
prot-c-4163_5_2,Histone H2A.z,histone H2A type 3 measurement,EFO:0021953,http://www.ebi.ac.uk/efo/EFO_0021953,0.758,None
ieu-a-1052,Transferrin,transferrin measurement,EFO:0006341,http://www.ebi.ac.uk/efo/EFO_0006341,0.85,None
prot-a-678,Cold shock domain-containing protein C2,cold shock domain-containing protein C2 measurement,EFO:0802415,http://www.ebi.ac.uk/efo/EFO_0802415,0.89,None
prot-a-3210,V-set and transmembrane domain-containing protein 4,v-set and transmembrane domain-containing protein 4 measurement,EFO:0803247,http://www.ebi.ac.uk/efo/EFO_0803247,0.784,None
prot-a-57,Protein argonaute-1,protein argonaute-1 measurement,EFO:0802926,http://www.ebi.ac.uk/efo/EFO_0802926,0.747,None
ebi-a-GCST90001606,CD4+ T cell %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.699,None
met-d-M_HDL_CE_pct,Cholesteryl esters to total lipids ratio in medium HDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.706,None
prot-a-1340,Homeodomain-interacting protein kinase 3,homeodomain-interacting protein kinase 3 measurement,EFO:0020457,http://www.ebi.ac.uk/efo/EFO_0020457,0.863,None
prot-a-754,Cytochrome c,cytochrome C measurement,EFO:0020302,http://www.ebi.ac.uk/efo/EFO_0020302,0.812,None
ebi-a-GCST90012028,Heat shock 27 kDa protein levels,heat shock 27 kDa protein measurement,EFO:0010915,http://www.ebi.ac.uk/efo/EFO_0010915,0.857,None
ubm-a-133,IDP T1 FAST ROIs R amygdala,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.608,None
prot-a-2132,Neurexophilin-1,neurexophilin-1 measurement,EFO:0008244,http://www.ebi.ac.uk/efo/EFO_0008244,0.757,None
prot-a-72,RAC-beta serine/threonine-protein kinase,RAC-beta serine/threonine-protein kinase measurement,EFO:0021989,http://www.ebi.ac.uk/efo/EFO_0021989,0.641,None
prot-a-381,Coiled-coil domain-containing protein 134,coiled-coil domain-containing protein 134 measurement,EFO:0802410,http://www.ebi.ac.uk/efo/EFO_0802410,0.844,None
prot-a-317,Glutaredoxin-like protein C5orf63,glutaredoxin-like protein C5orf63 measurement,EFO:0801634,http://www.ebi.ac.uk/efo/EFO_0801634,0.914,None
prot-a-1853,MAP kinase-activated protein kinase 5,MAP kinase-activated protein kinase 5 measurement,EFO:0020553,http://www.ebi.ac.uk/efo/EFO_0020553,0.862,None
met-d-M_VLDL_TG,Triglycerides in medium VLDL,triglycerides in medium VLDL measurement,EFO:0022155,http://www.ebi.ac.uk/efo/EFO_0022155,0.918,None
prot-a-2562,E3 ubiquitin-protein ligase RNF128,E3 ubiquitin-protein ligase RNF128 measurement,EFO:0801555,http://www.ebi.ac.uk/efo/EFO_0801555,0.903,None
prot-a-276,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement,EFO:0008014,http://www.ebi.ac.uk/efo/EFO_0008014,0.747,None
prot-a-256,Bone morphogenetic protein 6,bone morphogenetic protein 6 measurement,EFO:0020186,http://www.ebi.ac.uk/efo/EFO_0020186,0.893,None
prot-a-94,Angiopoietin-2,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.74,None
ebi-a-GCST004488,Insulin secretion rate,insulin secretion measurement,EFO:0008001,http://www.ebi.ac.uk/efo/EFO_0008001,0.885,None
ieu-a-1064,2-choice reaction time,reaction time measurement,EFO:0008393,http://www.ebi.ac.uk/efo/EFO_0008393,0.601,None
ukb-d-30070_irnt,Red blood cell (erythrocyte) distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
prot-a-849,DnaJ homolog subfamily C member 30,DnaJ homolog subfamily C member 30 measurement,EFO:0801542,http://www.ebi.ac.uk/efo/EFO_0801542,0.951,None
prot-a-1338,Histidine triad nucleotide-binding protein 1,histidine triad nucleotide-binding protein 1 measurement,EFO:0020450,http://www.ebi.ac.uk/efo/EFO_0020450,0.875,None
prot-a-3151,Uridine-cytidine kinase 2,uridine-cytidine kinase 2 measurement,EFO:0803238,http://www.ebi.ac.uk/efo/EFO_0803238,0.801,None
prot-a-241,B-cell lymphoma 6 protein,T-cell non-Hodgkin lymphoma,MONDO:0015760,http://purl.obolibrary.org/obo/MONDO_0015760,0.735,None
prot-a-3127,Non-receptor tyrosine-protein kinase TYK2,non-receptor tyrosine-protein kinase TYK2 measurement,EFO:0008251,http://www.ebi.ac.uk/efo/EFO_0008251,0.821,None
ieu-a-47,Lumbar spine bone mineral density,spine bone mineral density change measurement,EFO:0008474,http://www.ebi.ac.uk/efo/EFO_0008474,0.86,None
ebi-a-GCST90010279,Adhesion G-protein coupled receptor G2 levels,adhesion G protein-coupled receptor E2 measurement,EFO:0021892,http://www.ebi.ac.uk/efo/EFO_0021892,0.679,None
prot-c-2839_2_1,OX40 Ligand,combined immunodeficiency due to OX40 deficiency,MONDO:0014268,http://purl.obolibrary.org/obo/MONDO_0014268,0.676,None
prot-a-868,Down syndrome cell adhesion molecule,down syndrome cell adhesion molecule measurement,EFO:0022028,http://www.ebi.ac.uk/efo/EFO_0022028,0.903,None
prot-a-1941,"39S ribosomal protein L32, mitochondrial","39S ribosomal protein L34, mitochondrial measurement",EFO:0802238,http://www.ebi.ac.uk/efo/EFO_0802238,0.759,None
prot-a-2228,Platelet-derived growth factor D,platelet-derived growth factor D measurement,EFO:0801888,http://www.ebi.ac.uk/efo/EFO_0801888,0.799,None
prot-a-2550,Regulator of microtubule dynamics protein 3,regulator of microtubule dynamics protein 3 measurement,EFO:0803007,http://www.ebi.ac.uk/efo/EFO_0803007,0.94,None
met-d-Phe,Phenylalanine,phenylketonuria,MONDO:0009861,http://purl.obolibrary.org/obo/MONDO_0009861,0.899,None
ukb-b-1096,Heel bone mineral density (BMD) (left),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.82,None
prot-a-444,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 measurement,EFO:0021923,http://www.ebi.ac.uk/efo/EFO_0021923,0.747,None
met-a-435,X-08988,X-08988 measurement,EFO:0021207,http://www.ebi.ac.uk/efo/EFO_0021207,0.673,None
ebi-a-GCST90006922,Polyomavirus 2  JC VP1 antibody levels,anti-polyomavirus 2 antibody measurement,EFO:0010900,http://www.ebi.ac.uk/efo/EFO_0010900,0.625,None
prot-a-2396,Myeloblastin,myeloblastin measurement,EFO:0020585,http://www.ebi.ac.uk/efo/EFO_0020585,0.833,None
prot-a-1823,Cation-dependent mannose-6-phosphate receptor,cation-dependent mannose-6-phosphate receptor measurement,EFO:0801459,http://www.ebi.ac.uk/efo/EFO_0801459,0.735,None
prot-b-29,myeloperoxidase,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.875,None
prot-a-325,Bcl10-interacting CARD protein,bcl10-interacting CARD protein measurement,EFO:0801406,http://www.ebi.ac.uk/efo/EFO_0801406,0.792,None
prot-a-2942,Transcriptional enhancer factor TEF-5,transcriptional enhancer factor TEF-3 measurement,EFO:0803166,http://www.ebi.ac.uk/efo/EFO_0803166,0.798,None
prot-a-1473,Interleukin-12 receptor subunit beta-1,interleukin 6 receptor subunit beta measurement,EFO:0008188,http://www.ebi.ac.uk/efo/EFO_0008188,0.852,None
prot-a-1920,Neutrophil collagenase,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.992,None
prot-a-2322,DNA polymerase iota,DNA polymerase iota measurement,EFO:0802476,http://www.ebi.ac.uk/efo/EFO_0802476,0.901,None
prot-a-2920,Protachykinin-1,protachykinin-1 measurement,EFO:0801934,http://www.ebi.ac.uk/efo/EFO_0801934,0.789,None
ieu-a-786,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
met-a-537,Adrenate (22:4n6),adrenate 22:4n6 measurement,EFO:0021062,http://www.ebi.ac.uk/efo/EFO_0021062,0.649,None
prot-a-2663,Secreted and transmembrane protein 1,secreted and transmembrane protein 1 measurement,EFO:0021852,http://www.ebi.ac.uk/efo/EFO_0021852,0.906,None
met-d-ApoA1,Apolipoprotein A1,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.835,None
met-a-750,Ergothioneine,ergothioneine measurement,EFO:0021163,http://www.ebi.ac.uk/efo/EFO_0021163,0.894,None
prot-a-2760,Sodium-coupled monocarboxylate transporter 1,sodium-coupled monocarboxylate transporter 1 measurement,EFO:0802076,http://www.ebi.ac.uk/efo/EFO_0802076,0.876,None
met-c-942,Total cholesterol in very large HDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.749,None
prot-c-5062_60_3,CD226,CD226 antigen measurement,EFO:0020246,http://www.ebi.ac.uk/efo/EFO_0020246,0.745,None
prot-a-2703,Histone-lysine N-methyltransferase SETD2,histone-lysine N-methyltransferase SETD2 measurement,EFO:0802604,http://www.ebi.ac.uk/efo/EFO_0802604,0.813,None
ebi-a-GCST90002366,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
met-d-XXL_VLDL_PL_pct,Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.656,None
prot-a-2538,Regulator of G-protein signaling 8,regulator of G-protein signaling 8 measurement,EFO:0801997,http://www.ebi.ac.uk/efo/EFO_0801997,0.77,None
met-c-861,Glycerol,glycerol measurement,EFO:0010115,http://www.ebi.ac.uk/efo/EFO_0010115,0.798,None
ieu-a-113,Neo-agreeableness,agreeableness measurement,EFO:0007915,http://www.ebi.ac.uk/efo/EFO_0007915,0.828,None
prot-a-1088,Fibroblast growth factor 1,fibroblast growth factor 1 measurement,EFO:0020375,http://www.ebi.ac.uk/efo/EFO_0020375,0.906,None
prot-a-1327,HEPACAM family member 2,HEPACAM family member 2 measurement,EFO:0802591,http://www.ebi.ac.uk/efo/EFO_0802591,0.916,None
prot-a-2761,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement,EFO:0803304,http://www.ebi.ac.uk/efo/EFO_0803304,0.707,None
prot-a-3055,Tumor necrosis factor ligand superfamily member 12,tumor necrosis factor ligand superfamily member 12 measurement,EFO:0010801,http://www.ebi.ac.uk/efo/EFO_0010801,0.939,None
prot-c-4472_5_2,Tropomyosin 2,tropomyosin beta chain measurement,EFO:0020787,http://www.ebi.ac.uk/efo/EFO_0020787,0.642,None
prot-a-2019,Protein NDNF,protein NDNF measurement,EFO:0802953,http://www.ebi.ac.uk/efo/EFO_0802953,0.878,None
prot-a-1223,Glycolipid transfer protein domain-containing protein 2,glycolipid transfer protein domain-containing protein 2 measurement,EFO:0801643,http://www.ebi.ac.uk/efo/EFO_0801643,0.914,None
met-a-438,Cholate,cholate measurement,EFO:0021509,http://www.ebi.ac.uk/efo/EFO_0021509,0.734,None
prot-c-3487_32_2,BLC,Blomstrand lethal chondrodysplasia,ORPHANET.ORDO:50945,http://www.orpha.net/ORDO/Orphanet_50945,0.999,None
prot-a-315,Complement C4,complement C4 measurement,EFO:0004984,http://www.ebi.ac.uk/efo/EFO_0004984,0.907,None
met-d-IDL_FC_pct,Free cholesterol to total lipids ratio in IDL,free cholesterol:total lipids ratio,EFO:0020945,http://www.ebi.ac.uk/efo/EFO_0020945,0.735,None
ukb-b-7864,Vitamin B6,vitamin B6 measurement,EFO:0004621,http://www.ebi.ac.uk/efo/EFO_0004621,0.864,None
ebi-a-GCST90006887,Chlamydia trachomatis momp A antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.721,None
prot-a-2173,Pantothenate kinase 3,pantothenate kinase 3 measurement,EFO:0802843,http://www.ebi.ac.uk/efo/EFO_0802843,0.887,None
prot-a-2709,Secreted frizzled-related protein 1,secreted frizzled-related protein 1 measurement,EFO:0020718,http://www.ebi.ac.uk/efo/EFO_0020718,0.881,None
prot-a-690,CUB and sushi domain-containing protein 1,CUB and Sushi domain-containing protein 1 measurement,EFO:0803297,http://www.ebi.ac.uk/efo/EFO_0803297,0.872,None
prot-c-3805_16_2,Endocan,endocarditis,EFO:0000465,http://www.ebi.ac.uk/efo/EFO_0000465,0.625,None
prot-a-1144,Follistatin-related protein 1,follistatin-related protein 1 measurement,EFO:0021934,http://www.ebi.ac.uk/efo/EFO_0021934,0.823,None
prot-a-2970,Thrombospondin-2,thrombospondin-1 measurement,EFO:0020770,http://www.ebi.ac.uk/efo/EFO_0020770,0.735,None
prot-a-1644,Killer cell immunoglobulin-like receptor 2DL5A,killer cell immunoglobulin-like receptor 2DL5A measurement,EFO:0801745,http://www.ebi.ac.uk/efo/EFO_0801745,0.917,None
prot-a-2438,Tyrosine-protein phosphatase non-receptor type 1,tyrosine-protein phosphatase non-receptor type 1 measurement,EFO:0020834,http://www.ebi.ac.uk/efo/EFO_0020834,0.805,None
met-d-S_LDL_CE_pct,Cholesteryl esters to total lipids ratio in small LDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.713,None
prot-a-1979,Myc target protein 1,myc target protein 1 measurement,EFO:0801812,http://www.ebi.ac.uk/efo/EFO_0801812,0.894,None
prot-a-2582,Tyrosine-protein kinase transmembrane receptor ROR2,tyrosine-protein kinase transmembrane receptor ROR2 measurement,EFO:0803209,http://www.ebi.ac.uk/efo/EFO_0803209,0.898,None
ebi-a-GCST90012029,Tumor necrosis factor ligand superfamily member 14 levels,tumor necrosis factor ligand superfamily member 14 measurement,EFO:0010613,http://www.ebi.ac.uk/efo/EFO_0010613,0.897,None
prot-a-1693,Lymphocyte activation gene 3 protein,lymphocyte activation gene 3 protein measurement,EFO:0020540,http://www.ebi.ac.uk/efo/EFO_0020540,0.917,None
prot-a-290,UPF0729 protein C18orf32,UPF0729 protein C18orf32 measurement,EFO:0803236,http://www.ebi.ac.uk/efo/EFO_0803236,0.961,None
prot-a-1034,Membrane protein FAM174A,membrane protein FAM174A measurement,EFO:0801795,http://www.ebi.ac.uk/efo/EFO_0801795,0.935,None
met-a-310,Lactate,lactate measurement,EFO:0007745,http://www.ebi.ac.uk/efo/EFO_0007745,0.753,None
prot-a-2638,Scavenger receptor class A member 3,scavenger receptor class A member 3 measurement,EFO:0803044,http://www.ebi.ac.uk/efo/EFO_0803044,0.935,None
prot-c-3616_3_5,GNS,mucopolysaccharidosis type 3D,MONDO:0009658,http://purl.obolibrary.org/obo/MONDO_0009658,0.739,None
ukb-a-24,Number of treatments/medications taken,"number of treatments or medications taken, self-reported",EFO:0009803,http://www.ebi.ac.uk/efo/EFO_0009803,0.749,None
prot-a-1913,Collagenase 3,collagenase 3 measurement,EFO:0020271,http://www.ebi.ac.uk/efo/EFO_0020271,0.842,None
ebi-a-GCST90001824,IgD on IgD+ CD38+ B cell,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.64,None
ukb-a-297,Most recent bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.609,None
prot-c-2182_54_1,C4b,complement C4b measurement,EFO:0008092,http://www.ebi.ac.uk/efo/EFO_0008092,0.63,None
prot-a-2489,Rap1 GTPase-activating protein 1,rap1 GTPase-activating protein 1 measurement,EFO:0801987,http://www.ebi.ac.uk/efo/EFO_0801987,0.846,None
prot-a-2151,Origin recognition complex subunit 6,origin recognition complex subunit 6 measurement,EFO:0802833,http://www.ebi.ac.uk/efo/EFO_0802833,0.933,None
met-a-405,Glycodeoxycholate,glycodeoxycholate measurement,EFO:0010493,http://www.ebi.ac.uk/efo/EFO_0010493,0.897,None
ebi-a-GCST90010104,Agouti-related protein levels,Agouti-related protein measurement,EFO:0008016,http://www.ebi.ac.uk/efo/EFO_0008016,0.663,None
ebi-a-GCST004609,Monocyte percentage of white cells,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.993,None
ebi-a-GCST004602,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
ukb-b-18240,"Diastolic blood pressure, manual reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.787,None
prot-a-1271,Growth factor receptor-bound protein 2,growth factor receptor-bound protein 2 measurement,EFO:0021990,http://www.ebi.ac.uk/efo/EFO_0021990,0.824,None
prot-a-2750,Sodium-independent sulfate anion transporter,sodium-independent sulfate anion transporter measurement,EFO:0803087,http://www.ebi.ac.uk/efo/EFO_0803087,0.878,None
prot-a-64,"Apoptosis-inducing factor 1, mitochondrial","apoptosis-inducing factor 1, mitochondrial measurement",EFO:0801389,http://www.ebi.ac.uk/efo/EFO_0801389,0.807,None
prot-a-3075,DNA topoisomerase 2-binding protein 1,DNA topoisomerase 2-binding protein 1 measurement,EFO:0802480,http://www.ebi.ac.uk/efo/EFO_0802480,0.804,None
ukb-b-2772,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
ebi-a-GCST90010187,V-set and immunoglobulin domain-containing protein 2 levels,v-set and immunoglobulin domain-containing protein 2 measurement,EFO:0803308,http://www.ebi.ac.uk/efo/EFO_0803308,0.751,None
ebi-a-GCST90010129,Gastric intrinsic factor levels,Congenital intrinsic factor deficiency,ORPHANET.ORDO:332,http://www.orpha.net/ORDO/Orphanet_332,0.804,None
ebi-a-GCST006941,Irritable mood,Irritability,HP:0000737,http://purl.obolibrary.org/obo/HP_0000737,0.828,None
ebi-a-GCST90002312,Hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.768,None
prot-c-3758_68_3,Activated Protein C,activated protein C measurement,EFO:0020126,http://www.ebi.ac.uk/efo/EFO_0020126,0.867,None
prot-a-3039,Tumor necrosis factor receptor superfamily member 11B,tumor necrosis factor receptor superfamily member 11B measurement,EFO:0020801,http://www.ebi.ac.uk/efo/EFO_0020801,0.948,None
ieu-a-1005,Percent emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.816,None
prot-a-58,Anterior gradient protein 2 homolog,anterior gradient protein 2 homolog measurement,EFO:0020152,http://www.ebi.ac.uk/efo/EFO_0020152,0.929,None
prot-a-534,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial","coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial measurement",EFO:0801483,http://www.ebi.ac.uk/efo/EFO_0801483,0.738,None
prot-a-193,Retroviral-like aspartic protease 1,retroviral-like aspartic protease 1 measurement,EFO:0802008,http://www.ebi.ac.uk/efo/EFO_0802008,0.846,None
prot-c-4245_80_2,MDM2,myotonic dystrophy type 2,MONDO:0011266,http://purl.obolibrary.org/obo/MONDO_0011266,0.629,None
prot-a-2600,Ribosome-binding protein 1,ribosome-binding protein 1 measurement,EFO:0803026,http://www.ebi.ac.uk/efo/EFO_0803026,0.751,None
ebi-a-GCST90010315,Galanin peptide levels,galanin peptides measurement,EFO:0010615,http://www.ebi.ac.uk/efo/EFO_0010615,0.704,None
prot-a-3234,Protein Wnt-7a,protein wnt-7a measurement,EFO:0020689,http://www.ebi.ac.uk/efo/EFO_0020689,0.62,None
ubm-a-2670,volume Left-Accumbens-area,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.694,None
met-d-Albumin,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ebi-a-GCST90010257,Secretoglobin family 3A member 2 levels,secretoglobin family 1D member 2 measurement,EFO:0803046,http://www.ebi.ac.uk/efo/EFO_0803046,0.736,None
prot-a-92,Angiopoietin-1,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.742,None
prot-a-1326,HEPACAM family member 2,HEPACAM family member 2 measurement,EFO:0802591,http://www.ebi.ac.uk/efo/EFO_0802591,0.916,None
met-a-433,Levulinate (4-oxovalerate),levulinate 4-oxovalerate measurement,EFO:0021024,http://www.ebi.ac.uk/efo/EFO_0021024,0.764,None
ieu-a-115,Neo-extraversion,extraversion,EFO:0004317,http://www.ebi.ac.uk/efo/EFO_0004317,0.864,None
prot-a-1590,Integral membrane protein 2B,integral membrane protein 2B measurement,EFO:0802634,http://www.ebi.ac.uk/efo/EFO_0802634,0.917,None
prot-a-990,Endothelial cell-specific molecule 1,endothelial cell-specific molecule 1 measurement,EFO:0010912,http://www.ebi.ac.uk/efo/EFO_0010912,0.827,None
prot-c-3000_66_1,MBL,mannose-binding lectin deficiency,MONDO:0013714,http://purl.obolibrary.org/obo/MONDO_0013714,0.793,None
prot-a-319,Uncharacterized protein C6orf226,uncharacterized protein C6orf226 measurement,EFO:0802194,http://www.ebi.ac.uk/efo/EFO_0802194,0.955,None
prot-a-1225,Glia maturation factor gamma,glia maturation factor gamma measurement,EFO:0801624,http://www.ebi.ac.uk/efo/EFO_0801624,0.895,None
prot-a-2241,PDZ domain-containing protein 11,PDZ domain-containing protein 11 measurement,EFO:0802850,http://www.ebi.ac.uk/efo/EFO_0802850,0.879,None
prot-a-1795,Leucine-rich repeat transmembrane neuronal protein 1,leucine-rich repeat transmembrane neuronal protein 1 measurement,EFO:0020531,http://www.ebi.ac.uk/efo/EFO_0020531,0.882,None
ukb-b-530,Lamb intake,Carney complex,MONDO:0015285,http://purl.obolibrary.org/obo/MONDO_0015285,0.783,None
prot-a-2972,Thrombopoietin,thrombopoietin,EFO:0003236,http://www.ebi.ac.uk/efo/EFO_0003236,0.989,None
prot-a-2416,26S proteasome non-ATPase regulatory subunit 1,26S proteasome non-ATPase regulatory subunit 1 measurement,EFO:0802233,http://www.ebi.ac.uk/efo/EFO_0802233,0.887,None
ebi-a-GCST005232,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
prot-a-870,Desmoglein-2,desmoglein-1 measurement,EFO:0020321,http://www.ebi.ac.uk/efo/EFO_0020321,0.733,None
ebi-a-GCST90001637,CD4-CD8- Natural Killer T %T cell,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.627,None
prot-a-303,Complement C1q tumor necrosis factor-related protein 1,complement C1q tumor necrosis factor-related protein 1 measurement,EFO:0801493,http://www.ebi.ac.uk/efo/EFO_0801493,0.886,None
prot-a-596,Clusterin,clusterin measurement,EFO:0007655,http://www.ebi.ac.uk/efo/EFO_0007655,0.819,None
ebi-a-GCST90002234,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-240,Bcl-2-like protein 2,bcl-2-like protein 2 measurement,EFO:0021928,http://www.ebi.ac.uk/efo/EFO_0021928,0.618,None
ukb-b-9433,Age started oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.692,None
prot-a-2530,"Beta-1,3-N-acetylglucosaminyltransferase radical fringe","beta-1,3-N-acetylglucosaminyltransferase radical fringe measurement",EFO:0801408,http://www.ebi.ac.uk/efo/EFO_0801408,0.771,None
ebi-a-GCST90014297,DNA methylation-estimated plasminogen activator inhibitor-1 levels,plasminogen activator inhibitor 1 measurement,EFO:0004792,http://www.ebi.ac.uk/efo/EFO_0004792,0.709,None
met-a-675,X-13215,X-13215 measurement,EFO:0021347,http://www.ebi.ac.uk/efo/EFO_0021347,0.689,None
prot-a-1375,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,heparan sulfate glucosamine 3-O-sulfotransferase 3A1 measurement,EFO:0801671,http://www.ebi.ac.uk/efo/EFO_0801671,0.854,None
ebi-a-GCST90010288,Carbonic anhydrase 13 levels,carbonic anhydrase 13 measurement,EFO:0008067,http://www.ebi.ac.uk/efo/EFO_0008067,0.838,None
ebi-a-GCST90001576,Transitional B cell %B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.754,None
prot-a-1442,Immunoglobulin superfamily DCC subclass member 4,immunoglobulin superfamily DCC subclass member 4 measurement,EFO:0801690,http://www.ebi.ac.uk/efo/EFO_0801690,0.958,None
prot-a-2279,Phosphatidylinositol transfer protein beta isoform,phosphatidylinositol transfer protein beta isoform measurement,EFO:0802863,http://www.ebi.ac.uk/efo/EFO_0802863,0.948,None
ebi-a-GCST90013456,Psychoticism,mental or behavioural disorder,EFO:0000677,http://www.ebi.ac.uk/efo/EFO_0000677,0.794,None
ebi-a-GCST90010195,C-C motif chemokine 15 levels,CCL15 measurement,EFO:0009413,http://www.ebi.ac.uk/efo/EFO_0009413,0.684,None
prot-b-66,placental growth factor,placenta growth factor measurement,EFO:0010626,http://www.ebi.ac.uk/efo/EFO_0010626,0.846,None
prot-a-1102,Fibroblast growth factor receptor 2,fibroblast growth factor receptor 2 measurement,EFO:0020389,http://www.ebi.ac.uk/efo/EFO_0020389,0.929,None
prot-a-3276,Zinc finger protein 774,zinc finger protein 774 measurement,EFO:0803284,http://www.ebi.ac.uk/efo/EFO_0803284,0.928,None
met-a-486,Phenol sulfate,phenol sulfate measurement,EFO:0021011,http://www.ebi.ac.uk/efo/EFO_0021011,0.875,None
ebi-a-GCST90002022,CD4 on CD4+ T cell,immunodeficiency 79,MONDO:0030981,http://purl.obolibrary.org/obo/MONDO_0030981,0.659,None
prot-a-1846,Mitogen-activated protein kinase 13,mitogen-activated protein kinase 13 measurement,EFO:0020577,http://www.ebi.ac.uk/efo/EFO_0020577,0.817,None
prot-a-3240,Xaa-Pro aminopeptidase 1,xaa-pro aminopeptidase 1 measurement,EFO:0020856,http://www.ebi.ac.uk/efo/EFO_0020856,0.762,None
prot-b-79,platelet and endothelial cell adhesion molecule 1,platelet endothelial cell adhesion molecule measurement,EFO:0010598,http://www.ebi.ac.uk/efo/EFO_0010598,0.929,None
prot-a-3050,Tumor necrosis factor receptor superfamily member 21,tumor necrosis factor receptor superfamily member 21 measurement,EFO:0020810,http://www.ebi.ac.uk/efo/EFO_0020810,0.947,None
prot-a-3171,Protein unc-93 homolog B1,protein unc-93 homolog B1 measurement,EFO:0801968,http://www.ebi.ac.uk/efo/EFO_0801968,0.669,None
ebi-a-GCST90001450,CD62L- monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.637,None
prot-a-815,Probable ATP-dependent RNA helicase DHX58,probable ATP-dependent RNA helicase DHX58 measurement,EFO:0802901,http://www.ebi.ac.uk/efo/EFO_0802901,0.877,None
prot-a-1480,Interleukin-17A,interleukin-17A measurement,EFO:0022026,http://www.ebi.ac.uk/efo/EFO_0022026,0.739,None
prot-a-2948,Testis-expressed sequence 29 protein,testis-expressed sequence 29 protein measurement,EFO:0802125,http://www.ebi.ac.uk/efo/EFO_0802125,0.829,None
prot-a-589,Ceroid-lipofuscinosis neuronal protein 5,neuronal ceroid lipofuscinosis 5,MONDO:0009745,http://purl.obolibrary.org/obo/MONDO_0009745,0.948,None
prot-a-2695,Antithrombin-III,Reduced antithrombin III activity,HP:0001976,http://purl.obolibrary.org/obo/HP_0001976,0.836,None
prot-c-4162_54_2,Transferrin,transferrin measurement,EFO:0006341,http://www.ebi.ac.uk/efo/EFO_0006341,0.85,None
ebi-a-GCST90010255,Retinoic acid receptor responder protein 2 levels,retinoic acid receptor responder protein 2 measurement,EFO:0008274,http://www.ebi.ac.uk/efo/EFO_0008274,0.876,None
met-a-428,X-08766,X-08766 measurement,EFO:0021206,http://www.ebi.ac.uk/efo/EFO_0021206,0.672,None
met-a-642,X-12712,X-12712 measurement,EFO:0021323,http://www.ebi.ac.uk/efo/EFO_0021323,0.695,None
ebi-a-GCST90001777,CD25 on CD24+ CD27+ B cell,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.612,None
prot-a-1057,Tumor necrosis factor receptor superfamily member 6,tumor necrosis factor receptor superfamily member 6 measurement,EFO:0010610,http://www.ebi.ac.uk/efo/EFO_0010610,0.944,None
ebi-a-GCST004604,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
prot-a-1049,Protein FAM3B,protein FAM3B measurement,EFO:0021857,http://www.ebi.ac.uk/efo/EFO_0021857,0.898,None
ebi-a-GCST90012076,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
ukb-b-7408,Average total household income before tax,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.635,None
ebi-a-GCST90002090,CD11c on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.631,None
ukb-b-5090,Astigmatism angle (left),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.746,None
prot-a-1879,Protein MENT,protein MENT measurement,EFO:0801952,http://www.ebi.ac.uk/efo/EFO_0801952,0.875,None
prot-a-971,Endoplasmic reticulum aminopeptidase 1,endoplasmic reticulum aminopeptidase 1 measurement,EFO:0008119,http://www.ebi.ac.uk/efo/EFO_0008119,0.933,None
prot-a-526,Glycoprotein hormones alpha chain,glycoprotein hormones alpha chain measurement,EFO:0802577,http://www.ebi.ac.uk/efo/EFO_0802577,0.921,None
prot-a-713,Catenin alpha-2,mating type alpha,EFO:0001270,http://www.ebi.ac.uk/efo/EFO_0001270,0.688,None
prot-a-962,Ephrin type-B receptor 2,ephrin type-B receptor 2 measurement,EFO:0008124,http://www.ebi.ac.uk/efo/EFO_0008124,0.681,None
ieu-a-1042,Nucleus accumbens volume,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.992,None
prot-a-2270,PIK3CA/PIK3R1,PIK3CA/PIK3R1 measurement,EFO:0021971,http://www.ebi.ac.uk/efo/EFO_0021971,0.826,None
prot-a-835,DnaJ homolog subfamily A member 4,DnaJ homolog subfamily A member 4 measurement,EFO:0802486,http://www.ebi.ac.uk/efo/EFO_0802486,0.946,None
prot-a-2511,Recoverin,recoverin measurement,EFO:0803003,http://www.ebi.ac.uk/efo/EFO_0803003,0.825,None
ebi-a-GCST004632,Lymphocyte percentage of white cells,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.992,None
ebi-a-GCST90010339,Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels,tyrosine-protein kinase transmembrane receptor ROR1 measurement,EFO:0020831,http://www.ebi.ac.uk/efo/EFO_0020831,0.81,None
prot-a-2989,Toll-like receptor 2,toll-like receptor 2 measurement,EFO:0020777,http://www.ebi.ac.uk/efo/EFO_0020777,0.739,None
prot-c-2685_21_2,IGFBP-5,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.617,None
prot-a-190,ATPase ASNA1,ATPase ASNA1 measurement,EFO:0802296,http://www.ebi.ac.uk/efo/EFO_0802296,0.905,None
prot-a-2353,Putative uncharacterized protein PQLC2L,putative uncharacterized protein PQLC2L measurement,EFO:0802984,http://www.ebi.ac.uk/efo/EFO_0802984,0.956,None
prot-a-403,C-C motif chemokine 25,C-C motif chemokine 25 measurement,EFO:0008050,http://www.ebi.ac.uk/efo/EFO_0008050,0.71,None
prot-a-1475,Interleukin-13,interleukin 13 measurement,EFO:0008171,http://www.ebi.ac.uk/efo/EFO_0008171,0.87,None
prot-a-670,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
prot-a-916,Probable RNA-binding protein EIF1AD,probable RNA-binding protein EIF1AD measurement,EFO:0801918,http://www.ebi.ac.uk/efo/EFO_0801918,0.872,None
prot-a-151,Rho GTPase-activating protein 5,rho GTPase-activating protein 5 measurement,EFO:0803017,http://www.ebi.ac.uk/efo/EFO_0803017,0.841,None
ebi-a-GCST90010125,Follistatin levels,follistatin measurement,EFO:0010614,http://www.ebi.ac.uk/efo/EFO_0010614,0.711,None
prot-a-2820,Serine protease inhibitor Kazal-type 6,serine protease inhibitor Kazal-type 6 measurement,EFO:0802055,http://www.ebi.ac.uk/efo/EFO_0802055,0.865,None
prot-b-14,interleukin 27,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.85,None
prot-c-3651_50_5,VEGF sR2,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.676,None
ubm-a-2681,volume Right-Pallidum,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.885,None
prot-a-2765,Solute carrier organic anion transporter family member 5A1,solute carrier organic anion transporter family member 5A1 measurement,EFO:0803091,http://www.ebi.ac.uk/efo/EFO_0803091,0.96,None
prot-a-1586,Inter-alpha-trypsin inhibitor heavy chain H1,inter-alpha-trypsin inhibitor heavy chain H1 measurement,EFO:0801705,http://www.ebi.ac.uk/efo/EFO_0801705,0.839,None
met-a-747,"4-androsten-3beta,17beta-diol disulfate 1*","4-androsten-3beta,17beta-diol disulfate 1 measurement",EFO:0021113,http://www.ebi.ac.uk/efo/EFO_0021113,0.638,None
ebi-a-GCST008049,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
prot-a-2811,SPARC-like protein 1,SPARC-like protein 1 measurement,EFO:0008289,http://www.ebi.ac.uk/efo/EFO_0008289,0.615,None
prot-c-5132_71_3,TCCR,tarsal-carpal coalition syndrome,MONDO:0008521,http://purl.obolibrary.org/obo/MONDO_0008521,0.641,None
prot-a-2626,Histone deacetylase complex subunit SAP30,histone deacetylase complex subunit SAP30 measurement,EFO:0802601,http://www.ebi.ac.uk/efo/EFO_0802601,0.95,None
met-a-485,X-02269,X-02269 measurement,EFO:0021183,http://www.ebi.ac.uk/efo/EFO_0021183,0.668,None
prot-a-1840,Dual specificity mitogen-activated protein kinase kinase 1,dual specificity mitogen-activated protein kinase kinase 1 measurement,EFO:0020335,http://www.ebi.ac.uk/efo/EFO_0020335,0.898,None
ebi-a-GCST90012067,Proheparin-binding EGF-like growth factor levels,proheparin-binding EGF-like growth factor measurement,EFO:0010924,http://www.ebi.ac.uk/efo/EFO_0010924,0.742,None
prot-a-1939,Double-strand break repair protein MRE11A,double-strand break repair protein MRE11A measurement,EFO:0802493,http://www.ebi.ac.uk/efo/EFO_0802493,0.896,None
prot-a-2428,Prostaglandin reductase 1,prostaglandin reductase 1 measurement,EFO:0801932,http://www.ebi.ac.uk/efo/EFO_0801932,0.897,None
met-c-899,Cholesterol esters in medium HDL,cholesterol esters in medium LDL measurement,EFO:0022186,http://www.ebi.ac.uk/efo/EFO_0022186,0.803,None
met-c-941,Mean diameter for VLDL particles,LDL peak particle diameter measurement,EFO:0007677,http://www.ebi.ac.uk/efo/EFO_0007677,0.647,None
prot-c-3488_64_2,Catalase,catalase measurement,EFO:0008071,http://www.ebi.ac.uk/efo/EFO_0008071,0.726,None
prot-a-2242,PDZK1-interacting protein 1,PDZK1-interacting protein 1 measurement,EFO:0801869,http://www.ebi.ac.uk/efo/EFO_0801869,0.774,None
prot-a-1467,Interleukin-11 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.871,None
ebi-a-GCST90001906,CD86 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.659,None
prot-c-2731_29_2,NADPH-P450 Oxidoreductase,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,MONDO:0013310,http://purl.obolibrary.org/obo/MONDO_0013310,0.627,None
prot-c-3025_50_1,bFGF,basic fibroblast growth factor,EFO:0003316,http://www.ebi.ac.uk/efo/EFO_0003316,0.994,None
prot-a-1943,"39S ribosomal protein L34, mitochondrial","39S ribosomal protein L34, mitochondrial measurement",EFO:0802238,http://www.ebi.ac.uk/efo/EFO_0802238,0.846,None
prot-a-2857,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 measurement",EFO:0802270,http://www.ebi.ac.uk/efo/EFO_0802270,0.726,None
prot-a-270,Bromodomain testis-specific protein,bromodomain testis-specific protein measurement,EFO:0802339,http://www.ebi.ac.uk/efo/EFO_0802339,0.824,None
ebi-a-GCST90020053,Frailty index,frailty measurement,EFO:0009885,http://www.ebi.ac.uk/efo/EFO_0009885,0.692,None
ukb-b-8951,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
prot-a-2705,Seizure 6-like protein 2,Seizure,HP:0001250,http://purl.obolibrary.org/obo/HP_0001250,0.788,None
prot-a-2565,RING finger protein 148,RING finger protein 148 measurement,EFO:0803029,http://www.ebi.ac.uk/efo/EFO_0803029,0.912,None
met-b-170,CD4:%SCM,diastematomyelia,MONDO:0009106,http://purl.obolibrary.org/obo/MONDO_0009106,0.729,None
ebi-a-GCST90002238,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
prot-c-4128_27_2,Eotaxin-2,eotaxin measurement,EFO:0008122,http://www.ebi.ac.uk/efo/EFO_0008122,0.803,None
met-a-529,X-11530,X-11530 measurement,EFO:0021249,http://www.ebi.ac.uk/efo/EFO_0021249,0.707,None
prot-a-1017,FAS-associated factor 2,fAS-associated factor 2 measurement,EFO:0802541,http://www.ebi.ac.uk/efo/EFO_0802541,0.746,None
ieu-a-75,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-c-5228_25_2,KIF23,kinesin-like protein KIF23 measurement,EFO:0020522,http://www.ebi.ac.uk/efo/EFO_0020522,0.668,None
prot-a-1217,Glioma pathogenesis-related protein 1,glioma pathogenesis-related protein 1 measurement,EFO:0802567,http://www.ebi.ac.uk/efo/EFO_0802567,0.823,None
ebi-a-GCST90000512,Frozen shoulder,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.995,None
ebi-a-GCST90010135,Osteoclast-associated immunoglobulin-like receptor levels,osteoclast-associated immunoglobulin-like receptor measurement,EFO:0802837,http://www.ebi.ac.uk/efo/EFO_0802837,0.804,None
prot-c-4309_59_3,Triosephosphate isomerase,triosephosphate isomerase measurement,EFO:0020785,http://www.ebi.ac.uk/efo/EFO_0020785,0.896,None
met-a-667,X-12850,X-12850 measurement,EFO:0021341,http://www.ebi.ac.uk/efo/EFO_0021341,0.699,None
prot-a-1039,Protein FAM189A2,protein FAM189A2 measurement,EFO:0801949,http://www.ebi.ac.uk/efo/EFO_0801949,0.928,None
met-d-L_VLDL_TG_pct,Triglycerides to total lipids ratio in large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.714,None
ebi-a-GCST90012024,Interleukin-18 levels,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.814,None
ieu-a-69,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-2528,E3 ubiquitin-protein ligase rififylin,e3 ubiquitin-protein ligase rififylin measurement,EFO:0802509,http://www.ebi.ac.uk/efo/EFO_0802509,0.909,None
ebi-a-GCST90002059,CD8 on Natural Killer T,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.656,None
prot-b-50,C-C motif chemokine ligand 4,CCL4 measurement,EFO:0004751,http://www.ebi.ac.uk/efo/EFO_0004751,0.604,None
ebi-a-GCST90012030,Prolactin levels,Prolactin-Producing Pituitary Gland Adenoma,EFO:1000496,http://www.ebi.ac.uk/efo/EFO_1000496,0.656,None
prot-a-2474,Ras-related protein Rab-27A,ras-related protein Rab-27A measurement,EFO:0802992,http://www.ebi.ac.uk/efo/EFO_0802992,0.643,None
prot-c-2857_70_2,Glucocorticoid receptor,glucocorticoid receptor measurement,EFO:0020405,http://www.ebi.ac.uk/efo/EFO_0020405,0.91,None
prot-a-1525,Interleukin-3,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.95,None
prot-a-2719,SHC-transforming protein 4,SHC-transforming protein 4 measurement,EFO:0803071,http://www.ebi.ac.uk/efo/EFO_0803071,0.72,None
prot-a-751,C-X-C motif chemokine 9,CCL13 measurement,EFO:0009411,http://www.ebi.ac.uk/efo/EFO_0009411,0.622,None
prot-a-2824,Kunitz-type protease inhibitor 2,Kunitz-type protease inhibitor 2 measurement,EFO:0008200,http://www.ebi.ac.uk/efo/EFO_0008200,0.783,None
prot-a-2211,Neuroendocrine convertase 1,neuroendocrine convertase 1 measurement,EFO:0801830,http://www.ebi.ac.uk/efo/EFO_0801830,0.913,None
ebi-a-GCST90001593,CD8+ T cell %T cell,T-Cell Prolymphocytic Leukemia,EFO:1000560,http://www.ebi.ac.uk/efo/EFO_1000560,0.665,None
prot-a-479,Cadherin-12,cadherin-12 measurement,EFO:0020210,http://www.ebi.ac.uk/efo/EFO_0020210,0.67,None
met-d-IDL_L,Total lipids in IDL,total lipids in IDL,EFO:0022161,http://www.ebi.ac.uk/efo/EFO_0022161,0.963,None
prot-a-3044,Tumor necrosis factor receptor superfamily member 18,tumor necrosis factor receptor superfamily member 18 measurement,EFO:0020807,http://www.ebi.ac.uk/efo/EFO_0020807,0.946,None
prot-a-2725,Sialic acid-binding Ig-like lectin 12,sialic acid-binding Ig-like lectin 12 measurement,EFO:0802066,http://www.ebi.ac.uk/efo/EFO_0802066,0.688,None
prot-c-2999_6_2,LSAMP,lichen sclerosus et atrophicus,MONDO:0007899,http://purl.obolibrary.org/obo/MONDO_0007899,0.725,None
prot-c-5335_73_3,annexin VI,annexin A1 measurement,EFO:0008026,http://www.ebi.ac.uk/efo/EFO_0008026,0.639,None
ebi-a-GCST004626,Myeloid white cell count,myeloid white cell count,EFO:0007988,http://www.ebi.ac.uk/efo/EFO_0007988,0.982,None
ukb-a-500,Heel bone mineral density (BMD) T-score  automated,heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.695,None
prot-a-1657,Kallikrein-12,kallikrein-12 measurement,EFO:0008194,http://www.ebi.ac.uk/efo/EFO_0008194,0.771,None
prot-a-2588,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement,EFO:0801544,http://www.ebi.ac.uk/efo/EFO_0801544,0.859,None
met-a-323,Isoleucine,isoleucine measurement,EFO:0009793,http://www.ebi.ac.uk/efo/EFO_0009793,0.837,None
ebi-a-GCST90001799,CD27 on T cell,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.639,None
ukb-b-4462,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
prot-a-349,Calcium/calmodulin-dependent protein kinase type II subunit beta,calcium/calmodulin-dependent protein kinase type II subunit beta measurement,EFO:0020219,http://www.ebi.ac.uk/efo/EFO_0020219,0.836,None
ukb-b-17422,Age at menopause (last menstrual period),age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.693,None
prot-a-1199,GTP-binding protein GEM,GTP-binding protein GEM measurement,EFO:0801660,http://www.ebi.ac.uk/efo/EFO_0801660,0.717,None
ebi-a-GCST004610,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
prot-a-717,Lysosomal protective protein,lysosomal protective protein measurement,EFO:0008215,http://www.ebi.ac.uk/efo/EFO_0008215,0.896,None
prot-a-1990,N-acylethanolamine-hydrolyzing acid amidase,N-acylethanolamine-hydrolyzing acid amidase measurement,EFO:0008240,http://www.ebi.ac.uk/efo/EFO_0008240,0.825,None
prot-a-1741,Leukocyte immunoglobulin-like receptor subfamily A member 6,leukocyte immunoglobulin-like receptor subfamily A member 6 measurement,EFO:0801767,http://www.ebi.ac.uk/efo/EFO_0801767,0.922,None
prot-a-957,Ephrin type-A receptor 2,ephrin type-B receptor 2 measurement,EFO:0008124,http://www.ebi.ac.uk/efo/EFO_0008124,0.678,None
ieu-a-270,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
prot-a-2776,"Essential MCU regulator, mitochondrial","essential MCU regulator, mitochondrial measurement",EFO:0802530,http://www.ebi.ac.uk/efo/EFO_0802530,0.898,None
prot-a-2410,Proteasome subunit alpha type-1,proteasome subunit alpha type-1 measurement,EFO:0020663,http://www.ebi.ac.uk/efo/EFO_0020663,0.786,None
prot-a-165,Armadillo repeat-containing protein 5,armadillo repeat-containing protein 5 measurement,EFO:0802288,http://www.ebi.ac.uk/efo/EFO_0802288,0.858,None
ukb-b-19953,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
ieu-a-105,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-c-4903_72_1,Calcineurin,calcineurin measurement,EFO:0008061,http://www.ebi.ac.uk/efo/EFO_0008061,0.813,None
prot-c-4775_34_3,Gelsolin,gelsolin measurement,EFO:0020402,http://www.ebi.ac.uk/efo/EFO_0020402,0.834,None
prot-c-2809_25_2,ADAMTS-4,a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement,EFO:0008326,http://www.ebi.ac.uk/efo/EFO_0008326,0.652,None
prot-a-1221,Glycosyltransferase 8 domain-containing protein 1,glycosyltransferase 8 domain-containing protein 1 measurement,EFO:0801648,http://www.ebi.ac.uk/efo/EFO_0801648,0.898,None
ebi-a-GCST90010107,Bone morphogenetic protein 6 levels,bone morphogenetic protein 6 measurement,EFO:0020186,http://www.ebi.ac.uk/efo/EFO_0020186,0.821,None
prot-a-2313,Phosphomevalonate kinase,phosphomevalonate kinase measurement,EFO:0801883,http://www.ebi.ac.uk/efo/EFO_0801883,0.915,None
prot-a-2082,Neuropeptide W,neuropeptide S measurement,EFO:0802806,http://www.ebi.ac.uk/efo/EFO_0802806,0.77,None
ebi-a-GCST90007311,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-3271,Zinc finger protein 382,zinc finger protein 382 measurement,EFO:0803279,http://www.ebi.ac.uk/efo/EFO_0803279,0.927,None
met-a-632,X-12544,X-12544 measurement,EFO:0021315,http://www.ebi.ac.uk/efo/EFO_0021315,0.712,None
prot-a-105,Acidic leucine-rich nuclear phosphoprotein 32 family member B,acidic leucine-rich nuclear phosphoprotein 32 family member b measurement,EFO:0020125,http://www.ebi.ac.uk/efo/EFO_0020125,0.906,None
ebi-a-GCST007429,Lung function (FVC),pulmonary function measurement,EFO:0003892,http://www.ebi.ac.uk/efo/EFO_0003892,0.687,None
prot-a-2731,Sialic acid-binding Ig-like lectin 9,sialic acid-binding Ig-like lectin 9 measurement,EFO:0008286,http://www.ebi.ac.uk/efo/EFO_0008286,0.675,None
ebi-a-GCST90012025,Interleukin-6 receptor subunit alpha levels,interleukin 6 receptor subunit alpha measurement,EFO:0008187,http://www.ebi.ac.uk/efo/EFO_0008187,0.872,None
prot-a-171,Arylsulfatase A,arylsulfatase A measurement,EFO:0020163,http://www.ebi.ac.uk/efo/EFO_0020163,0.898,None
prot-a-3260,Zinc finger protein 134,zinc finger protein 134 measurement,EFO:0803271,http://www.ebi.ac.uk/efo/EFO_0803271,0.92,None
met-a-698,Hydroxyisovaleroyl carnitine,beta-hydroxyisovaleroylcarnitine measurement,EFO:0800031,http://www.ebi.ac.uk/efo/EFO_0800031,0.77,None
prot-a-3082,Tumor protein 63,tumor protein 63 measurement,EFO:0803202,http://www.ebi.ac.uk/efo/EFO_0803202,0.852,None
ebi-a-GCST90012043,Membrane-bound aminopeptidase P levels,membrane-bound aminopeptidase P measurement,EFO:0010920,http://www.ebi.ac.uk/efo/EFO_0010920,0.786,None
ebi-a-GCST90010189,CD166 antigen levels,CD166 antigen measurement,EFO:0020245,http://www.ebi.ac.uk/efo/EFO_0020245,0.792,None
prot-a-3030,Tumor necrosis factor alpha-induced protein 3,tumor necrosis factor alpha-induced protein 3 measurement,EFO:0803200,http://www.ebi.ac.uk/efo/EFO_0803200,0.843,None
prot-a-2284,Group XIIB secretory phospholipase A2-like protein,group XIIB secretory phospholipase A2-like protein measurement,EFO:0801657,http://www.ebi.ac.uk/efo/EFO_0801657,0.871,None
ebi-a-GCST90010262,ST2 protein levels,ST2 protein measurement,EFO:0010599,http://www.ebi.ac.uk/efo/EFO_0010599,0.716,None
prot-a-1632,UPF0577 protein KIAA1324-like,UPF0577 protein KIAA1324 measurement,EFO:0803235,http://www.ebi.ac.uk/efo/EFO_0803235,0.92,None
ebi-a-GCST90012018,Macrophage colony-stimulating factor 1 levels,macrophage colony stimulating factor measurement,EFO:0008217,http://www.ebi.ac.uk/efo/EFO_0008217,0.868,None
met-a-353,Cortisol,cortisol measurement,EFO:0005843,http://www.ebi.ac.uk/efo/EFO_0005843,0.778,None
ebi-a-GCST90010314,Peptidyl-prolyl cis-trans isomerase FKBP4 levels,peptidyl-prolyl cis-trans isomerase FKBP2 measurement,EFO:0802852,http://www.ebi.ac.uk/efo/EFO_0802852,0.684,None
prot-a-1372,HRAS-like suppressor 2,HRAS-like suppressor 2 measurement,EFO:0802610,http://www.ebi.ac.uk/efo/EFO_0802610,0.792,None
prot-a-2741,Signaling lymphocytic activation molecule,signaling lymphocytic activation molecule measurement,EFO:0803076,http://www.ebi.ac.uk/efo/EFO_0803076,0.935,None
met-c-888,Free cholesterol in large VLDL,free cholesterol in large LDL measurement,EFO:0022176,http://www.ebi.ac.uk/efo/EFO_0022176,0.815,None
prot-c-5238_26_3,PPIE,interstitial emphysema,MONDO:0000923,http://purl.obolibrary.org/obo/MONDO_0000923,0.638,None
prot-a-436,CMRF35-like molecule 7,CMRF35-like molecule 7 measurement,EFO:0802407,http://www.ebi.ac.uk/efo/EFO_0802407,0.801,None
bbj-a-12,Basophil count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.984,None
ebi-a-GCST90002342,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
prot-a-1655,Kelch-like protein 13,kelch-like protein 13 measurement,EFO:0801741,http://www.ebi.ac.uk/efo/EFO_0801741,0.765,None
prot-a-1534,Interleukin-5,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.94,None
prot-a-1704,Tyrosine-protein kinase Lck,tyrosine-protein kinase LCK measurement,EFO:0020826,http://www.ebi.ac.uk/efo/EFO_0020826,0.82,None
prot-a-1624,Uncharacterized protein KIAA0040,uncharacterized protein KIAA0040 measurement,EFO:0802196,http://www.ebi.ac.uk/efo/EFO_0802196,0.948,None
prot-a-566,Creatine kinase M-type,creatine kinase measurement,EFO:0004534,http://www.ebi.ac.uk/efo/EFO_0004534,0.677,None
met-a-687,2-palmitoylglycerophosphocholine*,1-palmitoylglycerophosphocholine measurement,EFO:0021089,http://www.ebi.ac.uk/efo/EFO_0021089,0.849,None
prot-a-2687,Small EDRK-rich factor 1,small EDRK-rich factor 1 measurement,EFO:0803082,http://www.ebi.ac.uk/efo/EFO_0803082,0.746,None
prot-c-3181_50_2,Cathepsin S,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.762,None
met-c-912,Total lipids in medium VLDL,total lipids in medium VLDL,EFO:0022153,http://www.ebi.ac.uk/efo/EFO_0022153,0.972,None
prot-a-2797,Suppressor of cytokine signaling 3,suppressor of cytokine signaling 3 measurement,EFO:0802104,http://www.ebi.ac.uk/efo/EFO_0802104,0.929,None
prot-a-942,Poly(U)-specific endoribonuclease,poly(U)-specific endoribonuclease measurement,EFO:0802879,http://www.ebi.ac.uk/efo/EFO_0802879,0.671,None
prot-a-173,Arylsulfatase K,arylsulfatase K measurement,EFO:0801395,http://www.ebi.ac.uk/efo/EFO_0801395,0.907,None
met-d-S_VLDL_PL,Phospholipids in small VLDL,phospholipids in small VLDL measurement,EFO:0022146,http://www.ebi.ac.uk/efo/EFO_0022146,0.909,None
prot-a-1874,Mediator of RNA polymerase II transcription subunit 1,mediator of RNA polymerase II transcription subunit 1 measurement,EFO:0008228,http://www.ebi.ac.uk/efo/EFO_0008228,0.952,None
prot-a-115,Amyloid beta A4 precursor protein-binding family B member 1,amyloid beta A4 precursor protein-binding family B member 1 measurement,EFO:0802275,http://www.ebi.ac.uk/efo/EFO_0802275,0.905,None
prot-a-1095,Fibroblast growth factor 5,fibroblast growth factor 5 measurement,EFO:0010784,http://www.ebi.ac.uk/efo/EFO_0010784,0.908,None
prot-c-2570_72_5,IGFBP-2,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.627,None
ebi-a-GCST90006895,Cytomegalovirus pp52 antibody levels,cytomegalovirus infection,EFO:0001062,http://www.ebi.ac.uk/efo/EFO_0001062,0.604,None
met-d-XL_HDL_TG,Triglycerides in very large HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.68,None
ukb-b-845,"Heel quantitative ultrasound index (QUI), direct entry (left)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.639,None
ebi-a-GCST90006919,Anti-herpes simplex virus 2 IgG seropositivity,Herpes simplex virus 2 seropositivity,EFO:0009339,http://www.ebi.ac.uk/efo/EFO_0009339,0.891,None
prot-a-181,Activating signal cointegrator 1 complex subunit 1,activating signal cointegrator 1 complex subunit 1 measurement,EFO:0801340,http://www.ebi.ac.uk/efo/EFO_0801340,0.949,None
ebi-a-GCST90000513,Frozen shoulder,bursitis,MONDO:0002471,http://purl.obolibrary.org/obo/MONDO_0002471,0.995,None
prot-a-1904,Malectin,malectin measurement,EFO:0802726,http://www.ebi.ac.uk/efo/EFO_0802726,0.735,None
prot-a-519,Cryptic protein,cryptic protein measurement,EFO:0020293,http://www.ebi.ac.uk/efo/EFO_0020293,0.853,None
prot-a-2971,Thrombospondin-3,thrombospondin-1 measurement,EFO:0020770,http://www.ebi.ac.uk/efo/EFO_0020770,0.732,None
prot-a-2246,E3 ubiquitin-protein ligase pellino homolog 2,e3 ubiquitin-protein ligase pellino homolog 2 measurement,EFO:0802507,http://www.ebi.ac.uk/efo/EFO_0802507,0.901,None
prot-a-417,Cell cycle progression protein 1,cell cycle progression protein 1 measurement,EFO:0802382,http://www.ebi.ac.uk/efo/EFO_0802382,0.912,None
ukb-b-18593,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
met-a-494,X-11299,X-11299 measurement,EFO:0021222,http://www.ebi.ac.uk/efo/EFO_0021222,0.692,None
met-c-843,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ebi-a-GCST004446,Interleukin-6 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.794,None
ukb-b-5427,White fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.67,None
ebi-a-GCST90001775,CD25 on B cell,immunodeficiency due to CD25 deficiency,MONDO:0011664,http://purl.obolibrary.org/obo/MONDO_0011664,0.615,None
ukb-d-30050_irnt,Mean corpuscular haemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.986,None
prot-a-2320,Protein O-glucosyltransferase 1,ALG6-congenital disorder of glycosylation 1C,MONDO:0011291,http://purl.obolibrary.org/obo/MONDO_0011291,0.8,None
prot-a-397,C-C motif chemokine 21,CCL21 measurement,EFO:0009416,http://www.ebi.ac.uk/efo/EFO_0009416,0.747,None
prot-a-1668,Kallikrein-8,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.772,None
prot-a-853,Delta and Notch-like epidermal growth factor-related receptor,delta and Notch-like epidermal growth factor-related receptor measurement,EFO:0802458,http://www.ebi.ac.uk/efo/EFO_0802458,0.823,None
prot-a-150,Rho GTPase-activating protein 36,rho GTPase-activating protein 36 measurement,EFO:0803016,http://www.ebi.ac.uk/efo/EFO_0803016,0.855,None
prot-a-56,Angiogenic factor with G patch and FHA domains 1,angiogenic factor with G patch and FHA domains 1 measurement,EFO:0802278,http://www.ebi.ac.uk/efo/EFO_0802278,0.924,None
ukb-b-2732,Time from waking to first cigarette,time to first cigarette measurement,EFO:0010126,http://www.ebi.ac.uk/efo/EFO_0010126,0.805,None
prot-c-3037_62_1,IL-1b,idiopathic type 1 diabetes,EFO:0009757,http://www.ebi.ac.uk/efo/EFO_0009757,0.7,None
prot-c-5340_24_3,Caspase-10,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.638,None
ebi-a-GCST90000487,Matrix metalloproteinase levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.866,None
prot-a-579,C-type lectin domain family 5 member A,C-type lectin domain family 5 member A measurement,EFO:0801436,http://www.ebi.ac.uk/efo/EFO_0801436,0.796,None
ukb-b-17553,Pregnant,pregnancy,EFO:0002950,http://www.ebi.ac.uk/efo/EFO_0002950,0.793,None
ebi-a-GCST90011349,O_Burkholderiales abundance,burkholderia infectious disease,MONDO:0043953,http://purl.obolibrary.org/obo/MONDO_0043953,0.696,None
met-d-L_HDL_FC_pct,Free cholesterol to total lipids ratio in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.699,None
prot-a-2807,Sperm-associated antigen 11B,sperm-associated antigen 11B measurement,EFO:0803098,http://www.ebi.ac.uk/efo/EFO_0803098,0.776,None
prot-a-2249,Peroxisomal membrane protein PEX14,peroxisomal membrane protein PEX14 measurement,EFO:0802857,http://www.ebi.ac.uk/efo/EFO_0802857,0.931,None
ebi-a-GCST90000481,Transforming growth factor-beta levels,transforming growth factor beta measurement,EFO:0004818,http://www.ebi.ac.uk/efo/EFO_0004818,0.858,None
prot-a-2431,Parathyroid hormone,parathyroid hormone measurement,EFO:0004752,http://www.ebi.ac.uk/efo/EFO_0004752,0.871,None
ukb-b-10768,Cascot confidence score,CASCOT confidence score measurement,EFO:0009815,http://www.ebi.ac.uk/efo/EFO_0009815,0.927,None
prot-a-2439,Tyrosine-protein phosphatase non-receptor type 2,tyrosine-protein phosphatase non-receptor type 2 measurement,EFO:0020836,http://www.ebi.ac.uk/efo/EFO_0020836,0.806,None
prot-c-2653_62_1,tau,trisomy 13,MONDO:0018068,http://purl.obolibrary.org/obo/MONDO_0018068,0.658,None
ieu-a-1104,Serum creatinine (eGFRcrea),creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.634,None
ebi-a-GCST90001964,FSC-A on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.795,None
ukb-a-390,Number of older siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.851,None
bbj-a-11,Blood urea nitrogen,blood urea nitrogen measurement,EFO:0004741,http://www.ebi.ac.uk/efo/EFO_0004741,0.901,None
met-d-Total_FA,Total fatty acids,fatty acid measurement,EFO:0005110,http://www.ebi.ac.uk/efo/EFO_0005110,0.614,None
prot-c-4545_53_3,DnaJ homolog,DNAj homolog subfamily b member 1 measurement,EFO:0020332,http://www.ebi.ac.uk/efo/EFO_0020332,0.632,None
prot-a-558,Carbohydrate sulfotransferase 6,carbohydrate sulfotransferase 6 measurement,EFO:0020226,http://www.ebi.ac.uk/efo/EFO_0020226,0.935,None
prot-a-2255,Phosphoglycerate kinase 1,phosphoglycerate kinase 1 measurement,EFO:0020638,http://www.ebi.ac.uk/efo/EFO_0020638,0.911,None
met-a-448,3-indoxyl sulfate,indoxyl sulfate measurement,EFO:0010502,http://www.ebi.ac.uk/efo/EFO_0010502,0.869,None
prot-c-4153_11_2,alpha-1-antichymotrypsin complex,alpha-1-antichymotrypsin complex measurement,EFO:0008018,http://www.ebi.ac.uk/efo/EFO_0008018,0.784,None
prot-a-2371,Protein kinase C iota type,protein kinase c iota type measurement,EFO:0020681,http://www.ebi.ac.uk/efo/EFO_0020681,0.89,None
prot-a-891,Endothelial differentiation-related factor 1,endothelial differentiation-related factor 1 measurement,EFO:0801571,http://www.ebi.ac.uk/efo/EFO_0801571,0.872,None
ukb-d-30080_irnt,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-a-611,Contactin-associated protein-like 2,contactin-associated protein-like 2 measurement,EFO:0801496,http://www.ebi.ac.uk/efo/EFO_0801496,0.735,None
prot-a-2951,Trefoil factor 1,trefoil factor 1 measurement,EFO:0021865,http://www.ebi.ac.uk/efo/EFO_0021865,0.902,None
ukb-d-12336_irnt,Ventricular rate,ventricular rate measurement,EFO:0007928,http://www.ebi.ac.uk/efo/EFO_0007928,0.856,None
ubm-a-2666,volume Brain-Stem,brain stem volume measurement,EFO:0010605,http://www.ebi.ac.uk/efo/EFO_0010605,0.875,None
ebi-a-GCST004426,Tumor necrosis factor alpha levels,tumor necrosis factor-alpha,EFO:0003271,http://www.ebi.ac.uk/efo/EFO_0003271,0.755,None
met-c-954,Concentration of very small VLDL particles,concentration of very small VLDL particles,EFO:0022151,http://www.ebi.ac.uk/efo/EFO_0022151,0.985,None
prot-c-3666_17_4,complement factor H-related 5,complement factor H measurement,EFO:0008097,http://www.ebi.ac.uk/efo/EFO_0008097,0.774,None
ubm-a-17,IDP T1 FIRST left pallidum volume,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.743,None
ebi-a-GCST90010231,Junctional adhesion molecule A levels,junctional adhesion molecule B measurement,EFO:0020509,http://www.ebi.ac.uk/efo/EFO_0020509,0.824,None
met-d-LDL_PL,Phospholipids in LDL,phospholipids in large LDL measurement,EFO:0022174,http://www.ebi.ac.uk/efo/EFO_0022174,0.82,None
prot-a-3079,TOX high mobility group box family member 3,TOX high mobility group box family member 3 measurement,EFO:0803161,http://www.ebi.ac.uk/efo/EFO_0803161,0.954,None
met-a-546,X-11805,X-11805 measurement,EFO:0021263,http://www.ebi.ac.uk/efo/EFO_0021263,0.718,None
prot-a-154,Rho guanine nucleotide exchange factor 10,rho guanine nucleotide exchange factor 10 measurement,EFO:0802014,http://www.ebi.ac.uk/efo/EFO_0802014,0.951,None
prot-a-821,Dickkopf-related protein 1,Dickkopf-related protein 3 measurement,EFO:0008109,http://www.ebi.ac.uk/efo/EFO_0008109,0.748,None
prot-a-14,Acyl-CoA-binding domain-containing protein 6,acyl-CoA binding domain containing protein 5 deficiency,MONDO:0100112,http://purl.obolibrary.org/obo/MONDO_0100112,0.834,None
prot-a-1138,Forkhead box protein L2,forkhead box protein L2 measurement,EFO:0802554,http://www.ebi.ac.uk/efo/EFO_0802554,0.928,None
prot-c-3903_49_2,Sorting nexin 4,sorting nexin-1 measurement,EFO:0803092,http://www.ebi.ac.uk/efo/EFO_0803092,0.72,None
prot-a-166,Actin-related protein 2/3 complex subunit 3,actin-related protein 2/3 complex subunit 3 measurement,EFO:0802252,http://www.ebi.ac.uk/efo/EFO_0802252,0.731,None
ebi-a-GCST90010192,Azurocidin levels,azurocidin measurement,EFO:0020170,http://www.ebi.ac.uk/efo/EFO_0020170,0.785,None
prot-c-2665_26_2,BCMA,blue cone monochromacy,MONDO:0010563,http://purl.obolibrary.org/obo/MONDO_0010563,0.644,None
ukb-b-969,Time spend outdoors in summer,time spent outdoors measurement,EFO:0600081,http://www.ebi.ac.uk/efo/EFO_0600081,0.746,None
prot-a-2046,Non-homologous end-joining factor 1,non-homologous end-joining factor 1 measurement,EFO:0802817,http://www.ebi.ac.uk/efo/EFO_0802817,0.713,None
prot-a-1133,Fibronectin type III domain-containing protein 5,fibronectin type III domain-containing protein 5 measurement,EFO:0801601,http://www.ebi.ac.uk/efo/EFO_0801601,0.887,None
prot-b-19,fibroblast growth factor 23,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.918,None
met-a-575,Valerate,valerate measurement,EFO:0021112,http://www.ebi.ac.uk/efo/EFO_0021112,0.785,None
prot-c-4491_4_2,IL-5 Ra,refractory anemia,EFO:0003802,http://www.ebi.ac.uk/efo/EFO_0003802,0.649,None
prot-a-2105,Neurexin-3-beta,neurexin-1-beta measurement,EFO:0020596,http://www.ebi.ac.uk/efo/EFO_0020596,0.634,None
prot-a-357,Calcium-regulated heat stable protein 1,calcium-regulated heat stable protein 1 measurement,EFO:0802358,http://www.ebi.ac.uk/efo/EFO_0802358,0.834,None
prot-a-2007,Neural cell adhesion molecule 1,neural cell adhesion molecule 1 measurement,EFO:0801826,http://www.ebi.ac.uk/efo/EFO_0801826,0.915,None
met-a-562,X-12013,X-12013 measurement,EFO:0021277,http://www.ebi.ac.uk/efo/EFO_0021277,0.667,None
prot-a-2435,Pleiotrophin,pleiotrophin,EFO:0003172,http://www.ebi.ac.uk/efo/EFO_0003172,0.984,None
prot-a-1626,Dyslexia-associated protein KIAA0319-like protein,dyslexia-associated protein KIAA0319 measurement,EFO:0802498,http://www.ebi.ac.uk/efo/EFO_0802498,0.855,None
prot-a-621,Collagen alpha-1(XXVIII) chain,collagen alpha-1(XXVIII) chain measurement,EFO:0802420,http://www.ebi.ac.uk/efo/EFO_0802420,0.642,None
prot-a-2546,Receptor-interacting serine/threonine-protein kinase 2,receptor-interacting serine/threonine-protein kinase 2 measurement,EFO:0802997,http://www.ebi.ac.uk/efo/EFO_0802997,0.727,None
ieu-a-58,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ukb-b-14203,Hot drink temperature,temperature,EFO:0001702,http://www.ebi.ac.uk/efo/EFO_0001702,0.691,None
prot-a-1593,Inositol-trisphosphate 3-kinase A,inositol-trisphosphate 3-kinase A measurement,EFO:0802627,http://www.ebi.ac.uk/efo/EFO_0802627,0.7,None
prot-c-4145_58_2,Neurotrophin-3,neurotrophin-3 measurement,EFO:0010791,http://www.ebi.ac.uk/efo/EFO_0010791,0.642,None
prot-a-478,Cadherin-12,cadherin-12 measurement,EFO:0020210,http://www.ebi.ac.uk/efo/EFO_0020210,0.67,None
ukb-a-343,Time from waking to first cigarette,time to first cigarette measurement,EFO:0010126,http://www.ebi.ac.uk/efo/EFO_0010126,0.805,None
prot-a-484,Cadherin-3,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.65,None
prot-a-2213,Prenylcysteine oxidase-like,prenylcysteine oxidase-like measurement,EFO:0801910,http://www.ebi.ac.uk/efo/EFO_0801910,0.842,None
prot-a-706,Cystatin-8,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.802,None
ebi-a-GCST90010267,Tumor necrosis factor receptor 2 levels,tumor necrosis factor receptor 1 measurement,EFO:0010931,http://www.ebi.ac.uk/efo/EFO_0010931,0.821,None
ebi-a-GCST90002232,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-c-3366_51_2,ECM1,Chiari malformation type I,MONDO:0007316,http://purl.obolibrary.org/obo/MONDO_0007316,0.66,None
prot-a-2464,Dihydropteridine reductase,dihydropteridine reductase measurement,EFO:0801527,http://www.ebi.ac.uk/efo/EFO_0801527,0.913,None
prot-a-1861,Myoglobin,myoglobin measurement,EFO:0005057,http://www.ebi.ac.uk/efo/EFO_0005057,0.833,None
prot-a-1907,"Malonyl-CoA decarboxylase, mitochondrial","malonyl-CoA decarboxylase, mitochondrial measurement",EFO:0802727,http://www.ebi.ac.uk/efo/EFO_0802727,0.847,None
ebi-a-GCST90010268,Tumor necrosis factor receptor superfamily member 10C levels,tumor necrosis factor receptor superfamily member 3 measurement,EFO:0020813,http://www.ebi.ac.uk/efo/EFO_0020813,0.812,None
prot-c-2819_23_2,Cadherin-5,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.641,None
prot-c-3807_1_2,FGF23,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.885,None
ebi-a-GCST90001471,CD62L- plasmacytoid Dendritic Cell %Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.808,None
prot-a-134,Apolipoprotein L1,apolipoprotein L1 measurement,EFO:0021854,http://www.ebi.ac.uk/efo/EFO_0021854,0.89,None
prot-a-1985,Myocardial zonula adherens protein,myocardial zonula adherens protein measurement,EFO:0802769,http://www.ebi.ac.uk/efo/EFO_0802769,0.925,None
prot-c-2728_62_2,Laminin,laminin measurement,EFO:0020528,http://www.ebi.ac.uk/efo/EFO_0020528,0.762,None
prot-a-2067,Neurogenic locus notch homolog protein 1,neurogenic locus notch homolog protein 1 measurement,EFO:0008246,http://www.ebi.ac.uk/efo/EFO_0008246,0.932,None
prot-a-1597,Protein jagged-2,protein jagged-1 measurement,EFO:0008271,http://www.ebi.ac.uk/efo/EFO_0008271,0.746,None
met-d-XS_VLDL_FC,Free cholesterol in very small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.74,None
ebi-a-GCST90000049,Age at first birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.907,None
prot-a-1056,Tumor necrosis factor receptor superfamily member 6,tumor necrosis factor receptor superfamily member 6 measurement,EFO:0010610,http://www.ebi.ac.uk/efo/EFO_0010610,0.944,None
prot-a-1953,Mitochondrial peptide methionine sulfoxide reductase,mitochondrial peptide methionine sulfoxide reductase measurement,EFO:0802750,http://www.ebi.ac.uk/efo/EFO_0802750,0.953,None
prot-a-1600,Junctional adhesion molecule B,junctional adhesion molecule B measurement,EFO:0020509,http://www.ebi.ac.uk/efo/EFO_0020509,0.924,None
met-a-351,Valine,valine measurement,EFO:0009792,http://www.ebi.ac.uk/efo/EFO_0009792,0.716,None
met-a-681,Oleoylcarnitine,oleoylcarnitine measurement,EFO:0021043,http://www.ebi.ac.uk/efo/EFO_0021043,0.895,None
prot-a-1284,Glutathione S-transferase A3,glutathione s-transferase a3 measurement,EFO:0020409,http://www.ebi.ac.uk/efo/EFO_0020409,0.815,None
ebi-a-GCST90010236,Monocyte chemoattractant protein-1 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.809,None
prot-c-4763_31_3,Afamin,afamin measurement,EFO:0008015,http://www.ebi.ac.uk/efo/EFO_0008015,0.811,None
prot-c-3046_31_1,resistin,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.727,None
prot-a-852,Delta and Notch-like epidermal growth factor-related receptor,delta and Notch-like epidermal growth factor-related receptor measurement,EFO:0802458,http://www.ebi.ac.uk/efo/EFO_0802458,0.823,None
prot-a-2200,Protocadherin alpha-7,protocadherin alpha-4 measurement,EFO:0801972,http://www.ebi.ac.uk/efo/EFO_0801972,0.713,None
prot-a-2081,Neuronal pentraxin-2,neuronal pentraxin-1 measurement,EFO:0801833,http://www.ebi.ac.uk/efo/EFO_0801833,0.756,None
prot-a-2979,"Fructose-2,6-bisphosphatase TIGAR","fructose-2,6-bisphosphatase TIGAR measurement",EFO:0801607,http://www.ebi.ac.uk/efo/EFO_0801607,0.714,None
prot-a-2350,Calcineurin subunit B type 1,calcineurin subunit B type 1 measurement,EFO:0020215,http://www.ebi.ac.uk/efo/EFO_0020215,0.897,None
prot-a-2787,Synaptosomal-associated protein 29,synaptosomal-associated protein 29 measurement,EFO:0803116,http://www.ebi.ac.uk/efo/EFO_0803116,0.825,None
prot-a-1114,Peptidyl-prolyl cis-trans isomerase FKBP2,peptidyl-prolyl cis-trans isomerase FKBP2 measurement,EFO:0802852,http://www.ebi.ac.uk/efo/EFO_0802852,0.831,None
ebi-a-GCST90000045,Age at first sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.931,None
ebi-a-GCST004606,Eosinophil counts,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.922,None
ebi-a-GCST90002354,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
prot-c-4964_67_1,ARTS1,Rothmund-Thomson syndrome type 1,MONDO:0016368,http://purl.obolibrary.org/obo/MONDO_0016368,0.785,None
prot-a-2855,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 measurement",EFO:0802270,http://www.ebi.ac.uk/efo/EFO_0802270,0.723,None
ukb-a-250,Pulse wave Arterial Stiffness index,arterial stiffness measurement,EFO:0004517,http://www.ebi.ac.uk/efo/EFO_0004517,0.706,None
met-d-Citrate,Citrate,citrate measurement,EFO:0010114,http://www.ebi.ac.uk/efo/EFO_0010114,0.789,None
ebi-a-GCST005348,Total body bone mineral density,bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.814,None
ukb-d-30720_irnt,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
met-a-611,X-12443,X-12443 measurement,EFO:0021309,http://www.ebi.ac.uk/efo/EFO_0021309,0.702,None
met-a-338,Pantothenate,pantothenate measurement,EFO:0021034,http://www.ebi.ac.uk/efo/EFO_0021034,0.845,None
ebi-a-GCST006368,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1576,Immunoglobulin superfamily containing leucine-rich repeat protein 2,immunoglobulin superfamily containing leucine-rich repeat protein 2 measurement,EFO:0021879,http://www.ebi.ac.uk/efo/EFO_0021879,0.91,None
ebi-a-GCST90001632,CD8+ Natural Killer T %lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.669,None
prot-a-1183,Glucokinase,glucokinase measurement,EFO:0801625,http://www.ebi.ac.uk/efo/EFO_0801625,0.869,None
prot-a-1589,Integral membrane protein 2A,integral membrane protein 2A measurement,EFO:0801704,http://www.ebi.ac.uk/efo/EFO_0801704,0.919,None
prot-a-3114,Tubulin--tyrosine ligase,tubulin--tyrosine ligase measurement,EFO:0802165,http://www.ebi.ac.uk/efo/EFO_0802165,0.709,None
prot-a-977,Epiregulin,epiregulin measurement,EFO:0020361,http://www.ebi.ac.uk/efo/EFO_0020361,0.845,None
prot-a-833,Dermokine,dermokine measurement,EFO:0802462,http://www.ebi.ac.uk/efo/EFO_0802462,0.797,None
ebi-a-GCST90002283,Facial pigmentation measurement (UV light),facial pigmentation measurement,EFO:0006942,http://www.ebi.ac.uk/efo/EFO_0006942,0.849,None
prot-a-253,Biliverdin reductase A,biliverdin reductase A measurement,EFO:0801426,http://www.ebi.ac.uk/efo/EFO_0801426,0.894,None
prot-c-4124_24_2,HSP 70,hereditary spastic paraplegia,MONDO:0019064,http://purl.obolibrary.org/obo/MONDO_0019064,0.792,None
prot-a-509,Chymotrypsin-like elastase family member 3B,chymotrypsin-like elastase family member 3B measurement,EFO:0802400,http://www.ebi.ac.uk/efo/EFO_0802400,0.905,None
prot-a-2922,Tachykinin-4,tachykinin-3 measurement,EFO:0803136,http://www.ebi.ac.uk/efo/EFO_0803136,0.751,None
prot-a-700,Cysteine and glycine-rich protein 2,cysteine and glycine-rich protein 2 measurement,EFO:0802444,http://www.ebi.ac.uk/efo/EFO_0802444,0.799,None
met-a-595,X-12236,GM12236,EFO:0001143,http://www.ebi.ac.uk/efo/EFO_0001143,0.733,None
met-d-Creatinine,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
prot-a-260,Cytoplasmic tyrosine-protein kinase BMX,cytoplasmic tyrosine-protein kinase BMX measurement,EFO:0020308,http://www.ebi.ac.uk/efo/EFO_0020308,0.871,None
prot-c-3855_56_1,Peroxiredoxin-1,peroxiredoxin-1 measurement,EFO:0020629,http://www.ebi.ac.uk/efo/EFO_0020629,0.819,None
met-a-425,1-stearoylglycerol (1-monostearin),1-stearoylglycerol 1-monostearin measurement,EFO:0021111,http://www.ebi.ac.uk/efo/EFO_0021111,0.741,None
ieu-a-794,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-c-3177_49_2,Carbonic Anhydrase IV,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.856,None
prot-a-911,EH domain-binding protein 1,EH domain-binding protein 1 measurement,EFO:0801561,http://www.ebi.ac.uk/efo/EFO_0801561,0.803,None
prot-a-63,"Apoptosis-inducing factor 1, mitochondrial","apoptosis-inducing factor 1, mitochondrial measurement",EFO:0801389,http://www.ebi.ac.uk/efo/EFO_0801389,0.807,None
met-d-M_HDL_CE,Cholesteryl esters in medium HDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.711,None
prot-a-587,CXADR-like membrane protein,CXADR-like membrane protein measurement,EFO:0801504,http://www.ebi.ac.uk/efo/EFO_0801504,0.809,None
prot-a-2358,PR domain zinc finger protein 4,PR domain zinc finger protein 4 measurement,EFO:0802893,http://www.ebi.ac.uk/efo/EFO_0802893,0.927,None
prot-a-928,ELAV-like protein 1,ELAV-like protein 1 measurement,EFO:0801562,http://www.ebi.ac.uk/efo/EFO_0801562,0.615,None
prot-a-593,Colipase-like protein 2,colipase-like protein 2 measurement,EFO:0802417,http://www.ebi.ac.uk/efo/EFO_0802417,0.764,None
prot-a-3038,Tumor necrosis factor receptor superfamily member 11B,tumor necrosis factor receptor superfamily member 11B measurement,EFO:0020801,http://www.ebi.ac.uk/efo/EFO_0020801,0.948,None
ebi-a-GCST90006923,Anti-Merkel cell polyomavirus IgG seropositivity,polyomavirus 2 seropositivity,EFO:0010907,http://www.ebi.ac.uk/efo/EFO_0010907,0.765,None
prot-c-2780_35_2,Lactoferrin,lactoferrin measurement,EFO:0802682,http://www.ebi.ac.uk/efo/EFO_0802682,0.875,None
prot-a-1012,"Fatty acid-binding protein, heart","fatty acid-binding protein, heart measurement",EFO:0020373,http://www.ebi.ac.uk/efo/EFO_0020373,0.747,None
prot-a-1160,Protein G6b,protein G6b measurement,EFO:0802945,http://www.ebi.ac.uk/efo/EFO_0802945,0.882,None
prot-a-361,Protein CASC4,protein CASC4 measurement,EFO:0802927,http://www.ebi.ac.uk/efo/EFO_0802927,0.883,None
met-a-619,1-palmitoylglycerophosphocholine,1-palmitoylglycerophosphocholine measurement,EFO:0021089,http://www.ebi.ac.uk/efo/EFO_0021089,0.85,None
ukb-b-14713,"Forced vital capacity (FVC), Best measure",vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.727,None
prot-a-518,Complement factor B,complement factor B measurement,EFO:0008096,http://www.ebi.ac.uk/efo/EFO_0008096,0.91,None
prot-a-2107,Neurexin-3-beta,neurexin-1-beta measurement,EFO:0020596,http://www.ebi.ac.uk/efo/EFO_0020596,0.634,None
prot-a-763,Death-associated protein kinase 2,death-associated protein kinase 2 measurement,EFO:0008107,http://www.ebi.ac.uk/efo/EFO_0008107,0.776,None
ebi-a-GCST90001473,CD62L- CD86+ myeloid Dendritic Cell %Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.662,None
ebi-a-GCST004601,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
prot-a-161,ADP-ribosylation factor-like protein 1,ADP-ribosylation factor-like protein 1 measurement,EFO:0801354,http://www.ebi.ac.uk/efo/EFO_0801354,0.747,None
prot-a-1530,Interleukin-3 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.897,None
ebi-a-GCST90012002,Osteoprotegerin levels,osteoprotegerin measurement,EFO:0005918,http://www.ebi.ac.uk/efo/EFO_0005918,0.769,None
prot-a-2305,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 measurement",EFO:0802913,http://www.ebi.ac.uk/efo/EFO_0802913,0.695,None
prot-a-2577,Roundabout homolog 1,roundabout homolog 1 measurement,EFO:0803039,http://www.ebi.ac.uk/efo/EFO_0803039,0.92,None
prot-a-2044,Tumor necrosis factor receptor superfamily member 16,tumor necrosis factor receptor superfamily member 16 measurement,EFO:0802168,http://www.ebi.ac.uk/efo/EFO_0802168,0.946,None
prot-a-1396,Bone sialoprotein 2,bone sialoprotein 2 measurement,EFO:0020190,http://www.ebi.ac.uk/efo/EFO_0020190,0.856,None
met-d-S_HDL_PL,Phospholipids in small HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.736,None
met-a-615,Octanoylcarnitine,octanoylcarnitine measurement,EFO:0021042,http://www.ebi.ac.uk/efo/EFO_0021042,0.901,None
met-d-Total_CE,Total esterified cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.856,None
ebi-a-GCST90002317,Lymphocyte counts,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
prot-a-2716,SH3 domain-binding protein 2,SH3 domain-binding protein 2 measurement,EFO:0802063,http://www.ebi.ac.uk/efo/EFO_0802063,0.823,None
ebi-a-GCST005849,Heart rate response to recovery post exercise (40 sec),heart rate response to recovery post exercise,EFO:0009185,http://www.ebi.ac.uk/efo/EFO_0009185,0.912,None
met-a-608,X-12435,X-12435 measurement,EFO:0021306,http://www.ebi.ac.uk/efo/EFO_0021306,0.697,None
ebi-a-GCST008050,Waist-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.784,None
prot-a-3024,Transmembrane protease serine 11D,transmembrane protease serine 11D measurement,EFO:0802149,http://www.ebi.ac.uk/efo/EFO_0802149,0.944,None
ubm-a-246,IDP dMRI TBSS MD Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.606,None
ebi-a-GCST90001514,Hematopoietic Stem Cell Absolute Count,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.661,None
prot-a-1258,Transmembrane glycoprotein NMB,transmembrane glycoprotein NMB measurement,EFO:0008303,http://www.ebi.ac.uk/efo/EFO_0008303,0.937,None
prot-a-803,Beta-defensin 136,beta-defensin 136 measurement,EFO:0802329,http://www.ebi.ac.uk/efo/EFO_0802329,0.771,None
prot-a-1740,Leukocyte immunoglobulin-like receptor subfamily A member 5,leukocyte immunoglobulin-like receptor subfamily A member 5 measurement,EFO:0801766,http://www.ebi.ac.uk/efo/EFO_0801766,0.921,None
prot-a-3154,Ubiquitin-fold modifier 1,ubiquitin-fold modifier 1 measurement,EFO:0020842,http://www.ebi.ac.uk/efo/EFO_0020842,0.834,None
ukb-b-3666,Family relationship satisfaction,family relationship,EFO:0004424,http://www.ebi.ac.uk/efo/EFO_0004424,0.785,None
ukb-b-4442,Ham intake,tropical spastic paraparesis,EFO:0007527,http://www.ebi.ac.uk/efo/EFO_0007527,0.746,None
prot-a-1379,Heparan-sulfate 6-O-sulfotransferase 2,heparan sulfate glucosamine 3-O-sulfotransferase 4 measurement,EFO:0802593,http://www.ebi.ac.uk/efo/EFO_0802593,0.709,None
ebi-a-GCST90016675,Pancreas fat,pancreatic neoplasm,EFO:0003860,http://www.ebi.ac.uk/efo/EFO_0003860,0.862,None
ebi-a-GCST90016669,Pancreas volume,pancreas volume,EFO:0600045,http://www.ebi.ac.uk/efo/EFO_0600045,0.981,None
prot-a-2492,Rap guanine nucleotide exchange factor 5,rap guanine nucleotide exchange factor 5 measurement,EFO:0802989,http://www.ebi.ac.uk/efo/EFO_0802989,0.949,None
ebi-a-GCST90010355,Thymidine phosphorylase levels,mitochondrial neurogastrointestinal encephalomyopathy,MONDO:0017575,http://purl.obolibrary.org/obo/MONDO_0017575,0.83,None
prot-c-3044_3_2,PARC,PARC syndrome,MONDO:0010867,http://purl.obolibrary.org/obo/MONDO_0010867,0.786,None
met-a-543,X-11793--oxidized bilirubin*,X-11793--oxidized bilirubin measurement,EFO:0021260,http://www.ebi.ac.uk/efo/EFO_0021260,0.693,None
prot-a-777,ATP-dependent RNA helicase DDX25,ATP-dependent RNA helicase DDX25 measurement,EFO:0802295,http://www.ebi.ac.uk/efo/EFO_0802295,0.851,None
ukb-a-249,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
met-a-411,X-06226,X-06226 measurement,EFO:0021198,http://www.ebi.ac.uk/efo/EFO_0021198,0.666,None
met-a-512,X-11438,X-11438 measurement,EFO:0021233,http://www.ebi.ac.uk/efo/EFO_0021233,0.691,None
prot-a-2195,Protocadherin-10,protocadherin-10 measurement,EFO:0801978,http://www.ebi.ac.uk/efo/EFO_0801978,0.723,None
prot-a-111,Retina-specific copper amine oxidase,retina-specific copper amine oxidase measurement,EFO:0803011,http://www.ebi.ac.uk/efo/EFO_0803011,0.832,None
prot-a-1,APOBEC1 complementation factor,APOBEC1 complementation factor measurement,EFO:0801386,http://www.ebi.ac.uk/efo/EFO_0801386,0.945,None
prot-a-2344,Peptidyl-prolyl cis-trans isomerase-like 2,peptidyl-prolyl cis-trans isomerase-like 2 measurement,EFO:0801877,http://www.ebi.ac.uk/efo/EFO_0801877,0.737,None
ebi-a-GCST005350,Total body bone mineral density (age 45-60),bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.674,None
prot-a-1723,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
prot-a-81,Intestinal-type alkaline phosphatase,intestinal-type alkaline phosphatase measurement,EFO:0801734,http://www.ebi.ac.uk/efo/EFO_0801734,0.829,None
prot-a-2722,Single Ig IL-1-related receptor,single Ig IL-1-related receptor measurement,EFO:0802072,http://www.ebi.ac.uk/efo/EFO_0802072,0.734,None
prot-a-681,Granulocyte-macrophage colony-stimulating factor,macrophage colony stimulating factor measurement,EFO:0008217,http://www.ebi.ac.uk/efo/EFO_0008217,0.792,None
ebi-a-GCST004734,Heart rate variability traits (SDNN),heart rate variability measurement,EFO:0008003,http://www.ebi.ac.uk/efo/EFO_0008003,0.601,None
prot-a-1265,Glutathione peroxidase 7,glutathione peroxidase 7 measurement,EFO:0801635,http://www.ebi.ac.uk/efo/EFO_0801635,0.909,None
prot-a-2912,Synaptotagmin-17,synaptotagmin-17 measurement,EFO:0803117,http://www.ebi.ac.uk/efo/EFO_0803117,0.771,None
ebi-a-GCST90010233,Low-density lipoprotein receptor levels,low-density lipoprotein receptor measurement,EFO:0021937,http://www.ebi.ac.uk/efo/EFO_0021937,0.712,None
met-a-655,1-linoleoylglycerophosphocholine,1-linoleoylglycerophosphocholine measurement,EFO:0021083,http://www.ebi.ac.uk/efo/EFO_0021083,0.858,None
ebi-a-GCST90002072,SSC-A on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.795,None
prot-a-2198,Protocadherin alpha-4,protocadherin alpha-4 measurement,EFO:0801972,http://www.ebi.ac.uk/efo/EFO_0801972,0.723,None
met-a-531,X-11538,X-11538 measurement,EFO:0021251,http://www.ebi.ac.uk/efo/EFO_0021251,0.712,None
prot-a-1292,General transcription factor II-I,general transcription factor II-I measurement,EFO:0801623,http://www.ebi.ac.uk/efo/EFO_0801623,0.746,None
ukb-d-30730_raw,Gamma glutamyltransferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.827,None
prot-a-2496,Retinoblastoma-associated protein,retinoblastoma-associated protein measurement,EFO:0020706,http://www.ebi.ac.uk/efo/EFO_0020706,0.809,None
prot-a-1540,Interleukin-6 receptor subunit alpha,interleukin 6 receptor subunit alpha measurement,EFO:0008187,http://www.ebi.ac.uk/efo/EFO_0008187,0.934,None
prot-a-1780,Low-density lipoprotein receptor-related protein 8,low-density lipoprotein receptor-related protein 8 measurement,EFO:0020538,http://www.ebi.ac.uk/efo/EFO_0020538,0.803,None
prot-a-135,Apolipoprotein L1,apolipoprotein L1 measurement,EFO:0021854,http://www.ebi.ac.uk/efo/EFO_0021854,0.89,None
prot-a-2181,Protein deglycase DJ-1,protein deglycase DJ-1 measurement,EFO:0021982,http://www.ebi.ac.uk/efo/EFO_0021982,0.687,None
prot-a-465,SLAM family member 5,SLAM family member 5 measurement,EFO:0020741,http://www.ebi.ac.uk/efo/EFO_0020741,0.91,None
prot-b-71,fatty acid binding protein 4,"fatty acid-binding protein, liver measurement",EFO:0021855,http://www.ebi.ac.uk/efo/EFO_0021855,0.653,None
prot-a-407,C-C motif chemokine 3,C-C motif chemokine 3 measurement,EFO:0008051,http://www.ebi.ac.uk/efo/EFO_0008051,0.678,None
prot-a-3123,Thioredoxin domain-containing protein 12,thioredoxin domain-containing protein 12 measurement,EFO:0008298,http://www.ebi.ac.uk/efo/EFO_0008298,0.895,None
prot-c-4210_19_2,Dynactin subunit 2,dynactin subunit 2 measurement,EFO:0020338,http://www.ebi.ac.uk/efo/EFO_0020338,0.894,None
prot-a-3037,Tumor necrosis factor receptor superfamily member 11A,tumor necrosis factor receptor superfamily member 11A measurement,EFO:0020800,http://www.ebi.ac.uk/efo/EFO_0020800,0.948,None
met-a-649,X-12740,X-12740 measurement,EFO:0021330,http://www.ebi.ac.uk/efo/EFO_0021330,0.707,None
prot-a-2039,Neurofascin,neurofascin measurement,EFO:0801831,http://www.ebi.ac.uk/efo/EFO_0801831,0.833,None
prot-a-2436,Protein tyrosine phosphatase type IVA 2,protein tyrosine phosphatase type IVA 2 measurement,EFO:0802967,http://www.ebi.ac.uk/efo/EFO_0802967,0.921,None
prot-a-2222,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta measurement",EFO:0802002,http://www.ebi.ac.uk/efo/EFO_0802002,0.827,None
prot-a-872,E3 ubiquitin-protein ligase DTX3L,E3 ubiquitin-protein ligase DTX3L measurement,EFO:0801553,http://www.ebi.ac.uk/efo/EFO_0801553,0.911,None
prot-a-1806,Latent-transforming growth factor beta-binding protein 4,latent-transforming growth factor beta-binding protein 4 measurement,EFO:0021940,http://www.ebi.ac.uk/efo/EFO_0021940,0.828,None
prot-a-43,Adhesion G-protein coupled receptor F1,adhesion G-protein coupled receptor F1 measurement,EFO:0801347,http://www.ebi.ac.uk/efo/EFO_0801347,0.829,None
met-a-456,Pyroglutamylglycine,pyroglutamylglycine measurement,EFO:0021133,http://www.ebi.ac.uk/efo/EFO_0021133,0.914,None
ebi-a-GCST005064,Aspartate aminotransferase levels,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.85,None
bbj-a-14,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
prot-a-2123,NT-3 growth factor receptor,nt-3 growth factor receptor measurement,EFO:0020613,http://www.ebi.ac.uk/efo/EFO_0020613,0.784,None
met-d-XL_VLDL_TG_pct,Triglycerides to total lipids ratio in very large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.684,None
prot-c-2190_55_1,Coagulation Factor XI,protein C measurement,EFO:0004633,http://www.ebi.ac.uk/efo/EFO_0004633,0.782,None
ebi-a-GCST004489,Insulin disposition index,disposition index measurement,EFO:0006832,http://www.ebi.ac.uk/efo/EFO_0006832,0.906,None
met-a-612,X-12450,X-12450 measurement,EFO:0021310,http://www.ebi.ac.uk/efo/EFO_0021310,0.687,None
met-a-691,X-13496,X-13496 measurement,EFO:0021352,http://www.ebi.ac.uk/efo/EFO_0021352,0.725,None
prot-a-2597,40S ribosomal protein S7,40s ribosomal protein S7 measurement,EFO:0020118,http://www.ebi.ac.uk/efo/EFO_0020118,0.922,None
met-c-916,Mono-unsaturated fatty acids,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.647,None
prot-a-1555,Inhibin beta A chain:Inhibin beta B chain heterodimer,inhibin beta A chain:inhibin beta B chain heterodimer measurement,EFO:0020470,http://www.ebi.ac.uk/efo/EFO_0020470,0.9,None
ieu-a-1093,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
prot-a-1276,"Glutamate receptor ionotropic, delta-2","glutamate receptor ionotropic, delta-2 measurement",EFO:0801631,http://www.ebi.ac.uk/efo/EFO_0801631,0.808,None
ebi-a-GCST005071,Insulin-like growth factor 1 levels,IGF-1 measurement,EFO:0004627,http://www.ebi.ac.uk/efo/EFO_0004627,0.914,None
met-a-590,X-12212,X-12212 measurement,EFO:0021293,http://www.ebi.ac.uk/efo/EFO_0021293,0.686,None
prot-c-4878_3_1,Coagulation Factor X,coagulation factor X measurement,EFO:0020265,http://www.ebi.ac.uk/efo/EFO_0020265,0.885,None
prot-a-1492,Interleukin-18 receptor 1,interleukin 18 receptor 1 measurement,EFO:0008178,http://www.ebi.ac.uk/efo/EFO_0008178,0.908,None
prot-a-575,C-type lectin domain family 2 member L,C-type lectin domain family 2 member L measurement,EFO:0802346,http://www.ebi.ac.uk/efo/EFO_0802346,0.793,None
ebi-a-GCST90012112,Total testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.868,None
met-d-VLDL_CE,Cholesteryl esters in VLDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.757,None
prot-a-1494,Interleukin-1 alpha,interleukin 1 alpha measurement,EFO:0009412,http://www.ebi.ac.uk/efo/EFO_0009412,0.889,None
prot-a-437,CMRF35-like molecule 1,CMRF35-like molecule 1 measurement,EFO:0802405,http://www.ebi.ac.uk/efo/EFO_0802405,0.797,None
prot-a-453,Complement decay-accelerating factor,complement decay-accelerating factor measurement,EFO:0008095,http://www.ebi.ac.uk/efo/EFO_0008095,0.839,None
met-a-503,X-11374,X-11374 measurement,EFO:0021227,http://www.ebi.ac.uk/efo/EFO_0021227,0.701,None
ukb-a-274,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
prot-c-3303_23_2,Cystatin M,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.755,None
ebi-a-GCST90010160,Placenta growth factor levels,placenta growth factor measurement,EFO:0010626,http://www.ebi.ac.uk/efo/EFO_0010626,0.81,None
prot-c-4464_10_2,Sialoadhesin,sialoadhesin measurement,EFO:0020740,http://www.ebi.ac.uk/efo/EFO_0020740,0.869,None
prot-a-2283,Group 10 secretory phospholipase A2,group 10 secretory phospholipase A2 measurement,EFO:0020423,http://www.ebi.ac.uk/efo/EFO_0020423,0.935,None
prot-a-419,Scavenger receptor cysteine-rich type 1 protein M130,scavenger receptor cysteine-rich type 1 protein m130 measurement,EFO:0020717,http://www.ebi.ac.uk/efo/EFO_0020717,0.891,None
prot-a-2840,Sulfiredoxin-1,sulfiredoxin-1 measurement,EFO:0802101,http://www.ebi.ac.uk/efo/EFO_0802101,0.802,None
met-a-410,1-stearoylglycerophosphoinositol,1-stearoylglycerophosphoinositol measurement,EFO:0021094,http://www.ebi.ac.uk/efo/EFO_0021094,0.85,None
ebi-a-GCST90001827,IgD on IgD+ B cell,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.716,None
prot-a-1557,72 kDa inositol polyphosphate 5-phosphatase,72 kDa inositol polyphosphate 5-phosphatase measurement,EFO:0802244,http://www.ebi.ac.uk/efo/EFO_0802244,0.884,None
ebi-a-GCST005219,Incremental insulin,insulin measurement,EFO:0004467,http://www.ebi.ac.uk/efo/EFO_0004467,0.653,None
prot-a-1013,"Fatty acid-binding protein, adipocyte","fatty acid-binding protein, adipocyte measurement",EFO:0010914,http://www.ebi.ac.uk/efo/EFO_0010914,0.79,None
ubm-a-329,IDP dMRI TBSS MO Cingulum hippocampus L,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.6,None
prot-a-2610,RUN and FYVE domain-containing protein 1,RUN and FYVE domain-containing protein 1 measurement,EFO:0803040,http://www.ebi.ac.uk/efo/EFO_0803040,0.887,None
bbj-a-19,Ejection fraction,ejection fraction measurement,EFO:0005527,http://www.ebi.ac.uk/efo/EFO_0005527,0.909,None
ieu-a-1079,Zinc,Zinc deficiency,EFO:1000003,http://www.ebi.ac.uk/efo/EFO_1000003,0.771,None
prot-a-2311,Protein TMEPAI,protein TMEPAI measurement,EFO:0801967,http://www.ebi.ac.uk/efo/EFO_0801967,0.893,None
prot-a-864,Dihydropyrimidinase-related protein 5,dihydropyrimidinase-related protein 5 measurement,EFO:0802468,http://www.ebi.ac.uk/efo/EFO_0802468,0.866,None
prot-a-2169,Serine/threonine-protein kinase PAK 3,serine/threonine-protein kinase PAK 3 measurement,EFO:0020728,http://www.ebi.ac.uk/efo/EFO_0020728,0.745,None
ebi-a-GCST90000461,CXCL5 levels,CXCL5 measurement,EFO:0009422,http://www.ebi.ac.uk/efo/EFO_0009422,0.796,None
met-a-596,X-12244--N-acetylcarnosine,X-12244--N-acetylcarnosine measurement,EFO:0021299,http://www.ebi.ac.uk/efo/EFO_0021299,0.632,None
prot-a-431,Programmed cell death 1 ligand 1,programmed cell death 1 ligand 1 measurement,EFO:0020654,http://www.ebi.ac.uk/efo/EFO_0020654,0.914,None
met-c-849,Citrate,citrate measurement,EFO:0010114,http://www.ebi.ac.uk/efo/EFO_0010114,0.789,None
ebi-a-GCST004620,Sum basophil neutrophil counts,sum of basophil and neutrophil counts,EFO:0009388,http://www.ebi.ac.uk/efo/EFO_0009388,0.957,None
ebi-a-GCST90010290,Coiled-coil domain-containing protein 80 levels,coiled-coil domain-containing protein 80 measurement,EFO:0020268,http://www.ebi.ac.uk/efo/EFO_0020268,0.807,None
prot-a-741,Stromal cell-derived factor 1,stromal cell-derived factor 1 measurement,EFO:0020756,http://www.ebi.ac.uk/efo/EFO_0020756,0.753,None
ukb-b-12901,Other alcohol intake,alcohol dependence,MONDO:0007079,http://purl.obolibrary.org/obo/MONDO_0007079,0.66,None
ukb-b-7435,Age diabetes diagnosed,diabetes mellitus,EFO:0000400,http://www.ebi.ac.uk/efo/EFO_0000400,0.717,None
prot-c-2754_50_2,C3,C3H/HeJ,EFO:0001329,http://www.ebi.ac.uk/efo/EFO_0001329,1.0,None
prot-a-3011,Transmembrane protein 41B,transmembrane protein 41B measurement,EFO:0803186,http://www.ebi.ac.uk/efo/EFO_0803186,0.931,None
prot-a-703,Cystatin-M,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.755,None
ebi-a-GCST006327,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
prot-a-2033,Neogenin,neogenin measurement,EFO:0801823,http://www.ebi.ac.uk/efo/EFO_0801823,0.77,None
ebi-a-GCST90002018,CCR2 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.611,None
met-d-IDL_C_pct,Cholesterol to total lipids ratio in IDL,total cholesterol in IDL,EFO:0022184,http://www.ebi.ac.uk/efo/EFO_0022184,0.75,None
ieu-b-4854,Forced expiratory volume in 1-second,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.898,None
ebi-a-GCST90012059,C-X-C motif chemokine 16 levels,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.635,None
ebi-a-GCST90010127,Growth/differentiation factor 2 levels,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.92,None
prot-a-1184,Glucokinase regulatory protein,glucokinase regulatory protein measurement,EFO:0020406,http://www.ebi.ac.uk/efo/EFO_0020406,0.924,None
prot-a-2069,Protein NOV homolog,protein nov homolog measurement,EFO:0020685,http://www.ebi.ac.uk/efo/EFO_0020685,0.898,None
met-a-650,X-12749,X-12749 measurement,EFO:0021331,http://www.ebi.ac.uk/efo/EFO_0021331,0.705,None
ebi-a-GCST90002365,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
met-a-535,X-11552,X-11552 measurement,EFO:0021255,http://www.ebi.ac.uk/efo/EFO_0021255,0.713,None
ebi-a-GCST90012108,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.754,None
prot-a-2649,Secretagogin,secretagogin measurement,EFO:0803045,http://www.ebi.ac.uk/efo/EFO_0803045,0.885,None
prot-a-28,Disintegrin and metalloproteinase domain-containing protein 23,disintegrin and metalloproteinase domain-containing protein 23 measurement,EFO:0801530,http://www.ebi.ac.uk/efo/EFO_0801530,0.913,None
prot-a-1625,Dyslexia-associated protein KIAA0319,dyslexia-associated protein KIAA0319 measurement,EFO:0802498,http://www.ebi.ac.uk/efo/EFO_0802498,0.887,None
prot-a-257,Bone morphogenetic protein 7,bone morphogenetic protein 7 measurement,EFO:0020187,http://www.ebi.ac.uk/efo/EFO_0020187,0.893,None
met-d-XXL_VLDL_L,Total lipids in chylomicrons and extremely large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.634,None
prot-a-1613,Potassium voltage-gated channel subfamily E regulatory beta subunit 5,potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement,EFO:0801902,http://www.ebi.ac.uk/efo/EFO_0801902,0.914,None
prot-a-2919,Synaptotagmin-like protein 4,synaptotagmin-like protein 4 measurement,EFO:0802109,http://www.ebi.ac.uk/efo/EFO_0802109,0.857,None
ebi-a-GCST004429,Stem cell factor levels,stem Cell Factor measurement,EFO:0008291,http://www.ebi.ac.uk/efo/EFO_0008291,0.703,None
prot-c-2247_20_11,EG-VEGF,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.828,None
prot-a-2282,Pyruvate kinase PKLR,pyruvate kinase PKLR measurement,EFO:0801982,http://www.ebi.ac.uk/efo/EFO_0801982,0.934,None
ebi-a-GCST90006892,Chlamydia trachomatis tarp-D F2 antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.661,None
ieu-b-5071,Cigarettes per day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.913,None
prot-a-1877,Myocyte-specific enhancer factor 2C,myocyte-specific enhancer factor 2C measurement,EFO:0802770,http://www.ebi.ac.uk/efo/EFO_0802770,0.855,None
prot-b-45,myoglobin,myoglobin measurement,EFO:0005057,http://www.ebi.ac.uk/efo/EFO_0005057,0.833,None
prot-a-367,Catalase,catalase measurement,EFO:0008071,http://www.ebi.ac.uk/efo/EFO_0008071,0.726,None
prot-a-2210,Procollagen C-endopeptidase enhancer 2,procollagen C-endopeptidase enhancer 2 measurement,EFO:0801921,http://www.ebi.ac.uk/efo/EFO_0801921,0.822,None
prot-c-3364_76_2,Cathepsin V,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.683,None
met-a-539,ADSGEGDFXAEGGGVR*,ADSGEGDFXAEGGGVR measurement,EFO:0021135,http://www.ebi.ac.uk/efo/EFO_0021135,0.957,None
prot-a-2657,"Succinate dehydrogenase assembly factor 2, mitochondrial","succinate dehydrogenase assembly factor 2, mitochondrial measurement",EFO:0803107,http://www.ebi.ac.uk/efo/EFO_0803107,0.91,None
met-c-856,Omega-6 fatty acids,omega-3 polyunsaturated fatty acid measurement,EFO:0010119,http://www.ebi.ac.uk/efo/EFO_0010119,0.612,None
prot-c-4430_44_3,Collectin Kidney 1,collecting duct carcinoma,EFO:0003016,http://www.ebi.ac.uk/efo/EFO_0003016,0.754,None
prot-c-2632_5_2,IL-12 Rb1,hereditary retinoblastoma,MONDO:0018160,http://purl.obolibrary.org/obo/MONDO_0018160,0.805,None
ubm-a-2693,volume CC Anterior,anterior thigh muscle volume,EFO:0020935,http://www.ebi.ac.uk/efo/EFO_0020935,0.632,None
prot-a-1649,Kin of IRRE-like protein 2,kin of IRRE-like protein 2 measurement,EFO:0802678,http://www.ebi.ac.uk/efo/EFO_0802678,0.783,None
prot-a-1240,Golgi SNAP receptor complex member 1,Golgi SNAP receptor complex member 1 measurement,EFO:0801651,http://www.ebi.ac.uk/efo/EFO_0801651,0.948,None
prot-c-2500_2_3,Angiopoietin-4,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.734,None
prot-a-3094,Translationally-controlled tumor protein,translationally-controlled tumor protein measurement,EFO:0020784,http://www.ebi.ac.uk/efo/EFO_0020784,0.85,None
prot-c-2831_29_1,Kallikrein 11,kallikrein-11 measurement,EFO:0010573,http://www.ebi.ac.uk/efo/EFO_0010573,0.771,None
met-d-XS_VLDL_FC_pct,Free cholesterol to total lipids ratio in very small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.712,None
prot-a-520,Complement factor H,complement factor H measurement,EFO:0008097,http://www.ebi.ac.uk/efo/EFO_0008097,0.915,None
prot-c-4696_2_2,FABP,diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.661,None
prot-a-838,DnaJ homolog subfamily B member 1,DNAj homolog subfamily b member 1 measurement,EFO:0020332,http://www.ebi.ac.uk/efo/EFO_0020332,0.945,None
ebi-a-GCST004451,Interleukin-7 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.788,None
ukb-d-30660_raw,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
prot-a-1195,Growth/differentiation factor 15,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.927,None
prot-a-922,Eukaryotic translation initiation factor 4B,eukaryotic translation initiation factor 4B measurement,EFO:0801592,http://www.ebi.ac.uk/efo/EFO_0801592,0.949,None
ebi-a-GCST007430,Peak expiratory flow,peak expiratory flow,EFO:0009718,http://www.ebi.ac.uk/efo/EFO_0009718,0.995,None
prot-a-780,Deformed epidermal autoregulatory factor 1 homolog,deformed epidermal autoregulatory factor 1 homolog measurement,EFO:0801522,http://www.ebi.ac.uk/efo/EFO_0801522,0.938,None
ebi-a-GCST90001641,CD3- lymphocyte %leukocyte,lymphocyte percentage of leukocytes,EFO:0007993,http://www.ebi.ac.uk/efo/EFO_0007993,0.761,None
prot-c-2811_27_1,Angiopoietin-1,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.742,None
prot-a-3043,Tumor necrosis factor receptor superfamily member 17,tumor necrosis factor receptor superfamily member 17 measurement,EFO:0020806,http://www.ebi.ac.uk/efo/EFO_0020806,0.946,None
met-a-518,X-11452,X-11452 measurement,EFO:0021239,http://www.ebi.ac.uk/efo/EFO_0021239,0.703,None
prot-a-1073,High affinity immunoglobulin gamma Fc receptor I,high affinity immunoglobulin gamma fc receptor i measurement,EFO:0020447,http://www.ebi.ac.uk/efo/EFO_0020447,0.954,None
prot-c-5024_67_1,Rb,retinoblastoma,MONDO:0008380,http://purl.obolibrary.org/obo/MONDO_0008380,1.0,None
prot-c-5033_27_1,Tropomyosin 1 alpha chain,tropomyosin alpha-1 chain measurement,EFO:0020786,http://www.ebi.ac.uk/efo/EFO_0020786,0.773,None
prot-c-2730_58_2,MICA,cancer,MONDO:0004992,http://purl.obolibrary.org/obo/MONDO_0004992,0.616,None
prot-a-984,Endoplasmic reticulum resident protein 29,endoplasmic reticulum resident protein 29 measurement,EFO:0020346,http://www.ebi.ac.uk/efo/EFO_0020346,0.94,None
prot-a-895,EF-hand calcium-binding domain-containing protein 14,EF-hand calcium-binding domain-containing protein 14 measurement,EFO:0802518,http://www.ebi.ac.uk/efo/EFO_0802518,0.744,None
prot-a-862,Protein dpy-30 homolog,protein dpy-30 homolog measurement,EFO:0802933,http://www.ebi.ac.uk/efo/EFO_0802933,0.699,None
ieu-b-4815,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
met-d-XXL_VLDL_TG,Triglycerides in chylomicrons and extremely large VLDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.65,None
ieu-b-4829,Waist-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.784,None
prot-a-1760,Ig Kappa chain V-I region HK102- like,ig Kappa chain V-I region HK102- like measurement,EFO:0802617,http://www.ebi.ac.uk/efo/EFO_0802617,0.759,None
prot-c-3710_49_2,Angiostatin,angiostatin measurement,EFO:0008024,http://www.ebi.ac.uk/efo/EFO_0008024,0.813,None
prot-a-1914,Matrix metalloproteinase-14,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.892,None
ukb-b-4717,Corneal resistance factor (left),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.903,None
prot-c-3032_11_2,FSH,follicle stimulating hormone,EFO:0003234,http://www.ebi.ac.uk/efo/EFO_0003234,0.996,None
ukb-b-3825,Age angina diagnosed,angina pectoris,EFO:0003913,http://www.ebi.ac.uk/efo/EFO_0003913,0.645,None
prot-a-2858,"Alpha-2,8-sialyltransferase 8B","alpha-2,8-sialyltransferase 8B measurement",EFO:0802265,http://www.ebi.ac.uk/efo/EFO_0802265,0.672,None
prot-a-1779,Low-density lipoprotein receptor-related protein 1B,low-density lipoprotein receptor-related protein 1B measurement,EFO:0021873,http://www.ebi.ac.uk/efo/EFO_0021873,0.813,None
prot-a-121,DNA-(apurinic or apyrimidinic site) lyase,DNA-(apurinic or apyrimidinic site) lyase measurement,EFO:0801533,http://www.ebi.ac.uk/efo/EFO_0801533,0.752,None
prot-a-2002,N-acetyltransferase 14,Ogden syndrome,MONDO:0010457,http://purl.obolibrary.org/obo/MONDO_0010457,0.828,None
prot-a-1423,Interferon alpha-6,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.953,None
prot-a-1506,Interleukin-21,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.84,None
prot-c-3449_58_2,Kallistatin,kallistatin measurement,EFO:0008196,http://www.ebi.ac.uk/efo/EFO_0008196,0.846,None
met-c-938,Tyrosine,Hypertyrosinemia,HP:0003231,http://purl.obolibrary.org/obo/HP_0003231,0.791,None
prot-a-3121,Thioredoxin,thioredoxin measurement,EFO:0803148,http://www.ebi.ac.uk/efo/EFO_0803148,0.879,None
bbj-a-50,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
ebi-a-GCST90000455,Colony stimulating factor levels,colony stimulating factor 1 measurement,EFO:0010775,http://www.ebi.ac.uk/efo/EFO_0010775,0.821,None
prot-a-1582,Integrin alpha-5,integrin alpha-5 measurement,EFO:0802637,http://www.ebi.ac.uk/efo/EFO_0802637,0.666,None
met-a-731,X-14658,X-14658 measurement,EFO:0021376,http://www.ebi.ac.uk/efo/EFO_0021376,0.705,None
prot-a-1405,ICOS ligand,icos ligand measurement,EFO:0020460,http://www.ebi.ac.uk/efo/EFO_0020460,0.83,None
prot-c-3192_3_2,Glutamate carboxypeptidase,glutamate carboxypeptidase 2 measurement,EFO:0020408,http://www.ebi.ac.uk/efo/EFO_0020408,0.912,None
prot-c-4155_3_2,Tenascin,tenascin measurement,EFO:0008296,http://www.ebi.ac.uk/efo/EFO_0008296,0.8,None
ebi-a-GCST90010278,Adhesion G protein-coupled receptor E2 levels,adhesion G protein-coupled receptor E2 measurement,EFO:0021892,http://www.ebi.ac.uk/efo/EFO_0021892,0.827,None
prot-a-3207,V-set and immunoglobulin domain-containing protein 1,v-set and immunoglobulin domain-containing protein 1 measurement,EFO:0803245,http://www.ebi.ac.uk/efo/EFO_0803245,0.786,None
prot-a-2861,"Alpha-2,8-sialyltransferase 8F","alpha-2,8-sialyltransferase 8F measurement",EFO:0802266,http://www.ebi.ac.uk/efo/EFO_0802266,0.685,None
prot-a-2793,Sorting nexin-1,sorting nexin-1 measurement,EFO:0803092,http://www.ebi.ac.uk/efo/EFO_0803092,0.731,None
ieu-a-792,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-3117,Tuftelin,tuftelin measurement,EFO:0803198,http://www.ebi.ac.uk/efo/EFO_0803198,0.854,None
prot-a-2297,Phospholipase D3,phospholipase D3 measurement,EFO:0802866,http://www.ebi.ac.uk/efo/EFO_0802866,0.901,None
prot-a-2553,Probable inactive ribonuclease-like protein 13,probable inactive ribonuclease-like protein 13 measurement,EFO:0802906,http://www.ebi.ac.uk/efo/EFO_0802906,0.899,None
prot-a-2386,Protein Largen,protein Largen measurement,EFO:0802952,http://www.ebi.ac.uk/efo/EFO_0802952,0.835,None
prot-a-618,Collagen alpha-1(I) chain,type 2 collagenopathy,MONDO:0022800,http://purl.obolibrary.org/obo/MONDO_0022800,0.639,None
ebi-a-GCST90010130,Lactoylglutathione lyase levels,lactoylglutathione lyase measurement,EFO:0802684,http://www.ebi.ac.uk/efo/EFO_0802684,0.863,None
prot-a-1875,Mediator of RNA polymerase II transcription subunit 1,mediator of RNA polymerase II transcription subunit 1 measurement,EFO:0008228,http://www.ebi.ac.uk/efo/EFO_0008228,0.952,None
ebi-a-GCST90010260,Tyrosine-protein phosphatase non-receptor type substrate 1 levels,tyrosine-protein phosphatase non-receptor type substrate 1 measurement,EFO:0802175,http://www.ebi.ac.uk/efo/EFO_0802175,0.803,None
bbj-a-2,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1685,"Keratin, type II cytoskeletal 5","keratin, type II cytoskeletal 5 measurement",EFO:0802674,http://www.ebi.ac.uk/efo/EFO_0802674,0.854,None
prot-c-2778_10_2,IL-22,ring chromosome 22,MONDO:0015438,http://purl.obolibrary.org/obo/MONDO_0015438,0.619,None
prot-a-3063,Tumor necrosis factor ligand superfamily member 8,tumor necrosis factor ligand superfamily member 8 measurement,EFO:0010592,http://www.ebi.ac.uk/efo/EFO_0010592,0.938,None
met-a-386,Phenylacetate,phenylacetate measurement,EFO:0021012,http://www.ebi.ac.uk/efo/EFO_0021012,0.876,None
ebi-a-GCST90012064,Protein S100-A12 levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.603,None
prot-a-1474,Interleukin-12 receptor subunit beta-2,interleukin 6 receptor subunit beta measurement,EFO:0008188,http://www.ebi.ac.uk/efo/EFO_0008188,0.85,None
ukb-b-3957,Sleeplessness / insomnia,insomnia,EFO:0004698,http://www.ebi.ac.uk/efo/EFO_0004698,0.609,None
ubm-a-18,IDP T1 FIRST right pallidum volume,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.733,None
prot-a-1131,Fibronectin Fragment 4,fibronectin fragment 4 measurement,EFO:0008132,http://www.ebi.ac.uk/efo/EFO_0008132,0.912,None
prot-a-1092,Fibroblast growth factor 20,fibroblast growth factor 20 measurement,EFO:0020381,http://www.ebi.ac.uk/efo/EFO_0020381,0.916,None
prot-a-951,Ectonucleoside triphosphate diphosphohydrolase 1,ectonucleoside triphosphate diphosphohydrolase 1 measurement,EFO:0020342,http://www.ebi.ac.uk/efo/EFO_0020342,0.96,None
prot-a-2689,Protein Z-dependent protease inhibitor,protein Z-dependent protease inhibitor measurement,EFO:0021849,http://www.ebi.ac.uk/efo/EFO_0021849,0.805,None
ebi-a-GCST90010158,Platelet-derived growth factor subunit B levels,platelet-derived growth factor subunit b measurement,EFO:0020650,http://www.ebi.ac.uk/efo/EFO_0020650,0.786,None
prot-a-1417,Interferon-induced protein with tetratricopeptide repeats 3,interferon-induced protein with tetratricopeptide repeats 3 measurement,EFO:0801710,http://www.ebi.ac.uk/efo/EFO_0801710,0.912,None
ebi-a-GCST90011996,Adrenomedullin levels,adrenomedullin measurement,EFO:0010909,http://www.ebi.ac.uk/efo/EFO_0010909,0.767,None
prot-c-3622_33_4,LGMN,large congenital melanocytic nevus,MONDO:0044792,http://purl.obolibrary.org/obo/MONDO_0044792,0.634,None
ebi-a-GCST90006913,Helicobacter pylori GroEL antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.635,None
ubm-a-2657,volume Left-Inf-Lat-Vent,left inferior lateral ventricle volume measurement,EFO:0006793,http://www.ebi.ac.uk/efo/EFO_0006793,0.667,None
prot-a-2357,PR domain zinc finger protein 1,PR domain zinc finger protein 1 measurement,EFO:0801904,http://www.ebi.ac.uk/efo/EFO_0801904,0.926,None
prot-b-80,natriuretic peptide B,natriuretic peptides B measurement,EFO:0010628,http://www.ebi.ac.uk/efo/EFO_0010628,0.853,None
ebi-a-GCST004459,Fibroblast growth factor basic levels,basic fibroblast growth factor,EFO:0003316,http://www.ebi.ac.uk/efo/EFO_0003316,0.922,None
ubm-a-2336,NET100 1180,1182-4H,EFO:0005648,http://www.ebi.ac.uk/efo/EFO_0005648,0.681,None
ebi-a-GCST90001910,CD45 on B cell,T-B+ severe combined immunodeficiency due to CD45 deficiency,MONDO:0015702,http://purl.obolibrary.org/obo/MONDO_0015702,0.623,None
met-a-685,X-13435,X-13435 measurement,EFO:0021350,http://www.ebi.ac.uk/efo/EFO_0021350,0.69,None
ieu-a-1017,Immunoglobulin G index levels,serum IgG measurement,EFO:0004565,http://www.ebi.ac.uk/efo/EFO_0004565,0.835,None
prot-a-851,Deoxyribonuclease-2-beta,Deoxyribonuclease digestion,EFO:0004186,http://www.ebi.ac.uk/efo/EFO_0004186,0.816,None
ukb-b-12039,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
met-d-M_HDL_PL_pct,Phospholipids to total lipids ratio in medium HDL,phospholipids:total lipids ratio,EFO:0020946,http://www.ebi.ac.uk/efo/EFO_0020946,0.745,None
ieu-b-32,lymphocyte cell count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.909,None
prot-a-197,Cyclic AMP-dependent transcription factor ATF-6 alpha,cyclic AMP-dependent transcription factor ATF-6 alpha measurement,EFO:0801505,http://www.ebi.ac.uk/efo/EFO_0801505,0.767,None
prot-a-1867,Multiple coagulation factor deficiency protein 2,"factor V and factor VIII, combined deficiency of, type 1",MONDO:0009206,http://purl.obolibrary.org/obo/MONDO_0009206,0.919,None
prot-a-3275,Zinc finger protein 75D,zinc finger protein 75D measurement,EFO:0803283,http://www.ebi.ac.uk/efo/EFO_0803283,0.933,None
prot-b-22,vascular endothelial growth factor A,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.977,None
ebi-a-GCST90001774,CD24 on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.698,None
prot-a-1847,Mitogen-activated protein kinase 14,mitogen-activated protein kinase 14 measurement,EFO:0020578,http://www.ebi.ac.uk/efo/EFO_0020578,0.818,None
prot-c-2769_3_2,HIV-2 Rev,HIV infection,EFO:0000764,http://www.ebi.ac.uk/efo/EFO_0000764,0.72,None
ebi-a-GCST90006886,Anti-chlamydia trachomatis IgG seropositivity,Chlamydia trachomatis seropositivity,EFO:0009330,http://www.ebi.ac.uk/efo/EFO_0009330,0.888,None
prot-c-2666_53_2,Bone proteoglycan II,proteoglycan 3 measurement,EFO:0802970,http://www.ebi.ac.uk/efo/EFO_0802970,0.667,None
prot-a-561,Cold-inducible RNA-binding protein,cold-inducible RNA-binding protein measurement,EFO:0801484,http://www.ebi.ac.uk/efo/EFO_0801484,0.749,None
met-c-944,Free cholesterol in very large HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.851,None
prot-a-1651,Kin of IRRE-like protein 3,kin of IRRE-like protein 3 measurement,EFO:0020521,http://www.ebi.ac.uk/efo/EFO_0020521,0.785,None
prot-a-1566,Interferon regulatory factor 1,interferon regulatory factor 1 measurement,EFO:0021908,http://www.ebi.ac.uk/efo/EFO_0021908,0.918,None
prot-a-2075,Nuclear protein localization protein 4 homolog,nuclear protein localization protein 4 homolog measurement,EFO:0801851,http://www.ebi.ac.uk/efo/EFO_0801851,0.948,None
bbj-a-35,Left ventricular mass index,left ventricular mass index,EFO:0009290,http://www.ebi.ac.uk/efo/EFO_0009290,0.99,None
ukb-d-30890_irnt,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
prot-a-684,Cytokine receptor common subunit beta,cytokine receptor common subunit beta measurement,EFO:0801518,http://www.ebi.ac.uk/efo/EFO_0801518,0.937,None
prot-a-2176,Pappalysin-2,pappalysin-1 measurement,EFO:0802845,http://www.ebi.ac.uk/efo/EFO_0802845,0.723,None
prot-a-699,Chondroitin sulfate proteoglycan 4,chondroitin sulfate proteoglycan 4 measurement,EFO:0802394,http://www.ebi.ac.uk/efo/EFO_0802394,0.922,None
prot-a-1829,Melanoma-associated antigen B10,melanoma-associated antigen B10 measurement,EFO:0802735,http://www.ebi.ac.uk/efo/EFO_0802735,0.832,None
prot-a-1404,Inducible T-cell costimulator,inducible T-cell costimulator measurement,EFO:0021967,http://www.ebi.ac.uk/efo/EFO_0021967,0.826,None
prot-c-5001_6_2,Mammaglobin 2,mammaglobin-b measurement,EFO:0020552,http://www.ebi.ac.uk/efo/EFO_0020552,0.725,None
prot-a-2412,Proteasome subunit alpha type-4,proteasome subunit alpha type-1 measurement,EFO:0020663,http://www.ebi.ac.uk/efo/EFO_0020663,0.78,None
ebi-a-GCST90000499,Tumor necrosis factor beta levels,tumor necrosis factor beta measurement,EFO:0008308,http://www.ebi.ac.uk/efo/EFO_0008308,0.809,None
prot-a-3201,Vitrin,vitrin measurement,EFO:0802217,http://www.ebi.ac.uk/efo/EFO_0802217,0.756,None
prot-a-2462,"Glycogen phosphorylase, liver form","glycogen phosphorylase, liver form measurement",EFO:0801642,http://www.ebi.ac.uk/efo/EFO_0801642,0.891,None
prot-c-4842_62_2,Glypican 3,glypican-1 measurement,EFO:0801649,http://www.ebi.ac.uk/efo/EFO_0801649,0.612,None
bbj-a-70,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
met-d-S_LDL_P,Concentration of small LDL particles,concentration of small LDL particles measurement,EFO:0022166,http://www.ebi.ac.uk/efo/EFO_0022166,0.925,None
prot-a-1185,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase measurement",EFO:0802308,http://www.ebi.ac.uk/efo/EFO_0802308,0.631,None
ebi-a-GCST90010176,Tissue factor levels,tissue factor measurement,EFO:0010623,http://www.ebi.ac.uk/efo/EFO_0010623,0.719,None
prot-a-369,Core-binding factor subunit beta,core-binding factor subunit beta measurement,EFO:0801498,http://www.ebi.ac.uk/efo/EFO_0801498,0.809,None
prot-a-2202,Protocadherin beta-10,protocadherin beta-10 measurement,EFO:0801974,http://www.ebi.ac.uk/efo/EFO_0801974,0.74,None
prot-a-2999,Transmembrane protein 132C,transmembrane protein 132C measurement,EFO:0802152,http://www.ebi.ac.uk/efo/EFO_0802152,0.935,None
prot-a-1256,Transmembrane glycoprotein NMB,transmembrane glycoprotein NMB measurement,EFO:0008303,http://www.ebi.ac.uk/efo/EFO_0008303,0.937,None
ukb-b-7372,Magnesium,magnesium measurement,EFO:0004845,http://www.ebi.ac.uk/efo/EFO_0004845,0.846,None
prot-a-3031,Tumor necrosis factor-inducible gene 6 protein,tumor necrosis factor-inducible gene 6 protein measurement,EFO:0008311,http://www.ebi.ac.uk/efo/EFO_0008311,0.856,None
prot-a-2887,Syntaxin-2,syntaxin-2 measurement,EFO:0802111,http://www.ebi.ac.uk/efo/EFO_0802111,0.605,None
prot-a-2483,UV excision repair protein RAD23 homolog A,UV excision repair protein RAD23 homolog A measurement,EFO:0803244,http://www.ebi.ac.uk/efo/EFO_0803244,0.955,None
ebi-a-GCST90010146,Interleukin-6 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.794,None
prot-a-1108,Fibrinogen C domain-containing protein 1,fibrinogen C domain-containing protein 1 measurement,EFO:0802548,http://www.ebi.ac.uk/efo/EFO_0802548,0.872,None
prot-c-2192_63_10,CTACK,chromatid-type aberration frequency,EFO:0009862,http://www.ebi.ac.uk/efo/EFO_0009862,0.637,None
prot-a-1072,Low affinity immunoglobulin epsilon Fc receptor,low affinity immunoglobulin epsilon Fc receptor measurement,EFO:0008210,http://www.ebi.ac.uk/efo/EFO_0008210,0.954,None
met-c-950,Concentration of very large VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.876,None
prot-a-2248,Pescadillo homolog,pescadillo homolog measurement,EFO:0020633,http://www.ebi.ac.uk/efo/EFO_0020633,0.918,None
prot-a-116,Amyloid beta A4 precursor protein-binding family B member 2,amyloid beta A4 precursor protein-binding family B member 2 measurement,EFO:0801379,http://www.ebi.ac.uk/efo/EFO_0801379,0.905,None
prot-a-2245,Platelet endothelial cell adhesion molecule,platelet endothelial cell adhesion molecule measurement,EFO:0010598,http://www.ebi.ac.uk/efo/EFO_0010598,0.937,None
prot-a-1762,Lysyl oxidase homolog 2,lysyl oxidase homolog 2 measurement,EFO:0802721,http://www.ebi.ac.uk/efo/EFO_0802721,0.918,None
ebi-a-GCST005186,Fasting blood glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.898,None
ebi-a-GCST005345,Total body bone mineral density (age 0-15),bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.714,None
prot-a-889,Enhancer of mRNA-decapping protein 4,enhancer of mRNA-decapping protein 4 measurement,EFO:0802523,http://www.ebi.ac.uk/efo/EFO_0802523,0.86,None
met-a-375,Kynurenine,kynurenine measurement,EFO:0008529,http://www.ebi.ac.uk/efo/EFO_0008529,0.884,None
prot-a-2534,Regulator of G-protein signaling 10,regulator of G-protein signaling 10 measurement,EFO:0803005,http://www.ebi.ac.uk/efo/EFO_0803005,0.776,None
ebi-a-GCST90001820,IgD on IgD+ CD24+ B cell,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.637,None
ebi-a-GCST004623,Neutrophil percentage of granulocytes,neutrophil percentage of granulocytes,EFO:0007994,http://www.ebi.ac.uk/efo/EFO_0007994,0.991,None
met-a-727,X-14588,X-14588 measurement,EFO:0021372,http://www.ebi.ac.uk/efo/EFO_0021372,0.715,None
prot-a-2229,Platelet-derived growth factor receptor alpha,platelet-derived growth factor receptor alpha measurement,EFO:0021844,http://www.ebi.ac.uk/efo/EFO_0021844,0.852,None
prot-a-2704,Histone-lysine N-methyltransferase SETMAR,histone-lysine N-methyltransferase SETMAR measurement,EFO:0802605,http://www.ebi.ac.uk/efo/EFO_0802605,0.802,None
prot-a-2498,E3 ubiquitin-protein ligase RBBP6,E3 ubiquitin-protein ligase RBBP6 measurement,EFO:0802508,http://www.ebi.ac.uk/efo/EFO_0802508,0.908,None
prot-a-989,S-formylglutathione hydrolase,S-formylglutathione hydrolase measurement,EFO:0008275,http://www.ebi.ac.uk/efo/EFO_0008275,0.8,None
ebi-a-GCST90010113,CD40 ligand levels,CD40 ligand measurement,EFO:0004790,http://www.ebi.ac.uk/efo/EFO_0004790,0.749,None
prot-a-769,Decorin,decorin measurement,EFO:0020315,http://www.ebi.ac.uk/efo/EFO_0020315,0.772,None
prot-a-647,Probable serine carboxypeptidase CPVL,probable serine carboxypeptidase CPVL measurement,EFO:0801919,http://www.ebi.ac.uk/efo/EFO_0801919,0.952,None
ukb-b-6503,"Systolic blood pressure, manual reading",systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.785,None
ieu-a-109,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
met-a-370,X-02973,HG02973,EFO:0010858,http://www.ebi.ac.uk/efo/EFO_0010858,0.733,None
prot-c-3055_54_2,IL-4 sR,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.791,None
ebi-a-GCST004770,Lean body mass,lean body mass,EFO:0004995,http://www.ebi.ac.uk/efo/EFO_0004995,0.993,None
ebi-a-GCST90012065,Tumor necrosis factor receptor superfamily member 5 levels,tumor necrosis factor receptor superfamily member 3 measurement,EFO:0020813,http://www.ebi.ac.uk/efo/EFO_0020813,0.877,None
ieu-a-98,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ubm-a-132,IDP T1 FAST ROIs L amygdala,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.607,None
met-a-407,Taurocholate,taurocholate measurement,EFO:0010538,http://www.ebi.ac.uk/efo/EFO_0010538,0.862,None
prot-a-3266,Zinc finger protein 264,zinc finger protein 264 measurement,EFO:0803275,http://www.ebi.ac.uk/efo/EFO_0803275,0.926,None
prot-a-917,"Eukaryotic translation initiation factor 1A, X-chromosomal","eukaryotic translation initiation factor 1A, X-chromosomal measurement",EFO:0801589,http://www.ebi.ac.uk/efo/EFO_0801589,0.828,None
ebi-a-GCST90020166,Executive function (trail making test B),executive function,EFO:0007046,http://www.ebi.ac.uk/efo/EFO_0007046,0.728,None
prot-a-48,Adrenomedullin,adrenomedullin measurement,EFO:0010909,http://www.ebi.ac.uk/efo/EFO_0010909,0.849,None
prot-c-5015_15_1,PAFAH,Fanconi anemia complementation group A,EFO:0009044,http://www.ebi.ac.uk/efo/EFO_0009044,0.646,None
met-b-139,Lymph:%T,T-lymphoblastic lymphoma,MONDO:0044917,http://purl.obolibrary.org/obo/MONDO_0044917,0.668,None
prot-a-1719,Leukocyte cell-derived chemotaxin 1,leukocyte cell-derived chemotaxin 1 measurement,EFO:0802704,http://www.ebi.ac.uk/efo/EFO_0802704,0.845,None
met-c-917,Other polyunsaturated fatty acids than 18:2,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.78,None
met-a-385,3-phenylpropionate (hydrocinnamate),3-phenylpropionate hydrocinnamate measurement,EFO:0021010,http://www.ebi.ac.uk/efo/EFO_0021010,0.859,None
prot-a-698,Casein kinase II 2-alpha':2-beta heterotetramer,casein kinase II 2-alpha:2-beta heterotetramer measurement,EFO:0020236,http://www.ebi.ac.uk/efo/EFO_0020236,0.676,None
met-d-L_VLDL_C,Cholesterol in large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.897,None
prot-a-2092,Nutritionally-regulated adipose and cardiac enriched protein homolog,nutritionally-regulated adipose and cardiac enriched protein homolog measurement,EFO:0803300,http://www.ebi.ac.uk/efo/EFO_0803300,0.905,None
prot-a-1218,Lactoylglutathione lyase,lactoylglutathione lyase measurement,EFO:0802684,http://www.ebi.ac.uk/efo/EFO_0802684,0.922,None
met-a-715,X-14056,X-14056 measurement,EFO:0021361,http://www.ebi.ac.uk/efo/EFO_0021361,0.696,None
met-a-376,Mannitol,mannitol measurement,EFO:0021027,http://www.ebi.ac.uk/efo/EFO_0021027,0.829,None
prot-a-399,C-C motif chemokine 23,CCL23 measurement,EFO:0009417,http://www.ebi.ac.uk/efo/EFO_0009417,0.75,None
prot-a-2809,SPARC,SPARC measurement,EFO:0020748,http://www.ebi.ac.uk/efo/EFO_0020748,0.746,None
prot-a-1707,Epididymal-specific lipocalin-10,epididymal-specific lipocalin-10 measurement,EFO:0801576,http://www.ebi.ac.uk/efo/EFO_0801576,0.767,None
met-a-355,Proline,proline measurement,EFO:0009773,http://www.ebi.ac.uk/efo/EFO_0009773,0.717,None
prot-a-844,DnaJ homolog subfamily C member 15,DnaJ homolog subfamily C member 15 measurement,EFO:0802489,http://www.ebi.ac.uk/efo/EFO_0802489,0.949,None
prot-a-1201,GDNF family receptor alpha-1,gdnf family receptor alpha-1 measurement,EFO:0020400,http://www.ebi.ac.uk/efo/EFO_0020400,0.833,None
prot-a-378,Kynurenine--oxoglutarate transaminase 3,kynurenine--oxoglutarate transaminase 3 measurement,EFO:0801752,http://www.ebi.ac.uk/efo/EFO_0801752,0.819,None
ukb-a-372,Financial situation satisfaction,financial situation satisfaction measurement,EFO:0009726,http://www.ebi.ac.uk/efo/EFO_0009726,0.927,None
met-b-261,IgG+B:%27+,anti-IgG,EFO:0005030,http://www.ebi.ac.uk/efo/EFO_0005030,0.717,None
ebi-a-GCST004618,White blood cell count (basophil),basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.827,None
prot-a-2746,Urea transporter 1,urea transporter 1 measurement,EFO:0803237,http://www.ebi.ac.uk/efo/EFO_0803237,0.887,None
prot-a-737,Coxsackievirus and adenovirus receptor,coxsackievirus and adenovirus receptor measurement,EFO:0802431,http://www.ebi.ac.uk/efo/EFO_0802431,0.945,None
ebi-a-GCST90002082,SSC-A on CD8+ T cell,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.678,None
ukb-b-4564,Age last used hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.79,None
met-a-381,N-acetylornithine,N-acetylornithine measurement,EFO:0021538,http://www.ebi.ac.uk/efo/EFO_0021538,0.733,None
met-d-LDL_P,Concentration of LDL particles,concentration of small LDL particles measurement,EFO:0022166,http://www.ebi.ac.uk/efo/EFO_0022166,0.857,None
ukb-b-2134,Past tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.904,None
prot-a-1152,Galactoside 3(4)-L-fucosyltransferase,galactoside 34-L-fucosyltransferase measurement,EFO:0008136,http://www.ebi.ac.uk/efo/EFO_0008136,0.701,None
prot-a-330,Carbonic anhydrase 3,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.948,None
met-a-703,4-hydroxyhippurate,3-hydroxyhippurate measurement,EFO:0800960,http://www.ebi.ac.uk/efo/EFO_0800960,0.803,None
ebi-a-GCST90010243,Osteoprotegerin levels,osteoprotegerin measurement,EFO:0005918,http://www.ebi.ac.uk/efo/EFO_0005918,0.769,None
ieu-b-4826,Cigarettes smoked per day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.773,None
prot-a-234,Breast cancer anti-estrogen resistance protein 3,breast cancer anti-estrogen resistance protein 3 measurement,EFO:0008040,http://www.ebi.ac.uk/efo/EFO_0008040,0.8,None
met-c-907,Concentration of medium LDL particles,concentration of medium LDL particles measurement,EFO:0022172,http://www.ebi.ac.uk/efo/EFO_0022172,0.936,None
prot-a-2214,Programmed cell death protein 1,programmed cell death protein 1 measurement,EFO:0801926,http://www.ebi.ac.uk/efo/EFO_0801926,0.91,None
ukb-d-30610_raw,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
prot-a-1622,Vascular endothelial growth factor receptor 2,vascular endothelial growth factor receptor 2 measurement,EFO:0008314,http://www.ebi.ac.uk/efo/EFO_0008314,0.938,None
prot-a-921,Eukaryotic initiation factor 4A-III,eukaryotic initiation factor 4a-III measurement,EFO:0020366,http://www.ebi.ac.uk/efo/EFO_0020366,0.78,None
prot-c-3839_60_2,AIP,autoimmune pancreatitis,MONDO:0015175,http://purl.obolibrary.org/obo/MONDO_0015175,0.999,None
prot-a-1537,Interleukin-5 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.933,None
prot-a-2995,Transmembrane emp24 domain-containing protein 4,transmembrane emp24 domain-containing protein 4 measurement,EFO:0803177,http://www.ebi.ac.uk/efo/EFO_0803177,0.914,None
met-d-L_LDL_L,Total lipids in large LDL,total lipids in large LDL,EFO:0022163,http://www.ebi.ac.uk/efo/EFO_0022163,0.971,None
prot-a-1800,Leucine-rich repeat and transmembrane domain-containing protein 2,leucine-rich repeat and transmembrane domain-containing protein 2 measurement,EFO:0801759,http://www.ebi.ac.uk/efo/EFO_0801759,0.86,None
prot-a-474,Cell division control protein 42 homolog,cell division control protein 42 homolog measurement,EFO:0802384,http://www.ebi.ac.uk/efo/EFO_0802384,0.94,None
prot-a-456,CD63 antigen,CD63 antigen measurement,EFO:0022033,http://www.ebi.ac.uk/efo/EFO_0022033,0.894,None
ebi-a-GCST000922,Openness,openness measurement,EFO:0007914,http://www.ebi.ac.uk/efo/EFO_0007914,0.822,None
prot-a-2023,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 measurement,EFO:0803307,http://www.ebi.ac.uk/efo/EFO_0803307,0.848,None
prot-a-235,B-cell lymphoma/leukemia 10,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.765,None
ukb-b-7323,Energy,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.718,None
ieu-a-300,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-b-28,prolactin,Prolactin-Producing Pituitary Gland Adenoma,EFO:1000496,http://www.ebi.ac.uk/efo/EFO_1000496,0.85,None
prot-c-3797_1_1,Cadherin-2,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.656,None
prot-a-933,RNA polymerase II elongation factor ELL2,RNA polymerase II elongation factor ELL2 measurement,EFO:0803035,http://www.ebi.ac.uk/efo/EFO_0803035,0.945,None
prot-a-1376,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,heparan sulfate glucosamine 3-O-sulfotransferase 3B1 measurement,EFO:0802592,http://www.ebi.ac.uk/efo/EFO_0802592,0.855,None
ubm-a-342,IDP dMRI TBSS L1 Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.605,None
prot-a-2959,Transferrin receptor protein 1,transferrin receptor protein 1 measurement,EFO:0802142,http://www.ebi.ac.uk/efo/EFO_0802142,0.916,None
prot-a-1713,Lactase-phlorizin hydrolase,lactase-phlorizin hydrolase measurement,EFO:0801753,http://www.ebi.ac.uk/efo/EFO_0801753,0.833,None
prot-a-3130,Splicing factor U2AF 65 kDa subunit,splicing factor U2AF 65 kDa subunit measurement,EFO:0803101,http://www.ebi.ac.uk/efo/EFO_0803101,0.95,None
prot-a-126,Apolipoprotein A-V,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.792,None
prot-a-1845,Mitogen-activated protein kinase 1,mitogen-activated protein kinase 1 measurement,EFO:0020574,http://www.ebi.ac.uk/efo/EFO_0020574,0.802,None
prot-c-3580_25_8,a1-Antitrypsin,alpha 1-antitrypsin deficiency,MONDO:0013282,http://purl.obolibrary.org/obo/MONDO_0013282,0.643,None
met-a-475,Indolepropionate,indolepropionate measurement,EFO:0021016,http://www.ebi.ac.uk/efo/EFO_0021016,0.878,None
prot-a-170,Arrestin domain-containing protein 3,arrestin domain-containing protein 3 measurement,EFO:0802289,http://www.ebi.ac.uk/efo/EFO_0802289,0.865,None
prot-a-2895,Sulfatase-modifying factor 1,sulfatase-modifying factor 1 measurement,EFO:0802098,http://www.ebi.ac.uk/efo/EFO_0802098,0.829,None
prot-c-3722_49_2,TNF-a,tumor necrosis factor measurement,EFO:0010834,http://www.ebi.ac.uk/efo/EFO_0010834,0.754,None
prot-a-209,"Beta-1,3-galactosyltransferase 6","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.76,None
prot-a-3051,Tumor necrosis factor receptor superfamily member 4,tumor necrosis factor receptor superfamily member 4 measurement,EFO:0020814,http://www.ebi.ac.uk/efo/EFO_0020814,0.944,None
met-d-XXL_VLDL_PL,Phospholipids in chylomicrons and extremely large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.668,None
met-d-L_LDL_PL_pct,Phospholipids to total lipids ratio in large LDL,total lipids in large LDL,EFO:0022163,http://www.ebi.ac.uk/efo/EFO_0022163,0.776,None
prot-a-1614,Potassium voltage-gated channel subfamily F member 1,potassium voltage-gated channel subfamily F member 1 measurement,EFO:0802890,http://www.ebi.ac.uk/efo/EFO_0802890,0.891,None
ukb-b-6244,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
prot-a-886,"Ectodysplasin-A, secreted form","ectodysplasin-a, secreted form measurement",EFO:0020341,http://www.ebi.ac.uk/efo/EFO_0020341,0.756,None
prot-a-2063,Glycylpeptide N-tetradecanoyltransferase 1,glycylpeptide n-tetradecanoyltransferase 1 measurement,EFO:0020413,http://www.ebi.ac.uk/efo/EFO_0020413,0.872,None
prot-a-304,Complement C1q tumor necrosis factor-related protein 3,complement C1q tumor necrosis factor-related protein 3 measurement,EFO:0802425,http://www.ebi.ac.uk/efo/EFO_0802425,0.887,None
prot-a-461,B-cell antigen receptor complex-associated protein alpha chain,B-cell antigen receptor complex-associated protein alpha chain measurement,EFO:0801402,http://www.ebi.ac.uk/efo/EFO_0801402,0.805,None
met-b-179,CD8:%SCM,diastematomyelia,MONDO:0009106,http://purl.obolibrary.org/obo/MONDO_0009106,0.718,None
prot-a-2137,Ornithine decarboxylase antizyme 1,ornithine decarboxylase antizyme 1 measurement,EFO:0802834,http://www.ebi.ac.uk/efo/EFO_0802834,0.94,None
prot-a-2594,40S ribosomal protein S3a,40S ribosomal protein S3a measurement,EFO:0801333,http://www.ebi.ac.uk/efo/EFO_0801333,0.929,None
prot-a-1921,Matrix metalloproteinase-9,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.921,None
ebi-a-GCST90002325,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,EFO:0004527,http://www.ebi.ac.uk/efo/EFO_0004527,0.988,None
ieu-a-273,Mean cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.978,None
ebi-a-GCST004435,Monokine induced by gamma interferon levels,monokine induced by gamma interferon measurement,EFO:0008236,http://www.ebi.ac.uk/efo/EFO_0008236,0.853,None
prot-a-1325,Protein HEG homolog 1,protein HEG homolog 1 measurement,EFO:0802947,http://www.ebi.ac.uk/efo/EFO_0802947,0.902,None
prot-c-3484_60_2,Angiotensinogen,angiotensinogen measurement,EFO:0008025,http://www.ebi.ac.uk/efo/EFO_0008025,0.871,None
ubm-a-2691,volume CC Central,volume,EFO:0001715,http://www.ebi.ac.uk/efo/EFO_0001715,0.636,None
met-a-548,X-11820,X-11820 measurement,EFO:0021265,http://www.ebi.ac.uk/efo/EFO_0021265,0.695,None
prot-a-1984,Myocardial zonula adherens protein,myocardial zonula adherens protein measurement,EFO:0802769,http://www.ebi.ac.uk/efo/EFO_0802769,0.925,None
met-c-956,Triglycerides in very small VLDL,triglycerides in very small VLDL measurement,EFO:0022144,http://www.ebi.ac.uk/efo/EFO_0022144,0.915,None
ukb-d-30300_irnt,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
ieu-a-1073,Copper,serum copper measurement,EFO:0005267,http://www.ebi.ac.uk/efo/EFO_0005267,0.631,None
prot-a-967,Erythropoietin,erythropoietin,EFO:0003233,http://www.ebi.ac.uk/efo/EFO_0003233,0.993,None
prot-b-54,matrix metallopeptidase 7,matrix metalloproteinase 7 measurement,EFO:0010591,http://www.ebi.ac.uk/efo/EFO_0010591,0.624,None
met-d-S_LDL_TG_pct,Triglycerides to total lipids ratio in small LDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.703,None
prot-a-1701,Linker for activation of T-cells family member 1,linker for activation of T-cells family member 1 measurement,EFO:0802709,http://www.ebi.ac.uk/efo/EFO_0802709,0.827,None
prot-a-1807,Tumor necrosis factor receptor superfamily member 3,tumor necrosis factor receptor superfamily member 3 measurement,EFO:0020813,http://www.ebi.ac.uk/efo/EFO_0020813,0.943,None
prot-a-1934,Myelin protein P0,myelin protein P0 measurement,EFO:0801813,http://www.ebi.ac.uk/efo/EFO_0801813,0.899,None
prot-c-3316_58_1,Heparin cofactor II,heparin cofactor 2 deficiency,MONDO:0012876,http://purl.obolibrary.org/obo/MONDO_0012876,0.854,None
prot-a-2607,Arginine/serine-rich protein 1,arginine/serine-rich protein 1 measurement,EFO:0802286,http://www.ebi.ac.uk/efo/EFO_0802286,0.64,None
prot-a-2050,Nidogen-2,nidogen-1 measurement,EFO:0008249,http://www.ebi.ac.uk/efo/EFO_0008249,0.642,None
prot-a-2515,Regenerating islet-derived protein 4,regenerating islet-derived protein 4 measurement,EFO:0021921,http://www.ebi.ac.uk/efo/EFO_0021921,0.81,None
met-a-514,X-11441,X-11441 measurement,EFO:0021235,http://www.ebi.ac.uk/efo/EFO_0021235,0.69,None
ukb-a-44,Townsend deprivation index at recruitment,Townsend deprivation index,EFO:0009711,http://www.ebi.ac.uk/efo/EFO_0009711,0.806,None
prot-a-3153,Ubiquitin-fold modifier-conjugating enzyme 1,ubiquitin-fold modifier-conjugating enzyme 1 measurement,EFO:0020843,http://www.ebi.ac.uk/efo/EFO_0020843,0.857,None
prot-c-3172_28_2,ARSB,mucopolysaccharidosis type 6,MONDO:0009661,http://purl.obolibrary.org/obo/MONDO_0009661,0.795,None
prot-a-310,Augurin,augurin measurement,EFO:0801399,http://www.ebi.ac.uk/efo/EFO_0801399,0.854,None
prot-a-2991,Toll-like receptor 4:Lymphocyte antigen 96 complex,toll-like receptor 4:Lymphocyte antigen 96 complex measurement,EFO:0008301,http://www.ebi.ac.uk/efo/EFO_0008301,0.768,None
met-b-208,CD4mem:R6+,ring chromosome 6,MONDO:0015440,http://purl.obolibrary.org/obo/MONDO_0015440,0.624,None
prot-a-2507,Retinol-binding protein 4,retinol-binding protein 4 measurement,EFO:0020707,http://www.ebi.ac.uk/efo/EFO_0020707,0.715,None
prot-a-199,Sodium/potassium-transporting ATPase subunit alpha-1,sodium/potassium-transporting ATPase subunit alpha-1 measurement,EFO:0802077,http://www.ebi.ac.uk/efo/EFO_0802077,0.736,None
prot-a-1091,Fibroblast growth factor 19,fibroblast growth factor 19 measurement,EFO:0010782,http://www.ebi.ac.uk/efo/EFO_0010782,0.916,None
met-c-870,Concentration of IDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.714,None
met-c-879,Phospholipids in large HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.909,None
prot-a-2647,Secretoglobin family 1D member 2,secretoglobin family 1D member 2 measurement,EFO:0803046,http://www.ebi.ac.uk/efo/EFO_0803046,0.936,None
prot-a-2101,Neurensin-1,neurensin-1 measurement,EFO:0801828,http://www.ebi.ac.uk/efo/EFO_0801828,0.626,None
prot-a-2598,40S ribosomal protein SA,40s ribosomal protein SA measurement,EFO:0020119,http://www.ebi.ac.uk/efo/EFO_0020119,0.906,None
ukb-b-11303,Father's age at death,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.835,None
prot-a-119,Protein APCDD1,protein APCDD1 measurement,EFO:0802924,http://www.ebi.ac.uk/efo/EFO_0802924,0.911,None
prot-a-1401,Intercellular adhesion molecule 5,intercellular adhesion molecule 5 measurement,EFO:0008164,http://www.ebi.ac.uk/efo/EFO_0008164,0.931,None
prot-a-1526,Interleukin-36 alpha,interleukin 1 alpha measurement,EFO:0009412,http://www.ebi.ac.uk/efo/EFO_0009412,0.752,None
ieu-a-71,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-389,C-C motif chemokine 13,CCL13 measurement,EFO:0009411,http://www.ebi.ac.uk/efo/EFO_0009411,0.739,None
ieu-b-4901,Anti-Epstein-Barr virus IgG levels,Epstein-Barr virus infection,EFO:0000769,http://www.ebi.ac.uk/efo/EFO_0000769,0.705,None
ukb-d-30880_irnt,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ebi-a-GCST90010312,"Fructose-1,6-bisphosphatase 1 levels","fructose-1,6-bisphosphatase 1 measurement",EFO:0801606,http://www.ebi.ac.uk/efo/EFO_0801606,0.645,None
prot-a-3224,WAP four-disulfide core domain protein 2,WAP four-disulfide core domain protein 2 measurement,EFO:0803263,http://www.ebi.ac.uk/efo/EFO_0803263,0.851,None
prot-a-1752,Lipase member K,lipase member K measurement,EFO:0802711,http://www.ebi.ac.uk/efo/EFO_0802711,0.885,None
prot-a-262,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 measurement,EFO:0802304,http://www.ebi.ac.uk/efo/EFO_0802304,0.816,None
ieu-a-64,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
ukb-a-19,Exposure to tobacco smoke at home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.831,None
prot-a-502,Carcinoembryonic antigen-related cell adhesion molecule 1,carcinoembryonic antigen-related cell adhesion molecule 1 measurement,EFO:0801456,http://www.ebi.ac.uk/efo/EFO_0801456,0.9,None
prot-a-1645,Killer cell immunoglobulin-like receptor 2DS2,killer cell immunoglobulin-like receptor 2DS2 measurement,EFO:0801746,http://www.ebi.ac.uk/efo/EFO_0801746,0.91,None
met-a-601,ADpSGEGDFXAEGGGVR*,ADpSGEGDFXAEGGGVR measurement,EFO:0021134,http://www.ebi.ac.uk/efo/EFO_0021134,0.959,None
prot-a-1360,Hepatocyte nuclear factor 4-alpha,hepatocyte nuclear factor 1-alpha measurement,EFO:0802596,http://www.ebi.ac.uk/efo/EFO_0802596,0.818,None
prot-c-2960_66_2,Properdin,properdin measurement,EFO:0008269,http://www.ebi.ac.uk/efo/EFO_0008269,0.799,None
ebi-a-GCST90010286,Arginase-1 levels,Argininemia,ORPHANET.ORDO:90,http://www.orpha.net/ORDO/Orphanet_90,0.601,None
prot-a-215,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 measurement",EFO:0802184,http://www.ebi.ac.uk/efo/EFO_0802184,0.721,None
met-a-554,X-11852,X-11852 measurement,EFO:0021271,http://www.ebi.ac.uk/efo/EFO_0021271,0.7,None
prot-a-701,Cysteine and glycine-rich protein 3,cysteine and glycine-rich protein 3 measurement,EFO:0022027,http://www.ebi.ac.uk/efo/EFO_0022027,0.801,None
ukb-d-12340_irnt,QRS duration,QRS duration,EFO:0005055,http://www.ebi.ac.uk/efo/EFO_0005055,0.992,None
ebi-a-GCST90006915,Helicobacter pylori UREA antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.675,None
ebi-a-GCST90002051,CD45 on basophil,basophil adenoma,EFO:1000834,http://www.ebi.ac.uk/efo/EFO_1000834,0.681,None
met-b-157,CD27 on CD8 T,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.649,None
met-d-M_LDL_L,Total lipids in medium LDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.972,None
met-d-XL_HDL_FC,Free cholesterol in very large HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.851,None
prot-a-2997,Transmembrane protein 132A,transmembrane protein 132A measurement,EFO:0802150,http://www.ebi.ac.uk/efo/EFO_0802150,0.933,None
ieu-a-1072,Sitting height ratio,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.993,None
prot-a-395,C-C motif chemokine 19,CCL19 measurement,EFO:0009415,http://www.ebi.ac.uk/efo/EFO_0009415,0.744,None
prot-a-2355,Protein regulator of cytokinesis 1,protein regulator of cytokinesis 1 measurement,EFO:0802959,http://www.ebi.ac.uk/efo/EFO_0802959,0.917,None
prot-a-3150,UBX domain-containing protein 4,UBX domain-containing protein 4 measurement,EFO:0803219,http://www.ebi.ac.uk/efo/EFO_0803219,0.879,None
prot-a-2682,Semenogelin-2,semenogelin-1 measurement,EFO:0802051,http://www.ebi.ac.uk/efo/EFO_0802051,0.732,None
prot-a-2732,Tyrosine-protein phosphatase non-receptor type substrate 1,tyrosine-protein phosphatase non-receptor type substrate 1 measurement,EFO:0802175,http://www.ebi.ac.uk/efo/EFO_0802175,0.841,None
prot-a-1453,Insulin growth factor-like family member 3,insulin growth factor-like family member 3 measurement,EFO:0801700,http://www.ebi.ac.uk/efo/EFO_0801700,0.87,None
ukb-a-21,Number of self-reported cancers,"number of cancers, self-reported",EFO:0009800,http://www.ebi.ac.uk/efo/EFO_0009800,0.808,None
prot-a-1927,Multiple PDZ domain protein,multiple PDZ domain protein measurement,EFO:0802763,http://www.ebi.ac.uk/efo/EFO_0802763,0.919,None
prot-a-2020,Protein NDRG4,protein NDRG4 measurement,EFO:0801954,http://www.ebi.ac.uk/efo/EFO_0801954,0.897,None
prot-a-995,Protein eva-1 homolog C,protein eva-1 homolog C measurement,EFO:0801942,http://www.ebi.ac.uk/efo/EFO_0801942,0.731,None
ieu-a-111,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ebi-a-GCST90001638,CD4-CD8- Natural Killer T %lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.623,None
prot-a-710,Cardiotrophin-1,cardiotrophin-1 measurement,EFO:0020235,http://www.ebi.ac.uk/efo/EFO_0020235,0.71,None
prot-a-3081,Tumor protein p53-inducible protein 11,tumor protein p53-inducible protein 11 measurement,EFO:0802169,http://www.ebi.ac.uk/efo/EFO_0802169,0.846,None
prot-a-2728,Sialic acid-binding Ig-like lectin 14,sialic acid-binding Ig-like lectin 14 measurement,EFO:0008284,http://www.ebi.ac.uk/efo/EFO_0008284,0.69,None
prot-a-2634,Secretory carrier-associated membrane protein 5,secretory carrier-associated membrane protein 5 measurement,EFO:0803049,http://www.ebi.ac.uk/efo/EFO_0803049,0.872,None
prot-a-429,CD226 antigen,CD226 antigen measurement,EFO:0020246,http://www.ebi.ac.uk/efo/EFO_0020246,0.899,None
prot-a-3188,Vesicle-associated membrane protein 8,vesicle-associated membrane protein 8 measurement,EFO:0803254,http://www.ebi.ac.uk/efo/EFO_0803254,0.846,None
ebi-a-GCST90000464,DNER levels,delta/notch like EGF Repeat Containing protein measurement,EFO:0010781,http://www.ebi.ac.uk/efo/EFO_0010781,0.734,None
ebi-a-GCST005058,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
ieu-a-1,Adiponectin,adiponectin measurement,EFO:0004502,http://www.ebi.ac.uk/efo/EFO_0004502,0.84,None
prot-a-945,Gamma-enolase,gamma-enolase measurement,EFO:0021845,http://www.ebi.ac.uk/efo/EFO_0021845,0.629,None
met-d-Lactate,Lactate,lactate measurement,EFO:0007745,http://www.ebi.ac.uk/efo/EFO_0007745,0.753,None
prot-a-1400,Intercellular adhesion molecule 4,intercellular adhesion molecule 4 measurement,EFO:0801708,http://www.ebi.ac.uk/efo/EFO_0801708,0.931,None
ebi-a-GCST90006918,Herpes simplex virus 1 mgG-1 antibody levels,Anti-herpes simplex virus 1 IgG measurement,EFO:0009349,http://www.ebi.ac.uk/efo/EFO_0009349,0.604,None
prot-c-4915_64_2,Hemoglobin,Hemoglobin A Measurement,EFO:0009208,http://www.ebi.ac.uk/efo/EFO_0009208,0.937,None
prot-a-986,Endogenous retrovirus group V member 1 Env polyprotein,endogenous retrovirus group V member 1 Env polyprotein measurement,EFO:0801565,http://www.ebi.ac.uk/efo/EFO_0801565,0.959,None
prot-a-1134,Glutamate carboxypeptidase 2,glutamate carboxypeptidase 2 measurement,EFO:0020408,http://www.ebi.ac.uk/efo/EFO_0020408,0.927,None
ebi-a-GCST90001819,CD38 on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.703,None
prot-c-2788_55_1,MMP-3,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.932,None
ebi-a-GCST90017136,Neck circumference (BMI adjusted),BMI-adjusted neck circumference,EFO:0011044,http://www.ebi.ac.uk/efo/EFO_0011044,0.871,None
prot-a-101,Ankyrin-2,ankyrin-2 measurement,EFO:0021874,http://www.ebi.ac.uk/efo/EFO_0021874,0.703,None
prot-a-2029,Neuronal growth regulator 1,neuronal growth regulator 1 measurement,EFO:0021932,http://www.ebi.ac.uk/efo/EFO_0021932,0.901,None
prot-a-1612,Potassium voltage-gated channel subfamily E regulatory beta subunit 5,potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement,EFO:0801902,http://www.ebi.ac.uk/efo/EFO_0801902,0.914,None
prot-c-2358_19_2,VEGF sR3,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.671,None
ebi-a-GCST90012039,Chitinase-3-like protein 1 levels,YKL40 measurement,EFO:0004869,http://www.ebi.ac.uk/efo/EFO_0004869,0.771,None
ebi-a-GCST004616,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
ukb-d-30640_raw,Apoliprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.673,None
ukb-b-11842,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
prot-a-157,Rho guanine nucleotide exchange factor 25,rho guanine nucleotide exchange factor 25 measurement,EFO:0803019,http://www.ebi.ac.uk/efo/EFO_0803019,0.952,None
ebi-a-GCST90014267,Ganglion cell inner plexiform layer (GCIPL) thickness,ganglion cell inner plexiform layer thickness measurement,EFO:0600005,http://www.ebi.ac.uk/efo/EFO_0600005,0.835,None
prot-a-564,Cytoskeleton-associated protein 2,cytoskeleton-associated protein 2 measurement,EFO:0020309,http://www.ebi.ac.uk/efo/EFO_0020309,0.843,None
ieu-a-1099,Serum creatinine (eGFRcrea),creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.634,None
prot-a-2589,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement,EFO:0801544,http://www.ebi.ac.uk/efo/EFO_0801544,0.859,None
prot-a-2011,Noncompact myelin-associated protein,noncompact myelin-associated protein measurement,EFO:0802818,http://www.ebi.ac.uk/efo/EFO_0802818,0.859,None
prot-a-1579,IST1 homolog,IST1 homolog measurement,EFO:0801736,http://www.ebi.ac.uk/efo/EFO_0801736,0.883,None
prot-a-2821,Serine protease inhibitor Kazal-type 8,serine protease inhibitor Kazal-type 8 measurement,EFO:0803059,http://www.ebi.ac.uk/efo/EFO_0803059,0.866,None
prot-a-3025,Enteropeptidase,enteropeptidase measurement,EFO:0020349,http://www.ebi.ac.uk/efo/EFO_0020349,0.871,None
prot-a-1149,Ferritin,ferritin measurement,EFO:0004459,http://www.ebi.ac.uk/efo/EFO_0004459,0.806,None
prot-a-1060,Fetal and adult testis-expressed transcript protein,fetal and adult testis-expressed transcript protein measurement,EFO:0802547,http://www.ebi.ac.uk/efo/EFO_0802547,0.854,None
prot-a-926,Eukaryotic translation initiation factor 5,eukaryotic translation initiation factor 5 measurement,EFO:0020369,http://www.ebi.ac.uk/efo/EFO_0020369,0.944,None
prot-a-1766,Leucine-rich repeat and calponin homology domain-containing protein 4,leucine-rich repeat and calponin homology domain-containing protein 4 measurement,EFO:0802688,http://www.ebi.ac.uk/efo/EFO_0802688,0.873,None
prot-a-528,Follicle stimulating hormone,follicle stimulating hormone,EFO:0003234,http://www.ebi.ac.uk/efo/EFO_0003234,0.992,None
ebi-a-GCST90002404,Red cell distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
prot-a-3139,Ubiquitin-conjugating enzyme E2 J1,ubiquitin-conjugating enzyme E2 J1 measurement,EFO:0803215,http://www.ebi.ac.uk/efo/EFO_0803215,0.914,None
prot-a-355,Calpain-3,autosomal recessive limb-girdle muscular dystrophy type 2A,MONDO:0009675,http://purl.obolibrary.org/obo/MONDO_0009675,0.738,None
met-d-S_HDL_CE_pct,Cholesteryl esters to total lipids ratio in small HDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.711,None
prot-a-2629,Diamine acetyltransferase 2,diamine acetyltransferase 2 measurement,EFO:0802465,http://www.ebi.ac.uk/efo/EFO_0802465,0.919,None
met-d-XL_HDL_L,Total lipids in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.892,None
prot-a-3216,Brorin,brorin measurement,EFO:0801432,http://www.ebi.ac.uk/efo/EFO_0801432,0.759,None
prot-a-1452,Insulin-like growth factor-binding protein-like 1,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.788,None
ukb-b-10831,Pack years of smoking,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.606,None
prot-a-31,A disintegrin and metalloproteinase with thrombospondin motifs 1,a disintegrin and metalloproteinase with thrombospondin motifs 1 measurement,EFO:0021968,http://www.ebi.ac.uk/efo/EFO_0021968,0.942,None
ebi-a-GCST90001620,HLA DR+ T cell%lymphocyte,T-cell immunodeficiency,MONDO:0003780,http://purl.obolibrary.org/obo/MONDO_0003780,0.616,None
prot-c-2670_67_4,CK-MM,Miyoshi myopathy,MONDO:0009685,http://purl.obolibrary.org/obo/MONDO_0009685,0.685,None
prot-a-359,Cocaine- and amphetamine-regulated transcript protein,cocaine- and amphetamine-regulated transcript protein measurement,EFO:0802409,http://www.ebi.ac.uk/efo/EFO_0802409,0.813,None
prot-a-26,Disintegrin and metalloproteinase domain-containing protein 12,disintegrin and metalloproteinase domain-containing protein 12 measurement,EFO:0020328,http://www.ebi.ac.uk/efo/EFO_0020328,0.911,None
met-d-IDL_CE,Cholesteryl esters in IDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.776,None
met-b-137,MDC (2):%CD1c-,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.685,None
ebi-a-GCST90000483,Monocyte chemoattractant protein-1 levels,CCL2 measurement,EFO:0004749,http://www.ebi.ac.uk/efo/EFO_0004749,0.809,None
prot-a-1636,Kinesin-like protein KIF1C,kinesin-like protein KIF1C measurement,EFO:0802679,http://www.ebi.ac.uk/efo/EFO_0802679,0.872,None
prot-c-5031_10_1,SPTA2,autosomal dominant osteopetrosis 2,MONDO:0008156,http://purl.obolibrary.org/obo/MONDO_0008156,0.678,None
prot-a-2347,Protein phosphatase 1 regulatory subunit 3B,protein phosphatase 1 regulatory subunit 3B measurement,EFO:0802956,http://www.ebi.ac.uk/efo/EFO_0802956,0.941,None
prot-a-333,Carbonic anhydrase 6,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.94,None
ukb-b-11480,Corneal hysteresis (right),corneal hysteresis,EFO:0010066,http://www.ebi.ac.uk/efo/EFO_0010066,0.879,None
prot-a-512,Centrosomal protein of 57 kDa,centrosomal protein of 57 kDa measurement,EFO:0801465,http://www.ebi.ac.uk/efo/EFO_0801465,0.91,None
prot-a-2583,Nuclear receptor ROR-beta,nuclear receptor ROR-beta measurement,EFO:0802823,http://www.ebi.ac.uk/efo/EFO_0802823,0.783,None
prot-a-866,Desmocollin-2,desmocollin-2 measurement,EFO:0021936,http://www.ebi.ac.uk/efo/EFO_0021936,0.724,None
ebi-a-GCST90001435,Plasma Blast-Plasma Cell %lymphocyte,lymphoid neoplasm,EFO:0001642,http://www.ebi.ac.uk/efo/EFO_0001642,0.767,None
prot-a-1678,Importin subunit alpha-3,importin subunit alpha-1 measurement,EFO:0020467,http://www.ebi.ac.uk/efo/EFO_0020467,0.778,None
prot-a-2405,Pregnancy-specific beta-1-glycoprotein 6,pregnancy-specific beta-1-glycoprotein 6 measurement,EFO:0802897,http://www.ebi.ac.uk/efo/EFO_0802897,0.694,None
prot-c-4883_56_2,Insulin,pancreatic insulinoma,MONDO:0024677,http://purl.obolibrary.org/obo/MONDO_0024677,0.845,None
ebi-a-GCST004612,High light scatter reticulocyte percentage of red cells,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.915,None
prot-a-23,Serine/threonine-protein kinase receptor R3,serine/threonine-protein kinase receptor R3 measurement,EFO:0020733,http://www.ebi.ac.uk/efo/EFO_0020733,0.775,None
prot-a-3144,Ubiquitin-conjugating enzyme E2 T,ubiquitin-conjugating enzyme E2 T measurement,EFO:0803217,http://www.ebi.ac.uk/efo/EFO_0803217,0.903,None
prot-a-2926,Tapasin,tapasin measurement,EFO:0802118,http://www.ebi.ac.uk/efo/EFO_0802118,0.8,None
prot-a-2676,Semaphorin-5A,semaphorin-5A measurement,EFO:0021864,http://www.ebi.ac.uk/efo/EFO_0021864,0.627,None
prot-a-2977,Thymocyte nuclear protein 1,thymocyte nuclear protein 1 measurement,EFO:0802132,http://www.ebi.ac.uk/efo/EFO_0802132,0.905,None
met-d-XL_HDL_PL_pct,Phospholipids to total lipids ratio in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.751,None
met-a-656,"Bradykinin, des-arg(9)","bradykinin, des-arg 9 measurement",EFO:0021146,http://www.ebi.ac.uk/efo/EFO_0021146,0.764,None
prot-a-2352,Pancreatic hormone,pancreatic hormone measurement,EFO:0020621,http://www.ebi.ac.uk/efo/EFO_0020621,0.866,None
ukb-a-20,Exposure to tobacco smoke outside home,tobacco smoke exposure measurement,EFO:0009115,http://www.ebi.ac.uk/efo/EFO_0009115,0.733,None
prot-a-222,Transcription regulator protein BACH1,transcription regulator protein BACH1 measurement,EFO:0802141,http://www.ebi.ac.uk/efo/EFO_0802141,0.94,None
prot-a-1059,"Tumor necrosis factor ligand superfamily member 6, soluble form","tumor necrosis factor ligand superfamily member 6, soluble form measurement",EFO:0020797,http://www.ebi.ac.uk/efo/EFO_0020797,0.897,None
ukb-d-30850_irnt,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
prot-a-557,Carbohydrate sulfotransferase 5,carbohydrate sulfotransferase 5 measurement,EFO:0802368,http://www.ebi.ac.uk/efo/EFO_0802368,0.935,None
ieu-a-50,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-2652,Sodium channel subunit beta-2,sodium channel subunit beta-2 measurement,EFO:0803085,http://www.ebi.ac.uk/efo/EFO_0803085,0.831,None
prot-a-651,Cellular retinoic acid-binding protein 2,cellular retinoic acid-binding protein 2 measurement,EFO:0802386,http://www.ebi.ac.uk/efo/EFO_0802386,0.819,None
met-a-643,X-12717,GM12717,EFO:0001148,http://www.ebi.ac.uk/efo/EFO_0001148,0.731,None
prot-a-1485,Interleukin-17F,interleukin-17F measurement,EFO:0021963,http://www.ebi.ac.uk/efo/EFO_0021963,0.766,None
met-a-566,X-12038,X-12038 measurement,EFO:0021279,http://www.ebi.ac.uk/efo/EFO_0021279,0.699,None
ebi-a-GCST90010106,Angiopoietin-1 levels,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.661,None
prot-c-3474_19_2,Thrombospondin-1,thrombospondin-1 measurement,EFO:0020770,http://www.ebi.ac.uk/efo/EFO_0020770,0.738,None
prot-a-1575,Insulin gene enhancer protein ISL-1,insulin gene enhancer protein ISL-1 measurement,EFO:0802628,http://www.ebi.ac.uk/efo/EFO_0802628,0.759,None
bbj-a-30,Lactate dehydrogenase,glycogen storage disease due to lactate dehydrogenase deficiency,MONDO:0016527,http://purl.obolibrary.org/obo/MONDO_0016527,0.869,None
prot-a-2192,Pterin-4-alpha-carbinolamine dehydratase 2,pterin-4 alpha-carbinolamine dehydratase 1 deficiency,MONDO:0009908,http://purl.obolibrary.org/obo/MONDO_0009908,0.774,None
ebi-a-GCST004454,Interleukin-2 receptor antagonist levels,interleukin 2 receptor antagonist measurement,EFO:0008332,http://www.ebi.ac.uk/efo/EFO_0008332,0.862,None
prot-a-439,Myeloid cell surface antigen CD33,myeloid cell surface antigen CD33 measurement,EFO:0008238,http://www.ebi.ac.uk/efo/EFO_0008238,0.931,None
met-a-733,X-14745,X-14745 measurement,EFO:0021378,http://www.ebi.ac.uk/efo/EFO_0021378,0.712,None
prot-a-2384,Pre-mRNA-processing factor 6,pre-mRNA-processing factor 6 measurement,EFO:0802894,http://www.ebi.ac.uk/efo/EFO_0802894,0.641,None
ebi-a-GCST006478,Worry,worry measurement,EFO:0009589,http://www.ebi.ac.uk/efo/EFO_0009589,0.814,None
prot-a-743,C-X-C motif chemokine 13,CCL13 measurement,EFO:0009411,http://www.ebi.ac.uk/efo/EFO_0009411,0.721,None
prot-a-179,Neutral ceramidase,neutral ceramidase measurement,EFO:0008247,http://www.ebi.ac.uk/efo/EFO_0008247,0.881,None
prot-a-469,Complement component C1q receptor,complement component C1q receptor measurement,EFO:0802427,http://www.ebi.ac.uk/efo/EFO_0802427,0.959,None
met-d-XL_HDL_P,Concentration of very large HDL particles,concentration of large HDL particles measurement,EFO:0022188,http://www.ebi.ac.uk/efo/EFO_0022188,0.871,None
prot-a-1486,Interleukin-17 receptor A,interleukin 17 receptor A measurement,EFO:0008175,http://www.ebi.ac.uk/efo/EFO_0008175,0.909,None
prot-c-4851_25_1,IL-1a,autoimmune type 1 diabetes,EFO:0009756,http://www.ebi.ac.uk/efo/EFO_0009756,0.696,None
ebi-a-GCST006359,IgM levels,serum IgM measurement,EFO:0004993,http://www.ebi.ac.uk/efo/EFO_0004993,0.976,None
prot-a-3040,Tumor necrosis factor receptor superfamily member 12A,tumor necrosis factor receptor superfamily member 12A measurement,EFO:0020802,http://www.ebi.ac.uk/efo/EFO_0020802,0.949,None
prot-a-2012,Nuclear receptor coactivator 2,nuclear receptor coactivator 2 measurement,EFO:0801852,http://www.ebi.ac.uk/efo/EFO_0801852,0.927,None
prot-a-788,Beta-defensin 112,beta-defensin 112 measurement,EFO:0801418,http://www.ebi.ac.uk/efo/EFO_0801418,0.761,None
met-a-442,X-10500,X-10500 measurement,EFO:0021215,http://www.ebi.ac.uk/efo/EFO_0021215,0.669,None
ebi-a-GCST90010145,Interleukin-4 receptor subunit alpha levels,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.836,None
ebi-a-GCST90002412,Low density lipoprotein cholesterol levels,low density lipoprotein cholesterol measurement,EFO:0004611,http://www.ebi.ac.uk/efo/EFO_0004611,0.862,None
prot-a-2429,Parathyroid hormone/parathyroid hormone-related peptide receptor,parathyroid hormone/parathyroid hormone-related peptide receptor measurement,EFO:0802847,http://www.ebi.ac.uk/efo/EFO_0802847,0.876,None
ukb-b-20124,"Heel bone mineral density (BMD) T-score, automated",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.695,None
ebi-a-GCST90010157,Poly [ADP-ribose] polymerase 1 levels,poly [ADP-ribose] polymerase 1 measurement,EFO:0802876,http://www.ebi.ac.uk/efo/EFO_0802876,0.644,None
bbj-a-21,Fractional shortening,fractional shortening,EFO:0009285,http://www.ebi.ac.uk/efo/EFO_0009285,0.994,None
prot-a-656,Protein CREG1,protein CREG1 measurement,EFO:0801937,http://www.ebi.ac.uk/efo/EFO_0801937,0.875,None
ebi-a-GCST90010184,Tumor necrosis factor receptor superfamily member 13B levels,tumor necrosis factor receptor superfamily member 13B measurement,EFO:0020803,http://www.ebi.ac.uk/efo/EFO_0020803,0.913,None
prot-a-498,Cerebral dopamine neurotrophic factor,cerebral dopamine neurotrophic factor measurement,EFO:0020254,http://www.ebi.ac.uk/efo/EFO_0020254,0.921,None
prot-c-4496_60_2,MMP-12,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.841,None
met-a-400,Glycylvaline,glycylvaline measurement,EFO:0021129,http://www.ebi.ac.uk/efo/EFO_0021129,0.877,None
prot-a-2936,T-box transcription factor TBX5,t-box transcription factor TBX5 measurement,EFO:0803129,http://www.ebi.ac.uk/efo/EFO_0803129,0.851,None
prot-a-1784,Leucine-rich repeat-containing protein 15,leucine-rich repeat-containing protein 15 measurement,EFO:0801761,http://www.ebi.ac.uk/efo/EFO_0801761,0.788,None
prot-a-930,ETS domain-containing protein Elk-1,ETS domain-containing protein Elk-1 measurement,EFO:0801587,http://www.ebi.ac.uk/efo/EFO_0801587,0.751,None
prot-a-3202,Charged multivesicular body protein 3,charged multivesicular body protein 3 measurement,EFO:0801469,http://www.ebi.ac.uk/efo/EFO_0801469,0.927,None
ebi-a-GCST90012032,Growth hormone levels,growth hormone measurement,EFO:0008438,http://www.ebi.ac.uk/efo/EFO_0008438,0.756,None
prot-c-3390_72_2,PIK3CA/PIK3R1,PIK3CA/PIK3R1 measurement,EFO:0021971,http://www.ebi.ac.uk/efo/EFO_0021971,0.826,None
met-d-S_VLDL_C,Cholesterol in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.89,None
met-a-617,N-acetylthreonine,N-acetylthreonine measurement,EFO:0800020,http://www.ebi.ac.uk/efo/EFO_0800020,0.764,None
prot-a-1986,Myocardial zonula adherens protein,myocardial zonula adherens protein measurement,EFO:0802769,http://www.ebi.ac.uk/efo/EFO_0802769,0.925,None
prot-c-5317_3_3,CD70,CD70 antigen measurement,EFO:0020249,http://www.ebi.ac.uk/efo/EFO_0020249,0.732,None
prot-a-2163,Polyadenylate-binding protein 3,polyadenylate-binding protein 3 measurement,EFO:0801896,http://www.ebi.ac.uk/efo/EFO_0801896,0.824,None
ebi-a-GCST90002284,Facial pigmentation measurement (polar light),facial pigmentation measurement,EFO:0006942,http://www.ebi.ac.uk/efo/EFO_0006942,0.862,None
ukb-b-4657,Heel bone mineral density (BMD) (right),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.808,None
ukb-b-9405,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-649,Carboxypeptidase Z,carboxypeptidase Z measurement,EFO:0801455,http://www.ebi.ac.uk/efo/EFO_0801455,0.909,None
prot-a-2595,"40S ribosomal protein S4, X isoform","40S ribosomal protein S4, X isoform measurement",EFO:0801334,http://www.ebi.ac.uk/efo/EFO_0801334,0.84,None
ebi-a-GCST90001460,Plasmacytoid Dendritic Cell Absolute Count,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.748,None
ieu-b-108,apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
prot-a-2295,Putative phospholipase B-like 2,putative phospholipase B-like 2 measurement,EFO:0802982,http://www.ebi.ac.uk/efo/EFO_0802982,0.814,None
ieu-a-1050,Ferritin,ferritin measurement,EFO:0004459,http://www.ebi.ac.uk/efo/EFO_0004459,0.806,None
prot-a-1849,Mitogen-activated protein kinase 8,mitogen-activated protein kinase 8 measurement,EFO:0020580,http://www.ebi.ac.uk/efo/EFO_0020580,0.807,None
prot-a-2387,Transmembrane gamma-carboxyglutamic acid protein 1,transmembrane gamma-carboxyglutamic acid protein 1 measurement,EFO:0802147,http://www.ebi.ac.uk/efo/EFO_0802147,0.891,None
ieu-b-4855,FEV1/FVC,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.709,None
ebi-a-GCST90001870,CD34 on Hematopoietic Stem Cell,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.718,None
ieu-b-4870,Sex hormone binding globulin (SHBG),sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.846,None
prot-a-1070,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor measurement,EFO:0802598,http://www.ebi.ac.uk/efo/EFO_0802598,0.965,None
ebi-a-GCST90000488,Matrix metalloproteinase-10 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.836,None
ebi-a-GCST90013452,Emotional lability,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.992,None
met-d-L_LDL_C,Cholesterol in large LDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.888,None
prot-a-2415,26S proteasome non-ATPase regulatory subunit 11,26S proteasome non-ATPase regulatory subunit 11 measurement,EFO:0802234,http://www.ebi.ac.uk/efo/EFO_0802234,0.891,None
prot-a-143,ADP-ribosylation factor 6,ADP-ribosylation factor 6 measurement,EFO:0801350,http://www.ebi.ac.uk/efo/EFO_0801350,0.769,None
prot-a-139,Amyloid beta A4 protein,amyloid beta A4 protein measurement,EFO:0020145,http://www.ebi.ac.uk/efo/EFO_0020145,0.905,None
prot-a-95,Angiopoietin-4,angiopoietin-1 measurement,EFO:0020146,http://www.ebi.ac.uk/efo/EFO_0020146,0.734,None
met-b-135,MDC:%CD1c+,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.704,None
ebi-a-GCST90010167,Receptor for advanced glycosylation end products levels,advanced glycosylation end product-specific receptor ligand measurement,EFO:0010762,http://www.ebi.ac.uk/efo/EFO_0010762,0.715,None
met-a-613,X-12456,X-12456 measurement,EFO:0021311,http://www.ebi.ac.uk/efo/EFO_0021311,0.706,None
prot-a-3267,Zinc finger protein 276,zinc finger protein 276 measurement,EFO:0802227,http://www.ebi.ac.uk/efo/EFO_0802227,0.926,None
prot-a-2984,"Thymidine kinase, cytosolic","thymidine kinase, cytosolic measurement",EFO:0020773,http://www.ebi.ac.uk/efo/EFO_0020773,0.858,None
ebi-a-GCST005847,Heart rate response to recovery post exercise (20 sec),heart rate response to recovery post exercise,EFO:0009185,http://www.ebi.ac.uk/efo/EFO_0009185,0.923,None
prot-a-1005,Coagulation factor Xa,coagulation factor XA measurement,EFO:0020266,http://www.ebi.ac.uk/efo/EFO_0020266,0.9,None
met-a-751,Palmitoyl sphingomyelin,palmitoyl sphingomyelin (d18:1/16:0) measurement,EFO:0800300,http://www.ebi.ac.uk/efo/EFO_0800300,0.658,None
prot-a-1834,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase","endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase measurement",EFO:0801568,http://www.ebi.ac.uk/efo/EFO_0801568,0.803,None
prot-a-2224,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a measurement",EFO:0020446,http://www.ebi.ac.uk/efo/EFO_0020446,0.778,None
ieu-b-70,Breast cancer,breast cancer,MONDO:0007254,http://purl.obolibrary.org/obo/MONDO_0007254,0.987,None
prot-a-1916,Matrix metalloproteinase-16,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.882,None
prot-a-2947,Calcineurin B homologous protein 3,calcineurin B homologous protein 3 measurement,EFO:0802354,http://www.ebi.ac.uk/efo/EFO_0802354,0.921,None
prot-a-909,Epidermal growth factor receptor,epidermal growth factor receptor measurement,EFO:0020359,http://www.ebi.ac.uk/efo/EFO_0020359,0.916,None
prot-c-2915_6_2,PCNA,cutaneous nodular amyloidosis,EFO:1001882,http://www.ebi.ac.uk/efo/EFO_1001882,0.993,None
prot-a-1399,Intercellular adhesion molecule 3,intercellular adhesion molecule 3 measurement,EFO:0020482,http://www.ebi.ac.uk/efo/EFO_0020482,0.931,None
prot-c-3180_46_2,Cathepsin D,cathepsin D measurement,EFO:0010611,http://www.ebi.ac.uk/efo/EFO_0010611,0.835,None
prot-a-3163,Serine/threonine-protein kinase ULK3,serine/threonine-protein kinase ULK3 measurement,EFO:0803065,http://www.ebi.ac.uk/efo/EFO_0803065,0.776,None
met-d-L_VLDL_PL,Phospholipids in large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.913,None
ebi-a-GCST90010258,E-selectin levels,e-selectin measurement,EFO:0004575,http://www.ebi.ac.uk/efo/EFO_0004575,0.711,None
ebi-a-GCST90002350,Neutrophil count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.978,None
met-d-Tyr,Tyrosine,Hypertyrosinemia,HP:0003231,http://purl.obolibrary.org/obo/HP_0003231,0.791,None
prot-a-2287,Putative inactive group IIC secretory phospholipase A2,putative inactive group IIC secretory phospholipase A2 measurement,EFO:0802981,http://www.ebi.ac.uk/efo/EFO_0802981,0.955,None
prot-a-1037,Protein FAM177A1,protein FAM177A1 measurement,EFO:0801948,http://www.ebi.ac.uk/efo/EFO_0801948,0.93,None
prot-a-2064,Noggin,noggin measurement,EFO:0021995,http://www.ebi.ac.uk/efo/EFO_0021995,0.854,None
prot-a-351,Cullin-associated NEDD8-dissociated protein 1,cullin-associated NEDD8-dissociated protein 1 measurement,EFO:0802438,http://www.ebi.ac.uk/efo/EFO_0802438,0.837,None
ebi-a-GCST006699,Parental longevity (mother's age at death),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.725,None
prot-a-472,M-phase inducer phosphatase 2,m-phase inducer phosphatase 2 measurement,EFO:0801780,http://www.ebi.ac.uk/efo/EFO_0801780,0.751,None
ukb-d-30690_irnt,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
prot-a-2315,Inactive pancreatic lipase-related protein 1,inactive pancreatic lipase-related protein 1 measurement,EFO:0801693,http://www.ebi.ac.uk/efo/EFO_0801693,0.858,None
prot-a-2940,Teratocarcinoma-derived growth factor 1,teratocarcinoma-derived growth factor 1 measurement,EFO:0008297,http://www.ebi.ac.uk/efo/EFO_0008297,0.829,None
prot-a-1046,Glycosaminoglycan xylosylkinase,glycosaminoglycan xylosylkinase measurement,EFO:0801647,http://www.ebi.ac.uk/efo/EFO_0801647,0.944,None
met-a-309,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
prot-c-5272_55_2,SHC1,thrombocytopenia 1,MONDO:0010743,http://purl.obolibrary.org/obo/MONDO_0010743,0.603,None
prot-c-2609_59_2,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
prot-a-601,Nuclear envelope phosphatase-regulatory subunit 1,nuclear envelope phosphatase-regulatory subunit 1 measurement,EFO:0802819,http://www.ebi.ac.uk/efo/EFO_0802819,0.9,None
met-a-736,Leucylleucine,leucylleucine measurement,EFO:0021130,http://www.ebi.ac.uk/efo/EFO_0021130,0.917,None
prot-a-910,Epidermal growth factor receptor variant III,epidermal growth factor receptor measurement,EFO:0020359,http://www.ebi.ac.uk/efo/EFO_0020359,0.767,None
ebi-a-GCST004434,Macrophage inflammatory protein 1a levels,macrophage inflammatory protein 1a measurement,EFO:0008218,http://www.ebi.ac.uk/efo/EFO_0008218,0.866,None
prot-a-3217,von Willebrand factor C domain-containing protein 2-like,von Willebrand factor C domain-containing protein 2-like measurement,EFO:0803259,http://www.ebi.ac.uk/efo/EFO_0803259,0.838,None
met-d-XL_HDL_C,Cholesterol in very large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.769,None
prot-a-3064,Tumor necrosis factor ligand superfamily member 9,tumor necrosis factor ligand superfamily member 9 measurement,EFO:0020798,http://www.ebi.ac.uk/efo/EFO_0020798,0.938,None
met-a-692,1-palmitoylglycerophosphoinositol*,1-palmitoylglycerophosphoinositol measurement,EFO:0021091,http://www.ebi.ac.uk/efo/EFO_0021091,0.866,None
ieu-a-1047,Putamen volume,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.987,None
prot-a-2617,Protein S100-A2,protein S100-A2 measurement,EFO:0802961,http://www.ebi.ac.uk/efo/EFO_0802961,0.654,None
bbj-a-29,Potassium,potassium measurement,EFO:0009283,http://www.ebi.ac.uk/efo/EFO_0009283,0.841,None
prot-a-2411,Proteasome subunit alpha type-2,proteasome subunit alpha type-1 measurement,EFO:0020663,http://www.ebi.ac.uk/efo/EFO_0020663,0.784,None
ukb-a-335,Sodium in urine,urinary sodium measurement,EFO:0021522,http://www.ebi.ac.uk/efo/EFO_0021522,0.963,None
prot-c-4960_72_1,annexin I,annexin A1 measurement,EFO:0008026,http://www.ebi.ac.uk/efo/EFO_0008026,0.677,None
prot-a-205,Aurora kinase B,aurora kinase B measurement,EFO:0020169,http://www.ebi.ac.uk/efo/EFO_0020169,0.861,None
prot-a-2914,Synaptotagmin-3,synaptotagmin-2 measurement,EFO:0803118,http://www.ebi.ac.uk/efo/EFO_0803118,0.778,None
prot-a-2351,Palmitoyl-protein thioesterase 1,palmitoyl-protein thioesterase 1 measurement,EFO:0801867,http://www.ebi.ac.uk/efo/EFO_0801867,0.828,None
prot-a-1383,Estradiol 17-beta-dehydrogenase 2,estradiol 17-beta-dehydrogenase 2 measurement,EFO:0802531,http://www.ebi.ac.uk/efo/EFO_0802531,0.721,None
prot-a-969,Epidermal growth factor receptor substrate 15-like 1,epidermal growth factor receptor substrate 15-like 1 measurement,EFO:0020360,http://www.ebi.ac.uk/efo/EFO_0020360,0.847,None
bbj-a-57,Uric acid,uric acid measurement,EFO:0004761,http://www.ebi.ac.uk/efo/EFO_0004761,0.769,None
prot-c-4203_50_2,Cofilin-1,cofilin-1 measurement,EFO:0020267,http://www.ebi.ac.uk/efo/EFO_0020267,0.636,None
prot-a-752,Cytochrome b5,cytochrome b5 measurement,EFO:0802448,http://www.ebi.ac.uk/efo/EFO_0802448,0.87,None
met-d-XL_VLDL_PL_pct,Phospholipids to total lipids ratio in very large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.752,None
prot-a-339,Cell adhesion molecule 4,cell adhesion molecule 4 measurement,EFO:0802380,http://www.ebi.ac.uk/efo/EFO_0802380,0.907,None
met-a-549,X-11843,X-11843 measurement,EFO:0021266,http://www.ebi.ac.uk/efo/EFO_0021266,0.706,None
met-a-360,Gamma-glutamyltyrosine,gamma-glutamyltyrosine measurement,EFO:0021144,http://www.ebi.ac.uk/efo/EFO_0021144,0.801,None
prot-a-1302,Granzyme M,granzyme M measurement,EFO:0801655,http://www.ebi.ac.uk/efo/EFO_0801655,0.877,None
ubm-a-2648,IDP T1 FIRST left accumbens volume plus IDP T1 FIRST right accumbens volume,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.621,None
bbj-a-62,Menarche,menarche,EFO:0003930,http://www.ebi.ac.uk/efo/EFO_0003930,0.979,None
prot-a-2928,Tax1-binding protein 1,tax1-binding protein 1 measurement,EFO:0803138,http://www.ebi.ac.uk/efo/EFO_0803138,0.665,None
ukb-d-30120_irnt,Lymphocyte count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
ubm-a-2708,volume MaskVol,volume,EFO:0001715,http://www.ebi.ac.uk/efo/EFO_0001715,0.614,None
prot-a-2701,Plasma protease C1 inhibitor,plasma protease C1 inhibitor measurement,EFO:0008261,http://www.ebi.ac.uk/efo/EFO_0008261,0.924,None
prot-a-1932,MAGUK p55 subfamily member 7,MAGUK p55 subfamily member 7 measurement,EFO:0802724,http://www.ebi.ac.uk/efo/EFO_0802724,0.951,None
prot-c-3593_72_3,Caspase-3,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.667,None
met-a-576,Palmitoleate (16:1n7),palmitoleate 16:1n7 measurement,EFO:0021072,http://www.ebi.ac.uk/efo/EFO_0021072,0.728,None
ebi-a-GCST008052,Waist-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.784,None
prot-a-3065,Tenomodulin,tenomodulin measurement,EFO:0803142,http://www.ebi.ac.uk/efo/EFO_0803142,0.833,None
prot-a-1563,Insulin-like peptide INSL6,insulin-like peptide INSL6 measurement,EFO:0802633,http://www.ebi.ac.uk/efo/EFO_0802633,0.881,None
ebi-a-GCST90010297,Chordin-like protein 2 levels,chordin-like protein 2 measurement,EFO:0801474,http://www.ebi.ac.uk/efo/EFO_0801474,0.673,None
prot-a-772,dCTP pyrophosphatase 1,DCTP pyrophosphatase 1 measurement,EFO:0020314,http://www.ebi.ac.uk/efo/EFO_0020314,0.927,None
prot-a-1303,Histone H1x,histone H1x measurement,EFO:0801681,http://www.ebi.ac.uk/efo/EFO_0801681,0.899,None
met-d-L_LDL_TG_pct,Triglycerides to total lipids ratio in large LDL,total lipids in large LDL,EFO:0022163,http://www.ebi.ac.uk/efo/EFO_0022163,0.703,None
prot-a-2724,Sialic acid-binding Ig-like lectin 11,sialic acid-binding Ig-like lectin 11 measurement,EFO:0802065,http://www.ebi.ac.uk/efo/EFO_0802065,0.687,None
prot-a-97,Angiopoietin-related protein 1,angiopoietin-related protein 1 measurement,EFO:0801382,http://www.ebi.ac.uk/efo/EFO_0801382,0.839,None
ukb-b-4650,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
prot-a-775,Aromatic-L-amino-acid decarboxylase,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,http://purl.obolibrary.org/obo/MONDO_0012084,0.896,None
prot-a-2978,"Tyrosine-protein kinase receptor Tie-1, soluble","tyrosine-protein kinase receptor Tie-1, soluble measurement",EFO:0008312,http://www.ebi.ac.uk/efo/EFO_0008312,0.761,None
ieu-a-60,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-2114,Neurotrophin-3,neurotrophin-3 measurement,EFO:0010791,http://www.ebi.ac.uk/efo/EFO_0010791,0.642,None
prot-a-1081,Fc receptor-like protein 3,Fc receptor-like protein 3 measurement,EFO:0008127,http://www.ebi.ac.uk/efo/EFO_0008127,0.8,None
ieu-a-1094,Parents' age at death,age at death,EFO:0005056,http://www.ebi.ac.uk/efo/EFO_0005056,0.773,None
prot-a-890,Epididymal secretory protein E3-beta,epididymal secretory protein E3-beta measurement,EFO:0802527,http://www.ebi.ac.uk/efo/EFO_0802527,0.798,None
ubm-a-232,IDP dMRI TBSS FA Cingulum hippocampus R,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.601,None
ieu-a-1078,Selenium,selenium measurement,EFO:0006331,http://www.ebi.ac.uk/efo/EFO_0006331,0.826,None
prot-a-1560,Insulin-like 3,insulin-like 3 measurement,EFO:0802630,http://www.ebi.ac.uk/efo/EFO_0802630,0.721,None
prot-a-1929,Thrombopoietin Receptor,thrombopoietin receptor measurement,EFO:0020769,http://www.ebi.ac.uk/efo/EFO_0020769,0.904,None
met-d-S_HDL_PL_pct,Phospholipids to total lipids ratio in small HDL,phospholipids:total lipids ratio,EFO:0020946,http://www.ebi.ac.uk/efo/EFO_0020946,0.75,None
prot-c-5115_31_3,RELT,sella turcica neoplasm,MONDO:0002720,http://purl.obolibrary.org/obo/MONDO_0002720,0.682,None
prot-a-1337,Hypoxia-inducible factor 1-alpha,hypoxia-inducible factor 1-alpha measurement,EFO:0021926,http://www.ebi.ac.uk/efo/EFO_0021926,0.759,None
prot-a-2109,Vesicle-fusing ATPase,vesicle-fusing ATPase measurement,EFO:0802214,http://www.ebi.ac.uk/efo/EFO_0802214,0.762,None
prot-c-5355_69_3,LIGHT,light,EFO:0000568,http://www.ebi.ac.uk/efo/EFO_0000568,0.988,None
ebi-a-GCST90010356,Tyrosine-protein kinase receptor TYRO3 levels,tyrosine-protein kinase receptor TYRO3 measurement,EFO:0020829,http://www.ebi.ac.uk/efo/EFO_0020829,0.837,None
met-a-538,Homostachydrine*,homostachydrine measurement,EFO:0021164,http://www.ebi.ac.uk/efo/EFO_0021164,0.873,None
prot-a-250,Myc box-dependent-interacting protein 1,myc box-dependent-interacting protein 1 measurement,EFO:0802765,http://www.ebi.ac.uk/efo/EFO_0802765,0.734,None
prot-a-782,Beta-defensin 104,beta-defensin 104 measurement,EFO:0801416,http://www.ebi.ac.uk/efo/EFO_0801416,0.774,None
prot-a-122,Amyloid-like protein 2,amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.767,None
prot-a-1299,Granzyme B,granzyme b measurement,EFO:0020418,http://www.ebi.ac.uk/efo/EFO_0020418,0.865,None
prot-a-1528,Interleukin-36 gamma,interleukin-36 gamma measurement,EFO:0802660,http://www.ebi.ac.uk/efo/EFO_0802660,0.718,None
ebi-a-GCST006572,Cognitive performance,neuropsychological test,EFO:0003926,http://www.ebi.ac.uk/efo/EFO_0003926,0.991,None
prot-c-2743_5_2,Sonic Hedgehog,sonic hedgehog protein measurement,EFO:0020746,http://www.ebi.ac.uk/efo/EFO_0020746,0.847,None
prot-a-443,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 measurement,EFO:0021923,http://www.ebi.ac.uk/efo/EFO_0021923,0.747,None
prot-a-1291,Glutathione S-transferase theta-2B,glutathione S-transferase theta-2B measurement,EFO:0802572,http://www.ebi.ac.uk/efo/EFO_0802572,0.685,None
prot-a-177,Artemin,artemin measurement,EFO:0020162,http://www.ebi.ac.uk/efo/EFO_0020162,0.74,None
prot-a-3196,Testis-specific basic protein Y 1,testis-specific basic protein Y 1 measurement,EFO:0802126,http://www.ebi.ac.uk/efo/EFO_0802126,0.818,None
prot-c-4811_33_3,ITI heavy chain H4,Heavy Chain Disease,EFO:1001341,http://www.ebi.ac.uk/efo/EFO_1001341,0.653,None
prot-a-2931,Tubulin-specific chaperone E,tubulin-specific chaperone E measurement,EFO:0802167,http://www.ebi.ac.uk/efo/EFO_0802167,0.834,None
prot-a-1207,Gamma-glutamyl hydrolase,gamma-glutamyl hydrolase measurement,EFO:0801616,http://www.ebi.ac.uk/efo/EFO_0801616,0.781,None
met-a-379,Carnitine,carnitine measurement,EFO:0010469,http://www.ebi.ac.uk/efo/EFO_0010469,0.787,None
prot-a-362,Caspase-10,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.638,None
prot-a-1700,Glycosyltransferase-like protein LARGE1,glycosyltransferase-like protein LARGE1 measurement,EFO:0802578,http://www.ebi.ac.uk/efo/EFO_0802578,0.883,None
ieu-b-142,Cigarettes smoked per day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.773,None
ieu-b-105,FVC,vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.999,None
prot-a-855,Docking protein 2,docking protein 2 measurement,EFO:0801543,http://www.ebi.ac.uk/efo/EFO_0801543,0.875,None
ubm-a-2667,volume Left-Hippocampus,hippocampus volume change measurement,EFO:0021492,http://www.ebi.ac.uk/efo/EFO_0021492,0.788,None
met-a-436,X-09026,X-09026 measurement,EFO:0021208,http://www.ebi.ac.uk/efo/EFO_0021208,0.664,None
prot-a-114,Amyloid beta A4 precursor protein-binding family B member 1,amyloid beta A4 precursor protein-binding family B member 1 measurement,EFO:0802275,http://www.ebi.ac.uk/efo/EFO_0802275,0.905,None
prot-a-978,Enhancer of rudimentary homolog,enhancer of rudimentary homolog measurement,EFO:0801573,http://www.ebi.ac.uk/efo/EFO_0801573,0.94,None
prot-a-2680,Semaphorin-7A,semaphorin-7A measurement,EFO:0803052,http://www.ebi.ac.uk/efo/EFO_0803052,0.632,None
prot-a-354,Calpain-2 catalytic subunit,calpain-2 catalytic subunit measurement,EFO:0801445,http://www.ebi.ac.uk/efo/EFO_0801445,0.826,None
ebi-a-GCST90016672,Abdominal subcutaneous adipose tissue volume,panniculitis,EFO:1000746,http://www.ebi.ac.uk/efo/EFO_1000746,0.797,None
prot-a-2816,Sphingosine kinase 2,sphingosine kinase 2 measurement,EFO:0020751,http://www.ebi.ac.uk/efo/EFO_0020751,0.886,None
ukb-d-30110_irnt,Platelet distribution width,platelet component distribution width,EFO:0007984,http://www.ebi.ac.uk/efo/EFO_0007984,0.992,None
prot-a-1443,Insulin-like growth factor I,insulin like growth factor measurement,EFO:0004628,http://www.ebi.ac.uk/efo/EFO_0004628,0.872,None
prot-c-4792_51_2,C34 gp41 HIV Fragment,"gp41 C34 peptide, HIV measurement",EFO:0008140,http://www.ebi.ac.uk/efo/EFO_0008140,0.7,None
ukb-d-30020_irnt,Haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.792,None
ukb-b-19253,Age started smoking in current smokers,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.642,None
ebi-a-GCST90010334,Paired immunoglobulin-like type 2 receptor beta levels,paired immunoglobulin-like type 2 receptor alpha measurement,EFO:0801866,http://www.ebi.ac.uk/efo/EFO_0801866,0.749,None
prot-a-83,"Amelogenin, X isoform","amelogenin, X isoform measurement",EFO:0801378,http://www.ebi.ac.uk/efo/EFO_0801378,0.832,None
bbj-a-9,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ubm-a-534,IDP dMRI TBSS OD Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.61,None
prot-a-289,Uncharacterized protein C17orf89,uncharacterized protein C17orf89 measurement,EFO:0803224,http://www.ebi.ac.uk/efo/EFO_0803224,0.954,None
ebi-a-GCST90011566,OTU97_119 (Desulfovibrio) prevalence,commensal Desulfovibrionaceae infectious disease,EFO:1000875,http://www.ebi.ac.uk/efo/EFO_1000875,0.647,None
prot-a-774,DCN1-like protein 5,DCN1-like protein 5 measurement,EFO:0801520,http://www.ebi.ac.uk/efo/EFO_0801520,0.735,None
ubm-a-24,IDP T1 FIRST right accumbens volume,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.6,None
ukb-b-621,Pulses intake,heart rate,EFO:0004326,http://www.ebi.ac.uk/efo/EFO_0004326,0.623,None
ebi-a-GCST90010214,Ephrin type-B receptor 4 levels,ephrin type-b receptor 4 measurement,EFO:0020354,http://www.ebi.ac.uk/efo/EFO_0020354,0.617,None
ieu-a-72,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-485,Cadherin-5,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.641,None
prot-a-160,ADP-ribosylation factor-like protein 11,ADP-ribosylation factor-like protein 11 measurement,EFO:0801355,http://www.ebi.ac.uk/efo/EFO_0801355,0.761,None
prot-a-2574,mRNA-capping enzyme,MRNA-capping enzyme measurement,EFO:0802756,http://www.ebi.ac.uk/efo/EFO_0802756,0.809,None
met-d-M_HDL_FC,Free cholesterol in medium HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.742,None
ebi-a-GCST90010216,Tumor necrosis factor receptor superfamily member 6 levels,tumor necrosis factor receptor superfamily member 6 measurement,EFO:0010610,http://www.ebi.ac.uk/efo/EFO_0010610,0.902,None
met-a-569,X-12056,GM12056,EFO:0001134,http://www.ebi.ac.uk/efo/EFO_0001134,0.731,None
prot-a-1596,Protein jagged-1,protein jagged-1 measurement,EFO:0008271,http://www.ebi.ac.uk/efo/EFO_0008271,0.749,None
prot-a-1064,"Fructose-1,6-bisphosphatase isozyme 2","fructose-1,6-bisphosphatase isozyme 2 measurement",EFO:0802556,http://www.ebi.ac.uk/efo/EFO_0802556,0.75,None
prot-a-2017,Natural cytotoxicity triggering receptor 3 ligand 1,natural cytotoxicity triggering receptor 3 ligand 1 measurement,EFO:0802787,http://www.ebi.ac.uk/efo/EFO_0802787,0.948,None
prot-a-1703,Layilin,layilin measurement,EFO:0020529,http://www.ebi.ac.uk/efo/EFO_0020529,0.851,None
prot-a-110,Annexin A9,annexin A9 measurement,EFO:0802283,http://www.ebi.ac.uk/efo/EFO_0802283,0.898,None
ieu-a-54,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-3009,Transmembrane protein 2,transmembrane protein 2 measurement,EFO:0802155,http://www.ebi.ac.uk/efo/EFO_0802155,0.908,None
met-d-L_LDL_P,Concentration of large LDL particles,concentration of large LDL particles measurement,EFO:0022160,http://www.ebi.ac.uk/efo/EFO_0022160,0.929,None
ukb-d-30140_irnt,Neutrophill count,neutrophil count,EFO:0004833,http://www.ebi.ac.uk/efo/EFO_0004833,0.886,None
met-c-841,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
ebi-a-GCST90010238,Matrix metalloproteinase-2 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.853,None
prot-a-573,C-type lectin domain family 2 member B,C-type lectin domain family 2 member B measurement,EFO:0802345,http://www.ebi.ac.uk/efo/EFO_0802345,0.793,None
ebi-a-GCST90001405,Plasma Blast-Plasma Cell Absolute Count,Plasma Cell Count,EFO:0009248,http://www.ebi.ac.uk/efo/EFO_0009248,0.733,None
prot-a-398,C-C motif chemokine 22,C-C motif chemokine 22 measurement,EFO:0020196,http://www.ebi.ac.uk/efo/EFO_0020196,0.712,None
prot-a-2720,Protein shisa-3 homolog,protein shisa-3 homolog measurement,EFO:0801964,http://www.ebi.ac.uk/efo/EFO_0801964,0.71,None
ebi-a-GCST90002105,HLA DR on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.81,None
ebi-a-GCST90010357,Ubiquitin carboxyl-terminal hydrolase 8 levels,ubiquitin carboxyl-terminal hydrolase 8 measurement,EFO:0802179,http://www.ebi.ac.uk/efo/EFO_0802179,0.8,None
ebi-a-GCST006697,"Parental longevity (combined parental attained age, Martingale residuals)",parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.642,None
prot-a-467,T-cell surface glycoprotein CD8 beta chain,t-cell surface glycoprotein CD8 beta chain measurement,EFO:0803135,http://www.ebi.ac.uk/efo/EFO_0803135,0.868,None
prot-a-2506,RNA-binding protein 39,rna-binding protein 39 measurement,EFO:0020712,http://www.ebi.ac.uk/efo/EFO_0020712,0.757,None
met-c-925,Total lipids in small LDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.966,None
ukb-b-16446,Basal metabolic rate,base metabolic rate measurement,EFO:0007777,http://www.ebi.ac.uk/efo/EFO_0007777,0.892,None
ebi-a-GCST004631,Basophil percentage of white cells,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.992,None
prot-a-2611,Runt-related transcription factor 3,runt-related transcription factor 3 measurement,EFO:0802034,http://www.ebi.ac.uk/efo/EFO_0802034,0.854,None
prot-a-1002,Exosome complex component RRP40,exosome complex component RRP40 measurement,EFO:0801594,http://www.ebi.ac.uk/efo/EFO_0801594,0.948,None
ieu-b-4816,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-306,Complement C1q and tumor necrosis factor-related protein 9A,complement C1q and tumor necrosis factor-related protein 9A measurement,EFO:0803293,http://www.ebi.ac.uk/efo/EFO_0803293,0.89,None
prot-a-1188,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 measurement",EFO:0801407,http://www.ebi.ac.uk/efo/EFO_0801407,0.634,None
prot-c-3416_2_2,BTK,Bruton-type agammaglobulinemia,MONDO:0010421,http://purl.obolibrary.org/obo/MONDO_0010421,0.819,None
prot-a-527,Human Chorionic Gonadotropin,human Chorionic Gonadotropin measurement,EFO:0008156,http://www.ebi.ac.uk/efo/EFO_0008156,0.925,None
prot-a-3243,Xyloside xylosyltransferase 1,xyloside xylosyltransferase 1 measurement,EFO:0802223,http://www.ebi.ac.uk/efo/EFO_0802223,0.951,None
prot-c-2579_17_5,MMP-9,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.91,None
met-d-Acetate,Acetate,acetate measurement,EFO:0010112,http://www.ebi.ac.uk/efo/EFO_0010112,0.761,None
prot-a-3104,Thymic stromal lymphopoietin,thymic stromal lymphopoietin measurement,EFO:0020772,http://www.ebi.ac.uk/efo/EFO_0020772,0.91,None
ebi-a-GCST90000453,CD6 levels,CD6 measurement,EFO:0010774,http://www.ebi.ac.uk/efo/EFO_0010774,0.63,None
met-a-657,X-12771,X-12771 measurement,EFO:0021332,http://www.ebi.ac.uk/efo/EFO_0021332,0.703,None
ukb-a-267,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
met-a-334,Myristate (14:0),myristate 14:0 measurement,EFO:0021067,http://www.ebi.ac.uk/efo/EFO_0021067,0.635,None
prot-b-52,advanced glycosylation end-product specific receptor,advanced glycosylation end product-specific receptor ligand measurement,EFO:0010762,http://www.ebi.ac.uk/efo/EFO_0010762,0.833,None
met-a-614,X-12465,X-12465 measurement,EFO:0021312,http://www.ebi.ac.uk/efo/EFO_0021312,0.711,None
ukb-b-6888,Vitamin E,vitamin E measurement,EFO:0004867,http://www.ebi.ac.uk/efo/EFO_0004867,0.805,None
met-a-340,Alpha-tocopherol,alpha-tocopherol measurement,EFO:0007898,http://www.ebi.ac.uk/efo/EFO_0007898,0.722,None
prot-a-2976,Thrombospondin type-1 domain-containing protein 7A,thrombospondin type-1 domain-containing protein 7A measurement,EFO:0803150,http://www.ebi.ac.uk/efo/EFO_0803150,0.827,None
ebi-a-GCST90001459,Myeloid Dendritic Cell %Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.765,None
ebi-a-GCST008034,Hemoglobin A1c levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.897,None
ubm-a-2699,volume CortexVol,volume,EFO:0001715,http://www.ebi.ac.uk/efo/EFO_0001715,0.622,None
prot-a-3181,Ubiquitin carboxyl-terminal hydrolase 8,ubiquitin carboxyl-terminal hydrolase 8 measurement,EFO:0802179,http://www.ebi.ac.uk/efo/EFO_0802179,0.842,None
ebi-a-GCST90000450,CD244 levels,CD244 measurement,EFO:0010772,http://www.ebi.ac.uk/efo/EFO_0010772,0.708,None
bbj-a-43,Sodium,sodium measurement,EFO:0009282,http://www.ebi.ac.uk/efo/EFO_0009282,0.808,None
prot-a-2982,Toll/interleukin-1 receptor domain-containing adapter protein,toll/interleukin-1 receptor domain-containing adapter protein measurement,EFO:0802134,http://www.ebi.ac.uk/efo/EFO_0802134,0.781,None
prot-a-338,Cell adhesion molecule 3,cell adhesion molecule 3 measurement,EFO:0020252,http://www.ebi.ac.uk/efo/EFO_0020252,0.907,None
met-d-Gln,Glutamine,glutamine measurement,EFO:0009768,http://www.ebi.ac.uk/efo/EFO_0009768,0.805,None
ebi-a-GCST90001742,CD19 on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.702,None
met-a-422,"1,6-anhydroglucose","1,6-anhydroglucose measurement",EFO:0021028,http://www.ebi.ac.uk/efo/EFO_0021028,0.632,None
ebi-a-GCST90014266,Retinal nerve fibre layer (RNFL) thickness,retinal nerve fibre layer thickness measurement,EFO:0600004,http://www.ebi.ac.uk/efo/EFO_0600004,0.807,None
prot-a-2548,Retinaldehyde-binding protein 1,retinaldehyde-binding protein 1 measurement,EFO:0802003,http://www.ebi.ac.uk/efo/EFO_0802003,0.806,None
prot-a-594,Calsyntenin-3,calsyntenin-3 measurement,EFO:0802363,http://www.ebi.ac.uk/efo/EFO_0802363,0.673,None
met-a-336,Ornithine,ornithine aminotransferase deficiency,MONDO:0009796,http://purl.obolibrary.org/obo/MONDO_0009796,0.823,None
prot-a-863,Dihydropyrimidinase-related protein 3,dihydropyrimidinase-related protein 3 measurement,EFO:0802467,http://www.ebi.ac.uk/efo/EFO_0802467,0.865,None
ebi-a-GCST006354,Anti-hepatitis B virus surface antigen (HBs) IgG levels,Anti-hepatitis B virus surface antigen IgG measurement,EFO:0009358,http://www.ebi.ac.uk/efo/EFO_0009358,0.755,None
prot-a-1186,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C","n-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C measurement",EFO:0802777,http://www.ebi.ac.uk/efo/EFO_0802777,0.739,None
prot-a-662,Cysteine-rich secretory protein 3,cysteine-rich secretory protein 3 measurement,EFO:0020301,http://www.ebi.ac.uk/efo/EFO_0020301,0.825,None
ebi-a-GCST90002239,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
ebi-a-GCST90001607,CD8+ T cell %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.693,None
prot-c-2706_69_2,Thyroxine-Binding Globulin,thyroxine-binding globulin measurement,EFO:0009172,http://www.ebi.ac.uk/efo/EFO_0009172,0.8,None
prot-a-346,Calcium/calmodulin-dependent protein kinase type 1,calcium/calmodulin-dependent protein kinase type 1 measurement,EFO:0008062,http://www.ebi.ac.uk/efo/EFO_0008062,0.797,None
met-b-123,NKT:%4+R5-,ring chromosome 5,MONDO:0016654,http://purl.obolibrary.org/obo/MONDO_0016654,0.625,None
ebi-a-GCST006350,Anti-influenza A virus IgG levels,Anti-influenza A virus IgG measurement,EFO:0009354,http://www.ebi.ac.uk/efo/EFO_0009354,0.779,None
prot-a-278,Butyrophilin-like protein 9,butyrophilin-like protein 9 measurement,EFO:0802341,http://www.ebi.ac.uk/efo/EFO_0802341,0.833,None
prot-c-3420_21_2,Carbonic anhydrase XIII,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.798,None
prot-a-583,Chloride intracellular channel protein 4,chloride intracellular channel protein 4 measurement,EFO:0802392,http://www.ebi.ac.uk/efo/EFO_0802392,0.942,None
ebi-a-GCST90010140,Interleukin-17D levels,interleukin-17D measurement,EFO:0021976,http://www.ebi.ac.uk/efo/EFO_0021976,0.688,None
prot-a-2798,Suppressor of cytokine signaling 7,suppressor of cytokine signaling 7 measurement,EFO:0803109,http://www.ebi.ac.uk/efo/EFO_0803109,0.93,None
ebi-a-GCST90000466,Fibroblast growth factor 19 levels,fibroblast growth factor 19 measurement,EFO:0010782,http://www.ebi.ac.uk/efo/EFO_0010782,0.847,None
prot-c-3508_78_3,MDC,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,1.0,None
prot-a-2091,Nuclear receptor subfamily 5 group A member 2,nuclear receptor subfamily 5 group A member 2 measurement,EFO:0802825,http://www.ebi.ac.uk/efo/EFO_0802825,0.952,None
ebi-a-GCST90010112,T-cell surface glycoprotein CD4 levels,t-cell surface glycoprotein CD4 measurement,EFO:0020760,http://www.ebi.ac.uk/efo/EFO_0020760,0.77,None
ukb-b-5991,Father's age,father's age at death,EFO:0009712,http://www.ebi.ac.uk/efo/EFO_0009712,0.647,None
ebi-a-GCST90010285,Amyloid-like protein 1 levels,amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.691,None
prot-a-1014,"Fatty acid-binding protein, epidermal","fatty acid-binding protein, epidermal measurement",EFO:0020372,http://www.ebi.ac.uk/efo/EFO_0020372,0.759,None
prot-a-2183,Poly [ADP-ribose] polymerase 11,poly [ADP-ribose] polymerase 11 measurement,EFO:0802877,http://www.ebi.ac.uk/efo/EFO_0802877,0.7,None
prot-a-2089,Mineralocorticoid receptor,mineralocorticoid receptor measurement,EFO:0801802,http://www.ebi.ac.uk/efo/EFO_0801802,0.909,None
ieu-b-4832,Estimated glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.867,None
ukb-b-12670,Other coffee type,coffee consumption,EFO:0004330,http://www.ebi.ac.uk/efo/EFO_0004330,0.613,None
prot-a-224,Bcl2-associated agonist of cell death,bcl2-associated agonist of cell death measurement,EFO:0021998,http://www.ebi.ac.uk/efo/EFO_0021998,0.817,None
ebi-a-GCST90007313,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-1715,L-lactate dehydrogenase B chain,L lactate dehydrogenase measurement,EFO:0004808,http://www.ebi.ac.uk/efo/EFO_0004808,0.786,None
prot-a-1813,T-lymphocyte surface antigen Ly-9,T-lymphocyte surface antigen Ly-9 measurement,EFO:0008295,http://www.ebi.ac.uk/efo/EFO_0008295,0.698,None
prot-a-2592,Ubiquitin,ubiquitin measurement,EFO:0020839,http://www.ebi.ac.uk/efo/EFO_0020839,0.865,None
prot-a-2354,Basic salivary proline-rich protein 4,basic salivary proline-rich protein 4 measurement,EFO:0801405,http://www.ebi.ac.uk/efo/EFO_0801405,0.831,None
ukb-b-18389,Fractured heel,bone fracture,EFO:0003931,http://www.ebi.ac.uk/efo/EFO_0003931,0.68,None
prot-a-1242,Platelet glycoprotein Ib alpha chain,platelet glycoprotein ib alpha chain measurement,EFO:0020645,http://www.ebi.ac.uk/efo/EFO_0020645,0.93,None
ebi-a-GCST90012016,Platelet-derived growth factor subunit B levels,platelet-derived growth factor subunit b measurement,EFO:0020650,http://www.ebi.ac.uk/efo/EFO_0020650,0.786,None
prot-a-644,Carboxypeptidase B,carboxypeptidase B measurement,EFO:0801453,http://www.ebi.ac.uk/efo/EFO_0801453,0.901,None
ukb-a-234,Forced expiratory volume in 1-second (FEV1)  predicted,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.731,None
ebi-a-GCST90000025,Appendicular lean mass,appendicular lean mass,EFO:0004980,http://www.ebi.ac.uk/efo/EFO_0004980,0.99,None
prot-a-2679,Semaphorin-6C,semaphorin-6C measurement,EFO:0803051,http://www.ebi.ac.uk/efo/EFO_0803051,0.637,None
ukb-a-248,Body mass index (BMI),body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.839,None
met-d-XS_VLDL_L,Total lipids in very small VLDL,total lipids in very small VLDL measurement,EFO:0022156,http://www.ebi.ac.uk/efo/EFO_0022156,0.91,None
prot-a-3247,YTH domain-containing protein 1,YTH domain-containing protein 1 measurement,EFO:0803268,http://www.ebi.ac.uk/efo/EFO_0803268,0.856,None
prot-a-1408,DNA-binding protein inhibitor ID-2,DNA-binding protein inhibitor ID-1 measurement,EFO:0802481,http://www.ebi.ac.uk/efo/EFO_0802481,0.72,None
prot-a-569,Stem Cell Growth Factor-beta,stem Cell Growth Factor beta measurement,EFO:0008292,http://www.ebi.ac.uk/efo/EFO_0008292,0.907,None
prot-a-2323,DNA-directed DNA/RNA polymerase mu,DNA-directed DNA/RNA polymerase mu measurement,EFO:0802485,http://www.ebi.ac.uk/efo/EFO_0802485,0.736,None
ubm-a-3109,a2009s rh S central thickness,central corneal thickness,EFO:0005213,http://www.ebi.ac.uk/efo/EFO_0005213,0.654,None
met-d-L_VLDL_TG,Triglycerides in large VLDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.91,None
prot-a-2191,Pterin-4-alpha-carbinolamine dehydratase,pterin-4 alpha-carbinolamine dehydratase 1 deficiency,MONDO:0009908,http://purl.obolibrary.org/obo/MONDO_0009908,0.781,None
prot-a-1799,Leucine-rich repeat and transmembrane domain-containing protein 1,leucine-rich repeat and transmembrane domain-containing protein 1 measurement,EFO:0802693,http://www.ebi.ac.uk/efo/EFO_0802693,0.859,None
ebi-a-GCST90000467,Fibroblast growth factor 21 levels,fibroblast growth factor 21 measurement,EFO:0010783,http://www.ebi.ac.uk/efo/EFO_0010783,0.849,None
prot-a-2915,Synaptotagmin-5,synaptotagmin-2 measurement,EFO:0803118,http://www.ebi.ac.uk/efo/EFO_0803118,0.773,None
met-c-900,Free cholesterol in medium HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.742,None
prot-c-3590_8_3,C1s,complement component C1s deficiency,MONDO:0013419,http://purl.obolibrary.org/obo/MONDO_0013419,0.791,None
met-a-413,X-06267,X-06267 measurement,EFO:0021200,http://www.ebi.ac.uk/efo/EFO_0021200,0.681,None
bbj-a-26,Hemoglobin A1c,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.995,None
prot-a-1944,"39S ribosomal protein L52, mitochondrial","39S ribosomal protein L52, mitochondrial measurement",EFO:0802239,http://www.ebi.ac.uk/efo/EFO_0802239,0.851,None
ebi-a-GCST90010292,T-cell surface glycoprotein CD1c levels,t-cell surface glycoprotein CD4 measurement,EFO:0020760,http://www.ebi.ac.uk/efo/EFO_0020760,0.621,None
prot-a-2430,Tuberoinfundibular peptide of 39 residues,tuberoinfundibular peptide of 39 residues measurement,EFO:0802163,http://www.ebi.ac.uk/efo/EFO_0802163,0.94,None
prot-a-2314,Bifunctional polynucleotide phosphatase/kinase,bifunctional polynucleotide phosphatase/kinase measurement,EFO:0801424,http://www.ebi.ac.uk/efo/EFO_0801424,0.837,None
met-d-S_VLDL_C_pct,Cholesterol to total lipids ratio in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.792,None
met-a-597,X-12253,X-12253 measurement,EFO:0021300,http://www.ebi.ac.uk/efo/EFO_0021300,0.705,None
prot-a-546,Calcineurin B homologous protein 1,calcineurin B homologous protein 1 measurement,EFO:0802353,http://www.ebi.ac.uk/efo/EFO_0802353,0.92,None
prot-a-245,BET1-like protein,BET1-like protein measurement,EFO:0802307,http://www.ebi.ac.uk/efo/EFO_0802307,0.653,None
ebi-a-GCST90002040,CD80 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.657,None
prot-a-9,Actin-binding LIM protein 3,actin-binding LIM protein 3 measurement,EFO:0802251,http://www.ebi.ac.uk/efo/EFO_0802251,0.787,None
prot-a-2764,Mitochondrial sodium/hydrogen exchanger 9B2,mitochondrial sodium/hydrogen exchanger 9B2 measurement,EFO:0801803,http://www.ebi.ac.uk/efo/EFO_0801803,0.847,None
prot-a-1140,Secreted frizzled-related protein 3,Secreted frizzled-related protein 3 measurement,EFO:0008277,http://www.ebi.ac.uk/efo/EFO_0008277,0.882,None
ebi-a-GCST90012109,Sex hormone-binding globulin levels,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.921,None
prot-a-2142,Ornithine decarboxylase,ornithine decarboxylase measurement,EFO:0802835,http://www.ebi.ac.uk/efo/EFO_0802835,0.913,None
bbj-a-32,Left ventricular internal dimension in diastole,left ventricular diastolic function measurement,EFO:0008204,http://www.ebi.ac.uk/efo/EFO_0008204,0.621,None
ukb-b-8909,Body fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.995,None
prot-a-335,Voltage-dependent calcium channel subunit alpha-2/delta-3,voltage-dependent calcium channel subunit alpha-2/delta-3 measurement,EFO:0802218,http://www.ebi.ac.uk/efo/EFO_0802218,0.747,None
prot-a-3060,Tumor necrosis factor ligand superfamily member 18,tumor necrosis factor ligand superfamily member 18 measurement,EFO:0020795,http://www.ebi.ac.uk/efo/EFO_0020795,0.941,None
ebi-a-GCST90001828,IgD on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.723,None
met-d-L_VLDL_CE,Cholesteryl esters in large VLDL,cholesterol esters in large VLDL measurement,EFO:0022170,http://www.ebi.ac.uk/efo/EFO_0022170,0.812,None
met-a-466,Glutamate,glutamate measurement,EFO:0010487,http://www.ebi.ac.uk/efo/EFO_0010487,0.823,None
ieu-a-964,Age of smoking initiation,age at initiation of smoking,EFO:0021784,http://www.ebi.ac.uk/efo/EFO_0021784,0.939,None
prot-a-650,Cellular retinoic acid-binding protein 1,cellular retinoic acid-binding protein 1 measurement,EFO:0801463,http://www.ebi.ac.uk/efo/EFO_0801463,0.818,None
ebi-a-GCST90010149,Lipoprotein lipase levels,familial lipoprotein lipase deficiency,MONDO:0009387,http://purl.obolibrary.org/obo/MONDO_0009387,0.785,None
ieu-a-1071,Sitting height ratio,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.993,None
prot-a-3028,Tenascin,tenascin measurement,EFO:0008296,http://www.ebi.ac.uk/efo/EFO_0008296,0.8,None
prot-c-4914_10_1,HCG,X-linked congenital generalized hypertrichosis,MONDO:0010614,http://purl.obolibrary.org/obo/MONDO_0010614,0.988,None
ebi-a-GCST004824,P wave terminal force,P wave terminal force measurement,EFO:0008379,http://www.ebi.ac.uk/efo/EFO_0008379,0.91,None
prot-a-1422,Interferon alpha-5,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.957,None
prot-a-2520,Tumor necrosis factor receptor superfamily member 19L,tumor necrosis factor receptor superfamily member 19L measurement,EFO:0008309,http://www.ebi.ac.uk/efo/EFO_0008309,0.953,None
ebi-a-GCST90001913,CD45 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.686,None
ebi-a-GCST90011365,OTU97_119 (Desulfovibrio) abundance,commensal Desulfovibrionaceae infectious disease,EFO:1000875,http://www.ebi.ac.uk/efo/EFO_1000875,0.663,None
prot-c-3320_49_2,IGFBP-7,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.608,None
prot-a-679,Cold shock domain-containing protein E1,cold shock domain-containing protein E1 measurement,EFO:0802416,http://www.ebi.ac.uk/efo/EFO_0802416,0.892,None
prot-a-622,Collagen alpha-1(VI) chain,type 2 collagenopathy,MONDO:0022800,http://purl.obolibrary.org/obo/MONDO_0022800,0.618,None
prot-a-1130,Feline leukemia virus subgroup C receptor-related protein 1,feline leukemia virus subgroup C receptor-related protein 1 measurement,EFO:0802546,http://www.ebi.ac.uk/efo/EFO_0802546,0.897,None
prot-a-1896,Melanoma-derived growth regulatory protein,melanoma-derived growth regulatory protein measurement,EFO:0008229,http://www.ebi.ac.uk/efo/EFO_0008229,0.849,None
prot-a-8,Abelson tyrosine-protein kinase 2,Abelson tyrosine-protein kinase 2 measurement,EFO:0008012,http://www.ebi.ac.uk/efo/EFO_0008012,0.829,None
ieu-b-4852,Wellbeing,wellbeing measurement,EFO:0007869,http://www.ebi.ac.uk/efo/EFO_0007869,0.872,None
prot-a-548,Chordin-like protein 1,chordin-like protein 1 measurement,EFO:0020257,http://www.ebi.ac.uk/efo/EFO_0020257,0.765,None
prot-a-1270,Growth factor receptor-bound protein 14,growth factor receptor-bound protein 14 measurement,EFO:0801658,http://www.ebi.ac.uk/efo/EFO_0801658,0.835,None
prot-a-1464,Interleukin-10,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.913,None
prot-c-5021_13_1,PPase,Primary progressive aphasia,EFO:0009053,http://www.ebi.ac.uk/efo/EFO_0009053,0.68,None
ieu-a-1100,Urinary albumin-to-creatinine ratio,urinary albumin to creatinine ratio,EFO:0007778,http://www.ebi.ac.uk/efo/EFO_0007778,0.995,None
prot-a-991,Estrogen receptor,estrogen receptor measurement,EFO:0008125,http://www.ebi.ac.uk/efo/EFO_0008125,0.858,None
met-d-M_LDL_TG_pct,Triglycerides to total lipids ratio in medium LDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.712,None
prot-a-1529,Interleukin-37,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.803,None
ebi-a-GCST006366,Central corneal thickness,central corneal thickness,EFO:0005213,http://www.ebi.ac.uk/efo/EFO_0005213,0.982,None
ubm-a-3064,DKTatlas rh MeanThickness thickness,cortical thickness,EFO:0004840,http://www.ebi.ac.uk/efo/EFO_0004840,0.647,None
prot-a-25,Disintegrin and metalloproteinase domain-containing protein 11,disintegrin and metalloproteinase domain-containing protein 11 measurement,EFO:0801529,http://www.ebi.ac.uk/efo/EFO_0801529,0.911,None
ukb-a-351,Length of menstrual cycle,menstrual cycle measurement,EFO:0007786,http://www.ebi.ac.uk/efo/EFO_0007786,0.728,None
prot-a-2366,AMP Kinase (alpha2beta2gamma1),amp kinase (alpha2beta2gamma1) measurement,EFO:0020143,http://www.ebi.ac.uk/efo/EFO_0020143,0.823,None
ieu-a-1070,Sitting height ratio,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.993,None
ebi-a-GCST90002291,Basophil count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.984,None
prot-a-2264,Peptidase inhibitor 15,peptidase inhibitor 15 measurement,EFO:0802851,http://www.ebi.ac.uk/efo/EFO_0802851,0.919,None
met-d-M_VLDL_PL_pct,Phospholipids to total lipids ratio in medium VLDL,total lipids in medium VLDL,EFO:0022153,http://www.ebi.ac.uk/efo/EFO_0022153,0.781,None
met-c-860,Glutamine,glutamine measurement,EFO:0009768,http://www.ebi.ac.uk/efo/EFO_0009768,0.805,None
ukb-b-18469,Particulate matter air pollution (pm10); 2010,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.729,None
met-d-HDL_CE,Cholesteryl esters in HDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.775,None
prot-a-1569,Interferon regulatory factor 4,interferon regulatory factor 4 measurement,EFO:0802648,http://www.ebi.ac.uk/efo/EFO_0802648,0.92,None
prot-a-3088,Thyroid peroxidase,thyroid peroxidase measurement,EFO:0020775,http://www.ebi.ac.uk/efo/EFO_0020775,0.879,None
ebi-a-GCST004608,Granulocyte percentage of myeloid white cells,granulocyte percentage of myeloid white cells,EFO:0007997,http://www.ebi.ac.uk/efo/EFO_0007997,0.99,None
ebi-a-GCST90010212,Epidermal growth factor levels,epidermal growth factor,EFO:0003298,http://www.ebi.ac.uk/efo/EFO_0003298,0.9,None
prot-a-731,cubilin,cubilin measurement,EFO:0802433,http://www.ebi.ac.uk/efo/EFO_0802433,0.81,None
met-a-516,X-11444,X-11444 measurement,EFO:0021237,http://www.ebi.ac.uk/efo/EFO_0021237,0.692,None
prot-b-49,"plasminogen activator, urokinase receptor",urokinase plasminogen activator surface receptor measurement,EFO:0010932,http://www.ebi.ac.uk/efo/EFO_0010932,0.838,None
prot-a-187,Agouti-signaling protein,Agouti-signaling protein measurement,EFO:0801357,http://www.ebi.ac.uk/efo/EFO_0801357,0.736,None
ebi-a-GCST011494,Daytime nap,daytime rest measurement,EFO:0007828,http://www.ebi.ac.uk/efo/EFO_0007828,0.657,None
ebi-a-GCST004448,Interleukin-1-beta levels,interleukin-1 beta measurement,EFO:0004812,http://www.ebi.ac.uk/efo/EFO_0004812,0.769,None
ebi-a-GCST90010138,Low affinity immunoglobulin gamma Fc region receptor II-b levels,low affinity immunoglobulin gamma Fc region receptor II-b measurement,EFO:0021970,http://www.ebi.ac.uk/efo/EFO_0021970,0.838,None
prot-a-2781,Acid sphingomyelinase-like phosphodiesterase 3a,acid sphingomyelinase-like phosphodiesterase 3a measurement,EFO:0008013,http://www.ebi.ac.uk/efo/EFO_0008013,0.902,None
prot-a-2847,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,RNA polymerase II subunit A C-terminal domain phosphatase SSU72 measurement,EFO:0802029,http://www.ebi.ac.uk/efo/EFO_0802029,0.895,None
ebi-a-GCST90010163,Serine protease 27 levels,serine protease 27 measurement,EFO:0008280,http://www.ebi.ac.uk/efo/EFO_0008280,0.771,None
ieu-a-48,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-2593,40S ribosomal protein S3,40s ribosomal protein S3 measurement,EFO:0020117,http://www.ebi.ac.uk/efo/EFO_0020117,0.92,None
prot-a-1828,Melanoma-associated antigen 3,melanoma-associated antigen 3 measurement,EFO:0801794,http://www.ebi.ac.uk/efo/EFO_0801794,0.797,None
prot-a-2899,SUN domain-containing protein 5,SUN domain-containing protein 5 measurement,EFO:0802103,http://www.ebi.ac.uk/efo/EFO_0802103,0.862,None
prot-a-2395,Myeloblastin,myeloblastin measurement,EFO:0020585,http://www.ebi.ac.uk/efo/EFO_0020585,0.833,None
ebi-a-GCST90002364,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
prot-c-2967_8_1,VCAM-1,VCaP,EFO:0007752,http://www.ebi.ac.uk/efo/EFO_0007752,0.631,None
prot-a-584,Chloride intracellular channel protein 5,chloride intracellular channel protein 5 measurement,EFO:0801472,http://www.ebi.ac.uk/efo/EFO_0801472,0.943,None
prot-a-2421,Proteasome activator complex subunit 3,proteasome activator complex subunit 3 measurement,EFO:0020662,http://www.ebi.ac.uk/efo/EFO_0020662,0.928,None
ieu-a-1044,Caudate volume,caudate nucleus volume,EFO:0004830,http://www.ebi.ac.uk/efo/EFO_0004830,0.794,None
ebi-a-GCST90010240,Matrix metalloproteinase-9 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.844,None
prot-a-2260,Membrane-associated progesterone receptor component 2,membrane-associated progesterone receptor component 2 measurement,EFO:0801796,http://www.ebi.ac.uk/efo/EFO_0801796,0.891,None
prot-c-3450_4_2,Kallikrein 6,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.775,None
prot-a-2924,Tumor-associated calcium signal transducer 2,tumor-associated calcium signal transducer 2 measurement,EFO:0020817,http://www.ebi.ac.uk/efo/EFO_0020817,0.865,None
prot-a-78,Fructose-bisphosphate aldolase C,fructose-bisphosphate aldolase C measurement,EFO:0802557,http://www.ebi.ac.uk/efo/EFO_0802557,0.857,None
met-c-886,Total cholesterol in large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.972,None
ebi-a-GCST90001588,T/B cell,T-Cell Prolymphocytic Leukemia,EFO:1000560,http://www.ebi.ac.uk/efo/EFO_1000560,0.653,None
prot-a-1513,Interleukin-23 receptor,interleukin 23 receptor measurement,EFO:0008181,http://www.ebi.ac.uk/efo/EFO_0008181,0.909,None
prot-a-1166,Galanin peptides,galanin peptides measurement,EFO:0010615,http://www.ebi.ac.uk/efo/EFO_0010615,0.876,None
prot-a-466,T-lymphocyte activation antigen CD86,t-lymphocyte activation antigen CD86 measurement,EFO:0020762,http://www.ebi.ac.uk/efo/EFO_0020762,0.836,None
met-d-IDL_CE_pct,Cholesteryl esters to total lipids ratio in IDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.755,None
ieu-b-4837,Cognitive function,cognition,EFO:0003925,http://www.ebi.ac.uk/efo/EFO_0003925,0.996,None
prot-a-2788,SNARE-associated protein Snapin,SNARE-associated protein Snapin measurement,EFO:0803084,http://www.ebi.ac.uk/efo/EFO_0803084,0.873,None
prot-c-3723_1_2,BNP-32,BNP measurement,EFO:0006920,http://www.ebi.ac.uk/efo/EFO_0006920,0.708,None
prot-a-2221,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D","cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement",EFO:0020224,http://www.ebi.ac.uk/efo/EFO_0020224,0.702,None
prot-a-283,UPF0454 protein C12orf49,UPF0454 protein C12orf49 measurement,EFO:0802199,http://www.ebi.ac.uk/efo/EFO_0802199,0.96,None
ukb-d-30790_raw,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
ieu-a-99,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ebi-a-GCST90002329,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
ebi-a-GCST008043,QT interval,QT interval,EFO:0004682,http://www.ebi.ac.uk/efo/EFO_0004682,0.99,None
prot-c-2976_58_2,Desmoglein-1,desmoglein-1 measurement,EFO:0020321,http://www.ebi.ac.uk/efo/EFO_0020321,0.736,None
prot-a-2110,Neuron-specific protein family member 1,neuron-specific protein family member 1 measurement,EFO:0802804,http://www.ebi.ac.uk/efo/EFO_0802804,0.846,None
ebi-a-GCST004430,Interleukin-16 levels,interleukin 16 measurement,EFO:0008173,http://www.ebi.ac.uk/efo/EFO_0008173,0.757,None
ukb-b-8765,Other grain intake,caryopsis,EFO:0006814,http://www.ebi.ac.uk/efo/EFO_0006814,0.749,None
ebi-a-GCST90010328,NAD kinase levels,NAD kinase measurement,EFO:0801821,http://www.ebi.ac.uk/efo/EFO_0801821,0.664,None
ukb-b-3018,Age at death,age at death,EFO:0005056,http://www.ebi.ac.uk/efo/EFO_0005056,0.988,None
prot-a-2759,Sodium/iodide cotransporter,sodium/iodide cotransporter measurement,EFO:0803088,http://www.ebi.ac.uk/efo/EFO_0803088,0.738,None
ebi-a-GCST90001979,CD16 on CD14- CD16+ monocyte,autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,MONDO:0014313,http://purl.obolibrary.org/obo/MONDO_0014313,0.666,None
met-d-IDL_TG,Triglycerides in IDL,triglycerides in IDL measurement,EFO:0022149,http://www.ebi.ac.uk/efo/EFO_0022149,0.882,None
prot-a-1827,Melanoma-associated antigen 10,melanoma-associated antigen 10 measurement,EFO:0801793,http://www.ebi.ac.uk/efo/EFO_0801793,0.804,None
met-a-315,Pyruvate,pyruvate measurement,EFO:0010117,http://www.ebi.ac.uk/efo/EFO_0010117,0.852,None
ebi-a-GCST90010269,Tumor necrosis factor receptor superfamily member 14 levels,tumor necrosis factor receptor superfamily member 14 measurement,EFO:0020805,http://www.ebi.ac.uk/efo/EFO_0020805,0.905,None
ebi-a-GCST004826,P wave duration,P wave duration,EFO:0005094,http://www.ebi.ac.uk/efo/EFO_0005094,0.992,None
prot-a-1190,Growth/differentiation factor 11,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.815,None
ebi-a-GCST90006912,Helicobacter pylori Catalase antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.656,None
prot-a-463,T-lymphocyte activation antigen CD80,t-lymphocyte activation antigen CD80 measurement,EFO:0020761,http://www.ebi.ac.uk/efo/EFO_0020761,0.837,None
ebi-a-GCST90000445,CCL23 levels,CCL23 measurement,EFO:0009417,http://www.ebi.ac.uk/efo/EFO_0009417,0.761,None
prot-c-3611_70_4,Endothelin-converting enzyme 1,endothelin-converting enzyme 1 measurement,EFO:0008121,http://www.ebi.ac.uk/efo/EFO_0008121,0.868,None
prot-a-1628,Uncharacterized family 31 glucosidase KIAA1161,uncharacterized family 31 glucosidase KIAA1161 measurement,EFO:0802188,http://www.ebi.ac.uk/efo/EFO_0802188,0.962,None
met-a-477,Myristoleate (14:1n5),myristoleate 14:1n5 measurement,EFO:0021068,http://www.ebi.ac.uk/efo/EFO_0021068,0.738,None
met-a-467,Hexanoylcarnitine,hexanoylcarnitine measurement,EFO:0021040,http://www.ebi.ac.uk/efo/EFO_0021040,0.907,None
ieu-a-785,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-2143,Obg-like ATPase 1,obg-like ATPase 1 measurement,EFO:0801858,http://www.ebi.ac.uk/efo/EFO_0801858,0.696,None
prot-a-2504,RNA-binding protein 28,RNA-binding protein 28 measurement,EFO:0803036,http://www.ebi.ac.uk/efo/EFO_0803036,0.756,None
prot-a-1222,Glycolipid transfer protein,glycolipid transfer protein measurement,EFO:0802575,http://www.ebi.ac.uk/efo/EFO_0802575,0.907,None
prot-a-1694,Leukocyte-associated immunoglobulin-like receptor 1,leukocyte-associated immunoglobulin-like receptor 1 measurement,EFO:0802706,http://www.ebi.ac.uk/efo/EFO_0802706,0.846,None
met-a-706,1-oleoylglycerophosphoethanolamine,1-linoleoylglycerophosphoethanolamine measurement,EFO:0021084,http://www.ebi.ac.uk/efo/EFO_0021084,0.85,None
prot-a-2294,Phospholipase B-like 1,phospholipase B-like 1 measurement,EFO:0802865,http://www.ebi.ac.uk/efo/EFO_0802865,0.759,None
prot-a-1987,Myeloid zinc finger 1,myeloid zinc finger 1 measurement,EFO:0802768,http://www.ebi.ac.uk/efo/EFO_0802768,0.902,None
ukb-d-30630_irnt,Apoliprotein A,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.658,None
prot-a-915,EP300-interacting inhibitor of differentiation 3,EP300-interacting inhibitor of differentiation 3 measurement,EFO:0802525,http://www.ebi.ac.uk/efo/EFO_0802525,0.866,None
met-c-852,"22:6, docosahexaenoic acid",docosahexaenoic acid measurement,EFO:0007761,http://www.ebi.ac.uk/efo/EFO_0007761,0.856,None
prot-c-2647_66_2,Rab GDP dissociation inhibitor beta,rab gdp dissociation inhibitor beta measurement,EFO:0020697,http://www.ebi.ac.uk/efo/EFO_0020697,0.937,None
ukb-b-960,Smoking/smokers in household,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.68,None
prot-a-657,Cysteine-rich with EGF-like domain protein 1,cysteine-rich with EGF-like domain protein 1 measurement,EFO:0021870,http://www.ebi.ac.uk/efo/EFO_0021870,0.765,None
prot-a-1536,Interleukin-5 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.933,None
prot-a-1479,Interleukin-16,interleukin 16 measurement,EFO:0008173,http://www.ebi.ac.uk/efo/EFO_0008173,0.872,None
ukb-b-14351,Grapefruit juice intake,grapefruit juice consumption measurement,EFO:0010094,http://www.ebi.ac.uk/efo/EFO_0010094,0.766,None
met-d-M_LDL_P,Concentration of medium LDL particles,concentration of medium LDL particles measurement,EFO:0022172,http://www.ebi.ac.uk/efo/EFO_0022172,0.936,None
ukb-b-16881,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
prot-a-1595,Intersectin-1,intersectin-1 measurement,EFO:0801733,http://www.ebi.ac.uk/efo/EFO_0801733,0.645,None
bbj-a-48,Posterior wall thickness,posterior wall thickness,EFO:0009288,http://www.ebi.ac.uk/efo/EFO_0009288,0.989,None
prot-a-1374,Ribonuclease UK114,ribonuclease UK114 measurement,EFO:0802020,http://www.ebi.ac.uk/efo/EFO_0802020,0.939,None
prot-a-1991,N-acetylated-alpha-linked acidic dipeptidase 2,n-acetylated-alpha-linked acidic dipeptidase 2 measurement,EFO:0801815,http://www.ebi.ac.uk/efo/EFO_0801815,0.732,None
prot-a-267,BPI fold-containing family A member 1,BPI fold-containing family A member 1 measurement,EFO:0802336,http://www.ebi.ac.uk/efo/EFO_0802336,0.857,None
ebi-a-GCST90001798,CD27 on CD24+ CD27+ B cell,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.736,None
ieu-b-24,Age Of Smoking Initiation,age at initiation of smoking,EFO:0021784,http://www.ebi.ac.uk/efo/EFO_0021784,0.939,None
prot-c-3726_62_4,PTH,Pitt-Hopkins syndrome,MONDO:0012589,http://purl.obolibrary.org/obo/MONDO_0012589,0.674,None
prot-a-1476,Interleukin-13 receptor subunit alpha-1,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.857,None
met-d-XXL_VLDL_C_pct,Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.604,None
met-a-409,Docosahexaenoate (DHA; 22:6n3),docosahexaenoate DHA; 22:6n3 measurement,EFO:0021047,http://www.ebi.ac.uk/efo/EFO_0021047,0.746,None
met-d-IDL_PL_pct,Phospholipids to total lipids ratio in IDL,phospholipids:total lipids ratio,EFO:0020946,http://www.ebi.ac.uk/efo/EFO_0020946,0.787,None
prot-a-288,Uncharacterized protein C17orf78,uncharacterized protein C17orf78 measurement,EFO:0802191,http://www.ebi.ac.uk/efo/EFO_0802191,0.954,None
prot-a-1250,Glycerol-3-phosphate dehydrogenase 1-like protein,glycerol-3-phosphate dehydrogenase 1-like protein measurement,EFO:0801640,http://www.ebi.ac.uk/efo/EFO_0801640,0.723,None
prot-c-2623_54_4,HPV E7 Type 16,human papilloma virus infection,EFO:0001668,http://www.ebi.ac.uk/efo/EFO_0001668,0.668,None
prot-a-3204,Vacuolar protein sorting-associated protein 4A,vacuolar protein sorting-associated protein 4A measurement,EFO:0802208,http://www.ebi.ac.uk/efo/EFO_0802208,0.878,None
prot-a-2197,Protocadherin-9,protocadherin beta-1 measurement,EFO:0802972,http://www.ebi.ac.uk/efo/EFO_0802972,0.685,None
prot-a-3241,DNA repair protein XRCC1,DNA repair protein XRCC1 measurement,EFO:0802479,http://www.ebi.ac.uk/efo/EFO_0802479,0.933,None
ebi-a-GCST90010299,CXADR-like membrane protein levels,CXADR-like membrane protein measurement,EFO:0801504,http://www.ebi.ac.uk/efo/EFO_0801504,0.753,None
prot-a-2640,Lysosome membrane protein 2,lysosome membrane protein 2 measurement,EFO:0020545,http://www.ebi.ac.uk/efo/EFO_0020545,0.887,None
prot-a-3259,Zinc finger protein 10,zinc finger protein 10 measurement,EFO:0803270,http://www.ebi.ac.uk/efo/EFO_0803270,0.904,None
prot-a-1445,Cation-independent mannose-6-phosphate receptor,cation-independent mannose-6-phosphate receptor measurement,EFO:0008075,http://www.ebi.ac.uk/efo/EFO_0008075,0.765,None
ebi-a-GCST005070,Urea levels,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.712,None
ebi-a-GCST90010239,Matrix metalloproteinase-3 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.85,None
prot-a-1414,Gamma-interferon-inducible protein 16,gamma-interferon-inducible protein 16 measurement,EFO:0801617,http://www.ebi.ac.uk/efo/EFO_0801617,0.78,None
met-a-559,1-palmitoleoylglycerophosphocholine*,1-palmitoleoylglycerophosphocholine measurement,EFO:0021088,http://www.ebi.ac.uk/efo/EFO_0021088,0.864,None
met-b-133,MDC:%CD1c-,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.704,None
ieu-a-16,Childhood intelligence,childhood cancer,EFO:1000654,http://www.ebi.ac.uk/efo/EFO_1000654,0.675,None
ebi-a-GCST006655,Breast size,breast size,EFO:0004884,http://www.ebi.ac.uk/efo/EFO_0004884,0.992,None
prot-a-2737,"NAD-dependent protein deacylase sirtuin-5, mitochondrial","NAD-dependent protein deacylase sirtuin-5, mitochondrial measurement",EFO:0801822,http://www.ebi.ac.uk/efo/EFO_0801822,0.796,None
met-a-491,"Bilirubin (E,E)*",bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.674,None
prot-a-802,Beta-defensin 135,beta-defensin 135 measurement,EFO:0802328,http://www.ebi.ac.uk/efo/EFO_0802328,0.769,None
ebi-a-GCST90000027,Appendicular lean mass,appendicular lean mass,EFO:0004980,http://www.ebi.ac.uk/efo/EFO_0004980,0.99,None
prot-c-4467_49_2,SPARCL1,autosomal recessive cutis laxa type 1,MONDO:0019572,http://purl.obolibrary.org/obo/MONDO_0019572,0.804,None
prot-a-3135,Ubiquitin-conjugating enzyme E2 B,ubiquitin-conjugating enzyme E2 B measurement,EFO:0803214,http://www.ebi.ac.uk/efo/EFO_0803214,0.904,None
prot-a-1121,Leucine-rich repeat transmembrane protein FLRT1,leucine-rich repeat transmembrane protein FLRT1 measurement,EFO:0020533,http://www.ebi.ac.uk/efo/EFO_0020533,0.9,None
prot-a-1720,LEM domain-containing protein 1,LEM domain-containing protein 1 measurement,EFO:0801757,http://www.ebi.ac.uk/efo/EFO_0801757,0.841,None
prot-a-1634,Uncharacterized protein KIAA2013,uncharacterized protein KIAA2013 measurement,EFO:0802197,http://www.ebi.ac.uk/efo/EFO_0802197,0.94,None
ebi-a-GCST90012037,Pentraxin-related protein PTX3 levels,pentraxin-related protein PTX3 measurement,EFO:0010923,http://www.ebi.ac.uk/efo/EFO_0010923,0.824,None
prot-a-1313,Heparin-binding EGF-like growth factor,heparin-binding egf-like growth factor measurement,EFO:0020438,http://www.ebi.ac.uk/efo/EFO_0020438,0.757,None
ebi-a-GCST90002377,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
prot-a-2058,Neuromedin-B,neuromedin U,EFO:0003266,http://www.ebi.ac.uk/efo/EFO_0003266,0.725,None
prot-a-685,Granulocyte colony-stimulating factor,granulocyte colony-stimulating factor measurement,EFO:0008142,http://www.ebi.ac.uk/efo/EFO_0008142,0.807,None
met-a-356,Citrulline,citrullinemia,MONDO:0015991,http://purl.obolibrary.org/obo/MONDO_0015991,0.872,None
prot-a-2808,SPARC,SPARC measurement,EFO:0020748,http://www.ebi.ac.uk/efo/EFO_0020748,0.746,None
ukb-a-230,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
prot-a-517,Cilia- and flagella-associated protein 45,cilia- and flagella-associated protein 45 measurement,EFO:0802401,http://www.ebi.ac.uk/efo/EFO_0802401,0.765,None
prot-a-2613,Tyrosine-protein kinase RYK,tyrosine-protein kinase RYK measurement,EFO:0803208,http://www.ebi.ac.uk/efo/EFO_0803208,0.845,None
ukb-b-13686,Mother's age,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.615,None
prot-c-2838_53_1,MMP-17,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.811,None
ebi-a-GCST90010310,Ectonucleoside triphosphate diphosphohydrolase 5 levels,ectonucleoside triphosphate diphosphohydrolase 5 measurement,EFO:0008115,http://www.ebi.ac.uk/efo/EFO_0008115,0.933,None
prot-a-174,Ecto-ADP-ribosyltransferase 3,ecto-ADP-ribosyltransferase 3 measurement,EFO:0801558,http://www.ebi.ac.uk/efo/EFO_0801558,0.724,None
prot-c-5089_11_3,IL-7 Ra,refractory anemia,EFO:0003802,http://www.ebi.ac.uk/efo/EFO_0003802,0.628,None
met-b-236,CD4mem:%R6+,ring chromosome 6,MONDO:0015440,http://purl.obolibrary.org/obo/MONDO_0015440,0.624,None
ebi-a-GCST90000493,Stem cell factor levels,stem Cell Factor measurement,EFO:0008291,http://www.ebi.ac.uk/efo/EFO_0008291,0.703,None
met-b-173,CD4:%Exhausted,exhaustion,EFO:0009852,http://www.ebi.ac.uk/efo/EFO_0009852,0.81,None
ebi-a-GCST90012060,Dickkopf-related protein 1 levels,Dickkopf-related protein 3 measurement,EFO:0008109,http://www.ebi.ac.uk/efo/EFO_0008109,0.693,None
ebi-a-GCST90010147,Kidney Injury Molecule levels,kidney injury molecule 1 measurement,EFO:0010917,http://www.ebi.ac.uk/efo/EFO_0010917,0.839,None
prot-a-3085,Tropomyosin alpha-1 chain,tropomyosin alpha-1 chain measurement,EFO:0020786,http://www.ebi.ac.uk/efo/EFO_0020786,0.773,None
prot-a-265,Bisphosphoglycerate mutase,bisphosphoglycerate mutase measurement,EFO:0802334,http://www.ebi.ac.uk/efo/EFO_0802334,0.926,None
prot-a-929,ETS-related transcription factor Elf-5,ETS-related transcription factor Elf-5 measurement,EFO:0802534,http://www.ebi.ac.uk/efo/EFO_0802534,0.734,None
ebi-a-GCST90010283,Angiopoietin-related protein 7 levels,angiopoietin-related protein 7 measurement,EFO:0802280,http://www.ebi.ac.uk/efo/EFO_0802280,0.782,None
prot-a-402,C-C motif chemokine 25,C-C motif chemokine 25 measurement,EFO:0008050,http://www.ebi.ac.uk/efo/EFO_0008050,0.71,None
ukb-b-5445,Number in household,household income,EFO:0009695,http://www.ebi.ac.uk/efo/EFO_0009695,0.709,None
prot-a-258,BMP-binding endothelial regulator protein,BMP-binding endothelial regulator protein measurement,EFO:0020183,http://www.ebi.ac.uk/efo/EFO_0020183,0.819,None
ebi-a-GCST90010252,Paraoxonase activity,paraoxonase-1 measurement,EFO:0801085,http://www.ebi.ac.uk/efo/EFO_0801085,0.653,None
prot-a-645,Carboxypeptidase M,carboxypeptidase M measurement,EFO:0801454,http://www.ebi.ac.uk/efo/EFO_0801454,0.907,None
prot-a-2503,RNA-binding protein 24,RNA-binding protein 24 measurement,EFO:0802030,http://www.ebi.ac.uk/efo/EFO_0802030,0.754,None
prot-c-2682_68_1,HSP 60,hereditary spastic paraplegia,MONDO:0019064,http://purl.obolibrary.org/obo/MONDO_0019064,0.795,None
ubm-a-2662,volume Left-Putamen,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.887,None
met-d-M_LDL_TG,Triglycerides in medium LDL,triglycerides in medium VLDL measurement,EFO:0022155,http://www.ebi.ac.uk/efo/EFO_0022155,0.802,None
prot-a-761,Cytohesin-interacting protein,cytohesin-interacting protein measurement,EFO:0802453,http://www.ebi.ac.uk/efo/EFO_0802453,0.84,None
prot-a-2773,Stromal membrane-associated protein 1,stromal membrane-associated protein 1 measurement,EFO:0802094,http://www.ebi.ac.uk/efo/EFO_0802094,0.814,None
met-a-404,Glycocholate,glycocholate measurement,EFO:0010491,http://www.ebi.ac.uk/efo/EFO_0010491,0.841,None
ebi-a-GCST90010358,Versican core protein levels,versican core protein measurement,EFO:0803248,http://www.ebi.ac.uk/efo/EFO_0803248,0.782,None
prot-a-6,Alpha/beta hydrolase domain-containing protein 14A,alpha/beta hydrolase domain-containing protein 14A measurement,EFO:0801376,http://www.ebi.ac.uk/efo/EFO_0801376,0.806,None
met-d-XS_VLDL_CE,Cholesteryl esters in very small VLDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.669,None
met-a-639,X-12680,X-12680 measurement,EFO:0021320,http://www.ebi.ac.uk/efo/EFO_0021320,0.717,None
prot-c-3457_57_1,Periostin,periostin measurement,EFO:0020628,http://www.ebi.ac.uk/efo/EFO_0020628,0.777,None
ukb-b-5945,Relative age of first facial hair,age at first facial hair,EFO:0009716,http://www.ebi.ac.uk/efo/EFO_0009716,0.823,None
ebi-a-GCST90012062,Galanin peptide levels,galanin peptides measurement,EFO:0010615,http://www.ebi.ac.uk/efo/EFO_0010615,0.704,None
met-d-IDL_P,Concentration of IDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.714,None
prot-a-613,Cochlin,cochlin measurement,EFO:0801481,http://www.ebi.ac.uk/efo/EFO_0801481,0.834,None
ebi-a-GCST90011994,Interleukin-8 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.79,None
prot-a-1601,Junctional adhesion molecule C,junctional adhesion molecule C measurement,EFO:0020510,http://www.ebi.ac.uk/efo/EFO_0020510,0.925,None
ukb-b-3278,Length of menstrual cycle,menstrual cycle measurement,EFO:0007786,http://www.ebi.ac.uk/efo/EFO_0007786,0.728,None
met-d-XL_HDL_FC_pct,Free cholesterol to total lipids ratio in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.669,None
prot-a-131,Apolipoprotein E (isoform E3),apolipoprotein E isoform E2 measurement,EFO:0008028,http://www.ebi.ac.uk/efo/EFO_0008028,0.764,None
prot-b-83,TNF receptor superfamily member 11b,tumor necrosis factor receptor superfamily member 11B measurement,EFO:0020801,http://www.ebi.ac.uk/efo/EFO_0020801,0.732,None
prot-a-229,BRCA1-associated RING domain protein 1,BRCA1-associated RING domain protein 1 measurement,EFO:0802337,http://www.ebi.ac.uk/efo/EFO_0802337,0.808,None
met-d-Omega_6,Omega-6 fatty acids,omega-3 polyunsaturated fatty acid measurement,EFO:0010119,http://www.ebi.ac.uk/efo/EFO_0010119,0.612,None
ebi-a-GCST90010173,Sortilin levels,sortilin measurement,EFO:0600000,http://www.ebi.ac.uk/efo/EFO_0600000,0.616,None
prot-a-2147,Osteomodulin,osteomodulin measurement,EFO:0020619,http://www.ebi.ac.uk/efo/EFO_0020619,0.861,None
ebi-a-GCST004633,Neutrophil percentage of white cells,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.988,None
prot-a-1431,Interferon gamma receptor 2,interferon gamma receptor 2 measurement,EFO:0022030,http://www.ebi.ac.uk/efo/EFO_0022030,0.906,None
bbj-a-46,Pulse pressure,pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.9,None
prot-a-1876,Mediator of RNA polymerase II transcription subunit 4,mediator of RNA polymerase II transcription subunit 4 measurement,EFO:0801791,http://www.ebi.ac.uk/efo/EFO_0801791,0.952,None
prot-a-532,Cell growth regulator with EF hand domain protein 1,cell growth regulator with EF hand domain protein 1 measurement,EFO:0801461,http://www.ebi.ac.uk/efo/EFO_0801461,0.937,None
prot-a-192,Asporin,asporin measurement,EFO:0801397,http://www.ebi.ac.uk/efo/EFO_0801397,0.795,None
prot-a-1001,Exosome complex component CSL4,exosome complex component CSL4 measurement,EFO:0802536,http://www.ebi.ac.uk/efo/EFO_0802536,0.944,None
met-d-L_HDL_P,Concentration of large HDL particles,concentration of large HDL particles measurement,EFO:0022188,http://www.ebi.ac.uk/efo/EFO_0022188,0.93,None
met-a-312,Arabinose,arabinose measurement,EFO:0021030,http://www.ebi.ac.uk/efo/EFO_0021030,0.806,None
prot-c-3343_1_4,Aminoacylase-1,Aminoacylase 1 deficiency,ORPHANET.ORDO:137754,http://www.orpha.net/ORDO/Orphanet_137754,0.84,None
prot-a-299,Uncharacterized protein C1orf226,uncharacterized protein C1orf226 measurement,EFO:0803229,http://www.ebi.ac.uk/efo/EFO_0803229,0.954,None
met-a-487,X-06126,X-06126 measurement,EFO:0021197,http://www.ebi.ac.uk/efo/EFO_0021197,0.659,None
ebi-a-GCST90000046,Age at first sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.931,None
prot-a-3205,Vacuolar protein sorting-associated protein 4B,vacuolar protein sorting-associated protein 4B measurement,EFO:0802209,http://www.ebi.ac.uk/efo/EFO_0802209,0.878,None
prot-a-2870,Signal transducer and activator of transcription 6,signal transducer and activator of transcription 6 measurement,EFO:0021916,http://www.ebi.ac.uk/efo/EFO_0021916,0.941,None
prot-c-5009_11_1,Moesin,moesin measurement,EFO:0020583,http://www.ebi.ac.uk/efo/EFO_0020583,0.794,None
prot-a-2262,Membrane-associated progesterone receptor component 2,membrane-associated progesterone receptor component 2 measurement,EFO:0801796,http://www.ebi.ac.uk/efo/EFO_0801796,0.891,None
met-d-Total_FC,Total free cholesterol,free cholesterol measurement,EFO:0008591,http://www.ebi.ac.uk/efo/EFO_0008591,0.785,None
met-d-L_HDL_CE,Cholesteryl esters in large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.803,None
prot-a-1647,Killer cell immunoglobulin-like receptor 3DL3,killer cell immunoglobulin-like receptor 3DL3 measurement,EFO:0802677,http://www.ebi.ac.uk/efo/EFO_0802677,0.911,None
prot-a-1358,Heme oxygenase 2,heme oxygenase 2 measurement,EFO:0020436,http://www.ebi.ac.uk/efo/EFO_0020436,0.887,None
prot-a-718,Cathepsin B,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.826,None
prot-c-3132_1_1,VEGF-C,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.92,None
ieu-b-72,Urinary sodium-potassium ratio,urinary sodium to potassium ratio,EFO:0009884,http://www.ebi.ac.uk/efo/EFO_0009884,0.975,None
ebi-a-GCST008044,Systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
ukb-d-30260_irnt,Mean reticulocyte volume,mean reticulocyte volume,EFO:0010701,http://www.ebi.ac.uk/efo/EFO_0010701,0.982,None
met-c-862,Glycoproteins,glycoproteinosis,MONDO:0017731,http://purl.obolibrary.org/obo/MONDO_0017731,0.799,None
ukb-b-5753,Breaded fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.657,None
prot-a-1054,Prolyl endopeptidase FAP,prolyl endopeptidase FAP measurement,EFO:0021856,http://www.ebi.ac.uk/efo/EFO_0021856,0.924,None
ebi-a-GCST90010249,Peptidoglycan recognition protein 1 levels,peptidoglycan recognition protein 1 measurement,EFO:0020624,http://www.ebi.ac.uk/efo/EFO_0020624,0.875,None
prot-a-3140,Ubiquitin-conjugating enzyme E2 J2,ubiquitin-conjugating enzyme E2 J2 measurement,EFO:0803216,http://www.ebi.ac.uk/efo/EFO_0803216,0.915,None
met-d-XL_VLDL_FC_pct,Free cholesterol to total lipids ratio in very large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.713,None
prot-a-1468,Interleukin-12,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.88,None
prot-a-2585,Ribose-5-phosphate isomerase,ribose-5-P isomerase deficiency,MONDO:0012073,http://purl.obolibrary.org/obo/MONDO_0012073,0.753,None
ebi-a-GCST90002240,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
ebi-a-GCST90012066,Tissue-type plasminogen activator levels,tissue plasminogen activator measurement,EFO:0004791,http://www.ebi.ac.uk/efo/EFO_0004791,0.808,None
prot-c-5441_67_3,Troponin I,cardiac troponin I measurement,EFO:0010071,http://www.ebi.ac.uk/efo/EFO_0010071,0.649,None
ebi-a-GCST90012073,Cathepsin L1 levels,cathepsin L1 measurement,EFO:0010619,http://www.ebi.ac.uk/efo/EFO_0010619,0.744,None
prot-c-5138_50_3,TWEAKR,tumor necrosis factor ligand superfamily member 12 measurement,EFO:0010801,http://www.ebi.ac.uk/efo/EFO_0010801,0.657,None
prot-a-1387,Heat shock 70 kDa protein 1-like,heat shock 70 kDa protein 1-like measurement,EFO:0801665,http://www.ebi.ac.uk/efo/EFO_0801665,0.858,None
prot-a-2771,Mothers against decapentaplegic homolog 2,mothers against decapentaplegic homolog 2 measurement,EFO:0021914,http://www.ebi.ac.uk/efo/EFO_0021914,0.943,None
prot-a-2233,Protein disulfide-isomerase A5,protein disulfide-isomerase A5 measurement,EFO:0801941,http://www.ebi.ac.uk/efo/EFO_0801941,0.807,None
ebi-a-GCST004447,Interleukin-1-receptor antagonist levels,interleukin 1 receptor antagonist measurement,EFO:0004754,http://www.ebi.ac.uk/efo/EFO_0004754,0.861,None
ebi-a-GCST90010110,C-C motif chemokine 17 levels,CCL17 measurement,EFO:0009414,http://www.ebi.ac.uk/efo/EFO_0009414,0.682,None
ukb-a-388,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-2446,Receptor-type tyrosine-protein phosphatase eta,receptor-type tyrosine-protein phosphatase eta measurement,EFO:0802999,http://www.ebi.ac.uk/efo/EFO_0802999,0.774,None
prot-a-1388,Heat shock 70 kDa protein 6,heat shock 70 kDa protein 6 measurement,EFO:0801666,http://www.ebi.ac.uk/efo/EFO_0801666,0.933,None
prot-c-5268_49_3,MMP-16,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.815,None
prot-a-347,Calcium/calmodulin-dependent protein kinase type 1D,calcium/calmodulin-dependent protein kinase type 1D measurement,EFO:0008063,http://www.ebi.ac.uk/efo/EFO_0008063,0.814,None
met-d-XS_VLDL_C,Cholesterol in very small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.817,None
prot-a-2769,SLIT and NTRK-like protein 5,slit and ntrk-like protein 5 measurement,EFO:0020743,http://www.ebi.ac.uk/efo/EFO_0020743,0.757,None
prot-a-1903,Multiple inositol polyphosphate phosphatase 1,multiple inositol polyphosphate phosphatase 1 measurement,EFO:0801811,http://www.ebi.ac.uk/efo/EFO_0801811,0.953,None
prot-a-2413,Proteasome subunit alpha type-6,proteasome subunit alpha type-1 measurement,EFO:0020663,http://www.ebi.ac.uk/efo/EFO_0020663,0.776,None
prot-a-2532,Repulsive guidance molecule A,repulsive guidance molecule A measurement,EFO:0008273,http://www.ebi.ac.uk/efo/EFO_0008273,0.936,None
prot-a-1787,Leucine-rich repeat-containing protein 37A2,leucine-rich repeat-containing protein 37A2 measurement,EFO:0802699,http://www.ebi.ac.uk/efo/EFO_0802699,0.828,None
prot-a-665,Crk-like protein,CRK-like protein measurement,EFO:0801503,http://www.ebi.ac.uk/efo/EFO_0801503,0.671,None
prot-a-3172,Uroplakin-3b,uroplakin-3b measurement,EFO:0803241,http://www.ebi.ac.uk/efo/EFO_0803241,0.644,None
met-d-XS_VLDL_PL_pct,Phospholipids to total lipids ratio in very small VLDL,phospholipids in very small VLDL measurement,EFO:0022150,http://www.ebi.ac.uk/efo/EFO_0022150,0.787,None
prot-a-2024,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial","NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial measurement",EFO:0802784,http://www.ebi.ac.uk/efo/EFO_0802784,0.829,None
met-a-616,Alpha-hydroxyisovalerate,alpha-hydroxyisovalerate measurement,EFO:0800023,http://www.ebi.ac.uk/efo/EFO_0800023,0.81,None
met-a-688,2-oleoylglycerophosphocholine*,2-oleoylglycerophosphocholine measurement,EFO:0021096,http://www.ebi.ac.uk/efo/EFO_0021096,0.812,None
prot-a-2125,Nuclear migration protein nudC,nuclear migration protein nudC measurement,EFO:0801849,http://www.ebi.ac.uk/efo/EFO_0801849,0.943,None
prot-a-3225,WAP four-disulfide core domain protein 3,WAP four-disulfide core domain protein 3 measurement,EFO:0802220,http://www.ebi.ac.uk/efo/EFO_0802220,0.851,None
prot-a-2958,Transferrin receptor protein 1,transferrin receptor protein 1 measurement,EFO:0802142,http://www.ebi.ac.uk/efo/EFO_0802142,0.916,None
prot-a-1132,Fibronectin type III domain-containing protein 4,fibronectin type III domain-containing protein 4 measurement,EFO:0802549,http://www.ebi.ac.uk/efo/EFO_0802549,0.887,None
met-a-368,Beta-hydroxyisovalerate,beta-hydroxyisovalerate measurement,EFO:0800125,http://www.ebi.ac.uk/efo/EFO_0800125,0.809,None
prot-a-1821,Lysozyme C,lysozyme C measurement,EFO:0008216,http://www.ebi.ac.uk/efo/EFO_0008216,0.874,None
prot-a-2337,Neutrophil-activating peptide 2,neutrophil-activating peptide 2 measurement,EFO:0020606,http://www.ebi.ac.uk/efo/EFO_0020606,0.795,None
prot-a-547,Chordin,chordin measurement,EFO:0802395,http://www.ebi.ac.uk/efo/EFO_0802395,0.735,None
met-d-Gly,Glycine,glycine measurement,EFO:0009767,http://www.ebi.ac.uk/efo/EFO_0009767,0.769,None
prot-a-2095,Neuregulin-1,neuregulin-1 measurement,EFO:0022029,http://www.ebi.ac.uk/efo/EFO_0022029,0.687,None
ebi-a-GCST90012022,Fibroblast growth factor 23 levels,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.851,None
ebi-a-GCST90007312,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-2263,PHD finger protein 3,PHD finger protein 3 measurement,EFO:0802859,http://www.ebi.ac.uk/efo/EFO_0802859,0.895,None
prot-c-3635_76_4,OCAD1,leukocyte adhesion deficiency 1,MONDO:0007293,http://purl.obolibrary.org/obo/MONDO_0007293,0.625,None
prot-a-1458,Immunoglobulin lambda-like polypeptide 1,immunoglobulin lambda-like polypeptide 1 measurement,EFO:0801688,http://www.ebi.ac.uk/efo/EFO_0801688,0.861,None
prot-a-1591,Integral membrane protein 2C,integral membrane protein 2C measurement,EFO:0802635,http://www.ebi.ac.uk/efo/EFO_0802635,0.923,None
prot-c-3893_64_1,Mesothelin,mesothelin measurement,EFO:0020565,http://www.ebi.ac.uk/efo/EFO_0020565,0.838,None
ukb-b-11141,"Forced expiratory volume in 1-second (FEV1), Best measure",forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.7,None
prot-a-2278,Phosphatidylinositol transfer protein alpha isoform,phosphatidylinositol transfer protein alpha isoform measurement,EFO:0802862,http://www.ebi.ac.uk/efo/EFO_0802862,0.95,None
met-c-931,Phospholipids in small VLDL,phospholipids in small VLDL measurement,EFO:0022146,http://www.ebi.ac.uk/efo/EFO_0022146,0.909,None
ukb-d-30000_irnt,White blood cell (leukocyte) count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.797,None
prot-c-3891_56_1,MBD4,Marchiafava-Bignami Disease,EFO:1001809,http://www.ebi.ac.uk/efo/EFO_1001809,0.619,None
prot-c-4337_49_2,CRP,Acro-pectoral syndrome,ORPHANET.ORDO:85203,http://www.orpha.net/ORDO/Orphanet_85203,0.704,None
met-d-LDL_TG,Triglycerides in LDL,low density lipoprotein triglyceride measurement,EFO:0009946,http://www.ebi.ac.uk/efo/EFO_0009946,0.831,None
prot-a-2346,Protein phosphatase 1L,protein phosphatase 1L measurement,EFO:0802958,http://www.ebi.ac.uk/efo/EFO_0802958,0.908,None
met-a-481,Caprylate (8:0),caprylate 8:0 measurement,EFO:0021103,http://www.ebi.ac.uk/efo/EFO_0021103,0.629,None
ebi-a-GCST006367,Central corneal thickness,central corneal thickness,EFO:0005213,http://www.ebi.ac.uk/efo/EFO_0005213,0.982,None
met-d-S_HDL_TG_pct,Triglycerides to total lipids ratio in small HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.678,None
prot-a-3263,Zinc finger protein 180,zinc finger protein 180 measurement,EFO:0803273,http://www.ebi.ac.uk/efo/EFO_0803273,0.922,None
prot-a-1512,Interleukin-2,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.958,None
prot-a-353,Calnexin,calnexin measurement,EFO:0801444,http://www.ebi.ac.uk/efo/EFO_0801444,0.86,None
ieu-a-79,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ukb-d-30500_irnt,Microalbumin in urine,urinary microalbumin measurement,EFO:0010967,http://www.ebi.ac.uk/efo/EFO_0010967,0.834,None
ubm-a-2658,volume Left-Cerebellum-White-Matter,cerebellum white matter volume change measurement,EFO:0021498,http://www.ebi.ac.uk/efo/EFO_0021498,0.823,None
prot-a-3061,Tumor necrosis factor ligand superfamily member 4,tumor necrosis factor ligand superfamily member 4 measurement,EFO:0020796,http://www.ebi.ac.uk/efo/EFO_0020796,0.937,None
prot-a-2482,Cell cycle checkpoint protein RAD1,cell cycle checkpoint protein RAD1 measurement,EFO:0802381,http://www.ebi.ac.uk/efo/EFO_0802381,0.948,None
prot-a-1370,15-hydroxyprostaglandin dehydrogenase [NAD(+)],15-hydroxyprostaglandin dehydrogenase [NAD(+)] measurement,EFO:0020111,http://www.ebi.ac.uk/efo/EFO_0020111,0.668,None
prot-a-1775,Prolow-density lipoprotein receptor-related protein 1,prolow-density lipoprotein receptor-related protein 1 measurement,EFO:0801929,http://www.ebi.ac.uk/efo/EFO_0801929,0.817,None
prot-a-1323,Vigilin,vigilin measurement,EFO:0802215,http://www.ebi.ac.uk/efo/EFO_0802215,0.819,None
prot-a-3067,"Troponin I, cardiac muscle","troponin i, cardiac muscle measurement",EFO:0020788,http://www.ebi.ac.uk/efo/EFO_0020788,0.78,None
prot-a-45,Adhesion G-protein coupled receptor G5,adhesion G-protein coupled receptor G5 measurement,EFO:0021980,http://www.ebi.ac.uk/efo/EFO_0021980,0.838,None
ebi-a-GCST003394,Parental longevity (combined parental age at death),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.814,None
prot-a-2104,Neurexin-2-beta,neurexin-1-beta measurement,EFO:0020596,http://www.ebi.ac.uk/efo/EFO_0020596,0.638,None
ieu-a-1021,Percent emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.816,None
met-a-316,Uridine,uridine measurement,EFO:0010546,http://www.ebi.ac.uk/efo/EFO_0010546,0.777,None
met-d-LDL_CE,Cholesteryl esters in LDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.779,None
ubm-a-2690,volume CC Mid Posterior,posterior thigh muscle volume,EFO:0020931,http://www.ebi.ac.uk/efo/EFO_0020931,0.607,None
prot-c-3852_19_2,HSP 40,hereditary spastic paraplegia,MONDO:0019064,http://purl.obolibrary.org/obo/MONDO_0019064,0.816,None
prot-a-2671,Semaphorin-3C,semaphorin-3C measurement,EFO:0802048,http://www.ebi.ac.uk/efo/EFO_0802048,0.635,None
met-a-579,Lathosterol,lathosterol measurement,EFO:0021121,http://www.ebi.ac.uk/efo/EFO_0021121,0.821,None
ebi-a-GCST004445,Interleukin-8 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.79,None
prot-c-2891_1_3,CD22,B-cell receptor CD22 measurement,EFO:0020171,http://www.ebi.ac.uk/efo/EFO_0020171,0.614,None
prot-a-1447,Insulin-like growth factor-binding protein 1,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.824,None
ebi-a-GCST90016673,Percent liver fat,liver fat measurement,EFO:0010821,http://www.ebi.ac.uk/efo/EFO_0010821,0.634,None
bbj-a-6,Alanine aminotransferase,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.904,None
prot-a-1680,Kremen protein 1,kremen protein 1 measurement,EFO:0801749,http://www.ebi.ac.uk/efo/EFO_0801749,0.914,None
ebi-a-GCST90010241,Myeloperoxidase levels,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.79,None
ieu-a-1029,Internalizing problems,internalizing disorder,EFO:0020971,http://www.ebi.ac.uk/efo/EFO_0020971,0.705,None
prot-a-2159,Oxytocin-neurophysin 1,oxytocin-neurophysin 1 measurement,EFO:0802839,http://www.ebi.ac.uk/efo/EFO_0802839,0.798,None
prot-a-2025,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial","NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement",EFO:0803292,http://www.ebi.ac.uk/efo/EFO_0803292,0.787,None
ebi-a-GCST90006916,Helicobacter pylori VacA antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.635,None
prot-a-2883,Syntaxin-10,syntaxin-10 measurement,EFO:0802110,http://www.ebi.ac.uk/efo/EFO_0802110,0.613,None
prot-a-1734,Legumain,legumain measurement,EFO:0020530,http://www.ebi.ac.uk/efo/EFO_0020530,0.843,None
ebi-a-GCST90012044,TNF-related activation-induced cytokine levels,TNF-related activation-induced cytokine measurement,EFO:0010929,http://www.ebi.ac.uk/efo/EFO_0010929,0.744,None
prot-a-1051,Protein FAM3D,protein FAM3D measurement,EFO:0021869,http://www.ebi.ac.uk/efo/EFO_0021869,0.9,None
prot-c-2654_19_1,TNF sR-I,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.619,None
ukb-b-4630,Neuroticism score,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.809,None
prot-a-2156,Oncostatin-M-specific receptor subunit beta,oncostatin-M-specific receptor subunit beta measurement,EFO:0801860,http://www.ebi.ac.uk/efo/EFO_0801860,0.774,None
prot-a-2576,RNA-binding protein 40,RNA-binding protein 40 measurement,EFO:0803037,http://www.ebi.ac.uk/efo/EFO_0803037,0.757,None
prot-a-2993,Transmembrane emp24 domain-containing protein 10,transmembrane emp24 domain-containing protein 10 measurement,EFO:0802146,http://www.ebi.ac.uk/efo/EFO_0802146,0.916,None
ebi-a-GCST006308,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-3001,Transmembrane protein 132D,transmembrane protein 132D measurement,EFO:0802153,http://www.ebi.ac.uk/efo/EFO_0802153,0.936,None
prot-a-98,Angiopoietin-related protein 3,angiopoietin-related protein 3 measurement,EFO:0020148,http://www.ebi.ac.uk/efo/EFO_0020148,0.841,None
prot-a-3029,Tumor necrosis factor,tumor necrosis factor measurement,EFO:0010834,http://www.ebi.ac.uk/efo/EFO_0010834,0.863,None
prot-a-1024,Protein FAM150B,protein FAM150B measurement,EFO:0801944,http://www.ebi.ac.uk/efo/EFO_0801944,0.922,None
prot-a-1268,GRB2-related adapter protein,GRB2-related adapter protein measurement,EFO:0802580,http://www.ebi.ac.uk/efo/EFO_0802580,0.801,None
prot-a-1077,Ficolin-1,immunodeficiency due to ficolin3 deficiency,MONDO:0013467,http://purl.obolibrary.org/obo/MONDO_0013467,0.703,None
prot-a-1992,NGFI-A-binding protein 1,NGFI-A-binding protein 1 measurement,EFO:0802811,http://www.ebi.ac.uk/efo/EFO_0802811,0.648,None
prot-a-1107,Bis(5'-adenosyl)-triphosphatase,"adenosine triphosphatase deficiency, anemia due to",MONDO:0007066,http://purl.obolibrary.org/obo/MONDO_0007066,0.619,None
prot-a-382,Coiled-coil domain-containing protein 167,coiled-coil domain-containing protein 167 measurement,EFO:0802411,http://www.ebi.ac.uk/efo/EFO_0802411,0.848,None
met-a-550,X-11845,X-11845 measurement,EFO:0021267,http://www.ebi.ac.uk/efo/EFO_0021267,0.707,None
prot-a-2184,Mono [ADP-ribose] polymerase PARP16,mono [ADP-ribose] polymerase PARP16 measurement,EFO:0803296,http://www.ebi.ac.uk/efo/EFO_0803296,0.728,None
prot-a-3238,Xanthine dehydrogenase/oxidase,xanthinuria type II,MONDO:0011346,http://purl.obolibrary.org/obo/MONDO_0011346,0.834,None
prot-a-74,CD166 antigen,CD166 antigen measurement,EFO:0020245,http://www.ebi.ac.uk/efo/EFO_0020245,0.893,None
prot-a-2664,Protein sel-1 homolog 2,protein sel-1 homolog 2 measurement,EFO:0801962,http://www.ebi.ac.uk/efo/EFO_0801962,0.729,None
prot-a-1349,High mobility group protein 20A,high mobility group protein 20A measurement,EFO:0802599,http://www.ebi.ac.uk/efo/EFO_0802599,0.935,None
prot-a-142,ADP-ribosylation factor 3,ADP-ribosylation factor 3 measurement,EFO:0802259,http://www.ebi.ac.uk/efo/EFO_0802259,0.766,None
ebi-a-GCST90010229,Interleukin-6 receptor subunit alpha levels,interleukin 6 receptor subunit alpha measurement,EFO:0008187,http://www.ebi.ac.uk/efo/EFO_0008187,0.872,None
prot-a-1531,Interleukin-3 receptor subunit alpha,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.897,None
met-c-911,Free cholesterol in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.804,None
ebi-a-GCST008591,Triglyceride levels,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.987,None
prot-a-1362,Heterogeneous nuclear ribonucleoprotein A/B,heterogeneous nuclear ribonucleoprotein M measurement,EFO:0801674,http://www.ebi.ac.uk/efo/EFO_0801674,0.903,None
prot-a-379,SAGA-associated factor 29 homolog,SAGA-associated factor 29 homolog measurement,EFO:0803042,http://www.ebi.ac.uk/efo/EFO_0803042,0.816,None
ebi-a-GCST90002073,SSC-A on monocyte,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.657,None
ukb-b-1252,Other fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.846,None
prot-a-3119,Twisted gastrulation protein homolog 1,twisted gastrulation protein homolog 1 measurement,EFO:0803205,http://www.ebi.ac.uk/efo/EFO_0803205,0.937,None
prot-a-2985,Transketolase,Wernicke-Korsakoff syndrome,EFO:1001242,http://www.ebi.ac.uk/efo/EFO_1001242,0.869,None
prot-c-5090_49_2,ILT-2,angioimmunoblastic T-cell lymphoma,EFO:0000255,http://www.ebi.ac.uk/efo/EFO_0000255,0.616,None
met-a-320,Deoxycholate,deoxycholate measurement,EFO:0010475,http://www.ebi.ac.uk/efo/EFO_0010475,0.88,None
ebi-a-GCST007857,Fasting blood insulin adjusted for BMI,BMI-adjusted fasting blood insulin measurement,EFO:0008037,http://www.ebi.ac.uk/efo/EFO_0008037,0.819,None
prot-a-1551,Alpha-internexin,alpha-internexin measurement,EFO:0802268,http://www.ebi.ac.uk/efo/EFO_0802268,0.748,None
met-c-868,Free cholesterol in IDL,free cholesterol in IDL measurement,EFO:0022181,http://www.ebi.ac.uk/efo/EFO_0022181,0.895,None
prot-a-296,Uncharacterized protein C1orf185,uncharacterized protein C1orf185 measurement,EFO:0803227,http://www.ebi.ac.uk/efo/EFO_0803227,0.952,None
prot-a-1768,Leucine-rich repeat and fibronectin type III domain-containing protein 1,leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement,EFO:0802689,http://www.ebi.ac.uk/efo/EFO_0802689,0.859,None
ieu-b-4908,Anti-Saccharomyces cerevisiae IgA levels,anti-saccharomyces cerevisiae IgA measurement,EFO:0801091,http://www.ebi.ac.uk/efo/EFO_0801091,0.79,None
met-a-584,X-12100--hydroxytryptophan*,X-12100--hydroxytryptophan measurement,EFO:0021288,http://www.ebi.ac.uk/efo/EFO_0021288,0.707,None
prot-a-10,Histo-blood group ABO system transferase,histo-blood group ABO system transferase measurement,EFO:0801679,http://www.ebi.ac.uk/efo/EFO_0801679,0.839,None
ukb-b-10546,Oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.682,None
prot-a-523,Complement factor I,complement factor I measurement,EFO:0008099,http://www.ebi.ac.uk/efo/EFO_0008099,0.909,None
prot-a-2053,Neuroligin-1,neuroligin-1 measurement,EFO:0802802,http://www.ebi.ac.uk/efo/EFO_0802802,0.652,None
ukb-b-14149,Able to walk or cycle unaided for 10 minutes,"ability to walk or cycle unaided for 10 minutes, self-reported",EFO:0009822,http://www.ebi.ac.uk/efo/EFO_0009822,0.71,None
prot-a-663,Cysteine-rich secretory protein LCCL domain-containing 2,cysteine-rich secretory protein LCCL domain-containing 2 measurement,EFO:0801512,http://www.ebi.ac.uk/efo/EFO_0801512,0.865,None
prot-a-2271,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement",EFO:0020637,http://www.ebi.ac.uk/efo/EFO_0020637,0.836,None
ukb-d-30820_irnt,Rheumatoid factor,rheumatoid factor measurement,EFO:0005767,http://www.ebi.ac.uk/efo/EFO_0005767,0.886,None
ukb-b-19657,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
prot-c-4146_58_2,Neurotrophin-5,neurotrophin-3 measurement,EFO:0010791,http://www.ebi.ac.uk/efo/EFO_0010791,0.636,None
prot-a-1162,Gamma-aminobutyric acid receptor-associated protein-like 2,gamma-aminobutyric acid receptor-associated protein-like 2 measurement,EFO:0801614,http://www.ebi.ac.uk/efo/EFO_0801614,0.786,None
prot-a-1466,Interleukin-11,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.881,None
met-b-146,CD27 on IgG+B,anti-IgG,EFO:0005030,http://www.ebi.ac.uk/efo/EFO_0005030,0.651,None
prot-a-3219,WW domain binding protein 1-like,WW domain binding protein 1-like measurement,EFO:0803265,http://www.ebi.ac.uk/efo/EFO_0803265,0.838,None
prot-a-189,N-acetylserotonin O-methyltransferase-like protein,n-acetylserotonin O-methyltransferase-like protein measurement,EFO:0801818,http://www.ebi.ac.uk/efo/EFO_0801818,0.77,None
prot-a-2555,Non-secretory ribonuclease,non-secretory ribonuclease measurement,EFO:0801845,http://www.ebi.ac.uk/efo/EFO_0801845,0.852,None
prot-a-642,Carboxypeptidase A2,carboxypeptidase A2 measurement,EFO:0801451,http://www.ebi.ac.uk/efo/EFO_0801451,0.905,None
met-a-305,Histidine,histidinemia,MONDO:0009345,http://purl.obolibrary.org/obo/MONDO_0009345,0.827,None
prot-a-39,AarF domain-containing protein kinase 4,aarF domain-containing protein kinase 4 measurement,EFO:0802247,http://www.ebi.ac.uk/efo/EFO_0802247,0.879,None
ebi-a-GCST90012010,Proteinase-activated receptor 1 levels,proteinase-activated receptor 1 measurement,EFO:0010926,http://www.ebi.ac.uk/efo/EFO_0010926,0.711,None
prot-a-2786,Synaptosomal-associated protein 25,synaptosomal-associated protein 25 measurement,EFO:0021858,http://www.ebi.ac.uk/efo/EFO_0021858,0.819,None
prot-a-2872,Double-stranded RNA-binding protein Staufen homolog 2,double-stranded RNA-binding protein Staufen homolog 2 measurement,EFO:0801547,http://www.ebi.ac.uk/efo/EFO_0801547,0.845,None
ieu-b-118,HOMA-IR,insulin resistance,EFO:0002614,http://www.ebi.ac.uk/efo/EFO_0002614,0.659,None
prot-c-2917_3_2,sRANKL,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.728,None
met-a-473,Dodecanedioate,dodecanedioate measurement,EFO:0021054,http://www.ebi.ac.uk/efo/EFO_0021054,0.895,None
prot-a-2393,Trypsin-3,trypsin-1 measurement,EFO:0020790,http://www.ebi.ac.uk/efo/EFO_0020790,0.677,None
prot-a-2846,Somatostatin-28,somatostatinoma,EFO:1001187,http://www.ebi.ac.uk/efo/EFO_1001187,0.748,None
prot-a-2842,Lupus La protein,lupus La protein measurement,EFO:0802713,http://www.ebi.ac.uk/efo/EFO_0802713,0.873,None
prot-a-2639,Scavenger receptor class A member 5,scavenger receptor class A member 5 measurement,EFO:0802037,http://www.ebi.ac.uk/efo/EFO_0802037,0.936,None
bbj-a-15,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
prot-a-3059,Tumor necrosis factor ligand superfamily member 15,tumor necrosis factor ligand superfamily member 15 measurement,EFO:0020794,http://www.ebi.ac.uk/efo/EFO_0020794,0.94,None
prot-a-2677,Semaphorin-6A,semaphorin-6A measurement,EFO:0020721,http://www.ebi.ac.uk/efo/EFO_0020721,0.627,None
prot-a-1808,Lactotransferrin,lactotransferrin measurement,EFO:0020526,http://www.ebi.ac.uk/efo/EFO_0020526,0.891,None
prot-a-90,Anaphase-promoting complex subunit 10,anaphase-promoting complex subunit 10 measurement,EFO:0802277,http://www.ebi.ac.uk/efo/EFO_0802277,0.854,None
ukb-b-8442,Intake of sugar added to tea,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.615,None
prot-a-1043,Protein FAM19A5,protein FAM19A5 measurement,EFO:0802942,http://www.ebi.ac.uk/efo/EFO_0802942,0.92,None
prot-a-1440,Immunoglobulin superfamily DCC subclass member 3,immunoglobulin superfamily DCC subclass member 3 measurement,EFO:0801689,http://www.ebi.ac.uk/efo/EFO_0801689,0.958,None
ebi-a-GCST90002337,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
prot-c-4151_6_2,Plasminogen,plasma plasminogen measurement,EFO:0006309,http://www.ebi.ac.uk/efo/EFO_0006309,0.818,None
met-d-S_HDL_L,Total lipids in small HDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.787,None
prot-a-1078,Ficolin-2,immunodeficiency due to ficolin3 deficiency,MONDO:0013467,http://purl.obolibrary.org/obo/MONDO_0013467,0.698,None
prot-a-73,RAC-beta serine/threonine-protein kinase,RAC-beta serine/threonine-protein kinase measurement,EFO:0021989,http://www.ebi.ac.uk/efo/EFO_0021989,0.641,None
met-a-313,Fructose,hereditary fructose intolerance,MONDO:0009249,http://purl.obolibrary.org/obo/MONDO_0009249,0.822,None
prot-a-2296,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 measurement",EFO:0020108,http://www.ebi.ac.uk/efo/EFO_0020108,0.828,None
prot-a-3197,"Vascular endothelial growth factor A, isoform 121","vascular endothelial growth factor A, isoform 121 measurement",EFO:0020847,http://www.ebi.ac.uk/efo/EFO_0020847,0.902,None
ukb-d-30200_irnt,Neutrophill percentage,neutrophil percentage of leukocytes,EFO:0007990,http://www.ebi.ac.uk/efo/EFO_0007990,0.917,None
prot-a-3160,NKG2D ligand 1,NKG2D ligand 1 measurement,EFO:0802814,http://www.ebi.ac.uk/efo/EFO_0802814,0.909,None
prot-a-2062,NmrA-like family domain-containing protein 1,nmrA-like family domain-containing protein 1 measurement,EFO:0801844,http://www.ebi.ac.uk/efo/EFO_0801844,0.836,None
prot-a-3155,UTP--glucose-1-phosphate uridylyltransferase,UTP--glucose-1-phosphate uridylyltransferase measurement,EFO:0803243,http://www.ebi.ac.uk/efo/EFO_0803243,0.708,None
met-c-908,Phospholipids in medium LDL,phospholipids in medium LDL measurement,EFO:0022183,http://www.ebi.ac.uk/efo/EFO_0022183,0.916,None
prot-a-2662,Protein transport protein Sec61 subunit gamma,protein transport protein Sec61 subunit gamma measurement,EFO:0802965,http://www.ebi.ac.uk/efo/EFO_0802965,0.955,None
prot-a-102,Ankyrin repeat domain-containing protein 27,ankyrin repeat domain-containing protein 27 measurement,EFO:0802281,http://www.ebi.ac.uk/efo/EFO_0802281,0.906,None
prot-c-5018_68_1,Peroxiredoxin-6,peroxiredoxin-1 measurement,EFO:0020629,http://www.ebi.ac.uk/efo/EFO_0020629,0.807,None
prot-a-988,Endothelial cell-selective adhesion molecule,endothelial cell-selective adhesion molecule measurement,EFO:0008120,http://www.ebi.ac.uk/efo/EFO_0008120,0.868,None
prot-a-819,Probable dimethyladenosine transferase,probable dimethyladenosine transferase measurement,EFO:0801915,http://www.ebi.ac.uk/efo/EFO_0801915,0.933,None
prot-a-2954,Trefoil factor 3,trefoil factor 3 measurement,EFO:0008304,http://www.ebi.ac.uk/efo/EFO_0008304,0.904,None
ieu-a-114,Neo-conscientiousness,conscientiousness measurement,EFO:0007912,http://www.ebi.ac.uk/efo/EFO_0007912,0.808,None
prot-a-2653,"Protein SCO1 homolog, mitochondrial","protein SCO1 homolog, mitochondrial measurement",EFO:0802962,http://www.ebi.ac.uk/efo/EFO_0802962,0.842,None
ebi-a-GCST90001720,BAFF-R on transitional B cell,transitional cell neoplasm,MONDO:0037254,http://purl.obolibrary.org/obo/MONDO_0037254,0.653,None
prot-a-820,GTP-binding protein Di-Ras3,GTP-binding protein Di-Ras3 measurement,EFO:0802584,http://www.ebi.ac.uk/efo/EFO_0802584,0.626,None
prot-a-1696,Laminin subunit alpha-4,laminin subunit alpha-4 measurement,EFO:0801755,http://www.ebi.ac.uk/efo/EFO_0801755,0.732,None
prot-a-1838,MANSC domain-containing protein 1,MANSC domain-containing protein 1 measurement,EFO:0801784,http://www.ebi.ac.uk/efo/EFO_0801784,0.858,None
prot-a-1435,Interferon lambda-1,interferon lambda receptor 1 measurement,EFO:0802646,http://www.ebi.ac.uk/efo/EFO_0802646,0.823,None
prot-a-1430,Interferon gamma receptor 1,interferon gamma receptor 1 measurement,EFO:0020484,http://www.ebi.ac.uk/efo/EFO_0020484,0.905,None
met-a-526,HWESASXX*,HWESASXX measurement,EFO:0021147,http://www.ebi.ac.uk/efo/EFO_0021147,0.928,None
prot-a-2835,"Spectrin alpha chain, non-erythrocytic 1","spectrin alpha chain, non-erythrocytic 1 measurement",EFO:0020749,http://www.ebi.ac.uk/efo/EFO_0020749,0.791,None
ebi-a-GCST90012011,TNF-related apoptosis-inducing ligand levels,TNF-related apoptosis-inducing ligand measurement,EFO:0008300,http://www.ebi.ac.uk/efo/EFO_0008300,0.721,None
prot-a-1683,"Keratin, type I cytoskeletal 18","keratin, type I cytoskeletal 18 measurement",EFO:0020517,http://www.ebi.ac.uk/efo/EFO_0020517,0.861,None
ebi-a-GCST90010109,"Carbonic anhydrase 5A,mitochondrial levels","carbonic anhydrase 5A, mitochondrial measurement",EFO:0801450,http://www.ebi.ac.uk/efo/EFO_0801450,0.808,None
met-d-M_VLDL_L,Total lipids in medium VLDL,total lipids in medium VLDL,EFO:0022153,http://www.ebi.ac.uk/efo/EFO_0022153,0.972,None
met-a-709,Tetradecanedioate,tetradecanedioate measurement,EFO:0021057,http://www.ebi.ac.uk/efo/EFO_0021057,0.906,None
met-a-633,X-12556,X-12556 measurement,EFO:0021316,http://www.ebi.ac.uk/efo/EFO_0021316,0.714,None
ebi-a-GCST90001475,HLA DR++ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.674,None
prot-a-1236,N-acetylglucosamine-6-sulfatase,mucopolysaccharidosis type 3D,MONDO:0009658,http://purl.obolibrary.org/obo/MONDO_0009658,0.707,None
prot-a-965,Ephrin type-B receptor 6,ephrin type-b receptor 6 measurement,EFO:0020355,http://www.ebi.ac.uk/efo/EFO_0020355,0.689,None
ebi-a-GCST90002096,CD11b on basophil,basophil adenoma,EFO:1000834,http://www.ebi.ac.uk/efo/EFO_1000834,0.627,None
ebi-a-GCST90010311,Protein FAM3C levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.6,None
prot-a-2943,Transcriptional enhancer factor TEF-3,transcriptional enhancer factor TEF-3 measurement,EFO:0803166,http://www.ebi.ac.uk/efo/EFO_0803166,0.801,None
ukb-b-9487,Age started hormone-replacement therapy (HRT),hormone replacement therapy,EFO:0003961,http://www.ebi.ac.uk/efo/EFO_0003961,0.798,None
prot-a-441,Hematopoietic progenitor cell antigen CD34,hematopoietic progenitor cell antigen CD34 measurement,EFO:0801667,http://www.ebi.ac.uk/efo/EFO_0801667,0.938,None
ieu-a-1076,Selenium,selenium measurement,EFO:0006331,http://www.ebi.ac.uk/efo/EFO_0006331,0.826,None
prot-a-392,C-C motif chemokine 15,CCL15 measurement,EFO:0009413,http://www.ebi.ac.uk/efo/EFO_0009413,0.743,None
ebi-a-GCST90010331,Neural proliferation differentiation and control protein 1 levels,neural proliferation differentiation and control protein 1 measurement,EFO:0802795,http://www.ebi.ac.uk/efo/EFO_0802795,0.896,None
prot-b-25,matrix metallopeptidase 3,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.613,None
prot-a-488,Cadherin-related family member 3,cadherin-related family member 3 measurement,EFO:0802352,http://www.ebi.ac.uk/efo/EFO_0802352,0.86,None
prot-a-3113,Tetratricopeptide repeat protein 9B,tetratricopeptide repeat protein 9B measurement,EFO:0803145,http://www.ebi.ac.uk/efo/EFO_0803145,0.942,None
prot-a-2681,Semenogelin-1,semenogelin-1 measurement,EFO:0802051,http://www.ebi.ac.uk/efo/EFO_0802051,0.735,None
ukb-b-4512,Duration of other exercises,exercise,EFO:0000483,http://www.ebi.ac.uk/efo/EFO_0000483,0.756,None
prot-a-1535,Interleukin-5,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.94,None
prot-a-711,Cardiotrophin-1,cardiotrophin-1 measurement,EFO:0020235,http://www.ebi.ac.uk/efo/EFO_0020235,0.71,None
prot-a-3189,Vesicle-associated membrane protein-associated protein A,vesicle-associated membrane protein-associated protein A measurement,EFO:0802213,http://www.ebi.ac.uk/efo/EFO_0802213,0.858,None
ebi-a-GCST90010350,Sulfatase-modifying factor 2 levels,sulfatase-modifying factor 1 measurement,EFO:0802098,http://www.ebi.ac.uk/efo/EFO_0802098,0.752,None
ieu-a-106,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
prot-a-412,Cerebral cavernous malformations 2 protein,famililal cerebral cavernous malformations,MONDO:0031037,http://purl.obolibrary.org/obo/MONDO_0031037,0.939,None
ukb-b-16156,Fasting time,fasting,EFO:0002756,http://www.ebi.ac.uk/efo/EFO_0002756,0.711,None
ebi-a-GCST004622,Reticulocyte count,reticulocyte count,EFO:0007986,http://www.ebi.ac.uk/efo/EFO_0007986,0.984,None
prot-a-294,C1GALT1-specific chaperone 1,C1GALT1-specific chaperone 1 measurement,EFO:0801437,http://www.ebi.ac.uk/efo/EFO_0801437,0.835,None
prot-a-147,Rho GTPase-activating protein 1,rho GTPase-activating protein 1 measurement,EFO:0803015,http://www.ebi.ac.uk/efo/EFO_0803015,0.838,None
prot-a-454,Lymphocyte function-associated antigen 3,lymphocyte function-associated antigen 3 measurement,EFO:0802715,http://www.ebi.ac.uk/efo/EFO_0802715,0.87,None
prot-a-3077,Torsin-1A-interacting protein 2,torsin-1A-interacting protein 2 measurement,EFO:0803160,http://www.ebi.ac.uk/efo/EFO_0803160,0.613,None
prot-a-543,Chitotriosidase-1,chitotriosidase-1 measurement,EFO:0008084,http://www.ebi.ac.uk/efo/EFO_0008084,0.753,None
prot-a-2644,Secretogranin-2,secretogranin-1 measurement,EFO:0803047,http://www.ebi.ac.uk/efo/EFO_0803047,0.746,None
prot-a-1063,"Fructose-1,6-bisphosphatase 1","fructose-1,6-bisphosphatase 1 measurement",EFO:0801606,http://www.ebi.ac.uk/efo/EFO_0801606,0.686,None
prot-a-756,Cytochrome P450 3A4,cytochrome p450 3a4 measurement,EFO:0020303,http://www.ebi.ac.uk/efo/EFO_0020303,0.922,None
prot-a-1111,Vascular endothelial growth factor D,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.968,None
prot-c-3004_67_2,PD-L2,late-onset Parkinson disease,MONDO:0008199,http://purl.obolibrary.org/obo/MONDO_0008199,0.757,None
prot-a-1702,Linker for activation of T-cells family member 2,linker for activation of T-cells family member 2 measurement,EFO:0802710,http://www.ebi.ac.uk/efo/EFO_0802710,0.827,None
prot-a-448,T-cell surface glycoprotein CD4,t-cell surface glycoprotein CD4 measurement,EFO:0020760,http://www.ebi.ac.uk/efo/EFO_0020760,0.834,None
prot-a-1470,Interleukin-12,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.88,None
prot-a-1244,Cell surface A33 antigen,cell surface A33 antigen measurement,EFO:0802385,http://www.ebi.ac.uk/efo/EFO_0802385,0.937,None
prot-a-1293,Guanylyl cyclase-activating protein 1,guanylyl cyclase-activating protein 1 measurement,EFO:0801663,http://www.ebi.ac.uk/efo/EFO_0801663,0.858,None
met-a-660,X-12786,X-12786 measurement,EFO:0021334,http://www.ebi.ac.uk/efo/EFO_0021334,0.7,None
prot-a-2799,"Superoxide dismutase [Mn], mitochondrial","superoxide dismutase [Mn], mitochondrial measurement",EFO:0008294,http://www.ebi.ac.uk/efo/EFO_0008294,0.661,None
ebi-a-GCST90002359,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-a-2779,SPARC-related modular calcium-binding protein 1,sPARC-related modular calcium-binding protein 1 measurement,EFO:0021868,http://www.ebi.ac.uk/efo/EFO_0021868,0.732,None
prot-a-1996,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,n-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase measurement,EFO:0801816,http://www.ebi.ac.uk/efo/EFO_0801816,0.802,None
met-a-603,1-docosahexaenoylglycerophosphocholine*,1-docosahexaenoylglycerophosphocholine measurement,EFO:0021079,http://www.ebi.ac.uk/efo/EFO_0021079,0.874,None
ubm-a-438,IDP dMRI TBSS L3 Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.604,None
ieu-a-1087,Chronotype,chronotype measurement,EFO:0008328,http://www.ebi.ac.uk/efo/EFO_0008328,0.818,None
met-a-461,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement,EFO:0021053,http://www.ebi.ac.uk/efo/EFO_0021053,0.624,None
met-b-141,CD123 on mDC,congenital muscular dystrophy,MONDO:0019950,http://purl.obolibrary.org/obo/MONDO_0019950,0.686,None
met-a-450,"Bilirubin (Z,Z)",bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.613,None
met-a-364,Phosphate,phosphate measurement,EFO:0010968,http://www.ebi.ac.uk/efo/EFO_0010968,0.799,None
met-a-634,1-arachidonoylglycerophosphoinositol*,1-arachidonoylglycerophosphoinositol measurement,EFO:0021078,http://www.ebi.ac.uk/efo/EFO_0021078,0.863,None
ebi-a-GCST90010156,Proteinase-activated receptor 1 levels,proteinase-activated receptor 1 measurement,EFO:0010926,http://www.ebi.ac.uk/efo/EFO_0010926,0.711,None
ubm-a-294,IDP dMRI TBSS MO Genu of corpus callosum,Agenesis of corpus callosum,HP:0001274,http://purl.obolibrary.org/obo/HP_0001274,0.614,None
prot-a-1151,"Alpha-(1,3)-fucosyltransferase 10",fucosyltransferase 6 deficiency,MONDO:0013462,http://purl.obolibrary.org/obo/MONDO_0013462,0.73,None
ieu-a-1069,Sitting height ratio,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.993,None
prot-a-885,"Ectodysplasin-A, secreted form","ectodysplasin-a, secreted form measurement",EFO:0020341,http://www.ebi.ac.uk/efo/EFO_0020341,0.756,None
ieu-b-4861,Chronotype,chronotype measurement,EFO:0008328,http://www.ebi.ac.uk/efo/EFO_0008328,0.818,None
prot-a-1169,Polypeptide N-acetylgalactosaminyltransferase 16,polypeptide N-acetylgalactosaminyltransferase 16 measurement,EFO:0801900,http://www.ebi.ac.uk/efo/EFO_0801900,0.891,None
prot-a-3000,Transmembrane protein 132C,transmembrane protein 132C measurement,EFO:0802152,http://www.ebi.ac.uk/efo/EFO_0802152,0.935,None
prot-a-1122,Leucine-rich repeat transmembrane protein FLRT1,leucine-rich repeat transmembrane protein FLRT1 measurement,EFO:0020533,http://www.ebi.ac.uk/efo/EFO_0020533,0.9,None
prot-a-2261,Membrane-associated progesterone receptor component 2,membrane-associated progesterone receptor component 2 measurement,EFO:0801796,http://www.ebi.ac.uk/efo/EFO_0801796,0.891,None
ieu-a-1037,Difference in height between childhood and adulthood,interstitial lung disease in childhood and adulthood,MONDO:0017030,http://purl.obolibrary.org/obo/MONDO_0017030,0.678,None
met-d-S_VLDL_TG_pct,Triglycerides to total lipids ratio in small VLDL,total lipids in small VLDL,EFO:0022148,http://www.ebi.ac.uk/efo/EFO_0022148,0.713,None
prot-a-59,Agouti-related protein,Agouti-related protein measurement,EFO:0008016,http://www.ebi.ac.uk/efo/EFO_0008016,0.738,None
ieu-a-76,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-1966,Mucin-1,cutaneous mucinosis,MONDO:0002523,http://purl.obolibrary.org/obo/MONDO_0002523,0.721,None
ebi-a-GCST90002230,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-2417,26S proteasome non-ATPase regulatory subunit 4,26S proteasome non-ATPase regulatory subunit 4 measurement,EFO:0802235,http://www.ebi.ac.uk/efo/EFO_0802235,0.888,None
prot-a-1113,Peptidyl-prolyl cis-trans isomerase FKBP14,peptidyl-prolyl cis-trans isomerase FKBP14 measurement,EFO:0801872,http://www.ebi.ac.uk/efo/EFO_0801872,0.841,None
prot-a-1329,Probable E3 ubiquitin-protein ligase HERC1,probable E3 ubiquitin-protein ligase HERC1 measurement,EFO:0802902,http://www.ebi.ac.uk/efo/EFO_0802902,0.91,None
prot-a-1515,Interleukin-25,interleukin 25 measurement,EFO:0008182,http://www.ebi.ac.uk/efo/EFO_0008182,0.875,None
met-a-465,Trans-4-hydroxyproline,hydroxyprolinemia,MONDO:0009374,http://purl.obolibrary.org/obo/MONDO_0009374,0.798,None
prot-c-4125_52_2,sRAGE,sRAGE measurement,EFO:0007622,http://www.ebi.ac.uk/efo/EFO_0007622,0.819,None
prot-a-790,Beta-defensin 115,beta-defensin 115 measurement,EFO:0802321,http://www.ebi.ac.uk/efo/EFO_0802321,0.762,None
prot-a-1243,Platelet glycoprotein V,platelet glycoprotein V measurement,EFO:0802872,http://www.ebi.ac.uk/efo/EFO_0802872,0.894,None
prot-c-4413_3_2,SLPI,lysinuric protein intolerance,MONDO:0009109,http://purl.obolibrary.org/obo/MONDO_0009109,0.609,None
met-a-525,X-11497,X-11497 measurement,EFO:0021246,http://www.ebi.ac.uk/efo/EFO_0021246,0.695,None
ieu-a-53,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ukb-b-17627,Non-oily fish intake,fish consumption measurement,EFO:0010139,http://www.ebi.ac.uk/efo/EFO_0010139,0.643,None
prot-a-3015,"Transmembrane protein 70, mitochondrial","transmembrane protein 70, mitochondrial measurement",EFO:0803188,http://www.ebi.ac.uk/efo/EFO_0803188,0.829,None
prot-c-2942_50_2,Cytochrome c,cytochrome C measurement,EFO:0020302,http://www.ebi.ac.uk/efo/EFO_0020302,0.812,None
met-a-472,Scyllo-inositol,scyllo-inositol measurement,EFO:0011001,http://www.ebi.ac.uk/efo/EFO_0011001,0.72,None
ebi-a-GCST90010206,Carboxypeptidase B levels,carboxypeptidase B measurement,EFO:0801453,http://www.ebi.ac.uk/efo/EFO_0801453,0.821,None
met-c-891,Phospholipids in large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.913,None
prot-a-426,CD209 antigen,CD209 antigen measurement,EFO:0008077,http://www.ebi.ac.uk/efo/EFO_0008077,0.898,None
prot-a-1965,"Peptide chain release factor 1-like, mitochondrial","peptide chain release factor 1-like, mitochondrial measurement",EFO:0801870,http://www.ebi.ac.uk/efo/EFO_0801870,0.82,None
prot-a-1124,Leucine-rich repeat transmembrane protein FLRT3,leucine-rich repeat transmembrane protein FLRT3 measurement,EFO:0021861,http://www.ebi.ac.uk/efo/EFO_0021861,0.903,None
ebi-a-GCST90010275,Urokinase plasminogen activator surface receptor levels,urokinase plasminogen activator surface receptor measurement,EFO:0010932,http://www.ebi.ac.uk/efo/EFO_0010932,0.908,None
ebi-a-GCST004453,Interleukin-4 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.802,None
ebi-a-GCST90012113,Total testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.868,None
met-a-743,Tryptophan betaine,tryptophan betaine measurement,EFO:0021017,http://www.ebi.ac.uk/efo/EFO_0021017,0.892,None
ukb-b-6591,Age first had sexual intercourse,age at first sexual intercourse measurement,EFO:0009749,http://www.ebi.ac.uk/efo/EFO_0009749,0.849,None
ieu-b-4859,Physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.995,None
met-d-PUFA_pct,Ratio of polyunsaturated fatty acids to total fatty acids,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.74,None
prot-b-27,TNF superfamily member 10,tumor necrosis factor alpha gene expression measurement,EFO:0600069,http://www.ebi.ac.uk/efo/EFO_0600069,0.716,None
ieu-a-1004,Age at menopause,age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.987,None
prot-a-47,Alcohol dehydrogenase 4,alcohol dehydrogenase 4 measurement,EFO:0802261,http://www.ebi.ac.uk/efo/EFO_0802261,0.902,None
ieu-a-116,Neo-neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.852,None
prot-a-2937,Thromboxane-A synthase,thromboxane-A synthase measurement,EFO:0803152,http://www.ebi.ac.uk/efo/EFO_0803152,0.76,None
prot-a-892,Endothelin-2,corneal endothelial dystrophy,MONDO:0000766,http://purl.obolibrary.org/obo/MONDO_0000766,0.67,None
ebi-a-GCST90010209,Cathepsin Z levels,cathepsin Z measurement,EFO:0008074,http://www.ebi.ac.uk/efo/EFO_0008074,0.735,None
ebi-a-GCST90012014,Tissue factor levels,tissue factor measurement,EFO:0010623,http://www.ebi.ac.uk/efo/EFO_0010623,0.719,None
ukb-b-5359,Alcohol,alcohol abuse,MONDO:0002046,http://purl.obolibrary.org/obo/MONDO_0002046,0.796,None
prot-a-2301,Angiostatin,angiostatin measurement,EFO:0008024,http://www.ebi.ac.uk/efo/EFO_0008024,0.813,None
prot-a-2678,Semaphorin-6A,semaphorin-6A measurement,EFO:0020721,http://www.ebi.ac.uk/efo/EFO_0020721,0.627,None
prot-c-4982_54_1,Elafin,elafin measurement,EFO:0008117,http://www.ebi.ac.uk/efo/EFO_0008117,0.846,None
ebi-a-GCST90010266,Tumor necrosis factor receptor 1 levels,tumor necrosis factor receptor 1 measurement,EFO:0010931,http://www.ebi.ac.uk/efo/EFO_0010931,0.847,None
prot-a-2734,Signal-regulatory protein beta-2,signal-regulatory protein beta-1 measurement,EFO:0802069,http://www.ebi.ac.uk/efo/EFO_0802069,0.717,None
prot-a-3166,Netrin receptor UNC5A,netrin receptor UNC5A measurement,EFO:0802791,http://www.ebi.ac.uk/efo/EFO_0802791,0.916,None
prot-a-82,Ameloblastin,ameloblastin measurement,EFO:0801377,http://www.ebi.ac.uk/efo/EFO_0801377,0.839,None
prot-a-475,Serine/threonine-protein kinase MRCK alpha,serine/threonine-protein kinase MRCK alpha measurement,EFO:0802058,http://www.ebi.ac.uk/efo/EFO_0802058,0.789,None
prot-a-1753,Lipase member N,lipase member N measurement,EFO:0801770,http://www.ebi.ac.uk/efo/EFO_0801770,0.881,None
ebi-a-GCST002920,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
prot-a-1472,Interleukin-23,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.839,None
ukb-d-30270_irnt,Mean sphered cell volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.801,None
ieu-b-109,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
met-c-946,Concentration of very large HDL particles,concentration of large HDL particles measurement,EFO:0022188,http://www.ebi.ac.uk/efo/EFO_0022188,0.871,None
ebi-a-GCST90010324,Low-density lipoprotein receptor-related protein 11 levels,low-density lipoprotein receptor-related protein 8 measurement,EFO:0020538,http://www.ebi.ac.uk/efo/EFO_0020538,0.722,None
prot-a-1426,Interferon alpha/beta receptor 1,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.767,None
prot-c-4158_54_2,uPA,urothelial papilloma,MONDO:0004041,http://purl.obolibrary.org/obo/MONDO_0004041,0.999,None
prot-a-2165,Marginal zone B- and B1-cell-specific protein,marginal zone B- and B1-cell-specific protein measurement,EFO:0802730,http://www.ebi.ac.uk/efo/EFO_0802730,0.663,None
prot-a-1638,DNA/RNA-binding protein KIN17,DNA/RNA-binding protein KIN17 measurement,EFO:0801536,http://www.ebi.ac.uk/efo/EFO_0801536,0.64,None
ieu-a-1032,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
prot-a-2988,Toll-like receptor 1,toll-like receptor 1 measurement,EFO:0803159,http://www.ebi.ac.uk/efo/EFO_0803159,0.738,None
ieu-a-1077,Selenium,selenium measurement,EFO:0006331,http://www.ebi.ac.uk/efo/EFO_0006331,0.826,None
ebi-a-GCST004427,Stromal-cell-derived factor 1 alpha levels,stromal cell-derived factor 1 alpha measurement,EFO:0008293,http://www.ebi.ac.uk/efo/EFO_0008293,0.738,None
met-c-951,Phospholipids in very large VLDL,phospholipids in large VLDL measurement,EFO:0022169,http://www.ebi.ac.uk/efo/EFO_0022169,0.855,None
ebi-a-GCST005073,Triglyceride levels,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.987,None
met-d-XS_VLDL_C_pct,Cholesterol to total lipids ratio in very small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.756,None
prot-a-1087,Fibroblast growth factor 10,fibroblast growth factor 10 measurement,EFO:0020376,http://www.ebi.ac.uk/efo/EFO_0020376,0.91,None
prot-a-1373,Activator of apoptosis harakiri,activator of apoptosis harakiri measurement,EFO:0802253,http://www.ebi.ac.uk/efo/EFO_0802253,0.927,None
prot-a-2533,RGM domain family member B,rgm domain family member b measurement,EFO:0020708,http://www.ebi.ac.uk/efo/EFO_0020708,0.929,None
prot-a-745,C-X-C motif chemokine 16,C-C motif chemokine 16 measurement,EFO:0008044,http://www.ebi.ac.uk/efo/EFO_0008044,0.688,None
prot-a-238,Bcl-2-like protein 1,bcl-2-like protein 2 measurement,EFO:0021928,http://www.ebi.ac.uk/efo/EFO_0021928,0.61,None
met-a-574,Pseudouridine,pseudouridine measurement,EFO:0021126,http://www.ebi.ac.uk/efo/EFO_0021126,0.874,None
prot-a-1334,Hepatocyte growth factor,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.995,None
met-c-928,Free cholesterol in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.792,None
ebi-a-GCST90000048,Age at first birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.907,None
prot-a-1345,"HLA class II histocompatibility antigen, DM alpha chain","HLA class II histocompatibility antigen, DM alpha chain measurement",EFO:0801684,http://www.ebi.ac.uk/efo/EFO_0801684,0.901,None
prot-c-2631_50_2,IL-10 Rb,retinoblastoma,MONDO:0008380,http://purl.obolibrary.org/obo/MONDO_0008380,0.773,None
ukb-a-368,Work/job satisfaction,job satisfaction measurement,EFO:0009723,http://www.ebi.ac.uk/efo/EFO_0009723,0.901,None
prot-a-188,Argininosuccinate lyase,argininosuccinate lyase measurement,EFO:0802287,http://www.ebi.ac.uk/efo/EFO_0802287,0.923,None
ukb-d-30830_irnt,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
prot-a-371,Cerebellin-1,cerebellin-1 measurement,EFO:0801466,http://www.ebi.ac.uk/efo/EFO_0801466,0.641,None
prot-a-2981,Tubulointerstitial nephritis antigen-like,tubulointerstitial nephritis antigen-like measurement,EFO:0803197,http://www.ebi.ac.uk/efo/EFO_0803197,0.868,None
prot-a-2673,Semaphorin-3G,semaphorin-3G measurement,EFO:0802049,http://www.ebi.ac.uk/efo/EFO_0802049,0.655,None
prot-a-1666,Kallikrein-7,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.769,None
ieu-b-4864,Total Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.694,None
prot-a-212,"Beta-1,4-glucuronyltransferase 1","beta-1,4-glucuronyltransferase 1 measurement",EFO:0801412,http://www.ebi.ac.uk/efo/EFO_0801412,0.709,None
prot-a-1507,Interleukin-22,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.831,None
prot-a-620,Collagen alpha-1(XXVI) chain,collagen alpha-1(XXVI) chain measurement,EFO:0802419,http://www.ebi.ac.uk/efo/EFO_0802419,0.601,None
prot-a-464,SLAM family member 5,SLAM family member 5 measurement,EFO:0020741,http://www.ebi.ac.uk/efo/EFO_0020741,0.91,None
prot-a-2300,Pleckstrin homology domain-containing family A member 7,pleckstrin homology domain-containing family A member 7 measurement,EFO:0801891,http://www.ebi.ac.uk/efo/EFO_0801891,0.921,None
prot-a-1331,E3 ISG15--protein ligase HERC5,E3 ISG15--protein ligase HERC5 measurement,EFO:0802501,http://www.ebi.ac.uk/efo/EFO_0802501,0.801,None
met-a-441,X-10429,X-10429 measurement,EFO:0021214,http://www.ebi.ac.uk/efo/EFO_0021214,0.706,None
prot-a-3264,Zinc finger protein 18,zinc finger protein 18 measurement,EFO:0802226,http://www.ebi.ac.uk/efo/EFO_0802226,0.909,None
ukb-b-4439,Ever had eye surgery,ophthalmic procedure,EFO:0010722,http://www.ebi.ac.uk/efo/EFO_0010722,0.785,None
prot-c-5106_52_3,NOTC2,DoTc2,EFO:0002171,http://www.ebi.ac.uk/efo/EFO_0002171,0.786,None
prot-a-553,Carbohydrate sulfotransferase 15,carbohydrate sulfotransferase 15 measurement,EFO:0008066,http://www.ebi.ac.uk/efo/EFO_0008066,0.939,None
ebi-a-GCST90001465,CD86+ myeloid Dendritic Cell %Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.721,None
ebi-a-GCST90010169,Stem cell factor levels,stem Cell Factor measurement,EFO:0008291,http://www.ebi.ac.uk/efo/EFO_0008291,0.703,None
met-c-878,Concentration of large HDL particles,concentration of large HDL particles measurement,EFO:0022188,http://www.ebi.ac.uk/efo/EFO_0022188,0.93,None
prot-c-2484_49_3,TWEAK,tumor necrosis factor ligand superfamily member 12 measurement,EFO:0010801,http://www.ebi.ac.uk/efo/EFO_0010801,0.998,None
prot-a-2524,Resistin,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.727,None
ebi-a-GCST004615,Hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.768,None
ieu-a-110,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
prot-a-1615,Potassium voltage-gated channel subfamily G member 4,potassium voltage-gated channel subfamily G member 4 measurement,EFO:0802891,http://www.ebi.ac.uk/efo/EFO_0802891,0.89,None
ebi-a-GCST004613,Sum neutrophil eosinophil counts,sum of neutrophil and eosinophil counts,EFO:0009390,http://www.ebi.ac.uk/efo/EFO_0009390,0.958,None
prot-a-1844,Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion,mitogen-activated protein kinase kinase kinase 7:tgf-beta-activated kinase 1 and map3k7-binding protein 1 fusion measurement,EFO:0020582,http://www.ebi.ac.uk/efo/EFO_0020582,0.82,None
prot-a-2603,Ribonucleoside-diphosphate reductase subunit M2 B,ribonucleoside-diphosphate reductase subunit M2 B measurement,EFO:0802022,http://www.ebi.ac.uk/efo/EFO_0802022,0.897,None
bbj-a-37,Mean arterial pressure,mean arterial pressure,EFO:0006340,http://www.ebi.ac.uk/efo/EFO_0006340,0.978,None
prot-a-585,Clathrin interactor 1,clathrin interactor 1 measurement,EFO:0801478,http://www.ebi.ac.uk/efo/EFO_0801478,0.874,None
ubm-a-2669,volume CSF,volume,EFO:0001715,http://www.ebi.ac.uk/efo/EFO_0001715,0.661,None
ebi-a-GCST90001944,CD123 on plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.8,None
prot-a-2918,Synaptotagmin-like protein 1,synaptotagmin-like protein 1 measurement,EFO:0803123,http://www.ebi.ac.uk/efo/EFO_0803123,0.855,None
prot-a-1308,Hyaluronan and proteoglycan link protein 1,hyaluronan and proteoglycan link protein 1 measurement,EFO:0020459,http://www.ebi.ac.uk/efo/EFO_0020459,0.924,None
prot-a-2327,Pro-opiomelanocortin,obesity due to pro-opiomelanocortin deficiency,MONDO:0012335,http://purl.obolibrary.org/obo/MONDO_0012335,0.71,None
prot-a-1708,Lipocalin-1,lipocalin-1 measurement,EFO:0802712,http://www.ebi.ac.uk/efo/EFO_0802712,0.647,None
ebi-a-GCST90000442,CCL11 levels,CCL11 measurement,EFO:0005188,http://www.ebi.ac.uk/efo/EFO_0005188,0.748,None
ebi-a-GCST90012058,Melusin levels,melusin measurement,EFO:0010919,http://www.ebi.ac.uk/efo/EFO_0010919,0.696,None
prot-a-2437,Tyrosine-protein phosphatase non-receptor type 11,tyrosine-protein phosphatase non-receptor type 11 measurement,EFO:0020835,http://www.ebi.ac.uk/efo/EFO_0020835,0.816,None
met-a-631,"Bilirubin (E,Z or Z,E)*",Zollinger-Ellison Syndrome,EFO:0007549,http://www.ebi.ac.uk/efo/EFO_0007549,0.641,None
prot-a-800,Beta-defensin 128,beta-defensin 128 measurement,EFO:0801420,http://www.ebi.ac.uk/efo/EFO_0801420,0.762,None
prot-a-2206,Protocadherin gamma-A8,protocadherin gamma-A8 measurement,EFO:0802973,http://www.ebi.ac.uk/efo/EFO_0802973,0.715,None
prot-a-3019,Transmembrane inner ear expressed protein,transmembrane inner ear expressed protein measurement,EFO:0802148,http://www.ebi.ac.uk/efo/EFO_0802148,0.944,None
prot-a-2488,Ran-binding protein 3,protein binding measurement,EFO:0010742,http://www.ebi.ac.uk/efo/EFO_0010742,0.714,None
ieu-a-1020,Percent emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.816,None
prot-a-2427,Prostaglandin F2 receptor negative regulator,prostaglandin F2 receptor negative regulator measurement,EFO:0801931,http://www.ebi.ac.uk/efo/EFO_0801931,0.948,None
prot-a-1491,Interleukin-18 receptor 1,interleukin 18 receptor 1 measurement,EFO:0008178,http://www.ebi.ac.uk/efo/EFO_0008178,0.908,None
met-d-M_LDL_C,Cholesterol in medium LDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.892,None
met-a-373,X-03094,X-03094 measurement,EFO:0021188,http://www.ebi.ac.uk/efo/EFO_0021188,0.673,None
ebi-a-GCST004443,Interleukin-13 levels,interleukin 13 measurement,EFO:0008171,http://www.ebi.ac.uk/efo/EFO_0008171,0.754,None
ubm-a-2675,volume Right-Inf-Lat-Vent,right ventricular systolic volume measurement,EFO:0021815,http://www.ebi.ac.uk/efo/EFO_0021815,0.622,None
prot-a-808,Protein DGCR14,protein DGCR14 measurement,EFO:0801940,http://www.ebi.ac.uk/efo/EFO_0801940,0.919,None
prot-a-1643,Killer cell immunoglobulin-like receptor 2DL5A,killer cell immunoglobulin-like receptor 2DL5A measurement,EFO:0801745,http://www.ebi.ac.uk/efo/EFO_0801745,0.917,None
met-a-551,X-11847,X-11847 measurement,EFO:0021268,http://www.ebi.ac.uk/efo/EFO_0021268,0.699,None
ebi-a-GCST90010119,Decorin levels,decorin measurement,EFO:0020315,http://www.ebi.ac.uk/efo/EFO_0020315,0.606,None
ukb-a-379,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
prot-a-3110,GDP-L-fucose synthase,GDP-L-fucose synthase measurement,EFO:0802564,http://www.ebi.ac.uk/efo/EFO_0802564,0.677,None
ebi-a-GCST008038,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
prot-a-1044,Protein FAM209B,protein FAM209B measurement,EFO:0802943,http://www.ebi.ac.uk/efo/EFO_0802943,0.924,None
met-a-665,X-12844,X-12844 measurement,EFO:0021339,http://www.ebi.ac.uk/efo/EFO_0021339,0.705,None
prot-a-1796,Leucine-rich repeat transmembrane neuronal protein 2,leucine-rich repeat transmembrane neuronal protein 2 measurement,EFO:0802696,http://www.ebi.ac.uk/efo/EFO_0802696,0.882,None
prot-a-614,Conserved oligomeric Golgi complex subunit 8,conserved oligomeric Golgi complex subunit 8 measurement,EFO:0802428,http://www.ebi.ac.uk/efo/EFO_0802428,0.951,None
prot-a-529,Luteinizing hormone,luteinizing hormone measurement,EFO:0007002,http://www.ebi.ac.uk/efo/EFO_0007002,0.899,None
met-d-L_VLDL_CE_pct,Cholesteryl esters to total lipids ratio in large VLDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.705,None
ebi-a-GCST90010224,Interleukin-17 receptor A levels,interleukin 17 receptor A measurement,EFO:0008175,http://www.ebi.ac.uk/efo/EFO_0008175,0.825,None
prot-a-138,MICOS complex subunit MIC26,MICOS complex subunit MIC26 measurement,EFO:0802743,http://www.ebi.ac.uk/efo/EFO_0802743,0.936,None
prot-a-1856,Megakaryocyte-associated tyrosine-protein kinase,megakaryocyte-associated tyrosine-protein kinase measurement,EFO:0020562,http://www.ebi.ac.uk/efo/EFO_0020562,0.831,None
ieu-a-1235,High grade and low grade serous ovarian cancer (survival),high grade ovarian serous adenocarcinoma,EFO:1001958,http://www.ebi.ac.uk/efo/EFO_1001958,0.697,None
prot-a-1048,Protein FAM24B,protein FAM24B measurement,EFO:0802944,http://www.ebi.ac.uk/efo/EFO_0802944,0.912,None
met-a-711,Hexadecanedioate,hexadecanedioate measurement,EFO:0021055,http://www.ebi.ac.uk/efo/EFO_0021055,0.914,None
prot-a-672,Cytotoxic and regulatory T-cell molecule,cytotoxic and regulatory t-cell molecule measurement,EFO:0020311,http://www.ebi.ac.uk/efo/EFO_0020311,0.836,None
prot-c-4989_7_1,Fibrinogen g-chain dimer,fibrinogen gamma chain measurement,EFO:0020374,http://www.ebi.ac.uk/efo/EFO_0020374,0.661,None
met-c-923,Triglycerides in small HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.901,None
prot-a-452,T-cell surface glycoprotein CD5,t-cell surface glycoprotein CD5 measurement,EFO:0803134,http://www.ebi.ac.uk/efo/EFO_0803134,0.847,None
prot-a-3282,Zona pellucida-like domain-containing protein 1,zona pellucida-like domain-containing protein 1 measurement,EFO:0803290,http://www.ebi.ac.uk/efo/EFO_0803290,0.815,None
ieu-a-1236,High grade serous ovarian cancer (survival),high grade ovarian serous adenocarcinoma,EFO:1001958,http://www.ebi.ac.uk/efo/EFO_1001958,0.682,None
prot-a-1117,Filamin-A,myofibrillar myopathy 5,MONDO:0012289,http://purl.obolibrary.org/obo/MONDO_0012289,0.697,None
prot-a-626,Collagen alpha-2(IX) chain,type 2 collagenopathy,MONDO:0022800,http://purl.obolibrary.org/obo/MONDO_0022800,0.602,None
prot-a-1793,Leucine-rich repeat neuronal protein 1,leucine-rich repeat neuronal protein 1 measurement,EFO:0801760,http://www.ebi.ac.uk/efo/EFO_0801760,0.831,None
prot-a-1765,Lactoperoxidase,lactoperoxidase measurement,EFO:0020525,http://www.ebi.ac.uk/efo/EFO_0020525,0.877,None
met-d-L_LDL_FC_pct,Free cholesterol to total lipids ratio in large LDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.734,None
met-a-553,X-11850,X-11850 measurement,EFO:0021270,http://www.ebi.ac.uk/efo/EFO_0021270,0.689,None
prot-a-1955,Macrophage-stimulating protein receptor,macrophage-stimulating protein receptor measurement,EFO:0020550,http://www.ebi.ac.uk/efo/EFO_0020550,0.821,None
prot-c-3038_9_2,I-TAC,persistent truncus arteriosus,MONDO:0018072,http://purl.obolibrary.org/obo/MONDO_0018072,0.851,None
bbj-a-34,Left ventricular mass,left ventricular mass,EFO:0009289,http://www.ebi.ac.uk/efo/EFO_0009289,0.99,None
ebi-a-GCST90012051,Urokinase plasminogen activator surface receptor levels,urokinase plasminogen activator surface receptor measurement,EFO:0010932,http://www.ebi.ac.uk/efo/EFO_0010932,0.908,None
ebi-a-GCST90006897,Anti-Epstein-Barr virus IgG seropositivity,Epstein-Barr virus seropositivity,EFO:0010908,http://www.ebi.ac.uk/efo/EFO_0010908,0.801,None
prot-a-2536,Regulator of G-protein signaling 19,regulator of G-protein signaling 19 measurement,EFO:0801996,http://www.ebi.ac.uk/efo/EFO_0801996,0.786,None
ebi-a-GCST004621,Sum basophil neutrophil counts,sum of basophil and neutrophil counts,EFO:0009388,http://www.ebi.ac.uk/efo/EFO_0009388,0.957,None
prot-a-2549,Regulator of microtubule dynamics protein 1,regulator of microtubule dynamics protein 1 measurement,EFO:0801998,http://www.ebi.ac.uk/efo/EFO_0801998,0.94,None
prot-a-2505,RNA-binding protein 3,RNA-binding protein 3 measurement,EFO:0802031,http://www.ebi.ac.uk/efo/EFO_0802031,0.712,None
prot-a-1310,Hepatitis A virus cellular receptor 1,hepatitis A virus cellular receptor 1 measurement,EFO:0010601,http://www.ebi.ac.uk/efo/EFO_0010601,0.925,None
met-d-L_LDL_C_pct,Cholesterol to total lipids ratio in large LDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.786,None
prot-a-1931,MAGUK p55 subfamily member 6,MAGUK p55 subfamily member 6 measurement,EFO:0801781,http://www.ebi.ac.uk/efo/EFO_0801781,0.951,None
met-c-921,Total lipids in small HDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.787,None
ukb-b-10787,Standing height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.708,None
prot-b-74,C-C motif chemokine ligand 20,C-C motif chemokine 20 measurement,EFO:0010910,http://www.ebi.ac.uk/efo/EFO_0010910,0.623,None
prot-a-66,Adenylate kinase isoenzyme 1,adenylate kinase isoenzyme 1 measurement,EFO:0020129,http://www.ebi.ac.uk/efo/EFO_0020129,0.925,None
prot-a-52,Adenylosuccinate synthetase isozyme 1,adenylosuccinate synthetase isozyme 1 measurement,EFO:0802256,http://www.ebi.ac.uk/efo/EFO_0802256,0.94,None
prot-a-574,C-type lectin domain family 2 member D,C-type lectin domain family 2 member D measurement,EFO:0801434,http://www.ebi.ac.uk/efo/EFO_0801434,0.797,None
prot-a-1739,Leukocyte immunoglobulin-like receptor subfamily A member 5,leukocyte immunoglobulin-like receptor subfamily A member 5 measurement,EFO:0801766,http://www.ebi.ac.uk/efo/EFO_0801766,0.921,None
prot-a-1381,17-beta-hydroxysteroid dehydrogenase 14,"46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",MONDO:0009916,http://purl.obolibrary.org/obo/MONDO_0009916,0.855,None
ebi-a-GCST90002301,Eosinophil counts,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.922,None
ebi-a-GCST006097,Moderate to vigorous physical activity levels,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.619,None
ieu-a-1083,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
ebi-a-GCST005063,Glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.992,None
prot-a-563,CDGSH iron-sulfur domain-containing protein 2,CDGSH iron-sulfur domain-containing protein 2 measurement,EFO:0802379,http://www.ebi.ac.uk/efo/EFO_0802379,0.861,None
prot-b-33,adrenomedullin,adrenomedullin measurement,EFO:0010909,http://www.ebi.ac.uk/efo/EFO_0010909,0.849,None
met-d-L_VLDL_FC_pct,Free cholesterol to total lipids ratio in large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.743,None
prot-a-1588,Integral membrane protein 2A,integral membrane protein 2A measurement,EFO:0801704,http://www.ebi.ac.uk/efo/EFO_0801704,0.919,None
prot-a-1816,Tyrosine-protein kinase Lyn,tyrosine-protein kinase lyn measurement,EFO:0020827,http://www.ebi.ac.uk/efo/EFO_0020827,0.814,None
prot-a-286,Uncharacterized protein C17orf67,uncharacterized protein C17orf67 measurement,EFO:0803223,http://www.ebi.ac.uk/efo/EFO_0803223,0.954,None
prot-a-1869,Malignant T-cell-amplified sequence 1,malignant T-cell-amplified sequence 1 measurement,EFO:0801782,http://www.ebi.ac.uk/efo/EFO_0801782,0.749,None
ebi-a-GCST90001470,CD62L- plasmacytoid Dendritic Cell Absolute Count,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.669,None
prot-a-191,Aspartyl/asparaginyl beta-hydroxylase,aspartyl/asparaginyl beta-hydroxylase measurement,EFO:0801396,http://www.ebi.ac.uk/efo/EFO_0801396,0.777,None
prot-a-1664,Kallikrein-5,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.779,None
ieu-b-107,apolipoprotein A-I,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.804,None
prot-a-3129,Tyrosine-protein kinase receptor TYRO3,tyrosine-protein kinase receptor TYRO3 measurement,EFO:0020829,http://www.ebi.ac.uk/efo/EFO_0020829,0.881,None
ebi-a-GCST90006893,Anti-cytomegalovirus IgG seropositivity,cytomegalovirus seropositivity,EFO:0007037,http://www.ebi.ac.uk/efo/EFO_0007037,0.888,None
met-a-701,X-13671,X-13671 measurement,EFO:0021358,http://www.ebi.ac.uk/efo/EFO_0021358,0.711,None
prot-a-2338,Phosphopantothenoylcysteine decarboxylase,phosphopantothenoylcysteine decarboxylase measurement,EFO:0802867,http://www.ebi.ac.uk/efo/EFO_0802867,0.95,None
prot-a-1498,Interleukin-1 receptor type 2,interleukin-1 receptor type 2 measurement,EFO:0021842,http://www.ebi.ac.uk/efo/EFO_0021842,0.795,None
met-a-659,Gamma-glutamylisoleucine*,gamma-glutamylisoleucine measurement,EFO:0021139,http://www.ebi.ac.uk/efo/EFO_0021139,0.813,None
ieu-a-1066,Simple reaction time,reaction time measurement,EFO:0008393,http://www.ebi.ac.uk/efo/EFO_0008393,0.624,None
prot-a-2004,Next to BRCA1 gene 1 protein,next to BRCA1 gene 1 protein measurement,EFO:0801838,http://www.ebi.ac.uk/efo/EFO_0801838,0.921,None
prot-a-385,"Coiled-coil domain-containing protein 90B, mitochondrial","coiled-coil domain-containing protein 90B, mitochondrial measurement",EFO:0802413,http://www.ebi.ac.uk/efo/EFO_0802413,0.808,None
prot-a-2274,Serine/threonine-protein kinase pim-1,serine/threonine-protein kinase PIM-1 measurement,EFO:0020731,http://www.ebi.ac.uk/efo/EFO_0020731,0.636,None
prot-a-1322,Haloacid dehalogenase-like hydrolase domain-containing protein 2,haloacid dehalogenase-like hydrolase domain-containing protein 2 measurement,EFO:0801664,http://www.ebi.ac.uk/efo/EFO_0801664,0.872,None
prot-a-144,ADP-ribosylation factor GTPase-activating protein 2,ADP-ribosylation factor GTPase-activating protein 2 measurement,EFO:0801351,http://www.ebi.ac.uk/efo/EFO_0801351,0.817,None
ebi-a-GCST90010105,Protein AMBP levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.641,None
prot-a-3242,DNA repair protein XRCC4,DNA repair protein XRCC4 measurement,EFO:0801532,http://www.ebi.ac.uk/efo/EFO_0801532,0.938,None
prot-a-2003,Neuroblastoma suppressor of tumorigenicity 1,neuroblastoma suppressor of tumorigenicity 1 measurement,EFO:0020598,http://www.ebi.ac.uk/efo/EFO_0020598,0.925,None
prot-a-3112,Tetratricopeptide repeat protein 17,tetratricopeptide repeat protein 17 measurement,EFO:0803144,http://www.ebi.ac.uk/efo/EFO_0803144,0.936,None
prot-a-959,Ephrin type-A receptor 5,ephrin type-a receptor 5 measurement,EFO:0020353,http://www.ebi.ac.uk/efo/EFO_0020353,0.683,None
ukb-b-4953,Most recent bowel cancer screening,intestinal cancer,EFO:0007330,http://www.ebi.ac.uk/efo/EFO_0007330,0.609,None
met-a-388,Aspartate,aspartate measurement,EFO:0010462,http://www.ebi.ac.uk/efo/EFO_0010462,0.823,None
ebi-a-GCST90002313,Hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.768,None
ebi-a-GCST003367,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
met-d-L_VLDL_C_pct,Cholesterol to total lipids ratio in large VLDL,total cholesterol in large VLDL,EFO:0022177,http://www.ebi.ac.uk/efo/EFO_0022177,0.793,None
prot-a-2276,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha,phosphatidylinositol 5-phosphate 4-kinase type-2 alpha measurement,EFO:0802861,http://www.ebi.ac.uk/efo/EFO_0802861,0.758,None
prot-a-1676,Histone-lysine N-methyltransferase 2C,histone-lysine N-methyltransferase 2C measurement,EFO:0801682,http://www.ebi.ac.uk/efo/EFO_0801682,0.784,None
met-c-893,"18:2, linoleic acid (LA)",linoleic acid measurement,EFO:0006807,http://www.ebi.ac.uk/efo/EFO_0006807,0.714,None
prot-a-1119,Filamin-A,myofibrillar myopathy 5,MONDO:0012289,http://purl.obolibrary.org/obo/MONDO_0012289,0.697,None
ebi-a-GCST005346,Total body bone mineral density (age 30-45),bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.678,None
met-a-328,Malate,malate measurement,EFO:0010508,http://www.ebi.ac.uk/efo/EFO_0010508,0.676,None
prot-a-943,Endoglin,endoglin measurement,EFO:0008118,http://www.ebi.ac.uk/efo/EFO_0008118,0.819,None
prot-a-2302,Plasmin,plasmin measurement,EFO:0020643,http://www.ebi.ac.uk/efo/EFO_0020643,0.749,None
met-a-745,Chiro-inositol,chiro-inositol measurement,EFO:0800270,http://www.ebi.ac.uk/efo/EFO_0800270,0.661,None
prot-a-3010,Transmembrane protein 40,transmembrane protein 40 measurement,EFO:0803185,http://www.ebi.ac.uk/efo/EFO_0803185,0.921,None
prot-a-271,Transcription factor IIIB 90 kDa subunit,transcription factor IIIb 90 kda subunit measurement,EFO:0020778,http://www.ebi.ac.uk/efo/EFO_0020778,0.951,None
ebi-a-GCST005065,"Cholesterol, total",total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-a-2072,Neural proliferation differentiation and control protein 1,neural proliferation differentiation and control protein 1 measurement,EFO:0802795,http://www.ebi.ac.uk/efo/EFO_0802795,0.936,None
met-a-446,Indoleacetate,indoleacetate measurement,EFO:0021015,http://www.ebi.ac.uk/efo/EFO_0021015,0.872,None
bbj-a-53,Total bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.738,None
prot-b-72,natriuretic peptide B,natriuretic peptides B measurement,EFO:0010628,http://www.ebi.ac.uk/efo/EFO_0010628,0.853,None
ebi-a-GCST90001835,CD62L on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.615,None
met-a-341,Citrate,citrate measurement,EFO:0010114,http://www.ebi.ac.uk/efo/EFO_0010114,0.789,None
prot-a-591,Caseinolytic peptidase B protein homolog,caseinolytic peptidase B protein homolog measurement,EFO:0802373,http://www.ebi.ac.uk/efo/EFO_0802373,0.936,None
prot-a-336,Calcyclin-binding protein,calcyclin-binding protein measurement,EFO:0801443,http://www.ebi.ac.uk/efo/EFO_0801443,0.817,None
prot-a-3199,Vascular endothelial growth factor C,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.975,None
ukb-d-30280_irnt,Immature reticulocyte fraction,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.994,None
prot-b-61,CD40 molecule,CD40 measurement,EFO:0010586,http://www.ebi.ac.uk/efo/EFO_0010586,0.644,None
met-a-572,Gamma-glutamylphenylalanine,gamma-glutamylphenylalanine measurement,EFO:0021142,http://www.ebi.ac.uk/efo/EFO_0021142,0.841,None
prot-a-1609,Voltage-gated potassium channel subunit beta-2,voltage-gated potassium channel subunit beta-2 measurement,EFO:0802219,http://www.ebi.ac.uk/efo/EFO_0802219,0.812,None
prot-a-2891,Extracellular sulfatase Sulf-2,extracellular sulfatase Sulf-2 measurement,EFO:0801596,http://www.ebi.ac.uk/efo/EFO_0801596,0.825,None
ebi-a-GCST90001580,CD14+ CD16+ monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.608,None
prot-a-242,Brain-derived neurotrophic factor,brain-derived neurotrophic factor measurement,EFO:0011018,http://www.ebi.ac.uk/efo/EFO_0011018,0.827,None
prot-a-178,Acid ceramidase,acid ceramidase measurement,EFO:0801339,http://www.ebi.ac.uk/efo/EFO_0801339,0.858,None
ebi-a-GCST004440,Interferon gamma-induced protein 10 levels,C-X-C motif chemokine 10 measurement,EFO:0008056,http://www.ebi.ac.uk/efo/EFO_0008056,0.779,None
ukb-a-345,Mother's age at death,mother's age at death,EFO:0009721,http://www.ebi.ac.uk/efo/EFO_0009721,0.831,None
ieu-a-789,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ebi-a-GCST006656,Dysmenorrheic pain severity,dysmenorrheic pain measurement,EFO:0007889,http://www.ebi.ac.uk/efo/EFO_0007889,0.773,None
prot-c-3195_50_2,Granulysin,granulysin measurement,EFO:0008144,http://www.ebi.ac.uk/efo/EFO_0008144,0.87,None
prot-a-2106,Neurexin-3-beta,neurexin-1-beta measurement,EFO:0020596,http://www.ebi.ac.uk/efo/EFO_0020596,0.634,None
ebi-a-GCST006979,Heel bone mineral density,heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.989,None
ebi-a-GCST90002246,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
ebi-a-GCST90001601,Lymphocyte Absolute Count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.798,None
prot-a-896,"Calcium uptake protein 3, mitochondrial","calcium uptake protein 3, mitochondrial measurement",EFO:0802355,http://www.ebi.ac.uk/efo/EFO_0802355,0.859,None
prot-a-1910,Stromelysin-2,stromelysin-2 measurement,EFO:0802095,http://www.ebi.ac.uk/efo/EFO_0802095,0.672,None
prot-a-1803,Lymphotoxin-alpha,lymphotoxin-alpha measurement,EFO:0020544,http://www.ebi.ac.uk/efo/EFO_0020544,0.788,None
prot-a-810,Protein DGCR6,protein DGCR6 measurement,EFO:0802931,http://www.ebi.ac.uk/efo/EFO_0802931,0.917,None
prot-a-1982,Myelin regulatory factor,myelin regulatory factor measurement,EFO:0802767,http://www.ebi.ac.uk/efo/EFO_0802767,0.899,None
ukb-b-7992,"Diastolic blood pressure, automated reading",diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.765,None
prot-c-4479_14_2,C1-Esterase Inhibitor,hereditary angioedema,MONDO:0019623,http://purl.obolibrary.org/obo/MONDO_0019623,0.881,None
prot-a-29,Disintegrin and metalloproteinase domain-containing protein 29,disintegrin and metalloproteinase domain-containing protein 29 measurement,EFO:0802471,http://www.ebi.ac.uk/efo/EFO_0802471,0.914,None
met-a-423,1-palmitoylglycerol (1-monopalmitin),1-palmitoylglycerol 1-monopalmitin measurement,EFO:0021110,http://www.ebi.ac.uk/efo/EFO_0021110,0.777,None
prot-a-1267,GRAM domain-containing protein 1C,GRAM domain-containing protein 1C measurement,EFO:0801652,http://www.ebi.ac.uk/efo/EFO_0801652,0.87,None
ieu-a-292,Inflammatory bowel disease,inflammatory bowel disease,EFO:0003767,http://www.ebi.ac.uk/efo/EFO_0003767,0.994,None
prot-a-1161,Gamma-aminobutyric acid receptor-associated protein-like 1,gamma-aminobutyric acid receptor-associated protein-like 1 measurement,EFO:0801613,http://www.ebi.ac.uk/efo/EFO_0801613,0.785,None
ebi-a-GCST90001469,CD62L- myeloid Dendritic Cell %Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.704,None
ebi-a-GCST004605,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.989,None
prot-a-2499,RNA binding protein fox-1 homolog 2,RNA binding protein fox-1 homolog 2 measurement,EFO:0803033,http://www.ebi.ac.uk/efo/EFO_0803033,0.811,None
met-d-HDL_PL,Phospholipids in HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.823,None
prot-a-2717,SHC-transforming protein 1,shc-transforming protein 1 measurement,EFO:0020738,http://www.ebi.ac.uk/efo/EFO_0020738,0.716,None
prot-b-62,"plasminogen activator, tissue type",tissue plasminogen activator measurement,EFO:0004791,http://www.ebi.ac.uk/efo/EFO_0004791,0.864,None
prot-a-3124,Thioredoxin domain-containing protein 5,thioredoxin domain-containing protein 5 measurement,EFO:0802128,http://www.ebi.ac.uk/efo/EFO_0802128,0.891,None
prot-a-2383,Proline-rich protein 1,proline-rich protein 1 measurement,EFO:0802916,http://www.ebi.ac.uk/efo/EFO_0802916,0.735,None
prot-a-963,Ephrin type-B receptor 3,ephrin type-B receptor 3 measurement,EFO:0801574,http://www.ebi.ac.uk/efo/EFO_0801574,0.683,None
prot-a-2084,Ribosyldihydronicotinamide dehydrogenase [quinone],ribosyldihydronicotinamide dehydrogenase [quinone] measurement,EFO:0803298,http://www.ebi.ac.uk/efo/EFO_0803298,0.838,None
prot-a-2034,Neuroepithelial cell-transforming gene 1 protein,neuroepithelial cell-transforming gene 1 protein measurement,EFO:0802800,http://www.ebi.ac.uk/efo/EFO_0802800,0.842,None
prot-a-1671,NKG2-E type II integral membrane protein,NKG2-D type II integral membrane protein measurement,EFO:0008250,http://www.ebi.ac.uk/efo/EFO_0008250,0.79,None
met-a-387,Glycerophosphorylcholine (GPC),glycerophosphorylcholine measurement,EFO:0020018,http://www.ebi.ac.uk/efo/EFO_0020018,0.802,None
prot-a-2871,Double-stranded RNA-binding protein Staufen homolog 1,double-stranded RNA-binding protein Staufen homolog 1 measurement,EFO:0801546,http://www.ebi.ac.uk/efo/EFO_0801546,0.845,None
met-a-653,Stearoylcarnitine,stearoylcarnitine measurement,EFO:0021045,http://www.ebi.ac.uk/efo/EFO_0021045,0.899,None
met-a-361,Hypoxanthine,Hypoxanthine measurement,EFO:0021604,http://www.ebi.ac.uk/efo/EFO_0021604,0.861,None
prot-c-5091_28_3,ILT-4,angioimmunoblastic T-cell lymphoma,EFO:0000255,http://www.ebi.ac.uk/efo/EFO_0000255,0.602,None
prot-a-2090,Nuclear receptor subfamily 4 group A member 1,nuclear receptor subfamily 4 group A member 1 measurement,EFO:0802824,http://www.ebi.ac.uk/efo/EFO_0802824,0.952,None
prot-a-845,DnaJ homolog subfamily C member 17,DnaJ homolog subfamily C member 17 measurement,EFO:0801541,http://www.ebi.ac.uk/efo/EFO_0801541,0.948,None
ebi-a-GCST90011794,Capecitabine drug response (AUC),response to fluoropyrimidines,EFO:0010825,http://www.ebi.ac.uk/efo/EFO_0010825,0.766,None
prot-a-973,Receptor tyrosine-protein kinase erbB-2,receptor tyrosine-protein kinase erbb-2 measurement,EFO:0020700,http://www.ebi.ac.uk/efo/EFO_0020700,0.709,None
ukb-b-4575,Age asthma diagnosed,asthma,MONDO:0004979,http://purl.obolibrary.org/obo/MONDO_0004979,0.661,None
ieu-a-1075,Selenium,selenium measurement,EFO:0006331,http://www.ebi.ac.uk/efo/EFO_0006331,0.826,None
ukb-d-20434_irnt,Age at last episode of depression,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.642,None
met-d-L_HDL_PL,Phospholipids in large HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.909,None
prot-a-2785,Zinc finger protein SNAI2,zinc finger protein SNAI2 measurement,EFO:0803286,http://www.ebi.ac.uk/efo/EFO_0803286,0.938,None
ukb-a-18,Smoking/smokers in household,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.68,None
prot-a-1960,Protein p13 MTCP-1,protein p13 MTCP-1 measurement,EFO:0802955,http://www.ebi.ac.uk/efo/EFO_0802955,0.742,None
met-a-749,2-hydroxyglutarate,2-hydroxyglutarate measurement,EFO:0021506,http://www.ebi.ac.uk/efo/EFO_0021506,0.746,None
met-a-440,X-10395,X-10395 measurement,EFO:0021213,http://www.ebi.ac.uk/efo/EFO_0021213,0.711,None
met-a-479,Propionylcarnitine,propionylcarnitine measurement,EFO:0020942,http://www.ebi.ac.uk/efo/EFO_0020942,0.895,None
prot-a-814,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 measurement,EFO:0801905,http://www.ebi.ac.uk/efo/EFO_0801905,0.78,None
ieu-a-1003,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
prot-a-186,Acid-sensing ion channel 4,acid-sensing ion channel 4 measurement,EFO:0802249,http://www.ebi.ac.uk/efo/EFO_0802249,0.8,None
prot-a-1031,Protein FAM171B,protein FAM171B measurement,EFO:0801947,http://www.ebi.ac.uk/efo/EFO_0801947,0.917,None
ieu-b-4905,Anti-Helicobacter pylori IgG levels,Anti-Helicobacter pylori IgG measurement,EFO:0009352,http://www.ebi.ac.uk/efo/EFO_0009352,0.768,None
met-a-604,X-12405,X-12405 measurement,EFO:0021303,http://www.ebi.ac.uk/efo/EFO_0021303,0.713,None
ieu-b-4850,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
prot-a-2404,Pregnancy-specific beta-1-glycoprotein 5,pregnancy-specific beta-1-glycoprotein 5 measurement,EFO:0801908,http://www.ebi.ac.uk/efo/EFO_0801908,0.693,None
prot-a-1301,Granzyme K,granzyme K measurement,EFO:0801654,http://www.ebi.ac.uk/efo/EFO_0801654,0.879,None
prot-a-2833,Protein sprouty homolog 1,protein sprouty homolog 1 measurement,EFO:0802963,http://www.ebi.ac.uk/efo/EFO_0802963,0.913,None
met-d-HDL_C,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-2836,Serine palmitoyltransferase 1,serine palmitoyltransferase 1 measurement,EFO:0803055,http://www.ebi.ac.uk/efo/EFO_0803055,0.922,None
met-a-564,Gamma-glutamylthreonine*,gamma-glutamylthreonine measurement,EFO:0021143,http://www.ebi.ac.uk/efo/EFO_0021143,0.817,None
met-d-M_VLDL_CE_pct,Cholesteryl esters to total lipids ratio in medium VLDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.697,None
prot-a-983,ERO1-like protein beta,ERO1-like protein beta measurement,EFO:0801583,http://www.ebi.ac.uk/efo/EFO_0801583,0.685,None
ebi-a-GCST90001391,IgD+ B cell %B cell,B cell derived cell line,EFO:0001640,http://www.ebi.ac.uk/efo/EFO_0001640,0.644,None
prot-a-1493,Interleukin-19,interleukin 19 measurement,EFO:0008180,http://www.ebi.ac.uk/efo/EFO_0008180,0.876,None
prot-a-1052,MIP18 family protein FAM96A,MIP18 family protein FAM96A measurement,EFO:0802747,http://www.ebi.ac.uk/efo/EFO_0802747,0.953,None
prot-a-1455,IGF-like family receptor 1,IGF-like family receptor 1 measurement,EFO:0801687,http://www.ebi.ac.uk/efo/EFO_0801687,0.751,None
ukb-d-30680_raw,Calcium,calcium measurement,EFO:0004838,http://www.ebi.ac.uk/efo/EFO_0004838,0.809,None
prot-c-2505_49_3,GFRa-3,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.631,None
ieu-b-4846,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-a-210,"Beta-1,3-glucosyltransferase",ALG6-congenital disorder of glycosylation 1C,MONDO:0011291,http://purl.obolibrary.org/obo/MONDO_0011291,0.813,None
prot-c-4126_22_1,BPI,"oculocerebrofacial syndrome, Kaufman type",MONDO:0009485,http://purl.obolibrary.org/obo/MONDO_0009485,0.64,None
ukb-b-19234,"Heel quantitative ultrasound index (QUI), direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.661,None
prot-a-1759,Leiomodin-1,leiomodin-1 measurement,EFO:0802687,http://www.ebi.ac.uk/efo/EFO_0802687,0.699,None
prot-a-1297,Granzyme A,granzyme A measurement,EFO:0008145,http://www.ebi.ac.uk/efo/EFO_0008145,0.865,None
ebi-a-GCST90010232,Kallikrein-6 levels,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.688,None
prot-a-2455,Poliovirus receptor,poliovirus receptor measurement,EFO:0802875,http://www.ebi.ac.uk/efo/EFO_0802875,0.886,None
prot-a-3138,SUMO-conjugating enzyme UBC9,sumo-conjugating enzyme UBC9 measurement,EFO:0020757,http://www.ebi.ac.uk/efo/EFO_0020757,0.852,None
prot-c-3452_17_2,LCK,severe combined immunodeficiency due to LCK deficiency,MONDO:0014334,http://purl.obolibrary.org/obo/MONDO_0014334,0.608,None
prot-a-422,OX-2 membrane glycoprotein,OX-2 membrane glycoprotein measurement,EFO:0008253,http://www.ebi.ac.uk/efo/EFO_0008253,0.742,None
ebi-a-GCST000571,Fasting blood insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.992,None
prot-a-1384,Heat shock protein HSP 90-alpha/beta,heat shock protein HSP 90-beta measurement,EFO:0021991,http://www.ebi.ac.uk/efo/EFO_0021991,0.71,None
ieu-b-4820,Age at first birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.907,None
prot-a-3013,Macoilin,macoilin measurement,EFO:0802722,http://www.ebi.ac.uk/efo/EFO_0802722,0.823,None
prot-a-712,Connective tissue growth factor,connective tissue growth factor measurement,EFO:0020284,http://www.ebi.ac.uk/efo/EFO_0020284,0.925,None
ieu-a-78,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ebi-a-GCST90010264,Metalloproteinase inhibitor 4 levels,metalloproteinase inhibitor 4 measurement,EFO:0801797,http://www.ebi.ac.uk/efo/EFO_0801797,0.854,None
ukb-b-13354,Whole body fat-free mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.717,None
prot-a-2902,Sushi domain-containing protein 2,Sushi domain-containing protein 2 measurement,EFO:0802106,http://www.ebi.ac.uk/efo/EFO_0802106,0.863,None
ebi-a-GCST90012045,Hepatocyte growth factor levels,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.91,None
prot-b-35,pappalysin 1,pappalysin-1 measurement,EFO:0802845,http://www.ebi.ac.uk/efo/EFO_0802845,0.726,None
prot-a-792,Beta-defensin 118,beta-defensin 118 measurement,EFO:0802323,http://www.ebi.ac.uk/efo/EFO_0802323,0.761,None
prot-a-1307,Hepcidin,hepcidin measurement,EFO:0020440,http://www.ebi.ac.uk/efo/EFO_0020440,0.856,None
ebi-a-GCST90010280,Retinal dehydrogenase 1 levels,retinol dehydrogenase 16 measurement,EFO:0802007,http://www.ebi.ac.uk/efo/EFO_0802007,0.627,None
prot-a-2265,Elafin,elafin measurement,EFO:0008117,http://www.ebi.ac.uk/efo/EFO_0008117,0.846,None
prot-a-2425,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN","phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase pten measurement",EFO:0020635,http://www.ebi.ac.uk/efo/EFO_0020635,0.868,None
prot-a-629,Collectin-12,collectin-12 measurement,EFO:0020272,http://www.ebi.ac.uk/efo/EFO_0020272,0.623,None
prot-a-1946,Protein MRVI1,protein MRVI1 measurement,EFO:0801953,http://www.ebi.ac.uk/efo/EFO_0801953,0.903,None
ukb-d-30190_irnt,Monocyte percentage,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.994,None
prot-a-714,Chymotrypsinogen B,chymotrypsinogen B measurement,EFO:0801477,http://www.ebi.ac.uk/efo/EFO_0801477,0.908,None
prot-a-2880,Stathmin-3,stathmin-2 measurement,EFO:0802087,http://www.ebi.ac.uk/efo/EFO_0802087,0.623,None
ebi-a-GCST90010115,Carcinoembryonic antigenrelated cell adhesion molecule 8 levels,carcinoembryonic antigen-related cell adhesion molecule 1 measurement,EFO:0801456,http://www.ebi.ac.uk/efo/EFO_0801456,0.813,None
ukb-b-10215,Hand grip strength (right),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.708,None
ebi-a-GCST90001639,CD3- lymphocyte Absolute Count,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.742,None
prot-a-2736,NAD-dependent protein deacetylase sirtuin-2,NAD-dependent protein deacetylase sirtuin-2 measurement,EFO:0008241,http://www.ebi.ac.uk/efo/EFO_0008241,0.808,None
prot-a-217,"Beta-1,4-galactosyltransferase 2","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.767,None
met-a-493,Heme*,heme measurement,EFO:0800158,http://www.ebi.ac.uk/efo/EFO_0800158,0.674,None
prot-a-1937,Macrophage mannose receptor 1,macrophage mannose receptor 1 measurement,EFO:0020548,http://www.ebi.ac.uk/efo/EFO_0020548,0.913,None
ieu-a-74,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
met-d-S_HDL_C,Cholesterol in small HDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.699,None
prot-a-816,ATP-dependent RNA helicase DHX8,ATP-dependent RNA helicase DHX8 measurement,EFO:0801398,http://www.ebi.ac.uk/efo/EFO_0801398,0.848,None
prot-a-2531,Regulatory factor X-associated protein,regulatory factor X-associated protein measurement,EFO:0801999,http://www.ebi.ac.uk/efo/EFO_0801999,0.816,None
prot-c-3171_57_2,amyloid precursor protein,amyloidosis,EFO:1001875,http://www.ebi.ac.uk/efo/EFO_1001875,0.665,None
ieu-a-302,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
ebi-a-GCST90001604,T cell %lymphocyte,T-cell immunodeficiency,MONDO:0003780,http://purl.obolibrary.org/obo/MONDO_0003780,0.745,None
prot-a-3226,WAP four-disulfide core domain protein 5,WAP four-disulfide core domain protein 5 measurement,EFO:0803264,http://www.ebi.ac.uk/efo/EFO_0803264,0.852,None
ebi-a-GCST90002370,Red cell distribution width,Red cell distribution width,EFO:0009188,http://www.ebi.ac.uk/efo/EFO_0009188,0.993,None
prot-a-1782,alpha-2-macroglobulin receptor-associated protein,alpha-2-macroglobulin receptor-associated protein measurement,EFO:0008021,http://www.ebi.ac.uk/efo/EFO_0008021,0.752,None
prot-a-175,Ecto-ADP-ribosyltransferase 3,ecto-ADP-ribosyltransferase 3 measurement,EFO:0801558,http://www.ebi.ac.uk/efo/EFO_0801558,0.724,None
ebi-a-GCST90010128,Growth hormone levels,growth hormone measurement,EFO:0008438,http://www.ebi.ac.uk/efo/EFO_0008438,0.756,None
prot-a-2752,Very long-chain acyl-CoA synthetase,very long-chain acyl-CoA synthetase measurement,EFO:0802211,http://www.ebi.ac.uk/efo/EFO_0802211,0.748,None
prot-a-3221,WAP four-disulfide core domain protein 10A,WAP four-disulfide core domain protein 10A measurement,EFO:0803260,http://www.ebi.ac.uk/efo/EFO_0803260,0.87,None
prot-a-824,Dickkopf-like protein 1,dickkopf-like protein 1 measurement,EFO:0020324,http://www.ebi.ac.uk/efo/EFO_0020324,0.766,None
ebi-a-GCST90012103,Bioavailable testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.61,None
prot-a-730,Cortexin-3,cortexin-3 measurement,EFO:0801500,http://www.ebi.ac.uk/efo/EFO_0801500,0.656,None
met-d-M_VLDL_C_pct,Cholesterol to total lipids ratio in medium VLDL,total cholesterol in medium VLDL,EFO:0022162,http://www.ebi.ac.uk/efo/EFO_0022162,0.799,None
prot-a-3215,Vitronectin,vitronectin measurement,EFO:0021843,http://www.ebi.ac.uk/efo/EFO_0021843,0.829,None
ukb-d-30650_irnt,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
prot-a-1106,Tyrosine-protein kinase Fgr,tyrosine-protein kinase FGR measurement,EFO:0020822,http://www.ebi.ac.uk/efo/EFO_0020822,0.83,None
ebi-a-GCST002783,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-2298,Inactive phospholipase D5,inactive phospholipase D5 measurement,EFO:0802625,http://www.ebi.ac.uk/efo/EFO_0802625,0.924,None
prot-a-993,Ethanolamine kinase 1,ethanolamine kinase 1 measurement,EFO:0802532,http://www.ebi.ac.uk/efo/EFO_0802532,0.893,None
prot-c-3601_54_3,CHL1,CHL1,EFO:0002132,http://www.ebi.ac.uk/efo/EFO_0002132,0.992,None
prot-c-3707_12_2,Albumin,ovalbumin,EFO:0002674,http://www.ebi.ac.uk/efo/EFO_0002674,0.821,None
met-a-563,Gamma-glutamylmethionine*,gamma-glutamylmethionine measurement,EFO:0021141,http://www.ebi.ac.uk/efo/EFO_0021141,0.814,None
met-a-680,Cysteine-glutathione disulfide,cysteine-glutathione disulfide measurement,EFO:0021001,http://www.ebi.ac.uk/efo/EFO_0021001,0.822,None
prot-c-4970_55_1,carbonic anhydrase II,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.899,None
ukb-b-5463,"Heel quantitative ultrasound index (QUI), direct entry (right)",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.634,None
prot-a-2310,Melanocyte protein PMEL,melanocyte protein PMEL measurement,EFO:0801792,http://www.ebi.ac.uk/efo/EFO_0801792,0.902,None
prot-a-1332,Hemojuvelin,hemojuvelin measurement,EFO:0008148,http://www.ebi.ac.uk/efo/EFO_0008148,0.884,None
met-c-877,Total lipids in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.971,None
ebi-a-GCST004628,Immature fraction of reticulocytes,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.945,None
prot-c-2828_82_2,HAI-1,autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,MONDO:0014493,http://purl.obolibrary.org/obo/MONDO_0014493,0.747,None
prot-a-2363,Salivary acidic proline-rich phosphoprotein 1/2,salivary acidic proline-rich phosphoprotein 1/2 measurement,EFO:0802035,http://www.ebi.ac.uk/efo/EFO_0802035,0.768,None
prot-a-542,Cysteine-rich hydrophobic domain-containing protein 2,cysteine-rich hydrophobic domain-containing protein 2 measurement,EFO:0801510,http://www.ebi.ac.uk/efo/EFO_0801510,0.837,None
prot-a-440,Hematopoietic progenitor cell antigen CD34,hematopoietic progenitor cell antigen CD34 measurement,EFO:0801667,http://www.ebi.ac.uk/efo/EFO_0801667,0.938,None
met-c-871,Phospholipids in IDL,phospholipids in IDL measurement,EFO:0022164,http://www.ebi.ac.uk/efo/EFO_0022164,0.888,None
prot-a-2713,Beta-sarcoglycan,Qualitative or quantitative defects of sarcoglycan,ORPHANET.ORDO:207052,http://www.orpha.net/ORDO/Orphanet_207052,0.719,None
prot-a-496,Cyclin-dependent kinase 4 inhibitor B,cyclin-dependent kinase 4 inhibitor B measurement,EFO:0802441,http://www.ebi.ac.uk/efo/EFO_0802441,0.884,None
prot-a-2893,Bile salt sulfotransferase,bile salt sulfotransferase measurement,EFO:0802333,http://www.ebi.ac.uk/efo/EFO_0802333,0.923,None
prot-b-82,epidermal growth factor,epidermal growth factor,EFO:0003298,http://www.ebi.ac.uk/efo/EFO_0003298,0.989,None
prot-a-1824,O-acetyl-ADP-ribose deacetylase MACROD1,o-acetyl-ADP-ribose deacetylase MACROD1 measurement,EFO:0802827,http://www.ebi.ac.uk/efo/EFO_0802827,0.763,None
met-d-M_VLDL_PL,Phospholipids in medium VLDL,phospholipids in medium VLDL measurement,EFO:0022154,http://www.ebi.ac.uk/efo/EFO_0022154,0.92,None
ebi-a-GCST90012026,Tumor necrosis factor receptor 2 levels,tumor necrosis factor receptor 1 measurement,EFO:0010931,http://www.ebi.ac.uk/efo/EFO_0010931,0.821,None
prot-a-764,Drebrin-like protein,drebrin-like protein measurement,EFO:0020333,http://www.ebi.ac.uk/efo/EFO_0020333,0.781,None
prot-a-2303,Serine/threonine-protein kinase PLK1,serine/threonine-protein kinase PLK1 measurement,EFO:0020732,http://www.ebi.ac.uk/efo/EFO_0020732,0.777,None
prot-a-1328,Hephaestin-like protein 1,hephaestin-like protein 1 measurement,EFO:0802597,http://www.ebi.ac.uk/efo/EFO_0802597,0.811,None
ukb-d-30700_irnt,Creatinine,creatinine measurement,EFO:0004518,http://www.ebi.ac.uk/efo/EFO_0004518,0.809,None
ieu-a-783,Triglycerides,triglyceride measurement,EFO:0004530,http://www.ebi.ac.uk/efo/EFO_0004530,0.775,None
ebi-a-GCST90010254,Pulmonary surfactant-associated protein D levels,pulmonary surfactant-associated protein d measurement,EFO:0020693,http://www.ebi.ac.uk/efo/EFO_0020693,0.813,None
ukb-d-30790_irnt,Lipoprotein A,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.929,None
prot-a-2512,Retinol dehydrogenase 16,retinol dehydrogenase 16 measurement,EFO:0802007,http://www.ebi.ac.uk/efo/EFO_0802007,0.899,None
prot-a-2400,Pregnancy-specific beta-1-glycoprotein 11,pregnancy-specific beta-1-glycoprotein 11 measurement,EFO:0802895,http://www.ebi.ac.uk/efo/EFO_0802895,0.704,None
prot-a-2471,Ras-related protein Rab-14,ras-related protein Rab-14 measurement,EFO:0801988,http://www.ebi.ac.uk/efo/EFO_0801988,0.606,None
prot-c-3168_8_2,ADAMTS-5,a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement,EFO:0008326,http://www.ebi.ac.uk/efo/EFO_0008326,0.648,None
prot-a-726,Cathepsin O,cathepsin O measurement,EFO:0802375,http://www.ebi.ac.uk/efo/EFO_0802375,0.845,None
prot-a-44,Adhesion G protein-coupled receptor F5,adhesion G protein-coupled receptor F5 measurement,EFO:0801346,http://www.ebi.ac.uk/efo/EFO_0801346,0.884,None
prot-a-2094,Neuronal cell adhesion molecule,neuronal cell adhesion molecule measurement,EFO:0020602,http://www.ebi.ac.uk/efo/EFO_0020602,0.915,None
met-a-522,X-11483,X-11483 measurement,EFO:0021243,http://www.ebi.ac.uk/efo/EFO_0021243,0.705,None
prot-a-1264,Alanine aminotransferase 1,alanine aminotransferase 1 measurement,EFO:0802260,http://www.ebi.ac.uk/efo/EFO_0802260,0.907,None
met-d-Phosphatidylc,Phosphatidylcholines,phosphatidylcholine measurement,EFO:0010226,http://www.ebi.ac.uk/efo/EFO_0010226,0.862,None
ebi-a-GCST008027,Smoking behaviour (cigarettes smoked per day),smoking behaviour measurement,EFO:0005671,http://www.ebi.ac.uk/efo/EFO_0005671,0.679,None
prot-a-1461,Immunoglobulin superfamily member 11,immunoglobulin superfamily member 11 measurement,EFO:0802621,http://www.ebi.ac.uk/efo/EFO_0802621,0.94,None
met-a-591,X-12216,X-12216 measurement,EFO:0021294,http://www.ebi.ac.uk/efo/EFO_0021294,0.691,None
prot-a-1543,Interleukin-7,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.923,None
prot-a-2514,Regenerating islet-derived protein 3-alpha,regenerating islet-derived protein 3-alpha measurement,EFO:0803004,http://www.ebi.ac.uk/efo/EFO_0803004,0.746,None
prot-a-3280,Zinc/RING finger protein 4,zinc finger protein measurement,EFO:0803269,http://www.ebi.ac.uk/efo/EFO_0803269,0.812,None
prot-a-2814,Spermatogenesis-associated protein 9,spermatogenesis-associated protein 9 measurement,EFO:0803099,http://www.ebi.ac.uk/efo/EFO_0803099,0.822,None
ukb-b-14905,Age at bilateral oophorectomy (both ovaries removed),bilateral oophorectomy,EFO:0009717,http://www.ebi.ac.uk/efo/EFO_0009717,0.682,None
ebi-a-GCST90001848,CD3 on Natural Killer T,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.647,None
ebi-a-GCST90001583,Monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.765,None
prot-a-2944,"Angiopoietin-1 receptor, soluble","angiopoietin-1 receptor, soluble measurement",EFO:0008023,http://www.ebi.ac.uk/efo/EFO_0008023,0.814,None
prot-a-2896,Small ubiquitin-related modifier 3,small ubiquitin-related modifier 3 measurement,EFO:0022025,http://www.ebi.ac.uk/efo/EFO_0022025,0.879,None
prot-a-2370,Protein kinase C beta type (splice variant beta-II),protein kinase c beta type (splice variant beta-II) measurement,EFO:0020678,http://www.ebi.ac.uk/efo/EFO_0020678,0.731,None
ebi-a-GCST90001586,CD14+ CD16- monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.629,None
prot-a-1881,LDLR chaperone MESD,LDLR chaperone MESD measurement,EFO:0802686,http://www.ebi.ac.uk/efo/EFO_0802686,0.924,None
prot-a-1425,Interferon alpha-8,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.948,None
prot-a-799,Beta-defensin 125,beta-defensin 125 measurement,EFO:0802326,http://www.ebi.ac.uk/efo/EFO_0802326,0.761,None
prot-a-1089,Fibroblast growth factor 16,fibroblast growth factor 16 measurement,EFO:0020378,http://www.ebi.ac.uk/efo/EFO_0020378,0.915,None
met-a-418,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
ebi-a-GCST005060,Hemoglobin levels,fetal hemoglobin measurement,EFO:0004576,http://www.ebi.ac.uk/efo/EFO_0004576,0.884,None
prot-c-4906_35_1,Coagulation Factor V,coagulation factor V measurement,EFO:0008087,http://www.ebi.ac.uk/efo/EFO_0008087,0.889,None
ukb-d-30720_raw,Cystatin C,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.811,None
prot-a-1232,N-acetylglucosamine-1-phosphotransferase subunit gamma,n-acetylglucosamine-1-phosphotransferase subunit gamma measurement,EFO:0802775,http://www.ebi.ac.uk/efo/EFO_0802775,0.806,None
prot-a-3017,Transmembrane protein 8B,transmembrane protein 8B measurement,EFO:0803189,http://www.ebi.ac.uk/efo/EFO_0803189,0.927,None
met-a-651,Stachydrine,stachydrine measurement,EFO:0021169,http://www.ebi.ac.uk/efo/EFO_0021169,0.84,None
ukb-d-30640_irnt,Apoliprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.673,None
prot-c-2870_29_2,RAC1,"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome",MONDO:0013875,http://purl.obolibrary.org/obo/MONDO_0013875,0.665,None
prot-a-3071,Tenascin-X,tenascin measurement,EFO:0008296,http://www.ebi.ac.uk/efo/EFO_0008296,0.751,None
met-a-500,3-dehydrocarnitine*,3-dehydrocarnitine measurement,EFO:0021037,http://www.ebi.ac.uk/efo/EFO_0021037,0.722,None
prot-a-255,Bone morphogenetic protein 6,bone morphogenetic protein 6 measurement,EFO:0020186,http://www.ebi.ac.uk/efo/EFO_0020186,0.893,None
prot-a-2077,Brain natriuretic peptide 32,brain natriuretic peptide 32 measurement,EFO:0020191,http://www.ebi.ac.uk/efo/EFO_0020191,0.928,None
prot-a-882,Dual specificity tyrosine-phosphorylation-regulated kinase 3,dual specificity tyrosine-phosphorylation-regulated kinase 3 measurement,EFO:0020337,http://www.ebi.ac.uk/efo/EFO_0020337,0.858,None
met-a-396,X-18601,X-18601 measurement,EFO:0021380,http://www.ebi.ac.uk/efo/EFO_0021380,0.708,None
prot-a-720,Cathepsin E,cathepsin E measurement,EFO:0020241,http://www.ebi.ac.uk/efo/EFO_0020241,0.836,None
prot-a-1524,Interleukin-34,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.815,None
prot-a-2356,Lysosomal Pro-X carboxypeptidase,lysosomal Pro-X carboxypeptidase measurement,EFO:0801777,http://www.ebi.ac.uk/efo/EFO_0801777,0.775,None
prot-a-524,Cofilin-1,cofilin-1 measurement,EFO:0020267,http://www.ebi.ac.uk/efo/EFO_0020267,0.636,None
prot-a-2336,Peroxisome proliferator-activated receptor alpha,peroxisome proliferator-activated receptor alpha measurement,EFO:0802858,http://www.ebi.ac.uk/efo/EFO_0802858,0.861,None
ieu-b-115,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
prot-a-2508,Retinoid-binding protein 7,retinoid-binding protein 7 measurement,EFO:0802006,http://www.ebi.ac.uk/efo/EFO_0802006,0.741,None
prot-a-384,Coiled-coil domain-containing protein 80,coiled-coil domain-containing protein 80 measurement,EFO:0020268,http://www.ebi.ac.uk/efo/EFO_0020268,0.843,None
prot-a-3109,Thiosulfate sulfurtransferase,thiosulfate sulfurtransferase measurement,EFO:0802130,http://www.ebi.ac.uk/efo/EFO_0802130,0.945,None
met-a-700,X-13658,X-13658 measurement,EFO:0021357,http://www.ebi.ac.uk/efo/EFO_0021357,0.707,None
ebi-a-GCST008594,Total cholesterol levels,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.987,None
met-d-HDL_P,Concentration of HDL particles,concentration of large HDL particles measurement,EFO:0022188,http://www.ebi.ac.uk/efo/EFO_0022188,0.849,None
prot-a-1317,Hemoglobin subunit zeta,hemoglobin subunit zeta measurement,EFO:0801670,http://www.ebi.ac.uk/efo/EFO_0801670,0.922,None
ebi-a-GCST008592,High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,EFO:0004612,http://www.ebi.ac.uk/efo/EFO_0004612,0.868,None
met-d-Omega_6_by_Omega_3,Ratio of omega-6 fatty acids to omega-3 fatty acids,omega-3 polyunsaturated fatty acid measurement,EFO:0010119,http://www.ebi.ac.uk/efo/EFO_0010119,0.602,None
ebi-a-GCST90010144,Interleukin-27 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.741,None
ebi-a-GCST90014291,DNA methylation-estimated plasminogen activator inhibitor-1 levels,plasminogen activator inhibitor 1 measurement,EFO:0004792,http://www.ebi.ac.uk/efo/EFO_0004792,0.709,None
prot-a-2442,Tyrosine-protein phosphatase non-receptor type 9,tyrosine-protein phosphatase non-receptor type 9 measurement,EFO:0802174,http://www.ebi.ac.uk/efo/EFO_0802174,0.809,None
bbj-a-25,Hemoglobin,Hemoglobin A Measurement,EFO:0009208,http://www.ebi.ac.uk/efo/EFO_0009208,0.937,None
prot-a-1888,Lactadherin,lactadherin measurement,EFO:0008203,http://www.ebi.ac.uk/efo/EFO_0008203,0.855,None
ebi-a-GCST90010318,Insulin-like growth factor-binding protein-like 1 levels,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.875,None
prot-b-30,growth hormone 1,growth hormone measurement,EFO:0008438,http://www.ebi.ac.uk/efo/EFO_0008438,0.842,None
prot-a-1756,VIP36-like protein,VIP36-like protein measurement,EFO:0802216,http://www.ebi.ac.uk/efo/EFO_0802216,0.716,None
ubm-a-2267,NET100 1111,G111,EFO:0006395,http://www.ebi.ac.uk/efo/EFO_0006395,0.61,None
prot-a-2757,Solute carrier family 41 member 2,solute carrier family 41 member 2 measurement,EFO:0803090,http://www.ebi.ac.uk/efo/EFO_0803090,0.937,None
ieu-a-1006,Mean platelet volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.978,None
ebi-a-GCST90001985,CD40 on monocytes,CD40 measurement,EFO:0010586,http://www.ebi.ac.uk/efo/EFO_0010586,0.646,None
met-a-552,X-11849,X-11849 measurement,EFO:0021269,http://www.ebi.ac.uk/efo/EFO_0021269,0.702,None
met-a-515,X-11442,X-11442 measurement,EFO:0021236,http://www.ebi.ac.uk/efo/EFO_0021236,0.685,None
ebi-a-GCST90000497,STAM binding protein levels,STAM binding protein measurement,EFO:0010796,http://www.ebi.ac.uk/efo/EFO_0010796,0.772,None
prot-a-1519,Interleukin-2 receptor subunit beta,interleukin 6 receptor subunit beta measurement,EFO:0008188,http://www.ebi.ac.uk/efo/EFO_0008188,0.893,None
met-c-905,Cholesterol esters in medium LDL,cholesterol esters in medium LDL measurement,EFO:0022186,http://www.ebi.ac.uk/efo/EFO_0022186,0.926,None
prot-a-1763,Putative apolipoprotein(a)-like protein 2,putative apolipoprotein(a)-like protein 2 measurement,EFO:0802979,http://www.ebi.ac.uk/efo/EFO_0802979,0.739,None
ieu-b-46,Urinary sodium-potassium ratio,urinary sodium to potassium ratio,EFO:0009884,http://www.ebi.ac.uk/efo/EFO_0009884,0.975,None
ebi-a-GCST90012104,Bioavailable testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.61,None
prot-a-941,Protein enabled homolog,protein enabled homolog measurement,EFO:0802934,http://www.ebi.ac.uk/efo/EFO_0802934,0.911,None
ebi-a-GCST90013658,Myeloperoxidase-DNA complexes,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.635,None
ebi-a-GCST90006894,Cytomegalovirus pp28 antibody levels,cytomegalovirus infection,EFO:0001062,http://www.ebi.ac.uk/efo/EFO_0001062,0.61,None
prot-a-497,Cyclin-dependent kinase inhibitor 3,cyclin-dependent kinase inhibitor 3 measurement,EFO:0802442,http://www.ebi.ac.uk/efo/EFO_0802442,0.88,None
prot-a-3233,Serine/threonine-protein kinase WNK3,serine/threonine-protein kinase WNK3 measurement,EFO:0021992,http://www.ebi.ac.uk/efo/EFO_0021992,0.785,None
ukb-b-3304,Friendships satisfaction,friendship satisfaction measurement,EFO:0009725,http://www.ebi.ac.uk/efo/EFO_0009725,0.827,None
prot-c-5026_66_1,RS3,TCF12-related craniosynostosis,MONDO:0014128,http://purl.obolibrary.org/obo/MONDO_0014128,0.649,None
prot-a-2513,ATP-dependent DNA helicase Q1,ATP-dependent DNA helicase Q1 measurement,EFO:0802293,http://www.ebi.ac.uk/efo/EFO_0802293,0.815,None
ebi-a-GCST90010222,Insulin-like growth factor-binding protein 2 levels,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.913,None
prot-b-69,cathepsin L,cathepsin B measurement,EFO:0008072,http://www.ebi.ac.uk/efo/EFO_0008072,0.726,None
ebi-a-GCST90002319,Lymphocyte counts,lymphocyte count,EFO:0004587,http://www.ebi.ac.uk/efo/EFO_0004587,0.984,None
prot-a-975,DNA excision repair protein ERCC-1,DNA excision repair protein ERCC-1 measurement,EFO:0802474,http://www.ebi.ac.uk/efo/EFO_0802474,0.827,None
prot-c-5264_65_3,calreticulin,calreticulin measurement,EFO:0020221,http://www.ebi.ac.uk/efo/EFO_0020221,0.874,None
prot-a-1552,Inhibitor of growth protein 1,inhibitor of growth protein 1 measurement,EFO:0020471,http://www.ebi.ac.uk/efo/EFO_0020471,0.916,None
ebi-a-GCST90011998,Growth differentiation factor-15 levels,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.989,None
prot-a-2364,DNA primase small subunit,DNA primase small subunit measurement,EFO:0802477,http://www.ebi.ac.uk/efo/EFO_0802477,0.908,None
ukb-b-18290,Age hayfever or allergic rhinitis diagnosed by doctor,allergic rhinitis,EFO:0005854,http://www.ebi.ac.uk/efo/EFO_0005854,0.623,None
prot-a-2823,Kunitz-type protease inhibitor 1,Kunitz-type protease inhibitor 1 measurement,EFO:0008199,http://www.ebi.ac.uk/efo/EFO_0008199,0.782,None
prot-a-1347,"HLA class II histocompatibility antigen, DQ alpha 2 chain","HLA class II histocompatibility antigen, DQ alpha 2 chain measurement",EFO:0801686,http://www.ebi.ac.uk/efo/EFO_0801686,0.912,None
prot-a-581,C-type lectin domain family 7 member A,C-type lectin domain family 7 member A measurement,EFO:0802349,http://www.ebi.ac.uk/efo/EFO_0802349,0.798,None
prot-a-1364,Heterogeneous nuclear ribonucleoproteins C1/C2,heterogeneous nuclear ribonucleoprotein M measurement,EFO:0801674,http://www.ebi.ac.uk/efo/EFO_0801674,0.823,None
prot-a-1897,MICAL-like protein 2,MICAL-like protein 2 measurement,EFO:0801799,http://www.ebi.ac.uk/efo/EFO_0801799,0.723,None
prot-a-828,Protein delta homolog 1,protein delta homolog 1 measurement,EFO:0801938,http://www.ebi.ac.uk/efo/EFO_0801938,0.898,None
prot-a-1831,MAM domain-containing protein 2,MAM domain-containing protein 2 measurement,EFO:0802728,http://www.ebi.ac.uk/efo/EFO_0802728,0.85,None
ieu-a-1007,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
met-a-507,X-01911,X-01911 measurement,EFO:0021181,http://www.ebi.ac.uk/efo/EFO_0021181,0.656,None
prot-c-2575_5_5,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
met-c-949,Total lipids in very large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.897,None
ieu-a-1035,Difference in height between childhood and adulthood,interstitial lung disease in childhood and adulthood,MONDO:0017030,http://purl.obolibrary.org/obo/MONDO_0017030,0.678,None
prot-a-771,Dynactin subunit 2,dynactin subunit 2 measurement,EFO:0020338,http://www.ebi.ac.uk/efo/EFO_0020338,0.894,None
prot-c-4122_12_2,discoidin domain receptor 1,discoidin domain-containing receptor 2 measurement,EFO:0020327,http://www.ebi.ac.uk/efo/EFO_0020327,0.722,None
ebi-a-GCST90010103,A disintegrin and metalloproteinase with thrombospondin motifs 13 levels,a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement,EFO:0008011,http://www.ebi.ac.uk/efo/EFO_0008011,0.912,None
ebi-a-GCST90001582,CD14+ CD16- monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.608,None
met-d-Leu,Leucine,leucine measurement,EFO:0009770,http://www.ebi.ac.uk/efo/EFO_0009770,0.786,None
prot-a-1018,Fumarylacetoacetase,fumarylacetoacetase measurement,EFO:0801609,http://www.ebi.ac.uk/efo/EFO_0801609,0.933,None
met-a-502,C-glycosyltryptophan*,C-glycosyltryptophan measurement,EFO:0021014,http://www.ebi.ac.uk/efo/EFO_0021014,0.751,None
prot-a-1189,Guanine deaminase,guanine deaminase measurement,EFO:0802585,http://www.ebi.ac.uk/efo/EFO_0802585,0.884,None
prot-a-2655,"Signal peptide, CUB and EGF-like domain-containing protein 1","signal peptide, CUB and EGF-like domain-containing protein 1 measurement",EFO:0803074,http://www.ebi.ac.uk/efo/EFO_0803074,0.793,None
met-a-669,X-12851,X-12851 measurement,EFO:0021342,http://www.ebi.ac.uk/efo/EFO_0021342,0.709,None
bbj-a-1,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
ebi-a-GCST90010304,Pro-cathepsin H levels,cathepsin H measurement,EFO:0020243,http://www.ebi.ac.uk/efo/EFO_0020243,0.668,None
prot-a-3105,Translin,translin measurement,EFO:0803172,http://www.ebi.ac.uk/efo/EFO_0803172,0.826,None
prot-a-1788,Leucine-rich repeat-containing protein 4B,leucine-rich repeat-containing protein 4B measurement,EFO:0802700,http://www.ebi.ac.uk/efo/EFO_0802700,0.796,None
prot-c-4979_34_2,DERM,isolated congenital adermatoglyphia,MONDO:0007619,http://purl.obolibrary.org/obo/MONDO_0007619,0.699,None
prot-a-2691,Kallistatin,kallistatin measurement,EFO:0008196,http://www.ebi.ac.uk/efo/EFO_0008196,0.846,None
prot-a-363,Caspase-2,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.673,None
prot-a-1886,Microfibril-associated glycoprotein 4,microfibril-associated glycoprotein 4 measurement,EFO:0802744,http://www.ebi.ac.uk/efo/EFO_0802744,0.834,None
ebi-a-GCST90014240,Forced expiratory volume in 1 second x sex interaction,forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.757,None
prot-a-2635,Scavenger receptor class A member 3,scavenger receptor class A member 3 measurement,EFO:0803044,http://www.ebi.ac.uk/efo/EFO_0803044,0.935,None
ukb-d-30210_irnt,Eosinophill percentage,eosinophil percentage of leukocytes,EFO:0007991,http://www.ebi.ac.uk/efo/EFO_0007991,0.922,None
prot-a-2907,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",EFO:0803113,http://www.ebi.ac.uk/efo/EFO_0803113,0.844,None
prot-a-3018,Transmembrane protein 9,transmembrane protein 9 measurement,EFO:0803190,http://www.ebi.ac.uk/efo/EFO_0803190,0.911,None
ebi-a-GCST90000490,Osteoprotegerin levels,osteoprotegerin measurement,EFO:0005918,http://www.ebi.ac.uk/efo/EFO_0005918,0.769,None
ebi-a-GCST90010225,Interleukin-18-binding protein levels,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.658,None
ieu-b-33,eosinophil cell count,eosinophil count,EFO:0004842,http://www.ebi.ac.uk/efo/EFO_0004842,0.916,None
ubm-a-2678,volume Right-Thalamus-Proper,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.814,None
met-a-581,X-12093,X-12093 measurement,EFO:0021285,http://www.ebi.ac.uk/efo/EFO_0021285,0.705,None
ukb-a-304,Number of children fathered,number of children fathered measurement,EFO:0009814,http://www.ebi.ac.uk/efo/EFO_0009814,0.914,None
prot-a-1176,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific","glyceraldehyde-3-phosphate dehydrogenase, testis-specific measurement",EFO:0802573,http://www.ebi.ac.uk/efo/EFO_0802573,0.795,None
prot-a-231,Basal Cell Adhesion Molecule,basal cell adhesion molecule measurement,EFO:0008032,http://www.ebi.ac.uk/efo/EFO_0008032,0.919,None
met-d-L_HDL_PL_pct,Phospholipids to total lipids ratio in large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.775,None
ebi-a-GCST90001436,Memory B cell %lymphocyte,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.608,None
prot-a-1395,Bone sialoprotein 2,bone sialoprotein 2 measurement,EFO:0020190,http://www.ebi.ac.uk/efo/EFO_0020190,0.856,None
met-a-707,1-palmitoylglycerophosphoethanolamine,1-palmitoylglycerophosphoethanolamine measurement,EFO:0021090,http://www.ebi.ac.uk/efo/EFO_0021090,0.878,None
prot-a-755,Cytoglobin,cytoglobin measurement,EFO:0802451,http://www.ebi.ac.uk/efo/EFO_0802451,0.848,None
prot-a-2952,Trefoil factor 2,trefoil factor 2 measurement,EFO:0021846,http://www.ebi.ac.uk/efo/EFO_0021846,0.903,None
prot-a-3206,Serine/threonine-protein kinase VRK1,serine/threonine-protein kinase VRK1 measurement,EFO:0803066,http://www.ebi.ac.uk/efo/EFO_0803066,0.782,None
prot-a-3034,Tumor necrosis factor receptor superfamily member 10D,tumor necrosis factor receptor superfamily member 10D measurement,EFO:0021942,http://www.ebi.ac.uk/efo/EFO_0021942,0.952,None
ebi-a-GCST90002305,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
prot-c-4874_3_1,Angiogenin,angiogenin measurement,EFO:0008022,http://www.ebi.ac.uk/efo/EFO_0008022,0.817,None
ebi-a-GCST90010274,Urokinase-type plasminogen activator levels,urokinase-type plasminogen activator measurement,EFO:0010803,http://www.ebi.ac.uk/efo/EFO_0010803,0.79,None
ukb-d-30710_raw,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
prot-a-565,Creatine kinase B-type,creatine kinase measurement,EFO:0004534,http://www.ebi.ac.uk/efo/EFO_0004534,0.711,None
prot-c-3472_40_2,Survivin,survival time,EFO:0000714,http://www.ebi.ac.uk/efo/EFO_0000714,0.732,None
ebi-a-GCST90000050,Age at first birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.907,None
prot-a-675,Gamma-crystallin D,gamma-crystallin D measurement,EFO:0802560,http://www.ebi.ac.uk/efo/EFO_0802560,0.728,None
prot-a-1933,3-mercaptopyruvate sulfurtransferase,3-mercaptopyruvate sulfurtransferase measurement,EFO:0802236,http://www.ebi.ac.uk/efo/EFO_0802236,0.899,None
prot-a-2751,Prestin,prestin measurement,EFO:0802899,http://www.ebi.ac.uk/efo/EFO_0802899,0.724,None
prot-a-69,Aldo-keto reductase family 1 member C1,aldo-keto reductase family 1 member C1 measurement,EFO:0801363,http://www.ebi.ac.uk/efo/EFO_0801363,0.793,None
prot-a-1248,Glypican-6,glypican-1 measurement,EFO:0801649,http://www.ebi.ac.uk/efo/EFO_0801649,0.602,None
ukb-b-2115,Time spent doing moderate physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.648,None
met-d-XL_HDL_PL,Phospholipids in very large HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.849,None
ukb-a-232,Forced vital capacity (FVC)  Best measure,vital capacity,EFO:0004312,http://www.ebi.ac.uk/efo/EFO_0004312,0.727,None
prot-a-704,Cystatin-M,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.755,None
ebi-a-GCST90006898,Epstein-Barr virus EA-D antibody levels,anti-Epstein Barr virus antibody measurement,EFO:0009273,http://www.ebi.ac.uk/efo/EFO_0009273,0.722,None
prot-a-1233,Progonadoliberin-1,progonadoliberin-1 measurement,EFO:0801924,http://www.ebi.ac.uk/efo/EFO_0801924,0.806,None
prot-a-1749,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 measurement,EFO:0802691,http://www.ebi.ac.uk/efo/EFO_0802691,0.839,None
prot-a-1090,Fibroblast growth factor 16,fibroblast growth factor 16 measurement,EFO:0020378,http://www.ebi.ac.uk/efo/EFO_0020378,0.915,None
prot-a-2226,Platelet-derived growth factor subunit B,platelet-derived growth factor subunit b measurement,EFO:0020650,http://www.ebi.ac.uk/efo/EFO_0020650,0.835,None
ieu-a-1043,Amygdala volume,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.986,None
prot-c-3143_3_1,sCD4,Schnyder corneal dystrophy,MONDO:0007374,http://purl.obolibrary.org/obo/MONDO_0007374,0.67,None
prot-a-1523,Interleukin-32,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.818,None
ebi-a-GCST005349,Total body bone mineral density (age over 60),bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.676,None
prot-a-2070,RNA-binding protein Nova-1,RNA-binding protein Nova-1 measurement,EFO:0803038,http://www.ebi.ac.uk/efo/EFO_0803038,0.622,None
prot-c-3728_52_2,Secretin,secretin measurement,EFO:0020719,http://www.ebi.ac.uk/efo/EFO_0020719,0.781,None
prot-a-784,Beta-defensin 106,beta-defensin 106 measurement,EFO:0802316,http://www.ebi.ac.uk/efo/EFO_0802316,0.771,None
met-a-580,X-12092,X-12092 measurement,EFO:0021284,http://www.ebi.ac.uk/efo/EFO_0021284,0.704,None
ieu-b-4871,Sex hormone binding globulin (SHBG),sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.846,None
prot-c-4490_65_2,IL-3 Ra,refractory anemia,EFO:0003802,http://www.ebi.ac.uk/efo/EFO_0003802,0.664,None
met-d-S_HDL_C_pct,Cholesterol to total lipids ratio in small HDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.657,None
prot-a-2908,Switch-associated protein 70,switch-associated protein 70 measurement,EFO:0802107,http://www.ebi.ac.uk/efo/EFO_0802107,0.808,None
ukb-b-11349,Folate,red blood cell folate measurement,EFO:0009703,http://www.ebi.ac.uk/efo/EFO_0009703,0.75,None
prot-a-1104,Fibroblast growth factor receptor 3,fibroblast growth factor receptor 3 measurement,EFO:0020390,http://www.ebi.ac.uk/efo/EFO_0020390,0.929,None
prot-a-3269,Zinc finger protein 334,zinc finger protein 334 measurement,EFO:0803277,http://www.ebi.ac.uk/efo/EFO_0803277,0.926,None
prot-b-10,"coagulation factor III, tissue factor",prothrombin fragments F1+2 measurement,EFO:0007776,http://www.ebi.ac.uk/efo/EFO_0007776,0.744,None
prot-c-3077_66_2,Coagulation Factor Xa,coagulation factor XA measurement,EFO:0020266,http://www.ebi.ac.uk/efo/EFO_0020266,0.9,None
prot-a-2729,Sialic acid-binding Ig-like lectin 7,sialic acid-binding ig-like lectin 7 measurement,EFO:0020739,http://www.ebi.ac.uk/efo/EFO_0020739,0.675,None
ukb-b-4043,Mushroom intake,mushroom workers' lung,EFO:0007385,http://www.ebi.ac.uk/efo/EFO_0007385,0.623,None
prot-a-219,"Beta-1,4-galactosyltransferase 5","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.761,None
prot-a-2700,Alpha-2-antiplasmin,alpha-2-plasmin inhibitor deficiency,MONDO:0009883,http://purl.obolibrary.org/obo/MONDO_0009883,0.635,None
met-b-174,CD4:%TM (1),targeted mutation,EFO:0004019,http://www.ebi.ac.uk/efo/EFO_0004019,0.788,None
prot-a-961,Ephrin type-B receptor 2,ephrin type-B receptor 2 measurement,EFO:0008124,http://www.ebi.ac.uk/efo/EFO_0008124,0.681,None
ieu-a-301,Total cholesterol,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-a-2259,Membrane-associated progesterone receptor component 1,membrane-associated progesterone receptor component 1 measurement,EFO:0802740,http://www.ebi.ac.uk/efo/EFO_0802740,0.89,None
met-a-343,Guanosine,guanosine measurement,EFO:0021124,http://www.ebi.ac.uk/efo/EFO_0021124,0.825,None
prot-a-2204,Protocadherin beta-2,protocadherin beta-1 measurement,EFO:0802972,http://www.ebi.ac.uk/efo/EFO_0802972,0.751,None
ebi-a-GCST90002306,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
prot-c-4548_4_2,Fucosyltransferase 3,fucosyltransferase 6 deficiency,MONDO:0013462,http://purl.obolibrary.org/obo/MONDO_0013462,0.847,None
met-a-389,X-04357,X-04357 measurement,EFO:0021189,http://www.ebi.ac.uk/efo/EFO_0021189,0.662,None
ebi-a-GCST90010265,Trem-like transcript 2 protein levels,trem-like transcript 2 protein measurement,EFO:0802159,http://www.ebi.ac.uk/efo/EFO_0802159,0.753,None
ieu-a-70,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-1105,Fibroblast growth factor receptor 4,fibroblast growth factor receptor 4 measurement,EFO:0020391,http://www.ebi.ac.uk/efo/EFO_0020391,0.93,None
prot-a-3229,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2","WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement",EFO:0008319,http://www.ebi.ac.uk/efo/EFO_0008319,0.843,None
prot-a-428,CD226 antigen,CD226 antigen measurement,EFO:0020246,http://www.ebi.ac.uk/efo/EFO_0020246,0.899,None
prot-a-2342,Peptidyl-prolyl cis-trans isomerase H,peptidyl-prolyl cis-trans isomerase H measurement,EFO:0801874,http://www.ebi.ac.uk/efo/EFO_0801874,0.776,None
prot-a-22,Activin receptor type-1B,activin receptor type-1B measurement,EFO:0020127,http://www.ebi.ac.uk/efo/EFO_0020127,0.666,None
prot-a-537,Serine/threonine-protein kinase Chk1,serine/threonine-protein kinase Chk1 measurement,EFO:0021965,http://www.ebi.ac.uk/efo/EFO_0021965,0.763,None
prot-a-468,Complement component C1q receptor,complement component C1q receptor measurement,EFO:0802427,http://www.ebi.ac.uk/efo/EFO_0802427,0.959,None
prot-a-555,Carbohydrate sulfotransferase 2,carbohydrate sulfotransferase 2 measurement,EFO:0020225,http://www.ebi.ac.uk/efo/EFO_0020225,0.934,None
ebi-a-GCST90000452,CD5 levels,CD5 measurement,EFO:0010773,http://www.ebi.ac.uk/efo/EFO_0010773,0.626,None
prot-a-2973,Thrombopoietin,thrombopoietin,EFO:0003236,http://www.ebi.ac.uk/efo/EFO_0003236,0.989,None
prot-c-2876_74_2,Topoisomerase I,DNA topoisomerase 1 measurement,EFO:0020331,http://www.ebi.ac.uk/efo/EFO_0020331,0.686,None
prot-a-1635,Kinesin-like protein KIF16B,kinesin-like protein KIF16B measurement,EFO:0801747,http://www.ebi.ac.uk/efo/EFO_0801747,0.888,None
prot-a-2509,Calcipressin-1,calcipressin-1 measurement,EFO:0801442,http://www.ebi.ac.uk/efo/EFO_0801442,0.75,None
prot-a-2133,Neurexophilin-3,neurexophilin-1 measurement,EFO:0008244,http://www.ebi.ac.uk/efo/EFO_0008244,0.751,None
prot-a-2864,AMSH-like protease,AMSH-like protease measurement,EFO:0802274,http://www.ebi.ac.uk/efo/EFO_0802274,0.725,None
prot-a-1410,"Indoleamine 2,3-dioxygenase 1","indoleamine 2,3-dioxygenase 1 measurement",EFO:0801695,http://www.ebi.ac.uk/efo/EFO_0801695,0.745,None
ebi-a-GCST006700,Parental longevity (father's age at death),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.709,None
prot-c-4925_54_2,MMP-13,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.828,None
met-a-636,X-12644,X-12644 measurement,EFO:0021318,http://www.ebi.ac.uk/efo/EFO_0021318,0.711,None
prot-a-2454,"tRNA pseudouridine synthase A, mitochondrial","tRNA pseudouridine synthase A, mitochondrial measurement",EFO:0803194,http://www.ebi.ac.uk/efo/EFO_0803194,0.891,None
prot-a-688,Chorionic somatomammotropin hormone,chorionic somatomammotropin hormone measurement,EFO:0021929,http://www.ebi.ac.uk/efo/EFO_0021929,0.929,None
prot-a-1357,Non-histone chromosomal protein HMG-14,non-histone chromosomal protein HMG-14 measurement,EFO:0021872,http://www.ebi.ac.uk/efo/EFO_0021872,0.682,None
ebi-a-GCST90001958,CD4 on monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.633,None
met-c-920,Pyruvate,pyruvate measurement,EFO:0010117,http://www.ebi.ac.uk/efo/EFO_0010117,0.852,None
ebi-a-GCST90000468,Fibroblast growth factor 23 levels,fibroblast growth factor 23 measurement,EFO:0009381,http://www.ebi.ac.uk/efo/EFO_0009381,0.851,None
met-a-416,X-06351,X-06351 measurement,EFO:0021203,http://www.ebi.ac.uk/efo/EFO_0021203,0.679,None
met-c-915,Triglycerides in medium VLDL,triglycerides in medium VLDL measurement,EFO:0022155,http://www.ebi.ac.uk/efo/EFO_0022155,0.918,None
prot-a-1437,Interferon lambda receptor 1,interferon lambda receptor 1 measurement,EFO:0802646,http://www.ebi.ac.uk/efo/EFO_0802646,0.928,None
prot-a-481,Cadherin-15,cadherin-15 measurement,EFO:0020211,http://www.ebi.ac.uk/efo/EFO_0020211,0.64,None
prot-c-3617_80_4,HGFA,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.614,None
prot-a-953,Ectonucleoside triphosphate diphosphohydrolase 5,ectonucleoside triphosphate diphosphohydrolase 5 measurement,EFO:0008115,http://www.ebi.ac.uk/efo/EFO_0008115,0.961,None
prot-a-216,"Beta-1,4-galactosyltransferase 1","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.752,None
met-c-869,Total lipids in IDL,total lipids in IDL,EFO:0022161,http://www.ebi.ac.uk/efo/EFO_0022161,0.963,None
prot-a-1697,Laminin subunit gamma-2,laminin subunit gamma-2 measurement,EFO:0801756,http://www.ebi.ac.uk/efo/EFO_0801756,0.768,None
prot-a-550,Carbohydrate sulfotransferase 11,carbohydrate sulfotransferase 11 measurement,EFO:0801448,http://www.ebi.ac.uk/efo/EFO_0801448,0.937,None
prot-a-666,Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex,cytokine receptor-like factor 1:cardiotrophin-like cytokine factor 1 complex measurement,EFO:0020305,http://www.ebi.ac.uk/efo/EFO_0020305,0.851,None
prot-a-667,Cytokine receptor-like factor 2,cytokine receptor-like factor 2 measurement,EFO:0020306,http://www.ebi.ac.uk/efo/EFO_0020306,0.829,None
prot-c-4930_21_1,Stanniocalcin-1,stanniocalcin-1 measurement,EFO:0020753,http://www.ebi.ac.uk/efo/EFO_0020753,0.763,None
met-a-723,X-14374,X-14374 measurement,EFO:0021368,http://www.ebi.ac.uk/efo/EFO_0021368,0.703,None
prot-c-3179_51_2,Cathepsin A,galactosialidosis,MONDO:0009737,http://purl.obolibrary.org/obo/MONDO_0009737,0.796,None
ebi-a-GCST008054,QRS duration,QRS duration,EFO:0005055,http://www.ebi.ac.uk/efo/EFO_0005055,0.992,None
met-a-689,2-stearoylglycerophosphocholine*,1-stearoylglycerophosphocholine measurement,EFO:0021092,http://www.ebi.ac.uk/efo/EFO_0021092,0.838,None
ebi-a-GCST90002242,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-b-7,coagulation factor II thrombin receptor,prothrombin fragments F1+2 measurement,EFO:0007776,http://www.ebi.ac.uk/efo/EFO_0007776,0.673,None
ieu-a-107,Weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.996,None
prot-a-2319,GDP-fucose protein O-fucosyltransferase 2,GDP-fucose protein O-fucosyltransferase 2 measurement,EFO:0801622,http://www.ebi.ac.uk/efo/EFO_0801622,0.743,None
prot-c-4774_62_3,FAM107B,protein fam107b measurement,EFO:0020674,http://www.ebi.ac.uk/efo/EFO_0020674,0.828,None
prot-a-1883,tRNA (guanine-N(7)-)-methyltransferase,guanidinoacetate methyltransferase deficiency,MONDO:0012999,http://purl.obolibrary.org/obo/MONDO_0012999,0.6,None
prot-a-729,Cathepsin Z,cathepsin Z measurement,EFO:0008074,http://www.ebi.ac.uk/efo/EFO_0008074,0.851,None
ebi-a-GCST90012048,Thrombomodulin levels,thrombomodulin measurement,EFO:0007774,http://www.ebi.ac.uk/efo/EFO_0007774,0.787,None
ebi-a-GCST90010136,Heat shock 27 kDa protein levels,heat shock 27 kDa protein measurement,EFO:0010915,http://www.ebi.ac.uk/efo/EFO_0010915,0.857,None
prot-a-228,B melanoma antigen 3,b melanoma antigen 3 measurement,EFO:0802299,http://www.ebi.ac.uk/efo/EFO_0802299,0.869,None
prot-c-3810_50_2,FGR,fetal growth restriction,EFO:0000495,http://www.ebi.ac.uk/efo/EFO_0000495,0.997,None
ukb-b-5811,Portion size,size,EFO:0001695,http://www.ebi.ac.uk/efo/EFO_0001695,0.775,None
prot-c-4831_4_2,sL-Selectin,SL,EFO:0007031,http://www.ebi.ac.uk/efo/EFO_0007031,0.662,None
met-a-598,X-12261,X-12261 measurement,EFO:0021301,http://www.ebi.ac.uk/efo/EFO_0021301,0.707,None
ebi-a-GCST002223,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-987,Endothelial cell-selective adhesion molecule,endothelial cell-selective adhesion molecule measurement,EFO:0008120,http://www.ebi.ac.uk/efo/EFO_0008120,0.868,None
ebi-a-GCST90001532,Basophil Absolute Count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.782,None
prot-a-377,Chromobox protein homolog 7,chromobox protein homolog 7 measurement,EFO:0801475,http://www.ebi.ac.uk/efo/EFO_0801475,0.916,None
prot-a-1439,Immunoglobulin-binding protein 1,immunoglobulin-binding protein 1 measurement,EFO:0801691,http://www.ebi.ac.uk/efo/EFO_0801691,0.834,None
ukb-b-14067,6mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
ebi-a-GCST006944,Experiencing mood swings,Emotional lability,HP:0000712,http://purl.obolibrary.org/obo/HP_0000712,0.731,None
ebi-a-GCST006347,Anti-herpes simplex virus 2 IgG levels,Anti-herpes simplex virus 2 IgG measurement,EFO:0009350,http://www.ebi.ac.uk/efo/EFO_0009350,0.768,None
prot-a-3274,Zinc finger protein 566,zinc finger protein 566 measurement,EFO:0803282,http://www.ebi.ac.uk/efo/EFO_0803282,0.926,None
prot-a-3174,Ubiquinol-cytochrome-c reductase complex assembly factor 3,ubiquinol-cytochrome-c reductase complex assembly factor 3 measurement,EFO:0803212,http://www.ebi.ac.uk/efo/EFO_0803212,0.827,None
prot-a-3005,Transmembrane protein 230,transmembrane protein 230 measurement,EFO:0802156,http://www.ebi.ac.uk/efo/EFO_0802156,0.93,None
prot-a-1892,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase","alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase measurement",EFO:0802263,http://www.ebi.ac.uk/efo/EFO_0802263,0.698,None
prot-a-2087,Oxysterols receptor LXR-beta,oxysterols receptor LXR-beta measurement,EFO:0801865,http://www.ebi.ac.uk/efo/EFO_0801865,0.768,None
prot-a-2345,Protein phosphatase 1A,protein phosphatase 1A measurement,EFO:0802957,http://www.ebi.ac.uk/efo/EFO_0802957,0.892,None
prot-a-34,A disintegrin and metalloproteinase with thrombospondin motifs 3,a disintegrin and metalloproteinase with thrombospondin motifs 3 measurement,EFO:0802245,http://www.ebi.ac.uk/efo/EFO_0802245,0.942,None
prot-a-2815,Maspardin,maspardin measurement,EFO:0801786,http://www.ebi.ac.uk/efo/EFO_0801786,0.812,None
ebi-a-GCST90012042,beta-nerve growth factor levels,beta-nerve growth factor measurement,EFO:0008035,http://www.ebi.ac.uk/efo/EFO_0008035,0.693,None
met-d-S_LDL_CE,Cholesteryl esters in small LDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.706,None
met-a-534,X-11550,X-11550 measurement,EFO:0021254,http://www.ebi.ac.uk/efo/EFO_0021254,0.701,None
prot-a-2040,Nuclear factor erythroid 2-related factor 1,nuclear factor erythroid 2-related factor 1 measurement,EFO:0801848,http://www.ebi.ac.uk/efo/EFO_0801848,0.881,None
met-d-Remnant_C,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.765,None
met-d-Total_L,Total lipids in lipoprotein particles,lipoprotein,EFO:0003836,http://www.ebi.ac.uk/efo/EFO_0003836,0.627,None
prot-a-2113,5'-Nucleotidase,nucleotide measurement,EFO:0010513,http://www.ebi.ac.uk/efo/EFO_0010513,0.671,None
prot-a-511,Centromere protein W,centromere protein W measurement,EFO:0802387,http://www.ebi.ac.uk/efo/EFO_0802387,0.758,None
prot-a-2460,Peroxidasin-like protein,peroxidasin-like protein measurement,EFO:0802854,http://www.ebi.ac.uk/efo/EFO_0802854,0.81,None
prot-a-1086,D-dimer,D dimer measurement,EFO:0004507,http://www.ebi.ac.uk/efo/EFO_0004507,0.8,None
ebi-a-GCST008042,PR interval,PR interval,EFO:0004462,http://www.ebi.ac.uk/efo/EFO_0004462,0.995,None
prot-a-3054,Tumor necrosis factor ligand superfamily member 11,tumor necrosis factor ligand superfamily member 11 measurement,EFO:0010617,http://www.ebi.ac.uk/efo/EFO_0010617,0.939,None
prot-a-1866,Guanine nucleotide exchange factor DBS,guanine nucleotide exchange factor DBS measurement,EFO:0802586,http://www.ebi.ac.uk/efo/EFO_0802586,0.952,None
met-d-Total_C,Total cholesterol,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
ieu-a-275,Red blood cell count,erythrocyte count,EFO:0004305,http://www.ebi.ac.uk/efo/EFO_0004305,0.991,None
prot-a-1722,Leptin,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.986,None
ebi-a-GCST90012053,Cathepsin D levels,cathepsin D measurement,EFO:0010611,http://www.ebi.ac.uk/efo/EFO_0010611,0.713,None
ebi-a-GCST005179,Homeostasis model assessment of insulin resistance,HOMA-IR,EFO:0004501,http://www.ebi.ac.uk/efo/EFO_0004501,0.976,None
prot-a-404,C-C motif chemokine 26,C-C motif chemokine 26 measurement,EFO:0022024,http://www.ebi.ac.uk/efo/EFO_0022024,0.717,None
met-c-884,Concentration of large LDL particles,concentration of large LDL particles measurement,EFO:0022160,http://www.ebi.ac.uk/efo/EFO_0022160,0.929,None
prot-b-18,TNF receptor superfamily member 10b,tumor necrosis factor receptor superfamily member 10B measurement,EFO:0021993,http://www.ebi.ac.uk/efo/EFO_0021993,0.749,None
prot-a-1249,Glycerophosphocholine phosphodiesterase GPCPD1,glycerophosphocholine phosphodiesterase GPCPD1 measurement,EFO:0802574,http://www.ebi.ac.uk/efo/EFO_0802574,0.963,None
prot-a-2155,Oncostatin-M,oncostatin M,EFO:0003200,http://www.ebi.ac.uk/efo/EFO_0003200,0.996,None
prot-a-1346,"HLA class II histocompatibility antigen, DP beta 1 chain","HLA class II histocompatibility antigen, DP beta 1 chain measurement",EFO:0801685,http://www.ebi.ac.uk/efo/EFO_0801685,0.897,None
met-a-694,X-13549,X-13549 measurement,EFO:0021354,http://www.ebi.ac.uk/efo/EFO_0021354,0.693,None
bbj-a-52,Systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
met-a-434,Palmitoylcarnitine,palmitoylcarnitine measurement,EFO:0021044,http://www.ebi.ac.uk/efo/EFO_0021044,0.904,None
ebi-a-GCST90016674,Liver iron content,liver iron measurement,EFO:0010056,http://www.ebi.ac.uk/efo/EFO_0010056,0.721,None
ebi-a-GCST90010296,Cadherin-related family member 5 levels,cadherin-related family member 5 measurement,EFO:0801440,http://www.ebi.ac.uk/efo/EFO_0801440,0.794,None
prot-a-2803,Sclerostin,sclerostin measurement,EFO:0010606,http://www.ebi.ac.uk/efo/EFO_0010606,0.803,None
ebi-a-GCST90010186,vascular endothelial growth factor D levels,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.913,None
ebi-a-GCST90002005,CD16 on CD14+ CD16+ monocyte,autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,MONDO:0014313,http://purl.obolibrary.org/obo/MONDO_0014313,0.666,None
met-c-896,Mean diameter for LDL particles,LDL peak particle diameter measurement,EFO:0007677,http://www.ebi.ac.uk/efo/EFO_0007677,0.736,None
met-d-S_VLDL_FC,Free cholesterol in small VLDL,total cholesterol in small VLDL,EFO:0022171,http://www.ebi.ac.uk/efo/EFO_0022171,0.792,None
prot-a-1361,Heterogeneous nuclear ribonucleoproteins A2/B1,heterogeneous nuclear ribonucleoprotein M measurement,EFO:0801674,http://www.ebi.ac.uk/efo/EFO_0801674,0.838,None
prot-a-728,Cathepsin L2,cathepsin L2 measurement,EFO:0020244,http://www.ebi.ac.uk/efo/EFO_0020244,0.859,None
prot-a-2186,Prostate and testis expressed protein 1,prostate and testis expressed protein 1 measurement,EFO:0802919,http://www.ebi.ac.uk/efo/EFO_0802919,0.903,None
met-a-640,X-12696,X-12696 measurement,EFO:0021321,http://www.ebi.ac.uk/efo/EFO_0021321,0.726,None
prot-a-873,Dual specificity protein phosphatase 13 isoform A,dual specificity protein phosphatase 13 isoform A measurement,EFO:0801549,http://www.ebi.ac.uk/efo/EFO_0801549,0.945,None
prot-a-2953,Trefoil factor 3,trefoil factor 3 measurement,EFO:0008304,http://www.ebi.ac.uk/efo/EFO_0008304,0.904,None
met-a-325,Tyrosine,Hypertyrosinemia,HP:0003231,http://purl.obolibrary.org/obo/HP_0003231,0.791,None
prot-a-2604,Retinoschisin,retinoschisis,MONDO:0004579,http://purl.obolibrary.org/obo/MONDO_0004579,0.913,None
prot-a-3099,Trem-like transcript 1 protein,trem-like transcript 1 protein measurement,EFO:0803193,http://www.ebi.ac.uk/efo/EFO_0803193,0.81,None
ebi-a-GCST004599,Mean platelet volume,mean platelet volume,EFO:0004584,http://www.ebi.ac.uk/efo/EFO_0004584,0.978,None
ebi-a-GCST90002016,CCR2 on CD62L+ plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.688,None
prot-a-3230,Wnt inhibitory factor 1,wnt inhibitory factor 1 measurement,EFO:0020853,http://www.ebi.ac.uk/efo/EFO_0020853,0.928,None
ebi-a-GCST90001649,HLA DR+ Natural Killer %Natural Killer,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.71,None
prot-c-3356_50_1,Carbonic anhydrase VII,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.866,None
ebi-a-GCST90001608,CD4+CD8+ T cell %leukocyte,leukocyte disorder,MONDO:0004805,http://purl.obolibrary.org/obo/MONDO_0004805,0.619,None
prot-b-38,interleukin 1 receptor like 1,interleukin 1 receptor-like 1 measurement,EFO:0008168,http://www.ebi.ac.uk/efo/EFO_0008168,0.816,None
prot-a-1150,Furin,furin measurement,EFO:0801610,http://www.ebi.ac.uk/efo/EFO_0801610,0.766,None
met-a-644,X-12719,X-12719 measurement,EFO:0021325,http://www.ebi.ac.uk/efo/EFO_0021325,0.689,None
prot-a-1289,Glutathione S-transferase P,glutathione s-transferase p measurement,EFO:0020410,http://www.ebi.ac.uk/efo/EFO_0020410,0.795,None
prot-a-1032,Protein FAM172A,protein FAM172A measurement,EFO:0802937,http://www.ebi.ac.uk/efo/EFO_0802937,0.916,None
prot-a-3268,Zinc finger protein 329,zinc finger protein 329 measurement,EFO:0803276,http://www.ebi.ac.uk/efo/EFO_0803276,0.925,None
ieu-a-1045,Hippocampus volume,hippocampus volume change measurement,EFO:0021492,http://www.ebi.ac.uk/efo/EFO_0021492,0.85,None
prot-c-3831_21_1,pTEN,glioma susceptibility 2,MONDO:0013092,http://purl.obolibrary.org/obo/MONDO_0013092,0.601,None
prot-c-2696_87_2,Persephin,persephin measurement,EFO:0020632,http://www.ebi.ac.uk/efo/EFO_0020632,0.816,None
prot-c-3221_54_1,SARP-2,NARP syndrome,MONDO:0010794,http://purl.obolibrary.org/obo/MONDO_0010794,0.612,None
ieu-a-1080,Zinc,Zinc deficiency,EFO:1000003,http://www.ebi.ac.uk/efo/EFO_1000003,0.771,None
ukb-b-223,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
ieu-b-4873,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
ebi-a-GCST90010250,Elafin levels,elafin measurement,EFO:0008117,http://www.ebi.ac.uk/efo/EFO_0008117,0.719,None
prot-a-1112,Four-jointed box protein 1,four-jointed box protein 1 measurement,EFO:0801605,http://www.ebi.ac.uk/efo/EFO_0801605,0.725,None
ukb-b-12043,Protein,Proteinuria,HP:0000093,http://purl.obolibrary.org/obo/HP_0000093,0.744,None
prot-c-4916_2_1,IgD,hyperimmunoglobulinemia D with periodic fever,MONDO:0009849,http://purl.obolibrary.org/obo/MONDO_0009849,0.788,None
prot-a-669,Peroxisomal carnitine O-octanoyltransferase,peroxisomal carnitine O-octanoyltransferase measurement,EFO:0802856,http://www.ebi.ac.uk/efo/EFO_0802856,0.829,None
ubm-a-1159,NET100 0003,C1 100080003,EFO:0009495,http://www.ebi.ac.uk/efo/EFO_0009495,0.669,None
prot-a-2388,Transmembrane gamma-carboxyglutamic acid protein 1,transmembrane gamma-carboxyglutamic acid protein 1 measurement,EFO:0802147,http://www.ebi.ac.uk/efo/EFO_0802147,0.891,None
ebi-a-GCST90006921,Anti-polyomavirus 2 IgG seropositivity,polyomavirus 2 seropositivity,EFO:0010907,http://www.ebi.ac.uk/efo/EFO_0010907,0.882,None
ukb-d-3160_irnt,"Weight, manual entry",body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.623,None
ukb-a-23,Number of operations  self-reported,"number of operations, self-reported",EFO:0009802,http://www.ebi.ac.uk/efo/EFO_0009802,0.819,None
prot-c-2943_5_2,Cytochrome P450 3A4,cytochrome p450 3a4 measurement,EFO:0020303,http://www.ebi.ac.uk/efo/EFO_0020303,0.922,None
prot-a-2590,Regulation of nuclear pre-mRNA domain-containing protein 1A,regulation of nuclear pre-mRNA domain-containing protein 1A measurement,EFO:0801994,http://www.ebi.ac.uk/efo/EFO_0801994,0.825,None
prot-a-1509,Interleukin-22 receptor subunit alpha-1,interleukin 5 receptor subunit alpha measurement,EFO:0008186,http://www.ebi.ac.uk/efo/EFO_0008186,0.841,None
met-a-380,Choline,choline measurement,EFO:0010116,http://www.ebi.ac.uk/efo/EFO_0010116,0.724,None
prot-a-2223,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A","high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7a measurement",EFO:0020445,http://www.ebi.ac.uk/efo/EFO_0020445,0.757,None
ebi-a-GCST006360,IgA levels,serum IgA measurement,EFO:0004912,http://www.ebi.ac.uk/efo/EFO_0004912,0.989,None
prot-a-840,DnaJ homolog subfamily B member 14,DnaJ homolog subfamily B member 14 measurement,EFO:0801538,http://www.ebi.ac.uk/efo/EFO_0801538,0.948,None
ebi-a-GCST90002107,HLA DR on Hematopoietic Stem Cell,hematopoietic and lymphoid cell neoplasm,MONDO:0044881,http://purl.obolibrary.org/obo/MONDO_0044881,0.722,None
ukb-b-1572,Difficulty not smoking for 1 day,Difficulty standing,HP:0003698,http://purl.obolibrary.org/obo/HP_0003698,0.615,None
prot-a-846,DnaJ homolog subfamily C member 18,DnaJ homolog subfamily C member 18 measurement,EFO:0802490,http://www.ebi.ac.uk/efo/EFO_0802490,0.949,None
ukb-b-7288,3mm asymmetry angle (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.611,None
ebi-a-GCST90011771,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
ebi-a-GCST90001455,CD62L- HLA DR++ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.603,None
prot-a-107,Annexin A1,annexin A1 measurement,EFO:0008026,http://www.ebi.ac.uk/efo/EFO_0008026,0.882,None
prot-a-3193,Vascular cell adhesion protein 1,vascular cell adhesion protein 1 measurement,EFO:0020846,http://www.ebi.ac.uk/efo/EFO_0020846,0.911,None
prot-a-1950,Prostate-associated microseminoprotein,prostate-associated microseminoprotein measurement,EFO:0802920,http://www.ebi.ac.uk/efo/EFO_0802920,0.849,None
met-a-337,5-oxoproline,5-oxoprolinase deficiency,MONDO:0009825,http://purl.obolibrary.org/obo/MONDO_0009825,0.765,None
met-a-498,X-11327,X-11327 measurement,EFO:0021225,http://www.ebi.ac.uk/efo/EFO_0021225,0.698,None
ieu-b-4834,Alcohol consumption,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.998,None
ebi-a-GCST90012012,kallikrein-11 levels,kallikrein-11 measurement,EFO:0010573,http://www.ebi.ac.uk/efo/EFO_0010573,0.69,None
ukb-b-16407,Trunk fat percentage,body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.678,None
ukb-b-1997,Number of older siblings,number of siblings,EFO:0009713,http://www.ebi.ac.uk/efo/EFO_0009713,0.851,None
met-a-728,X-14625,X-14625 measurement,EFO:0021373,http://www.ebi.ac.uk/efo/EFO_0021373,0.693,None
prot-a-1110,Vascular endothelial growth factor D,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.968,None
prot-a-1553,Inhibin beta A chain,inhibin beta A chain measurement,EFO:0020469,http://www.ebi.ac.uk/efo/EFO_0020469,0.9,None
prot-a-2164,Polyadenylate-binding protein 4,polyadenylate-binding protein 4 measurement,EFO:0801897,http://www.ebi.ac.uk/efo/EFO_0801897,0.825,None
prot-a-2380,Activated Protein C,activated protein C measurement,EFO:0020126,http://www.ebi.ac.uk/efo/EFO_0020126,0.867,None
prot-c-2424_69_4,bFGF-R,basic fibroblast growth factor,EFO:0003316,http://www.ebi.ac.uk/efo/EFO_0003316,0.956,None
prot-a-1424,Interferon alpha-7,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.945,None
ebi-a-GCST90002033,CD39 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.679,None
prot-a-249,BH3-interacting domain death agonist,BH3-interacting domain death agonist measurement,EFO:0021994,http://www.ebi.ac.uk/efo/EFO_0021994,0.807,None
prot-a-2916,Synaptotagmin-7,synaptotagmin-2 measurement,EFO:0803118,http://www.ebi.ac.uk/efo/EFO_0803118,0.766,None
prot-a-648,Probable carboxypeptidase X1,probable carboxypeptidase X1 measurement,EFO:0801914,http://www.ebi.ac.uk/efo/EFO_0801914,0.939,None
prot-a-2348,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform measurement,EFO:0803067,http://www.ebi.ac.uk/efo/EFO_0803067,0.88,None
ebi-a-GCST90010322,Leukocyte immunoglobulin-like receptor subfamily A member 5 levels,leukocyte immunoglobulin-like receptor subfamily A member 5 measurement,EFO:0801766,http://www.ebi.ac.uk/efo/EFO_0801766,0.891,None
prot-a-292,Angiopoietin-like protein 8,angiopoietin-like protein 8 measurement,EFO:0802279,http://www.ebi.ac.uk/efo/EFO_0802279,0.838,None
prot-a-875,Dual specificity protein phosphatase 16,dual specificity protein phosphatase 16 measurement,EFO:0802495,http://www.ebi.ac.uk/efo/EFO_0802495,0.932,None
prot-a-1798,Leucine-rich repeat transmembrane neuronal protein 4,leucine-rich repeat transmembrane neuronal protein 4 measurement,EFO:0802697,http://www.ebi.ac.uk/efo/EFO_0802697,0.883,None
prot-a-936,ER membrane protein complex subunit 4,ER membrane protein complex subunit 4 measurement,EFO:0801580,http://www.ebi.ac.uk/efo/EFO_0801580,0.93,None
prot-a-1263,G-protein coupled receptor 26,g-protein coupled receptor 26 measurement,EFO:0802558,http://www.ebi.ac.uk/efo/EFO_0802558,0.778,None
prot-a-2675,Semaphorin-4D,semaphorin-4D measurement,EFO:0802050,http://www.ebi.ac.uk/efo/EFO_0802050,0.634,None
prot-b-81,ribonuclease A family member 3,ribonuclease 4 measurement,EFO:0802017,http://www.ebi.ac.uk/efo/EFO_0802017,0.653,None
prot-a-307,Complement C1r subcomponent-like protein,complement C1r subcomponent-like protein measurement,EFO:0801495,http://www.ebi.ac.uk/efo/EFO_0801495,0.911,None
prot-a-1041,Protein FAM19A3,protein FAM19A3 measurement,EFO:0802940,http://www.ebi.ac.uk/efo/EFO_0802940,0.917,None
prot-a-2158,Ubiquitin thioesterase OTUB2,ubiquitin thioesterase OTUB2 measurement,EFO:0803213,http://www.ebi.ac.uk/efo/EFO_0803213,0.94,None
met-a-496,X-11317,X-11317 measurement,EFO:0021224,http://www.ebi.ac.uk/efo/EFO_0021224,0.691,None
ubm-a-328,IDP dMRI TBSS MO Cingulum hippocampus R,Hypoplastic hippocampus,HP:0025517,http://purl.obolibrary.org/obo/HP_0025517,0.6,None
prot-a-1412,Radiation-inducible immediate-early gene IEX-1,radiation-inducible immediate-early gene IEX-1 measurement,EFO:0802987,http://www.ebi.ac.uk/efo/EFO_0802987,0.78,None
prot-c-2697_7_2,PF-4,pemphigus foliaceus,EFO:0008601,http://www.ebi.ac.uk/efo/EFO_0008601,0.923,None
ieu-b-110,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
met-a-402,Eicosapentaenoate (EPA; 20:5n3),eicosapentaenoate EPA; 20:5n3 measurement,EFO:0021049,http://www.ebi.ac.uk/efo/EFO_0021049,0.73,None
ukb-b-19885,Duration of questionnaire,health study participation,EFO:0010130,http://www.ebi.ac.uk/efo/EFO_0010130,0.678,None
met-a-582,X-12094,X-12094 measurement,EFO:0021286,http://www.ebi.ac.uk/efo/EFO_0021286,0.707,None
prot-a-2856,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5","alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 measurement",EFO:0802270,http://www.ebi.ac.uk/efo/EFO_0802270,0.722,None
prot-a-1562,Insulin-like peptide INSL5,insulin-like peptide INSL5 measurement,EFO:0802632,http://www.ebi.ac.uk/efo/EFO_0802632,0.879,None
prot-c-4908_6_1,Endoglin,endoglin measurement,EFO:0008118,http://www.ebi.ac.uk/efo/EFO_0008118,0.819,None
prot-a-2269,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement,EFO:0801881,http://www.ebi.ac.uk/efo/EFO_0801881,0.845,None
prot-a-2523,Proto-oncogene tyrosine-protein kinase receptor Ret,proto-oncogene tyrosine-protein kinase receptor Ret measurement,EFO:0008272,http://www.ebi.ac.uk/efo/EFO_0008272,0.803,None
ieu-a-63,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-1210,GH3 domain-containing protein,GH3 domain-containing protein measurement,EFO:0802565,http://www.ebi.ac.uk/efo/EFO_0802565,0.871,None
prot-a-108,Annexin A2,annexin A2 measurement,EFO:0008027,http://www.ebi.ac.uk/efo/EFO_0008027,0.872,None
prot-a-2199,Protocadherin alpha-4,protocadherin alpha-4 measurement,EFO:0801972,http://www.ebi.ac.uk/efo/EFO_0801972,0.723,None
prot-a-1794,Leucine-rich repeat neuronal protein 3,leucine-rich repeat neuronal protein 3 measurement,EFO:0802695,http://www.ebi.ac.uk/efo/EFO_0802695,0.833,None
met-d-ApoB,Apolipoprotein B,apolipoprotein B measurement,EFO:0004615,http://www.ebi.ac.uk/efo/EFO_0004615,0.872,None
ieu-b-4813,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
prot-a-3186,Vesicle-associated membrane protein 4,vesicle-associated membrane protein 4 measurement,EFO:0803252,http://www.ebi.ac.uk/efo/EFO_0803252,0.844,None
ebi-a-GCST007858,Fasting blood glucose adjusted for BMI,BMI-adjusted fasting blood glucose measurement,EFO:0008036,http://www.ebi.ac.uk/efo/EFO_0008036,0.822,None
ebi-a-GCST90011433,OTU99_140 (Desulfovibrio) abundance,commensal Desulfovibrionaceae infectious disease,EFO:1000875,http://www.ebi.ac.uk/efo/EFO_1000875,0.657,None
ebi-a-GCST90012105,Estradiol levels,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.984,None
prot-c-2913_1_2,MPIF-1,CCL23 measurement,EFO:0009417,http://www.ebi.ac.uk/efo/EFO_0009417,0.627,None
prot-a-305,Complement C1q tumor necrosis factor-related protein 5,complement C1q tumor necrosis factor-related protein 5 measurement,EFO:0801494,http://www.ebi.ac.uk/efo/EFO_0801494,0.887,None
prot-a-1324,E3 ubiquitin-protein ligase HECW1,E3 ubiquitin-protein ligase HECW1 measurement,EFO:0802505,http://www.ebi.ac.uk/efo/EFO_0802505,0.905,None
prot-a-1598,Tyrosine-protein kinase JAK2,tyrosine-protein kinase JAK2 measurement,EFO:0020825,http://www.ebi.ac.uk/efo/EFO_0020825,0.841,None
ubm-a-21,IDP T1 FIRST left amygdala volume,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.763,None
prot-a-2080,Neuronal pentraxin-1,neuronal pentraxin-1 measurement,EFO:0801833,http://www.ebi.ac.uk/efo/EFO_0801833,0.758,None
met-a-722,X-14304--leucylalanine,X-14304--leucylalanine measurement,EFO:0021367,http://www.ebi.ac.uk/efo/EFO_0021367,0.664,None
ukb-d-30820_raw,Rheumatoid factor,rheumatoid factor measurement,EFO:0005767,http://www.ebi.ac.uk/efo/EFO_0005767,0.886,None
prot-a-1146,Follistatin-related protein 4,follistatin-related protein 4 measurement,EFO:0801603,http://www.ebi.ac.uk/efo/EFO_0801603,0.826,None
prot-a-2756,Solute carrier family 35 member G2,solute carrier family 35 member G2 measurement,EFO:0802080,http://www.ebi.ac.uk/efo/EFO_0802080,0.946,None
prot-a-3257,Protrudin,protrudin measurement,EFO:0802976,http://www.ebi.ac.uk/efo/EFO_0802976,0.835,None
prot-a-1062,Fibulin-1,fibulin-1 measurement,EFO:0802550,http://www.ebi.ac.uk/efo/EFO_0802550,0.614,None
ieu-b-31,monocyte cell count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.893,None
prot-a-2822,Serine protease inhibitor Kazal-type 9,serine protease inhibitor Kazal-type 9 measurement,EFO:0803060,http://www.ebi.ac.uk/efo/EFO_0803060,0.866,None
prot-a-1641,Killer cell immunoglobulin-like receptor 2DL4,killer cell immunoglobulin-like receptor 2DL4 measurement,EFO:0008197,http://www.ebi.ac.uk/efo/EFO_0008197,0.911,None
prot-a-2622,Protein S100-A9,protein s100-a9 measurement,EFO:0020687,http://www.ebi.ac.uk/efo/EFO_0020687,0.609,None
prot-a-1587,Inter-alpha-trypsin inhibitor heavy chain H5,inter-alpha-trypsin inhibitor heavy chain H5 measurement,EFO:0801706,http://www.ebi.ac.uk/efo/EFO_0801706,0.844,None
prot-a-3,"Alanine--tRNA ligase, cytoplasmic","alanine--tRNA ligase, cytoplasmic measurement",EFO:0801359,http://www.ebi.ac.uk/efo/EFO_0801359,0.745,None
prot-a-1274,Gremlin-2,gremlin-1 measurement,EFO:0020421,http://www.ebi.ac.uk/efo/EFO_0020421,0.732,None
prot-c-3858_5_1,PPAC,progressive pseudorheumatoid arthropathy of childhood,MONDO:0008827,http://purl.obolibrary.org/obo/MONDO_0008827,0.997,None
prot-a-2027,Neurofilament heavy polypeptide,neurofilament heavy polypeptide measurement,EFO:0802801,http://www.ebi.ac.uk/efo/EFO_0802801,0.939,None
met-c-875,Cholesterol esters in large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.92,None
ukb-b-11697,Intake of sugar added to cereal,sugar consumption measurement,EFO:0010158,http://www.ebi.ac.uk/efo/EFO_0010158,0.604,None
met-d-XS_VLDL_P,Concentration of very small VLDL particles,concentration of very small VLDL particles,EFO:0022151,http://www.ebi.ac.uk/efo/EFO_0022151,0.985,None
ieu-b-4827,Number of children ever born measurement,number of children ever born measurement,EFO:0009102,http://www.ebi.ac.uk/efo/EFO_0009102,0.972,None
ukb-a-375,Number of depression episodes,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.613,None
prot-a-20,Tartrate-resistant acid phosphatase type 5,tartrate-resistant acid phosphatase type 5 measurement,EFO:0020763,http://www.ebi.ac.uk/efo/EFO_0020763,0.853,None
met-b-267,MDCL%274+,congenital muscular dystrophy due to LMNA mutation,MONDO:0013178,http://purl.obolibrary.org/obo/MONDO_0013178,0.766,None
met-a-664,X-12833,X-12833 measurement,EFO:0021338,http://www.ebi.ac.uk/efo/EFO_0021338,0.714,None
ebi-a-GCST90010154,NF-kappa-B essential modulator levels,immunodeficiency 33,MONDO:0010386,http://purl.obolibrary.org/obo/MONDO_0010386,0.714,None
prot-c-4911_49_2,Glutathione S-transferase Pi,glutathione s-transferase p measurement,EFO:0020410,http://www.ebi.ac.uk/efo/EFO_0020410,0.655,None
prot-a-578,C-type lectin domain family 4 member M,C-type lectin domain family 4 member M measurement,EFO:0020202,http://www.ebi.ac.uk/efo/EFO_0020202,0.804,None
prot-c-2939_10_2,Artemin,artemin measurement,EFO:0020162,http://www.ebi.ac.uk/efo/EFO_0020162,0.74,None
prot-a-218,"Beta-1,4-galactosyltransferase 3","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.764,None
prot-a-724,Cathepsin H,cathepsin H measurement,EFO:0020243,http://www.ebi.ac.uk/efo/EFO_0020243,0.842,None
prot-a-323,UPF0488 protein C8orf33,UPF0488 protein C8orf33 measurement,EFO:0802200,http://www.ebi.ac.uk/efo/EFO_0802200,0.962,None
met-c-897,Leucine,leucine measurement,EFO:0009770,http://www.ebi.ac.uk/efo/EFO_0009770,0.786,None
ebi-a-GCST90010117,Cathepsin L1 levels,cathepsin L1 measurement,EFO:0010619,http://www.ebi.ac.uk/efo/EFO_0010619,0.744,None
prot-a-1483,Interleukin-17C,interleukin-17C measurement,EFO:0802656,http://www.ebi.ac.uk/efo/EFO_0802656,0.762,None
ebi-a-GCST008039,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
ebi-a-GCST90006884,Anti-BK polyomavirus IgG seropositivity,BK polyomavirus seropositivity,EFO:0010905,http://www.ebi.ac.uk/efo/EFO_0010905,0.899,None
met-d-M_VLDL_TG_pct,Triglycerides to total lipids ratio in medium VLDL,total lipids in medium VLDL,EFO:0022153,http://www.ebi.ac.uk/efo/EFO_0022153,0.722,None
prot-a-1848,Mitogen-activated protein kinase 3,mitogen-activated protein kinase 3 measurement,EFO:0020579,http://www.ebi.ac.uk/efo/EFO_0020579,0.804,None
ukb-b-13330,Food weight,body weight,EFO:0004338,http://www.ebi.ac.uk/efo/EFO_0004338,0.756,None
ukb-a-10,Getting up in morning,"ease of getting up in the morning, self-reported",EFO:0009817,http://www.ebi.ac.uk/efo/EFO_0009817,0.616,None
ebi-a-GCST90010202,Chitotriosidase-1 levels,chitotriosidase-1 measurement,EFO:0008084,http://www.ebi.ac.uk/efo/EFO_0008084,0.679,None
prot-a-1457,Immunoglobulin J chain,immunoglobulin J chain measurement,EFO:0802620,http://www.ebi.ac.uk/efo/EFO_0802620,0.916,None
ukb-b-6412,Number of stillbirths,number of stillbirths,EFO:0009722,http://www.ebi.ac.uk/efo/EFO_0009722,0.988,None
met-c-858,Free cholesterol,free cholesterol measurement,EFO:0008591,http://www.ebi.ac.uk/efo/EFO_0008591,0.888,None
prot-a-1975,Matrix-remodeling-associated protein 8,matrix-remodeling-associated protein 8 measurement,EFO:0802731,http://www.ebi.ac.uk/efo/EFO_0802731,0.728,None
prot-a-2189,PAX-interacting protein 1,PAX-interacting protein 1 measurement,EFO:0801868,http://www.ebi.ac.uk/efo/EFO_0801868,0.67,None
prot-a-2026,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial","NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial measurement",EFO:0802785,http://www.ebi.ac.uk/efo/EFO_0802785,0.814,None
prot-c-3423_59_2,Chymase,chymase measurement,EFO:0020259,http://www.ebi.ac.uk/efo/EFO_0020259,0.798,None
prot-a-2102,Neurexin-1-beta,neurexin-1-beta measurement,EFO:0020596,http://www.ebi.ac.uk/efo/EFO_0020596,0.641,None
prot-a-1075,Low affinity immunoglobulin gamma Fc region receptor II-b,low affinity immunoglobulin gamma Fc region receptor II-b measurement,EFO:0021970,http://www.ebi.ac.uk/efo/EFO_0021970,0.868,None
met-a-478,Dehydroisoandrosterone sulfate (DHEA-S),dehydroisoandrosterone sulfate DHEA-S measurement,EFO:0021119,http://www.ebi.ac.uk/efo/EFO_0021119,0.836,None
prot-a-2645,Secretogranin-3,secretogranin-1 measurement,EFO:0803047,http://www.ebi.ac.uk/efo/EFO_0803047,0.743,None
prot-a-334,Carbonic anhydrase 9,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.94,None
ebi-a-GCST90012110,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.754,None
met-a-371,X-03003,X-03003 measurement,EFO:0021185,http://www.ebi.ac.uk/efo/EFO_0021185,0.647,None
ubm-a-19,IDP T1 FIRST left hippocampus volume,hippocampus fimbria volume,EFO:0009402,http://www.ebi.ac.uk/efo/EFO_0009402,0.68,None
prot-a-3016,Transmembrane protein 87B,transmembrane protein 87B measurement,EFO:0802158,http://www.ebi.ac.uk/efo/EFO_0802158,0.936,None
bbj-a-23,Gamma glutamyl transferase,serum gamma-glutamyl transferase measurement,EFO:0004532,http://www.ebi.ac.uk/efo/EFO_0004532,0.918,None
ukb-b-15178,Corneal resistance factor (right),corneal resistance factor,EFO:0010067,http://www.ebi.ac.uk/efo/EFO_0010067,0.886,None
ebi-a-GCST90001463,CD62L- Dendritic Cell %Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.766,None
prot-a-340,Calbindin,calbindin measurement,EFO:0801441,http://www.ebi.ac.uk/efo/EFO_0801441,0.828,None
prot-a-2956,Tissue factor pathway inhibitor 2,tissue factor pathway inhibitor 2 measurement,EFO:0803156,http://www.ebi.ac.uk/efo/EFO_0803156,0.941,None
prot-a-1764,Lysophosphatidylcholine acyltransferase 2,lysophosphatidylcholine acyltransferase 2 measurement,EFO:0801775,http://www.ebi.ac.uk/efo/EFO_0801775,0.943,None
ebi-a-GCST90000030,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
ukb-b-19703,Low calorie drink intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.6,None
prot-a-1767,Leucine-rich repeat and calponin homology domain-containing protein 4,leucine-rich repeat and calponin homology domain-containing protein 4 measurement,EFO:0802688,http://www.ebi.ac.uk/efo/EFO_0802688,0.873,None
ukb-b-13378,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
prot-a-2227,Platelet-derived growth factor C,platelet-derived growth factor c measurement,EFO:0020648,http://www.ebi.ac.uk/efo/EFO_0020648,0.796,None
prot-a-30,Disintegrin and metalloproteinase domain-containing protein 9,disintegrin and metalloproteinase domain-containing protein 9 measurement,EFO:0020329,http://www.ebi.ac.uk/efo/EFO_0020329,0.909,None
prot-a-570,C-type lectin domain family 12 member A,C-type lectin domain family 12 member A measurement,EFO:0801433,http://www.ebi.ac.uk/efo/EFO_0801433,0.806,None
ebi-a-GCST90010180,Angiopoietin-1 receptor levels,angiopoietin-1 receptor measurement,EFO:0010600,http://www.ebi.ac.uk/efo/EFO_0010600,0.733,None
prot-a-293,Nuclear nucleic acid-binding protein C1D,nuclear nucleic acid-binding protein C1D measurement,EFO:0802820,http://www.ebi.ac.uk/efo/EFO_0802820,0.887,None
ieu-a-118,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
prot-a-627,Collectin-10,empyema,EFO:0003097,http://www.ebi.ac.uk/efo/EFO_0003097,0.608,None
prot-a-80,Arachidonate 15-lipoxygenase B,arachidonate 15-lipoxygenase B measurement,EFO:0801391,http://www.ebi.ac.uk/efo/EFO_0801391,0.81,None
prot-a-2975,Thrombospondin type-1 domain-containing protein 1,thrombospondin type-1 domain-containing protein 1 measurement,EFO:0802131,http://www.ebi.ac.uk/efo/EFO_0802131,0.81,None
prot-a-2378,Protein arginine N-methyltransferase 3,protein arginine N-methyltransferase 3 measurement,EFO:0802925,http://www.ebi.ac.uk/efo/EFO_0802925,0.843,None
prot-a-912,EH domain-containing protein 4,EH domain-containing protein 4 measurement,EFO:0802519,http://www.ebi.ac.uk/efo/EFO_0802519,0.851,None
ebi-a-GCST004625,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
ukb-b-3357,Birth weight of first child,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.695,None
prot-c-5265_12_3,GRB2-related adapter protein 2,grb2-related adapter protein 2 measurement,EFO:0020420,http://www.ebi.ac.uk/efo/EFO_0020420,0.806,None
met-d-XL_VLDL_CE,Cholesteryl esters in very large VLDL,cholesterol esters in large VLDL measurement,EFO:0022170,http://www.ebi.ac.uk/efo/EFO_0022170,0.741,None
ebi-a-GCST90010256,Resistin levels,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.976,None
ubm-a-2665,volume 4th-Ventricle,lateral ventricle volume measurement,EFO:0008487,http://www.ebi.ac.uk/efo/EFO_0008487,0.662,None
prot-a-2941,Tyrosyl-DNA phosphodiesterase 1,tyrosyl-DNA phosphodiesterase 1 measurement,EFO:0803210,http://www.ebi.ac.uk/efo/EFO_0803210,0.795,None
ebi-a-GCST90010197,C-C motif chemokine 24 levels,CCL24 measurement,EFO:0009418,http://www.ebi.ac.uk/efo/EFO_0009418,0.692,None
ebi-a-GCST90012040,ST2 protein levels,ST2 protein measurement,EFO:0010599,http://www.ebi.ac.uk/efo/EFO_0010599,0.716,None
prot-a-1047,Redox-regulatory protein FAM213A,redox-regulatory protein FAM213A measurement,EFO:0801993,http://www.ebi.ac.uk/efo/EFO_0801993,0.845,None
ukb-b-20188,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
prot-a-247,Biglycan,biglycan measurement,EFO:0020182,http://www.ebi.ac.uk/efo/EFO_0020182,0.838,None
prot-a-1547,Interleukin enhancer-binding factor 3,interleukin enhancer-binding factor 3 measurement,EFO:0802652,http://www.ebi.ac.uk/efo/EFO_0802652,0.85,None
prot-a-544,Choline/ethanolamine kinase,ethanolamine kinase 1 measurement,EFO:0802532,http://www.ebi.ac.uk/efo/EFO_0802532,0.782,None
prot-a-495,Cyclin-dependent kinase inhibitor 1B,cyclin-dependent kinase inhibitor 1b measurement,EFO:0020298,http://www.ebi.ac.uk/efo/EFO_0020298,0.889,None
met-a-458,DSGEGDFXAEGGGVR*,DSGEGDFXAEGGGVR measurement,EFO:0021136,http://www.ebi.ac.uk/efo/EFO_0021136,0.955,None
met-a-630,X-12524,X-12524 measurement,EFO:0021314,http://www.ebi.ac.uk/efo/EFO_0021314,0.707,None
prot-c-5020_50_1,phosphoglycerate kinase 1,phosphoglycerate kinase 1 measurement,EFO:0020638,http://www.ebi.ac.uk/efo/EFO_0020638,0.911,None
ebi-a-GCST90000460,CXCL11 levels,CXCL11 measurement,EFO:0010779,http://www.ebi.ac.uk/efo/EFO_0010779,0.799,None
met-a-682,1-arachidonoylglycerophosphoethanolamine*,1-arachidonoylglycerophosphoethanolamine measurement,EFO:0021077,http://www.ebi.ac.uk/efo/EFO_0021077,0.88,None
ebi-a-GCST007557,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
prot-a-1177,Growth arrest-specific protein 1,growth arrest-specific protein 1 measurement,EFO:0020425,http://www.ebi.ac.uk/efo/EFO_0020425,0.806,None
prot-a-560,Cartilage intermediate layer protein 1,cartilage intermediate layer protein 1 measurement,EFO:0801457,http://www.ebi.ac.uk/efo/EFO_0801457,0.922,None
ebi-a-GCST000568,Fasting blood glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.898,None
prot-a-1462,Immunoglobulin superfamily member 8,immunoglobulin superfamily member 8 measurement,EFO:0802622,http://www.ebi.ac.uk/efo/EFO_0802622,0.939,None
ebi-a-GCST90017138,Neck circumference (BMI adjusted),BMI-adjusted neck circumference,EFO:0011044,http://www.ebi.ac.uk/efo/EFO_0011044,0.871,None
prot-a-2406,Putative pregnancy-specific beta-1-glycoprotein 7,putative pregnancy-specific beta-1-glycoprotein 7 measurement,EFO:0802983,http://www.ebi.ac.uk/efo/EFO_0802983,0.74,None
prot-a-2332,Periostin,periostin measurement,EFO:0020628,http://www.ebi.ac.uk/efo/EFO_0020628,0.777,None
prot-a-1409,Insulin-degrading enzyme,insulin-degrading enzyme measurement,EFO:0020472,http://www.ebi.ac.uk/efo/EFO_0020472,0.837,None
prot-a-1148,Ferritin,ferritin measurement,EFO:0004459,http://www.ebi.ac.uk/efo/EFO_0004459,0.806,None
prot-a-2324,DNA-directed RNA polymerases I and III subunit RPAC1,DNA-directed RNA polymerases I and III subunit RPAC1 measurement,EFO:0801535,http://www.ebi.ac.uk/efo/EFO_0801535,0.892,None
ebi-a-GCST90007314,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
met-a-730,X-14632,X-14632 measurement,EFO:0021375,http://www.ebi.ac.uk/efo/EFO_0021375,0.706,None
prot-a-3272,Zinc finger protein 410,zinc finger protein 410 measurement,EFO:0803280,http://www.ebi.ac.uk/efo/EFO_0803280,0.922,None
ebi-a-GCST90002295,Basophil count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.984,None
prot-a-2656,Stromal cell-derived factor 2-like protein 1,stromal cell-derived factor 2-like protein 1 measurement,EFO:0803105,http://www.ebi.ac.uk/efo/EFO_0803105,0.733,None
prot-c-2950_57_2,IGFBP-4,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.62,None
prot-a-1451,Insulin-like growth factor-binding protein 7,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.812,None
prot-a-2609,Reticulon-4 receptor,reticulon-4 receptor measurement,EFO:0020705,http://www.ebi.ac.uk/efo/EFO_0020705,0.71,None
prot-a-1549,Inosine-5'-monophosphate dehydrogenase 1,inosine-5'-monophosphate dehydrogenase 1 measurement,EFO:0008158,http://www.ebi.ac.uk/efo/EFO_0008158,0.704,None
ebi-a-GCST90002409,Childhood body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.708,None
ebi-a-GCST90010227,Interleukin-1 receptor type 2 levels,interleukin-1 receptor type 2 measurement,EFO:0021842,http://www.ebi.ac.uk/efo/EFO_0021842,0.722,None
prot-a-842,DnaJ homolog subfamily B member 9,DnaJ homolog subfamily B member 9 measurement,EFO:0801540,http://www.ebi.ac.uk/efo/EFO_0801540,0.946,None
prot-a-450,Leukocyte surface antigen CD47,leukocyte surface antigen CD47 measurement,EFO:0022010,http://www.ebi.ac.uk/efo/EFO_0022010,0.941,None
prot-a-2036,Neuropilin and tolloid-like protein 2,neuropilin and tolloid-like protein 2 measurement,EFO:0802808,http://www.ebi.ac.uk/efo/EFO_0802808,0.784,None
prot-a-2566,E3 ubiquitin-protein ligase RNF149,E3 ubiquitin-protein ligase RNF149 measurement,EFO:0802511,http://www.ebi.ac.uk/efo/EFO_0802511,0.907,None
bbj-a-27,Hematocrit,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.994,None
prot-a-3145,Ubiquitin-conjugating enzyme E2 variant 1,ubiquitin-conjugating enzyme E2 variant 1 measurement,EFO:0802182,http://www.ebi.ac.uk/efo/EFO_0802182,0.912,None
prot-a-2494,Retinoic acid receptor responder protein 3,retinoic acid receptor responder protein 3 measurement,EFO:0802005,http://www.ebi.ac.uk/efo/EFO_0802005,0.931,None
prot-a-932,RNA polymerase II elongation factor ELL,RNA polymerase II elongation factor ELL measurement,EFO:0802028,http://www.ebi.ac.uk/efo/EFO_0802028,0.939,None
prot-c-3700_15_4,IgG,anti-IgG,EFO:0005030,http://www.ebi.ac.uk/efo/EFO_0005030,0.999,None
prot-a-2179,E3 ubiquitin-protein ligase parkin,e3 ubiquitin-protein ligase parkin measurement,EFO:0802506,http://www.ebi.ac.uk/efo/EFO_0802506,0.883,None
prot-a-344,Calreticulin,calreticulin measurement,EFO:0020221,http://www.ebi.ac.uk/efo/EFO_0020221,0.874,None
prot-a-1976,Matrix-remodeling-associated protein 8,matrix-remodeling-associated protein 8 measurement,EFO:0802731,http://www.ebi.ac.uk/efo/EFO_0802731,0.728,None
prot-a-513,Centrosomal protein of 57 kDa,centrosomal protein of 57 kDa measurement,EFO:0801465,http://www.ebi.ac.uk/efo/EFO_0801465,0.91,None
prot-a-571,C-type lectin domain family 14 member A,C-type lectin domain family 14 member A measurement,EFO:0802343,http://www.ebi.ac.uk/efo/EFO_0802343,0.807,None
prot-a-1204,GDNF family receptor alpha-like,GDNF family receptor alpha-like measurement,EFO:0801620,http://www.ebi.ac.uk/efo/EFO_0801620,0.853,None
prot-a-183,Asialoglycoprotein receptor 2,asialoglycoprotein receptor 2 measurement,EFO:0802290,http://www.ebi.ac.uk/efo/EFO_0802290,0.901,None
prot-a-721,Cathepsin F,cathepsin F measurement,EFO:0022038,http://www.ebi.ac.uk/efo/EFO_0022038,0.842,None
ukb-a-265,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
prot-a-2571,E3 ubiquitin-protein ligase RNF34,E3 ubiquitin-protein ligase RNF34 measurement,EFO:0802512,http://www.ebi.ac.uk/efo/EFO_0802512,0.904,None
ieu-b-116,Fasting insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.803,None
ebi-a-GCST006306,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-2326,Corticotropin,ACTH-Producing Pituitary Gland Adenoma,EFO:1000066,http://www.ebi.ac.uk/efo/EFO_1000066,0.905,None
ieu-b-104,HbA1C,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.997,None
prot-a-2745,SLAM family member 8,SLAM family member 8 measurement,EFO:0803079,http://www.ebi.ac.uk/efo/EFO_0803079,0.911,None
prot-a-1817,Ly6/PLAUR domain-containing protein 3,Ly6/PLAUR domain-containing protein 3 measurement,EFO:0021931,http://www.ebi.ac.uk/efo/EFO_0021931,0.701,None
ebi-a-GCST90002311,Hemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.768,None
prot-a-13,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2","arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 measurement",EFO:0803311,http://www.ebi.ac.uk/efo/EFO_0803311,0.772,None
ebi-a-GCST90000449,CCL4 levels,CCL4 measurement,EFO:0004751,http://www.ebi.ac.uk/efo/EFO_0004751,0.731,None
met-a-335,Pipecolate,pipecolate measurement,EFO:0021006,http://www.ebi.ac.uk/efo/EFO_0021006,0.837,None
prot-a-324,Complement component C9,complement component C9 measurement,EFO:0020282,http://www.ebi.ac.uk/efo/EFO_0020282,0.952,None
prot-a-2909,Heterogeneous nuclear ribonucleoprotein Q,heterogeneous nuclear ribonucleoprotein q measurement,EFO:0020443,http://www.ebi.ac.uk/efo/EFO_0020443,0.954,None
prot-a-549,Chordin-like protein 2,chordin-like protein 2 measurement,EFO:0801474,http://www.ebi.ac.uk/efo/EFO_0801474,0.767,None
prot-a-2321,DNA polymerase eta,DNA polymerase eta measurement,EFO:0802475,http://www.ebi.ac.uk/efo/EFO_0802475,0.89,None
ebi-a-GCST90006911,Helicobacter pylori CagA antibody levels,Helicobacter pylori infectious disease,EFO:1000961,http://www.ebi.ac.uk/efo/EFO_1000961,0.637,None
met-a-693,X-13548,X-13548 measurement,EFO:0021353,http://www.ebi.ac.uk/efo/EFO_0021353,0.704,None
prot-a-955,Ephrin type-A receptor 10,ephrin type-a receptor 10 measurement,EFO:0020350,http://www.ebi.ac.uk/efo/EFO_0020350,0.697,None
ukb-b-4424,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
prot-a-2699,Pigment epithelium-derived factor,pigment epithelium-derived factor measurement,EFO:0021847,http://www.ebi.ac.uk/efo/EFO_0021847,0.825,None
ebi-a-GCST90010273,Tartrate-resistant acid phosphatase type 5 levels,tartrate-resistant acid phosphatase type 5 measurement,EFO:0020763,http://www.ebi.ac.uk/efo/EFO_0020763,0.805,None
prot-a-460,HLA class II histocompatibility antigen gamma chain,HLA class II histocompatibility antigen gamma chain measurement,EFO:0802607,http://www.ebi.ac.uk/efo/EFO_0802607,0.947,None
prot-a-2335,Phosphatidate phosphatase PPAPDC1A,phosphatidate phosphatase PPAPDC1A measurement,EFO:0802860,http://www.ebi.ac.uk/efo/EFO_0802860,0.962,None
prot-a-1572,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial","iron-sulfur cluster assembly enzyme ISCU, mitochondrial measurement",EFO:0802665,http://www.ebi.ac.uk/efo/EFO_0802665,0.84,None
prot-c-2474_54_5,SAP,sap,EFO:0001047,http://www.ebi.ac.uk/efo/EFO_0001047,0.997,None
prot-a-2925,Transgelin,transgelin measurement,EFO:0803171,http://www.ebi.ac.uk/efo/EFO_0803171,0.856,None
prot-a-2642,Scavenger receptor class F member 2,scavenger receptor class F member 2 measurement,EFO:0020716,http://www.ebi.ac.uk/efo/EFO_0020716,0.937,None
prot-a-2172,Peptidyl-glycine alpha-amidating monooxygenase,peptidyl-glycine alpha-amidating monooxygenase measurement,EFO:0801871,http://www.ebi.ac.uk/efo/EFO_0801871,0.822,None
met-a-573,Isobutyrylcarnitine,isobutyrylcarnitine measurement,EFO:0021023,http://www.ebi.ac.uk/efo/EFO_0021023,0.922,None
prot-c-3222_11_2,Semaphorin 3A,semaphorin-3A measurement,EFO:0008278,http://www.ebi.ac.uk/efo/EFO_0008278,0.657,None
ukb-b-4206,Age when last used oral contraceptive pill,age at initiation of oral contraceptive pill use,EFO:0021782,http://www.ebi.ac.uk/efo/EFO_0021782,0.707,None
prot-a-3265,Zinc finger protein 23,zinc finger protein 23 measurement,EFO:0803274,http://www.ebi.ac.uk/efo/EFO_0803274,0.913,None
ieu-b-4911,Anti-Theiler's virus IgG levels,anti-Theiler's virus IgG measurement,EFO:0801092,http://www.ebi.ac.uk/efo/EFO_0801092,0.632,None
ieu-b-4824,Age at menopause,age at menopause,EFO:0004704,http://www.ebi.ac.uk/efo/EFO_0004704,0.987,None
prot-a-1083,Fc receptor-like protein 5,Fc receptor-like protein 5 measurement,EFO:0802545,http://www.ebi.ac.uk/efo/EFO_0802545,0.802,None
prot-c-5012_67_1,"Myokinase, human",disease,EFO:0000408,http://www.ebi.ac.uk/efo/EFO_0000408,0.607,None
prot-a-1689,Kynureninase,kynureninase measurement,EFO:0008201,http://www.ebi.ac.uk/efo/EFO_0008201,0.892,None
met-d-L_HDL_C,Cholesterol in large HDL,cholesterol esters in large HDL measurement,EFO:0022159,http://www.ebi.ac.uk/efo/EFO_0022159,0.843,None
prot-a-2542,Rhophilin-2,rhophilin-2 measurement,EFO:0802015,http://www.ebi.ac.uk/efo/EFO_0802015,0.665,None
prot-a-1781,alpha-2-macroglobulin receptor-associated protein,alpha-2-macroglobulin receptor-associated protein measurement,EFO:0008021,http://www.ebi.ac.uk/efo/EFO_0008021,0.752,None
ubm-a-2668,volume Left-Amygdala,amygdala volume,EFO:0006934,http://www.ebi.ac.uk/efo/EFO_0006934,0.91,None
prot-a-2360,Peroxiredoxin-4,peroxiredoxin-1 measurement,EFO:0020629,http://www.ebi.ac.uk/efo/EFO_0020629,0.812,None
prot-a-2145,Olfactomedin-like protein 3,olfactomedin-like protein 3 measurement,EFO:0802829,http://www.ebi.ac.uk/efo/EFO_0802829,0.832,None
prot-a-715,Chymotrypsin-C,chymotrypsin-C measurement,EFO:0802398,http://www.ebi.ac.uk/efo/EFO_0802398,0.764,None
ukb-d-30660_irnt,Direct bilirubin,bilirubin measurement,EFO:0004570,http://www.ebi.ac.uk/efo/EFO_0004570,0.694,None
prot-a-99,Angiopoietin-related protein 4,angiopoietin-related protein 4 measurement,EFO:0020149,http://www.ebi.ac.uk/efo/EFO_0020149,0.842,None
met-c-901,Total lipids in medium HDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.802,None
ebi-a-GCST004904,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1748,Protein lin-7 homolog B,protein lin-7 homolog B measurement,EFO:0021978,http://www.ebi.ac.uk/efo/EFO_0021978,0.718,None
prot-a-3212,Vesicle transport through interaction with t-SNAREs homolog 1A,vesicle transport through interaction with t-SNAREs homolog 1A measurement,EFO:0803250,http://www.ebi.ac.uk/efo/EFO_0803250,0.876,None
met-c-926,Concentration of small LDL particles,concentration of small LDL particles measurement,EFO:0022166,http://www.ebi.ac.uk/efo/EFO_0022166,0.925,None
prot-a-1973,MAX-interacting protein 1,MAX-interacting protein 1 measurement,EFO:0802732,http://www.ebi.ac.uk/efo/EFO_0802732,0.653,None
prot-a-3096,TNF receptor-associated factor 4,TNF receptor-associated factor 4 measurement,EFO:0803158,http://www.ebi.ac.uk/efo/EFO_0803158,0.832,None
prot-a-196,ATPase family AAA domain-containing protein 2,ATPase family AAA domain-containing protein 2 measurement,EFO:0802298,http://www.ebi.ac.uk/efo/EFO_0802298,0.902,None
prot-a-1208,Inactive gamma-glutamyltranspeptidase 2,inactive gamma-glutamyltranspeptidase 2 measurement,EFO:0801692,http://www.ebi.ac.uk/efo/EFO_0801692,0.861,None
prot-c-3737_6_3,Cathepsin H,cathepsin H measurement,EFO:0020243,http://www.ebi.ac.uk/efo/EFO_0020243,0.842,None
prot-a-61,Alpha-2-HS-glycoprotein,glycoprotein hormones alpha chain measurement,EFO:0802577,http://www.ebi.ac.uk/efo/EFO_0802577,0.612,None
met-a-489,X-11247,X-11247 measurement,EFO:0021220,http://www.ebi.ac.uk/efo/EFO_0021220,0.69,None
ebi-a-GCST90010313,Fc receptor-like protein 1 levels,Fc receptor-like protein 1 measurement,EFO:0801598,http://www.ebi.ac.uk/efo/EFO_0801598,0.716,None
prot-c-5307_12_3,Coagulation Factor IXab,coagulation factor IXAB measurement,EFO:0020264,http://www.ebi.ac.uk/efo/EFO_0020264,0.927,None
prot-c-4133_54_2,Granzyme B,granzyme b measurement,EFO:0020418,http://www.ebi.ac.uk/efo/EFO_0020418,0.865,None
prot-a-130,Apolipoprotein D,apolipoprotein D measurement,EFO:0020156,http://www.ebi.ac.uk/efo/EFO_0020156,0.877,None
prot-a-804,Beta-defensin 1,beta-defensin 1 measurement,EFO:0801415,http://www.ebi.ac.uk/efo/EFO_0801415,0.691,None
prot-a-1698,Lysosome-associated membrane glycoprotein 3,lysosome-associated membrane glycoprotein 3 measurement,EFO:0802720,http://www.ebi.ac.uk/efo/EFO_0802720,0.847,None
prot-a-817,ATP-dependent RNA helicase A,ATP-dependent RNA helicase A measurement,EFO:0802294,http://www.ebi.ac.uk/efo/EFO_0802294,0.782,None
prot-a-2341,Peptidyl-prolyl cis-trans isomerase E,peptidyl-prolyl cis-trans isomerase E measurement,EFO:0008257,http://www.ebi.ac.uk/efo/EFO_0008257,0.774,None
prot-a-221,"Beta-1,4-galactosyltransferase 7","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.756,None
prot-a-55,Arf-GAP domain and FG repeat-containing protein 1,arf-GAP domain and FG repeat-containing protein 1 measurement,EFO:0803312,http://www.ebi.ac.uk/efo/EFO_0803312,0.756,None
prot-c-2850_3_2,ARGI1,dentinogenesis imperfecta type 2,MONDO:0007441,http://purl.obolibrary.org/obo/MONDO_0007441,0.612,None
prot-a-1873,E3 ubiquitin-protein ligase Mdm2,e3 ubiquitin-protein ligase mdm2 measurement,EFO:0020340,http://www.ebi.ac.uk/efo/EFO_0020340,0.895,None
ieu-b-38,systolic blood pressure,systolic blood pressure,EFO:0006335,http://www.ebi.ac.uk/efo/EFO_0006335,0.984,None
ieu-a-999,Body fat,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.815,None
ebi-a-GCST90010166,Pentraxin-related protein PTX3 levels,pentraxin-related protein PTX3 measurement,EFO:0010923,http://www.ebi.ac.uk/efo/EFO_0010923,0.824,None
ebi-a-GCST008030,Estimated glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.867,None
met-a-567,X-12039,X-12039 measurement,EFO:0021280,http://www.ebi.ac.uk/efo/EFO_0021280,0.699,None
ieu-a-77,Waist-to-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.745,None
ebi-a-GCST90001448,CD11c+ monocyte Absolute Count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.648,None
ieu-a-65,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-588,CXADR-like membrane protein,CXADR-like membrane protein measurement,EFO:0801504,http://www.ebi.ac.uk/efo/EFO_0801504,0.809,None
met-a-536,X-11593--O-methylascorbate*,X-11593--O-methylascorbate measurement,EFO:0021256,http://www.ebi.ac.uk/efo/EFO_0021256,0.632,None
prot-a-1674,NKG2-D type II integral membrane protein,NKG2-D type II integral membrane protein measurement,EFO:0008250,http://www.ebi.ac.uk/efo/EFO_0008250,0.791,None
ieu-b-4812,25 hydroxyvitamin D level,25-hydroxyvitamin D2 measurement,EFO:0803356,http://www.ebi.ac.uk/efo/EFO_0803356,0.612,None
prot-a-79,RNA demethylase ALKBH5,RNA demethylase ALKBH5 measurement,EFO:0803034,http://www.ebi.ac.uk/efo/EFO_0803034,0.941,None
prot-a-847,Mitochondrial import inner membrane translocase subunit TIM14,mitochondrial import inner membrane translocase subunit tim14 measurement,EFO:0020573,http://www.ebi.ac.uk/efo/EFO_0020573,0.963,None
prot-a-53,alpha-Fetoprotein,alpha fetoprotein measurement,EFO:0010583,http://www.ebi.ac.uk/efo/EFO_0010583,0.884,None
prot-a-2567,RING finger protein 150,RING finger protein 150 measurement,EFO:0803030,http://www.ebi.ac.uk/efo/EFO_0803030,0.91,None
ebi-a-GCST004423,Macrophage Migration Inhibitory Factor levels,macrophage migration inhibitory factor measurement,EFO:0008221,http://www.ebi.ac.uk/efo/EFO_0008221,0.889,None
ebi-a-GCST90001916,CD45 on CD4+ T cell,T-B+ severe combined immunodeficiency due to CD45 deficiency,MONDO:0015702,http://purl.obolibrary.org/obo/MONDO_0015702,0.645,None
prot-a-2398,PH and SEC7 domain-containing protein 1,PH and SEC7 domain-containing protein 1 measurement,EFO:0803302,http://www.ebi.ac.uk/efo/EFO_0803302,0.865,None
ebi-a-GCST90002336,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
met-a-459,Pyridoxate,pyridoxate measurement,EFO:0010527,http://www.ebi.ac.uk/efo/EFO_0010527,0.882,None
met-d-S_LDL_L,Total lipids in small LDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.966,None
ieu-a-49,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-2037,E3 ubiquitin-protein ligase NEURL1,E3 ubiquitin-protein ligase NEURL1 measurement,EFO:0801554,http://www.ebi.ac.uk/efo/EFO_0801554,0.89,None
prot-a-610,Contactin-associated protein 1,contactin-associated protein 1 measurement,EFO:0802429,http://www.ebi.ac.uk/efo/EFO_0802429,0.809,None
prot-a-3213,Vesicle transport through interaction with t-SNAREs homolog 1B,vesicle transport through interaction with t-SNAREs homolog 1B measurement,EFO:0802212,http://www.ebi.ac.uk/efo/EFO_0802212,0.877,None
prot-a-2851,"Beta-galactoside alpha-2,6-sialyltransferase 1","beta-galactoside alpha-2,6-sialyltransferase 1 measurement",EFO:0802330,http://www.ebi.ac.uk/efo/EFO_0802330,0.669,None
prot-a-2280,Piwi-like protein 1,piwi-like protein 1 measurement,EFO:0802870,http://www.ebi.ac.uk/efo/EFO_0802870,0.716,None
ebi-a-GCST90012107,Sex hormone-binding globulin levels,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.921,None
prot-a-2710,Secreted frizzled-related protein 2,secreted frizzled-related protein 2 measurement,EFO:0802039,http://www.ebi.ac.uk/efo/EFO_0802039,0.882,None
prot-a-1211,Growth hormone receptor,growth hormone receptor measurement,EFO:0020426,http://www.ebi.ac.uk/efo/EFO_0020426,0.896,None
prot-a-2648,Mammaglobin-B,mammaglobin-b measurement,EFO:0020552,http://www.ebi.ac.uk/efo/EFO_0020552,0.72,None
prot-a-2015,Natural cytotoxicity triggering receptor 2,natural cytotoxicity triggering receptor 2 measurement,EFO:0020589,http://www.ebi.ac.uk/efo/EFO_0020589,0.943,None
ieu-a-1046,Pallidum volume,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.988,None
ukb-b-8882,Astigmatism angle (right),Astigmatism,HP:0000483,http://purl.obolibrary.org/obo/HP_0000483,0.732,None
ebi-a-GCST90016671,Visceral adipose tissue volume,visceral adipose tissue measurement,EFO:0004765,http://www.ebi.ac.uk/efo/EFO_0004765,0.806,None
prot-a-1344,Hexokinase-2,hexokinase-1 measurement,EFO:0021939,http://www.ebi.ac.uk/efo/EFO_0021939,0.723,None
prot-a-16,Angiotensin-converting enzyme 2,angiotensin-converting enzyme 2 measurement,EFO:0020150,http://www.ebi.ac.uk/efo/EFO_0020150,0.866,None
prot-a-252,Baculoviral IAP repeat-containing protein 5,baculoviral IAP repeat-containing protein 5 measurement,EFO:0020174,http://www.ebi.ac.uk/efo/EFO_0020174,0.873,None
met-d-MUFA,Monounsaturated fatty acids,"monounsaturated fatty acids; 16:1, 18:1 measurement",EFO:0022187,http://www.ebi.ac.uk/efo/EFO_0022187,0.667,None
ebi-a-GCST90001634,CD8dim Natural Killer T %T cell,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.604,None
ieu-a-68,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-c-2987_37_3,Histone H1.2,H1-hESC,EFO:0003042,http://www.ebi.ac.uk/efo/EFO_0003042,0.631,None
prot-a-470,T-cell surface protein tactile,T-cell surface protein tactile measurement,EFO:0802115,http://www.ebi.ac.uk/efo/EFO_0802115,0.814,None
prot-a-1237,Golgi membrane protein 1,Golgi membrane protein 1 measurement,EFO:0801650,http://www.ebi.ac.uk/efo/EFO_0801650,0.921,None
prot-a-749,Interleukin-8,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.928,None
prot-a-2905,Synaptic vesicle glycoprotein 2A,synaptic vesicle glycoprotein 2A measurement,EFO:0803115,http://www.ebi.ac.uk/efo/EFO_0803115,0.926,None
prot-c-4875_73_1,C3d,complement component 3 deficiency,MONDO:0013417,http://purl.obolibrary.org/obo/MONDO_0013417,1.0,None
prot-a-279,Mitotic checkpoint serine/threonine-protein kinase BUB1,mitotic checkpoint serine/threonine-protein kinase BUB1 measurement,EFO:0801806,http://www.ebi.ac.uk/efo/EFO_0801806,0.85,None
prot-a-1815,"Tyrosine-protein kinase Lyn, isoform B","tyrosine-protein kinase LYN, isoform b measurement",EFO:0020828,http://www.ebi.ac.uk/efo/EFO_0020828,0.746,None
prot-c-3187_52_2,CRIS3,lissencephaly due to TUBA1A mutation,MONDO:0012703,http://purl.obolibrary.org/obo/MONDO_0012703,0.703,None
prot-a-1286,Glutathione S-transferase kappa 1,glutathione S-transferase kappa 1 measurement,EFO:0802571,http://www.ebi.ac.uk/efo/EFO_0802571,0.84,None
met-c-890,Concentration of large VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.932,None
prot-a-1342,Histone H2A type 3,histone H2A type 3 measurement,EFO:0021953,http://www.ebi.ac.uk/efo/EFO_0021953,0.89,None
prot-a-1022,Protein FAM107B,protein fam107b measurement,EFO:0020674,http://www.ebi.ac.uk/efo/EFO_0020674,0.921,None
prot-a-451,CD48 antigen,CD48 antigen measurement,EFO:0020247,http://www.ebi.ac.uk/efo/EFO_0020247,0.883,None
prot-c-2900_53_3,HCC-1,hepatocellular carcinoma,EFO:0000182,http://www.ebi.ac.uk/efo/EFO_0000182,0.964,None
prot-a-1101,Fibroblast growth factor 9,fibroblast growth factor 9 measurement,EFO:0020387,http://www.ebi.ac.uk/efo/EFO_0020387,0.909,None
prot-a-483,Cadherin-2,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.656,None
met-d-XXL_VLDL_P,Concentration of chylomicrons and extremely large VLDL particles,concentration of large VLDL particles measurement,EFO:0022173,http://www.ebi.ac.uk/efo/EFO_0022173,0.687,None
prot-a-2845,FACT complex subunit SSRP1,fact complex subunit ssrp1 measurement,EFO:0020371,http://www.ebi.ac.uk/efo/EFO_0020371,0.937,None
prot-a-1500,Interleukin-1 Receptor accessory protein,interleukin 1 Receptor accessory protein measurement,EFO:0008167,http://www.ebi.ac.uk/efo/EFO_0008167,0.933,None
ebi-a-GCST90001451,CD62L- monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.652,None
prot-a-77,Fructose-bisphosphate aldolase A,fructose-bisphosphate aldolase A measurement,EFO:0801608,http://www.ebi.ac.uk/efo/EFO_0801608,0.856,None
prot-a-1434,Interferon lambda-1,interferon lambda receptor 1 measurement,EFO:0802646,http://www.ebi.ac.uk/efo/EFO_0802646,0.823,None
prot-a-1606,Anosmin-1,anosmin-1 measurement,EFO:0802284,http://www.ebi.ac.uk/efo/EFO_0802284,0.633,None
prot-a-2423,Persephin,persephin measurement,EFO:0020632,http://www.ebi.ac.uk/efo/EFO_0020632,0.816,None
prot-a-2791,U1 small nuclear ribonucleoprotein A,U1 small nuclear ribonucleoprotein A measurement,EFO:0802176,http://www.ebi.ac.uk/efo/EFO_0802176,0.954,None
prot-a-1836,Beta-mannosidase,beta-mannosidosis,MONDO:0009562,http://purl.obolibrary.org/obo/MONDO_0009562,0.745,None
met-d-XS_VLDL_TG,Triglycerides in very small VLDL,triglycerides in very small VLDL measurement,EFO:0022144,http://www.ebi.ac.uk/efo/EFO_0022144,0.915,None
ieu-a-274,Packed cell volume,hematocrit,EFO:0004348,http://www.ebi.ac.uk/efo/EFO_0004348,0.813,None
prot-b-46,thrombomodulin,thrombomodulin measurement,EFO:0007774,http://www.ebi.ac.uk/efo/EFO_0007774,0.867,None
prot-a-1692,Lymphocyte activation gene 3 protein,lymphocyte activation gene 3 protein measurement,EFO:0020540,http://www.ebi.ac.uk/efo/EFO_0020540,0.917,None
prot-a-2180,Protein deglycase DJ-1,protein deglycase DJ-1 measurement,EFO:0021982,http://www.ebi.ac.uk/efo/EFO_0021982,0.687,None
prot-a-1889,Mitofusin-1,mitofusin-1 measurement,EFO:0802751,http://www.ebi.ac.uk/efo/EFO_0802751,0.72,None
prot-a-1228,Granulysin,granulysin measurement,EFO:0008144,http://www.ebi.ac.uk/efo/EFO_0008144,0.87,None
prot-a-2727,Sialic acid-binding Ig-like lectin 14,sialic acid-binding Ig-like lectin 14 measurement,EFO:0008284,http://www.ebi.ac.uk/efo/EFO_0008284,0.69,None
prot-a-1771,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2","leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 measurement",EFO:0802702,http://www.ebi.ac.uk/efo/EFO_0802702,0.851,None
prot-a-2960,Thyroglobulin,thyroglobulin measurement,EFO:0010050,http://www.ebi.ac.uk/efo/EFO_0010050,0.856,None
prot-a-1538,Interleukin-6,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.934,None
prot-a-3222,WAP four-disulfide core domain protein 12,WAP four-disulfide core domain protein 12 measurement,EFO:0803261,http://www.ebi.ac.uk/efo/EFO_0803261,0.857,None
prot-a-499,Cell adhesion molecule-related/down-regulated by oncogenes,cell adhesion molecule-related/down-regulated by oncogenes measurement,EFO:0008079,http://www.ebi.ac.uk/efo/EFO_0008079,0.732,None
prot-a-696,Casein kinase II subunit alpha,casein kinase II subunit alpha measurement,EFO:0020238,http://www.ebi.ac.uk/efo/EFO_0020238,0.919,None
ebi-a-GCST005220,Insulin levels,insulin measurement,EFO:0004467,http://www.ebi.ac.uk/efo/EFO_0004467,0.861,None
ebi-a-GCST90010298,C-type lectin domain family 5 member A levels,C-type lectin domain family 5 member A measurement,EFO:0801436,http://www.ebi.ac.uk/efo/EFO_0801436,0.746,None
prot-a-300,"Complement component 1 Q subcomponent-binding protein, mitochondrial","complement component 1 q subcomponent-binding protein, mitochondrial measurement",EFO:0020280,http://www.ebi.ac.uk/efo/EFO_0020280,0.919,None
ukb-d-30740_raw,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
ukb-b-5447,Heel broadband ultrasound attenuation (left),bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.891,None
prot-a-2239,Pyridoxal kinase,pyridoxal kinase measurement,EFO:0021919,http://www.ebi.ac.uk/efo/EFO_0021919,0.898,None
prot-a-592,Colipase,colipase measurement,EFO:0801485,http://www.ebi.ac.uk/efo/EFO_0801485,0.781,None
prot-a-432,CMRF35-like molecule 8,CMRF35-like molecule 8 measurement,EFO:0801480,http://www.ebi.ac.uk/efo/EFO_0801480,0.801,None
prot-a-220,"Beta-1,4-galactosyltransferase 6","Ehlers-Danlos syndrome, progeroid type",ORPHANET.ORDO:75496,http://www.orpha.net/ORDO/Orphanet_75496,0.759,None
prot-a-1035,Membrane protein FAM174B,membrane protein FAM174B measurement,EFO:0802738,http://www.ebi.ac.uk/efo/EFO_0802738,0.937,None
met-a-560,X-11905,X-11905 measurement,EFO:0021275,http://www.ebi.ac.uk/efo/EFO_0021275,0.716,None
prot-c-3681_87_3,kallikrein 14,kallikrein-14 measurement,EFO:0020513,http://www.ebi.ac.uk/efo/EFO_0020513,0.759,None
ebi-a-GCST90012038,Renin levels,resistin measurement,EFO:0004819,http://www.ebi.ac.uk/efo/EFO_0004819,0.65,None
ukb-a-286,Arm fat percentage (left),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.667,None
ebi-a-GCST006250,Intelligence,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.987,None
prot-a-457,CD70 antigen,CD70 antigen measurement,EFO:0020249,http://www.ebi.ac.uk/efo/EFO_0020249,0.899,None
prot-a-1279,Gastrin-releasing peptide,gastrin-releasing peptide measurement,EFO:0022000,http://www.ebi.ac.uk/efo/EFO_0022000,0.824,None
prot-a-2099,Neuropilin-1,neuropilin-1 measurement,EFO:0020603,http://www.ebi.ac.uk/efo/EFO_0020603,0.618,None
ebi-a-GCST90013422,Ultradistal forearm bone mineral density,bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.674,None
ieu-a-46,Femoral neck bone mineral density,femoral neck bone mineral density,EFO:0007785,http://www.ebi.ac.uk/efo/EFO_0007785,0.996,None
prot-a-2790,Alpha-synuclein,alpha synuclein measurement,EFO:0009323,http://www.ebi.ac.uk/efo/EFO_0009323,0.871,None
prot-a-376,Chromobox protein homolog 5,chromobox protein homolog 5 measurement,EFO:0020258,http://www.ebi.ac.uk/efo/EFO_0020258,0.915,None
prot-a-67,Alcohol dehydrogenase [NADP(+)],alcohol dehydrogenase 4 measurement,EFO:0802261,http://www.ebi.ac.uk/efo/EFO_0802261,0.783,None
prot-a-1380,3-hydroxyacyl-CoA dehydrogenase type-2,HSD10 mitochondrial disease,MONDO:0010327,http://purl.obolibrary.org/obo/MONDO_0010327,0.797,None
prot-a-843,DnaJ homolog subfamily C member 10,DnaJ homolog subfamily C member 10 measurement,EFO:0802488,http://www.ebi.ac.uk/efo/EFO_0802488,0.947,None
met-a-501,Pyroglutamine*,pyroglutamine measurement,EFO:0005408,http://www.ebi.ac.uk/efo/EFO_0005408,0.868,None
prot-a-3142,Ubiquitin-conjugating enzyme E2 L3,ubiquitin-conjugating enzyme E2 L3 measurement,EFO:0020840,http://www.ebi.ac.uk/efo/EFO_0020840,0.908,None
prot-a-1599,Janus kinase and microtubule-interacting protein 3,janus kinase and microtubule-interacting protein 3 measurement,EFO:0801738,http://www.ebi.ac.uk/efo/EFO_0801738,0.86,None
prot-a-1608,Potassium voltage-gated channel subfamily A member 10,potassium voltage-gated channel subfamily A member 10 measurement,EFO:0802888,http://www.ebi.ac.uk/efo/EFO_0802888,0.891,None
prot-a-2138,Odorant-binding protein 2a,odorant-binding protein 2a measurement,EFO:0802828,http://www.ebi.ac.uk/efo/EFO_0802828,0.805,None
prot-a-794,Beta-defensin 119,beta-defensin 119 measurement,EFO:0801419,http://www.ebi.ac.uk/efo/EFO_0801419,0.764,None
ieu-b-4848,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
ubm-a-2687,volume Right-choroid-plexus,choroid plexus volume measurement,EFO:0010293,http://www.ebi.ac.uk/efo/EFO_0010293,0.826,None
ukb-d-30690_raw,Cholesterol,esterified cholesterol measurement,EFO:0008589,http://www.ebi.ac.uk/efo/EFO_0008589,0.798,None
prot-a-1809,Lactotransferrin,lactotransferrin measurement,EFO:0020526,http://www.ebi.ac.uk/efo/EFO_0020526,0.891,None
prot-a-2844,Translocon-associated protein subunit alpha,translocon-associated protein subunit alpha measurement,EFO:0803173,http://www.ebi.ac.uk/efo/EFO_0803173,0.881,None
met-d-XL_HDL_CE_pct,Cholesteryl esters to total lipids ratio in very large HDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.695,None
prot-a-850,DnaJ homolog subfamily C member 4,DnaJ homolog subfamily C member 4 measurement,EFO:0802492,http://www.ebi.ac.uk/efo/EFO_0802492,0.946,None
prot-a-2620,Protein S100-A6,protein S100-A6 measurement,EFO:0021927,http://www.ebi.ac.uk/efo/EFO_0021927,0.604,None
ebi-a-GCST006677,Acute insulin response (insulin secretion adjusted),acute insulin response measurement,EFO:0006831,http://www.ebi.ac.uk/efo/EFO_0006831,0.708,None
met-d-M_HDL_TG_pct,Triglycerides to total lipids ratio in medium HDL,triglycerides:total lipids ratio,EFO:0020947,http://www.ebi.ac.uk/efo/EFO_0020947,0.669,None
prot-a-2230,Platelet-derived growth factor receptor beta,platelet-derived growth factor receptor beta measurement,EFO:0008265,http://www.ebi.ac.uk/efo/EFO_0008265,0.846,None
met-a-454,X-10810,X-10810 measurement,EFO:0021218,http://www.ebi.ac.uk/efo/EFO_0021218,0.688,None
ebi-a-GCST006305,"Cholesterol, total",total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-a-2892,Estrogen sulfotransferase,estrogen sulfotransferase measurement,EFO:0801586,http://www.ebi.ac.uk/efo/EFO_0801586,0.917,None
ukb-d-30750_irnt,Glycated haemoglobin,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.72,None
prot-a-2935,T-box transcription factor TBX3,t-box transcription factor TBX3 measurement,EFO:0803128,http://www.ebi.ac.uk/efo/EFO_0803128,0.852,None
prot-a-1580,T-cell immunomodulatory protein,t-cell immunomodulatory protein measurement,EFO:0803130,http://www.ebi.ac.uk/efo/EFO_0803130,0.801,None
ebi-a-GCST90016670,Kidney volume,kidney volume,EFO:0600044,http://www.ebi.ac.uk/efo/EFO_0600044,0.984,None
met-a-699,Glutaroyl carnitine,glutaroyl carnitine measurement,EFO:0021005,http://www.ebi.ac.uk/efo/EFO_0021005,0.896,None
prot-a-2402,Pregnancy-specific beta-1-glycoprotein 3,pregnancy-specific beta-1-glycoprotein 3 measurement,EFO:0801906,http://www.ebi.ac.uk/efo/EFO_0801906,0.691,None
ebi-a-GCST90010181,Thrombomodulin levels,thrombomodulin measurement,EFO:0007774,http://www.ebi.ac.uk/efo/EFO_0007774,0.787,None
prot-a-787,Beta-defensin 110,beta-defensin 110 measurement,EFO:0802319,http://www.ebi.ac.uk/efo/EFO_0802319,0.758,None
ebi-a-GCST90010306,Aromatic-L-amino-acid decarboxylase levels,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,http://purl.obolibrary.org/obo/MONDO_0012084,0.847,None
ieu-b-4840,Depressive symptoms,unipolar depression,EFO:0003761,http://www.ebi.ac.uk/efo/EFO_0003761,0.984,None
ebi-a-GCST90002343,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
prot-a-3179,Ubiquitin carboxyl-terminal hydrolase 21,ubiquitin carboxyl-terminal hydrolase 21 measurement,EFO:0802178,http://www.ebi.ac.uk/efo/EFO_0802178,0.85,None
prot-a-3184,UDP-glucuronic acid decarboxylase 1,UDP-glucuronic acid decarboxylase 1 measurement,EFO:0803221,http://www.ebi.ac.uk/efo/EFO_0803221,0.841,None
met-c-864,Total cholesterol in HDL,total cholesterol in IDL,EFO:0022184,http://www.ebi.ac.uk/efo/EFO_0022184,0.78,None
prot-a-687,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement,EFO:0801473,http://www.ebi.ac.uk/efo/EFO_0801473,0.893,None
prot-a-595,Clathrin heavy chain 1,clathrin heavy chain 1 measurement,EFO:0802402,http://www.ebi.ac.uk/efo/EFO_0802402,0.913,None
prot-a-1851,MAP kinase-activated protein kinase 2,MAP kinase-activated protein kinase 2 measurement,EFO:0008225,http://www.ebi.ac.uk/efo/EFO_0008225,0.86,None
prot-a-1463,Protein turtle homolog A,protein turtle homolog A measurement,EFO:0802966,http://www.ebi.ac.uk/efo/EFO_0802966,0.914,None
prot-a-2990,Toll-like receptor 4,toll-like receptor 4 measurement,EFO:0021920,http://www.ebi.ac.uk/efo/EFO_0021920,0.744,None
met-a-717,X-14086,X-14086 measurement,EFO:0021363,http://www.ebi.ac.uk/efo/EFO_0021363,0.712,None
prot-a-1478,Interleukin-15 receptor subunit alpha,interleukin 15 receptor subunit alpha measurement,EFO:0008172,http://www.ebi.ac.uk/efo/EFO_0008172,0.937,None
ukb-b-7710,Pulse rate (during blood-pressure measurement),pulse pressure measurement,EFO:0005763,http://www.ebi.ac.uk/efo/EFO_0005763,0.785,None
prot-a-1266,GRAM domain-containing protein 1C,GRAM domain-containing protein 1C measurement,EFO:0801652,http://www.ebi.ac.uk/efo/EFO_0801652,0.87,None
prot-a-879,Dynactin-associated protein,dynactin-associated protein measurement,EFO:0801551,http://www.ebi.ac.uk/efo/EFO_0801551,0.825,None
prot-a-2618,Protein S100-A4,protein S100-A4 measurement,EFO:0021893,http://www.ebi.ac.uk/efo/EFO_0021893,0.613,None
ebi-a-GCST006358,IgE levels ,serum IgE measurement,EFO:0004579,http://www.ebi.ac.uk/efo/EFO_0004579,0.992,None
prot-a-778,Spliceosome RNA helicase DDX39B,spliceosome RNA helicase DDX39B measurement,EFO:0802084,http://www.ebi.ac.uk/efo/EFO_0802084,0.944,None
prot-a-1843,Mitogen-activated protein kinase kinase kinase 3,mitogen-activated protein kinase kinase kinase 3 measurement,EFO:0801805,http://www.ebi.ac.uk/efo/EFO_0801805,0.91,None
met-c-842,Apolipoprotein A-I,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.804,None
ukb-b-4282,Prospective memory result,episodic memory,EFO:0004333,http://www.ebi.ac.uk/efo/EFO_0004333,0.805,None
prot-a-2136,2'-5'-oligoadenylate synthase 1,2'-5'-oligoadenylate synthase 1 measurement,EFO:0021911,http://www.ebi.ac.uk/efo/EFO_0021911,0.621,None
prot-a-391,C-C motif chemokine 15,CCL15 measurement,EFO:0009413,http://www.ebi.ac.uk/efo/EFO_0009413,0.743,None
met-c-952,Triglycerides in very large VLDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.847,None
met-d-S_HDL_P,Concentration of small HDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.8,None
met-a-369,Taurodeoxycholate,taurodeoxycholate measurement,EFO:0010539,http://www.ebi.ac.uk/efo/EFO_0010539,0.912,None
prot-a-3218,WW domain-binding protein 1,WW domain-binding protein 1 measurement,EFO:0803266,http://www.ebi.ac.uk/efo/EFO_0803266,0.821,None
prot-a-2479,Rab9 effector protein with kelch motifs,rab9 effector protein with kelch motifs measurement,EFO:0801984,http://www.ebi.ac.uk/efo/EFO_0801984,0.949,None
prot-a-1490,Interleukin-18-binding protein,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.689,None
prot-a-2187,Prostate and testis expressed protein 4,prostate and testis expressed protein 4 measurement,EFO:0803301,http://www.ebi.ac.uk/efo/EFO_0803301,0.904,None
prot-c-3473_78_2,Thrombopoietin Receptor,thrombopoietin receptor measurement,EFO:0020769,http://www.ebi.ac.uk/efo/EFO_0020769,0.904,None
met-a-488,X-07765,X-07765 measurement,EFO:0021204,http://www.ebi.ac.uk/efo/EFO_0021204,0.663,None
prot-a-2817,Serine protease inhibitor Kazal-type 13,serine protease inhibitor Kazal-type 13 measurement,EFO:0803057,http://www.ebi.ac.uk/efo/EFO_0803057,0.871,None
prot-a-3279,E3 ubiquitin-protein ligase ZNRF3,E3 ubiquitin-protein ligase ZNRF3 measurement,EFO:0021943,http://www.ebi.ac.uk/efo/EFO_0021943,0.911,None
prot-b-3,cystatin B,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.987,None
ukb-b-15851,"Heel Broadband ultrasound attenuation, direct entry",bone quantitative ultrasound measurement,EFO:0004514,http://www.ebi.ac.uk/efo/EFO_0004514,0.835,None
met-a-366,Pelargonate (9:0),pelargonate 9:0 measurement,EFO:0021106,http://www.ebi.ac.uk/efo/EFO_0021106,0.607,None
prot-a-1546,Interleukin-9,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.934,None
prot-a-1532,Interleukin-4,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.946,None
prot-a-146,Arfaptin-2,arfaptin-1 measurement,EFO:0801392,http://www.ebi.ac.uk/efo/EFO_0801392,0.711,None
ebi-a-GCST004431,RANTES levels,CCL5 measurement,EFO:0005117,http://www.ebi.ac.uk/efo/EFO_0005117,0.712,None
ebi-a-GCST006676,Peak insulin response (insulin secretion adjusted),peak insulin response measurement,EFO:0008000,http://www.ebi.ac.uk/efo/EFO_0008000,0.712,None
prot-a-2001,Arylamine N-acetyltransferase 1,Ogden syndrome,MONDO:0010457,http://purl.obolibrary.org/obo/MONDO_0010457,0.871,None
prot-a-1460,Immunoglobulin superfamily member 11,immunoglobulin superfamily member 11 measurement,EFO:0802621,http://www.ebi.ac.uk/efo/EFO_0802621,0.94,None
ebi-a-GCST90000492,PD-L1 levels,late-onset Parkinson disease,MONDO:0008199,http://purl.obolibrary.org/obo/MONDO_0008199,0.612,None
prot-a-1432,Interferon gamma receptor 2,interferon gamma receptor 2 measurement,EFO:0022030,http://www.ebi.ac.uk/efo/EFO_0022030,0.906,None
ieu-b-4833,Alcohol consumption,alcohol drinking,EFO:0004329,http://www.ebi.ac.uk/efo/EFO_0004329,0.998,None
bbj-a-51,Relative wall thickness,heart relative wall thickness,EFO:0009286,http://www.ebi.ac.uk/efo/EFO_0009286,0.905,None
prot-a-1363,Heterogeneous nuclear ribonucleoprotein A/B,heterogeneous nuclear ribonucleoprotein M measurement,EFO:0801674,http://www.ebi.ac.uk/efo/EFO_0801674,0.903,None
met-d-S_VLDL_TG,Triglycerides in small VLDL,triglycerides in small VLDL measurement,EFO:0022145,http://www.ebi.ac.uk/efo/EFO_0022145,0.905,None
ebi-a-GCST004458,Granulocyte-colony stimulating factor levels,granulocyte colony-stimulating factor measurement,EFO:0008142,http://www.ebi.ac.uk/efo/EFO_0008142,0.763,None
ebi-a-GCST90010183,Tumor necrosis factor receptor superfamily member 11A levels,tumor necrosis factor receptor superfamily member 11A measurement,EFO:0020800,http://www.ebi.ac.uk/efo/EFO_0020800,0.91,None
prot-a-375,Cystathionine beta-synthase,cystathionine beta-synthase measurement,EFO:0802443,http://www.ebi.ac.uk/efo/EFO_0802443,0.788,None
prot-a-62,Allograft inflammatory factor 1,allograft inflammatory factor 1 measurement,EFO:0020135,http://www.ebi.ac.uk/efo/EFO_0020135,0.929,None
ebi-a-GCST90001647,Natural Killer %lymphocyte,monocytopenia with susceptibility to infections,MONDO:0013607,http://purl.obolibrary.org/obo/MONDO_0013607,0.725,None
prot-a-3245,Tyrosine-protein kinase Yes,tyrosine-protein kinase YES measurement,EFO:0020832,http://www.ebi.ac.uk/efo/EFO_0020832,0.802,None
met-d-PUFA,Polyunsaturated fatty acids,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.885,None
prot-a-789,Beta-defensin 113,beta-defensin 113 measurement,EFO:0802320,http://www.ebi.ac.uk/efo/EFO_0802320,0.757,None
prot-a-1837,"Glycoprotein endo-alpha-1,2-mannosidase","glycoprotein endo-alpha-1,2-mannosidase measurement",EFO:0801644,http://www.ebi.ac.uk/efo/EFO_0801644,0.626,None
prot-a-744,C-X-C motif chemokine 14,C-C motif chemokine 14 measurement,EFO:0008042,http://www.ebi.ac.uk/efo/EFO_0008042,0.686,None
prot-c-5066_134_3,CLM6,NALM6,EFO:0002245,http://www.ebi.ac.uk/efo/EFO_0002245,0.656,None
prot-a-3062,Tumor necrosis factor ligand superfamily member 4,tumor necrosis factor ligand superfamily member 4 measurement,EFO:0020796,http://www.ebi.ac.uk/efo/EFO_0020796,0.937,None
prot-a-1392,"Serine protease HTRA2, mitochondrial","serine protease HTRA2, mitochondrial measurement",EFO:0020723,http://www.ebi.ac.uk/efo/EFO_0020723,0.835,None
ukb-b-589,Particulate matter air pollution (pm10); 2007,particulate matter air pollution measurement,EFO:0008255,http://www.ebi.ac.uk/efo/EFO_0008255,0.737,None
met-a-740,Taurolithocholate 3-sulfate,taurolithocholate 3-sulfate measurement,EFO:0021036,http://www.ebi.ac.uk/efo/EFO_0021036,0.815,None
prot-a-2330,NADPH--cytochrome P450 reductase,NADPH--cytochrome P450 reductase measurement,EFO:0008242,http://www.ebi.ac.uk/efo/EFO_0008242,0.761,None
met-a-561,X-12007,X-12007 measurement,EFO:0021276,http://www.ebi.ac.uk/efo/EFO_0021276,0.663,None
ukb-b-20531,Leg fat percentage (right),body fat percentage,EFO:0007800,http://www.ebi.ac.uk/efo/EFO_0007800,0.657,None
met-c-872,Triglycerides in IDL,triglycerides in IDL measurement,EFO:0022149,http://www.ebi.ac.uk/efo/EFO_0022149,0.882,None
prot-c-4252_33_4,Nucleoside diphosphate kinase A,nucleoside diphosphate kinase A measurement,EFO:0009947,http://www.ebi.ac.uk/efo/EFO_0009947,0.928,None
ebi-a-GCST90001807,CD27 on Plasma Blast-Plasma Cell,plasma cell neoplasm,EFO:0000200,http://www.ebi.ac.uk/efo/EFO_0000200,0.734,None
prot-a-2451,Pentraxin-related protein PTX3,pentraxin-related protein PTX3 measurement,EFO:0010923,http://www.ebi.ac.uk/efo/EFO_0010923,0.879,None
prot-a-841,DnaJ homolog subfamily B member 2,DnaJ homolog subfamily B member 2 measurement,EFO:0801539,http://www.ebi.ac.uk/efo/EFO_0801539,0.945,None
ebi-a-GCST006361,Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels,Epstein Barr virus nuclear antigen 1 IgG measurement,EFO:0007790,http://www.ebi.ac.uk/efo/EFO_0007790,0.774,None
met-d-L_LDL_FC,Free cholesterol in large LDL,free cholesterol in large LDL measurement,EFO:0022176,http://www.ebi.ac.uk/efo/EFO_0022176,0.914,None
prot-a-2209,Procollagen C-endopeptidase enhancer 1,procollagen C-endopeptidase enhancer 1 measurement,EFO:0801920,http://www.ebi.ac.uk/efo/EFO_0801920,0.822,None
met-a-684,X-13431--nonanoylcarnitine*,X-13431--nonanoylcarnitine measurement,EFO:0021349,http://www.ebi.ac.uk/efo/EFO_0021349,0.668,None
prot-a-2755,Adenosine 3'-phospho 5'-phosphosulfate transporter 2,adenosine 3'-phospho 5'-phosphosulfate transporter 2 measurement,EFO:0802255,http://www.ebi.ac.uk/efo/EFO_0802255,0.723,None
prot-a-1319,Tyrosine-protein kinase HCK,tyrosine-protein kinase HCK measurement,EFO:0020824,http://www.ebi.ac.uk/efo/EFO_0020824,0.818,None
prot-a-2466,Glutaminyl-peptide cyclotransferase-like protein,glutaminyl-peptide cyclotransferase-like protein measurement,EFO:0801632,http://www.ebi.ac.uk/efo/EFO_0801632,0.83,None
ebi-a-GCST90001406,Memory B cell %B cell,B cell derived cell line,EFO:0001640,http://www.ebi.ac.uk/efo/EFO_0001640,0.63,None
prot-a-2006,"Neural cell adhesion molecule 1, 120 kDa isoform","neural cell adhesion molecule 1, 120 kda isoform measurement",EFO:0020593,http://www.ebi.ac.uk/efo/EFO_0020593,0.91,None
prot-a-284,Uncharacterized protein C14orf93,uncharacterized protein C14orf93 measurement,EFO:0802190,http://www.ebi.ac.uk/efo/EFO_0802190,0.955,None
ebi-a-GCST90010248,Platelet endothelial cell adhesion molecule levels,platelet endothelial cell adhesion molecule measurement,EFO:0010598,http://www.ebi.ac.uk/efo/EFO_0010598,0.892,None
met-c-947,Phospholipids in very large HDL,phospholipids in large HDL measurement,EFO:0022190,http://www.ebi.ac.uk/efo/EFO_0022190,0.849,None
prot-a-1171,Polypeptide N-acetylgalactosaminyltransferase 2,polypeptide N-acetylgalactosaminyltransferase 2 measurement,EFO:0802884,http://www.ebi.ac.uk/efo/EFO_0802884,0.886,None
prot-a-3246,Protein YIPF6,protein YIPF6 measurement,EFO:0802969,http://www.ebi.ac.uk/efo/EFO_0802969,0.928,None
prot-c-2911_27_2,Midkine,midkine measurement,EFO:0020571,http://www.ebi.ac.uk/efo/EFO_0020571,0.872,None
prot-a-3152,Unique cartilage matrix-associated protein,unique cartilage matrix-associated protein measurement,EFO:0802198,http://www.ebi.ac.uk/efo/EFO_0802198,0.83,None
met-a-638,Asparagine,asparagine measurement,EFO:0009766,http://www.ebi.ac.uk/efo/EFO_0009766,0.838,None
ebi-a-GCST90001419,CD20- B cell %B cell,B cell derived cell line,EFO:0001640,http://www.ebi.ac.uk/efo/EFO_0001640,0.623,None
prot-a-883,Endothelin-converting enzyme 1,endothelin-converting enzyme 1 measurement,EFO:0008121,http://www.ebi.ac.uk/efo/EFO_0008121,0.868,None
met-a-412,X-06246,X-06246 measurement,EFO:0021199,http://www.ebi.ac.uk/efo/EFO_0021199,0.672,None
prot-a-638,"Cytochrome c oxidase subunit 5B, mitochondrial","cytochrome c oxidase subunit 5B, mitochondrial measurement",EFO:0802449,http://www.ebi.ac.uk/efo/EFO_0802449,0.858,None
met-c-924,Total cholesterol in small LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.968,None
prot-a-636,Coactosin-like protein,coactosin-like protein measurement,EFO:0020262,http://www.ebi.ac.uk/efo/EFO_0020262,0.783,None
prot-a-919,Eukaryotic translation initiation factor 3 subunit G,eukaryotic translation initiation factor 3 subunit G measurement,EFO:0801590,http://www.ebi.ac.uk/efo/EFO_0801590,0.951,None
prot-a-2134,NTF2-related export protein 1,NTF2-related export protein 1 measurement,EFO:0801847,http://www.ebi.ac.uk/efo/EFO_0801847,0.794,None
ebi-a-GCST90010123,Fibroblast growth factor 21 levels,fibroblast growth factor 21 measurement,EFO:0010783,http://www.ebi.ac.uk/efo/EFO_0010783,0.849,None
prot-a-87,Amphoterin-induced protein 1,amphoterin-induced protein 1 measurement,EFO:0802273,http://www.ebi.ac.uk/efo/EFO_0802273,0.835,None
prot-a-521,Complement factor H-related protein 5,complement factor H-related protein 5 measurement,EFO:0008098,http://www.ebi.ac.uk/efo/EFO_0008098,0.785,None
prot-a-295,Uncharacterized protein C1orf115,uncharacterized protein C1orf115 measurement,EFO:0803226,http://www.ebi.ac.uk/efo/EFO_0803226,0.951,None
prot-a-1894,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B","alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B measurement",EFO:0801369,http://www.ebi.ac.uk/efo/EFO_0801369,0.697,None
ukb-d-30850_raw,Testosterone,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.815,None
prot-c-2829_19_2,IL-27,CAL 27,EFO:0006366,http://www.ebi.ac.uk/efo/EFO_0006366,0.698,None
met-a-513,X-11440,X-11440 measurement,EFO:0021234,http://www.ebi.ac.uk/efo/EFO_0021234,0.696,None
prot-a-415,Cyclin-C,cyclin-C measurement,EFO:0801507,http://www.ebi.ac.uk/efo/EFO_0801507,0.603,None
ebi-a-GCST011038,Parkinson's disease progression (motor),Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.727,None
prot-a-1020,Protein FAM107A,protein fam107a measurement,EFO:0020673,http://www.ebi.ac.uk/efo/EFO_0020673,0.92,None
prot-a-2218,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A","calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A measurement",EFO:0802359,http://www.ebi.ac.uk/efo/EFO_0802359,0.762,None
prot-a-2236,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement",EFO:0008010,http://www.ebi.ac.uk/efo/EFO_0008010,0.795,None
prot-c-3060_43_2,C9,C9 carnitine measurement,EFO:0801155,http://www.ebi.ac.uk/efo/EFO_0801155,0.608,None
ukb-b-7478,Hand grip strength (left),grip strength measurement,EFO:0006941,http://www.ebi.ac.uk/efo/EFO_0006941,0.721,None
ebi-a-GCST90002027,CD4 on CD45RA+ CD4+ T cell,immunodeficiency 79,MONDO:0030981,http://purl.obolibrary.org/obo/MONDO_0030981,0.603,None
ebi-a-GCST005062,Fibrinogen levels,fibrinogen measurement,EFO:0004623,http://www.ebi.ac.uk/efo/EFO_0004623,0.977,None
prot-a-1305,GDH/6PGL endoplasmic bifunctional protein,GDH/6PGL endoplasmic bifunctional protein measurement,EFO:0801619,http://www.ebi.ac.uk/efo/EFO_0801619,0.784,None
prot-a-2272,Paired immunoglobulin-like type 2 receptor alpha,paired immunoglobulin-like type 2 receptor alpha measurement,EFO:0801866,http://www.ebi.ac.uk/efo/EFO_0801866,0.892,None
prot-a-1735,Lutropin subunit beta,lutropin subunit beta measurement,EFO:0801773,http://www.ebi.ac.uk/efo/EFO_0801773,0.898,None
prot-a-834,Myotonin-protein kinase,myotonin-protein kinase measurement,EFO:0801814,http://www.ebi.ac.uk/efo/EFO_0801814,0.78,None
prot-a-2121,High affinity nerve growth factor receptor,high affinity nerve growth factor receptor measurement,EFO:0020448,http://www.ebi.ac.uk/efo/EFO_0020448,0.947,None
prot-b-21,interleukin 18,interleukin 18 measurement,EFO:0004581,http://www.ebi.ac.uk/efo/EFO_0004581,0.873,None
prot-a-753,NADH-cytochrome b5 reductase 3,NADH-cytochrome b5 reductase 3 measurement,EFO:0802786,http://www.ebi.ac.uk/efo/EFO_0802786,0.761,None
bbj-a-24,High-density-lipoprotein cholesterol,high density lipoprotein cholesterol measurement,EFO:0004612,http://www.ebi.ac.uk/efo/EFO_0004612,0.929,None
prot-a-1684,"Keratin, type I cytoskeletal 20","keratin, type I cytoskeletal 20 measurement",EFO:0802673,http://www.ebi.ac.uk/efo/EFO_0802673,0.86,None
prot-a-370,E3 ubiquitin-protein ligase CBL,E3 ubiquitin-protein ligase CBL measurement,EFO:0801552,http://www.ebi.ac.uk/efo/EFO_0801552,0.875,None
ebi-a-GCST90010353,Thyrotropin subunit beta levels,lutropin subunit beta measurement,EFO:0801773,http://www.ebi.ac.uk/efo/EFO_0801773,0.605,None
prot-a-2057,"NACHT, LRR and PYD domains-containing protein 4","NACHT, LRR and PYD domains-containing protein 4 measurement",EFO:0802782,http://www.ebi.ac.uk/efo/EFO_0802782,0.83,None
ukb-b-19393,Whole body fat mass,fat body mass,EFO:0005409,http://www.ebi.ac.uk/efo/EFO_0005409,0.819,None
ebi-a-GCST006352,Anti-mumps virus IgG levels,Anti-mumps virus IgG measurement,EFO:0009356,http://www.ebi.ac.uk/efo/EFO_0009356,0.695,None
met-a-623,5-dodecenoate (12:1n7),5-dodecenoate 12:1n7 measurement,EFO:0021100,http://www.ebi.ac.uk/efo/EFO_0021100,0.61,None
ebi-a-GCST003375,Glomerular filtration rate (cystatin C),glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.865,None
ebi-a-GCST90014303,DNA methylation-estimated plasminogen activator inhibitor-1 levels,plasminogen activator inhibitor 1 measurement,EFO:0004792,http://www.ebi.ac.uk/efo/EFO_0004792,0.709,None
prot-a-1568,Interferon regulatory factor 2,interferon regulatory factor 2 measurement,EFO:0801709,http://www.ebi.ac.uk/efo/EFO_0801709,0.919,None
ukb-b-17859,3mm asymmetry index (left),hemifacial hypertrophy,MONDO:0007590,http://purl.obolibrary.org/obo/MONDO_0007590,0.618,None
prot-a-2468,Sulfhydryl oxidase 1,sulfhydryl oxidase 1 measurement,EFO:0802099,http://www.ebi.ac.uk/efo/EFO_0802099,0.929,None
prot-c-4407_10_1,MSP,corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,MONDO:0014089,http://purl.obolibrary.org/obo/MONDO_0014089,0.617,None
prot-a-38,ADAMTS-like protein 1,ADAMTS-like protein 1 measurement,EFO:0802254,http://www.ebi.ac.uk/efo/EFO_0802254,0.789,None
prot-a-1428,Interferon gamma,interferon gamma,EFO:0003024,http://www.ebi.ac.uk/efo/EFO_0003024,0.996,None
ebi-a-GCST90001476,HLA DR++ monocyte %leukocyte,monocyte percentage of leukocytes,EFO:0007989,http://www.ebi.ac.uk/efo/EFO_0007989,0.708,None
prot-a-682,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,granulocyte-macrophage colony-stimulating factor receptor subunit alpha measurement,EFO:0802579,http://www.ebi.ac.uk/efo/EFO_0802579,0.849,None
prot-c-5301_7_3,Eotaxin,eotaxin measurement,EFO:0008122,http://www.ebi.ac.uk/efo/EFO_0008122,0.829,None
prot-a-106,Annexin A10,annexin A10 measurement,EFO:0801383,http://www.ebi.ac.uk/efo/EFO_0801383,0.896,None
met-d-S_LDL_PL,Phospholipids in small LDL,phospholipids in small VLDL measurement,EFO:0022146,http://www.ebi.ac.uk/efo/EFO_0022146,0.794,None
prot-a-2450,6-pyruvoyl tetrahydrobiopterin synthase,6-pyruvoyl tetrahydrobiopterin synthase measurement,EFO:0802242,http://www.ebi.ac.uk/efo/EFO_0802242,0.85,None
prot-b-42,TNF receptor superfamily member 1B,tumor necrosis factor receptor superfamily member 1B measurement,EFO:0010624,http://www.ebi.ac.uk/efo/EFO_0010624,0.72,None
prot-a-1594,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1","inositol 1,4,5-trisphosphate receptor-interacting protein-like 1 measurement",EFO:0801697,http://www.ebi.ac.uk/efo/EFO_0801697,0.689,None
ukb-a-299,Relative age of first facial hair,age at first facial hair,EFO:0009716,http://www.ebi.ac.uk/efo/EFO_0009716,0.823,None
ebi-a-GCST90000446,CCL25 levels,CCL25 measurement,EFO:0010768,http://www.ebi.ac.uk/efo/EFO_0010768,0.753,None
prot-a-244,Beclin-1,beclin-1 measurement,EFO:0802306,http://www.ebi.ac.uk/efo/EFO_0802306,0.66,None
ubm-a-23,IDP T1 FIRST left accumbens volume,nucleus accumbens volume,EFO:0006931,http://www.ebi.ac.uk/efo/EFO_0006931,0.609,None
ebi-a-GCST90001926,CD127 on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.653,None
prot-a-1662,Kallikrein-4,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.782,None
prot-c-3280_49_2,Aggrecan,"spondyloepimetaphyseal dysplasia, aggrecan type",MONDO:0013014,http://purl.obolibrary.org/obo/MONDO_0013014,0.707,None
ieu-b-4822,Age at menarche,age at menarche,EFO:0004703,http://www.ebi.ac.uk/efo/EFO_0004703,0.975,None
prot-a-2819,Serine protease inhibitor Kazal-type 5,serine protease inhibitor Kazal-type 5 measurement,EFO:0803058,http://www.ebi.ac.uk/efo/EFO_0803058,0.865,None
prot-c-2890_59_2,CCL28,CCL28 measurement,EFO:0010769,http://www.ebi.ac.uk/efo/EFO_0010769,0.875,None
prot-a-1198,Glial cell line-derived neurotrophic factor,glial cell line-derived neurotrophic factor measurement,EFO:0021887,http://www.ebi.ac.uk/efo/EFO_0021887,0.835,None
met-a-588,X-12189,X-12189 measurement,EFO:0021291,http://www.ebi.ac.uk/efo/EFO_0021291,0.696,None
prot-a-1259,Probable G-protein coupled receptor 101,probable G-protein coupled receptor 101 measurement,EFO:0802905,http://www.ebi.ac.uk/efo/EFO_0802905,0.845,None
prot-a-689,Tyrosine-protein kinase CSK,tyrosine-protein kinase CSK measurement,EFO:0020820,http://www.ebi.ac.uk/efo/EFO_0020820,0.822,None
ebi-a-GCST90000501,Tumor necrosis factor ligand superfamily member 14 levels,tumor necrosis factor ligand superfamily member 14 measurement,EFO:0010613,http://www.ebi.ac.uk/efo/EFO_0010613,0.897,None
prot-a-1517,Interleukin-27 receptor subunit alpha,interleukin 27 receptor subunit alpha measurement,EFO:0008183,http://www.ebi.ac.uk/efo/EFO_0008183,0.939,None
ebi-a-GCST90016676,Pancreas iron content,pancreatic neoplasm,EFO:0003860,http://www.ebi.ac.uk/efo/EFO_0003860,0.673,None
ebi-a-GCST90001467,CD86+ plasmacytoid Dendritic Cell %Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.825,None
ukb-d-30800_irnt,Oestradiol,estradiol measurement,EFO:0004697,http://www.ebi.ac.uk/efo/EFO_0004697,0.647,None
ebi-a-GCST90006888,Chlamydia trachomatis momp D antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.716,None
ieu-a-100,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-322,Complement component C8,complement component C8 measurement,EFO:0008094,http://www.ebi.ac.uk/efo/EFO_0008094,0.952,None
ubm-a-2663,volume Left-Pallidum,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.902,None
ebi-a-GCST90000470,Flt3L levels,fms related receptor tyrosine kinase-3 ligand measurement,EFO:0010785,http://www.ebi.ac.uk/efo/EFO_0010785,0.891,None
prot-a-1957,Growth/differentiation factor 8,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.835,None
ieu-b-4825,Cigarettes smoked per day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.773,None
met-d-VLDL_P,Concentration of VLDL particles,concentration of small VLDL particles,EFO:0022147,http://www.ebi.ac.uk/efo/EFO_0022147,0.917,None
ebi-a-GCST90012000,E-selectin levels,e-selectin measurement,EFO:0004575,http://www.ebi.ac.uk/efo/EFO_0004575,0.711,None
prot-c-5400_52_3,sLeptin R,leptin,EFO:0003199,http://www.ebi.ac.uk/efo/EFO_0003199,0.654,None
ukb-d-30830_raw,SHBG,sex hormone-binding globulin,EFO:0003941,http://www.ebi.ac.uk/efo/EFO_0003941,0.997,None
prot-a-999,Envoplakin,envoplakin measurement,EFO:0802524,http://www.ebi.ac.uk/efo/EFO_0802524,0.883,None
prot-a-1786,Leucine-rich repeat-containing protein 3,leucine-rich repeat-containing protein 3 measurement,EFO:0802698,http://www.ebi.ac.uk/efo/EFO_0802698,0.775,None
prot-a-1000,RNA-binding protein EWS,RNA-binding protein EWS measurement,EFO:0802032,http://www.ebi.ac.uk/efo/EFO_0802032,0.784,None
ieu-a-787,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-2043,Tumor necrosis factor receptor superfamily member 16,tumor necrosis factor receptor superfamily member 16 measurement,EFO:0802168,http://www.ebi.ac.uk/efo/EFO_0802168,0.946,None
ukb-d-30060_irnt,Mean corpuscular haemoglobin concentration,mean corpuscular hemoglobin concentration,EFO:0004528,http://www.ebi.ac.uk/efo/EFO_0004528,0.988,None
ukb-b-7244,Carbohydrate,carbohydrate measurement,EFO:0004998,http://www.ebi.ac.uk/efo/EFO_0004998,0.867,None
prot-a-857,Dipeptidase 2,dipeptidase 2 measurement,EFO:0801528,http://www.ebi.ac.uk/efo/EFO_0801528,0.87,None
prot-a-96,Angiopoietin-related protein 1,angiopoietin-related protein 1 measurement,EFO:0801382,http://www.ebi.ac.uk/efo/EFO_0801382,0.839,None
met-a-326,Lysine,lysine measurement,EFO:0005002,http://www.ebi.ac.uk/efo/EFO_0005002,0.745,None
met-a-708,3-(3-hydroxyphenyl)propionate,3-3-hydroxyphenylpropionate measurement,EFO:0021007,http://www.ebi.ac.uk/efo/EFO_0021007,0.641,None
prot-a-3231,WNT1-inducible-signaling pathway protein 1,WNT1-inducible-signaling pathway protein 1 measurement,EFO:0008321,http://www.ebi.ac.uk/efo/EFO_0008321,0.804,None
prot-a-954,Ectonucleoside triphosphate diphosphohydrolase 6,ectonucleoside triphosphate diphosphohydrolase 6 measurement,EFO:0802517,http://www.ebi.ac.uk/efo/EFO_0802517,0.961,None
prot-c-3028_36_2,Ck-b-8-1,CK syndrome,MONDO:0010441,http://purl.obolibrary.org/obo/MONDO_0010441,0.625,None
prot-a-1446,Insulin-like growth factor-binding protein 1,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.824,None
prot-c-4143_74_2,Lymphotactin,lymphotactin measurement,EFO:0008214,http://www.ebi.ac.uk/efo/EFO_0008214,0.852,None
ebi-a-GCST004450,Interleukin-9 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.794,None
prot-a-3195,Vinculin,vinculin measurement,EFO:0803257,http://www.ebi.ac.uk/efo/EFO_0803257,0.838,None
ebi-a-GCST90002081,SSC-A on CD4+ T cell,systemic scleroderma,EFO:0000717,http://www.ebi.ac.uk/efo/EFO_0000717,0.685,None
ubm-a-2659,volume Left-Cerebellum-Cortex,cerebellar cortex volume measurement,EFO:0010291,http://www.ebi.ac.uk/efo/EFO_0010291,0.859,None
met-a-314,Mannose,mannose measurement,EFO:0006958,http://www.ebi.ac.uk/efo/EFO_0006958,0.791,None
ebi-a-GCST90000491,Oncostatin-M levels,oncostatin M,EFO:0003200,http://www.ebi.ac.uk/efo/EFO_0003200,0.864,None
prot-a-1257,Transmembrane glycoprotein NMB,transmembrane glycoprotein NMB measurement,EFO:0008303,http://www.ebi.ac.uk/efo/EFO_0008303,0.937,None
prot-a-194,Astacin-like metalloendopeptidase,astacin-like metalloendopeptidase measurement,EFO:0802291,http://www.ebi.ac.uk/efo/EFO_0802291,0.87,None
prot-a-2860,"CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase","CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase measurement",EFO:0802404,http://www.ebi.ac.uk/efo/EFO_0802404,0.62,None
ebi-a-GCST90006928,Anti-varicella zoster virus IgG seropositivity,Varicella zoster virus seropositivity,EFO:0009340,http://www.ebi.ac.uk/efo/EFO_0009340,0.892,None
prot-c-3657_74_3,Calcineurin B a,calcineurin measurement,EFO:0008061,http://www.ebi.ac.uk/efo/EFO_0008061,0.744,None
prot-a-2690,Serpin A12,serpin A12 measurement,EFO:0802061,http://www.ebi.ac.uk/efo/EFO_0802061,0.88,None
prot-a-695,Casein kinase II subunit alpha,casein kinase II subunit alpha measurement,EFO:0020238,http://www.ebi.ac.uk/efo/EFO_0020238,0.919,None
prot-a-767,Deoxycytidine kinase,deoxycytidine kinase measurement,EFO:0801523,http://www.ebi.ac.uk/efo/EFO_0801523,0.911,None
prot-a-768,Serine/threonine-protein kinase DCLK3,serine/threonine-protein kinase DCLK3 measurement,EFO:0803064,http://www.ebi.ac.uk/efo/EFO_0803064,0.799,None
ebi-a-GCST90010213,epithelial cell adhesion molecule levels,epithelial cell adhesion molecule measurement,EFO:0010574,http://www.ebi.ac.uk/efo/EFO_0010574,0.862,None
prot-a-2581,Tyrosine-protein kinase transmembrane receptor ROR1,tyrosine-protein kinase transmembrane receptor ROR1 measurement,EFO:0020831,http://www.ebi.ac.uk/efo/EFO_0020831,0.897,None
prot-a-1098,Fibroblast growth factor 7,fibroblast growth factor 7 measurement,EFO:0020384,http://www.ebi.ac.uk/efo/EFO_0020384,0.91,None
met-a-555,X-11858,X-11858 measurement,EFO:0021272,http://www.ebi.ac.uk/efo/EFO_0021272,0.7,None
ukb-b-3376,Number of measurements made,number of teeth measurement,EFO:0010073,http://www.ebi.ac.uk/efo/EFO_0010073,0.631,None
prot-c-3122_6_2,SMAC,malignant syringoma,MONDO:0003519,http://purl.obolibrary.org/obo/MONDO_0003519,0.698,None
prot-a-491,Cyclin-dependent kinase 2-associated protein 1,cyclin-dependent kinase 2-associated protein 1 measurement,EFO:0802440,http://www.ebi.ac.uk/efo/EFO_0802440,0.81,None
prot-c-2585_2_5,PRL,familial hyperprolactinemia,MONDO:0014250,http://purl.obolibrary.org/obo/MONDO_0014250,0.742,None
prot-a-2434,Protein-tyrosine kinase 6,protein-tyrosine kinase 6 measurement,EFO:0020691,http://www.ebi.ac.uk/efo/EFO_0020691,0.765,None
prot-a-225,BAG family molecular chaperone regulator 3,BAG family molecular chaperone regulator 3 measurement,EFO:0802302,http://www.ebi.ac.uk/efo/EFO_0802302,0.943,None
prot-a-1737,Leukemia inhibitory factor receptor,leukemia inhibitory factor receptor measurement,EFO:0010788,http://www.ebi.ac.uk/efo/EFO_0010788,0.927,None
met-a-626,10-nonadecenoate (19:1n9),10-nonadecenoate 19:1n9 measurement,EFO:0021061,http://www.ebi.ac.uk/efo/EFO_0021061,0.629,None
bbj-a-58,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
prot-c-2625_53_4,HSP 90a/b,hereditary spastic paraplegia,MONDO:0019064,http://purl.obolibrary.org/obo/MONDO_0019064,0.66,None
ebi-a-GCST90001954,CD33 on basophil,basophil adenoma,EFO:1000834,http://www.ebi.ac.uk/efo/EFO_1000834,0.671,None
prot-a-3167,Netrin receptor UNC5B,netrin receptor UNC5B measurement,EFO:0802792,http://www.ebi.ac.uk/efo/EFO_0802792,0.917,None
prot-a-1822,Lysozyme-like protein 2,lysozyme-like protein 2 measurement,EFO:0801779,http://www.ebi.ac.uk/efo/EFO_0801779,0.803,None
prot-c-2789_26_2,MMP-7,mucous membrane pemphigoid,EFO:1000680,http://www.ebi.ac.uk/efo/EFO_1000680,0.896,None
prot-a-1521,Interleukin-31,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.82,None
met-d-S_LDL_PL_pct,Phospholipids to total lipids ratio in small LDL,total lipids in small LDL,EFO:0022168,http://www.ebi.ac.uk/efo/EFO_0022168,0.779,None
prot-c-4834_61_2,Epithelial cell kinase,thyrocyte,EFO:0003076,http://www.ebi.ac.uk/efo/EFO_0003076,0.692,None
prot-c-3292_75_1,CD48,CD48 antigen measurement,EFO:0020247,http://www.ebi.ac.uk/efo/EFO_0020247,0.696,None
prot-a-1977,"Myosin-binding protein C, slow-type","myosin-binding protein C, slow-type measurement",EFO:0802772,http://www.ebi.ac.uk/efo/EFO_0802772,0.624,None
ieu-a-101,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
ebi-a-GCST90000448,CCL3 levels,CCL3 measurement,EFO:0010770,http://www.ebi.ac.uk/efo/EFO_0010770,0.715,None
prot-a-507,Bile salt-activated lipase,bile salt-activated lipase measurement,EFO:0801425,http://www.ebi.ac.uk/efo/EFO_0801425,0.747,None
ebi-a-GCST004733,Heart rate variability traits (RMSSD),root mean square of the successive differences of inter beat intervals,EFO:0009257,http://www.ebi.ac.uk/efo/EFO_0009257,0.629,None
ubm-a-2689,volume CC Posterior,posterior thigh muscle volume,EFO:0020931,http://www.ebi.ac.uk/efo/EFO_0020931,0.657,None
prot-a-2670,Semaphorin-3B,semaphorin-3B measurement,EFO:0802047,http://www.ebi.ac.uk/efo/EFO_0802047,0.664,None
prot-a-3281,Zona pellucida sperm-binding protein 4,zona pellucida sperm-binding protein 4 measurement,EFO:0802229,http://www.ebi.ac.uk/efo/EFO_0802229,0.808,None
prot-a-2182,Poly [ADP-ribose] polymerase 1,poly [ADP-ribose] polymerase 1 measurement,EFO:0802876,http://www.ebi.ac.uk/efo/EFO_0802876,0.684,None
prot-a-24,Acylphosphatase-2,acylphosphatase-2 measurement,EFO:0801344,http://www.ebi.ac.uk/efo/EFO_0801344,0.737,None
met-a-673,X-13069,X-13069 measurement,EFO:0021345,http://www.ebi.ac.uk/efo/EFO_0021345,0.698,None
ukb-b-14540,Whole body water mass,whole body water mass,EFO:0009805,http://www.ebi.ac.uk/efo/EFO_0009805,0.994,None
ukb-a-362,Heel bone mineral density (BMD) T-score  automated (right),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.658,None
met-a-606,X-12428,X-12428 measurement,EFO:0021305,http://www.ebi.ac.uk/efo/EFO_0021305,0.706,None
prot-a-1343,Hexokinase-1,hexokinase-1 measurement,EFO:0021939,http://www.ebi.ac.uk/efo/EFO_0021939,0.725,None
prot-a-302,Complement C1q-like protein 4,complement C1q-like protein 4 measurement,EFO:0802426,http://www.ebi.ac.uk/efo/EFO_0802426,0.75,None
ubm-a-2682,volume Right-Hippocampus,hippocampus volume change measurement,EFO:0021492,http://www.ebi.ac.uk/efo/EFO_0021492,0.776,None
prot-a-757,Cytochrome P450 3A4,cytochrome p450 3a4 measurement,EFO:0020303,http://www.ebi.ac.uk/efo/EFO_0020303,0.922,None
ukb-b-8865,Time spent doing light physical activity,physical activity,EFO:0003940,http://www.ebi.ac.uk/efo/EFO_0003940,0.662,None
ebi-a-GCST90010134,Heme oxygenase 1 levels,heme oxygenase 1 deficiency,MONDO:0013536,http://purl.obolibrary.org/obo/MONDO_0013536,0.759,None
ebi-a-GCST90002341,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
prot-c-4261_55_2,paraoxonase 1,paraoxonase-1 measurement,EFO:0801085,http://www.ebi.ac.uk/efo/EFO_0801085,0.746,None
prot-a-1123,Leucine-rich repeat transmembrane protein FLRT2,leucine-rich repeat transmembrane protein FLRT2 measurement,EFO:0021860,http://www.ebi.ac.uk/efo/EFO_0021860,0.902,None
prot-a-1616,Kv channel-interacting protein 1,kv channel-interacting protein 1 measurement,EFO:0801751,http://www.ebi.ac.uk/efo/EFO_0801751,0.829,None
prot-a-3164,Uromodulin-like 1,uromodulin-like 1 measurement,EFO:0803239,http://www.ebi.ac.uk/efo/EFO_0803239,0.758,None
prot-a-1744,Leukocyte immunoglobulin-like receptor subfamily B member 2,leukocyte immunoglobulin-like receptor subfamily B member 2 measurement,EFO:0008209,http://www.ebi.ac.uk/efo/EFO_0008209,0.921,None
bbj-a-17,Diastolic blood pressure,diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.99,None
prot-a-2188,Paired box protein Pax-4,paired box protein Pax-4 measurement,EFO:0802841,http://www.ebi.ac.uk/efo/EFO_0802841,0.699,None
prot-a-1033,Protein FAM173A,protein FAM173A measurement,EFO:0802938,http://www.ebi.ac.uk/efo/EFO_0802938,0.917,None
ebi-a-GCST90000502,Tumor necrosis factor ligand superfamily member 10 levels,tumor necrosis factor ligand superfamily member 10 measurement,EFO:0010800,http://www.ebi.ac.uk/efo/EFO_0010800,0.894,None
prot-a-1619,Keratinocyte-associated transmembrane protein 2,keratinocyte-associated transmembrane protein 2 measurement,EFO:0802676,http://www.ebi.ac.uk/efo/EFO_0802676,0.873,None
prot-a-136,Apolipoprotein M,apolipoprotein M measurement,EFO:0021945,http://www.ebi.ac.uk/efo/EFO_0021945,0.883,None
met-a-393,"X-04499--3,4-dihydroxybutyrate","X-04499--3,4-dihydroxybutyrate measurement",EFO:0021193,http://www.ebi.ac.uk/efo/EFO_0021193,0.627,None
met-d-L_LDL_CE_pct,Cholesteryl esters to total lipids ratio in large LDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.716,None
prot-a-1015,FAS-associated factor 2,fAS-associated factor 2 measurement,EFO:0802541,http://www.ebi.ac.uk/efo/EFO_0802541,0.746,None
prot-c-3738_54_1,CSF-1,Abnormal cerebrospinal fluid morphology,HP:0002921,http://purl.obolibrary.org/obo/HP_0002921,0.644,None
ieu-b-25,Cigarettes per Day,cigarettes per day measurement,EFO:0006525,http://www.ebi.ac.uk/efo/EFO_0006525,0.913,None
met-a-705,1-myristoylglycerophosphocholine,1-myristoylglycerophosphocholine measurement,EFO:0021085,http://www.ebi.ac.uk/efo/EFO_0021085,0.84,None
prot-a-243,Transcription factor TFIIIB component B'' homolog,transcription factor TFIIIB component B'' homolog measurement,EFO:0803163,http://www.ebi.ac.uk/efo/EFO_0803163,0.859,None
prot-a-680,Macrophage colony-stimulating factor 1,macrophage colony stimulating factor measurement,EFO:0008217,http://www.ebi.ac.uk/efo/EFO_0008217,0.92,None
prot-a-341,Procalcitonin,procalcitonin measurement,EFO:0802910,http://www.ebi.ac.uk/efo/EFO_0802910,0.856,None
ebi-a-GCST000760,"Cholesterol, total",total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.868,None
prot-a-214,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 measurement",EFO:0803220,http://www.ebi.ac.uk/efo/EFO_0803220,0.72,None
prot-a-374,Carbonyl reductase [NADPH] 3,carbonyl reductase [NADPH] 3 measurement,EFO:0803315,http://www.ebi.ac.uk/efo/EFO_0803315,0.712,None
prot-a-2994,Transmembrane emp24 domain-containing protein 2,transmembrane emp24 domain-containing protein 2 measurement,EFO:0803176,http://www.ebi.ac.uk/efo/EFO_0803176,0.914,None
bbj-a-8,Aspartate aminotransferase,aspartate aminotransferase measurement,EFO:0004736,http://www.ebi.ac.uk/efo/EFO_0004736,0.916,None
met-d-GlycA,Glycoprotein acetyls,glycoproteinosis,MONDO:0017731,http://purl.obolibrary.org/obo/MONDO_0017731,0.61,None
prot-a-501,Testis-specific chromodomain protein Y 1,testis-specific chromodomain protein Y 1 measurement,EFO:0802127,http://www.ebi.ac.uk/efo/EFO_0802127,0.842,None
prot-a-2521,Renin,renin measurement,EFO:0010616,http://www.ebi.ac.uk/efo/EFO_0010616,0.654,None
ebi-a-GCST90001966,FSC-A on granulocyte,Granulocytosis,HP:0032310,http://purl.obolibrary.org/obo/HP_0032310,0.636,None
ieu-a-62,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
ebi-a-GCST90001745,CD20 on CD24+ CD27+ B cell,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.605,None
prot-a-1369,Haptoglobin,haptoglobin measurement,EFO:0004640,http://www.ebi.ac.uk/efo/EFO_0004640,0.876,None
prot-a-766,"Discoidin, CUB and LCCL domain-containing protein 2","discoidin, CUB and LCCL domain-containing protein 2 measurement",EFO:0803294,http://www.ebi.ac.uk/efo/EFO_0803294,0.867,None
ebi-a-GCST004487,Peak insulin response,peak insulin response measurement,EFO:0008000,http://www.ebi.ac.uk/efo/EFO_0008000,0.905,None
prot-c-5071_3_3,Desmoglein-2,desmoglein-1 measurement,EFO:0020321,http://www.ebi.ac.uk/efo/EFO_0020321,0.733,None
ebi-a-GCST90017134,Neck circumference,neck circumference,EFO:0011043,http://www.ebi.ac.uk/efo/EFO_0011043,0.993,None
prot-a-2493,Retinoic acid receptor responder protein 1,retinoic acid receptor responder protein 1 measurement,EFO:0802004,http://www.ebi.ac.uk/efo/EFO_0802004,0.931,None
prot-a-2161,Prolyl 4-hydroxylase subunit alpha-1,prolyl 4-hydroxylase subunit alpha-1 measurement,EFO:0802917,http://www.ebi.ac.uk/efo/EFO_0802917,0.741,None
prot-a-3156,UDP-glucuronosyltransferase 1-6,UDP-glucuronosyltransferase 2A1 measurement,EFO:0802186,http://www.ebi.ac.uk/efo/EFO_0802186,0.744,None
met-a-647,X-12729,X-12729 measurement,EFO:0021328,http://www.ebi.ac.uk/efo/EFO_0021328,0.703,None
ebi-a-GCST005185,Fasting blood insulin,fasting blood insulin measurement,EFO:0004466,http://www.ebi.ac.uk/efo/EFO_0004466,0.992,None
ebi-a-GCST90001457,CD11c+ HLA DR++ monocyte %monocyte,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.61,None
met-a-621,1-oleoylglycerophosphocholine,2-oleoylglycerophosphocholine measurement,EFO:0021096,http://www.ebi.ac.uk/efo/EFO_0021096,0.813,None
ebi-a-GCST007344,Estimated glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.867,None
met-a-690,2-linoleoylglycerophosphocholine*,1-linoleoylglycerophosphocholine measurement,EFO:0021083,http://www.ebi.ac.uk/efo/EFO_0021083,0.857,None
prot-a-577,C-type lectin domain family 4 member E,C-type lectin domain family 4 member E measurement,EFO:0801435,http://www.ebi.ac.uk/efo/EFO_0801435,0.8,None
prot-a-1444,Insulin-like growth factor 1 receptor,insulin-like growth factor 1 receptor measurement,EFO:0020473,http://www.ebi.ac.uk/efo/EFO_0020473,0.869,None
prot-a-1226,Guanine nucleotide-binding protein G(k) subunit alpha,guanine nucleotide-binding protein G(k) subunit alpha measurement,EFO:0801661,http://www.ebi.ac.uk/efo/EFO_0801661,0.734,None
prot-a-2167,Multifunctional protein ADE2,multifunctional protein ADE2 measurement,EFO:0802761,http://www.ebi.ac.uk/efo/EFO_0802761,0.921,None
prot-a-1761,"Lon protease homolog, mitochondrial","lon protease homolog, mitochondrial measurement",EFO:0801771,http://www.ebi.ac.uk/efo/EFO_0801771,0.817,None
ebi-a-GCST90001796,CD27 on CD20- B cell,autosomal recessive lymphoproliferative disease,MONDO:0016536,http://purl.obolibrary.org/obo/MONDO_0016536,0.62,None
prot-a-1390,Oxidoreductase HTATIP2,oxidoreductase HTATIP2 measurement,EFO:0801863,http://www.ebi.ac.uk/efo/EFO_0801863,0.933,None
ukb-a-198,Birth weight,birth weight,EFO:0004344,http://www.ebi.ac.uk/efo/EFO_0004344,0.994,None
prot-a-141,Amphiregulin,amphiregulin measurement,EFO:0020144,http://www.ebi.ac.uk/efo/EFO_0020144,0.876,None
ebi-a-GCST005074,Testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.977,None
met-a-395,Dihomo-linoleate (20:2n6),dihomo-linoleate 20:2n6 measurement,EFO:0021064,http://www.ebi.ac.uk/efo/EFO_0021064,0.65,None
prot-a-2747,Urea transporter 2,urea transporter 2 measurement,EFO:0802203,http://www.ebi.ac.uk/efo/EFO_0802203,0.888,None
prot-a-3146,Ubiquitin-like protein 4A,ubiquitin-like protein 4A measurement,EFO:0802183,http://www.ebi.ac.uk/efo/EFO_0802183,0.855,None
prot-c-3627_71_4,MMEL2,elliptocytosis 2,MONDO:0007533,http://purl.obolibrary.org/obo/MONDO_0007533,0.621,None
ukb-a-344,Difficulty not smoking for 1 day,Difficulty standing,HP:0003698,http://purl.obolibrary.org/obo/HP_0003698,0.615,None
prot-a-1040,Protein FAM19A2,protein FAM19A2 measurement,EFO:0802939,http://www.ebi.ac.uk/efo/EFO_0802939,0.916,None
ebi-a-GCST006357,IgG levels,serum IgG measurement,EFO:0004565,http://www.ebi.ac.uk/efo/EFO_0004565,0.856,None
prot-a-3211,Vacuolar protein sorting-associated protein VTA1 homolog,vacuolar protein sorting-associated protein VTA1 homolog measurement,EFO:0020845,http://www.ebi.ac.uk/efo/EFO_0020845,0.905,None
prot-a-2275,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4,peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 measurement,EFO:0801875,http://www.ebi.ac.uk/efo/EFO_0801875,0.778,None
prot-a-1673,Killer cell lectin-like receptor subfamily F member 1,killer cell lectin-like receptor subfamily F member 1 measurement,EFO:0020520,http://www.ebi.ac.uk/efo/EFO_0020520,0.907,None
prot-a-1025,Protein FAM151A,protein FAM151A measurement,EFO:0801945,http://www.ebi.ac.uk/efo/EFO_0801945,0.918,None
prot-a-158,Rho guanine nucleotide exchange factor 7,rho guanine nucleotide exchange factor 7 measurement,EFO:0803020,http://www.ebi.ac.uk/efo/EFO_0803020,0.951,None
prot-c-3049_61_2,Trypsin,trypsin-1 measurement,EFO:0020790,http://www.ebi.ac.uk/efo/EFO_0020790,0.708,None
prot-a-2403,Pregnancy-specific beta-1-glycoprotein 4,pregnancy-specific beta-1-glycoprotein 4 measurement,EFO:0801907,http://www.ebi.ac.uk/efo/EFO_0801907,0.692,None
prot-a-2495,Ras GTPase-activating protein 1,ras GTPase-activating protein 1 measurement,EFO:0020698,http://www.ebi.ac.uk/efo/EFO_0020698,0.826,None
prot-a-438,CMRF35-like molecule 9,CMRF35-like molecule 9 measurement,EFO:0802408,http://www.ebi.ac.uk/efo/EFO_0802408,0.801,None
ebi-a-GCST004456,Interferon gamma levels,interferon gamma,EFO:0003024,http://www.ebi.ac.uk/efo/EFO_0003024,0.88,None
prot-a-1812,Lymphocyte antigen 86,lymphocyte antigen 86 measurement,EFO:0020541,http://www.ebi.ac.uk/efo/EFO_0020541,0.913,None
prot-a-1235,N-acetylglucosamine-6-sulfatase,mucopolysaccharidosis type 3D,MONDO:0009658,http://purl.obolibrary.org/obo/MONDO_0009658,0.707,None
ebi-a-GCST004076,Optic disc area,optic disc area measurement,EFO:0006937,http://www.ebi.ac.uk/efo/EFO_0006937,0.861,None
prot-a-568,C-type lectin domain family 10 member A,C-type lectin domain family 10 member A measurement,EFO:0802342,http://www.ebi.ac.uk/efo/EFO_0802342,0.802,None
prot-a-2518,RELT-like protein 2,RELT-like protein 2 measurement,EFO:0803008,http://www.ebi.ac.uk/efo/EFO_0803008,0.683,None
prot-a-1993,NGFI-A-binding protein 2,NGFI-A-binding protein 2 measurement,EFO:0802812,http://www.ebi.ac.uk/efo/EFO_0802812,0.649,None
met-a-468,Glycine,glycine measurement,EFO:0009767,http://www.ebi.ac.uk/efo/EFO_0009767,0.769,None
prot-a-966,Ephrin type-B receptor 6,ephrin type-b receptor 6 measurement,EFO:0020355,http://www.ebi.ac.uk/efo/EFO_0020355,0.689,None
met-d-Ile,Isoleucine,isoleucine measurement,EFO:0009793,http://www.ebi.ac.uk/efo/EFO_0009793,0.837,None
ebi-a-GCST90011323,G_Bacteroides abundance,Bacteroides infectious disease,EFO:1000832,http://www.ebi.ac.uk/efo/EFO_1000832,0.606,None
prot-a-2572,E3 ubiquitin-protein ligase RNF43,e3 ubiquitin-protein ligase RNF43 measurement,EFO:0021886,http://www.ebi.ac.uk/efo/EFO_0021886,0.905,None
ebi-a-GCST90011634,OTU99_140 (Desulfovibrio) prevalence,commensal Desulfovibrionaceae infectious disease,EFO:1000875,http://www.ebi.ac.uk/efo/EFO_1000875,0.641,None
ebi-a-GCST90010215,"Fatty acid-binding protein, adipocyte levels","fatty acid-binding protein, adipocyte measurement",EFO:0010914,http://www.ebi.ac.uk/efo/EFO_0010914,0.74,None
met-d-S_VLDL_L,Total lipids in small VLDL,total lipids in small VLDL,EFO:0022148,http://www.ebi.ac.uk/efo/EFO_0022148,0.967,None
ebi-a-GCST006586,Urinary albumin excretion,albuminuria,EFO:0004285,http://www.ebi.ac.uk/efo/EFO_0004285,0.995,None
met-a-605,X-12407,X-12407 measurement,EFO:0021304,http://www.ebi.ac.uk/efo/EFO_0021304,0.72,None
ebi-a-GCST90017133,Neck circumference,neck circumference,EFO:0011043,http://www.ebi.ac.uk/efo/EFO_0011043,0.993,None
prot-a-3254,Tyrosine-protein kinase ZAP-70,tyrosine-protein kinase ZAP-70 measurement,EFO:0020833,http://www.ebi.ac.uk/efo/EFO_0020833,0.654,None
prot-a-2076,Atrial natriuretic factor,atrial natriuretic factor measurement,EFO:0004789,http://www.ebi.ac.uk/efo/EFO_0004789,0.915,None
ieu-a-797,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ukb-b-3433,Cake intake,energy intake,EFO:0003939,http://www.ebi.ac.uk/efo/EFO_0003939,0.638,None
ebi-a-GCST90002244,Glycated hemoglobin levels,HbA1c measurement,EFO:0004541,http://www.ebi.ac.uk/efo/EFO_0004541,0.986,None
prot-a-2903,Sushi domain-containing protein 3,Sushi domain-containing protein 3 measurement,EFO:0803112,http://www.ebi.ac.uk/efo/EFO_0803112,0.864,None
prot-a-3149,UBX domain-containing protein 4,UBX domain-containing protein 4 measurement,EFO:0803219,http://www.ebi.ac.uk/efo/EFO_0803219,0.879,None
ieu-b-4819,Age at first birth,age at first birth measurement,EFO:0009101,http://www.ebi.ac.uk/efo/EFO_0009101,0.907,None
prot-a-2349,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha,serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha measurement,EFO:0802060,http://www.ebi.ac.uk/efo/EFO_0802060,0.82,None
ukb-d-30880_raw,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
ukb-a-369,Health satisfaction,health satisfaction measurement,EFO:0009724,http://www.ebi.ac.uk/efo/EFO_0009724,0.907,None
prot-a-1665,Kallikrein-6,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.775,None
ieu-a-66,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-1157,Tyrosine-protein kinase Fyn,tyrosine-protein kinase FYN measurement,EFO:0020823,http://www.ebi.ac.uk/efo/EFO_0020823,0.845,None
ebi-a-GCST90002224,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
prot-a-776,Discoidin domain-containing receptor 2,discoidin domain-containing receptor 2 measurement,EFO:0020327,http://www.ebi.ac.uk/efo/EFO_0020327,0.874,None
ebi-a-GCST005072,Ferritin levels,ferritin measurement,EFO:0004459,http://www.ebi.ac.uk/efo/EFO_0004459,0.882,None
prot-a-3035,Tumor necrosis factor receptor superfamily member 11A,tumor necrosis factor receptor superfamily member 11A measurement,EFO:0020800,http://www.ebi.ac.uk/efo/EFO_0020800,0.948,None
prot-a-125,Apolipoprotein A-V,apolipoprotein A 1 measurement,EFO:0004614,http://www.ebi.ac.uk/efo/EFO_0004614,0.792,None
ebi-a-GCST90000476,Interleukin-10 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.781,None
ukb-b-8875,Heel bone mineral density (BMD),heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.878,None
prot-a-1141,Secreted frizzled-related protein 3,Secreted frizzled-related protein 3 measurement,EFO:0008277,http://www.ebi.ac.uk/efo/EFO_0008277,0.882,None
ebi-a-GCST011037,Parkinson's disease progression (cognitive),Parkinson disease,MONDO:0005180,http://purl.obolibrary.org/obo/MONDO_0005180,0.659,None
prot-a-3020,Tropomodulin-1,tropomodulin-1 measurement,EFO:0803195,http://www.ebi.ac.uk/efo/EFO_0803195,0.726,None
prot-c-3521_16_2,TSH,central congenital hypothyroidism,MONDO:0016410,http://purl.obolibrary.org/obo/MONDO_0016410,0.735,None
ukb-b-6214,Doughnut intake,Calvarial doughnut lesions - bone fragility,ORPHANET.ORDO:85192,http://www.orpha.net/ORDO/Orphanet_85192,0.65,None
ukb-b-6373,Liver intake,liver disease,EFO:0001421,http://www.ebi.ac.uk/efo/EFO_0001421,0.633,None
prot-a-2651,Polycomb protein SCMH1,polycomb protein SCMH1 measurement,EFO:0801898,http://www.ebi.ac.uk/efo/EFO_0801898,0.922,None
ebi-a-GCST005068,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
ebi-a-GCST006702,Parental longevity (combined parental age at death),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.814,None
ebi-a-GCST004603,Platelet count,platelet count,EFO:0004309,http://www.ebi.ac.uk/efo/EFO_0004309,0.979,None
prot-c-3854_24_1,NACA,permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,MONDO:0012192,http://purl.obolibrary.org/obo/MONDO_0012192,0.602,None
prot-a-1371,Hematopoietic prostaglandin D synthase,hematopoietic prostaglandin D synthase measurement,EFO:0801668,http://www.ebi.ac.uk/efo/EFO_0801668,0.929,None
prot-a-3191,Valine--tRNA ligase,valine--tRNA ligase measurement,EFO:0802210,http://www.ebi.ac.uk/efo/EFO_0802210,0.679,None
ieu-a-1095,Age at menarche,age at menarche,EFO:0004703,http://www.ebi.ac.uk/efo/EFO_0004703,0.975,None
prot-a-1681,Kremen protein 2,kremen protein 2 measurement,EFO:0020523,http://www.ebi.ac.uk/efo/EFO_0020523,0.915,None
ebi-a-GCST90002386,High light scatter reticulocyte percentage of red cells,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.915,None
ebi-a-GCST90010354,Thioredoxin domain-containing protein 5 levels,thioredoxin domain-containing protein 5 measurement,EFO:0802128,http://www.ebi.ac.uk/efo/EFO_0802128,0.842,None
prot-a-1421,Interferon alpha-4,interferon alpha,EFO:0003021,http://www.ebi.ac.uk/efo/EFO_0003021,0.962,None
ebi-a-GCST90010198,Scavenger receptor cysteine-rich type 1 protein M130 levels,scavenger receptor cysteine-rich type 1 protein m130 measurement,EFO:0020717,http://www.ebi.ac.uk/efo/EFO_0020717,0.854,None
met-d-Sphingomyelins,Sphingomyelins,sphingomyelin measurement,EFO:0010118,http://www.ebi.ac.uk/efo/EFO_0010118,0.803,None
prot-a-248,Biglycan,biglycan measurement,EFO:0020182,http://www.ebi.ac.uk/efo/EFO_0020182,0.838,None
prot-c-3169_70_2,IDUA,mucopolysaccharidosis type 1,MONDO:0001586,http://purl.obolibrary.org/obo/MONDO_0001586,0.783,None
met-a-463,Acetylcarnitine,acetylcarnitine measurement,EFO:0021038,http://www.ebi.ac.uk/efo/EFO_0021038,0.884,None
prot-b-43,hepatocyte growth factor,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.995,None
met-a-462,3-(4-hydroxyphenyl)lactate,3- 4-hydroxyphenyl lactate measurement,EFO:0021008,http://www.ebi.ac.uk/efo/EFO_0021008,0.708,None
prot-a-974,Receptor tyrosine-protein kinase erbB-3,receptor tyrosine-protein kinase erbb-2 measurement,EFO:0020700,http://www.ebi.ac.uk/efo/EFO_0020700,0.707,None
prot-a-1972,A/G-specific adenine DNA glycosylase,A/G-specific adenine DNA glycosylase measurement,EFO:0802246,http://www.ebi.ac.uk/efo/EFO_0802246,0.703,None
met-c-933,Serum total cholesterol,total cholesterol measurement,EFO:0004574,http://www.ebi.ac.uk/efo/EFO_0004574,0.721,None
ebi-a-GCST90006889,Chlamydia trachomatis pGP3 antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.675,None
prot-a-321,Uncharacterized protein C7orf69,uncharacterized protein C7orf69 measurement,EFO:0802195,http://www.ebi.ac.uk/efo/EFO_0802195,0.952,None
ieu-a-29,Birth length,body height at birth,EFO:0006784,http://www.ebi.ac.uk/efo/EFO_0006784,0.992,None
prot-a-1714,Lactase-like protein,lactase-like protein measurement,EFO:0802681,http://www.ebi.ac.uk/efo/EFO_0802681,0.74,None
ukb-a-196,Fluid intelligence score,intelligence,EFO:0004337,http://www.ebi.ac.uk/efo/EFO_0004337,0.634,None
prot-a-3053,Tumor necrosis factor receptor superfamily member 8,tumor necrosis factor receptor superfamily member 8 measurement,EFO:0020816,http://www.ebi.ac.uk/efo/EFO_0020816,0.944,None
prot-a-117,Amyloid beta A4 precursor protein-binding family B member 2,amyloid beta A4 precursor protein-binding family B member 2 measurement,EFO:0801379,http://www.ebi.ac.uk/efo/EFO_0801379,0.905,None
prot-a-2453,Transcriptional activator protein Pur-alpha,transcriptional activator protein Pur-alpha measurement,EFO:0803165,http://www.ebi.ac.uk/efo/EFO_0803165,0.83,None
prot-a-510,CUGBP Elav-like family member 2,CUGBP Elav-like family member 2 measurement,EFO:0802434,http://www.ebi.ac.uk/efo/EFO_0802434,0.818,None
prot-a-1197,Growth/differentiation factor 9,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.837,None
met-a-344,N-acetylalanine,N-acetylalanine measurement,EFO:0800118,http://www.ebi.ac.uk/efo/EFO_0800118,0.71,None
prot-a-1339,"Histidine triad nucleotide-binding protein 2, mitochondrial","histidine triad nucleotide-binding protein 2, mitochondrial measurement",EFO:0802600,http://www.ebi.ac.uk/efo/EFO_0802600,0.863,None
met-a-742,Succinylcarnitine,succinylcarnitine measurement,EFO:0020020,http://www.ebi.ac.uk/efo/EFO_0020020,0.91,None
prot-c-4708_3_2,17-beta-HSD 1,"46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",MONDO:0009916,http://purl.obolibrary.org/obo/MONDO_0009916,0.628,None
ukb-d-30220_irnt,Basophill percentage,basophil percentage of leukocytes,EFO:0007992,http://www.ebi.ac.uk/efo/EFO_0007992,0.917,None
prot-a-2535,Regulator of G-protein signaling 18,regulator of G-protein signaling 18 measurement,EFO:0801995,http://www.ebi.ac.uk/efo/EFO_0801995,0.785,None
prot-a-352,Soluble calcium-activated nucleotidase 1,soluble calcium-activated nucleotidase 1 measurement,EFO:0803089,http://www.ebi.ac.uk/efo/EFO_0803089,0.864,None
prot-a-2022,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial","NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial measurement",EFO:0802783,http://www.ebi.ac.uk/efo/EFO_0802783,0.833,None
prot-a-1365,Heterogeneous nuclear ribonucleoprotein D-like,heterogeneous nuclear ribonucleoprotein D-like measurement,EFO:0801673,http://www.ebi.ac.uk/efo/EFO_0801673,0.885,None
prot-a-1969,Mitochondrial ubiquitin ligase activator of NFKB 1,mitochondrial ubiquitin ligase activator of NFKB 1 measurement,EFO:0801804,http://www.ebi.ac.uk/efo/EFO_0801804,0.953,None
prot-a-2949,Testis-expressed sequence 29 protein,testis-expressed sequence 29 protein measurement,EFO:0802125,http://www.ebi.ac.uk/efo/EFO_0802125,0.829,None
met-c-892,Triglycerides in large VLDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.91,None
ebi-a-GCST90001600,Leukocyte Absolute Count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.795,None
prot-a-2738,Signaling threshold-regulating transmembrane adapter 1,signaling threshold-regulating transmembrane adapter 1 measurement,EFO:0803077,http://www.ebi.ac.uk/efo/EFO_0803077,0.898,None
prot-a-2392,Trypsin-2,trypsin-1 measurement,EFO:0020790,http://www.ebi.ac.uk/efo/EFO_0020790,0.682,None
met-c-880,Total cholesterol in large LDL,total cholesterol in large LDL,EFO:0022167,http://www.ebi.ac.uk/efo/EFO_0022167,0.972,None
ebi-a-GCST004940,Alanine transaminase levels,serum alanine aminotransferase measurement,EFO:0004735,http://www.ebi.ac.uk/efo/EFO_0004735,0.798,None
ebi-a-GCST90011995,Vascular endothelial growth factor levels,vascular endothelial growth factor,EFO:0003276,http://www.ebi.ac.uk/efo/EFO_0003276,0.935,None
prot-c-3898_5_2,PSD7,glycogen storage disease VII,MONDO:0009295,http://purl.obolibrary.org/obo/MONDO_0009295,0.622,None
prot-a-2714,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,small glutamine-rich tetratricopeptide repeat-containing protein alpha measurement,EFO:0020744,http://www.ebi.ac.uk/efo/EFO_0020744,0.868,None
prot-a-2875,Stromal interaction molecule 1,stromal interaction molecule 1 measurement,EFO:0802093,http://www.ebi.ac.uk/efo/EFO_0802093,0.887,None
met-a-533,X-11546,X-11546 measurement,EFO:0021253,http://www.ebi.ac.uk/efo/EFO_0021253,0.711,None
prot-a-1459,IgLON family member 5,igLON family member 5 measurement,EFO:0802618,http://www.ebi.ac.uk/efo/EFO_0802618,0.908,None
prot-c-3538_26_1,dopa decarboxylase,aromatic L-amino acid decarboxylase deficiency,MONDO:0012084,http://purl.obolibrary.org/obo/MONDO_0012084,0.893,None
ieu-a-1055,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-3066,"Troponin I, cardiac muscle","troponin i, cardiac muscle measurement",EFO:0020788,http://www.ebi.ac.uk/efo/EFO_0020788,0.78,None
prot-a-2627,"Serine--tRNA ligase, mitochondrial","serine--tRNA ligase, mitochondrial measurement",EFO:0803061,http://www.ebi.ac.uk/efo/EFO_0803061,0.743,None
prot-a-3176,Uroporphyrinogen-III synthase,cutaneous porphyria,MONDO:0009902,http://purl.obolibrary.org/obo/MONDO_0009902,0.858,None
prot-a-635,COP9 signalosome complex subunit 2,COP9 signalosome complex subunit 2 measurement,EFO:0801497,http://www.ebi.ac.uk/efo/EFO_0801497,0.928,None
ukb-a-382,Waist circumference,waist circumference,EFO:0004342,http://www.ebi.ac.uk/efo/EFO_0004342,0.992,None
prot-a-827,Protein delta homolog 1,protein delta homolog 1 measurement,EFO:0801938,http://www.ebi.ac.uk/efo/EFO_0801938,0.898,None
prot-a-2570,RING finger protein 219,RING finger protein 219 measurement,EFO:0803032,http://www.ebi.ac.uk/efo/EFO_0803032,0.911,None
ukb-a-197,Prospective memory result,episodic memory,EFO:0004333,http://www.ebi.ac.uk/efo/EFO_0004333,0.805,None
ubm-a-16,IDP T1 FIRST right putamen volume,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.703,None
prot-a-414,E3 ubiquitin-protein ligase CCNB1IP1,E3 ubiquitin-protein ligase CCNB1IP1 measurement,EFO:0802502,http://www.ebi.ac.uk/efo/EFO_0802502,0.925,None
prot-c-5073_30_2,DR3,progressive familial intrahepatic cholestasis type 3,MONDO:0011214,http://purl.obolibrary.org/obo/MONDO_0011214,0.601,None
prot-c-3378_49_2,Kallikrein 7,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.769,None
prot-a-455,CD59 glycoprotein,CD59 glycoprotein measurement,EFO:0021924,http://www.ebi.ac.uk/efo/EFO_0021924,0.905,None
prot-c-3401_8_2,TCPTP,Paris-Trousseau thrombocytopenia,MONDO:0008557,http://purl.obolibrary.org/obo/MONDO_0008557,0.709,None
ebi-a-GCST004772,"Bone mineral density (paediatric, total body less head)",bone density,EFO:0003923,http://www.ebi.ac.uk/efo/EFO_0003923,0.62,None
prot-a-2131,Nuclear RNA export factor 1,nuclear RNA export factor 1 measurement,EFO:0801855,http://www.ebi.ac.uk/efo/EFO_0801855,0.925,None
prot-a-500,Corneodesmosin,corneodesmosin measurement,EFO:0801499,http://www.ebi.ac.uk/efo/EFO_0801499,0.874,None
prot-a-145,Arfaptin-1,arfaptin-1 measurement,EFO:0801392,http://www.ebi.ac.uk/efo/EFO_0801392,0.714,None
met-a-654,1-stearoylglycerophosphoethanolamine,1-stearoylglycerophosphoethanolamine measurement,EFO:0021093,http://www.ebi.ac.uk/efo/EFO_0021093,0.87,None
prot-a-2969,Homeobox protein TGIF2,homeobox protein TGIF2 measurement,EFO:0802608,http://www.ebi.ac.uk/efo/EFO_0802608,0.941,None
prot-a-449,CD44 antigen,CD44 antigen measurement,EFO:0802378,http://www.ebi.ac.uk/efo/EFO_0802378,0.881,None
prot-a-380,Coiled-coil domain-containing protein 126,coiled-coil domain-containing protein 126 measurement,EFO:0801482,http://www.ebi.ac.uk/efo/EFO_0801482,0.844,None
prot-a-719,Dipeptidyl peptidase 1,dipeptidyl peptidase 1 measurement,EFO:0020325,http://www.ebi.ac.uk/efo/EFO_0020325,0.937,None
prot-a-1496,Interleukin-1 receptor type 1,interleukin-1 receptor type 1 measurement,EFO:0020487,http://www.ebi.ac.uk/efo/EFO_0020487,0.801,None
ieu-b-47,Urinary sodium-potassium ratio,urinary sodium to potassium ratio,EFO:0009884,http://www.ebi.ac.uk/efo/EFO_0009884,0.975,None
met-a-577,Alpha-ketoglutarate,Alpha ketoglutarate measurement,EFO:0010457,http://www.ebi.ac.uk/efo/EFO_0010457,0.9,None
ukb-a-34,Comparative body size at age 10,"comparative body size at age 10, self-reported",EFO:0009819,http://www.ebi.ac.uk/efo/EFO_0009819,0.701,None
met-a-521,X-11478,X-11478 measurement,EFO:0021242,http://www.ebi.ac.uk/efo/EFO_0021242,0.715,None
prot-a-3278,E3 ubiquitin-protein ligase ZNRF3,E3 ubiquitin-protein ligase ZNRF3 measurement,EFO:0021943,http://www.ebi.ac.uk/efo/EFO_0021943,0.911,None
met-c-889,Total lipids in large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.971,None
prot-a-2467,Orexigenic neuropeptide QRFP,orexigenic neuropeptide QRFP measurement,EFO:0802832,http://www.ebi.ac.uk/efo/EFO_0802832,0.946,None
met-d-IDL_C,Cholesterol in IDL,total cholesterol in IDL,EFO:0022184,http://www.ebi.ac.uk/efo/EFO_0022184,0.854,None
prot-a-3239,Glycoprotein Xg,glycoprotein Xg measurement,EFO:0801646,http://www.ebi.ac.uk/efo/EFO_0801646,0.898,None
ebi-a-GCST90002106,HLA DR on Dendritic Cell,dendritic cell tumor,MONDO:0020082,http://purl.obolibrary.org/obo/MONDO_0020082,0.661,None
met-a-593,X-12230,X-12230 measurement,EFO:0021296,http://www.ebi.ac.uk/efo/EFO_0021296,0.699,None
ebi-a-GCST90010162,Prolargin levels,prolargin measurement,EFO:0801928,http://www.ebi.ac.uk/efo/EFO_0801928,0.659,None
met-d-S_HDL_FC,Free cholesterol in small HDL,free cholesterol in large HDL measurement,EFO:0022157,http://www.ebi.ac.uk/efo/EFO_0022157,0.738,None
met-d-M_HDL_TG,Triglycerides in medium HDL,triglycerides in medium VLDL measurement,EFO:0022155,http://www.ebi.ac.uk/efo/EFO_0022155,0.737,None
ubm-a-2680,volume Right-Putamen,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.868,None
ieu-a-780,HDL cholesterol,HDL cholesterol change measurement,EFO:0007805,http://www.ebi.ac.uk/efo/EFO_0007805,0.813,None
prot-a-2166,Platelet-activating factor acetylhydrolase IB subunit beta,platelet-activating factor acetylhydrolase ib subunit beta measurement,EFO:0020646,http://www.ebi.ac.uk/efo/EFO_0020646,0.886,None
ukb-d-30130_irnt,Monocyte count,monocyte count,EFO:0005091,http://www.ebi.ac.uk/efo/EFO_0005091,0.987,None
prot-a-1469,Interleukin-12,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.88,None
prot-a-2141,Inositol polyphosphate 5-phosphatase OCRL-1,inositol polyphosphate 5-phosphatase OCRL-1 measurement,EFO:0801699,http://www.ebi.ac.uk/efo/EFO_0801699,0.788,None
prot-b-13,platelet derived growth factor subunit B,platelet-derived growth factor subunit b measurement,EFO:0020650,http://www.ebi.ac.uk/efo/EFO_0020650,0.835,None
met-a-724,X-14450--phenylalanylleucine,X-14450--phenylalanylleucine measurement,EFO:0021369,http://www.ebi.ac.uk/efo/EFO_0021369,0.741,None
ieu-a-51,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
met-d-M_LDL_PL,Phospholipids in medium LDL,phospholipids in medium LDL measurement,EFO:0022183,http://www.ebi.ac.uk/efo/EFO_0022183,0.916,None
met-d-S_LDL_FC,Free cholesterol in small LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.778,None
ebi-a-GCST006355,Anti-hepatitis B virus core antigen (HBc) IgG levels,Anti-hepatitis B virus core antigen IgG measurement,EFO:0009359,http://www.ebi.ac.uk/efo/EFO_0009359,0.721,None
prot-a-2830,Speckle-type POZ protein,speckle-type POZ protein measurement,EFO:0803097,http://www.ebi.ac.uk/efo/EFO_0803097,0.816,None
ieu-b-4910,Anti-Toxoplasma gondii IgG levels,Anti-Toxoplasma gondii IgG measurement,EFO:0009353,http://www.ebi.ac.uk/efo/EFO_0009353,0.761,None
prot-a-2028,Neuronal growth regulator 1,neuronal growth regulator 1 measurement,EFO:0021932,http://www.ebi.ac.uk/efo/EFO_0021932,0.901,None
ukb-a-16,Current tobacco smoking,nicotine dependence,EFO:0003768,http://www.ebi.ac.uk/efo/EFO_0003768,0.814,None
prot-a-3194,Versican core protein,versican core protein measurement,EFO:0803248,http://www.ebi.ac.uk/efo/EFO_0803248,0.886,None
prot-a-1029,Protein FAM171B,protein FAM171B measurement,EFO:0801947,http://www.ebi.ac.uk/efo/EFO_0801947,0.917,None
prot-a-664,Adapter molecule crk,adapter molecule CRK measurement,EFO:0020128,http://www.ebi.ac.uk/efo/EFO_0020128,0.924,None
ebi-a-GCST90010221,Insulin-like growth factor-binding protein 1 levels,IGFBP-3 measurement,EFO:0004626,http://www.ebi.ac.uk/efo/EFO_0004626,0.915,None
prot-a-153,Rho GDP-dissociation inhibitor 2,rho GDP-dissociation inhibitor 2 measurement,EFO:0802010,http://www.ebi.ac.uk/efo/EFO_0802010,0.847,None
prot-a-2212,Proprotein convertase subtilisin/kexin type 7,proprotein convertase subtilisin/kexin type 7 measurement,EFO:0008270,http://www.ebi.ac.uk/efo/EFO_0008270,0.834,None
ubm-a-2702,volume CerebralWhiteMatterVol,cerebral white matter volume change measurement,EFO:0021499,http://www.ebi.ac.uk/efo/EFO_0021499,0.626,None
ukb-d-30610_irnt,Alkaline phosphatase,Low alkaline phosphatase,HP:0003282,http://purl.obolibrary.org/obo/HP_0003282,0.911,None
prot-a-1215,Gap junction delta-2 protein,gap junction delta-2 protein measurement,EFO:0802562,http://www.ebi.ac.uk/efo/EFO_0802562,0.8,None
ukb-d-30090_irnt,Platelet crit,platelet crit,EFO:0007985,http://www.ebi.ac.uk/efo/EFO_0007985,0.994,None
prot-a-264,BolA-like protein 2,bolA-like protein 2 measurement,EFO:0802335,http://www.ebi.ac.uk/efo/EFO_0802335,0.685,None
prot-a-985,Endoplasmic reticulum resident protein 44,endoplasmic reticulum resident protein 44 measurement,EFO:0801569,http://www.ebi.ac.uk/efo/EFO_0801569,0.94,None
met-c-873,Isoleucine,isoleucine measurement,EFO:0009793,http://www.ebi.ac.uk/efo/EFO_0009793,0.837,None
met-d-XL_HDL_C_pct,Cholesterol to total lipids ratio in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.712,None
prot-a-1918,72 kDa type IV collagenase,72 kda type IV collagenase measurement,EFO:0020122,http://www.ebi.ac.uk/efo/EFO_0020122,0.923,None
met-d-S_VLDL_PL_pct,Phospholipids to total lipids ratio in small VLDL,total lipids in small VLDL,EFO:0022148,http://www.ebi.ac.uk/efo/EFO_0022148,0.778,None
prot-a-2480,Ras-related C3 botulinum toxin substrate 3,ras-related C3 botulinum toxin substrate 3 measurement,EFO:0021987,http://www.ebi.ac.uk/efo/EFO_0021987,0.881,None
prot-a-163,Armadillo repeat-containing protein 5,armadillo repeat-containing protein 5 measurement,EFO:0802288,http://www.ebi.ac.uk/efo/EFO_0802288,0.858,None
ukb-b-1464,Number of depression episodes,depressive episode measurement,EFO:0007704,http://www.ebi.ac.uk/efo/EFO_0007704,0.613,None
prot-a-366,Calpastatin,calpastatin measurement,EFO:0008065,http://www.ebi.ac.uk/efo/EFO_0008065,0.84,None
met-d-S_HDL_CE,Cholesteryl esters in small HDL,cholesteryl ester measurement,EFO:0010351,http://www.ebi.ac.uk/efo/EFO_0010351,0.703,None
met-d-XS_VLDL_PL,Phospholipids in very small VLDL,phospholipids in very small VLDL measurement,EFO:0022150,http://www.ebi.ac.uk/efo/EFO_0022150,0.917,None
ebi-a-GCST90012878,Family history of Alzheimer's disease,family history of Alzheimers disease,EFO:0009268,http://www.ebi.ac.uk/efo/EFO_0009268,0.99,None
met-d-M_HDL_C,Cholesterol in medium HDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.719,None
prot-a-2299,Pleckstrin homology domain-containing family A member 1,pleckstrin homology domain-containing family A member 1 measurement,EFO:0802873,http://www.ebi.ac.uk/efo/EFO_0802873,0.919,None
prot-a-54,"Advanced glycosylation end product-specific receptor, soluble","advanced glycosylation end product-specific receptor, soluble measurement",EFO:0020131,http://www.ebi.ac.uk/efo/EFO_0020131,0.863,None
prot-a-1238,Golgi membrane protein 1,Golgi membrane protein 1 measurement,EFO:0801650,http://www.ebi.ac.uk/efo/EFO_0801650,0.921,None
prot-a-1283,Glutathione S-transferase A1,glutathione S-transferase A1 measurement,EFO:0801636,http://www.ebi.ac.uk/efo/EFO_0801636,0.805,None
prot-a-2157,Osteocrin,osteocrin measurement,EFO:0802838,http://www.ebi.ac.uk/efo/EFO_0802838,0.821,None
ukb-b-18445,Polyunsaturated fat,polyunsaturated fatty acid measurement,EFO:0010733,http://www.ebi.ac.uk/efo/EFO_0010733,0.795,None
prot-a-2433,Protein-tyrosine kinase 2-beta,immunodeficiency 35,MONDO:0012682,http://purl.obolibrary.org/obo/MONDO_0012682,0.675,None
ebi-a-GCST90001739,CD19 on Plasma Blast-Plasma Cell,plasma cell neoplasm,EFO:0000200,http://www.ebi.ac.uk/efo/EFO_0000200,0.737,None
prot-a-1209,Somatotropin,growth hormone-producing pituitary gland neoplasm,MONDO:0019927,http://purl.obolibrary.org/obo/MONDO_0019927,0.906,None
ebi-a-GCST90010133,Proheparin-binding EGF-like growth factor levels,proheparin-binding EGF-like growth factor measurement,EFO:0010924,http://www.ebi.ac.uk/efo/EFO_0010924,0.742,None
met-a-367,Undecanoate (11:0),undecanoate 11:0 measurement,EFO:0021107,http://www.ebi.ac.uk/efo/EFO_0021107,0.648,None
prot-a-2849,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2","CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 measurement",EFO:0802403,http://www.ebi.ac.uk/efo/EFO_0802403,0.661,None
prot-a-2047,NHL repeat-containing protein 3,NHL repeat-containing protein 3 measurement,EFO:0801839,http://www.ebi.ac.uk/efo/EFO_0801839,0.844,None
ukb-d-30890_raw,Vitamin D,vitamin D deficiency,EFO:0003762,http://www.ebi.ac.uk/efo/EFO_0003762,0.875,None
met-d-Phosphoglyc,Phosphoglycerides,phosphoglyceric acid measurement,EFO:0010523,http://www.ebi.ac.uk/efo/EFO_0010523,0.718,None
met-a-437,X-09108,X-09108 measurement,EFO:0021209,http://www.ebi.ac.uk/efo/EFO_0021209,0.676,None
ebi-a-GCST90017137,Neck circumference (BMI adjusted),BMI-adjusted neck circumference,EFO:0011044,http://www.ebi.ac.uk/efo/EFO_0011044,0.871,None
prot-c-2526_53_3,OPG,osteoprotegerin measurement,EFO:0005918,http://www.ebi.ac.uk/efo/EFO_0005918,0.813,None
prot-a-3147,Ubiquilin-4,ubiquilin-4 measurement,EFO:0802177,http://www.ebi.ac.uk/efo/EFO_0802177,0.718,None
ieu-a-835,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-1940,"39S ribosomal protein L14, mitochondrial","39S ribosomal protein L14, mitochondrial measurement",EFO:0802237,http://www.ebi.ac.uk/efo/EFO_0802237,0.854,None
ebi-a-GCST90006900,Epstein-Barr virus VCA p18 antibody levels,anti-Epstein Barr virus antibody measurement,EFO:0009273,http://www.ebi.ac.uk/efo/EFO_0009273,0.621,None
prot-a-46,Alcohol dehydrogenase 1B,alcohol dehydrogenase 1B measurement,EFO:0801360,http://www.ebi.ac.uk/efo/EFO_0801360,0.913,None
met-c-882,Free cholesterol in large LDL,free cholesterol in large LDL measurement,EFO:0022176,http://www.ebi.ac.uk/efo/EFO_0022176,0.914,None
prot-a-3223,WAP four-disulfide core domain protein 13,WAP four-disulfide core domain protein 13 measurement,EFO:0803262,http://www.ebi.ac.uk/efo/EFO_0803262,0.858,None
ubm-a-2674,volume Right-Lateral-Ventricle,lateral ventricle volume measurement,EFO:0008487,http://www.ebi.ac.uk/efo/EFO_0008487,0.816,None
prot-a-1968,Mucin-4,cutaneous mucinosis,MONDO:0002523,http://purl.obolibrary.org/obo/MONDO_0002523,0.702,None
prot-a-33,A disintegrin and metalloproteinase with thrombospondin motifs 15,a disintegrin and metalloproteinase with thrombospondin motifs 15 measurement,EFO:0020123,http://www.ebi.ac.uk/efo/EFO_0020123,0.944,None
prot-c-3811_1_2,Ficolin-3,immunodeficiency due to ficolin3 deficiency,MONDO:0013467,http://purl.obolibrary.org/obo/MONDO_0013467,0.793,None
prot-a-861,Dermatopontin,dermatopontin measurement,EFO:0008108,http://www.ebi.ac.uk/efo/EFO_0008108,0.832,None
ebi-a-GCST005327,Neuroticism,neurotic disorder,EFO:0004257,http://www.ebi.ac.uk/efo/EFO_0004257,0.985,None
ebi-a-GCST90002294,Basophil count,basophil count,EFO:0005090,http://www.ebi.ac.uk/efo/EFO_0005090,0.984,None
prot-a-2035,Neuropilin and tolloid-like protein 1,neuropilin and tolloid-like protein 1 measurement,EFO:0802807,http://www.ebi.ac.uk/efo/EFO_0802807,0.783,None
met-d-XL_HDL_TG_pct,Triglycerides to total lipids ratio in very large HDL,total lipids in large HDL,EFO:0022189,http://www.ebi.ac.uk/efo/EFO_0022189,0.675,None
prot-a-3161,NKG2D ligand 2,NKG2D ligand 2 measurement,EFO:0802815,http://www.ebi.ac.uk/efo/EFO_0802815,0.909,None
prot-a-1315,Hemoglobin subunit gamma-1,hemoglobin subunit gamma-1 measurement,EFO:0802590,http://www.ebi.ac.uk/efo/EFO_0802590,0.81,None
met-d-L_VLDL_L,Total lipids in large VLDL,total lipids in large VLDL,EFO:0022175,http://www.ebi.ac.uk/efo/EFO_0022175,0.971,None
prot-a-410,C-C motif chemokine 7,C-C motif chemokine 7 measurement,EFO:0008054,http://www.ebi.ac.uk/efo/EFO_0008054,0.685,None
prot-a-1561,Early placenta insulin-like peptide,early placenta insulin-like peptide measurement,EFO:0802515,http://www.ebi.ac.uk/efo/EFO_0802515,0.873,None
ebi-a-GCST90001443,CD20- B cell %lymphocyte,chronic lymphocytic leukemia,EFO:0000095,http://www.ebi.ac.uk/efo/EFO_0000095,0.602,None
ebi-a-GCST90001631,CD8+ Natural Killer T %T cell,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.684,None
met-b-181,CD8:%CM,cutaneous mastocytosis,EFO:1000886,http://www.ebi.ac.uk/efo/EFO_1000886,0.788,None
prot-c-4961_17_1,annexin II,annexin A1 measurement,EFO:0008026,http://www.ebi.ac.uk/efo/EFO_0008026,0.635,None
prot-c-4306_4_2,Transketolase,Wernicke-Korsakoff syndrome,EFO:1001242,http://www.ebi.ac.uk/efo/EFO_1001242,0.869,None
met-d-DHA_pct,Ratio of docosahexaenoic acid to total fatty acids,docosahexaenoic acid measurement,EFO:0007761,http://www.ebi.ac.uk/efo/EFO_0007761,0.736,None
prot-a-2526,"Oligoribonuclease, mitochondrial","oligoribonuclease, mitochondrial measurement",EFO:0802831,http://www.ebi.ac.uk/efo/EFO_0802831,0.907,None
prot-a-2897,Small ubiquitin-related modifier 3,small ubiquitin-related modifier 3 measurement,EFO:0022025,http://www.ebi.ac.uk/efo/EFO_0022025,0.879,None
ebi-a-GCST006288,Heel bone mineral density,heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.989,None
ieu-b-4831,Estimated glomerular filtration rate,glomerular filtration rate,EFO:0005208,http://www.ebi.ac.uk/efo/EFO_0005208,0.867,None
met-c-903,Phospholipids in medium HDL,phospholipids in medium LDL measurement,EFO:0022183,http://www.ebi.ac.uk/efo/EFO_0022183,0.783,None
prot-a-2637,Scavenger receptor class A member 3,scavenger receptor class A member 3 measurement,EFO:0803044,http://www.ebi.ac.uk/efo/EFO_0803044,0.935,None
prot-a-1573,Ubiquitin-like protein ISG15,ubiquitin-like protein ISG15 measurement,EFO:0021875,http://www.ebi.ac.uk/efo/EFO_0021875,0.888,None
ebi-a-GCST90012083,Eosinophil cationic protein levels,eosinophil cationic protein measurement,EFO:0010913,http://www.ebi.ac.uk/efo/EFO_0010913,0.821,None
ebi-a-GCST004634,Basophil percentage of granulocytes,basophil percentage of granulocytes,EFO:0007995,http://www.ebi.ac.uk/efo/EFO_0007995,0.993,None
prot-a-2625,Histone deacetylase complex subunit SAP18,histone deacetylase complex subunit SAP18 measurement,EFO:0801680,http://www.ebi.ac.uk/efo/EFO_0801680,0.949,None
ebi-a-GCST90006925,Anti-Toxoplasma gondii IgG seropositivity,Toxoplasma gondii seropositivity,EFO:0007047,http://www.ebi.ac.uk/efo/EFO_0007047,0.892,None
prot-a-490,Cadherin-related family member 5,cadherin-related family member 5 measurement,EFO:0801440,http://www.ebi.ac.uk/efo/EFO_0801440,0.861,None
ukb-a-337,Forced expiratory volume in 1-second (FEV1),forced expiratory volume,EFO:0004314,http://www.ebi.ac.uk/efo/EFO_0004314,0.794,None
met-d-M_LDL_CE_pct,Cholesteryl esters to total lipids ratio in medium LDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.708,None
met-d-S_LDL_C_pct,Cholesterol to total lipids ratio in small LDL,total cholesterol in small LDL,EFO:0022179,http://www.ebi.ac.uk/efo/EFO_0022179,0.785,None
met-a-451,Creatine,creatine measurement,EFO:0010472,http://www.ebi.ac.uk/efo/EFO_0010472,0.765,None
prot-a-2418,26S proteasome non-ATPase regulatory subunit 5,26S proteasome non-ATPase regulatory subunit 5 measurement,EFO:0801331,http://www.ebi.ac.uk/efo/EFO_0801331,0.888,None
met-d-Acetoacetate,Acetoacetate,acetoacetate measurement,EFO:0010111,http://www.ebi.ac.uk/efo/EFO_0010111,0.903,None
prot-a-2409,Proteasome subunit alpha type-1,proteasome subunit alpha type-1 measurement,EFO:0020663,http://www.ebi.ac.uk/efo/EFO_0020663,0.786,None
prot-a-643,Carboxypeptidase A4,carboxypeptidase A4 measurement,EFO:0801452,http://www.ebi.ac.uk/efo/EFO_0801452,0.917,None
met-a-431,Homocitrulline,homocitrulline measurement,EFO:0021018,http://www.ebi.ac.uk/efo/EFO_0021018,0.885,None
ebi-a-GCST90001945,CD123 on CD62L+ plasmacytoid Dendritic Cell,blastic plasmacytoid dendritic cell neoplasm,EFO:0010580,http://www.ebi.ac.uk/efo/EFO_0010580,0.694,None
prot-a-1724,Leptin receptor,leptin receptor measurement,EFO:0004635,http://www.ebi.ac.uk/efo/EFO_0004635,0.858,None
prot-a-1865,Mast cell-expressed membrane protein 1,mast cell-expressed membrane protein 1 measurement,EFO:0801787,http://www.ebi.ac.uk/efo/EFO_0801787,0.804,None
ebi-a-GCST90010161,Polymeric immunoglobulin receptor levels,polymeric immunoglobulin receptor measurement,EFO:0008267,http://www.ebi.ac.uk/efo/EFO_0008267,0.875,None
prot-a-859,Dipeptidyl peptidase 2,dipeptidyl peptidase 2 measurement,EFO:0020326,http://www.ebi.ac.uk/efo/EFO_0020326,0.937,None
prot-a-176,Ecto-ADP-ribosyltransferase 4,ecto-ADP-ribosyltransferase 4 measurement,EFO:0801559,http://www.ebi.ac.uk/efo/EFO_0801559,0.725,None
ieu-b-4761,Fasting glucose,fasting blood glucose measurement,EFO:0004465,http://www.ebi.ac.uk/efo/EFO_0004465,0.861,None
prot-a-762,Dystroglycan,dystroglycan measurement,EFO:0802500,http://www.ebi.ac.uk/efo/EFO_0802500,0.824,None
ukb-a-195,Sitting height,sitting height ratio,EFO:0007118,http://www.ebi.ac.uk/efo/EFO_0007118,0.887,None
prot-a-1269,GRB2-related adapter protein 2,grb2-related adapter protein 2 measurement,EFO:0020420,http://www.ebi.ac.uk/efo/EFO_0020420,0.806,None
prot-a-1930,Myeloperoxidase,myeloperoxidase measurement,EFO:0005243,http://www.ebi.ac.uk/efo/EFO_0005243,0.875,None
ebi-a-GCST90006885,BK polyomavirus VP1 antibody levels,anti-BK polyomavirus antibody measurement,EFO:0010904,http://www.ebi.ac.uk/efo/EFO_0010904,0.664,None
ukb-d-30710_irnt,C-reactive protein,C-reactive protein measurement,EFO:0004458,http://www.ebi.ac.uk/efo/EFO_0004458,0.645,None
prot-c-2643_57_2,P-Cadherin,cadherin-1 measurement,EFO:0020209,http://www.ebi.ac.uk/efo/EFO_0020209,0.605,None
met-d-L_LDL_TG,Triglycerides in large LDL,triglycerides in large VLDL measurement,EFO:0022178,http://www.ebi.ac.uk/efo/EFO_0022178,0.788,None
prot-a-1164,Gamma-aminobutyric acid type B receptor subunit 2,gamma-aminobutyric acid type B receptor subunit 2 measurement,EFO:0801615,http://www.ebi.ac.uk/efo/EFO_0801615,0.863,None
prot-a-2795,Sorting nexin-7,sorting nexin-1 measurement,EFO:0803092,http://www.ebi.ac.uk/efo/EFO_0803092,0.705,None
prot-a-2723,Sialic acid-binding Ig-like lectin 10,sialic acid-binding Ig-like lectin 10 measurement,EFO:0802064,http://www.ebi.ac.uk/efo/EFO_0802064,0.682,None
prot-a-1277,Granulins,granulins measurement,EFO:0008141,http://www.ebi.ac.uk/efo/EFO_0008141,0.83,None
met-a-403,Estrone 3-sulfate,estrone 3-sulfate measurement,EFO:0800606,http://www.ebi.ac.uk/efo/EFO_0800606,0.688,None
ebi-a-GCST90000454,CDCP1 levels,CUB domain containing protein 1 measurement,EFO:0010776,http://www.ebi.ac.uk/efo/EFO_0010776,0.88,None
ieu-b-4851,Wellbeing,wellbeing measurement,EFO:0007869,http://www.ebi.ac.uk/efo/EFO_0007869,0.872,None
met-a-622,1-stearoylglycerophosphocholine,1-stearoylglycerophosphocholine measurement,EFO:0021092,http://www.ebi.ac.uk/efo/EFO_0021092,0.839,None
prot-a-3056,Tumor necrosis factor ligand superfamily member 13B,tumor necrosis factor ligand superfamily member 13B measurement,EFO:0020793,http://www.ebi.ac.uk/efo/EFO_0020793,0.945,None
prot-a-2160,P2X purinoceptor 6,P2X purinoceptor 6 measurement,EFO:0802840,http://www.ebi.ac.uk/efo/EFO_0802840,0.916,None
prot-c-5196_7_3,NMT1,Isaacs syndrome,EFO:1000638,http://www.ebi.ac.uk/efo/EFO_1000638,0.659,None
ieu-a-982,Lumbar spine bone mineral density,spine bone mineral density change measurement,EFO:0008474,http://www.ebi.ac.uk/efo/EFO_0008474,0.86,None
prot-c-3890_8_2,LDH-H 1,glycogen storage disease due to lactate dehydrogenase deficiency,MONDO:0016527,http://purl.obolibrary.org/obo/MONDO_0016527,0.604,None
ukb-b-2227,Number of children fathered,number of children fathered measurement,EFO:0009814,http://www.ebi.ac.uk/efo/EFO_0009814,0.914,None
ebi-a-GCST004619,Reticulocyte fraction of red cells,Immature Reticulocyte Fraction Measurement,EFO:0009253,http://www.ebi.ac.uk/efo/EFO_0009253,0.708,None
prot-a-3141,Ubiquitin-conjugating enzyme E2 J2,ubiquitin-conjugating enzyme E2 J2 measurement,EFO:0803216,http://www.ebi.ac.uk/efo/EFO_0803216,0.915,None
ebi-a-GCST90010235,Myoglobin levels,myoglobin measurement,EFO:0005057,http://www.ebi.ac.uk/efo/EFO_0005057,0.713,None
prot-c-2624_31_2,HPV E7 Type18,human papilloma virus infection,EFO:0001668,http://www.ebi.ac.uk/efo/EFO_0001668,0.605,None
prot-a-2343,Peptidyl-prolyl cis-trans isomerase-like 1,peptidyl-prolyl cis-trans isomerase-like 1 measurement,EFO:0801876,http://www.ebi.ac.uk/efo/EFO_0801876,0.736,None
prot-a-2554,Ribonuclease pancreatic,ribonuclease pancreatic measurement,EFO:0802019,http://www.ebi.ac.uk/efo/EFO_0802019,0.916,None
prot-a-2128,"Nucleoside diphosphate-linked moiety X motif 8, mitochondrial","nucleoside diphosphate-linked moiety X motif 8, mitochondrial measurement",EFO:0802826,http://www.ebi.ac.uk/efo/EFO_0802826,0.863,None
prot-a-1272,Growth factor receptor-bound protein 7,growth factor receptor-bound protein 7 measurement,EFO:0801659,http://www.ebi.ac.uk/efo/EFO_0801659,0.828,None
prot-a-1175,Gigaxonin,gigaxonin measurement,EFO:0802566,http://www.ebi.ac.uk/efo/EFO_0802566,0.876,None
prot-c-3604_6_4,CNDP1,X-linked corneal dermoid,MONDO:0010579,http://purl.obolibrary.org/obo/MONDO_0010579,0.623,None
prot-a-791,Beta-defensin 116,beta-defensin 116 measurement,EFO:0802322,http://www.ebi.ac.uk/efo/EFO_0802322,0.764,None
prot-a-1900,Macrophage migration inhibitory factor,macrophage migration inhibitory factor measurement,EFO:0008221,http://www.ebi.ac.uk/efo/EFO_0008221,0.938,None
ebi-a-GCST90010153,Matrix metalloproteinase-7 levels,matrix metalloproteinase 8 measurement,EFO:0008466,http://www.ebi.ac.uk/efo/EFO_0008466,0.84,None
ebi-a-GCST90010271,Tissue-type plasminogen activator levels,tissue plasminogen activator measurement,EFO:0004791,http://www.ebi.ac.uk/efo/EFO_0004791,0.808,None
prot-a-530,Thyroid Stimulating Hormone,thyroid stimulating hormone measurement,EFO:0004748,http://www.ebi.ac.uk/efo/EFO_0004748,0.903,None
prot-a-2171,Serine/threonine-protein kinase PAK 7,serine/threonine-protein kinase PAK 7 measurement,EFO:0020730,http://www.ebi.ac.uk/efo/EFO_0020730,0.749,None
prot-c-4474_19_2,Ubiquitin,ubiquitin measurement,EFO:0020839,http://www.ebi.ac.uk/efo/EFO_0020839,0.865,None
prot-a-2256,Phosphoglycerate kinase 2,phosphoglycerate kinase 2 measurement,EFO:0802864,http://www.ebi.ac.uk/efo/EFO_0802864,0.912,None
prot-a-2744,SLAM family member 7,SLAM family member 7 measurement,EFO:0008287,http://www.ebi.ac.uk/efo/EFO_0008287,0.911,None
prot-a-2207,Protocadherin gamma-C5,protocadherin gamma-C5 measurement,EFO:0801977,http://www.ebi.ac.uk/efo/EFO_0801977,0.737,None
prot-a-1602,Junctophilin-1,junctophilin-1 measurement,EFO:0802667,http://www.ebi.ac.uk/efo/EFO_0802667,0.723,None
prot-a-3116,Titin,titin measurement,EFO:0803157,http://www.ebi.ac.uk/efo/EFO_0803157,0.697,None
prot-a-1962,5-formyltetrahydrofolate cyclo-ligase,5-formyltetrahydrofolate cyclo-ligase measurement,EFO:0801335,http://www.ebi.ac.uk/efo/EFO_0801335,0.775,None
prot-a-204,Aurora kinase A,aurora kinase A measurement,EFO:0020168,http://www.ebi.ac.uk/efo/EFO_0020168,0.861,None
prot-a-2124,Neurotensin/neuromedin N,neurotensin/neuromedin N measurement,EFO:0802809,http://www.ebi.ac.uk/efo/EFO_0802809,0.729,None
ebi-a-GCST90010341,Protein S100-A12 levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.603,None
ebi-a-GCST90012102,Bioavailable testosterone levels,testosterone measurement,EFO:0004908,http://www.ebi.ac.uk/efo/EFO_0004908,0.61,None
prot-c-4785_30_3,CBG,corticosteroid-binding globulin deficiency,MONDO:0012675,http://purl.obolibrary.org/obo/MONDO_0012675,0.794,None
prot-a-877,Dual specificity protein phosphatase 6,dual specificity protein phosphatase 6 measurement,EFO:0802496,http://www.ebi.ac.uk/efo/EFO_0802496,0.928,None
ebi-a-GCST004611,High light scatter reticulocyte count,Reticulocyte Mean Corpuscular Hemoglobin Measurement,EFO:0009202,http://www.ebi.ac.uk/efo/EFO_0009202,0.811,None
prot-a-1646,Killer cell immunoglobulin-like receptor 3DL2,killer cell immunoglobulin-like receptor 3DL2 measurement,EFO:0020518,http://www.ebi.ac.uk/efo/EFO_0020518,0.911,None
prot-a-2911,Synaptotagmin-11,synaptotagmin-11 measurement,EFO:0802108,http://www.ebi.ac.uk/efo/EFO_0802108,0.789,None
prot-a-492,Cyclin-dependent kinase 2:Cyclin-A2 complex,cyclin-dependent kinase 2:cyclin-A2 complex measurement,EFO:0020295,http://www.ebi.ac.uk/efo/EFO_0020295,0.745,None
bbj-a-33,Left ventricular internal dimension in systole,left ventricular systolic function measurement,EFO:0008206,http://www.ebi.ac.uk/efo/EFO_0008206,0.61,None
prot-a-2837,Serine palmitoyltransferase 2,serine palmitoyltransferase 2 measurement,EFO:0803056,http://www.ebi.ac.uk/efo/EFO_0803056,0.923,None
ebi-a-GCST90001622,Natural Killer T %T cell,aggressive NK-cell leukemia,MONDO:0019470,http://purl.obolibrary.org/obo/MONDO_0019470,0.739,None
met-d-SFA,Saturated fatty acids,very long-chain saturated fatty acid measurement,EFO:0006796,http://www.ebi.ac.uk/efo/EFO_0006796,0.627,None
prot-a-3047,Tumor necrosis factor receptor superfamily member 1B,tumor necrosis factor receptor superfamily member 1B measurement,EFO:0010624,http://www.ebi.ac.uk/efo/EFO_0010624,0.947,None
prot-c-3897_61_1,PLPP,pustulosis palmaris et plantaris,MONDO:0015597,http://purl.obolibrary.org/obo/MONDO_0015597,0.64,None
prot-b-67,matrix metallopeptidase 12,matrix metalloproteinase 12 measurement,EFO:0010590,http://www.ebi.ac.uk/efo/EFO_0010590,0.643,None
ubm-a-2656,volume Left-Lateral-Ventricle,left inferior lateral ventricle volume measurement,EFO:0006793,http://www.ebi.ac.uk/efo/EFO_0006793,0.837,None
prot-a-1658,Kallikrein-14,kallikrein-14 measurement,EFO:0020513,http://www.ebi.ac.uk/efo/EFO_0020513,0.759,None
prot-a-232,Brevican core protein,brevican core protein measurement,EFO:0020193,http://www.ebi.ac.uk/efo/EFO_0020193,0.894,None
ubm-a-11,IDP T1 FIRST left thalamus volume,thalamus volume,EFO:0006935,http://www.ebi.ac.uk/efo/EFO_0006935,0.732,None
ebi-a-GCST90016668,Lung volume,lung volume,EFO:0600046,http://www.ebi.ac.uk/efo/EFO_0600046,0.984,None
prot-a-1864,"Methylmalonyl-CoA epimerase, mitochondrial","methylmalonyl-CoA epimerase, mitochondrial measurement",EFO:0802742,http://www.ebi.ac.uk/efo/EFO_0802742,0.852,None
met-d-M_LDL_CE,Cholesteryl esters in medium LDL,cholesterol esters in medium LDL measurement,EFO:0022186,http://www.ebi.ac.uk/efo/EFO_0022186,0.812,None
prot-a-1514,Interleukin-24,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.839,None
prot-a-1193,Growth/differentiation factor 11,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.815,None
ebi-a-GCST90010185,TNF-related apoptosis-inducing ligand receptor 2 levels,TNF-related apoptosis-inducing ligand receptor 2 measurement,EFO:0010930,http://www.ebi.ac.uk/efo/EFO_0010930,0.768,None
prot-a-2768,SLIT and NTRK-like protein 4,SLIT and NTRK-like protein 4 measurement,EFO:0803080,http://www.ebi.ac.uk/efo/EFO_0803080,0.756,None
prot-a-2778,Small integral membrane protein 9,small integral membrane protein 9 measurement,EFO:0802075,http://www.ebi.ac.uk/efo/EFO_0802075,0.924,None
prot-a-1776,"Low-density lipoprotein receptor-related protein 1, soluble","low-density lipoprotein receptor-related protein 1, soluble measurement",EFO:0801772,http://www.ebi.ac.uk/efo/EFO_0801772,0.802,None
met-a-746,"5alpha-androstan-3beta,17beta-diol disulfate","5alpha-androstan-3beta,17beta-diol disulfate measurement",EFO:0021115,http://www.ebi.ac.uk/efo/EFO_0021115,0.691,None
prot-a-425,C-type lectin domain family 4 member K,C-type lectin domain family 4 member K measurement,EFO:0020201,http://www.ebi.ac.uk/efo/EFO_0020201,0.806,None
met-d-M_LDL_C_pct,Cholesterol to total lipids ratio in medium LDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.792,None
prot-a-269,Bromodomain-containing protein 1,bromodomain-containing protein 1 measurement,EFO:0801431,http://www.ebi.ac.uk/efo/EFO_0801431,0.846,None
prot-a-2843,Serine-rich single-pass membrane protein 1,serine-rich single-pass membrane protein 1 measurement,EFO:0802056,http://www.ebi.ac.uk/efo/EFO_0802056,0.775,None
prot-a-1320,Histone deacetylase 8,histone deacetylase 8 measurement,EFO:0020453,http://www.ebi.ac.uk/efo/EFO_0020453,0.9,None
ebi-a-GCST90010246,Proprotein convertase subtilisin/kexin type 9 levels,proprotein convertase subtilisin/kexin type 9 measurement,EFO:0009312,http://www.ebi.ac.uk/efo/EFO_0009312,0.801,None
prot-a-976,DNA repair endonuclease XPF,DNA repair endonuclease XPF measurement,EFO:0802478,http://www.ebi.ac.uk/efo/EFO_0802478,0.941,None
met-a-587,X-12188,X-12188 measurement,EFO:0021290,http://www.ebi.ac.uk/efo/EFO_0021290,0.697,None
prot-a-471,CD97 antigen,CD97 antigen measurement,EFO:0020250,http://www.ebi.ac.uk/efo/EFO_0020250,0.897,None
prot-a-1899,Probable E3 ubiquitin-protein ligase MID2,probable E3 ubiquitin-protein ligase MID2 measurement,EFO:0802904,http://www.ebi.ac.uk/efo/EFO_0802904,0.908,None
prot-a-3237,Lymphotactin,lymphotactin measurement,EFO:0008214,http://www.ebi.ac.uk/efo/EFO_0008214,0.852,None
prot-a-37,A disintegrin and metalloproteinase with thrombospondin motifs 6,a disintegrin and metalloproteinase with thrombospondin motifs 6 measurement,EFO:0801338,http://www.ebi.ac.uk/efo/EFO_0801338,0.942,None
prot-a-2,Lactosylceramide 4-alpha-galactosyltransferase,lactosylceramide 4-alpha-galactosyltransferase measurement,EFO:0802683,http://www.ebi.ac.uk/efo/EFO_0802683,0.834,None
prot-a-1578,Isochorismatase domain-containing protein 1,isochorismatase domain-containing protein 1 measurement,EFO:0801735,http://www.ebi.ac.uk/efo/EFO_0801735,0.878,None
prot-a-3183,Urotensin-2 receptor,urotensin-2 receptor measurement,EFO:0803242,http://www.ebi.ac.uk/efo/EFO_0803242,0.733,None
prot-c-2834_54_1,kallikrein 8,plasma kallikrein measurement,EFO:0008260,http://www.ebi.ac.uk/efo/EFO_0008260,0.772,None
prot-a-2185,Alpha-parvin,alpha-parvin measurement,EFO:0802271,http://www.ebi.ac.uk/efo/EFO_0802271,0.674,None
prot-a-1116,Peptidyl-prolyl cis-trans isomerase FKBP7,peptidyl-prolyl cis-trans isomerase FKBP7 measurement,EFO:0801873,http://www.ebi.ac.uk/efo/EFO_0801873,0.838,None
met-a-542,X-11792,X-11792 measurement,EFO:0021259,http://www.ebi.ac.uk/efo/EFO_0021259,0.714,None
ebi-a-GCST90010226,Interleukin-1 receptor type 1 levels,interleukin-1 receptor type 1 measurement,EFO:0020487,http://www.ebi.ac.uk/efo/EFO_0020487,0.731,None
ebi-a-GCST90000456,Cystatin D levels,cystatin B measurement,EFO:0010593,http://www.ebi.ac.uk/efo/EFO_0010593,0.646,None
ebi-a-GCST008025,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-533,Chondroadherin,chondroadherin measurement,EFO:0802393,http://www.ebi.ac.uk/efo/EFO_0802393,0.858,None
prot-a-383,Coiled-coil domain-containing protein 51,coiled-coil domain-containing protein 51 measurement,EFO:0802412,http://www.ebi.ac.uk/efo/EFO_0802412,0.84,None
prot-a-924,Eukaryotic translation initiation factor 4E-binding protein 2,eukaryotic translation initiation factor 4E type 2 measurement,EFO:0801593,http://www.ebi.ac.uk/efo/EFO_0801593,0.861,None
prot-a-1030,Protein FAM171B,protein FAM171B measurement,EFO:0801947,http://www.ebi.ac.uk/efo/EFO_0801947,0.917,None
met-d-XS_VLDL_CE_pct,Cholesteryl esters to total lipids ratio in very small VLDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.685,None
met-c-881,Cholesterol esters in large VLDL,cholesterol esters in large VLDL measurement,EFO:0022170,http://www.ebi.ac.uk/efo/EFO_0022170,0.923,None
prot-a-658,Corticoliberin,corticoliberin measurement,EFO:0802430,http://www.ebi.ac.uk/efo/EFO_0802430,0.876,None
ebi-a-GCST006362,Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels,Epstein Barr viral capsid antigen IgG measurement,EFO:0009274,http://www.ebi.ac.uk/efo/EFO_0009274,0.772,None
ukb-b-11364,"Heel bone mineral density (BMD), manual entry",heel bone mineral density,EFO:0009270,http://www.ebi.ac.uk/efo/EFO_0009270,0.735,None
prot-a-600,Cytosolic non-specific dipeptidase,cytosolic non-specific dipeptidase measurement,EFO:0020310,http://www.ebi.ac.uk/efo/EFO_0020310,0.854,None
ukb-d-4700_irnt,Age cataract diagnosed,cataract,MONDO:0005129,http://purl.obolibrary.org/obo/MONDO_0005129,0.659,None
met-a-702,2-tetradecenoyl carnitine,tetradecenoylcarnitine meaasurement,EFO:0021809,http://www.ebi.ac.uk/efo/EFO_0021809,0.728,None
ieu-a-795,Urate,urate measurement,EFO:0004531,http://www.ebi.ac.uk/efo/EFO_0004531,0.703,None
prot-a-17,ATP-citrate synthase,ATP-citrate synthase measurement,EFO:0802292,http://www.ebi.ac.uk/efo/EFO_0802292,0.663,None
prot-a-2777,Small integral membrane protein 10,small integral membrane protein 10 measurement,EFO:0803083,http://www.ebi.ac.uk/efo/EFO_0803083,0.925,None
prot-a-1705,Tyrosine-protein kinase Lck,tyrosine-protein kinase LCK measurement,EFO:0020826,http://www.ebi.ac.uk/efo/EFO_0020826,0.82,None
ebi-a-GCST90000444,CCL20 levels,CCL20 measurement,EFO:0010766,http://www.ebi.ac.uk/efo/EFO_0010766,0.757,None
prot-a-2632,SAYSvFN domain-containing protein 1,SAYSvFN domain-containing protein 1 measurement,EFO:0803043,http://www.ebi.ac.uk/efo/EFO_0803043,0.904,None
prot-a-505,CCAAT/enhancer-binding protein beta,"acute myeloid leukemia, CEBPA gene mutation",MONDO:0100414,http://purl.obolibrary.org/obo/MONDO_0100414,0.752,None
prot-a-540,Chitinase-3-like protein 1,chitinase-3-like protein 1 measurement,EFO:0801470,http://www.ebi.ac.uk/efo/EFO_0801470,0.661,None
prot-a-2804,Sperm acrosome membrane-associated protein 3,sperm acrosome membrane-associated protein 3 measurement,EFO:0802081,http://www.ebi.ac.uk/efo/EFO_0802081,0.842,None
ieu-b-40,body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-653,Cyclic AMP-responsive element-binding protein 3-like protein 1,cyclic AMP-responsive element-binding protein 3-like protein 1 measurement,EFO:0802439,http://www.ebi.ac.uk/efo/EFO_0802439,0.804,None
ukb-d-30740_irnt,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
prot-c-3202_28_2,KREM2,EM2,EFO:0002176,http://www.ebi.ac.uk/efo/EFO_0002176,0.634,None
met-c-906,Total lipids in medium LDL,total lipids in medium LDL,EFO:0022180,http://www.ebi.ac.uk/efo/EFO_0022180,0.972,None
ebi-a-GCST003839,Sleep duration,sleep duration,EFO:0005271,http://www.ebi.ac.uk/efo/EFO_0005271,0.995,None
met-a-648,X-12734,X-12734 measurement,EFO:0021329,http://www.ebi.ac.uk/efo/EFO_0021329,0.706,None
prot-a-40,Pituitary adenylate cyclase-activating polypeptide 27,pituitary adenylate cyclase-activating polypeptide 27 measurement,EFO:0020640,http://www.ebi.ac.uk/efo/EFO_0020640,0.891,None
ebi-a-GCST90020165,Executive function (trail making test B) x time interaction,executive function,EFO:0007046,http://www.ebi.ac.uk/efo/EFO_0007046,0.669,None
prot-a-531,Choriogonadotropin subunit beta variant 2,choriogonadotropin subunit beta variant 2 measurement,EFO:0802396,http://www.ebi.ac.uk/efo/EFO_0802396,0.941,None
prot-a-683,Cytokine receptor common subunit beta,cytokine receptor common subunit beta measurement,EFO:0801518,http://www.ebi.ac.uk/efo/EFO_0801518,0.937,None
prot-c-3189_61_2,Enterokinase,congenital enteropathy due to enteropeptidase deficiency,MONDO:0009173,http://purl.obolibrary.org/obo/MONDO_0009173,0.805,None
ebi-a-GCST90012074,CX3CL1 levels,CX3CL1 measurement,EFO:0009419,http://www.ebi.ac.uk/efo/EFO_0009419,0.818,None
prot-a-1895,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C","alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C measurement",EFO:0802264,http://www.ebi.ac.uk/efo/EFO_0802264,0.698,None
ebi-a-GCST90006891,Chlamydia trachomatis tarp-D F1 antibody levels,anti-chlamydia trachomatis antibody measurement,EFO:0010903,http://www.ebi.ac.uk/efo/EFO_0010903,0.667,None
prot-a-947,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,ectonucleotide pyrophosphatase/phosphodiesterase family member 5 measurement,EFO:0801560,http://www.ebi.ac.uk/efo/EFO_0801560,0.894,None
prot-a-1860,Myc-associated zinc finger protein,myc-associated zinc finger protein measurement,EFO:0802766,http://www.ebi.ac.uk/efo/EFO_0802766,0.757,None
ieu-a-1089,Body mass index,body mass index,EFO:0004340,http://www.ebi.ac.uk/efo/EFO_0004340,0.995,None
prot-a-3190,Vesicle-associated membrane protein-associated protein B/C,vesicle-associated membrane protein-associated protein A measurement,EFO:0802213,http://www.ebi.ac.uk/efo/EFO_0802213,0.834,None
prot-a-274,Serine/threonine-protein kinase BRSK2,serine/threonine-protein kinase BRSK2 measurement,EFO:0803063,http://www.ebi.ac.uk/efo/EFO_0803063,0.786,None
met-c-898,Total cholesterol in medium HDL,total cholesterol in medium LDL,EFO:0022185,http://www.ebi.ac.uk/efo/EFO_0022185,0.816,None
bbj-a-40,Mean corpuscular volume,mean corpuscular volume,EFO:0004526,http://www.ebi.ac.uk/efo/EFO_0004526,0.979,None
prot-a-297,Uncharacterized protein C1orf198,uncharacterized protein C1orf198 measurement,EFO:0803228,http://www.ebi.ac.uk/efo/EFO_0803228,0.954,None
met-c-859,Glucose,glucose measurement,EFO:0004468,http://www.ebi.ac.uk/efo/EFO_0004468,0.79,None
prot-a-1300,Granzyme H,granzyme h measurement,EFO:0020419,http://www.ebi.ac.uk/efo/EFO_0020419,0.874,None
ebi-a-GCST90000471,Hepatocyte growth factor levels,hepatocyte growth factor,EFO:0003303,http://www.ebi.ac.uk/efo/EFO_0003303,0.91,None
prot-a-3125,Thioredoxin-interacting protein,thioredoxin-interacting protein measurement,EFO:0803149,http://www.ebi.ac.uk/efo/EFO_0803149,0.852,None
ebi-a-GCST90010247,Platelet-derived growth factor subunit A levels,platelet-derived growth factor subunit A measurement,EFO:0801890,http://www.ebi.ac.uk/efo/EFO_0801890,0.786,None
prot-a-1499,Interleukin-1 Receptor accessory protein,interleukin 1 Receptor accessory protein measurement,EFO:0008167,http://www.ebi.ac.uk/efo/EFO_0008167,0.933,None
prot-a-2630,DNA-binding protein SATB1,DNA-binding protein SATB1 measurement,EFO:0802483,http://www.ebi.ac.uk/efo/EFO_0802483,0.815,None
met-a-506,X-11412,X-11412 measurement,EFO:0021229,http://www.ebi.ac.uk/efo/EFO_0021229,0.694,None
ebi-a-GCST006701,Parental longevity (father's attained age),parental longevity,EFO:0007796,http://www.ebi.ac.uk/efo/EFO_0007796,0.701,None
prot-a-2377,Prolactin receptor,prolactin receptor measurement,EFO:0020656,http://www.ebi.ac.uk/efo/EFO_0020656,0.86,None
prot-a-203,"ATP synthase subunit beta, mitochondrial","ATP synthase subunit beta, mitochondrial measurement",EFO:0020166,http://www.ebi.ac.uk/efo/EFO_0020166,0.888,None
prot-a-3093,Protein-tyrosine sulfotransferase 2,protein-tyrosine sulfotransferase 2 measurement,EFO:0801971,http://www.ebi.ac.uk/efo/EFO_0801971,0.848,None
prot-a-2414,Proteasome subunit beta type-5,proteasome subunit beta type-5 measurement,EFO:0802923,http://www.ebi.ac.uk/efo/EFO_0802923,0.747,None
prot-c-4157_2_1,Thrombin,thrombin,EFO:0003183,http://www.ebi.ac.uk/efo/EFO_0003183,0.983,None
prot-a-2154,Oncostatin-M,oncostatin M,EFO:0003200,http://www.ebi.ac.uk/efo/EFO_0003200,0.996,None
prot-c-4542_24_2,Clusterin,clusterin measurement,EFO:0007655,http://www.ebi.ac.uk/efo/EFO_0007655,0.819,None
prot-a-2906,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1","Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement",EFO:0803113,http://www.ebi.ac.uk/efo/EFO_0803113,0.844,None
met-a-641,X-12704,X-12704 measurement,EFO:0021322,http://www.ebi.ac.uk/efo/EFO_0021322,0.714,None
ieu-b-39,diastolic blood pressure,diastolic blood pressure,EFO:0006336,http://www.ebi.ac.uk/efo/EFO_0006336,0.99,None
ebi-a-GCST90010303,Crk-like protein levels,protein measurement,EFO:0004747,http://www.ebi.ac.uk/efo/EFO_0004747,0.653,None
ubm-a-2645,IDP T1 FIRST left pallidum volume plus IDP T1 FIRST right pallidum volume,pallidum volume,EFO:0006933,http://www.ebi.ac.uk/efo/EFO_0006933,0.746,None
prot-a-1570,Interferon regulatory factor 6,interferon regulatory factor 6 measurement,EFO:0802649,http://www.ebi.ac.uk/efo/EFO_0802649,0.92,None
ukb-b-660,Number of self-reported cancers,"number of cancers, self-reported",EFO:0009800,http://www.ebi.ac.uk/efo/EFO_0009800,0.808,None
prot-a-1118,Filamin-A,myofibrillar myopathy 5,MONDO:0012289,http://purl.obolibrary.org/obo/MONDO_0012289,0.697,None
prot-a-326,Carbonic anhydrase-related protein 10,carbonic anhydrase-related protein 10 measurement,EFO:0020233,http://www.ebi.ac.uk/efo/EFO_0020233,0.858,None
prot-a-908,Epidermal growth factor,epidermal growth factor,EFO:0003298,http://www.ebi.ac.uk/efo/EFO_0003298,0.989,None
prot-a-2079,Neuropeptide S,neuropeptide S measurement,EFO:0802806,http://www.ebi.ac.uk/efo/EFO_0802806,0.77,None
ubm-a-2644,IDP T1 FIRST left putamen volume plus IDP T1 FIRST right putamen volume,putamen volume,EFO:0006932,http://www.ebi.ac.uk/efo/EFO_0006932,0.717,None
prot-a-1710,Epididymal-specific lipocalin-8,epididymal-specific lipocalin-10 measurement,EFO:0801576,http://www.ebi.ac.uk/efo/EFO_0801576,0.745,None
prot-a-3136,Ubiquitin-conjugating enzyme E2 D4,ubiquitin-conjugating enzyme E2 D4 measurement,EFO:0802181,http://www.ebi.ac.uk/efo/EFO_0802181,0.91,None
prot-a-2244,Platelet endothelial aggregation receptor 1,platelet endothelial aggregation receptor 1 measurement,EFO:0801886,http://www.ebi.ac.uk/efo/EFO_0801886,0.937,None
met-d-L_HDL_CE_pct,Cholesteryl esters to total lipids ratio in large HDL,cholesteryl esters:total lipids ratio,EFO:0020944,http://www.ebi.ac.uk/efo/EFO_0020944,0.714,None
ubm-a-2664,volume 3rd-Ventricle,third ventricle volume measurement,EFO:0010335,http://www.ebi.ac.uk/efo/EFO_0010335,0.668,None
prot-a-1654,Kelch-like protein 12,kelch-like protein 12 measurement,EFO:0802670,http://www.ebi.ac.uk/efo/EFO_0802670,0.764,None
ebi-a-GCST90012005,Interleukin-6 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.794,None
met-c-910,Cholesterol esters in medium VLDL,cholesterol esters in medium VLDL measurement,EFO:0022182,http://www.ebi.ac.uk/efo/EFO_0022182,0.929,None
ebi-a-GCST90002375,White blood cell count,leukocyte count,EFO:0004308,http://www.ebi.ac.uk/efo/EFO_0004308,0.992,None
ebi-a-GCST90010139,Pro-interleukin-16 levels,interleukin 16 measurement,EFO:0008173,http://www.ebi.ac.uk/efo/EFO_0008173,0.702,None
prot-a-65,Endothelial monocyte-activating polypeptide 2,endothelial monocyte-activating polypeptide 2 measurement,EFO:0020348,http://www.ebi.ac.uk/efo/EFO_0020348,0.864,None
prot-c-2475_1_3,SCF sR,SR,EFO:0002352,http://www.ebi.ac.uk/efo/EFO_0002352,0.606,None
prot-a-226,BAG family molecular chaperone regulator 4,BAG family molecular chaperone regulator 4 measurement,EFO:0802303,http://www.ebi.ac.uk/efo/EFO_0802303,0.943,None
ebi-a-GCST004575,Acute insulin response,acute insulin response measurement,EFO:0006831,http://www.ebi.ac.uk/efo/EFO_0006831,0.891,None
ieu-b-4838,Cognitive function,cognition,EFO:0003925,http://www.ebi.ac.uk/efo/EFO_0003925,0.996,None
prot-a-948,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,ectonucleotide pyrophosphatase/phosphodiesterase family member 7 measurement,EFO:0020344,http://www.ebi.ac.uk/efo/EFO_0020344,0.894,None
ieu-a-97,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
ebi-a-GCST008051,Waist-hip ratio,waist-hip ratio,EFO:0004343,http://www.ebi.ac.uk/efo/EFO_0004343,0.784,None
prot-a-2767,SLIT and NTRK-like protein 3,SLIT and NTRK-like protein 3 measurement,EFO:0802074,http://www.ebi.ac.uk/efo/EFO_0802074,0.755,None
prot-a-735,CUB and zona pellucida-like domain-containing protein 1,CUB and zona pellucida-like domain-containing protein 1 measurement,EFO:0803309,http://www.ebi.ac.uk/efo/EFO_0803309,0.828,None
prot-a-2950,Serotransferrin,serotransferrin measurement,EFO:0020735,http://www.ebi.ac.uk/efo/EFO_0020735,0.882,None
prot-a-1003,Exostosin-like 2,exostosis,MONDO:0002181,http://purl.obolibrary.org/obo/MONDO_0002181,0.768,None
prot-a-3042,Tumor necrosis factor receptor superfamily member 14,tumor necrosis factor receptor superfamily member 14 measurement,EFO:0020805,http://www.ebi.ac.uk/efo/EFO_0020805,0.946,None
prot-a-2527,Rieske domain-containing protein,rieske domain-containing protein measurement,EFO:0802026,http://www.ebi.ac.uk/efo/EFO_0802026,0.865,None
prot-a-2008,Neural cell adhesion molecule 2,neural cell adhesion molecule 2 measurement,EFO:0801827,http://www.ebi.ac.uk/efo/EFO_0801827,0.916,None
ebi-a-GCST90001591,CD4+ T cell %T cell,T-Cell Prolymphocytic Leukemia,EFO:1000560,http://www.ebi.ac.uk/efo/EFO_1000560,0.671,None
ukb-b-2830,Financial situation satisfaction,financial situation satisfaction measurement,EFO:0009726,http://www.ebi.ac.uk/efo/EFO_0009726,0.927,None
prot-c-4141_79_1,IP-10,incontinentia pigmenti,MONDO:0010631,http://purl.obolibrary.org/obo/MONDO_0010631,0.858,None
prot-a-1999,Nucleosome assembly protein 1-like 2,nucleosome assembly protein 1-like 2 measurement,EFO:0801857,http://www.ebi.ac.uk/efo/EFO_0801857,0.847,None
ieu-b-4828,Number of children ever born measurement,number of children ever born measurement,EFO:0009102,http://www.ebi.ac.uk/efo/EFO_0009102,0.972,None
prot-c-2571_12_3,IGFBP-3,IGFBP-1 measurement,EFO:0005118,http://www.ebi.ac.uk/efo/EFO_0005118,0.622,None
prot-a-406,C-C motif chemokine 28,C-C motif chemokine 28 measurement,EFO:0020199,http://www.ebi.ac.uk/efo/EFO_0020199,0.717,None
ebi-a-GCST004425,Tumor necrosis factor beta levels,tumor necrosis factor beta measurement,EFO:0008308,http://www.ebi.ac.uk/efo/EFO_0008308,0.809,None
prot-a-1398,Intercellular adhesion molecule 2,intercellular adhesion molecule 2 measurement,EFO:0008163,http://www.ebi.ac.uk/efo/EFO_0008163,0.93,None
ebi-a-GCST004614,Granulocyte count,granulocyte count,EFO:0007987,http://www.ebi.ac.uk/efo/EFO_0007987,0.988,None
prot-a-2018,Kinetochore protein NDC80 homolog,kinetochore protein NDC80 homolog measurement,EFO:0801748,http://www.ebi.ac.uk/efo/EFO_0801748,0.945,None
prot-a-2832,"Sprouty-related, EVH1 domain-containing protein 1","sprouty-related, EVH1 domain-containing protein 1 measurement",EFO:0803102,http://www.ebi.ac.uk/efo/EFO_0803102,0.838,None
prot-a-2661,Protein transport protein Sec61 subunit beta,protein transport protein Sec61 subunit beta measurement,EFO:0802964,http://www.ebi.ac.uk/efo/EFO_0802964,0.956,None
prot-a-329,Carbonic anhydrase 2,carbonic anhydrase 2,EFO:0010161,http://www.ebi.ac.uk/efo/EFO_0010161,0.994,None
prot-a-259,Bone morphogenetic protein receptor type-1A,bone morphogenetic protein receptor type-1a measurement,EFO:0020188,http://www.ebi.ac.uk/efo/EFO_0020188,0.777,None
prot-a-2032,Neudesin,neudesin measurement,EFO:0802793,http://www.ebi.ac.uk/efo/EFO_0802793,0.804,None
met-a-738,N-Butyl Oleate,n-Butyl Oleate measurement,EFO:0021058,http://www.ebi.ac.uk/efo/EFO_0021058,0.66,None
ebi-a-GCST90000451,CD40 levels,CD40 measurement,EFO:0010586,http://www.ebi.ac.uk/efo/EFO_0010586,0.765,None
ebi-a-GCST90007308,circulating leptin levels,circulating cell free DNA measurement,EFO:0004739,http://www.ebi.ac.uk/efo/EFO_0004739,0.647,None
prot-a-2365,AMP Kinase (alpha1beta1gamma1),amp kinase (alpha1beta1gamma1) measurement,EFO:0020142,http://www.ebi.ac.uk/efo/EFO_0020142,0.825,None
prot-a-364,Caspase-3,autoimmune lymphoproliferative syndrome type 2B,MONDO:0011804,http://purl.obolibrary.org/obo/MONDO_0011804,0.667,None
prot-a-673,Alpha-crystallin A chain,alpha-crystallin A chain measurement,EFO:0802267,http://www.ebi.ac.uk/efo/EFO_0802267,0.759,None
met-d-bOHbutyrate,3-Hydroxybutyrate,3-hydroxybutyrate measurement,EFO:0010982,http://www.ebi.ac.uk/efo/EFO_0010982,0.781,None
ieu-a-57,Hip circumference,hip circumference,EFO:0005093,http://www.ebi.ac.uk/efo/EFO_0005093,0.993,None
prot-a-476,Serine/threonine-protein kinase MRCK beta,serine/threonine-protein kinase MRCK beta measurement,EFO:0020727,http://www.ebi.ac.uk/efo/EFO_0020727,0.781,None
ebi-a-GCST90001488,Activated CD4 regulatory T cell %CD4+ T cell,T cell activation assay,EFO:0030037,http://www.ebi.ac.uk/efo/EFO_0030037,0.611,None
ieu-a-1023,Percent emphysema,emphysema,EFO:0000464,http://www.ebi.ac.uk/efo/EFO_0000464,0.816,None
prot-a-120,Serum amyloid P-component,serum amyloid P-component measurement,EFO:0008283,http://www.ebi.ac.uk/efo/EFO_0008283,0.769,None
prot-a-2743,SLAM family member 7,SLAM family member 7 measurement,EFO:0008287,http://www.ebi.ac.uk/efo/EFO_0008287,0.911,None
prot-a-773,DCN1-like protein 3,DCN1-like protein 3 measurement,EFO:0802456,http://www.ebi.ac.uk/efo/EFO_0802456,0.732,None
prot-c-2993_1_2,IL-18 Rb,retinoblastoma,MONDO:0008380,http://purl.obolibrary.org/obo/MONDO_0008380,0.71,None
prot-a-494,Cyclin-dependent kinase 8:Cyclin-C complex,cyclin-dependent kinase 8:cyclin-c complex measurement,EFO:0020297,http://www.ebi.ac.uk/efo/EFO_0020297,0.739,None
prot-c-3864_5_2,RS7,craniosynostosis 7,MONDO:0044315,http://purl.obolibrary.org/obo/MONDO_0044315,0.667,None
prot-a-1010,Fatty-acid amide hydrolase 2,fatty-acid amide hydrolase 2 measurement,EFO:0802543,http://www.ebi.ac.uk/efo/EFO_0802543,0.784,None
prot-a-2334,"POU domain, class 2, transcription factor 1","POU domain, class 2, transcription factor 1 measurement",EFO:0802892,http://www.ebi.ac.uk/efo/EFO_0802892,0.851,None
ukb-b-4509,Age of stopping smoking,smoking behavior,EFO:0004318,http://www.ebi.ac.uk/efo/EFO_0004318,0.61,None
ieu-a-1051,Transferrin Saturation,transferrin saturation measurement,EFO:0006333,http://www.ebi.ac.uk/efo/EFO_0006333,0.905,None
prot-c-2948_58_2,Growth hormone receptor,growth hormone receptor measurement,EFO:0020426,http://www.ebi.ac.uk/efo/EFO_0020426,0.896,None
ukb-d-30670_raw,Urea,urea measurement,EFO:0011005,http://www.ebi.ac.uk/efo/EFO_0011005,0.738,None
prot-a-1738,Leukocyte immunoglobulin-like receptor subfamily A member 4,leukocyte immunoglobulin-like receptor subfamily A member 4 measurement,EFO:0801765,http://www.ebi.ac.uk/efo/EFO_0801765,0.921,None
prot-c-4134_4_2,HB-EGF,hemoglobin measurement,EFO:0004509,http://www.ebi.ac.uk/efo/EFO_0004509,0.72,None
prot-a-2252,Prefoldin subunit 5,prefoldin subunit 5 measurement,EFO:0020652,http://www.ebi.ac.uk/efo/EFO_0020652,0.914,None
prot-a-3095,Transformer-2 protein homolog beta,transformer-2 protein homolog beta measurement,EFO:0802143,http://www.ebi.ac.uk/efo/EFO_0802143,0.819,None
prot-a-1801,Limbic system-associated membrane protein,limbic system-associated membrane protein measurement,EFO:0020537,http://www.ebi.ac.uk/efo/EFO_0020537,0.814,None
met-d-LDL_C,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
prot-a-2217,Phosducin-like protein 2,phosducin-like protein 2 measurement,EFO:0801880,http://www.ebi.ac.uk/efo/EFO_0801880,0.84,None
met-d-HDL_TG,Triglycerides in HDL,triglycerides in small HDL measurement,EFO:0022158,http://www.ebi.ac.uk/efo/EFO_0022158,0.825,None
prot-a-1947,Mesothelin,mesothelin measurement,EFO:0020565,http://www.ebi.ac.uk/efo/EFO_0020565,0.838,None
prot-a-2059,Nucleoside diphosphate kinase A,nucleoside diphosphate kinase A measurement,EFO:0009947,http://www.ebi.ac.uk/efo/EFO_0009947,0.928,None
prot-a-1402,Intercellular adhesion molecule 5,intercellular adhesion molecule 5 measurement,EFO:0008164,http://www.ebi.ac.uk/efo/EFO_0008164,0.931,None
prot-c-3031_66_1,Ferritin,ferritin measurement,EFO:0004459,http://www.ebi.ac.uk/efo/EFO_0004459,0.806,None
prot-a-1181,Glucagon,glucagon measurement,EFO:0008463,http://www.ebi.ac.uk/efo/EFO_0008463,0.866,None
prot-a-2882,Erythrocyte band 7 integral membrane protein,erythrocyte band 7 integral membrane protein measurement,EFO:0801584,http://www.ebi.ac.uk/efo/EFO_0801584,0.94,None
prot-a-277,Tyrosine-protein kinase BTK,tyrosine-protein kinase BTK measurement,EFO:0020819,http://www.ebi.ac.uk/efo/EFO_0020819,0.837,None
prot-a-2329,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2","protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement",EFO:0801956,http://www.ebi.ac.uk/efo/EFO_0801956,0.703,None
prot-a-2591,"Ubiquitin+1, truncated mutation for UbB","ubiquitin+1, truncated mutation for UBB measurement",EFO:0020844,http://www.ebi.ac.uk/efo/EFO_0020844,0.782,None
prot-c-3363_31_4,CSK,clear cell sarcoma of the kidney,EFO:0000350,http://www.ebi.ac.uk/efo/EFO_0000350,0.625,None
ebi-a-GCST90010152,Matrix metalloproteinase-12 levels,matrix metalloproteinase 12 measurement,EFO:0010590,http://www.ebi.ac.uk/efo/EFO_0010590,0.841,None
ebi-a-GCST90001914,CD45 on lymphocyte,pseudolymphoma,EFO:1001831,http://www.ebi.ac.uk/efo/EFO_1001831,0.65,None
ieu-a-1034,Height,body height,EFO:0004339,http://www.ebi.ac.uk/efo/EFO_0004339,0.992,None
ebi-a-GCST90010201,Chitinase-3-like protein 1 levels,YKL40 measurement,EFO:0004869,http://www.ebi.ac.uk/efo/EFO_0004869,0.771,None
prot-a-1922,Multimerin-2,multimerin-2 measurement,EFO:0801809,http://www.ebi.ac.uk/efo/EFO_0801809,0.669,None
prot-a-1672,Killer cell lectin-like receptor subfamily F member 1,killer cell lectin-like receptor subfamily F member 1 measurement,EFO:0020520,http://www.ebi.ac.uk/efo/EFO_0020520,0.907,None
prot-c-3656_9_1,Cadherin-12,cadherin-12 measurement,EFO:0020210,http://www.ebi.ac.uk/efo/EFO_0020210,0.67,None
prot-a-168,cAMP-regulated phosphoprotein 21,cAMP-regulated phosphoprotein 21 measurement,EFO:0802364,http://www.ebi.ac.uk/efo/EFO_0802364,0.828,None
met-a-420,2-hydroxybutyrate (AHB),3-hydroxybutyrate measurement,EFO:0010982,http://www.ebi.ac.uk/efo/EFO_0010982,0.645,None
prot-a-2041,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial","NFU1 iron-sulfur cluster scaffold homolog, mitochondrial measurement",EFO:0802810,http://www.ebi.ac.uk/efo/EFO_0802810,0.885,None
ubm-a-2958,DKTatlas lh MeanThickness thickness,cortical thickness,EFO:0004840,http://www.ebi.ac.uk/efo/EFO_0004840,0.646,None
prot-a-3131,UDP-N-acetylhexosamine pyrophosphorylase,UDP-N-acetylhexosamine pyrophosphorylase measurement,EFO:0802187,http://www.ebi.ac.uk/efo/EFO_0802187,0.836,None
ebi-a-GCST004444,Interleukin-10 levels,interleukin,EFO:0004100,http://www.ebi.ac.uk/efo/EFO_0004100,0.781,None
prot-a-1191,Growth/differentiation factor 11,growth differentiation factor 15 measurement,EFO:0009181,http://www.ebi.ac.uk/efo/EFO_0009181,0.815,None
prot-a-342,Calcium-binding and coiled-coil domain-containing protein 2,calcium-binding and coiled-coil domain-containing protein 2 measurement,EFO:0802356,http://www.ebi.ac.uk/efo/EFO_0802356,0.805,None
met-a-483,Docosapentaenoate (n3 DPA; 22:5n3),docosapentaenoate n3 DPA; 22:5n3 measurement,EFO:0021048,http://www.ebi.ac.uk/efo/EFO_0021048,0.78,None
ebi-a-GCST002222,LDL cholesterol,LDL cholesterol,EFO:0004195,http://www.ebi.ac.uk/efo/EFO_0004195,0.988,None
